{"chunk_type":"transcript_chunk","text":"Finals archive index page. í•™ìŠµ ë³¸ë¬¸ì´ ì•„ë‹Œ ë¬¸ì„œ ë„¤ë¹„ê²Œì´ì…˜ ë§í¬ ëª¨ìŒ.","subject":"Finals archive 2d146f2986ee809f85c5e7369f731832","page_title":"Finals archive 2d146f2986ee809f85c5e7369f731832","episode":"Finals archive 2d146f2986ee809f85c5e7369f731832","section_path":["Finals archive 2d146f2986ee809f85c5e7369f731832"],"source_doc_id":"Finals archive 2d146f2986ee809f85c5e7369f731832","source_page":null,"source_anchor":"Finals archive 2d146f2986ee809f85c5e7369f731832-1","focus_area":"Archive Index","tags":["usmle-step2","index","exclude-feed"]}
{"chunk_type":"transcript_chunk","text":"Finals archive index page (continued). í•™ìŠµ ë³¸ë¬¸ì´ ì•„ë‹Œ ë§í¬ ëª¨ìŒ.","subject":"Finals archive 2d146f2986ee809f85c5e7369f731832","page_title":"Finals archive 2d146f2986ee809f85c5e7369f731832","episode":"Finals archive 2d146f2986ee809f85c5e7369f731832","section_path":["Finals archive 2d146f2986ee809f85c5e7369f731832"],"source_doc_id":"Finals archive 2d146f2986ee809f85c5e7369f731832","source_page":null,"source_anchor":"Finals archive 2d146f2986ee809f85c5e7369f731832-21","focus_area":"Archive Index","tags":["usmle-step2","index","exclude-feed"]}
{"chunk_type":"transcript_chunk","text":"Finals archive index tail link.","subject":"Finals archive 2d146f2986ee809f85c5e7369f731832","page_title":"Finals archive 2d146f2986ee809f85c5e7369f731832","episode":"Finals archive 2d146f2986ee809f85c5e7369f731832","section_path":["Finals archive 2d146f2986ee809f85c5e7369f731832"],"source_doc_id":"Finals archive 2d146f2986ee809f85c5e7369f731832","source_page":null,"source_anchor":"Finals archive 2d146f2986ee809f85c5e7369f731832-41","focus_area":"Archive Index","tags":["usmle-step2","index","exclude-feed"]}
{"chunk_type":"transcript_chunk","text":"# Neurology\n# Brain stem localization\n## 1. The Golden Rule: \"Rule of 4\"\n*ë‡Œê°„ ë‹¨ë©´ë„ì—ì„œ ë³‘ë³€ì˜ ìœ„ì¹˜(Medial vs Lateral)ë¥¼ ê²°ì •í•˜ëŠ” ì ˆëŒ€ ë²•ì¹™*\n### ğŸ…°ï¸ Medial Structures (The 4 M's)\n*í˜ˆê´€: **ASA** (Medulla), **Basilar** (Pons)ë³‘ë³€ ì‹œ íŠ¹ì§•: **Motor(ìš´ë™)** ë¬¸ì œê°€ ì£¼ë¨*\n1. **M**otor Pathway (**Corticospinal Tract**): ë°˜ëŒ€ìª½ íŒ”ë‹¤ë¦¬ ë§ˆë¹„ (Hemiparesis)\n2. **M**edial Lemniscus (**DCML**): ë°˜ëŒ€ìª½ ì§„ë™/ìœ„ì¹˜ ê°ê° ì†Œì‹¤\n3. **M**LF (Medial Longitudinal Fasciculus): ëˆˆ ì›€ì§ì„ ì¡°ì ˆ (INO)\n4. **M**otor Nuclei (CN 3, 4, 6, 12): \"12ì˜ ì•½ìˆ˜\"ì¸ ë‡Œì‹ ê²½ë“¤. ì¤‘ì•™ì„  ê·¼ì²˜ì— ìœ„ì¹˜.\n    - *CN 12 (Medulla): í˜€ ë§ˆë¹„*\n    - *CN 6 (Pons): ëˆˆ ë°”ê¹¥ìª½ ì£¼ì‹œ ë¶ˆê°€*\n    - *CN 3 (Midbrain): ëˆˆêº¼í’€ ì²˜ì§, ëˆˆë™ì ì›€ì§ì„ ì œí•œ*\n### ğŸ…±ï¸ Lateral Structures (The 4 S's)\n*í˜ˆê´€: **PICA** (Medulla), **AICA** (Pons)ë³‘ë³€ ì‹œ íŠ¹ì§•: **Sensory(ê°ê°)**, **Cerebellar(ì†Œë‡Œ)**, **Autonomic(ììœ¨ì‹ ê²½)** ë¬¸ì œê°€ ì£¼ë¨*\n1. **S**pinothalamic Tract: ë°˜ëŒ€ìª½ ëª¸ í†µì¦/ì˜¨ë„ ê°ê° ì†Œì‹¤\n2. **S**pinocerebellar Tract: ë™ì¸¡ ì†Œë‡Œ ì‹¤ì¡° (Ataxia, ë¹„í‹€ê±°ë¦¼)\n3. **S**ensory Nucleus of CN 5: ë™ì¸¡ ì–¼êµ´ í†µì¦/ì˜¨ë„ ê°ê° ì†Œì‹¤\n4. **S**ympathetic Pathway: ë™ì¸¡ í˜¸ë„ˆ ì¦í›„êµ° (Horner's Syn - ëˆˆêº¼í’€ ì²˜ì§, ë™ê³µ ì¶•ì†Œ)\n(ì–¼êµ´ì€ ë³‘ë³€ ìª½ ê°ê° ì†Œì‹¤ vs ëª¸ì€ ë°˜ëŒ€ìª½ ê°ê° ì†Œì‹¤)\n## 2. Clinical Syndromes by Level (ì‹¤ì „ ë§¤í•‘)\ní™˜ìì˜ ë‡Œì‹ ê²½(CN) ì¦ìƒì„ ë³´ê³  ì¸µìˆ˜(Level)ë¥¼ ë¨¼ì € íŒŒì•…í•œë‹¤.\n| Level | Medial Syndrome (Anterior/Paramedian) | Lateral Syndrome (Side/Circumferential) |\n| --- | --- | --- |\n| **Midbrain**\n(CN 3, 4) | **Weber Syndrome**\nâ€¢ V: PCA\nâ€¢ Sx: CN 3 ë§ˆë¹„ + ë°˜ëŒ€ìª½ ì „ì‹  ë§ˆë¹„ | **Benedikt Syndrome**\nâ€¢ V: PCA\nâ€¢ Sx: CN 3 ë§ˆë¹„ + **Tremor/Ataxia** (Red nucleus ì¹¨ë²”) |\n| **Pons**\n(CN 5~8) | **Medial Pontine Syn.**\nâ€¢ V: Basilar A.\nâ€¢ Sx: **CN 6 ë§ˆë¹„** (ëˆˆ ëª» ëŒë¦¼) + ë°˜ëŒ€ìª½ ì „ì‹  ë§ˆë¹„ | **Lateral Pontine Syn.**\nâ€¢ V: **AICA**\nâ€¢ Sx: **CN 7(ì•ˆë©´ë§ˆë¹„), 8(ì²­ë ¥ì†Œì‹¤)** + 4S ì¦ìƒ |\n| **Medulla**\n(CN 9~12) | **Medial Medullary Syn.**\nâ€¢ V: **ASA**\nâ€¢ Sx: **CN 12 ë§ˆë¹„** (í˜€ê°€ ë³‘ë³€ ìª½ìœ¼ë¡œ íœ¨) + ë°˜ëŒ€ìª½ ì „ì‹  ë§ˆë¹„ | **Lateral Medullary (Wallenberg)**\nâ€¢ V: **PICA** (or Vertebral)\nâ€¢ Sx: **CN 9, 10, Ambiguus** (ì‚¼í‚´ê³¤ë€, ì‰° ëª©ì†Œë¦¬) + 4S ì¦ìƒ |\n---\n## 3. High-Yield Differentiation (ì‚¬ìˆ˜ ê¿€íŒ)\n### ğŸš¨ AICA vs PICA ê°ë³„ë²• (Lateral Pons vs Lateral Medulla)\n*ë‘˜ ë‹¤ ì–´ì§€ëŸ½ê³ , ê°ê° ì´ìƒí•˜ê³ , í˜¸ë„ˆ ì¦í›„êµ°ì´ ì˜¨ë‹¤. ê²°ì •ì  ì°¨ì´ëŠ”?*\n- **PICA (Medulla):** **\"ëª©êµ¬ë©\"** ë¬¸ì œ\n    - Nucleus Ambiguus ì¹¨ë²” â†’ **Dysphagia (ì‚¼í‚´ê³¤ë€), Hoarseness (ì‰° ëª©ì†Œë¦¬)**\n    - *Mnemonic: Don't **PICA** **H**orse (Hoarse) that can't eat.*\n- **AICA (Pons):** **\"ì–¼êµ´ & ê·€\"** ë¬¸ì œ\n    - Facial(7) & Vestibulocochlear(8) Nuclei ì¹¨ë²” â†’ **Facial Droop (ì•ˆë©´ë§ˆë¹„), Hearing Loss (ì²­ë ¥ì†Œì‹¤/ì´ëª…)**","subject":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf","page_title":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf","episode":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf","section_path":["Neurology 2d146f2986ee80f7a1a3fbf485dcaebf"],"source_doc_id":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf","source_page":null,"source_anchor":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf-1","focus_area":"Brainstem Localization","tags":["usmle-step2","neurology","diagnosis","algorithm","mnemonic","table"]}
{"chunk_type":"transcript_chunk","text":"# Neuro Decision Tree + Neurocutaneous Mnemonics\n## Decision tree summary\n- CN levelë¡œ ì¸µìˆ˜(midbrain/pons/medulla)ë¥¼ ë¨¼ì € ì¡ê³ , medial vs lateralì„ ë¶„ê¸°.\n- Lateral lesionì€ motor sparing ê°€ëŠ¥ì„±ì´ ë†’ê³ , hemiparesisë©´ medial/cerebral lesionì„ ìš°ì„  ê³ ë ¤.\n\n## Memory block (retained)\n- NF1/NF2, Tuberous sclerosis, Sturge-Weber ì•”ê¸° í¬ì¸íŠ¸ë¥¼ ìœ ì§€.\n- ëª©ì : syndrome pattern recognition ê°•í™”.\n\n## Note\n- ë³¸ ì²­í¬ì˜ mermaid/treeëŠ” ë³„ë„ tree ë³µìŠµìš©ìœ¼ë¡œë„ ì¬ì‚¬ìš© ê°€ëŠ¥.","subject":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf","page_title":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf","episode":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf","section_path":["Neurology 2d146f2986ee80f7a1a3fbf485dcaebf"],"source_doc_id":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf","source_page":null,"source_anchor":"Neurology 2d146f2986ee80f7a1a3fbf485dcaebf-21","focus_area":"Neuro Decision Tree","tags":["usmle-step2","neurology","tree","mnemonic","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"Hema page is mostly image references with minimal standalone text in this chunk.","subject":"Hema 2e546f2986ee8016be2cdeeb27806221","page_title":"Hema 2e546f2986ee8016be2cdeeb27806221","episode":"Hema 2e546f2986ee8016be2cdeeb27806221","section_path":["Hema 2e546f2986ee8016be2cdeeb27806221"],"source_doc_id":"Hema 2e546f2986ee8016be2cdeeb27806221","source_page":null,"source_anchor":"Hema 2e546f2986ee8016be2cdeeb27806221-1","focus_area":"Hema Media Index","tags":["usmle-step2","hema","media","exclude-feed"]}
{"chunk_type":"transcript_chunk","text":"Mnemo Pulmo/Rheuma image-heavy chunk. í•µì‹¬ í…ìŠ¤íŠ¸ ë‹¨ì„œë§Œ ì¡´ì¬í•˜ë©° ë³¸ë¬¸í˜• í•™ìŠµì—ëŠ” ì •ë³´ ë°€ë„ê°€ ë‚®ìŒ.","subject":"Mnemo 2e546f2986ee8059a937d53740312b31","page_title":"Mnemo 2e546f2986ee8059a937d53740312b31","episode":"Mnemo 2e546f2986ee8059a937d53740312b31","section_path":["Mnemo 2e546f2986ee8059a937d53740312b31"],"source_doc_id":"Mnemo 2e546f2986ee8059a937d53740312b31","source_page":null,"source_anchor":"Mnemo 2e546f2986ee8059a937d53740312b31-1","focus_area":"Mnemo Pulmo-Rheuma","tags":["usmle-step2","mnemonic","media","exclude-feed"]}
{"chunk_type":"transcript_chunk","text":"DKA vs HHS, glucagonoma(DM/diarrhea/dermatitis), potassium-insulin sequence ë“± í…ìŠ¤íŠ¸ ë‹¨ì„œ ìœ ì§€. ì´ë¯¸ì§€ ë¼ì¸ì€ ì œê±°ë¨.","subject":"Mnemo 2e546f2986ee8059a937d53740312b31","page_title":"Mnemo 2e546f2986ee8059a937d53740312b31","episode":"Mnemo 2e546f2986ee8059a937d53740312b31","section_path":["Mnemo 2e546f2986ee8059a937d53740312b31"],"source_doc_id":"Mnemo 2e546f2986ee8059a937d53740312b31","source_page":null,"source_anchor":"Mnemo 2e546f2986ee8059a937d53740312b31-21","focus_area":"Endocrine Mnemonics","tags":["usmle-step2","endo","pathophysiology","treatment","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"Primary adrenal insufficiency(Addison), thyroid storm 4P/PTU/Lugol/steroid, pheochromocytoma(alpha before beta) í•µì‹¬ í…ìŠ¤íŠ¸ ìœ ì§€.","subject":"Mnemo 2e546f2986ee8059a937d53740312b31","page_title":"Mnemo 2e546f2986ee8059a937d53740312b31","episode":"Mnemo 2e546f2986ee8059a937d53740312b31","section_path":["Mnemo 2e546f2986ee8059a937d53740312b31"],"source_doc_id":"Mnemo 2e546f2986ee8059a937d53740312b31","source_page":null,"source_anchor":"Mnemo 2e546f2986ee8059a937d53740312b31-41","focus_area":"Endocrine Emergency Mnemonics","tags":["usmle-step2","endo","diagnosis","treatment","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"GCA red flags, lead vs AIP ê°ë³„, chelation threshold, pheo ì—°ê´€ ì§ˆí™˜(NF1/VHL/MEN) í…ìŠ¤íŠ¸ ìœ ì§€.","subject":"Mnemo 2e546f2986ee8059a937d53740312b31","page_title":"Mnemo 2e546f2986ee8059a937d53740312b31","episode":"Mnemo 2e546f2986ee8059a937d53740312b31","section_path":["Mnemo 2e546f2986ee8059a937d53740312b31"],"source_doc_id":"Mnemo 2e546f2986ee8059a937d53740312b31","source_page":null,"source_anchor":"Mnemo 2e546f2986ee8059a937d53740312b31-61","focus_area":"Heme-Neuro Mnemonics","tags":["usmle-step2","diagnosis","treatment","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"| **ì‹œê°ì  ìš”ì†Œ (Visual Element)** | **ì˜í•™ì  í•µì‹¬ ê°œë… (Medical Concept)** | **ì„¤ëª… (Description)** |\n| --- | --- | --- |\n| **ë³´ë¼ìƒ‰ ì™•ì˜ ì˜ë³µ (Purple Robes)** | **Porphyria (í¬ë¥´í”¼ë¦°ì¦)** | ì§ˆë³‘ëª… 'Porphyria'ê°€ ê·¸ë¦¬ìŠ¤ì–´ë¡œ 'ë³´ë¼ìƒ‰'ì„ ëœ»í•˜ëŠ” ë‹¨ì–´ì—ì„œ ìœ ë˜í–ˆìŒì„ ì‹œê°ì ìœ¼ë¡œ ì—°ê²°í•©ë‹ˆë‹¤. |\n| **ë³µë¶€ì˜ ë¶‰ì€ ì‚¬ìŠ¬ (\"BELLY PAIN\")** | **Severe Abdominal Pain** | AIPì˜ ê°€ì¥ í”í•œ ì´ˆê¸° ì¦ìƒì¸ ê·¹ì‹¬í•œ ë³µí†µì„ ì‹œê°í™”í–ˆìŠµë‹ˆë‹¤. ë³´í†µ ì—¼ì¦ ë°˜ì‘ ì—†ì´ ì‹ ê²½í•™ì ìœ¼ë¡œ ë°œìƒí•©ë‹ˆë‹¤. |\n| **í’€ë ¤ê°€ëŠ” ì‹¤ ê°™ì€ ì†ë°œ (\"NERVE WEAKNESS\")** | **Peripheral Neuropathy** | ë§ì´ˆ ì‹ ê²½ ì†ìƒìœ¼ë¡œ ì¸í•œ ê·¼ìœ¡ ì•½í™”ì™€ ê°ê° ì´ìƒì„ 'í—¤ì§„ ì‹¤'ë¡œ í‘œí˜„í•˜ì—¬ ì‹ ê²½ë³‘ì¦ì„ ë¬˜ì‚¬í–ˆìŠµë‹ˆë‹¤. |\n| **ìŠ¤íŒŒí¬ê°€ íŠ€ëŠ” ì™•ê´€ (\"PSYCHOSIS\")** | **Neuropsychiatric Symptoms** | í™˜ê°, ë¶ˆì•ˆ, ì •ì‹ ë³‘ì  ì¦ìƒ ë“± AIPì˜ ì¤‘ì¶”ì‹ ê²½ê³„ ì¹¨ë²” ì¦ìƒì„ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤. |\n| **ë³´ë¼ìƒ‰ ì•¡ì²´ê°€ ë‹´ê¸´ ìš”ê°• (\"URINE\")** | **Port-wine Urine** | ì†Œë³€ ë‚´ì˜ í¬ë¥´í¬ë¹Œë¦¬ë…¸ê²(PBG)ì´ ë¹›ì— ë…¸ì¶œë˜ì–´ ì‚°í™”ë˜ë©´ í¬íŠ¸ì™€ì¸ìƒ‰(ì–´ë‘ìš´ ë¶‰ì€ ë³´ë¼ìƒ‰)ìœ¼ë¡œ ë³€í•˜ëŠ” íŠ¹ì§•ì„ ë³´ì—¬ì¤ë‹ˆë‹¤. |\n| **ê±°ëŒ€í•œ ì„¤íƒ• íë¸Œ (\"GLUCOSE\")** | **Glucose Loading (ì¹˜ë£Œ)** | ê³ ë†ë„ í¬ë„ë‹¹ íˆ¬ì—¬ëŠ” heme í•©ì„± ê²½ë¡œì˜ íš¨ì†Œë¥¼ ì–µì œí•˜ì—¬ ë…ì„± ì „êµ¬ë¬¼ì§ˆì˜ ìƒì„±ì„ ì¤„ì´ëŠ” 1ì°¨ ì¹˜ë£Œë²•ì…ë‹ˆë‹¤. |\n| **ê²€ì€ ìœ ë¦¬ë³‘ (\"HEMIN\")** | **Hemin/Heme Arginate (ì¹˜ë£Œ)** | ë¶€ì¡±í•œ hemeì„ ì§ì ‘ ë³´ì¶©í•˜ì—¬ ìŒì„± í”¼ë“œë°±ì„ í†µí•´ ìƒìœ„ ë‹¨ê³„ì˜ ë…ì„± ë¬¼ì§ˆ ì¶•ì ì„ ë§‰ëŠ” í•µì‹¬ ì¹˜ë£Œì œì…ë‹ˆë‹¤. |\n| **\"A.I.P.\" í…ìŠ¤íŠ¸ ë¼ë²¨** | **Acute Intermittent Porphyria** | ì§ˆë³‘ì˜ ì •ì‹ ëª…ì¹­ì„ ì´ë¯¸ì§€ì— ê°ì¸ì‹œì¼œ í•™ìŠµì˜ ëª©ì ì„±ì„ ëª…í™•íˆ í•©ë‹ˆë‹¤. |\nCLL\n- **ë…¸ì¸ ì—°ê¸ˆìˆ ì‚¬:** CLLì˜ ì£¼ëœ ë°œë³‘ ì—°ë ¹ì¸µì¸ **ë…¸ì¸(Elderly)**ì„ ìƒì§•í•©ë‹ˆë‹¤.\n- **ëª©ê³¼ ê²¨ë“œë‘ì´ì˜ íŒŒë€ ì§„ì£¼:** **ë¦¼í”„ì ˆ ì¢…ëŒ€(Lymphadenopathy)**ë¥¼ ì‹œê°í™”í–ˆìŠµë‹ˆë‹¤. (Cervical, Axillary)\n- **ë°”ë‹¥ì˜ ì‰í¬ ì–¼ë£© (Smudge Cells):** CLLì˜ ì§„ë‹¨ì  íŠ¹ì§•ì¸ **Smudge cell**ì„ 'ìœ¼ê¹¨ì§„ íŒŒë€ ì‰í¬'ë¡œ ë¬˜ì‚¬í–ˆìŠµë‹ˆë‹¤.\n- **ìˆ«ìê°€ ìƒˆê²¨ì§„ ìœ ë¦¬ë³‘:** ì§„ë‹¨ì— í•„ìˆ˜ì ì¸ **ìœ ì„¸í¬ ë¶„ì„(Flow cytometry)** ìˆ˜ì¹˜ì¸ **CD5, 19, 20, 23**ì„ ì•”ê¸° ìš”ì†Œë¡œ ë„£ì—ˆìŠµë‹ˆë‹¤. **CLLì€ ì¡°ì§ê²€ì‚¬ì•ˆí•¨!**\n- **ë…¹ì•„ë‚´ë¦¬ëŠ” ë¶‰ì€ ë§í† ì™€ ë¶‰ì€ í•´:** ìê°€ë©´ì—­ì„± ìš©í˜ˆì„± ë¹ˆí˜ˆ(**Warm AIHA**)ì„ 'ì—´ê¸°ì— ë…¹ëŠ” ë¹¨ê°„ìƒ‰'ìœ¼ë¡œ í‘œí˜„í–ˆìŠµë‹ˆë‹¤.\n- **ê´´ë¬¼ë¡œ ë³€í•˜ëŠ” ê·¸ë¦¼ì:** CLLì´ ê°‘ìê¸° ê³µê²©ì ì¸ ë¦¼í”„ì¢…ìœ¼ë¡œ ë³€í•˜ëŠ” **ë¦¬íˆí„° ë³€í™˜(Richter transformation)**ì„ ìƒì§•í•©ë‹ˆë‹¤.\n- **ë¶€í’€ì–´ ì˜¤ë¥¸ í—ˆë¦¬ ì£¼ë¨¸ë‹ˆ:** **ë¹„ì¥ ë¹„ëŒ€(Splenomegaly)**ì™€ ê·¸ë¡œ ì¸í•œ ì˜ˆí›„ ë¶ˆëŸ‰ì„ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤.\n#hairy cell leukemia\n- **Hairy Yeti & Hairy B-cells:** **í„¸ì´ ë‚œ ì„¸í¬(Hairy cell)**ì˜ íŠ¹ì§•ê³¼ ì£¼ëœ ë°œë³‘ ì—°ë ¹ì¸µ(ì¤‘ë…„)ì„ 'í„¸ë³µìˆ­ì´ ì˜ˆí‹°'ë¡œ ì‹œê°í™”í–ˆìŠµë‹ˆë‹¤.\n- **Golden Bear-Trap:** **TRAP ì–‘ì„±(TRAP positive)**ì„ 'ê³° ë«(Bear-Trap)'ì— ê±¸ë¦° ëª¨ìŠµìœ¼ë¡œ ì§ê´€ì ìœ¼ë¡œ í‘œí˜„í–ˆìŠµë‹ˆë‹¤.\n- **Massive Spleen vs. Smooth Neck:** **ê±°ëŒ€í•œ ë¹„ì¥(Massive Splenomegaly)**ì„ ë“  ëª¨ìŠµê³¼ **ë§¤ëˆí•˜ê³  ë¶€ì˜¤ë¥´ì§€ ì•Šì€ ëª©(without Lymphadenopathy)**ì„ ì‹œê°ì ìœ¼ë¡œ ê·¹ëª…í•˜ê²Œ ëŒ€ë¹„ì‹œì¼œ, ë¦¼í”„ì ˆ ì¢…ëŒ€ê°€ ì—†ë‹¤ëŠ” í•µì‹¬ ê°ë³„ í¬ì¸íŠ¸ë¥¼ ê°•ì¡°í–ˆìŠµë‹ˆë‹¤.\n- **Dry Bone Desert & Dust Faucet:** ê³¨ìˆ˜ ì„¬ìœ í™”ë¡œ ì¸í•œ **'Dry Tap'(ê³¨ìˆ˜ í¡ì¸ ì‹¤íŒ¨)**ì„ ë§ˆë¥¸ ë¼ˆ ì‚¬ë§‰ì—ì„œ ë¨¼ì§€ë§Œ ë‚˜ì˜¤ëŠ” ìˆ˜ë„ê¼­ì§€ë¡œ ë¬˜ì‚¬í–ˆìŠµë‹ˆë‹¤.\n- **BRAF V600E Flag:** ì§„ë‹¨ì— ì¤‘ìš”í•œ **BRAF V600E ëŒì—°ë³€ì´**ë¥¼ ê¹ƒë°œì— ëª…ì‹œí–ˆìŠµë‹ˆë‹¤.\n- **Silk Ribbons (Cladribine):** ì¹˜ë£Œì œì¸ **Cladribine**ì„ ë°œìŒì´ ë¹„ìŠ·í•œ **'Clad in Ribbons'(ë¦¬ë³¸ì„ ë‘ë¥¸)**ë¡œ ì—°ê²°í•˜ì—¬, ë¦¬ë³¸ì´ ë‚´ë ¤ì™€ ì˜ˆí‹°ë¥¼ ì¹˜ìœ í•˜ëŠ” ëª¨ìŠµìœ¼ë¡œ ì¹˜ë£Œ íš¨ê³¼ê°€ ìš°ìˆ˜í•¨ì„ í‘œí˜„í–ˆìŠµë‹ˆë‹¤.\nSickle cell disease SCD\nGenetics (The Crown): 6ë²ˆ ìœ„ì¹˜ì˜ Glutamate(ì¹œìˆ˜ì„±)ê°€ Valine(ì†Œìˆ˜ì„±)ìœ¼ë¡œ ì¹˜í™˜ë¨ì„ ì‹œê°í™”.\nDactylitis (The Gauntlets): ì˜ìœ ì•„ê¸° ì²« ì¦ìƒì¸ ìˆ˜ì¡± ì¦í›„êµ° (ë¶€ì–´ì˜¤ë¥¸ ì†).\nì°½ë°– ì„¤ì›: acute chest syndrome íí˜ˆê´€ì´ ë§‰í˜€ì„œ íë ´. (ê°ì—¼) í•­ìƒì œ ì¹˜ë£Œ\nAvascular Necrosis (The Armrests): ëŒ€í‡´ê³¨ë‘ ë¬´í˜ˆì„± ê´´ì‚¬ (USMLE ë¹ˆì¶œ í•©ë³‘ì¦).\nSalmonella Osteomyelitis (The Lizard): ë¹„ì¥ ê¸°ëŠ¥ ì €í•˜ë¡œ ì¸í•œ ì‚´ëª¨ë„¬ë¼ ê· ì˜ ê³¨ìˆ˜ì—¼ ê³µê²©.\nIsosthenuria (The Clear Water): ê¹¨ì§„ í•­ì•„ë¦¬. ì‹ ì¥ì˜ ë†ì¶• ëŠ¥ë ¥ ìƒì‹¤ë¡œ ì¸í•´ ë¬½ì€ ì†Œë³€ì´ ë‚˜ì˜´.\nPigment Gallstones (The Green Emeralds): ë§Œì„± ìš©í˜ˆë¡œ ì¸í•´ ë°œìƒí•˜ëŠ” ë¹Œë¦¬ë£¨ë¹ˆ(ë…¹ìƒ‰) ë‹´ì„.\nAplastic Crisis (The B19 Dragon): Parvovirus B19 ê°ì—¼ ì‹œ ì í˜ˆêµ¬ ìƒì„±ì´ ë©ˆì¶”ëŠ” ìœ„ê¸°.\nElectrophoresis (The Banner): HbSëŠ” ìŒì „í•˜ê°€ ì ì–´ ì–‘ê·¹(+) ìª½ìœ¼ë¡œ ì ê²Œ ì´ë™í•¨ (Diagnosis).","subject":"Mnemo 2e546f2986ee8059a937d53740312b31","page_title":"Mnemo 2e546f2986ee8059a937d53740312b31","episode":"Mnemo 2e546f2986ee8059a937d53740312b31","section_path":["Mnemo 2e546f2986ee8059a937d53740312b31"],"source_doc_id":"Mnemo 2e546f2986ee8059a937d53740312b31","source_page":null,"source_anchor":"Mnemo 2e546f2986ee8059a937d53740312b31-81","focus_area":"Hematology Pattern Mnemonics","tags":["usmle-step2","hema","diagnosis","complications","mnemonic","table"]}
{"chunk_type":"transcript_chunk","text":"Hydroxyurea & HbF (The Cherub): ì¹˜ë£Œì œì¸ í•˜ì´ë“œë¡ì‹œìœ ë ˆì•„ê°€ íƒœì•„ í—¤ëª¨ê¸€ë¡œë¹ˆì„ ë†’ì—¬ ì¦ìƒì„ ì™„í™”í•¨\n---\nTTP: vwfë¥¼ ìë¥´ëŠ” ADAMSê°€ìœ„ê°€ ì˜ ì‘ë™ì•ˆí•œë‹¤.\nì¹˜ë£Œ: ê°€ìœ„ë¥¼ ìƒˆë¡œ ë³´ì¶© = plasma exchange, ê°€ìœ„ë¥¼ ë³´í˜¸ from ìê°€í•­ì²´ (rituximab, steroids)\nPNH\n---\nB12 vs B9\n| **Condition** | **MMA** | **Homocysteine** | **Neuro symptoms** |\n| --- | --- | --- | --- |\n| B12 deficiency | â†‘ | â†‘ | O |\n| Folate deficiency | Normal | â†‘ | X |\n**M-M-A:** **M**ethyl-**M**alonic **A**cidëŠ” **M**ake **M**yelin **A**bnormal (ë¯¸ì—˜ë¦°ì„ ë³‘ë“¤ê²Œ í•¨)!\n---\n**\"Iron Man Feels Bad\" (ì•„ì´ì–¸ë§¨ ê¸°ë¶„ì´ ë³„ë¡œì•¼...)**\n- **I**ron: **D**uodenum (1ë²ˆ íƒ€ì)\n- **F**eels (**F**olate): **J**ejunum (2ë²ˆ íƒ€ì)\n- **B**ad (**B**12): **I**leum (ë§ˆì§€ë§‰ íƒ€ì)\n---\n1. í—¤ëª¨ê¸€ë¡œë¹ˆ ì¡°í•©:\n(a) HbA: Î±2Î²2\n(b) HbA2: Î±2Î´2\n(c) HbF: Î±2Î³2\n(d) HbH: Î²4\n(e) Hb Barts: Î³4","subject":"Mnemo 2e546f2986ee8059a937d53740312b31","page_title":"Mnemo 2e546f2986ee8059a937d53740312b31","episode":"Mnemo 2e546f2986ee8059a937d53740312b31","section_path":["Mnemo 2e546f2986ee8059a937d53740312b31"],"source_doc_id":"Mnemo 2e546f2986ee8059a937d53740312b31","source_page":null,"source_anchor":"Mnemo 2e546f2986ee8059a937d53740312b31-101","focus_area":"Hematology Core Facts","tags":["usmle-step2","hema","diagnosis","treatment","table"]}
{"chunk_type":"transcript_chunk","text":"Thalassemia hemoglobin composition(HbA/A2/F/H/Barts), HbH/Hb Barts mnemonic, alcohol withdrawal DT(2-3ì¼) í•µì‹¬ í…ìŠ¤íŠ¸ ìœ ì§€.","subject":"Mnemo 2e546f2986ee8059a937d53740312b31","page_title":"Mnemo 2e546f2986ee8059a937d53740312b31","episode":"Mnemo 2e546f2986ee8059a937d53740312b31","section_path":["Mnemo 2e546f2986ee8059a937d53740312b31"],"source_doc_id":"Mnemo 2e546f2986ee8059a937d53740312b31","source_page":null,"source_anchor":"Mnemo 2e546f2986ee8059a937d53740312b31-121","focus_area":"Thalassemia + DT Mnemonics","tags":["usmle-step2","hema","psychiatry","mnemonic","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"# ENT\n| **êµ¬ë¶„** | **AOM (ê¸‰ì„± ì¤‘ì´ì—¼)** | **OME (ì‚¼ì¶œì„± ì¤‘ì´ì—¼)** | **CSOM (ë§Œì„± í™”ë†ì„±)** | **Cholesteatoma (ì§„ì£¼ì¢…)** |\n| --- | --- | --- | --- | --- |\n| **í•µì‹¬ ì´ë¯¸ì§€** | ğŸˆÂ **í’ì„  í­ë°œ ì§ì „** | ğŸ’§Â **ë¬¼ ì°¬ ì›…ë©ì´** | ğŸšï¸Â **ëŒ ë¶•ê´´ (êµ¬ë©)** | ğŸœÂ **ë¼ˆ ê°‰ì•„ë¨¹ëŠ” í°ê°œë¯¸** |\n| **ë³‘íƒœìƒë¦¬** | **[ì„¸ê·  ê°ì—¼ + ê¸‰ì„± ì—¼ì¦]**\nì´ê´€ íì‡„ â†’ ê·  ì¦ì‹ â†’ ë†(Pus) ì°¸ â†’Â **ê³ ë§‰ íŒ½ì°½(Bulging)** | **[ì´ê´€ ê¸°ëŠ¥ ì¥ì•  + ìŒì••]**\nê¸‰ì„± ì—¼ì¦ ì†Œì‹¤ í›„ **ë¬´ê· ì„± ì‚¼ì¶œì•¡(ë¬¼)ë§Œ ë‚¨ìŒ | [ê³ ë§‰ ì²œê³µ + ë§Œì„± ê°ì—¼]\nê³ ë§‰ì— ì˜êµ¬ì  êµ¬ë© â†’ ì„¸ê·  ì¹¨ì… ë°˜ë³µ | [ì´ì†Œì„± í”¼ë¶€ ì¦ì‹]\ní”¼ë¶€(ê°ì§ˆ)ê°€ ì¤‘ì´ë¡œ ì¹¨ì… â†’ ë©ì–´ë¦¬ê°€ ì»¤ì§€ë©° ë¼ˆ íŒŒê´´ |\n| ì¦ìƒ/ì†Œê²¬ | ì‹¬í•œ ì´í†µ(Pain), ë°œì—´(Fever)\nê³ ë§‰ ë°œì  & íŒ½ë¥œ(Bulging) | ë¬´ì¦ìƒ, ë‚œì²­(ë¨¹ë¨¹í•¨)\nê³ ë§‰ ê¸°í¬(Bubble), ì•¡ë©´ | ì´ë£¨(ëƒ„ìƒˆë‚˜ëŠ” ê³ ë¦„), ë‚œì²­\nì²œê³µ(Perforation) í™•ì¸ | ì•…ì·¨, ë‚œì²­, ì–´ì§€ëŸ¬ì›€\në°±ìƒ‰ ì¢…ë¬¼(White mass) |\n| ì¹˜ë£Œ ê²°ì •\n(Who?)** | **ğŸš¨ [39 6 224] ë²•ì¹™**\n1.Â **39**ë„ ê³ ì—´ (or 48ì‹œê°„ í†µì¦)\n2.Â **6**ê°œì›” ë¯¸ë§Œ\n3.Â **2**ì„¸ ë¯¸ë§Œ +Â **2**ìª½(ì–‘ì¸¡)\nğŸ‘‰Â **ì¦‰ì‹œ í•­ìƒì œ**\n*(ë‚˜ë¨¸ì§€ëŠ” 2-3ì¼Â **ê²½ê³¼ ê´€ì°°**)* | **ê¸°ë³¸: 3ê°œì›” ê²½ê³¼ ê´€ì°°**\n*(í•­ìƒì œ/í•­íˆìŠ¤íƒ€ë¯¼ íš¨ê³¼ ë¯¸ë¯¸)*\nğŸ‘‰Â **ìˆ˜ìˆ  ê³ ë ¤ ëŒ€ìƒ:**\n1. 3ê°œì›” ì´ìƒ ì§€ì†\n2. ì²­ë ¥ê°ì†Œ > 40dB\n3. ì–¸ì–´ì§€ì—° ìš°ë ¤ ì‹œ | **ë‚´ê³¼ì  ì¹˜ë£Œ ìš°ì„ **\nì—¼ì¦(ì´ë£¨) ì¡°ì ˆ í›„ ìˆ˜ìˆ  | **ë¬´ì¡°ê±´ ìˆ˜ìˆ **\nì§„ë‹¨ ì¦‰ì‹œ ìˆ˜ìˆ  ê³„íš ì¡ìŒ |\n| **ì•½ë¬¼ ìš”ë²•**\n**(What?)** | **1ì°¨: High-dose Amoxicillin**\n*(80-90mg/kg/day)*\n**2ì°¨: Amoxicillin-Clavulanate**\n*(ì•„ëª¨í´ë¼/ì˜¤ê·¸ë©˜í‹´ 14:1 ì œì œ)*\nğŸ‘‰Â **ëˆˆ.ì¹˜.ì¬**ì¼ ë•Œ ë°”ë¡œ 2ì°¨!\n(**ëˆˆ**ë³‘,Â **ì¹˜**ë£Œì‹¤íŒ¨,Â **ì¬**ë°œ/30ì¼ë‚´ íˆ¬ì•½) | **ì•½ë¬¼ ì¹˜ë£Œ ë¹„ê¶Œì¥**\n(ê¸‰ì„± ë¹„ì—¼ ë™ë°˜ ì‹œì—ë§Œ ì œí•œì  í•­ìƒì œ ì‚¬ìš©) | **1ì°¨: Topical Abx (ì ì´ì•¡)**\n*(Ofloxacin/Ciprofloxacin)*\nğŸ‘‰ ê²½êµ¬ì•½ë³´ë‹¤ ì ì´ì•¡ì´ íš¨ê³¼ì !\n**2ì°¨:**Â ê²½êµ¬ í•­ìƒì œ (ì „ì‹ ì¦ìƒ ì‹œ) | ì•½ë¬¼ë¡œ ì™„ì¹˜ ë¶ˆê°€.\nìˆ˜ìˆ  ì „ ì—¼ì¦ ì¡°ì ˆìš©ìœ¼ë¡œë§Œ ì œí•œì  ì‚¬ìš©. |\n| **ìˆ˜ìˆ  ìš”ë²•** | ê³ ë§‰ì ˆê°œìˆ  (Myringotomy)\n*(í†µì¦ ë„ˆë¬´ ì‹¬í•˜ê±°ë‚˜ ì•ˆ ë‚˜ì„ ë•Œ)* | **í™˜ê¸°ê´€ ì‚½ì…ìˆ  (VT)**\n*(Ventilation Tube Insertion)*\në¬¼ ë¹¼ê³  ë°”ëŒ í†µí•˜ê²Œ í•¨. | **ê³ ì‹¤ ì„±í˜•ìˆ **\n*(Tympanoplasty)*\nêµ¬ë© ë©”ìš°ëŠ” ìˆ˜ìˆ . | **ìœ ì–‘ëŒê¸° ì ˆì œìˆ **\n*(Mastoidectomy)*\në¼ˆ ê¹ì•„ì„œ ë³‘ë³€ ì œê±°. |\n### AOM vs OME vs CSOM\n- **AOM** = **A**ngry (**A**cute, **A**ntibiotics)\n    - ê³ ë§‰ì´ í™”ê°€ ë‚˜ì„œ(Angry) **ë¹¨ê°›ê³  íŠ€ì–´ë‚˜ì˜¤ë ¤ê³  í•¨(Bulging)**.\n    - **A** = **A**hh! (ì•„íŒŒ!)\n- **OME** = **O**cean (**O**bservation mostly)\n    - ê·€ ì•ˆì— ë°”ë‹¤(**O**cean)ì²˜ëŸ¼ **ë¬¼(Fluid/Effusion)**ë§Œ ì°¼ìŒ.\n    - ë¬¼ì†ì— ìˆìœ¼ë©´ ì†Œë¦¬ ì•ˆ ë“¤ë¦¬ì§€? (Conductive Hearing Loss).\n    - **O** = **O**h, no pain. (ì•ˆ ì•„í””).\n- **CSOM** = **C**ontinuous **S**tinking discharge\n    - **C**: **C**hronic (ë§Œì„±).\n    - **S**: **S**him-hole (ì‹¬í•œ êµ¬ë©/Perforation).\n###","subject":"ENT 2e746f2986ee803e8769f26736748454","page_title":"ENT 2e746f2986ee803e8769f26736748454","episode":"ENT 2e746f2986ee803e8769f26736748454","section_path":["ENT 2e746f2986ee803e8769f26736748454"],"source_doc_id":"ENT 2e746f2986ee803e8769f26736748454","source_page":null,"source_anchor":"ENT 2e746f2986ee803e8769f26736748454-1","focus_area":"Otitis Media Spectrum","tags":["usmle-step2","ent","diagnosis","treatment","mnemonic","table"]}
{"chunk_type":"transcript_chunk","text":"# pulmo\nHigh-Risk ê¸°ì¤€: í¬ê¸° 2cm ì´ìƒ, ë‚˜ì´ 60ì„¸ ì´ˆê³¼, ê·¸ë¦¬ê³  ìµœê·¼ 5ë…„ ë‚´ í¡ì—°ë ¥(í˜„ì¬ í¡ì—° í¬í•¨).\nì˜ë¯¸: ì´ ì¡°ê±´ì— í•´ë‹¹í•˜ë©´ ì•”(Malignancy)ì¼ í™•ë¥ ì´ ë§¤ìš° ë†’ìœ¼ë¯€ë¡œ ì ê·¹ì ì¸ ì²˜ì¹˜(Biopsy/Resection)ê°€ í•„ìš”í•¨.\n0.8-2 ì‚¬ì´ë©´ ìƒê²€, PET\n---\n| **ì§ˆí™˜ëª…** | **ì£¼ìš” ë…¸ì¶œì› (Job History)** | **í˜¸ë°œ ë¶€ìœ„ (Location)** | **í•µì‹¬ íŠ¹ì§• (Key Finding)** | **ë¹„ê³  (Hyperlink)** |\n| --- | --- | --- | --- | --- |\n| **Asbestosis**Â (ì„ë©´íì¦) | ë°°(Shipbuilding), ê±´ì„¤, ë‹¨ì—´ì¬, ë¸Œë ˆì´í¬ ë¼ì´ë‹ | **Lower Lobes**Â (í•˜ì—½) | **Pleural Plaques**Â (í‰ë§‰ ë°˜), Ferruginous bodies | í¡ì—° ì‹œ íì•” ìœ„í—˜ í­ë°œì  ì¦ê°€! |\n| **Silicosis**Â (ê·œíì¦) | ëª¨ë˜ ë¶„ì‚¬(Sandblasting), ê´‘ì‚°, ìœ ë¦¬ ê³µì˜ˆ, ì„ê³µ | **Upper Lobes**Â (ìƒì—½) | **Eggshell calcification**Â (ë¦¼í”„ì ˆ ì„íšŒí™”) | **ê²°í•µ(TB)**Â ê°ì—¼ ìœ„í—˜ ì¦ê°€! (ëŒ€ì‹ì„¸í¬ ë§ˆë¹„) |\n| **Coal Worker's**(íƒ„ê´‘ë¶€ ì§„íì¦) | íƒ„ê´‘, ì„íƒ„ ì·¨ê¸‰ | **Upper Lobes**Â (ìƒì—½) | Coal macule, Anthracosis (íê°€ ê¹Œë§¤ì§) | **Caplan Syndrome**(ì§„íì¦ + RA ê²°ì ˆ) |\n| **Berylliosis**Â (ë² ë¦´ë¥¨ì¦) | í•­ê³µìš°ì£¼, ì „ìì œí’ˆ, ì²¨ë‹¨ ê¸ˆì† ì‚°ì—… | **Upper Lobes**Â (ìƒì—½) | **Non-caseating granuloma**(ìœ¡ì•„ì¢…) | Steroidì— ë°˜ì‘í•¨ (Sarcoidosisì™€ ìœ ì‚¬) |\nìœ ë¦¬ê³µì¥, ê´‘ì‚°, sand and sandblsating. eggshell - lymphadenopathy\nì§€ë¶•!ì— ë‹¨ì—´ì œ í™•ì¸.\n### SCLC \"S(ìŠ¤)ëª¨í‚¹í•˜ë©° C(ì¿ )ì…˜ íƒ„ L(ë¨)ë¸Œê°€ C(ì¼€)ëª¨ ë§ëŠ”ë‹¤!â€\n**í•´ì„ (Decoding):**\n- **ì„¼í„°(Central):** ì•”ì˜ ìœ„ì¹˜ (Central Lung).\n- **ì¤„ë‹´ë°°:** ê°€ì¥ ê°•ë ¥í•œ Risk Factor (Smoking).\n- **ì–‘(Lamb):** **Lamb**ert-Eaton Syndrome (ê·¼ë ¥ ì•½í™”).\n- **ì¿ ì…˜(Cushing):** ACTH ë¶„ë¹„ -> **Cushing** Syndrome.\n- **í™ìˆ˜:** ë¬¼ì´ ë„˜ì¹¨ -> ADH ë¶„ë¹„ -> **SIADH** (ëª¸ì— ë¬¼ì´ ë§ì•„ì ¸ì„œ **Hyponatremia**).\n- **ë– ë‚´ë ¤ê° (ëª» ê±´ì§):** **Surgery X** (ìˆ˜ìˆ  ë¶ˆê°€ëŠ¥, ì „ì‹  í•­ì•” í•„ìš”).\n- ì™¸ê³¼ ì˜ì‚¬ê°€ ë©€ë¦¬ìˆìŒ: ìˆ˜ìˆ ë¶ˆê°€\n- chemo, radiaion","subject":"pulmo 2e746f2986ee805e834ce9e38827be43","page_title":"pulmo 2e746f2986ee805e834ce9e38827be43","episode":"pulmo 2e746f2986ee805e834ce9e38827be43","section_path":["pulmo 2e746f2986ee805e834ce9e38827be43"],"source_doc_id":"pulmo 2e746f2986ee805e834ce9e38827be43","source_page":null,"source_anchor":"pulmo 2e746f2986ee805e834ce9e38827be43-1","focus_area":"Pulmonary Oncology & Occupation","tags":["usmle-step2","pulmo","diagnosis","treatment","pathophysiology","mnemonic","table"]}
{"chunk_type":"transcript_chunk","text":"# nephro\n---\n## hyponatremia = í™ìˆ˜ = ADH, polydipsia\n- í•µì‹¬ ëŒ€ìƒ: \"ADH\"ë¼ê³  ì íŒ ê±°ëŒ€í•˜ê³  ìœ„ì••ì ì¸ ì½˜í¬ë¦¬íŠ¸ ëŒ.\n- ëŒ ì•ˆìª½ (ìƒë¥˜/ëª¸): ì°½ë°±í•˜ê³  í¬ì„ëœ í‘¸ë¥¸ ë¬¼ì´ ë„˜ì‹¤ëŒ€ëŠ” ê±°ëŒ€í•œ ì €ìˆ˜ì§€. ë¬¼ì´ ë„ˆë¬´ ë§ìŒ. ë“œë¬¸ë“œë¬¸ ë– ë‹¤ë‹ˆëŠ” ì†Œê¸ˆí†µìœ¼ë¡œ ì €ë‚˜íŠ¸ë¥¨í˜ˆì¦ í‘œí˜„.\n- ëŒ ë°”ê¹¥ìª½ (í•˜ë¥˜/ì†Œë³€): ì™„ì „íˆ ë§ë¼ë²„ë¦° ê°•ë°”ë‹¥. ì©ì© ê°ˆë¼ì§„ ìƒ›ë…¸ë€ ë•…. ì•„ì£¼ ì ì€ ì–‘ì˜ ë„¤ì˜¨ ì‚¬ì¸ì²˜ëŸ¼ ì§„í•œ ë…¸ë€ìƒ‰ ì§„í™(ë†ì¶•ë‡¨)ë§Œ í˜ëŸ¬ë‚˜ì˜´.\n- ì¹˜ë£Œì œ ì•¡ì…˜: \"DEMECLOCYCLINE (DEMOLISH-CYCLINE)\"ì´ë¼ê³  ì íŒ ê±°ëŒ€í•œ ë ˆí‚¹ë³¼ì´ ëŒ ë²½ì„ ê²©ë ¬í•˜ê²Œ ë¶€ìˆ˜ê³  ìˆìŒ.\n- hyponatremiaì˜ ë‹¤ë¥¸ ì›ì¸: primary polydipsia, CHF, cirrhosis\n- ADHì¦ê°€ì˜ ì›ì¸\n    - SIADH ëŒ\n    - hypothyroidism: ì¶”ìœ„ì—ë– ëŠ” ì‚¬ëŒë“¤ì´ ëŒì„ ê³ ì¹˜ê³ ìˆìŒ\n    - secondary adrenal insufficiency = ACTH â†“ = aldosteroneì€ ì •ìƒ ìŠ¤í…Œë¡œì´ë“œë§Œ ë¶€ì¡±\n        - primary AI(hyperpigmentation)ì´ë‘ ë°˜ëŒ€ë˜ëŠ” paleí•œ ì‚¬ëŒë“¤.\n## hypernatremia = ìš”ë¶•ì¦ = ADH ì—†ìŒ\n- í•µì‹¬ ëŒ€ìƒ: ì´ì „ ì´ë¯¸ì§€ì™€ ê°™ì€ ëŒì´ì§€ë§Œ, ì¤‘ì•™ì´ ì™„ì „íˆ í„°ì ¸ë²„ë¦° ìƒíƒœ.\n- ëŒ ì•ˆìª½ (ìƒë¥˜/ëª¸): ì™„ì „íˆ ë§ë¼ë²„ë¦° ì €ìˆ˜ì§€ ë°”ë‹¥. ì‚¬ë§‰ ê°™ì€ í’ê²½. í•˜ì–€ ì†Œê¸ˆ ê²°ì •ë”ë¯¸ê°€ ê°€ë“ ìŒ“ì—¬ ê³ ë‚˜íŠ¸ë¥¨í˜ˆì¦ í‘œí˜„. ëª©ë§ˆë¥¸ ì‚¬ëŒë“¤ì´ ë¬¼ì„ ì°¾ê³  ìˆìŒ.\n- ëŒ ë°”ê¹¥ìª½ (í•˜ë¥˜/ì†Œë³€): í„°ì§„ í‹ˆìœ¼ë¡œ ë§‘ê³  ë¬½ì€ ë¬¼ì´ í†µì œ ë¶ˆëŠ¥ì˜ í™ìˆ˜ì²˜ëŸ¼ ìŸì•„ì ¸ ë‚˜ì˜´.\n- ì¹˜ë£Œì œ ì•¡ì…˜: \"DESMOPRESSIN (PRESS-IN)\"ì´ë¼ê³  ì íŒ ê±°ëŒ€í•œ ê¸°ê³„ ì†ì´ë‚˜ ìœ ì•• í”„ë ˆìŠ¤ê°€ í„°ì§„ í‹ˆì„ ê°•í•˜ê²Œ ê¾¹ ëˆŒëŸ¬ì„œ ë§‰ìœ¼ë ¤ê³  ì‹œë„í•¨.\n---\n---\nêµ°ì˜ê´€ë‹˜, ì´ ë©‹ì§„ \"ì „í•´ì§ˆ ë¯¸ì‹ ì„¸ê³„ê´€\"ì„ ì™„ë²½í•˜ê²Œ ì •ë¦¬í•´ ë“œë¦´ê²Œìš”. ë‚˜ì¤‘ì— ì´ ì„¤ëª…ê³¼ ì´ë¯¸ì§€ë§Œ ë´ë„ ë³‘íƒœìƒë¦¬ê°€ ì§ê´€ì ìœ¼ë¡œ ë– ì˜¤ë¥´ì‹¤ ê²ë‹ˆë‹¤! ğŸ‘¨â€âš•ï¸ğŸ³ğŸ‹ğŸ§€ğŸ¥¨ğŸŒ\n---\n## ğŸ³ ë‹¥í„° ì…°í”„ì˜ \"ì „í•´ì§ˆ ì£¼ë°©\" ì„¸ê³„ê´€ ê°€ì´ë“œ ğŸ§ª\nìš°ë¦¬ ëª¸ì† ì´ì˜¨ë“¤ì„ ì£¼ë°©ì˜ ìŒì‹ ì¬ë£Œë¡œ ì‹œê°í™”í•œ ì§ê´€ì ì¸ í•™ìŠµ ëª¨ë¸ì…ë‹ˆë‹¤. ì´ í‘œë¥¼ ê¸°ì¤€ìœ¼ë¡œ ì•„ë˜ ì´ë¯¸ì§€ë“¤ì„ í•´ì„í•´ ë³´ì„¸ìš”!\n| **ì´ì˜¨(Ion) / ìš”ì†Œ** | **ìŒì‹ ì•„ë°”íƒ€(Avatar)** | **íŠ¹ì§• ë° ì—­í•  (Role & Trait)** | **ìƒíƒœ ë³€í™” (Pathophysiology)** |\n| --- | --- | --- | --- |\n| **Hâº (ìˆ˜ì†Œ ì´ì˜¨)** | ğŸ‹ **ë ˆëª¬ ê°€ì‹œ** | ì°Œë¥´ëŠ” ì‹ ë§›, ê³µê²©ì ì¸ ë…¸ë€ìƒ‰ ìŠ¤íŒŒì´í¬.\nì¹˜ì¦ˆë¥¼ ì¤‘í™”ì‹œí‚´. | ê³¼ë‹¤ = **Acidosis (ì‚°ì¦)**\n(ê°€ì‹œë°­ì´ ë“œëŸ¬ë‚¨) |\n| **HCOâ‚ƒâ» (ì¤‘íƒ„ì‚°ì—¼)** | ğŸ§€ **ì¹˜ì¦ˆ ì†ŒìŠ¤** | ë¶€ë“œëŸ½ê³  ëŠë¼í•œ ì£¼í™©ìƒ‰ ì´ë¶ˆ.\në ˆëª¬ ê°€ì‹œë¥¼ ë®ì–´ ë³´í˜¸í•¨. | ê³¼ë‹¤ = **Alkalosis (ì•Œì¹¼ë¦¬ì¦)**\n(ì˜¨í†µ ì¹˜ì¦ˆ ë²”ë²…) |\n| **Clâ» (ì—¼í™”ë¬¼)** | ğŸ¥¨ **í”„ë ˆì¦** | ë”±ë”±í•˜ê³  ì§­ì§¤í•œ ê°ˆìƒ‰ ë•œë¹µìš© ê°„ì‹.\nì¹˜ì¦ˆê°€ ì—†ì„ ë•Œ ë¹ˆ ê³µê°„ì„ ì±„ì›€. | ê³¼ë‹¤ = **Hyperchloremia**\n(ì¹˜ì¦ˆ ëŒ€ì‹  í”„ë ˆì¦ì´ ê½‰ ì°¸) |\n| **Kâº (í¬íƒ€ìŠ˜/ì¹¼ë¥¨)** | ğŸŒ **ë°”ë‚˜ë‚˜** | ë¬¼ì— ì‰½ê²Œ íœ©ì“¸ë ¤ ë‚˜ê°€ëŠ” ë¶€ë“œëŸ¬ìš´ ê³¼ì¼.\nì¹˜ì¦ˆë‚˜ ë¬¼ì´ë‘ ê°™ì´ ì˜ ë¹ ì ¸ë‚˜ê°. | ë¶€ì¡± = **Hypokalemia (ì €ì¹¼ë¥¨í˜ˆì¦)**\n(í•˜ìˆ˜êµ¬ë¡œ ë– ë‚´ë ¤ê°) |\n| **ì•Œë„ìŠ¤í…Œë¡ ** | ğŸ¿ **íŒì½˜ ê°€ê²Œ ì£¼ì¸** | ì§ ëŒì´ ë§¤ë‹ˆì €.\nì†Œê¸ˆ(Naâº)ê³¼ ì¹˜ì¦ˆ(HCOâ‚ƒâ»)ë¥¼ ì¢‹ì•„í•˜ê³ ,\nì‹ ë§›(Hâº)ê³¼ ê³¼ì¼(Kâº)ì„ ì‹«ì–´í•¨. | ì¦ê°€ = ì¹˜ì¦ˆ íŒì½˜ íŒŒí‹° (Alkalosis)\nê°ì†Œ = ê°€ê²Œ íì—… (Acidosis) |\n---\n### ğŸ–¼ï¸ ì´ë¯¸ì§€ë³„ ìƒì„¸ í•´ì„¤ (The Gallery)\n### 1. ğŸŒŸ [ê¸°ë³¸ ì¬ë£Œ ì†Œê°œ] ì „í•´ì§ˆ 4ëŒ€ ì²œì™•ì˜ ì§ˆê°","subject":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","page_title":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","episode":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","section_path":["nephro 2f046f2986ee8011a1f5d23b6032fc8d"],"source_doc_id":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","source_page":null,"source_anchor":"nephro 2f046f2986ee8011a1f5d23b6032fc8d-1","focus_area":"Sodium Disorders","tags":["usmle-step2","nephrology","diagnosis","treatment","pathophysiology","mnemonic","table"]}
{"chunk_type":"transcript_chunk","text":"# Nephro Acid-Base Mnemonic Block\n## Core diagnosis links\n- Vomiting/diuretic-like loss: metabolic alkalosis + hypokalemia + hypochloremia.\n- NAGMA: bicarbonate loss framework (diarrhea/RTA/adrenal context).\n\n## Treatment-linked points\n- ì›ì¸ êµì •ê³¼ ì „í•´ì§ˆ ë³´ì •ì„ í•¨ê»˜ ë³¸ë‹¤.\n- Potassium/depletion correctionì€ ë¶€ì •ë§¥ ìœ„í—˜ ê´€ë¦¬ì™€ ì§ì ‘ ì—°ê²°.\n\n## Mnemonics retained\n- Lemon/cheese/pretzel kitchen analogyë¥¼ ë³‘íƒœìƒë¦¬ ê¸°ì–µ ì¥ì¹˜ë¡œ ìœ ì§€.","subject":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","page_title":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","episode":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","section_path":["nephro 2f046f2986ee8011a1f5d23b6032fc8d"],"source_doc_id":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","source_page":null,"source_anchor":"nephro 2f046f2986ee8011a1f5d23b6032fc8d-21","focus_area":"Acid-Base + Potassium","tags":["usmle-step2","nephrology","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"Hypokalemia: weakness, flat T, U wave, digoxin toxicity risk ìƒìŠ¹. ì„ìƒì—ì„œ ECG + ì•½ë¬¼ìœ„í—˜ ê°™ì´ ë³¸ë‹¤.","subject":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","page_title":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","episode":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","section_path":["nephro 2f046f2986ee8011a1f5d23b6032fc8d"],"source_doc_id":"nephro 2f046f2986ee8011a1f5d23b6032fc8d","source_page":null,"source_anchor":"nephro 2f046f2986ee8011a1f5d23b6032fc8d-41","focus_area":"Hypokalemia","tags":["usmle-step2","nephrology","diagnosis","ecg","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Nephro Rapid Core: Electrolytes\n## Hyponatremia\n- ì €ë‚˜íŠ¸ë¥¨ ì ‘ê·¼ì€ volume status + urine osmolality/urine sodium ì¶•ìœ¼ë¡œ ì •ë¦¬.\n- SIADH, polydipsia, CHF/cirrhosis, endocrine causesë¥¼ ìš°ì„  ê°ë³„.\n\n## Hypernatremia / DI\n- free-water loss íŒ¨í„´ê³¼ dilute urine ì—¬ë¶€ë¡œ central vs nephrogenic DI ë¶„ê¸°.\n- ì¹˜ë£ŒëŠ” êµì • ì†ë„ ì•ˆì „ì„± + ì›ì¸ êµì • + desmopressin ë°˜ì‘ í‰ê°€.\n\n## Exam reflex\n- ì „í•´ì§ˆ ë¬¸ì œëŠ” í•­ìƒ ì¦ìƒ ì¤‘ì¦ë„(ì‹ ê²½ ì¦ìƒ/ë¶€ì •ë§¥ ìœ„í—˜)ì™€ ê°™ì´ íŒë‹¨.","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-1","focus_area":"Nephro Electrolytes Rapid","tags":["usmle-step2","nephrology","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Nephro Rapid Core: Calcium/Phosphate/PTH Axis\n- Chvostek/Trousseau signì€ hypocalcemia ë‹¨ì„œ.\n- Thyroid/parathyroid ìˆ˜ìˆ  í›„ ì €ì¹¼ìŠ˜ì€ hypoparathyroidism ê°€ëŠ¥ì„±ì„ ìš°ì„  ê³ ë ¤.\n- CKDì—ì„œëŠ” phosphate retention -> secondary hyperparathyroidism ì¶•ìœ¼ë¡œ ë³¸ë‹¤.\n- ê¸‰ì„± ì €ì¹¼ìŠ˜ ì¦ìƒ(í…Œíƒ€ë‹ˆ/ê²½ë ¨/ECG ë³€í™”)ì—ì„œëŠ” calcium ë³´ì¶©ì„ ìš°ì„ .","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-21","focus_area":"Calcium-PTH Disorders","tags":["usmle-step2","nephrology","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Nephro Rapid Core: Acute Interstitial Nephritis (AIN)\n## Diagnosis\n- ì•½ë¬¼ ì‹œì‘ í›„ fever + rash + eosinophiluria íŒ¨í„´ì´ë©´ AIN ì˜ì‹¬.\n- creatinine ìƒìŠ¹ê³¼ ì†Œë³€ ì†Œê²¬ì„ í•¨ê»˜ í•´ì„.\n\n## Treatment\n- ì›ì¸ ì•½ë¬¼ ì¦‰ì‹œ ì¤‘ë‹¨.\n- íšŒë³µ ì§€ì—°/ì¤‘ì¦ì´ë©´ steroid ê³ ë ¤.\n- ê°ë³„ ì‹œ ATN, GN, postrenal causeë¥¼ ê°™ì´ ë°°ì œ.","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-41","focus_area":"AIN Drug Reaction","tags":["usmle-step2","nephrology","diagnosis","treatment","drug-toxicity"]}
{"chunk_type":"transcript_chunk","text":"# Nephro Rapid Core: Dialysis Indication + AKI Next-Step\n- ì•½ë¬¼ë¡œ ì¡°ì ˆ ë¶ˆê°€í•œ ìƒí™©ì—ì„œ AEIOU ê¸°ì¤€ì„ ì ìš©.\n- A: severe acidosis, E: refractory hyperkalemia, I: dialyzable intoxication, O: volume overload, U: uremic complications.\n- ì‹œí—˜ì—ì„œëŠ” â€œì§€ê¸ˆ ë°”ë¡œ dialysisì¸ê°€?â€ë¥¼ ë¬»ëŠ” ë¬¸í•­ì´ ë§ì•„ AEIOUë¥¼ ìš°ì„  í™•ì¸.","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-61","focus_area":"Dialysis Indication","tags":["usmle-step2","nephrology","next-step","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Nephro Rapid Core: Stone Pattern Recognition\n## Diagnosis\n- Calcium oxalate: envelope/dumbbell, radiopaque.\n- Uric acid: radiolucent ê°€ëŠ¥, acidic urine ì—°ê´€.\n- Struvite: infection stone, staghorn, urease-positive organisms.\n- Cystine: hexagonal crystal, inherited transporter defect.\n\n## Treatment linkage\n- stone typeì— ë”°ë¼ hydration, urine pH control, infection control, metabolic preventionì„ ë¶„ê¸°.","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-81","focus_area":"Nephrolithiasis","tags":["usmle-step2","nephrology","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Nephro/Urology Rapid Core: UTI Syndromes\n- Cystitis: dysuria + suprapubic pain, ë³´í†µ fever ì—†ìŒ.\n- Pyelonephritis: fever/flank pain/CVA tenderness í¬í•¨.\n- complicated UTIëŠ” risk factor(ë‚¨ì„±, ì„ì‹ , obstruction, instrumentation, immunocompromised) í™•ì¸ í›„ ë” ê³µê²©ì ìœ¼ë¡œ ì¹˜ë£Œ.\n- recurrent patternì—ì„œëŠ” ì˜ˆë°© ì „ëµê³¼ êµ¬ì¡°ì  ì›ì¸ í‰ê°€ í•„ìš”.","subject":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","page_title":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","episode":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","section_path":["nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe"],"source_doc_id":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe","source_page":null,"source_anchor":"nephro ì¦‰ë°˜ 2f046f2986ee807a8db9e274de1558fe-101","focus_area":"UTI Classification","tags":["usmle-step2","nephrology","urology","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Psy\n- **Mummy (Anticholinergic):**Â Dryí•¨ì„ ê°•ì¡°.\n- **Wet T-shirt (Cocaine):**Â ë•€ë‚˜ê³  í¥ë¶„ ìƒíƒœ.\n- **Slime (Cholinergic):**Â ëª¨ë“  ë¶„ë¹„ë¬¼ì´ ì½¸ì½¸(Leaking).\n- **Kicking leg (SS):**Â Clonus(ë°˜ì‚¬ í•­ì§„) ì‹œê°í™”.\n- **Metal Statue (NMS):**Â Lead-pipe rigidity(ê°•ì§) ì‹œê°í™”.\n| **ì§ˆí™˜ (Syndrome)** | **ì›ì¸ (Trigger)** | **ë™ê³µ (Pupil)** | **í”¼ë¶€/ë•€ (Skin)** | **ì¥ìŒ (Bowel)** | **ê·¼ìœ¡/ë°˜ì‚¬ (Muscle) ğŸ”¥** | **í•µì‹¬ ì•”ê¸°ë²• (Mnemonic)** |\n| --- | --- | --- | --- | --- | --- | --- |\n| **SS**Â (Serotonin) | SSRI, Tramadol | **í™•ëŒ€ (Big)** | **Wet** | ì¦ê°€ (ì„¤ì‚¬) | **Clonus (íˆ­ ì¹˜ë©´ íŠ€ì–´ì˜¤ë¦„)** | **S**ky-high Reflex / ìŠ¥ìŠ¥(ë•€, ë°œ) |\n| **NMS**Â (Neuroleptic) | Antipsychotics | **ì •ìƒ (Normal)** | Wet (ê°€ë” Dry) | ì •ìƒ/ê°ì†Œ | **Rigid (ë‚© íŒŒì´í”„ ê°•ì§)** | **N**oÂ **M**ovement /Â **N**o **M**ydriasis |\n| **MH**Â (Malignant Hyper) | ë§ˆì·¨ì œ (Succinyl) | ì •ìƒ (Normal) | Wet | ê°ì†Œ | **Rigid (í„±ë¶€í„° êµ³ìŒ)** | ìˆ˜ìˆ ë°©ì—ì„œ ë¶ˆë‚¬ë‹¤ |\n| **DT**Â (Delirium T) | Alcohol ëŠìŒ | **í™•ëŒ€ (Big)** | **Wet** | ì¦ê°€ | **Tremor (ì „ì‹  ë–¨ë¦¼)** | **D**olÂ **D**ol (ëœëœ) / D(dual)T(tri) = 2-3ì¼ / D for ëœëœ T for tachycardia |\n| **Sympathomimetic** | Cocaine, Meth | **í™•ëŒ€ (Big)** | **Wet. êµê°ì‹ ê²½ì´ì–´ë„ ì‹¬ì¥ì´ ê³¼ë¶€í™”ë˜ì–´ ë°œì—´, ì—´ì‹íˆë ¤ê³  ë•€ë‚¨.** | ì¦ê°€ | ê¸´ì¥ë¨ (Not Rigid) | **C**razyÂ **W**et (ë¯¸ì¹œ ë“¯ì´ ì –ìŒ) |\n| **Anticholinergic** | Atropine | **í™•ëŒ€ (Big)** | **DRY (í•µì‹¬!)** | **ê°ì†Œ (ë³€ë¹„)** | ì •ìƒ/Clonus ë“œë¬¾ | **ì‚¬ë§‰**ì˜ í† ë¼ (ë¹¨ê°›ê³  ë§ˆë¥´ê³  ëˆˆ í¼)\na-DRY-pine. Antiì½¸ì½¸ |\n| **Cholinergic** | ë†ì•½, Nerve gas | **ì¶•ì†Œ (Pinpoint)** | **WET (í™ìˆ˜)** | **ì¦ê°€ (ì„¤ì‚¬)** | ìœ„ì•½ê°, Fasciculation | **ì½¸ì½¸**Â (ìœ„ì•„ë˜ë¡œ ë‹¤ ìƒ˜) |\n### 1. Serotonin Syndrome (SS)\n- **One-Line Vibe:**Â **\"ì –ì€ ì±„ë¡œ í„ì© ë›°ëŠ” ì‚¬ë§‰ ì•„ì €ì”¨\"**Â (ê³ ì—´ + ë•€ + ê·¼ìœ¡ íŠ)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"S\"**haking, **\"S\"**weating, **\"S\"**ky-high reflex\n    - **ìŠ¥ìŠ¥:**Â ë•€ ë‹¦ëŠë¼Â **ìŠ¥ìŠ¥**, ë°œëª© ì¹˜ë©´Â **ìŠ¥ìŠ¥**Â íŠ€ì–´ ì˜¤ë¦„ (**Clonus**).\n    - **Pupil:**Â **í™•ëŒ€ (Dilated)**.\n### 2. Neuroleptic Malignant Syndrome (NMS)\n- **One-Line Vibe:**Â **\"ë¶ˆíƒ€ëŠ” ë‚© ë™ìƒ\"**Â (ê³ ì—´ + ë•€ + ê¼¼ì§ë„ ì•ˆ í•¨)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"N\"**o **\"M\"**otion **\"S\"**yndrome\n    - **No Motion:**Â ê·¼ìœ¡ì´ ë‚© íŒŒì´í”„ì²˜ëŸ¼ êµ³ìŒ (**Lead-pipe Rigidity**).\n    - **Normal Pupil:**Â ë™ê³µì€ ë³´í†µÂ **ì •ìƒ**Â (SSì™€ ê²°ì •ì  ì°¨ì´!).\n### 3. Delirium Tremens (DT)\n- **One-Line Vibe:**Â **\"ìˆ  ëŠê³  ì°¾ì•„ì˜¨ í­í’\"**Â (ë¯¸ì¹œ ë“¯í•œ ë–¨ë¦¼ + ììœ¨ì‹ ê²½ í­ì£¼)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"D\"**ual - **\"T\"**ri (2-3) &Â **\"ëœëœ\"**\n    - **Dual-Tri:**Â **2~3ì¼(48~72h)**Â í›„ í”¼í¬ íƒ€ì„.\n    - **ëœëœ:**Â ì˜¨ëª¸ì„Â **ëœëœ**Â ë–ª (**Tremor**).\n    - **T:**Â **T**achycardia &Â **T**emperature (ì‹¬ì¥ ë›°ê³  ì—´ ë‚¨).\n### 4. Anticholinergic (Atropine)\n- **One-Line Vibe:**Â **\"ì‚¬ë§‰ì— ê³ ë¦½ëœ ë¯¸ì¹œ í† ë¼\"**Â (ë°”ì§ ë§ˆë¦„ + ë¹¨ê°œì§ + ëˆˆ í¼)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"A-Dry-Pine\"**Â &Â **\"Anti-Cola\"**\n    - **A-Dry-Pine:**Â ì•„íŠ¸ë¡œí•€ì€Â **Dry**í•˜ë‹¤ (ê²¨ë“œë‘ì´ ë½€ì†¡ë½€ì†¡ =Â **í•µì‹¬ ê°ë³„ì **).\n    - **Anti-Cola:**Â ì•ˆí‹°-ì½œë¼ë¼Â **ëª©ë§ë¼**Â (ì¹¨ë„ ì•ˆ ë‚˜ì˜´).\n    - **Pupil:**Â **í™•ëŒ€ (Dilated)**Â & ì™•ëˆˆì´ í† ë¼.\n### 5. Cholinergic (Organophosphate/ë†ì•½)\n- **One-Line Vibe:**Â **\"ìˆ˜ë„ê¼­ì§€ ê³ ì¥ ë‚œ ë¬¼í’ì„ \"**Â (ìœ„ì•„ë˜ë¡œ ë‹¤ ìƒœìŒ)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"Chol\"**inergic = **\"ì½¸\"**ë¦¬ë„ˆì§\n    - **ì½¸ì½¸:**Â ëˆˆë¬¼, ì¹¨, ë•€, ì„¤ì‚¬, ì†Œë³€ ë‹¤ ì½¸ì½¸ (**Wet í™ìˆ˜**).\n    - **Pupil:**Â **ì¶•ì†Œ (Pinpoint)**Â (ìˆ˜ì•• ë•Œë¬¸ì— ìª¼ê·¸ë¼ë“¦).\n### 6. Sympathomimetic (Cocaine)\n- **One-Line Vibe:**Â **\"ëƒ‰ê°ìˆ˜ í„°ì§„ ìŠ¤í¬ì¸ ì¹´\"**Â (í’€ ì—‘ì…€ + ë•€ë²”ë²…)\n- **âš¡ï¸ ì•”ê¸°ë²•:**Â **\"C\"**razy **\"W\"**et\n    - **Wet:**Â êµê°ì‹ ê²½ í•­ì§„ì¸ë°Â **ë•€ì´ ë‚¨**Â (Anticholinergicê³¼ ë°˜ëŒ€!).\n    - **Pupil:**Â **í™•ëŒ€ (Dilated)**.","subject":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","page_title":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","episode":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","section_path":["Psy 2ea46f2986ee807ab05efc7d2a0edd28"],"source_doc_id":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","source_page":null,"source_anchor":"Psy 2ea46f2986ee807ab05efc7d2a0edd28-1","focus_area":"Toxidrome Recognition","tags":["usmle-step2","psychiatry","toxicology","diagnosis","treatment","table"]}
{"chunk_type":"transcript_chunk","text":"# Psychiatry Emergency Med Notes\n- TCA toxicity ECG ë³€í™”(QRS widening)ë©´ sodium bicarbonate.\n- sedative/hypnotic intoxicationê³¼ withdrawalì€ vital sign + mental status íŒ¨í„´ìœ¼ë¡œ êµ¬ë¶„.\n- agitation managementëŠ” patient safetyì™€ reversible cause evaluationì„ ë™ì‹œì— ì§„í–‰.","subject":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","page_title":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","episode":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","section_path":["Psy 2ea46f2986ee807ab05efc7d2a0edd28"],"source_doc_id":"Psy 2ea46f2986ee807ab05efc7d2a0edd28","source_page":null,"source_anchor":"Psy 2ea46f2986ee807ab05efc7d2a0edd28-21","focus_area":"Psych Emergency Treatment","tags":["usmle-step2","psychiatry","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Psy and number\nUSMLE Step 2 ì¤€ë¹„ ê³¼ì •ì—ì„œ ì •ì‹ ê³¼ ì§ˆí™˜ì˜ ì§„ë‹¨ ê¸°ì¤€, íŠ¹íˆ 'ìˆ«ì(ê¸°ê°„, ë‚˜ì´, ë¹ˆë„)'ê°€ í—·ê°ˆë¦¬ëŠ” ê²ƒì€ ë§¤ìš° í”í•œ ì¼ì…ë‹ˆë‹¤. ì •ì‹ ê³¼ ì§„ë‹¨ì€ ì¦ìƒì˜ **ì§€ì† ê¸°ê°„(Duration)**ê³¼ **ë°œë³‘ ì—°ë ¹(Onset Age)**ì´ ë‹¤ë¥¸ ì§ˆí™˜ê³¼ì˜ ê°ë³„ í¬ì¸íŠ¸(Differential Diagnosis)ê°€ ë˜ëŠ” ê²½ìš°ê°€ ë§ìŠµë‹ˆë‹¤.\nì œê³µí•´ì£¼ì‹  ìë£Œë¥¼ ë°”íƒ•ìœ¼ë¡œ, ì‹œí—˜ì— ìì£¼ ë‚˜ì˜¤ëŠ” í—·ê°ˆë¦¬ëŠ” ì§ˆí™˜ë“¤ì„ 'ìˆ«ì'ë¥¼ ì¤‘ì‹¬ìœ¼ë¡œ ì¬êµ¬ì„±í•˜ì—¬ ì •ë¦¬í•´ ë“œë¦½ë‹ˆë‹¤.\n1. íƒ€ì„ë¼ì¸ psychotic :1, 6\n2. stress: 1ê¸°ì¤€ìœ¼ë¡œ ë°”ë€œ\n3. anxiety: 6ê°œì›”ì´ìƒ\n4. ê¸°ë¶„ì¥ì•  2ì˜ ë²•ì¹™. ë§Œì„± 2ë…„ì´ìƒ\n---\n### **1. Psychotic Disorders (ì •ì‹ ë³‘ì  ì¥ì• ): \"ê¸°ê°„\"ì´ ì§„ë‹¨ëª…ì´ë‹¤**\nì´ íŒŒíŠ¸ì˜ í•µì‹¬ì€ ì¦ìƒ(ë§ìƒ, í™˜ê° ë“±)ì€ ê°™ì§€ë§Œ, **ì¦ìƒì´ ì–¼ë§ˆë‚˜ ì§€ì†ë˜ì—ˆëŠ”ê°€**ì— ë”°ë¼ ì§„ë‹¨ëª…ì´ ë°”ë€ë‹¤ëŠ” ì ì…ë‹ˆë‹¤.\n- **General Rule:** ì¦ìƒì´ 1ê°œì›” ë¯¸ë§Œì´ë©´ Brief, 6ê°œì›” ë„˜ìœ¼ë©´ Schizophrenia, ê·¸ ì‚¬ì´ë©´ Schizophreniformì…ë‹ˆë‹¤.\n| **ì§„ë‹¨ëª… (Diagnosis)** | **í•µì‹¬ ê¸°ê°„ (Key Timeline)** | **íŠ¹ì§•** |\n| --- | --- | --- |\n| **Brief Psychotic Disorder** | **1ì¼ ì´ìƒ ~ 1ê°œì›” ë¯¸ë§Œ** | ê¸‰ê²©í•œ ë°œë³‘, ê¸°ëŠ¥ì˜ ì™„ì „í•œ íšŒë³µ. |\n| **Schizophreniform Disorder** | **1ê°œì›” ì´ìƒ ~ 6ê°œì›” ë¯¸ë§Œ** | Schizophreniaì™€ ì¦ìƒì€ ê°™ìœ¼ë‚˜, ì‚¬íšŒì /ì§ì—…ì  ê¸°ëŠ¥ ì €í•˜ëŠ” í•„ìˆ˜ ì•„ë‹˜. |\n| **Schizophrenia** | **6ê°œì›” ì´ìƒ** | í™œì„±ê¸° ì¦ìƒ(Active symptoms) 1ê°œì›” ì´ìƒ í¬í•¨, ê¸°ëŠ¥ ì €í•˜ í•„ìˆ˜. |\n| **Delusional Disorder** | **1ê°œì›” ì´ìƒ** | ê¸°ì´í•˜ì§€ ì•Šì€ í–‰ë™, ë§ìƒ ì™¸ì—ëŠ” ê¸°ëŠ¥ì´ ì •ìƒì ì„. |\n| **Schizoaffective Disorder** | **2ì£¼ (2 weeks)** | í‰ìƒ ë™ì•ˆ ê¸°ë¶„ ì‚½í™”(Mood episode) **ì—†ì´** ë§ìƒì´ë‚˜ í™˜ê°ë§Œ ìˆëŠ” ê¸°ê°„ì´ **2ì£¼ ì´ìƒ** ìˆì–´ì•¼ í•¨ (ê¸°ë¶„ ì¥ì• ì™€ ê°ë³„í•˜ëŠ” í•µì‹¬ í¬ì¸íŠ¸). |\n---\n### **2. Mood Disorders (ê¸°ë¶„ ì¥ì• ): \"ê¸‰ì„± vs ë§Œì„±\" 2**\nê¸°ë¶„ ì¥ì• ëŠ” **ì‚½í™”(Episode)ì˜ ì§€ì† ê¸°ê°„**ê³¼ **ë§Œì„±ë„(Chronicity)**ê°€ ìˆ«ìì˜ í•µì‹¬ì…ë‹ˆë‹¤.\n- **General Rule:** ManiaëŠ” ì‘ê¸‰ ìƒí™©(ì…ì› ë˜ëŠ” 1ì£¼), HypomaniaëŠ” 4ì¼, ìš°ìš¸ì¦ì€ 2ì£¼ì…ë‹ˆë‹¤. ë§Œì„±(Chronic)ì´ ë¶™ìœ¼ë ¤ë©´ ì„±ì¸ì€ 2ë…„ì…ë‹ˆë‹¤.\n| **ì§„ë‹¨ëª… (Diagnosis)** | **í•µì‹¬ ê¸°ê°„ (Key Timeline)** | **íŠ¹ì§•** |\n| --- | --- | --- |\n| **Manic Episode** | **1ì£¼ ì´ìƒ** (í˜¹ì€ ì…ì› í•„ìš” ì‹œ ì¦‰ì‹œ) | ì‹¬ê°í•œ ì‚¬íšŒì  ê¸°ëŠ¥ ì†ìƒ. |\n| **Hypomanic Episode** | **4ì¼ ì´ìƒ** (ì—°ì†) | ê¸°ëŠ¥ì˜ ë³€í™”ëŠ” ìˆìœ¼ë‚˜ ì…ì›í•  ì •ë„ëŠ” ì•„ë‹˜. |\n| **Major Depressive Disorder (MDD)** | **2ì£¼ ì´ìƒ** | ìš°ìš¸ ê¸°ë¶„ í¬í•¨ 5/9 ì¦ìƒ ì¶©ì¡±. |\n| **Persistent Depressive Disorder (Dysthymia)** | **2ë…„ ì´ìƒ** (ì†Œì•„/ì²­ì†Œë…„ì€ 1ë…„) | ë¬´ì¦ìƒ ê¸°ê°„ì´ **2**ê°œì›”ì„ ë„˜ì§€ ì•ŠìŒ. |\n| **Cyclothymic Disorder** | **2ë…„ ì´ìƒ** | ê²½ë¯¸í•œ Hypomanic/Depressive ì¦ìƒì˜ ë°˜ë³µ (MDD ê¸°ì¤€ ë§Œì¡± X), ì •ìƒ ê¸°ê°„ 2ê°œì›” ë¯¸ë§Œ,. |\n| **Adjustment Disorder** | **3ê°œì›” ì´ë‚´** ë°œë³‘ | ìŠ¤íŠ¸ë ˆìŠ¤ ìš”ì¸ ë°œìƒ í›„ 3ê°œì›” ë‚´ ì‹œì‘. ë‹¤ë¥¸ ì •ì‹  ì§ˆí™˜ ê¸°ì¤€ì„ ë§Œì¡±í•˜ì§€ ì•Šì•„ì•¼ í•¨. |\n| **Rapid Cycling (Bipolar)** | **12ê°œì›” ë‚´ 4íšŒ ì´ìƒ** | 1ë…„ ë™ì•ˆ 4ë²ˆ ì´ìƒì˜ ê¸°ë¶„ ì‚½í™” ë°œìƒ. |\n---\n### **3. Anxiety & Trauma (ë¶ˆì•ˆ ë° ì™¸ìƒ): \"1ê°œì›”ê³¼ 6ê°œì›”ì˜ ë²•ì¹™\"**\në¶ˆì•ˆ ì¥ì• ëŠ” ì¼ì‹œì ì¸ ë°˜ì‘ê³¼ ë³‘ì ì¸ ìƒíƒœë¥¼ êµ¬ë¶„í•˜ê¸° ìœ„í•´ íŠ¹ì • ê¸°ê°„ì„ ìš”êµ¬í•©ë‹ˆë‹¤.\n- **General Rule:** íŠ¸ë¼ìš°ë§ˆ ê´€ë ¨ì€ **1ê°œì›”**ì„ ê¸°ì¤€ìœ¼ë¡œ ë³‘ëª…ì´ ë°”ë€ë‹ˆë‹¤. ì¼ë°˜ì ì¸ ë¶ˆì•ˆ/ê³µí¬ì¦ì€ **6ê°œì›”** ì´ìƒ ì§€ì†ë˜ì–´ì•¼ ì§„ë‹¨í•©ë‹ˆë‹¤.\n| **ì§„ë‹¨ëª… (Diagnosis)** | **í•µì‹¬ ê¸°ê°„ (Key Timeline)** | **íŠ¹ì§•** |\n| --- | --- | --- |\n| **Acute Stress Disorder (ASD)** | **3ì¼ ì´ìƒ ~ 1ê°œì›” ì´ë‚´** | íŠ¸ë¼ìš°ë§ˆ í›„ 1ê°œì›” ë‚´ ì¦ìƒ ë°œìƒ ë° ì¢…ë£Œ. |\n| **Post-Traumatic Stress Disorder (PTSD)** | **1ê°œì›” ì´ˆê³¼** | íŠ¸ë¼ìš°ë§ˆ í›„ ì¦ìƒì´ 1ê°œì›” ì´ìƒ ì§€ì†. |\n| **Panic Disorder** | **1ê°œì›” ì´ìƒ** | ê³µí™© ë°œì‘ í›„, ì¶”ê°€ ë°œì‘ì— ëŒ€í•œ ê±±ì •ì´ë‚˜ íšŒí”¼ê°€ 1ê°œì›” ì´ìƒ ì§€ì†. |\n| **Generalized Anxiety Disorder (GAD)** | **6ê°œì›” ì´ìƒ** | í†µì œí•˜ê¸° í˜ë“  ê³¼ë„í•œ ê±±ì •. |\n| **Specific Phobia** | **6ê°œì›” ì´ìƒ** | íŠ¹ì • ëŒ€ìƒì— ëŒ€í•œ í˜„ì €í•œ ê³µí¬. |\n| **Social Anxiety Disorder** | **6ê°œì›” ì´ìƒ** | ì‚¬íšŒì  ìƒí™©ì— ëŒ€í•œ ë¶ˆì•ˆ. |\n---","subject":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","page_title":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","episode":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","section_path":["Psy and number 2ec46f2986ee80a98293f3e61f584e06"],"source_doc_id":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","source_page":null,"source_anchor":"Psy and number 2ec46f2986ee80a98293f3e61f584e06-1","focus_area":"Toxidrome Recognition","tags":["usmle-step2","psychiatry","toxicology","diagnosis","treatment","table"]}
{"chunk_type":"transcript_chunk","text":"### **4. Childhood Disorders (ì†Œì•„ ì§ˆí™˜): \"ë‚˜ì´ì™€ ì§€ì† ê¸°ê°„\"**\nì†Œì•„ê³¼ëŠ” **\"ëª‡ ì‚´ë¶€í„° ì§„ë‹¨ ê°€ëŠ¥í•œê°€?\"**ì™€ **\"ì¦ìƒì´ ì–¸ì œ ì‹œì‘ë˜ì—ˆëŠ”ê°€?\"**ê°€ ì¤‘ìš”í•©ë‹ˆë‹¤.\n- **General Rule:** ë°°ì„¤ ì¥ì• ëŠ” ë°œë‹¬ ì—°ë ¹(4~5ì„¸)ì„ ê³ ë ¤í•´ì•¼ í•˜ë©°, ADHDëŠ” 12ì„¸ ì´ì „ ë°œë³‘ì´ í•„ìˆ˜ì…ë‹ˆë‹¤.\n- 5ì¤Œ\n- 4ë³€\n| **ì§„ë‹¨ëª… (Diagnosis)** | **í•µì‹¬ ë‚˜ì´/ê¸°ê°„ (Key Age/Timeline)** | **íŠ¹ì§•** |\n| --- | --- | --- |\n| **ADHD** | **12ì„¸ ì´ì „** ë°œë³‘ / **6ê°œì›” ì´ìƒ** ì§€ì† | ë‘ êµ°ë° ì´ìƒì˜ ì¥ì†Œ(ì§‘, í•™êµ ë“±)ì—ì„œ ì¦ìƒ ë°œí˜„. |\n| **Tourette Syndrome** | **18ì„¸ ì´ì „** ë°œë³‘ / **1ë…„ ì´ìƒ** ì§€ì†\nddx. ì•„ë™ê¸° ì¼ê³¼ì„± í‹±ì¥ì•  | ìš´ë™ í‹±(Motor) + ìŒì„± í‹±(Vocal)ì´ ëª¨ë‘ ìˆì–´ì•¼ í•¨ (ë™ì‹œì¼ í•„ìš”ëŠ” ì—†ìŒ). |\n| **Encopresis (ìœ ë¶„ì¦)** | **4ì„¸ ì´ìƒ** | ëŒ€ë³€ì„ ê°€ë ¤ì•¼ í•  ë‚˜ì´. |\n| **Enuresis (ìœ ë‡¨ì¦)** | **5ì„¸ ì´ìƒ** | ì†Œë³€ì„ ê°€ë ¤ì•¼ í•  ë‚˜ì´. |\n| **Reactive Attachment Disorder** | **5ì„¸ ì´ì „** ì§•í›„ | ë°©ì„ ë“±ìœ¼ë¡œ ì¸í•´ ì–‘ìœ¡ìì—ê²Œ ì •ì„œì  ë°˜ì‘ì„ ë³´ì´ì§€ ì•ŠìŒ. |\n| **Oppositional Defiant Disorder (ODD)** | **6ê°œì›” ì´ìƒ** | ê¶Œìœ„ì— ëŒ€í•œ ì ëŒ€ì , ë°˜í•­ì  í–‰ë™ íŒ¨í„´. |\n| **Intermittent Explosive Disorder** | **6ì„¸ ì´í›„** ë°œë³‘ / ë°œì‘ **30ë¶„ ë¯¸ë§Œ(ì§§ê°•)**\n**vs. disruptive DMDD:** 10ì„¸ì´ì „. 6ì„¸ì´ì „ 18ì„¸ ì´í›„ ì§„ë‹¨ë¶ˆê°€. ì‚¬ì´ì‚¬ì´ì—ë„ í™”ë‚˜ìˆìŒ. ì§€ì†ì  | ë„ë°œì— ë¹„í•´ ê³¼ë„í•œ ê³µê²©ì„±, ê³„íšë˜ì§€ ì•ŠìŒ. í›„íšŒ. |\n---\n### **5. Somatic & Eating Disorders (ì‹ ì²´ ë° ì„­ì‹ ì¥ì• ): \"ë¹ˆë„ì™€ ìˆ˜ì¹˜\"**\n- **General Rule:** ì„­ì‹ ì¥ì• ëŠ” **3ê°œì›”** ë™ì•ˆ **ì£¼ 1íšŒ** ì´ìƒ í–‰ë™ì´ ë°˜ë³µë˜ì–´ì•¼ í•˜ë©°, AnorexiaëŠ” ì²´ì¤‘(BMI)ì´ ê²°ì •ì ì…ë‹ˆë‹¤.\n| **ì§„ë‹¨ëª… (Diagnosis)** | **í•µì‹¬ ìˆ˜ì¹˜ (Key Metrics)** | **íŠ¹ì§•** |\n| --- | --- | --- |\n| **Anorexia Nervosa** | **BMI < 18.5 kg/mÂ²** | ì €ì²´ì¤‘ì´ í•„ìˆ˜ ì§„ë‹¨ ê¸°ì¤€. ì…ì› ê¸°ì¤€ì€ **BMI < 15** ë˜ëŠ” í™œë ¥ì§•í›„ ë¶ˆì•ˆì •,. |\n| **Bulimia Nervosa** | **ì£¼ 1íšŒ ì´ìƒ, 3ê°œì›”ê°„** | í­ì‹ + ë³´ìƒ í–‰ë™(êµ¬í†  ë“±). ì²´ì¤‘ì€ ì •ìƒì´ê±°ë‚˜ ê³¼ì²´ì¤‘ì¼ ìˆ˜ ìˆìŒ. |\n| **Somatic Symptom Disorder** | **6ê°œì›” ì´ìƒ** | 1ê°œ ì´ìƒì˜ ì‹ ì²´ ì¦ìƒ + ê³¼ë„í•œ ê±±ì •/ì‹œê°„ ì†Œë¹„. |\n| **Gender Dysphoria** | **6ê°œì›” ì´ìƒ** | ì§€ì •ëœ ì„±ë³„ê³¼ ê²½í—˜í•˜ëŠ” ì„±ë³„ì˜ ë¶ˆì¼ì¹˜ë¡œ ì¸í•œ ê³ í†µ. |\n---\n### **6. ì•½ë¬¼ ë° ì¹˜ë£Œ ê´€ë ¨ ìˆ«ì (Pharmacology & Management)**\n- **Antidepressant Trial:** ì¹˜ë£Œ íš¨ê³¼ë¥¼ íŒì •í•˜ê¸° ìœ„í•´ **4~6ì£¼** ë™ì•ˆ ì¹˜ë£Œ ìš©ëŸ‰ì„ ìœ ì§€í•´ì•¼ í•©ë‹ˆë‹¤.\n- **Maintenance Therapy (ìš°ìš¸ì¦):**\n    - ì²« ë°œë³‘(Single episode): ê´€í•´ í›„ **6ê°œì›”** ì¶”ê°€ ìœ ì§€.\n    - ì¬ë°œ(Recurrent): **1~3ë…„** ë˜ëŠ” ë¬´ê¸°í•œ ìœ ì§€.\n- **Alcohol Withdrawal Timeline:**\n    - 6-24ì‹œê°„: ê²½ë¯¸í•œ ì¦ìƒ, ë¶ˆì•ˆ, ë–¨ë¦¼.\n    - 12-48ì‹œê°„: ë°œì‘(Seizures), ì•Œì½”ì˜¬ í™˜ê°(Alcoholic hallucinosis - ì˜ì‹ ëª…ë£Œí•¨).\n    - 48-96ì‹œê°„: ì§„ì „ ì„¬ë§(Delirium Tremens - ì˜ì‹ í˜¼íƒ, í™œë ¥ì§•í›„ ë¶ˆì•ˆì •).\nì´ ì •ë¦¬ê°€ USMLE Step 2 ì¤€ë¹„ì— í° ê·¸ë¦¼ì„ ê·¸ë¦¬ëŠ” ë° ë„ì›€ì´ ë˜ê¸°ë¥¼ ë°”ëë‹ˆë‹¤. íŠ¹íˆ **2ì£¼(Schizoaffective)**, **1ê°œì›”(Psychosis/PTSD ê²½ê³„)**, **6ê°œì›”(Anxiety/Schizophrenia)** ê°™ì€ ê¸°ì¤€ì ë“¤ì€ ì‹œí—˜ì— ë¹ˆì¶œë˜ë¯€ë¡œ ê¼­ ìˆ™ì§€í•˜ì‹œê¸° ë°”ëë‹ˆë‹¤.","subject":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","page_title":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","episode":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","section_path":["Psy and number 2ec46f2986ee80a98293f3e61f584e06"],"source_doc_id":"Psy and number 2ec46f2986ee80a98293f3e61f584e06","source_page":null,"source_anchor":"Psy and number 2ec46f2986ee80a98293f3e61f584e06-21","focus_area":"Psych Emergency Treatment","tags":["usmle-step2","psychiatry","diagnosis","treatment","table"]}
{"chunk_type":"transcript_chunk","text":"# Cardiac Electrophysiology Core\n- K+ëŠ” resting membrane potentialê³¼ repolarization í•µì‹¬ ì´ì˜¨.\n- phaseë³„ ion movementë¥¼ ì´í•´í•˜ë©´ ë¶€ì •ë§¥ ì•½ë¬¼ ê¸°ì „ê¹Œì§€ ì—°ê²°ë¨.\n- hypo/hyperkalemiaëŠ” ECG ë³€í™”ì™€ ë¶€ì •ë§¥ ìœ„í—˜ìœ¼ë¡œ ë°”ë¡œ ì´ì–´ì ¸ ì„ìƒ ìš°ì„ ìˆœìœ„ê°€ ë†’ìŒ.","subject":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","page_title":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","episode":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","section_path":["Cardio 2eb46f2986ee80b9af19e02cbdc1795f"],"source_doc_id":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","source_page":null,"source_anchor":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f-1","focus_area":"Cardiac Electrophysiology","tags":["usmle-step2","cardiology","pathophysiology","ecg"]}
{"chunk_type":"transcript_chunk","text":"# Cardiac Action Potential Storyline\n- depolarization ì´í›„ repolarizationì€ K+ effluxê°€ ì¤‘ì‹¬.\n- ionic reset(íŠ¹íˆ Na/K ATPase, Ca handling) ì‹¤íŒ¨ ì‹œ conduction instabilityì™€ arrhythmia risk ì¦ê°€.\n- ì‹œí—˜ì—ì„œëŠ” phase mechanismê³¼ ì•½ë¬¼ classë¥¼ ì—°ê²°í•´ ë¬»ëŠ” ê²½ìš°ê°€ ë§ìŒ.","subject":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","page_title":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","episode":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","section_path":["Cardio 2eb46f2986ee80b9af19e02cbdc1795f"],"source_doc_id":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f","source_page":null,"source_anchor":"Cardio 2eb46f2986ee80b9af19e02cbdc1795f-21","focus_area":"Action Potential Phases","tags":["usmle-step2","cardiology","pathophysiology","arrhythmia"]}
{"chunk_type":"transcript_chunk","text":"# LM_pulmo\n# Physiology\n---\n## 2. The Ventilator Framework: A Mental Model ğŸ§ \nICUì˜ ì¸ê³µí˜¸í¡ê¸°(Ventilator)ëŠ” ë³µì¡í•´ ë³´ì´ì§€ë§Œ, ë³¸ì§ˆì ìœ¼ë¡œ **ë‘ ê°€ì§€** ë³„ê°œì˜ ë¬¸ì œë¥¼ ê´€ë¦¬í•˜ëŠ” ê²ƒì…ë‹ˆë‹¤.\n| **ê¸°ëŠ¥** | **ëª©í‘œ** | **ì¡°ì ˆ ë ˆë²„ (Controls)** |\n| --- | --- | --- |\n| **Oxygenation (ì‚°ì†Œí™”)** | í˜ˆì•¡ì— ì‚°ì†Œ ê³µê¸‰ (Raise PO2) | **FiO2** (ì‚°ì†Œ ë†ë„), **PEEP** (í˜¸ê¸°ë§ ì–‘ì••) |\n| **Ventilation (í™˜ê¸°)** | ì´ì‚°í™”íƒ„ì†Œ ë°°ì¶œ (Remove CO2) | **Respiratory Rate** (RR), **Tidal Volume** (TV) |\n### A. Oxygenation Controls (ì‚°ì†Œí™” ì¡°ì ˆ) ğŸ”´\n1. **FiO2 (Fraction of Inspired Oxygen)**: í¡ì… ì‚°ì†Œ ë†ë„. (ëŒ€ê¸° 21% ~ 100%)\n2. **PEEP (Positive End-Expiratory Pressure)**: í˜¸í¡ ëì— íí¬ê°€ ìª¼ê·¸ë¼ë“¤ì§€ ì•Šê²Œ ì¡ì•„ì£¼ëŠ” ì••ë ¥.\n    - *Rule*: SpO2ê°€ ë‚®ìœ¼ë©´(ì €ì‚°ì†Œì¦), **FiO2**ë¥¼ ì˜¬ë¦¬ê±°ë‚˜ **PEEP**ì„ ì˜¬ë¦½ë‹ˆë‹¤.\n    - â˜… **Safety Rule**: 100% ì‚°ì†Œë¥¼ ì˜¤ë˜ ì“°ë©´ **Oxygen Toxicity** (Free radical ì†ìƒ)ê°€ ë°œìƒí•©ë‹ˆë‹¤. ëª©í‘œëŠ” FiO2ë¥¼ 60% ë¯¸ë§Œìœ¼ë¡œ ë‚®ì¶”ëŠ” ê²ƒì…ë‹ˆë‹¤. ì´ë¥¼ ìœ„í•´ **PEEPì„ ë†’ì—¬ì„œ** íí¬ë¥¼ ì—´ì–´ë‘ê³  ì‚°ì†Œ ë†ë„ëŠ” ì¤„ì´ëŠ” ì „ëµì„ ì”ë‹ˆë‹¤.\n### B. Ventilation Controls (í™˜ê¸° ì¡°ì ˆ) ğŸ”µ\n1. **Respiratory Rate (RR)**: í˜¸í¡ìˆ˜.\n2. **Tidal Volume (TV)**: 1íšŒ í™˜ê¸°ëŸ‰.\n    - *Rule*: CO2ê°€ ë†’ìœ¼ë©´(ì‚°ì¦), **RR**ì„ ë†’ì´ê±°ë‚˜ **TV**ë¥¼ í‚¤ì›Œì„œ CO2ë¥¼ ì”»ì–´ëƒ…ë‹ˆë‹¤ (Blow off).\n    - **Minute Ventilation (ë¶„ë‹¹ í™˜ê¸°ëŸ‰)** = RR Ã— TV. ë‘˜ ì¤‘ í•˜ë‚˜ë¥¼ ì˜¬ë¦¬ë©´ ë¨.\n    - â˜… **Safety Rule**: **Tidal Volumeì€ Ideal Body Weight (IBW) ê¸°ì¤€ 6-8 mL/kg**ë¡œ ì„¤ì •í•´ì•¼ í•©ë‹ˆë‹¤. (ì‹¤ì œ ì²´ì¤‘ ì•„ë‹˜! 150kg í™˜ìë„ í‚¤ê°€ ì‘ìœ¼ë©´ í ìš©ì ì€ ì‘ìŒ). ê³¼ë„í•œ TVëŠ” íë¥¼ í„°ëœ¨ë¦´ ìˆ˜ ìˆìŒ (**Barotrauma/Volutrauma**).\n---\n## 3. ARDS Strategy: \"Baby Lung\" Concept ğŸ‘¶ğŸ«\n**ARDS (Acute Respiratory Distress Syndrome)** í™˜ìì˜ íëŠ” ë”±ë”±í•˜ê³  ë¬´ê²ê³  ì –ì–´ ìˆìŠµë‹ˆë‹¤(Stiff, wet, heavy). ê¸°ëŠ¥í•˜ëŠ” í ìš©ì ì€ ì•„ì£¼ ì‘ìŠµë‹ˆë‹¤ (Baby lung).\n- **Lung Protective Ventilation (í ë³´í˜¸ í™˜ê¸°)** ì „ëµ:\n    1. **Low Tidal Volume**: ì‘ì€ íì— ë§ì¶° TVë¥¼ ë‚®ê²Œ ì„¤ì • (**4-6 mL/kg**ê¹Œì§€ ì¤„ì„).\n    2. **High PEEP**: ì –ì€ íí¬ê°€ ì°Œê·¸ëŸ¬ì§€ëŠ” ê²ƒì„ ë§‰ê¸° ìœ„í•´ PEEPì„ ë†’ê²Œ ì„¤ì • (> 10 cmH2O).\n    3. **Permissive Hypercapnia**: TVë¥¼ ì¤„ì˜€ìœ¼ë‹ˆ CO2ê°€ ì¢€ ìŒ“ì—¬ë„(pH > 7.25) ìš©ì¸í•©ë‹ˆë‹¤. íë¥¼ í„°ëœ¨ë¦¬ëŠ” ê²ƒë³´ë‹¤ ë‚˜ìŒ.\n    4. **Prone Positioning (ì—ë“œë¦° ìì„¸)**: ë“± ìª½ í(Dorsal lung)ë¥¼ í´ì„œ ì‚°ì†Œí™”ë¥¼ ê°œì„ í•˜ê³  ì‚¬ë§ë¥ ì„ ë‚®ì¶¤. (â˜… **Mortality Benefit** ìˆìŒ!)\n---\n## 4. The Pressure Puzzle: PIP vs. Plateau ğŸ§©\në²¤í‹¸ë ˆì´í„° ì•ŒëŒì´ \"High Pressure!\"ë¼ê³  ìš¸ë¦´ ë•Œ, ë‘ ê°€ì§€ ìˆ«ìë¥¼ í™•ì¸í•˜ë©´ ì§„ë‹¨ì´ ëë‚©ë‹ˆë‹¤.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-1","focus_area":"Ventilator Framework + ARDS","tags":["usmle-step2","pulmonology","diagnosis","treatment","table"]}
{"chunk_type":"transcript_chunk","text":"# Ventilator Alarm + Pulmonary Pattern Recognition\n## Diagnosis\n- PIP ìƒìŠ¹ + plateau ì •ìƒ: airway resistance problem(ê¸°ê´€ì§€ì—°ì¶•, mucus plug, tube issue).\n- PIP ìƒìŠ¹ + plateau ìƒìŠ¹: compliance problem(ARDS, edema, pneumonia, pneumothorax).\n- Capnography shark-finì€ obstructive pattern ë‹¨ì„œ.\n\n## Treatment linkage\n- ì›ì¸ì— ë”°ë¼ bronchodilator/suction/reposition/decompression ë“± ì¦‰ì‹œ ì²˜ì¹˜ë¥¼ ë¶„ê¸°.\n- hypoxemia í‰ê°€ëŠ” A-a gradient ê¸°ë°˜ìœ¼ë¡œ V/Q mismatch vs shuntë¥¼ êµ¬ë¶„.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-21","focus_area":"Ventilator Pressure Pattern","tags":["usmle-step2","pulmonology","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Toxic Inhalation Core: Carbon Monoxide / Methemoglobinemia / Cyanide\n- CO: pulse ox ì‹ ë¢° ë¶ˆê°€, co-oximetryë¡œ ì§„ë‹¨, 100% O2 Â± hyperbaric consideration.\n- Methemoglobinemia: saturation gap + chocolate-blood clue, methylene blue.\n- Cyanide: severe lactic acidosis context, hydroxocobalamin.\n- house-fire scenarioì—ì„œëŠ” ë³µí•© ë…ì„± ê°€ëŠ¥ì„±ì„ í•­ìƒ ì—¼ë‘.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-41","focus_area":"Inhalation Toxicology","tags":["usmle-step2","pulmonology","toxicology","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Carbon Monoxide Diagnostic Pitfall\n- Pulse oximeterëŠ” COHbë¥¼ oxyhemoglobinìœ¼ë¡œ ì˜¤ì¸í•´ ì •ìƒì²˜ëŸ¼ ë³´ì¼ ìˆ˜ ìˆìŒ.\n- ABG ìì²´ ìˆ˜ì¹˜ë³´ë‹¤ co-oximetryê°€ í™•ì§„ì— ì¤‘ìš”.\n- smoke inhalationì—ì„œëŠ” ì‹ ê²½í•™ ì¦ìƒ/ischemia riskë¥¼ ê°™ì´ í‰ê°€.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-61","focus_area":"CO Diagnostic Pitfall","tags":["usmle-step2","pulmonology","diagnosis","pitfall"]}
{"chunk_type":"transcript_chunk","text":"# Cyanide + Upper Airway Emergency Notes\n- cyanide toxicityëŠ” ê³ ì –ì‚°í˜ˆì¦ê³¼ ì¡°ì§ ì €ì‚°ì†Œ ì¶”ì •ì´ í•µì‹¬.\n- airway compromise ì˜ì‹¬ ì‹œ imagingë³´ë‹¤ ë¨¼ì € airway/oxygenation stabilization.\n- clinical instabilityê°€ ìˆìœ¼ë©´ empiric antidoteë¥¼ ì§€ì²´í•˜ì§€ ì•ŠìŒ.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-81","focus_area":"Cyanide & Airway Emergency","tags":["usmle-step2","pulmonology","emergency","treatment"]}
{"chunk_type":"recap_summary","text":"# Rapid Fire Recap: Toxic Pulmo Essentials\n- CO: pulse ox false reassurance, co-oximetry mandatory, 100% oxygen treatment.\n- Methemoglobinemia: saturation gap + methylene blue.\n- Cyanide: severe lactic acidosis + hydroxocobalamin.\n- Massive hemoptysis: bad lung down strategy.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-94","focus_area":"Rapid Fire Toxic Recap","tags":["usmle-step2","recap","pulmonology","quiz-ready"]}
{"chunk_type":"transcript_chunk","text":"ê°‘ì‘ìŠ¤ëŸ¬ìš´ í˜¸í¡ ê³¤ë€ê³¼ ì†ŒìŒì´ ë°œìƒí–ˆì„ ë•Œ ê°€ì¥ ë¨¼ì € êµ¬ë¶„í•´ì•¼ í•  ë‘ ê°€ì§€ì…ë‹ˆë‹¤.\n| **êµ¬ë¶„** | **Croup (Laryngotracheobronchitis)** | **Foreign Body Aspiration (ì´ë¬¼ì§ˆ í¡ì¸)** |\n| --- | --- | --- |\n| **ì¦ìƒ** | Barking Seal Cough (ì§–ëŠ” ë“¯í•œ ê¸°ì¹¨) ğŸ¦­, ì—´(Fever), ì½§ë¬¼(Runny nose) | **No Fever**, **Sudden Onset** (ê°‘ì‘ìŠ¤ëŸ¬ìš´ ë°œìƒ) |\n| **íŠ¹ì§•** | ì•¼ê°„ì— ì•…í™”ë¨, Viral Protoplasms | ì•„ì´ê°€ ì˜ ë†€ë‹¤ê°€ ê°‘ìê¸° ì¼ì¼ê±°ë¦¼ (LEGO ë“± ì‚¼í‚´) |\n| **ì²­ì§„ ì†Œê²¬** | ìƒê¸°ë„ ì „ì²´ì— ì—¼ì¦ ì†Œê²¬ | â˜… **Focal Finding** (í•œìª½ì—ì„œë§Œ ì†Œë¦¬ê°€ ê°ì†Œí•¨ - Diminished breath sounds on one side) |\n| **í•µì‹¬ ë‹¨ì„œ** | \"Steeple sign\" (X-ray), Barking cough | History is King! (ë³´í˜¸ìê°€ ëª» ë´¤ì–´ë„ ì˜ì‹¬í•´ì•¼ í•¨) |\n---\n## 3. Chronic Pediatric Stridor: The Big Three ğŸ‘¶\në§Œì„±ì ì¸ Stridor(ìˆ˜ì£¼ ì´ìƒ ì§€ì†)ì˜ ê²½ìš°, **Top 3 ì›ì¸**ì„ ë°˜ë“œì‹œ êµ¬ë³„í•´ì•¼ í•©ë‹ˆë‹¤.\n### A. Laryngomalacia (í›„ë‘ì—°í™”ì¦) - The MVP ğŸ†\n- **ì •ì˜:** ì„ ì²œì ìœ¼ë¡œ í›„ë‘ ì¡°ì§ì´ ë„ˆë¬´ ë¶€ë“œëŸ¬ì›Œ(Floppy), ìˆ¨ì„ ë“¤ì´ë§ˆì‹¤ ë•Œ ìŒì••ìœ¼ë¡œ ì¸í•´ ê¸°ë„ê°€ ì°Œê·¸ëŸ¬ì§€ëŠ” í˜„ìƒ.\n- **Visual:** \"Wet paper straw\" ğŸ¥¤ (ì –ì€ ì¢…ì´ ë¹¨ëŒ€ë¡œ ì‰ì´í¬ë¥¼ ë§ˆì‹¤ ë•Œ ë¹¨ëŒ€ê°€ ë‹¬ë¼ë¶™ëŠ” ê²ƒê³¼ ê°™ìŒ).\n- **ì•…í™”/ì™„í™” ìš”ì¸ (Position is Everything!):**\n    - **Supine (ëˆ„ì› ì„ ë•Œ):** ì¤‘ë ¥ì— ì˜í•´ ì¡°ì§ì´ ë’¤ë¡œ ì³ì ¸ ì¦ìƒ ì•…í™” ğŸ“‰.\n    - **Prone (ì—ë“œë ¸ì„ ë•Œ):** ì¤‘ë ¥ì— ì˜í•´ ê¸°ë„ê°€ ì—´ë ¤ ì¦ìƒ ì™„í™” ğŸ“ˆ.\n- **ì§„ë‹¨:** Flexible Fiberoptic Laryngoscopy â†’ **Omega (Î©) shaped epiglottis** í™•ì¸.\n- **ì¹˜ë£Œ:** â˜… **Reassurance (ì•ˆì‹¬ì‹œí‚¤ê¸°).** ìƒí›„ 18ê°œì›”ê²½ ì—°ê³¨ì´ ë‹¨ë‹¨í•´ì§€ë©° ìì—° ì¹˜ìœ ë¨. (ìˆ˜ìˆ ì€ ì•„ì´ê°€ ì„±ì¥ë¶€ì§„/ì €ì‚°ì†Œì¦ì´ ìˆì„ ë•Œë§Œ ì‹œí–‰ - Supraglottoplasty).\n    - *Management Note:* GERD(ì—­ë¥˜)ê°€ ë™ë°˜ë˜ë©´ ì¦ìƒì´ ì•…í™”ë˜ë¯€ë¡œ ì—­ë¥˜ ì¹˜ë£Œê°€ ë„ì›€ì´ ë¨.\n### B. Vascular Ring (í˜ˆê´€ ê³ ë¦¬) ğŸ’\n- **ë©”ì»¤ë‹ˆì¦˜:** ëŒ€ë™ë§¥ê¶(Aortic arch) ë“±ì˜ í˜ˆê´€ì´ ë¹„ì •ìƒì ìœ¼ë¡œ í˜•ì„±ë˜ì–´ ê¸°ë„(Trachea)ì™€ ì‹ë„(Esophagus)ë¥¼ ë‘˜ëŸ¬ì‹¸ê³  ì¡°ì´ëŠ” ìƒíƒœ.\n- **ì°¨ë³„ì :** â˜… **Neck Extension(ëª© ì‹ ì „) ì‹œ í˜¸ì „ë¨.**\n    - ë¬´ì–¸ê°€ ëª©ì„ ì¡°ì¼ ë•Œ ë³¸ëŠ¥ì ìœ¼ë¡œ ëª©ì„ ë’¤ë¡œ ì –í˜€ ê¸°ë„ë¥¼ í™•ë³´í•˜ë ¤ëŠ” ìì„¸ë¥¼ ì·¨í•¨.\n- **ì¦ìƒ:** í˜¸í¡ê³¤ë€ + **Dysphagia (ì—°í•˜ê³¤ë€/êµ¬í† ).** (ì‹ë„ë„ ê°™ì´ ëˆŒë¦¬ê¸° ë•Œë¬¸).\n### C. Airway Hemangioma (ê¸°ë„ í˜ˆê´€ì¢…) ğŸ“\n- **ì •ì˜:** ê¸°ë„ ë‚´ë¶€ì— ìƒê¸´ ì–‘ì„± í˜ˆê´€ ì¢…ì–‘.\n- **ë‹¨ì„œ (Clue):** â˜… **Beard Distribution Hemangioma** (í„± ë¼ì¸ì„ ë”°ë¼ í”¼ë¶€ì— ë”¸ê¸° ê°™ì€ ë¶‰ì€ ë°˜ì ì´ ìˆëŠ” ê²½ìš°, ê¸°ë„ ì•ˆì—ë„ ìˆì„ í™•ë¥  ë†’ìŒ).\n- **ì¦ìƒ:** Biphasic Stridor (í¡ê¸°/í˜¸ê¸° ëª¨ë‘ì—ì„œ ì†Œë¦¬ê°€ ë‚¨).\n---\n## 4. Adult & Older Kids Airway Issues ğŸ§‘\nì„±ì¸ì´ë‚˜ í° ì•„ì´ë“¤ì˜ í˜¸í¡ ê³¤ë€ ì›ì¸ì€ ë‹¤ë¦…ë‹ˆë‹¤.\n### A. Tracheal Stenosis (ê¸°ê´€ í˜‘ì°©)\n- **ë³‘ë ¥ (History):** â˜… **ICU ì…ì› ë˜ëŠ” ì¥ê¸°ê°„ ì‚½ê´€(Intubation) ê³¼ê±°ë ¥.**\n- **ë©”ì»¤ë‹ˆì¦˜:** ì‚½ê´€ íŠœë¸Œì˜ ì»¤í”„(Cuff) ì••ë ¥ìœ¼ë¡œ ì¸í•œ í‰í„°(Scarring) í˜•ì„± â†’ ê³ ì •ëœ ì¢ì€ ê¸°ë„(Fixed rigid narrowing).\n- **íŠ¹ì§•:** ë°œê´€(Extubation) í›„ ê´œì°®ë‹¤ê°€ ëª‡ ì£¼ ë’¤ ìŒ•ìŒ•ê±°ë¦¼(Wheezing) ì‹œì‘. ì²œì‹ìœ¼ë¡œ ì˜¤ì§„í•˜ê¸° ì‰¬ì›€.\n### B. Vocal Cord Dysfunction (VCD, ì„±ëŒ€ ê¸°ëŠ¥ ë¶€ì „)\n- **ë³„ëª…:** \"The Asthma that isn't Asthma\" (ì²œì‹ì´ ì•„ë‹Œ ì²œì‹).\n- **í™˜ìêµ°:** ì Šì€ ì—¬ì„±, ìš´ë™ì„ ìˆ˜, ìŠ¤íŠ¸ë ˆìŠ¤ ìƒí™©, Type A ì„±ê²©.\n- **ì¦ìƒ:** ìˆ¨ì„ ë“¤ì´ë§ˆì‹¤ ë•Œ(Inspiration) ì„±ëŒ€ê°€ ì—´ë ¤ì•¼ í•˜ëŠ”ë° ì—­ì„¤ì ìœ¼ë¡œ ë‹«í˜(Adduct). í—ë–¡ê±°ë¦¼(Gasping).\n- **ê°ë³„ í¬ì¸íŠ¸:** ê¸°ê´€ì§€í™•ì¥ì œ(Albuterol)ë¥¼ ì¨ë„ íš¨ê³¼ ì—†ìŒ âŒ.\n- **ì§„ë‹¨:** Laryngoscopyë¡œ í¡ê¸° ì‹œ ì„±ëŒ€ê°€ ë‹«íˆëŠ” ê²ƒì„ í™•ì¸.\n- **ì¹˜ë£Œ:** **Speech Therapy (ì–¸ì–´ ì¹˜ë£Œ)** & â˜… **Sniffing Maneuver** (ê½ƒ ëƒ„ìƒˆ ë§¡ë“¯ ì½”ë¡œ í‚í‚ê±°ë¦¬ë©´ ë°˜ì‚¬ì ìœ¼ë¡œ ì„±ëŒ€ê°€ ì—´ë¦¼ - Physiological trick).\n---\n## 5. Oral Masses (ì…ì•ˆì˜ ë©ì–´ë¦¬) ğŸ‘„","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-104","focus_area":"Croup vs Foreign Body","tags":["usmle-step2","pulmonology","pediatrics","diagnosis","table"]}
{"chunk_type":"transcript_chunk","text":"| **ì§„ë‹¨ëª…** | **íŠ¹ì§• ë° ì†Œê²¬** | **ê´€ë¦¬/ì¹˜ë£Œ (Management)** |\n| --- | --- | --- |\n| **Torus Palatinus** | ì…ì²œì¥(Hard Palate) ì¤‘ì•™ì˜ ëŒì²˜ëŸ¼ ë”±ë”±í•œ ë©ì–´ë¦¬(Bony mass). ì•”ì´ ì•„ë‹˜. | **Leave it alone (ê´€ì°°).** ì˜ì¹˜(Denture) ì œì‘ ì‹œ ë°©í•´ë  ë•Œë§Œ ì œê±°. |\n| **Leukoplakia** | í˜€ë‚˜ ì…ì•ˆì˜ í•˜ì–€ ë°˜ì  (White patch). | **ë¨¼ì € ë‹¦ì•„ë³¸ë‹¤ (Wipe it off!).** |\n| (1) ë‹¦ì¸ë‹¤ë©´? | **Oral Thrush (Candidiasis).** ê¸°ì € ì§ˆí™˜ ì˜ì‹¬. | Anti-fungal ì¹˜ë£Œ + â˜… **HIV/Diabetes ê²€ì‚¬.** |\n| (2) ì•ˆ ë‹¦ì¸ë‹¤ë©´? | **True Leukoplakia.** ì „ì•”ì„± ë³‘ë³€(Pre-malignant) ê°€ëŠ¥ì„±. | â˜… **Biopsy (ì¡°ì§ê²€ì‚¬)** í•„ìˆ˜. (Squamous Cell Ca ë°°ì œ) |\n| **Hairy Leukoplakia** | í˜€ì˜ ì¸¡ë©´(Lateral border)ì— ê¹ƒí„¸/ì£¼ë¦„ì§„ ëª¨ì–‘. | **EBV (Epstein-Barr Virus)** ê´€ë ¨. ë©´ì—­ì €í•˜ì(HIV)ì—ì„œ ë°œìƒ. ì „ì•”ì„± ì•„ë‹˜. |\n---\n## 6. Deep Neck Space Infections (ì‹¬ê²½ë¶€ ê°ì—¼) ğŸ¦ \n### A. Retropharyngeal Abscess (ì¸ë‘í›„ ë†ì–‘)\n- **ëŒ€ìƒ:** **Toddlers (2~4ì„¸).** (Retropharyngeal ë¦¼í”„ì ˆì€ 6ì„¸ ì´í›„ í‡´í™”ë¨).\n- **ì¦ìƒ:** ê³ ì—´, ì¹¨ í˜ë¦¼, **Stiff Neck (ëª©ì„ ëª» ì›€ì§ì„).**\n- **ìœ„í—˜ì„±:** \"Danger Space\"ë¥¼ í†µí•´ ê°€ìŠ´(Mediastinum)ìœ¼ë¡œ ë†ì–‘ì´ ë‚´ë ¤ê°€ **Mediastinitis** ìœ ë°œ ê°€ëŠ¥ ğŸ’€.\n### B. Peritonsillar Abscess (í¸ë„ì£¼ìœ„ ë†ì–‘)\n- **ëŒ€ìƒ:** **Teenagers & Adults.**\n- **ì¦ìƒ:**\n    - **Trismus (ê°œêµ¬ì¥ì• ):** ì…ì„ ë²Œë¦¬ì§€ ëª»í•¨.\n    - **Hot Potato Voice:** ëœ¨ê±°ìš´ ê°ìë¥¼ ë¬¸ ë“¯í•œ ëª©ì†Œë¦¬.\n    - **Uvula Deviation:** ëª©ì –ì´ ë³‘ë³€ ë°˜ëŒ€ìª½ìœ¼ë¡œ ë°€ë ¤ë‚¨.\n- **ì¹˜ë£Œ:** Needle Aspiration (ë°”ëŠ˜ í¡ì¸) or I & D + Antibiotics.\n---\n## 7. Sinusitis (ë¶€ë¹„ë™ì—¼) ğŸ¤§\nëŒ€ë¶€ë¶„ ë°”ì´ëŸ¬ìŠ¤ì„±ì´ë¯€ë¡œ í•­ìƒì œê°€ í•„ìš” ì—†ìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ **ì„¸ê· ì„±(Bacterial)** ì„ ì‹œì‚¬í•˜ëŠ” **3ê°€ì§€ ì¡°ê±´** ì¤‘ í•˜ë‚˜ë¼ë„ ë§Œì¡±í•˜ë©´ í•­ìƒì œ(Amoxicillin-Clavulanate)ë¥¼ ì‚¬ìš©í•©ë‹ˆë‹¤.\n1. â˜… **Persistence:** ì¦ìƒì´ **10ì¼ ì´ìƒ** ì§€ì†ë˜ë©° í˜¸ì „ ì—†ìŒ.\n2. **Severe Onset:** ì‹œì‘ë¶€í„° 39ë„ ì´ìƒì˜ ê³ ì—´(102Â°F+) + í™”ë†ì„± ì½§ë¬¼(Purulent discharge)ì´ 3ì¼ ì´ìƒ ì§€ì†.\n3. **Double Sickening:** ê°ê¸°ê°€ ë‚«ëŠ” ë“¯í•˜ë‹¤ê°€(Day 5~6) ê°‘ìê¸° ë‹¤ì‹œ ê³ ì—´ê³¼ ë‘í†µìœ¼ë¡œ ì•…í™”ë¨.\n---\n## 8. Nasopharyngeal Carcinoma (ë¹„ì¸ë‘ì•”) & Neck Masses\n### Nasopharyngeal Carcinoma (NPC)\n- **ì—°ê´€ì„±:** **EBV (Epstein-Barr Virus)**, ì¤‘êµ­ ë‚¨ë¶€ ì¶œì‹ (Southern China).\n- **ì„±ì¸ì˜ Triad ì¦ìƒ:**\n    1. Nasal Congestion (ì½”ë§‰í˜).\n    2. Epistaxis (ì½”í”¼).\n    3. **Serous Otitis Media (ì‚¼ì¶œì„± ì¤‘ì´ì—¼):** ì„±ì¸ì—ì„œ í•œìª½ ê·€ì— ë¬¼ì´ ì°¼ë‹¤ë©´ ì¢…ì–‘ì´ ìœ ìŠ¤íƒ€í‚¤ì˜¤ê´€(Eustachian tube)ì„ ë§‰ê³  ìˆëŠ”ì§€ ì˜ì‹¬í•´ì•¼ í•¨.\n### Neck Masses (ê²½ë¶€ ì¢…ê´´) ìœ„ì¹˜ë³„ ê°ë³„\n- **Midline (ì •ì¤‘ì•™):**\n    - **Thyroglossal Duct Cyst:** í˜€ë¥¼ ë‚´ë°€ë©´(Protrude tongue) ë©ì–´ë¦¬ê°€ ìœ„ë¡œ ì›€ì§ì„ ğŸ‘…. (ìˆ˜ìˆ ì  ì œê±° í•„ìš” - Sistrunk procedure).\n- **Lateral (ì¸¡ë©´, SCM ê·¼ìœ¡ ì•):**\n    - **Branchial Cleft Cyst:** ì„ ì²œì„± ë‚­ì¢…. ë•Œë•Œë¡œ ëˆ„ê³µ(Fistula) í˜•ì„±.\n- **Posterior Triangle / Transilluminates:**\n    - **Cystic Hygroma (Lymphangioma):** ë¹›ì„ ë¹„ì¶”ë©´ í†µê³¼í•¨(Transilluminate). í„°ë„ˆ ì¦í›„êµ°(Turner Syndrome)ê³¼ ì—°ê´€.\n---","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-124","focus_area":"Upper Airway Differential Table","tags":["usmle-step2","pulmonology","diagnosis","treatment","table"]}
{"chunk_type":"recap_summary","text":"# Rapid Fire Recap: Pediatric Stridor\n- inspiratory stridor patternê³¼ ìì„¸ ë³€í™”ë¡œ laryngomalaciaë¥¼ êµ¬ë¶„.\n- sudden onset/unilateral findingì´ë©´ foreign body aspiration ìš°ì„ .\n- red flag(ë…ì„± ì™¸ê´€, drooling, severe distress) ì‹œ airway team ìš°ì„  í˜¸ì¶œ.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-142","focus_area":"Pediatric Stridor Recap","tags":["usmle-step2","recap","pediatrics","airway"]}
{"chunk_type":"transcript_chunk","text":"# Upper Respiratory / Airway Emergency Intro (Clinical Focus)\n- í•µì‹¬ì€ â€œsick vs not sickâ€ ì¦‰ì‹œ ë¶„ë¥˜.\n- ì§„ë‹¨ ë¼ë²¨ë³´ë‹¤ airway ì•ˆì •í™”, ì‚°ì†Œí™”, next-step ê²°ì •ì´ ìš°ì„ .\n- Step 2ì—ì„œëŠ” ì‹œê°„ ë¯¼ê°í•œ ì˜ì‚¬ê²°ì •(ê¸°ë„ í™•ë³´, ì˜ìƒ, í•­ìƒì œ/ìŠ¤í…Œë¡œì´ë“œ, ìˆ˜ìˆ  consultation)ì´ ì ìˆ˜ í¬ì¸íŠ¸.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-152","focus_area":"Airway Emergency Framework","tags":["usmle-step2","pulmonology","next-step","emergency"]}
{"chunk_type":"transcript_chunk","text":"# Retropharyngeal Abscess Pattern\n- ì†Œì•„(íŠ¹íˆ 2-4ì„¸) + URI ì´í›„ neck stiffness/torticollis/droolingì´ë©´ ì˜ì‹¬.\n- ì„±ì¸ì—ì„œëŠ” ì™¸ìƒ/ê¸°êµ¬ ì¡°ì‘ ë³‘ë ¥ì´ ë‹¨ì„œ.\n- unstable airway signs ìˆìœ¼ë©´ imaging ì§€ì—°í•˜ê³  airway/surgical team ìš°ì„ .","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-172","focus_area":"Retropharyngeal Abscess","tags":["usmle-step2","ent","diagnosis","emergency","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Acute Rhinosinusitis: Viral vs Bacterial\n- ëŒ€ë¶€ë¶„ viralì´ë¼ ì´ˆê¸°ì— í•­ìƒì œ ë¶ˆí•„ìš”.\n- bacterial clue: severe onset, prolonged >10 days, double-worsening.\n- í•­ìƒì œ ì‹œì‘ ì—¬ë¶€ëŠ” ì„ìƒ ê¸°ì¤€ê³¼ í•©ë³‘ì¦ ìœ„í—˜ìœ¼ë¡œ ê²°ì •.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-192","focus_area":"Rhinosinusitis","tags":["usmle-step2","ent","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Practical Decision-Tree Mindset (Step 2)\n- ê¸°ì „ ì„¤ëª…ë³´ë‹¤ â€œì§€ê¸ˆ í•  í–‰ë™â€ì´ ìš°ì„ .\n- symptom cluster + risk + instabilityë¥¼ ë¬¶ì–´ next-stepì„ ì¦‰ì‹œ ì„ íƒ.\n- airway/respiratory casesëŠ” deterioration ì†ë„ê°€ ë¹¨ë¼ reassessment intervalì„ ì§§ê²Œ ë‘”ë‹¤.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-212","focus_area":"Decision Tree Mindset","tags":["usmle-step2","framework","next-step","emergency"]}
{"chunk_type":"transcript_chunk","text":"# Septal Hematoma (Nasal Trauma Emergency)\n## Diagnosis\n- nasal trauma í›„ septumì˜ soft, fluctuant swellingì€ septal hematoma ì˜ì‹¬.\n\n## Treatment\n- ì¦‰ì‹œ drainage + ENT follow-up.\n- ì§€ì—° ì‹œ cartilage necrosis, saddle-nose deformity ìœ„í—˜.\n- ë‹¨ìˆœ ë¹„ì¶œí˜ˆê³¼ êµ¬ë¶„í•´ â€œë†“ì¹˜ë©´ ì•ˆ ë˜ëŠ” ë‹¤ìŒ ë‹¨ê³„â€ë¡œ ê¸°ì–µ.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-232","focus_area":"Septal Hematoma","tags":["usmle-step2","ent","diagnosis","treatment","next-step"]}
{"chunk_type":"transcript_chunk","text":"# Pediatric Airway Sounds Core\n## Diagnosis\n- Inspiratory stridor + supine ì•…í™”ëŠ” laryngomalaciaë¥¼ ìš°ì„  ì‹œì‚¬.\n- sudden onset + unilateral breath sound ë³€í™”ëŠ” foreign body aspiration ê°€ëŠ¥ì„± ë†’ìŒ.\n- barking cough/viral prodromeë©´ croup íŒ¨í„´ì„ ìš°ì„  ê³ ë ¤.\n\n## Treatment\n- mild laryngomalaciaëŠ” ê²½ê³¼ê´€ì°°ì´ ê¸°ë³¸.\n- croupëŠ” dexamethasone, ì¤‘ë“±ë„ ì´ìƒì€ nebulized epinephrine ê³ ë ¤.\n- foreign body ì˜ì‹¬ ì‹œ bronchoscopy ê¸°ë°˜ ì œê±°ê°€ definitive.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-252","focus_area":"Pediatric Airway Sounds","tags":["usmle-step2","pulmonology","pediatrics","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"## 2. ì „ë°© ì¢…ê²©ë™ (Anterior Mediastinum): The \"4 Ts\"\nì „ë°© ì¢…ê²©ë™ì€ í‰ê³¨(Sternum)ê³¼ ì‹¬ì¥ ì‚¬ì´ì˜ ê³µê°„ì…ë‹ˆë‹¤. ì´ê³³ì˜ ì¢…ê´´ëŠ” **'4 Ts'**ë¡œ ê¸°ì–µí•´ì•¼ í•©ë‹ˆë‹¤.\n### ğŸš© 1. Thymoma (í‰ì„ ì¢…)\n- **ì—°ê´€ ì§ˆí™˜:** **â˜… ì¤‘ì¦ê·¼ë¬´ë ¥ì¦ (Myasthenia Gravis)**. í‰ì„ ì¢… í™˜ìì˜ 30~50%ê°€ ì¤‘ì¦ê·¼ë¬´ë ¥ì¦ì„ ë™ë°˜í•©ë‹ˆë‹¤.\n- **ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤:** ì „ë°© ì¢…ê´´ + ì•ˆê²€í•˜ìˆ˜(Ptosis) ë˜ëŠ” í•˜ë£¨ ì¤‘ ì‹¬í•´ì§€ëŠ” ê·¼ë ¥ ì•½í™”.\n- **ì¶”ê°€ ì—°ê´€ì„±:** ìˆœìˆ˜ ì í˜ˆêµ¬ ë¬´í˜•ì„±ì¦(Pure red cell aplasia)ê³¼ë„ ì—°ê´€ë  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n### ğŸš© 2. Thyroid Neoplasm (ê°‘ìƒì„  ì¢…ì–‘)\n- **íŠ¹ì§•:** ì¼ë°˜ì ì¸ ëª©ì˜ ê²°ì ˆì´ ì•„ë‹Œ, í‰ê³½ ë‚´ë¡œ ìë¼ ë‚´ë ¤ì˜¨ **í‰ê³¨í•˜ ê°‘ìƒì„ ì¢…(Substernal Goiter)**ì…ë‹ˆë‹¤.\n- **ì˜ìƒ ì†Œê²¬:** ì—‘ìŠ¤ë ˆì´ìƒ ê¸°ê´€(Trachea)ì´ ì˜†ìœ¼ë¡œ ë°€ë¦° ì†Œê²¬(Deviation)ì´ í”í•©ë‹ˆë‹¤.\n- **ì¦ìƒ:** ì••ë°• ì¦ìƒ (ì‚¼í‚´ ê³¤ë€, í˜‘ì°©ìŒ ë“±).\n- **â˜… Pemberton's Sign (í¨ë²„íŠ¼ ì§•í›„):**\n    - í™˜ìì—ê²Œ ì–‘íŒ”ì„ ë¨¸ë¦¬ ìœ„ë¡œ ë“¤ê²Œ í–ˆì„ ë•Œ, í‰ê³¨í•˜ ê°‘ìƒì„ ì¢…ì´ í‰ê³½ ì…êµ¬ë¥¼ ë§‰ì•„ ì¼ì‹œì ì¸ **ìƒëŒ€ì •ë§¥ ì¦í›„êµ°(SVC syndrome)**ì„ ìœ ë°œí•©ë‹ˆë‹¤.\n    - ì–¼êµ´ì´ ë¶‰ì–´ì§€ê³ (Flushed), ëª©ì˜ ì •ë§¥ì´ í™•ì¥ë©ë‹ˆë‹¤.\n### ğŸš© 3. Teratoma (ê¸°í˜•ì¢…) & Germ Cell Tumors\n- **ëŒ€ìƒ:** ì Šì€ ì„±ì¸ (ì£¼ë¡œ 15~35ì„¸ ë‚¨ì„±).\n- **ì¢…ë¥˜:**\n    - **Teratoma:** ì¹˜ì•„ë‚˜ ë¨¸ë¦¬ì¹´ë½ ë“±ì„ í¬í•¨.\n    - **Seminoma (ì •ìƒí”¼ì¢…) & Non-seminoma.**\n- **ì§„ë‹¨ ë§ˆì»¤ (Biomarkers):** ì Šì€ ë‚¨ì„±ì—ê²Œ ì „ë°© ì¢…ê´´ê°€ ìˆë‹¤ë©´ ë°˜ë“œì‹œ í™•ì¸í•´ì•¼ í•©ë‹ˆë‹¤.\n    - **Non-seminoma:** Beta-HCGì™€ AFP ë‘˜ ë‹¤ ìƒìŠ¹.\n    - **Seminoma:** ì£¼ë¡œ Beta-HCGë§Œ ìƒìŠ¹ (AFPëŠ” ìƒìŠ¹í•˜ì§€ ì•ŠìŒ).\n### ğŸš© 4. \"Terrible\" Lymphoma (ë¦¼í”„ì¢…)\n- **ì£¼ì˜ì :** ë¦¼í”„ì¢…(íŠ¹íˆ í˜¸ì§€í‚¨ ë¦¼í”„ì¢…, ì Šì€ ì—¬ì„±)ì´ ì „ë°© ì¢…ê²©ë™ì— ìƒê¸¸ ìˆ˜ ìˆì§€ë§Œ, ë¦¼í”„ì ˆì€ ì–´ë””ì—ë‚˜ ìˆìœ¼ë¯€ë¡œ **â˜… ë¦¼í”„ì¢…ì€ ì „ë°©, ì¤‘ë°©, í›„ë°© ì–´ë””ì„œë“  ë°œìƒí•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.** (\"Tunnel vision\"ì„ ê°–ì§€ ë§ ê²ƒ!)\n### ğŸ’¡ í‰ì„ (Thymus)ì— ëŒ€í•œ ì¤‘ìš”í•œ ë‚˜ì´ë³„ ê·œì¹™\n| êµ¬ë¶„ | ì‹ ìƒì•„/ì˜ì•„ (<3ì„¸) | ì„±ì¸ |\n| --- | --- | --- |\n| **ì •ìƒ ì†Œê²¬** | **Thymic Sail Sign** (ê±°ëŒ€í•œ ì‚¼ê°í˜• ê·¸ë¦¼ì)ì€ ì •ìƒ ìƒë¦¬ì  ì†Œê²¬ì„. | í‰ì„ ì€ ìœ„ì¶•ë˜ì–´ ì§€ë°©ìœ¼ë¡œ ë³€í•¨. ì—‘ìŠ¤ë ˆì´ì—ì„œ ë³´ì´ë©´ ì•ˆ ë¨. |\n| **ë³‘ì  ì†Œê²¬** | **â˜… ê·¸ë¦¼ìê°€ ì—†ëŠ” ê²½ìš°:** ë©´ì—­ ê²°í• ì˜ì‹¬ (DiGeorge Syndrome, SCID). | **â˜… ìŒì˜ì´ ë³´ì´ëŠ” ê²½ìš°:** ë¬´ì¡°ê±´ ë³‘ì ì„ (Thymoma, Lymphoma, Germ cell tumor ë“±). ì •ë°€ ê²€ì‚¬ í•„ìš”. |\n---\n## 3. ì¤‘ë°© ì¢…ê²©ë™ (Middle Mediastinum): The Busy Center\nì‹¬ì¥, ì‹¬ë§‰(Pericardium), ëŒ€ë™ë§¥, ê¸°ë„, ì‹ë„, ê·¸ë¦¬ê³  **ë¦¼í”„ì ˆ(Lymph nodes)**ì´ ì¡´ì¬í•˜ëŠ” ë‚´ì¥ ê³µê°„(Visceral space)ì…ë‹ˆë‹¤.\n- **â˜… ë¦¼í”„ì ˆ ë¹„ëŒ€ (Lymphadenopathy):**\n    - ê°€ì¥ ë¨¼ì € ë– ì˜¬ë ¤ì•¼ í•  ì§ˆí™˜: **Sarcoidosis (ì‚¬ë¥´ì½”ì´ë“œì¦)**.\n    - **ì „í˜•ì  ì¦ìƒ:** í‘ì¸ ì—¬ì„±, ê¸°ì¹¨, **ì–‘ì¸¡ íë¬¸ ë¦¼í”„ì ˆ ë¹„ëŒ€(Bilateral Hilar Lymphadenopathy)**.\n    - ê¸°íƒ€ ì›ì¸: íì•” ì „ì´, ì§„ê·  ê°ì—¼ ë“±.\n- **ë‚­ì¢… (Cysts):**\n    - **Bronchogenic cyst:** ê¸°ë„ì˜ ë°œë‹¬ ì´ìƒ.\n    - **Pericardial cyst:** ì‹¬ë§‰ì— ë¶™ì€ ì•¡ì²´ ì£¼ë¨¸ë‹ˆ (ì£¼ë¡œ ìš°ì—°íˆ ë°œê²¬).\n- **í˜ˆê´€ ë° ì‹ë„:** ëŒ€ë™ë§¥ê¶ ë™ë§¥ë¥˜(Aortic arch aneurysm), ì‹ë„ë‚˜ ê¸°ë„ì˜ ì¢…ì–‘.\n---\n## 4. í›„ë°© ì¢…ê²©ë™ (Posterior Mediastinum): Neuro Focus\nì²™ì¶”, êµê°ì‹ ê²½ì‚¬ìŠ¬(Sympathetic chain), ì²™ì¶”ì—ì„œ ë‚˜ì˜¤ëŠ” ì‹ ê²½ë“¤ì´ ìœ„ì¹˜í•œ ê³³ì…ë‹ˆë‹¤.\n- **í•µì‹¬ í…Œë§ˆ:** **â˜… ì‹ ê²½ (Neuro)**.\n- **ê°€ì¥ í”í•œ ì§„ë‹¨:** **Neurogenic tumor (ì‹ ê²½ì¸ì„± ì¢…ì–‘)**.\n    - Schwannoma (ì‹ ê²½ì´ˆì¢…), Neurofibroma (ì‹ ê²½ì„¬ìœ ì¢…).\n- **â˜… ë¤ë²¨ ì¢…ì–‘ (Dumbbell Tumor):**\n    - ì¢…ì–‘ì´ ì¶”ê°„ê³µ(Intervertebral foramen)ì„ í†µí•´ ìë¼ë‚˜ì„œ, ì¼ë¶€ëŠ” ì²™ì¶”ê´€ì—, ì¼ë¶€ëŠ” ì¢…ê²©ë™ì— ìœ„ì¹˜í•˜ì—¬ ë¤ë²¨ ëª¨ì–‘ì„ í˜•ì„±í•©ë‹ˆë‹¤.\n- **ê¸°íƒ€ ì›ì¸:** ì²™ì¶” ì „ì´(Spinal mets), ìˆ˜ë§‰ë¥˜(Meningocele), ë¦¼í”„ì¢…(ì¹´ë©œë ˆì˜¨ì²˜ëŸ¼ ì–´ë””ë“  ì¡´ì¬ ê°€ëŠ¥), ì‹ë„ ì—´ê³µ íƒˆì¥(Hiatus hernia - ì‹¬ì¥ ë’¤ì— ê±°ëŒ€í•œ ê³µê¸° ë°©ìš¸ì´ ë³´ì„).","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-272","focus_area":"Anterior Mediastinum 4Ts","tags":["usmle-step2","pulmonology","diagnosis","oncology","next-step","table"]}
{"chunk_type":"transcript_chunk","text":"# Acute Mediastinitis (Do-Not-Miss Emergency)\n## Diagnosis\n- severe toxic appearance + fever + retrosternal chest pain + recent instrumentation/esophageal source ë³‘ë ¥ì€ mediastinitis ê²½ê³ .\n\n## Treatment\n- broad-spectrum IV antibiotics ì¦‰ì‹œ ì‹œì‘.\n- urgent surgical consultationê³¼ source controlì´ í•µì‹¬.\n- ì§€ì—° ì‹œ mortality ë†’ì•„ ì¦‰ì‹œ ëŒ€ì‘ í•„ìš”.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-292","focus_area":"Acute Mediastinitis","tags":["usmle-step2","emergency","diagnosis","treatment","surgery"]}
{"chunk_type":"recap_summary","text":"## 7. âš¡ Rapid Fire Recap (í•µì‹¬ ìš”ì•½)\n| êµ¬íš | ì£¼ìš” ì§ˆí™˜ ë° íŠ¹ì§• |\n| --- | --- |\n| **ì „ë°© (Anterior)** | **4 Ts:** Thymoma(ì¤‘ì¦ê·¼ë¬´ë ¥ì¦), Thyroid(Pemberton's sign), Teratoma(Germ cell), Terrible Lymphoma.\n**Thymus:** ì†Œì•„ëŠ” í¼(ì •ìƒ- no: Digeorge, SCID ), ì„±ì¸ì€ ì•ˆ ë³´ì—¬ì•¼ ì •ìƒ-ìˆìœ¼ë©´ bx. |\n| **ì¤‘ë°© (Middle)** | **ë¦¼í”„ì ˆ & ë‚­ì¢…:** Sarcoidosis(ì–‘ì¸¡ íë¬¸ ë¦¼í”„ì ˆ), Bronchogenic cysts. |\n| **í›„ë°© (Posterior)** | **ì‹ ê²½(Neuro):** Neurogenic tumors (Dumbbell shape). |\n| **ê¸‰ì„± ì¢…ê²©ë™ì—¼** | ìˆ˜ìˆ  í›„ ë˜ëŠ” Danger spaceë¥¼ í†µí•œ ê°ì—¼ í™•ì‚°. **ì¦‰ê°ì ì¸ ìˆ˜ìˆ ì  ë°°ë† í•„ìš”.** |\n| **ê¸°ì¢…ê²©ë™** | í‚¤ í¬ê³  ë§ˆë¥¸ ì†Œë…„ + ë°œì‚´ë°” + **Hammond's sign**. íœ´ì‹ìœ¼ë¡œ ì¹˜ë£Œ. |\n---\n## 8. ë§ˆì§€ë§‰ ì„ìƒ ì§„ì£¼ (Clinical Pearl): Clubbing & COPD ğŸ’\n- **ìƒí™©:** ì‹ ì²´ ê²€ì§„ì—ì„œ **ê³¤ë´‰ì§€(Digital Clubbing)**ê°€ ê´€ì°°ë¨.\n- **í”í•œ ì˜¤í•´:** ë§ì€ í•™ìƒë“¤ì´ ê³¤ë´‰ì§€ë¥¼ COPD(ë§Œì„±íì‡„ì„±íì§ˆí™˜)ì™€ ë°”ë¡œ ì—°ê²°ì§€ìŒ.\n- **â˜… íŒ©íŠ¸ ì²´í¬:** í•©ë³‘ì¦ì´ ì—†ëŠ” ë‹¨ìˆœ COPDëŠ” ê³¤ë´‰ì§€ë¥¼ ìœ ë°œí•˜ì§€ ì•ŠìŒ.\n- **Red Flag:** ë§Œì•½ ë§Œì„± COPD í™˜ìê°€ **ìƒˆë¡œìš´ ê³¤ë´‰ì§€**ë¥¼ ë³´ì¸ë‹¤ë©´?\n    - ë‹¨ìˆœíˆ COPD ë•Œë¬¸ì´ë¼ê³  ì¹˜ë¶€í•˜ë©´ ì•ˆ ë¨.\n    - **ìˆ¨ê²¨ì§„ ì•…ì„± ì¢…ì–‘(Occult Malignancy)**, íŠ¹íˆ **â˜… íì•”(Bronchogenic Carcinoma)**ì„ ì¦‰ì‹œ ì˜ì‹¬í•´ì•¼ í•¨.\n    - **í–‰ë™ ì§€ì¹¨:** ì¦‰ì‹œ CT ì´¬ì˜ ë“± ì •ë°€ ê²€ì‚¬ ì§„í–‰.\n# ğŸ« Obstructive Lung Disease: Battle Strategy âš”ï¸\nUSMLE Step 2ëŠ” ëª¨í˜¸í•œ ê²ƒì„ ì‹«ì–´í•©ë‹ˆë‹¤. **Binary(ì´ë¶„ë²•)**ì ì¸ ê²°ì •ì´ ìƒëª…ì…ë‹ˆë‹¤! âš–ï¸\nì˜¤ëŠ˜ì˜ ë¯¸ì…˜ì€ **Acute Bronchitis(í•¨ì •)**ì™€ **COPD(ê´´ë¬¼)**ë¥¼ ì •ë³µí•˜ëŠ” ê²ƒì…ë‹ˆë‹¤.\n---\n### 1. ğŸ¦  Acute Bronchitis (ê¸‰ì„± ê¸°ê´€ì§€ì—¼) : The Trap ğŸª¤","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-303","focus_area":"Mediastinum Rapid Recap","tags":["usmle-step2","recap","pulmonology","table","quiz-ready"]}
{"chunk_type":"transcript_chunk","text":"ì‹œí—˜ì—ì„œ ê°€ì¥ í”íˆ íŒŒëŠ” í•¨ì •ì…ë‹ˆë‹¤. \"í•­ìƒì œë¥¼ ì¤„ ê²ƒì¸ê°€ ë§ ê²ƒì¸ê°€?\"\n- **ì •ì˜ & ì›ì¸**: ëŒ€ê¸°ë„(Large airways)ì˜ ì—¼ì¦.\n    - â˜… **90% Viral** ğŸ¦ : Influenza, Rhinovirus ë“±. (BacteriaëŠ” ê±°ì˜ ì—†ìŒ! ğŸ™…â€â™‚ï¸)\n- **ì¦ìƒ ê¸°ê°„ ğŸ—“ï¸**: ê¸°ì¹¨ì€ **5ì¼ ~ 3ì£¼(3 weeks)**ê¹Œì§€ ê°ˆ ìˆ˜ ìˆìŒ.\n    - âš ï¸ **Trap**: 3ì£¼ ë™ì•ˆ ê¸°ì¹¨í•œë‹¤ê³  íë ´(Pneumonia)ì´ ì•„ë‹™ë‹ˆë‹¤!\n- **ì§„ë‹¨ (Diagnosis) ğŸ©º**:\n    - **Clinical Diagnosis**: ì„ìƒì ìœ¼ë¡œ ì§„ë‹¨í•¨.\n    - **No Systemic Signs**: ê³ ì—´(High fever) ğŸŒ¡ï¸, ì˜¤í•œ(Chills) ğŸ¥¶, ê²½ì§(Rigors) âŒ.\n    - **Lung Exam**: Wheezing(ìŒ•ìŒ•ê±°ë¦¼)ì€ OK, í•˜ì§€ë§Œ **Crackles(ì•…ì„¤ìŒ)**ì€ ì—†ì–´ì•¼ í•¨. ğŸ”‡\n    - **CXR?** ğŸ“¸: **No!** í™œë ¥ ì§•í›„ê°€ ì•ˆì •ì ì´ë©´ ì°ì§€ ë§ˆì„¸ìš”.\n- **ì¹˜ë£Œ (Treatment) ğŸ’Š**:\n    - ì˜¤ì§ **Symptom Control**: ì§„í†µì œ(NSAIDs), ê¸°ê´€ì§€ í™•ì¥ì œ.\n    - â˜… **No Antibiotics** ğŸš«: í™˜ìê°€ ì• ì›í•´ë„ í•­ìƒì œ ì£¼ë©´ ì‹œí—˜ì—ì„œ ê°ì ì…ë‹ˆë‹¤!\n---\n### 2. ğŸš¬ COPD: The Beast ğŸ¦\nCOPDëŠ” ë‘ ê°€ì§€ ë³‘íƒœìƒë¦¬ë¥¼ í¬í•¨í•˜ëŠ” **ìš°ì‚°(Umbrella) â˜‚ï¸** ê°™ì€ ê°œë…ì…ë‹ˆë‹¤.\n### A. Pathophysiology âš™ï¸\n1. **Chronic Bronchitis (ë§Œì„± ê¸°ê´€ì§€ì—¼)** ğŸš°:\n    - **\"Clogged, Wet Plumbing\"**: ë°°ê´€ì´ ë§‰íˆê³  ì –ì–´ ìˆìŒ.\n    - Goblet cell ê³¼ë‹¤ ë¶„ë¹„ â†’ ê°€ë˜(Mucus) ì½¸ì½¸ ğŸ¤®\n2. **Emphysema (íê¸°ì¢…)** ğŸˆ:\n    - **\"Old Balloon\"**: í—Œ í’ì„ ì²˜ëŸ¼ íƒ„ì„±(Elastic recoil)ì„ ìƒìŒ.\n    - ê³µê¸°ê°€ ë“¤ì–´ì˜¤ê¸´ í•˜ëŠ”ë° ë‚˜ê°€ì§€ ëª»í•¨ (**Air Trapping**) ğŸ“¦\n### B. Diagnosis (Gold Standard) ğŸ†\n- **Spirometry**: â˜… **FEV1/FVC < 0.7** ğŸ“‰\n- **Irreversible**: ê¸°ê´€ì§€ í™•ì¥ì œë¥¼ ì¨ë„ ëŒì•„ì˜¤ì§€ ì•ŠìŒ. (ì²œì‹ê³¼ ë‹¤ë¦„ â†”ï¸)\n- **Loop ëª¨ì–‘**: **\"Scooped out sail\"** (í‘¹ êº¼ì§„ ë›ë‹¨ë°° ëª¨ì–‘ â›µ)\n### C. Emphysema vs. Chronic Bronchitis êµ¬ë¶„ë²•: DLCO ğŸŒ¬ï¸\n- **Emphysema**: ë²½ì´ íŒŒê´´ë¨ ğŸšï¸ â†’ í‘œë©´ì  ê°ì†Œ â†’ **Low DLCO** â¬‡ï¸\n- **Chronic Bronchitis**: íí¬(Alveoli)ëŠ” ë©€ì©¡í•¨ âœ¨ â†’ **Normal DLCO** â¡ï¸\n    - *Tip*: íì‡„ì„± íŒ¨í„´ì¸ë° DLCOê°€ ë‚®ë‹¤? â†’ Emphysema!\n---\n### 3. ğŸš¨ COPD Exacerbation (ê¸‰ì„± ì•…í™”) : Emergency Room ğŸ¥\nì‘ê¸‰ì‹¤ì—ì„œ ìˆ¨ì´ ì°¨ì„œ ì˜¨ í™˜ì, **COPDì¸ê°€ ì‹¬ë¶€ì „(CHF)ì¸ê°€?** ì´ê²ƒì´ ë¬¸ì œì…ë‹ˆë‹¤. ğŸ¤”\n### A. The Classic Differential: ABG is King ğŸ‘‘\në‘ ì§ˆí™˜ ëª¨ë‘ ìŒ•ìŒ•ê±°ë¦´(Wheezing) ìˆ˜ ìˆìŠµë‹ˆë‹¤. êµ¬ë¶„ì€ **ê°€ìŠ¤(Gas)**ë¡œ í•©ë‹ˆë‹¤.\n| **Feature** | **ğŸš¬ COPD Exacerbation** | **ğŸ’” CHF (Heart Failure)** |\n| --- | --- | --- |\n| **ë¬¸ì œì ** | Air Trapping (ê³µê¸°ê°€ ê°‡í˜) ğŸ“¦ | Wet Lungs (ë¬¼ì— ì ê¹€) ğŸŒŠ |\n| **í™˜ê¸°** | CO2 Retain (ì´ì‚°í™”íƒ„ì†Œ ì €ë¥˜) â¬†ï¸ | Hyperventilate (ê³¼í˜¸í¡) ğŸŒ¬ï¸ |\n| **â˜… ABG** | **Respiratory Acidosis** (High CO2) ğŸ”´ | **Respiratory Alkalosis** (Low CO2) ğŸ”µ |\n| **Sound** | Wheezing ğŸ¶ | Crackles ğŸ¿ |\n### B. Treatment Steps (ìˆœì„œ ì¤‘ìš”!) 1ï¸âƒ£2ï¸âƒ£3ï¸âƒ£\n1. **Oxygen ğŸ…¾ï¸**:\n    - Target SpO2: **88 ~ 92%** ğŸ¯ (100% ì£¼ë©´ CO2 í˜¼ìˆ˜ ì™€ì„œ í°ì¼ ë‚¨ â˜ ï¸)\n2. **Meds ğŸ’Š**:\n    - Inhaled Bronchodilators (Albuterol + Ipratropium = Duoneb) ğŸ’¨\n    - â˜… **Systemic Steroids**: **Oral Prednisone** or IV. (í¡ì…ì œ ì•„ë‹˜! ì „ì‹  ìŠ¤í…Œë¡œì´ë“œ í•„ìˆ˜ ğŸ’ª)\n3. **Antibiotics ğŸ¦ **:\n    - ë¬´ì¡°ê±´ ì£¼ëŠ” ê±° ì•„ë‹˜! ğŸ™…\n    - **3 Cardinal Symptoms**: Dyspnea, Sputum Volume, **Sputum Purulence(ëˆ„ëŸ° ê°€ë˜)**.\n    - Rule: 2ê°€ì§€ ì¦ìƒ + ê·¸ì¤‘ í•˜ë‚˜ê°€ **Purulence**ì¼ ë•Œ íˆ¬ì—¬.\n4. **NIPPV (BiPAP) ğŸ­**:\n    - ì‚°ì¦(Acidosis)ì´ ê³„ì†ë˜ë©´ ì‚½ê´€(Intubation) ì „ì— ë¬´ì¡°ê±´ ì‹œë„!\n    - \"Blow off CO2\" ğŸŒ¬ï¸ â†’ ì‚½ê´€ì„ ë§‰ì•„ì£¼ëŠ” êµ¬ì„¸ì£¼.\n---","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-313","focus_area":"Acute Bronchitis","tags":["usmle-step2","pulmonology","diagnosis","treatment","pitfall","table"]}
{"chunk_type":"transcript_chunk","text":"# Chronic Pulmonary Management (Mortality Focus)\n- ë§Œì„± íì§ˆí™˜ ê´€ë¦¬ì—ì„œ mortality benefitì´ ìˆëŠ” interventionê³¼ symptom-control interventionì„ êµ¬ë¶„í•´ì•¼ í•¨.\n- smoking cessation, long-term oxygen(ì ì‘ì¦ ì¶©ì¡± ì‹œ), ì ì ˆí•œ maintenance therapy adherenceê°€ ì¥ê¸° ì˜ˆí›„ì— ì¤‘ìš”.\n- ì•…í™” ì˜ˆë°©(ë°±ì‹ , trigger control, ì¬í™œ/ìš´ë™) ì „ëµì„ ë³‘í–‰.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-333","focus_area":"Chronic Pulmonary Management","tags":["usmle-step2","pulmonology","treatment","long-term-management"]}
{"chunk_type":"transcript_chunk","text":"# Asthma Core Mechanism + Clinical Logic\n## Pathophysiology\n- asthmaëŠ” airway-centric disease(ê¸°ê´€ì§€ ì—¼ì¦/ê³¼ë¯¼ì„±/ê°€ì—­ì  íì‡„).\n- air trappingìœ¼ë¡œ expiration ì¥ì• ê°€ í•µì‹¬.\n\n## Diagnosis\n- reversible obstruction pattern + trigger ì—°ê´€ ì¦ìƒ.\n- severe exacerbationì—ì„œëŠ” silent chest/í”¼ë¡œ ì†Œê²¬ì„ ê³ ìœ„í—˜ìœ¼ë¡œ ë³¸ë‹¤.\n\n## Treatment\n- ê¸‰ì„±ê¸°: bronchodilator + systemic steroid.\n- ì¥ê¸°: ICS ê¸°ë°˜ step-up/step-down.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-353","focus_area":"Asthma Core","tags":["usmle-step2","pulmonology","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"# Exercise-Induced Bronchoconstriction (EIB)\n- ìš´ë™ í›„ ìˆ˜ë¶„ ë‚´ ê¸°ì¹¨/ìŒ•ìŒ•ê±°ë¦¼ ë°œìƒ, íœ´ì‹ ì‹œ í˜¸ì „.\n- ì˜ˆë°©: ìš´ë™ ì „ SABA pre-treatment.\n- baseline uncontrolled asthmaê°€ ìˆìœ¼ë©´ controller ìµœì í™”ê°€ ìš°ì„ .","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-373","focus_area":"Exercise-Induced Bronchoconstriction","tags":["usmle-step2","pulmonology","diagnosis","treatment"]}
{"chunk_type":"recap_summary","text":"# Asthma Rapid Recap\n- Spirometry obstructive pattern + bronchodilator reversibilityê°€ ì§„ë‹¨ ì¶•.\n- ê¸‰ì„± ì•…í™”ëŠ” severityì— ë”°ë¼ inhaled bronchodilator, steroid, í•„ìš” ì‹œ escalation.\n- ì¥ê¸° ê´€ë¦¬ëŠ” ICS ê¸°ë°˜ì´ë©° trigger/ìˆœì‘ë„/í¡ì…ê¸° í…Œí¬ë‹‰ ì ê²€ì´ í•„ìˆ˜.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-383","focus_area":"Asthma Recap","tags":["usmle-step2","recap","pulmonology","quiz-ready"]}
{"chunk_type":"transcript_chunk","text":"# Restrictive Lung Disease Tree (Pattern Recognition)\n- TLC ì €í•˜ + FEV1/FVC ì •ìƒ/ìƒìŠ¹ì´ë©´ restrictive pattern.\n- DLCO lowëŠ” interstitial/parenchymal problem ê°€ëŠ¥ì„±.\n- DLCO normalì´ë©´ extrapulmonary cause(chest wall/neuromuscular/obesity) ìš°ì„  ê³ ë ¤.\n- pattern-based differentialì„ imaging/ë…¸ì¶œë ¥/ìê°€ë©´ì—­ ë§¥ë½ìœ¼ë¡œ í™•ì •.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-393","focus_area":"Restrictive Pattern Tree","tags":["usmle-step2","pulmonology","diagnosis","tree"]}
{"chunk_type":"transcript_chunk","text":"# Sleep + Pediatric Pulmonary Tricky Points\n- OSAëŠ” risk factor(ë¹„ë§Œ, neck circumference, êµ¬ì¡°ì  í˜‘ì°©) í™•ì¸ì´ ì¤‘ìš”.\n- daytime sleepiness/ì¸ì§€ì €í•˜/ì‹¬í˜ˆê´€ í•©ë³‘ì¦ riskë¥¼ í•¨ê»˜ í‰ê°€.\n- ì†Œì•„ì—ì„œëŠ” adenotonsillar issue, ì„±ì¥/í–‰ë™ ì˜í–¥ê¹Œì§€ í•¨ê»˜ ë³¸ë‹¤.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-413","focus_area":"Sleep/Peds Pulmo","tags":["usmle-step2","pulmonology","sleep","pediatrics","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"# Pulmonary Embolism (PE) Step 2 Framework\n## Diagnosis\n- hemodynamic stability ë¨¼ì € í‰ê°€.\n- ì„ìƒ í™•ë¥ (ì˜ˆ: likely/unlikely scoring) ê¸°ë°˜ìœ¼ë¡œ ì˜ìƒ/ê²€ì‚¬ ìˆœì„œ ê²°ì •.\n\n## Treatment (critical)\n- unstable/high-risk í™˜ìëŠ” ì˜ìƒ ì§€ì—° ì „ì— anticoagulation ìš°ì„  ê³ ë ¤.\n- massive PE with shockì´ë©´ reperfusion(thrombolysis/embolectomy) ê²€í† .\n- ì•ˆì • í™˜ìëŠ” risk stratification í›„ í•­ì‘ê³  í‘œì¤€ì¹˜ë£Œ.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-1","focus_area":"Pulmonary Embolism","tags":["usmle-step2","pulmonology","diagnosis","treatment","next-step"]}
{"chunk_type":"transcript_chunk","text":"# PE Safety Rule (Heparin-first in high-likelihood distress)\n- likely score + significant respiratory distress/clinical concernì´ë©´ CT ì „ì— anticoagulation ë¨¼ì € ì‹œì‘í•  ìˆ˜ ìˆìŒ.\n- í•µì‹¬ì€ delayë¡œ ì¸í•œ harm ìµœì†Œí™”.\n- bleeding risk/contraindicationì€ ì¦‰ì‹œ ë³‘í–‰ í‰ê°€.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-21","focus_area":"PE Heparin-First Rule","tags":["usmle-step2","pulmonology","treatment","safety","next-step"]}
{"chunk_type":"transcript_chunk","text":"# Pulmonary Embolism Severity + Special Emboli\n## Risk Stratification and Treatment\n1. **Low-risk PE (stable, no RV strain):** anticoagulation (heparin/LMWH/DOAC).\n2. **Submassive PE (stable + RV dysfunction/troponin/BNP ìƒìŠ¹):** anticoagulation + ICU close monitoring; hypotension ì „í™˜ ì‹œ reperfusion ì „ëµ ê³ ë ¤.\n3. **Massive PE (SBP < 90 or shock):** systemic thrombolysis (tPA) ìš°ì„ , ê¸ˆê¸° ì‹œ catheter-directed therapy ë˜ëŠ” surgical embolectomy.\n4. **IVC filter ì ì‘ì¦:** anticoagulation absolute contraindication ë˜ëŠ” anticoagulation failure.\n\n## Special Variants\n- **Fat embolism syndrome (24-72h after long-bone fracture):** hypoxemia + neurologic change + petechial rash; ì¹˜ë£ŒëŠ” supportive care.\n- **Air embolism:** central line/surgery/diving ì´í›„ ë°œìƒ ê°€ëŠ¥; left lateral decubitus + head-down(Durant maneuver).\n- **Amniotic fluid embolism:** peripartum sudden shock + DIC.\n- **Trousseau syndrome:** migratory thrombophlebitisëŠ” occult malignancy ì‹ í˜¸.\n\n## Next Step Link\n- PE í‰ê°€ê°€ ëë‚˜ë©´ í•­ìƒ DVT source localizationìœ¼ë¡œ ì´ì–´ê°„ë‹¤.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-41","focus_area":"PE Severity and Special Emboli","tags":["usmle-step2","pulmonology","pe","dvt","treatment","risk-stratification"]}
{"chunk_type":"transcript_chunk","text":"# DVT Source-Oriented Framework for PE Prevention\n## Diagnosis + Risk\n- **Proximal DVT (popliteal/femoral/iliac):** embolization riskê°€ ê°€ì¥ ë†’ì•„ ì¹˜ë£Œ ìš°ì„ ìˆœìœ„ê°€ ë†’ë‹¤.\n- **Distal calf DVT:** ìœ„í—˜ë„ì— ë”°ë¼ serial ultrasoundë¡œ propagation í™•ì¸ ê°€ëŠ¥.\n- **Upper-extremity effort thrombosis (Paget-Schroetter):** ì Šì€ ìš´ë™ì„ ìˆ˜ì—ì„œ subclavian compression ê´€ë ¨.\n- ê³ ë ¹ì—ì„œ **unprovoked DVT**ë©´ occult malignancy workup í•„ìš”.\n- **Phlegmasia cerulea dolens:** painful blue swollen limb + ischemia riskë¡œ limb-threatening emergency.\n\n## Treatment + Procedure\n- Compression ultrasoundì—ì„œ non-compressible veinì´ë©´ DVT ì§„ë‹¨ ì§€ì§€.\n- Proximal DVTëŠ” anticoagulation ê¸°ë³¸.\n- Phlegmasia ë˜ëŠ” ê³ ìœ„í—˜ ìƒì§€ í˜ˆì „ì€ thrombolysis/thrombectomy ë“± ì ê·¹ì  ì¬ê°œí†µ ê³ ë ¤.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-61","focus_area":"DVT Source Risk Stratification","tags":["usmle-step2","pulmonology","dvt","diagnosis","treatment"]}
{"chunk_type":"recap_summary","text":"## PE Recap Decision Table\n| **ìƒí™© (Patient Snapshot)** | **í–‰ë™ (Next Move)** |\n| --- | --- |\n| Stable (BP > 90) | Wells score ê³„ì‚° |\n| Wells â‰¤ 4 | D-dimer |\n| Wells > 4 | CT pulmonary angiography |\n| Likely PE + severe distress | Heparin ë¨¼ì €, ì´í›„ CT |\n| Unstable (BP < 90) | Bedside echo í›„ reperfusion (tPA ë“±) |\n| Renal failure/Pregnancy | V/Q scan |\n| Femur fracture + rash + confusion | Fat embolism, supportive care |\n| Central line event + shock | Air embolism, left lateral decubitus |\n| Elderly unprovoked DVT | Cancer screening |\n\n## ARDS Big Picture Tree\n- Bilateral pulmonary opacitiesë¥¼ ë³´ë©´ cardiogenic edemaì™€ ARDSë¥¼ ë¨¼ì € ë¶„ê¸°í•œë‹¤.\n- ARDS branch í•µì‹¬: non-cardiogenic pattern + P/F ratio ì €í•˜ + lung-protective ventilation í•„ìš”.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-75","focus_area":"PE Recap + ARDS Entry","tags":["usmle-step2","pulmonology","recap","table","ards","decision-tree"]}
{"chunk_type":"transcript_chunk","text":"# ARDS: Pathophysiology, Berlin Diagnosis, and Ventilation Core\n## Pathophysiology\n- ì „ì‹  ì—¼ì¦(ì˜ˆ: sepsis/trauma)ìœ¼ë¡œ íí˜ˆê´€ íˆ¬ê³¼ì„±ì´ ì¦ê°€í•´ protein-rich edemaê°€ íí¬ë¡œ ëˆ„ì¶œ.\n- ê²°ê³¼: hyaline membrane, shunt physiology(V/Q=0), refractory hypoxemia.\n\n## Berlin Criteria\n1. ë°œë³‘ 1ì£¼ ì´ë‚´.\n2. ì˜ìƒì—ì„œ bilateral opacities.\n3. ì‹¬ë¶€ì „ìœ¼ë¡œ ì™„ì „ ì„¤ëª…ë˜ì§€ ì•ŠìŒ.\n4. P/F ratioë¡œ ì¤‘ì¦ë„ ë¶„ë¥˜(mild/moderate/severe).\n\n## Treatment Core\n- **Low tidal volume ventilation (6 mL/kg PBW):** mortality benefit í•µì‹¬.\n- **PEEP optimization:** íí¬ recruitmentë¡œ ì‚°ì†Œí™” ê°œì„ , ê³¼ë„í•œ FiO2 ë…¸ì¶œ ê°ì†Œ.\n- **Permissive hypercapnia:** pHê°€ í—ˆìš© ë²”ìœ„ë©´ TVë¥¼ ì˜¬ë ¤ íì†ìƒ ìœ ë°œí•˜ì§€ ì•ŠìŒ.\n- severe hypoxemiaì—ì„œëŠ” prone positioning ì „ëµìœ¼ë¡œ ì´ì–´ê°„ë‹¤.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-85","focus_area":"ARDS Core Diagnosis and Ventilation","tags":["usmle-step2","pulmonology","ards","pathophysiology","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# ARDS Rescue + Lung Cancer Transition Tree\n## Refractory ARDS\n- **Prone positioning:** severe ARDS(P/F < 150)ì—ì„œ ì‚¬ë§ë¥  ê°ì†Œ.\n- **Neuromuscular blockade:** ventilator dyssynchronyê°€ ì‹¬í•  ë•Œ ì´ˆê¸° ë‹¨ê¸° ì‚¬ìš© ê³ ë ¤.\n- **ECMO:** í‘œì¤€ì¹˜ë£Œ ì‹¤íŒ¨ ì‹œ ìµœí›„ ì˜µì…˜.\n- ê°ë³„: TRALI vs TACO, ARDSëŠ” PCWP ë‚®ê±°ë‚˜ ì •ìƒì¸ non-cardiogenic pattern.\n\n## ARDS Rapid Recap\n- Berlin criteria ì¶©ì¡± í™•ì¸.\n- ì €ìš©ì  í™˜ê¸° + ì ì ˆí•œ PEEPì´ ê¸°ë³¸.\n- refractory caseëŠ” prone/ê³ ë„ì¹˜ë£Œ escalation.\n\n## Lung Nodule/Lung Cancer Next-Step Tree\n- old imaging ë¹„êµê°€ í•­ìƒ 1ë‹¨ê³„.\n- risk ê¸°ë°˜ìœ¼ë¡œ serial CT, PET/biopsy, ë˜ëŠ” definitive resectionë¡œ ë¶„ê¸°.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-105","focus_area":"ARDS Rescue + Lung Cancer Tree","tags":["usmle-step2","pulmonology","ards","critical-care","oncology","decision-tree"]}
{"chunk_type":"transcript_chunk","text":"# Lung Cancer + Solitary Pulmonary Nodule (SPN)\n## Screening (USPSTF-aligned)\n- Age 50-80, â‰¥20 pack-years, current smoker ë˜ëŠ” quit <15ë…„ì´ë©´ annual low-dose CT.\n\n## SPN Risk Table\n| Feature | Benign pattern | Malignant pattern |\n| --- | --- | --- |\n| Size | <0.8 cm | >2.0 cm |\n| Margin | Smooth | Spiculated |\n| Calcification | Popcorn/central | Eccentric/sparse |\n| Patient | Younger/non-smoker | Older/smoker |\n| Next step | Serial CT | PET/biopsy or resection |\n\n## Histology + Clinical Signals\n- **Small cell:** central, ë¹ ë¥¸ ì „ì´, ACTH/SIADH/Lambert-Eaton ì—°ê´€, chemo+radiation ì¤‘ì‹¬.\n- **Squamous:** central/cavitation, PTHrP hypercalcemia.\n- **Adenocarcinoma:** peripheral, non-smoker/femaleì—ì„œ í”í•¨.\n- **Large cell:** peripheral, poor differentiation, paraneoplastic presentation ê°€ëŠ¥.\n\n## Surgical fitness\n- NSCLCëŠ” resectabilityì™€ pulmonary reserve(FEV1, DLCO) í‰ê°€ê°€ í•µì‹¬.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-125","focus_area":"Lung Cancer and SPN Management","tags":["usmle-step2","pulmonology","lung-cancer","spn","diagnosis","table"]}
{"chunk_type":"transcript_chunk","text":"# Thoracic Oncology Complications + Pulmonary Misc Core\n## Lung Cancer Complications\n- **Pancoast tumor:** shoulder pain + Horner syndrome + hand weakness/atrophy.\n- **SVC syndrome:** facial plethora/neck vein distension, ì›ì¸ ì¢…ì–‘ ê°ì†Œê°€ ì¹˜ë£Œ í•µì‹¬.\n- **Carcinoid tumor:** airway-origin neuroendocrine tumor, recurrent same-lobe pneumonia/hemoptysis ë‹¨ì„œ.\n\n## High-yield Recap\n- old film comparison ë¨¼ì €.\n- screening criteria ê¸°ì–µ.\n- histologyë³„ ìœ„ì¹˜/íŒ¨ëŸ¬ë‹ˆì˜¤í”Œë¼ìŠ¤í‹± ì—°ê²°.\n\n## Pulmonary Misc Transition\n- chronic cough ì ‘ê·¼: ACE inhibitor í™•ì¸ í›„ UACS/asthma/GERD ìˆœì°¨ í‰ê°€.\n- hyperventilation tetany: respiratory alkalosisë¡œ ionized calcium ì €í•˜ê°€ ê¸°ì „.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-145","focus_area":"Thoracic Oncology Complications","tags":["usmle-step2","pulmonology","oncology","complications","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"# HAPE vs Pneumonia, DAH, and Decompression Sickness\n## HAPE\n- ê³ ë„ ë…¸ì¶œ í›„ 2-4ì¼ ë‚´ í˜¸í¡ê³¤ë€/ì¹¨ìœ¤ ë°œìƒ ê°€ëŠ¥.\n- ê°ë³„ í¬ì¸íŠ¸: procalcitonin ì •ìƒ, ì‚°ì†Œ íˆ¬ì—¬ì— ë¹ ë¥¸ í˜¸ì „.\n- ë³‘íƒœìƒë¦¬: uneven hypoxic vasoconstriction + capillary leak.\n\n## Diffuse Alveolar Hemorrhage (DAH)\n- ê°í˜ˆì´ ì—†ì–´ë„ ë°°ì œ ë¶ˆê°€.\n- bronchoscopy lavageì—ì„œ aliquotì´ ì§„í–‰ë ìˆ˜ë¡ bloodierí•´ì§€ë©´ ê°•í•˜ê²Œ ì‹œì‚¬.\n- ì¹˜ë£ŒëŠ” ë©´ì—­ë§¤ê°œ ì›ì¸ ì§ˆí™˜ ì¡°ì ˆ(ì˜ˆ: ê³ ìš©ëŸ‰ ìŠ¤í…Œë¡œì´ë“œ).\n\n## Decompression Sickness\n- ê¸‰ìƒìŠ¹ ì‹œ dissolved nitrogenì´ ê¸°í¬í™”ë˜ì–´ ê´€ì ˆ/ì‹ ê²½/í ì¦ìƒ ìœ ë°œ.\n- ì¹˜ë£ŒëŠ” IV hydration + hyperbaric oxygen.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-165","focus_area":"HAPE DAH Decompression","tags":["usmle-step2","pulmonology","hape","dah","decompression","diagnosis","treatment"]}
{"chunk_type":"recap_summary","text":"# Rapid Pulmonary Misc Recap + Pediatric Pulmonology Intro\n## One-line Recap\n- chronic coughëŠ” ACEi/UACS/asthma/GERD ìˆœì„œë¡œ ì ‘ê·¼.\n- hyperventilation tetanyëŠ” ionized calcium ê°ì†Œì™€ ì—°ê²°.\n- HAPEëŠ” oxygen ë°˜ì‘ì„±ì´ ê°ë³„ì— ì¤‘ìš”.\n- DAHëŠ” ê°í˜ˆ ë¶€ì¬ê°€ í”í•´ë„ ì˜ì‹¬ ìœ ì§€.\n\n## Pediatric Pulmonology Focus\n- Step 2ì—ì„œëŠ” ë³‘ëª… ì•”ê¸°ë³´ë‹¤ **next best step** ê²°ì •ì´ í•µì‹¬.\n- ì‹ ìƒì•„ ê¸°ë„ ë¬¸ì œ, íì‹¤ì§ˆ ë¬¸ì œ, ìœ ì•„ ì´ë¬¼ì§ˆ, ìˆ˜ë©´/í–‰ë™ ë¬¸ì œë¥¼ ì‹œë‚˜ë¦¬ì˜¤ ê¸°ë°˜ìœ¼ë¡œ ì—°ê²°í•´ ë³¸ë‹¤.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-176","focus_area":"Pulmonary Misc Rapid Recap","tags":["usmle-step2","pulmonology","recap","pediatrics","next-step"]}
{"chunk_type":"transcript_chunk","text":"# Pediatric Airway: Choanal Atresia First Principles\n## Clinical Pattern\n- **Blue when feeding, pink when crying**ëŠ” choanal atresia ì „í˜•ì  ë‹¨ì„œ.\n- ì‹ ìƒì•„ëŠ” obligate nasal breatherë¼ì„œ bilateral obstruction ì‹œ ì‘ê¸‰.\n\n## Diagnostic + Management Sequence\n1. Bedside catheter passage test.\n2. CTë¡œ í•´ë¶€í•™ í™•ì¸.\n3. Bilateral caseëŠ” ì¦‰ì‹œ airway í™•ë³´ í›„ definitive surgery.\n\n## Syndromic Link\n- CHARGE association í™•ì¸(ì‹¬ì¥/ì²­ê° í¬í•¨).\n- ë”°ë¼ì„œ echoì™€ hearing evaluationì„ ì´ˆê¸° í‰ê°€ì— í¬í•¨.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-186","focus_area":"Choanal Atresia","tags":["usmle-step2","pediatrics","airway","choanal-atresia","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# NRDS, PPHN, and Foreign Body Aspiration (Peds Core)\n## NRDS\n- surfactant deficiencyë¡œ atelectasisì™€ work of breathing ì¦ê°€.\n- CXR: low lung volume + ground-glass + air bronchogram.\n- ì¹˜ë£Œ: antenatal steroid ì˜ˆë°©, CPAP ì‹œì‘, ì‹¤íŒ¨ ì‹œ intubation + exogenous surfactant.\n- ì¥ê¸° í•©ë³‘ì¦: BPD riskë¥¼ ì¤„ì´ê¸° ìœ„í•´ ventilator injury ìµœì†Œí™”.\n\n## PPHN\n- íí˜ˆê´€ ì €í•­ ì§€ì†ìœ¼ë¡œ right-to-left shunt ìœ ì§€.\n- differential cyanosis(ìƒì§€/í•˜ì§€ ì‚°ì†Œí¬í™”ë„ ì°¨ì´)ê°€ í•µì‹¬ ë‹¨ì„œ.\n- ì¹˜ë£Œ: oxygen + inhaled nitric oxide, refractoryë©´ ECMO.\n\n## Foreign Body Aspiration\n- sudden onset choking + focal/monophonic wheeze.\n- high suspicionì´ë©´ X-ray ì •ìƒì´ì–´ë„ rigid bronchoscopyê°€ definitive.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-206","focus_area":"NRDS PPHN FBA","tags":["usmle-step2","pediatrics","nrds","pphn","foreign-body","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Pediatric Pulmonary High-yield: Nose, Sleep, Safety\n## Nasal Foreign Body\n- unilateral foul-smelling dischargeëŠ” ì´ë¬¼ì§ˆ ìš°ì„ .\n- button batteryëŠ” í™”í•™ì  ì†ìƒ ìœ„í—˜ìœ¼ë¡œ ì¦‰ì‹œ ì œê±°.\n\n## Pediatric OSA\n- ì£¼ì›ì¸: adenotonsillar hypertrophy.\n- daytime behavior issue/secondary enuresisê°€ ë‹¨ì„œê°€ ë  ìˆ˜ ìˆìŒ.\n- ì§„ë‹¨ì€ polysomnography, ì¹˜ë£ŒëŠ” adenotonsillectomy.\n\n## Breath-holding Spells\n- ìœ ë°œ ìš”ì¸ ìˆëŠ” ì§§ì€ ì‹¤ì‹  + ë¹ ë¥¸ íšŒë³µ + post-ictal state ì—†ìŒ.\n- reassurance ì¤‘ì‹¬, iron deficiency ë™ë°˜ ì—¬ë¶€ í™•ì¸.\n\n## SIDS/Drowning\n- SIDS ì˜ˆë°©: supine sleep, separate sleep surface, smoke exposure íšŒí”¼.\n- drowning í›„ ê²½ì¦ ì¦ìƒì´ì–´ë„ delayed pulmonary edema ëŒ€ë¹„ ê´€ì°° í•„ìš”.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-226","focus_area":"Pediatric Pulmonary Safety","tags":["usmle-step2","pediatrics","osa","sids","drowning","safety","treatment"]}
{"chunk_type":"recap_summary","text":"## Pediatric Rapid Fire Recap Table\n| ìƒí™© (Scenario) | ì§„ë‹¨ (Diagnosis) | í•µì‹¬ ì¡°ì¹˜ (Key Action) |\n| --- | --- | --- |\n| Feeding ì‹œ ì²­ìƒ‰ì¦, crying ì‹œ í˜¸ì „ | Choanal atresia | Catheter test -> CT -> bilateralì´ë©´ ì¦‰ì‹œ airway í™•ë³´ í›„ ìˆ˜ìˆ  |\n| Prematurity + ground-glass CXR | NRDS | CPAP, í•„ìš” ì‹œ intubation + surfactant |\n| Differential cyanosis + relatively clear lungs | PPHN | Oxygen + inhaled nitric oxide |\n| Sudden cough + focal monophonic wheeze | Foreign body aspiration | Rigid bronchoscopy (X-ray ì •ìƒì´ì–´ë„ ì§„í–‰) |\n| Unilateral foul nasal discharge | Nasal foreign body | Prompt removal, button battery emergency |\n| Snoring + behavior decline/enuresis | Pediatric OSA | Sleep study í›„ adenotonsillectomy |\n| Provoked syncope with rapid recovery | Breath-holding spell | Reassurance + iron status check |\n| Post-submersion respiratory symptoms | Drowning-associated lung injury | ìµœì†Œ 6-8ì‹œê°„ ê´€ì°° |\n\n## Step 2 Decision Rule\n- ì†Œì•„ í˜¸í¡ê¸° ë¬¸í•­ì€ ë³‘ëª… ì•”ê¸°ë³´ë‹¤ **ë‹¤ìŒ ë‹¨ê³„(airway í™•ë³´, ë‚´ì‹œê²½, ìˆ˜ë©´ê²€ì‚¬, ê´€ì°° ì—¬ë¶€)**ë¥¼ ì •í™•íˆ ì„ íƒí•˜ëŠ” ë¬¸ì œê°€ í•µì‹¬ì´ë‹¤.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-242","focus_area":"Pediatric Rapid Fire Recap","tags":["usmle-step2","pediatrics","recap","table","quiz-ready","next-step"]}
{"chunk_type":"transcript_chunk","text":"# Thoracic Surgery Physics Framework + Perioperative Respiratory Timeline\n## Pre-op Optimization\n- íìˆ˜ìˆ  ì „ í•µì‹¬ì€ anatomy ì•”ê¸°ë³´ë‹¤ pressure-volume physiologyë¥¼ ì„ìƒ ê²°ì •ì— ì—°ê²°í•˜ëŠ” ê²ƒ.\n- **Smoking cessation:** ìµœì†Œ 4-8ì£¼ ì „ ê¸ˆì—°ì´ postoperative pulmonary complication ê°ì†Œì— ìœ ë¦¬.\n- **Pulmonary reserve:** FEV1, DLCOë¡œ baseline í‰ê°€ í›„ borderlineì´ë©´ predicted postoperative function ê³„ì‚°(V/Q ê¸°ë°˜).\n\n## Post-op Hypoxemia Timeline\n- immediate: airway obstruction/ì”ë¥˜ ì•½ë¬¼ íš¨ê³¼ ìš°ì„  í‰ê°€.\n- day 2-3: atelectasis ê°€ëŠ¥ì„± ë†’ìŒ(í†µì¦ìœ¼ë¡œ shallow breathing).\n- day 3-5: pneumonia ê°ë³„(ë°œì—´, purulent sputum, inflammatory signs).\n\n## Atelectasis Core Management\n- aggressive pain control + incentive spirometry + í•„ìš” ì‹œ CPAP.\n- imagingì—ì„œ volume lossì™€ mediastinal pull ì†Œê²¬ í™•ì¸.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-252","focus_area":"Thoracic Surgery Periop Framework","tags":["usmle-step2","surgery","pulmonology","perioperative","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Blunt Chest Trauma + Structural Failure Management\n## Trauma Triage\n- unstable traumaëŠ” imaging ì§€ì—° ì—†ì´ resuscitation/eFAST/OR ìš°ì„ .\n- stable traumaëŠ” CT ê¸°ë°˜ ì†ìƒ ì§€ë„í™”.\n\n## High-yield Injuries\n- **Rib fractures (elderly):** pain control ì‹¤íŒ¨ ì‹œ atelectasis/pneumonia ìœ„í—˜ ì¦ê°€.\n- **Flail chest:** paradoxical motion, severe caseì—ì„œ PPVê°€ pneumatic splint ì—­í• .\n- **Pulmonary contusion:** 6-24ì‹œê°„ í›„ ì•…í™” ê°€ëŠ¥, fluid overloadë¥¼ í”¼í•˜ê³  íë¶€ì¢… ì•…í™” ë°©ì§€.\n- **Hemothorax:** chest tube ìš°ì„ , massive outputë©´ thoracotomy ê¸°ì¤€ ì ìš©.\n- **Tracheobronchial injury:** persistent air leak + non-expanding lungì´ë©´ bronchoscopyë¡œ í™•ì¸ í›„ ìˆ˜ìˆ .\n\n## Additional emergency pearls\n- major hemoptysisëŠ” airway ìš°ì„  í™•ë³´í•˜ê³  bleeding lung dependent positioning.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-272","focus_area":"Blunt Chest Trauma Management","tags":["usmle-step2","trauma","pulmonology","diagnosis","treatment","emergency"]}
{"chunk_type":"transcript_chunk","text":"# Diaphragmatic Injury + Rapid Trauma Recap Table\n## Diaphragmatic Rupture/Paralysis\n- blunt trauma í›„ bowel sounds in chestë©´ diaphragmatic rupture ê°•í•˜ê²Œ ì˜ì‹¬.\n- NG tube tipì´ thoraxë¡œ ì˜¬ë¼ê°€ëŠ” tube signì€ ì§„ë‹¨ ë‹¨ì„œ.\n- phrenic nerve injuryëŠ” elevated hemidiaphragm + sniff test paradoxical movementë¡œ í™•ì¸.\n\n## Rapid Fire Table\n| ìƒí™© (Scenario) | ì§„ë‹¨/ìƒíƒœ | í•µì‹¬ ì¡°ì¹˜ (Key Action) |\n| --- | --- | --- |\n| ìˆ˜ìˆ  ì „ í¡ì—°ì | íí•©ë³‘ì¦ ìœ„í—˜ | ìµœì†Œ 4-8ì£¼ ê¸ˆì—° |\n| ìˆ˜ìˆ  ì „ ë‚®ì€ FEV1 | ìˆ˜ìˆ  ìœ„í—˜í‰ê°€ í•„ìš” | predicted postop function ê³„ì‚° |\n| ìˆ˜ìˆ  í›„ 2-3ì¼ ì €ì‚°ì†Œì¦ | Atelectasis ê°€ëŠ¥ì„± | pain control + incentive spirometry |\n| ìˆ˜ìˆ  í›„ 3-5ì¼ ë°œì—´/ë†ì„±ê°€ë˜ | Pneumonia ê°€ëŠ¥ì„± | í•­ìƒì œ ë° ê°ì—¼í‰ê°€ |\n| ì—­ì„¤ì  í‰ë²½ìš´ë™ | Flail chest | í†µì¦ì¡°ì ˆ, í•„ìš” ì‹œ PPV |\n| ì§€ì—°ì„± ì¹¨ìœ¤ ì•…í™” | Pulmonary contusion | fluid strategy ë³´ìˆ˜ì  ì ìš© |\n| large chest tube blood output | Massive hemothorax | thoracotomy ê¸°ì¤€ ì ìš© |\n| persistent large air leak | Bronchial rupture | bronchoscopy + ìˆ˜ìˆ  |\n| chest bowel sounds | Diaphragmatic rupture | surgical repair |\n| elevated hemidiaphragm post-op | Diaphragmatic paralysis | sniff test í™•ì¸ |","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-292","focus_area":"Diaphragmatic Injury and Trauma Recap","tags":["usmle-step2","trauma","surgery","table","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Administrative Episode Index (Non-learning Source)\nì´ ì¤„ì€ ì—í”¼ì†Œë“œ ëª©ë¡ ë©”íƒ€ë°ì´í„°ì´ë©° í•™ìŠµìš© ì˜í•™ ì½˜í…ì¸ ê°€ ì•„ë‹˜.\n- ë°ì´í„° ë¬´ê²°ì„± ìœ ì§€ë¥¼ ìœ„í•´ ë³´ì¡´.\n- í•™ìŠµ í”¼ë“œì—ì„œëŠ” ì œì™¸(exclude-feed).","subject":"DIP 2ec46f2986ee8056a3cedf522b3f7170","page_title":"DIP 2ec46f2986ee8056a3cedf522b3f7170","episode":"DIP 2ec46f2986ee8056a3cedf522b3f7170","section_path":["DIP 2ec46f2986ee8056a3cedf522b3f7170"],"source_doc_id":"DIP 2ec46f2986ee8056a3cedf522b3f7170","source_page":null,"source_anchor":"DIP 2ec46f2986ee8056a3cedf522b3f7170-1","focus_area":"Administrative Episode Index 1","tags":["usmle-step2","meta","exclude-feed"]}
{"chunk_type":"transcript_chunk","text":"# Administrative Episode Index Continuation (Non-learning Source)\nì´ ì¤„ì€ ê°•ì˜ ëª©ë¡/ì¹´í…Œê³ ë¦¬ ì¸ë±ìŠ¤ ë©”íƒ€ë°ì´í„°ì…ë‹ˆë‹¤.\n- ì„ìƒ ê°œë…/ì§„ë‹¨/ì¹˜ë£Œ ì •ë³´ê°€ ì—†ì–´ í•™ìŠµ ë…¸ì¶œì—ì„œ ì œì™¸.\n- ë°ì´í„° ì¶”ì ìš©ìœ¼ë¡œë§Œ ìœ ì§€.","subject":"DIP 2ec46f2986ee8056a3cedf522b3f7170","page_title":"DIP 2ec46f2986ee8056a3cedf522b3f7170","episode":"DIP 2ec46f2986ee8056a3cedf522b3f7170","section_path":["DIP 2ec46f2986ee8056a3cedf522b3f7170"],"source_doc_id":"DIP 2ec46f2986ee8056a3cedf522b3f7170","source_page":null,"source_anchor":"DIP 2ec46f2986ee8056a3cedf522b3f7170-21","focus_area":"Administrative Episode Index 2","tags":["usmle-step2","meta","exclude-feed"]}
{"chunk_type":"transcript_chunk","text":"# UTI Management Master Table\n## Core Treatment Table\n| ì§„ë‹¨ëª… | ëŒ€ìƒ | 1ì°¨ ì¹˜ë£Œ | ê¸°ê°„ | í•µì‹¬ í¬ì¸íŠ¸ |\n| --- | --- | --- | --- | --- |\n| ASB | ì¼ë°˜ì¸/ë…¸ì¸/ë„ë‡¨ê´€ | ì¹˜ë£Œí•˜ì§€ ì•ŠìŒ | - | ë¶ˆí•„ìš”í•œ í•­ìƒì œë¡œ ë‚´ì„± ì¦ê°€ |\n| ASB | ì„ì‚°ë¶€/ë¹„ë‡¨ê¸° ì‹œìˆ  ì „ | nitrofurantoin ë˜ëŠ” cephalosporin ê³„ì—´ | 4-7ì¼ | ì‚°ê³¼ í•©ë³‘ì¦ ì˜ˆë°© ëª©ì  ì¹˜ë£Œ |\n| Uncomplicated cystitis | ê±´ê°•í•œ ë¹„ì„ì‹  ì—¬ì„± | nitrofurantoin/fosfomycin/TMP-SMX | ëŒ€ê°œ 3-5ì¼ | ì§§ì€ ì½”ìŠ¤ ê°€ëŠ¥ |\n| Complicated cystitis | ë‚¨ì„±/êµ¬ì¡°ì  ì´ìƒ ë“± | culture-guided regimen(ì˜ˆ: FQ í¬í•¨) | ë³´í†µ ë” ê¸¸ê²Œ | ì›ì¸ êµì • ë™ë°˜ |\n| Pyelonephritis (mild) | ì•ˆì • í™˜ì | ê²½êµ¬ regimen ê°€ëŠ¥ | ìƒí™©ë³„ | ì™¸ë˜ ê°€ëŠ¥ì„± í‰ê°€ |\n| Pyelonephritis (complicated/pregnancy) | ê³ ìœ„í—˜êµ° | IV therapy í›„ ë‹¨ê³„ì  ì „í™˜ | ëŒ€ê°œ ì¥ê¸° | ì…ì› ë° í•©ë³‘ì¦ ê°ì‹œ |\n\n## Exam pearls\n- sterile pyuriaëŠ” STI(ì˜ˆ: chlamydia/gonorrhea) ê°ë³„ í•„ìš”.\n- male UTIëŠ” complicatedë¡œ ì ‘ê·¼.\n- recurrent UTIëŠ” trigger-targeted prophylaxis ì „ëµ ê³ ë ¤.","subject":"UTI ì¹˜ë£Œ 2ef46f2986ee8096b55ccd4f633547fb","page_title":"UTI ì¹˜ë£Œ 2ef46f2986ee8096b55ccd4f633547fb","episode":"UTI ì¹˜ë£Œ 2ef46f2986ee8096b55ccd4f633547fb","section_path":["UTI ì¹˜ë£Œ 2ef46f2986ee8096b55ccd4f633547fb"],"source_doc_id":"UTI ì¹˜ë£Œ 2ef46f2986ee8096b55ccd4f633547fb","source_page":null,"source_anchor":"UTI ì¹˜ë£Œ 2ef46f2986ee8096b55ccd4f633547fb-1","focus_area":"UTI Treatment Framework","tags":["usmle-step2","internal-medicine","uti","treatment","table","infectious-disease"]}
{"chunk_type":"transcript_chunk","text":"# Pediatric Endocrinology: Thyroid-in-Pregnancy + Neonatal Interface\n## Midline Neck Mass in Child\n- thyroglossal duct cystë¡œ ë³´ì´ë”ë¼ë„ ectopic thyroid ê°€ëŠ¥ì„± ë¨¼ì € ë°°ì œ.\n- ì ˆì œ ì „ neck ultrasound + thyroid function(TSH/T4) í™•ì¸ì´ í•„ìˆ˜.\n\n## Maternal-Fetal Thyroid Physiology\n- estrogen ìƒìŠ¹ìœ¼ë¡œ TBG ì¦ê°€ -> total T4 ìƒìŠ¹ ê°€ëŠ¥.\n- 1st trimester hCG peakëŠ” TSH suppressionì„ ìœ ë°œí•  ìˆ˜ ìˆìŒ.\n\n## Graves in Pregnancy Management Principle\n- maternal overtreatmentëŠ” fetal hypothyroidism/goiter ìœ„í—˜.\n- maternal-fetal ê· í˜•ì„ ê³ ë ¤í•œ ëª©í‘œì¹˜ ì„¤ì •ì´ í•„ìš”.\n\n## Neonatal Thyrotoxicosis\n- maternal TSH receptor antibody transplacental transferë¡œ ë°œìƒ ê°€ëŠ¥.\n- tachycardia/irritability/poor weight gain ë‹¨ì„œ, ëŒ€ì²´ë¡œ ì¼ê³¼ì„±.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-1","focus_area":"Pediatric Endocrine Thyroid Interface","tags":["usmle-step2","pediatrics","endocrinology","thyroid","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Pediatric Endocrinology: Calcium/Adrenal/Diabetes Pattern Recognition\n## Neonatal Hypocalcemia Scenario\n- seizure + low calcium + ë¶€ì ì ˆí•œ PTH ë°˜ì‘ì—ì„œ maternal physiology(FHH) ì—­ì¶”ì ì´ ì¤‘ìš”.\n- mother urine calcium í‰ê°€ê°€ ì§„ë‹¨ ë‹¨ì„œ.\n\n## Hypertensive CAH Differential\n| ê²°í• íš¨ì†Œ | í˜ˆì••/ì „í•´ì§ˆ | ì„±ë°œë‹¬ ë‹¨ì„œ |\n| --- | --- | --- |\n| 11Î²-hydroxylase deficiency | ê³ í˜ˆì•• + ì €ì¹¼ë¥¨ ê°€ëŠ¥ | androgen excess/virilization |\n| 17Î±-hydroxylase deficiency | ê³ í˜ˆì•• + ì €ì¹¼ë¥¨ ê°€ëŠ¥ | sexual infantilism/hypogonadism |\n\n## Pediatric Diabetes Sorting\n- type 1: low/absent C-peptide + autoantibody positive.\n- type 2: ìƒëŒ€ì  ê³ ì¸ìŠë¦°/C-peptide ë³´ì¡´, antibody negative.\n- MODY: strong family history + non-obese + antibody negative.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-21","focus_area":"Pediatric Endocrine Differential","tags":["usmle-step2","pediatrics","endocrinology","cah","diabetes","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"# Pediatric Endocrine Recap + Pancreas Framework Entry\n## Rapid Recap\n1. midline neck massëŠ” ìˆ˜ìˆ  ì „ ectopic thyroid ì—¬ë¶€ í™•ì¸.\n2. ì„ì‹  ê°‘ìƒì„  í•´ì„ì€ TBG/hCG ìƒë¦¬ ë³€í™”ë¥¼ ë°˜ì˜.\n3. neonatal hypocalcemiaëŠ” maternal metabolic context í¬í•¨í•´ í•´ì„.\n4. hypertensive CAHëŠ” 11Î² vs 17Î± deficiency íŒ¨í„´ìœ¼ë¡œ êµ¬ë¶„.\n5. pediatric diabetesëŠ” C-peptide/autoantibodyë¡œ subtype ë¶„ë¥˜.\n\n## Pancreas Operational Framework (Step 2)\n- ë‹¹ë‡¨ subtype êµ¬ë¶„ì€ age stereotypeë³´ë‹¤ biochemical evidence ìš°ì„ .\n- C-peptideëŠ” endogenous insulin production ì§€í‘œ.\n\n| í•­ëª© | Type 1 DM | Type 2 DM |\n| --- | --- | --- |\n| í•µì‹¬ ê¸°ì „ | beta-cell autoimmune destruction | insulin resistance + relative beta-cell dysfunction |\n| C-peptide | ë‚®ìŒ/ì†Œì‹¤ | ì •ìƒ~ìƒìŠ¹(ì´ˆê¸°) |\n| í•­ì²´ | ì–‘ì„± ê°€ëŠ¥(GAD ë“±) | ëŒ€ê°œ ìŒì„± |\n| ì„ìƒ ë§¥ë½ | ê¸‰ì„±, DKA ë™ë°˜ ê°€ëŠ¥ | ì ì§„ì , ë¹„ë§Œ/ëŒ€ì‚¬ì¦í›„êµ° ì—°ê´€ |","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-41","focus_area":"Pediatric Endocrine Recap and Pancreas Entry","tags":["usmle-step2","pediatrics","endocrinology","recap","diabetes","table"]}
{"chunk_type":"transcript_chunk","text":"# Diabetes Classification + Screening + Complication Monitoring\n## Subtype differentiation\n- MODYëŠ” ì Šê³  ë§ˆë¥¸ í™˜ìì—ì„œë„ ê°€ëŠ¥í•˜ë©° autoantibody negative + preserved C-peptide + strong autosomal dominant family historyê°€ ë‹¨ì„œ.\n- type 1/2 ê°€ì • ëŒ€ì‹  biochemical evidence ê¸°ë°˜ ë¶„ë¥˜ê°€ Step 2 í•µì‹¬.\n\n## Screening and diagnosis\n- ì„±ì¸ screeningì€ ì—°ë ¹/ì²´ì¤‘/ìœ„í—˜êµ°(ì´ì‹, HIV, CF ë“±) ë§¥ë½ìœ¼ë¡œ í™•ì¥ ì ìš©.\n- ì§„ë‹¨ì€ A1c, fasting glucose, random glucose(ì¦ìƒ ë™ë°˜), OGTT ê¸°ì¤€ì„ ìƒí™©ë³„ë¡œ ì‚¬ìš©.\n\n## Health maintenance\n- í•©ë³‘ì¦ screening: kidney(UACR), retina(ìœ í˜•ë³„ ì‹œì  ì°¨ì´), neuropathy(foot exam), ASCVD risk ë™ì‹œ ê´€ë¦¬.\n- ëª©í‘œ A1cëŠ” ì—°ë ¹/ë™ë°˜ì§ˆí™˜/ì €í˜ˆë‹¹ ìœ„í—˜ì— ë”°ë¼ ê°œì¸í™”.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-61","focus_area":"Diabetes Classification and Screening","tags":["usmle-step2","endocrinology","diabetes","diagnosis","screening"]}
{"chunk_type":"transcript_chunk","text":"# Gastroparesis + DKA Entry Logic\n## Gastroparesis clue\n- ë‹¹ë‡¨ í™˜ìì—ì„œ ì‹í›„ ì˜¤ì‹¬/êµ¬í†  + ì‹í›„ ì €í˜ˆë‹¹ íŒ¨í„´ì€ delayed gastric emptyingê³¼ insulin timing mismatchë¥¼ ì‹œì‚¬.\n\n## DKA clinical signal\n- polyuria/polydipsia, abdominal pain, Kussmaul respiration, ketosis/anion-gap acidosisë¥¼ í•˜ë‚˜ì˜ syndromeìœ¼ë¡œ ë¬¶ì–´ í•´ì„.\n- stress hyperglycemiaëŠ” ì¤‘í™˜ì ìƒí™©ì—ì„œ adaptive responseì¼ ìˆ˜ ìˆì–´ context-based í•´ì„ í•„ìš”.\n\n## Transition\n- ì´í›„ ê´€ë¦¬ëŠ” DKA/HHS ë¶„ê¸°ì™€ ì‘ê¸‰ í”„ë¡œí† ì½œ ìš°ì„ ìˆœìœ„(ìˆ˜ì•¡-ì „í•´ì§ˆ-ì¸ìŠë¦°)ë¡œ ì´ì–´ì§„ë‹¤.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-81","focus_area":"Gastroparesis and DKA Entry","tags":["usmle-step2","endocrinology","diabetes","gastroparesis","dka"]}
{"chunk_type":"transcript_chunk","text":"# DKA vs HHS + Acute Management + Drug Class Table\n## DKA vs HHS core\n- DKA: insulin deficiency + ketogenesis + anion-gap metabolic acidosis.\n- HHS: extreme hyperglycemia/hyperosmolarity ì¤‘ì‹¬, ë³´í†µ ketosisëŠ” ê²½ë¯¸.\n\n## Emergency sequence\n1. isotonic fluidsë¡œ intravascular volume ë¨¼ì € íšŒë³µ.\n2. potassium ìƒíƒœë¥¼ ë¨¼ì € í™•ì¸/ë³´ì • í›„ insulin ì§„í–‰.\n3. insulin infusion ì¤‘ anion gap closureë¥¼ ì¹˜ë£Œ ì¢…ë£Œ ê¸°ì¤€ìœ¼ë¡œ ì‚¼ëŠ”ë‹¤.\n4. glucoseê°€ ë¨¼ì € ë–¨ì–´ì ¸ë„ gapì´ ì•ˆ ë‹«íˆë©´ dextrose ë³‘í–‰í•˜ë©° insulin ì§€ì†.\n\n## Antidiabetic drug class table\n| ì•½ë¬¼ ê³„ì—´ | í•µì‹¬ ê¸°ì „/ì¥ì  | ì£¼ìš” ì£¼ì˜ì  |\n| --- | --- | --- |\n| Metformin | hepatic glucose output ê°ì†Œ, first-line | eGFR ì €í•˜/ì –ì‚°ì‚°ì¦ ìœ„í—˜ ìƒí™© ì£¼ì˜ |\n| Sulfonylurea | insulin secretion ì¦ê°€ | hypoglycemia, weight gain |\n| TZD | insulin sensitivity ê°œì„  | edema/heart failure ì•…í™” ê°€ëŠ¥ |\n| GLP-1 RA | ì²´ì¤‘ê°ì†Œ + CV benefit | GI adverse effect, íŠ¹ì • ì¢…ì–‘ ë³‘ë ¥ ì£¼ì˜ |\n| DPP-4 inhibitor | incretin íš¨ê³¼ ì—°ì¥ | ìƒëŒ€ì  íš¨ëŠ¥/ë¶€ì‘ìš© profile ê³ ë ¤ |\n| SGLT2 inhibitor | cardiorenal benefit, glycosuria | genital/urinary infection, euglycemic DKA ì£¼ì˜ |","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-101","focus_area":"DKA HHS and Drug Classes","tags":["usmle-step2","endocrinology","dka","hhs","pharmacology","table"]}
{"chunk_type":"transcript_chunk","text":"# Insulin Strategy + T2DM Outpatient Escalation\n## Insulin use framework\n- basal-bolus ì ‘ê·¼ì´ inpatient glycemic controlì˜ í‘œì¤€.\n- correction insulinì€ ë³´ì¡° ìˆ˜ë‹¨ì´ë©° sliding scale ë‹¨ë…ì€ í”¼í•œë‹¤.\n\n## Outpatient escalation\n- metformin ì‹œì‘ í›„ A1c ë¯¸ë‹¬ ì‹œ comorbidity-driven add-on ì ìš©.\n- severe hyperglycemia/catabolic stateì—ì„œëŠ” ì´ˆê¸° insulin ë„ì…ì„ ìš°ì„  ê³ ë ¤.\n\n## Comorbidity-based add-on table\n| ë™ë°˜ ì§ˆí™˜ | ìš°ì„  ê³ ë ¤ ì•½ë¬¼ | ê·¼ê±° í¬ì¸íŠ¸ |\n| --- | --- | --- |\n| Heart failure | SGLT2 inhibitor | HF hospitalization ê°ì†Œ |\n| CKD | SGLT2 inhibitor(ì ì‘ì¦ ë²”ìœ„ ë‚´) | renal outcome ê°œì„  |\n| ASCVD | GLP-1 RA ë˜ëŠ” SGLT2 inhibitor | major CV event ê°ì†Œ |\n| Obesity | GLP-1 RA | weight loss íš¨ê³¼ |\n| ë¹„ìš© ì œì•½ | sulfonylurea/TZD | ì €ë¹„ìš© ëŒ€ì•ˆ(ë¶€ì‘ìš© trade-off) |","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-121","focus_area":"Insulin and T2DM Escalation","tags":["usmle-step2","endocrinology","diabetes","insulin","treatment","table"]}
{"chunk_type":"transcript_chunk","text":"# Diabetic Nephropathy + Metabolic Syndrome + Hypoglycemia Intro\n## Diabetic nephropathy\n- hyperfiltrationê³¼ intraglomerular pressure ìƒìŠ¹ì´ ì´ˆê¸° ì†ìƒ ì¶•.\n- UACRë¡œ ë¯¸ì„¸ì•Œë¶€ë¯¼ë‡¨ë¥¼ ì¡°ê¸° ë°œê²¬í•˜ê³ , ë‹¹ë‡¨ ìœ í˜•ë³„ screening ì‹œì ì„ ì§€í‚¨ë‹¤.\n- microalbuminuriaê°€ í™•ì¸ë˜ë©´ í˜ˆì••ê³¼ ë¬´ê´€í•˜ê²Œ ACEi/ARBë¥¼ ì‹ ì¥ë³´í˜¸ ëª©ì ìœ¼ë¡œ ê³ ë ¤.\n- SGLT2 inhibitorsëŠ” CKD progression ì§€ì—°ì— ì¤‘ìš”í•œ ì¶•.\n\n## Metabolic syndrome\n- central obesity, TG, HDL, BP, fasting glucose ìš”ì†Œë¥¼ ì¡°í•©í•´ CV riskë¥¼ êµ¬ì¡°ì ìœ¼ë¡œ í‰ê°€.\n\n## Transition\n- ë‹¤ìŒ ë‹¨ê³„ëŠ” ì €í˜ˆë‹¹ ì •ì˜/ì‘ê¸‰ì²˜ì¹˜/ì›ì¸ê°ë³„ ì•Œê³ ë¦¬ì¦˜.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-141","focus_area":"Diabetic Nephropathy and Metabolic Syndrome","tags":["usmle-step2","endocrinology","nephropathy","metabolic-syndrome","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Hypoglycemia Workup + DKA Drug Pearls + Adrenal Entry\n## Hypoglycemia basics\n- Whipple triadë¡œ true hypoglycemia í™•ì¸ í›„ ì¦‰ì‹œ ì²˜ì¹˜.\n- awakeë©´ oral rapid carbohydrate, unconsciousë©´ IV dextrose ë˜ëŠ” IM glucagon.\n\n## Etiology differentiation table\n| Condition | Insulin | C-peptide | Pro-insulin | Sulfonylurea screen |\n| --- | --- | --- | --- | --- |\n| Exogenous insulin | High | Low | Low | Negative |\n| Insulinoma | High | High | High | Negative |\n| Sulfonylurea exposure | High | High | Variable/normal-high | Positive |\n\n## Rapid pearls\n- DKA/HHSëŠ” fluids-first.\n- insulin ì‹œì‘ ì „ potassium safety check í•„ìˆ˜.\n- cardiorenal comorbidityì—ì„œëŠ” SGLT2 ê¸°ë°˜ ì „ëµ ê³ ë ¤.\n\n## Adrenal framework entry\n- adrenal mass ì ‘ê·¼ ì›ì¹™: functional ì—¬ë¶€ë¥¼ biochemical testingìœ¼ë¡œ ë¨¼ì € í™•ì¸.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-161","focus_area":"Hypoglycemia Workup and Adrenal Entry","tags":["usmle-step2","endocrinology","hypoglycemia","diagnosis","table","adrenal"]}
{"chunk_type":"transcript_chunk","text":"# Adrenal Pathology Core: Hyperaldosteronism, Cushing, Pheochromocytoma, Insufficiency\n## Primary hyperaldosteronism\n- resistant HTN + hypokalemia ì˜ì‹¬.\n- screen(aldosterone/renin), confirmatory suppression test, subtype localization ìˆœì„œ.\n- unilateral lesionì€ ìˆ˜ìˆ , bilateral hyperplasiaëŠ” MRA ì¹˜ë£Œ.\n\n## Cushing syndrome\n- clinical phenotype í™•ì¸ í›„ ì ì ˆí•œ screening test ì¡°í•©ìœ¼ë¡œ í™•ì§„.\n- ACTH levelë¡œ ACTH-dependent ì—¬ë¶€ ë¶„ê¸°í•˜ê³  high-dose dex/ì˜ìƒìœ¼ë¡œ ì›ì¸ ë¶„í™”.\n\n## Pheochromocytoma\n- paroxysmal headache/palpitation/sweating + episodic HTN.\n- metanephrine ê¸°ë°˜ ì§„ë‹¨.\n- ìˆ˜ìˆ  ì „ alpha blockade í›„ beta blockade ìˆœì„œ(ì ˆëŒ€ ì—­ì „ ê¸ˆì§€).\n\n## Adrenal insufficiency\n- primary vs secondary/tertiaryë¥¼ ì „í•´ì§ˆ/ACTH/ìƒ‰ì†Œì¹¨ì°©ìœ¼ë¡œ êµ¬ë¶„.\n- adrenal crisisëŠ” ê²€ì‚¬ ëŒ€ê¸° ì—†ì´ stress-dose steroid + fluid resuscitation ì¦‰ì‹œ ì‹œì‘.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-181","focus_area":"Adrenal Pathology Core","tags":["usmle-step2","endocrinology","adrenal","diagnosis","treatment"]}
{"chunk_type":"recap_summary","text":"# Adrenal Rapid Recap + Thyroid/Adrenal Tumor Algorithm Entry\n## Rapid recap\n1. Conn syndrome: screen -> confirm -> subtype ë¶„í™” í›„ ì¹˜ë£Œ ê²°ì •.\n2. Cushing: ìµœì†Œ 2ê°œ screening test ì–‘ì„±ìœ¼ë¡œ í™•ì¸.\n3. ì „í•´ì§ˆ íŒ¨í„´ê³¼ ìƒ‰ì†Œì¹¨ì°©ì€ ë¶€ì‹  ì§ˆí™˜ ë¶„ë¥˜ì— ë§¤ìš° ìœ ìš©.\n4. refractory hypotensionì€ adrenal crisisë¥¼ í•­ìƒ í¬í•¨í•´ í‰ê°€.\n5. steroid exposure ë³‘ë ¥ì€ secondary adrenal insufficiencyë¥¼ ìš°ì„  ì˜ì‹¬.\n\n## Transition\n- ì´í›„ íŒŒíŠ¸ëŠ” thyroid nodule/adrenal massë¥¼ algorithm ê¸°ë°˜ìœ¼ë¡œ ì ‘ê·¼í•œë‹¤.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-199","focus_area":"Adrenal Recap and Tumor Algorithm Entry","tags":["usmle-step2","endocrinology","adrenal","recap","algorithm"]}
{"chunk_type":"transcript_chunk","text":"# Thyroid Nodule Algorithm + Pediatric Neck Mass + Thyroid Lymphoma/Storm\n## Thyroid nodule stepwise approach\n- **Step 1: TSH**ë¡œ hot vs cold ë°©í–¥ì„ ë¨¼ì € ê°€ë¥¸ë‹¤.\n- low TSHë©´ hyperfunctioning nodule í‰ê°€(scintigraphy) ìš°ì„ , ëŒ€ê°œ malignancy risk ë‚®ìŒ.\n- normal/high TSHë©´ ultrasound risk featureë¥¼ ë³¸ ë’¤ í•„ìš” ì‹œ FNA.\n\n## Pediatric midline neck mass\n- thyroglossal duct cyst ì˜ì‹¬ ì‹œ ìˆ˜ìˆ  ì „ ì •ìƒ ìœ„ì¹˜ ê°‘ìƒì„  ì¡´ì¬ë¥¼ ë°˜ë“œì‹œ í™•ì¸.\n- ectopic thyroidë¥¼ ì ˆì œí•´ ì˜êµ¬ hypothyroidism ë§Œë“œëŠ” ì‹¤ìˆ˜ë¥¼ í”¼í•´ì•¼ í•¨.\n\n## Thyroid emergencies/malignancy context\n- Hashimoto backgroundì—ì„œ ê¸‰ê²©íˆ ì»¤ì§€ëŠ” hard neck massëŠ” lymphoma ì˜ì‹¬.\n- thyroid stormì€ ê³ ì—´/ë¹ˆë§¥/ì‹ ê²½ì •ì‹  ì¦ìƒ ë™ë°˜í•˜ëŠ” ì‘ê¸‰ìœ¼ë¡œ ì¦‰ì‹œ ë‹¤ì¤‘ ì•½ì œ ì¹˜ë£Œ í•„ìš”.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-209","focus_area":"Thyroid Nodule and Pediatric Neck Mass","tags":["usmle-step2","endocrinology","thyroid","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Thyroid Storm Differential + Adrenal Tumors + MEN Syndromes\n## Thyroid storm differential\n| êµ¬ë¶„ | Thyroid storm | Malignant hyperthermia |\n| --- | --- | --- |\n| ê³µí†µì  | ìˆ˜ìˆ /ìŠ¤íŠ¸ë ˆìŠ¤ ì´í›„ ê³ ì—´Â·ë¹ˆë§¥ ê°€ëŠ¥ | ìˆ˜ìˆ /ë§ˆì·¨ ì´í›„ ê³ ì—´Â·ë¹ˆë§¥ ê°€ëŠ¥ |\n| ì°¨ì´ì  | ê°•í•œ êµê°í•­ì§„ + thyroid toxicosis ë§¥ë½, ê°•ì§ì€ ì „í˜•ì ì´ì§€ ì•ŠìŒ | ì „ì‹  ê°•ì§/ë§ˆì·¨ì•½ ì—°ê´€ì´ ë‘ë“œëŸ¬ì§ |\n| ì¹˜ë£Œ í•µì‹¬ | cooling + beta-blocker + thionamide + iodine + steroid | dantrolene ì¤‘ì‹¬ |\n\n## Adrenal tumors\n- pheochromocytomaëŠ” catecholamine surgesë¡œ episodic symptoms ìœ ë°œ.\n- neuroblastomaëŠ” ì†Œì•„ ë³µë¶€ ì¢…ê´´ì—ì„œ midline crossing/opsoclonus-myoclonusê°€ ë‹¨ì„œ.\n- incidental adrenal massëŠ” biopsy ì „ hormonal evaluation ìš°ì„ .\n\n## MEN syndromes table\n| Syndrome | í•µì‹¬ êµ¬ì„± |\n| --- | --- |\n| MEN1 | Pituitary + Parathyroid + Pancreatic neuroendocrine tumors |\n| MEN2A | Medullary thyroid carcinoma + Pheochromocytoma + Parathyroid hyperplasia |\n| MEN2B | Medullary thyroid carcinoma + Pheochromocytoma + Mucosal neuroma/Marfanoid habitus |","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-229","focus_area":"Thyroid Storm Adrenal Tumors MEN","tags":["usmle-step2","endocrinology","thyroid-storm","pheochromocytoma","men","table"]}
{"chunk_type":"recap_summary","text":"# Endocrine Oncology Rapid Fire Recap\n- thyroid noduleì€ TSH-first algorithmì„ ê³ ì • ì›ì¹™ìœ¼ë¡œ ì ìš©.\n- low TSH hyperfunctioning lesionì€ malignant riskê°€ ë‚®ì•„ ì ‘ê·¼ì´ ë‹¤ë¥´ë‹¤.\n- thyroglossal duct cystëŠ” ectopic thyroid ë°°ì œ í›„ ìˆ˜ìˆ .\n- pheochromocytomaëŠ” metanephrine ì§„ë‹¨ + alpha-before-beta ì „ì²˜ì¹˜.\n- MEN syndrome íŒ¨í„´ì€ ì¢…ì–‘ ì¡°í•©ìœ¼ë¡œ ì•”ê¸°í•œë‹¤.\n- ê°‘ìƒì„ í­í’/ë¶€ì‹ ìœ„ê¸°ëŠ” ì¦‰ì‹œ ì¹˜ë£Œê°€ ì˜ˆí›„ë¥¼ ì¢Œìš°í•œë‹¤.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-249","focus_area":"Endocrine Oncology Rapid Recap","tags":["usmle-step2","endocrinology","recap","oncology","next-step"]}
{"chunk_type":"transcript_chunk","text":"# Pituitary Hyperfunction Core: Prolactinoma First-pass Framework\n## Clinical pattern by population\n| í™˜ìêµ° | ì£¼ìš” ë‹¨ì„œ | ì„ìƒ ì˜ë¯¸ |\n| --- | --- | --- |\n| Premenopausal women | amenorrhea/oligomenorrhea, infertility, galactorrhea | hypogonadism ë° bone loss ìœ„í—˜ |\n| Men/postmenopausal women | headache, bitemporal visual loss ë“± mass effect | ëŒ€ê°œ macroadenomaë¡œ ëŠ¦ê²Œ ë°œê²¬ |\n\n## Diagnostic order\n- prolactinì´ ë§¤ìš° ë†’ì•„ë„ mimics(ì•½ë¬¼, ì„ì‹ , hypothyroidism, renal failure) ë°°ì œê°€ ì„ í–‰.\n- TSH/creatinine/pregnancy status í™•ì¸ í›„ pituitary MRIë¡œ ì§„í–‰.\n\n## Core principle\n- Step 2ì—ì„œëŠ” \"ìˆ˜ì¹˜ í™•ì¸ -> ì›ì¸ ë¶„ê¸° -> ì˜ìƒ\" ìˆœì„œë¥¼ ì§€í‚¤ëŠ”ì§€ê°€ ì ìˆ˜ í¬ì¸íŠ¸.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-1","focus_area":"Pituitary Prolactinoma Framework","tags":["usmle-step2","endocrinology","pituitary","prolactinoma","diagnosis","table"]}
{"chunk_type":"transcript_chunk","text":"# Prolactinoma Treatment + Acromegaly + SIADH/DI Entry\n## Prolactinoma treatment\n- 1ì°¨ ì¹˜ë£ŒëŠ” dopamine agonist(cabergoline ì„ í˜¸)ì´ë©° ìˆ˜ìˆ ì€ ì•½ë¬¼ ì‹¤íŒ¨/ê¸´ê¸‰ ì••ë°• ìƒí™©ì—ì„œ ê³ ë ¤.\n\n## Acromegaly logic\n- IGF-1ë¡œ ìŠ¤í¬ë¦¬ë‹, oral glucose suppression failureë¡œ í™•ì§„, ì´í›„ ìˆ˜ìˆ  ì¤‘ì‹¬ ì¹˜ë£Œ.\n- í•©ë³‘ì¦(ì‹¬í˜ˆê´€, OSA, ë‹¹ëŒ€ì‚¬, ëŒ€ì¥ë³‘ë³€) ë™ì‹œ í‰ê°€ í•„ìš”.\n\n## SIADH basics\n- euvolemic hyponatremia íŒ¨í„´, ì›ì¸(CNS/lung/drug) ì¶”ì .\n- ì¤‘ì¦ ì¦ìƒì—ì„œëŠ” hypertonic salineì„ ì‹ ì¤‘í•œ êµì • ì†ë„ë¡œ ì‚¬ìš©.\n\n## DI vs primary polydipsia entry\n- í•µì‹¬ ë¶„ê¸°: free-water loss ì—¬ë¶€ì™€ serum sodium ë°©í–¥.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-21","focus_area":"Prolactinoma Acromegaly SIADH DI","tags":["usmle-step2","endocrinology","acromegaly","siadh","di","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Hypopituitarism + Primary vs Secondary Adrenal Insufficiency + Pituitary Recap\n## Hypopituitarism\n- ì¢…ì–‘ ì••ë°•, apoplexy, postpartum ischemia(Sheehan), ì¹¨ìœ¤ì„± ì§ˆí™˜ì´ ì£¼ìš” ì›ì¸.\n- ë‹¤ì¶• í˜¸ë¥´ëª¬ ê²°í• íŒ¨í„´ì„ êµ¬ì¡°ì ìœ¼ë¡œ í™•ì¸.\n\n## Primary vs Secondary adrenal insufficiency table\n| í•­ëª© | Primary AI (Adrenal) | Secondary AI (Pituitary/Hypothalamic) |\n| --- | --- | --- |\n| Aldosterone | ê°ì†Œ ê°€ëŠ¥ | ëŒ€ê°œ ë³´ì¡´ |\n| Potassium | ìƒìŠ¹ ê²½í–¥ | ëŒ€ì²´ë¡œ ì •ìƒ |\n| ACTH/pigmentation | ACTH ìƒìŠ¹, hyperpigmentation ê°€ëŠ¥ | ACTH ë‚®ìŒ, pigmentation ì—†ìŒ |\n| ì„ìƒ ë‹¨ì„œ | salt craving/volume depletion | ë‹¤ë¥¸ pituitary axis ê²°í• ë™ë°˜ ê°€ëŠ¥ |\n\n## Pituitary rapid recap\n- prolactinomaëŠ” mimic exclusion í›„ ì ‘ê·¼.\n- acromegalyëŠ” IGF-1 -> suppression test -> ìˆ˜ìˆ  ìˆœì„œ.\n- SIADH/DIëŠ” sodiumê³¼ volume ë§¥ë½ìœ¼ë¡œ ê°ë³„.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-41","focus_area":"Hypopituitarism and Adrenal Differential","tags":["usmle-step2","endocrinology","hypopituitarism","adrenal-insufficiency","table"]}
{"chunk_type":"transcript_chunk","text":"# Primary Hyperparathyroidism vs FHH Framework\n## Primary hyperparathyroidism\n- ê³ ì¹¼ìŠ˜í˜ˆì¦ + ë¶€ì ì ˆí•˜ê²Œ ë†’ê±°ë‚˜ ì–µì œë˜ì§€ ì•Šì€ PTH ì¡°í•©ì´ í•µì‹¬.\n- ë¬´ì¦ìƒ ë°œê²¬ì´ í”í•˜ë©° renal/bone í•©ë³‘ì¦ riskë¥¼ ë³‘í–‰ í‰ê°€.\n\n## FHH differentiation\n| í•­ëª© | Primary hyperparathyroidism | FHH |\n| --- | --- | --- |\n| Serum calcium | ìƒìŠ¹ | ê²½ë„ ìƒìŠ¹ |\n| PTH | ìƒìŠ¹ ë˜ëŠ” inappropriately normal | ì •ìƒ~ê²½ë„ ìƒìŠ¹ |\n| Urine calcium excretion | ìƒëŒ€ì ìœ¼ë¡œ ë†’ìŒ | ë‚®ìŒ (Ca/Cr clearance ratio ë‚®ìŒ) |\n| ì¹˜ë£Œ ì „ëµ | ìˆ˜ìˆ  ê³ ë ¤ ê°€ëŠ¥ | ìˆ˜ìˆ  ë¹„ê¶Œì¥(ë³´ì¡´ì  ê´€ë¦¬) |\n\n## Step 2 pearl\n- parathyroid surgery ì „ FHH ë°°ì œëŠ” í•„ìˆ˜ ì•ˆì „ ë‹¨ê³„.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-61","focus_area":"Primary Hyperparathyroidism vs FHH","tags":["usmle-step2","endocrinology","hyperparathyroidism","fhh","diagnosis","table"]}
{"chunk_type":"transcript_chunk","text":"# Neonatal Hypocalcemia (Maternal FHH Context) + Parathyroid Surgery Indications + CKD Progression\n## Neonatal scenario\n- maternal hypercalcemia í™˜ê²½ì—ì„œ fetal parathyroid suppression ë°œìƒ í›„ ì¶œìƒ ì§í›„ ì €ì¹¼ìŠ˜ ë°œì‘ ê°€ëŠ¥.\n- supportive calcium/vitamin D bridgeê°€ í•µì‹¬.\n\n## Surgery indications in primary hyperparathyroidism\n- symptomatic diseaseëŠ” ìˆ˜ìˆ  ìš°ì„ .\n- asymptomaticì—ì„œë„ ì—°ë ¹, calcium burden, renal function/stones, bone density/fracture, urine calcium ê¸°ì¤€ìœ¼ë¡œ ìˆ˜ìˆ  ê³ ë ¤.\n\n## Secondary/Tertiary hyperparathyroidism\n- CKDì—ì„œ phosphate retention + calcitriol ì €í•˜ë¡œ secondary hyperPTH.\n- ì¥ê¸°í™” ì‹œ autonomous tertiary ìƒíƒœë¡œ ì „í™˜ ê°€ëŠ¥í•˜ë©° severe mineral complication ë™ë°˜.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-81","focus_area":"Neonatal Hypocalcemia and HyperPTH Surgery Rules","tags":["usmle-step2","endocrinology","neonatal","hyperparathyroidism","surgery"]}
{"chunk_type":"transcript_chunk","text":"# Calciphylaxis + Post-surgical Hypoparathyroidism + Calcium-Phosphate Product Safety\n## Calciphylaxis\n- CKD/ê³ ì¹¼ìŠ˜-ê³ ì¸ì‚° í™˜ê²½ì—ì„œ vascular calcificationìœ¼ë¡œ í”¼ë¶€ ê´´ì‚¬/ê³ í†µ/ë†’ì€ ì‚¬ë§ë¥ .\n- severe refractory caseëŠ” parathyroid interventionê¹Œì§€ ê³ ë ¤.\n\n## Post-op hypoparathyroidism\n- neck surgery ì´í›„ hypocalcemia ê´€ë¦¬ì—ì„œ calcium + active vitamin D ë³´ì¶©.\n\n## Calcium-phosphate product target\n- ì—°ì¡°ì§/ê¸°ì €í•µ ì„íšŒí™” ìœ„í—˜ì„ ì¤„ì´ê¸° ìœ„í•´ Ca x P product ê³¼ìƒìŠ¹ì„ í”¼í•œë‹¤.\n- ë‹¨ìˆœ ì¹¼ìŠ˜ ë³´ì¶©ì´ ì•„ë‹ˆë¼ phosphate controlê³¼ ê· í˜• ê´€ë¦¬ê°€ ì¤‘ìš”.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-101","focus_area":"Calciphylaxis and Post-op Hypoparathyroidism","tags":["usmle-step2","endocrinology","calciphylaxis","hypoparathyroidism","safety"]}
{"chunk_type":"transcript_chunk","text":"# Endocrine Decision Framework: Pituitary, Thyroid, Parathyroid, Adrenal, Diabetes\n## Core tree principle\n- ì§„ë‹¨ëª… ì•”ê¸°ë³´ë‹¤ next-best-step ë¶„ê¸°(ë¨¼ì € ë°°ì œí•  ê²ƒ, ë¨¼ì € ì¸¡ì •í•  ê²ƒ, ë¨¼ì € ì¹˜ë£Œí•  ê²ƒ)ë¥¼ ê³ ì •í•œë‹¤.\n\n## Pituitary water-balance table\n| êµ¬ë¶„ | ë³‘íƒœìƒë¦¬ í¬ì¸íŠ¸ | í˜ˆì²­ Na ê²½í–¥ |\n| --- | --- | --- |\n| Primary polydipsia | ê³¼ë„í•œ ë¬¼ ì„­ì·¨ | ë‚®ì•„ì§€ê¸° ì‰¬ì›€ |\n| Central DI | ADH ê²°í•ìœ¼ë¡œ ììœ ìˆ˜ë¶„ ì†Œì‹¤ | ë†’ì•„ì§€ê¸° ì‰¬ì›€ |\n| Nephrogenic DI | ADH resistance, ë³´ìƒì  ìŒìˆ˜ ì‹œ Naê°€ ëœ ìƒìŠ¹ | ì •ìƒ~ìƒìŠ¹ |\n\n## Thyroid/parathyroid/adrenal integration\n- ì„ì‹ , ë…¸ì¸, ì¤‘í™˜ì ì»¨í…ìŠ¤íŠ¸ê°€ ê°™ì€ ìˆ˜ì¹˜ë¼ë„ ì²˜ì¹˜ë¥¼ ë°”ê¾¸ëŠ” í•µì‹¬ ë³€ìˆ˜.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-121","focus_area":"Cross-Endocrine Decision Framework","tags":["usmle-step2","endocrinology","decision-tree","di","thyroid","table"]}
{"chunk_type":"transcript_chunk","text":"# Thyroid in Pregnancy + Nodule + Hyperaldosteronism + Adrenal Insufficiency Integration\n## Thyroid in pregnancy\n- ìƒë¦¬ì  TBG/hCG ë³€í™”ì™€ ì§„ì„± ê°‘ìƒì„  ì§ˆí™˜ì„ êµ¬ë¶„.\n- hypothyroidism ì„ì‹ ì—ì„œëŠ” ë¹ ë¥¸ hormone dose adjustmentê°€ fetal neurodevelopmentì— ì¤‘ìš”.\n\n## Thyroid nodule algorithm\n- TSH ê¸°ë°˜ìœ¼ë¡œ scintigraphy í•„ìš”êµ°ê³¼ ultrasound/FNA ì¤‘ì‹¬êµ°ì„ ë¶„ë¦¬.\n\n## Hyperaldosteronism\n- resistant HTN + hypokalemiaì—ì„œ ARR ì„ ë³„ í›„ subtype ë¶„ë¥˜.\n\n## Adrenal insufficiency\n- hyponatremia/hyperkalemia/eosinophilia íŒ¨í„´ê³¼ stress-state deteriorationë¥¼ í•¨ê»˜ ë³¸ë‹¤.\n- adrenal crisis ì˜ì‹¬ ì‹œ ì§€ì—° ì—†ì´ steroid + fluids.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-141","focus_area":"Thyroid Pregnancy and Adrenal Integration","tags":["usmle-step2","endocrinology","thyroid","pregnancy","adrenal","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"# Diabetes Autonomic Failure + Gastroparesis + Thyroid Gray-zone Management\n## Hypoglycemia-associated autonomic failure\n- ë°˜ë³µ ì €í˜ˆë‹¹ì´ adrenergic warning ì‹ í˜¸ë¥¼ ë‘”í™”ì‹œì¼œ severe unrecognized hypoglycemia ìœ„í—˜ ì¦ê°€.\n\n## Gastroparesis in diabetes\n- delayed gastric emptyingìœ¼ë¡œ insulin-action/absorption mismatchê°€ ë°œìƒí•´ postprandial glycemic variabilityë¥¼ ìœ ë°œ.\n\n## Thyroid gray-zone pearls\n- subclinical hypothyroidism ì¹˜ë£Œ ì—¬ë¶€ëŠ” ì—°ë ¹/TSH ìˆ˜ì¤€/ì¦ìƒ/ë¦¬ìŠ¤í¬ë¡œ ê°œë³„í™”.\n- euthyroid sick syndromeì€ ì¤‘ì¦ì§ˆí™˜ ì ì‘ë°˜ì‘ ë§¥ë½ì—ì„œ ê³¼ì¹˜ë£Œë¥¼ í”¼í•œë‹¤.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-161","focus_area":"Diabetes Autonomic Failure and Thyroid Gray Zones","tags":["usmle-step2","endocrinology","diabetes","gastroparesis","thyroid"]}
{"chunk_type":"recap_summary","text":"# Rapid Recap + Endocrine Pharmacology Management Entry\n## Rapid endocrine recap\n1. prolactin elevationì€ MRI ì „ì— mimic ë°°ì œê°€ ìš°ì„ .\n2. thyroid noduleì€ TSH-firstë¡œ ê²½ë¡œ ë¶„ê¸°.\n3. ì„ì‹  hypothyroidismì€ ì¡°ê¸° ìš©ëŸ‰ ì¡°ì •ì´ ì¤‘ìš”.\n4. hypercalcemiaì—ì„œ urine calciumìœ¼ë¡œ FHHë¥¼ ë°°ì œ.\n5. adrenal insufficiency ì˜ì‹¬ ì‹œ ì§€ì—° ì—†ëŠ” í‰ê°€/ì¹˜ë£Œ.\n6. ë…¸ì¸/ì¤‘í™˜ì thyroid ìˆ˜ì¹˜ëŠ” overtreatmentë¥¼ í”¼í•˜ëŠ” íŒë‹¨ì´ ì¤‘ìš”.\n\n## Transition\n- ë‹¤ìŒ íŒŒíŠ¸ëŠ” endocrine pharmacologyì—ì„œ í™˜ìêµ°ë³„ ì•½ì œ ì„ íƒ/ê¸ˆê¸°ë¥¼ ì—°ê²°í•œë‹¤.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-171","focus_area":"Endocrine Rapid Recap and Pharm Entry","tags":["usmle-step2","endocrinology","recap","pharmacology","next-step"]}
{"chunk_type":"transcript_chunk","text":"# Pituitary/Thyroid Pharmacology Decisions + SIADH/DI Emergency Actions\n## Prolactinoma medication-first\n- macro lesionê³¼ visual symptomsê°€ ìˆì–´ë„ dopamine agonistë¥¼ ìš°ì„  ì‹œë„í•˜ëŠ” ê²ƒì´ í‘œì¤€ì  ìƒí™©ì´ ë§ë‹¤.\n\n## SIADH vs DI practical management\n- SIADH severe neurologic symptoms: 3% saline í¬í•¨ ì‘ê¸‰ êµì •.\n- DIëŠ” desmopressin ì‚¬ìš© ì‹œ ê³¼êµì •/ìˆ˜ë¶„ ê³¼ë‹¤ ì„­ì·¨ë¥¼ í•¨ê»˜ ê°ì‹œ.\n\n## Graves treatment in pregnancy table\n| ì‹œê¸° | ìš°ì„  ì•½ë¬¼ | í•µì‹¬ ì´ìœ  |\n| --- | --- | --- |\n| 1ë¶„ê¸° | PTU | ì´ˆê¸° íƒœì•„ ê¸°í˜• ìœ„í—˜ ìµœì†Œí™” |\n| 2-3ë¶„ê¸° | Methimazole | PTU ì¥ê¸° ê°„ë…ì„± ìœ„í—˜ ê°ì†Œ |\n\n## Graves with ophthalmopathy\n- radioiodineê°€ eye disease ì•…í™” ê°€ëŠ¥í•´ ì•½ë¬¼/ìˆ˜ìˆ  ì „ëµì„ ìš°ì„  ê³ ë ¤.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-181","focus_area":"Pituitary Thyroid Pharmacology Decisions","tags":["usmle-step2","endocrinology","graves","siadh","di","table"]}
{"chunk_type":"transcript_chunk","text":"# Thyroid Replacement Nuance + Adrenal and Parathyroid Safety Rules\n## Thyroid follow-up nuance\n- hyperthyroidism ì¹˜ë£Œ ì´ˆê¸° ì¶”ì ì€ TSH lagë¥¼ ê³ ë ¤í•´ free hormone ì¤‘ì‹¬ìœ¼ë¡œ ë³¸ë‹¤.\n- hypothyroidism replacementëŠ” ë…¸ì¸ì—ì„œ ì €ìš©ëŸ‰ ì‹œì‘ í›„ ì ì§„ ì¦ëŸ‰.\n- ì„ì‹ ë¶€ëŠ” í™•ì§„ ëŒ€ê¸°ë³´ë‹¤ ì¡°ê¸° dose adjustmentê°€ ìš°ì„ ë  ìˆ˜ ìˆìŒ.\n\n## Adrenal/parathyroid safety\n- unilateral vs bilateral hyperaldosteronism ì¹˜ë£Œ ë¶„ê¸°ë¥¼ êµ¬ë¶„.\n- septic physiologyì—ì„œ adrenal reserve ì €í•˜ ìœ„í—˜ ì•½ë¬¼(ì˜ˆ: etomidate) ì‚¬ìš©ì— ì£¼ì˜.\n- tertiary hyperparathyroidism/calcification riskëŠ” mineral balanceì™€ ìˆ˜ìˆ  ì ì‘ì¦ì„ í•¨ê»˜ íŒë‹¨.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-201","focus_area":"Thyroid Replacement and Adrenal Safety","tags":["usmle-step2","endocrinology","hypothyroidism","adrenal","parathyroid","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Diabetes Maintenance + High-yield Scenario Recap + Thyroid Deep Dive Entry\n## Diabetes maintenance\n- foot neuropathy screening(monofilament)ì€ ì ˆë‹¨ ìœ„í—˜ ì˜ˆë°©ì˜ í•µì‹¬.\n- ê³ ë ¹ ë‹¹ë‡¨ í™˜ìì—ì„œëŠ” ì €í˜ˆë‹¹ í”¼í•´ë¥¼ ì¤„ì´ê¸° ìœ„í•œ ì™„í™”ëœ A1c ëª©í‘œê°€ í•©ë¦¬ì .\n\n## Scenario rapid checks\n- prolactinoma: meds first.\n- Graves + significant ophthalmopathy: RAI íšŒí”¼.\n- pregnancy-specific thyroid managementëŠ” trimester context ë°˜ì˜.\n- severe hyponatremic symptomsì—ì„œëŠ” ì œí•œì  ì²˜ì¹˜ë³´ë‹¤ ì‘ê¸‰ êµì • í•„ìš”.\n\n## Transition to thyroid deep dive\n- ë‹¤ìŒ í•™ìŠµ ë¸”ë¡ì€ hyper/hypothyroidismê³¼ nodule algorithmì„ Step 2 ê´€ë¦¬ ë¬¸ì œ ê´€ì ìœ¼ë¡œ í™•ì¥.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-221","focus_area":"Diabetes Maintenance and Thyroid Transition","tags":["usmle-step2","endocrinology","diabetes","recap","thyroid","next-step"]}
{"chunk_type":"transcript_chunk","text":"# Hyperthyroidism Diagnostic Nuance: Lid Lag vs Proptosis + RAIU Logic\n## Key distinction\n- lid lag/stareëŠ” ë‹¤ì–‘í•œ thyrotoxic stateì—ì„œ ê°€ëŠ¥.\n- true proptosis/exophthalmosëŠ” Graves orbitopathyë¥¼ ê°•í•˜ê²Œ ì‹œì‚¬.\n\n## Diagnostic flow\n- low TSH + high free hormone í™•ì¸ í›„ ì›ì¸ ë¶„ë¥˜.\n- ì„ìƒì ìœ¼ë¡œ Gravesê°€ ëª…í™•í•˜ì§€ ì•Šìœ¼ë©´ RAIUë¡œ ê³¼ìƒì‚° vs ëˆ„ì¶œ/ì™¸ì¸ì„± ìƒíƒœë¥¼ êµ¬ë¶„.\n\n## RAIU interpretation table\n| íŒ¨í„´ | RAIU | ëŒ€í‘œ ìƒí™© | ì¹˜ë£Œ í¬ì¸íŠ¸ |\n| --- | --- | --- | --- |\n| Factory overproduction | ë†’ìŒ | Graves, toxic adenoma/multinodular goiter | thionamide/definitive therapy ê³ ë ¤ |\n| Leak/factitious | ë‚®ìŒ | thyroiditis, exogenous hormone, struma ovarii | methimazole íš¨ê³¼ ì œí•œ, ëŒ€ì¦ì¹˜ë£Œ ì¤‘ì‹¬ |","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-241","focus_area":"Hyperthyroidism RAIU Nuance","tags":["usmle-step2","endocrinology","thyroid","diagnosis","table"]}
{"chunk_type":"transcript_chunk","text":"# Hyperthyroidism Treatment and Thyroiditis Subtypes\n## Hyperthyroidism treatment\n- methimazoleì´ ê¸°ë³¸ì´ì§€ë§Œ agranulocytosis warning symptom(ë°œì—´/ì¸í›„í†µ) êµìœ¡ í•„ìˆ˜.\n- ì„ì‹  1ë¶„ê¸°ëŠ” PTU, ì´í›„ methimazole ì „í™˜.\n- ì¤‘ë“±ë„ ì´ìƒ ophthalmopathyì—ì„œëŠ” radioiodine ì „ëµì„ ì‹ ì¤‘íˆ ì„ íƒ.\n\n## Thyroid storm clue\n- ê³ ì—´ + ì •ì‹ ìƒíƒœ ë³€í™” + severe thyrotoxicosis ë§¥ë½ì€ ì‘ê¸‰ ë‹¤ì¤‘ì¹˜ë£Œ í•„ìš”.\n\n## Thyroiditis profile\n- painless/silent, subacute(painful, ESR/CRP ìƒìŠ¹), postpartumë¥¼ êµ¬ë¶„.\n- postpartumì—ì„œ Gravesì™€ ê°ë³„ì´ í•„ìš”í•˜ë©´ ì ì ˆí•œ í•­ì²´/ì„ìƒ ë§¥ë½ í™œìš©.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-261","focus_area":"Hyperthyroidism Treatment and Thyroiditis","tags":["usmle-step2","endocrinology","thyroid","treatment","pregnancy"]}
{"chunk_type":"transcript_chunk","text":"# Thyroid Gray-zone Algorithms: Nodule, Subclinical, Euthyroid Sick\n## Thyroid nodule sequence\n1. TSH first.\n2. low TSHë©´ scintigraphy branch.\n3. normal/high TSHë©´ ultrasound risk stratification í›„ FNA.\n\n## Subclinical hypothyroidism\n- TSH level, ì¦ìƒ, ì„ì‹  ê³„íš, ì—°ë ¹ì— ë”°ë¼ ì¹˜ë£Œ/ê´€ì°°ì„ ë¶„ê¸°.\n\n## Euthyroid sick syndrome\n- critical illnessì—ì„œ ë°œìƒí•˜ëŠ” adaptive patternìœ¼ë¡œ, thyroid hormone routine replacementë¥¼ í”¼í•˜ê³  ê¸°ì €ì§ˆí™˜ ì¹˜ë£Œì— ì§‘ì¤‘.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-281","focus_area":"Thyroid Gray-zone Algorithms","tags":["usmle-step2","endocrinology","thyroid-nodule","diagnosis"]}
{"chunk_type":"recap_summary","text":"# Thyroid Rapid Recap\n- hyperthyroidismì€ ì›ì¸ë¶„ë¥˜(ê³¼ìƒì‚° vs ëˆ„ì¶œ)ë¥¼ ë¨¼ì € ê²°ì •.\n- thyroid stormì€ fever/neurologic change ë™ë°˜ ì‹œ ì¦‰ì‹œ ì‘ê¸‰ì¹˜ë£Œ.\n- ì„ì‹ ì—ì„œëŠ” trimesterë³„ í•­ê°‘ìƒì„ ì œ ì „ëµê³¼ hypothyroid dose-up íƒ€ì´ë°ì´ í•µì‹¬.\n- noduleì€ TSH-first, euthyroid sick syndromeì€ ê³¼ì¹˜ë£Œ ê¸ˆì§€.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-294","focus_area":"Thyroid Rapid Recap","tags":["usmle-step2","endocrinology","recap","thyroid"]}
{"chunk_type":"transcript_chunk","text":"# Hypertension Framework: Physiology + Measurement Strategy\n## Physiology lens\n- diastolic pressureëŠ” SVR, pulse pressureëŠ” stroke volume/arterial complianceë¥¼ ë°˜ì˜.\n- ê³ ë ¹ isolated systolic HTNì€ arterial stiffnessì™€ ì—°ê²°.\n\n## Confirming diagnosis\n- office BP ë‹¨ë…ë³´ë‹¤ ambulatory/home BPê°€ ì‹¤ì œ burdenì„ ë” ì˜ ë°˜ì˜.\n- white-coat/masked HTNì„ ë°˜ë“œì‹œ ê³ ë ¤.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-1","focus_area":"Hypertension Physiology and Diagnosis","tags":["usmle-step2","cardiology","hypertension","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"# Hypertension Treatment Staging + Lifestyle + Comorbidity-tailored Drug Choice\n## Treatment staging\n- stage 1ì€ global risk ë™ë°˜ ì—¬ë¶€ë¡œ lifestyle-only vs medication ë³‘í–‰ì„ ë¶„ê¸°.\n- stage 2ëŠ” ë³´í†µ ì•½ë¬¼ ì¹˜ë£Œë¥¼ ì¡°ê¸° ì‹œì‘.\n\n## Decision table\n| ë‹¨ê³„ | í™˜ì íŠ¹ì„± | ê¸°ë³¸ ì „ëµ |\n| --- | --- | --- |\n| Stage 1 | ë‚®ì€ ASCVD risk | lifestyle ìš°ì„  |\n| Stage 1 | ê³ ìœ„í—˜(DM/CKD/ASCVD risk ìƒìŠ¹) | lifestyle + ì•½ë¬¼ |\n| Stage 2 | ìœ„í—˜ë„ì™€ ë¬´ê´€í•˜ê²Œ ê³ í˜ˆì•• ì§€ì† | ì•½ë¬¼ í¬í•¨ ì ê·¹ ì¹˜ë£Œ |\n\n## Comorbidity-based selection\n- post-MI/HFrEF: ACEi/ARB + beta-blocker.\n- gout: losartan ì„ í˜¸, thiazide ì£¼ì˜.\n- osteoporosis: thiazide ì´ì  ê³ ë ¤.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-21","focus_area":"Hypertension Treatment and Comorbidity","tags":["usmle-step2","cardiology","hypertension","treatment","table"]}
{"chunk_type":"transcript_chunk","text":"# Secondary Hypertension Clues + Hypertensive Crisis Triage\n## Secondary clues\n- abdominal bruit/ACEi í›„ Cr ìƒìŠ¹/flash pulmonary edema -> renovascular HTN.\n- hypokalemic metabolic alkalosis -> primary aldosteronism.\n- episodic headache-palpitations-sweating -> pheochromocytoma.\n- arm-leg BP gradient -> coarctation.\n\n## Crisis table\n| êµ¬ë¶„ | End-organ damage | ì¹˜ë£Œ ì ‘ê·¼ |\n| --- | --- | --- |\n| Hypertensive urgency | ì—†ìŒ | ê²½êµ¬ì œ + ì ì§„ì  ì¡°ì ˆ |\n| Hypertensive emergency | ìˆìŒ(ë‡Œ/ì‹¬ì¥/ì‹ ì¥/ë§ë§‰) | IV ì•½ì œ + ëª¨ë‹ˆí„°ë§ í•˜ ì‹ ì† ì¡°ì ˆ |","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-41","focus_area":"Secondary HTN and Crisis","tags":["usmle-step2","cardiology","secondary-hypertension","emergency","table"]}
{"chunk_type":"recap_summary","text":"# Hypertension Recap + Transition to IE/RHD\n## Rapid recap\n1. ê³ í˜ˆì•• ì¹˜ë£ŒëŠ” ìˆ˜ì¹˜+ìœ„í—˜ë„+ë™ë°˜ì§ˆí™˜ì„ ê°™ì´ ë³¸ë‹¤.\n2. ìƒí™œìŠµê´€ ì¤‘ ì²´ì¤‘ê°ëŸ‰/DASHëŠ” BP ìì²´ë¥¼ ìœ ì˜ë¯¸í•˜ê²Œ ë‚®ì¶˜ë‹¤.\n3. secondary HTN ë‹¨ì„œê°€ ìˆìœ¼ë©´ ì›ì¸í‰ê°€ë¥¼ ìš°ì„ .\n4. emergencyëŠ” ì¥ê¸°ì†ìƒ ìœ ë¬´ë¡œ ì •ì˜.\n\n## Transition\n- ë‹¤ìŒ ë¸”ë¡ì€ infective endocarditisì™€ rheumatic diseaseì˜ ê°ì—¼ vs ë©´ì—­ ê¸°ì „ ë¶„ë¦¬ì— ì´ˆì ì„ ë‘”ë‹¤.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-51","focus_area":"Hypertension Recap and IE Transition","tags":["usmle-step2","cardiology","hypertension","recap"]}
{"chunk_type":"transcript_chunk","text":"# Infective Endocarditis Core: Risk, Signs, and Etiologic Pattern\n## Major risk settings\n- prosthetic valve, prior IE, IVDU, intravascular accessê°€ ê³ ìœ„í—˜.\n\n## Clinical signs and mechanism\n| ì†Œê²¬ | ì„ìƒ íŠ¹ì§• | ê¸°ì „ |\n| --- | --- | --- |\n| Janeway lesions | í†µì¦ ì—†ëŠ” ì†ë°œë°”ë‹¥ ë³‘ë³€ | septic microemboli |\n| Osler nodes | í†µì¦ ìˆëŠ” ê²°ì ˆ | immune complex-mediated |\n| Roth spots/splinter hemorrhage | í˜ˆê´€ì„± ë¯¸ì„¸ë³‘ë³€ | ì—¼ì¦/ë¯¸ì„¸ìƒ‰ì „ ì—°ê´€ |\n\n## Etiology cues\n- IVDUëŠ” right-sided IE(tricuspid)ì™€ pulmonary septic embolië¥¼ ë™ë°˜í•  ìˆ˜ ìˆìŒ.\n- íŠ¹ì • ê· ì£¼ ë‹¨ì„œ(ì˜ˆ: S. gallolyticus)ì—ì„œëŠ” ì—°ê´€ ì¥ê¸° í‰ê°€(ì˜ˆ: colon pathology)ë¥¼ ì—°ê²°.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-61","focus_area":"Infective Endocarditis Core","tags":["usmle-step2","cardiology","infective-endocarditis","diagnosis","table"]}
{"chunk_type":"transcript_chunk","text":"# IE Management + Prophylaxis + RHD Introduction\n## IE management\n- ë°˜ë³µ blood culture + echo(í•„ìš” ì‹œ TEE)ë¡œ í™•ì§„ ê²½ë¡œë¥¼ ë°ŸëŠ”ë‹¤.\n- hemodynamic instability, heart failure, uncontrolled infection, embolic riskì—ì„œ ìˆ˜ìˆ  ì ì‘ì¦ ê³ ë ¤.\n\n## Prophylaxis boundaries\n- prophylaxisëŠ” ê³ ìœ„í—˜ cardiac group + ê³ ìœ„í—˜ ì‹œìˆ ì— ì œí•œì ìœ¼ë¡œ ì ìš©.\n- ì €ìœ„í—˜êµ°ì—ëŠ” ë¶ˆí•„ìš”í•œ í•­ìƒì œ ì˜ˆë°©ì„ í”¼í•œë‹¤.\n\n## RHD transition\n- ARF/RHDëŠ” ê°ì—¼ ìì²´ê°€ ì•„ë‹Œ post-streptococcal immune mechanismìœ¼ë¡œ ì´í•´.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-81","focus_area":"IE Management and RHD Entry","tags":["usmle-step2","cardiology","infective-endocarditis","treatment","prophylaxis"]}
{"chunk_type":"transcript_chunk","text":"# Rheumatic Heart Disease: Jones Logic + Secondary Prevention\n## Core mechanism\n- untreated GAS pharyngitis ì´í›„ molecular mimicryë¡œ ë‹¤ê¸°ê´€ ì—¼ì¦ì´ ë°œìƒ.\n- Jones criteriaë¥¼ ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤ì™€ ì—°ê²°í•´ í•´ì„.\n\n## Long-term course\n- ë°˜ë³µ ì—¼ì¦ í›„ ë§Œì„± íŒë§‰ ì†ìƒ(íŠ¹íˆ mitral pathology)ë¡œ ì§„í–‰.\n\n## Secondary prophylaxis table\n| ì„ìƒêµ° | í˜ë‹ˆì‹¤ë¦° 2ì°¨ ì˜ˆë°© ê¸°ê°„ ê°œë… |\n| --- | --- |\n| carditis ì—†ìŒ | ë‹¨ê¸°-ì¤‘ê¸° ì˜ˆë°© |\n| carditis ìˆìœ¼ë‚˜ ì”ì—¬íŒë§‰ ì†ìƒ ì—†ìŒ | ë” ê¸´ ì˜ˆë°© |\n| carditis + ì”ì—¬ íŒë§‰ì§ˆí™˜ | ì¥ê¸°/í‰ìƒ ì˜ˆë°© ê³ ë ¤ |","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-101","focus_area":"RHD Prevention Framework","tags":["usmle-step2","cardiology","rheumatic-heart-disease","prevention","table"]}
{"chunk_type":"transcript_chunk","text":"# Cholesterol Crystal Embolism + Statin Indication Framework\n## Cholesterol embolism\n- í˜ˆê´€ ì‹œìˆ  í›„ í”¼ë¶€í—ˆí˜ˆ/AKI/eosinophilia ì¡°í•©ì—ì„œ ì˜ì‹¬.\n- ìƒê²€ì˜ cholesterol cleft ì†Œê²¬ì´ ì§„ë‹¨ ì§€ì§€.\n- ê¸‰ì„±ê¸° íŠ¹íš¨ì•½ë³´ë‹¤ supportive care + plaque stabilization ì „ëµì´ ì¤‘ì‹¬.\n\n## Statin 4-group framework\n| ê·¸ë£¹ | ê¸°ì¤€ | ì „ëµ |\n| --- | --- | --- |\n| Secondary prevention | established ASCVD | statin í•„ìˆ˜(ê°•ë„ëŠ” ì—°ë ¹/ë‚´ì•½ì„± ë°˜ì˜) |\n| Severe LDL elevation | LDL â‰¥ 190 | ê³ ê°•ë„ statin ìš°ì„  |\n| Diabetes age-range | 40-75 + diabetes | ìµœì†Œ ì¤‘ê°•ë„ ì´ìƒ ê³ ë ¤ |\n| Elevated primary risk | 40-75, no DM, risk ìƒìŠ¹ | ìœ„í—˜ë„ ê¸°ë°˜ statin ë„ì… |","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-121","focus_area":"Cholesterol Embolism and Statin Groups","tags":["usmle-step2","cardiology","lipids","statin","table"]}
{"chunk_type":"transcript_chunk","text":"# Hypertriglyceridemia Priorities + ACS Statin Role + Lifestyle\n## TG priority\n- ë§¤ìš° ë†’ì€ TGì—ì„œëŠ” ASCVDë³´ë‹¤ ê¸‰ì„± ì·Œì¥ì—¼ ì˜ˆë°©ì´ immediate goal.\n- fibrate/omega-3/ê¸ˆì£¼/ì²´ì¤‘ê°ëŸ‰ì„ ì ê·¹ ì ìš©.\n\n## ACS context\n- ACS ê¸‰ì„±ê¸° ê³ ìš©ëŸ‰ statinì€ lipid loweringë¿ ì•„ë‹ˆë¼ plaque stabilization/anti-inflammatory íš¨ê³¼ê°€ í•µì‹¬.\n\n## Lifestyle backbone\n- Mediterranean/DASH pattern, ê¸ˆì£¼, ì²´ì¤‘ê°ëŸ‰, ìš´ë™ì„ ì•½ë¬¼ì¹˜ë£Œì™€ ë³‘í–‰.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-141","focus_area":"Triglyceride and ACS Lipid Strategy","tags":["usmle-step2","cardiology","triglyceride","acs","treatment"]}
{"chunk_type":"recap_summary","text":"# Lipid Rapid Recap + Transition to Aorta/Carotid Disease\n## Rapid recap\n- procedure í›„ blue toe + AKI + eosinophiliaëŠ” cholesterol embolism red flag.\n- statin ì ì‘ì¦ì€ 4-groupìœ¼ë¡œ êµ¬ì¡°í™”.\n- severe TGëŠ” pancreatitis preventionì„ ìµœìš°ì„ .\n- ACSì—ì„œëŠ” ì´ˆê¸° ê³ ê°•ë„ statinì„ ì§€ì—°í•˜ì§€ ì•ŠëŠ”ë‹¤.\n\n## Transition\n- ë‹¤ìŒì€ ëŒ€ë™ë§¥/ê²½ë™ë§¥ ì§ˆí™˜ì„ dissection, aneurysm, occlusion íŒ¨í„´ìœ¼ë¡œ êµ¬ë¶„.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-151","focus_area":"Lipid Recap and Aorta Transition","tags":["usmle-step2","cardiology","lipid","recap"]}
{"chunk_type":"transcript_chunk","text":"# Aortic Dissection and AAA Framework\n## Aortic dissection\n- tearing chest/back pain + risk factors(HTN/connective tissue disease)ì—ì„œ ì˜ì‹¬.\n- pulse deficit ë¶€ì¬ê°€ ë°°ì œë¥¼ ì˜ë¯¸í•˜ì§€ ì•ŠëŠ”ë‹¤.\n\n## Imaging choice table\n| í™˜ì ìƒíƒœ | ìš°ì„  ê²€ì‚¬ | ì´ìœ  |\n| --- | --- | --- |\n| Hemodynamically unstable | Bedside TEE | ì¦‰ì‹œ í™•ì¸ ë° ì¹˜ë£Œ ê²°ì • ê°€ëŠ¥ |\n| Hemodynamically stable | CT angiography | í•´ë¶€í•™ì  ë²”ìœ„ í‰ê°€ì— ìœ ë¦¬ |\n\n## AAA\n- rupture suspicion(ë³µí†µ+ì €í˜ˆì••) ì‹œ ì¦‰ì‹œ ìˆ˜ìˆ  ê²½ë¡œ.\n- ì•ˆì • í™˜ìëŠ” í¬ê¸°/ì„±ì¥ì†ë„/ì¦ìƒìœ¼ë¡œ ìˆ˜ìˆ  ì‹œì ì„ ê²°ì •.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-161","focus_area":"Aortic Dissection and AAA","tags":["usmle-step2","cardiology","aortic-dissection","aaa","emergency"]}
{"chunk_type":"transcript_chunk","text":"# AAA Size-based Management + Coarctation + Leriche Syndrome\n## AAA management table\n| ìƒí™© | ê´€ë¦¬ |\n| --- | --- |\n| ruptured or impending rupture | ì¦‰ì‹œ ìˆ˜ìˆ /ì‘ê¸‰ì²˜ì¹˜ |\n| >5.5 cm ë˜ëŠ” rapid expansion ë˜ëŠ” symptomatic | elective repair ê³ ë ¤ |\n| ì¤‘ê°„ í¬ê¸°, ë¬´ì¦ìƒ | ì£¼ê¸°ì  ì˜ìƒ ì¶”ì  |\n\n## Coarctation clues\n- arm>leg BP, radio-femoral delay, rib notching.\n- neonatal critical caseì—ì„œ ductal patency ìœ ì§€(PGE1) í•„ìš”.\n\n## Leriche triad\n- buttock claudication + erectile dysfunction + diminished femoral pulses.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-181","focus_area":"AAA Coarctation Leriche","tags":["usmle-step2","cardiology","aaa","coarctation","leriche","table"]}
{"chunk_type":"transcript_chunk","text":"# Carotid Stenosis/Dissection: Stroke Prevention Strategy\n## Carotid stenosis intervention table\n| í™˜ìêµ° | í˜‘ì°© ì •ë„/ì¡°ê±´ | ì ‘ê·¼ |\n| --- | --- | --- |\n| Symptomatic | ê³ ë„ í˜‘ì°© | CEA ì ê·¹ ê³ ë ¤ |\n| Asymptomatic | ë§¤ìš° ê³ ë„ í˜‘ì°©ì—ì„œ ì„ íƒì  | ëŒ€ê°œ medical therapy ìš°ì„  |\n| All | risk factor control | antiplatelet/statin/BP control |\n\n## Carotid dissection\n- neck trauma/rotation ì´í›„ focal neuro deficit + partial Horner patternì´ ë‹¨ì„œ.\n- CTA ì§„ë‹¨ í›„ antithrombotic strategyë¡œ embolic stroke ì˜ˆë°©.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-201","focus_area":"Carotid Stenosis and Dissection","tags":["usmle-step2","cardiology","carotid-stenosis","carotid-dissection","stroke","table"]}
{"chunk_type":"recap_summary","text":"# Aorta-Carotid Rapid Fire Recap\n1. dissection: unstable=TEE, stable=CTA.\n2. AAA rupture suspicionì€ imaging ì§€ì—°ë³´ë‹¤ OR pathway ìš°ì„ .\n3. coarctationì€ upper-lower pressure gradientì™€ collateral signsë¡œ ì§„ë‹¨.\n4. LericheëŠ” aortoiliac occlusive triadë¡œ ì¸ì‹.\n5. carotid stenosisëŠ” ì¦ìƒ ì—¬ë¶€ + í˜‘ì°©ë¥ ë¡œ CEA ì ì‘ì¦ ê²°ì •.\n6. carotid dissectionì€ trauma/neck movement historyì™€ neurologic deficitë¥¼ ì—°ê²°.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-215","focus_area":"Aorta Carotid Rapid Recap","tags":["usmle-step2","cardiology","recap","vascular"]}
{"chunk_type":"transcript_chunk","text":"# Acute MI Initial Triage and Early Medication Bundle\n## First split: ECG + biomarker\n- STEMIëŠ” ì¦‰ì‹œ ì¬ê´€ë¥˜ ê²½ë¡œë¡œ ë¶„ê¸°í•˜ê³ , NSTEMI/UAëŠ” troponin + risk stratificationìœ¼ë¡œ ì§„í–‰.\n- ìƒˆ LBBB/ëª…í™•í•œ ST elevationì€ time-critical reperfusion signal.\n\n## Early medication table\n| ì•½ë¬¼ | í•µì‹¬ ëª©ì  | ì£¼ìš” ì£¼ì˜ì  |\n| --- | --- | --- |\n| Nitrates | preload ê°ì†Œ ë° ischemic pain ì™„í™” | hypotension/RV infarct ì˜ì‹¬ ì‹œ ì£¼ì˜ |\n| Beta-blocker | myocardial oxygen demand ê°ì†Œ | shock/bradycardia/acute decomp HFì—ì„œëŠ” ì œí•œ |\n| Dual antiplatelet | platelet thrombosis ì–µì œ | bleeding risk í‰ê°€ ë³‘í–‰ |\n| Anticoagulant | clot propagation ì–µì œ | renal function/bleeding ìƒí™© ë°˜ì˜ |\n| High-intensity statin | plaque stabilization + anti-inflammatory | ê¸‰ì„±ê¸° ì¡°ê¸° íˆ¬ì—¬ ê¶Œì¥ |","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-1","focus_area":"Acute MI Triage and Initial Medications","tags":["usmle-step2","cardiology","mi","acute-management","table"]}
{"chunk_type":"transcript_chunk","text":"# NSTEMI/UA TIMI Risk and MI Localization\n## TIMI-based pathway\n- NSTEMI/UAëŠ” TIMI ì ìˆ˜ë¡œ early invasive í•„ìš”ë„ë¥¼ ê³„ì¸µí™”.\n- hemodynamic instability/refractory pain/arrhythmiaëŠ” ì ìˆ˜ì™€ ë¬´ê´€í•˜ê²Œ ì¦‰ì‹œ invasive strategy.\n\n## Ischemia localization table\n| ê²½ìƒ‰ ë¶€ìœ„ | ê´€ë ¨ í˜ˆê´€ | ECG íŒíŠ¸ |\n| --- | --- | --- |\n| Anterior | LAD | V1-V6 ST ë³€í™” |\n| Inferior | RCA(Â±LCX) | II, III, aVF |\n| Lateral | LCX/branch | I, aVL, V5-6 |\n| Posterior | posterior circulation | V1-3 reciprocal change |\n\n## RV infarct pearl\n- inferior MI + hypotension + clear lungs/JVDë©´ RV involvement ê³ ë ¤.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-21","focus_area":"NSTEMI UA Risk and Localization","tags":["usmle-step2","cardiology","nstemi","timi","ecg","table"]}
{"chunk_type":"recap_summary","text":"# MI Early-phase Rapid Recap + Stable Angina Transition\n## Acute MI key recap\n1. STEMIëŠ” door-to-device time ì¤‘ì‹¬ìœ¼ë¡œ ì¬ê´€ë¥˜ ìš°ì„ .\n2. NSTEMI/UAëŠ” risk stratification í›„ ì¹¨ìŠµ ì „ëµ ê²°ì •.\n3. RV MIì—ì„œëŠ” preload-dependent physiologyë¥¼ ì¸ì‹í•´ nitrate/diureticì„ í”¼í•œë‹¤.\n4. í‡´ì› í›„ì—ëŠ” antiplatelet/statin/beta-blocker/RAAS blockade ê¸°ë°˜ 2ì°¨ ì˜ˆë°©.\n\n## Transition\n- ë‹¤ìŒ ë¸”ë¡ì€ stable anginaì—ì„œ pretest probabilityì™€ stress-test ì„ íƒ ì•Œê³ ë¦¬ì¦˜ìœ¼ë¡œ ì´ì–´ì§„ë‹¤.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-40","focus_area":"MI Recap and Stable Angina Transition","tags":["usmle-step2","cardiology","mi","recap"]}
{"chunk_type":"transcript_chunk","text":"# Stable Angina Diagnostic Entry: Symptom Pattern + Risk Context\n## Classic symptom triad\n| í•­ëª© | ì§ˆë¬¸ |\n| --- | --- |\n| Character/location | retrosternal pressure-type painì¸ê°€ |\n| Provocation | exertion/emotional stressë¡œ ì•…í™”ë˜ëŠ”ê°€ |\n| Relief | rest ë˜ëŠ” nitroglycerinìœ¼ë¡œ í˜¸ì „ë˜ëŠ”ê°€ |\n\n- 3ê°œ ëª¨ë‘ë©´ typical angina ê°€ëŠ¥ì„± ë†’ìŒ.\n- ë¹„ì „í˜• í‰í†µ/ë¹„ì‹¬ì¥ì„± í†µì¦ ê°ë³„ì—ì„œ aortic dissection, GERD, musculoskeletal painì„ í•¨ê»˜ ë³¸ë‹¤.\n\n## Risk context\n- age/sex/risk factors ê¸°ë°˜ pretest probabilityë¥¼ ë¨¼ì € ì„¤ì •í•´ ë¶ˆí•„ìš”í•œ ê²€ì‚¬/ëˆ„ë½ì„ ì¤„ì¸ë‹¤.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-50","focus_area":"Stable Angina Symptom and Risk Pattern","tags":["usmle-step2","cardiology","stable-angina","diagnosis","table"]}
{"chunk_type":"transcript_chunk","text":"# Stable Angina Testing Algorithm + Treatment Tracks + Vasospastic Angina\n## Stress-test selection table\n| ìš´ë™ ê°€ëŠ¥ ì—¬ë¶€ | baseline ECG í•´ì„ ê°€ëŠ¥ | ì„ íƒ ê²€ì‚¬ |\n| --- | --- | --- |\n| ê°€ëŠ¥ | ê°€ëŠ¥ | Exercise ECG |\n| ê°€ëŠ¥ | ë¶ˆê°€ | Exercise + imaging |\n| ë¶ˆê°€ | ë¬´ê´€ | Pharmacologic stress + imaging |\n\n## Core treatment tracks\n- symptom relief: short-acting nitrate.\n- event prevention: beta-blocker ì¤‘ì‹¬ + antiplatelet/statin/risk-factor control.\n\n## Vasospastic (Prinzmetal) pattern\n- rest/night-morning chest pain + transient ST elevation.\n- CCB/nitrateê°€ ì¤‘ì‹¬, ë¹„ì„ íƒì  beta-blockerëŠ” ì•…í™” ìœ„í—˜.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-70","focus_area":"Stable Angina Testing and Vasospastic Management","tags":["usmle-step2","cardiology","stable-angina","stress-test","vasospastic","table"]}
{"chunk_type":"recap_summary","text":"# Stable Angina Recap + MI Part 2 Entry (Post-MI Phase)\n## Recap\n- pretest probabilityê°€ ê²€ì‚¬ ì„ íƒì˜ ì¶œë°œì .\n- ì¤‘ê°„ í™•ë¥ êµ°ì—ì„œ stress test utilityê°€ ê°€ì¥ ë†’ë‹¤.\n- vasospastic anginaëŠ” ê³ ì • í˜‘ì°©ê³¼ ì¹˜ë£Œ ì›ì¹™ì´ ë‹¤ë¥´ë‹¤.\n\n## Transition\n- ì´í›„ ë‚´ìš©ì€ post-MI í•©ë³‘ì¦ timeline, ì¬ì›/í‡´ì› í›„ ê´€ë¦¬, í‰í†µ ê°ë³„ ì‹¬í™”ë¡œ í™•ì¥.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-88","focus_area":"Stable Angina Recap and Post-MI Entry","tags":["usmle-step2","cardiology","stable-angina","recap"]}
{"chunk_type":"transcript_chunk","text":"# Post-MI Mechanical Complications Timeline\n## 3-5 day danger zone table\n| í•©ë³‘ì¦ | í•µì‹¬ ê¸°ì „ | ì„ìƒ ë‹¨ì„œ |\n| --- | --- | --- |\n| Papillary muscle rupture | acute severe MR | pulmonary edema + new murmur |\n| Ventricular septal rupture | left-to-right shunt | new harsh murmur + RV O2 step-up |\n| Free-wall rupture | hemopericardium/tamponade | sudden shock/PEA arrest |\n\n## Late complication\n- LV aneurysmì€ ìˆ˜ì£¼-ìˆ˜ê°œì›” í›„ dyskinetic scar segmentì™€ mural thrombus riskë¥¼ ìœ ë°œ.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-98","focus_area":"Post-MI Mechanical Complications","tags":["usmle-step2","cardiology","post-mi","mechanical-complications","table"]}
{"chunk_type":"transcript_chunk","text":"# Post-MI Long-term Pharmacology + Stress Imaging + Chest Pain Differential\n## Long-term core medications\n| ì¶• | ì£¼ìš” ì•½ì œ | ëª©ì  |\n| --- | --- | --- |\n| Antithrombotic | aspirin Â± additional antiplatelet | recurrent thrombosis ê°ì†Œ |\n| Neurohormonal blockade | beta-blocker, ACEi/ARB, selected MRA | remodeling/HF risk ê°ì†Œ |\n| Lipid stabilization | high-intensity statin | plaque stabilization |\n\n## Stress imaging selection\n- pharmacologic stressëŠ” í™˜ì ì¡°ê±´(ê¸°ê´€ì§€ê²½ë ¨ ìœ„í—˜ ë“±)ì— ë”°ë¼ ì•½ì œë¥¼ ì„ íƒ.\n\n## Differential discipline\n- ACS, dissection, PE, GERD, vasospasmì„ ì‹œë‚˜ë¦¬ì˜¤ ë‹¨ì„œë¡œ ë¶„ê¸°.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-118","focus_area":"Post-MI Long-term Management and Differential","tags":["usmle-step2","cardiology","post-mi","pharmacology","diagnosis","table"]}
{"chunk_type":"recap_summary","text":"# Post-MI and Chest Pain Rapid Recap\n- ê¸°ê³„ì  í•©ë³‘ì¦ì€ ì‹œê¸°ì™€ ì²­ì§„/í˜ˆì—­í•™ ë‹¨ì„œë¡œ êµ¬ë¶„.\n- post-MIì—ì„œëŠ” êµ¬ì¡°ì  ì•…í™”ì™€ ì¬ë°œ ì˜ˆë°© ì•½ë¬¼ ì¡°í•©ì„ ë™ì‹œì— ê´€ë¦¬.\n- ì´ˆê¸° ECG/troponin ìŒì„±ì´ë¼ë„ ì„ìƒ ìœ„í—˜ì´ ë†’ìœ¼ë©´ serial evaluationì´ í•„ìš”.\n- í‰í†µ ê°ë³„ì—ì„œ vasospastic anginaëŠ” rest pain + transient ST changeë¥¼ ê¸°ì–µ.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-135","focus_area":"Post-MI Rapid Recap","tags":["usmle-step2","cardiology","post-mi","recap"]}
{"chunk_type":"transcript_chunk","text":"# Valvular Stenosis Framework Entry (Images Removed)\n## Murmur interpretation basics\n| ì†Œê²¬ | ë³‘ì  ê°€ëŠ¥ì„± ë†’ìŒ | ìƒëŒ€ì ìœ¼ë¡œ ì–‘ì„± ê°€ëŠ¥ |\n| --- | --- | --- |\n| Timing | diastolic ë˜ëŠ” holosystolic | ì§§ì€ systolic flow murmur |\n| Intensity/quality | loud/harsh, radiation ë™ë°˜ | low-grade positional murmur |\n| Context | symptoms/signs ë™ë°˜ | ë¬´ì¦ìƒ, ë‹¤ë¥¸ ì´ìƒì†Œê²¬ ì—†ìŒ |\n\n## Added sounds\n- S3: volume overload/dilated ventricle ìƒí™©.\n- S4: stiff ventricle(pressure overload/ischemia) ìƒí™©.\n\n## Perioperative valve logic\n- ì¤‘ë“±ë„ ì´ìƒ íŒë§‰ì§ˆí™˜ì€ ì¦ìƒê³¼ ìˆ˜ìˆ  ìœ„í—˜ë„ë¥¼ í•¨ê»˜ ë°˜ì˜í•´ ìš°ì„ ìˆœìœ„ë¥¼ ì •í•œë‹¤.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-145","focus_area":"Valvular Stenosis Framework","tags":["usmle-step2","cardiology","valvular","murmur","table"]}
{"chunk_type":"transcript_chunk","text":"# Aortic and Mitral Stenosis Core\n## Aortic stenosis\n- ì›ì¸: calcific degeneration(ê³ ë ¹), bicuspid valve(ì Šì€ í™˜ì).\n- ì „í˜• triad: exertional dyspnea/angina/syncope.\n- severe criteria(hemodynamic echo markers) ì¶©ì¡± ì‹œ valve intervention ê³ ë ¤.\n- symptomatic severe ASì—ì„œ stress testëŠ” ê¸ˆê¸°.\n\n## Mitral stenosis\n- left atrial pressure overloadë¡œ dyspnea/orthopnea/hemoptysis ê°€ëŠ¥.\n- opening snap + diastolic rumble, LA enlargement ë‹¨ì„œ.\n- í•´ë¶€í•™ ì í•©í•˜ë©´ PMBV ê°™ì€ ì‹œìˆ  ì˜µì…˜ ê³ ë ¤.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-165","focus_area":"Aortic and Mitral Stenosis","tags":["usmle-step2","cardiology","aortic-stenosis","mitral-stenosis"]}
{"chunk_type":"recap_summary","text":"# Stenosis Rapid Recap + Regurgitant Valve Transition\n## Stenosis recap table\n| êµ¬ë¶„ | Aortic stenosis | Mitral stenosis |\n| --- | --- | --- |\n| ëŒ€í‘œ ì¦ìƒ | exertional syncope/angina/dyspnea | pulmonary congestion symptoms |\n| ì£¼ìš” ì²­ì§„ | systolic crescendo-decrescendo | opening snap + diastolic rumble |\n| ì£¼ìš” ê´€ë¦¬ í¬ì¸íŠ¸ | severe symptomatic ì‹œ intervention | anatomy ê¸°ë°˜ PMBV/ìˆ˜ìˆ  íŒë‹¨ |\n\n## Transition\n- ë‹¤ìŒì€ regurgitant lesionìœ¼ë¡œ, pressure overloadë³´ë‹¤ volume overload physiologyê°€ ì¤‘ì‹¬.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-180","focus_area":"Stenosis Recap and Regurgitation Transition","tags":["usmle-step2","cardiology","valvular","recap","table"]}
{"chunk_type":"transcript_chunk","text":"# Regurgitant Valve Disease Part 1: AR and Acute/Chronic MR\n## Core comparison table\n| ì§ˆí™˜ | í•µì‹¬ ë³‘íƒœìƒë¦¬ | ì„ìƒ í¬ì¸íŠ¸ | ì¹˜ë£Œ íƒ€ì´ë° í¬ì¸íŠ¸ |\n| --- | --- | --- | --- |\n| Aortic regurgitation | diastolic backflowë¡œ LV volume overload | wide pulse pressure, water-hammer pulse | ì›ì¸/ì¤‘ì¦ë„ ê¸°ë°˜ intervention |\n| Acute mitral regurgitation | ê°‘ì‘ìŠ¤ëŸ° severe MRë¡œ forward output ë¶•ê´´ | pulmonary edema/shock, new murmur | ì‘ê¸‰ ì•ˆì •í™” í›„ ì¡°ê¸° ìˆ˜ìˆ  í‰ê°€ |\n| Chronic mitral regurgitation | ì¥ê¸° volume overloadì™€ remodeling | ë¬´ì¦ìƒ ê¸°ê°„ ê¸¸ ìˆ˜ ìˆìŒ | LV dysfunction ì„ê³„ì¹˜ ì „ì— ê°œì… |\n\n## Key pearls\n- AR murmur locationì€ root pathology vs leaflet pathology ê°ë³„ì— ë„ì›€.\n- acute MRì—ì„œëŠ” EFê°€ ì •ìƒì²˜ëŸ¼ ë³´ì—¬ë„ ì‹¤ì œ í˜ˆì—­í•™ì€ ë¶ˆì•ˆì •í•  ìˆ˜ ìˆë‹¤.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-190","focus_area":"Regurgitant Valve Core","tags":["usmle-step2","cardiology","aortic-regurgitation","mitral-regurgitation"]}
{"chunk_type":"transcript_chunk","text":"# Regurgitant Valve Disease Part 2: Right-sided Lesions and Tricuspid Atresia\n## Right-sided murmurs\n- inspiration ì‹œ venous return ì¦ê°€ë¡œ right-sided murmurê°€ ì»¤ì§€ëŠ” Carvallo signì„ í™œìš©.\n\n## Right-sided valve disease cues\n- TR/PR/PSëŠ” ìš°ì‹¬ì‹¤ ì••ë ¥/ìš©ì  ë§¥ë½ê³¼ íì§ˆí™˜/ìˆ˜ìˆ  í›„ ìƒíƒœë¥¼ í•¨ê»˜ í•´ì„.\n\n## Tricuspid atresia neonatal clue\n- cyanotic newborn + axis pattern ì´ìƒ(ì‹ ìƒì•„ ê¸°ëŒ€ì¶•ê³¼ ë°˜ëŒ€)ì—ì„œ ê°•í•˜ê²Œ ì˜ì‹¬.\n- intracardiac mixing physiologyë¥¼ ì´í•´í•˜ë©´ ECG/ì„ìƒ ì†Œê²¬ì´ ì—°ê²°ëœë‹¤.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-210","focus_area":"Right-sided Valves and Tricuspid Atresia","tags":["usmle-step2","cardiology","right-heart","tricuspid-atresia"]}
{"chunk_type":"recap_summary","text":"# Regurgitant Valve Rapid Fire Recap\n1. ARì€ diastolic volume overloadì™€ wide pulse pressureê°€ í•µì‹¬.\n2. acute MRì€ \"ì •ìƒì²˜ëŸ¼ ë³´ì´ëŠ” EF\" í•¨ì •ì´ ìˆì–´ forward failureë¥¼ ì§ì ‘ í‰ê°€í•´ì•¼ í•œë‹¤.\n3. chronic MRì€ LV dysfunction ì „ ë‹¨ê³„ì—ì„œ ìˆ˜ìˆ  ì‹œì ì„ ë†“ì¹˜ì§€ ì•ŠëŠ” ê²ƒì´ ì¤‘ìš”.\n4. right-sided murmurëŠ” inspiration augmentationìœ¼ë¡œ êµ¬ë¶„.\n5. cyanotic neonate axis clueëŠ” tricuspid atresia ê°ë³„ì˜ ê³ ìˆ˜ìµ í¬ì¸íŠ¸.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-227","focus_area":"Regurgitant Valve Recap","tags":["usmle-step2","cardiology","valvular","recap"]}
{"chunk_type":"transcript_chunk","text":"# ECG Arrhythmia Framework: Supraventricular to Ventricular\n## Supraventricular patterns\n- PSVT: narrow regular tachycardia, AV nodal re-entry ë§¥ë½ì—ì„œ vagal maneuver/adenosine ê¸°ë°˜ ì ‘ê·¼.\n- Atrial fibrillation: irregularly irregular rhythm, rate-control vs rhythm-controlì„ ì¦ìƒ/ìƒí™© ê¸°ë°˜ìœ¼ë¡œ ì„ íƒ.\n- MAT: irregular rhythm + â‰¥3 P-wave morphologies, COPD/íì§ˆí™˜ ë§¥ë½ì„ ë°˜ë“œì‹œ í™•ì¸.\n\n## Ventricular emergency patterns\n- VTëŠ” ì•ˆì •/ë¶ˆì•ˆì • ì—¬ë¶€ê°€ ì¹˜ë£Œ ìš°ì„ ìˆœìœ„ë¥¼ ê²°ì •.\n- TorsadesëŠ” prolonged QT ê¸°ë°˜ polymorphic VTë¡œ magnesiumì´ 1ì°¨.\n- wide-complex tachycardiaì—ì„œëŠ” capture/fusion beat ë‹¨ì„œê°€ VT ì§„ë‹¨ì— ìœ ìš©.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-237","focus_area":"ECG Arrhythmia Framework","tags":["usmle-step2","cardiology","ecg","arrhythmia","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Bradycardia and AV Block Management Table\n## Symptomatic bradycardia algorithm\n- ë¶ˆì•ˆì • ì„œë§¥ì€ atropine ìš°ì„  í›„ pacing escalation.\n- ë¬´ì¦ìƒ ìƒë¦¬ì  ì„œë§¥ì€ ì¹˜ë£Œë³´ë‹¤ ê´€ì°°ì´ ì›ì¹™.\n\n## AV block table\n| ìœ í˜• | ECG í•µì‹¬ | ìœ„í—˜ë„/ì¹˜ë£Œ |\n| --- | --- | --- |\n| 1ë„ AV block | PR ì—°ì¥, ì „ë„ëŠ” ìœ ì§€ | ëŒ€ê°œ ê´€ì°° |\n| 2ë„ Mobitz I | PR ì ì°¨ ì—°ì¥ í›„ beat drop | ëŒ€ê°œ ì•ˆì •, ì›ì¸ êµì • |\n| 2ë„ Mobitz II | PR ì¼ì • + ê°‘ì‘ìŠ¤ëŸ° QRS íƒˆë½ | ê³ ìœ„í—˜, pacemaker ê³ ë ¤ |\n| 3ë„ complete block | AV dissociation | ì‘ê¸‰ pacing/permanent pacemaker |\n\n## Sick sinus syndrome\n- brady-tachy ë³€ë™ì´ ë°˜ë³µë˜ë©´ pacing + ë™ë°˜ ë¹ˆë§¥ì¹˜ë£Œë¥¼ ë³‘í–‰.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-257","focus_area":"Bradycardia and AV Blocks","tags":["usmle-step2","cardiology","bradycardia","av-block","table","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Heart Failure Framework and Diagnostic Specificity\n## HF phenotypes\n- HFrEF(ìˆ˜ì¶•ê¸°), HFpEF(ì´ì™„ê¸°), cor pulmonale(íê¸°ì› ìš°ì‹¬ë¶€ì „), high-output HFë¥¼ êµ¬ë¶„.\n\n## Diagnostic clue table\n| ì†Œê²¬ | í•´ì„ | ì„ìƒ ê°€ì¹˜ |\n| --- | --- | --- |\n| Dyspnea | ë¯¼ê°í•˜ì§€ë§Œ ë¹„íŠ¹ì´ | ë‹¨ë…ìœ¼ë¡œ í™•ì§„ ì–´ë ¤ì›€ |\n| S3 gallop | volume overload ë‹¨ì„œ | íŠ¹ì´ë„ ë†’ì•„ HF ì§€ì§€ |\n| Orthopnea/PND | ì¢Œì‹¬ê³„ ìš¸í˜ˆ ë‹¨ì„œ | íŠ¹ì´ë„ ìƒëŒ€ì ìœ¼ë¡œ ë†’ìŒ |\n| BNP/NT-proBNP | ì‹¬ì‹¤ wall stress ë°˜ì˜ | ê°ë³„ ë° ì¶”ì ì— ìœ ìš© |\n\n## Severity framing\n- NYHA classëŠ” ì˜ˆí›„/ì¹˜ë£Œê°•ë„ ì„¤ì •ì— ì§ì ‘ ì—°ê²°.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-1","focus_area":"Heart Failure Diagnosis Framework","tags":["usmle-step2","cardiology","heart-failure","diagnosis","table"]}
{"chunk_type":"transcript_chunk","text":"# HFrEF Prognosis, Acute Decompensation, and Chronic GDMT\n## Poor prognostic signals\n- ê³ NYHA, ì €í˜ˆì••, ê³ BNP, ì „ë„ì´ìƒ, hyponatremia ë“±ì€ ê³ ìœ„í—˜êµ° ë‹¨ì„œ.\n\n## Hyponatremia mechanism\n- ì €ë°•ì¶œ ìƒíƒœì—ì„œ neurohormonal activation(ADH ë“±)ìœ¼ë¡œ í¬ì„ì„± ì €ë‚˜íŠ¸ë¥¨ì´ ë°œìƒ.\n\n## Acute decompensated HF\n- oxygenation, preload/afterload ì¡°ì ˆ, ì´ë‡¨ ì „ëµ, ì²´ìœ„/í™˜ê¸° ë³´ì¡°ë¥¼ ë‹¨ê³„ì ìœ¼ë¡œ ì ìš©.\n\n## Chronic HFrEF pillars\n- ARNI/ACEi/ARB + evidence-based beta-blocker + MRA + SGLT2 inhibitor.\n- ì ì‘ì¦ ì¶©ì¡± ì‹œ ICD/CRT ê°™ì€ ê¸°ê¸°ì¹˜ë£Œë¥¼ ê³ ë ¤.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-21","focus_area":"HFrEF Acute and Chronic Management","tags":["usmle-step2","cardiology","hfrEF","acute-care","gdmt"]}
{"chunk_type":"transcript_chunk","text":"# HFpEF, Cor Pulmonale, and High-output HF\n## HFpEF\n- hypertensive/aging/obesity backgroundì—ì„œ diastolic stiffnessê°€ ì¤‘ì‹¬.\n- volume/BP controlê³¼ ë™ë°˜ì§ˆí™˜ êµì •ì´ í•µì‹¬.\n\n## Cor pulmonale\n- chronic lung diseaseë¡œ ì¸í•œ pulmonary HTN -> RV failure íŒ¨í„´(JVD, edema, hepatomegaly).\n\n## High-output HF\n- AV fistula, severe anemia, thyrotoxicosis, beriberi ë“± demand ê³¼ë‹¤ ìƒí™©ì—ì„œ ë°œìƒ.\n- EFê°€ ë³´ì¡´ë˜ì–´ë„ ì„ìƒì  HFë¥¼ ë³´ì¼ ìˆ˜ ìˆì–´ ì›ì¸êµì •ì´ ì¹˜ë£Œì˜ ì¤‘ì‹¬.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-41","focus_area":"HFpEF Cor Pulmonale High-output HF","tags":["usmle-step2","cardiology","hfpef","cor-pulmonale","high-output-hf"]}
{"chunk_type":"recap_summary","text":"# Heart Failure Rapid Recap + Peripheral Vascular Disease Entry\n## HF recap\n1. HF ì§„ë‹¨ì€ ì¦ìƒ + íŠ¹ì´ ì‹ ì²´ì†Œê²¬ + biomarker/echo í†µí•©ìœ¼ë¡œ í•œë‹¤.\n2. HFrEFëŠ” ì§ˆë³‘ì™„í™”ë³´ë‹¤ ìƒì¡´ì´ë“ ì•½ë¬¼ì˜ ì¡°ê¸° ì¡°í•©ì´ ì¤‘ìš”.\n3. hyponatremiaëŠ” ì¤‘ì¦ë„ ì•…í™” ì‹ í˜¸.\n4. cor pulmonale/high-output HFëŠ” ì›ì¸ ì¶•ì´ ë‹¤ë¥´ë¯€ë¡œ êµ¬ë¶„ ì¹˜ë£Œê°€ í•„ìš”.\n\n## Transition\n- ë‹¤ìŒ ë¸”ë¡ì€ PAD/venous diseaseë¥¼ ì „ì‹  ì‹¬í˜ˆê´€ ìœ„í—˜ ê´€ì ì—ì„œ ì—°ê²°í•œë‹¤.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-53","focus_area":"Heart Failure Recap and PVD Entry","tags":["usmle-step2","cardiology","heart-failure","recap"]}
{"chunk_type":"transcript_chunk","text":"# Peripheral Artery Disease: ABI Trap and Global Risk Strategy\n## PAD big picture\n- í•˜ì§€ ì¦ìƒì€ ì „ì‹  ë™ë§¥ê²½í™” burdenì˜ ë§ì´ˆ í‘œí˜„ìœ¼ë¡œ ë³¸ë‹¤.\n\n## ABI interpretation\n- ABI <0.9ëŠ” PAD ì‹œì‚¬.\n- ABIê°€ ê³¼ë„í•˜ê²Œ ë†’ìœ¼ë©´(ë¹„ì••ë°•ì„± ì„íšŒí™” í˜ˆê´€) ìœ„ìŒì„± ê°€ëŠ¥ì„±ì´ ìˆì–´ ëŒ€ì²´ ê²€ì‚¬ í•„ìš”.\n\n## Treatment priorities\n- limb symptom ê´€ë¦¬ì™€ ë³„ê°œë¡œ antiplatelet/statin/smoking cessation/exerciseë¡œ MACEë¥¼ ì¤„ì´ëŠ” ê²ƒì´ í•µì‹¬.\n- supervised exerciseëŠ” collateral developmentì™€ ê¸°ëŠ¥íšŒë³µì— íš¨ê³¼ì .","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-63","focus_area":"PAD Diagnostic and Treatment Strategy","tags":["usmle-step2","cardiology","pad","abi","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Venous Disease and Anaphylactic Shock Core\n## Venous insufficiency framework\n- dependent edema/skin change/ulcer patternì„ ë™ë§¥ì„± í—ˆí˜ˆê³¼ êµ¬ë¶„.\n- compression, elevation, êµ­ì†Œ í”¼ë¶€ê´€ë¦¬ ë“± ë³´ì¡´ì  ì¹˜ë£Œê°€ ê¸°ë°˜.\n\n## Anaphylactic shock\n- 1ì°¨ ì¹˜ë£ŒëŠ” IM epinephrine.\n- airway/breathing/circulation ë™ì‹œ ì•ˆì •í™”, í•„ìš” ì‹œ ë°˜ë³µ epi/ìˆ˜ì•¡/ë³´ì¡°ì•½ì œ ì‚¬ìš©.\n- í”¼ë¶€ì†Œê²¬ + í˜¸í¡ê¸°/í˜ˆì•• ì§•í›„ë¥¼ í•¨ê»˜ í™•ì¸í•´ ì§€ì—°ì„ ì¤„ì¸ë‹¤.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-83","focus_area":"Venous Disease and Anaphylaxis","tags":["usmle-step2","cardiology","venous-insufficiency","anaphylaxis"]}
{"chunk_type":"transcript_chunk","text":"# Hemorrhagic Shock and Damage Control Resuscitation\n## Modern trauma resuscitation\n- ëŒ€ëŸ‰ crystalloid íšŒí”¼, ì¡°ê¸° í˜ˆì•¡ì œì œ ì¤‘ì‹¬ resuscitationì´ ì›ì¹™.\n- ì‘ê³ ì¥ì• /ì €ì²´ì˜¨/ì‚°ì¦ ì•…ìˆœí™˜(triad)ì„ ëŠëŠ” ì „ëµì´ í•µì‹¬.\n\n## Key actions\n- balanced transfusion strategy(ëŒ€ëŸ‰ì¶œí˜ˆ í”„ë¡œí† ì½œ).\n- TXA ì ì ˆ ì‹œì  íˆ¬ì—¬ ê³ ë ¤.\n- source control ì „ê¹Œì§€ permissive hypotensionì„ ì ìš©í•˜ë˜ TBI ë™ë°˜ ì‹œ ëª©í‘œí˜ˆì•• ì „ëµì„ ìˆ˜ì •.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-103","focus_area":"Hemorrhagic Shock DCR","tags":["usmle-step2","critical-care","hemorrhagic-shock","trauma","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Obstructive vs Cardiogenic Shock Hemodynamics\n## Obstructive shock\n- PE, tension pneumothorax, tamponade ë“± ê¸°ê³„ì  ìœ ì¶œì… ì¥ì• .\n- scenarioë³„ bedside clueë¡œ ë¹ ë¥´ê²Œ ì›ì¸ ë°°ì œ/í™•ì¸.\n\n## Cardiogenic shock\n- pump failureë¡œ íìš¸í˜ˆ/ì €ê´€ë¥˜ê°€ ë™ë°˜.\n\n## Hemodynamic contrast\n- filling pressure/PCWPì™€ lung exam(wet vs relatively clear)ì„ í†µí•©í•˜ë©´ ë¶„ë¥˜ ì •í™•ë„ê°€ ë†’ì•„ì§„ë‹¤.\n- ë¶„ë¥˜ì— ë”°ë¼ ì²˜ì¹˜(ì›ì¸ ì œê±° vs inotrope/reperfusion)ê°€ ë‹¬ë¼ì§„ë‹¤.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-123","focus_area":"Obstructive vs Cardiogenic Shock","tags":["usmle-step2","critical-care","obstructive-shock","cardiogenic-shock","diagnosis"]}
{"chunk_type":"recap_summary","text":"# Shock Rapid Fire Recap Table\n| ì‡¼í¬ ìœ í˜• | í•µì‹¬ ê¸°ì „ | ì£¼ìš” ë‹¨ì„œ | ìš°ì„  ì²˜ì¹˜ |\n| --- | --- | --- | --- |\n| Anaphylactic | distributive + capillary leak | skin/airway/hypotension | IM epinephrine + airway + fluids |\n| Hemorrhagic | intravascular volume loss | trauma/bleeding markers | balanced transfusion + source control |\n| Obstructive | mechanical block | JVD/íŠ¹ì • ì›ì¸ ë‹¨ì„œ | cause-specific decompression/removal |\n| Cardiogenic | pump failure | low output + pulmonary congestion | inotrope/reperfusion/support |\n\n- permissive hypotensionì€ selected trauma ìƒí™©ì—ì„œë§Œ ì ìš©í•˜ë©° ì˜ˆì™¸(TBI)ë¥¼ ê¸°ì–µ.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-139","focus_area":"Shock Rapid Recap","tags":["usmle-step2","critical-care","shock","recap","table"]}
{"chunk_type":"transcript_chunk","text":"# Pericarditis, Constrictive Pericarditis, Myocarditis, Tamponade\n## Acute pericarditis\n- pleuritic chest pain + positional relief(leaning forward)ê°€ í•µì‹¬ ë‹¨ì„œ.\n\n## Constrictive pericarditis\n- chronic rigid pericardiumìœ¼ë¡œ ìš°ì‹¬ë¶€ì „ ì–‘ìƒê³¼ pericardial knockë¥¼ ë³´ì¼ ìˆ˜ ìˆë‹¤.\n\n## Myocarditis\n- viral prodrome ë’¤ ìƒˆë¡œ ë°œìƒí•œ LV dysfunction/arrhythmiaë¥¼ ì˜ì‹¬.\n\n## Cardiac tamponade\n- hypotension/JVD/muffled heart sound + pulsus paradoxus.\n- hemodynamic collapseì—ì„œëŠ” ì§€ì²´ ì—†ëŠ” pericardial drainageê°€ ìƒëª…êµ¬ì¡°.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-149","focus_area":"Pericardial and Myocardial Inflammation","tags":["usmle-step2","cardiology","pericarditis","myocarditis","tamponade"]}
{"chunk_type":"transcript_chunk","text":"# Myocarditis and Tamponade Hemodynamic Pearls\n- myocarditisëŠ” \"ì Šì€ í™˜ì + ê°ì—¼ í›„ + ì„¤ëª… ì•ˆ ë˜ëŠ” ì‹¬ë¶€ì „\" ì¡°í•©ì—ì„œ ì§„ë‹¨ ê°€ì¹˜ë¥¼ ê°–ëŠ”ë‹¤.\n- tamponadeëŠ” diastolic filling ì œí•œìœ¼ë¡œ chamber pressure equalization ì†Œê²¬ì´ ë‚˜ì˜¬ ìˆ˜ ìˆë‹¤.\n- electrical alternans, enlarged cardiac silhouette ë“± ì˜ìƒ/ECG ë‹¨ì„œë¥¼ clinical pictureì™€ ê²°í•©í•œë‹¤.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-169","focus_area":"Myocarditis and Tamponade Pearls","tags":["usmle-step2","cardiology","tamponade","myocarditis","diagnosis"]}
{"chunk_type":"recap_summary","text":"# Cardio Misc Integration + Final Structural Signal Recap\n## Misc integration highlights\n- vasovagal syncopeëŠ” reflex-mediated bradycardia/vasodilationìœ¼ë¡œ ì„¤ëª….\n- ìš´ë™ ì¤‘ ì‹¤ì‹ ì€ êµ¬ì¡°ì /ì „ê¸°ì  ì¹˜ëª… ì›ì¸(ì˜ˆ: anomalous coronary, HCM)ì„ ìš°ì„  ë°°ì œ.\n- stent thrombosis/valve thrombosisëŠ” í•­í˜ˆì „ ìœ ì§€ ì‹¤íŒ¨ì™€ ì§ê²°.\n- recurrent epistaxis + AVM ë§¥ë½ì—ì„œëŠ” HHT ê´€ë ¨ systemic risk(ë‡Œë†ì–‘/ìƒ‰ì „)ë¥¼ ì—°ê²°.\n\n## Final recap\n- chest pain/ì‹¤ì‹ /ì‡¼í¬/ì‹¬ìŒì„ ê°œë³„ ì•”ê¸°ê°€ ì•„ë‹ˆë¼ pressure-flow-structure ëª¨ë¸ë¡œ í†µí•©í•˜ë©´ Step 2 ë¬¸ì œ í•´ê²°ë ¥ì´ ë†’ì•„ì§„ë‹¤.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-180","focus_area":"Cardio Misc Integration Recap","tags":["usmle-step2","cardiology","misc","integration","recap"]}
{"chunk_type":"transcript_chunk","text":"# Pericardial/Myocardial Structural Signal Comparison Table\n| ì§ˆí™˜ | í•µì‹¬ ë‹¨ì„œ | íŠ¹ì§• ì†Œê²¬ | ì¦‰ì‹œ ì¡°ì¹˜ |\n| --- | --- | --- | --- |\n| Acute pericarditis | positional pleuritic chest pain | friction rub, diffuse ST/PR pattern ê°€ëŠ¥ | anti-inflammatory ì¤‘ì‹¬ ì¹˜ë£Œ |\n| Constrictive pericarditis | chronic right-sided congestion | pericardial knock, diastolic filling ì œí•œ | ì›ì¸êµì •/ìˆ˜ìˆ ì  í‰ê°€ |\n| Myocarditis | viral prodrome í›„ ì‹¬ê¸°ëŠ¥ ì €í•˜ | arrhythmia + new HF pattern | hemodynamic support, trigger evaluation |\n| Cardiac tamponade | hypotension + JVD + muffled heart sounds | pulsus paradoxus, electrical alternans | emergent pericardial drainage |\n\n- tamponade ì˜ì‹¬ ì‹œ ì§€ì—° ì—†ëŠ” source reliefê°€ ìƒì¡´ ê²°ì • ìš”ì¸.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-190","focus_area":"Cardio Structural Signal Table","tags":["usmle-step2","cardiology","pericarditis","tamponade","table"]}
{"chunk_type":"transcript_chunk","text":"# Cardiovascular Pharmacology by Clinical Context (Hero vs Villain)\n## Core principle\n- ê°™ì€ ì•½ì´ë¼ë„ ì§ˆí™˜/í˜ˆì—­í•™ ìƒíƒœì— ë”°ë¼ ì´ë“ê³¼ ìœ„í•´ê°€ ì—­ì „ëœë‹¤.\n\n## High-yield context switches\n- CKD/albuminuria HTNì—ì„œëŠ” RAAS blockade(ACEi/ARB)ê°€ ì‹ ì¥ë³´í˜¸ ìš°ì„ .\n- goutì—ì„œëŠ” thiazideê°€ ìš”ì‚° ì•…í™” ê°€ëŠ¥, osteoporosis ë§¥ë½ì—ì„œëŠ” ì´ì  ê°€ëŠ¥.\n- ACS/HFì—ì„œëŠ” beta-blockerì˜ timingê³¼ contraindicationì„ ë°˜ë“œì‹œ í™•ì¸.\n\n## Integration\n- ì²˜ë°© ì „ \"í˜„ì¬ stage(ê¸‰ì„±/ë§Œì„±) + ë™ë°˜ì§ˆí™˜ + hemodynamics\" 3ì¶•ì„ í™•ì¸.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-210","focus_area":"Cardio Pharmacology Context","tags":["usmle-step2","cardiology","pharmacology","hypertension","heart-failure"]}
{"chunk_type":"recap_summary","text":"# Cardio Pharmacology Rapid Recap + Misc Cardio Entry\n- ACSì—ì„œ beta-blockerëŠ” ì•ˆì • í˜ˆì—­í•™ì—ì„œ ìœ ìµí•˜ì§€ë§Œ shock/bradycardiaì—ì„œëŠ” í•´ê°€ ë  ìˆ˜ ìˆë‹¤.\n- RV infarct ë§¥ë½ì—ì„œëŠ” preload-dependent physiologyë¥¼ ê³ ë ¤í•´ nitrateë¥¼ í”¼í•œë‹¤.\n- ê¸‰ì„± HF ì•…í™”ê¸°ì™€ ë§Œì„± ì•ˆì •ê¸° ì•½ë¬¼ ì „ëµì€ ë‹¤ë¥´ë‹¤.\n- HFrEFì—ì„œëŠ” ARNI/ACEi/ARB + BB + MRA + SGLT2i ê¸°ë°˜ì´ ìƒì¡´ì´ë“ ì¶•.\n\n## Transition\n- ë‹¤ìŒì€ syncopal syndromes, tamponade physiology, vascular anomaly ê°™ì€ \"misc but high-yield\" í†µí•© ê°œë….","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-230","focus_area":"Cardio Pharm Recap and Misc Entry","tags":["usmle-step2","cardiology","recap","pharmacology"]}
{"chunk_type":"transcript_chunk","text":"# Cardio Misc Integration: Syncope, Tamponade, Device Thrombosis, HHT\n## Syncope split\n- vasovagal syncope: trigger/prodrome + reflex bradycardia/vasodilation.\n- exertional syncope in athletes: structural/electrical lethal causes(AAOCA/HCM ë“±) ìš°ì„  ë°°ì œ.\n\n## Tamponade physiology\n- pulsus paradoxusì™€ ventricular interdependenceë¥¼ ì—°ê²°í•´ í•´ì„.\n\n## Device-related risk\n- DAPT ì¤‘ë‹¨ í›„ stent thrombosis, ê¸°ê³„íŒë§‰ í•­ì‘ê³  ë¶ˆê· í˜•ì€ ê³ ìœ„í—˜ ì‚¬ê±´ìœ¼ë¡œ ì§ê²°.\n\n## HHT bridge\n- recurrent epistaxis + AVM ë§¥ë½ì—ì„œ paradoxical embolic infection/stroke riskë¥¼ í‰ê°€.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-240","focus_area":"Cardio Misc Syncope Tamponade HHT","tags":["usmle-step2","cardiology","syncope","tamponade","hht"]}
{"chunk_type":"transcript_chunk","text":"# Pediatric Cardiology Entry: Cyanotic Infant First-pass Algorithm\n## First decision: lung vs heart cyanosis\n- hyperoxia testì—ì„œ ì‚°ì†Œ ë°˜ì‘ì´ ì œí•œë˜ë©´ intracardiac/right-to-left shunt ê°€ëŠ¥ì„± ì¦ê°€.\n\n## Duct-dependent physiology\n- ì¼ë¶€ critical congenital heart diseaseëŠ” PDA patency ìœ ì§€ê°€ ìƒì¡´ í•µì‹¬.\n- PGE1ì´ ì´ˆê¸° bridge therapyê°€ ë  ìˆ˜ ìˆë‹¤.\n\n## Target diseases in this block\n- VSD, tricuspid atresia, PPHN, HLHSë¥¼ ì‹œë‚˜ë¦¬ì˜¤ ê¸°ë°˜ìœ¼ë¡œ êµ¬ë¶„.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-260","focus_area":"Pediatric Cardio Cyanosis Entry","tags":["usmle-step2","pediatrics","cardiology","cyanosis","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"# Pediatric Cyanotic Lesion Comparison Table\n| ì§ˆí™˜ | í•µì‹¬ ë³‘íƒœìƒë¦¬ | ëŒ€í‘œ ë‹¨ì„œ | ì´ˆê¸° ê´€ë¦¬ í¬ì¸íŠ¸ |\n| --- | --- | --- | --- |\n| VSD (large) | left-to-right shuntë¡œ pulmonary overcirculation | CHF/poor feeding/failure to thrive | diuretic/nutrition/support, í•„ìš” ì‹œ ìˆ˜ìˆ  |\n| Tricuspid atresia | RV inflow obstruction + mixing dependence | cyanosis + characteristic ECG axis clue | PDA/atrial-level mixing support |\n| PPHN | pulmonary vascular resistanceê°€ íƒœì•„í˜•ìœ¼ë¡œ ìœ ì§€ | differential oxygenation pattern | oxygenation + pulmonary vasodilation ì „ëµ |\n| HLHS | left-sided systemic output failure | duct-dependent systemic perfusion | PGE1 + staged palliation pathway |","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-280","focus_area":"Pediatric Cyanotic Lesion Table","tags":["usmle-step2","pediatrics","cardiology","congenital-heart","table"]}
{"chunk_type":"transcript_chunk","text":"# VSD and Tricuspid Atresia High-yield Distinction\n## VSD paradox\n- small defectëŠ” loud murmur but hemodynamic impactëŠ” ìƒëŒ€ì ìœ¼ë¡œ ì ì„ ìˆ˜ ìˆìŒ.\n- large defectëŠ” murmurê°€ ëœ ê·¹ì ì´ì–´ë„ volume overload/HF ìœ„í—˜ì´ í¼.\n\n## Tricuspid atresia clue\n- cyanotic infantì—ì„œ RV hypoplasia physiologyì™€ axis patternì„ ì—°ê²°.\n- intracardiac shunt ê²½ë¡œê°€ ìƒì¡´ì— í•„ìˆ˜ë¼ëŠ” ì ì„ ê¸°ì–µ.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-300","focus_area":"VSD and Tricuspid Atresia","tags":["usmle-step2","pediatrics","vsd","tricuspid-atresia"]}
{"chunk_type":"transcript_chunk","text":"# Preoperative Cardiac Risk: RCRI + Functional Capacity Table\n| ì§ˆë¬¸ | í‰ê°€ í•­ëª© | í•´ì„ |\n| --- | --- | --- |\n| ìˆ˜ìˆ  ìì²´ ìœ„í—˜ | ê³ ìœ„í—˜ ìˆ˜ìˆ  ì—¬ë¶€ | baseline procedural risk ì„¤ì • |\n| í™˜ì ìœ„í—˜ | RCRI ìš”ì†Œ(ì‹¬ì§ˆí™˜/CHF/CVA/insulin DM/Cr ë“±) | periop MACE ì¶”ì • |\n| ê¸°ëŠ¥ ìƒíƒœ | METs (â‰¥4 ì—¬ë¶€) | ì¶”ê°€ ê²€ì‚¬ í•„ìš”ì„± ê²°ì • |\n\n## Practical algorithm\n- emergencyë©´ ì¦‰ì‹œ ìˆ˜ìˆ  ê²½ë¡œ.\n- active cardiac conditionì´ë©´ ë¨¼ì € ì‹¬ì¥ì•ˆì •í™”.\n- ë‚˜ë¨¸ì§€ëŠ” RCRI + METsë¡œ testing í•„ìš” ì—¬ë¶€ë¥¼ ê³„ì¸µí™”.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-320","focus_area":"Preop Cardiac Risk Framework","tags":["usmle-step2","cardiology","perioperative","rcri","table"]}
{"chunk_type":"transcript_chunk","text":"# Perioperative Special Cases: Valve Disease, Arrhythmia, Anticoagulation\n## Valve disease\n- symptomatic severe valvular lesionì€ ë¹„ì‹¬ì¥ ìˆ˜ìˆ  ì „ êµì • ìš°ì„  ê³ ë ¤.\n\n## Arrhythmia\n- rate/rhythm ì•ˆì •í™”ì™€ thromboembolic riskë¥¼ ë™ì‹œì— ê´€ë¦¬.\n\n## Anticoagulation periop\n- thrombotic riskê°€ ë†’ì€ ì§‘ë‹¨(ì˜ˆ: mechanical valve ë“±)ì—ì„œëŠ” bridging ì „ëµ ê²€í† .\n- low-riskëŠ” ë‹¨ìˆœ ì¤‘ë‹¨/ì¬ê°œ ì „ëµì´ ê°€ëŠ¥.\n\n## Testing discipline\n- ì €ìœ„í—˜ í™˜ìì—ì„œ ë¬´ë¶„ë³„í•œ pre-op testingì„ í”¼í•˜ê³ , indication-basedë¡œ ì‹œí–‰.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-340","focus_area":"Perioperative Special Cases","tags":["usmle-step2","cardiology","perioperative","arrhythmia","anticoagulation"]}
{"chunk_type":"transcript_chunk","text":"# Postoperative and Vascular Trauma Triage Table\n| ìƒí™© | í•µì‹¬ ë‹¨ì„œ | ì¦‰ì‹œ ëŒ€ì‘ |\n| --- | --- | --- |\n| Sternal dehiscence | click/instability at sternum | surgical fixation í‰ê°€ |\n| Post-pericardiotomy syndrome | ìˆ˜ì£¼ í›„ pleuritic pain/fever/rub | anti-inflammatory management |\n| Cardiac tamponade | Beck triad/hemodynamic collapse | urgent drainage |\n| Vascular trauma hard signs | pulsatile bleeding/expanding hematoma/ischemia | ì¦‰ì‹œ OR (ì˜ìƒ ì§€ì—° ê¸ˆì§€) |\n| Vascular trauma soft signs | ì• ë§¤í•œ neurovascular change | CTA/Doppler í›„ ê³„íš ì¹˜ë£Œ |\n\n- blunt cardiac injuryëŠ” ECG rhythm monitoringì´ í•µì‹¬.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-360","focus_area":"Postop and Vascular Trauma Table","tags":["usmle-step2","trauma","cardiology","vascular-trauma","table"]}
{"chunk_type":"transcript_chunk","text":"# Perioperative and Trauma Rapid Recap\n1. pre-op í‰ê°€ëŠ” \"ì‘ê¸‰ ì—¬ë¶€ -> active cardiac issue -> RCRI/METs\" ìˆœì„œ.\n2. high-risk anticoagulated patientëŠ” bridging í•„ìš”ì„±ì„ ë³„ë„ í‰ê°€.\n3. postoperative tamponade/dehiscenceëŠ” ì‹œê°„ ì§€ì—°ì´ ì¹˜ëª…ì .\n4. vascular traumaì—ì„œ hard signì€ imagingë³´ë‹¤ OR ìš°ì„ .\n5. blunt chest traumaëŠ” arrhythmia surveillanceë¥¼ ë†“ì¹˜ì§€ ì•ŠëŠ”ë‹¤.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-380","focus_area":"Periop Trauma Recap","tags":["usmle-step2","cardiology","recap","perioperative","trauma"]}
{"chunk_type":"transcript_chunk","text":"# Gynecology Physiology Lifecycle Framework\n## Lifecycle tree overview\n- puberty -> reproductive cycle issues -> menopause/postmenopausal red flag ìˆœì„œë¡œ ì ‘ê·¼.\n\n## Core rule\n- ì—°ë ¹ëŒ€ + symptom timingì„ ë§¤ì¹­í•˜ë©´ ì§„ë‹¨ ë¶„ê¸°ê°€ ë¹¨ë¼ì§„ë‹¤.\n\n## High-yield anchors\n- puberty sequence, cyclic mood/pain disorders, menopause treatment constraints, postmenopausal bleeding workup.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-1","focus_area":"Gyne Lifecycle Framework","tags":["usmle-step2","gynecology","physiology","lifecycle"]}
{"chunk_type":"transcript_chunk","text":"# Reproductive-age Gyne Differential Table (Timing + Exam Pattern)\n| ë¬¸ì œ | íƒ€ì´ë°/ë³‘íƒœìƒë¦¬ | í•µì‹¬ ë‹¨ì„œ | ìš°ì„  ê´€ë¦¬ |\n| --- | --- | --- | --- |\n| PMS/PMDD | luteal phase cyclic symptom | symptom-free interval ì¡´ì¬ | SSRI/ìƒí™œê°œì…, severeë©´ escalated care |\n| Primary dysmenorrhea | prostaglandin-mediated pain | normal pelvic exam | NSAID ìš°ì„  |\n| Endometriosis | ectopic endometrial tissue | dysmenorrhea + dyspareunia + dyschezia | hormonal/surgical context care |\n| Adenomyosis | myometrial invasion | boggy globally enlarged tender uterus | symptom-directed management |\n| Fibroid | leiomyoma mass effect | irregular/lumpy uterus, heavy bleeding | imaging + medical/procedural care |","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-21","focus_area":"Reproductive-age Gyne Differential","tags":["usmle-step2","gynecology","dysmenorrhea","pms-pmdd","table"]}
{"chunk_type":"transcript_chunk","text":"# Menopause and Postmenopausal Bleeding Management\n## Menopause care\n- diagnosisëŠ” 12ê°œì›” ë¬´ì›”ê²½ + í˜¸ë¥´ëª¬ ì¶• ë³€í™” ë§¥ë½.\n- GSMëŠ” nonhormonalë¶€í„° ì‹œì‘í•˜ê³  í•„ìš” ì‹œ topical estrogenìœ¼ë¡œ ë‹¨ê³„ ìƒìŠ¹.\n- vasomotor symptom HRTëŠ” ê¸ˆê¸° ì—¬ë¶€ì™€ uterus ì¡´ì¬ ì—¬ë¶€ì— ë”°ë¼ regimen ê²°ì •.\n\n## Postmenopausal bleeding red flag\n- endometrial malignancy ë°°ì œë¥¼ ìµœìš°ì„ ìœ¼ë¡œ ë‘ê³  TVUS/endometrial sampling ì•Œê³ ë¦¬ì¦˜ì„ ë”°ë¥¸ë‹¤.\n- endometrial thicknessì™€ clinical riskë¥¼ í†µí•©í•´ biopsy í•„ìš”ì„±ì„ ê²°ì •.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-41","focus_area":"Menopause and PMB","tags":["usmle-step2","gynecology","menopause","postmenopausal-bleeding"]}
{"chunk_type":"recap_summary","text":"# Gyn Lifecycle Rapid Recap + Next Scaffold Entry\n1. puberty sequenceë¥¼ í˜¼ë™í•˜ì§€ ë§ê³  growth spurt timing í•¨ì •ì„ í”¼í•œë‹¤.\n2. cyclic symptomsëŠ” timing diaryê°€ ì§„ë‹¨ ì •í™•ë„ë¥¼ ë†’ì¸ë‹¤.\n3. dysmenorrheaëŠ” primary vs secondary(êµ¬ì¡°ë³‘ë³€)ë¡œ ë¶„ê¸°í•´ ì ‘ê·¼í•œë‹¤.\n4. menopause HRTëŠ” contraindicationê³¼ uterus ìœ ë¬´ë¥¼ ë°˜ë“œì‹œ í™•ì¸.\n5. postmenopausal bleedingì€ cancer until proven otherwise ì›ì¹™.\n\n## Transition\n- ë‹¤ìŒ ë¸”ë¡ì€ reproductive healthì˜ ë” ë„“ì€ ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤ë¥¼ ë…¼ë¦¬ íŠ¸ë¦¬ë¡œ í™•ì¥.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-53","focus_area":"Gyne Rapid Recap","tags":["usmle-step2","gynecology","recap","next-step"]}
{"chunk_type":"transcript_chunk","text":"# Amenorrhea Framework Overview\n## Three pillars\n1. amenorrhea algorithm(primary vs secondary).\n2. infertility workup with OHSS risk.\n3. gynecologic pain/bleeding/mass differential.\n\n## Core principle\n- ì •ì˜ì™€ ë¶„ë¥˜ë¥¼ ë¨¼ì € ê³ ì •í•˜ë©´ ë¶ˆí•„ìš”í•œ ê²€ì‚¬ì™€ ì§„ë‹¨ ëˆ„ë½ì´ ì¤„ì–´ë“ ë‹¤.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-63","focus_area":"Amenorrhea Framework Overview","tags":["usmle-step2","gynecology","amenorrhea","algorithm"]}
{"chunk_type":"transcript_chunk","text":"# Primary Amenorrhea Algorithm Table\n| ë‹¨ê³„ | ì§ˆë¬¸ | ë‹¤ìŒ ë¶„ê¸° |\n| --- | --- | --- |\n| 1 | uterus ì¡´ì¬ ì—¬ë¶€(ì˜ìƒ) | absent vs presentë¡œ ë¶„ê¸° |\n| 2 | uterus absentë©´ karyotype | 46XX(outflow/development) vs 46XY(DSD spectrum) |\n| 3 | uterus presentë©´ FSH | high: ovarian failure, low: central axis issue |\n| 4 | central suspicion ì‹œ | hypothalamic/pituitary imaging/evaluation |\n\n## High-yield outlier\n- imperforate hymen: cyclic pain + obstructed outflow pattern.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-83","focus_area":"Primary Amenorrhea Algorithm","tags":["usmle-step2","gynecology","primary-amenorrhea","table","diagnosis"]}
{"chunk_type":"recap_summary","text":"# Secondary Amenorrhea Diagnostic Sequence\n## Stepwise logic\n1. pregnancy test first.\n2. progesterone challengeë¡œ estrogenization/anovulation ì—¬ë¶€ ì¶”ì •.\n3. í•„ìš” ì‹œ combined hormonal challengeë¡œ outflow tract ë¬¸ì œ í‰ê°€.\n4. FSH/LH/other axis testingìœ¼ë¡œ ovarian vs central ì›ì¸ ë¶„ê¸°.\n\n## Key mimics\n- PCOS, hyperprolactinemia, thyroid dysfunction, hypothalamic suppression ë“±ì„ ë³‘ë ¥ê³¼ ê²€ì‚¬ë¡œ í†µí•©.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-95","focus_area":"Secondary Amenorrhea Sequence","tags":["usmle-step2","gynecology","secondary-amenorrhea","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"# Ectopic Pregnancy vs Torsion vs Ruptured Cyst Table\n| ì§ˆí™˜ | ëŒ€í‘œ ë‹¨ì„œ | í•µì‹¬ ê²€ì‚¬/ì²˜ì¹˜ |\n| --- | --- | --- |\n| Ectopic pregnancy | reproductive-age pain/bleeding + positive hCG | hemodynamic status + TVUS ê¸°ë°˜ ì¦‰ì‹œ ê²°ì • |\n| Ovarian torsion | sudden severe unilateral pain Â± vomiting | ì„ìƒì˜ì‹¬ ê°•í•˜ë©´ ìˆ˜ìˆ ì  detorsion ì§€ì—° ê¸ˆì§€ |\n| Ruptured cyst | acute pain after activity/intercourse, free fluid ê°€ëŠ¥ | ì•ˆì • ì‹œ ë³´ì¡´ì¹˜ë£Œ, ë¶ˆì•ˆì • ì‹œ ìˆ˜ìˆ  |\n\n## Trap\n- Doppler flowê°€ ë‚¨ì•„ ìˆì–´ë„ torsion ì™„ì „ ë°°ì œë¥¼ ì˜ë¯¸í•˜ì§€ ì•ŠëŠ”ë‹¤.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-105","focus_area":"Acute Gyn Pain Differential","tags":["usmle-step2","gynecology","ectopic-pregnancy","ovarian-torsion","table"]}
{"chunk_type":"transcript_chunk","text":"# Chronic Cyclic Pelvic Pain and Uterine Morphology Table\n| ì§„ë‹¨ | í†µì¦ íŒ¨í„´/ì¦ìƒ | ì§„ì°°/ì˜ìƒ ë‹¨ì„œ |\n| --- | --- | --- |\n| Endometriosis | dysmenorrhea + dyspareunia + dyschezia | fixed uterus/uterosacral tenderness, laparoscopy confirm |\n| Adenomyosis | heavy painful menses | boggy globular tender uniformly enlarged uterus |\n| Fibroids | bleeding ë˜ëŠ” bulk symptoms | irregular, firm, nodular enlarged uterus |\n\n## Clinical value\n- pain pattern + uterine feel ì¡°í•©ì´ ê³ ìˆ˜ìµ ë‹¨ì„œ.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-125","focus_area":"Cyclic Pain Uterine Differential","tags":["usmle-step2","gynecology","endometriosis","adenomyosis","fibroid","table"]}
{"chunk_type":"transcript_chunk","text":"# PCOS Mechanism and Exclusion Strategy\n## Diagnostic core\n- oligo/anovulation, hyperandrogenic signs, polycystic morphology ì¤‘ ì¡°í•©ìœ¼ë¡œ ì§„ë‹¨.\n\n## Mechanistic bridge\n- insulin resistance/adipose-endocrine effectê°€ androgen excessì™€ ovulatory dysfunctionì„ ê°•í™”.\n\n## Exclusion workup\n- virilization ê¸‰ì§„í–‰ì´ë©´ androgen-secreting tumor ë°°ì œ.\n- CAH, Cushing, thyroid/prolactin axis ì´ìƒì„ ìƒí™©ì— ë§ê²Œ ì œì™¸.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-145","focus_area":"PCOS Workup and Exclusion","tags":["usmle-step2","gynecology","pcos","pathophysiology","diagnosis"]}
{"chunk_type":"recap_summary","text":"# Breast Problem-solving Framework\n## Breast mass/discharge basics\n- age-stratified imaging ì ‘ê·¼(ì Šì€ í™˜ì ultrasound ìš°ì„ , ê³ ë ¹/ê³ ìœ„í—˜ mammography ë³‘í–‰).\n- palpable massëŠ” ì˜ìƒ ìŒì„±ì´ì–´ë„ ì„ìƒ ì§€ì† ì˜ì‹¬ ì‹œ tissue diagnosis ê³ ë ¤.\n\n## Nipple discharge clues\n- physiologic pattern(ì–‘ì¸¡/ë‹¤ê´€/ìœ ì¦™í˜•) vs pathologic pattern(í˜ˆì„±, ë‹¨ì¼ê´€, ìë°œì„±)ì„ êµ¬ë¶„.\n\n## Mastitis/abscess\n- lactational contextì—ì„œ í•­ìƒì œ + ë°°ë† ì ì‘ì¦ íŒë‹¨ì´ í•µì‹¬.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-155","focus_area":"Breast Problem-solving Framework","tags":["usmle-step2","gynecology","breast","diagnosis","management"]}
{"chunk_type":"transcript_chunk","text":"# Nipple Discharge and Breast Risk Stratification Table\n| ì†Œê²¬ | ì €ìœ„í—˜ ê°€ëŠ¥ | ì¶”ê°€ í‰ê°€ í•„ìš” |\n| --- | --- | --- |\n| ë‹¤ê´€/ì–‘ì¸¡/ìœ ì¦™ì„± | physiologic ê°€ëŠ¥ | ì§€ì† ì‹œ ì›ì¸í‰ê°€ |\n| ë‹¨ì¼ê´€/í˜ˆì„±/ìë°œì„± | ë³‘ì  ê°€ëŠ¥ì„± ë†’ìŒ | ì˜ìƒ + í•„ìš” ì‹œ biopsy |\n| ì—¼ì¦ì„± ë³€í™” + ê³ ì—´ | mastitis/abscess ìš°ì„  | antibiotics Â± drainage |\n| ì—¼ì¦ì„± í”¼ë¶€ë³€í™” + í•­ìƒì œ ë¶ˆì‘ | inflammatory cancer ì˜ì‹¬ | ì¡°ì§ì§„ë‹¨ |\n\n## Male breast clue\n- ìƒˆë¡œìš´ gynecomastiaëŠ” testicular/endocrine/drug ì›ì¸ì„ ê°™ì´ ë³¸ë‹¤.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-165","focus_area":"Nipple Discharge Risk Table","tags":["usmle-step2","gynecology","breast-discharge","table","risk-stratification"]}
{"chunk_type":"transcript_chunk","text":"# Uterine War-room Entry: Pain, Bleeding, Mass + Age Filter\n## Symptom-first table\n| ì¶• | ëŒ€í‘œ ì§ˆë¬¸ | ê³ ìœ„í—˜ ì‹ í˜¸ |\n| --- | --- | --- |\n| Pain | cyclic vs acute severe pain? | torsion/ectopic/rupture íŒ¨í„´ |\n| Bleeding | ageì™€ cycle relation? | postmenopausal bleeding, hemodynamic instability |\n| Mass effect | ì••ë°•ì¦ìƒ(urinary/bowel) ë™ë°˜? | rapid growth, severe anemia, systemic signs |\n\n## Age filter\n- adolescent AUBëŠ” anovulatory axis immaturity ê°€ëŠ¥ì„±ì´ ë†’ë‹¤.\n- postmenopausal bleedingì€ malignancy ë°°ì œë¥¼ ìš°ì„ í•œë‹¤.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-185","focus_area":"Uterine War-room Entry","tags":["usmle-step2","gynecology","uterus","triage"]}
{"chunk_type":"transcript_chunk","text":"# Fibroid Deep Dive (Location-driven Symptoms)\n## Location determines presentation\n- submucosal: bleeding/infertility.\n- intramural: mixed symptoms.\n- subserosal/pedunculated: bulk symptoms/torsion ê°€ëŠ¥.\n\n## Special scenarios\n- pregnancy ì¤‘ red degenerationì€ ë³´ì¡´ì  í†µì¦ì¡°ì ˆì´ ê¸°ë³¸.\n- prolapsing fibroidëŠ” infection/necrosis riskë¥¼ ë™ë°˜í•´ procedural managementê°€ í•„ìš”.\n\n## Fertility-aware treatment\n- future fertilityë©´ myomectomy, complete definitive controlì€ hysterectomy.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-205","focus_area":"Fibroid Deep Dive","tags":["usmle-step2","gynecology","fibroid","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Fibroid vs Adenomyosis vs Endometriosis Comparison Table\n| ì§ˆí™˜ | í•´ë¶€í•™ì  ìœ„ì¹˜ | í•µì‹¬ ì§„ì°° ë‹¨ì„œ | ê´€ë¦¬ ë°©í–¥ |\n| --- | --- | --- | --- |\n| Fibroid | myometrial smooth muscle mass | irregular firm nodular uterus | symptom/fertility ê¸°ë°˜ ì ˆì œ ë˜ëŠ” ì¡°ì ˆ |\n| Adenomyosis | endometrium within myometrium | boggy tender globular uterus | hormonal control, definitiveëŠ” hysterectomy |\n| Endometriosis | ectopic endometrial implants | fixed pelvis, cyclic deep pain triad | medical suppression Â± lap surgery |\n\n- ì„¸ ì§ˆí™˜ ëª¨ë‘ í†µì¦/ì¶œí˜ˆ ê°€ëŠ¥í•˜ì§€ë§Œ ì´‰ì§„/ì˜ìƒ íŒ¨í„´ì´ ë‹¤ë¥´ë‹¤.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-225","focus_area":"Fibroid Adenomyosis Endometriosis Table","tags":["usmle-step2","gynecology","fibroid","adenomyosis","endometriosis","table"]}
{"chunk_type":"transcript_chunk","text":"# AUB, Prolapse, and Uterus Rapid Recap\n- AUBëŠ” age-stratified cancer riskë¥¼ ìš°ì„  ë°˜ì˜.\n- postmenopausal bleedingì€ ì¡°ì§ì§„ë‹¨ ê²½ë¡œë¥¼ ëŠ¦ì¶”ì§€ ì•ŠëŠ”ë‹¤.\n- prolapseëŠ” ê³¨ë°˜ì € ì•½í™” ê¸°ì „ê³¼ compartment(ì˜ˆ: rectocele splinting) ì¦ìƒì„ ì—°ê²°.\n- uterus ë¬¸ì œëŠ” \"ì¦ìƒì¶• + ë‚˜ì´ + ì´‰ì§„íŒ¨í„´\"ìœ¼ë¡œ ë¹ ë¥´ê²Œ ë¶„ë¥˜.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-245","focus_area":"AUB and Prolapse Recap","tags":["usmle-step2","gynecology","aub","prolapse","recap"]}
{"chunk_type":"recap_summary","text":"# Gyne Rapid Fire Integration\n1. amenorrheaëŠ” pregnancy-first, ì´í›„ axis/outflow ë¶„ê¸°.\n2. acute pelvic painì—ì„œëŠ” ectopic/torsion killersë¥¼ ë¨¼ì € ë°°ì œ.\n3. PCOS ì§„ë‹¨ ì „ mimic exclusionì€ í•„ìˆ˜.\n4. breast ë¬¸ì œëŠ” age-based imaging + red-flag discharge ê¸°ì¤€ìœ¼ë¡œ ë¶„ê¸°.\n5. uterine disordersëŠ” ìœ„ì¹˜/ì´‰ì§„/cycle timingì„ í†µí•©í•˜ë©´ í•¨ì •ì„ í”¼í•  ìˆ˜ ìˆë‹¤.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-261","focus_area":"Gyne Rapid Integration","tags":["usmle-step2","gynecology","recap","integration"]}
{"chunk_type":"transcript_chunk","text":"# Cervical Pathology Framework Entry (Cervicitis to Screening)\n## Four pillars\n- cervicitis recognition.\n- screening algorithm adherence.\n- abnormal cytology triage.\n- precancer/cancer management.\n\n## Cervicitis high-yield\n- mucopurulent discharge + friable cervixëŠ” cervicitis ë‹¨ì„œ.\n- PIDì™€ëŠ” ê°ì—¼ í™•ì¥ ë²”ìœ„ ë° systemic signsë¡œ êµ¬ë¶„.\n- pregnancyì—ì„œëŠ” anatomy/physiology ì°¨ì´ë¡œ ì§„ì°° í•´ì„ì˜ í•¨ì •ì„ ì¸ì‹í•´ì•¼ í•œë‹¤.","subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null,"source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-1","focus_area":"Cervical Pathology Entry","tags":["usmle-step2","gynecology","cervicitis","cervical-screening"]}
{"chunk_type":"transcript_chunk","text":"# Cervicitis Treatment + Cervical Screening Core\n## Cervicitis treatment\n| í™˜ìêµ° | í•­ìƒì œ | í¬ì¸íŠ¸ |\n| --- | --- | --- |\n| ì¼ë°˜ | Ceftriaxone + Doxycycline | Gonorrhea + Chlamydia ë™ì‹œ ì»¤ë²„ |\n| ì„ì‚°ë¶€ | Ceftriaxone + Azithromycin | Doxycycline ê¸ˆê¸° |\n\n## Pap screening\n- ì‹œì‘: 21ì„¸(ì„±ê²½í—˜ ì‹œì‘ ë‚˜ì´ì™€ ë¬´ê´€).\n- ì¢…ë£Œ: 65ì„¸, ì§€ë‚œ 10ë…„ adequate negative screening + CIN2+ ë³‘ë ¥ ì—†ìŒ.\n- 21-29ì„¸: Pap cytology only, 3ë…„ë§ˆë‹¤.\n- 30-65ì„¸: Pap + HPV co-test, 5ë…„ë§ˆë‹¤.\n\n## Hysterectomy ì´í›„\n- ì–‘ì„± ì§ˆí™˜ìœ¼ë¡œ ìê¶ê²½ë¶€ ì œê±° + dysplasia ë³‘ë ¥ ì—†ìŒ: ì¤‘ë‹¨.\n- ì•”ìœ¼ë¡œ ìˆ˜ìˆ : vaginal cuff screening ì§€ì†.\n\n## ë©´ì—­ì €í•˜ì\n- HIV/ì¥ê¸°ì´ì‹ ë“±ì€ ì„±ìƒí™œ ì‹œì‘ ë˜ëŠ” ì§„ë‹¨ ì‹œë¶€í„°, ë§¤ë…„ ê²€ì‚¬.","source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-21","focus_area":"Cervicitis Treatment and Pap Screening","tags":["usmle-step2","gynecology","cervicitis","pap-smear","screening","treatment"],"subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null}
{"chunk_type":"transcript_chunk","text":"# Abnormal Cytology and CIN/Invasive Cancer Management\n## Cytology algorithm\n- ASCUS: reflex HPV í™•ì¸.\n- ASCUS + HPV(-): 3ë…„ í›„ routine.\n- ASCUS + HPV(+): colposcopy.\n- LSIL/HSIL: ëŒ€ë¶€ë¶„ ì¦‰ì‹œ colposcopy.\n- AGC: ê³ ìœ„í—˜. Colposcopy + ECC + (35ì„¸ ì´ìƒ/ë‚´ë§‰ì•” ìœ„í—˜ ìˆìœ¼ë©´) EMB.\n- Benign endometrial cells:\n- ì Šì€ ì—¬ì„±ì—ì„œ ë¬´ì¦ìƒ: ëŒ€ê°œ ê²½ê³¼ê´€ì°°.\n- AUB/ë¹„ë§Œ/íê²½ í›„: endometrial evaluation ê³ ë ¤ ë˜ëŠ” ì‹œí–‰.\n\n## CIN treatment\n- CIN1: ê´€ì°°(ëŒ€ë¶€ë¶„ ìì—° ì†Œì‹¤).\n- CIN2/3: LEEP ë˜ëŠ” cone ë“± ì ˆì œ/ì†Œì‘.\n- ì„ì‹  ì¤‘ CIN2/3: invasive cancer ì˜ì‹¬ ì—†ìœ¼ë©´ ì¹˜ë£Œ ì—°ê¸°(ë¶„ë§Œ í›„), ìƒê²€ì€ ê°€ëŠ¥.\n\n## Invasive cervical cancer\n- ìœ¡ì•ˆ ë³‘ë³€ ë³´ì´ë©´ Pap ê¸ˆì§€.\n- ì¦‰ì‹œ direct biopsy.\n- ìê¶ê²½ë¶€ì•” stagingì€ ì„ìƒì  staging ê¸°ë°˜.","source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-41","focus_area":"Abnormal Pap to CIN and Invasive Cancer","tags":["usmle-step2","gynecology","ascus","hsil","agc","cin","cervical-cancer","diagnosis","treatment"],"subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null}
{"chunk_type":"recap_summary","text":"# Rapid Fire Recap: Cervicitis/Pap + Ovary Transition\n## Cervicitis/Pap high-yield\n1. Mucopurulent discharge + friable cervix: cervicitis(ceftriaxone ê¸°ë°˜, ì„ì‚°ë¶€ëŠ” azithro ì‚¬ìš©).\n2. Screening ì‹œì‘ 21ì„¸, 30ì„¸ ì´ìƒì€ co-test 5ë…„ ê°„ê²©.\n3. ASCUSëŠ” HPVë¡œ ë¶„ê¸°, AGCëŠ” colposcopy + ECC + í•„ìš” ì‹œ EMB.\n4. Visible cervical lesionì€ Papê°€ ì•„ë‹ˆë¼ direct biopsy.\n5. ì„ì‹  ì¤‘ CIN2/3ëŠ” ëŒ€ê°œ ë¶„ë§Œ í›„ ì¹˜ë£Œ.\n\n## Ovary framework entry\n- ë‚œì†Œ ë¬¸ì œëŠ” \"ì •ìƒ-ì‘ê¸‰-ì•…ì„±\" ìŠ¤í™íŠ¸ëŸ¼ìœ¼ë¡œ ì ‘ê·¼.\n- ì•”ê¸°ë³´ë‹¤ ì•Œê³ ë¦¬ì¦˜(ë¶„ê¸°ì  ì„¤ì •: ì„ì‹  ì—¬ë¶€, íê²½ ì—¬ë¶€, ì˜ìƒ ì†Œê²¬)ì´ í•µì‹¬.","source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-61","focus_area":"Rapid Recap Cervix and Ovary Framework","tags":["usmle-step2","gynecology","recap","cervicitis","pap-smear","ovary"],"subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null}
{"chunk_type":"transcript_chunk","text":"# Adnexal Mass Algorithm + Ovarian Emergencies\n## Step 0\n- ê°€ì„ê¸° ì—¬ì„±ì€ ë°˜ë“œì‹œ beta-hCG ë¨¼ì €.\n- í•µì‹¬ ë¶„ê¸°: premenopausal vs postmenopausal.\n\n## Premenopausal mass\n- Simple cyst: ë³´í†µ ê¸°ëŠ¥ì„±. ì•½ 6ì£¼ ì¶”ì  ê´€ì°°.\n- Complex mass: ì•…ì„± ì†Œê²¬ ì—†ìœ¼ë©´ ë³´ì¡´ì  ê´€ë¦¬/ì¶”ì , ì§€ì†/ì•…í™” ì‹œ ìˆ˜ìˆ  ê³ ë ¤.\n\n## Postmenopausal mass\n- ë‚œì†Œê°€ ì‘ì•„ì ¸ì•¼ í•˜ëŠ” ì‹œê¸°ë¼ massëŠ” ì•…ì„± ê°€ëŠ¥ì„± ë†’ê²Œ í‰ê°€.\n- CA-125:\n- íê²½ ì „: ìœ„ì–‘ì„± ë§ì•„ ì œí•œì .\n- íê²½ í›„: ì„ìƒì ìœ¼ë¡œ ìœ ìš©.\n- Complex malignant US ì†Œê²¬ ë˜ëŠ” CA-125 ìƒìŠ¹ì´ë©´ ìˆ˜ìˆ /íƒìƒ‰.\n\n## Never event\n- ì˜ì‹¬ ë‚œì†Œì•” massëŠ” biopsy ê¸ˆì§€(ë³µê°• íŒŒì¢… ìœ„í—˜).\n- ì›ì¹™: ìˆ˜ìˆ ì  ì œê±°(oophorectomy).\n\n## Acute pain: rupture vs torsion\n| í•­ëª© | Ruptured cyst | Ovarian torsion |\n| --- | --- | --- |\n| ë‹¨ì„œ | í™œë™/ì„±ê´€ê³„ í›„ ê¸‰ì„± í†µì¦, free fluid | ê¸‰ì„± í†µì¦ + ì‹¬í•œ ì˜¤ì‹¬/êµ¬í†  |\n| ë³‘íƒœ | íŒŒì—´+ì¶œí˜ˆ | í˜ˆë¥˜ ì°¨ë‹¨ í—ˆí˜ˆ |\n| ì¹˜ë£Œ | ì•ˆì •: ì§„í†µ+ê´€ì°°, ë¶ˆì•ˆì •: ìˆ˜ìˆ  | ì‘ê¸‰ ìˆ˜ìˆ (detorsion) |\n- ë„í”ŒëŸ¬ í˜ˆë¥˜ê°€ ì •ìƒì´ì–´ë„ torsion ì™„ì „ ë°°ì œ ë¶ˆê°€(ì„ìƒ íŒë‹¨ ì¤‘ìš”).","source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-71","focus_area":"Adnexal Mass and Torsion/Rupture","tags":["usmle-step2","gynecology","adnexal-mass","ovarian-torsion","ruptured-cyst","ca-125","algorithm"],"subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null}
{"chunk_type":"transcript_chunk","text":"# Ovarian Cancer and Special Ovarian Tumors\n## Epithelial ovarian cancer\n- ì¦ìƒ: ë³µë¶€íŒ½ë§Œ/ì†Œí™”ë¶ˆëŸ‰/ì¡°ê¸°í¬ë§Œê° ë“± ë¹„íŠ¹ì´ì ì´ë¼ late stage ì§„ë‹¨ í”í•¨.\n- ê°€ì„¤: incessant ovulation(ë°˜ë³µ ë°°ë€-ìˆ˜ë³µ ê³¼ì •)ë¡œ ëŒì—°ë³€ì´ ìœ„í—˜ ì¦ê°€.\n\n## Risk vs protective\n| Risk factors | Protective factors |\n| --- | --- |\n| Nulliparity, early menarche, late menopause | OCP, pregnancy, breastfeeding |\n| BRCA1/2, Lynch | Tubal ligation |\n\n## Screening/management\n- í‰ê· ìœ„í—˜êµ° routine screening ì—†ìŒ.\n- ê³ ìœ„í—˜êµ°(BRCA/Lynch): TVUS + CA-125 ì£¼ê¸°ì  ê³ ë ¤, ì™„ë£Œ ì¶œì‚° í›„ rrBSO ê³ ë ¤.\n- ì§„ë‹¨/ì¹˜ë£Œ: staging ìˆ˜ìˆ (debulking) + platinum/taxane.\n\n## Special tumors\n- Sertoli-Leydig: testosterone ê³¼ë‹¤, virilization.\n- Granulosa cell: estrogen ê³¼ë‹¤, precocious puberty ë˜ëŠ” postmenopausal bleeding, Call-Exner bodies, EMBë¡œ ë‚´ë§‰ì•” ë°°ì œ.\n- Germ cell markers: dysgerminoma(LDH), yolk sac(AFP), choriocarcinoma(beta-hCG).\n\n## Pregnancy-related masses\n- Luteoma: ì„ì‹  ì¤‘ ê³ í˜• mass + virilization ê°€ëŠ¥, ëŒ€ê°œ ë¶„ë§Œ í›„ í‡´ì¶•.\n- Theca lutein cyst: ê³ hCG(ì˜ˆ: molar pregnancy) ê´€ë ¨, ì›ì¸ ì¹˜ë£Œ ì‹œ í˜¸ì „.","source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-91","focus_area":"Ovarian Cancer and Special Tumors","tags":["usmle-step2","gynecology","ovarian-cancer","brca","lynch","granulosa","sertoli-leydig","germ-cell"],"subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null}
{"chunk_type":"transcript_chunk","text":"# Vulva/Vagina Core + Pediatric Cases\n## Pediatric\n- Labial adhesions(ì €ì—ìŠ¤íŠ¸ë¡œê²): ë¬´ì¦ìƒ ê´€ì°°, ì¦ìƒ ìˆìœ¼ë©´ topical estrogen.\n- ì†Œì•„ foul discharge/bleeding + ì™¸ìƒ ì—†ìŒ: foreign body(íœ´ì§€) í”í•¨, speculum í”¼í•˜ê³  irrigation ìš°ì„ .\n- Child mass clue: donut-shaped=urethral prolapse(ì–‘ì„±), grape-like=sarcoma botryoides(ì•…ì„±).\n\n## Vulva/Vagina ê°ë³„ ê¸°ë³¸ì¶•\n- ìœ„ì¹˜(ì™¸ìŒë¶€ vs ì§ˆ ë‚´ë¶€), ë³‘ë³€ ëª¨ì–‘, ì—°ë ¹/ì¦ìƒ íŒ¨í„´ì´ í•µì‹¬ ë¶„ê¸°ì .\n- ì‹œí—˜ í¬ì¸íŠ¸ëŠ” ë‹¨ì¼ ë””í…Œì¼(ìœ„ì¹˜, ëª¨ì–‘, ë™ë°˜ ì¦ìƒ)ë¡œ ì§„ë‹¨ì´ ê°ˆë¦°ë‹¤ëŠ” ì .","source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-111","focus_area":"Pediatric Vulvovaginal Differentiation","tags":["usmle-step2","gynecology","vulva","vagina","pediatrics","foreign-body","labial-adhesions"],"subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null}
{"chunk_type":"transcript_chunk","text":"# Lichen Disorders + Cysts + Vulvar/Vaginal Malignancy\n## Lichen sclerosus vs lichen planus\n| í•­ëª© | Lichen sclerosus | Lichen planus |\n| --- | --- | --- |\n| ì£¼ì¦ìƒ | ì‹¬í•œ ê°€ë ¤ì›€ | í†µì¦/ì‘ì—´ê°/ê°€ë ¤ì›€ |\n| ìœ„ì¹˜ | ì™¸ìŒë¶€ ì¤‘ì‹¬(outside only) | ì§ˆ ë‚´ë¶€ + ì™¸ìŒë¶€ ê°€ëŠ¥ |\n| í”¼ë¶€/ì ë§‰ | ì–‡ì€ í° í”¼ë¶€(cigarette paper), figure-of-8 | Wickham striae, ì§ˆ ë¯¸ë€ |\n| ì—°ê´€ | SCC ìœ„í—˜ ì¦ê°€ | êµ¬ê°• ê¶¤ì–‘/ì¹˜ì€ì—¼ ë™ë°˜ ê°€ëŠ¥ |\n| ì§„ë‹¨/ì¹˜ë£Œ | biopsy, high-potency steroid | biopsy, steroid |\n\n## Cysts and urethral diverticulum\n- Bartholin cyst(4ì‹œ/8ì‹œ): ë¬´ì¦ìƒ ê´€ì°°, í†µì¦/ë†ì–‘ì€ I&D + Word catheter, ì¬ë°œ ì‹œ marsupialization.\n- Skene cyst(10ì‹œ/2ì‹œ): ìš”ë„ ì£¼ë³€.\n- Urethral diverticulum: post-void dribbling(3D: dysuria/dyspareunia/dribbling), anterior vaginal wall mass, MRI ì§„ë‹¨.\n\n## Malignancy\n- Vulvar SCC: HPV/í¡ì—°, lichen sclerosus ê´€ë ¨. ë§Œì„± ì†Œì–‘ì¦/ê¶¤ì–‘/í”Œë¼í¬ëŠ” biopsy í•„ìˆ˜.\n- Vaginal cancer:\n| ìœ í˜• | Squamous cell | Clear cell adenocarcinoma |\n| --- | --- | --- |\n| í™˜ìêµ° | ê³ ë ¹ | ì Šì€ ì—¬ì„± |\n| ìœ„ì¹˜ | ìƒë¶€ 1/3 í›„ë²½ | ì „ë²½ |\n| ìœ„í—˜ì¸ì | HPV/í¡ì—° | ìê¶ë‚´ DES ë…¸ì¶œ |","source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-131","focus_area":"Lichen Cyst and Vulvovaginal Cancer","tags":["usmle-step2","gynecology","lichen-sclerosus","lichen-planus","bartholin","urethral-diverticulum","vulvar-cancer","vaginal-cancer"],"subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null}
{"chunk_type":"transcript_chunk","text":"# Functional Vulvar Pain + DSD Intro\n## Functional pain\n- Vaginismus: ì‚½ì… ì‹œ ë²½ì— ë§‰íˆëŠ” ëŠë‚Œ, ë¶ˆìˆ˜ì˜ì  ê²½ë ¨. ì¹˜ë£ŒëŠ” desensitization(dilator) + pelvic floor PT.\n- Vulvodynia: ê²‰ë³´ê¸° ì •ìƒì¸ë° í‘œì¬ ì ‘ì´‰ í†µì¦(Q-tip test ì–‘ì„±). ì¹˜ë£ŒëŠ” neuropathic pain meds(ì˜ˆ: amitriptyline/gabapentin) + pelvic floor PT.\n\n## Rapid recap points\n- ì†Œì•„ fused labia: ì €ì—ìŠ¤íŠ¸ë¡œê², ì¦ìƒê¸°ë°˜ ì¹˜ë£Œ.\n- Foul discharge child: foreign body ìš°ì„ .\n- Postmenopausal itch + white lesion: lichen sclerosus, biopsy.\n- 4 o'clock cyst: Bartholin, í•„ìš” ì‹œ I&D + Word catheter.\n- Post-void dribble: urethral diverticulum, MRI.\n- Grape-like mass child: sarcoma botryoides.\n- DES ë…¸ì¶œ + ì Šì€ ì—¬ì„± ì§ˆì•”: clear cell ê°€ëŠ¥.\n\n## DSD unit transition\n- ì´í›„ íŒŒíŠ¸ëŠ” DSDì™€ í•´ë¶€í•™ì  ê²°ì†ì˜ ì‹œí—˜í˜• ê°ë³„(í•µí˜•+í˜¸ë¥´ëª¬+í‘œí˜„í˜•) ì¤‘ì‹¬.","source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-151","focus_area":"Functional Pain and DSD Transition","tags":["usmle-step2","gynecology","vaginismus","vulvodynia","dsd","recap"],"subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null}
{"chunk_type":"transcript_chunk","text":"# Urethral Diverticulum + DSD Framework Entry\n## Urethral diverticulum\n- ë³‘íƒœ: periurethral gland ê°ì—¼/ë†ì–‘ í›„ outpouching í˜•ì„±, ì†Œë³€ ì €ë¥˜ pocket ë°œìƒ.\n- í•µì‹¬ ì¦ìƒ 3D: dysuria, dyspareunia, post-void dribbling.\n- ì§„ì°°: anterior vaginal wall tender mass, ì••ë°• ì‹œ ë¶„ë¹„ë¬¼ ê°€ëŠ¥.\n- í™•ì§„: pelvic MRI.\n- ì¹˜ë£Œ: surgical excision.\n\n## DSD framework ì‹œì‘\n- ë¬¸ì œ í•´ê²° ë³€ìˆ˜: ê°€(ê°€ìŠ´), í„¸(ìŒëª¨), ì(ìê¶), ì§„(ì§„ë‹¨ ê²€ì‚¬/í•µí˜•) ì‹ìœ¼ë¡œ ì •ë¦¬í•˜ë©´ ê°ë³„ì´ ì‰¬ì›€.\n- Turnerë¡œ ì´ì–´ì§€ëŠ” íŒŒíŠ¸ì˜ ëª©ì ì€ \"í•µí˜•-í˜¸ë¥´ëª¬-ì „ì‹  í•©ë³‘ì¦\"ì„ ë™ì‹œì— ë¬»ëŠ” ë¬¸ì œ ëŒ€ì‘.","source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-171","focus_area":"Urethral Diverticulum and DSD Framework","tags":["usmle-step2","gynecology","urethral-diverticulum","mri","dsd","turner"],"subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null}
{"chunk_type":"transcript_chunk","text":"# Turner, Aromatase Deficiency, 5-Alpha Reductase Deficiency\n## Turner syndrome (45,XO)\n- ë³‘íƒœ: streak ovaryë¡œ ovarian failure.\n- í˜¸ë¥´ëª¬: low estrogen + high FSH/LH(hypergonadotropic hypogonadism).\n- ì„ìƒ: primary amenorrhea, short stature, webbed neck, broad chest.\n- ë‹¤ìŒ ë‹¨ê³„(ì‹œí—˜ í¬ì¸íŠ¸): ë™ë°˜ì§ˆí™˜ í‰ê°€.\n- ì‹¬ì¥: coarctation, bicuspid AV(echo/cardiac MRI).\n- ì‹ ì¥: horseshoe kidney(renal US).\n- ê°‘ìƒì„ /ì²­ë ¥/ì‹œë ¥/ê³¨ê±´ê°• í‰ê°€.\n\n## Aromatase deficiency (46,XX)\n- androgen to estrogen ì „í™˜ ë¶ˆê°€.\n- maternal virilization(ì„ì‹  ì¤‘ ì‚°ëª¨ ë‚¨ì„±í™”) + íƒœì•„ ambiguous genitaliaê°€ í•µì‹¬ ë‹¨ì„œ.\n- ì‚¬ì¶˜ê¸°: amenorrhea + virilization, tall stature(ì„±ì¥íŒ íì‡„ ì§€ì—°).\n\n## 5-alpha reductase deficiency (46,XY)\n- testosteroneì€ ì¡´ì¬í•˜ë‚˜ DHT ìƒì„± ì €í•˜.\n- ì¶œìƒ ì‹œ ambiguous/female-appearing genitalia ê°€ëŠ¥.\n- ì‚¬ì¶˜ê¸° testosterone surge í›„ virilization ì§„í–‰(ìœ ë°©ë°œë‹¬ ì—†ìŒ).","source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-191","focus_area":"Turner Aromatase 5alpha Disorders","tags":["usmle-step2","gynecology","turner-syndrome","aromatase-deficiency","5-alpha-reductase-deficiency","amenorrhea"],"subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null}
{"chunk_type":"transcript_chunk","text":"# No-Uterus Differential + Male Reproductive Transition\n## Mullerian agenesis vs AIS\n| í•­ëª© | Mullerian agenesis (MRKH) | Androgen insensitivity syndrome (AIS) |\n| --- | --- | --- |\n| í•µí˜• | 46,XX | 46,XY |\n| ê°€ìŠ´ | ë°œë‹¬ | ë°œë‹¬ |\n| ìŒëª¨ | ì •ìƒ | í¬ë°•/ê²°ì—¬ |\n| ë‚´ë¶€ ì¥ê¸° | ë‚œì†Œ ìˆìŒ, ìê¶/ìƒë¶€ì§ˆ ê²°ì† | ì ë³µê³ í™˜, ìê¶ ì—†ìŒ |\n| ë™ë°˜ ë¦¬ìŠ¤í¬ | ì‹ ì¥ê¸°í˜• | ê³ í™˜ì•” ìœ„í—˜(ì„±ì„  ê´€ë¦¬ í•„ìš”) |\n\n## Rapid recap\n- Turner: short stature + webbed neck + high FSH, ì‹¬ì¥/ì‹ ì¥ í‰ê°€ í•„ìˆ˜.\n- Aromatase deficiency: virilized mother + ambiguous genitalia.\n- 5-alpha deficiency: ì¶œìƒ ì—¬ì„±í˜•ì²˜ëŸ¼ ë³´ì´ì§€ë§Œ ì‚¬ì¶˜ê¸° virilization.\n- MRKH vs AISëŠ” pubic hairê°€ ê³ ìˆ˜ìµ ë¶„ê¸°ì .\n\n## Male reproductive block transition\n- ì´í›„ íŒŒíŠ¸ëŠ” male breast, hypogonadism axis, prostate/scrotal pathologyë¥¼ ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤ë¡œ ì •ë¦¬.","source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-211","focus_area":"No Uterus Differential and Male Transition","tags":["usmle-step2","gynecology","mrkh","ais","dsd","male-reproductive"],"subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null}
{"chunk_type":"transcript_chunk","text":"# Male Breast and Hypogonadism + Prostate Core\n## Male breast\n- Pseudogynecomastia: ì§€ë°©ì¡°ì§, ë¹„ë§Œ ê´€ë ¨.\n- True gynecomastia: ìœ ë‘ í•˜ë¶€ ì¤‘ì‹¬ì˜ rubbery disc, ëŒ€ì¹­ì„± í”í•¨.\n\n| ìœ í˜• | í•µì‹¬ íŠ¹ì§• | ê¸°ë³¸ ê´€ë¦¬ |\n| --- | --- | --- |\n| Physiologic gynecomastia | ì‚¬ì¶˜ê¸°/ë…¸í™”ì˜ ì¼ì‹œì  í˜¸ë¥´ëª¬ ë¶ˆê· í˜• | ê´€ì°° ë° ì•ˆì‹¬ |\n| Pathologic gynecomastia | ì•½ë¬¼(spironolactone/cimetidine/ketoconazole), ê°„ì§ˆí™˜, hypogonadism ë“± | ì›ì¸ êµì •/ê¸°ì €ì§ˆí™˜ ì¹˜ë£Œ |\n\n- ë‚¨ì„± ìœ ë°©ì•” ë‹¨ì„œ: í¸ì¸¡, eccentric, hard/fixed, peau d'orange, í˜ˆì„± ë¶„ë¹„ë¬¼, BRCA2 ì—°ê´€.\n\n## Hypogonadism axis\n- Primary: low T + high LH/FSH(ê³ í™˜ ë¬¸ì œ).\n- Secondary: low T + low/normal LH/FSH(ì‹œìƒí•˜ë¶€/ë‡Œí•˜ìˆ˜ì²´ ë¬¸ì œ).\n- ì¤‘ìš” ì›ì¸: opioid, hemochromatosis, prolactinoma, anabolic steroid, systemic illness/weight loss.\n\n## Prostate\n- Acute bacterial prostatitis: ê³ ì—´/íšŒìŒë¶€ í†µì¦/boggy tender prostate.\n- ê¸ˆê¸°: vigorous massage, urethral Foley íšŒí”¼(í•„ìš” ì‹œ suprapubic ê³ ë ¤).\n- BPH ì•½ë¬¼: alpha blocker(ë¹ ë¥¸ íš¨ê³¼) vs 5-alpha reductase inhibitor(ëŠë¦¬ì§€ë§Œ í¬ê¸° ê°ì†Œ).\n- Prostate cancer: peripheral zone, firm/nodular/asymmetric, osteoblastic bone metastasis ê°€ëŠ¥.","source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-231","focus_area":"Male Breast Hypogonadism and Prostate","tags":["usmle-step2","male-reproductive","gynecomastia","hypogonadism","prostatitis","bph","prostate-cancer"],"subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null}
{"chunk_type":"transcript_chunk","text":"# Scrotal/Testicular and Penile/Urethral High-Yield\n## Scrotal masses\n- Hydrocele: transillumination(+).\n- Varicocele: bag-of-worms, ë³´í†µ ì¢Œì¸¡.\n- ìš°ì¸¡ varicocele ë˜ëŠ” ëˆ„ì›Œë„ ì§€ì†: retroperitoneal/IVC pathology í‰ê°€ í•„ìš”(ì˜ˆ: RCC).\n\n## Testicular cancer\n- ì „í˜•: 15-35ì„¸, painless solid mass, transillumination(-).\n- ê¸ˆê¸°: trans-scrotal biopsy.\n- ì¹˜ë£Œ: radical inguinal orchiectomy.\n- Marker: seminomaëŠ” AFP ìŒì„±, non-seminomaëŠ” AFP/beta-hCG ìƒìŠ¹ ê°€ëŠ¥.\n- ìœ„í—˜ì¸ì: cryptorchidism.\n\n## Penis/urethra emergencies\n- ED: psychogenicì€ nocturnal tumescence ë³´ì¡´, organicì€ ì ì§„ì .\n- Peyronie: tunica fibrosisë¡œ curvature.\n- Penile fracture: snap + eggplant deformity, ì¦‰ì‹œ ìˆ˜ìˆ .\n- Priapism: 4ì‹œê°„ ì´ìƒ ì‘ê¸‰(í—ˆí˜ˆ ìœ„í—˜).\n- Paraphimosis: ì‘ê¸‰, phimosisì™€ êµ¬ë¶„.\n- Hypospadias: í¬ê²½ìˆ˜ìˆ  ê¸ˆì§€(ì¬ê±´ ì¡°ì§ ë³´ì¡´).\n\n## Urethritis\n- Gonorrhea: purulent discharge.\n- Chlamydia: watery discharge.\n- ê²½í—˜ì  ë™ì‹œì¹˜ë£Œ: ceftriaxone + doxycycline.\n- Trichomonas: metronidazole(íŒŒíŠ¸ë„ˆ ë™ì‹œ ì¹˜ë£Œ).","source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-251","focus_area":"Scrotal Testicular Penile Urethral","tags":["usmle-step2","male-reproductive","testicular-cancer","varicocele","penile-fracture","urethritis","emergency"],"subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null}
{"chunk_type":"recap_summary","text":"# Rapid Fire Recap: Male Reproductive\n1. Painless solid testicular mass: testicular cancer, trans-scrotal biopsy ê¸ˆì§€, radical inguinal orchiectomy.\n2. Right-sided varicocele ë˜ëŠ” supine non-resolving varicocele: ë³µë¶€/í›„ë³µë§‰ ì•…ì„±ì§ˆí™˜ í‰ê°€.\n3. Acute prostatitis: prostate massage/Foley í”¼í•˜ê³  ê°ì—¼ ì¹˜ë£Œ.\n4. BPH: tamsulosin(ë¹ ë¦„, ê¸°ë¦½ì„± ì €í˜ˆì••) vs finasteride(ëŠë¦¼, í¬ê¸° ê°ì†Œ).\n5. Gynecomastia in puberty: ëŒ€ë¶€ë¶„ ê´€ì°°.\n6. Male breast cancer: hard/eccentric/unilateral + BRCA2 ì—°ê´€.\n7. Penile fracture: snap + eggplant deformityë©´ ìˆ˜ìˆ .\n8. Torsion red flag(ê°ë³„ ì¤‘ìš”): ê¸‰ì„± í†µì¦, cremasteric reflex ì†Œì‹¤ ì‹œ ìˆ˜ìˆ ì  ëŒ€ì‘ ìš°ì„ .","source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-264","focus_area":"Rapid Recap Male Reproductive","tags":["usmle-step2","male-reproductive","recap","high-yield"],"subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null}
{"subject":"Gyne 2f646f2986ee80f8b89eef6e8dc2f9f5","page_title":"Gyne 2f646f2986ee80f8b89eef6e8dc2f9f5","episode":"Gyne 2f646f2986ee80f8b89eef6e8dc2f9f5","section_path":["Gyne 2f646f2986ee80f8b89eef6e8dc2f9f5"],"source_doc_id":"Gyne 2f646f2986ee80f8b89eef6e8dc2f9f5","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"Gyne 2f646f2986ee80f8b89eef6e8dc2f9f5-1","focus_area":"Gonadal Tumor Lineage Map Female and Male","tags":["usmle-step2","gynecology","gonadal-tumor","germ-cell","sex-cord","stromal"],"text":"# Gonadal Tumor Lineage Framework (Female + Male)\n## Origin-based map\n| Origin | Female tumors | Male tumors | Key markers/clinical clues |\n| --- | --- | --- | --- |\n| Germ cell (primitive) | Dysgerminoma | Seminoma | fried-egg morphology; seminoma-like pattern |\n| Germ cell (embryonal) | Embryonal carcinoma | Embryonal carcinoma | aggressive, necrosis/hemorrhage ê°€ëŠ¥ |\n| Germ cell (yolk sac) | Yolk sac tumor | Yolk sac tumor | AFP ìƒìŠ¹, Schiller-Duval body |\n| Germ cell (placental) | Choriocarcinoma | Choriocarcinoma | hCG ìƒìŠ¹, hematogenous spread |\n| Germ cell (3 layers) | Teratoma | Teratoma | mature(ì£¼ë¡œ ì–‘ì„±) vs immature(ì•…ì„±) |\n| Sex-cord stromal | Granulosa, Sertoli-Leydig | Sertoli, Leydig | granulosa: estrogen excess / sertoli-leydig: virilization / leydig: androgen + Reinke crystals |\n\n## Female high-yield\n- Granulosa: ì„±ì¡°ìˆ™ì¦ ë˜ëŠ” íê²½í›„ì¶œí˜ˆ, Call-Exner body.\n- Sertoli-Leydig: androgen excessë¡œ ì—¬ì„± ë‚¨ì„±í™”.\n- Fibroma/Thecoma: ê³ í˜• ì¢…ì–‘, fibromaëŠ” Meigs syndrome ì—°ê´€ ê°€ëŠ¥.\n\n## Pregnancy-related ovarian entities\n| Entity | Mechanism | Hormone profile/clinical clue |\n| --- | --- | --- |\n| Theca-lutein cyst | hCG ê³¼ìê·¹(ì˜ˆ: molar pregnancy) | ì–‘ì¸¡ ë‚­ì¢…, androgen effect ìƒëŒ€ì ìœ¼ë¡œ ì ìŒ |\n| Pregnancy luteoma | ovarian stroma luteinization | maternal virilization ê°€ëŠ¥, ë¶„ë§Œ í›„ í˜¸ì „ ê°€ëŠ¥ |"}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-1","focus_area":"Pregnancy Physiology Renal and Musculoskeletal","tags":["usmle-step2","obstetrics","pregnancy-physiology","renal","hydronephrosis","back-pain"],"text":"# Pregnancy Physiology: Renal and Musculoskeletal Baseline\n## Renal physiology\n- ì„ì‹  ì¤‘ progesterone + uterine compressionìœ¼ë¡œ ureter dilation/hydronephrosis(ìš°ì¸¡ ìš°ì„¸) ê°€ëŠ¥.\n- ê°ì—¼/ê²°ì„ ë‹¨ì„œ ì—†ìœ¼ë©´ physiologic hydronephrosisë¡œ í•´ì„.\n- GFR ì•½ 50% ì¦ê°€ë¡œ creatinineì€ ë” ë‚®ì•„ì§.\n\n| Condition | Non-pregnant Cr | Pregnant interpretation |\n| --- | --- | --- |\n| Typical baseline | 1.0-1.1 | ì„ì‹ ì—ì„œëŠ” ë†’ê²Œ ë³´ì¼ ìˆ˜ ìˆìŒ |\n| Pregnancy physiologic range | - | 0.4-0.8 |\n| Red flag | 1.0-1.1 in pregnancy | renal insufficiency ì˜ì‹¬ |\n\n## Musculoskeletal back pain\n- ë¬´ê²Œì¤‘ì‹¬ ì „ë°© ì´ë™ + lordosis ì¦ê°€ + relaxin/progesteroneì— ì˜í•œ ì¸ëŒ€ ì´ì™„.\n- ì „í˜•ì  ì„ì‹ ì„± ìš”í†µì€ ì˜ìƒê²€ì‚¬ë³´ë‹¤ ë³´ì¡´ì  ì¹˜ë£Œ(ìì„¸, ì§€ì§€ëŒ€, ì˜¨ì—´, reassurance).\n- ì§„í–‰ì„± ì‹ ê²½í•™ì  ê²°ì† ë“± red flagì—ì„œë§Œ ì¶”ê°€ ì˜ìƒ ê³ ë ¤."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-21","focus_area":"Rh Hemorrhage Oxytocin Hyponatremia Amniotic Fluid","tags":["usmle-step2","obstetrics","rh-incompatibility","kleihauer-betke","oxytocin","amniotic-fluid"],"text":"# Fetomaternal Hemorrhage, Oxytocin Effect, and Amniotic Fluid Logic\n## Rh-negative trauma scenario\n- fetomaternal hemorrhage ê°€ëŠ¥ ì‹œ RhoGAM í•„ìš”.\n- Kleihauer-Betke testë¡œ fetal RBC ë¹„ìœ¨ ì‚°ì¶œ í›„ RhoGAM ìš©ëŸ‰ ì¡°ì ˆ.\n- ì›ë¦¬: HbAëŠ” acidì— ì•½í•´ ghost cell, HbFëŠ” pink cellë¡œ ë‚¨ìŒ.\n\n## Oxytocin and water intoxication\n- ê³ ìš©ëŸ‰ oxytocinì€ ADH-like effectë¡œ water retentionê³¼ hyponatremia ìœ ë°œ ê°€ëŠ¥.\n- confusion/seizure ë°œìƒ ì‹œ ì „í•´ì§ˆ/ìˆ˜ì•¡ ìƒíƒœ ì¦‰ì‹œ ì ê²€.\n\n## Amniotic fluid disorders\n- Polyhydramnios: ì‚¼í‚´ ì¥ì• (esophageal atresia/anencephaly) ë˜ëŠ” fetal polyuria(ë‹¹ë‡¨ ì—°ê´€).\n- Oligohydramnios: renal agenesis, urinary obstruction, placental insufficiency.\n- OligohydramniosëŠ” cord compressionìœ¼ë¡œ variable deceleration ìœ„í—˜ ì¦ê°€."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-37","focus_area":"Rapid Recap Physiology to Fetal Section Transition","tags":["usmle-step2","obstetrics","recap","fetal-surveillance","renal","amniotic-fluid"],"text":"# Rapid Recap: Pregnancy Physiology High Yield\n| Scenario | Interpretation | Action |\n| --- | --- | --- |\n| Pregnant Cr 1.0 | ì„ì‹ ì—ì„œëŠ” ë³‘ì  ê°€ëŠ¥ | renal insufficiency í‰ê°€ |\n| Mild right hydro without infection signs | physiologic hydronephrosis | reassurance/ê²½ê³¼ê´€ì°° |\n| Typical pregnancy back pain | lordosis/ligament laxity | conservative care |\n| Rh-negative trauma | fetomaternal hemorrhage risk | KB test + RhoGAM dosing |\n| Induction ì¤‘ confusion/seizure | oxytocin-associated hyponatremia ê°€ëŠ¥ | fluid/electrolyte ê´€ë¦¬ |\n| Oligohydramnios | fetal urine ê°ì†Œ ìƒíƒœ | ì›ì¸í‰ê°€ + FHR cord compression ì£¼ì˜ |\n\n## Next unit\n- Fetal section í•µì‹¬: gestational dating, fetal surveillance, fetal heart tracing, prenatal testing ì•Œê³ ë¦¬ì¦˜."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-47","focus_area":"Gestational Dating and Fetal Surveillance","tags":["usmle-step2","obstetrics","gestational-age","nst","bpp","fetal-surveillance"],"text":"# Gestational Age and Fetal Surveillance Framework\n## Dating\n- 1st trimester ultrasound(CRL)ê°€ ê°€ì¥ ì •í™•í•˜ë©° EDDë¥¼ ê³ ì •í•œë‹¤.\n- LMP ë¶ˆì¼ì¹˜ ì‹œ ì´ˆê¸° ì´ˆìŒíŒŒ ìš°ì„ .\n- ì´ˆê¸° US ì—†ìœ¼ë©´ 20ì£¼ ì´í›„ fundal height(cm) â‰ˆ gestational age(week) ì°¸ê³ .\n- landmark: umbilicusâ‰ˆ20ì£¼, xiphoidâ‰ˆ36ì£¼, term near lighteningìœ¼ë¡œ fundal height ê°ì†Œ ê°€ëŠ¥.\n\n## NST\n- Reactive NST: 20ë¶„ ë‚´ 15x15 acceleration 2íšŒ ì´ìƒ.\n- Non-reactiveì˜ í”í•œ ì›ì¸: fetal sleep cycle.\n- vibroacoustic stimulation/ì‹œê°„ ì—°ì¥ í›„ ì¬í‰ê°€.\n\n## BPP\n- êµ¬ì„±: NST + breathing + movement + tone + AFI(ì´ 10ì ).\n- 8-10 reassuring, 6 equivocal(ì¬ê²€), 0-4ëŠ” ì¦‰ì‹œ ë¶„ë§Œ ê³ ë ¤.\n- AFIëŠ” chronic hypoxia ë°˜ì˜í•˜ëŠ” ì¤‘ìš” í•­ëª©."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-67","focus_area":"Fetal Heart Tracing and Prenatal Testing","tags":["usmle-step2","obstetrics","fetal-heart-rate","deceleration","prenatal-testing","aneuploidy"],"text":"# Fetal Heart Rate Patterns and Prenatal Testing\n## FHR baseline\n- normal 110-160.\n- tachycardia: maternal fever/chorioamnionitis ë“±.\n- bradycardia: maternal hypothermia, beta-blocker, SLE(anti-Ro/La) ê´€ë ¨ congenital heart block.\n\n## Deceleration logic (VEAL CHOP)\n- Variable -> cord compression -> maternal reposition.\n- Early -> head compression -> physiologic.\n- Late -> placental insufficiency -> intrauterine resuscitation(O2, IV fluid, reposition, stop oxytocin), ì§€ì† ì‹œ C-section.\n- Sinusoidal -> severe fetal anemia red alert.\n\n## Prenatal testing timeline\n- ì´ˆê¸°: blood type/Rh, HIV/syphilis/HBV, rubella/varicella immunity, urine culture.\n- 24-28ì£¼: GDM screen(1h, í•„ìš” ì‹œ 3h), Rh-ëŠ” antibody rescreen.\n- 35-37ì£¼: GBS swab.\n- Aneuploidy:\n- 1st trimester: PAPP-A + beta-hCG + NT.\n- NIPTëŠ” screening, ì–‘ì„± ì‹œ CVS(10-13ì£¼)/amnio(15-20ì£¼)ë¡œ í™•ì§„.\n- Quad pattern: T21(hCG/inhibin Aâ†‘, AFP/estriolâ†“), T18ì€ ì „ë°˜ì  ì €í•˜."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-80","focus_area":"Rapid Recap Fetal Monitoring to Infection Transition","tags":["usmle-step2","obstetrics","recap","fetal-monitoring","deceleration","prenatal-screening"],"text":"# Rapid Recap: Fetal Monitoring Core\n1. Dating conflictëŠ” 1ë¶„ê¸° CRL ì´ˆìŒíŒŒ ìš°ì„ .\n2. Decreased fetal movementë©´ NSTë¶€í„° ì‹œì‘, non-reactiveë©´ ìê·¹ í›„ BPP.\n3. BPP 0-4ëŠ” ì¦‰ì‹œ ë¶„ë§Œ ê³ ë ¤.\n4. Variable decelì€ cord compression, late decelì€ placental insufficiency.\n5. NIPTëŠ” screeningì´ë©° ì–‘ì„± ì‹œ CVS/amnio í™•ì§„ í•„ìš”.\n6. Quadì—ì„œ T21ì€ hCG/inhibin A ìƒìŠ¹ íŒ¨í„´.\n\n## Next unit: congenital infection and vertical transmission prevention\n- í•µì‹¬ì€ ëˆ„ê°€/ì–¸ì œ ìŠ¤í¬ë¦¬ë‹í•˜ê³  ë¶„ë§Œ ì‹œ ë¬´ì—‡ì„ ê¸ˆê¸° ë˜ëŠ” ê°•í–‰í• ì§€ ê²°ì •í•˜ëŠ” ê²ƒ."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-90","focus_area":"Prenatal Infection Screening and Vaccination","tags":["usmle-step2","obstetrics","congenital-infection","screening","vaccine","gbs"],"text":"# Prenatal Infection Screening and Vaccination Logic\n## Screening strategy\n- Universal first-visit: HIV, syphilis, HBsAg, rubella/varicella immunity.\n- High-risk STIêµ°ì€ chlamydia/gonorrhea ì¶”ê°€ + 3rd trimester ì¬ê²€ ê³ ë ¤.\n- GBSëŠ” transient colonization ë•Œë¬¸ì— 36-38ì£¼ rectovaginal culture.\n\n## Vaccine rule\n| Vaccine type | Examples | Pregnancy principle |\n| --- | --- | --- |\n| Live attenuated | MMR, varicella, intranasal live flu | ì„ì‹  ì¤‘ ê¸ˆê¸°, postpartum ì ‘ì¢… |\n| Inactivated/toxoid | Tdap, HepB, inactivated flu | ì„ì‹  ì¤‘ ì‚¬ìš© ê°€ëŠ¥/ê¶Œì¥ |\n| Selected high-risk | meningococcus, pneumococcus, HepA | ìœ„í—˜ë„ ê¸°ë°˜ ì„ íƒ |\n\n## GBS management\n- GBS positive: intrapartum penicillin/ampicillin.\n- Preterm labor with unknown GBS: ê²°ê³¼ ê¸°ë‹¤ë¦¬ì§€ ë§ê³  ì¦‰ì‹œ ê²½í—˜ì  ì¹˜ë£Œ.\n\n## Congenital syphilis clue\n- snuffles, saber shins, Hutchinson teeth."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-110","focus_area":"Syphilis Rubella HSV HIV in Pregnancy","tags":["usmle-step2","obstetrics","syphilis","rubella","hsv","hiv"],"text":"# Congenital Infection: Syphilis, Rubella, HSV, HIV\n## Syphilis\n- screening: RPR/VDRL(ìœ„ì–‘ì„± ê°€ëŠ¥).\n- confirmation: treponemal test(FTA-ABS).\n- ì¹˜ë£Œ: penicillin G.\n- ì„ì‹ ë¶€ penicillin allergyë„ desensitization í›„ penicillinì´ ì›ì¹™.\n\n## Rubella\n- CRS triad: cataract, cochlear deafness, cardiac defect(PDA).\n- <16ì£¼ ê°ì—¼ì€ íƒœì•„ ìœ„í—˜ ë§¤ìš° ë†’ìŒ.\n- ë©´ì—­ ì—†ìœ¼ë©´ ì„ì‹  ì¤‘ MMR ê¸ˆê¸°, postpartum ì ‘ì¢….\n\n## HSV\n- ë¶„ë§Œ ì‹œ active genital lesion/prodrome ìˆìœ¼ë©´ C-section.\n- ì¬ë°œ ê°ì†Œë¥¼ ìœ„í•´ 36ì£¼ ì´í›„ suppressive antiviral ê³ ë ¤ ê°€ëŠ¥.\n\n## HIV\n| Viral load | Delivery | Intrapartum management |\n| --- | --- | --- |\n| >1000 copies/mL | C-section ê¶Œê³  | intrapartum zidovudine ê³ ë ¤ |\n| <1000 on ART | vaginal delivery ê°€ëŠ¥ | ART ìœ ì§€ + ë…¸ì¶œ ìµœì†Œí™” ì›ì¹™ |"}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-130","focus_area":"Intrapartum HIV Donts and Obstetric Emergency Tree","tags":["usmle-step2","obstetrics","hiv","intrapartum","iugr","twins","hydrops"],"text":"# Intrapartum HIV \"Don'ts\" + Next Pathology Tree\n## HIV intrapartum exposure minimization\n- artificial ROM ìµœì†Œí™”/íšŒí”¼.\n- fetal scalp electrode íšŒí”¼.\n- vacuum/forceps íšŒí”¼.\n- ì‹ ìƒì•„ ì§„ë‹¨ì€ maternal IgG ê°„ì„­ ë•Œë¬¸ì— í•­ì²´ê²€ì‚¬ ëŒ€ì‹  HIV DNA PCR ì‚¬ìš©.\n\n## Rapid recap points\n- congenital rubella triad, congenital syphilis signs, penicillin allergy in pregnancyëŠ” desensitization í›„ penicillin.\n- HIV viral load ê¸°ì¤€ìœ¼ë¡œ ë¶„ë§Œë²• ê²°ì •.\n- Preterm labor + unknown GBSëŠ” ì¦‰ì‹œ penicillin.\n\n## Next pathology set (Sections 5-8)\n- IUGR: placental insufficiency, umbilical artery Dopplerë¡œ ìœ„í—˜ë„ íŒë‹¨.\n- Twins: placental mass ì¦ê°€ ê´€ë ¨ í•©ë³‘ì¦ + ë¶„ë§Œ ì „ëµ.\n- IUFD: ì§„ë‹¨/ë¶„ë§Œ ì›ì¹™.\n- Hydrops: immune/non-immune ì›ì¸ ê°ë³„."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-150","focus_area":"IUGR and Twin Risk Framework","tags":["usmle-step2","obstetrics","iugr","umbilical-artery-doppler","twins","preeclampsia"],"text":"# Sections 5-8 Entry: IUGR and Twin Complications\n## IUGR algorithm\n- 32ì£¼ + chronic HTN + fundal lagì—ì„œëŠ” IUGR ìš°ì„  í‰ê°€.\n- US/BPP í›„ í•µì‹¬ì€ umbilical artery Doppler.\n- ì €í•­ ì¦ê°€ ì†Œê²¬: reduced -> absent -> reverse end-diastolic flow ìˆœìœ¼ë¡œ ì•…í™”.\n- Reverse end-diastolic flowëŠ” íƒœì•„ ì €ì‚°ì†Œì¦ ê³ ìœ„í—˜ìœ¼ë¡œ ì¦‰ì‹œ ë¶„ë§Œ(ëŒ€ê°œ C-section) ê³ ë ¤.\n\n## Why oligohydramnios in placental insufficiency\n- brain-sparingìœ¼ë¡œ ì‹ ì¥ í˜ˆë¥˜ ê°ì†Œ -> fetal urine ê°ì†Œ -> oligohydramnios.\n\n## Twins high-yield physiology\n- placental mass ì¦ê°€ë¡œ hyperemesis(hCGâ†‘), preeclampsia ìœ„í—˜ ìƒìŠ¹.\n- ë¶„ë§Œ ì „ëµì€ ì œì‹œë¶€/ì²«ì§¸ íƒœì•„ ìœ„ì¹˜ì™€ ì‚°ëª¨-íƒœì•„ ìƒíƒœ ê¸°ë°˜ìœ¼ë¡œ ê²°ì •."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-170","focus_area":"Twin Delivery IUFD and Hydrops Framework","tags":["usmle-step2","obstetrics","twins","iufd","hydrops"],"text":"# Twin Delivery Rules + IUFD + Hydrops Basics\n## Twin delivery\n- Twin A presentationì´ ë¶„ë§Œ ì „ëµ ê²°ì •.\n- Twinsì—ì„œëŠ” ECV ê¸ˆê¸°(placental abruption/cord complication ìœ„í—˜).\n- Vasa previaëŠ” ë§‰ íŒŒì—´ ì‹œ fetal exsanguination ìœ„í—˜ìœ¼ë¡œ ì¦‰ì‹œ C-section.\n\n## IUFD\n- í™•ì§„: real-time ultrasoundë¡œ cardiac activity ë¶€ì¬ í™•ì¸.\n- ê¸°ë³¸ ê´€ë¦¬: ìœ ë„ë¶„ë§Œ í†µí•œ vaginal delivery ì„ í˜¸(ë¯¸ë˜ ì„ì‹ ì˜ uterine scar risk ìµœì†Œí™”).\n- ì˜ˆì™¸ì  ìˆ˜ìˆ  ì ì‘ì¦: classical scar, placenta previa, ì‚°ëª¨ ì‘ê¸‰ìƒí™©.\n- ì¥ê¸° ì§€ì—° ìœ„í—˜: retained fetusë¡œ DIC ê°€ëŠ¥.\n\n## Hydrops fetalis\n- 2ê°œ ì´ìƒ compartment fluid accumulation(skin edema/ascites/effusion).\n- severe anemia -> high-output cardiac failure -> generalized edema."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-190","focus_area":"Hydrops Etiology and HTN Disorders Intro","tags":["usmle-step2","obstetrics","hydrops","rh-incompatibility","preeclampsia"],"text":"# Hydrops Causes and Hypertensive Disorders Entry\n## Hydrops causes\n- Immune: Rh incompatibility(hemolysis).\n- Non-immune(í˜„ëŒ€ì— ë” í”í•¨): parvovirus B19(erythroid suppression), alpha-thalassemia major(Hb Barts), ì¼ë¶€ ì—¼ìƒ‰ì²´/êµ¬ì¡° ì´ìƒ.\n\n## Rapid recap points\n1. IUGR + reverse end-diastolic flow -> ì¦‰ì‹œ ë¶„ë§Œ ê³ ë ¤.\n2. Twin A breech in twins -> ìˆ˜ìˆ ë¶„ë§Œ ìš°ì„ .\n3. IUFD ì§„ë‹¨ì€ ì‹¤ì‹œê°„ ì´ˆìŒíŒŒ.\n4. IUFDëŠ” ì‚°ëª¨ ë¯¸ë˜ ìœ„í—˜ ìµœì†Œí™” ê´€ì ìœ¼ë¡œ ìœ ë„ë¶„ë§Œ ìš°ì„ .\n5. Hydrops í•µì‹¬ë³‘íƒœëŠ” severe fetal anemia.\n\n## Hypertensive disorders core frame\n- 20ì£¼ ì´ì „ ê³ í˜ˆì••ì€ chronic HTN ê°€ëŠ¥ì„±.\n- 20ì£¼ ì´í›„ placenta-related disease spectrum(gestational HTN, preeclampsia, eclampsia)ë¡œ ì ‘ê·¼."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-210","focus_area":"Hypertensive Disorder Classification and Severe Features","tags":["usmle-step2","obstetrics","hypertension","preeclampsia","eclampsia"],"text":"# Hypertensive Disorders in Pregnancy: Classification and Severe Features\n| Disorder | Timing | Key finding |\n| --- | --- | --- |\n| Chronic HTN | <20ì£¼ ë˜ëŠ” ì„ì‹  ì „ë¶€í„° | baseline HTN |\n| Gestational HTN | >=20ì£¼ | HTN only, proteinuria/end-organ ì—†ìŒ |\n| Preeclampsia | >=20ì£¼ | HTN + proteinuria ë˜ëŠ” end-organ damage |\n| Superimposed preeclampsia | chronic HTN ìœ„ì— ë°œìƒ | BP ì•…í™”/ìƒˆ ë‹¨ë°±ë‡¨/ì¥ê¸°ì†ìƒ |\n| Eclampsia | preeclampsia with seizure | ê²½ë ¨ ë™ë°˜ |\n\n## Severe features\n- BP >=160/110.\n- platelet <100k.\n- LFT ìƒìŠ¹ ë˜ëŠ” ì‹¬í•œ RUQ/epigastric pain.\n- Cr >1.1 ë˜ëŠ” baselineì˜ 2ë°°.\n- pulmonary edema.\n- ì§€ì† ë‘í†µ/ì‹œì•¼ì¦ìƒ.\n\n## Eclampsia acute priorities\n1. magnesium sulfate.\n2. ì‚°ëª¨ ì•ˆì •í™”(airway/positioning).\n3. ì•ˆì • í›„ ë¶„ë§Œ."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-230","focus_area":"Preeclampsia Pharmacology HELLP and AFLP","tags":["usmle-step2","obstetrics","magnesium","hellp","aflp"],"text":"# Management of Severe Preeclampsia and Hepatic Mimics\n## Antihypertensives in pregnancy\n- labetalol, hydralazine, nifedipine ì‚¬ìš©.\n- ACEi/ARB ê¸ˆê¸°.\n\n## Magnesium sulfate\n- ëª©ì : seizure prophylaxis(í˜ˆì••ì•½ ì•„ë‹˜).\n- ë…ì„± ì§„í–‰: DTR ì†Œì‹¤ -> í˜¸í¡ì €í•˜ -> ì‹¬ì •ì§€.\n- í•´ë…ì œ: calcium gluconate.\n- ì£¼ì˜: myasthenia gravis, renal failure.\n\n## Fluid principle\n- intravascularly dry but extravascular edema ìƒíƒœ ê°€ëŠ¥.\n- diureticì€ íë¶€ì¢… ë“± ì„ íƒì  ìƒí™©ì—ì„œë§Œ ì‚¬ìš©.\n\n## HELLP\n- hemolysis + elevated liver enzymes + low platelets.\n- definitive managementëŠ” ë¶„ë§Œ.\n\n## AFLP vs HELLP\n- AFLPëŠ” ê°„ í•©ì„±ê¸°ëŠ¥ ì €í•˜(ì €í˜ˆë‹¹, INR/PT ì—°ì¥, ì•”ëª¨ë‹ˆì•„ ìƒìŠ¹) ë‹¨ì„œê°€ ë” ëšœë ·."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-245","focus_area":"Rapid Recap Severe HTN Disorders","tags":["usmle-step2","obstetrics","recap","preeclampsia","hellp"],"text":"# Rapid Recap: Hypertensive Emergencies\n1. 20ì£¼ ì´ì „ HTNì€ chronic HTN ìš°ì„ .\n2. 160/110 + ë‘í†µ/ë‹¨ë°±ë‡¨ëŠ” severe preeclampsiaë¡œ ì¦‰ì‹œ ì•ˆì •í™” í›„ ë¶„ë§Œ ê³„íš.\n3. Mg ì‚¬ìš© ì¤‘ DTR ì†Œì‹¤/í˜¸í¡ì €í•˜ëŠ” magnesium toxicity, calcium gluconate íˆ¬ì—¬.\n4. RUQ pain + thrombocytopeniaëŠ” HELLP ì˜ì‹¬.\n5. ì €í˜ˆë‹¹ + coagulopathyëŠ” AFLP ìª½ ë‹¨ì„œ."}
{"subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-255","focus_area":"AFLP Clinical Scenario","tags":["usmle-step2","obstetrics","aflp","liver-failure"],"text":"# AFLP Scenario Anchor\n- 3ë¶„ê¸° ì‚°ëª¨ì˜ nausea/vomiting + jaundice + hypoglycemia + INR ìƒìŠ¹ì€ AFLPë¥¼ ê°•í•˜ê²Œ ì‹œì‚¬.\n- managementëŠ” ì‚°ëª¨ ì•ˆì •í™”(í¬ë„ë‹¹/ì‘ê³ ê´€ë¦¬)ì™€ ì‹ ì†í•œ ë¶„ë§Œ."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-1","focus_area":"Gestational Diabetes Screening Diagnosis","tags":["usmle-step2","obstetrics","gdm","screening","gtt"],"text":"# Gestational Diabetes: Screening and Diagnostic Algorithm\n## Pathophysiology\n- placental hormone(HPL) ì¦ê°€ë¡œ maternal insulin resistanceê°€ í›„ê¸° ì„ì‹ ì—ì„œ ì¦ê°€.\n\n## Who and when to screen\n- ê¸°ë³¸: 24-28ì£¼.\n- ê³ ìœ„í—˜(ë¹„ë§Œ + ìœ„í—˜ì¸ì)ì—ì„œëŠ” ì²« ë°©ë¬¸ ì¦‰ì‹œ ê²€ì‚¬ í›„, ì´ˆê¸° ìŒì„±ì´ì–´ë„ 24-28ì£¼ ì¬ê²€.\n\n## Two-step test\n| Step | Test | Rule |\n| --- | --- | --- |\n| 1 | 50g GCT(non-fasting) | 1ì‹œê°„ ê°’ >=140ì´ë©´ step 2 |\n| 2 | 100g OGTT(fasting) | ê³µë³µ/1h/2h/3h ì¤‘ 2ê°œ ì´ìƒ ì´ìƒì´ë©´ GDM |\n\n## Carpenter-Coustan cutoffs\n- Fasting 95, 1h 180, 2h 155, 3h 140."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-21","focus_area":"GDM Management and Complications","tags":["usmle-step2","obstetrics","gdm","insulin","neonatal-complications"],"text":"# GDM Management and Maternal-Fetal Complications\n## Treatment hierarchy\n- 1ì°¨: ì‹ì´/ìš´ë™ + glucose monitoring.\n- ëª©í‘œ: fasting <=95, 1h postprandial <=140, 2h <=120.\n- ì¡°ì ˆ ì‹¤íŒ¨ ì‹œ insulinì´ ë³´ë“œ ê¸°ì¤€ 1ìˆœìœ„(placenta í†µê³¼ ì•ˆ í•¨).\n\n## Complications by timing\n- ì„ì‹  ì´ˆê¸° ê³ í˜ˆë‹¹(ëŒ€ê°œ pre-existing DM): congenital anomaly risk(ì˜ˆ: caudal regression).\n- GDM í›„ê¸° ì˜í–¥: fetal hyperinsulinemia -> macrosomia, shoulder dystocia.\n\n## Neonatal\n- hypoglycemia, polycythemia, jaundice, hypocalcemia/hypomagnesemia, RDS risk ì¦ê°€.\n- ì¼ë¶€ëŠ” transient hypertrophic cardiomyopathy ë™ë°˜ ê°€ëŠ¥.\n\n## Postpartum\n- 6-12ì£¼ 75g 2h OGTTë¡œ ì¬í‰ê°€, ì¥ê¸°ì  T2DM ì¶”ì  í•„ìš”."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-41","focus_area":"Rapid Recap GDM and Labor Transition","tags":["usmle-step2","obstetrics","recap","gdm","labor"],"text":"# Rapid Recap: GDM Essentials\n| Scenario | Interpretation | Action |\n| --- | --- | --- |\n| BMI ë†’ê³  GDM ê³¼ê±°ë ¥ | high-risk pregnancy | ì²« ë°©ë¬¸ ì¦‰ì‹œ GDM screen |\n| 50g GCT >=140 | screen positive | 100g OGTT ì§„í–‰ |\n| OGTT 2ê°œ ì´ìƒ ì´ìƒ | GDM í™•ì§„ | lifestyle -> í•„ìš” ì‹œ insulin |\n| ì„ì‹  ì¤‘ ì¡°ì ˆë¶ˆëŸ‰ ê³ í˜ˆë‹¹ | macrosomia/shoulder dystocia ìœ„í—˜ | ë¶„ë§Œê³„íš ì‹œ ë‚œì‚° ëŒ€ë¹„ |\n| ì‚°í›„ í‰ê°€ | T2DM ê³ ìœ„í—˜êµ° | 6-12ì£¼ 75g OGTT |\n\n## Next unit\n- labor timing(too early vs too late)ê³¼ ì¶œí˜ˆ ì‘ê¸‰ ë¶„ê¸°."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-51","focus_area":"Preterm Labor Zones and Deceleration Logic","tags":["usmle-step2","obstetrics","preterm-labor","tocolysis","deceleration"],"text":"# Preterm Labor Zone Strategy and FHR Pattern Logic\n## Preterm labor diagnosis\n- ê·œì¹™ì  ìˆ˜ì¶• + cervical changeê°€ í•¨ê»˜ ìˆì–´ì•¼ ì§„ë‹¨.\n\n## Gestational age-based strategy\n| Zone | GA | Management highlights |\n| --- | --- | --- |\n| Zone 1 | <32ì£¼ | magnesium(neuroprotection) + indomethacin + steroid + GBS coverage |\n| Zone 2 | 32-34ì£¼ | nifedipine ì¤‘ì‹¬, indomethacin ì¥ê¸° ì‚¬ìš© íšŒí”¼(ductus closure risk) |\n| Zone 3 | 34-37ì£¼ | tocolysis ì´ë“ ë‚®ì•„ ë¶„ë§Œ ì§„í–‰ í—ˆìš© |\n\n## Deceleration\n- Early: head compression(ëŒ€ê°œ ìƒë¦¬ì ).\n- Variable: cord compression(V/W shape, low fluid/ROM ê´€ë ¨)."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-71","focus_area":"Breech ECV Shoulder Dystocia Postterm","tags":["usmle-step2","obstetrics","breech","ecv","shoulder-dystocia","postterm"],"text":"# Breech, ECV, Shoulder Dystocia, and Postterm Management\n## Breech with non-viable fetus\n- non-viable ìƒíƒœì—ì„œëŠ” ì‚°ëª¨ ìœ„í—˜ ìµœì†Œí™”ë¥¼ ìœ„í•´ vaginal delivery ì„ íƒ ê°€ëŠ¥.\n\n## ECV\n- 37ì£¼ ì „í›„ selected caseì—ì„œ ê³ ë ¤.\n- rupture of membranes, fetal distress ë“±ì€ ê¸ˆê¸°.\n\n## Internal podalic version\n- twin A ë¶„ë§Œ í›„ twin B ì¡°ì‘ì— ì œí•œì ìœ¼ë¡œ ì‚¬ìš©.\n\n## Shoulder dystocia\n- turtle signì€ ì¦‰ì‹œ ì‚°ê³¼ì  ì‘ê¸‰ì²˜ì¹˜ í•„ìš”.\n- ìœ„í—˜ì¸ì: macrosomia(GDM/postterm).\n\n## Postterm\n- 41ì£¼ ì´í›„ íƒœë°˜ ê¸°ëŠ¥ ì €í•˜ì™€ oligohydramnios/cord compression ìœ„í—˜ ì¦ê°€.\n- 41-42ì£¼ ì‚¬ì´ ìœ ë„ë¶„ë§Œ ê³ ë ¤, ë¬´ê¸°í•œ ëŒ€ê¸° ê¸ˆì§€."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-88","focus_area":"Rapid Recap Preterm to Third Trimester Bleed","tags":["usmle-step2","obstetrics","recap","preterm-labor","postterm","third-trimester-bleeding"],"text":"# Rapid Recap: Labor Timing and Bleeding Entry\n| Scenario | Key point | Action |\n| --- | --- | --- |\n| 29ì£¼ preterm labor | zone 1 | neuroprotection + tocolysis + steroid |\n| 33ì£¼ labor | zone 2 | nifedipine ì¤‘ì‹¬ ì „í™˜ |\n| deep variable decel | cord compression | maternal reposition, fluid/context êµì • |\n| postterm physiology | placental aging | oligohydramnios/ë‚œì‚°/ì‚¬ì‚° ìœ„í—˜ í‰ê°€ |\n\n## Next unit\n- third-trimester bleedingì€ pain vs painless, uterine tone, fetal statusë¡œ ì¦‰ì‹œ ë¶„ê¸°."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-98","focus_area":"Third Trimester Bleeding Differential and Management","tags":["usmle-step2","obstetrics","placenta-previa","vasa-previa","abruption","uterine-rupture"],"text":"# Third Trimester Bleeding: Previa vs Vasa vs Rupture vs Abruption\n## First split: painful vs painless + uterine tone\n- soft/painless uterusëŠ” previa/vasa ìª½.\n- board-like painful uterusëŠ” abruption/rupture ìª½ ì‘ê¸‰.\n\n## Placenta previa\n- painless bleeding + soft uterus.\n- ë””ì§€í„¸ ì§ˆê²€ì‚¬ ê¸ˆì§€.\n- ì§„ë‹¨ì€ ultrasound, ë¶„ë§Œì€ ê³„íš C-section(ë³´í†µ 36-37ì£¼ ì „í›„).\n\n## Vasa previa\n- ROM ì§í›„ ì¶œí˜ˆ + fetal bradycardia/sinusoidalì´ë©´ fetal blood loss ì˜ì‹¬.\n- ì¦‰ì‹œ C-section.\n\n## Uterine rupture\n- TOLAC ì¤‘ sudden tearing pain, contraction ì†Œì‹¤, fetal station loss.\n- ì¦‰ì‹œ laparotomy/ì‘ê¸‰ìˆ˜ìˆ .\n\n## Placental abruption\n- painful bleeding, hypertonic uterus, concealed hemorrhage ê°€ëŠ¥.\n- ì§„ë‹¨ì€ ì„ìƒ ì¤‘ì‹¬(US ìŒì„±ì´ì–´ë„ ë°°ì œ ë¶ˆê°€).\n- fibrinogen ì €í•˜/DIC ìœ„í—˜ ëª¨ë‹ˆí„°ë§.\n- ì•ˆì • ì‹œ vaginal delivery ê°€ëŠ¥, ë¶ˆì•ˆì •/íƒœì•„ê³¤ë€ ì‹œ operative delivery."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-118","focus_area":"Rapid Recap Third Trimester Bleeding Emergencies","tags":["usmle-step2","obstetrics","recap","placenta-previa","abruption","uterine-rupture"],"text":"# Rapid Recap: Third Trimester Bleeding Differentiation\n| Scenario | Most likely diagnosis | Key action |\n| --- | --- | --- |\n| Painful bleeding + loss of station + uterine scar history | Uterine rupture | Immediate laparotomy |\n| Painless bleeding + soft uterus + prior C-section | Placenta previa | No digital exam, US confirmation, planned C-section |\n| ROM + painless bleeding + fetal brady/sinusoidal | Vasa previa | Emergency C-section |\n| Painful rigid uterus + HTN/cocaine/trauma | Placental abruption | Clinical diagnosis, DIC/fibrinogen monitoring, delivery per stability |\n\n- 3ë¶„ê¸° ì¶œí˜ˆì—ì„œëŠ” uterine toneê³¼ fetal tracingì´ ì´ˆê¸° ê²½ê³  ì‹ í˜¸."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-128","focus_area":"PPROM Chorio Miscarriage RPL Framework","tags":["usmle-step2","obstetrics","pprom","chorioamnionitis","miscarriage","rpl"],"text":"# Sections 13-16 Framework: PPROM, Chorio, Miscarriage, RPL\n## PPROM\n- ì§„ë‹¨: sterile speculumì—ì„œ pooling/nitrazine/ferning.\n- <34ì£¼ ì•ˆì •: latency management(antibiotics + steroid + neuroprotection).\n- >=34ì£¼ ë˜ëŠ” ê°ì—¼/íƒœì•„ê³¤ë€: ì¦‰ì‹œ ë¶„ë§Œ.\n\n## Chorioamnionitis\n- maternal fever + fetal tachycardia ì¤‘ì‹¬ì˜ ì„ìƒì§„ë‹¨.\n- í•­ìƒì œ í›„ ë¶„ë§Œ, íŠ¹ë³„í•œ ì‚°ê³¼ì  ì ì‘ì¦ ì—†ìœ¼ë©´ vaginal delivery ìš°ì„ .\n\n## Early loss and recurrent loss\n- <20ì£¼ ìœ ì‚°ì€ cervical os(open/closed)ì™€ US ì†Œê²¬ìœ¼ë¡œ ë¶„ë¥˜.\n- recurrent lossëŠ” í•´ë¶€í•™/ìœ ì „/APS/ë‚´ë¶„ë¹„ ì›ì¸ ìˆœì„œë¡œ í‰ê°€."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-148","focus_area":"Miscarriage Classification and Recurrent Loss Workup","tags":["usmle-step2","obstetrics","miscarriage","septic-abortion","aps","recurrent-pregnancy-loss"],"text":"# Miscarriage Spectrum and Recurrent Pregnancy Loss\n| Type | Cervical os | Core finding | Initial management |\n| --- | --- | --- | --- |\n| Threatened | Closed | bleeding + viable heartbeat | ê¸°ëŒ€/ì•ˆì •ê³¼ ì¶”ì  |\n| Inevitable | Open | ì§„í–‰ ì¤‘ ìœ ì‚° | expectant/medical/surgical ì˜µì…˜ |\n| Incomplete | Open | retained products ì¼ë¶€ ì”ì¡´ | misoprostol ë˜ëŠ” suction D&C |\n| Complete | Closed | uterus empty + ì¶œí˜ˆ ê°ì†Œ | ì¶”ê°€ ì²˜ì¹˜ ë³´í†µ ë¶ˆí•„ìš” |\n| Missed | Closed | nonviable embryo without expulsion | medical/surgical evacuation ê³ ë ¤ |\n| Septic | ëŒ€ê°œ open | fever/purulence + retained tissue | broad antibiotics + urgent D&C |\n\n## Recurrent pregnancy loss(>=3 losses)\n- Structural: septum/submucosal fibroid/polyp.\n- Genetic: parental balanced translocation.\n- Immunologic: APS(heparin + aspirin).\n- Endocrine: thyroid, diabetes, prolactin ì´ìƒ êµì •."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-160","focus_area":"Rapid Recap PPROM Chorio Miscarriage to Ectopic Transition","tags":["usmle-step2","obstetrics","recap","pprom","chorioamnionitis","ectopic-pregnancy"],"text":"# Rapid Recap: PPROM/Chorio/Miscarriage\n| Scenario | Diagnosis | Key action |\n| --- | --- | --- |\n| 33ì£¼ ROM, ì•ˆì • | PPROM <34ì£¼ | antibiotics + steroid + magnesium, latency management |\n| 35ì£¼ ROM | PPROM >=34ì£¼ | ë¶„ë§Œ ì§„í–‰ |\n| fever + fetal tachy + uterine tenderness | Chorioamnionitis | ampicillin+gentamicin + vaginal delivery ìœ ë„ |\n| os closed + fetal heartbeat | Threatened abortion | expectant care |\n| septic abortion ì†Œê²¬ | Septic abortion | broad Abx + suction D&C |\n| recurrent 1st-trimester losses | RPL | APS í¬í•¨ ì›ì¸í‰ê°€ í›„ í‘œì ì¹˜ë£Œ |\n\n## Next unit\n- ectopic pregnancyëŠ” hemodynamic stabilityê°€ 1ì°¨ ë¶„ê¸°."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-170","focus_area":"Ectopic Pregnancy Core Algorithm","tags":["usmle-step2","obstetrics","ectopic-pregnancy","hemodynamic-stability","tvus","hcg"],"text":"# Ectopic Pregnancy: Stability-First Algorithm\n## Step 0\n- ìƒë¦¬ì§€ì—° + ë³µí†µ/ì¶œí˜ˆ í™˜ìì—ì„œ hemodynamic stability ë¨¼ì € íŒë‹¨.\n- unstableì´ë©´ ê²€ì‚¬ ì§€ì—° ì—†ì´ OR.\n\n## Sites and risk\n- ëŒ€ë¶€ë¶„ tubal(ampulla ìš°ì„¸).\n- cornual/interstitialëŠ” ëŠ¦ê²Œ íŒŒì—´í•˜ë©° ì¶œí˜ˆ ëŒ€ëŸ‰ ìœ„í—˜.\n- ìœ„í—˜ì¸ì: prior ectopic, tubal/pelvic surgery, PID.\n\n## Diagnostic flow in stable patient\n- TVUSë¡œ IUP í™•ì¸ ì‹œ ectopic ê°€ëŠ¥ì„± í¬ê²Œ ê°ì†Œ.\n- empty uterus + adnexal massë©´ ectopic ì§„ë‹¨ ê°€ëŠ¥.\n- empty uterus + mass ì—†ìŒì´ë©´ PULë¡œ beta-hCG ì¶”ì  ë° ì¬ì˜ìƒ."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-190","focus_area":"Ectopic Gray Zone hCG DnC and Treatment","tags":["usmle-step2","obstetrics","ectopic-pregnancy","methotrexate","laparoscopy","dnc"],"text":"# Ectopic Gray Zone: hCG Trend, D&C, and Treatment Choice\n## Discriminatory zone logic\n- TVUS ê¸°ì¤€ hCG ì•½ 3500 ì´ìƒì¸ë° empty uterusë©´ ectopic ê°•ì˜ì‹¬.\n- 3500 ë¯¸ë§Œ empty uterusëŠ” 48ì‹œê°„ beta-hCG ì¬ì¸¡ì •ìœ¼ë¡œ ì¶”ì .\n- ì •ìƒ IUPëŠ” ì¦ê°€ í­ì´ ì¶©ë¶„í•˜ê³ , ectopicì€ plateau/slow riseê°€ í”í•¨.\n\n## Diagnostic D&C role\n- D&C í›„ hCG ê¸‰ê°í•˜ë©´ failed IUP ê°€ëŠ¥.\n- hCGê°€ ìœ ì§€/ìƒìŠ¹í•˜ë©´ ectopic ê°€ëŠ¥ì„±ì´ ë†’ì•„ ì¦‰ì‹œ ì¹˜ë£Œ.\n\n## Treatment\n- unstable/ruptured/MTX ê¸ˆê¸°: ìˆ˜ìˆ (laparoscopy/laparotomy).\n- stable + ì¡°ê±´ ì¶©ì¡± ì‹œ MTX ê°€ëŠ¥(hCG ë‚®ê³  mass ì‘ê³  fetal cardiac activity ì—†ìŒ ë“±).\n- MTX í›„ day4/day7 hCG ê°ì†Œ(>=15%) í™•ì¸, ì‹¤íŒ¨ ì‹œ ì¶”ê°€ MTX ë˜ëŠ” ìˆ˜ìˆ ."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-210","focus_area":"Rapid Recap Ectopic Decision Points","tags":["usmle-step2","obstetrics","recap","ectopic-pregnancy","methotrexate","surgery"],"text":"# Rapid Recap: Ectopic Decision Table\n| Vignette | Interpretation | Action |\n| --- | --- | --- |\n| unstable + positive hCG + peritoneal signs | ruptured ectopic ê°€ëŠ¥ | ì¦‰ì‹œ ìˆ˜ìˆ  |\n| empty uterus + hCG > DZ | ectopic ê³ ì˜ì‹¬ | MTX ì í•©ì„± í‰ê°€ ë˜ëŠ” ìˆ˜ìˆ  |\n| empty uterus + hCG < DZ | PUL | 48h hCG/US ì¶”ì  |\n| hCG plateau/slow rise | abnormal pregnancy/ectopic | ì¶”ê°€ í‰ê°€(D&C í¬í•¨) í›„ ì¹˜ë£Œ |\n| MTX contraindication(renal/hepatic/blood disorder ë“±) | MTX ë¶ˆê°€ | ìˆ˜ìˆ  ìš°ì„  |\n| cornual ectopic | íŒŒì—´ ì‹œ ëŒ€ëŸ‰ì¶œí˜ˆ ìœ„í—˜ | ê³ ìœ„í—˜ ìˆ˜ìˆ ì  ì ‘ê·¼ ê³ ë ¤ |"}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-220","focus_area":"Molar Pregnancy and GTN Surveillance","tags":["usmle-step2","obstetrics","molar-pregnancy","gtn","hcg-surveillance"],"text":"# Molar Pregnancy and GTN Surveillance\n## Clinical clues\n- uterus larger than dates, severe hyperemesis, vaginal bleeding.\n- 20ì£¼ ì´ì „ preeclampsiaëŠ” mole ê°•ë ¥ ë‹¨ì„œ.\n\n## Diagnosis and initial treatment\n- US: snowstorm/grape-like pattern.\n- ì¦‰ì‹œ suction D&C.\n\n## Post-evacuation surveillance\n- weekly beta-hCG until zero.\n- ì´í›„ monthly beta-hCG for 6 months.\n- ì¶”ì  ê¸°ê°„ reliable contraception í•„ìˆ˜(ì¬ì„ì‹ ê³¼ ì¬ë°œ êµ¬ë¶„ ìœ„í•´)."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-240","focus_area":"Choriocarcinoma and Hyperemesis Gravidarum","tags":["usmle-step2","obstetrics","choriocarcinoma","hyperemesis-gravidarum","thiamine"],"text":"# Choriocarcinoma and Hyperemesis Gravidarum\n## Choriocarcinoma\n- postpartum irregular bleeding + lung nodules(cannonball) + ë§¤ìš° ë†’ì€ hCG.\n- hematogenous spread(í ì „ì´ í”í•¨), vaginal vascular lesionì€ biopsy ê¸ˆê¸°(ì¶œí˜ˆ ìœ„í—˜).\n- ì¹˜ë£ŒëŠ” chemotherapyê°€ í•µì‹¬ì´ë©° ì˜ˆí›„ê°€ ë¹„êµì  ì¢‹ìŒ.\n\n## Hyperemesis gravidarum\n- ì‹¬í•œ ì§€ì† êµ¬í†  + ì„ì‹ ì „ ì²´ì¤‘ ëŒ€ë¹„ >5% ê°ì†Œ + ketonuria.\n- ëŒ€ì‚¬ì´ìƒ: hypochloremic metabolic alkalosis + hypokalemia.\n- ì¹˜ë£Œ: ì…ì› ìˆ˜ì•¡/í•­êµ¬í† , thiamineì„ glucoseë³´ë‹¤ ë¨¼ì € ë˜ëŠ” ë™ì‹œ íˆ¬ì—¬í•´ Wernicke ì˜ˆë°©."}
{"subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-260","focus_area":"Rapid Recap Mole Choriocarcinoma Hyperemesis","tags":["usmle-step2","obstetrics","recap","molar-pregnancy","choriocarcinoma","hyperemesis-gravidarum"],"text":"# Rapid Recap: Mole/Choriocarcinoma/Hyperemesis\n1. 20ì£¼ ì´ì „ preeclampsia + large uterus + bleeding -> molar pregnancy ì˜ì‹¬.\n2. Mole ì¹˜ë£Œ í›„ hCGëŠ” zeroê¹Œì§€ ì£¼ê°„ ì¶”ì , ì´í›„ ì›”ê°„ ì¶”ì  + í”¼ì„ í•„ìˆ˜.\n3. ì‚°í›„ ì¶œí˜ˆ + í ë³‘ë³€ + hCG ê³ ìˆ˜ì¹˜ -> choriocarcinoma.\n4. HyperemesisëŠ” >5% ì²´ì¤‘ê°ì†Œì™€ ketonuriaê°€ ì§„ë‹¨ ë‹¨ì„œ.\n5. Hyperemesis ì²˜ì¹˜ì—ì„œ thiamine ì„ íˆ¬ì—¬ ì›ì¹™."}
{"subject":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","page_title":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","episode":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","section_path":["LM_obs3 2f646f2986ee80daa439daec387f9ad7"],"source_doc_id":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs3 2f646f2986ee80daa439daec387f9ad7-1","focus_area":"Postpartum Physiology and Normal vs Emergency","tags":["usmle-step2","obstetrics","postpartum","physiology","lochia","involution"],"text":"# Postpartum Period: Normal Physiologic Changes vs Emergencies\n## Normal but alarming findings\n- postpartum rigors/chillsëŠ” vitals ì•ˆì • ì‹œ ìƒë¦¬ì  ë³€í™”ì¼ ìˆ˜ ìˆìŒ.\n- 24-48ì‹œê°„ fluid mobilizationìœ¼ë¡œ edemaì™€ diuresisê°€ ë‚˜íƒ€ë‚  ìˆ˜ ìˆìŒ.\n- lochia progression: rubra -> serosa -> alba.\n\n## Red flag threshold\n- ì‹œê°„ë‹¹ íŒ¨ë“œ 1ì¥ ì´ìƒ ì ì‹œëŠ” ì¶œí˜ˆì€ PPH í‰ê°€ í•„ìš”.\n- postpartum careì˜ í•µì‹¬ì€ reassureì™€ emergency actionì„ êµ¬ë¶„í•˜ëŠ” ê²ƒ."}
{"subject":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","page_title":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","episode":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","section_path":["LM_obs3 2f646f2986ee80daa439daec387f9ad7"],"source_doc_id":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs3 2f646f2986ee80daa439daec387f9ad7-21","focus_area":"Postpartum Checklist PPH Endometritis and GDM Followup","tags":["usmle-step2","obstetrics","postpartum-hemorrhage","endometritis","gdm-followup"],"text":"# Postpartum Checklist and Complications\n| Check point | Core clinical meaning |\n| --- | --- |\n| Fundus tone | boggy uterusë©´ uterine atony(ê°€ì¥ í”í•œ PPH ì›ì¸) |\n| Voiding status | retention/overflow incontinence ì¡°ê¸° í™•ì¸ |\n\n## Key complications\n- Firm uterus + ongoing bleedingì€ genital tract laceration ì˜ì‹¬.\n- Fever + uterine tendernessëŠ” postpartum endometritis ì˜ì‹¬.\n- Severe bladder distension/dribblingì€ overflow incontinenceë¡œ catheterization ìš°ì„ .\n\n## GDM postpartum protocol\n- 24-72h fasting glucose ì²´í¬.\n- 6-12ì£¼ 75g OGTTë¡œ T2DM ìœ„í—˜ ì¬í‰ê°€.\n\n## Delayed zebra\n- ì‚°í›„ ìˆ˜ê°œì›” í›„ ë¶ˆê·œì¹™ ì¶œí˜ˆ + íê²°ì ˆì€ choriocarcinoma ê°ë³„."}
{"subject":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","page_title":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","episode":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","section_path":["LM_obs3 2f646f2986ee80daa439daec387f9ad7"],"source_doc_id":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_obs3 2f646f2986ee80daa439daec387f9ad7-39","focus_area":"Rapid Recap Postpartum Core and Next Unit Entry","tags":["usmle-step2","obstetrics","recap","postpartum","pph","endometritis"],"text":"# Rapid Recap: Postpartum Core\n| Scenario | Interpretation | Action |\n| --- | --- | --- |\n| ì¦‰ì‹œ ì‚°í›„ ì˜¤í•œ/ë–¨ë¦¼, vital ì•ˆì • | physiologic rigors ê°€ëŠ¥ | ë³´ì˜¨ + ê´€ì°° |\n| boggy fundus + ì¶œí˜ˆ | uterine atony | fundal massage/PPH protocol |\n| firm fundus + ì¶œí˜ˆ ì§€ì† | laceration ê°€ëŠ¥ | ì‚°ë„ í™•ì¸ ë° ìˆ˜ë³µ |\n| dribbling + distended bladder | overflow retention | intermittent catheterization |\n| fever + uterine tenderness | endometritis | í•­ìƒì œ ì¹˜ë£Œ |\n| ì‚°í›„ GDM ì´ë ¥ | future T2DM risk | 6-12ì£¼ 75g OGTT |\n| ì‚°í›„ ìˆ˜ê°œì›” ì¶œí˜ˆ + lung lesions | choriocarcinoma ê°€ëŠ¥ | beta-hCG ì¤‘ì‹¬ í‰ê°€ |\n\n## Next block\n- ì„ì‹  ì¤‘ liver/psychiatric/social high-yield ê°ë³„."}
{"subject":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","page_title":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","episode":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","section_path":["LM_obs3 2f646f2986ee80daa439daec387f9ad7"],"source_doc_id":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs3 2f646f2986ee80daa439daec387f9ad7-49","focus_area":"Pregnancy Liver Disorders ICP HELLP AFLP","tags":["usmle-step2","obstetrics","icp","hellp","aflp","liver-disorder"],"text":"# Liver Disorders in Late Pregnancy: ICP vs HELLP vs AFLP\n## ICP\n- í•µì‹¬ ì¦ìƒ: ì†ë°”ë‹¥/ë°œë°”ë‹¥ ì‹¬í•œ ì†Œì–‘ê°, ë°œì§„ ì—†ìŒ.\n- bile acid ìƒìŠ¹(ë³´í†µ >10), ê²½ë„ transaminitis ê°€ëŠ¥.\n- íƒœì•„ ìœ„í—˜(IUFD) ë•Œë¬¸ì— 37ì£¼ ë¶„ë§Œ ì „ëµ.\n- ì•½ë¬¼: ursodeoxycholic acid.\n\n## HELLP\n- hemolysis + elevated liver enzymes + low platelets.\n- RUQ/epigastric pain, preeclampsia ë§¥ë½ì—ì„œ ì‘ê¸‰.\n- ì‚°ëª¨ ì•ˆì •í™”(MgSO4, BP control) í›„ ì¦‰ì‹œ ë¶„ë§Œ.\n\n## AFLP\n- jaundice/vomiting/encephalopathy + hypoglycemia.\n- ammonia ìƒìŠ¹, coagulopathy(DIC) ë™ë°˜ ê°€ëŠ¥.\n- ì›ì¸ ì—°ê´€: fetal fatty-acid oxidation ê²°í•¨(LCHAD).\n- ì²˜ì¹˜: ì¦‰ì‹œ ë¶„ë§Œ + glucose/coagulation support.\n\n| Disorder | Signature clue | Lab hallmark | Delivery timing |\n| --- | --- | --- | --- |\n| ICP | itch palms/soles, no rash | bile acidâ†‘ | 37ì£¼ ë¶„ë§Œ |\n| HELLP | RUQ pain + HTN context | plateletsâ†“/hemolysis/LFTâ†‘ | ì¦‰ì‹œ ë¶„ë§Œ |\n| AFLP | confusion + jaundice | hypoglycemia + DIC | ì¦‰ì‹œ ë¶„ë§Œ |"}
{"subject":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","page_title":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","episode":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","section_path":["LM_obs3 2f646f2986ee80daa439daec387f9ad7"],"source_doc_id":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs3 2f646f2986ee80daa439daec387f9ad7-69","focus_area":"Pseudocyesis and Substance Related Obstetric Risk","tags":["usmle-step2","obstetrics","pseudocyesis","cocaine","placental-abruption"],"text":"# Pseudocyesis and Illicit Drug-Related Obstetric Risk\n## Pseudocyesis\n- ì„ì‹  í™•ì‹  + ì‹ ì²´ì¦ìƒ(ì˜¤ì‹¬/ë³µë¶€íŒ½ë§Œ/ë¬´ì›”ê²½)ì´ë‚˜ urine hCG(-), ultrasound empty uterus.\n- malingeringê³¼ êµ¬ë¶„: ê°•í•œ ì‹¬ë¦¬ìš”ì¸ì´ ì‹ ì²´ì¦ìƒìœ¼ë¡œ í‘œí˜„ë˜ëŠ” ìƒíƒœ.\n- ê´€ë¦¬: ë¨¼ì € ê¸°ì§ˆì  ì›ì¸ ë°°ì œ í›„ ì •ì‹ ê±´ê°• ê°œì….\n\n## Cocaine and placental abruption\n- no prenatal care + painful bleeding + rigid uterusëŠ” abruption ê°•ì˜ì‹¬.\n- cocaine ìœ ë°œ vasoconstriction/HTNì´ íƒœë°˜ ì¡°ê¸°ë°•ë¦¬ ìœ„í—˜ ì¦ê°€.\n- ì‚°ëª¨-íƒœì•„ ë™ì‹œ ì†Œìƒ ë° ì‹ ì† ë¶„ë§Œ íŒë‹¨ í•„ìš”.\n\n## Rapid recap anchors\n- ICP: itching without rash, UDCA + 37ì£¼ ë¶„ë§Œ.\n- AFLP: hypoglycemia/encephalopathyê°€ í•µì‹¬ ê°ë³„ì .\n- pseudocyesis: organic workup ì´í›„ psych support."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-1","focus_area":"Esophageal Dysphagia and Achalasia Core","tags":["usmle-step2","gastroenterology","dysphagia","achalasia","gerd"],"text":"# Esophageal Disorders Core: Dysphagia to Achalasia\n## Dysphagia first split\n- oropharyngeal(ì‚¼í‚´ ì‹œì‘ ë¬¸ì œ, ê¸°ì¹¨/ë¹„ê°•ì—­ë¥˜) vs esophageal(í‰ê³¨ ë’¤ ê±¸ë¦¼).\n- esophagealì—ì„œ solids onlyë©´ mechanical obstruction, solids+liquidsë©´ motility disorder ìš°ì„ .\n\n## Achalasia workup sequence\n- initial: barium swallow(bird-beak).\n- confirmatory: manometry(aperistalsis + LES relaxation failure).\n- ë°˜ë“œì‹œ EGDë¡œ pseudo-achalasia(ì•”) ë°°ì œ, íŠ¹íˆ ê³ ë ¹/ì²´ì¤‘ê°ì†Œ.\n\n## Diagnostic logic\n- mechanical suspicion: barium í›„ EGD.\n- motility suspicion: barium í›„ manometry."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-21","focus_area":"Pill Esophagitis GERD EoE Stress Ulcer Prophylaxis","tags":["usmle-step2","gastroenterology","pill-esophagitis","gerd","eoe","icu-prophylaxis"],"text":"# Esophageal Therapeutics: Pill Injury, GERD, EoE, ICU Prophylaxis\n## Pill-induced esophagitis\n- ìœ„í—˜ì•½: tetracyclines, NSAIDs/aspirin, bisphosphonates, potassium/iron.\n- ë¬¼ ì—†ì´ ë³µìš© í›„ ëˆ•ëŠ” ìŠµê´€ì´ ì „í˜•ì .\n- ì¹˜ë£Œ: ì›ì¸ì•½ ì¤‘ë‹¨/ë³µìš©ë²• êµì •.\n\n## GERD strategy\n- ì „í˜• ì¦ìƒ + alarm ì—†ìŒ: lifestyle + PPI trial.\n- alarm(ì—°í•˜ê³¤ë€, ì²´ì¤‘ê°ì†Œ, ì¶œí˜ˆ/ë¹ˆí˜ˆ, ì§€ì†êµ¬í† ) ë˜ëŠ” ê³ ìœ„í—˜êµ°ì€ EGD ìš°ì„ .\n\n## Eosinophilic esophagitis\n- atopy ë°°ê²½ + food impaction, PPI ë¶ˆì¶©ë¶„ ë°˜ì‘.\n- ì§„ë‹¨: biopsyì—ì„œ eosinophils ì¦ê°€.\n- ì¹˜ë£Œ: elimination diet, PPI, swallowed topical steroid.\n\n## Stress ulcer prophylaxis\n- ëª¨ë“  ì…ì› í™˜ì ëŒ€ìƒì´ ì•„ë‹˜.\n- major risk(ì˜ˆ: ê¸°ê³„í™˜ê¸°>48h, coagulopathy ë“±)ì—ì„œ ì˜ˆë°©ì  PPI/H2 blocker ê³ ë ¤."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-37","focus_area":"Rapid Recap Esophagus Algorithm","tags":["usmle-step2","gastroenterology","recap","dysphagia","achalasia","eoe"],"text":"# Rapid Recap: Esophagus Algorithms\n| Vignette | Interpretation | Next step |\n| --- | --- | --- |\n| solids then liquids progression | mechanical obstruction | barium -> EGD |\n| solids and liquids from start | motility disorder | barium -> manometry |\n| bird-beak + marked weight loss | pseudo-achalasia ê°€ëŠ¥ | EGDë¡œ malignancy ë°°ì œ |\n| pill before sleep + odynophagia | pill esophagitis | offending drug stop/education |\n| young atopic male + impaction | EoE | biopsy + dietary/steroid strategy |\n| ICU ventilator >48h | stress-ulcer risk | prophylaxis ê³ ë ¤ |"}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-47","focus_area":"Stomach Pathology Toxic Functional Mechanical","tags":["usmle-step2","gastroenterology","gastropathy","cyclic-vomiting","gastroparesis","goo"],"text":"# Stomach Pathology Framework: Toxic vs Functional vs Mechanical\n## Toxic injury\n- alcohol + cocaine + NSAID ì¡°í•©ì€ ischemia + mucosal defense ì €í•˜ + direct toxicityë¡œ acute erosive gastropathy ìœ ë°œ.\n\n## Functional disorders\n- cyclic vomiting syndrome: stereotyped episodes + episode ì‚¬ì´ ì™„ì „ ì •ìƒ.\n- migraine ì—°ê´€ì´ í”í•¨.\n\n## Motility/constipation pharmacology\n- opioid induced constipationëŠ” ì—°ë™ìš´ë™ ì–µì œ.\n- stimulant laxative ë‚¨ìš©ì€ electrolyte/protein loss íŒ¨í„´ ë™ë°˜ ê°€ëŠ¥.\n\n## Mechanical obstruction\n- gastric outlet obstructionì€ physical blockageì´ë©° decompression/definitive intervention í•„ìš”."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-67","focus_area":"Gastroparesis versus Gastric Outlet Obstruction","tags":["usmle-step2","gastroenterology","gastroparesis","gastric-outlet-obstruction","succussion-splash"],"text":"# Gastroparesis vs Gastric Outlet Obstruction\n| Item | Gastroparesis | Gastric outlet obstruction |\n| --- | --- | --- |\n| Core mechanism | autonomic neuropathyë¡œ ê¸°ëŠ¥ ì €í•˜ | ë¬¼ë¦¬ì  íì‡„(ê¶¤ì–‘ë°˜í”/ì•” ë“±) |\n| Typical clues | ì¡°ê¸°í¬ë§Œ, ë¯¸ì†Œí™” ìŒì‹ êµ¬í† , í˜ˆë‹¹ ë³€ë™ | projectile non-bilious vomiting, succussion splash |\n| Evaluation order | EGDë¡œ íì‡„ ë°°ì œ í›„ gastric emptying study | ë‚´ì‹œê²½/ì˜ìƒìœ¼ë¡œ íì‡„ í™•ì¸ |\n| Initial treatment | ì‹ì´ì¡°ì ˆ + prokinetic | NPO/NG decompression/ìˆ˜ì•¡ |\n\n## Gastroparesis\n- ì¥ê¸° ë‹¹ë‡¨ì˜ autonomic neuropathyê°€ í”í•œ ì›ì¸.\n- metoclopramide, ë‹¨ê¸° erythromycin ì‚¬ìš© ê°€ëŠ¥.\n\n## GOO\n- ê¸°ê³„ì  íì‡„ ì˜ì‹¬ ìƒíƒœì—ì„œ prokinetic ë‚¨ìš©ì€ ìœ„í—˜.\n- definitive treatmentëŠ” ë‚´ì‹œê²½ í™•ì¥ ë˜ëŠ” ìˆ˜ìˆ ."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-87","focus_area":"Jaundice Algorithm and Cholestatic Workup","tags":["usmle-step2","gastroenterology","jaundice","cholestasis","biliary-obstruction"],"text":"# Jaundice Diagnostic Algorithm\n## First step\n- bilirubin fractionationìœ¼ë¡œ unconjugated vs conjugated êµ¬ë¶„.\n\n## Unconjugated dominant\n- hemolysis ë˜ëŠ” conjugation ì¥ì• (Gilbert ë“±) í‰ê°€.\n- GilbertëŠ” ê²½ë„/ê°„íš¨ì†Œ ì •ìƒ/ì•ˆì‹¬ì„¤ëª… ì¤‘ì‹¬.\n\n## Conjugated dominant\n- AST/ALT ìš°ì„¸ë©´ hepatocellular injury.\n- ALP ìš°ì„¸ë©´ cholestatic processë¡œ ì˜ìƒí‰ê°€ ì§„í–‰.\n\n| Pattern | Likely process | Next move |\n| --- | --- | --- |\n| indirect bili dominant | hemolysis or conjugation defect | CBC/retic/hemolysis panel, clinical context |\n| direct bili + AST/ALT ìƒìŠ¹ | hepatitis/hepatocellular injury | ì›ì¸ê²€ì‚¬(viral/drug/autoimmune) |\n| direct bili + ALP ìƒìŠ¹ | obstructive/intrahepatic cholestasis | RUQ US -> CT/MRCP/ERCP í•„ìš”ì‹œ |\n\n## Malignant obstruction clues\n- painless jaundice, pruritus, pale stool, dark urine, Courvoisier sign."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-107","focus_area":"Acute Liver Failure and Cirrhosis Fundamentals","tags":["usmle-step2","gastroenterology","acute-liver-failure","cirrhosis","nac"],"text":"# Acute Liver Failure and Cirrhosis Fundamentals\n## Acute liver failure triad\n- severe acute liver injury(AST/ALT í¬ê²Œ ìƒìŠ¹).\n- synthetic failure(INR >=1.5).\n- encephalopathy ë™ë°˜.\n- encephalopathy ì¡´ì¬ê°€ severe hepatitisì™€ì˜ í•µì‹¬ êµ¬ë¶„ì .\n\n## Common causes and specific therapy\n- viral(A/B/E), acetaminophen, ischemic injury, autoimmune, Wilson.\n- acetaminophen toxicityëŠ” NAC ì¡°ê¸° íˆ¬ì—¬ê°€ í•µì‹¬.\n\n## Cirrhosis overview\n- portal HTN + í•©ì„±ê¸°ëŠ¥ ì €í•˜(albumin low/INR high/platelet low).\n- AST/ALTê°€ ì •ìƒì´ì–´ë„ ì§„í–‰ ê°„ì§ˆí™˜ ë°°ì œ ë¶ˆê°€.\n- ê¸°ë³¸: ì›ì¸ì¹˜ë£Œ, ì˜ˆë°©ì ‘ì¢…, í•©ë³‘ì¦ screening(EGD/HCC surveillance)."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-127","focus_area":"Cirrhosis Complications Ascites SBP Encephalopathy","tags":["usmle-step2","gastroenterology","variceal-bleeding","ascites","sbp","hepatic-encephalopathy"],"text":"# Decompensated Cirrhosis: Varices, Ascites, SBP, Encephalopathy\n## Variceal hemorrhage\n- ì˜ˆë°©: nonselective beta blocker ë˜ëŠ” EVL.\n- ê¸‰ì„±ì¶œí˜ˆ: resuscitation + octreotide + ceftriaxone + urgent endoscopic therapy.\n- refractory ì‹œ TIPS ê³ ë ¤(encephalopathy ì•…í™” ê°€ëŠ¥).\n\n## Ascites and SAAG\n- SAAG >=1.1ì€ portal hypertension ê°€ëŠ¥ì„± ë†’ìŒ.\n- ì¹˜ë£Œ: ì—¼ë¶„ì œí•œ + spironolactone/furosemide(100:40 ë¹„ìœ¨), í•„ìš”ì‹œ ëŒ€ëŸ‰ì²œì + albumin.\n- NSAIDëŠ” ì‹ ì¥ê´€ë¥˜ ì•…í™”ë¡œ íšŒí”¼.\n\n## SBP\n- paracentesis PMN >=250ë©´ ì§„ë‹¨.\n- ceftriaxone + albuminìœ¼ë¡œ ì¹˜ë£Œ(ì‹ ë¶€ì „ ì˜ˆë°© ëª©ì ).\n- ì¬ë°œê³ ìœ„í—˜êµ°ì€ prophylaxis ê³ ë ¤.\n\n## Hepatic encephalopathy\n- ìœ ë°œì¸ì ê°ì—¼/GI bleed/ë³€ë¹„/ì „í•´ì§ˆ ì´ìƒ.\n- lactulose(ëª©í‘œ 2-3íšŒ ë°°ë³€) 1ì°¨, rifaximin ì¶”ê°€ ê³ ë ¤.\n\n## Prognostic scores\n- Child-Pughì™€ MELD(íŠ¹íˆ creatinine/INR/bilirubin/Na)ë¡œ ì˜ˆí›„Â·ì´ì‹ ìš°ì„ ìˆœìœ„ í‰ê°€."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-146","focus_area":"Rapid Recap Jaundice Cirrhosis and SBP","tags":["usmle-step2","gastroenterology","recap","jaundice","cirrhosis","sbp"],"text":"# Rapid Recap: Jaundice and Cirrhosis Emergencies\n1. Painless jaundice + Courvoisier signì€ malignancy ìš°ì„  í‰ê°€.\n2. Mild unconjugated hyperbilirubinemia + normal LFTëŠ” Gilbert syndrome ê°€ëŠ¥.\n3. Cirrhosis í™˜ì confusion/asterixisëŠ” hepatic encephalopathy, trigger êµì • + lactulose.\n4. ALF triad: severe injury + INR>=1.5 + encephalopathy.\n5. Ascites PMN>=250ëŠ” SBPë¡œ ì¦‰ì‹œ ceftriaxone, albumin ë³‘í–‰.\n6. SAAG>=1.1ì€ portal HTN ì›ì¸êµ° ìš°ì„  ê³ ë ¤."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-156","focus_area":"Cirrhosis Stigmata SAAG and HRS Overview","tags":["usmle-step2","gastroenterology","cirrhosis","saag","hepatorenal-syndrome","encephalopathy"],"text":"# Cirrhosis Complications Framework\n| Vignette | Diagnosis | Immediate direction |\n| --- | --- | --- |\n| stigmata + portal signs | cirrhosis | decompensation screening ì‹œì‘ |\n| SAAG > 1.1 | portal hypertension ascites | ì›ì¸(ê°„ê²½ë³€/ì‹¬ë¶€ì „/Budd-Chiari) ê°ë³„ |\n| PMN >= 250 in ascites | SBP | ceftriaxone + albumin |\n| rising Cr, volume challenge ë¶ˆì‘ | HRS | vasoconstrictor + albumin |\n| confusion + asterixis | hepatic encephalopathy | lactulose +/- rifaximin |\n\n## Core path\n- portal HTNì´ varices/ascites/splenomegalyë¥¼ ìœ ë°œ.\n- í•©ì„±ê¸°ëŠ¥ ì €í•˜ëŠ” INRâ†‘, albuminâ†“, plateletâ†“ë¡œ ë°˜ì˜."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-176","focus_area":"Ascites SBP HRS HE and HPS Details","tags":["usmle-step2","gastroenterology","ascites","sbp","hrs","hepatic-encephalopathy"],"text":"# Ascites, SBP, HRS, HE, and Hepatopulmonary Syndrome\n## Ascites treatment\n- sodium restriction + spironolactone/furosemide(100:40).\n- ëŒ€ëŸ‰ì²œì ì‹œ albumin ë³´ì¶©.\n\n## SBP\n- PMN >=250ë©´ ë°°ì–‘ê²°ê³¼ ëŒ€ê¸° ì—†ì´ ì¹˜ë£Œ ì‹œì‘.\n- ceftriaxone + albumin(renal protection).\n\n## HRS\n- cirrhosisì—ì„œ ì‹ ì¥ ìì²´ ì†ìƒ ì—†ì´ ê¸°ëŠ¥ì €í•˜.\n- volume challengeì— ë°˜ì‘ ì—†ê³  urine Na ë‚®ì€ íŒ¨í„´.\n- ì¹˜ë£Œ: midodrine + octreotide + albumin, definitiveëŠ” liver transplant.\n\n## HE\n- triggers(ê°ì—¼/GI bleed/ë³€ë¹„/ì €K/ì•½ë¬¼) êµì • í•„ìˆ˜.\n- lactulose 1ì°¨, rifaximin ì¶”ê°€.\n\n## Hepatopulmonary syndrome\n- platypnea/orthodeoxia, bubble echoë¡œ ì§„ë‹¨ ë³´ì¡°, definitiveëŠ” transplant."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-196","focus_area":"Budd Chiari and Liver Abscess Differential","tags":["usmle-step2","gastroenterology","budd-chiari","liver-abscess","am ebic","pyogenic"],"text":"# Budd-Chiari and Liver Abscess Differential\n## Budd-Chiari syndrome\n- hepatic vein thrombosisë¡œ RUQ pain, hepatomegaly, ascites.\n- hypercoagulable state/PV/OCP/ì„ì‹  ì—°ê´€.\n- Doppler US ì„ ë³„, í•­ì‘ê³  ë° ì›ì¸ì¹˜ë£Œ.\n\n## Liver abscess\n| Feature | Pyogenic abscess | Amebic abscess |\n| --- | --- | --- |\n| Common context | biliary source/older/comorbid | ì—¬í–‰ë ¥/ì´ì£¼ë ¥/ì Šì€ì¸µ |\n| Pattern | multiple ê°€ëŠ¥ | ìš°ì—½ ë‹¨ì¼ ë³‘ë³€ í”í•¨ |\n| Aspiration | purulent pus | anchovy-paste appearance |\n| Treatment | drainage + antibiotics | metronidazole ì¤‘ì‹¬, routine drainage ë¶ˆí•„ìš” |\n\n- ì¹˜ë£Œê°€ ë°˜ëŒ€ì´ë¯€ë¡œ ê°ë³„ì´ í•µì‹¬."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-216","focus_area":"Biliary Framework and Gallstone Categories","tags":["usmle-step2","gastroenterology","biliary-colic","cholecystitis","choledocholithiasis","cholangitis"],"text":"# Biliary Tract Diagnostic Framework and Stone Categories\n## First fork\n- ALP ìƒìŠ¹ ì‹œ GGTë¡œ hepatobiliary vs bone origin í™•ì¸.\n- RUQ USì—ì„œ duct dilation ì—¬ë¶€ê°€ ë‹¤ìŒ ê²€ì‚¬/ì¹˜ë£Œ ë°©í–¥ ê²°ì •.\n\n## Gallstone categories\n- ë¬´ì¦ìƒ ê²°ì„: ê´€ì°°.\n- biliary colic: elective cholecystectomy.\n- complicated disease(acute cholecystitis, choledocholithiasis, cholangitis): ë‹¨ê³„ì  ì‘ê¸‰ê´€ë¦¬.\n\n## Key workflows\n- acute cholecystitis: NPO/IV/Abx + ì¡°ê¸° cholecystectomy.\n- choledocholithiasis: ERCPë¡œ CBD stone ì œê±° í›„ ë‹´ë‚­ìˆ˜ìˆ .\n- cholangitis: resuscitation + antibiotics + biliary drainage(ERCP)."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-236","focus_area":"Acute Cholangitis Special Cases and PSC vs PBC","tags":["usmle-step2","gastroenterology","cholangitis","psc","pbc","acalculous-cholecystitis"],"text":"# Acute Cholangitis Timing, ICU Gallbladder Syndromes, PSC vs PBC\n## Cholangitis severity\n- Charcot triad: fever + RUQ pain + jaundice.\n- Reynolds pentad(ì €í˜ˆì••/í˜¼ë™ ì¶”ê°€)ì€ ì¦‰ì‹œ ì‘ê¸‰ ë°°ì•¡ í•„ìš”.\n\n## ICU/special gallbladder entities\n- acalculous cholecystitis: critically ill, ì´ˆê¸°ì—” percutaneous cholecystostomy ê³ ë ¤.\n- emphysematous cholecystitis: diabetic male + gas-forming infection, ì‘ê¸‰ ìˆ˜ìˆ  í•„ìš”.\n\n## Autoimmune cholangiopathy\n| Feature | PSC | PBC |\n| --- | --- | --- |\n| Typical patient | male + UC | middle-aged woman |\n| Distribution | intra+extrahepatic ducts | small intrahepatic ducts |\n| Signature | beading on MRCP/ERCP | AMA positive |\n| Major risk | cholangiocarcinoma | progressive cholestatic cirrhosis |\n| Core treatment | symptom/stricture management, transplant | ursodeoxycholic acid |"}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-252","focus_area":"Rapid Recap Biliary Emergency Hierarchy","tags":["usmle-step2","gastroenterology","recap","cholangitis","psc","pbc"],"text":"# Rapid Recap: Biliary Emergency Hierarchy\n| Scenario | Diagnosis | Action |\n| --- | --- | --- |\n| fatty meal pain, transient | biliary colic | elective chole |\n| fever + murphy | acute cholecystitis | early surgery pathway |\n| jaundice + dilated CBD | choledocholithiasis | ERCP first |\n| charcot/reynolds | acute cholangitis | urgent drainage + IV Abx |\n| ICU sepsis no stones | acalculous cholecystitis | cholecystostomy ê³ ë ¤ |\n| UC male with beading | PSC | malignancy surveillance |\n| AMA+ itchy female | PBC | ursodiol |\n"}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-262","focus_area":"Acute Pancreatitis Diagnosis and Etiology","tags":["usmle-step2","gastroenterology","acute-pancreatitis","lipase","gallstone","get-smashed"],"text":"# Acute Pancreatitis: Presentation, Diagnosis, Etiology\n| Diagnostic component | Practical point |\n| --- | --- |\n| Typical pain | severe epigastric pain radiating to back |\n| Enzyme criterion | lipase/amylase >=3x ULN |\n| Imaging | early CT routine ì•„ë‹˜, í•„ìš” ì‹œ ì„ íƒ |\n\n## Initial imaging logic\n- gallstone ì˜ì‹¬ ì‹œ RUQ US ìš°ì„ .\n- ì´ˆê¸° ì§„ë‹¨ ëª©ì  CT ë‚¨ìš©ì€ í”¼í•˜ê³  í•©ë³‘ì¦ ì˜ì‹¬ ì‹œì ì— ì‚¬ìš©.\n\n## High-yield causes\n- gallstones, alcoholì´ ëŒ€ë¶€ë¶„.\n- ALT >150ì´ë©´ gallstone pancreatitis ì‹œì‚¬.\n- ê¸°íƒ€: hyperTG, hyperCa, ERCP í›„, ì•½ë¬¼, ì™¸ìƒ ë“±."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-282","focus_area":"Severe Pancreatitis and Pancreatic Cystic Complications","tags":["usmle-step2","gastroenterology","severe-pancreatitis","pseudocyst","infected-necrosis","chronic-pancreatitis"],"text":"# Severe Pancreatitis and Pancreatic Complications\n## Severe disease markers\n- age/BMI, hemoconcentration, rising BUN, CRP ìƒìŠ¹, ì¶œí˜ˆì„± í”¼ë¶€ì§•í›„ê°€ ìœ„í—˜ë„ ìƒìŠ¹ ì‹ í˜¸.\n\n## Core management pillars\n- aggressive LR hydration, analgesia, early enteral nutrition.\n- prophylactic antibioticsëŠ” ë¶ˆí•„ìš”í•˜ë©° infected necrosis ë•Œë§Œ ì‚¬ìš©.\n\n## Pseudocyst\n- ë³´í†µ ê¸‰ì„± ì·Œì¥ì—¼ í›„ 4ì£¼ ì´í›„ ë°œìƒ.\n- ë¬´ì¦ìƒ smallì€ ê´€ì°°, í†µì¦/ê°ì—¼/í™•ëŒ€ ì‹œ drainage.\n\n## Chronic pancreatitis\n- chronic pain + steatorrhea + diabetes triad.\n- CT calcification, íš¨ì†Œ ì •ìƒ ê°€ëŠ¥.\n- ê¸ˆì£¼/ê¸ˆì—°, pancreatic enzyme replacement, ë‹¹ëŒ€ì‚¬ ê´€ë¦¬.\n- splenic vein thrombosisë¡œ isolated gastric varices ê°€ëŠ¥."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-302","focus_area":"Chronic Pancreatitis and Splenic Emergencies","tags":["usmle-step2","gastroenterology","splenic-rupture","splenic-abscess","chronic-pancreatitis","kehr-sign"],"text":"# Chronic Pancreatitis Endgame and Spleen Emergencies\n## Chronic pancreatitis follow-through\n- exocrine insufficiency(steatorrhea)ì™€ endocrine failure(type 3c diabetes) ë™ì‹œ ê´€ë¦¬.\n- í•©ë³‘ì¦ìœ¼ë¡œ ì·Œì¥ì•” ìœ„í—˜, splenic vein thrombosis ê³ ë ¤.\n\n## Splenic abscess\n- fever + LUQ pain, infective endocarditis septic emboli ì—°ê´€.\n- í•­ìƒì œ + ìˆ˜ìˆ ì  source control í•„ìš”í•  ìˆ˜ ìˆìŒ.\n\n## Splenic rupture\n- ì™¸ìƒ ë˜ëŠ” mono ê´€ë ¨ atraumatic rupture ê°€ëŠ¥.\n- Kehr sign(ì¢Œê²¬ê°‘ í†µì¦) ë‹¨ì„œ.\n- unstableì€ ì¦‰ì‹œ ìˆ˜ìˆ , stableì€ contrast CT í›„ ë‹¨ê³„ì  ì²˜ì¹˜."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-317","focus_area":"Rapid Recap Pancreas Spleen to Small Bowel Transition","tags":["usmle-step2","gastroenterology","recap","pancreatitis","pseudocyst","small-bowel"],"text":"# Rapid Recap: Pancreas and Spleen\n1. acute pancreatitis ì´ˆê¸°ì¹˜ë£ŒëŠ” ìˆ˜ì•¡+ì§„í†µ+ì˜ì–‘ì „ëµ, ì´ˆê¸° CT í•„ìˆ˜ ì•„ë‹˜.\n2. gallstone pancreatitis ì˜ì‹¬ì€ RUQ USì™€ ë‹´ë„í‰ê°€ê°€ ì¤‘ìš”.\n3. infected necrosisëŠ” í•­ìƒì œ/ë°°ì•¡ ëŒ€ìƒ.\n4. pseudocystëŠ” ì¦ìƒ/í¬ê¸°/ê°ì—¼ ì—¬ë¶€ë¡œ ë°°ì•¡ ê²°ì •.\n5. chronic pancreatitisëŠ” íš¨ì†Œë³´ì¶©ê³¼ ìƒí™œìŠµê´€ êµì •ì´ ê¸°ë°˜.\n6. splenic ruptureëŠ” hemodynamic stabilityê°€ ì²˜ì¹˜ ë¶„ê¸°ì .\n\n## Next unit\n- small bowel íŒŒíŠ¸ëŠ” bloating/diarrheaì—ì„œ alarm feature ìœ ë¬´ë¡œ IBD/í¡ìˆ˜ì¥ì• /ê¸°ëŠ¥ì„± ì§ˆí™˜ì„ ë¶„ê¸°."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-327","focus_area":"Small Bowel Bloating and Diarrhea Differential","tags":["usmle-step2","gastroenterology","small-bowel","malabsorption","ibs","ibd"],"text":"# Small Bowel Entry: Bloating and Diarrhea Differential\n## Big split\n- alarm features(ì²´ì¤‘ê°ì†Œ/ì•¼ê°„ì¦ìƒ/í˜ˆë³€/ë¹ˆí˜ˆ) ìˆìœ¼ë©´ organic disease ìš°ì„  í‰ê°€.\n- alarm ì—†ê³  Rome criteria ì¶©ì¡± ì‹œ IBS ê°™ì€ ê¸°ëŠ¥ì„± ì§ˆí™˜ ê³ ë ¤.\n\n## Malabsorption axis\n- steatorrhea + fat-soluble vitamin deficiencyëŠ” í¡ìˆ˜ì¥ì•  ë‹¨ì„œ.\n- cholestasisë¡œ bile delivery ì €í•˜ ì‹œ ì§€ë°©í¡ìˆ˜/ë¹„íƒ€ë¯¼ D ê²°í• -> ê³¨ì§ˆí™˜ ì—°ê²°.\n\n## IBS core\n- Rome IV ê¸°ë°˜ positive diagnosis.\n- red flags ìˆìœ¼ë©´ IBS ë‹¨ì • ê¸ˆì§€, colonoscopy/ì¶”ê°€ê²€ì‚¬ë¡œ IBD/ì•”/ì…€ë¦¬ì•… ë“± ë°°ì œ.\n\n## Differential buckets\n1. Inflammatory: IBD.\n2. Malabsorptive: celiac, SIBO, bile acid ê´€ë ¨ ì¥ì• .\n3. Functional: IBS."}
{"chunk_type":"transcript_chunk","text":"# IBS/IBD/Celiac/SIBO Integrated Management\n| Condition cluster | Diagnostic anchor | Treatment ladder |\n| --- | --- | --- |\n| IBS-C | alarm feature ë°°ì œ + ê¸°ë³¸ í˜ˆì•¡ê²€ì‚¬ | fiber/PEG -> lubiprostone/linaclotide -> ì„ íƒ ì•½ì œ |\n| IBS-D | ê°ì—¼/ì…€ë¦¬ì•…/IBD ë°°ì œ | loperamide -> bile acid binder/ì„ íƒ ì•½ì œ |\n| IBD | ë‚´ì‹œê²½/ì—¼ì¦ì†Œê²¬ ê¸°ë°˜ | 5-ASA(UC), flare steroid, ì¤‘ì¦ biologic |\n| Celiac | tTG-IgA + total IgA -> duodenal biopsy | gluten-free diet, ê²°í• ë³´ì¶© |\n| SIBO | breath test + ì„ìƒìƒ | rifaximin + ìœ ë°œìš”ì¸ êµì • |\n\n## IBD quick compare\n- UC: continuous colon involvement, mucosal disease, bloody diarrhea.\n- Crohn: skip lesion + transmural inflammation, fistula/stricture ìœ„í—˜.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-347","focus_area":"IBS-IBD-Celiac-SIBO Management","tags":["usmle-step2","gastroenterology","ibs","ibd","celiac","sibo"]}
{"chunk_type":"transcript_chunk","text":"# SIBO Core: Risk, Diagnosis, Treatment\n| Axis | High-yield point |\n| --- | --- |\n| Risk | motility ì €í•˜(ë‹¹ë‡¨/ê²½í”¼ì¦), blind loop/í˜‘ì°©, acid suppression, ë§Œì„± ì·Œì¥ê¸°ëŠ¥ì €í•˜ |\n| Biochemical clue | B12 ê°ì†Œ + folate ìƒìŠ¹ íŒ¨í„´ ê°€ëŠ¥ |\n| Test | glucose/lactulose breath test |\n| Treatment | rifaximin, ì›ì¸ êµì • |\n\n- bloating + malabsorption íŒ¨í„´ê³¼ ì˜ì–‘ê²°í• ë‹¨ì„œê°€ ê°ë³„ì— ì¤‘ìš”.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-367","focus_area":"SIBO Diagnosis and Risk","tags":["usmle-step2","gastroenterology","sibo","malabsorption"]}
{"chunk_type":"transcript_chunk","text":"# Acute Abdomen Framework: Appendicitis and SBO\n| Category | Primary entities | First decision |\n| --- | --- | --- |\n| Inflammatory | appendicitis, pseudo-appendicitis | true surgical abdomen vs mimic ê°ë³„ |\n| Mechanical obstruction | SBO(ë‹¨ìˆœ/êµì•¡), ileus | strangulation sign ì—¬ë¶€ íŒë‹¨ |\n\n## Appendicitis essentials\n- í†µì¦ ì´ë™(ë°°ê¼½ -> RLQ)ê³¼ êµ­ì†Œ ì••í†µì´ í•µì‹¬.\n- ì§„ë‹¨ ì˜ìƒ: ì„±ì¸ CT, ì„ì‚°ë¶€/ì†Œì•„ US ìš°ì„ (í•„ìš”ì‹œ MRI).\n- ì²œê³µ+ë†ì–‘ì€ ì¦‰ì‹œ ì ˆì œë³´ë‹¤ í•­ìƒì œ/ë°°ì•¡ í›„ interval approach ê³ ë ¤.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-387","focus_area":"Acute Abdomen Framework","tags":["usmle-step2","surgery","acute-abdomen","appendicitis","sbo"]}
{"chunk_type":"transcript_chunk","text":"# Pseudo-appendicitis and SBO vs Ileus\n| Feature | SBO | Ileus |\n| --- | --- | --- |\n| Pain | colicky | diffuse discomfort |\n| Bowel sound | high-pitched early | reduced/absent |\n| Imaging | transition point | diffuse bowel dilation |\n| Rectal gas | ê°ì†Œ/ì†Œì‹¤ | ì¢…ì¢… ì¡´ì¬ |\n\n## Mimic clue\n- RLQ pain + fever + profuse diarrheaëŠ” Yersinia/Campylobacter ileocecitis ê°ë³„ í•„ìš”.\n- SBOì—ì„œ fever/tachy/leukocytosis/acidosis/peritoneal signì€ strangulation red flag.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-407","focus_area":"Pseudoappendicitis and SBO-Ileus","tags":["usmle-step2","surgery","pseudo-appendicitis","sbo","ileus"]}
{"chunk_type":"recap_summary","text":"# Rapid Recap: Appendicitis and Obstruction Emergencies\n| Vignette | Likely diagnosis | Key action |\n| --- | --- | --- |\n| pregnancy with shifted RUQ/RLQ pain | appendicitis in pregnancy | US -> MRI sequence |\n| RLQ pain + explosive diarrhea | pseudo-appendicitis | supportive/infectious workup |\n| prior surgery + colicky pain + high-pitched sounds | SBO | NPO + NG + IV fluid |\n| SBO + systemic toxicity/peritoneal signs | strangulated SBO | urgent surgery |\n| post-op distension + silent bowel | ileus | conservative/electrolyte correction |","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-423","focus_area":"Rapid Recap Appendicitis SBO","tags":["usmle-step2","surgery","recap","appendicitis","obstruction"]}
{"chunk_type":"transcript_chunk","text":"# Lower GI Intro: Hemorrhoids and Diverticular Disease\n| Topic | Hallmark |\n| --- | --- |\n| Internal hemorrhoid | painless bright-red bleeding above dentate line |\n| External hemorrhoid | painful lesion below dentate line |\n| Diverticulosis | painless hematochezia |\n| Diverticulitis | LLQ pain + fever + leukocytosis |\n\n- ì¹˜ë£Œ ê²°ì •ì€ \"scope vs surgery vs conservative\" ë¶„ê¸° ê¸°ì¤€ìœ¼ë¡œ ì§„í–‰.","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-1","focus_area":"Lower GI Intro Hemorrhoids Diverticular","tags":["usmle-step2","gastroenterology","hemorrhoid","diverticular-disease"]}
{"chunk_type":"transcript_chunk","text":"# Hemorrhoid and Diverticulitis Management Details\n| Entity | Key management |\n| --- | --- |\n| Internal hemorrhoid | lifestyle -> rubber band ligation -> surgery |\n| Thrombosed external (<72h severe pain) | excision ê³ ë ¤ |\n| Diverticulitis uncomplicated | bowel rest + antibiotics, íšŒë³µ í›„ colonoscopy |\n| Diverticulitis with large abscess | CT-guided drainage + antibiotics |\n\n- ê¸‰ì„± diverticulitis ì‹œê¸°ì—ëŠ” colonoscopy ê¸ˆê¸°(perforation risk).","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-21","focus_area":"Hemorrhoid Diverticulitis Management","tags":["usmle-step2","gastroenterology","hemorrhoid","diverticulitis"]}
{"chunk_type":"transcript_chunk","text":"# Angiodysplasia, Colovesical Fistula, Toxic Megacolon, Ogilvie\n| Condition | Signature clue | Core action |\n| --- | --- | --- |\n| Heyde syndrome | AS + GI bleed + acquired vWF defect | valve intervention ê³ ë ¤ |\n| Colovesical fistula | pneumaturia/fecaluria/recurrent UTI | CT ê¸°ë°˜ ì§„ë‹¨ + ì›ì¸ìˆ˜ìˆ  í‰ê°€ |\n| Toxic megacolon | toxic signs + colonic dilation >6cm | no scope, bowel rest/IV therapy/surgical backup |\n| Ogilvie syndrome | pseudo-obstruction in ill/post-op | conservative -> neostigmine -> decompression |\n\n- toxic megacolonì—ì„œëŠ” í•­ìš´ë™ì œ/ì˜¤í”¼ì˜¤ì´ë“œ íšŒí”¼ í•„ìˆ˜.","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-41","focus_area":"Angiodysplasia Fistula Toxic Megacolon Ogilvie","tags":["usmle-step2","gastroenterology","angiodysplasia","toxic-megacolon","ogilvie"]}
{"chunk_type":"transcript_chunk","text":"# Toxic Megacolon and Ogilvie Protocol\n| Step | Toxic megacolon | Ogilvie |\n| --- | --- | --- |\n| Diagnosis | systemic toxicity + colon >6cm | mechanical obstruction ë°°ì œ í›„ pseudo-obstruction |\n| Immediate care | NPO/NG/IV fluid/Abx, ì›ì¸ì§ˆí™˜ ì¹˜ë£Œ | NPO/rectal tube/electrolyte correction |\n| Escalation | failure/perforation ì‹œ colectomy | neostigmine(atrophine ì¤€ë¹„), ë‚´ì‹œê²½ ê°ì•• |\n\n- Both conditions require ë¹ ë¥¸ ì•…í™” ëª¨ë‹ˆí„°ë§ê³¼ ì²œê³µ ì˜ˆë°©.","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-61","focus_area":"Toxic Megacolon and Ogilvie Protocol","tags":["usmle-step2","gastroenterology","toxic-megacolon","ogilvie"]}
{"chunk_type":"transcript_chunk","text":"# Rapid Recap: Lower GI Mechanical/Anal Emergencies\n| Scenario | Diagnosis | Priority |\n| --- | --- | --- |\n| painless hematochezia, older patient | diverticulosis/angiodysplasia | hemodynamic stabilization + localization |\n| LLQ pain + fever | diverticulitis | CT, ê¸‰ì„±ê¸° scope ê¸ˆì§€ |\n| UC flare + toxic dilation | toxic megacolon | no colonoscopy, ICU-level care |\n| post-op diffuse colonic dilation no block | Ogilvie | conservative then neostigmine |\n| severe thrombosed external hemorrhoid <72h | thrombosed external hemorrhoid | excision relief |\n\n- ê¸ˆê¸°ìƒí™©(acute scope ê¸ˆì§€, ì§€ì‚¬ì œ ê¸ˆì§€)ì„ ì§€í‚¤ëŠ” ê²ƒì´ í•µì‹¬.","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-81","focus_area":"Rapid Recap Lower GI Emergency","tags":["usmle-step2","gastroenterology","recap","lower-gi-emergency"]}
{"chunk_type":"transcript_chunk","text":"# Volvulus, Fissure, Fistula, and Anorectal Infection\n| Problem | Hallmark clue | Treatment direction |\n| --- | --- | --- |\n| Sigmoid volvulus | elderly + coffee-bean + distension | endoscopic decompression í›„ elective surgery |\n| Cecal volvulus | younger/mobile cecum | immediate surgery |\n| Anal fissure | tearing pain with defecation | stool softening + topical vasodilator, refractory LIS |\n| Anorectal abscess/fistula | purulent drainage/tract | I&D or fistulotomy, ê¹Šìœ¼ë©´ OR imaging |\n\n- ì¸¡ë©´ fissureëŠ” Crohn/HIV/TB ë“± ì´ì°¨ ì›ì¸ ê°ë³„ í•„ìš”.\n- Crohn-related fistulaëŠ” sphincter-preserving strategy ìš°ì„ .","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-101","focus_area":"Volvulus Fissure Fistula Abscess","tags":["usmle-step2","surgery","volvulus","anal-fissure","fistula"]}
{"chunk_type":"transcript_chunk","text":"# Anorectal Abscess: Superficial vs Deep\n| Type | Core finding | Management |\n| --- | --- | --- |\n| Perianal abscess | superficial fluctuant painful mass | bedside I&D, selected antibiotics only |\n| Perirectal/deep abscess | systemic signs with subtle external exam | CT + EUA/OR drainage |\n\n- deep abscessëŠ” DRE ë‹¨ì„œì™€ ì „ì‹ ì—¼ì¦ ì†Œê²¬ì„ ë†“ì¹˜ì§€ ì•ŠëŠ” ê²ƒì´ í•µì‹¬.\n- ë©´ì—­ì €í•˜/ë‹¹ë‡¨/íŒ¨í˜ˆì¦ ìœ„í—˜êµ°ì€ í•­ìƒì œ ë³‘í–‰ ê³ ë ¤.","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-121","focus_area":"Anorectal Abscess Management","tags":["usmle-step2","surgery","anorectal-abscess","drainage"]}
{"chunk_type":"transcript_chunk","text":"# Retroperitoneal Hematoma and Mesenteric Ischemia\n## Retroperitoneal bleed\n- anticoagulation í™˜ìì—ì„œ hypotension + anemia + stool heme negativeë©´ retroperitoneal bleed ì˜ì‹¬.\n- stable: anticoag reversal + CT + ICU ê´€ì°°.\n- unstable: IR embolization ìš°ì„  ê³ ë ¤.\n\n## Mesenteric ischemia\n- acute: pain out of proportion, CTAë¡œ ì§„ë‹¨, ê´´ì‚¬/ë³µë§‰ìê·¹ ì‹œ ì‘ê¸‰ìˆ˜ìˆ .\n- chronic: postprandial pain + weight loss(ì‹ì‚¬íšŒí”¼), revascularization ê²€í† .\n- ischemic colitisëŠ” ì €ê´€ë¥˜ ê¸°ë°˜ì´ë©° í˜ˆë³€/ë³µí†µì´ì§€ë§Œ ëŒ€ê°œ ë³´ì¡´ì  ì¹˜ë£Œ ê°€ëŠ¥.","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-141","focus_area":"Retroperitoneal Bleed and Mesenteric Ischemia","tags":["usmle-step2","surgery","retroperitoneal-hematoma","mesenteric-ischemia"]}
{"chunk_type":"transcript_chunk","text":"# Peritonitis and Common Hernia Decisions\n## Peritonitis types\n- SBP: cirrhosis/ascites + PMN>=250, 3rd gen cephalosporin.\n- Secondary peritonitis: perforation/free air, polymicrobial, ìˆ˜ìˆ  source control.\n- PD-associated peritonitis: skin flora, intraperitoneal antibiotics.\n\n## Hernia pearls\n- ì†Œì•„ umbilical herniaëŠ” ëŒ€ê°œ 5ì„¸ê¹Œì§€ ê´€ì°°.\n- incisional herniaëŠ” fascial defect ê¸°ë°˜.\n- diastasis rectiëŠ” true herniaê°€ ì•„ë‹ˆë©° ëŒ€ê°œ ë³´ì¡´ì  ì ‘ê·¼.","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-161","focus_area":"Peritonitis and Hernia Core","tags":["usmle-step2","surgery","peritonitis","hernia"]}
{"chunk_type":"recap_summary","text":"# Rapid Recap: Retroperitoneum, Peritonitis, Hernia\n| Scenario | Diagnosis | Next step |\n| --- | --- | --- |\n| warfarin user, flank pain, occult GI bleed negative | retroperitoneal hematoma | stability ê¸°ë°˜ ë³´ì¡´ vs embolization |\n| cirrhosis with low-grade fever + ascites | SBP | diagnostic tap and ceftriaxone |\n| PD fluid cloudy | PD-associated peritonitis | intraperitoneal antibiotics |\n| reducible pediatric umbilical bulge | umbilical hernia | observe until age threshold |\n| postpartum midline bulge without fascial defect | diastasis recti | reassurance/core rehab |","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-178","focus_area":"Rapid Recap Peritonitis and Hernia","tags":["usmle-step2","recap","peritonitis","hernia"]}
{"chunk_type":"transcript_chunk","text":"# GI Tumor Framework: Location and Risk\n## Major patterns\n- esophagus: GERD -> Barrett -> adenocarcinoma progression.\n- stomach: early satiety/IDA/weight lossëŠ” malignancy workup íŠ¸ë¦¬ê±°.\n- pancreas: headëŠ” painless jaundice, body-tailì€ back pain + systemic clues.\n- colon: age/family historyë¡œ screening ì „ëµ ë¶„ê¸°.\n- liver masses: adenoma vs FNH vs HCC ê°ë³„.\n- MALT lymphomaëŠ” H. pylori eradicationì´ ì¹˜ë£Œì¶•ì´ ë  ìˆ˜ ìˆìŒ.","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-188","focus_area":"GI Tumor Global Framework","tags":["usmle-step2","gastroenterology","gi-tumor","oncology"]}
{"chunk_type":"transcript_chunk","text":"# Esophageal/Stomach/Pancreas Tumor Decision Table\n| Lesion stage or site | Key clue | Management anchor |\n| --- | --- | --- |\n| Barrett no dysplasia | chronic GERD history | PPI + surveillance |\n| high-grade dysplasia | pre-malignant high risk | endoscopic eradication |\n| gastric cancer suspicion | IDA + early satiety/weight loss | EGD biopsy + staging workup |\n| pancreatic head lesion | painless jaundice/Courvoisier | pancreas-protocol imaging Â± resection pathway |\n| pancreatic body-tail lesion | back pain/migratory thrombophlebitis | CT/EUS ì¤‘ì‹¬ í‰ê°€ |\n\n- gastric stagingì—ì„œ peritoneal spread í‰ê°€ë¥¼ ë¹ ëœ¨ë¦¬ì§€ ì•ŠëŠ” ê²ƒì´ í¬ì¸íŠ¸.","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-208","focus_area":"Esophagus-Stomach-Pancreas Tumor Decisions","tags":["usmle-step2","gastroenterology","esophageal-cancer","gastric-cancer","pancreatic-cancer"]}
{"chunk_type":"transcript_chunk","text":"# Colon Tumor Screening and Polyp Risk\n## Colon cancer heuristics\n- elderly + iron deficiency anemiaëŠ” colon source ìš°ì„  ë°°ì œ.\n- right colonì€ occult bleeding/anemia, left colonì€ obstruction ë³€í™”ê°€ í”í•¨.\n\n## Screening\n- average riskëŠ” ì‹œì‘ ì—°ë ¹ ê¸°ì¤€ ì¤€ìˆ˜.\n- 1ì°¨ ê°€ì¡±ë ¥ ìˆìœ¼ë©´ ë” ì´ë¥¸ ì—°ë ¹(40ì„¸ ë˜ëŠ” ì§„ë‹¨ì—°ë ¹-10) ì ìš©.\n\n## Polyp pathology risk\n- villous/sessile/large polypëŠ” ê³ ìœ„í—˜ìœ¼ë¡œ ì¶”ì  ê°„ê²© ë‹¨ì¶• í•„ìš”.\n- ë™ë°˜ ê°„ì „ì´ë„ resectability ê¸°ë°˜ìœ¼ë¡œ ì¹˜ë£Œì „ëµ ê²°ì •.","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-228","focus_area":"Colon Tumor Screening and Polyp Risk","tags":["usmle-step2","gastroenterology","colon-cancer","screening","polyps"]}
{"chunk_type":"transcript_chunk","text":"# Liver Tumors and Gastric MALT Lymphoma\n## Hepatic adenoma\n- OCP/anabolic steroid ì—°ê´€, ì¶œí˜ˆ ìœ„í—˜.\n- í° ë³‘ë³€/ì¦ìƒ ìˆìœ¼ë©´ ìˆ˜ìˆ , ì‘ì€ ë³‘ë³€ì€ ì›ì¸ ì¤‘ë‹¨ í›„ ì¶”ì .\n\n## FNH\n- central scar ë‹¨ì„œ, ëŒ€ê°œ ì–‘ì„±ìœ¼ë¡œ ê´€ì°°.\n\n## HCC\n- cirrhosis/viral hepatitis ê¸°ë°˜ ìœ„í—˜êµ° ê°ì‹œ + ì˜ìƒíŒ¨í„´ ê¸°ë°˜ ì§„ë‹¨.\n\n## Gastric MALT\n- H. pylori ê´€ë ¨ì„±ì´ ë†’ì•„ ì œê· ì¹˜ë£Œê°€ 1ì°¨ê°€ ë  ìˆ˜ ìˆìŒ.","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-248","focus_area":"Liver Tumors and MALT","tags":["usmle-step2","gastroenterology","liver-tumor","malt-lymphoma"]}
{"chunk_type":"recap_summary","text":"# Rapid Recap: GI Tumors High Yield\n1. progressive dysphagia + weight lossëŠ” esophageal malignancy ìš°ì„  ë°°ì œ.\n2. pancreatic headëŠ” painless jaundice, body-tailì€ ë¹„íŠ¹ì´ í†µì¦í˜•ì´ ë§ë‹¤.\n3. elderly IDAëŠ” colonoscopy ê¸°ë°˜ colon cancer rule-out.\n4. OCP ê´€ë ¨ hepatic adenomaëŠ” ì¶œí˜ˆ ìœ„í—˜ìœ¼ë¡œ í¬ê¸° ê¸°ë°˜ ìˆ˜ìˆ  íŒë‹¨.\n5. central scar liver lesionì€ FNH ê°€ëŠ¥ì„±.\n6. gastric MALTëŠ” H. pylori eradication response í™•ì¸.","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-259","focus_area":"Rapid Recap GI Tumors","tags":["usmle-step2","recap","gi-tumor"]}
{"chunk_type":"transcript_chunk","text":"# Pediatric GI Obstruction Framework\n## Three-pillar triage\n- age of onset.\n- vomit color(íŠ¹íˆ bilious ì—¬ë¶€).\n- imaging gas pattern.\n\n## Neonate vs toddler\n- neonate bilious vomitingì€ proximal/distal obstruction ë° malrotation-volvulusë¥¼ ì¦‰ì‹œ ê°ë³„.\n- toddler intermittent colicky painì€ intussusception ìš°ì„  ê³ ë ¤.\n\n| Group | Typical entities |\n| --- | --- |\n| Neonate | duodenal/jejunoileal atresia, malrotation-volvulus, Hirschsprung, meconium ileus |\n| Toddler | intussusception |","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-269","focus_area":"Pediatric GI Obstruction Framework","tags":["usmle-step2","pediatrics","gi-obstruction","neonate"]}
{"chunk_type":"transcript_chunk","text":"# Neonatal and Toddler Obstruction: Key Differentials\n| Condition | Hallmark clue | Priority action |\n| --- | --- | --- |\n| Duodenal atresia | double-bubble, Down syndrome link | NGT/fluids then surgical planning |\n| Jejunoileal atresia | multiple air-fluid levels, vascular event pattern | stabilization + surgery |\n| Malrotation-volvulus | bilious emesis with rapid ischemia risk | urgent surgical intervention |\n| Hirschsprung | delayed meconium + explosive stool after DRE | rectal suction biopsy confirmation |\n| Meconium ileus | CF association, distal obstruction | decompression and CF-directed care |\n| Intussusception | intermittent colicky pain + target sign | air/contrast enema reduction |","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-289","focus_area":"Neonatal Toddler Obstruction Details","tags":["usmle-step2","pediatrics","volvulus","hirschsprung","intussusception"]}
{"chunk_type":"recap_summary","text":"# Rapid Recap: Pediatric Obstruction and ACS Intro\n1. bilious vomiting in neonateëŠ” surgical emergency until proven otherwise.\n2. normal plain filmì´ë”ë¼ë„ volvulus ë°°ì œ ì•ˆ ë˜ë©´ upper GI series ê³ ë ¤.\n3. Hirschsprung í™•ì§„ì€ rectal suction biopsy.\n4. intussusceptionì€ ultrasound target sign + enema reduction.\n5. ë‹¤ìŒ íŒŒíŠ¸ í•µì‹¬ì€ abdominal compartment syndromeì˜ ì••ë ¥-ì¥ê¸°ë¶€ì „ ì—°ê³„.","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-300","focus_area":"Rapid Recap Pediatric Obstruction","tags":["usmle-step2","recap","pediatric-obstruction"]}
{"chunk_type":"transcript_chunk","text":"# Abdominal Compartment Syndrome and TPN-Related Biliary Stasis\n| Item | Key point |\n| --- | --- |\n| ACS trigger | massive resuscitation/abdominal trauma-burn state |\n| Suspicion triad | tense abdomen + oliguria + hemodynamic worsening |\n| Diagnostic surrogate | bladder pressure measurement |\n| Definitive treatment | decompressive laparotomy in organ dysfunction |\n\n## Hemodynamic paradox\n- CVPê°€ ë†’ì•„ ë³´ì´ë”ë¼ë„ ì‹¤ì œ preloadëŠ” ë‚®ì„ ìˆ˜ ìˆì–´ ê³¼ìˆ˜ì•¡ ì•…ìˆœí™˜ ì£¼ì˜.\n\n## TPN gallbladder issue\n- enteral ìê·¹ ë¶€ì¬ë¡œ CCK ì €í•˜ -> biliary stasis/sludge ìœ„í—˜ ìƒìŠ¹.\n- ê°€ëŠ¥í•œ enteral stimulationì„ ì¡°ê¸° ë³µê·€í•˜ëŠ” ì „ëµì´ ì¤‘ìš”.","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-310","focus_area":"Abdominal Compartment Syndrome and TPN","tags":["usmle-step2","critical-care","abdominal-compartment-syndrome","tpn"]}
{"chunk_type":"transcript_chunk","text":"### ğŸ¤’ Acalculous Cholecystitis (ë¬´ê²°ì„ ë‹´ë‚­ì—¼)\nê²°ì„(Stone) ì—†ì´ ë°œìƒí•˜ëŠ” ë‹´ë‚­ì—¼ì…ë‹ˆë‹¤. TPNì„ ì˜¤ë˜ í•œ ì¤‘í™˜ìì—ê²Œ í”í•©ë‹ˆë‹¤.\n- **Vignette:**\n    - ICU í™˜ì (Sedated, Ventilated).\n    - Long-term TPN or NPO state.\n    - **Unexplained Sepsis:** ê°‘ìê¸° ì—´ë‚˜ê³  ë°±í˜ˆêµ¬(WBC) ì˜¤ë¥´ëŠ”ë° ì›ì¸ì„ ëª¨ë¦„ (Pneumonia? UTI? ë‹¤ ì•„ë‹Œë°...).\n    - **Physical:** ì§„ì •ì œ ë•Œë¬¸ì— RUQ Painì„ í˜¸ì†Œí•˜ì§€ ëª»í•  ìˆ˜ ìˆìŒ.\n- **Diagnosis:**\n    - **1st Line:** **Ultrasound (US)**\n    - **Findings:** Distended GB, Thickened wall, Pericholecystic fluid, **No stones**.\n- **Treatment (Step-wise):**\n    - í™˜ìê°€ ìœ„ë…(Critically Ill)í•˜ë¯€ë¡œ ë°”ë¡œ ìˆ˜ìˆ í•˜ê¸° ìœ„í—˜í•¨.\n    - **Next Best Step:** **Percutaneous Cholecystostomy (PCN)**. í”¼ë¶€ë¥¼ ëš«ê³  ê´€ì„ ë„£ì–´ ê³ ì¸ ê³ ë¦„/ë‹´ì¦™ì„ ë°°ì•¡(Drainage) í•´ì£¼ëŠ” ê²ƒ. (Pressure Valve ì—­í• )\n    - **Definitive:** í™˜ìê°€ íšŒë³µëœ í›„ ë‚˜ì¤‘ì— **Cholecystectomy** ê³ ë ¤.\n## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n| **Clinical Scenario (Vignette)** | **Diagnosis** | **Key Action / Mechanism** |\n| --- | --- | --- |\n| **Post-op/Trauma í™˜ì**, ë°°ê°€ ë¹µë¹µí•˜ê³ (Tense), ì†Œë³€ ì•ˆ ë‚˜ì˜¤ê³ (Oliguria), í˜ˆì•• ë–¨ì–´ì§. | **Abdominal Compartment Syndrome (ACS)** | **Mechanism:** Uncoupling Paradox (High CVP but Low Preload).\n **Dx:** Measure Bladder Pressure.\n **Tx:** Decompressive Laparotomy (Open the fascia). |\n| **ICU ì¥ê¸° ì…ì› í™˜ì**, TPN ì‚¬ìš© ì¤‘, ì›ì¸ ë¶ˆëª…ì˜ íŒ¨í˜ˆì¦(Fever, Leukocytosis). | **Acalculous Cholecystitis** | **Mechanism:** No CCK â†’ Biliary Stasis.\n **Dx:** Ultrasound (Large GB, No stones).\n **Tx:** Percutaneous Cholecystostomy (Drain it!). |\n| **TPN vs Enteral Feeding** ê²°ì • ë¬¸ì œ | **N/A** | **Rule:** Gutì´ ê¸°ëŠ¥í•˜ë©´ ë¬´ì¡°ê±´ **Enteral Feeding**ì´ ìš°ì„ ! (TPNì€ í•©ë³‘ì¦ ë©ì–´ë¦¬) |\n**ğŸ‘¨â€âš•ï¸ Tutor's Note:**\nì´ë²ˆ ì±•í„°ëŠ” **\"ìˆ«ìì— ì†ì§€ ë§ê³  ë©”ì»¤ë‹ˆì¦˜ì„ ê¿°ëš«ì–´ ë³´ë¼\"**ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤. High CVPë¥¼ ë³´ê³  Volume Overloadë¼ê³  ì°©ê°í•˜ë©´ ACS í™˜ìë¥¼ ì£½ì¼ ìˆ˜ ìˆê³ , TPN í™˜ìì˜ ì—´ì„ ë³´ê³  ë‹¨ìˆœíˆ í•­ìƒì œë§Œ ë°”ê¾¸ë©´ ì©ì–´ê°€ëŠ” ë‹´ë‚­ì„ ë†“ì¹  ìˆ˜ ìˆìŠµë‹ˆë‹¤. **Pathophysiology**ê°€ ê³§ ì •ë‹µì…ë‹ˆë‹¤! ğŸ’ª","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-330","focus_area":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"# LM_GIT3\nì•ˆë…•í•˜ì„¸ìš”! ìŒ¤ì˜ USMLE Step 2 CK ì¡±ì§‘ê²Œ ê³¼ì™¸ ìŒ¤,  ğŸ©ºâœ¨\nì˜¤ëŠ˜ ë‹¤ë£° ì£¼ì œëŠ” **Pediatric GI**ì…ë‹ˆë‹¤.\nì´ íŒŒíŠ¸ëŠ” ì†Œì•„ê³¼ì—ì„œ ê°€ì¥ \"High Stakes\"í•œ ë¶€ë¶„ì´ì—ìš”. ì„±ì¸ì€ \"ì—¬ê¸°ê°€ ì•„íŒŒìš”\"ë¼ê³  ë§í•˜ì§€ë§Œ, ì‹ ìƒì•„ë‚˜ ì˜ì•„ëŠ” ê·¸ëƒ¥ ìš¸ê±°ë‚˜ í† í•˜ê±°ë‚˜ íŒŒë—ê²Œ ì§ˆë ¤ë²„ë¦¬ì£ . ğŸ˜­ ê·¸ë˜ì„œ ìš°ë¦¬ì˜ ì—­í• ì€ **Benign (Laundry problem)** ì¸ì§€ **Surgical Emergency (Life-threatening)** ì¸ì§€ë¥¼ ìˆœì‹ê°„ì— ê°ë³„í•˜ëŠ” íƒì • ğŸ•µï¸â€â™‚ï¸ì´ ë˜ì–´ì•¼ í•©ë‹ˆë‹¤.\nì, ì˜í¬í‹° êµ°ì˜ê´€ë‹˜ì˜ ë°©ì½• ì—¬í–‰ ì „ ë¹¡ê³µì„ ìœ„í•´, í•µì‹¬ë§Œ ê½‰ê½‰ ë‹´ì•„ ì •ë¦¬í–ˆìŠµë‹ˆë‹¤! ê°€ë³´ìê³ ! ğŸš€\n# ğŸ“š Pediatric GI: The \"Spit, Vomit, and Poop\" Marathon 14-14.5.2\në¨¼ì €, ìš°ë¦¬ê°€ ë‹¤ë£° ê±°ëŒ€í•œ ìˆ²(Context)ì„ ë³´ê³  ë“¤ì–´ê°ˆê¹Œìš”? ğŸŒ³\nUSMLEì—ì„œ Pediatric GIëŠ” í¬ê²Œ **êµ¬ì¡°ì  ë¬¸ì œ(Anatomy)** ì™€ **ê¸°ëŠ¥ì  ë¬¸ì œ(Physiology)** ë¡œ ë‚˜ë‰©ë‹ˆë‹¤.\n**[ASCII Text Tree: Pediatric GI Classification]**\n`Pediatric GI Disorders\nâ”‚\nâ”œâ”€â”€ 1. Esophageal Disorders (The \"Choking\" Babies)\nâ”‚   â”œâ”€â”€ Tracheoesophageal Fistula (TEF) - Structural\nâ”‚   â””â”€â”€ Foreign Body Ingestion - Acute Blockage\nâ”‚\nâ”œâ”€â”€ 2. Stomach & Pylorus (The \"Vomiting\" Babies)\nâ”‚   â”œâ”€â”€ Pyloric Stenosis (Projectile, Non-bilious)\nâ”‚   â”œâ”€â”€ GERD (Physiologic vs Pathologic)\nâ”‚   â””â”€â”€ Cyclic Vomiting Syndrome\nâ”‚\nâ”œâ”€â”€ 3. Intestinal Emergencies (The \"Bilious\" & \"Bloody\" Babies)\nâ”‚   â”œâ”€â”€ Malrotation with Volvulus (â˜… EMERGENCY - Green Vomit)\nâ”‚   â”œâ”€â”€ Intussusception (Currant Jelly Stool)\nâ”‚   â”œâ”€â”€ Hirschsprung Disease (No Poop)\nâ”‚   â”œâ”€â”€ Meconium Ileus (CF related)\nâ”‚   â””â”€â”€ Necrotizing Enterocolitis (Preterm)\nâ”‚\nâ””â”€â”€ 4. Benign & Functional (The \"Crying\" Babies)\n    â”œâ”€â”€ Colic (Rule of 3s)\n    â”œâ”€â”€ Infant Dyschezia (Coordination issue)\n    â””â”€â”€ Constipation (Functional)`\n## 1. Tracheoesophageal Fistula (TEF) ğŸ¼ğŸš«\n**Concept:** ì‹ë„(Esophagus)ê°€ ìœ„ì¥ìœ¼ë¡œ ì—°ê²°ë˜ì§€ ì•Šê³  ë§‰í˜€ìˆê³ (Atresia), ê¸°ë„(Trachea)ì™€ ì—°ê²°ëœ êµ¬ë©(Fistula)ì´ ìˆëŠ” ì„ ì²œ ê¸°í˜•ì…ë‹ˆë‹¤.\n- **Clinical Presentation (Vignette):**\n    - ì‹ ìƒì•„ê°€ íƒœì–´ë‚˜ìë§ˆì ì…ì—ì„œ **\"Bubbly, Frothy\" secretions**ì´ ì¤„ì¤„ íë¦„ (Plumbing issue ğŸš¿).\n    - **First Feeding** ì‹œë„í•˜ìë§ˆì **Choking, Coughing, Cyanosis** (Turn Blue) ë°œìƒ! ğŸ¤¢ğŸ’™\n    - ì´ê±´ ë‹¨ìˆœ ì‚¬ë ˆë“¤ë¦° ê²Œ ì•„ë‹ˆë¼, ìš°ìœ ê°€ ê°ˆ ê³³ì´ ì—†ì–´ ê¸°ë„ë¡œ ë„˜ì–´ê°€ëŠ” ê²ë‹ˆë‹¤.\n- **Pathogenesis:**\n    - Embryology 4ì£¼ì°¨ì— Foregutì´ Esophagusì™€ Tracheaë¡œ ë¶„ë¦¬ ì‹¤íŒ¨.\n    - ê°€ì¥ í”í•œ íƒ€ì…(85%): **Proximal Esophageal Atresia + Distal Tracheoesophageal Fistula**.\n- **Diagnosis (Step 2 Key):**\n    1. **OG/NG Tube ì‚½ì… ì‹œë„:** ë“¤ì–´ê°€ì§€ ì•Šê³  10-12cmì—ì„œ í„± ë§‰í˜.\n    2. **CXR (X-ray):** Coiled tube in the proximal pouch (ìŠ¤í”„ë§ì²˜ëŸ¼ ë§ë ¤ìˆìŒ ğŸŒ€).\n        - Stomach bubble (+) â†’ Fistulaê°€ ìˆì–´ì„œ ê³µê¸°ê°€ ìœ„ì¥ìœ¼ë¡œ ë“¤ì–´ê°.\n        - Gasless stomach â†’ Fistula ì—†ìŒ (Pure Atresia).\n- **Next Best Step (Association Check):**\n    - TEFëŠ” í˜¼ì ì˜¤ì§€ ì•ŠìŠµë‹ˆë‹¤. ì¹œêµ¬ë“¤ì„ ë°ë¦¬ê³  ë‹¤ë…€ìš”. **VACTERL Association!**\n    - ë°˜ë“œì‹œ **Echocardiogram (Cardiac)** ê³¼ **Renal Ultrasound (Renal)** ë¥¼ í™•ì¸í•´ì•¼ í•©ë‹ˆë‹¤.\n    - *V*ertebral(spine xray), *A*nal atresia, *C*ardiac, *T*EF, *R*enal, *L*imb defects.\n## 2. Foreign Body Ingestion ğŸª™ğŸ”‹","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-1","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","diagnosis","tree"]}
{"chunk_type":"transcript_chunk","text":"ì‘ê¸‰ì‹¤ ë‹¨ê³¨ ì†ë‹˜ì…ë‹ˆë‹¤. \"ìš°ë¦¬ ì• ê°€ ë­˜ ì‚¼ì¼°ì–´ìš”!\" ğŸ˜±\nìœ„ì¹˜ëŠ” **Cricopharyngeus muscle** (ì‹ë„ ì…êµ¬)ì—ì„œ ê°€ì¥ ì˜ ê±¸ë¦½ë‹ˆë‹¤.\n- PA, LATERAL Xray ë¡œ workup ì‹œì‘\n### A. Coins (ë™ì „) ğŸª™\n- **X-ray Trick (Face on vs Side on) AP VIEW, LAT VIEW ë‘˜ë‹¤ í•´ì•¼ë¨!:**\n    - **Esophagus (ì‹ë„):** ì‹ë„ëŠ” ì•ë’¤ë¡œ ë‚©ì‘í•œ íŠœë¸Œì…ë‹ˆë‹¤. ë™ì „ì´ ì •ë©´ìœ¼ë¡œ ë³´ì„ (**Face on**, Full moon ğŸŒ•).\n    - **Trachea (ê¸°ë„):** ê¸°ë„ëŠ” C-shaped cartilage ë•Œë¬¸ì— ë™ì „ì´ ì˜†ìœ¼ë¡œ ì„­ë‹ˆë‹¤ (**Side on**, Slit/Line â–).\n- **Management:**\n    - **Symptomatic:** ë‹¹ì¥ **Flexible Endoscopy**ë¡œ ì œê±°.\n    - **Asymptomatic & in Esophagus:** 24ì‹œê°„ ê´€ì°° (ìì—° ë°°ì¶œ ê¸°ëŒ€).\n    - **In Stomach:** ê·¸ëƒ¥ ë‘ë©´ ëŒ€ë³€ìœ¼ë¡œ ë‚˜ì˜µë‹ˆë‹¤. (Pass freely).\n### B. Button Batteries (ë‹¨ì¶”í˜• ì „ì§€) ğŸ”‹â˜ ï¸ â˜… EMERGENCY â˜…\n- **Why dangerous?** ì¹¨(Saliva)ê³¼ ë§Œë‚˜ë©´ ì „ê¸° íšŒë¡œê°€ í˜•ì„±ë˜ì–´ **Liquefactive Necrosis** (Fluid ë…¹ìŒ)ë¥¼ ìœ ë°œ. ì‹ë„ ì²œê³µ(Perforation)ê¹Œì§€ **2ì‹œê°„**ì´ë©´ ì¶©ë¶„í•©ë‹ˆë‹¤. ğŸ”¥\n- **Management:**\n    - **Esophagus:** **IMMEDIATE Endoscopic Removal**. 1ì´ˆë„ ì§€ì²´ ê¸ˆì§€.\n    - **Stomach:** ì¦ìƒì´ ìˆê±°ë‚˜, ì¼ì • í¬ê¸° ì´ìƒì´ë©´ ì œê±°. (í•˜ì§€ë§Œ ì‹ë„ì— ìˆì„ ë•Œê°€ í›¨ì”¬ ìœ„í—˜í•¨).\n### C. Magnets (ìì„) ğŸ§²\n- í•œ ê°œëŠ” ê´œì°®ì§€ë§Œ, **ë‘ ê°œ ì´ìƒ**ì´ë©´ ì„œë¡œ ë‹¤ë¥¸ ì¥(Bowel) loopë¥¼ ì‚¬ì´ì— ë‘ê³  ë”± ë¶™ì–´ë²„ë¦½ë‹ˆë‹¤.\n- **Pressure Necrosis â†’ Perforation**.\n- **Multiple magnets = Removal**.\n## 3. The Crying Infant: Colic vs. Pathology ğŸ˜­\nì•„ê¸°ê°€ ìš´ë‹¤ê³  ë‹¤ ì•„í”ˆ ê±´ ì•„ë‹™ë‹ˆë‹¤. í•˜ì§€ë§Œ ì˜ì‚¬ëŠ” **Red Flags**ë¥¼ ì°¾ì•„ì•¼ í•˜ì£ .\n### A. Colic (ì˜ì•„ ì‚°í†µ) - The \"Rule of 3s\"\n- **Definition:** ê±´ê°•í•œ(Healthy) ì•„ê¸°ê°€, ì˜ ë¨¹ê³  ëª¸ë¬´ê²Œë„ ì˜ ëŠëŠ”ë° ì›ë‹ˆë‹¤.\n- **Rule of 3s:**\n    - í•˜ë£¨ **3**ì‹œê°„ ì´ìƒ\n    - ì¼ì£¼ì¼ì— **3**ì¼ ì´ìƒ\n    - ìƒí›„ **3**ê°œì›” ë¯¸ë§Œ\n- **Management:** **Reassurance**. ë¶€ëª¨ë¥¼ ì•ˆì‹¬ì‹œí‚¤ëŠ” ê²Œ ì¹˜ë£Œì…ë‹ˆë‹¤. (ë°±ìƒ‰ ì†ŒìŒ, ë“œë¼ì´ë¸Œ ë“±). ì‹œê°„ì´ ì•½ì…ë‹ˆë‹¤. ğŸ’Š\n### B. Differential Diagnosis (Red Flags) ğŸš©\n- ìš°ëŠ” ì•„ê¸°ì—ê²Œì„œ ë°˜ë“œì‹œ ì²´í¬í•´ì•¼ í•  ê²ƒë“¤ (From Top to Bottom):\n    - **Eye:** **Corneal Abrasion** (Fluorescein stainìœ¼ë¡œ í™•ì¸). ì•„ê¸°ê°€ ìê¸° ì†í†±ìœ¼ë¡œ ê¸ìŒ.\n    - **GI:** GERD, Intussusception (ë‹¤ë¦¬ ì›…í¬ë¦¼).\n    - **GU:** Testicular Torsion, Hernia.\n    - **Skin:** **Hair Tourniquet** (ë¨¸ë¦¬ì¹´ë½ì´ ë°œê°€ë½/ì„±ê¸°ë¥¼ ê°ì•„ ê´´ì‚¬ì‹œí‚´). ì–‘ë§ ë²—ê²¨ì„œ ê¼­ í™•ì¸! ğŸ§¦âœ‚ï¸\n    - **Trauma:** Non-accidental trauma (Abuse).\n## 4. Constipation (ë³€ë¹„) ğŸ’©\n### A. Functional Constipation (Most Common)\n- **Cycle of Pain:** ë”±ë”±í•œ ë˜¥ ì‹¸ë‹¤ ì•„í”” ğŸ˜– â†’ ì°¸ìŒ (Withholding) â†’ ë˜¥ì´ ë” ì»¤ì§€ê³  ë”±ë”±í•´ì§ â†’ ë” ì•„í”” ğŸ˜­.\n- **Treatment:** Diet (Fiber, Water) + Laxatives (**PEG/Miralax**). í–‰ë™ êµì •.","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-21","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### B. Hirschsprung Disease (ì„ ì²œì„± ê±°ëŒ€ê²°ì¥)\n- **Pathophysiology:** Neural crest cellì´ ì§ì¥(Rectum) ëê¹Œì§€ ì´ë™ ì‹¤íŒ¨ â†’ **Aganglionic segment** (ì‹ ê²½ì ˆ ì—†ìŒ) â†’ ì¥ì´ ì´ì™„ì„ ëª»í•˜ê³  ê½‰ ìˆ˜ì¶•í•´ ìˆìŒ.\n- **Clues:**\n    - ìƒí›„ **48ì‹œê°„** ë‚´ íƒœë³€(Meconium) ë°°ì¶œ ì‹¤íŒ¨.\n    - **Rectal Exam:** ì†ê°€ë½ ë„£ì—ˆë‹¤ ë¹¼ë©´ **\"Explosive stool\"** ğŸŒ‹ (ë§‰í˜”ë˜ ëŒì´ í„°ì§).\n    - **Down Syndrome**ê³¼ ì—°ê´€.\n- **Diagnosis:**\n    - Sick infant, 48ì‹œê°„ì´ë‚´ ëª»ì‹¸ë©´ ê·¸ë•ŒëŠ” healthy constipationì´ë¼ê³  ìƒê°í•˜ì§€ë§ê³  workupí•´ì•¼ë¨!\n    1. **Contrast Enema:** **Transition Zone** (ì¢ì€ ë³‘ë³€ ë¶€ìœ„ì™€ ëŠ˜ì–´ë‚œ ì •ìƒ ë¶€ìœ„ì˜ ê²½ê³„) í™•ì¸.\n    2. **Suction Rectal Biopsy (Gold Standard):** ì‹ ê²½ì ˆ ì„¸í¬(Ganglion) ë¶€ì¬ í™•ì¸.\n## 5. Vomiting: The \"Colors\" Matter ğŸ¤®ğŸ¨\n### A. GERD (healthy vs pathologic)\n- Happy spitter: Healthy\n    - LES bit loose\n    - spits up frequently\n    - ì˜ìëŒ\n    - Reassurance, NO MED, ë°¥ë¨¹ê³  ì„¸ì›Œë¼\n- Pathologic\n    - Irritable, ì˜ ì•ˆìëŒ\n    - Back arching\n    - Thickened feed (oatmeal), consider PPI (PPIëŠ” ê°ì—¼ìœ„í—˜ ë†’ì´ë¯€ë¡œ ì‹ ì¤‘í•˜ê²Œ ì‚¬ìš©)\nêµ¬í†  ìƒ‰ê¹”ì´ ì§„ë‹¨ëª…ì…ë‹ˆë‹¤. **Non-bilious (ìœ„ì¥ ë‚´ìš©ë¬¼)** vs **Bilious (ì´ˆë¡ìƒ‰, ë‹´ì¦™)**.\n### B. Pyloric Stenosis (ë¹„í›„ì„± ìœ ë¬¸í˜‘ì°©ì¦)\n- **Vomit:** **Non-bilious**, **Projectile** (ë¶„ìˆ˜í†  â›²). ë¨¹ìë§ˆì ë¿œìŒ.\n- **Patient:** ìƒí›„ 3-6ì£¼, First born male ğŸ‘¦. ë°°ê°€ ê³ íŒŒì„œ í† í•˜ê³  ë˜ ë¨¹ìœ¼ë ¤ í•¨ (Hungry vomiter).\n- **Exam:** ëª…ì¹˜(Epigastrium)ì—ì„œ **\"Olive-shaped mass\"** ğŸ«’ ì´‰ì§„ë¨.\n- **Labs:** **Hypochloremic, Hypokalemic Metabolic Alkalosis** (ìœ„ì‚° HClì„ ë‹¤ í† í•´ì„œ).\n- **Diagnosis:** **Abdominal Ultrasound** (Target sign / Donut sign ğŸ©).\n- **Treatment:**\n    1. **IV Fluids & Electrolyte Correction** (First Step! ìˆ˜ìˆ ë³´ë‹¤ íƒˆìˆ˜ êµì •ì´ ë¨¼ì €). ğŸ’§\n    2. **Pyloromyotomy** (Surgery).\n### C. Malrotation with Volvulus (ì¥íšŒì „ì´ìƒ ë° ì¤‘ì¥ê¼¬ì„) â˜… EMERGENCY â˜…\n- **Vomit:** **Bilious (GREEN)** ğŸ¤¢. ì‹ ìƒì•„ì˜ ì´ˆë¡ìƒ‰ êµ¬í† ëŠ” ë¬´ì¡°ê±´ ì‘ê¸‰ ìˆ˜ìˆ  ë£°ì•„ì›ƒ!\n- **Pathophysiology:** ì¥ì´ ë±ƒì†ì—ì„œ íšŒì „ì„ ì˜ëª»í•´ì„œ ì—‰í‚´. **Ladd bands**ê°€ ì‹­ì´ì§€ì¥ì„ ëˆ„ë¦„ + í˜ˆê´€(SMA)ì´ ê¼¬ì—¬ì„œ ì¥ ê´´ì‚¬(Ischemia).\n- **Diagnosis:**\n    - Xray to ê°ë³„\n        - Double bubble? â†’ duodenal atresia\n        - Delayed passage of meconium, Rectal tone â†‘ ?, Dilated loops of bowel: Microcolon(enemaìƒ microcolon), Hirschsprung disease(enemaìƒ transition zone) (ë‘˜ì€ contrast enemaë¡œ ê°ë³„)\n        - NORMAL? MALROTATIONì˜ì‹¬í•˜ê¸° ìœ„í•´ UPPER GI SERIES\n    - **Upper GI Series (Contrast study):** **\"Corkscrew appearance\"** (ë‚˜ì‚¬ëª¨ì–‘ ğŸŒªï¸) / Right sided Treitz ligament (ì›ë˜ ì™¼ìª½ì´ì–´ì•¼ë¨) â†’ ì‘ê¸‰ ìˆ˜ìˆ !\n- **Treatment:** **Ladd Procedure** (Emergency Surgery). ì‹œê°„ ì‹¸ì›€ (Time is bowel). â³\n## 6. Vomiting Variants & Others\n### A. Cyclical Vomiting Syndrome\n- **Concept:** ì†Œì•„ì˜ **Migraine (í¸ë‘í†µ)** ë³€ì´í˜•.\n- **Symptoms:** ì£¼ê¸°ì ìœ¼ë¡œ ë¯¸ì¹œ ë“¯ì´ í† í•¨ (Stereotypical episodes). í‰ì†Œì—” ë©€ì©¡.\n- **Family Hx:** ë¶€ëª¨ê°€ í¸ë‘í†µì´ ìˆëŠ” ê²½ìš°ê°€ ë§ìŒ.\n- **Tx:** Sumatriptan, Ondansetron, Hydration.\n### B. FPIAP (Food Protein-Induced Allergic Proctocolitis)\n- **Vignette:** ê±´ê°•í•´ ë³´ì´ëŠ” ì•„ê¸° ê¸°ì €ê·€ì— **í”¼ ì„ì¸ ë˜¥(Bloody stool)**. ğŸ©¸\n- **Cause:** **Milk** or **Soy** protein allergy. (IgE mediatedê°€ ì•„ë‹˜).\n- **Tx:** ì—„ë§ˆê°€ ìœ ì œí’ˆ/ì½© ì„­ì·¨ ì¤‘ë‹¨ (ëª¨ìœ  ìˆ˜ìœ  ì‹œ) ë˜ëŠ” **Hydrolyzed Formula** (ê°€ìˆ˜ë¶„í•´ ë¶„ìœ )ë¡œ êµì²´.\n### C. Necrotizing Enterocolitis (NEC)\n- **Patient:** **Premature (ë¯¸ìˆ™ì•„)** ğŸ‘¶.\n- **X-ray:** **Pneumatosis intestinalis** (ì¥ ë²½ì— ê³µê¸° ë°©ìš¸ ğŸ«§).\n- **Tx:** NPO (ê¸ˆì‹), Antibiotics, Surgery if perforated.","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-41","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"## 7. Breastfeeding Jaundice vs. Breast Milk Jaundice ğŸŸ¡\n### Breast feeding benefits\n- ì—„ë§ˆì—ê²Œ ì¢‹ì€ì \n    - uterine contractionì¼ìœ¼í‚´ â†’ atony risk â†“\n- ì• ê¸°ì—ê²Œ ì¢‹ì€ì \n    - NEC, ì¤‘ì´ì—¼ ë“± ê°ì—¼ì— ì¢‹ìŒ\n- Contraindication\n    - ì ‘ì´‰ì£¼ì˜ (active untreated TB,  herpetic breast lesions\n    - ìš°ìœ í†µí•´ì„œ ë„˜ì–´ê° (maternal HIV, chemo, radiation, drugs, alcohol)\n    - ì• ê¸°: galactosemia\n    - NOTE) HEP B, HEP CëŠ” ê´œì°®ìŒ! ê·¸ ë°”ì´ëŸ¬ìŠ¤ëŠ” ì•ˆë„˜ì–´ê°\n    - NOTE) ì—„ë§ˆê°€ ë§ˆì•½ì¹˜ë£Œ methadoneí•˜ê³  ìˆë‹¤ë©´ ëª¨ìœ ìˆ˜ìœ í•¨. ì• ê¸°ë„ methadone ë„˜ì–´ê°€ì„œ withdrawl sx ì¤„ì—¬ì¤Œ.\nì´ê±° ì¡±ë³´ì…ë‹ˆë‹¤. í—·ê°ˆë¦¬ê¸° ë”± ì¢‹ìŒ.\n| **Feature** | **Breastfeeding Jaundice (ìˆ˜ìœ  ë¶€ì¡± í™©ë‹¬)** | **Breast Milk Jaundice (ëª¨ìœ  í™©ë‹¬)** |\n| --- | --- | --- |\n| **Mechanism** | **Lactation Failure**. ì –ì„ ëª» ë¨¹ì–´ì„œ íƒˆìˆ˜ + ë°°ë³€ ê°ì†Œ â†’ Bilirubin ì¬í¡ìˆ˜ ì¦ê°€. | ëª¨ìœ  ë‚´ ì„±ë¶„(Enzyme)ì´ Bilirubin ëŒ€ì‚¬ ë°©í•´. ì„±ë¶„ì´ ë¹Œë¦¬ë£¨ë¹ˆì„ deconjugationí•´ì„œ ì¬í¡ìˆ˜ë˜ì–´ ì¬í™œìš©ë˜ê²Œí•¨. |\n| **Timing** | ìƒí›„ **1ì£¼ ì´ë‚´** (ì´ˆê¸°). | ìƒí›„ **1ì£¼ ì´í›„** (í›„ê¸°). |\n| **Baby Status** | íƒˆìˆ˜ ì§•í›„ (Dehydrated), ì²´ì¤‘ ê°ì†Œ. ğŸ“‰ | ê±´ê°•í•¨, ì²´ì¤‘ ì¦ê°€ ì¢‹ìŒ. ğŸ‘¶ğŸ‘ |\n| **Treatment** | ìˆ˜ìœ  íšŸìˆ˜ ì¦ê°€, ìˆ˜ìœ  ìì„¸ êµì •. (Feed more!) | ëª¨ìœ  ê³„ì† ë¨¹ì„ (ìˆ˜ì¹˜ ë„ˆë¬´ ë†’ìœ¼ë©´ ì ì‹œ ì¤‘ë‹¨). |\n## 8. Dehydration\n- normal\n    - normal new borns ì²´ì¤‘ì´ ì²˜ìŒì— ì¢€ ë¹ ì§ ì²« 5ì¼.\n    - ì˜¤ì¤Œ ë§ì´ì‹¸ì„œ ê·¸ëŸ¼. ì•ˆì‹¬ (ê·¸ë˜ë„ 10%ì”© ë¹ ì§€ë©´ ì¢€ ê±±ì •â€¦)\n- Mild\n    - 3-5% volume loss\n    - hydration, oral\n- Moderate\n    - 6-9%\n    - Physical signs ë³´ì´ê¸° ì‹œì‘í•¨.(decreased skin tugor. í”¼ë¶€ ê¼¬ì§‘ì–´ë´¤ëŠ”ë° ë°”ë¡œ ì•ˆë‚˜ì˜´, decreased urine, decreased capillaryâ€¦)\n- Severe\n    - 10-15%\n    - cool Extremeties, sunken fontanelle, capillary refill >3, cracked lips\n- Moderate-Severe: ìˆ˜ì•¡ **20ML/kg â˜…â˜… ì•”ê¸°í•´ì•¼ë¨.**\n- Wet diapers rule: ì²« 1ì£¼ì¼ì—ëŠ” ë‚ ì§œë³„ë¡œ wet diaper ê°œìˆ˜ê°€ ë§ì•„ì•¼ë¨. 3ì¼ëœ ì• ê¸°ëŠ” wet diaper 3ê°œì´ìƒ..! ì¼ì£¼ì¼ ë„˜ì–´ê°€ë©´ 6-7ê°œ ì´ìƒì´ì—¬ì•¼ë¨.\n# ğŸ”¥ Rapid Fire Recap (Audio-Based High Yield)\në¹ ë¥´ê²Œ ë³µìŠµí•˜ê³  ë§ˆë¬´ë¦¬í•©ì‹œë‹¤!\n- **Vignette:** ì‹ ìƒì•„, ì²« ìˆ˜ìœ  ì‹œ **Choking**, ì…ì— ê±°í’ˆ(Frothy). NG tube ì•ˆ ë“¤ì–´ê°.\n    - **Diagnosis:** **Tracheoesophageal Fistula (TEF)**.\n    - **Next Step:** CXR (Coiled tube) & Look for **VACTERL** (Kidney US, Echo).\n- **Vignette:** 2ì‚´ ì•„ê¸°, **ë™ì „(Coin)** ì‚¼í‚´. X-ray ì •ë©´ì—ì„œ ë™ê·¸ë—ê²Œ(Face on) ë³´ì„.\n    - **Location:** **Esophagus**.\n    - **Action:** ì¦ìƒ ìˆìœ¼ë©´ **Removal**. ì—†ìœ¼ë©´ 24ì‹œê°„ ê´€ì°°.\n- **Vignette:** **Button Battery** ì‚¼í‚´. ì‹ë„ì— ìœ„ì¹˜.\n    - **Action:** **EMERGENCY Endoscopy**. (2ì‹œê°„ ë‚´ ì²œê³µ ìœ„í—˜ ğŸ”¥).\n- **Vignette:** ìƒí›„ 4ì£¼, **Projectile Vomiting**, **Non-bilious**. ë°°ì—ì„œ ì˜¬ë¦¬ë¸Œ(Olive) ë§Œì ¸ì§.\n    - **Diagnosis:** **Pyloric Stenosis**.\n    - **First Step:** **IV Fluids/Electrolytes** (Alkalosis êµì • ë¨¼ì €!).\n    - **Diagnostic Test:** Abdominal US.\n- **Vignette:** ì‹ ìƒì•„, **Bilious (Green)** Vomiting. ë³µë¶€ íŒ½ë§Œ.\n    - **Diagnosis:** **Malrotation with Volvulus**.\n    - **Diagnostic Test:** **Upper GI Series** (Corkscrew sign).\n    - **Action:** **Surgery (Ladd procedure)** ASAP.\n- **Vignette:** ìƒí›„ 24ì‹œê°„ ë‚´ íƒœë³€ ë°°ì¶œ ì•ˆ ë¨. í•­ë¬¸ ê²€ì‚¬ ì‹œ **Explosive stool**.\n    - **Diagnosis:** **Hirschsprung Disease**.\n    - **Gold Standard:** **Rectal Suction Biopsy**.\n- **Vignette:** ë¯¸ìˆ™ì•„(Preterm), í˜ˆë³€, X-rayì—ì„œ ì¥ë²½ ë‚´ ê³µê¸°(Pneumatosis intestinalis).\n    - **Diagnosis:** **Necrotizing Enterocolitis (NEC)**.\n    - **Action:** NPO, IV Antibiotics.\n- **Vignette:** ìš°ëŠ” ì•„ê¸° ë°œê°€ë½ì´ ë¶‰ê³  ë¶€ì–´ìˆìŒ. ë¨¸ë¦¬ì¹´ë½ì´ ê°ê²¨ìˆìŒ.\n    - **Diagnosis:** **Hair Tourniquet**.\n    - **Action:** ì¦‰ì‹œ ì œê±° (Unwind or Cut).\nìŒ¤, ì˜¤ëŠ˜ ë‚´ìš©ì€ ì—¬ê¸°ê¹Œì§€! ğŸ\nPediatric GIëŠ” **\"Green vomit = Surgery\"**, **\"Battery in esophagus = Emergency\"** ê³µì‹ë§Œ ë¨¸ë¦¬ì— ë°•ê³  ê°€ë„ ì ˆë°˜ì€ ë¨¹ê³  ë“¤ì–´ê°‘ë‹ˆë‹¤. ë°©ì½• ê°€ì„œ ë§›ìˆëŠ” ê±° ë“œì‹œë ¤ë©´(Spicy food! ğŸŒ¶ï¸) ì•„ê¸°ë“¤ ë°° ì•„í”ˆ ê±´ ë¹¨ë¦¬ í•´ê²°í•´ ì£¼ê³  ê°€ìêµ¬ìš”.\në‚¨ì€ ê³µë¶€ë„ í™”ì´íŒ…! ë‹¥í„° í‚´(Kim)! ğŸ’ªâœ¨\n# ğŸ©º Pediatric GI Emergencies: The \"Plumbing Problems\" of the Gut\n## ğŸŒŸ One Line Vibe & Summary","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-61","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"\"ë§ ëª» í•˜ëŠ” ì•„ê¸°ë“¤ì´ í† í•˜ê³  ë°° ì•„íŒŒí•  ë•Œ, **Anatomyì™€ Pathologyì˜ ì¶¤(Dance)**ì„ ì´í•´í•´ì„œ Surgical Emergencyë¥¼ ë†“ì¹˜ì§€ ì•ŠëŠ” ê²ƒì´ í•µì‹¬! ğŸš‘ğŸ‘¶\"\nì´ ê°•ì˜ëŠ” Pediatric GI Emergencies ì¤‘ì—ì„œë„ ë†“ì¹˜ë©´ ì¹˜ëª…ì ì¸(Must-know) ì„¸ ê°€ì§€ ì§ˆí™˜: **Malrotation with Midgut Volvulus**, **Intussusception**, **Necrotizing Enterocolitis (NEC)**ë¥¼ ë‹¤ë£¹ë‹ˆë‹¤.\n## ğŸŒ³ Top-down Classification (Structure)\nMedical Questionì´ë¯€ë¡œ ì „ì²´ì ì¸ ê·¸ë¦¼ì„ ë¨¼ì € ì¡ì•„ë“œë¦´ê²Œìš”. ì´ ì§ˆí™˜ë“¤ì€ Pediatric Surgery íŒŒíŠ¸ì˜ Acute Abdomenì— í•´ë‹¹í•©ë‹ˆë‹¤.\nPlaintext\n`Pediatric GI Disorders\nâ”œâ”€â”€ Congenital / Structural Defects\nâ”‚   â”œâ”€â”€ Esophageal Atresia / TEF\nâ”‚   â”œâ”€â”€ Hypertrophic Pyloric Stenosis\nâ”‚   â””â”€â”€ â˜… Malrotation with Midgut Volvulus (Topic 1)\nâ”œâ”€â”€ Acquired / Functional Obstruction\nâ”‚   â”œâ”€â”€ â˜… Intussusception (Topic 2)\nâ”‚   â”œâ”€â”€ Hirschsprung Disease\nâ”‚   â””â”€â”€ Meconium Ileus\nâ””â”€â”€ Inflammatory / Ischemic\n    â””â”€â”€ â˜… Necrotizing Enterocolitis (NEC) (Topic 3)`\n## 1. Malrotation with Midgut Volvulus (Section 14.8)\n**\"The Twisted Garden Hose\"** ğŸŒ€\n### ğŸ“ Clinical Vignette (The Doorway Thought)\n- **Patient:** ìƒí›„ 1ê°œì›” ë¯¸ë§Œì˜ ì‹ ìƒì•„ (Neonate).\n- **Symptom:** ë¶€ëª¨ëŠ” ì• ê°€ ì•„íŒŒ ë³´ì¸ë‹¤ê³  í•˜ê³ , ì•„ê¸°ëŠ” **Bilious Emesis (Green vomit)**ë¥¼ í•©ë‹ˆë‹¤. ë°°ëŠ” ë¶ˆëŸ¬ ë³´ì„ (Distended).\n- **Concept:** **\"Bilious emesis in a neonate is Midgut Volvulus until proven otherwise.\"** (ì¦ëª…ë˜ê¸° ì „ê¹Œì§„ ë¬´ì¡°ê±´ Volvulusë¡œ ê°„ì£¼!)\n    - ì´ê²Œ ì™œ ì¤‘ìš”í•˜ëƒë©´, ê·¸ëƒ¥ ë‘ë©´ ì¥ì´ ì©ì–´ì„œ(Necrosis) ì•„ì´ë¥¼ ìƒì„ ìˆ˜ë„ ìˆëŠ” ì´ˆì‘ê¸‰ ìƒí™©ì´ê¸° ë•Œë¬¸ì…ë‹ˆë‹¤. \"Time is bowel.\" â°ğŸ’©\n### ğŸ§¬ Pathophysiology (The Embryology Flashback)\níƒœì•„ ë°œë‹¬ ê³¼ì •(Week 10)ì—ì„œ ì¥ì´ ë°° ë°–ìœ¼ë¡œ ë‚˜ê°”ë‹¤ê°€ ë‹¤ì‹œ ë“¤ì–´ì˜¤ë©´ì„œ **270ë„ ë°˜ì‹œê³„ ë°©í–¥(Counter-clockwise) íšŒì „**ì„ í•´ì•¼ í•©ë‹ˆë‹¤. ì´ê²Œ ì œëŒ€ë¡œ ì•ˆ ë˜ë©´ ë¬¸ì œê°€ ìƒê¹ë‹ˆë‹¤.\n1. **Ladd Bands:** Cecumì´ ì—‰ëš±í•œ ê³³(Right Upper Quadrantê°€ ì•„ë‹Œ ê³³)ì— ìœ„ì¹˜í•˜ë©´ì„œ, ë¹„ì •ìƒì ì¸ ë°´ë“œ(Ladd bands)ê°€ Duodenumì„ ê°€ë¡œì§ˆëŸ¬ ë§‰ì•„ë²„ë¦¼ â†’ **Obstruction**.\n2. **Narrow Mesenteric Base:** ì •ìƒì ì¸ ì¥ì€ ë„“ì€ ì»¤íŠ¼ ë´‰(Broad curtain rod)ì— ë§¤ë‹¬ë ¤ ìˆëŠ”ë°, ì–˜ëŠ” ì•„ì£¼ ì–‡ì€ ì „ì„  í•˜ë‚˜ì— ê±°ëŒ€í•œ ìƒ¹ë“¤ë¦¬ì—ê°€ ë§¤ë‹¬ë¦° ê¼´ì…ë‹ˆë‹¤.\n    - ê²°ê³¼: ë¶ˆì•ˆì •í•˜ë‹ˆê¹Œ **SMA (Superior Mesenteric Artery)**ë¥¼ ì¶•ìœ¼ë¡œ ë±…ê¸€ ë•ë‹ˆë‹¤. ì´ê²Œ ë°”ë¡œ **Volvulus**! í˜ˆë¥˜ê°€ ëŠê¸°ë‹ˆ **Ischemia â†’ Gut death**.\n### ğŸ” Diagnosis & Workup\n1. **X-ray (First Step):**\n    - ë³´í†µ **Double Bubble sign**ì´ ë³´ì¼ ìˆ˜ ìˆì§€ë§Œ, **Normal**ë¡œ ë³´ì¼ ìˆ˜ë„ ìˆìŒ! (í•¨ì • ì£¼ì˜ âš ï¸)\n    - X-rayê°€ ì •ìƒì´ì–´ë„ ì´ˆë¡ìƒ‰ í† ë¥¼ í•œë‹¤ë©´ ë©ˆì¶”ë©´ ì•ˆ ë¨.\n2. **Upper GI Series (Gold Standard):**\n    - Trietz ligamentê°€ ì´ìƒí•œë° ìˆìŒ (ì™¼ìª½ì— ìˆì–´ì•¼í•˜ëŠ”ë° ì˜¤ë¥¸ìª½ì— ìˆìŒ.)\n    - ì¡°ì˜ì œë¥¼ ë¨¹ì´ê³  ì°ì–´ë³´ë©´ **\"Corkscrew appearance\"** (ë‚˜ì‚¬ ëª¨ì–‘)ê°€ ë³´ì„. ğŸŒªï¸\n    - Duodenumì´ ê¼¬ì—¬ìˆëŠ” ëª¨ìŠµ. ì´ ì†Œê²¬ì´ ë³´ì´ë©´ ê²Œì„ ë. í™•ì§„ì…ë‹ˆë‹¤.\n### ğŸ”ª Treatment\n- **Surgical Emergency:** í•´ ëœ¨ê¸¸ ê¸°ë‹¤ë¦¬ì§€ ì•ŠìŠµë‹ˆë‹¤. ë°”ë¡œ ìˆ˜ìˆ ë°©ìœ¼ë¡œ!\n- **Ladd Procedure:**\n    1. Untwist (Counter-clockwiseë¡œ ê¼¬ì¸ ê±¸ í’€ì–´ì¤Œ).\n    2. Ladd bandsë¥¼ ì˜ë¼ì¤Œ.\n    3. Mesenteryë¥¼ ë„“í˜€ì¤Œ (ë‹¤ì‹œ ì•ˆ ê¼¬ì´ê²Œ).\n    4. ìœ„ì¹˜ ì¬ë°°ì¹˜: Small bowelì€ ì˜¤ë¥¸ìª½, Colonì€ ì™¼ìª½ì— ë‘  (ì •ìƒì€ ì•„ë‹ˆì§€ë§Œ ì•ˆì „í•œ ë°°ì¹˜). + Appendectomy (ë§¹ì¥ ìœ„ì¹˜ê°€ ì´ìƒí•´ì§€ë‹ˆê¹Œ ë‚˜ì¤‘ì„ ìœ„í•´ ë¯¸ë¦¬ ì œê±°).","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-81","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"## 2. Intussusception 6mo-3yr\n**\"The Telescoping Bowel\"** ğŸ”­\n### ğŸ“ Clinical Vignette\n- **Patient:** 6ê°œì›” ~ 3ì„¸ (ê°€ì¥ í”í•¨).\n- **Symptom:**\n    - **Intermittent Colicky Pain:** ë©€ì©¡í•˜ê²Œ ì˜ ë†€ë‹¤ê°€ ê°‘ìê¸° ìì§€ëŸ¬ì§€ê²Œ ìš¸ë©´ì„œ **ë‹¤ë¦¬ë¥¼ ë°° ìª½ìœ¼ë¡œ ëŒì–´ë‹¹ê¹€ (Knees to chest)**. 10~20ë¶„ ë’¤ì—” ì–¸ì œ ê·¸ë¬ëƒëŠ” ë“¯ ë‹¤ì‹œ ë†ˆ. (ì´ê²Œ ë¶€ëª¨ë‹˜ì´ë‚˜ ì˜ì‚¬ë¥¼ í—·ê°ˆë¦¬ê²Œ í•¨!) ğŸ­\n    - **Currant Jelly Stool:** ëŠ¦ê²Œ ë‚˜íƒ€ë‚˜ëŠ” ì†Œê²¬(Late finding). ì ì•¡(Mucosa)ê³¼ í”¼ê°€ ì„ì¸ ë³€. ì´ê±´ ë‚˜ìœ ì§•ì¡°(Bad sign).\n- **Exam:** ìš°ì¸¡ ë°°(Right side)ì—ì„œ **\"Sausage-shaped mass\"**ê°€ ë§Œì ¸ì§. ë°˜ë©´ Right Lower QuadrantëŠ” í…… ë¹„ì–´ìˆëŠ” ëŠë‚Œ (**Dance sign**).\n### ğŸ§¬ Pathophysiology\n- ì¥ì˜ í•œ ë¶€ë¶„ì´ ë’·ë¶€ë¶„ ì•ˆìœ¼ë¡œ ë§ì›ê²½ì²˜ëŸ¼ ë§ë ¤ ë“¤ì–´ê°€ëŠ” ê²ƒ (Telescoping). ì£¼ë¡œ **Ileumì´ Cecumìœ¼ë¡œ (Ileocecal)** ë“¤ì–´ê°‘ë‹ˆë‹¤.\n- **Mechanism:** ë§ë ¤ ë“¤ì–´ê°€ë©´ì„œ Mesenteryë„ ê°™ì´ ëŒê³  ë“¤ì–´ê° â†’ ì •ë§¥(Vein)ì´ ëˆŒë¦¼ â†’ ë¶“ê¸°(Edema) â†’ ë™ë§¥(Artery) ì°¨ë‹¨ â†’ **Ischemia**.\n- **Lead Point (ë¬´ì—‡ì´ ëŒê³  ë“¤ì–´ê°€ëŠ”ê°€?):**\n    - **Typical Age (6mo-3y):** **Hypertrophied Peyer's Patches** (ì¥ë‚´ ë¦¼í”„ ì¡°ì§). ë°”ì´ëŸ¬ìŠ¤ ê°ì—¼(ê°ê¸°, ì¥ì—¼) í›„ì— ë¦¼í”„ì ˆì´ ë¶€ì–´ì„œ Lead pointê°€ ë¨.\n    - **Older Kids (>6y):** ë¹„ì •ìƒì ì¸ êµ¬ì¡°ë¬¼ ì˜ì‹¬. **Meckel's Diverticulum**, Polyp, Tumor (Lymphoma) ë“± **Pathologic Lead Point**ë¥¼ ì°¾ì•„ì•¼ í•¨.\n### ğŸ” Diagnosis & Treatment (One Shot!)\n- **Ultrasound (Best Initial):** **Target sign** (ê³¼ë… ëª¨ì–‘) ë˜ëŠ” **Bull's eye lesion**. (ë„ë„› ì•ˆì— ë„ë„›ì´ ìˆëŠ” ëª¨ì–‘ ğŸ©).\n- **Air or Contrast Enema (Gold Standard & Treatment):**\n    - ì§„ë‹¨ê³¼ ë™ì‹œì— ì¹˜ë£Œ! í•­ë¬¸ìœ¼ë¡œ ê³µê¸°ë‚˜ ì¡°ì˜ì œë¥¼ ì´ì„œ ì••ë ¥ìœ¼ë¡œ ë§ë ¤ ë“¤ì–´ê°„ ì¥ì„ ë°€ì–´ëƒ„ (Un-telescoping).\n    - **ì£¼ì˜ (Contraindication):** **Peritonitis** ì‚¬ì¸ì´ ìˆê±°ë‚˜ X-rayì—ì„œ **Free Air**ê°€ ë³´ì´ë©´ ì ˆëŒ€ ê¸ˆê¸°! (ì¥ í„°ì§€ëŠ”ë° ì••ë ¥ ì£¼ë©´ í°ì¼ ë‚¨ ğŸ’£). ì´ë• ë°”ë¡œ ìˆ˜ìˆ (Surgery).\n## 3. Necrotizing Enterocolitis (NEC) (Section 14.9)\n**\"The Premie's Nightmare\"** ğŸ‘»\n### ğŸ“ Clinical Vignette\n- **Patient:** **Premature (ë¯¸ìˆ™ì•„)**, Low birth weight.\n- **Risk Factor:** **Formula feeding (ë¶„ìœ  ìˆ˜ìœ )**. (ëª¨ìœ ëŠ” ë©´ì—­ ì„±ë¶„ì´ ìˆì–´ì„œ ë³´í˜¸ íš¨ê³¼ê°€ ìˆìŒ ğŸ›¡ï¸).\n- **Symptom:** ì˜ ë¨¹ë˜ ë¯¸ìˆ™ì•„ê°€ ê°‘ìê¸° ë°°ê°€ ë¶ˆëŸ¬ì˜¤ê³ (Distension), ìˆ˜ìœ ë¥¼ ëª»í•˜ê³ (Feeding intolerance), í˜ˆë³€(Bloody stool)ì„ ë´„.\n### ğŸ§¬ Pathophysiology\n- ë¯¸ìˆ™ì•„ì˜ ì¥ì€ ì•½í•¨ + ë¶„ìœ  ìˆ˜ìœ (ë°•í…Œë¦¬ì•„ê°€ ì¢‹ì•„í•¨) â†’ ì¥ ì ë§‰ ì¹¨íˆ¬ â†’ ì—¼ì¦ ë° ê´´ì‚¬(Necrosis).\n- **Formula feeding**ì´ Breast milkë³´ë‹¤ ìœ„í—˜ë„ê°€ ë†’ìŒ.\n### ğŸ” Diagnosis\n- **Abdominal X-ray:**\n    - **Pneumatosis Intestinalis:** ì¥ ë²½ ì•ˆì— ê³µê¸°ê°€ ë“¤ì–´ê°„ ê²ƒ. (Train track lucency ğŸš‚). ê°€ì¥ íŠ¹ì§•ì ì¸ ì†Œê²¬.\n    - **Portal Venous Gas:** ì¥ ë²½ì˜ ê°€ìŠ¤ê°€ í˜ˆê´€ íƒ€ê³  ê°„(Liver)ê¹Œì§€ ê°. (Very bad sign).\n    - **Pneumoperitoneum:** ì¥ì´ í„°ì ¸ì„œ íš¡ê²©ë§‰ ì•„ë˜ì— ê³µê¸°ê°€ ëœ¸ (Free air). â†’ **Surgical Emergency**.\n### ğŸ’Š Management\n1. **Medical (ì´ˆê¸°):**\n    - **Stop Feeds (NPO):** ì¥ì„ ì‰¬ê²Œ í•´ì¤Œ.\n    - **NG Tube:** Decompression.\n    - **Antibiotics:** Broad-spectrum.\n    - **IV Fluids/TPN.**\n2. **Surgical (ì‘ê¸‰):**\n    - *Perforation (Free air)**ì´ ë³´ì´ê±°ë‚˜, ë‚´ê³¼ì  ì¹˜ë£Œì—ë„ ë¶ˆêµ¬í•˜ê³  ìƒíƒœê°€ ë‚˜ë¹ ì§€ë©´ ê´´ì‚¬ëœ ì¥ì„ ì˜ë¼ëƒ„ (Resection). ë‹¨ì ì€ ë‚˜ì¤‘ì— Short Bowel Syndromeì´ ì˜¬ ìˆ˜ ìˆìŒ.","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-101","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_summary","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\nì‹œí—˜ ì§ì „ ì´ê²ƒë§Œì€ ê¼­ ê¸°ì–µí•˜ì„¸ìš”! âš¡ï¸\n| **Feature** | **Malrotation w/ Volvulus ğŸŒ€** | **Intussusception ğŸ”­** | **Necrotizing Enterocolitis (NEC) ğŸ’€** |\n| --- | --- | --- | --- |\n| **Typical Patient** | **Neonate (<1 mo)** | **6mo ~ 3yo** | **Premature Infant** |\n| **Key Symptom** | **Bilious Emesis (Green!)** ğŸ¤® | **Colicky Pain** (Knees to chest), Currant Jelly Stool | Abdominal Distension, Bloody stool |\n| **Pathophysiology** | Rotation ì‹¤íŒ¨ + Ladd bands | Telescoping (Lymphoid hyperplasia) | Ischemia + Bacterial invasion (Formula) |\n| **Diagnostic Sign** | **Corkscrew** (UGI series) | **Target Sign** (US), Sausage Mass | **Pneumatosis Intestinalis** (X-ray) |\n| **Gold Standard/Tx** | **Ladd Procedure** (Surgery) | **Air/Contrast Enema** | NPO + Abx (Medical) â†’ Surgery if perf |\n| **Key Vibe/Pearl** | **\"Time is Bowel\"** (Twisted hose) | **Intermittent pain** is tricky! | **Breast milk is protective** ğŸ¤± |\n### ğŸ‘¨â€ğŸ« Tutor's Note:\n- **Age is the biggest clue.** 1ê°œì›” ë¯¸ë§Œì´ë©´ Volvulus, 6ê°œì›”~3ì„¸ë©´ Intussusception, NICUì— ìˆëŠ” ë¯¸ìˆ™ì•„ë©´ NEC. ë‚˜ì´ë¥¼ ë¨¼ì € ë³´ê³  ë“¤ì–´ê°€ì„¸ìš”.\n- **Green Vomit = Emergency.** ì‹ ìƒì•„ì˜ ì´ˆë¡ìƒ‰ í† ëŠ” ì ˆëŒ€ ë¬´ì‹œí•˜ë©´ ì•ˆ ë©ë‹ˆë‹¤.\n- **Enemaì˜ ì´ì¤‘ ì—­í• :** Intussusceptionì—ì„œ EnemaëŠ” ì§„ë‹¨ì´ì ì¹˜ë£Œì…ë‹ˆë‹¤. (Therapeutic & Diagnostic).\nStep 2 CK ì¤€ë¹„ íŒŒì´íŒ…ì…ë‹ˆë‹¤! ì´ ì„¸ ê°€ì§€ ì‹œë‚˜ë¦¬ì˜¤ë§Œ ë¨¸ë¦¿ì†ì— í™•ì‹¤íˆ ê·¸ë ¤ë‘ë©´ Pediatric GI ë¬¸ì œë“¤ì€ ë‹¤ ë§ì¶œ ìˆ˜ ìˆìŠµë‹ˆë‹¤! ğŸ‘Š\n**One Line Vibe:** ğŸ‘¶ ì‹ ìƒì•„ í™©ë‹¬ë¶€í„° ì¥íìƒ‰ê¹Œì§€, ìƒ‰ê¹”(Yellow vs Green)ê³¼ íƒ€ì´ë°(Timing)ìœ¼ë¡œ ìŠ¹ë¶€ ë³´ëŠ” USMLE Step 2 ì¡±ì§‘ê²Œ ê°•ì˜!","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-121","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","recap","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"\". I hope you're awake, because today we are walking into the nursery and frankly, the nursery scares me more than the trauma bay. Oh, come on. No, seriously. In the trauma bay, the pathology is usually screaming at you. In the nursery, it's subtle, it's silent, and if you miss it, the consequences are... well, they're catastrophic. That is a bit dramatic, but I'll admit, it's entirely fair.\"\n### **ğŸŒ³ Top-Down Classification: Neonatal GI Pathology**\nì´ ê°•ì˜ëŠ” í¬ê²Œ **Jaundice (Yellow)**ì™€ **Obstruction (Green)** ë‘ ê°€ì§€ í…Œë§ˆë¡œ ë‚˜ë‰©ë‹ˆë‹¤. ë¨¸ë¦¿ì†ì— ì´ ì§€ë„ë¥¼ ê·¸ë¦¬ê³  ì‹œì‘í•´ë´…ì‹œë‹¤!\nPlaintext\n`Neonatal Pathology\nâ”‚\nâ”œâ”€â”€ 1. Jaundice (Yellow Baby)\nâ”‚   â”œâ”€â”€ Indirect Hyperbilirubinemia (Unconjugated)\nâ”‚   â”‚   â”œâ”€â”€ Breastfeeding Jaundice (Quantity issue: Starvation)\nâ”‚   â”‚   â””â”€â”€ Breast Milk Jaundice (Quality issue: Enzyme inhibition)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Direct Hyperbilirubinemia (Conjugated)\nâ”‚       â””â”€â”€ Biliary Atresia (Plumbing issue)\nâ”‚\nâ””â”€â”€ 2. Intestinal Obstruction (Green Vomit)\n    â”œâ”€â”€ Duodenal Atresia (Failure of Recanalization)\n    â”‚   â””â”€â”€ Associated with Down Syndrome\n    â”‚\n    â””â”€â”€ Jejunal/Ileal Atresia (Vascular Accident)\n        â””â”€â”€ Associated with Vasoconstrictors (Cocaine/Tobacco)`\n## **ğŸ“ Lecture Notes: Neonatal Jaundice & Atresias**\nì˜¤ëŠ˜ì˜ í•µì‹¬ ì»¬ëŸ¬ëŠ” **Yellow (Jaundice)**ì™€ **Green (Bile)**ì…ë‹ˆë‹¤. USMLEëŠ” í•­ìƒ **Timing**ê³¼ **Color**ë¡œ íŒíŠ¸ë¥¼ ì¤ë‹ˆë‹¤!\n### **1. Neonatal Jaundice: The \"Yellow\" Baby**\në¨¼ì € **Indirect (Unconjugated) Hyperbilirubinemia**ì…ë‹ˆë‹¤. ì—¬ê¸°ì„œëŠ” **Breastfeeding** vs **Breast Milk** ë‘ ê°€ì§€ë¥¼ êµ¬ë¶„í•˜ëŠ” ê²Œ ì‹œí—˜ì˜ í•µì‹¬ì´ì—ìš”. ì´ë¦„ì´ ë¹„ìŠ·í•´ì„œ í—·ê°ˆë¦¬ì£ ? ë©”ì»¤ë‹ˆì¦˜ìœ¼ë¡œ ë°•ì‚´ ëƒ…ì‹œë‹¤. ğŸ‘Š\n### **ğŸ†š Showdown: Breastfeeding vs. Breast Milk Jaundice**\n| **Feature** | **Breastfeeding Jaundice (ìˆ˜ìœ  ë¶€ì¡± í™©ë‹¬) = Starvation jaundice** | **Breast Milk Jaundice (ëª¨ìœ  í™©ë‹¬)** |\n| --- | --- | --- |\n| **Mechanism** | **Quantity Issue (Volume Deficit)** ğŸ¼\nì•„ê¸°ê°€ ì –ì„ ëª» ë¨¹ì–´ì„œ ìƒê¹€.\nDehydration â†’ Bowel movement ê°ì†Œ â†’ Bilirubin ë°°ì„¤ ì•ˆ ë˜ê³  ì¬í¡ìˆ˜ (Enterohepatic circulation â†‘). | **Quality Issue (Enzyme Interference)** ğŸ§ª\nëª¨ìœ  ì„±ë¶„ ë¬¸ì œ.\nëª¨ìœ  ì† íš¨ì†Œ(Î²-glucuronidase)ê°€ Liverì˜ ì¼ì„ ë°©í•´í•¨ (Deconjugation). |\n| **Timing** | **Week 1** (ìƒí›„ 2~7ì¼)\nì—„ë§ˆ ì –ì´ ì•„ì§ ì˜ ì•ˆ ëŒ ë•Œ ë°œìƒ. | **Week 2** (ìƒí›„ 7ì¼ ì´í›„)\nìƒí›„ 2ì£¼ì¯¤ í”¼í¬ë¥¼ ì°ìŒ. |\n| **Baby Status** | **\"Dry & Hungry\"** ğŸ˜«\níƒˆìˆ˜ ì¦ìƒ, ì²´ì¤‘ ê°ì†Œ (>7-10%). | **\"Happy & Chubby\"** ğŸ˜Š\nì˜ ë¨¹ê³ , ì˜ í¬ê³ , ì‚´ë„ ì˜ ì°œ. ê·¸ëƒ¥ ìƒ‰ê¹”ë§Œ ì˜¤ë Œì§€ìƒ‰. |\n| **Diaper clue** | **Brick Red Urate Crystals** ğŸ§±Â = Dehydration\nê¸°ì €ê·€ì— ë¶‰ì€ ê°€ë£¨ê°€ ë³´ì„ (í”¼ê°€ ì•„ë‹˜! ë†ì¶•ëœ ì†Œë³€). | Normal wet/dirty diapers. |\n| **Management** | **Feed More!** ğŸ¼\nìˆ˜ìœ  íšŸìˆ˜ ëŠ˜ë¦¬ê¸°, ì‹¬í•˜ë©´ Formula ë³´ì¶©. | **Keep Breastfeeding!** ğŸ’ª\nê³„ì† ë¨¹ì„. (Bilirubin ìˆ˜ì¹˜ê°€ ë„ˆë¬´ ë†’ìœ¼ë©´ ì ì‹œ ì¤‘ë‹¨ ê³ ë ¤í•˜ì§€ë§Œ ë“œë¬¾). |\n### **âš ï¸ Severe Jaundice Management**\n- **Kernicterus (í•µí™©ë‹¬):** Unconjugated bilirubinì´ ë‡Œ(Basal ganglia)ì— ì¹¨ì°©ë˜ëŠ” ë¬´ì„œìš´ ìƒí™©.\n    - irriversible\n    - Chronic Tetrad\n        - Choreoathetoid movement (basal ganglia ê³ ì¥)\n        - â˜… Hearing loss\n        - upward gaze palsy\n        - developmental delay\n- **Treatment Threshold:**\n    1. **Phototherapy:** Blue-green lightê°€ Bilirubin ëª¨ì–‘ì„ ë°”ê¿”ì„œ(Isomerization) ë¬¼ì— ë…¹ê²Œ ë§Œë“¦ â†’ ì†Œë³€ìœ¼ë¡œ ë°°ì¶œ. ğŸ’¡\n    2. **Exchange Transfusion:** ë¹›ìœ¼ë¡œ í•´ê²° ì•ˆ ë  ì •ë„ë¡œ ìˆ˜ì¹˜ê°€ ì¹˜ì†Ÿê±°ë‚˜ ì‹ ê²½í•™ì  ì¦ìƒ(Arching back, Seizures)ì´ ë³´ì´ë©´ ë°”ë¡œ í”¼ë¥¼ ê°ˆì•„ì¤˜ì•¼ í•¨! ğŸ©¸\n### **2. Biliary Atresia: The \"Plumbing\" Problem**\nì´ì œ **Direct (Conjugated) Hyperbilirubinemia**ë¡œ ë„˜ì–´ê°‘ë‹ˆë‹¤. ê°„ì€ ì¼ì„ ì˜í–ˆëŠ”ë°, **ë°°ì¶œêµ¬(Bile ducts)**ê°€ ë§‰íŒ ìƒí™©ì…ë‹ˆë‹¤.\n- **Scenario:** ìƒí›„ 2ì£¼~8ì£¼ ëœ ì•„ê¸°. ì²˜ìŒì—” ìƒë¦¬ì  í™©ë‹¬ì¸ ì¤„ ì•Œì•˜ëŠ”ë° ì•ˆ ì—†ì–´ì§.\n- **Color Clues:**\n    - **Stool:** **Pale / Clay-colored** (Bileì´ ì¥ìœ¼ë¡œ ëª» ê°€ì„œ ë³€ ìƒ‰ê¹”ì´ í•˜ì–—ê²Œ ë¨). âšªï¸\n    - **Urine:** **Dark / Brown** (Direct bilirubinì€ ë¬¼ì— ë…¹ì•„ì„œ ì†Œë³€ìœ¼ë¡œ ë‚˜ì˜´). ğŸŸ¤\n- **Pathology:** Extrahepatic bile ductsì˜ **Fibrosis & Obliteration**. ê¸¸ì´ ë§‰í˜€ë²„ë¦¼.","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-131","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### **âš™ï¸ Workup Strategy (The Trap Alert! ğŸš¨)**\nì‹œí—˜ì—ì„œëŠ” ìˆœì„œë¥¼ ë¬¼ì–´ë´…ë‹ˆë‹¤. ì—¬ê¸°ì„œ ë‚šì´ë©´ ì•ˆ ë¼ìš”!\n1. **Step 1: Ultrasound (US)** ğŸ“¸\n    - ê°€ì¥ ë¨¼ì € í•  ê²ƒ. Gallbladderê°€ ì—†ê±°ë‚˜ ì‘ì•„ ë³´ì„ (**Triangular Cord Sign**).\n    - í•˜ì§€ë§Œ ì´ê±¸ë¡œ í™•ì§„ì€ ë¶ˆê°€ëŠ¥.\n2. **Step 2: HIDA Scan (The \"Trap\")** â˜¢ï¸\n    - ê°„ì´ ì¡°ì˜ì œë¥¼ ë¨¹ëŠ”ì§€, ì¥ìœ¼ë¡œ ë°°ì¶œí•˜ëŠ”ì§€ ë³´ëŠ” ê²€ì‚¬.\n    - **Trap:** Phenobarbitalì„ 5ì¼ ë™ì•ˆ ë¯¸ë¦¬ ì¤˜ì„œ íš¨ì†Œë¥¼ ìœ ë„í•´ì•¼ ì •í™•í•œë°, ì‹œê°„ì´ ë„ˆë¬´ ê±¸ë¦¼. ë”œë ˆë§ˆê°€ ìˆì§€ë§Œ ì‹œí—˜ì—” ë‚˜ì˜´.\n    - ê²°ê³¼: ê°„ì€ ì¡°ì˜ì œë¥¼ ë¨¹ëŠ”ë°(Uptake OK), ì¥ìœ¼ë¡œëŠ” ì•ˆ ë‚˜ì˜´(Excretion Fail).\n3. **Step 3: Liver Biopsy** ğŸ”¬Â HIDA(optional)ê°€ ì–´ë–»ê²Œ ë‚˜ì˜¤ë“  ìƒê²€ì„ í•¨.\n    - **Next Best Step after US.** (ê°€ì¥ í˜„ëª…í•œ ì„ íƒ).\n    - Bile duct proliferation, Portal tract edema/fibrosis ì†Œê²¬.\n4. **Step 4: Intraoperative Cholangiogram (Gold Standard)** ğŸ’‰\n    - ìˆ˜ìˆ ë°© ë“¤ì–´ê°€ì„œ ì§ì ‘ ì¡°ì˜ì œ GUTìœ¼ë¡œ ì˜ê³  ëˆˆìœ¼ë¡œ í™•ì¸. ì´ê²Œ **í™•ì§„(Definitive Diagnosis)**.\n- **Treatment:** **Kasai Procedure (Hepatoportoenterostomy)**. ì¥ì„ ì˜ë¼ì„œ ê°„ì— ì§ì ‘ ë¶™ì—¬ì£¼ëŠ” ìˆ˜ìˆ . ë¹¨ë¦¬(ìƒí›„ 8ì£¼ ì´ë‚´ â˜… )ì•ˆ í•˜ë©´ ê°„ì´ ë§ê°€ì ¸ì„œ **Liver Transplant** í•´ì•¼ í•¨. â³\n### 3. Biliary cyst\n1. Triad: ì‹¤ì œë¡œëŠ” ì˜ ì—†ë‹¤\n    1. abdominal pain\n    2. RUQ mass\n    3. Jaundice\n2. Ultrasound, MRCP\n3. Management:\n    - ê·¸ëƒ¥ Drain? â†’ NO! (cyst wallì€ ì—¼ì¦ì´ ë§Œì„±ì ìœ¼ë¡œ ìˆì—ˆì—ˆìŒ. cholangitis, cancer risk high)\n    - cyst resection! â†’ rebuild plumbing (Roux en Y)\n### **4. Intestinal Atresia: The \"Green\" Vomit** ğŸ¤®\nì, ì´ì œ **Bilious Vomiting (ì´ˆë¡ìƒ‰ í† )**ì…ë‹ˆë‹¤. ì´ê±´ ë¬´ì¡°ê±´ **Surgical Emergency**!\nì¥ì´ ë§‰í˜”ëŠ”ë°, x-rayë¥¼ ë³´ê³  **ì–´ë””ê°€** ë§‰í˜”ëŠëƒ í™•ì¸ì— ë”°ë¼ ì›ì¸ê³¼ ì¡±ë³´ê°€ ë‹¬ë¼ì§‘ë‹ˆë‹¤.\n### **ğŸ†š Duodenal vs. Jejunal/Ileal Atresia**\n| **Feature** | **Duodenal Atresia (ì‹­ì´ì§€ì¥ íì‡„)** | **Jejunal/Ileal Atresia (ê³µì¥/íšŒì¥ íì‡„)** |\n| --- | --- | --- |\n| **Mechanism** | **Failure of Recanalization** ğŸš§\nì„ì‹  ì´ˆê¸°ì— ì¥ì´ ê½‰ ì°¼ë‹¤ê°€ ë‹¤ì‹œ ëš«ë ¤ì•¼ í•˜ëŠ”ë°(Recanalization), ê·¸ê²Œ ì‹¤íŒ¨í•¨. | **Vascular Accident** ğŸ’¥\nì˜ ë§Œë“¤ì–´ì§„ ì¥ì— í˜ˆì•¡ ê³µê¸‰ì´ ëŠê²¨ì„œ(Ischemia) ê´´ì‚¬í•˜ê³  ëŠì–´ì§. (Apple peel deformity). |\n| **X-ray Sign** | **\"Double Bubble\" Sign** ğŸ«§ğŸ«§\nìœ„(Stomach)ì— ê³µê¸° í•˜ë‚˜, ì‹­ì´ì§€ì¥(Duodenum)ì— ê³µê¸° í•˜ë‚˜. ë’¤ìª½ì—” ê°€ìŠ¤ ì—†ìŒ (Gasless distal bowel). | **\"Triple Bubble\"** or Multiple Air-Fluid Levels.\nì—¬ëŸ¬ êµ°ë°ê°€ ë§‰í˜€ì„œ ê³µê¸° ë°©ìš¸ì´ ì—¬ëŸ¬ ê°œ ë³´ì„. |\n| **Association** | **Down Syndrome (Trisomy 21)** ğŸ§¬\n30% ì •ë„ ì—°ê´€ë¨. ì‹¬ì¥ ê¸°í˜•(VSD, ASD)ë„ ê°™ì´ í™•ì¸ í•„ìš”. | **Vasoconstrictors** ğŸš¬ğŸ’Š\nì—„ë§ˆê°€ ë‹´ë°°ë¥¼ í”¼ì› ê±°ë‚˜(Smoking), ì½”ì¹´ì¸ì„ í–ˆê±°ë‚˜(Cocaine). í˜ˆê´€ì„ ìˆ˜ì¶•ì‹œí‚¤ëŠ” ë¬¼ì§ˆ ë•Œë¬¸. |","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-151","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_summary","text":"## **ğŸ”¥ Rapid Fire Recap (High Yield Summary)**\n1. **Vignette:** ìƒí›„ 4ì¼, ëª¨ìœ  ìˆ˜ìœ  ì¤‘, ì²´ì¤‘ ê°ì†Œ, ê¸°ì €ê·€ì— ë¶‰ì€ ê°€ë£¨(Brick red crystals).\n    - **Diagnosis:** **Breastfeeding Jaundice** (ìˆ˜ìœ  ë¶€ì¡±).\n    - **Action:** **Feed more!** (ìˆ˜ìœ ëŸ‰ ëŠ˜ë¦¬ê¸°).\n2. **Vignette:** ìƒí›„ 14ì¼, ê±´ê°•í•´ ë³´ì„(Happy baby), í™©ë‹¬ ì§€ì†, Direct bilirubin ì •ìƒ.\n    - **Diagnosis:** **Breast Milk Jaundice** (ëª¨ìœ  ì„±ë¶„ ë¬¸ì œ).\n    - **Action:** **Continue Breastfeeding.** (ì•ˆì‹¬ì‹œí‚¤ê¸°).\n3. **Vignette:** ìƒí›„ 3ì£¼, í™©ë‹¬, íšŒìƒ‰ ë³€(Clay stool), ì½œë¼ìƒ‰ ì†Œë³€(Dark urine).\n    - **Diagnosis:** **Biliary Atresia**.\n    - **Next Step:** Ultrasound â†’ **Liver Biopsy** / Intraoperative Cholangiogram (Gold Standard).\n    - **Treatment:** **Kasai Procedure** (ASAP).\n4. **Vignette:** ìƒí›„ 1ì¼, ì´ˆë¡ìƒ‰ í† (Bilious vomiting), X-rayìƒ Double Bubble.\n    - **Diagnosis:** **Duodenal Atresia**.\n    - **Association:** **Down Syndrome**.\n5. **Vignette:** ì‚°ëª¨ê°€ ì½”ì¹´ì¸/ë‹´ë°° ì‚¬ìš©, ì•„ê¸°ëŠ” ì´ˆë¡ìƒ‰ í† , X-rayìƒ Triple bubble/Multiple air-fluid levels.\n    - **Diagnosis:** **Jejunal/Ileal Atresia**.\n    - **Mechanism:** **Vascular Accident** (Ischemic necrosis).\n## ğŸŒ³ USMLE Step 2 CK: Pediatric GI Emergencies & Metabolic Disasters\nì•ˆë…•! ì˜¤ëŠ˜ì€ ì†Œì•„ê³¼ GI íŒŒíŠ¸ ì¤‘ì—ì„œë„ **\"Time is vital\"**ì¸ ì‘ê¸‰ ì§ˆí™˜ë“¤ê³¼ ëŒ€ì‚¬ ì§ˆí™˜ë“¤ì„ ë‹¤ë£° ê±°ì•¼. ğŸ•’ ì‹œí—˜ì¥ì—ì„œë„, ì‹¤ì œ ì‘ê¸‰ì‹¤ì—ì„œë„ ë†“ì¹˜ë©´ í°ì¼ ë‚˜ëŠ” **High Yield** ì£¼ì œë“¤ì´ë‹ˆê¹Œ ì§‘ì¤‘í•´!\nìš°ì„  í° ê·¸ë¦¼(Big Picture)ë¶€í„° ì¡ê³  ê°€ì. ì•„ì´ê°€ ë°°ê°€ ì•„í”„ê±°ë‚˜ í† í•  ë•Œ, **ë‚˜ì´(Age)**ì™€ **ë³€ì˜ ì–‘ìƒ(Stool pattern)**ì´ ê°ë³„ ì§„ë‹¨ì˜ í•µì‹¬ì´ì•¼.\nPlaintext","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-164","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","recap","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"`Pediatric GI Emergencies (The \"Must-Not-Miss\" List)\nâ”œâ”€â”€ Newborn (0~1 mo)\nâ”‚   â””â”€â”€ ğŸ’© Failure to Pass Meconium\nâ”‚       â””â”€â”€ Hirschsprung Disease (Distal obstruction)\nâ”œâ”€â”€ Infant/Toddler (6 mo ~ 3 yr)\nâ”‚   â”œâ”€â”€ ğŸ©¸ Painful Bleeding + Obstruction\nâ”‚   â”‚   â””â”€â”€ Intussusception (Currant jelly stool, Cyclic pain)\nâ”‚   â””â”€â”€ ğŸ©¸ Painless Bleeding\nâ”‚       â””â”€â”€ Meckel's Diverticulum (Ectopic gastric tissue)\nâ”œâ”€â”€ Preterm Infant (NICU)\nâ”‚   â””â”€â”€ ğŸ¦  Bloody Stool + Distention\nâ”‚       â””â”€â”€ Necrotizing Enterocolitis (NEC) (Pneumatosis intestinalis)\nâ””â”€â”€ Metabolic/Systemic\n    â”œâ”€â”€ ğŸ’Š Liver Failure after Aspirin\n    â”‚   â””â”€â”€ Reye Syndrome (Mitochondrial injury)\n    â””â”€â”€ ğŸ¦´ Malnutrition\n        â”œâ”€â”€ Marasmus (Total calorie deficit)\n        â””â”€â”€ Kwashiorkor (Protein deficit, Edema)`\n### 1. Hirschsprung Disease (Congenital Aganglionic Megacolon) [14.14]\nì´ ë³‘ì€ **\"Migration Failure\"**ê°€ í•µì‹¬ì´ì•¼. íƒœì•„ ë•Œ Neural crest cellì´ í•­ë¬¸ ëê¹Œì§€ ì´ë™í•´ì•¼ í•˜ëŠ”ë°, ì¤‘ê°„ì— ë©ˆì¶°ë²„ë¦° ê±°ì§€. ğŸš§\n- **Concept:**\n    - ì‹ ê²½ì ˆ(Ganglion)ì´ ì—†ëŠ” ì¥ ë¶€ìœ„ëŠ” ì´ì™„ì„ ëª»í•¨ â†’ **Permanent Contraction (Clamp shut)** ğŸ”’.\n    - ë³€ì´ ëª» ë‚´ë ¤ê°€ë‹ˆê¹Œ ê·¸ ìœ—ë¶€ë¶„ì€ ê°€ìŠ¤ë¡œ ë¹µë¹µí•´ì§ (Megacolon).\n- **Clinical Presentation:**\n    - â˜… **Failure to pass meconium within 48 hours** (99%ì˜ ê±´ê°•í•œ ì‹ ìƒì•„ëŠ” 48ì‹œê°„ ë‚´ì— íƒœë³€ì„ ë´„).\n    - **Bilious vomiting** (Obstruction sign).\n    - **Abdominal distension**.\n    - íƒœì•„ë•Œ ì•„ë‹ˆë”ë¼ë„ ë‚˜ì¤‘ì— ì–´ë¦°ì´ë•Œ ì˜¬ ìˆ˜ë„ ìˆìŒ. íƒœì•„ë•Œë„ ì¢ì•„ì ¸ìˆê¸´ í•˜ì§€ë§Œ ì¡°ê¸ˆì€ ì—´ë ¤ìˆë‹¤ê°€ aganglionic í•œê²Œ ì‹¬í•´ì§€ë©´ì„œ ë‚˜ì¤‘ì— ë°œí˜„ ê°€ëŠ¥. Failure to thrive.\n- **Physical Exam:**\n    - **Rectal Exam:** ì§ì¥ì€ ë¹„ì–´ìˆê³  ê½‰ ì¡°ì—¬ì ¸ ìˆìŒ (Tight sphincter).\n    - â˜… **Squirt Sign (Blast Sign):** ì†ê°€ë½ì„ ë„£ì—ˆë‹¤ ë¹¼ë©´ ë§‰í˜€ìˆë˜ ê°€ìŠ¤ì™€ ë³€ì´ **\"í­ë°œí•˜ë“¯ì´(Explosive expulsion)\"** ë¿œì–´ì ¸ ë‚˜ì˜´. ğŸŒ‹\n- **Diagnosis:**\n    1. **Screening:** **Contrast Enema** â†’ **Transition Zone** í™•ì¸ (ëŠ˜ì–´ë‚œ ì •ìƒ ì¥ê³¼ ì¢ì•„ì§„ ë³‘ë³€ ì‚¬ì´ì˜ ê¹”ë•Œê¸° ëª¨ì–‘).\n    2. **Gold Standard:** **Rectal Suction Biopsy** â†’ Ganglion cellì´ ì—†ìœ¼ë©´ í™•ì§„.\n- **Treatment:** **Surgical Resection** (ì‹ ê²½ ì—†ëŠ” ë¶€ìœ„ë¥¼ ì˜ë¼ë‚´ì•¼ í•¨).\n### 2. Intussusception (ì¥ì¤‘ì²©ì¦) [14.15]\nì¥ì´ ë§ì›ê²½(Telescope)ì²˜ëŸ¼ ë§ë ¤ ë“¤ì–´ê°€ëŠ” ë³‘ì´ì•¼. **6ê°œì›”~3ì„¸** ì‚¬ì´ ë³µí†µì˜ ê°€ì¥ í”í•œ ì›ì¸ ì¤‘ í•˜ë‚˜! ğŸ”­\n- **Pathophysiology:**\n    - ì¥ ì¼ë¶€ê°€ ì•ˆìœ¼ë¡œ ë§ë ¤ ë“¤ì–´ê°€ë©´ì„œ í˜ˆê´€ë„ ê°™ì´ ëŒê³  ë“¤ì–´ê° â†’ **Venous congestion** & Swelling â†’ **Ischemia** â†’ **Mucosal sloughing**.\n    - ì´ë•Œ íƒˆë½ëœ ì ë§‰ê³¼ í”¼ê°€ ì„ì—¬ì„œ ë‚˜ì˜¤ëŠ” ê²Œ ë°”ë¡œ ê·¸ ìœ ëª…í•œ **Currant Jelly Stool**. ğŸ“\n- **Clinical Presentation:**\n    - **Colicky Pain:** ì• ê°€ ì˜ ë†€ë‹¤ê°€ ê°‘ìê¸° ìì§€ëŸ¬ì§€ê²Œ ìš¸ê³  ë‹¤ë¦¬ë¥¼ ë°°ë¡œ ëŒì–´ë‹¹ê¹€ (Legs to chest). 15ë¶„ ë’¤ì—” ë˜ ë©€ì©¡í•˜ê²Œ ë†‚. (Intermittent!). ğŸŒŠ\n    - **Lethargy/Altered Mental Status:** ì˜ì™¸ë¡œ ì¤‘ìš”í•œ ì‚¬ì¸! ì• ê°€ ì¶• ì²˜ì ¸ì„œ ì˜¬ ìˆ˜ë„ ìˆì–´. (Sepsisë‚˜ ë‡Œìˆ˜ë§‰ì—¼ìœ¼ë¡œ ì˜¤ì¸í•˜ê¸° ì‰¬ì›€).\n- **Physical Exam:**\n    - **Sausage-shaped mass:** ìš°ìƒë³µë¶€(RUQ)ì—ì„œ ë§Œì ¸ì§. (ì†Œì„¸ì§€ ëª¨ì–‘!) ğŸŒ­\n- **Diagnosis & Treatment (Two birds with one stone!):**\n    1. **Ultrasound:** **Target Sign** (Bull's eye) ğŸ¯.\n    2. **Air (or Contrast) Enema:** ì§„ë‹¨ì´ì ì¹˜ë£Œ! ê³µê¸° ì••ë ¥ìœ¼ë¡œ ë§ë ¤ ë“¤ì–´ê°„ ì¥ì„ ë°€ì–´ëƒ„ (Un-telescoping).\n    - âš ï¸ **Contraindication:** **Peritonitis** ì‚¬ì¸ì´ ìˆìœ¼ë©´ Enema ì ˆëŒ€ ê¸ˆì§€! ë°”ë¡œ ìˆ˜ìˆ ë°©(OR) ê°€ì•¼ í•¨.\n### 3. Meckel's Diverticulum [14.16]\n- *\"Rule of 2s\"**ë¡œ ìœ ëª…í•œ ë…€ì„ì´ì§€. ë‚œí™©ê´€(Vitelline duct)ì´ í‡´í™”í•˜ì§€ ì•Šê³  ë‚¨ì€ í”ì ì´ì•¼.\n- **Rule of 2s:**\n    - 2% of population.\n    - 2 feet from ileocecal valve.\n    - 2 inches long.\n    - 2 types of ectopic tissue (Gastric & Pancreatic).\n    - Present by age 2.\n- **Pathophysiology:**\n    - ì´ ì£¼ë¨¸ë‹ˆ(Diverticulum) ì•ˆì— ëœ¬ê¸ˆì—†ì´ **ìœ„ ì ë§‰(Ectopic gastric mucosa)**ì´ ìˆì–´ì„œ ì‚°(Acid)ì„ ë¶„ë¹„í•¨. ğŸ§ª\n    - ì£¼ë³€ì˜ ì•½í•œ ì†Œì¥ ì ë§‰ì´ ì‚° ë•Œë¬¸ì— í—ì–´ì„œ ê¶¤ì–‘ì´ ìƒê¸°ê³  í”¼ê°€ ë‚¨.\n- **Clinical Presentation:**\n    - â˜… **Painless Hematochezia:** ì• ëŠ” ë©€ì©¡í•œë° ê¸°ì €ê·€ì— í”¼ê°€ í¥ê±´í•¨ (Brick-red or Maroon). ì•„í”„ì§€ ì•Šë‹¤ëŠ” ê²Œ Intussusceptionê³¼ì˜ ê²°ì •ì  ì°¨ì´! ğŸ©¸\n- **Diagnosis:**\n    - **Meckel's Scan (Technetium-99m pertechnetate):** ì´ ë™ìœ„ì›ì†Œê°€ ìœ„ ì ë§‰(Gastric mucosa)ì„ ì¢‹ì•„í•´ì„œ ê±°ê¸° ê°€ì„œ ë”± ë¶™ìŒ. ìš°í•˜ë³µë¶€ê°€ ë°˜ì§ê±°ë¦¼. âœ¨\n- Treatment: sx æœ‰ ìˆ˜ìˆ \n### 4. Necrotizing Enterocolitis (NEC) [14.17]\nNICU(ì‹ ìƒì•„ ì¤‘í™˜ìì‹¤)ì˜ ì•…ëª½. **ë¯¸ìˆ™ì•„(Premature)**ì—ê²Œ **ë¶„ìœ (Formula)**ë¥¼ ë¨¹ì¼ ë•Œ ì£¼ë¡œ ìƒê¸°ëŠ” ì¬ì•™(Perfect Storm)ì´ì•¼. ğŸŒªï¸\n- **Pathophysiology:**\n    - ë¯¸ìˆ™í•œ ì¥ + ë¶„ìœ  ìˆ˜ìœ (ë°•í…Œë¦¬ì•„ ì¦ì‹ì˜ ë¨¹ì´) â†’ ì„¸ê· ì´ ì¥ë²½ ì¹¨íˆ¬ â†’ ê°€ìŠ¤ ìƒì„± â†’ ì¥ ê´´ì‚¬.\n- **Diagnosis (X-ray Findings):**\n    - â˜… **Pneumatosis Intestinalis:** ì¥ë²½ ì•ˆì— ê³µê¸°ê°€ ë“¤ì–´ê°€ì„œ ê¸°ì°¨ ì„ ë¡œ(Train track)ì²˜ëŸ¼ ë³´ì„. ğŸš‚\n    - **Portal Venous Gas:** ê°€ìŠ¤ê°€ í˜ˆê´€ íƒ€ê³  ê°„ë¬¸ë§¥ê¹Œì§€ ê° (Bad sign). ğŸ“‰\n    - **Pneumoperitoneum:** ì¥ì´ í„°ì ¸ì„œ íš¡ê²©ë§‰ ì•„ë˜ì— ê³µê¸°ê°€ ëœ¸ (Free air) â†’ **Emergency!**\n- **Management:**\n    - **Gut Rest (NPO):** ì…ìœ¼ë¡œ ì•„ë¬´ê²ƒë„ ì£¼ì§€ ë§ˆ. ğŸ›‘\n    - **NG tube:** Decompression.\n    - **Antibiotics & IV Fluids.**\n    - **Surgery:** Perforation(Free air) ìˆê±°ë‚˜ ë‚´ê³¼ì  ì¹˜ë£Œ ì‹¤íŒ¨ ì‹œ ì¥ ì ˆì œ.\n- **Long-term Complication:** **Stricture** (ì¥ í˜‘ì°©). íšŒë³µë˜ì–´ë„ ë‚˜ì¤‘ì— ì¥ì´ ì¢ì•„ì ¸ì„œ ë§‰í ìˆ˜ ìˆìŒ.\n### 5. Reye Syndrome [14.18]\n**\"Aspirin + Virus = Liver Disaster\"** ğŸ’£","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-174","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"ì•„ì´ì—ê²Œ ë°”ì´ëŸ¬ìŠ¤ ì§ˆí™˜(ë…ê°, ìˆ˜ë‘)ì´ ìˆì„ ë•Œ ì•„ìŠ¤í”¼ë¦°(Salicylates)ì„ ì“°ë©´ ìƒê¸°ëŠ” ì¹˜ëª…ì ì¸ ë³‘ì´ì•¼.\n- **Mechanism:**\n    - Salicylateê°€ ê°„ì„¸í¬ì˜ **Mitochondria**ë¥¼ ë§ê°€ëœ¨ë¦¼ (Uncoupling of oxidative phosphorylation). ğŸ”‹ğŸš«\n    - **Fatty Liver:** ê°„ì´ ì§€ë°© ëŒ€ì‚¬ë¥¼ ëª»í•´ì„œ ê¸°ë¦„ì´ ë‚Œ (**Microvesicular Steatosis**).\n    - **Hyperammonemia:** ê°„ì´ ì•”ëª¨ë‹ˆì•„ í•´ë…ì„ ëª»í•¨ â†’ ë‡Œë¶€ì¢…(Encephalopathy). ğŸ§ \n- **Clinical Presentation:**\n    - ë°”ì´ëŸ¬ìŠ¤ ì•“ê³  ë©°ì¹  ë’¤ ê°‘ìê¸° **Vomiting** + **Confusion/Lethargy** (Encephalopathy).\n- **Labs:**\n    - â¬†ï¸ AST/ALT, â¬†ï¸ PT/PTT, â¬†ï¸ **Ammonia**., hypoglycemia (seizure ê°€ëŠ¥)\n    - â˜… **Normal Bilirubin** (í™©ë‹¬ì€ ì—†ìŒ! ì´ê²Œ Viral hepatitisë‘ ê°ë³„ì ).\n- **Prevention:** ì•„ì´ë“¤ì—ê²Œ í•´ì—´ì œëŠ” Tylenol(Acetaminophen)ì´ë‚˜ Ibuprofenì„ ì“¸ ê²ƒ! (ë‹¨, ê°€ì™€ì‚¬í‚¤ë³‘ì€ ì˜ˆì™¸ì ìœ¼ë¡œ ì•„ìŠ¤í”¼ë¦° ì‚¬ìš©).\n### 6. Malnutrition: Marasmus vs. Kwashiorkor [14.19]\nì´ ë‘ ê°€ì§€ëŠ” í—·ê°ˆë¦¬ê¸° ì‰¬ìš´ë° ê¸°ì „ì´ ì™„ì „íˆ ë‹¬ë¼.\n| **Feature** | **Marasmus ğŸ¦´** | **Kwashiorkor ğŸ¡** |\n| --- | --- | --- |\n| **Deficiency** | **Total Calorie** (Energy) | **Protein** (Albumin) |\n| **Appearance** | Skin & Bones (Emaciated) | **albumin drops â†’ fluid í˜ˆê´€ì— ì—†ê³  tissueì—\nEdema (Pot belly)**, Swollen legs |\n| **Mechanism** | Muscle & Fat wasting | Low Albumin â†’ Low Oncotic pressure â†’ Fluid leak |\n| **Key Signs** | \"Old man\" face, No fat | Fatty Liver, Dermatitis (Flaky paint), Edema |\n| **Analogy** | **M**arasmus = **M**uscle wasting | **K**washiorkor = **K**arbs (Carbs) only (No protein) |\n- **Refeeding Syndrome Warning:** âš ï¸\n    - êµ¶ì£¼ë¦° ì•„ì´ì—ê²Œ ê°‘ìê¸° ë°¥ì„ ë§ì´ ì£¼ë©´ **Insulin**ì´ í™• ë‚˜ì˜´.\n    - ì¸ìŠë¦°ì´ í˜ˆì•¡ ì†ì˜ ì¸(Phosphate), ì¹¼ë¥¨(K), ë§ˆê·¸ë„¤ìŠ˜(Mg)ì„ ì„¸í¬ ì•ˆìœ¼ë¡œ ë‹¤ ëŒê³  ë“¤ì–´ê°.\n    - **Hypophosphatemia** (ì €ì¸ì‚°í˜ˆì¦) â†’ ATP ë¶€ì¡± â†’ í˜¸í¡ê·¼ ë§ˆë¹„, ì‹¬ë¶€ì „ ë°œìƒ.\n    - **\"Start low and go slow!\"** ì²œì²œíˆ ë¨¹ì—¬ì•¼ í•´.\n## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n1. **Newborn + No stool 48hr + Squirt sign** â†’ **Hirschsprung Disease** â†’ ğŸ¥ **Dx:** Contrast Enema then Biopsy.\n2. **Toddler + Colicky pain + Currant jelly stool + Sausage mass** â†’ **Intussusception** â†’ ğŸ”­ **Dx/Tx:** Air Enema (Unless peritonitis!).\n3. **2yo + Painless bloody diaper** â†’ **Meckel's Diverticulum** â†’ â˜¢ï¸ **Dx:** Meckel Scan (Technetium-99m).\n4. **Premie + Formula + Bloody stool + X-ray \"Train tracks\"** â†’ **NEC** â†’ ğŸ›‘ **Action:** NPO, Antibiotics (Surgery if free air).\n5. **Child + Flu + Aspirin + Confusion** â†’ **Reye Syndrome** â†’ ğŸ”¬ **Bx:** Microvesicular Steatosis.\n6. **Edematous child + Pot belly** â†’ **Kwashiorkor** (Protein deficiency) â†’ âš ï¸ **Trap:** Watch out for Refeeding Syndrome (Low Phosphate).\n**Next Step for You:**\nêµ°ì˜ê´€ë‹˜, ì´ë²ˆ íŒŒíŠ¸ë„ ì •ë§ ì¤‘ìš”í•©ë‹ˆë‹¤! ğŸš‘ íŠ¹íˆ **NEC**ë‚˜ **Intussusception** ì—‘ìŠ¤ë ˆì´ ì†Œê²¬(Pneumatosis intestinalis, Target sign)ì€ êµ¬ê¸€ ì´ë¯¸ì§€ë¡œ ê¼­ í•œ ë²ˆ ëˆˆì— ìµí˜€ë‘ì‹œëŠ” ê²Œ ì¢‹ìŠµë‹ˆë‹¤. ğŸ–¼ï¸ ì›í•˜ì‹œë©´ ê´€ë ¨ ì´ë¯¸ì§€ë¥¼ ê²€ìƒ‰í•´ë“œë¦´ê¹Œìš”?\n## ğŸ¥ **USMLE Step 2 CK: GI Surgery & Post-Op Complications**\n**Topic:** Bariatric Surgery, Gastric Bypass, Billroth II, Nissen, & Whipple Procedure\n**Reference:** Audio Sections 15.1 - 15.5\nì•ˆë…•í•˜ì„¸ìš”, ì„ ìƒë‹˜! ì˜¤ëŠ˜ì€ **GIT Surgery** íŒŒíŠ¸ë¥¼ ì •ë¦¬í•´ ë“œë¦´ê²Œìš”.\në‹¨ìˆœíˆ ìˆ˜ìˆ  ì´ë¦„ë§Œ ì™¸ìš°ëŠ” ê²Œ ì•„ë‹ˆë¼, **\"Anatomyê°€ ì™„ì „íˆ ë°”ë€ í›„(Rewritten Anatomy)ì— ì–´ë–¤ Physiology ë³€í™”ê°€ ìƒê¸°ëŠ”ê°€?\"**ë¥¼ ì´í•´í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤. Board Examì€ ìˆ˜ìˆ ë²•ë³´ë‹¤ **Complicationê³¼ Altered Physiology**ë¥¼ ì§‘ìš”í•˜ê²Œ ë¬¼ì–´ë´…ë‹ˆë‹¤. ğŸ§ âœ¨","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-194","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"### 1ï¸âƒ£ **Bariatric Surgery Indications (Section 15.1)**\nìˆ˜ìˆ ì¥ì— ë“¤ì–´ê°€ê¸° ì „, ëˆ„ê°€ ì´ ìˆ˜ìˆ ì„ ë°›ì„ ìê²©ì´ ìˆëŠ”ì§€(Indications)ë¶€í„° í™•ì‹¤íˆ í•´ì•¼ í•©ë‹ˆë‹¤.\n**ğŸ“‰ The Magic Numbers (BMI Criteria)**\n- **BMI â‰¥ 40:** Weight alone qualifies. (ë¬»ì§€ë„ ë”°ì§€ì§€ë„ ì•Šê³  Green light ğŸŸ¢)\n- **BMI â‰¥ 35:** Weight + **Severe Comorbidity** í•„ìš”.\n    - **The \"Big 3\" Comorbidities:**\n        1. Type 2 Diabetes (T2DM)\n        2. Hypertension (HTN)\n        3. Severe Obstructive Sleep Apnea (OSA)\n- **BMI â‰¥ 30:** ì•„ì£¼ ë“œë¬¼ê²Œ, ì•½ë¬¼ë¡œ ì¡°ì ˆ ì•ˆ ë˜ëŠ” Metabolic Syndromeì´ ìˆì„ ë•Œ ê³ ë ¤ ê°€ëŠ¥ (Lower tier).\n**ğŸ§  Psychiatric Clearance (The \"Psych Evil\")**\n- ìˆ˜ìˆ ë¡œ ìœ„ì¥ì€ ê³ ì³ë„ ë‡ŒëŠ” ëª» ê³ ì¹©ë‹ˆë‹¤. **Psychiatric Clearance**ê°€ Cardiac Clearanceë§Œí¼ ì¤‘ìš”í•©ë‹ˆë‹¤.\n- í™˜ìê°€ ì‹ë‹¨ ì¡°ì ˆê³¼ ìš´ë™ì„ ì‹œë„í•´ ë´¤ëŠ”ì§€(Previous weight loss attempts), Coping skillì´ ìˆëŠ”ì§€ í™•ì¸í•´ì•¼ í•©ë‹ˆë‹¤.\n- Foodë¥¼ coping mechanismìœ¼ë¡œ ì“°ëŠ” í™˜ìì—ê²Œ ìˆ˜ìˆ ë¡œ ê·¸ ì˜µì…˜ì„ ì—†ì• ë²„ë¦¬ë©´, ìˆ˜ìˆ ì€ ì‹¤íŒ¨í•˜ê³  í™˜ìëŠ” ë¬´ë„ˆì§‘ë‹ˆë‹¤.\n### 2ï¸âƒ£ **Surgical Physiology & Intra-op Scare**\n**ğŸˆ Laparoscopic Insufflation Reflex**\n- Laparoscopic surgeryë¥¼ ìœ„í•´ ë°°ì— CO2ë¥¼ ì±„ì›Œ **Dome**ì„ ë§Œë“¤ ë•Œ ë°œìƒí•˜ëŠ” í˜„ìƒì…ë‹ˆë‹¤.\n- **Peritoneum Stretch â†’ Vagal Nerve Stretch (Massive Spike in Vagal Tone)**\n- **Result:** Severe Bradycardia, AV Block, ì‹¬ì§€ì–´ **Asystole**ê¹Œì§€ ê°ˆ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- **Mechanism:** Vagus nerveëŠ” Heartì˜ \"Brake pedal\"ì…ë‹ˆë‹¤. ë°°ì— ê°€ìŠ¤ë¥¼ ë„£ëŠ” ìˆœê°„ ë¸Œë ˆì´í¬ë¥¼ ê½‰ ë°ŸëŠ” ê²ƒê³¼ ê°™ìŠµë‹ˆë‹¤.\n- **Management:** ê°€ìŠ¤ë¥¼ ëº€ë‹¤(Deflation). (Immediate deflation usually fixes it).\n### 3ï¸âƒ£ **Gastric Bypass Complications (Section 15.2)**\nê°€ì¥ ì¤‘ìš”í•˜ê³  ë¬´ì„œìš´ íŒŒíŠ¸ì…ë‹ˆë‹¤. **Anastomotic Leak**ë¥¼ ë†“ì¹˜ë©´ í™˜ìëŠ” ì‚¬ë§í•©ë‹ˆë‹¤.\n### **ğŸš¨ Anastomotic Leak (The Acute Nightmare)**\n- **Timing:** Post-op 2ì¼ì°¨ ì •ë„.\n- **Signs:**\n    - í™˜ìê°€ \"ë­”ê°€ ì˜ëª»ëœ ê²ƒ ê°™ì•„ìš”\"ë¼ê³  í•˜ì§€ ì•Šì„ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n    - Feverë‚˜ Abdominal Painë³´ë‹¤ í›¨ì”¬ ë¨¼ì € ë‚˜íƒ€ë‚˜ëŠ” **ê°€ì¥ ì˜ˆë¯¼í•œ ì§€í‘œ(The Canary in the Coal Mine)**ëŠ”?\n    - ğŸ‘‰ **Tachycardia (> 120 bpm)** ğŸ’“\n    - ë”´ê±° ë‹¤ ê´œì°®ì•„ë„ ë³µë¶€ ìˆ˜ìˆ  í›„ì— ì‹¬ì¥ë¹¨ë¦¬ë›°ë©´ â€˜ã…ˆëë‹¤â€™ìƒê°í•˜ê³  CTì°ì–´ì•¼ë¨.\n- **Pathophysiology:**\n    - Stomachê³¼ Bowelì„ ì—°ê²°í•œ ë¶€ìœ„ê°€ ìƒˆì„œ **Gut content**ê°€ ë³µê°•ìœ¼ë¡œ í˜ëŸ¬ë‚˜ì˜µë‹ˆë‹¤.\n    - Sympathetic Nervous Systemì´ Chemical irritationì„ ê°ì§€í•˜ê³  ì—¼ì¦ ë°˜ì‘ì´ ìƒê¸°ê¸° **ì „**ì— ì‹¬ë°•ìˆ˜ë¶€í„° ì˜¬ë¦½ë‹ˆë‹¤.\n- **Next Best Step (Diagnosis):**\n    - **CT Abdomen with Oral Contrast** (High Yield! â˜…)\n    - High IV ContrastëŠ” Blood flowë¥¼ ë³´ì§€ë§Œ, **Oral Contrast**ê°€ ìƒˆì–´ ë‚˜ì˜¤ëŠ” ê²ƒ(Plumbing leak)ì„ ë´ì•¼ í•©ë‹ˆë‹¤.\n- **Treatment:**\n    - **Emergency Surgery:** ì”»ì–´ë‚´ê³  ë‹¤ì‹œ ê¿°ë§¤ì•¼ í•©ë‹ˆë‹¤(Wash out and sew it up).\n### **â³ Stomal Stenosis (The Slow Burn)**\n- **Scenario:** ìˆ˜ìˆ  6ê°œì›” í›„, ì‚´ë„ ë¹ ì¡ŒëŠ”ë° í™˜ìê°€ ë‹¤ì‹œ ì˜´.\n- **Symptom:** \"ë¬¼ë„ ì‚¼í‚¤ê¸° í˜ë“¤ì–´ìš”.\"\n    - ë³´í†µ Tumor ë“±ì—ì„œëŠ” Solidë¶€í„° ë§‰íˆì§€ë§Œ, ì´ ê²½ìš° **Liquid**ê°€ ë§‰íˆëŠ” íŒ¨í„´ì´ íŠ¹ì§•ì ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤. (Anastomosisê°€ ë„ˆë¬´ ê½‰ ì¡°ì—¬ì„œ Liquidê°€ pressure waveë¥¼ ë§Œë“¤ê³  íŠ•ê²¨ ë‚˜ì˜¤ëŠ” í˜„ìƒ).\n- **Pathophysiology:** ì—°ê²° ë¶€ìœ„(Anastomosis)ì˜ Scar tissueê°€ êµ³ì–´ì ¸ ì¢ì•„ì§(Stricture).\n- **Treatment:** **EGD (Endoscopy) + Balloon Dilation**. (ìˆ˜ìˆ  ë¶ˆí•„ìš”, í’ì„ ìœ¼ë¡œ ë„“í˜€ì¤Œ).\n### **ğŸª¨ Gallstones (Cholelithiasis)**\n- **Why?** ê¸‰ê²©í•œ ì²´ì¤‘ ê°ì†Œ(Rapid weight loss) â†’ Cholesterol saturation ë³€í™” â†’ Stone í˜•ì„±.\n- Bariatric ìˆ˜ìˆ  í™˜ìê°€ ë‚˜ì¤‘ì— RUQ painì´ë‚˜ Pancreatitisë¡œ ì˜¤ë©´ 100% Gallstoneì…ë‹ˆë‹¤.\n- ì˜ˆë°©ì„ ìœ„í•´ ìˆ˜ìˆ  ì‹œ ì“¸ê°œ(Gallbladder)ë¥¼ ê°™ì´ ë–¼ê¸°ë„ í•©ë‹ˆë‹¤.","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-214","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"### 4ï¸âƒ£ **Billroth II & Iron Deficiency (Section 15.3)**\n**âš™ï¸ Procedure:** ìœ„ í•˜ë¶€(Antrum)ë¥¼ ì˜ë¼ë‚´ê³  ë‚¨ì€ ìœ„ë¥¼ Jejunumì— ë°”ë¡œ ì—°ê²° (Duodenum bypass).\n**ğŸ©¸ Complication: Iron Deficiency Anemia**\n- **Mechanism:**\n    1. **Lost Acid:** Iron í¡ìˆ˜ì—ëŠ” Acidic environmentê°€ í•„ìš”í•œë°, ì‚°ì„ ë¶„ë¹„í•˜ëŠ” Antrumì´ ë‚ ì•„ê°. (Ferric $Fe^{3+}$ â†’  Ferrous $Fe^{2+}$ ë³€í™˜ ì‹¤íŒ¨).\n    2. **Bypassed Factory:** Ironì´ ì£¼ë¡œ í¡ìˆ˜ë˜ëŠ” ì¥ì†Œê°€ ë°”ë¡œ **Duodenum**ì¸ë°, ì—¬ê¸°ë¥¼ ê±´ë„ˆëœ€(Bypass).\n- **Treatment:** Oral Ironì€ í¡ìˆ˜ê°€ ì˜ ì•ˆë˜ë¯€ë¡œ **IV Iron**ì´ë‚˜ High doseê°€ í•„ìš”í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n### 5ï¸âƒ£ **Dumping Syndrome (Section 15.4)**\n**ğŸ¢ The Rollercoaster Gut**\n- **Pathophysiology:**\n    - *Pyloric Sphincter (Gatekeeper)**ê°€ ì—†ì–´ì§.\n    - ì„¤íƒ• ë©ì–´ë¦¬(Candy bar ğŸ«)ë¥¼ ë¨¹ìœ¼ë©´ Hypertonic sugar loadê°€ Small bowelë¡œ ì§í–‰.\n    - **Osmotic Shift:** ì‚¼íˆ¬ì•• ë•Œë¬¸ì— í˜ˆê´€ ë‚´ì˜ ë¬¼(Fluid)ì´ ì¥ìœ¼ë¡œ ì½¸ì½¸ ìŸì•„ì ¸ ë“¤ì–´ì˜´.\n    - **Hypovolemia:** í˜ˆì•¡ëŸ‰ì´ ì¤„ì–´ë“œë‹ˆê¹Œ ì–´ì§€ëŸ½ê³ (Dizzy), ì‹ì€ë•€ ë‚˜ê³ , ì‹¬ë°•ìˆ˜ ë¹¨ë¼ì§.\n- **Treatment (The Food Police):**\n    - ìˆ˜ìˆ ì´ ì•„ë‹ˆë¼ **ì‹ë‹¨ ì¡°ì ˆ(Dietary modification)**ì´ ë‹µì…ë‹ˆë‹¤.\n    - ğŸš« No simple sugars, No huge meals.\n    - âœ… Small, frequent meals. High Protein, High Fiber, High Fat.\n### 6ï¸âƒ£ **Nissen Fundoplication Complications (Section 15.5)**\nGERD ì¹˜ë£Œë¥¼ ìœ„í•´ ìœ„ ë°”ë‹¥(Fundus)ìœ¼ë¡œ ì‹ë„ í•˜ë¶€ë¥¼ ê°ì‹¸ì£¼ëŠ” ìˆ˜ìˆ ì…ë‹ˆë‹¤. (ìƒˆë¡œìš´ Sphincterë¥¼ ë§Œë“¤ì–´ì¤Œ).\n| **Scenario** | **Diagnosis** | **Pathophysiology** |\n| --- | --- | --- |\n| **\"ìŒì‹ì´ ê°€ìŠ´ì— ê±¸ë ¤ìš”\"** | **Dysphagia** (Too Tight) | ìˆ˜ìˆ  ë¶€ìœ„ë¥¼ ë„ˆë¬´ ê½‰ ì¡°ì„. ë¶“ê¸°ê°€ ë¹ ì§ˆ ë•Œê¹Œì§€(12ì£¼) ê¸°ë‹¤ë¦¬ê±°ë‚˜(Soft diet), ì•ˆ ë˜ë©´ í’ì„  í™•ì¥ìˆ . |\n| **\"ë°°ê°€ ë¹µë¹µí•˜ê³  íŠ¸ë¦¼ì„ ëª»í•´ìš”\"** | **Gas Bloat Syndrome** | Valveê°€ ë„ˆë¬´ ì™„ë²½í•´ì„œ ë“¤ì–´ê°ˆ ìˆœ ìˆì–´ë„ ë‚˜ê°ˆ(Burp) ìˆ˜ê°€ ì—†ìŒ. íƒ„ì‚°ìŒë£Œ ê¸ˆì§€ ğŸš«. |\n| **\"ì†Œí™” ì•ˆ ëœ ìŒì‹ í† í•´ìš” + ë¹¨ë¦¬ ë°°ë¶ˆëŸ¬ìš”\"** | **Gastroparesis** | ìˆ˜ìˆ  ì¤‘ **Vagus Nerve**ë¥¼ ì‹¤ìˆ˜ë¡œ ì˜ë¼ë²„ë¦¼(Accidental Vagotomy). ìœ„ì¥ ìš´ë™ ë§ˆë¹„. |\n### 7ï¸âƒ£ **The Whipple Procedure & Metabolic Acidosis (Section 15.6)**\nì·Œì¥ì•”(Pancreatic Cancer) ë“±ì—ì„œ ì·Œì¥ ë¨¸ë¦¬, ì‹­ì´ì§€ì¥, ë‹´ë‚­ ë“±ì„ ë‹¤ ë“¤ì–´ë‚´ëŠ” ëŒ€ìˆ˜ìˆ .\n**ğŸ§ª The Specific Leak: Pancreatic Fistula**\n- **Scenario:** Whipple ìˆ˜ìˆ  í›„ 3ì¼ì°¨, ë°°ì•¡ê´€(Drain) ì–‘ì´ ë§ê³  í™˜ì ìƒíƒœê°€ ì´ìƒí•¨.\n- **Lab Finding:** **Non-Anion Gap Metabolic Acidosis** ğŸ“‰\n- **Why?**\n    - PancreasëŠ” ìš°ë¦¬ ëª¸ì˜ **Bicarbonate (Bicarb) Factory**ì…ë‹ˆë‹¤.\n    - Anastomosisê°€ ìƒˆë©´(Leak), Bicarbonateê°€ í’ë¶€í•œ ì·Œì¥ì•¡ì´ ëª¸ ë°–ìœ¼ë¡œ ì¤„ì¤„ ìƒ™ë‹ˆë‹¤.\n    - **Loss of Base (Bicarb) = Acidosis.**\n    - Anion Gapì€ ì •ìƒì…ë‹ˆë‹¤. (Bicarbì´ Chlorideë¡œ ëŒ€ì²´ë¨).\n- Prevention: octreotide (turn off the factory to heal. GI factoryë¥¼ ì¡°ìš©íˆì‹œì¼œ íš¨ì†Œ ëœ ë‚˜ì˜¤ê²Œí•¨.)\n- **Diagnosis:** Drain fluidì˜ **Amylase** ìˆ˜ì¹˜ë¥¼ í™•ì¸ (í˜ˆì²­ë³´ë‹¤ ë†’ìœ¼ë©´ Leak í™•ì§„).\n### ğŸ› **Bonus: Blind Loop Syndrome**\n- **Discussion:** Billroth IIë‚˜ Gastric Bypass í›„ ë‚¨ê²¨ì§„ ì¥(Blind loop)ì— ìŒì‹ë¬¼ì´ ì •ì²´ë¨.\n- **Result:** **Bacterial Overgrowth (SIBO)**.\n- **Deficiency:** ë°•í…Œë¦¬ì•„ê°€ **Vitamin B12**ë¥¼ ë‹¤ ë¨¹ì–´ì¹˜ì›€ â†’ Macrocytic Anemia, Neuropathy.\n- **Diagnosis:** Schilling test (Classic) or Breath test.","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-234","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"## ğŸ”¥ **Rapid Fire Recap (High Yield Summary)**\n| **Clinical Vignette (Post-op)** | **Diagnosis** | **Key Action / Mechanism** |\n| --- | --- | --- |\n| Gastric Bypass í›„ 2ì¼ì°¨, **HR > 120 bpm** | **Anastomotic Leak** | **CT with *Oral* Contrast**. (Painë³´ë‹¤ Tachycardiaê°€ ë¨¼ì € ì˜´!)  |\n| Gastric Bypass í›„, **ë¬¼(Liquid)ë„ ì‚¼í‚¤ê¸° í˜ë“¦** | **Stomal Stenosis** | **EGD with Balloon Dilation**. (Scaring/Stricture) |\n| Post-Gastrectomy, **ì–´ì§€ëŸ¬ì›€ + ì‹ì€ë•€** after eating | **Dumping Syndrome** | **Diet Change** (High Protein/Fiber, No Sugar). Osmotic fluid shift ë•Œë¬¸. |\n| Post-Gastrectomy, **Fatigue + Pale** (ë¹ˆí˜ˆ) | **Iron Deficiency** | Duodenum(í¡ìˆ˜ ì¥ì†Œ) Bypass + Acid(í¡ìˆ˜ ë„ìš°ë¯¸) ë¶€ì¡±. |\n| Nissen í›„, **íŠ¸ë¦¼ ëª»í•¨ + ë³µë¶€ íŒ½ë§Œ** | **Gas Bloat Syndrome** | Valveê°€ ë„ˆë¬´ tightí•¨ (One-way valve). íƒ„ì‚° ê¸ˆì§€. |\n| Whipple í›„, **Non-Anion Gap Acidosis** | **Pancreatic Leak** | **Bicarbonate Loss** via Drain. Check Drain Amylase. |\n**ğŸ‘¨â€âš•ï¸ Tutor's Note:**\nì„ ìƒë‹˜, ì´ íŒŒíŠ¸ëŠ” **\"Anatomyê°€ ë°”ë€Œë©´ì„œ ì–´ë–¤ ìƒë¦¬ì  ê¸°ëŠ¥ì´ ë§ê°€ì¡ŒëŠ”ê°€?\"**ë¥¼ ì—°ê²°í•˜ëŠ” ê²Œ í•µì‹¬ì…ë‹ˆë‹¤.\n- Stomach ì˜ë¼ëƒ„ â†’  Acid â†“  â†’  Iron í¡ìˆ˜ â†“\n- Pylorus ì—†ì–´ì§ â†’  Dumping Syndrome\n- Duodenum ê±´ë„ˆëœ€ â†’  Iron/Calcium í¡ìˆ˜ â†“\n- Pancreas ìƒœìŒ â†’  Bicarb â†“  â†’  Acidosis\nUSMLE ë¬¸ì œ í’€ ë•Œ ìˆ˜ìˆ  í›„ í™˜ìê°€ ë‚˜ì˜¤ë©´ **Vital Sign(íŠ¹íˆ HR)**ê³¼ **ì˜ì–‘ ê²°í•(Iron, B12)**, ê·¸ë¦¬ê³  **Acid/Base** ìƒíƒœë¥¼ ê¼­ ì²´í¬í•˜ì„¸ìš”! í™”ì´íŒ…ì…ë‹ˆë‹¤! ğŸ’ª\nHere is the comprehensive lecture note based on the audio analysis.\n# ğŸ¥ Section 16.0: Abdominal Trauma & Wound â€“ When to Cut or Wait?\n**Overview:**\nì˜¤ëŠ˜ì˜ ì£¼ì œëŠ” **\"Decision Making\"**ì…ë‹ˆë‹¤. ë‹¨ìˆœíˆ ì¥ê¸°ì˜ ì •ì˜ë¥¼ ë¬»ëŠ” ê²Œ ì•„ë‹ˆë¼, í”¼ë¥¼ í˜ë¦¬ê³  ìˆëŠ” í™˜ì ì•ì—ì„œ **ì§€ê¸ˆ ë‹¹ì¥ ìˆ˜ìˆ ë°©(OR)ìœ¼ë¡œ ë›¸ ê²ƒì¸ê°€, ì•„ë‹ˆë©´ ê¸°ë‹¤ë¦´ ê²ƒì¸ê°€(Conservative)**ë¥¼ ê²°ì •í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\nBoard Examì˜ ë‹¨ê³¨ í…Œë§ˆ: **Weight vs Cut** (ê¸°ë‹¤ë¦¼ vs ì§¸ê¸°).\nì´ íŒŒíŠ¸ëŠ” ì‘ê¸‰ì‹¤(ER)ì— í™˜ìê°€ ì‹¤ë ¤ ë“¤ì–´ì˜¤ëŠ” ìˆœê°„ë¶€í„°, ì™¸ê³¼ ì˜ì‚¬ê°€ **\"CTì‹¤ë¡œ ë³´ë‚¼ ê²ƒì¸ê°€(Scan), ìˆ˜ìˆ ë°©ìœ¼ë¡œ ì§í–‰í•  ê²ƒì¸ê°€(Cut)?\"**ë¥¼ ê²°ì •í•˜ëŠ” ê¸´ë°•í•œ ì˜ì‚¬ê²°ì • ê³¼ì •(Decision-making process)ì„ ë‹¤ë£¹ë‹ˆë‹¤.\nì„ìƒ í˜„ì¥ì˜ íë¦„ì— ë§ì¶° **ì†ìƒ ê¸°ì „(Mechanism)**ê³¼ **í™˜ìì˜ ìƒíƒœ(Hemodynamics)**ë¥¼ ì¶•ìœ¼ë¡œ ì…ì²´ì ìœ¼ë¡œ ì¬êµ¬ì„±í–ˆìŠµë‹ˆë‹¤.\n--------------------------------------------------------------------------------\n### **1. The Golden Rule: \"Hemodynamics Dictates Action\"**","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-254","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"ë³µë¶€ ì™¸ìƒ í™˜ìë¥¼ ë³¼ ë•Œ ê°€ì¥ ë¨¼ì € í™•ì¸í•´ì•¼ í•  ê²ƒì€ **í˜ˆì••(BP)ê³¼ ë§¥ë°•(HR)**ì…ë‹ˆë‹¤.\n- **Stable (ì•ˆì •ì ):** ì‹œê°„ì´ ìˆìŠµë‹ˆë‹¤. ì •ë°€ ì§„ë‹¨ì„ ìœ„í•´ **CT Scan**ì´ í‘œì¤€(Gold standard)ì…ë‹ˆë‹¤.\n- **Unstable (ë¶ˆì•ˆì •/ì‡¼í¬):** CT ì°ì„ ì‹œê°„ì´ ì—†ìŠµë‹ˆë‹¤. ì¶œí˜ˆ ë¶€ìœ„ë¥¼ ë¹¨ë¦¬ ì°¾ì•„ì„œ ë§‰ì•„ì•¼ í•©ë‹ˆë‹¤. ì´ë•Œ **FAST(ì´ˆìŒíŒŒ)**ê°€ ìƒì‚¬ë¥¼ ê°€ë¥´ëŠ” ë„êµ¬ê°€ ë©ë‹ˆë‹¤.\n--------------------------------------------------------------------------------\n### **2. Blunt Abdominal Trauma (ë³µë¶€ ë‘”ìƒ): \"ë³´ì´ì§€ ì•ŠëŠ” ì¶œí˜ˆì„ ì°¾ì•„ë¼\"**\nêµí†µì‚¬ê³ (í•¸ë“¤ ì†ìƒ, ì•ˆì „ë²¨íŠ¸ í”ì )ë‚˜ ì¶”ë½ ì‚¬ê³ ê°€ ëŒ€í‘œì ì…ë‹ˆë‹¤. ê²‰ìœ¼ë¡œëŠ” ë©€ì©¡í•´ ë³´ì—¬ë„ ë±ƒì†ì—ì„œ ëŒ€ëŸ‰ ì¶œí˜ˆì´ ì¼ì–´ë‚  ìˆ˜ ìˆì–´ ê°€ì¥ ê¹Œë‹¤ë¡­ìŠµë‹ˆë‹¤.\n**A. Hemodynamically Unstable (í˜ˆì••ì´ í”ë“¤ë¦´ ë•Œ)** í™˜ìê°€ ì‡¼í¬ ìƒíƒœë¼ë©´ ì˜ë£Œì§„ì€ ë‹¤ìŒ ì•Œê³ ë¦¬ì¦˜ì„ ì¦‰ê° ìˆ˜í–‰í•©ë‹ˆë‹¤.\n1. **ë³µë§‰ì—¼ ì†Œê²¬(Peritonitis)ì´ ìˆëŠ”ê°€?**\n- ë°°ê°€ ë”±ë”±í•˜ë‹¤(Rigid) â†’ **ì¦‰ì‹œ ê°œë³µìˆ (Laparotomy)**. (ì¥ íŒŒì—´ì´ë‚˜ ì‹¬ê°í•œ ì¶œí˜ˆ ì‹œì‚¬)\n2. **ë³µë§‰ì—¼ ì†Œê²¬ì´ ë¶ˆëª…í™•í•˜ë‹¤ë©´?** â†’ **FAST ì‹œí–‰**\n- **FAST ì–‘ì„± (+):** ë³µê°• ë‚´ì— ì•¡ì²´(í”¼)ê°€ ë³´ì„ â†’ **ì¦‰ì‹œ ê°œë³µìˆ **.\n- **FAST ìŒì„± (-) / ë¶ˆí™•ì‹¤:**\n    - ë‹¤ë¥¸ ì¶œí˜ˆ ì›ì¸(ê³¨ë°˜ ê³¨ì ˆ, ëŒ€í‡´ê³¨ ê³¨ì ˆ ë“±)ì„ ì°¾ìŠµë‹ˆë‹¤.\n    - ì—¬ì „íˆ ë³µê°• ë‚´ ì¶œí˜ˆì´ ì˜ì‹¬ë˜ë©´ **DPL(ì§„ë‹¨ì  ë³µê°• ì„¸ì²™ìˆ )**ì„ ê³ ë ¤í•˜ê±°ë‚˜, ìˆ˜ì•¡ ì†Œìƒìˆ ë¡œ ì ê¹ ì•ˆì •ë˜ë©´ CTë¥¼ ì‹œë„í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n        - *Note:* DPLì€ ì¹¨ìŠµì ì´ë¼ ìµœê·¼ì—ëŠ” FASTë‚˜ CTë¡œ ëŒ€ì²´ë˜ëŠ” ì¶”ì„¸ì§€ë§Œ, ë‘”ìƒ(Blunt) í‰ê°€ì—ì„œ ì—¬ì „íˆ ìœ íš¨í•œ ì˜µì…˜ì…ë‹ˆë‹¤.\n**B. Hemodynamically Stable (í˜ˆì••ì´ ì•ˆì •ì ì¼ ë•Œ)**\n- ê°€ì¥ ì¢‹ì€ ì§„ë‹¨ ë„êµ¬ëŠ” **CT Scan (Abdomen & Pelvis)**ì…ë‹ˆë‹¤. ë¹„ì¥, ê°„, ì½©íŒ¥ ë“± ê³ í˜• ì¥ê¸°ì˜ ì†ìƒ ì •ë„ë¥¼ ì •í™•íˆ ë³´ì—¬ì¤ë‹ˆë‹¤.\n### **3. Penetrating Abdominal Trauma (ë³µë¶€ ê´€í†µìƒ): \"ì–´ë””ê¹Œì§€ ëš«ë ¸ë‚˜?\"**\nì¹¼(Stab wound)ì´ë‚˜ ì´ì•Œ(Gunshot wound)ì— ì˜í•œ ì†ìƒì…ë‹ˆë‹¤.\n**A. í•´ë¶€í•™ì  ê¸°ì¤€ (The Boundary)**\n- **4ë²ˆì§¸ ëŠ‘ê°„(4th Intercostal space, ì –ê¼­ì§€ ë¼ì¸) ì•„ë˜**ì˜ ëª¨ë“  ê´€í†µìƒì€ ë³µë¶€ ì†ìƒ ê°€ëŠ¥ì„±ì´ ìˆë‹¤ê³  ê°„ì£¼í•©ë‹ˆë‹¤.\n**B. ì¦‰ê°ì ì¸ ìˆ˜ìˆ (Immediate Laparotomy)ì˜ ì ˆëŒ€ ì ì‘ì¦** ê³ ë¯¼í•  í•„ìš” ì—†ì´ ë°”ë¡œ ìˆ˜ìˆ ë°©ì„ ì¡ì•„ì•¼ í•˜ëŠ” 4ê°€ì§€ ìƒí™©ì…ë‹ˆë‹¤:\n1. **Hemodynamic Instability:** ì‡¼í¬ ìƒíƒœ.\n2. **Peritonitis:** ë³µë§‰ì—¼ ì†Œê²¬ (ë°°ë¥¼ ëˆ„ë¥¼ ë•Œë³´ë‹¤ ë—„ ë•Œ ë” ì•„í”ˆ ë°˜ë™ì••í†µ ë“±).","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-274","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core"]}
{"chunk_type":"transcript_chunk","text":"3. **Evisceration (ì¥ê¸° íƒˆì¶œ):** ìƒì²˜ ë°–ìœ¼ë¡œ ì¥ì´ íŠ€ì–´ë‚˜ì˜¨ ê²½ìš°.\n4. **Impalement (ë°•í˜€ìˆëŠ” ë¬¼ì²´):** ì¹¼ì´ë‚˜ ì² ê·¼ì´ ê½‚í˜€ìˆëŠ” ê²½ìš° (ì ˆëŒ€ ì‘ê¸‰ì‹¤ì—ì„œ ë½‘ìœ¼ë©´ ì•ˆ ë©ë‹ˆë‹¤).\n**C. ìœ„ ì§•í›„ê°€ ì—†ë‹¤ë©´? (Stable patient)**\n- CTë¥¼ ì°ê±°ë‚˜, êµ­ì†Œ ìƒì²˜ íƒìƒ‰(Local wound exploration)ì„ í†µí•´ ë³µë§‰(Peritoneum)ì´ ëš«ë ¸ëŠ”ì§€ í™•ì¸í•©ë‹ˆë‹¤.\n- ë³µë§‰ì´ ëš«ë¦¬ì§€ ì•Šì•˜ë‹¤ë©´ ë´‰í•© í›„ ê·€ê°€ ê°€ëŠ¥í•˜ì§€ë§Œ, ëš«ë ¸ê±°ë‚˜ ì¥ê¸° ì†ìƒì´ ì˜ì‹¬ë˜ë©´ ì…ì›í•˜ì—¬ ì—°ì†ì ì¸ ì‹ ì²´ ê²€ì§„(Serial Exam)ì´ë‚˜ ìˆ˜ìˆ ì„ ê³ ë ¤í•©ë‹ˆë‹¤.\n### **4. Rib Fractures: The Anatomical Clues (ê°ˆë¹„ë¼ˆê°€ ë§í•´ì£¼ëŠ” ë‹¨ì„œ)**\nê°ˆë¹„ë¼ˆ ê³¨ì ˆ ìœ„ì¹˜ëŠ” ê·¸ ì•„ë˜ ìˆ¨ê²¨ì§„ ì¥ê¸° ì†ìƒì„ ê°•ë ¥í•˜ê²Œ ì‹œì‚¬í•©ë‹ˆë‹¤.\n- **Ribs 1-3:** ì—„ì²­ë‚œ í˜ì´ ê°€í•´ì¡ŒìŒì„ ì˜ë¯¸. ëŒ€ë™ë§¥(Aorta)ì´ë‚˜ ì‡„ê³¨í•˜í˜ˆê´€ ë“± **ëŒ€í˜ˆê´€ ì†ìƒ** ì£¼ì˜.\n- **Ribs 9-12 (í•˜ë¶€ ëŠ‘ê³¨):** ë³µë¶€ ì¥ê¸°ë¥¼ ì°Œë¥¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n    - **Right (ì˜¤ë¥¸ìª½):** **ê°„(Liver)** ì†ìƒ ì˜ì‹¬.\n    - **Left (ì™¼ìª½):** **ë¹„ì¥(Spleen)** ì†ìƒ ì˜ì‹¬.\n    - **Posterior 11-12 (ë“±ìª½):** **ì‹ ì¥(Kidney)** ì†ìƒ ì˜ì‹¬.\n**ğŸ’¡ Clinical Pearl (ì„ìƒ ìš”ì•½)**\n1. **FASTì˜ ì—­í• :** ë‘”ìƒ(Blunt) í™˜ìê°€ **ì‡¼í¬(Unstable)**ì¼ ë•Œ, \"ìˆ˜ìˆ ë°©ìœ¼ë¡œ ê°ˆê¹Œ?\"ë¥¼ ê²°ì •í•˜ëŠ” **ì‹ í˜¸ë“±** ì—­í• ì…ë‹ˆë‹¤.\n2. **ì§€ì—°ëœ ì²œê³µ:** ë‘”ìƒ í™˜ìì—ì„œ ì¥ê°„ë§‰(Mesentery) ì†ìƒìœ¼ë¡œ í˜ˆë¥˜ê°€ ë‚˜ë¹ ì§€ë©´, ë‹¹ì¥ì€ ê´œì°®ì•„ë„ **ë©°ì¹  ë’¤ì— ì¥ ê´´ì‚¬ ë° ì²œê³µ**ì´ ë°œìƒí•  ìˆ˜ ìˆìŠµë‹ˆë‹¤. ì™¸ìƒ í™˜ìê°€ ë©°ì¹  ë’¤ ê°‘ìê¸° ë°°ê°€ ì•„í”„ë‹¤ê³  í•˜ë©´ ì´ë¥¼ ì˜ì‹¬í•´ì•¼ í•©ë‹ˆë‹¤.\n3. **ì´ìƒ vs ììƒ:** ì´ìƒ(Gunshot)ì€ ê¶¤ì ì„ ì˜ˆì¸¡í•˜ê¸° í˜ë“¤ì–´ ëŒ€ë¶€ë¶„ ìˆ˜ìˆ ì  íƒìƒ‰ì´ í•„ìš”í•˜ì§€ë§Œ, ììƒ(Stab)ì€ ì•ˆì •ì´ë©´ CTë‚˜ ê´€ì°°ë¡œ ì§€ì¼œë³´ëŠ” ê²½ìš°ê°€ ëŠ˜ê³  ìˆìŠµë‹ˆë‹¤.\n## 16.1 Pancreatic Injury: The Silent Killer ğŸ¥·\nì´ ë…€ì„ì€ **Retroperitoneal(ë³µë§‰ ë’¤)** ì¥ê¸°ë¼ëŠ” í•´ë¶€í•™ì  ìœ„ì¹˜ ë•Œë¬¸ì— ì§„ë‹¨í•˜ê¸°ê°€ ë§¤ìš° ê¹Œë‹¤ë¡­ìŠµë‹ˆë‹¤.\n### **Scenario & Mechanism**\n- **Classic Vignette:** ìì „ê±° í•¸ë“¤ì— ë°°ë¥¼ ë¶€ë”ªì¹œ ê²½ìš° (**Handlebar injury**).\n- ì²˜ìŒì—” ë©€ì©¡í•´ ë³´ì´ê³  ERì—ì„œ í‡´ì›í•  ìˆ˜ë„ ìˆìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ **2~3ì¼ ë’¤**ì— ì§€ì†ì ì¸ **Epigastric pain, Nausea, Bilious vomiting**ìœ¼ë¡œ ë‹¤ì‹œ ì°¾ì•„ì˜µë‹ˆë‹¤.\n### **Why did we miss it? (The Anatomy Trap)**\n- **Abdomen**ì€ ë§ˆì¹˜ ê±°ì‹¤(Living room)ê³¼ ê°™ìŠµë‹ˆë‹¤. Liver, Spleen, Bowelì€ ê±°ì‹¤ì— ë‚˜ì™€ ìˆì–´ì„œ ë‹¤ì¹˜ë©´ í”¼ê°€ ì² ì²  ë‚˜ê³ , **FAST scan** (ì´ˆìŒíŒŒ)ì—ì„œ ë°”ë¡œ ë³´ì…ë‹ˆë‹¤.\n- í•˜ì§€ë§Œ **Pancreas**ëŠ” ë²½ ì†ì— ìˆ¨ì–´ ìˆìŠµë‹ˆë‹¤ (**Retroperitoneal**).\n- ì²™ì¶”(Spine)ì— ëˆŒë ¤ì„œ ìœ¼ê¹¨ì§€ëŠ”ë°, ê·¸ ì•¡ì²´ê°€ ë²½(Retroperitoneum) ì•ˆì— ê°‡í˜€ ìˆì–´ì„œ **FAST scanì—ì„œëŠ” Normal**ë¡œ ë‚˜ì˜µë‹ˆë‹¤.\n    - â˜… **Key Concept:** **Negative FAST does NOT rule out pancreatic injury!**","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-294","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### **Diagnosis**\n1. **Lab:** **Serial Amylase measurements**. í•œ ë²ˆ ì •ìƒì´ë¼ê³  ì•ˆì‹¬ ê¸ˆì§€. 12~24ì‹œê°„ ì§€ì¼œë³´ë©´ì„œ ìˆ˜ì¹˜ê°€ ì˜¤ë¥´ëŠ”ì§€ ë´ì•¼ í•©ë‹ˆë‹¤ (**Rising Amylase = Smoke signal**).\n2. **Gold Standard:** **CT Abdomen**.\n    - Retroperitoneal space, Peripancreatic fluid, Necrosisë¥¼ ë³¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n    - í•˜ì§€ë§Œ CTë„ **Main Pancreatic Duct**ê°€ ëŠì–´ì¡ŒëŠ”ì§€ëŠ” ì˜ ëª» ë´…ë‹ˆë‹¤.\n### **Management**\n- **Duct Intact:** **Conservative** (Bowel rest, Pain control, NG tube). ë§ˆì¹˜ ë©ë“  ê²ƒ(Contusion)ì²˜ëŸ¼ ì·¨ê¸‰í•©ë‹ˆë‹¤.\n- **Duct Ruptured:** **Surgery** (Distal pancreatectomy ë“±). íŒŒì´í”„ê°€ í„°ì¡Œìœ¼ë©´ ê³ ì³ì•¼ì£ !.\n    - Duct ìƒíƒœê°€ ì• ë§¤í•˜ë©´? **MRCP**ë‚˜ **ERCP**ë¡œ íŒŒì´í”„(Duct)ë¥¼ ì‹œê°í™”í•´ì•¼ í•©ë‹ˆë‹¤.\n## 16.3 Duodenal Perforation: The Slow Burn ğŸ”¥\nPancreasì™€ ê°™ì€ **Retroperitoneal** ì´ì›ƒì‚¬ì´Œì…ë‹ˆë‹¤.\n### **Scenario**\n- **Blunt trauma** (Seatbelt injury ë“±).\n- ì²˜ìŒì—” ê´œì°®ì•„ ë³´ì´ë‹¤ê°€ **í•˜ë£¨ ë’¤**ì— **Fever**, Diffuse painì´ ìƒê¹ë‹ˆë‹¤.\n### **Diagnosis**\n- **Imaging:** **CT Abdomen with Oral Contrast**.\n- **Finding:** **Retroperitoneal Free Air**.\n    - ì¥ì´ í„°ì ¸ì„œ ê³µê¸°ê°€ ë’¤ìª½ ê³µê°„(Retroperitoneum)ìœ¼ë¡œ ìƒŒ ê²ƒì…ë‹ˆë‹¤.\n    - Stomachì´ í„°ì§€ë©´ ë°° ì „ì²´ì— ê³µê¸°ê°€ ì°¨ì„œ ë°”ë¡œ ì•Œì§€ë§Œ(Peritonitis), Duodenumì€ ë’¤ìª½ìœ¼ë¡œ ìƒˆê¸° ë•Œë¬¸ì— ëŠ¦ê²Œ ë°œê²¬ë©ë‹ˆë‹¤.\n### **Management**\n- **Perforation = Surgery**.\n- êµ¬ë© ë‚œ ê³³ì„ ê¸°ì›Œì¤˜ì•¼ í•©ë‹ˆë‹¤ (**Patch repair**).\n- í•­ìƒì œ + ìˆ˜ìˆ ì´ ë‹µì…ë‹ˆë‹¤. \"Wait\" í•˜ë©´ ì•ˆ ë©ë‹ˆë‹¤.\n## 16.4 Duodenal Hematoma: The Blockage ğŸ›‘\nê°™ì€ ì¥ê¸°(Duodenum)ì§€ë§Œ, êµ¬ë©(Perforation)ì´ ì•„ë‹ˆë¼ ë©(Hematoma)ì´ ë“  ê²½ìš°ì…ë‹ˆë‹¤.\n### **Scenario**\n- **Kids + Handlebar injury** (Pancreasë‘ ë¹„ìŠ·í•˜ì£ ?).\n- ì²™ì¶”(Vertebral column)ì— Duodenumì´ ì°§ì´ë©´ì„œ ë²½ ì•ˆì— í”¼ê°€ ê³ ì…ë‹ˆë‹¤ (**Intramural Hematoma**).\n- Crush injury, not tear.\n- ì´ í”¼ë¬¼ì§‘(Hematoma)ì´ ì ì  ë¶€í’€ì–´ ì˜¬ë¼ì„œ **Lumenì„ ë§‰ì•„ë²„ë¦½ë‹ˆë‹¤**.\n### **Symptoms**\n- **Mechanical Obstruction symptoms**: 24~36ì‹œê°„ ë’¤ **Bilious Vomiting** (ë‹´ì¦™ì„± êµ¬í† ).\n    - ë§‰íŒ ìœ„ì¹˜ê°€ Bile ductê°€ ë“¤ì–´ì˜¤ëŠ” ê³³(Ampulla of Vater)ë³´ë‹¤ ë’¤ìª½ì´ë¼ì„œ í† ì‚¬ë¬¼ì— ë‹´ì¦™ì´ ì„ì…ë‹ˆë‹¤.\n### **Management: DO NOT OPERATE! ğŸš«**","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-314","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"- ì´ê±´ ë©(Bruise)ì¼ ë¿ì…ë‹ˆë‹¤. ì €ì ˆë¡œ í¡ìˆ˜ë©ë‹ˆë‹¤.\n- **Treatment:** **NG Tube** (Decompression) + **TPN** (Total Parenteral Nutrition) + **Bowel Rest**.\n- ë³´í†µ 1~2ì£¼ ì•ˆì— í•´ê²°ë©ë‹ˆë‹¤. ìˆ˜ìˆ í•˜ë ¤ê³  ê±´ë“œë¦¬ë©´ ì˜¤íˆë ¤ í„°ì§‘ë‹ˆë‹¤.\n## 16.2 Splenic Rupture: The Screamer ğŸ“¢\nPancreasì™€ ì •ë°˜ëŒ€ì…ë‹ˆë‹¤. Spleenì€ **Peritoneal cavity** ì•ˆì— ìˆê³  í˜ˆê´€ ë©ì–´ë¦¬ë¼ ë‹¤ì¹˜ë©´ ë¹„ëª…ì„ ì§€ë¥´ë©° í”¼ë¥¼ ìŸìŠµë‹ˆë‹¤.\n### **Scenario**\n- **Blunt Trauma** (êµí†µì‚¬ê³  ë“±).\n- **Medical History Trap:** **Mononucleosis (EBV)** í™˜ì.\n    - ë¹„ì¥ì´ ì»¤ì ¸ ìˆì–´ì„œ(Splenomegaly) ì‘ì€ ì¶©ê²©ì—ë„ ë¬¼í’ì„ ì²˜ëŸ¼ í„°ì§ˆ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n### **Physical Exam: Kehr Sign**\n- **Symptoms:** Abdominal pain + **Left Shoulder Pain**.\n- **Mechanism:** Spleenì—ì„œ ë‚œ í”¼ê°€ íš¡ê²©ë§‰(Diaphragm)ì„ ìê·¹í•©ë‹ˆë‹¤.\n- **Nerve Root:** **Phrenic nerve (C3, 4, 5)**. ì´ ì‹ ê²½ì´ ì–´ê¹¨ì˜ ê°ê°ë„ ë‹´ë‹¹í•˜ê¸° ë•Œë¬¸ì— ë‡Œê°€ ì–´ê¹¨ê°€ ì•„í”„ë‹¤ê³  ì°©ê°í•˜ëŠ” **Referred Pain**ì…ë‹ˆë‹¤.\n### **Algorithm: Stable vs Unstable** (ê°€ì¥ ì¤‘ìš”! â˜…)\nì˜ì‚¬ê²°ì •ì˜ ì²« ë²ˆì§¸ ì§ˆë¬¸: **\"í™˜ìê°€ Stable í•œê°€?\"**\n**1. Unstable Patient (Hypotension, Tachycardia)**\n- **Action:** ìˆ˜ì•¡(Fluid) ì¤˜ë„ ë°˜ì‘ ì—†ìœ¼ë©´ ë°”ë¡œ **Operating Room (OR)**ìœ¼ë¡œ ì§í–‰.\n- **Procedure:** **Exploratory Laparotomy (Ex-lap)** â†’ ë³´í†µ **Splenectomy** ì‹œí–‰.\n- **CT ì°ì§€ ë§ˆì„¸ìš”!** (Unstable í™˜ìëŠ” CTì‹¤ ê°€ë‹¤ê°€ ì£½ìŠµë‹ˆë‹¤. 20ë¶„ë„ ì—†ìŠµë‹ˆë‹¤).\n**2. Stable Patient**\n- **Action:** **CT Abdomen**. Injury gradeë¥¼ í™•ì¸í•©ë‹ˆë‹¤.\n- **Trap:** Stable í•˜ë‹¤ê³  ì•ˆì‹¬í–ˆëŠ”ë° ê°‘ìê¸° Hemoglobinì´ ëš ë–¨ì–´ì§€ê±°ë‚˜ ë¶ˆì•ˆí•˜ë©´?\n    - **FAST**ë¥¼ ë‹¤ì‹œ í•˜ê±°ë‚˜ **CT**ë¥¼ ì°ìŠµë‹ˆë‹¤.\n    - **Active Bleed (Blush on CT)**ê°€ ë³´ì´ë©´?\n        - **Next Best Step:** **Angioembolization** (Interventional Radiology). ìˆ˜ìˆ  ëŒ€ì‹  í˜ˆê´€ ì•ˆìœ¼ë¡œ ë“¤ì–´ê°€ì„œ êµ¬ë©ì„ ë§‰ìŠµë‹ˆë‹¤.\n        - ìš”ì¦˜ íŠ¸ë Œë“œëŠ” **Spleenì„ ì‚´ë¦¬ëŠ” ê²ƒ**ì…ë‹ˆë‹¤ (Immunologic role ë•Œë¬¸, OPSI ë°©ì§€).\n## 16.5 Rectus Sheath Hematoma: The Fake Acute Abdomen ğŸ­\në³µê°• ë‚´ ì¥ê¸°ê°€ ì•„ë‹ˆë¼, **ë³µë²½(Abdominal Wall)** ê·¼ìœ¡ ì¸µì— í”¼ê°€ ë‚œ ê²ƒì…ë‹ˆë‹¤.\n### **Scenario**\n- **Elderly female** on **Anticoagulation** (Warfarin, NOAC ë“±).\n- ì‹¬í•˜ê²Œ **ê¸°ì¹¨(Coughing fit)**ì„ í•˜ë‹¤ê°€ ê°‘ìê¸° ë°°ì— ë©ì–´ë¦¬(Mass)ì™€ í†µì¦ì´ ìƒê¹€.\n- **Inferior Epigastric Artery**ê°€ ì°¢ì–´ì ¸ì„œ Rectus muscle sheath ì•ˆì— í”¼ê°€ ê³ ì¸ ê²ƒì…ë‹ˆë‹¤.","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-334","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"### **Physical Exam: Fothergill Sign**\n- í™˜ìë¥¼ ëˆ•íˆê³  ë©ì–´ë¦¬ë¥¼ ë§Œì§‘ë‹ˆë‹¤.\n- í™˜ìì—ê²Œ **ìœ—ëª¸ì¼ìœ¼í‚¤ê¸°(Half sit-up)**ë¥¼ ì‹œí‚µë‹ˆë‹¤ (ë³µê·¼ì— í˜ì£¼ê¸°).\n    - **Intra-abdominal mass (Tumor):** ê·¼ìœ¡ì´ ë‹¨ë‹¨í•´ì§€ë©´ ë©ì–´ë¦¬ê°€ ì˜ ì•ˆ ë§Œì ¸ì§ (ì‚¬ë¼ì§).\n    - **Rectus Sheath Hematoma:** ê·¼ìœ¡ ì¸µ ì•ˆì— ìˆìœ¼ë‹ˆê¹Œ í˜ì„ ì£¼ë©´ **ë” ì˜ ë§Œì ¸ì§ (Remains palpable or more prominent)** â†’ **Positive Fothergill Sign**.\n### **Management**\n- **Conservative**.\n- Anticoagulation ì¤‘ë‹¨, í•„ìš”í•˜ë©´ Reversal, ì§„í†µì œ. ìˆ˜ìˆ  ì•ˆ í•©ë‹ˆë‹¤.\n## 16.6 Wound Dehiscence: The Pink Fluid Warning âš ï¸\nìˆ˜ìˆ  í›„ í•©ë³‘ì¦ì…ë‹ˆë‹¤. ìƒì²˜ê°€ ë²Œì–´ì§€ëŠ” ì•…ëª½ì´ì£ .\n### **Scenario**\n- ìˆ˜ìˆ  í›„ **Day 5~7**. (ë³´í†µ ê¸°ì¹¨í•˜ê±°ë‚˜ í˜ì¤„ ë•Œ 'í½' í•˜ëŠ” ëŠë‚Œ).\n- **Sign:** ë“œë ˆì‹±ì´ í ë»‘ ì –ì–´ ìˆìŠµë‹ˆë‹¤.\n- **Color:** **\"Salmon-colored fluid\"** (ì—°ì–´ìƒ‰ ì•¡ì²´).\n    - ì´ê²Œ í•µì‹¬ì…ë‹ˆë‹¤!\n    - **Pinkish Watery Fluid = Peritoneal Fluid + Serum/Blood**.\n    - ì¦‰, í”¼ë¶€ë§Œ ë²Œì–´ì§„ ê²Œ ì•„ë‹ˆë¼ ì†ì˜ **Fascia(ê·¼ë§‰)**ê°€ í„°ì ¸ì„œ ë³µìˆ˜ê°€ ìƒˆì–´ ë‚˜ì˜¤ëŠ” ê²ë‹ˆë‹¤.\n    - Deep dehiscenceë¥¼ ì˜ë¯¸í•¨.\n### **Mechanism: Fascial Failure**\n- **Superficial Dehiscence:** í”¼ë¶€ë§Œ ë²Œì–´ì§. ë³„ê±° ì•„ë‹˜.\n- **Deep Dehiscence (Fascial Dehiscence):** ê·¼ë§‰ì´ ì—´ë¦¼. ì¥(Bowel)ì´ ìŸì•„ì ¸ ë‚˜ì˜¤ê¸° ì§ì „ì…ë‹ˆë‹¤ (**Evisceration** ì „ì¡°ì¦ìƒ).\n### **Management**\n- **Surgical Emergency!** ğŸš¨\n- ì´ê±´ **Evisceration**ìœ¼ë¡œ ì§„í–‰ë  ìˆ˜ ìˆìœ¼ë¯€ë¡œ ë‹¹ì¥ ORë¡œ ê°€ì„œ ë‹¤ì‹œ ê¿°ë§¤ì•¼ í•©ë‹ˆë‹¤.\n- ì ˆëŒ€ \"í•­ìƒì œ ì£¼ê³  ì§€ì¼œë³´ì\" í•˜ë©´ ì•ˆ ë©ë‹ˆë‹¤. **Salmon fluid = OR**.\n## 16.7 Pilonidal Sinus: The Truck Driver's Bump ğŸšš\n### **Scenario**\n- **Young, Hairy Male**, ë§ì´ ì•‰ì•„ ìˆëŠ” ì§ì—… (íŠ¸ëŸ­ ìš´ì „ì‚¬ ë“±).\n- **Location:** **Gluteal Cleft** (ì—‰ë©ì´ ê³¨) ë§¨ ìœ„ìª½ (ê¼¬ë¦¬ë¼ˆ ë¶€ê·¼).\n- **Pathology:** í„¸ì´ ì‚´ì„ íŒŒê³ ë“¤ì–´ì„œ(**Ingrown hair**) ì—¼ì¦ê³¼ ê³ ë¦„ì§‘(Abscess)ì„ ë§Œë“¤ê³ , í”¼ë¶€ ë°‘ìœ¼ë¡œ í„°ë„(Sinus tract)ì„ ëš«ìŠµë‹ˆë‹¤.\n### **Management**\n1. **Acute Abscess:** **I&D (Incision and Drainage)**. ì¼ë‹¨ ê³ ë¦„ì„ ëºë‹ˆë‹¤.\n2. **Definitive Treatment:** í•­ìƒì œë§Œìœ¼ë¡œëŠ” í•´ê²° ì•ˆ ë¨. **Surgical Excision** of the sinus tract (í„°ë„ ìì²´ë¥¼ ë„ë ¤ëƒ„).","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-354","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"recap_summary","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n| **Injury** | **Key Vignette / Symptom** | **Diagnosis** | **Treatment (Cut vs Wait)** |\n| --- | --- | --- | --- |\n| **Pancreatic Injury** | Handlebar injury, Rising Amylase | CT Abdomen (Gold Std) | **Wait** (if duct intact) / **Cut** (if duct ruptured) |\n| **Splenic Rupture** | Kehr Sign (L. Shoulder pain), Mono hx | CT (Stable) / Clinical (Unstable) | **Unstable:** Ex-lap (Cut)\n**Stable:** Embolization or Observe (Wait) |\n| **Duodenal Perforation** | Fever next day, Retroperitoneal Air | CT w/ Oral Contrast | **Cut** (Surgery is mandatory) |\n| **Duodenal Hematoma** | Peds, Handlebar, Bilious vomiting | CT Abdomen | **Wait** (NGT + TPN). **Do NOT Cut** |\n| **Rectus Sheath Hematoma** | Coughing elderly, Warfarin, **Fothergill Sign** | CT / Physical Exam | **Wait** (Conservative) |\n| **Wound Dehiscence** | Post-op Day 5, **Salmon-colored fluid** | Clinical (Look at the dressing) | **Cut** (Emergency Fascial Repair) |\n| **Pilonidal Sinus** | Hairy male, Gluteal cleft abscess | Physical Exam | **Cut** (I&D + Excision) |\n## ğŸ¥ **Managing Acute GI Bleeding & Variceal Hemorrhage**\n**(Section 17-17.3)**\nì•ˆë…•í•˜ì‹­ë‹ˆê¹Œ ì„ ìƒë‹˜! ì˜¤ëŠ˜ë„ USMLE Step 2 CK ì •ë³µì„ ìœ„í•´ \"High Acuity Medicine\" íŒŒíŠ¸, ì¦‰ ì‘ê¸‰ì‹¤ì—ì„œ ê°€ì¥ ê¸´ì¥ë˜ëŠ” **GI Bleeding**ì„ ë‹¤ë¤„ë³´ê² ìŠµë‹ˆë‹¤. ë‹¨ìˆœíˆ ë¦¬ìŠ¤íŠ¸ë¥¼ ì™¸ìš°ëŠ” ê²Œ ì•„ë‹ˆë¼, í™˜ìê°€ í”¼ë¥¼ í† í•˜ë©° ë“¤ì–´ì™”ì„ ë•Œ ë¨¸ë¦¿ì†ì— ë°”ë¡œ ë– ì˜¬ë¼ì•¼ í•˜ëŠ” **Mental Framework**ë¥¼ ë§Œë“œëŠ” ê²ƒì´ ëª©í‘œì…ë‹ˆë‹¤.\n### ğŸŒ³ **Big Picture: Top-down Classification**","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-374","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","recap","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"ë¨¼ì € ìˆ²ì„ ë´…ì‹œë‹¤. GI Bleedingì€ í™˜ìì˜ **Stability**ì™€ **Source**ì— ë”°ë¼ ì ‘ê·¼ì´ ì™„ì „íˆ ë‹¬ë¼ì§‘ë‹ˆë‹¤.\nPlaintext\n`Acute GI Bleeding Management\nâ”œâ”€â”€ 1. Initial Stabilization (The \"Doorway\" Thought)\nâ”‚   â”œâ”€â”€ ğŸ©¸ ABCs (Airway, Breathing, Circulation)\nâ”‚   â”œâ”€â”€ ğŸ’‰ Access (2 Large Bore IVs)\nâ”‚   â””â”€â”€ ğŸ“‰ Transfusion Thresholds (Hb <7 or <9)\nâ”‚\nâ”œâ”€â”€ 2. Upper GI Bleed (UGIB)\nâ”‚   â”œâ”€â”€ General Approach (BUN/Cr ratio > 30:1)\nâ”‚   â””â”€â”€ Variceal Hemorrhage (Cirrhosis Hx)\nâ”‚       â”œâ”€â”€ ğŸ’Š Medical: Octreotide + Antibiotics(Ceftriaxone)\nâ”‚       â”œâ”€â”€ ğŸŒ¬ï¸ Airway: Intubation (If AMS/Hematemesis)\nâ”‚       â”œâ”€â”€ ğŸ“· Procedure: EGD + Band Ligation\nâ”‚       â””â”€â”€ ğŸ†˜ Rescue: Balloon Tamponade -> TIPS\nâ”‚\nâ”œâ”€â”€ 3. Lower GI Bleed (LGIB) & Hematochezia\nâ”‚   â”œâ”€â”€ Stable Patient â†’ Colonoscopy\nâ”‚   â””â”€â”€ Unstable Patient â†’ EGD (Rule out brisk UGIB) â†’ Angiography\nâ”‚\nâ””â”€â”€ 4. Rare Causes: Hemobilia\n    â””â”€â”€ âš ï¸ Triad: RUQ Pain + Jaundice + GI Bleed`\n### **1. General Approach to GI Bleed (Item 17)**\nì‘ê¸‰ì‹¤ ë¬¸ì„ ì—´ê³  ë“¤ì–´ê°”ëŠ”ë°, í™˜ìê°€ **Alcoholic Cirrhosis** ë³‘ë ¥ì´ ìˆê³  í”¼ë¥¼ í† í•˜ê³  ìˆìŠµë‹ˆë‹¤(Bright red blood hematemesis). ê°€ìš´ì´ í”¼ë²”ë²…ì´ê³  ìƒí™©ì€ Chaosì…ë‹ˆë‹¤. ì´ë•Œ ê°€ì¥ ë¨¼ì € í•´ì•¼ í•  ìƒê°ì€?\n### **âœ… Transfusion Rules (ìˆ˜í˜ˆ ê¸°ì¤€)**\nUSMLEê°€ ì‚¬ë‘í•˜ëŠ” \"Magic Number\"ë“¤ì…ë‹ˆë‹¤.\n- **Hb < 7 g/dL:** General Goal.\n- **Hb < 9 g/dL:** ë‘ ê°€ì§€ ì˜ˆì™¸ ìƒí™©.\n    1. **Acute Coronary Syndrome (ACS):** ì‹¬ì¥ì— í—ˆí˜ˆì´ ìˆìœ¼ë©´ ì‚°ì†Œë¥¼ êµ¶ê¸¸ ìˆ˜ ì—†ìŠµë‹ˆë‹¤.\n    2. **Active Massive Bleeding:** í”¼ê°€ ì½¸ì½¸ ìŸì•„ì§€ëŠ” ì¤‘ì´ë¼ë©´ Bufferê°€ í•„ìš”í•©ë‹ˆë‹¤.\n- **Platelets:**\n    - **< 50,000:** Active Bleedingì´ ìˆì„ ë•Œ ìˆ˜í˜ˆ.\n    - **< 10,000:** Bleedingì´ ë©ˆì·„ë”ë¼ë„ ìˆ˜í˜ˆ (Spontaneous bleeding risk).\n### **ğŸš¨ The \"Dilution Trap\" (í•¨ì • ì£¼ì˜)**\ní™˜ìì—ê²Œ ìˆ˜ì•¡(Normal Saline, Lactated Ringer's)ì„ ë§ˆêµ¬ ìŸì•„ë¶“ê³  1ì‹œê°„ ë’¤ Labsë¥¼ ë´¤ë”ë‹ˆ **Hemoglobinì´ ëš ë–¨ì–´ì¡ŒìŠµë‹ˆë‹¤.**\n- **ì´ˆë³´ì˜ ìƒê°:** \"í—‰! í”¼ê°€ ë” ë‚˜ê³  ìˆë‚˜ ë´!\" (Panic) ğŸ˜±\n- **ê³ ìˆ˜ì˜ ìƒê°:** \"Fluid ë•Œë¬¸ì— í”¼ê°€ ë¬½ì–´ì§„ ê²ƒë¿ì´ì•¼(Dilution).\" ğŸ˜\n    - ìˆ˜ì•¡ë§Œ ì£¼ë©´ ì í˜ˆêµ¬ ì—†ì´ Volumeë§Œ ëŠ˜ì–´ë‚˜ë¯€ë¡œ Hb ìˆ˜ì¹˜ëŠ” ë–¨ì–´ì§ˆ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ë‹¹í™©í•˜ì§€ ë§ˆì„¸ìš”.\n### **ğŸ§­ Diagnostic Shortcut: BUN/Cr Ratio**\nUpperì¸ì§€ Lowerì¸ì§€ í—·ê°ˆë¦´ ë•Œ ì“°ëŠ” ë‚˜ì¹¨ë°˜ì…ë‹ˆë‹¤.\n- **BUN/Cr Ratio > 30:1** â¡ï¸ **Upper GI Bleed** ê°•ë ¥ ì‹œì‚¬.\n    - **Why?** ì†Œì¥(Small Intestine)ì„ í†µê³¼í•˜ëŠ” í”¼ëŠ” ë‹¨ë°±ì§ˆ ë©ì–´ë¦¬ì…ë‹ˆë‹¤. ì´ê²Œ ì†Œí™”ë˜ë©´ì„œ Urea(BUN)ê°€ í­ë°œì ìœ¼ë¡œ í¡ìˆ˜ë˜ê¸° ë•Œë¬¸ì…ë‹ˆë‹¤. (Lower bleedëŠ” ì†Œí™”ë  ì‹œê°„ì´ ì—†ì–´ì„œ BUNì´ ì•ˆ ì˜¤ë¦„)\n### **2. Variceal Hemorrhage (Item 17.1)**\n**Mortality Rate**ê°€ ë§¤ìš° ë†’ì€ ì‘ê¸‰ ìƒí™©ì…ë‹ˆë‹¤. ì•Œê³ ë¦¬ì¦˜ëŒ€ë¡œ ê¸°ê³„ì²˜ëŸ¼ ì›€ì§ì—¬ì•¼ í•©ë‹ˆë‹¤.\n### **ğŸš‘ Step-by-Step Algorithm**","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-384","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","diagnosis","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"**Step 1: Access**\n- **2 Large Bore IV Catheters (18G or larger).** ì°”ë”ì°”ë” ë“¤ì–´ê°€ëŠ” ì–‡ì€ ë¼ì¸ì€ ì•ˆ ë©ë‹ˆë‹¤. Flowê°€ ìƒëª…ì…ë‹ˆë‹¤.\n**Step 2: Medication Cocktail (3ê°€ì§€ ë™ì‹œì—!)**\n1. **Fluids:** Volume resuscitation.\n2. **IV Octreotide:**\n    - Splanchnic vasoconstrictionì„ ìœ ë°œí•˜ì—¬ Portal systemìœ¼ë¡œ ë“¤ì–´ê°€ëŠ” í˜ˆë¥˜ëŸ‰ì„ ì¤„ì…ë‹ˆë‹¤. (\"ìˆ˜ë„ê¼­ì§€ë¥¼ ì ê·¸ëŠ” ì—­í• \")\n3. **â˜… Antibiotics (IV Ceftriaxone for 7 days):**\n    - **ì´ê±¸ ìŠìœ¼ë©´ ê°ì !** Cirrhosis í™˜ìê°€ GI Bleedingì´ ìƒê¸°ë©´ ì¥ë‚´ ì„¸ê·  ì´ë™(Translocation)ìœ¼ë¡œ **SBP (Spontaneous Bacterial Peritonitis)** ìœ„í—˜ì´ ê¸‰ì¦í•©ë‹ˆë‹¤.\n    - í•­ìƒì œ íˆ¬ì—¬ëŠ” **Mortality**ë¥¼ ë‚®ì¶”ëŠ” í•„ìˆ˜ ì¡°ì¹˜ì…ë‹ˆë‹¤.\n**Step 3: Airway Protection (Critical Decision)**\n- í™˜ìê°€ ì˜ì‹ì´ ë–¨ì–´ì§€ê±°ë‚˜(Depressed mental status), í”¼ë¥¼ ê³„ì† í† í•œë‹¤ë©´?\n- **Intubate FIRST!** ğŸŒ¬ï¸\n- ë‚´ì‹œê²½(EGD) ë„£ê¸° ì „ì— ê¸°ë„ë¥¼ í™•ë³´í•´ì•¼ í•©ë‹ˆë‹¤. ì•ˆ ê·¸ëŸ¬ë©´ Aspiration Pneumoniaë¡œ í™˜ìë¥¼ ìƒìŠµë‹ˆë‹¤.\n**Step 4: The Procedure (Definitive Tx)**\n- **Urgent Endoscopy (EGD)**\n- **Treatment:** **Band Ligation** (ì •ë§¥ë¥˜ë¥¼ ê³ ë¬´ì¤„ë¡œ ë¬¶ì–´ ê´´ì‚¬ì‹œí‚´).\n**Step 5: Troubleshooting (í”¼ê°€ ì•ˆ ë©ˆì¶”ë©´?)**\n- ë‚´ì‹œê²½ìœ¼ë¡œë„ ì§€í˜ˆ ì‹¤íŒ¨ ì‹œ: **Balloon Tamponade** (Sengstaken-Blakemore tube).\n    - ì‹ë„/ìœ„ ì•ˆì—ì„œ í’ì„ ì„ ë¶ˆì–´ ë¬¼ë¦¬ì ìœ¼ë¡œ í˜ˆê´€ì„ ì••ë°•í•©ë‹ˆë‹¤.\n    - **ì£¼ì˜:** ì´ê±´ **Temporary Bridge** (ìµœëŒ€ 24ì‹œê°„)ì…ë‹ˆë‹¤. ì˜êµ¬ì ì¸ ì¹˜ë£Œë²•ì´ ì•„ë‹™ë‹ˆë‹¤.\n- **Re-bleeding (ì¬ì¶œí˜ˆ) ì‹œ:**\n    - Repeat Endoscopy -> ë‹¤ì‹œ ì‹œë„.\n    - ê·¸ë˜ë„ ì‹¤íŒ¨í•˜ë©´? â¡ï¸ **TIPS (Transjugular Intrahepatic Portosystemic Shunt)**\n        - ê°„ì„ ìš°íšŒí•˜ì—¬ Portal pressureë¥¼ ë‚®ì¶”ëŠ” ì‹œìˆ  (Interventional Radiology).\n**Step 6: Secondary Prophylaxis (í‡´ì› í›„ ê´€ë¦¬)**\n- ì•ˆì •ì´ ëœ í›„ì—ëŠ” ì¬ë°œ ë°©ì§€ë¥¼ ìœ„í•´ **Non-selective Beta-blocker (Nadolol, Propranolol)**ë¥¼ ì‹œì‘í•©ë‹ˆë‹¤.\n- 1-2ì£¼ ë’¤ì— **Repeat Band Ligation**ì„ ìŠ¤ì¼€ì¤„ ì¡ìŠµë‹ˆë‹¤.\n### **3. Hematochezia & Occult Bleeding (Item 17.2)**\n**Clinical Vignette:** 55ì„¸ í™˜ì, **Bright Red Blood Per Rectum (BRBPR)** í˜¸ì†Œ.\n### **âš–ï¸ The \"Stability\" Fork**\nì—¬ê¸°ì„œ ê°€ì¥ ì¤‘ìš”í•œ ê±´ í™˜ìê°€ **Stable**í•œì§€ **Unstable**í•œì§€ì…ë‹ˆë‹¤.\n1. **Stable Patient:**\n    - **Next Best Step:** **Colonoscopy**.\n    - ì²œì²œíˆ ì›ì¸(Diverticulosis, Cancer, Angiodysplasia ë“±)ì„ ì°¾ìœ¼ë©´ ë©ë‹ˆë‹¤.\n    - Colono ìŒì„± â†’ EGD. EGD ìŒì„± â†’ OCCULT\n        - look for small intestine: capsule ë‚´ì‹œê²½\n        - Angyiodysplasia\n            - Heydeâ€™s sydrome: Arotic stenosis\n            - Renal disease\n2. **Unstable Patient (Hypotensive, Tachycardic):**\n    - **Trap!** ğŸš¨ í˜ˆë³€(Hematochezia)ì´ë¼ê³  ë¬´ì¡°ê±´ Lower GI Bleedê°€ ì•„ë‹™ë‹ˆë‹¤.\n    - **Massive Upper GI Bleed**ê°€ ì¥ì„ ë„ˆë¬´ ë¹¨ë¦¬ í†µê³¼í•˜ë©´(Rapid transit), í”¼ê°€ ê²€ê²Œ ë³€í•  ì‹œê°„(Melena) ì—†ì´ ë¹¨ê°„ìƒ‰ ê·¸ëŒ€ë¡œ ë‚˜ì˜µë‹ˆë‹¤.\n    - **Management:**\n        1. **Resuscitate** (ìˆ˜ì•¡, í˜ˆì•¡).\n        2. **EGD (Upper Endoscopy) FIRST!** â¡ï¸ ìœ„ì¥ê´€ ì¶œí˜ˆ(Upper source)ì„ ë¨¼ì € ë°°ì œí•´ì•¼ í•©ë‹ˆë‹¤.\n        3. EGDê°€ ê¹¨ë—í•œë°(Negative) ê³„ì† í”¼ê°€ ë‚œë‹¤ë©´?\n        4. **Angiography (Interventional Radiology):** ì¶œí˜ˆ í˜ˆê´€ì„ ì°¾ì•„ ìƒ‰ì „ìˆ (Embolization) ì‹œí–‰. (ëŒ€ì¥ë‚´ì‹œê²½ì€ í”¼, ë˜¥ë°”ë‹¤ ì†ì—ì„œ ì‹œì•¼ í™•ë³´ê°€ ì•ˆ ë¼ì„œ Unstable í•  ë•Œ ëª» ì”ë‹ˆë‹¤.)\nnote:\n- ì–´ë¥¸ ê°€ì¥ í”í•œ lower GI bleeding: diverticulosis â†’ erosion â†’ massive painless bleeding\n- ì†Œì•„: Meckelâ€™s diverticulum: massive painless bleeding: í•µ scan","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-404","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"### **4. Hemobilia (Item 17.3)**\në§¤ìš° ë“œë¬¼ì§€ë§Œ, USMLEê°€ ì¢‹ì•„í•˜ëŠ” \"ì¡±ë³´\" í† í”½ì…ë‹ˆë‹¤.\n- **Scenario:** í™˜ìê°€ ìµœê·¼ **Liver Biopsy**ë¥¼ í–ˆê±°ë‚˜ ë³µë¶€ ì™¸ìƒ(Trauma)ì´ ìˆì—ˆìŒ.\n- **Symptoms (Quincke's Triad):**\n    1. **RUQ Pain** (ìš°ìƒë³µë¶€ í†µì¦)\n    2. **Jaundice** (í™©ë‹¬ - ë‹´ë„ê°€ ë§‰í˜€ì„œ)\n    3. **GI Bleeding** (í˜ˆì•¡ì´ ë‹´ë„ë¡œ í˜ëŸ¬ ë“¤ì–´ê°)\n- **Pathophysiology:** ê°„ë‚´ í˜ˆê´€ê³¼ ë‹´ë„ ì‚¬ì´ì— ëˆ„ê³µ(Fistula)ì´ ìƒê²¨ ë‹´ë„(Biliary tree)ë¡œ í”¼ê°€ íë¥´ëŠ” ê²ƒ.\n- **Dx & Tx:**\n    - Usually self limiting\n    - **Angiography with Embolization**. (í”¼ íë¦„ì„ ë§‰ì•„ì•¼ í•¨).\n## ğŸ”¥ **Rapid Fire Recap (High Yield Summary)**\n| **Clinical Vignette (ìƒí™©)** | **Diagnosis / Context** | **Key Action / Next Best Step** |\n| --- | --- | --- |\n| **Cirrhosis + Hematemesis** | **Variceal Hemorrhage** | **2 Large Bore IVs + Octreotide + Ceftriaxone** (í•­ìƒì œ í•„ìˆ˜!) |\n| **Vomiting blood + Altered Mental Status** | **Airway Risk** | **Intubate** before Endoscopy |\n| **Active Bleeding + Platelets 40k** | **Thrombocytopenia** | **Transfuse Platelets** (Threshold < 50k for active bleed) |\n| **Hb drops after 2L Saline** | **Dilution (Not re-bleed)** | **Observation** (Don't panic) |\n| **Unstable + Bright Red Blood per Rectum** | **Massive UGIB (Rapid transit)** | **EGD (Upper Endoscopy)** first to rule out Upper source |\n| **Recent Liver Biopsy + RUQ Pain + Jaundice** | **Hemobilia** | **Angiography** (Embolization) |\n| **Variceal Bleeding Refractory to Banding** | **Failed Endoscopy** | **TIPS** (Definitive) or Balloon Tamponade (Bridge) |\n**ğŸ‘¨â€âš•ï¸ Tutor's One-Liner:**\n\"ì„ ìƒë‹˜, GI Bleed í™˜ìëŠ” **'í”¼ë¥¼ ì–´ë””ê¹Œì§€ í˜ë ¤ë„ ë˜ë‚˜(Thresholds)'**ì™€ **'ì•ˆì •ì ì¸ê°€(Stability)'** ë‘ ê°€ì§€ë§Œ ê¸°ì–µí•˜ë©´ ë°˜ì€ ë¨¹ê³  ë“¤ì–´ê°‘ë‹ˆë‹¤. íŠ¹íˆ **Unstableí•œ í˜ˆë³€ í™˜ìì—ì„œ EGD ë¨¼ì €** ì°Œë¥´ëŠ” ê²ƒ, ì´ê±° ë‚šì‹œ ë¬¸ì œë¡œ ì§„ì§œ ë§ì´ ë‚˜ì˜¤ë‹ˆê¹Œ ê¼­ ì±™ê²¨ê°€ì„¸ìš”! í™”ì´íŒ…!\" ğŸ’ª","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-424","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"# ACS\n```mermaid\ngraph LR\n    %% 1. STEMI ì„¹ì…˜\n    subgraph STEMI [\"1. STEMI (Acute, 100% Blocked)\"]\n        direction LR\n        S1[í‰í†µ ë°œìƒ <br> EKG STìƒìŠ¹ / Trop++]\n        S1 --> S3[\"ğŸ“˜ ì´ˆê¸°ì¹˜ë£Œ: MONASH + BB <br> (Heparin-O, Nitrate-O, ACEi-X)\"]\n        S3 --> S4[\"ğŸ“˜ ì¬ê´€ë¥˜: Primary PCI\"]\n        S4 --> S5[\"ğŸ“˜ í•©ë³‘ì¦ ê´€ë¦¬\"]\n        S5 --> S6[\"ğŸ“˜ í‰ìƒì¹˜ë£Œ: BASS M <br> (ACEi/ARB, Spirono, SGLT2-O)\"]\n    end\n%% ë””ìì¸ ì„¸íŒ…\n    style S3 fill:#f0f7ff,stroke:#007bff\n        style S4 fill:#f0f7ff,stroke:#007bff\n                style S5 fill:#f0f7ff,stroke:#007bff\nstyle S6 fill:#f0f7ff,stroke:#007bff\n```\n```mermaid\ngraph LR\n    subgraph NSTEMI [\"2. NSTEMI/UA (Acute, Partial)\"]\n        direction LR\n        N2[\"í‰í†µë°œìƒ <br> EKG STD or ì •ìƒ or Trop+\"] --> N3\n        N3[\"ğŸ“˜ ì´ˆê¸°ì¹˜ë£Œ: MONASH + BB <br> (Heparin-O, Nitrate-O, ACEi-X)\"] --> N4{\"ğŸ“˜ ìœ„í—˜ë„ í‰ê°€\"}\n%% 1. ìœ„í—˜ë„ ê·¸ë£¹: íˆ¬ëª…ì„ (~~~) ì œê±°í•˜ê³  ìˆœìˆ˜í•˜ê²Œ ë¬¶ìŒ\n        subgraph Risk_Group [\"Risk Categories\"]\n            direction TB\n            N97[\"High/Refractory<br>í˜ˆì—­í•™ì  ë¶ˆì•ˆ\"]\n            N98[\"Intermediate\"]\n            N99[\"Low Risk<br>ì‹¬ì¥ì¸ì§€ ì•„ë‹Œì§€ ì• ë§¤í•˜ë‹¤\"]\n        end\n%% 2. ì¹˜ë£Œë²• ê·¸ë£¹: ì—¬ê¸°ë„ íˆ¬ëª…ì„  ì œê±°\n        subgraph Action_Group [\"Management Strategy\"]\n            direction TB\n            N5[\"2h ë‚´ PCI\"]\n            N6[\"24h ë‚´ PCI\"]\n            N7[\"Non-invasive Evalulation<br>Stress testâ­ or CT\"]\n        end\n%% 3. ì—°ê²°: ë¶€ëª¨(N4)ì—ì„œ ìì‹ë“¤ë¡œ ê°ê° ì—°ê²°\n        N4 --> N97\n        N4 --> N98\n        N4 --> N99\n%% 4. 1:1 ëŒ€ì‘ ì—°ê²° (ìˆ˜í‰ ìœ ì§€)\n        N97 --> N5\n        N98 --> N6\n        N99 --> N7\n%% ê²°ê³¼ ì„¹ì…˜\n        subgraph Evaluation [\"Result\"]\n            direction TB\n            N7 -- \"í˜‘ì°© ì—†ìŒ\" --> N9[\"í‡´ì›\"]\n            N7 -- \"í˜‘ì°© ìˆìŒ\" --> N8[\"CAG\"]\n        end\nN5 & N6 & N8 --> N100[\"ğŸ“˜ í‰ìƒì¹˜ë£Œ: BASS M <br> (ACEi/ARB, Spirono, SGLT2-O)\"]\n%% ìŠ¤íƒ€ì¼ë§: ë°•ìŠ¤ í…Œë‘ë¦¬ íˆ¬ëª…í™” (í•„ìˆ˜ ì•„ë‹˜)\n        style Risk_Group fill:none,stroke:none\n        style Action_Group fill:none,stroke:none\n        style N3 fill:#f0f7ff,stroke:#007bff\n        style N4 fill:#f0f7ff,stroke:#007bff\n       style N100 fill:#f0f7ff,stroke:#007bff\n              style N5 fill:#f0f7ff,stroke:#007bff\n                     style N6 fill:#f0f7ff,stroke:#007bff\n                            style N7 fill:#f0f7ff,stroke:#007bff\n    end\n```\n```mermaid\ngraph LR\nsubgraph Stable_Angina [\"3. Stable Angina Workflow\"]\ndirection LR\nN2[\"Exertional í‰í†µ\"] --> N4\nsubgraph P [\" \"]\nN4[\"ğŸ“˜ í™•ë¥ í‰ê°€ (PTP)\"]\nN7[\"ğŸŸ¢ Low Risk (<15%)<br>20ëŒ€ ì½•ì½•ì•„í”” <br> ì¢…ê²°\"]\n   N_Desc[\"<div style='text-align:left; font-size:12px; line-height:1.4;'><b>1. Typicality</b><br>â€¢ Location, Provocation, Palliation<br><br><b>2. Risk Factors</b><br>â€¢ HTN, DM, Dyslipidemia, Smoking<br><br><b>3. Equivalents</b><br>â€¢ CKD, PAD, Established CAD<br><br><b>4. DDx</b><br>â€¢ GERD, PE, Aortic Dissection</div>\"]\nend","subject":"ACS 2f546f2986ee80e28108e122ed92ca06","page_title":"ACS 2f546f2986ee80e28108e122ed92ca06","episode":"ACS 2f546f2986ee80e28108e122ed92ca06","section_path":["ACS 2f546f2986ee80e28108e122ed92ca06"],"source_doc_id":"ACS 2f546f2986ee80e28108e122ed92ca06","source_page":null,"source_anchor":"ACS 2f546f2986ee80e28108e122ed92ca06-1","focus_area":"ACS 2f546f2986ee80e28108e122ed92ca06","tags":["usmle-step2","core","diagnosis","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"%% 2. [ìœ„í—˜ë„ ê¸°ë‘¥] Low -> High ìˆœì„œ (íˆ¬ëª…ì„  ëŒ€ì‹  invisible link ì‚¬ìš©)\nsubgraph Risk_Block [\"Step 2: Risk Stratification\"]\ndirection TB\nN6[\"ğŸŸ  Intermediate (15-85%)<br> 40ëŒ€ ë‚¨ì\"]\nN5[\"ğŸ”´ High Risk (>85%)<br> ë‹¹ë‡¨ 70ëŒ€ í• ì•„ë²„ì§€\"]\n%% [í•µì‹¬] ì‹¤ì œ í™”ì‚´í‘œë¡œ ì—°ê²°í•˜ë˜ ë‚˜ì¤‘ì— ì•ˆ ë³´ì´ê²Œ ì²˜ë¦¬ (ìˆœì„œ ê°•ì œ)\nend\n%% 3. [ì¹˜ë£Œ ê¸°ë‘¥] ìœ„ ìˆœì„œì— ëŒ€ì‘\nsubgraph Action_Block [\"Step 3: Workup Strategy\"]\ndirection TB\nN51[\"Non-invasive Eval<br>(Stress testâ­ / CCTA) <br> i. ìš´ë™+EKG <br> ii. ìš´ë™+ì˜ìƒ <br> iii. ì•½ë¬¼+ì˜ìƒ\"]\nN88[\"Direct CAG (Invasive) <br> ë°”ë¡œ CAGí•¨!!\"]\n%% ì—¬ê¸°ë„ ìˆœì„œ ê°•ì œ\nend\n%% 4. ê° ë‹¨ê³„ ì—°ê²° (ê°€ë¡œ)\nN4 --> N6\nN4 --> N5\nN6 --> N51\nN5 --> N88\n%% 5. ê²°ê³¼ (Evaluation)","subject":"ACS 2f546f2986ee80e28108e122ed92ca06","page_title":"ACS 2f546f2986ee80e28108e122ed92ca06","episode":"ACS 2f546f2986ee80e28108e122ed92ca06","section_path":["ACS 2f546f2986ee80e28108e122ed92ca06"],"source_doc_id":"ACS 2f546f2986ee80e28108e122ed92ca06","source_page":null,"source_anchor":"ACS 2f546f2986ee80e28108e122ed92ca06-21","focus_area":"ACS 2f546f2986ee80e28108e122ed92ca06","tags":["usmle-step2","core","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"subgraph Result_Block [\"Final Decision\"]\ndirection TB\nN77[\"CAG\"]\nN78[\"OMT / Revasc <br> BB Aspirin Statin Â± ACEIARB Â± spironolactone\"]\nend\nN51 -- \"í˜‘ì°©ì´ ì‹¬í•¨ <br> ë°”ë¡œ STD ë‚˜íƒ€ë‚¨, ì €í˜ˆì••\" --> N77\nN51 -- \"Negative\" --> N78\nN88 --> N77\nN77 --> N78\n%% ë°•ìŠ¤ í…Œë‘ë¦¬ ì œê±°\nstyle Risk_Block fill:none,stroke:none\nstyle Action_Block fill:none,stroke:none\nstyle Result_Block fill:none,stroke:none\n%% ë…¸ë“œ ë””ìì¸\nstyle N4 fill:#e3f2fd,stroke:#007bff,stroke-width:2px\nstyle N7 fill:#e8f5e9,stroke:#388e3c\nstyle N5 fill:#ffebee,stroke:#d32f2f\nstyle N6 fill:#fff3e0,stroke:#f57c00\nstyle N51 fill:#fff3e0,stroke:#f57c00\nstyle N88 fill:#ffebee,stroke:#d32f2f","subject":"ACS 2f546f2986ee80e28108e122ed92ca06","page_title":"ACS 2f546f2986ee80e28108e122ed92ca06","episode":"ACS 2f546f2986ee80e28108e122ed92ca06","section_path":["ACS 2f546f2986ee80e28108e122ed92ca06"],"source_doc_id":"ACS 2f546f2986ee80e28108e122ed92ca06","source_page":null,"source_anchor":"ACS 2f546f2986ee80e28108e122ed92ca06-41","focus_area":"ACS 2f546f2986ee80e28108e122ed92ca06","tags":["usmle-step2","core"]}
{"chunk_type":"transcript_chunk","text":"end\n```","subject":"ACS 2f546f2986ee80e28108e122ed92ca06","page_title":"ACS 2f546f2986ee80e28108e122ed92ca06","episode":"ACS 2f546f2986ee80e28108e122ed92ca06","section_path":["ACS 2f546f2986ee80e28108e122ed92ca06"],"source_doc_id":"ACS 2f546f2986ee80e28108e122ed92ca06","source_page":null,"source_anchor":"ACS 2f546f2986ee80e28108e122ed92ca06-61","focus_area":"ACS 2f546f2986ee80e28108e122ed92ca06","tags":["usmle-step2","core"]}
{"chunk_type":"transcript_chunk","text":"# LM_Blood 1\n# ğŸ©¸ **USMLE Step 2 CK: Hematology - Red Blood Cells & Anemia Algorithms**\n### **(HemOnc Map Sections 1.0 - 1.2)**\nì•ˆë…•í•˜ì„¸ìš”! ì˜¤ëŠ˜ë„ Deep Diveì˜ ë‚´ìš©ì„ ë°”íƒ•ìœ¼ë¡œ **USMLE Step 2 CK**ë¥¼ ìœ„í•œ ì¡±ì§‘ê²Œ ê°•ì˜ë¥¼ ì‹œì‘í•´ ë´…ì‹œë‹¤. ğŸ©º ì˜¤ëŠ˜ì€ **Anemia(ë¹ˆí˜ˆ)** íŒŒíŠ¸ì…ë‹ˆë‹¤. ë‹¨ìˆœíˆ 'Hbê°€ ë‚®ë‹¤'ê°€ ì•„ë‹ˆë¼, **\"Why is the assembly line broken?\"** (ì™œ ê³µì¥ì´ ë©ˆì·„ë‚˜?)ë¥¼ íŒŒì•…í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\nêµ°ì˜ê´€ë‹˜ê»˜ì„œ ì¢‹ì•„í•˜ì‹œëŠ” **Top-down Classification**ë¶€í„° ì¡ê³  ë“¤ì–´ê°‘ë‹ˆë‹¤! ğŸŒ³\n## **ğŸŒ³ The Big Picture: Anemia Algorithm Tree**\nPlaintext\n`ANEMIA (Low Hb)\nâ”‚\nâ”œâ”€â”€ 1. Production Failure (Factory Problem) [Reticulocyte Count < 2%]\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Microcytic (MCV < 80)\nâ”‚   â”‚   â”œâ”€â”€ Iron Deficiency Anemia (IDA) - Raw material shortage\nâ”‚   â”‚   â”œâ”€â”€ Thalassemia - Globin defect (Genetic blueprint error)\nâ”‚   â”‚   â”œâ”€â”€ Anemia of Chronic Disease (ACD) - Iron lockdown (Hepcidin)\nâ”‚   â”‚   â””â”€â”€ Sideroblastic Anemia - Protoporphyrin defect\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Normocytic (MCV 80-100)\nâ”‚   â”‚   â”œâ”€â”€ Anemia of Chronic Disease (Early)\nâ”‚   â”‚   â”œâ”€â”€ Aplastic Anemia (Factory destruction)\nâ”‚   â”‚   â””â”€â”€ CKD (No EPO signal)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Macrocytic (MCV > 100)\nâ”‚       â”œâ”€â”€ Megaloblastic (DNA Synthesis Issue)\nâ”‚       â”‚   â”œâ”€â”€ B12 Deficiency\nâ”‚       â”‚   â””â”€â”€ Folate Deficiency\nâ”‚       â””â”€â”€ Non-Megaloblastic\nâ”‚           â”œâ”€â”€ Alcohol / Liver Disease\nâ”‚           â”œâ”€â”€ Hypothyroidism\nâ”‚           â””â”€â”€ Drugs (Hydroxyurea, MTX)\nâ”‚\nâ””â”€â”€ 2. Destruction or Loss (Product Loss) [Reticulocyte Count > 2%]\n    â”‚\n    â”œâ”€â”€ Blood Loss (Obvious leak)\n    â”‚\n    â””â”€â”€ Hemolysis (Destruction)\n        â”œâ”€â”€ Intrinsic (Born with defect)\n        â”‚   â”œâ”€â”€ Membrane: Hereditary Spherocytosis\n        â”‚   â”œâ”€â”€ Enzyme: G6PD Deficiency\n        â”‚   â””â”€â”€ Hemoglobin: Sickle Cell\n        â”‚\n        â””â”€â”€ Extrinsic (Environment is hostile)\n            â”œâ”€â”€ Immune: AIHA (Autoimmune)\n            â”œâ”€â”€ Non-Immune: MAHA (TTP/HUS, DIC), Mechanical Heart Valve`\n## **1.0 RBC General: Factory vs. Destruction** ğŸ­ğŸ’¥\nê°€ì¥ ë¨¼ì € í•´ì•¼ í•  ì§ˆë¬¸: **\"ê³µì¥ì´ ê³ ì¥ ë‚¬ëŠ”ê°€(Production Failure), ì•„ë‹ˆë©´ ë§Œë“¤ì–´ì§„ ë¬¼ê±´ì´ ë¶€ì„œì§€ê³  ìˆëŠ”ê°€(Destruction/Loss)?\"**\n### **â˜… The Golden Rule: Reticulocyte Count**\nì´ê±¸ êµ¬ë¶„í•˜ëŠ” ìœ ì¼í•œ ì—´ì‡ ëŠ” **Reticulocyte Count**ì…ë‹ˆë‹¤.\n- **High Retic (>2% corrected):** ê³µì¥ì€ ë©€ì©¡í•¨! ì—´ì‹¬íˆ ë³´ìƒ ì¤‘ì„. â†’ **Hemolysis or Bleeding**.\n- **Low Retic (<2% corrected):** ê³µì¥ì´ ì…§ë‹¤ìš´ ë¨. â†’ **Production Failure** (ì¬ë£Œ ë¶€ì¡± or ê³¨ìˆ˜ ë¬¸ì œ).\n### **Hemolysis: Intrinsic vs. Extrinsic**\n- **Intrinsic (Internal Hardware Problem):** ì„¸í¬ ìì²´ê°€ ë¶ˆëŸ‰í’ˆìœ¼ë¡œ íƒœì–´ë‚œ ê²½ìš°.\n    - **Membrane:** Hereditary Spherocytosis (ë™ê¸€ë™ê¸€í•´ì„œ ì˜ í„°ì§)\n    - **Enzyme:** G6PD Deficiency (ì‚°í™” ìŠ¤íŠ¸ë ˆìŠ¤ì— ì•½í•¨)\n    - **Hemoglobin:** Sickle Cell, Thalassemia\n- **Extrinsic (External Environment Problem):** ì„¸í¬ëŠ” ì •ìƒì¸ë° ë°–ì—ì„œ ëˆ„ê°€ ë•Œë¦¬ëŠ” ê²½ìš°.\n    - **Immune:** Autoimmune Hemolytic Anemia (AIHA) - ë‚´ ëª¸ì´ ì•„êµ° ì‚¬ê²©.\n    - **Non-Immune:** Mechanical Heart Valve(ë¬¼ë¦¬ì  ì¶©ê²©), Microangiopathic(í˜ˆê´€ì´ ì¢ì•„ì„œ ì°¢ì–´ì§ - TTP, HUS).","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-1","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","diagnosis","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"## **1.1 Microcytic Anemia (MCV < 80)** ğŸ¤\n: \"ì‘ì€ ì„¸í¬ë“¤\" = í—¤ëª¨ê¸€ë¡œë¹ˆì„ ì±„ìš¸ ì¬ë£Œê°€ ë¶€ì¡±í•˜ê±°ë‚˜ ë¶ˆëŸ‰í’ˆì¸ ìƒíƒœ.\n### **ğŸ§ª Critical Vignette: The CKD Trap**\n- **Case:** íˆ¬ì„ ì¤‘ì¸ CKD í™˜ì. EPO(Erythropoietin)ë¥¼ íˆ¬ì—¬í–ˆëŠ”ë° ê°‘ìê¸° Hbê°€ ì •ì²´ë˜ê³  MCVê°€ ëš ë–¨ì–´ì§. ì™œ ê·¸ëŸ´ê¹Œ?\n- **Mechanism:** EPOë¥¼ ì£¼ë©´ ê³¨ìˆ˜ ê³µì¥ì´ ë¯¸ì¹œ ë“¯ì´ ëŒì•„ê°‘ë‹ˆë‹¤(Rev up!). ê·¸ëŸ¬ë©´ ì €ì¥í•´ ë‘” ì² ë¶„ì„ ìˆœì‹ê°„ì— ë‹¤ ì¨ë²„ë¦½ë‹ˆë‹¤. â†’ **Functional Iron Deficiency** ë°œìƒ.\n- **Treatment:** **IV Iron** (Not Oral!).\n    - Why? CKD í™˜ìëŠ” ì—¼ì¦ ìƒíƒœ(Inflammation)ë¼ **Hepcidin** ìˆ˜ì¹˜ê°€ ë†’ìŠµë‹ˆë‹¤. Hepcidinì€ ì¥(Gut)ì—ì„œ ì² ë¶„ì´ í¡ìˆ˜ë˜ëŠ” ë¬¸ì„ ì ê°€ë²„ë¦¬ê¸° ë•Œë¬¸ì— Oral Ironì€ í¡ìˆ˜ê°€ ì•ˆ ë©ë‹ˆë‹¤.\n### **ğŸ§¬ Thalassemia Screening Protocol**\n- **Step 1:** CBC í™•ì¸ (MCVê°€ ë§¤ìš° ë‚®ìŒ).\n- **Step 2 (Next Best Step):** **Hb Electrophoresis**.\n- **Don't:** ìœ ì „ì ê²€ì‚¬(Genetic testing)ë¶€í„° í•˜ì§€ ë§ˆì„¸ìš”. ë„ˆë¬´ ë¹„ì‹¸ê³  ë¶ˆí•„ìš”í•©ë‹ˆë‹¤.\n### **ğŸ§  Mentzer Index (Tying breaker)**\nMCVê°€ ë‚®ì€ë°, ì´ê²Œ ì² ë¶„ ê²°í•(IDA)ì¸ì§€ Thalassemiaì¸ì§€ í—·ê°ˆë¦´ ë•Œ ì”ë‹ˆë‹¤.\n- **Formula:** MCV / RBC count\n- **< 13 (Thalassemia):** ì„¸í¬ê°€ ì—„ì²­ ì‘ê³ (MCV â†“), ê°œìˆ˜ëŠ” ë§ìŒ(RBC â†‘). ë¶ˆëŸ‰í’ˆì„ ë§ì´ ì°ì–´ë‚´ëŠ” ìƒíƒœ.\n- **> 13 (Iron Deficiency):** ì¬ë£Œê°€ ì—†ì–´ì„œ ê³µì¥ì´ ë©ˆì¶¤. RBC ê°œìˆ˜ ìì²´ê°€ ì¤„ì–´ë“¦.\n### Anemia â†’ Reactive thrombocytosis\n- RBCë‘ Platelet (megakaryocyte)ëŠ” ê°™ì€ lineage\\\n- Anemiaì—ì„œ RBCë§ì´ ë§Œë“œëŠ” ìê·¹ì´ ë“¤ì–´ì˜¤ë©´ plateletì´ ì¦ê°€í•¨.\n- Anemiaì—ì„œ platelet ëŠ˜ì–´ë„ ë†€ë¼ì§€ë§ˆì„¸ìš”.\n| **í•­ëª©** | **IDA (ì² ê²°í•ì„±)** | **ACD (ë§Œì„±ì§ˆí™˜)** | **Thalassemia (ì§€ì¤‘í•´)** | **ë¹„ê³  (Mental Model)** |\n| --- | --- | --- | --- | --- |\n| **MCV** | **Down** ğŸ“‰ | **Normal or Down** ğŸ“‰ | **Way Down** ğŸ“‰ğŸ“‰ | ACDëŠ” Normocyticì¸ ê²½ìš°ë„ ë§ìŒ! |\n| **RDW** | **Up** ğŸ“ˆ â˜… | **Normal** â†”ï¸ | **Normal** â†”ï¸ | IDAëŠ” í¬ê¸°ê°€ ì œê°ê°, ThalassemiaëŠ” ë‹¤ ê°™ì´ ì‘ìŒ. |\n| **RBC Count** | **Down** ğŸ“‰ | **Down** ğŸ“‰ | **Normal or Up** ğŸ“ˆ â˜… | ThalassemiaëŠ” ê°œìˆ˜ëŠ” ë§ì§€ë§Œ ì§ˆì´ ë–¨ì–´ì§. |\n| **P/S (ë§ì´ˆë„ë§)** | **Microcytic/Hypochromic** |  | **Target cell**, Basophilic stippling | IDAëŠ” ë»¥ ëš«ë¦° ê³ ë¦¬ ëª¨ì–‘ ì„¸í¬.\nì í˜ˆêµ¬ì˜ 'í‘œë©´ì (Cell Membrane)'ì— ë¹„í•´ 'ë‚´ìš©ë¬¼(Hemoglobin)'ì´ ë„ˆë¬´ ì ìŒ.\nThalassemiaì²˜ëŸ¼ í—¤ëª¨ê¸€ë¡œë¹ˆ í•©ì„±ì´ ì•ˆ ë˜ë©´, ì•ˆìª½ì´ í—ë í•´ì§€ë©´ì„œ ì„¸í¬ê°€ ì­ˆê¸€ |\n| **Serum Iron** | **Down** ğŸ“‰ | **Down** ğŸ“‰ â˜… | **Normal or Up** ğŸ“ˆ | ACDëŠ” í”¼ ì†ì— ì² ì´ ì—†ì–´ì„œ IDAì™€ í—·ê°ˆë¦¼! |\n| **Ferritin** | **Down** ğŸ“‰ â˜… | **Normal or Up** ğŸ“ˆ â˜… | **Normal or Up** ğŸ“ˆ | **ê°€ì¥ ì¤‘ìš”í•œ ì°¨ì´ì !** ACDëŠ” ì €ì¥ê³ ì— ì² ì´ ê°€ë“í•¨! |\n| **TIBC** | **Up** ğŸ“ˆ | **Down** ğŸ“‰ â˜… | **Normal** â†”ï¸ | **TIBC= Truck=negative acute phase reactant**\nì² ì´ ì—†ìœ¼ë‹ˆ íŠ¸ëŸ­ì„ í•œëŒ€ë¼ë„ ëŠ˜ë¦¼.\nì—¼ì¦ì—ì„œëŠ” ì„¸ê· í•œí…Œ ì²  ê°–ë‹¤ì£¼ëŠ” íŠ¸ëŸ­ ê¼´ë² ê¸° ì‹«ì–´ì„œ ê°„ì—ì„œ ì•ˆë§Œë“¤ì–´ì¤Œ. |\n| **Target Cell** | ë“œë¬¾ | ì—†ìŒ | **ìì£¼ ê´€ì°°ë¨** ğŸ¯ | Thalassemiaì˜ ì‹œê·¸ë‹ˆì²˜! |\n### **ğŸ”’ Anemia of Chronic Disease (ACD)**\n- **Core Concept:** **Hepcidin**ì´ í•µì‹¬ ë¹ŒëŸ°.\n- **Mechanism:** ìš°ë¦¬ ëª¸ì´ ê°ì—¼/ì—¼ì¦ ìƒíƒœì¼ ë•Œ, ì„¸ê· ì´ ì² ë¶„ì„ ëª» ì“°ê²Œ í•˜ë ¤ê³  ì² ë¶„ì„ **Macrophage ì•ˆì— ê°€ë‘¬ë²„ë¦½ë‹ˆë‹¤(Lockdown).**\n- **Labs:**\n    - Serum Iron: â†“ (í˜ˆì•¡ ë‚´ ì² ë¶„ì€ ë‚®ìŒ)\n    - TIBC: â†“ (Transferrinì€ Negative acute phase reactantë¼ ì¤„ì–´ë“¦)\n        - ëª¸ì— ì—¼ì¦ì´ ìƒê¸°ë©´ ê°„ì—ì„œëŠ” â€˜truckâ€™ì„ ëœ ë§Œë“¦. ì„¸ê· ì— ì²  ì£¼ê¸° ì‹«ì–´ì„œ ê°„ì´ ê¼¬ì¥ë¶€ë¦¼.\n    - **Ferritin: â†‘ (â˜…Key Point)** (ì² ë¶„ì„ ì°½ê³  ì•ˆì— ê½‰ê½‰ ì±„ì›Œ ë†¨ìœ¼ë‹ˆ ì €ì¥ì² ì€ ë†’ìŒ!)\n## **1.2 Macrocytic Anemia (MCV > 100)** ğŸˆ\n: \"í° ì„¸í¬ë“¤\" = DNA í•©ì„±ì´ ì•ˆ ë¼ì„œ ë¶„ì—´ì„ ëª» í•˜ê³  ëª¸ì§‘ë§Œ ë¶ˆë¦° ìƒíƒœ.","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-21","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"| Category | Causes |\n| --- | --- |\n| **Impaired RBC Maturation** | Vitamin B12/Folate deficiency, Medications (Hydroxyurea-DNA, Methotrexate-B9) |\n| **Increased Reticulocytes**\nReticulocyte í¬ê¸°ê°€ í¬ë‹¤ë³´ë‹ˆê¹Œ MCV í¬ê²Œ ë‚˜íƒ€ë‚¨. | **Hemolytic** anemia, Bone marrow recovery |\n| **Bone Marrow Disorders** | Myelodysplastic syndrome, Multiple myeloma, Sideroblastic anemia |\n| **Lipid Abnormalities**\nì„¸í¬ë§‰ì´ ë¬¸ì œì„. ì„¸í¬ë§‰ì´ ì•ˆì—†ì–´ì ¸ì„œ ì»¤ë³´ì„ | Liver disease, Hypothyroidism |\n### **ğŸ•µï¸â€â™‚ï¸ The Glossitis Vignette**\n- **Case:** ìœ„ì „ì ˆì œìˆ (Gastrectomy) ê³¼ê±°ë ¥. í˜€ê°€ ë°˜ë“¤ë°˜ë“¤í•¨(Glossitis). Labì—ì„œ LDH â†‘, Indirect Bilirubin â†‘.\n- **Trap:** LDHë†’ê³  indirect bilirubin ë†’ì•„ì„œ ìš©í˜ˆ(Hemolysis)ì¸ê°€? ê·¼ë° ì•„ë‹˜.\n    - **Truth:** **Intramedullary Hemolysis** (Ineffective Erythropoiesis). DNA í•©ì„±ì´ ì•ˆ ë˜ë‹ˆ ê³¨ìˆ˜ ì•ˆì—ì„œ ì„¸í¬ê°€ ë§Œë“¤ì–´ì§€ë‹¤ê°€ í„°ì ¸ ì£½ëŠ” ê²ƒ. ì‹¤ì œë¡œëŠ” **B12 Deficiency**ì…ë‹ˆë‹¤.\n### **B12 vs. Folate (The Showdown)**\në‘˜ ë‹¤ Megaloblastic Anemiaë¥¼ ì¼ìœ¼í‚¤ì§€ë§Œ, ê²°ì •ì  ì°¨ì´ê°€ ìˆìŠµë‹ˆë‹¤.\n| **Feature** | **Vitamin B12 (Cobalamin)** | **Folate (B9)** |\n| --- | --- | --- |\n| **Neuro Symptoms** | **Yes!** (Paresthesia, Ataxia) | No |\n| **Methylmalonic Acid (MMA)** | **High (â˜…Distinctive)** | Normal |\n| **Homocysteine** | High | High |\n| **Causes** | Pernicious Anemia, Gastrectomy, Vegans | Alcoholism, Diet (No veggies) |\n- **Pathophysiology (Neuro):** B12ëŠ” Methylmalonyl CoAë¥¼ ë³€í™˜í•˜ëŠ” ë° í•„ìš”í•œë°, ì—†ìœ¼ë©´ MMAê°€ ìŒ“ì—¬ì„œ ì‹ ê²½ì˜ Myelin sheathë¥¼ íŒŒê´´í•©ë‹ˆë‹¤ (Subacute Combined Degeneration).\n### **ğŸ’€ The \"Hypokalemia Death\" Trap (Clinical Pearl)**\n- **Scenario:** ì‹¬í•œ B12 ê²°í• í™˜ìì—ê²Œ B12 ì£¼ì‚¬ë¥¼ ì¤Œ. í™˜ìê°€ ë©°ì¹  ë’¤ ì‚¬ë§. ì™œ?\n- **Mechanism:** B12ê°€ ë“¤ì–´ì˜¤ë©´ ê³¨ìˆ˜ê°€ ë¯¸ì¹œ ë“¯ì´ ì í˜ˆêµ¬ë¥¼ ì°ì–´ë‚´ê¸° ì‹œì‘í•¨. ìƒˆë¡œìš´ ì„¸í¬ë“¤ì´ í˜ˆì•¡ ì†ì˜ **Potassium(K+)**ì„ ì„¸í¬ ì•ˆìœ¼ë¡œ ì«™ ë¹¨ì•„ë“¤ì„.\n- **Result:** Severe **Hypokalemia** â†’ Fatal Arrhythmia.\n- **Action:** B12 ì¹˜ë£Œ ì´ˆë°˜ì—ëŠ” ë°˜ë“œì‹œ **K+ ëª¨ë‹ˆí„°ë§ ë° ë³´ì¶©**ì„ í•´ì•¼ í•©ë‹ˆë‹¤!\n### **Other Macrocytic Causes (Non-Megaloblastic)**\nDNA ë¬¸ì œ ì—†ì´ ê·¸ëƒ¥ ì„¸í¬ë§‰ ë¬¸ì œ ë“±ìœ¼ë¡œ ì»¤ ë³´ì´ëŠ” ê²½ìš°ë“¤.\n- **Alcoholism / Liver Disease:** ì„¸í¬ë§‰ì— ì§€ì§ˆ(Lipid)ì´ ê»´ì„œ ì»¤ì§.\n- **Reticulocytosis:** ì•„ê¸° ì„¸í¬(Reticulocyte)ëŠ” ì›ë˜ í½ë‹ˆë‹¤. ìš©í˜ˆì´ ì‹¬í•˜ë©´ MCVê°€ ì»¤ ë³´ì¼ ìˆ˜ ìˆìŒ.\n- **Drugs:** Hydroxyurea (Sickle cell ì¹˜ë£Œì œ), Methotrexate.\n- **Hypothyroidism.**","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-41","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","pathophysiology"]}
{"chunk_type":"recap_summary","text":"## **ğŸ”¥ Rapid Fire Recap (Summary)**\n1. **Vignette:** CKD on EPO, decreasing Hb.\n    - **Diagnosis:** Functional Iron Deficiency.\n    - **Action:** Give **IV Iron** (Not oral!).\n2. **Vignette:** Microcytic anemia, High Ferritin, Low TIBC.\n    - **Diagnosis:** Anemia of Chronic Disease (ACD).\n    - **Mechanism:** Hepcidin locking iron in macrophages.\n3. **Vignette:** Microcytic anemia, RBC count is actually high or normal. Mentzer Index < 13, Target cells.\n    - **Diagnosis:** **Thalassemia**.\n    - **Next Step:** Hb Electrophoresis.\n4. **Vignette:** Gastrectomy patient with neuropathy (tingling) & anemia.\n    - **Diagnosis:** B12 Deficiency.\n    - **Lab Clue:** High **Methylmalonic Acid (MMA)**.\n5. **Vignette:** Treating severe B12 deficiency, patient develops palpitations/weakness.\n    - **Complication:** **Hypokalemia**. (Cell turnover uses up K+).\n**Confidence:** 1.0 (Based strictly on the provided audio content).\n**Caveat:** Mentzer IndexëŠ” ì£¼ë¡œ ì†Œì•„ê³¼(Pediatrics)ì—ì„œ ë§ì´ ë‚˜ì˜¤ì§€ë§Œ ì„±ì¸ ë‚´ê³¼(IM)ì—ì„œë„ ê°ë³„ í¬ì¸íŠ¸ë¡œ ìœ ìš©í•©ë‹ˆë‹¤. B12 ì¹˜ë£Œ ì‹œ HypokalemiaëŠ” ì‹¤ì „/ì‹œí—˜ ëª¨ë‘ì—ì„œ ë†“ì¹˜ë©´ ì•ˆ ë˜ëŠ” ì¹˜ëª…ì ì¸ í¬ì¸íŠ¸ì…ë‹ˆë‹¤!\n# ğŸ©¸ **Intrinsic Hemolytic Anemias: The Deep Dive**\n<aside>\nğŸ’¡","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-55","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","recap","diagnosis","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"1. Enzyme defect?(G6PD) â†’ avoid trigger\n2. Membrane defect? (HS) â†’ remove the filter (splenectomy)\n3. Hemoglobin defect (SCD) â†’ fix o2 and acidosis state\n4. ì‰´ë“œê°€ ì—†ìŒ? (PNH) â†’ block complement pathway\n</aside>\n## **ğŸ“‹ Overview (TL;DR)**\nì˜¤ëŠ˜ì˜ Deep DiveëŠ” **USMLE Step 2 CK**ë¥¼ ì¤€ë¹„í•˜ëŠ” ìˆ˜í—˜ìƒì„ ìœ„í•´ **Intrinsic Hemolytic Anemias**ì˜ í•µì‹¬ ë³‘íƒœìƒë¦¬ì™€ ì„ìƒì  í•¨ì •(Clinical Pearls)ì„ ì™„ë²½í•˜ê²Œ í•´ë¶€í•©ë‹ˆë‹¤. ë‹¨ìˆœ ì•”ê¸°ê°€ ì•„ë‹ˆë¼ *Why*ë¥¼ ì´í•´í•´ì„œ ê¸°ì–µì— ë‚¨ë„ë¡ ì„¤ê³„ë˜ì—ˆìŠµë‹ˆë‹¤.\n- **Topic:** Intrinsic Hemolytic Anemias (Red Blood Cell Defects)\n- **Key Pathologies:**\n    1. **G6PD Deficiency**: The Shield Generator Failure ğŸ›¡ï¸\n    2. **PNH (Paroxysmal Nocturnal Hemoglobinuria)**: The Missing Anchor âš“ï¸\n    3. **Sickle Cell Disease**: The Shape-Shifter Crisis ğŸŒ™\n    4. **Hereditary Spherocytosis**: The Rigid Sphere ğŸˆ\n## **ğŸŒ³ Top-Down Classification: Hemolytic Anemias**\nì˜í•™ì  Contextë¥¼ ì¡ê¸° ìœ„í•´ ê³„ì¸µ êµ¬ì¡°ë¥¼ ë¨¼ì € ë³´ì—¬ë“œë¦½ë‹ˆë‹¤. ìš°ë¦¬ê°€ ì˜¤ëŠ˜ ë‹¤ë£¨ëŠ” ë‚´ìš©ì€ **Intrinsic** íŒŒíŠ¸ì…ë‹ˆë‹¤.\nPlaintext\n`Anemia\nâ”œâ”€â”€ Microcytic (TAILS)\nâ”œâ”€â”€ Macrocytic\nâ””â”€â”€ Normocytic\n    â”œâ”€â”€ Non-Hemolytic (Low Reticulocyte Index)\n    â””â”€â”€ Hemolytic (High Reticulocyte Index)\n        â”œâ”€â”€ Extrinsic (Autoimmune, MAHA, Infections)\n        â””â”€â”€ Intrinsic (The RBC itself is the problem!) â˜… TODAY'S TOPIC\n            â”œâ”€â”€ Enzyme Defects\n            â”‚   â””â”€â”€ G6PD Deficiency (Oxidative Stress) ğŸ›¡ï¸\n            â”œâ”€â”€ Membrane Defects\n            â”‚   â”œâ”€â”€ PNH (Acquired, Stem cell defect) âš“ï¸\n            â”‚   â””â”€â”€ Hereditary Spherocytosis (Inherited, Cytoskeleton) ğŸˆ\n            â””â”€â”€ Hemoglobinopathies\n                â””â”€â”€ Sickle Cell Disease (HbS polymerization) ğŸŒ™`\n## **1. G6PD Deficiency (1.3)**\n### **ğŸ›¡ï¸ Concept: The Broken Shield Generator**\n- **Analogy:** RBCëŠ” ì‚°ì†Œ(O2)ë¥¼ ìš´ë°˜í•˜ì§€ë§Œ, ì•„ì´ëŸ¬ë‹ˆí•˜ê²Œë„ ì‚°ì†ŒëŠ” **Free Radicals (Oxidative Stress)**ë¥¼ ë§Œë“­ë‹ˆë‹¤. ì´ë¥¼ ë§‰ì•„ì£¼ëŠ” **'Shield Generator'**ê°€ ë°”ë¡œ **Glutathione**ì…ë‹ˆë‹¤.\n- **Pathophysiology:**\n    - **G6PD enzyme**ì€ **NADPH**ë¥¼ ìƒì„± â†’ NADPHê°€ **Glutathione**ì„ ì¶©ì „(Recharge) â†’ Free Radical ì¤‘í™”.\n    - **Deficiency:** G6PDê°€ ë¶€ì¡±í•˜ë©´ Shieldê°€ êº¼ì§‘ë‹ˆë‹¤(Offline). Oxidative Stressê°€ ì˜¤ë©´ Hemoglobinì´ ì‚°í™”ë˜ì–´ ë³€ì„±ë©ë‹ˆë‹¤.\n    - **Heinz Bodies:** ë³€ì„±ëœ Hemoglobinì´ ë­‰ì¹œ ê²ƒ (Precipitation).\n    - **Bite Cells (Degmacytes):** Spleenì˜ Macrophageê°€ Heinz Bodyë¥¼ 'í•œ ì… ë² ì–´ ë¬¸(Bite)' ìêµ­.\n- ì‚°í™” ìŠ¤íŠ¸ë ˆìŠ¤ë¥¼ ë²„í‹°ì§€ ëª»í•˜ê³  RBCë“¤ì´ INTRAVASCULAR HEMOLYSIS â†’ dark urine.\n### **âš ï¸ Clinical Pearls & Triggers**\n- **Inheritance:** **X-linked Recessive** (ì£¼ë¡œ **Male** í™˜ì).\n- **Triggers (The \"Offending\" Agents):**\n    - **Infection** (Most common trigger! â˜…) - ìš°ë¦¬ ëª¸ì˜ WBCê°€ ë¿œì–´ë‚´ëŠ” Free radical ë•Œë¬¸.\n    - **Antibiotics:** TMP-SMX (Bactrim), Nitrofurantoin.\n    - Dapsone\n    - **Antimalarials:** Primaquine.\n    - **Foods:** Fava beans (Favism).\n- **Symptoms:** **Jaundice**, **Dark Urine** (Cola-colored), **Fatigue**.\n### **ğŸš« The USMLE Trap: Diagnosis Timing**\n- **Scenario:** í™˜ìê°€ **Acute Hemolysis** ìƒíƒœë¡œ ì™”ìŠµë‹ˆë‹¤. Dark urine, Bite cells í™•ì¸ë¨.\n    - Dipstickìƒ hematuria +, but NO blood under microscope. (í•¨ì •)\n        - Why? dipstick detects heme molecule. (molecular testing)\n    - Prussian blueëŠ” ì–‘ì„±: hemosiderin(iron storage complex) positive. = ë©°ì¹ ì´ìƒ ë˜ì—ˆë‹¤ëŠ” ì†Œê²¬\n        - hemolysisë¡œ ì¸í•œ hemoglobinì´ ì˜¤ì¤Œê´€ìœ¼ë¡œ ê°€ë©´ì„œ ì‹ ì¥ì„¸í¬ë“¤ì´ hemoglobin ì¬í™œìš©í•˜ë ¤ê³  í¡ìˆ˜í•¨. ì„¸í¬ë¡œ í¡ìˆ˜í•˜ê³  hbë¥¼ ironìœ¼ë¡œ ì¬í™œìš©í•˜ê¸° ìœ„í•´ hemosiderin (ironì„ ì €ì¥í•˜ëŠ” ë‹¨ìœ„)ìœ¼ë¡œ ë°”ê¿ˆ. ê·¼ë° í•´ë„í•´ë„ hbì´ ë„ˆë¬´ ë§ë‹¤ë³´ë‹ˆê¹Œ ì‹ ì¥ ì„¸í¬ë“¤ì´ í„°ì§. í„°ì§€ë©´ì„œ ìê¸°ë“¤ì´ ì¬í™œìš©í•˜ë ¤ê³  í–ˆë˜ hemosiderinì´ ì˜¤ì¤Œìœ¼ë¡œ í˜ëŸ¬ë‚˜ì˜´.\n- **Question:** What is the best next step?\n- **DON'T DO THIS:** ì§€ê¸ˆ ë‹¹ì¥ **G6PD Enzyme Assay**ë¥¼ ì²˜ë°©í•˜ë©´ ì•ˆ ë©ë‹ˆë‹¤! ğŸ™…â€â™‚ï¸\n    - **Reason (False Negative):** íš¨ì†Œê°€ ë¶€ì¡±í•œ 'ëŠ™ì€ RBC'ë“¤ì€ ì´ë¯¸ ë‹¤ í„°ì ¸ ì£½ì—ˆìŠµë‹ˆë‹¤. ì‚´ì•„ë‚¨ì€ ê±´ íš¨ì†Œ í™œì„±ì´ ë†’ì€ 'ì Šì€ RBC(Reticulocytes)' ë¿ì…ë‹ˆë‹¤. ê²€ì‚¬í•˜ë©´ ìˆ˜ì¹˜ê°€ **ì •ìƒ(Normal)**ìœ¼ë¡œ ë‚˜ì˜µë‹ˆë‹¤. *â€œMeasuring the survivorsâ€*\n- **Correct Step:** Acute episodeê°€ ëë‚˜ê³  **3ê°œì›” ë’¤(3 months later)**ì— ê²€ì‚¬í•©ë‹ˆë‹¤.\n## **2. Paroxysmal Nocturnal Hemoglobinuria (PNH) (1.3.1)**","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-65","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","diagnosis","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"### **âš“ï¸ Concept: The Missing Anchor**\n- **Definition:** **Acquired Mutation** in the **PIG-A gene** of a hematopoietic stem cell. (ìœ ì „ë˜ëŠ” ê²Œ ì•„ë‹ˆë¼ ì‚´ë‹¤ê°€ ìƒê¸°ëŠ” ê²ƒ!)\n- **Mechanism:**\n    - RBC í‘œë©´ì—ëŠ” **Complement System** (ìš°ë¦¬ ëª¸ì˜ ë©´ì—­ ë¯¸ì‚¬ì¼)ìœ¼ë¡œ ë¶€í„° ìì‹ ì„ ë³´í˜¸í•˜ëŠ” ë°©íŒ¨(**CD55, CD59**)ê°€ ìˆìŠµë‹ˆë‹¤.\n    - ì´ ë°©íŒ¨ë¥¼ RBCì— ë¶™ë“¤ì–´ ë§¤ëŠ” ë°§ì¤„ì´ **GPI Anchor**ì…ë‹ˆë‹¤.\n    - **PIG-A mutation** = GPI Anchorë¥¼ ëª» ë§Œë“¦ = ë°©íŒ¨(CD55/59)ê°€ ë–¨ì–´ì ¸ ë‚˜ê° = **Complement Attack!** ğŸ’£\n### **ğŸŒ™ The \"Nocturnal\" Myth vs. Reality**\n- **Myth:** ë°¤ì—ë§Œ í„°ì§„ë‹¤?\n- **Fact:** **Low-level hemolysis**ëŠ” í•­ìƒ ì¼ì–´ë‚©ë‹ˆë‹¤. í•˜ì§€ë§Œ ë°¤ì— **Hypoventilation** (ìˆ¨ì„ ì–•ê²Œ ì‰¼) â†’ **CO2 Retention** â†’ **Respiratory Acidosis** (pH ê°ì†Œ) â†’ **Complement System í™œì„±í™”** â†’ **Hemolysis ì•…í™”**. ê·¸ë˜ì„œ ì•„ì¹¨ ì²« ì†Œë³€ì´ ì œì¼ ì§„í•©ë‹ˆë‹¤ (**Dark Urine**).\n### **â˜ ï¸ Clinical Triad & Complications**\n1. **Coombs Negative Hemolytic Anemia**\n2. **Pancytopenia** (Stem cell defectë‹ˆê¹Œ WBC, Plateletë„ ì˜í–¥ë°›ìŒ â†’ Aplastic Anemiaì™€ ì‚¬ì´Œ ê´€ê³„).\n3. **Venous Thrombosis (The Killer ğŸ’€):**\n    - **Weird Locations:** **Hepatic vein (Budd-Chiari syndrome)**, Cerebral veins, Mesenteric veins.\n    - Why? Free Hemoglobinì´ **NO (Nitric Oxide)**ë¥¼ ìŠ¤í€ì§€ì²˜ëŸ¼ ë¹¨ì•„ë“¤ì„ â†’ Vasoconstriction + Platelet Aggregation ì´‰ì§„.\n### **ğŸ” Diagnosis & Treatment**\n- **Gold Standard:** **Flow Cytometry** (CD55, CD59 ë¶€ì¬ í™•ì¸).\n    - *Old Test (Do not pick):* Ham test, Sucrose lysis test.\n- **Treatment:**\n    - Supportive care (Iron, Folate).\n    - **Eculizumab:** Terminal Complement Inhibitor (C5 ì–µì œ).\n    - **Safety Warning:** Eculizumab ì‚¬ìš© ì „ ë°˜ë“œì‹œ **Meningococcal Vaccine** (Neisseria meningitidis) ì ‘ì¢… í•„ìˆ˜! (Complement ë§‰ìœ¼ë©´ ìº¡ìŠ ì„¸ê· ì— ì·¨ì•½í•´ì§).\n## **3. Sickle Cell Disease (1.3.2)**\n### **ğŸŒ™ Concept: The Shape-Shifter**\n- **Genetics:** Point mutation (Glu â†’ Val) on Beta-chain. HbS polymerizes when deoxygenated.\n- **Trigger:** Deoxygenation, Dehydration, Acidosis. â†’ RBCê°€ ë‚« ëª¨ì–‘(Sickle)ìœ¼ë¡œ ë³€í•¨ â†’ **Vaso-occlusion** (í˜ˆê´€ ë§‰í˜).\n### **ğŸ”¥ Types of Crisis (USMLE Favorites)**\n| **Crisis Type** | **Feature** | **Key Pearl** |\n| --- | --- | --- |\n| **Vaso-occlusive (Pain)** | Most common. Bone pain (Dactylitis in babies). | Hydration + Pain control (Opioids). |\n| **Acute Chest Syndrome** | **New infiltrate on CXR** + Fever/Resp sx. | Leading cause of death in adults.\nTriggered by fat emboli (from bone necrosis) or infection.\nâ†’ pain in the ribs\nâ†’ ì•„íŒŒì„œ ìˆ¨ ëª»ì‰¼\nâ†’ ë¬´ê¸°í, **low oxygen\nâ†’ more sickling\nâ†’ more lung damage**\nâ†’ â€¦ ì•…ìˆœí™˜\nì¹˜ë£Œ: í•­ìƒì œ (azithromycin for atypical pneumoniae), pain control, oxygen\nâ†’ refractory: transfusion, exchange transfusion |\n| **Splenic Sequestration** | Pediatric emergency. Hypotension + Rapidly enlarging spleen. Normal Reticulocytes | Spleenì´ í”¼ë¥¼ ë‹¤ ë¹¨ì•„ë“¤ì—¬ì„œ Shock ì˜´. Volume resuscitation + Transfusion. |\n| **Aplastic Crisis** | Acute drop in Hb + **Low Reticulocytes**. | **Parvovirus B19** infection. (Destroys erythroid precursors). |","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-85","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"### **ğŸ¦  Infection & Prevention**\n- **Autosplenectomy:** ë°˜ë³µì ì¸ Infarctionìœ¼ë¡œ ë¹„ì¥ì´ ìª¼ê·¸ë¼ë“¤ì–´ ê¸°ëŠ¥ ìƒì‹¤ (Functional Asplenia by age 5).\n    - **Risk:** Encapsulated bacteria (**Streptococcus pneumoniae**, **H. influenzae**, **N. meningitidis**)ì— ë§¤ìš° ì·¨ì•½.\n    - **Management:**\n        - **Penicillin Prophylaxis:** Age 5ê¹Œì§€ ë§¤ì¼ ë³µìš©.\n        - **Vaccination:** Pneumococcal, Meningococcal, Hib.\n        - **Hydroxyurea:** Increases **HbF** (Fetal Hemoglobin) â†’ HbS polymerization ë°©í•´.\n- **Osteomyelitis:** Sickle Cell í™˜ìì˜ ê³¨ìˆ˜ì—¼ ì›ì¸ 1ìœ„ëŠ” **Salmonella** (íŠ¹ì´í•˜ê²Œë„ Staph aureusë³´ë‹¤ í”í•¨!).\n- AVN: chornic hip pain with walking. No warmth, No fever. Dead bone ì°Œêº¼ê¸°ê°€ ë¬¼ë¦¬ì ìœ¼ë¡œ ë°©í•´í•¨.\n- Kidney: Renal medulla is hypoxic. Constant sickling â†’ í˜ˆê´€ ë§‰ìŒ. *SCD ë§ê³  Traitì—ì„œë„ ê°€ëŠ¥í•¨.*\n    - Renal papillary necrosis: episodes of painless hematuria\n    - Iso/hypo - sthen - uria: STHEN=to concentrate. ì˜¤ì¤Œ ëŠ¥ì¶• ëŠ¥ë ¥(=ë¬¼ì„ ì¬í¡ìˆ˜í•˜ëŠ” ëŠ¥ë ¥)ì˜ ìƒì‹¤. ìš”ë¶•ì¦ê³¼ ë¹„ìŠ·.\n- Stroke\n    - Ischemic stroke: ì•„ì´ì—ê²Œì„œ ë§ìŒ. ì¢ƒê°™ì€ RBC ë“¤ë•Œë¬¸ì— í˜ˆê´€ë“¤ ìƒì²˜ì…ê³  hyperplasia â†’ ê²½ë™ë§¥ê³¼ ê°™ì€ í° í˜ˆê´€ë“¤ì´ ì¢ì•„ì§.\n    - Hemorrhagic: ì–´ë¥¸ì—ì„œ ë§ìŒ. ë§Œì„±ì ìœ¼ë¡œ ê³µê²©ë°›ì€ í˜ˆê´€ì´ ì•½í•´ì§. â†’ í„°ì§.\n    - Prevention\n        - ì–´ë¦°ì´ì—ê²Œì„œ Transcranial doppler screening: í”¼ê°€íë¥´ëŠ” ì†ë„ë¥¼ ë³¸ë‹¤. ì†ë„ê°€ ë¹ ë¥´ë‹¤ëŠ”ê±´ í˜ˆê´€ì´ ì¢ë‹¤ëŠ”ê²ƒ\n            - í˜ˆê´€ì†ë„ê°€ ë¹ ë¥´ê²Œ ì¸¡ì •ë˜ë©´ HbSë¥¼ í¬ì„?ì‹œí‚¤ê¸°ìœ„í•´ transfusion, exchange transfusion\n- Pregnancy: íƒœë°˜í˜ˆê´€ë„ ì¢ƒë¨\n    - abortion, abruptio placenta, ì „ìê°„ì¦, ì–‘ìˆ˜ê³¼ì†Œì¦, FGR\n    - aspirin\n### Management for Maintenance\n- Vaccination\n- Penicillin until age of 5\n- Folic acid supplementation: bone marrow is working over time. B9ê°€ ê¸ˆë°© ê³ ê°ˆë¨.\n- Hydroxyurea: HbFë¥¼ ëŠ˜ë¦°ë‹¤. Higher affinity for oxygen and DOES NOT sickle. í˜ˆê´€ì— ê¼½ì‚¬ë¦¬ê»´ì„œ HbSì• ë“¤ì´ ì•ˆë­‰ì¹˜ê²Œí•œë‹¤.\n    - Ix: recurrent vaso-occlusive syndrome. hx of Acute chest syndrome.\n## **4. Hereditary Spherocytosis (1.3.3)**\n### **ğŸˆ Concept: The Rigid Sphere**\n- **Pathophysiology:** RBC ë§‰ì„ ì§€ì§€í•˜ëŠ” ë‹¨ë°±ì§ˆ (**Spectrin, Ankyrin**) ìœ ì „ì ê²°í•¨.\n- **Result:** RBCê°€ í‘œë©´ì (Membrane)ì„ ìƒê³  ë™ê·¸ë€ ê³µ ëª¨ì–‘(**Spherocyte**)ì´ ë¨ â†’ ìœ ì—°ì„±ì´ ì—†ì–´ Spleen í†µê³¼ ëª»í•¨ â†’ **Extravascular Hemolysis**.\n- Spleomegaly, Jaundice\n- Pigmented gallstones â˜… BLACK gallstones = ì§€ì†ëœ ìš©í˜ˆë¡œ ì¸í•´ BILIRUBIN gallstonesê°€ ì˜ìƒê¹€ at very young age\n    - ì–´ë¦°ì•„ì´ê°€ ë¹ˆí˜ˆì´ ìˆìœ¼ë©´ì„œ ë‹´ë‚­ì—¼ ì¦ìƒê°™ì´ ìˆìœ¼ë©´ HSì˜ì‹¬í•´ì•¼ë¨! â˜…\n### **ğŸ“Š Diagnosis**\n- **Labs:**\n    - Coombs test -ve â˜… êµ¬í˜• ì í˜ˆêµ¬ë¥¼ ë³´ì´ëŠ” ë‹¤ë¥¸ ë©´ì—­ mediated anemiaë‘ ê°ë³„í•˜ê¸° ìœ„í•´ í•„ìš”í•¨!\n    - **High MCHC** (Mean Corpuscular Hemoglobin Concentration) â˜… Specific finding! (ì„¸í¬ëŠ” ì‘ì•„ì§€ëŠ”ë° Hb ì–‘ì€ ê·¸ëŒ€ë¡œë¼ ë†ë„ ì¦ê°€).\n    - High RDW.\n- **Tests:**\n    - **Osmotic Fragility Test:** (Classic) ì†Œê¸ˆë¬¼ì— ë„£ìœ¼ë©´ ì˜ í„°ì§.\n    - **Eosin-5-Maleimide (EMA) Binding / Flow Cytometry:** (Current Gold Standard).\n### **âœ‚ï¸ Treatment**\n- Folic acid\n- **Splenectomy:** ë¹„ì¥ ì ˆì œê°€ ì¹˜ë£Œë²• (ìš©í˜ˆ ì¥ì†Œë¥¼ ì—†ì• ë²„ë¦¼).\n    - **Outcome:** SpherocytesëŠ” ê·¸ëŒ€ë¡œ ìˆì§€ë§Œ, ë¹ˆí˜ˆì€ í•´ê²°ë¨.\n        - *5ì‚´ ì´í›„ë¡œ splenectomyë¥¼ ë¯¸ë£¨ë©´ ì¢‹ìŒ*. ë©´ì—­ì²´ê³„ê°€ ì•ˆì¢‹ì€ 5ì‚´ ì „ì—ëŠ” Strep. pneumoniae ê°™ì€ encapuslated ê· ë“¤ë¡œë¶€í„° ìµœëŒ€í•œ ë³´í˜¸í•˜ê¸° ìœ„í•¨ì„.\n        - **Howell-Jolly Bodies:** ë¹„ì¥ ì ˆì œ í›„ ë§ì´ˆ í˜ˆì•¡ ë„ë§ì—ì„œ ë³´ì„ (ë³´ë¼ìƒ‰ í•µ ì¡°ê°ì´ ì œê±° ì•ˆ ë˜ê³  ë‚¨ì•„ìˆëŠ” ê²ƒ).","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-105","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"recap_summary","text":"## **âš¡ï¸ Rapid Fire Recap (High Yield Q&A)**\nì˜¤ë””ì˜¤ ë§ˆì§€ë§‰ì— ë‚˜ì˜¨ Rapid Fire Recapì…ë‹ˆë‹¤. ì‹œí—˜ ì§ì „ ë¦¬ë§ˆì¸ë“œìš©!\n- **Q: African American male, back pain, dark urine after taking TMP-SMX?**\n    - **A:** **G6PD Deficiency**. (Antibiotic trigger).\n- Q: G6PD ë¹ˆí˜ˆí™˜ìì—ì„œ í”¼í•´ì•¼í•  UTIì•½\n    - A: TMPSMX(Bactrim), Nitrofurantoin\n- **Q: Best test for G6PD during active hemolysis?**\n    - **A:** **None.** Wait 3 months. (False negative risk).\n- **Q: Dark urine in the morning, history of DVT(Budd Chiari) in weird places?**\n    - **A:** **PNH (Paroxysmal Nocturnal Hemoglobinuria)**.\n    - **A:** **Flow Cytometry** (Looking for CD55/59 absence).\n- **Q: Sickle Cell patient with fever, chest pain, new infiltrate on CXR?**\n    - **A:** **Acute Chest Syndrome**. (Treat aggressively!).\n    Ceftriaxone, Azithromycin â˜…\n- Q: SCD stroke prevention\n    - A: ë‡Œ ë„í”ŒëŸ¬ í˜ˆë¥˜ ì†ë„ ê²€ì‚¬.\n- **Q: Sickle Cell patient with osteomyelitis. Most likely bug?**\n    - **A:** **Salmonella**.\n- Q: HSì—ì„œ í˜ˆì—­í•™ì  ì†Œê²¬\n    - High MCHC (due to dehydration)\n- **Q: High MCHC, splenomegaly, Coombs negative?**\n    - **A:** **Hereditary Spherocytosis**.\n- **Q: Treatment for Hereditary Spherocytosis?**\n    - **A:** **Splenectomy** (Don't forget vaccines first!).\n\"All right, everyone, settle in. We are back, and today, we are going directly into the trenches. We are. I'm your attending for this session, and my job is pretty simple. I'm here to make sure that when you see a patient, or, you know, a question stem on your board exam, you know exactly what the next best step is. No memorizing. We are not just memorizing facts here; we're building that clinical intuition.\"\n## ğŸ“‹ Overview: Sickle Cell Disease (SCD)","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-120","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","recap","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"- **Core Concept:** HbS mutation (Glu â†’ Val) leading to polymerization under stress (hypoxia, dehydration) â†’ RBC distortion (Sickling) â†’ Vaso-occlusion & Hemolysis.\n- **Key Pathophysiology:** **Hydrophobic Valine** replaces Hydrophilic Glutamate â†’ \"Molecular Velcro\" effect.\n- **Major Crises:** Vaso-occlusive (Pain), Acute Chest Syndrome (Killer), Sequestration (Spleen), Aplastic (Parvo B19), Stroke.\n- **Golden Rule:** **HbF prevents sickling**. Treatment aims to â†‘HbF (Hydroxyurea) or replace HbS (Transfusion).\n## ğŸŒ³ Big Picture: Systemic Devastation of SCD\nPlaintext\n`Sickle Cell Disease (SCD)\nâ”‚\nâ”œâ”€â”€ 1. Genetics & Pathophysiology (The Root Cause)\nâ”‚   â”œâ”€â”€ Point Mutation: Beta-globin chain (Glu â†’ Val)\nâ”‚   â”œâ”€â”€ Result: HbS (Sickle Hemoglobin)\nâ”‚   â”‚   â””â”€â”€ Hydrophobic interactions â†’ Polymerization (Rigid Rods)\nâ”‚   â””â”€â”€ Sickle Trait (HbAS) vs Disease (HbSS)\nâ”‚       â””â”€â”€ Trait: Has HbA (prevent polymerization), mostly benign usually\nâ”‚       â””â”€â”€ Disease: NO HbA, severe complications\nâ”‚\nâ”œâ”€â”€ 2. Acute Complications (The Storms)\nâ”‚   â”œâ”€â”€ Vaso-occlusive Crisis (Pain)\nâ”‚   â”‚   â”œâ”€â”€ Dactylitis (Hand-Foot Syndrome) [Infants 6mo-4yr]\nâ”‚   â”‚   â””â”€â”€ Bone Pain, Chest Pain\nâ”‚   â”œâ”€â”€ Acute Chest Syndrome (The Killer)\nâ”‚   â”‚   â””â”€â”€ New Infiltrate + Fever/Hypoxia\nâ”‚   â”œâ”€â”€ Splenic Sequestration\nâ”‚   â”‚   â””â”€â”€ Trapped blood â†’ Shock + Splenomegaly\nâ”‚   â”œâ”€â”€ Aplastic Crisis\nâ”‚   â”‚   â””â”€â”€ Parvovirus B19 â†’ Bone Marrow Shutdown (Low Retic)\nâ”‚   â””â”€â”€ Stroke\nâ”‚       â””â”€â”€ Vaso-occlusion in brain (Moyamoya)\nâ”‚\nâ””â”€â”€ 3. Chronic Management & Prevention (The Shield)\n    â”œâ”€â”€ Infection Prophylaxis (Penicillin, Vaccines)\n    â”œâ”€â”€ Hydroxyurea (â†‘ HbF)\n    â””â”€â”€ Screening (TCD for stroke risk)`\n## 1. Genetics & Diagnosis: The \"Doorway Thought\" ğŸ§¬\n**Scenario:** ì‹ ìƒì•„ ìŠ¤í¬ë¦¬ë‹ ê²°ê³¼ê°€ Abnormalí•˜ê²Œ ë‚˜ì˜´. ë¶€ëª¨ê°€ ê²ì— ì§ˆë ¤ \"ìš°ë¦¬ ì• ê°€ ë³‘ì— ê±¸ë¦° ê±´ê°€ìš”?\"ë¼ê³  ë¬¼ì–´ë´„.\n### **Mechanism (Deep Dive)**\n- **Mutation:** Beta-globin chainì˜ 6ë²ˆì§¸ positionì—ì„œ **Glutamate (Hydrophilic)** ê°€ **Valine (Hydrophobic)** ìœ¼ë¡œ ë°”ë€œ.\n- **Result:** Deoxygenated stateì—ì„œ Valineì´ ë¬¼ì„ ì‹«ì–´í•´ì„œ(Hydrophobic) ë‹¤ë¥¸ Hb moleculeì˜ hydrophobic pocketì— ë‹¬ë¼ë¶™ìŒ (**Molecular Velcro**).\n    - ì´ë¡œ ì¸í•´ Hbê°€ polymerization ë˜ì–´ **Long Rigid Chain**ì„ í˜•ì„± â†’ RBCê°€ **Sickle shape**ìœ¼ë¡œ ì°Œê·¸ëŸ¬ì§.\n### **Electrophoresis Pattern (ì¡±ì§‘ê²Œ êµ¬ë¶„ë²•)**\nì‹œí—˜ì— ìì£¼ ë‚˜ì˜¤ëŠ” **Gel Electrophoresis** íŒ¨í„´ì„ í•´ì„í•˜ëŠ” ë²•ì…ë‹ˆë‹¤.\n| **Type** | **HbA (Adult)\nAlpha 2 Beta2** | **HbS (Sickle)** | **HbF (Fetal)** | **Clinical Note** |\n| --- | --- | --- | --- | --- |\n| **Normal** | High (+++) | None | Trace | No disease. |\n| **Sickle Trait (HbAS)** | Present (+) | Present (+) | Trace | **Benign**.\n**Painless Hematuria is the only common** renal complication (Renal Papillary Necrosis). |\n| **Sickle Disease (HbSS)** | **NONE (0)** | High (+++) | Low/High (compensatory) | **Severe**. No HbA to stop polymerization. |\n## 2. Vaso-occlusive Crisis (Pain Crisis) ğŸ’¥\n### **Dactylitis (Hand-Foot Syndrome)**\n- **Vignette:** 6ê°œì›”~4ì„¸ ì•„ì´ê°€ ì†ë°œì´ í‰í‰ ë¶€ì–´ì„œ(Swollen like sausages) ìš¸ë©´ì„œ ì˜´. ì•„ì´ëŠ” ê±·ê±°ë‚˜ ë¬¼ê±´ ì¡ê¸°ë¥¼ ê±°ë¶€í•¨.\n- **Pathology:** ì‘ì€ ë¼ˆë“¤ì˜ Bone marrow infarction.\n- **Management:** **Hydration + Pain Control (NSAIDs/Opioids)**.\n| VOC | Osteomyelitis |\n| --- | --- |\n| ì†ë°œí‰í‰ / Multiple sites | ONE site |\n| low grade ever\n | high prolonged fever\nBlood culture |\n| fluids | Surgery and antibiotics |","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-130","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### **Acute Pain Crisis (General)**\n- **Trigger:** Hypoxia, Dehydration, Acidosis, Cold.\n- **Management (Three Pillars):**\n    1. **Hydration:** (Bloodë¥¼ ë¬½ê²Œ í•´ì„œ Flow ê°œì„ )\n    2. **Analgesia:** (Do **NOT** undertreat. Severe pain needs **IV Opioids** like Morphine. **Oxygen** only if hypoxic.) ì•„íŒŒì„œ ìˆ¨ ì˜ ì•ˆì‰¬ë©´ ACS(ì•„ë˜) ìœ„í—˜.\n    3. **Transfusion:** (Only if symptomatic anemia or specific complications like Acute Chest/Stroke).\n## 3. Acute Chest Syndrome (The Killer) ğŸ«ğŸ’€\n**â˜… Leading Cause of Death in Adults**\n- **Vignette:** Sickle cell í™˜ìê°€ ë‹¤ë¦¬ í†µì¦(Pain crisis)ìœ¼ë¡œ ì…ì›í–ˆë‹¤ê°€ ê°‘ìê¸° **Chest Pain, Fever, Difficulty Breathing** í˜¸ì†Œ.\n    - ì•„ì´ì—ì„œëŠ”  infectionì´ trigger\n    - ì–´ë¥¸ì—ì„œëŠ” fat embolismì´ trigger\n- **Diagnostic Criteria:** **New Infiltrate on CXR** (í•„ìˆ˜!) + Fever/Resp symptoms. * **Pathophysiology:** Vicious Cycle!\n    1. Pain â†’ Shallow breathing (Splinting) â†’ Atelectasis/Hypoxia.\n    2. **ì–´ë¥¸ì—ì„œëŠ” Fat Embolism** (from Bone Marrow necrosis) often triggers it.\n    3. Hypoxia â†’ More Sickling â†’ Pulmonary Infarction â†’ More Hypoxia.\n- **Treatment (Aggressive!):**\n    - **Antibiotics:** Ceftriaxone + Azithromycin (Cover community-acquired + Atypical pneumonia like *Mycoplasma/Chlamydia*).\n    - **IV Fluids & Pain Control.**\n    - **O2 Support.**\n    - **Blood Transfusion:** Simple transfusion or **Exchange Transfusion** (severe cases) to washout HbS cells.\n## 4. Spleen & Infection Risks ğŸ›¡ï¸ğŸ¦ \n### **Splenic Sequestration (The Dam Breaks)**\n- **Vignette:** ì–´ë¦°ì•„ì´(Toddler)ê°€ ì°½ë°±í•˜ê³ (Pale), ì¶• ëŠ˜ì–´ì§(Lethargic). ë°°ë¥¼ ë§Œì ¸ë³´ë‹ˆ **Massive Splenomegaly**.\n- **Pathology:** Sickled cellsê°€ Spleenì˜ outflowë¥¼ ë§‰ìŒ â†’ Spleenì´ í”¼ë¥¼ ê°€ë‘ëŠ” **Dam** ì—­í•  â†’ **Hypovolemic Shock**.\n- **Labs:** **Acute drop in Hemoglobin**, **High Reticulocyte count** (Bone marrow is screaming trying to compensate).\n- **Tx:** IV Fluids (Resuscitation) + Transfusion (cautious, to 50% deficit to avoid hyperviscosity later) â†’ Eventual Splenectomy.\n### **Functional Asplenia (Auto-infarction)**\n- ë°˜ë³µì ì¸ Infarctionìœ¼ë¡œ ì¸í•´ 5ì„¸ì¯¤ ë˜ë©´ Spleenì´ ìª¼ê·¸ë¼ë“¤ê³  ê¸°ëŠ¥ ìƒì‹¤ (**Fibrosis/Auto-splenectomy**).\n- **Risk:** **Encapsulated Organisms** ê°ì—¼ ìœ„í—˜ ê¸‰ì¦!\n    - *Strep. pneumoniae* (Sepsis is #1 cause of death in kids).\n    - *H. influenzae*.\n    - *Salmonella*.\n- **Osteomyelitis Vignette:** SCD í™˜ìê°€ ë¼ˆê°€ ì•„í”„ê³  ì—´ì´ ë‚¨.\n    - **Most Common Organism overall:** *Staph. aureus*.\n    - **Unique/Testable Organism:** **Salmonella** (ë§Œì•½ ë³´ê¸°ì— *Salmonella*ê°€ ìˆìœ¼ë©´ ì´ê±¸ ê³¨ë¼ì•¼ í•¨! SCD íŠ¹ì´ì ì„).\n## 5. Aplastic Crisis vs. Splenic Sequestration ğŸ“‰\n**â˜… USMLE Trap:** ë‘˜ ë‹¤ Hemoglobinì´ ëš ë–¨ì–´ì§. ì–´ë–»ê²Œ êµ¬ë¶„í• ê¹Œ?\n| **Feature** | **Aplastic Crisis** | **Splenic Sequestration** |\n| --- | --- | --- |\n| **Cause** | **Parvovirus B19** (Infects Erythroid Progenitors) | Spleen Trapping Blood |\n| **Reticulocyte Count** | **LOW (Absent)** â¬‡ï¸â¬‡ï¸ | **HIGH (Compensatory)** â¬†ï¸â¬†ï¸ |\n| **Spleen Size** | Normal (usually) | **Massive** |\n| **Mechanism** | Factory (Marrow) Shutdown | Dam blocked (Plumbing issue) |\n## 6. Stroke & Prevention ğŸ§ \n- **Pathology:** Large vessel occlusion (Moyamoya syndrome)\n- **Screening:** 2ì„¸~16ì„¸ ì•„ì´ë“¤ì€ ë§¤ë…„ **Transcranial Doppler (TCD)** ë¡œ ë‡Œí˜ˆë¥˜ ì†ë„ ì¸¡ì •.\n    - **High Velocity** = High Risk (Narrow vessel).\n- **Management:**\n    - **Acute:** **Exchange Transfusion** (Target HbS < 30%). Do not just top up!\n    - **Chronic Prevention:** Regular transfusion program.\n## 7. Chronic Complications","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-150","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"- Lungs\n    - íìˆœí™˜ í˜ˆê´€ ë§ê°€ì§ â†’  right sided heart failure\n    - Exertional dyspnea\n    - Tricuspid regurgitation\n- Kidneys\n    - Iso -sthen - uria\n    - Chronic: Renal papillary necrosis\n## 8. Maintenance & Pregnancy ğŸ’ŠğŸ¤°\n### **Maintenance**\n1. **Hydroxyurea:**\n    - **Mechanism:** Increases **HbF** (Gamma globin).\n    - **Indication:** Frequent pain crises (>3/yr), Acute Chest history.\n    - **Side Effect:** Myelosuppression (Neutropenia).\n2. **Penicillin Prophylaxis:** Daily until age 5 (prevents *Strep pneumo*).\n3. **Vaccination:** Pneumococcal, Meningococcal, Hib, Influenza.\n### **Pregnancy**\n- **Risks:** Spontaneous abortion, Pre-eclampsia, Fetal growth restriction.\n- **Treatment:** Low dose **Aspirin** (Pre-eclampsia prevention), Serial Ultrasounds.\n## ğŸ”¥ Rapid Fire Recap\n1. **Vignette:** Child with massive spleen + shock + High Retic.\n    - **Dx:** **Splenic Sequestration**.\n    - **Action:** IV Fluids + Transfusion.\n2. **Vignette:** Child with pale skin + shock + **LOW** Retic.\n    - **Dx:** **Aplastic Crisis** (Parvo B19).\n    - **Action:** Isolation + Transfusion.\n3. **Vignette:** Adult with chest pain, fever, new infiltrate.\n    - **Dx:** **Acute Chest Syndrome**.\n    - **Action:** Antibiotics + O2 + Fluids + Exchange Transfusion (if severe).\n4. **Vignette:** Osteomyelitis in SCD.\n    - **Bug:** *Staph aureus* (most common), but choose **Salmonella** if asked for unique association.\n5. **Vignette:** Painless hematuria in a healthy young man.\n    - **Dx:** **Sickle Cell Trait** (Renal Papillary Necrosis).\n- Audio notes mentioned specific antibiotic coverage (Ceftriaxone/Azithro) â€“ verify local guidelines as they change.\n- Focus was heavily on differentiating Retic counts for crisis types â€“ memorize this logic!\n# ğŸ©¸ USMLE Step 2 CK: Hematology High-Yield \"Deep Dive\" ğŸ©¸\n**Overview:**\nì´ë²ˆ Deep Diveì—ì„œëŠ” Hematologyì˜ í•µì‹¬ì¸ **Hemolytic Anemia**ì˜ ì¼ë¶€(Hereditary Spherocytosis, Mechanical Valve Hemolysis)ì™€ **Heme Synthesis Pathology**(AIP, Lead Poisoning)ë¥¼ ë‹¤ë£¹ë‹ˆë‹¤. ë‹¨ìˆœ ì•”ê¸°ê°€ ì•„ë‹Œ **\"Logic Puzzle\"** ì²˜ëŸ¼ ì ‘ê·¼í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤! ğŸ§©","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-170","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"## ğŸŒ³ Top-down Classification (Mental Model)\nì˜¤ëŠ˜ ë‹¤ë£¬ ì£¼ì œë“¤ì´ Hematologyì˜ í° ê·¸ë¦¼ ì–´ë””ì— ìœ„ì¹˜í•˜ëŠ”ì§€ ë¨¼ì € íŒŒì•…í•©ì‹œë‹¤.\nPlaintext\n`Anemia\nâ”‚\nâ”œâ”€â”€ Kinetic Approach (Reticulocyte Count High = Hemolysis/Blood Loss)\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Intrinsic Defect (RBC ìì²´ì˜ ë¬¸ì œ)\nâ”‚   â”‚   â”œâ”€â”€ Membrane Defect: â˜… Hereditary Spherocytosis (1.3.4)\nâ”‚   â”‚   â”œâ”€â”€ Enzyme Defect: G6PD deficiency, PK deficiency\nâ”‚   â”‚   â””â”€â”€ Hemoglobin Defect: Sickle Cell, Thalassemia\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Extrinsic Defect (ì™¸ë¶€ ìš”ì¸)\nâ”‚       â”œâ”€â”€ Mechanical Destruction: â˜… Macroangiopathic (Valve) (1.3.5)\nâ”‚       â””â”€â”€ Autoimmune: AIHA (Warm/Cold)\nâ”‚\nâ””â”€â”€ Heme Synthesis Disorder (Porphyrias)\n    â”œâ”€â”€ â˜… Acute Intermittent Porphyria (AIP) (1.4)\n    â””â”€â”€ â˜… Lead Poisoning (Differential Diagnosis)`\n## 1. Hereditary Spherocytosis (1.3.4) ğŸˆ\n### ğŸ©º Clinical Vignette (The \"Doorway\" Scenario)\n- **Patient:** ì†Œì•„ê³¼ í´ë¦¬ë‹‰ì— ì—„ë§ˆê°€ ì•„ì´ë¥¼ ë°ë ¤ì˜´.\n- **Observation:** ì•„ì´ì˜ ëˆˆì´ ë…¸ë—ë‹¤ (**Scleral Icterus**).\n- **Physical Exam:** ë°°ë¥¼ ë§Œì ¸ë³´ë‹ˆ ë¹„ì¥ì´ ì»¤ì ¸ ìˆìŒ (**Splenomegaly**). * **History:** ì—„ë§ˆ ì™ˆ, \"ìš°ë¦¬ ì§‘ì•ˆ ì‚¬ëŒë“¤ì€ í”¼ê°€ ì¢€ ì•½í•´ìš” (**Weak blood**).\" (Family history of anemia/gallstones).\n### ğŸ§¬ Pathophysiology (Mechanism)\n- **Problem:** RBC Membraneì˜ **Spectrin** or **Ankyrin** ë‹¨ë°±ì§ˆ ê²°í•¨.\n- **Analogy (Tent):** ì •ìƒ RBCëŠ” í…íŠ¸ í´ëŒ€(Cytoskeleton)ê°€ íŠ¼íŠ¼í•´ì„œ ìœ ì—°í•œ ë„ë„› ëª¨ì–‘ì„ ìœ ì§€í•¨. í•˜ì§€ë§Œ í´ëŒ€ê°€ ë¶€ì‹¤í•˜ë©´? í‘œë©´ì (Surface area)ì„ ìƒê³  ê°€ì¥ íš¨ìœ¨ì ì¸ í˜•íƒœì¸ **Sphere(ê³µ ëª¨ì–‘)** ë¡œ ë³€í•¨.\n- **Result:** ë™ê·¸ë—ê³  ëš±ëš±í•œ RBCëŠ” ìœ ì—°í•˜ì§€ ì•ŠìŒ(Rigid). ë¹„ì¥ì˜ ì¢ì€ í‹ˆ(Splenic cords)ì„ í†µê³¼í•˜ì§€ ëª»í•˜ê³  ê°‡í˜.\n- **Outcome:** ë¹„ì¥ ë‚´ Macrophage(Clean up crew)ê°€ ì´ë“¤ì„ ì¡ì•„ë¨¹ìŒ â†’ **Extravascular Hemolysis** â†’ **Jaundice** & **Splenomegaly**.\n### ğŸ§ª Diagnosis & Key Labs\n- **The Million Dollar Question:** ì–´ë–»ê²Œ Autoimmune Hemolytic Anemia(AIHA)ì™€ êµ¬ë³„í•  ê²ƒì¸ê°€?\n    - ë‘˜ ë‹¤ Spherocyteê°€ ë³´ì¼ ìˆ˜ ìˆìŒ.\n    - **â˜… Coombs Test:** Hereditary SpherocytosisëŠ” **Negative** (í•­ì²´ê°€ ë¶™ì€ ê²Œ ì•„ë‹ˆë¼ ë§‰ì´ ì•½í•œ ê²ƒ). AIHAëŠ” Positive.\n- **MCHC:** **Increased**. (ì„¸í¬ê°€ ìª¼ê·¸ë¼ë“¤ê³  í—¤ëª¨ê¸€ë¡œë¹ˆì´ ë†ì¶•ë¨).\n- **Osmotic Fragility Test:** Positive (ì €ì¥ì•¡ì—ì„œ ì‰½ê²Œ í„°ì§).\n### ğŸ’Š Treatment\n- **Splenectomy:** ë¹„ì¥ì´ RBCë¥¼ íŒŒê´´í•˜ëŠ” ì£¼ë²”ì´ë¯€ë¡œ ì œê±°. (RBC ëª¨ì–‘ì€ ì—¬ì „íˆ ë™ê·¸ë—ì§€ë§Œ, ë” ì´ìƒ íŒŒê´´ë˜ì§€ëŠ” ì•ŠìŒ).\n## 2. Macroangiopathic Hemolytic Anemia (1.3.5) âš™ï¸\n*(Specifically: Mechanical Heart Valve Hemolysis)*\n### ğŸ©º Clinical Vignette\n- **Patient:** ëª‡ ë…„ ì „ ê¸°ê³„ íŒë§‰ ì¹˜í™˜ìˆ (Mechanical Heart Valve replacement)ì„ ë°›ì€ í™˜ì.\n- **Complaint:** \"ê³„ë‹¨ì„ ì˜¤ë¥¼ ë•Œ ë„ˆë¬´ í”¼ê³¤í•´ìš”.\" (Anemia sx).\n- **Urinalysis:** ì†Œë³€ ìƒ‰ì´ **\"Dark Tea\"** ìƒ‰ì„. (Hemoglobinuria).","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-190","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"### ğŸ§¬ Pathophysiology: \"The Blender Effect\" ğŸŒªï¸\n- ê¸°ê³„ íŒë§‰ì´ ë…¸í›„ë˜ê±°ë‚˜ ê¸°ëŠ¥ì´ ë–¨ì–´ì§€ë©´(Paravalvular leak ë“±), í˜ˆë¥˜ì— ë‚œê¸°ë¥˜(Turbulence)ì™€ ë†’ì€ ì••ë ¥(Shear force)ì´ ë°œìƒ.\n- ì í˜ˆêµ¬ê°€ ì´ ë¯¹ì„œê¸° ê°™ì€ íŒë§‰ì„ í†µê³¼í•˜ë©´ì„œ **ë¬¼ë¦¬ì ìœ¼ë¡œ ì°¢ì–´ì§(Shredded)**.\n- **Intravascular Hemolysis:** í˜ˆê´€ ì•ˆì—ì„œ í„°ì§€ë¯€ë¡œ Hemoglobinì´ ë°”ë¡œ ì†Œë³€ìœ¼ë¡œ ë‚˜ì˜´ â†’ **Dark Urine**.\n### ğŸ§ª Key Labs\n- **Peripheral Smear:** **Schistocytes** (Helmet cells, Fragmented RBCs). * *Note:* ì ‘ì‹œ ìœ„ì— ë§ì¹˜ë¡œ ë‚´ë ¤ì¹œ ë“¯ ê¹¨ì§„ ì¡°ê°ë“¤.\n- **Platelets:** ë‚®ì„ ìˆ˜ ìˆìŒ (Thrombocytopenia) - ê¸°ê³„ì  ì†ìƒ ì‹œ í˜ˆì†ŒíŒë„ ê°™ì´ ê°ˆë ¤ë‚˜ê°€ê±°ë‚˜ í™œì„±í™”ë¨.\n- **Diagnostic Move:** **Transthoracic Echocardiogram (TTE)** ë¡œ íŒë§‰ ìƒíƒœ í™•ì¸ í•„ìˆ˜.\n## 3. Acute Intermittent Porphyria (AIP) vs Lead Poisoning (1.4) ğŸ­\n*Heme Synthesis Pathwayì˜ \"Traffic Jam\" ë¬¸ì œ*\nì´ íŒŒíŠ¸ëŠ” **\"5 P's\"** ì™€ **\"Factory Assembly Line\"** ë¹„ìœ ë¡œ ì´í•´í•´ì•¼ í•¨.\n### ğŸ­ The Factory Analogy (Heme Synthesis)\nHemeì„ ë§Œë“œëŠ” ê³µì¥ ë¼ì¸ì´ ìˆìŒ.\n1. **First Step:** **ALA Synthase** (ì†ë„ ì¡°ì ˆ ë‹¨ê³„, Glucoseê°€ ì–˜ë¥¼ ë©ˆì¶¤).\n2. **Next Step:** ALA â†’ Porphobilinogen (PBG).\n3. **Next Step:** PBG â†’ Heme...\n### A. Acute Intermittent Porphyria (AIP) ğŸŸ£\n### ğŸ©º Clinical Vignette: \"The Psych Patient with a Belly Ache\"\n- **Patient:** ì Šì€ ì—¬ì„±.\n- **Symptoms:**\n    1. **Pain:** ê·¹ì‹¬í•œ ë³µí†µ(Severe Abdominal Pain). í•˜ì§€ë§Œ **Belly is Soft** (No guarding, no rebound) â†’ **Pain out of proportion to exam**. (ì‹ ê²½ë³‘ì„± í†µì¦ì´ê¸° ë•Œë¬¸).\n    2. **Psych:** í™˜ê°(Hallucination), ë¶ˆì•ˆ(Anxiety), í¸ì§‘ì¦(Paranoia). ì •ì‹ ê³¼ í™˜ìë¡œ ì˜¤ì§„ë˜ê¸° ì‰¬ì›€.\n    3. **Polyneuropathy:** íŒ”ë‹¤ë¦¬ í˜ì´ ë¹ ì§(Proximal weakness).\n    4. **Port-wine Urine:** ì†Œë³€ì„ ë°›ì•„ë‘ê³  í–‡ë¹›ì— ë‘ë©´ **ë³´ë¼ìƒ‰/ë¶‰ì€ìƒ‰**ìœ¼ë¡œ ë³€í•¨ (Porphobilinogen ì‚°í™”).\n    5. **Precipitating Factors:** ìˆ , ì•½ë¬¼, êµ¶ê¸°(Starvation).\n### ğŸ§¬ Pathophysiology (The Blockage)\n- **Enzyme Defect:** **Porphobilinogen Deaminase (PBG Deaminase)** ê²°í•.\n- **Result:** ê³µì¥ ë¼ì¸ ì¤‘ê°„ì´ ë§‰í˜. ì• ë‹¨ê³„ ë¬¼ì§ˆì¸ **PBG**ì™€ **ALA**ê°€ ë…ì„± ìˆ˜ì¤€ìœ¼ë¡œ ìŒ“ì„ â†’ ì‹ ê²½ ë…ì„±(Neurotoxicity) ìœ ë°œ.\n- **Triggers (The 5th P):**\n    - **CYP450 Inducers:** Alcohol, Barbiturates, Sulfas, Smoking. (ì–˜ë„¤ê°€ Heme ì†Œëª¨ë¥¼ ëŠ˜ë ¤ì„œ ê³µì¥ì„ ê³¼ë™ì‘ì‹œí‚´).\n    - **Starvation:** êµ¶ìœ¼ë©´ Stressë¡œ Heme í•©ì„± ì¦ê°€.\n### ğŸ’Š Treatment (Turning off the Factory)\n- **Glucose (Dextrose):** \"ê³µì¥ì¥ì—ê²Œ ì‰¬ë¼ê³  í•¨.\" GlucoseëŠ” ALA Synthaseë¥¼ ì–µì œí•¨ (Negative Feedback).\n- **Hemin:** ìµœì¢… ì‚°ë¬¼ì„ ë„£ì–´ì¤˜ì„œ ê³µì¥ì„ ë©ˆì¶¤.\n### B. Lead Poisoning (The Imposter) âœï¸","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-210","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"### ğŸ•µï¸â€â™‚ï¸ Spot the Difference (Differential Diagnosis)\nAIPì™€ ì¦ìƒ(ë³µí†µ, ì‹ ê²½ë³‘ì¦)ì´ ë¹„ìŠ·í•˜ì§€ë§Œ ê²°ì •ì ì¸ ì°¨ì´ê°€ ìˆìŒ.\n| **Feature** | **AIP (Acute Intermittent Porphyria)** | **Lead Poisoning (ë‚©ì¤‘ë…)** |\n| --- | --- | --- |\n| **Enzyme Block** | PBG Deaminase | **ALA Dehydratase** & **Ferrochelatase** |\n| **Accumulation** | PBG & ALA | Only **ALA** (PBGëŠ” ì •ìƒ) |\n| **Blood Smear** | Normal | **â˜… Basophilic Stippling** (rRNA clumps) |\n| **Physical Exam** | Soft belly, Psych | **Burton's Line** (Gum lineì— í‘¸ë¥¸ ì„ ) |\n| **Urinalysis** | Port-wine Urine (PBGâ†‘) | No Port-wine (PBG Normal) |\n## ğŸ”¥ Rapid Fire Recap (Scenario Practice)\nì˜¤ë””ì˜¤ ë§ˆì§€ë§‰ì— ë‚˜ì˜¨ Scenario Quizì…ë‹ˆë‹¤. ê°€ë¦¬ê³  ë§ì¶°ë³´ì„¸ìš”!\n1. **Scenario:** Child + Anemia + Splenomegaly + Jaundice + **Coombs Negative**.\n    - **Diagnosis:** ğŸ‘‰ **Hereditary Spherocytosis**\n    - **Mechanism:** Cytoskeleton defect (Spectrin/Ankyrin).\n2. **Scenario:** Patient with Mechanical Valve + Fatigue + **Dark Urine**.\n    - **Test to Order:** ğŸ‘‰ **Echocardiogram** (Check for valve blender effect).\n    - **Findings:** Schistocytes on smear.\n3. **Scenario:** Severe Abdominal Pain + Psychosis + **Soft Belly** + Weakness.\n    - **Enzyme Defect:** ğŸ‘‰ **PBG Deaminase** deficiency (**AIP**).\n    - **Treatment:** Glucose & Hemin.\n4. **Scenario:** Abdominal Pain + Neuropathy + **Basophilic Stippling** on smear.\n    - **Diagnosis:** ğŸ‘‰ **Lead Poisoning**.\n    - **Distinction:** Urine PBG is normal (unlike AIP).\n5. **Scenario:** AIP Patient having an acute attack.\n    - **Immediate Action:** ğŸ‘‰ Give **Glucose** (Stop the factory).\n    - **Trigger:** Did they starve? Drink alcohol? Take sulfas?","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-230","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"# LM_Blood2\n# **Hematology & Oncology: Leukemias (Acute & Chronic)**\n## **TL;DR Overview**\n- **Acute Leukemia:** Medical Emergency ğŸš¨. Sick patient, rapid onset.\n    - **ALL:** Children, Bone pain, Sanctuary sites (Testes/CNS).\n    - **AML:** Adults (usually), Auer Rods (APL subtype).\n- **Chronic Leukemia:** Incidental finding usually. Slow onset.\n    - **CML:** High WBC, Basophilia, t(9;22) BCR-ABL, Tx with Imatinib.\n    - **CLL:** Elderly, Smudge cells, Hypogammaglobulinemia, Richter transformation.\n    - **Hairy Cell:** Massive Splenomegaly + Pancytopenia (Dry Tap) + NO Adenopathy.\n## **ğŸŒ³ Top-Down Classification (The Big Picture)**\nêµ°ì˜ê´€ë‹˜, ì˜¤ëŠ˜ ì£¼ì œëŠ” Hematologyì˜ ê½ƒ, Leukemiaì…ë‹ˆë‹¤. í¬ê²Œ **ì†ë„(Acute vs Chronic)**ì™€ **ê³„ì—´(Myeloid vs Lymphoid)**ë¡œ ë‚˜ëˆ•ë‹ˆë‹¤.\nPlaintext\n`Leukemia (Blood Cancer)\nâ”‚\nâ”œâ”€â”€ Acute (Blasts > 20%, Emergency)\nâ”‚   â”œâ”€â”€ ALL (Lymphoid) -> Kids ğŸ‘¶, Bone Pain, T-cell (Mediastinal Mass)\nâ”‚   â””â”€â”€ AML (Myeloid) -> Adults ğŸ‘´, Auer Rods, M3 (DIC risk)\nâ”‚\nâ””â”€â”€ Chronic (Mature cells, Indolent)\n    â”œâ”€â”€ CML (Myeloid) -> t(9;22), Basophilia, Splenomegaly\n    â”‚   â””â”€â”€ Diff Dx: Leukemoid Reaction (Infection)\n    â”‚\n    â””â”€â”€ Lymphoid Types\n        â”œâ”€â”€ CLL -> Elderly, Smudge Cells, AIHA risk\n        â””â”€â”€ Hairy Cell -> Splenomegaly, Dry Tap, TRAP(+), Cladribine`\n## **2.1 Acute Leukemia (AML, ALL)**\n### **ğŸšª Doorway Thought: The \"Refusal to Walk\" Kid**\n**Scenario:** 4ì„¸ ë‚¨ì ì•„ì´. ì—„ë§ˆê°€ ë°ë ¤ì™”ëŠ”ë°, ì£¼ìš” ì¦ìƒì´ \"ì• ê°€ ì•ˆ ê±¸ìœ¼ë ¤ê³  í•´ìš”(Refusal to walk)\"ì…ë‹ˆë‹¤. ê¸°ì¹¨ì´ë‚˜ ë°œì§„ì´ ì•„ë‹ˆë¼ **Limping** í˜¹ì€ ì•„ì˜ˆ ê±·ê¸°ë¥¼ ê±°ë¶€í•¨.\n- **History:** Low-grade feverê°€ ì•ˆ ë–¨ì–´ì§.\n- **CBC:** Pancytopenia (Anemia, Thrombocytopenia, Neutropenia).\n**ğŸ’¡ Why is he limping? (Concept)**\nê´€ì ˆì—¼(Joint issue)ì´ ì•„ë‹™ë‹ˆë‹¤. **Bone Pain**ì…ë‹ˆë‹¤.\n- **Marrow Overcrowding:** ê³¨ìˆ˜(Bone Marrow)ë¼ëŠ” ê³µì¥ì€ ê³µê°„ì´ í•œì •ì ì¸ë°, Blast cells(ë¶ˆëŸ‰í’ˆ)ì´ ë¯¸ì¹œ ë“¯ì´ ì¦ì‹í•˜ë©´ì„œ ê³¨ë§‰(Periosteum)ì„ ì•ˆì—ì„œ ë°–ìœ¼ë¡œ ë°€ì–´ë‚´ë©° ì°¢ì–´ì§ˆ ë“¯í•œ í†µì¦ì„ ìœ ë°œí•©ë‹ˆë‹¤. (Screaming malignancy!)\n- **Production Line Failure:** ê³µì¥ì´ Blastë¡œ ê½‰ ì°¨ì„œ ì •ìƒ ì œí’ˆ(RBC, Plt, Neutrophil)ì„ ëª» ë§Œë“­ë‹ˆë‹¤.\n    - No RBC â†’ Anemia (Pale, Tired)\n    - No Plt â†’ Bleeding (Bruising, Petechiae)\n    - No Neutrophil â†’ Infection (Fever)","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-1","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### **1. Acute Lymphoblastic Leukemia (ALL)**\n- **Demographics:** Most common childhood cancer (Peak 2-5yo).\n- **Subtypes & Red Flags:**\n    - **B-cell ALL:** Most common.\n    - **T-cell ALL:** **T** for **T**hymus, **T**eenager.\n        - `* Chest X-rayì—ì„œ **Mediastinal Mass** í™•ì¸ í•„ìˆ˜! â†’ ì´ ë©ì–´ë¦¬ê°€ ê¸°ë„ë¥¼ ëˆ„ë¥´ê±°ë‚˜ **SVC Syndrome** (ì–¼êµ´ ë¶“ê³  ëª© ì •ë§¥ ëŠ˜ì–´ë‚¨) ìœ ë°œ ê°€ëŠ¥. Oncologic Emergency!`\n### **2. Diagnostic Workup & \"Sanctuary Sites\"**\n- **Initial:** CBC with peripheral smear (Blasts í™•ì¸).\n- **Gold Standard:** **Bone Marrow Biopsy** (>20% Blasts).\n- **Sanctuary Sites (ì„±ì—­):** í•­ì•”ì œ(Chemo)ê°€ ì˜ ë„ë‹¬í•˜ì§€ ëª»í•´ì„œ ì•”ì„¸í¬ê°€ ìˆ¨ì–´ìˆëŠ” ê³³.\n    1. **CNS (Central Nervous System):** ë‘í†µ, êµ¬í† , ë‡Œì‹ ê²½ ë§ˆë¹„ í™•ì¸. â†’ **Lumbar Puncture (LP)** í•„ìˆ˜! (CSFì— ìˆ¨ì–´ìˆëŠ”ì§€ í™•ì¸ + ì˜ˆë°©ì  í•­ì•”ì œ ì£¼ì…).\n    2. **Testes:** ë‚¨ì•„ì˜ ê²½ìš° **Scrotal exam** í•„ìˆ˜. (Painless testicular enlargement).\n## **2.2 Chronic Leukemia**\n### **1. Chronic Myeloid Leukemia (CML)**\n**Scenario:** ê±´ê°•ê²€ì§„ ë°›ì€ ì•„ì¬. \"ë³„ ì¦ìƒ ì—†ëŠ”ë°ìš”?\" í˜¹ì€ \"ì¢€ í”¼ê³¤í•´ìš”.\"\n- **Lab:** WBCê°€ ë¯¸ì³¤ìŒ (>100,000). ê·¼ë° í™˜ìëŠ” ë©€ì©¡í•´ ë³´ì„(Not septic).\n**ğŸ•µï¸â€â™‚ï¸ Detective Work: CML vs. Leukemoid Reaction**\nëª¸ì´ ê°ì—¼ì´ë‘ ì‹¸ìš°ëŠë¼ WBCë¥¼ ì˜¬ë¦° ê±´ì§€(Leukemoid), ì•”ì¸ì§€(CML) êµ¬ë¶„í•´ì•¼ í•©ë‹ˆë‹¤.\n| **Feature** | **Leukemoid Reaction (Infection)** | **CML (Cancer)** |\n| --- | --- | --- |\n| **Cause** | Infection/Stress | t(9;22) PhiladelphiaMutation |\n| **LAP Score** | **High** (ì„¸í¬ë“¤ì´ ì—´ì¼ ì¤‘) | **Low** (ì„¸í¬ë“¤ì´ ë©ì²­í•¨/ê¸°ëŠ¥ì¥ì• ) |\n| **Basophils** | Normal | **Increased (Basophilia)** â˜…Key Hint! |\n| **Spleen** | Normal | Splenomegaly (Early satiety) |\n- **Pathophysiology:** **Philadelphia Chromosome t(9;22)**.\n    - **BCR-ABL fusion gene:** Tyrosine Kinaseê°€ í•­ìƒ ì¼œì ¸ ìˆìŒ(Always on). ì„¸í¬ ë¶„ì—´ ë©ˆì¶°! ê°€ ì•ˆë¨.\n- **Tx:** **Imatinib** (Tyrosine Kinase Inhibitor). ê¸°ì ì˜ ì¹˜ë£Œì œ.\n- **Danger:** ì¹˜ë£Œ ì•ˆ í•˜ë©´ **Blast Crisis** (Acute Leukemiaë¡œ ë³€ì‹ ) â†’ ì‚¬ë§ ìœ„í—˜.\n### **2. Chronic Lymphocytic Leukemia (CLL)**\n**Scenario:** 70ëŒ€ í• ì•„ë²„ì§€. ì¦ìƒ ì—†ìŒ. (Grandpa leukemia).\n- **Lab:** Isolated Lymphocytosis.\n- **Smear:** * **Smudge Cells:** B-cellë“¤ì´ ë„ˆë¬´ ì•½í•´ì„œ(fragile), ìŠ¬ë¼ì´ë“œ ë§Œë“¤ ë•Œ í„°ì ¸ì„œ ì–¼ë£©ì²˜ëŸ¼ ë³´ì„. (\"Basket cells\").\n- **Markers:** **CD5+** on B-cells (ì›ë˜ CD5ëŠ” T-cell ë§ˆì»¤ì¸ë° B-cellì´ ë‹¬ê³  ë‚˜ì˜´).\n- â˜… Lymph node, bone marrow biopsy í•„ìš” ì—†ìŒ â˜…\n- **Complications (The \"Bad Turns\"):**\n    1. **Hypogammaglobulinemia:** í•­ì²´ë¥¼ ëª» ë§Œë“¦ â†’ ê°ì—¼ ì·¨ì•½.\n    2. **Autoimmune Hemolytic Anemia (AIHA):** ë©ì²­í•œ ë¦¼í”„êµ¬ë“¤ì´ ì•„êµ° ì í˜ˆêµ¬ ê³µê²©. (Warm/Cold agglutinins).\n    3. **Richter Transformation:** ê°‘ìê¸° ë¦¼í”„ì ˆì´ ì»¤ì§€ê±°ë‚˜ ë¹„ì¥ì´ í™• ì»¤ì§€ë©´ì„œ B-symptoms(ë°œì—´, ì²´ì¤‘ê°ì†Œ) ìƒê¹€. â†’ **DLBCL (Diffuse Large B-cell Lymphoma)**ë¡œ ì•…ì„± ë³€í™”. (Worst prognosis).\n### **3. Hairy Cell Leukemia**\n**Scenario:** ì¤‘ë…„ ë‚¨ì„±. ë°°ê°€ ë¶ˆëŸ¬ì„œ ì™”ëŠ”ë°(Massive Splenomegaly), ë¦¼í”„ì ˆì€ ì•ˆ ë§Œì ¸ì§(**No Lymphadenopathy**).\n- **Triad:**\n    1. **Splenomegaly:** ë¹„ì¥ì´ ì—„ì²­ ì»¤ì§ (Early satiety).\n    2. **Pancytopenia:** ê³¨ìˆ˜ê°€ í„¸ë¶ìˆ­ì´ ì„¸í¬ë“¤ë¡œ ê½‰ ì°¸ + ë¹„ì¥ì—ì„œ í˜ˆêµ¬ íŒŒê´´.\n    3. **Dry Tap:** ê³¨ìˆ˜ ê²€ì‚¬í•˜ë ¤ëŠ”ë° ì£¼ì‚¬ê¸°ë¡œ ì•„ë¬´ê²ƒë„ ì•ˆ ë¹¨ë ¤ ë‚˜ì˜´. (Bone Marrow Fibrosis ë•Œë¬¸ì—).\n- **Diagnosis:**\n    - Smear: **Hairy Cells** (ì„¸í¬ì§ˆì´ í„¸ì²˜ëŸ¼ ì‚ì£½ì‚ì£½).\n    - Stain: **TRAP** (Tartrate-Resistant Acid Phosphatase) positive.\n- **Tx:** **Cladribine** (Purine analog).\n    - *Mnemonic:* \"Hairy\" beast is \"Clad\" (ì…í˜€ì§„) in fur.","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-21","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"## **ğŸ”¥ Rapid Fire Recap (High Yield Summary)**\n1. **Scenario:** 4ì„¸ ë‚¨ì•„, ë‹¤ë¦¬ ì•„íŒŒì„œ ì•ˆ ê±¸ìŒ + ì—´ + Pancytopenia.\n    - **Diagnosis:** **ALL (Acute Lymphoblastic Leukemia)**\n    - **Action:** Bone Marrow Biopsy (>20% blasts). Check **Testes** & **CSF** (Sanctuary sites)!\n2. **Scenario:** Teenager with Mediastinal Mass + SVC Syndrome.\n    - **Diagnosis:** **T-cell ALL**\n    - **Recall:** \"T\" for Teen, Thymus.\n3. **Scenario:** Adult, WBC > 100k, Basophilia, Low LAP score.\n    - **Diagnosis:** **CML (Chronic Myeloid Leukemia)**\n    - **Next Step:** Check for **t(9;22) BCR-ABL**. Treat with Imatinib.\n4. **Scenario:** Elderly, Asymptomatic, Smudge Cells on smear.\n    - **Diagnosis:** **CLL (Chronic Lymphocytic Leukemia)**\n    - **Trap:** Don't treat immediately (Watch & Wait). Watch out for **Richter Transformation** (Rapidly enlarging nodes).\n5. **Scenario:** Middle-aged man, Massive Spleen, No Nodes, Dry Tap.\n    - **Diagnosis:** **Hairy Cell Leukemia**\n    - **Treatment:** **Cladribine**. (Adenosine deaminase inhibitor).\n### **STEP 2: OVERVIEW & BIG PICTURE (TL;DR)**\nì´ ê°•ì˜ëŠ” Hematology/Oncologyì˜ ë‘ ê°€ì§€ í•µì‹¬ ì¶•ì„ ë‹¤ë£¹ë‹ˆë‹¤.\n1. **Hodgkin Lymphomaì˜ ì¥ê¸° ìƒì¡´ì ê´€ë¦¬:** ì¹˜ë£Œê°€ í™˜ìë¥¼ ì‚´ë ¸ì§€ë§Œ, ê·¸ ì¹˜ë£Œ(Radiation/Chemo)ê°€ 15ë…„ ë’¤ ìƒˆë¡œìš´ ì (Secondary Malignancy, CAD)ì„ ë¶€ë¥´ëŠ” ì—­ì„¤.\n2. **Plasma Cell Dyscrasias:** ë¼ˆë¥¼ ë…¹ì´ëŠ” Multiple Myelomaì™€ í”¼ë¥¼ ëˆì í•˜ê²Œ ë§Œë“œëŠ” Waldenstrom'sì˜ ê°ë³„, ê·¸ë¦¬ê³  ì˜ìƒ ì§„ë‹¨ì˜ í•¨ì •.\n### **ğŸ§  Mental Model: Top-Down Classification Tree (ASCII Text)**\nPlaintext\n`Hematologic Malignancies (Context)\nâ”‚\nâ”œâ”€â”€ 1. Hodgkin Lymphoma (Survivorship Phase)\nâ”‚    â”‚\nâ”‚    â”œâ”€â”€ Concept: \"The Price of the Cure\" (Collateral Damage)\nâ”‚    â”œâ”€â”€ Timeline Risk (The \"Shift Change\")\nâ”‚    â”‚    â”œâ”€â”€ < 10 Years: Relapse of Hodgkin's\nâ”‚    â”‚    â””â”€â”€ > 15 Years: Secondary Malignancy (Lung, Breast, etc.) & CVD\nâ”‚    â”‚\nâ”‚    â””â”€â”€ Unique Sign: Alcohol-induced Lymph Node Pain (Vasodilation)\nâ”‚\nâ””â”€â”€ 2. Plasma Cell Dyscrasias (Monoclonal Gammopathy)\n     â”‚\n     â”œâ”€â”€ Pathophysiology: Uncontrolled Antibody Production (M-Spike)\n     â”‚\n     â”œâ”€â”€ A. Multiple Myeloma (MM)\n     â”‚    â”œâ”€â”€ Antibody: IgG or IgA (Small monomers)\n     â”‚    â”œâ”€â”€ Key Pathology: Osteoclast Activation (Bone eating)\n     â”‚    â””â”€â”€ Clinical: CRAB (Calcium, Renal, Anemia, Bone)\n     â”‚\n     â””â”€â”€ B. Waldenstrom Macroglobulinemia (WM)\n          â”œâ”€â”€ Antibody: IgM (Huge Pentamer)\n          â”œâ”€â”€ Key Pathology: Hyperviscosity (Sludge blood)\n          â””â”€â”€ Clinical: Blurry vision, Bleeding, Engorged Spleen/Liver`\n### **STEP 3: DETAILED LECTURE NOTES (\"ZERO-LOSS\")**\n# 1. Hodgkin Lymphoma Survivorship: The Long Game\n*(Section 2.3 of the Source Material)*","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-41","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"### ğŸšª Vignette Anchor (Doorway Thought)\n### A. The \"Shift Change\" (Timeline of Risk)\nê°•ì˜ì—ì„œëŠ” ì´ë¥¼ **\"The Shift Change\"**ë¼ê³  í‘œí˜„í•˜ë©° ê·¸ë˜í”„ë¡œ ì‹œê°í™”í•˜ë¼ê³  ì¡°ì–¸í•©ë‹ˆë‹¤.\n- **Year 0 ~ 10:** ê°€ì¥ í° ì‚¬ë§ ì›ì¸ì€ **Hodgkin Lymphoma Relapse** (ì›ë˜ ë³‘ì˜ ì¬ë°œ).\n- **The Crossing Point (15 Year Mark):** â˜… ì¤‘ìš”! ì„ ì´ êµì°¨í•©ë‹ˆë‹¤.\n- **Year 15+:** ì‚¬ë§ ì›ì¸ 1ìœ„ëŠ” ë” ì´ìƒ ë¦¼í”„ì¢…ì´ ì•„ë‹™ë‹ˆë‹¤. **Secondary Malignancy**ì…ë‹ˆë‹¤.\n    - **Stat:** ì¼ë°˜ì¸ ëŒ€ë¹„ ì•” ë°œìƒ ìœ„í—˜ì´ **18.5ë°° (1,850%)** ì¦ê°€í•©ë‹ˆë‹¤.\n    - **Mechanism:** ê³¼ê±°ì˜ Radiation(ë°©ì‚¬ì„ )ê³¼ Chemoê°€ ì„¸í¬ ìœ ì „ìì— ì†ìƒì„ ì…íŒ ê²ƒ(Collateral Damage). \"Shotgun blast to the chest.\"\n### B. Screening Targets (High Vigilance) ğŸ•µï¸â€â™‚ï¸\në°©ì‚¬ì„  ì¡°ì‚¬ ë²”ìœ„(Radiation Field)ì— ë“¤ì–´ê°”ë˜ ëª¨ë“  ì¥ê¸°ê°€ ìœ„í—˜í•©ë‹ˆë‹¤.\n1. **Secondary Cancers:**\n    - **Lung Cancer:** ê°€ì¥ í”í•¨.\n    - **Breast Cancer:** í‰ë¶€ ë°©ì‚¬ì„ ì„ ë°›ì€ ì—¬ì„±.\n    - **Thyroid Cancer:** ëª© ë¶€ìœ„ ë°©ì‚¬ì„ .\n    - **Bone Sarcomas:** ë°©ì‚¬ì„  ì¡°ì‚¬ ë¶€ìœ„ ë¼ˆ.\n2. **Cardiovascular Disease (Non-malignant cause):**\n    - **Pathology:** Radiationì´ í˜ˆê´€ì„ ë”±ë”±í•˜ê²Œ(Hardening) ë§Œë“¤ê³ , íŒë§‰(Valve)ì— í‰í„°ë¥¼ ë‚¨ê¹€(Scarring).\n    - **Chemo Effect:** Doxorubicin(Anthracycline) ê°™ì€ ì•½ë¬¼ì€ ì‹¬ì¥ ë…ì„±(Cardiotoxic)ì´ ìˆì–´ Cardiomyopathy ìœ ë°œ.\n    - **Condition:** Coronary Artery Disease (Accelerated Atherosclerosis), Valve Damage, Heart Failure.\n### C. The Bizarre Symptom: Alcohol Pain ğŸº\në§¤ìš° ë“œë¬¼ì§€ë§Œ Hodgkin's Lymphomaì— **Highly Specific**í•œ ì¦ìƒì…ë‹ˆë‹¤.\n- **Symptom:** ë§¥ì£¼ í•œ ì”(Even small amount) ë§ˆì‹œìë§ˆì ë¦¼í”„ì ˆ ë¶€ìœ„ì— ë‚ ì¹´ë¡œìš´ í†µì¦(Sharp Localized Pain) ë°œìƒ.\n- **Mechanism (Leading Theory):** **Vasodilation**.\n    - ì•Œì½”ì˜¬ì´ í˜ˆê´€ì„ í™•ì¥ì‹œí‚´ â†’ ì¢…ì–‘ ì„¸í¬ë¡œ ê½‰ ì°¬ ë¦¼í”„ì ˆ(Packed tight) ë‚´ë¶€ì˜ í˜ˆê´€ì´ íŒ½ì°½í•˜ë ¤ê³  í•¨ â†’ ìº¡ìŠ(Capsule)ì´ ëŠ˜ì–´ë‚˜ë©´ì„œ ê·¹ì‹¬í•œ í†µì¦ ìœ ë°œ.\n- **Clinical Pearl:** í™˜ìê°€ ì´ ì´ì•¼ê¸°ë¥¼ í•˜ë©´ ì¦‰ì‹œ Hodgkin's Workupì„ ì‹œì‘í•´ì•¼ í•©ë‹ˆë‹¤.\n# 2. Plasma Cell Dyscrasias: MM vs. WM\n*(Section 2.4 of the Source Material)*\n### ğŸšª Vignette Anchor (Patient A vs. Patient B)\nê°•ì˜ì—ì„œëŠ” ë‘ ëª…ì˜ í™˜ìë¥¼ ëŒ€ì¡°í•˜ì—¬ ì„¤ëª…í•©ë‹ˆë‹¤. ë‘˜ ë‹¤ **Protein Spike (Monoclonal Gammopathy)**ê°€ ë©ì—ì„œ ë–´ì§€ë§Œ, ì„ìƒ ì–‘ìƒì€ ì™„ì „íˆ ë‹¤ë¦…ë‹ˆë‹¤.\n| **Feature** | **Patient A (Multiple Myeloma)** | **Patient B (Waldenstrom's)** |\n| --- | --- | --- |\n| **Chief Complaint** | ë¼ˆê°€ ì•„í”„ê³  ê°ˆë¹„ë¼ˆ ê³¨ì ˆ (Agony), ì‹ ë¶€ì „ | ëˆˆì´ ì¹¨ì¹¨í•¨(Blurry Vision), ì‡ëª¸ ì¶œí˜ˆ |\n| **Organs** | **Kidney & Bone** | **Eyes, Mucosa, Spleen/Liver** (Huge) |\n| **Antibody Type** | **IgG or IgA** (Small Monomer) | **IgM** (Huge Pentamer) |\n| **Pathophysiology** | Bone Destruction & Kidney Clogging | **Hyperviscosity** (Sludge Blood) |\n### A. Multiple Myeloma (MM) ğŸ¦´\n- **Antibody Size:** IgG/IgAëŠ” ì‘ìŠµë‹ˆë‹¤(Small).\n- **Renal Failure:** ì´ ì‘ì€ ë‹¨ë°±ì§ˆë“¤ì´ ì‹ ì¥ ì„¸ë‡¨ê´€(Kidney Tubules)ì— ë¼ì–´ë²„ë¦¼ â†’ **Clog up & Kidney Failure**.\n- **Bone Destruction (Key Feature):**\n    - ì¢…ì–‘ ì„¸í¬ê°€ **Osteoclast(ë¼ˆ íŒŒê´´ì„¸í¬)**ì—ê²Œ \"ë¼ˆë¥¼ ë…¹ì—¬ë¼(Eat bone)\"ë¼ëŠ” Cytokine ì‹ í˜¸ë¥¼ ë³´ëƒ„.\n    - **Result:** Lytic Lesions (Punched out holes).\n    - **CRAB Criteria:**\n        - **C**alcium Elevated (ë¼ˆê°€ ë…¹ì•„ì„œ ì¹¼ìŠ˜ì´ í˜ˆì•¡ìœ¼ë¡œ ìŸì•„ì ¸ ë‚˜ì˜´).\n        - **R**enal Insufficiency.\n        - **A**nemia (ê³¨ìˆ˜ê°€ ì•”ì„¸í¬ë¡œ ê½‰ ì°¨ì„œ ì í˜ˆêµ¬ë¥¼ ëª» ë§Œë“¦).\n        - **B**one Lesions/Pain.","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-61","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","diagnosis","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### B. Waldenstrom Macroglobulinemia (WM) ğŸ©¸\n- **Antibody Size:** **IgM**ì€ 5ê°œê°€ ë­‰ì¹œ ê±°ëŒ€ ë¶„ì(Pentamer)ì…ë‹ˆë‹¤. **\"Clunky Molecule\"**.\n- **Hyperviscosity Syndrome (The Real Issue):**\n    - ë¶„ìê°€ ë„ˆë¬´ ì»¤ì„œ í˜ˆì•¡ì´ **\"Sludge (ì§„í™/ì˜¤ë‹ˆ)\"**ì²˜ëŸ¼ ë³€í•¨.\n    - í”¼ê°€ ëˆì í•´ì„œ ë§ë§‰(Retina)ì˜ ë¯¸ì„¸ í˜ˆê´€ì„ í†µê³¼ ëª» í•¨ â†’ **Blurry Vision**.\n    - í˜ˆì†ŒíŒ(Platelet)ì„ ì½”íŒ…í•´ë²„ë ¤ ê¸°ëŠ¥ì„ ëª» í•˜ê²Œ í•¨ â†’ **Bleeding**.\n    - ê°„ê³¼ ë¹„ì¥ì— ì°Œêº¼ê¸°ê°€ ë‚Œ â†’ **Hepatosplenomegaly**.\n- **Distinct Feature:** MMê³¼ ë‹¬ë¦¬ **Lytic Bone Lesionì´ ì—†ìŠµë‹ˆë‹¤.** (No holes in bones).\n# 3. The Imaging Trap: Don't Fail the Exam! ğŸš¨\n*(Section 2.4.1 - Critical Error)*\nì´ ë¶€ë¶„ì€ ì‹œí—˜ì´ë‚˜ ì‹¤ì œ ì„ìƒì—ì„œ ê°€ì¥ ë§ì´ í‹€ë¦¬ëŠ” \"Fail Button\"ì…ë‹ˆë‹¤.\n### ğŸ“‰ The Trap: Nuclear Bone Scan\n- **Scenario:** Myelomaê°€ ì˜ì‹¬ë˜ì–´ ë¼ˆ í†µì¦ì„ í˜¸ì†Œí•˜ëŠ” í™˜ìì—ê²Œ ì¸í„´ì´ \"Bone Scan\"ì„ ì˜¤ë”í•¨.\n- **Result:** **\"False Negative\" (ì•„ë¬´ê²ƒë„ ì•ˆ ë‚˜ì˜´, ê¹¨ë—í•¨).**\n- **Why? (Mechanism):**\n    - Nuclear Bone Scanì€ **Osteoblastic Activity(ë¼ˆë¥¼ ë§Œë“œëŠ” í™œë™/ìˆ˜ë¦¬í•˜ëŠ” í™œë™)**ë¥¼ ê°ì§€í•´ì„œ ë¶ˆì´ ë“¤ì–´ì˜´(Light up).\n    - Multiple MyelomaëŠ” **Purely Lytic** (100% íŒŒê´´) ì§ˆí™˜ì„.\n    - Osteoblast(ë¼ˆ ìƒì„± ì„¸í¬)ëŠ” ì–µì œ(Suppressed)ë˜ì–´ ìˆìŒ. ì¦‰, ìˆ˜ë¦¬(Repair) ì‘ì—…ì´ ì „í˜€ ì¼ì–´ë‚˜ì§€ ì•ŠìŒ.\n    - ê²°ê³¼ì ìœ¼ë¡œ ìŠ¤ìº”ì—ëŠ” ì•„ë¬´ê²ƒë„ ì°íˆì§€ ì•ŠìŒ. (ì²™ì¶”ê°€ ë¬´ë„ˆì ¸ ë‚´ë ¤ë„ ìŠ¤ìº”ì€ ì •ìƒìœ¼ë¡œ ë³´ì¼ ìˆ˜ ìˆìŒ).\n### âœ… The Gold Standard: Skeletal Survey\n- **What to order:** **Full Body X-ray (Skeletal Survey)** í˜¹ì€ **Low-dose Whole Body CT**.\n- **What you see:** ë¼ˆê°€ ì—†ì–´ì§„ êµ¬ë©(Absence of bone), ì¦‰ **\"Punched out lesions\"**ì„ ëˆˆìœ¼ë¡œ í™•ì¸í•´ì•¼ í•¨.","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-81","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"recap_summary","text":"### **STEP 4: RAPID FIRE RECAP (Summary Table)**\n| **Condition** | **Key Mechanism** | **Critical Symptom/Sign** | **Gold Standard / Next Step** |\n| --- | --- | --- | --- |\n| **Hodgkin Survivorship** | Radiation/Chemo DNA Damage | New cough/pain >15 yrs post-cure | **Secondary Malignancy Workup** (Lung/Breast/Thyroid) + Cardiac Echo |\n| **Hodgkin (Active)** | Vasodilation in Capsule | **Alcohol-induced Pain** | Biopsy / Staging |\n| **Multiple Myeloma** | IgG/IgA, Osteoclast Activation | **CRAB**, Bone Pain, High Ca2+ | **Skeletal Survey** (Look for lytic lesions) |\n| **Waldenstrom's** | IgM (Pentamer), Hyperviscosity | Blurry Vision, Bleeding, Huge Spleen | Serum Viscosity, Plasmapheresis (if symptomatic) |\n| **Imaging Trap** | Pure Lytic Nature of MM | Bone Scan looks \"Normal\" | **Avoid Bone Scan** â†’ Do X-ray/CT Survey |\n### **STEP 5: REFLECTION & CAVEATS**\n- **Confidence:** 1.0 (ëª¨ë“  í•µì‹¬ ë‚´ìš© í¬í•¨ë¨).\n    - Secondary Malignancyì˜ 18.5ë°° ë¦¬ìŠ¤í¬ ìˆ˜ì¹˜ëŠ” ë§¤ìš° ì¤‘ìš”í•˜ë¯€ë¡œ ì•”ê¸° í•„ìš”.\n    - High Calciumì´ ë‚˜ì˜¤ë©´ í•­ìƒ PTH(ë¶€ê°‘ìƒì„  í˜¸ë¥´ëª¬)ë¥¼ ì²´í¬í•˜ì—¬ Negative Feedback Loop(Suppressed PTH)ë¥¼ í™•ì¸í•´ì•¼ í•¨. MyelomaëŠ” PTHê°€ ë‚®ì•„ì•¼ ì •ìƒ(High Ca -> Low PTH).\n    - Waldenstrom'sì˜ ê²½ìš° IgM ìŠ¤íŒŒì´í¬ì™€ Hyperviscosity ì¦ìƒì´ ë§¤ì¹­ë˜ì–´ì•¼ í•¨.\n**Would you like me to generate a specific quiz based on the \"Imaging Trap\" or \"Shift Change\" concepts to test your retention?**\nì•„ì´ê³ , ì£„ì†¡í•©ë‹ˆë‹¤! ğŸ˜… ì œê°€ ì—´ì •ì´ ë„˜ì³ì„œ ê·¸ë§Œ ì˜ì–´ë¡œ ì­‰ ë‹¬ë ¤ë²„ë ¸ë„¤ìš”.\nì €ì¥ëœ ì„¤ì •([2025-12-08])ì— ë”°ë¼, **ì˜í•™ ìš©ì–´ëŠ” ëª…í™•í•˜ê²Œ English**ë¡œ ìœ ì§€í•˜ê³ , ì„¤ëª…ì€ **ì•„ì£¼ ì°°ì§€ê³  ì¬ë¯¸ìˆëŠ” í•œêµ­ì–´(ê³¼ì™¸ ì„ ìƒë‹˜ í†¤)**ë¡œ ë‹¤ì‹œ ì •ë¦¬í•´ ë“œë¦´ê²Œìš”. \"Zero-Loss\" ì›ì¹™ ê·¸ëŒ€ë¡œ, ë¹ ì§„ ë‚´ìš© ì—†ì´ ê½‰ ì±„ì› ìŠµë‹ˆë‹¤!\nì, ë‹¤ì‹œ ê°‘ë‹ˆë‹¤! ğŸš€","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-93","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","recap","diagnosis","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### ğŸ“‹ Overview / TL;DR\n- **ì£¼ì œ:** The Bleeding Patient (Platelets & Hemostasis) - USMLE Step 2 CK High Yield.\n- **í•µì‹¬ êµ¬ë¶„:** Platelet ì¶œí˜ˆ (í”¼ë¶€/ì ë§‰) vs. Factor ì¶œí˜ˆ (ê¹Šì€ ê´€ì ˆ).\n- **ì£¼ìš” ì§ˆí™˜:** Thrombocytopenia, ITP, TTP, HUS, Vitamin K Deficiency.\n- **ì¹˜ëª…ì  ì¡°ì¹˜:** Mixing Studies í•´ì„, TTPì—” PLEX, HUSì—” **Antibiotics ì ˆëŒ€ ê¸ˆì§€**.\n(ì›Œë°ì—… ì—†ì´ ë°”ë¡œ ë³¸ë¡ ìœ¼ë¡œ ë“¤ì–´ê°„ë‹¤ëŠ” ë‚´ìš© í™•ì¸ ì™„ë£Œ! ğŸ”¥)\n### ğŸŒ³ Top-Down Classification: The Bleeding Patient\nìš°ë¦¬ê°€ ì§€ê¸ˆ ì–´ë””ë¥¼ ê³µë¶€í•˜ê³  ìˆëŠ”ì§€ **Big Picture**ë¶€í„° ì¡ê³  ê°‘ì‹œë‹¤.\nPlaintext\n`THE BLEEDING PATIENT (ì¶œí˜ˆ í™˜ì)\nâ”‚\nâ”œâ”€â”€ 1. Primary Hemostasis (Platelets: í˜ˆì†ŒíŒ) ğŸ©¸\nâ”‚   â”‚  * ì¦ìƒ: Mucosal bleeding (ì ë§‰), Petechiae (ì ìƒì¶œí˜ˆ), Epistaxis (ì½”í”¼)\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Low Quantity (Thrombocytopenia: ìˆ˜ì  ë¶€ì¡±)\nâ”‚   â”‚   â”œâ”€â”€ Production Failure (ê³µì¥ì´ ë©ˆì¶¤: ê³¨ìˆ˜ ì–µì œ, ë°”ì´ëŸ¬ìŠ¤, ì•Œì½”ì˜¬)\nâ”‚   â”‚   â”œâ”€â”€ Sequestration (ê°€ë‘¬ë‘ : Splenomegaly)\nâ”‚   â”‚   â””â”€â”€ Destruction (ë¶€ìˆ´ë²„ë¦¼: ë§ì´ˆ íŒŒê´´)\nâ”‚   â”‚       â”œâ”€â”€ Immune: ITP (í•­ì²´ê°€ ê³µê²©)\nâ”‚   â”‚       â””â”€â”€ Non-Immune (MAHA): TTP, HUS, DIC (ê°ˆë ¤ë‚˜ê°)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Low Quality (Function Defect: ê¸°ëŠ¥ ê³ ì¥)\nâ”‚       â””â”€â”€ Uremia, Aspirin, vWD (von Willebrand Disease)\nâ”‚\nâ””â”€â”€ 2. Secondary Hemostasis (Coagulation Factors: ì‘ê³  ì¸ì) ğŸ§¶\n    â”‚  * ì¦ìƒ: Hemarthrosis (ê´€ì ˆ ì¶œí˜ˆ), Deep Muscle Hematoma (ê¹Šì€ ê·¼ìœ¡)\n    â”‚  * Lab: PT/INR (Extrinsic), PTT (Intrinsic)\n    â”‚\n    â”œâ”€â”€ Factor Deficiency (Mixing Study êµì • ë¨)\n    â”‚   â”œâ”€â”€ Hemophilia A (8), B (9)\n    â”‚   â””â”€â”€ Vitamin K Deficiency (2, 7, 9, 10, C, S)\n    â”‚\n    â””â”€â”€ Inhibitors (Mixing Study êµì • ì•ˆ ë¨)\n        â””â”€â”€ Lupus Anticoagulant (Anti-phospholipid Syndrome)`\n# ğŸ©¸ H1: SECTION 3.0 - PLATELETS (The Basics)\n### ğŸšª Doorway Thought (ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤)\n- **ìƒí™©:** íšŒì§„ ë„ëŠ”ë° í™˜ì ì •ê°•ì´ì— **ë°”ëŠ˜ë¡œ ì½•ì½• ì°Œë¥¸ ë“¯í•œ ë¶‰ì€ ì (Petechiae)**ì´ ì«™ ê¹”ë ¤ ìˆìŠµë‹ˆë‹¤.\n- **ì¤‘ìš” í¬ì¸íŠ¸:** í™˜ìê°€ \"ë¬´ë¦ ê´€ì ˆì´ ì•„íŒŒìš”(Deep joint pain)\"ë¼ê³ ëŠ” **ì•ˆ í•´ìš”**.\n- **í•´ì„:** ì´ê±´ ë¬´ì¡°ê±´ **Platelet ë¬¸ì œ**ì…ë‹ˆë‹¤.\n    - **Platelet Defect:** ì ë§‰ ì¶œí˜ˆ, Epistaxis(ì½”í”¼), Hematuria, Petechiae/Purpura.\n    - **Factor Defect (Clotting):** ê¹Šì€ ì¡°ì§ ì¶œí˜ˆ, **Hemarthrosis** (ë¬´ë¦ ê°™ì€ ê´€ì ˆ ì•ˆì— í”¼ê°€ ì°¨ì„œ ë¶“ëŠ” ê²ƒ).\n### ğŸ¥ The Thrombocytopenia Framework (í˜ˆì†ŒíŒ ê°ì†Œì¦ ì ‘ê·¼ë²•)\në¬´ì‘ì • ì™¸ìš°ì§€ ë§ê³ , ë”± **ë‘ ê°€ì§€ ë°”êµ¬ë‹ˆ(Bucket)**ë¡œ ë‚˜ëˆ„ì„¸ìš”:\n### Bucket A: Decreased Production (ê³µì¥ì´ ê³ ì¥ ë‚¨) ğŸ­\n- **Viral Infections:** EBV, Hepatitis C, HIV.\n    - â˜… **Clinical Pearl:** Thrombocytopeniaê°€ **HIVì˜ ìœ ì¼í•œ ì´ˆê¸° ì¦ìƒ**ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ë¬´ì¡°ê±´ Screen í•˜ì„¸ìš”!\n- **Toxins/Drugs:** Chemotherapy, **Alcohol** (ì•Œì½”ì˜¬ì€ ê³¨ìˆ˜ë¥¼ ì§ì ‘ ì–µì œí•©ë‹ˆë‹¤).\n- **Nutritional:** B12/Folate deficiency (DNA ì¬ë£Œê°€ ì—†ìœ¼ë‹ˆ ëª» ë§Œë“¦).\n- **Congenital:** Fanconi Syndrome (Pancytopenia).\n### Bucket B: Increased Destruction (ë§Œë“¤ì–´ë†¨ëŠ”ë° ë¶€ì„œì§) ğŸ”¨","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-103","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","treatment"]}
{"chunk_type":"transcript_chunk","text":"- **Immune:** ITP, HIT (Heparin Induced), Lupus.\n- **Non-Immune (MAHA):** TTP, HUS, DIC (í˜ˆê´€ ì•ˆì—ì„œ ê°ˆë ¤ ë‚˜ê°).\n- **Sequestration:** **Splenomegaly** (Cirrhosis/Portal Hypertension).\n    - *ê°œë…:* ë¹„ì¥(Spleen)ì€ ê±°ëŒ€í•œ ìŠ¤í€ì§€ì˜ˆìš”. í˜ˆì†ŒíŒì˜ 80-90%ë¥¼ ê°€ë‘¬ë‘˜ ìˆ˜ ìˆì–´ìš”. ìˆ˜ì¹˜ëŠ” ë‚®ê²Œ ì°íˆì§€ë§Œ, í™˜ìëŠ” ë³´í†µ ê´œì°®ìŠµë‹ˆë‹¤.\n### âš ï¸ The Trap: Pseudothrombocytopenia (ê°€ì§œ í˜ˆì†ŒíŒ ê°ì†Œì¦)\n- **ìƒí™©:** ì»´í“¨í„°ëŠ” í˜ˆì†ŒíŒ ìˆ˜ì¹˜ê°€ ë°”ë‹¥ì´ë¼ê³  ë‚œë¦¬ ë‚¬ëŠ”ë°, í™˜ìëŠ” ë„ˆë¬´ ë©€ì©¡í•´ìš”.\n- **ì›ì¸:** **EDTA (ë³´ë¼ìƒ‰ ëšœê»‘ íŠœë¸Œ)**ê°€ í˜ˆì†ŒíŒë¼ë¦¬ ë­‰ì¹˜ê²Œ(Clumping) ë§Œë“¤ì–´ìš”. ê¸°ê³„ëŠ” ì´ ë©ì–´ë¦¬ë¥¼ ì„¸í¬ 1ê°œë¡œ ì„¸ë²„ë¦¬ëŠ” ê±°ì£ .\n- **â˜… Next Best Step:** **Citrate (íŒŒë€ ëšœê»‘)** ë˜ëŠ” Heparin íŠœë¸Œë¡œ ë‹¤ì‹œ ì±„í˜ˆ(Repeat CBC).\n    - í˜¹ì€ Peripheral smearë¥¼ ë´ì„œ ë­‰ì³ìˆëŠ”ì§€ í™•ì¸í•©ë‹ˆë‹¤.\n# ğŸ§¬ H1: SECTION 3.1 - HEMOSTASIS (Coagulation)\n### ğŸšª Doorway Thought\n- **ìƒí™©:** í™˜ì AëŠ” ë¬´ë¦ì„ ì‚´ì§ ì°§ì—ˆëŠ”ë° í‰í‰ ë¶€ìŒ (Hemarthrosis). í™˜ì BëŠ” ë©´ë„í•˜ë‹¤ ë² ì˜€ëŠ”ë° 20ë¶„ì§¸ í”¼ê°€ ì•ˆ ë©ˆì¶¤.\n- **Labs:** PT í˜¹ì€ PTTê°€ ë†’ê²Œ ë‚˜ì˜´(Elevated).\n### ğŸ§ª The Fork in the Road: Mixing Study (ë¯¹ì‹± ìŠ¤í„°ë””)\nPTT/PTê°€ ë–´ì„ ë•Œ ê°€ì¥ ë¨¼ì € í•´ì•¼ í•  **First Step**ì…ë‹ˆë‹¤.\n- **ë°©ë²•:** í™˜ìì˜ í˜ˆì¥(Plasma) 1 + ì •ìƒì¸ì˜ í˜ˆì¥ 1ì„ ì„ìŠµë‹ˆë‹¤.\n- **ë…¼ë¦¬:** ìš°ë¦¬ ëª¸ì€ ì‘ê³  ì¸ìê°€ **50%**ë§Œ ìˆì–´ë„ ì •ìƒì ìœ¼ë¡œ í”¼ê°€ êµ³ìŠµë‹ˆë‹¤.\n| **ê²°ê³¼ (Result)** | **í•´ì„ (Interpretation)** | **ì˜ˆì‹œ (Examples)** |\n| --- | --- | --- |\n| **Corrects to Normal (ì •ìƒí™” ë¨)** | **Factor Deficiency (ë¶€ì¡±)** | Hemophilia A/B, Vit K Def. (ì •ìƒ í˜ˆì¥ì´ ë¶€ì¡±ë¶„ì„ ì±„ì›Œì¤Œ). |\n| **Fails to Correct (êµì • ì•ˆ ë¨)** | **Inhibitor Present (ë°©í•´ê¾¼)** | Lupus Anticoagulant, Factor 8 Inhibitor. (ë°©í•´ê¾¼ì´ ë„£ì–´ì¤€ ì •ìƒ í˜ˆì¥ê¹Œì§€ ê³µê²©í•¨). |\n# ğŸ¥¦ H1: SECTION 3.1.1 - VITAMIN K DEFICIENCY\n### ğŸ§  Pathophysiology\n- Vitamin KëŠ” **Gamma-Carboxylation**ì˜ í•„ìˆ˜ ì¡°ìˆ˜(Co-factor)ì…ë‹ˆë‹¤.\n- í™œì„± ì¸ì: **2, 7, 9, 10, Protein C, Protein S**.\n- **ê³µê¸‰ì›:** ìì±„ì†Œ(Leafy greens) ğŸ¥¬ & **ì¥ë‚´ ì„¸ê· (Gut Bacteria)** ğŸ¦ .\n### ğŸ‘¶ Scenario A: The Newborn Bleed (ì‹ ìƒì•„ ì¶œí˜ˆ)\n- **Vignette:** ìƒí›„ 4ì¼ ëœ ì•„ê¸°. ë°°ê¼½(Umbilical stump)ì—ì„œ í”¼ê°€ ê³„ì† ë‚¨.\n- **ì´ìœ :** ì‹ ìƒì•„ëŠ” **Sterile Gut (ë¬´ê·  ìƒíƒœ)**ìœ¼ë¡œ íƒœì–´ë‚¨ -> ë°•í…Œë¦¬ì•„ê°€ ì—†ìœ¼ë‹ˆ Vit K ê³µì¥ ê°€ë™ ë¶ˆê°€ + íƒœë°˜ í†µê³¼ ì˜ ì•ˆë¨ + ëª¨ìœ ì— Vit K ì ìŒ.\n- **í•©ë³‘ì¦:** **Intracranial Hemorrhage** (ë‡Œì¶œí˜ˆ... ì¹˜ëª…ì ì…ë‹ˆë‹¤).\n- **â˜… Gold Standard Prevention:** íƒœì–´ë‚˜ìë§ˆì **IM Vitamin K** ì£¼ì‚¬ (í‘œì¤€ ì¹˜ë£Œ).\n    - *ì‹œí—˜ ë¬¸ì œ:* ì§‘ì—ì„œ ì¶œì‚°(Home birth)í•´ì„œ ì˜ë£Œ ì²˜ì¹˜ ëª» ë°›ì€ ì•„ê¸° -> ë¬´ì¡°ê±´ Vit K ê²°í• ì˜ì‹¬!\n### ğŸ’Š Scenario B: The \"Sick Liver\" Trap (ê°„ì§ˆí™˜/í•­ìƒì œ)\n- **í™˜ì:** Cirrhosis í™˜ì í˜¹ì€ ICUì—ì„œ ì˜¤ë«ë™ì•ˆ **Broad-Spectrum Antibiotics** ì“°ëŠ” í™˜ì.\n- **ê¸°ì „:** í•­ìƒì œê°€ ì¥ë‚´ ì„¸ê· (Flora)ì„ ë‹¤ ì£½ì„ -> Vit K ìƒì‚° ì¤‘ë‹¨ -> ì¶œí˜ˆ.\n- **Lab:** **PT/INRì´ ê°€ì¥ ë¨¼ì € ì˜¤ë¦„** (Factor 7ì˜ ë°˜ê°ê¸°ê°€ ì œì¼ ì§§ê¸° ë•Œë¬¸).","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-123","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"# ğŸ›¡ï¸ H1: SECTION 3.1.2 - ITP (Immune Thrombocytopenic Purpura)\n### ğŸšª Doorway Thought\n- **Vignette:** ê±´ê°•í•˜ë˜ 5ì„¸ ì•„ì´ (í˜¹ì€ ì Šì€ ì—¬ì„±). 2ì£¼ ì „ì— ê°ê¸° ê¸°ìš´ ìˆì—ˆëŠ”ë° ë‹¤ ë‚˜ìŒ. ê·¼ë° ê°‘ìê¸° ë‹¤ë¦¬ì— ë¹¨ê°„ ì (Petechiae)ì´ ì«™ ì˜¬ë¼ì˜´.\n- **Pathophysiology:** ìê°€ë©´ì—­ ê³µê²©. IgG í•­ì²´ê°€ í˜ˆì†ŒíŒì˜ **GPIIb/IIIa** ìˆ˜ìš©ì²´ì— ë“¤ëŸ¬ë¶™ìŒ. ë¹„ì¥(Spleen)ì˜ Macrophageê°€ ì´ 'ì–‘ë… ëœ' í˜ˆì†ŒíŒì„ ì¡ì•„ë¨¹ìŒ.\n### ğŸ” Diagnosis (ì§„ë‹¨)\n- **ë°°ì œ ì§„ë‹¨ (Diagnosis of Exclusion).**\n- **Labs:** Isolated Thrombocytopenia (í˜ˆì†ŒíŒë§Œ ë‚®ìŒ). Hb, WBC, PT/PTTëŠ” ë‹¤ ì •ìƒì´ì–´ì•¼ í•¨.\n- **Smear:** í˜ˆì†ŒíŒ ìˆ˜ëŠ” ì ì§€ë§Œ, í¬ê¸°ê°€ ì—„ì²­ í¼ **Megathrombocytes** (ê³¨ìˆ˜ê°€ ì—´ì‹¬íˆ ì¼í•˜ê³  ìˆë‹¤ëŠ” ì¦ê±°).\n- ì„±ì¸ì—ì„œëŠ” HIV, Hep C ë°˜ë“œì‹œ ê²€ì‚¬í•´ì•¼ë¨!\n### ğŸ’Š Management (ì¹˜ë£Œ ì•Œê³ ë¦¬ì¦˜ - ì¤‘ìš”!)\n*ì¹˜ë£Œë¥¼ ì‹œì‘í•˜ëŠ” ê¸°ì¤€ì´ ì—„ê²©í•©ë‹ˆë‹¤.*\n**1. Children (ì†Œì•„):**\n- **ì„ìƒ:** ëŒ€ë¶€ë¶„ ì €ì ˆë¡œ ì¢‹ì•„ì§ (Self-limiting).\n- **â˜… Next Best Step:** í”¼ë¶€ ì¦ìƒë§Œ ìˆë‹¤ë©´ **Observation (ê²½ê³¼ ê´€ì°°)**.\n- **Treat if:** ì ë§‰ ì¶œí˜ˆ(Active mucosal bleeding)ì´ ìˆì„ ë•Œë§Œ.\n    - **Rx:** IVIG or Glucocorticoids.\n**2. Adults (ì„±ì¸):**\n- **Platelets > 30,000 & ì¶œí˜ˆ ì—†ìŒ:** Observe.\n- **Platelets < 30,000 OR ì¶œí˜ˆ ìˆìŒ:** TREAT.\n    - **First Line:** **Corticosteroids** (Prednisone) í˜¹ì€ **IVIG** (ìˆ˜ì¹˜ ë¹¨ë¦¬ ì˜¬ë ¤ì•¼ í•  ë•Œ).\n    - **Refractory (ì•ˆ ë“¤ìœ¼ë©´):** Rituximab í˜¹ì€ **Splenectomy** (íŒŒê´´ ì¥ì†Œì¸ ë¹„ì¥ ì œê±°).\n    - **Adjunct:** RhoGAM (Anti-D) *ë‹¨, í™˜ìê°€ Rh+ì´ê³  ë¹„ì¥ì´ ìˆì„ ë•Œë§Œ* (ë¹„ì¥ì´ í˜ˆì†ŒíŒ ëŒ€ì‹  ì í˜ˆêµ¬ë¥¼ ë¨¹ê²Œ ì†ì´ëŠ” ì›ë¦¬).\n# ğŸ•¸ï¸ H1: SECTION 3.1.3 - TTP (Thrombotic Thrombocytopenic Purpura)\n### â˜ ï¸ The Mechanism (ì§„ì§œ ë¬´ì„œìš´ ë³‘, High Yield)\n- **ê²°í•:** **ADAMTS13** (vWFë¥¼ ì ì ˆí•œ í¬ê¸°ë¡œ ì˜ë¼ì£¼ëŠ” ê°€ìœ„ íš¨ì†Œ).\n- **ê²°ê³¼:** ê°€ìœ„ê°€ ì—†ìœ¼ë‹ˆ vWFê°€ ì—„ì²­ ê¸¸ê²Œ ì´ì–´ì§(Multimers) -> í˜ˆê´€ ì•ˆì— ëˆì í•œ ê±°ë¯¸ì¤„(Microthrombi) ì¹¨ -> í˜ˆì†ŒíŒì´ ê±°ê¸° ê±¸ë ¤ì„œ ì†Œëª¨ë¨(ìˆ˜ì¹˜ â†“) -> ì í˜ˆêµ¬ê°€ ì§€ë‚˜ê°€ë‹¤ ì°¢ì–´ì§ (**Schistocytes**).\n- **ë¹„ìœ :** \"ê°•ì²  ì™€ì´ì–´ë¡œ ëœ ê±°ë¯¸ì¤„ ì‚¬ì´ë¥¼ í†µê³¼í•˜ëŠ” ê²ƒê³¼ ê°™ì•„ìš”.\"\n- PT, aPTT normal (cascadeí™œì„±í™”ì•ˆë¨) (vs DIC)\n- shictocytes\n- LDH â†‘ , haptoglobin â†“\n- coombs negative -\n### ğŸš© The \"FAT RN\" Pentad (5ëŒ€ ì¦ìƒ)\nì§„ë‹¨ì„ ìœ„í•´ ê¼­ ì™¸ì›Œì•¼ í•©ë‹ˆë‹¤ (ë‹¤ ìˆì„ í•„ìš”ëŠ” ì—†ì§€ë§Œ PentadëŠ” í´ë˜ì‹!).\n1. **F**ever\n2. **A**nemia (Microangiopathic Hemolytic Anemia - MAHA)\n3. **T**hrombocytopenia (í˜ˆì†ŒíŒ ë‹¤ ì¨ë²„ë¦¼)\n4. **R**enal Failure (Creatinine ìƒìŠ¹) (ì£¼ì¦ìƒì´ ì•„ë‹˜! Renal failureê°€ ì£¼ì¦ìƒì´ë©´ HUS)\n5. **N**euro Symptoms (í˜¼ë€, ë‘í†µ, ë‡Œì¡¸ì¤‘, ë°œì‘) â˜… **ê°€ì¥ ë‘ë“œëŸ¬ì§€ëŠ” íŠ¹ì§• (DOMINANT FEATURE)**","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-143","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"### âš ï¸ Management (ì‚¶ê³¼ ì£½ìŒì˜ ê²½ê³„)\n- **â˜… Next Best Step:** **Plasma Exchange (PLEX)**.\n    - *ì´ìœ ?* ADAMTS13 í•­ì²´ë¥¼ ì œê±°í•˜ê³ , ì •ìƒ íš¨ì†Œë¥¼ ë„£ì–´ì¤ë‹ˆë‹¤.\n- **HARD STOP / CONTRAINDICATION:** **NEVER GIVE PLATELETS! (í˜ˆì†ŒíŒ ìˆ˜í˜ˆ ì ˆëŒ€ ê¸ˆì§€)** ğŸš«\n    - *ì´ìœ ?* \"ë¶ˆë‚œ ì§‘ì— ê¸°ë¦„ ë¶“ê¸°\"ì…ë‹ˆë‹¤. í˜ˆì†ŒíŒ ë„£ì–´ì£¼ë©´ í˜ˆì „(Thrombi)ë§Œ ë” ë§Œë“¤ì–´ì„œ í™˜ì ìƒíƒœ ì•…í™”ë©ë‹ˆë‹¤.\n# ğŸ” H1: SECTION 3.1.4 - HUS (Hemolytic Uremic Syndrome)\n### ğŸšª Doorway Thought\n- **Vignette:** ì•„ì´ê°€ BBQ íŒŒí‹° ê°€ì„œ **ëœ ìµì€ í–„ë²„ê±°** ë¨¹ìŒ. í”¼ ì„ì¸ ì„¤ì‚¬(Bloody diarrhea) í•¨. ì¼ì£¼ì¼ ë’¤ -> í”¼ê³¤í•´í•˜ê³  ì†Œë³€ì´ ì•ˆ ë‚˜ì˜´(Oliguria).\n- **Bug:** E. Coli O157:H7 (Shiga-like toxin).\n### ğŸ” Pathophysiology\n- TTPë‘ ë¹„ìŠ·í•¨ (MAHA + Thrombocytopenia) í•˜ì§€ë§Œ...\n- **íƒ€ê¹ƒ:** ë…ì†Œ(Toxin)ê°€ ë‡Œë³´ë‹¤ëŠ” **ì‹ ì¥(Kidney)** ìˆ˜ìš©ì²´ë¥¼ ì¢‹ì•„í•¨.\n- **Dominant Feature:** **Renal Failure** (BUN/Creatinine íŒ íŠ).\n- **ëŒ€ì¡°:** TTP = Neuro ìœ„ì£¼ / HUS = Kidney ìœ„ì£¼.\n### ğŸ’Š Management\n- **ì£¼ìš” ì¹˜ë£Œ:** **Supportive Care** (ìˆ˜ì•¡, í•„ìš”í•˜ë©´ íˆ¬ì„ Dialysis).\n- **CONTRAINDICATION:** **NO ANTIBIOTICS** & **NO ANTI-MOTILITY** (ì§€ì‚¬ì œ ê¸ˆì§€).\n    - *ì´ìœ ?* ë°•í…Œë¦¬ì•„ë¥¼ ì£½ì´ë©´ ë…ì†Œê°€ í•œêº¼ë²ˆì— ìŸì•„ì ¸ ë‚˜ì™€ì„œ(Herxheimer-like reaction) ì‹ ì¥ì´ ì™„ì „íˆ ë§ê°€ì§‘ë‹ˆë‹¤. ê·¸ëƒ¥ ë˜¥ìœ¼ë¡œ ë°°ì¶œë˜ê²Œ ë†”ë‘¬ì•¼ í•´ìš”.","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-163","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"recap_summary","text":"# âš¡ Rapid Fire Recap (ìš”ì•½ í…Œì´ë¸”)\n| **ì§ˆí™˜ (Condition)** | **ê¸°ì „ (Mechanism)** | **í•µì‹¬ Vignette íŠ¹ì§•** | **ì¹˜ë£Œ / Pearl (Tx)** |\n| --- | --- | --- | --- |\n| **Pseudothrombocytopenia** | Lab ì˜¤ë¥˜ (Clumping) | ìˆ˜ì¹˜ëŠ” ë‚®ì€ë° í™˜ìëŠ” ë©€ì©¡ | **Blue Tube (Citrate)ë¡œ ì¬ê²€** |\n| **Vitamin K Def.** | Factor 2,7,9,10,C,S ë¶€ì¡± | ì‹ ìƒì•„ ì¶œí˜ˆ, ì¥ê¸° í•­ìƒì œ ì‚¬ìš© | **IM Vit K**, ê¸‰í•˜ë©´ FFP |\n| **ITP** | ìê°€ë©´ì—­ (Anti-GPIIb/IIIa) | Isolated Low Platelets, ê°ê¸° í›„ | **Steroids/IVIG** (<30k ì¼ ë•Œ). **HIV/Hep C ë°°ì œ**. |\n| **TTP** | ADAMTS13 ê²°í• | **FAT RN** (Neuro ì¦ìƒ), Schistocytes | **PLEX** ì¦‰ì‹œ ì‹œí–‰. **Platelets ê¸ˆì§€!** |\n| **HUS** | Shiga Toxin (E. Coli) | Bloody Diarrhea + **Renal Failure** | **Supportive**. **Antibiotics ì ˆëŒ€ ê¸ˆì§€!** |\n| **Mixing Study** | Lab ë…¼ë¦¬ | PTT ìƒìŠ¹ ì‹œ ì‹œí–‰ | **Corrects** = ê²°í•. **Fails** = ì–µì œì œ(Inhibitor). |\n| **Massive Transfusion** | í¬ì„ë¨ (Dilutional) | PRBC 10íŒ© ì´ìƒ ìˆ˜í˜ˆ ì‹œ | **FFP & Platelets** ê°™ì´ ì¤˜ë¼ (1:1:1 ë¹„ìœ¨) |\n- **Splenic Sequestration:** \"ì¦ìƒ ì—†ëŠ”\" í˜ˆì†ŒíŒ ê°ì†Œ í™˜ìì—ì„œ ê°„ê²½í™”(Cirrhosis)ë‚˜ ë¹„ì¥ë¹„ëŒ€(Splenomegaly) ê¼­ í™•ì¸í•˜ì„¸ìš”.\n- **TTP vs DIC:** TTPëŠ” Coags(PT/PTT)ê°€ **ì •ìƒ**ì…ë‹ˆë‹¤. DICëŠ” Coagsê°€ **ìƒìŠ¹**í•©ë‹ˆë‹¤. ì´ê²Œ ê°ë³„ í¬ì¸íŠ¸!\n- **Confidence:** ì˜¤ë””ì˜¤ ë‚´ìš©ì„ 100% ë°˜ì˜í•˜ì—¬ ì‘ì„±í–ˆìŠµë‹ˆë‹¤.\n**\"FAT RN\" 5ëŒ€ ì¦ìƒì„ ì´ìš©í•´ì„œ USMLE ìŠ¤íƒ€ì¼ì˜ ì—°ìŠµ ë¬¸ì œë¥¼ í•˜ë‚˜ ë§Œë“¤ì–´ ë“œë¦´ê¹Œìš”?**\n### ğŸ“‹ Overview: The Hemostasis Battlefield (TL;DR)\n| **Topic** | **Key Concept (Mental Model)** | **Critical \"Do Not Miss\"** |\n| --- | --- | --- |\n| **MAHA** | **Razor Wire** (Micro-clots shred RBCs) ğŸ©¸ğŸ”ª | Look for **Schistocytes** (Helmet cells) on smear. |\n| **TTP** | **Missing Scissors** (ADAMTS13 deficiency) âœ‚ï¸ğŸš« | **NEVER give platelets** (Fuel to fire). Rx: Plasma Exchange (PEX). |\n| **HUS** | **The Antibiotic Trap** (E. coli toxin bomb) ğŸ”ğŸ’£ | **NO Antibiotics** for bloody diarrhea in kids (causes renal failure). |\n| **ITP** | **Mistaken Identity** (Antibodies eat platelets) ğŸ·ï¸ğŸ½ï¸ | Diagnosis of exclusion. **Test for HIV/Hep C**. |\n| **Mixing Study** | **The Logic Puzzle** (Deficiency vs. Inhibitor) ğŸ§© | Corrects = Deficiency. No correction = Inhibitor. |\n| **DIC** | **The Consumer** (Everything used up) ğŸ“‰ | Acute = Bleeding (Sepsis). Chronic = Clotting (Cancer). |","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-174","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","recap","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"### ğŸŒ³ Top-down Classification: Hemostasis Disorders\nPlaintext\n#\n`HEMOSTASIS (Stopping the Bleed)\nâ”‚\nâ”œâ”€â”€ Primary Hemostasis (Platelet Plug) â†’ \"Mucosal Bleeding\" (Gums, Nose, Menses)\nâ”‚   â”œâ”€â”€ Destruction/Consumption (Low Count)\nâ”‚   â”‚   â”œâ”€â”€ Immune Mediated: ITP (Antibodies vs Platelets)\nâ”‚   â”‚   â””â”€â”€ Non-Immune (MAHA - The Razor Wire)\nâ”‚   â”‚       â”œâ”€â”€ TTP (ADAMTS13 deficiency â†’ CNS symptoms)\nâ”‚   â”‚       â”œâ”€â”€ HUS (E. coli toxin â†’ Renal failure)\nâ”‚   â”‚       â””â”€â”€ DIC (Acute/Sepsis â†’ Consumptive Coagulopathy)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Dysfunction (Normal Count, Bad Quality)\nâ”‚       â”œâ”€â”€ Von Willebrand Disease (Bad glue)\nâ”‚       â””â”€â”€ Uremia (Kidney failure makes platelets \"drunk\")\nâ”‚\nâ””â”€â”€ Secondary Hemostasis (Coagulation Cascade) â†’ \"Deep Bleeding\" (Joints, Muscles)\n    â”œâ”€â”€ Factor Deficiency (Mixing Study Corrects)\n    â”‚   â”œâ”€â”€ Hemophilia A (Factor 8)\n    â”‚   â”œâ”€â”€ Hemophilia B (Factor 9)\n    â”‚   â””â”€â”€ Vitamin K Deficiency (Factors 2, 7, 9, 10)\n    â”‚\n    â””â”€â”€ Factor Inhibitors (Mixing Study FAILS to Correct)\n        â”œâ”€â”€ Acquired Hemophilia (Antibodies vs Factor 8)\n        â””â”€â”€ Lupus Anticoagulant (Paradox: Lab Bleed, Body Clot)`\n### ğŸ–¼ï¸ Big Picture: The \"Goldilocks\" System ğŸ»ğŸ‘±â€â™€ï¸\n**Context & Pathophysiology:**\ní˜ˆì•¡(Blood)ì€ ì•¡ì²´(Liquid) ìƒíƒœë¡œ ì „ì‹  60,000ë§ˆì¼ì˜ í˜ˆê´€ì„ ìˆœí™˜í•˜ë©° ì‚°ì†Œë¥¼ ê³µê¸‰í•´ì•¼ í•©ë‹ˆë‹¤. í•˜ì§€ë§Œ í˜ˆê´€ì— êµ¬ë©(Cut, Bruise)ì´ ìƒê¸°ëŠ” ìˆœê°„, ê·¸ ì¦‰ì‹œ! í•´ë‹¹ ë¶€ìœ„ë§Œ! ê³ ì²´(Solid)ë¡œ ë³€í•´ì•¼ í•©ë‹ˆë‹¤.\n- **Too Much Clotting:** Stroke, PE (Pulmonary Embolism).\n- **Too Little Clotting:** ì¢…ì´ì—ë§Œ ë² ì—¬ë„ ê³¼ë‹¤ì¶œí˜ˆë¡œ ì‚¬ë§(Bleed to death).\n- **Margin for Error:** Effectively ZERO.\nì˜¤ëŠ˜ì˜ ì£¼ì œëŠ” ì´ ë°¸ëŸ°ìŠ¤ê°€ ë¬´ë„ˆì¡Œì„ ë•Œ ë°œìƒí•˜ëŠ” **\"Unintended Consequences (ì˜ë„ì¹˜ ì•Šì€ ê²°ê³¼ë“¤)\"**ì…ë‹ˆë‹¤.\n# H1: The Microangiopathic Hemolytic Anemias (MAHA) ğŸ”ªğŸ©¸\n### H2: The Concept of \"Razor Wire\"\ní˜ˆê´€(Highways)ì€ ì›ë˜ ë§¤ë„ëŸ½ê²Œ í¬ì¥ë˜ì–´ ìˆì–´ì•¼ í•©ë‹ˆë‹¤. í•˜ì§€ë§Œ MAHAì—ì„œëŠ” í˜ˆê´€ ë²½ì— ë¬¸ì œê°€ ìƒê²¨ ë¯¸ì„¸í•œ í˜ˆì „(Micro-clots)ë“¤ì´ í˜•ì„±ë©ë‹ˆë‹¤. ì´ í˜ˆì „ë“¤ì´ ë§ˆì¹˜ **\"Razor Wire (ì² ì¡°ë§)\"**ì²˜ëŸ¼ ì‘ìš©í•©ë‹ˆë‹¤.\n- **RBC Fate:** ì í˜ˆêµ¬ê°€ ì´ ì¢ì€ í‹ˆì„ ì§€ë‚˜ê°€ë ¤ë‹¤ ì°¢ê²¨ë²„ë¦¼(Shearing).\n- **Result:** **Schistocytes** (Helmet cells, Burrs, Fragments) visible on the slide.\n- **Core Logic:** í˜ˆì†ŒíŒ(Platelet)ë“¤ì´ ì´ ë¯¸ì„¸ í˜ˆì „ì„ ë§Œë“œëŠë¼ ë‹¤ ì†Œëª¨ë˜ì–´ **Thrombocytopenia**(í˜ˆì†ŒíŒ ê°ì†Œ)ê°€ ë°œìƒí•˜ê³ , ì í˜ˆêµ¬ëŠ” íŒŒê´´ë˜ì–´ **Anemia**(ë¹ˆí˜ˆ)ê°€ ë°œìƒí•©ë‹ˆë‹¤.\n### H2: TTP (Thrombotic Thrombocytopenic Purpura) - The Missing Scissors âœ‚ï¸\n**ğŸšª Vignette Anchor:** í™˜ìê°€ ì—´ì´ ë‚˜ê³ , í˜¼ë€ìŠ¤ëŸ¬ì›Œí•˜ë©°(Confusion/Neuro sx), ë©ì´ ë“¤ì–´ì„œ ì™”ëŠ”ë° ì½©íŒ¥ ìˆ˜ì¹˜ë„ ì•½ê°„ ì´ìƒí•˜ë‹¤. (Pentad: Fever, Anemia, Thrombocytopenia, Renal, **Neuro**)","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-184","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"**1. Mechanism: The Sticky Tape Problem**\n- **vWF (von Willebrand Factor):** í˜ˆê´€ ë²½ì´ ë‹¤ì³¤ì„ ë•Œ í˜ˆì†ŒíŒì„ ë¶™ì—¬ì£¼ëŠ” \"Sticky Tape\"ì…ë‹ˆë‹¤. ì›ë˜ ëª¸ì—ì„œ ìƒì„±ë  ë•ŒëŠ” ì—„ì²­ë‚˜ê²Œ ê¸´(Ultra-long) í˜•íƒœë¡œ ë‚˜ì˜µë‹ˆë‹¤.\n- **ADAMTS13 (The Scissors):** ì´ íš¨ì†ŒëŠ” ë„ˆë¬´ ê¸´ vWF í…Œì´í”„ë¥¼ ì ì ˆí•œ í¬ê¸°ë¡œ ì˜ë¼ì£¼ëŠ” ê°€ìœ„ ì—­í• ì„ í•©ë‹ˆë‹¤.\n- **Pathology:** TTPì—ì„œëŠ” **ADAMTS13 (ê°€ìœ„)**ê°€ ì—†ìŠµë‹ˆë‹¤ (Auto-antibody ë“±ì— ì˜í•´).\n- **Result:** ìë¥´ì§€ ì•Šì€ ì—„ì²­ë‚˜ê²Œ ê¸´ ëˆì í•œ í…Œì´í”„(Long vWF strands)ê°€ í˜ˆê´€ì„ ë– ë‹¤ë‹ˆë‹¤ê°€ \"ê·¸ë¬¼(Net)\"ì²˜ëŸ¼ ì‘ìš©í•˜ì—¬ ì§€ë‚˜ê°€ëŠ” í˜ˆì†ŒíŒë“¤ì„ ë‹¤ ì¡ì•„ë²„ë¦½ë‹ˆë‹¤. â†’ ì „ì‹ ì ì¸ Micro-clots í˜•ì„±.\n**ğŸš¨ Critical Clinical Dilemma**\n- **The Trap:** í˜ˆì†ŒíŒ ìˆ˜ì¹˜ê°€ ë‚®ë‹¤ê³  í•´ì„œ ìˆ˜í˜ˆí•˜ë©´?\n- **Effect:** **Adding Fuel to the Fire.** ğŸ”¥ ë¶ˆ ë‚œ ì§‘ì— ê¸°ë¦„ ë¶“ê¸°ì…ë‹ˆë‹¤. ë„£ì–´ì¤€ í˜ˆì†ŒíŒë“¤ì´ ê·¸ë¬¼ì— ë” ê±¸ë ¤ì„œ í˜ˆì „ì„ ë” ë§ì´ ë§Œë“­ë‹ˆë‹¤. Stroke/Heart Attack ìœ ë°œ ê°€ëŠ¥.\n**â˜… Gold Standard Treatment:**\n- **Plasma Exchange (PEX):** í™˜ìì˜ ë‚˜ìœ í˜ˆì¥(í•­ì²´ê°€ ìˆëŠ”)ì„ ë¹¼ë‚´ê³ , **Donor Plasma (Fresh Scissors âœ‚ï¸ê°€ ë“¤ì–´ìˆëŠ”)**ë¥¼ ë„£ì–´ì£¼ëŠ” ê²ƒ.\n- **â˜… Contraindication:** **Do NOT give Platelets!**\n### H2: HUS (Hemolytic Uremic Syndrome) - The Antibiotic Trap ğŸ”ğŸ’Š\n**ğŸšª Vignette Anchor:** ì•„ì´ê°€ ëœ ìµì€ í–„ë²„ê±°(Undercooked burger)ë¥¼ ë¨¹ê³  ë©°ì¹  ë’¤ **Bloody Diarrhea**ë¥¼ í•˜ë”ë‹ˆ ì†Œë³€ì´ ì•ˆ ë‚˜ì˜¨ë‹¤(Renal Failure).\n**1. Mechanism: The Dirty Bomb**\n- **Trigger:** **E. coli O157:H7**. ì´ ë°•í…Œë¦¬ì•„ëŠ” ê·¸ì € ê· ì´ ì•„ë‹ˆë¼ **\"Shiga-like toxin\"**ì´ë¼ëŠ” ë…ì†Œë¥¼ ê°€ë“ í’ˆê³  ìˆëŠ” ì»¨í…Œì´ë„ˆ(Container)ì…ë‹ˆë‹¤.\n- **Target:** ì´ ë…ì†ŒëŠ” íŠ¹íˆ **Kidney (ì‹ ì¥)** í˜ˆê´€ì„ ê³µê²©í•˜ì—¬ ì°¢ì–´ë²„ë¦½ë‹ˆë‹¤(Shreds lining). â†’ Micro-clots â†’ Kidney Failure.\n**ğŸš¨ The Antibiotic Trap (USMLE High Yield)**\n- **Instinct:** \"ì„¸ê·  ê°ì—¼ì´ë‹ˆê¹Œ í•­ìƒì œë¥¼ ì¨ì„œ ê· ì„ ì£½ì´ì!\" (Infection = Antibiotics logic).\n- **Reality:** í•­ìƒì œê°€ ê· ì„ ê³µê²©í•˜ë©´, ê· ì´ ì£½ìœ¼ë©´ì„œ í„°ì§ˆ ë•Œ ê°€ì§€ê³  ìˆë˜ **Toxin Bomb**ë¥¼ í•œêº¼ë²ˆì— ë°©ì¶œí•©ë‹ˆë‹¤.\n- **Result:** ì—„ì²­ë‚œ ì–‘ì˜ ë…ì†Œê°€ ì‹ ì¥ì„ ê°•íƒ€í•˜ì—¬ HUSë¥¼ ìœ ë°œí•˜ê±°ë‚˜ ì•…í™”ì‹œí‚µë‹ˆë‹¤.\n**â˜… Next Best Step:**\n- **Supportive Care:** Hydration (ìˆ˜ì•¡ ê³µê¸‰), Dialysis if needed.\n- **â˜… Contraindication:** **NO Antibiotics**, **NO Anti-motility agents** (Imodium ë“±, ë…ì†Œ ë°°ì¶œì„ ë§‰ìŒ).\n# H1: ITP (Immune Thrombocytopenia) - The Innocent Bystander ğŸ·ï¸ğŸ˜¢\n### H2: Mechanism & Diagnosis\n**ğŸšª Vignette Anchor:** ê±´ê°•í•´ ë³´ì´ëŠ” ì—¬ì„±ì´ ì–‘ì¹˜í•  ë•Œ í”¼ê°€ ë‚˜ê±°ë‚˜ ë‹¤ë¦¬ì— ì‘ì€ ë¶‰ì€ ë°˜ì (Petechiae)ì´ ìƒê²¨ì„œ ì™”ë‹¤. ë‹¤ë¥¸ ìˆ˜ì¹˜ëŠ” ë‹¤ ì •ìƒì¸ë° í˜ˆì†ŒíŒë§Œ ë‚®ë‹¤.\n**1. Mechanism: Mistaken Identity**","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-204","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"- ë©´ì—­ ì²´ê³„ê°€ í˜ˆì†ŒíŒì„ ì™¸ë¶€ ì¹¨ì…ìë¡œ ì˜¤ì¸í•˜ì—¬ **\"Eat Me\"** íƒœê·¸(Antibody)ë¥¼ ë¶™ì…ë‹ˆë‹¤.\n- **Spleen (ë¹„ì¥):** íƒœê·¸ëœ í˜ˆì†ŒíŒì„ ë³´ê³  \"í•„í„°\" ì—­í• ë¡œì„œ ì¡ì•„ë¨¹ìŠµë‹ˆë‹¤. (Splenic Macrophage consumption).\n**2. Diagnosis of Exclusion**\n- ITPëŠ” ë‹¤ë¥¸ ì›ì¸ì´ ì—†ì„ ë•Œ ë¶™ì´ëŠ” ì§„ë‹¨ëª…ì…ë‹ˆë‹¤.\n- **â˜… Sentinel Event (Must Do):** ë°˜ë“œì‹œ **HIV**ì™€ **Hepatitis C** ê²€ì‚¬ë¥¼ í•´ì•¼ í•©ë‹ˆë‹¤. ì´ ë°”ì´ëŸ¬ìŠ¤ë“¤ì´ ì´ˆê¸° ì¦ìƒìœ¼ë¡œ ITPì²˜ëŸ¼ ë‚˜íƒ€ë‚  ìˆ˜ ìˆìŠµë‹ˆë‹¤. (5-10% of patients).\n**3. Treatment Strategy: \"Less is More\"**\n- í˜ˆì†ŒíŒ ìˆ˜ì¹˜ê°€ **>30,000**ì´ê³  ì¶œí˜ˆì´ ì—†ë‹¤ë©´? â†’ **Observe** (ì•„ë¬´ê²ƒë„ í•˜ì§€ ì•ŠìŒ).\n- **Treatment:**\n    - **Steroids:** ë©´ì—­ ë°˜ì‘ ì–µì œ.\n    - **IVIG (Intravenous Immunoglobulin):** ë¹„ì¥(Spleen)ì—ê²Œ ë˜ì ¸ì£¼ëŠ” \"ë¯¸ë¼(Distraction)\"ì…ë‹ˆë‹¤. ë¹„ì¥ì´ IVIGë¥¼ ë¨¹ëŠë¼ ë°”ë¹ ì„œ í˜ˆì†ŒíŒì„ ì•ˆ ê±´ë“œë¦¬ê²Œ í•¨.\n# H1: The Coagulation Cascade & The Mixing Study Logic ğŸ§©\n### H2: Hemophilia vs. Inhibitors\n**ğŸšª Vignette Anchor:** ì–´ë¦° ì•„ì´ê°€ ê±·ê¸° ì‹œì‘í•˜ë©´ì„œ ìê¾¸ ë„˜ì–´ì ¸ ë¬´ë¦ì´ ì—„ì²­ë‚˜ê²Œ ë¶“ëŠ”ë‹¤(Hemarthrosis). PTTê°€ ì—°ì¥ë˜ì–´ ìˆë‹¤.\n**1. Clinical Picture: Joint vs. Mucosal**\n- **Platelet issue:** Skin, Mucosa bleeding (Petechiae).\n- **Factor issue (Hemophilia):** **Deep bleeding** (Joints, Muscles). í”¼ê°€ ê´€ì ˆ ë‚´ì˜ ì—°ê³¨ê³¼ ë¼ˆë¥¼ íŒŒê´´í•©ë‹ˆë‹¤(Iron destroys cartilage).\n**2. The Mixing Study (The Detective Test)**\nPTTê°€ ì—°ì¥ë˜ì—ˆì„ ë•Œ, ì´ê²Œ **\"ì¬ë£Œ ë¶€ì¡±(Deficiency)\"**ì¸ì§€ **\"ë°©í•´ê¾¼(Inhibitor)\"**ì¸ì§€ êµ¬ë³„í•˜ëŠ” ë°©ë²•ì…ë‹ˆë‹¤.\n- **Method:** í™˜ìì˜ í˜ˆì¥(Patient Plasma) + ì •ìƒ í˜ˆì¥(Normal Plasma)ì„ **50:50**ìœ¼ë¡œ ì„ìŒ.\n    - ì •ìƒ í˜ˆì¥ì—ëŠ” ëª¨ë“  ì¸ìê°€ 100% ë“¤ì–´ìˆìœ¼ë¯€ë¡œ, ì„ìœ¼ë©´ ìµœì†Œ 50%ì˜ ì¸ìê°€ í™•ë³´ë¨ (clotting í•˜ê¸°ì— ì¶©ë¶„í•¨).\n| **Scenario** | **Mixing Result** | **Interpretation** | **Diagnosis Example** |\n| --- | --- | --- | --- |\n| **A** | **Corrects (Normalizes)** | ë¶€ì¡±í•œ ì¬ë£Œê°€ ì±„ì›Œì ¸ì„œ í•´ê²°ë¨ | **Hemophilia A/B** (Factor Deficiency) |\n| **B** | **Does NOT Correct** | ì •ìƒ í˜ˆì¥ì„ ë„£ì–´ë„ ì—¬ì „íˆ ì‘ê³  ì•ˆ ë¨ | **Inhibitor** present (e.g., Lupus Anticoagulant) |\n### H3: Lupus Anticoagulant - The Great Misnomer ğŸ­\n- **Name:** \"Anticoagulant\"ë¼ê³  ë¶€ë¥´ì§€ë§Œ ì‹¤ì œë¡œëŠ” ëª¸ ì•ˆì—ì„œ **Clotting (Hypercoagulable)**ì„ ìœ ë°œí•©ë‹ˆë‹¤. (Anti-phospholipid Syndrome).\n- **Laboratory Artifact:** í…ŒìŠ¤íŠ¸ íŠœë¸Œ(In vitro) ì•ˆì—ì„œëŠ” ì‹œì•½(Chemicals)ê³¼ ê²°í•©í•˜ì—¬ ë§ˆì¹˜ Inhibitorì²˜ëŸ¼ ì‘ìš©í•´ PTTë¥¼ ì—°ì¥ì‹œí‚µë‹ˆë‹¤.\n- **Confirmation:** **Russel Viper Venom Time** or adding excess phospholipids (Overwhelms the artifact).\n- **Result:** **Body = Clots (DVT/PE/Miscarriage)**, Lab = Bleeds (High PTT).\n# H1: DIC (Disseminated Intravascular Coagulation) ğŸ“‰","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-224","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### H2: The Consumer\n**Concept:** ì‘ê³  ì¸ìì™€ í˜ˆì†ŒíŒì„ ë¯¸ì¹œ ë“¯ì´ ì¨ë²„ë ¤ì„œ(Consumption) ë‚¨ëŠ” ê²Œ ì—†ëŠ” ìƒíƒœ.\n| **Type** | **Trigger** | **Presentation** | **Mechanism** |\n| --- | --- | --- | --- |\n| **Acute DIC** | Sepsis, Trauma, Obstetric complications | **Bleeding** from everywhere (IV sites, gums) | \"Flash Fire\" - Factors used up instantly. |\n| **Chronic DIC** | **Malignancy** (Cancer) | **Thrombosis** (DVT/PE) | Body compensates enough to stop bleeding but keeps clotting. |\n# H1: Vitamin K & The Gut Flora Factory ğŸ¥¦ğŸ­\n- **Dependent Factors:** **2, 7, 9, 10**, Protein C, S.\n- **Source:** ë…¹ìƒ‰ ì±„ì†Œ(Leafy Greens) + **Gut Bacteria (ì¥ë‚´ ì„¸ê· )**.\n- **Antibiotic Connection:** ê´‘ë²”ìœ„ í•­ìƒì œ(Broad-spectrum Abx)ë¥¼ ì“°ë©´ ì¥ë‚´ ì„¸ê· (Factory workers)ì´ ì£½ìŠµë‹ˆë‹¤. â†’ Vitamin K ìƒì‚° ì¤‘ë‹¨ â†’ 7~10ì¼ ë’¤ ì¶œí˜ˆ ê²½í–¥(INR ìƒìŠ¹) ë°œìƒ.\n# H1: Reversal Agents (The \"Undo\" Buttons) â†©ï¸ğŸ’Š\n| **Drug** | **Reversal Agent (Antidote)** | **Notes** |\n| --- | --- | --- |\n| **Warfarin** | **PCC (Prothrombin Complex Concentrate)** | Fastest! (Instant restock). Vit K is too slow. |\n| **Heparin** | **Protamine Sulfate** | Binds and neutralizes. |\n| **DOACs** | Andexanet alfa / Idarucizumab | Specific reversal agents exist now. |\n| **Platelet Anti-agents** | Platelet Transfusion | Usually just wait, but severe cases need platelets. |","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-244","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","pathophysiology"]}
{"chunk_type":"recap_summary","text":"### âš¡ Rapid Fire Recap (High Yield)\n- **Schistocytes on smear** â†’ Think **MAHA** (TTP, HUS, DIC). ğŸ”ª\n- **TTP Pentad** â†’ Fever, Neuro sx, Renal, Anemia, Low Platelets. **Tx: Plasma Exchange**. (NO PLATELETS!). ğŸ©¸ğŸš«\n- **Kid + Bloody Diarrhea** â†’ **HUS**. **NO ANTIBIOTICS**. ğŸ”ğŸ’£\n- **Isolated Thrombocytopenia** â†’ **ITP**. Check **HIV/HCV**. ğŸ¦ \n- **Mixing Study Corrects** â†’ Factor Deficiency (Hemophilia). âœ…\n- **Mixing Study No Correction** â†’ Inhibitor (Lupus Anticoagulant). âŒ\n- **Deep Bleeding (Joints)** â†’ Factor problem. **Mucosal Bleeding** â†’ Platelet problem.\n- ì˜¤ë””ì˜¤ì—ì„œëŠ” Mixing studyì—ì„œ Inhibitorê°€ ìˆì„ ë•Œ \"clotting time does not correct\"ë¼ê³  ëª…í™•íˆ ì„¤ëª…í–ˆìŠµë‹ˆë‹¤. ì´ëŠ” ì‹¤ì œ ì„ìƒì—ì„œ Lupus Anticoagulant ë“±ì„ ì˜ì‹¬í•˜ëŠ” ê°•ë ¥í•œ ë‹¨ì„œì…ë‹ˆë‹¤.\n- \"Antibiotic Trap\" in HUS is a critical USMLE concept often tested. Do not confuse with treating standard sepsis.\n- Warfarin reversalì—ì„œ Vitamin KëŠ” íš¨ê³¼ê°€ ë‚˜íƒ€ë‚˜ê¸°ê¹Œì§€ ì‹œê°„ì´ ê±¸ë¦¬ë¯€ë¡œ(hours to days), ê¸‰í•œ ì¶œí˜ˆ(Acute Bleed)ì—ëŠ” ë°˜ë“œì‹œ **PCC (Factor replacement)**ë¥¼ ì¨ì•¼ í•œë‹¤ëŠ” ì ì„ ê°•ì¡°í–ˆìŠµë‹ˆë‹¤.\n# 5.0-5.4 ğŸ“ Senior Medical Scribe & USMLE Expert Note: Hodgkin Lymphoma Survivorship & Complications\n## ğŸ“‹ TL;DR Overview (Executive Summary)\n- **Core Topic:** Hodgkin Lymphoma (HL) ìƒì¡´ìì˜ ì¥ê¸° í•©ë³‘ì¦ (Late Complications) ë° 2ì°¨ ì•” (Secondary Malignancy).\n- **Key Concept:** ì¹˜ë£Œ í›„ 15ë…„ì´ ì§€ë‚˜ë©´, ì›ë˜ì˜ ë¦¼í”„ì¢… ì¬ë°œ(Relapse)ë³´ë‹¤ **ì¹˜ë£Œ ë¶€ì‘ìš©ìœ¼ë¡œ ì¸í•œ 2ì°¨ ì•”(Secondary Malignancy)**ìœ¼ë¡œ ì‚¬ë§í•  í™•ë¥ ì´ ë” ë†’ìŒ.\n- **High Yield Traps:**\n    1. **Timeframe:** 5ë…„ ì´ë‚´ = Relapse / 15ë…„ ì´í›„ = Secondary Cancer.\n    2. **Cardio:** Radiation (Restrictive/CAD) vs. Doxorubicin (Dilated).\n    3. **Emergency:** Tumor Lysis Syndrome & G6PD deficiency contraindication for Rasburicase.","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-254","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","recap","treatment"]}
{"chunk_type":"transcript_chunk","text":"\"We are going to start right at the doorway today. I want you to picture a specific patient because this... uh... this clinical vignette is going to frame everything we discuss about oncology complications for Step 2. Itâ€™s the classic survivor scenario isnâ€™t it? It is. So youâ€™re in the clinic, a 42-year-old man walks in... You know, looks pretty good, but heâ€™s complaining of a new dry cough, some, you know, shortness of breath when he exercises, and this vague chest pain.\"\n## ğŸŒ³ Top-Down Classification Tree (Big Picture)\nUSMLE ê´€ì ì—ì„œ Oncology ComplicationsëŠ” í¬ê²Œ **Time Course**ì™€ **Etiology**ë¡œ ë‚˜ë‰©ë‹ˆë‹¤.\nPlaintext\n`Complications of Cancer Therapy\nâ”œâ”€â”€ 1. Acute Emergencies (ì¹˜ë£Œ ì§í›„)\nâ”‚   â”œâ”€â”€ Tumor Lysis Syndrome (TLS)\nâ”‚   â”‚   â”œâ”€â”€ Hyperkalemia\nâ”‚   â”‚   â”œâ”€â”€ Hyperphosphatemia\nâ”‚   â”‚   â””â”€â”€ Hyperuricemia (-> Renal Failure)\nâ”‚   â””â”€â”€ Neutropenic Fever\nâ”‚\nâ””â”€â”€ 2. Late Effects / Survivorship (ì¹˜ë£Œ ìˆ˜ë…„~ìˆ˜ì‹­ë…„ í›„)\n    â”œâ”€â”€ Secondary Malignancies (ê°€ì¥ ì¤‘ìš” â˜…)\n    â”‚   â”œâ”€â”€ Solid Tumors (Radiation induced: Lung, Breast, Thyroid)\n    â”‚   â””â”€â”€ Hematologic (Chemo induced: AML, MDS)\n    â”‚\n    â”œâ”€â”€ Cardiovascular Disease\n    â”‚   â”œâ”€â”€ Chemotherapy (Doxorubicin -> DCM)\n    â”‚   â””â”€â”€ Radiation (Fibrosis -> RCM, CAD, Valve)\n    â”‚\n    â””â”€â”€ Endocrine/Pulmonary\n        â”œâ”€â”€ Hypothyroidism\n        â””â”€â”€ Pulmonary Fibrosis (Bleomycin, Radiation)`\n## Step 3: \"Zero-Loss\" Lecture Notes ğŸš€\n### 1. The Clinical Vignette: The \"Doorway\" Thought ğŸšª\n- **Patient:** 42ì„¸ ë‚¨ì„±.\n- **History:** 20ëŒ€ ì´ˆë°˜ì— Hodgkin Lymphoma (HL) ì§„ë‹¨. Chemo (ABVD) + Mantle Field Radiation ë°›ìŒ. 20ë…„ê°„ ê´€í•´(Remission) ìƒíƒœ.\n- **Presenting Complaint:** New dry cough, Dyspnea on exertion (SOB), Vague chest pain.\n- **The Clinical Trap:**\n    - ì¦ìƒë§Œ ë³´ë©´ Respiratory Infection (Bronchitis) í˜¹ì€ Lymphoma Relapseë¥¼ ì˜ì‹¬í•˜ê¸° ì‰¬ì›€.\n    - **BUT:** Historyê°€ ëª¨ë“  ê²ƒì„ ê²°ì •í•¨ (Context is King).\n    - ë§Œì•½ ì¹˜ë£Œ í›„ **2ë…„** ì§€ë‚¬ë‹¤ë©´? â†’ **Relapse**ê°€ 1ìˆœìœ„.\n    - ë§Œì•½ ì¹˜ë£Œ í›„ **20ë…„** ì§€ë‚¬ë‹¤ë©´? â†’ **Secondary Malignancy** (Solid tumor)ê°€ 1ìˆœìœ„.\n### 2. The Survivorship Paradox (Survivorship & Risk) ğŸ“ˆ\nHodgkin'sëŠ” í˜„ëŒ€ ì˜í•™ì˜ ìŠ¹ë¦¬(Cure rate > 75~90%)ì´ì§€ë§Œ, ê·¸ ëŒ€ê°€ê°€ ë”°ë¦…ë‹ˆë‹¤.\n- **ì¶©ê²©ì ì¸ í†µê³„ (The Scary Stat):** ì¼ë°˜ì¸ ëŒ€ë¹„ 2ì°¨ ì•” ë°œìƒ ìœ„í—˜ì´ **18.5ë°°(18.5-fold)** ì¦ê°€í•¨.\n- **The \"Cross-Over\" Point:**\n    - ì¹˜ë£Œ í›„ 15ë…„ ì‹œì (15-year mark)ì„ ê¸°ì ìœ¼ë¡œ, ì‚¬ë§ ì›ì¸ 1ìœ„ê°€ HL ì¬ë°œì´ ì•„ë‹ˆë¼ **Secondary Malignancy**ë¡œ ì—­ì „ë¨.\n### 3. Radiation vs. Chemotherapy Risks (The Rules) â˜¢ï¸ vs ğŸ’Š\nì–´ë–¤ ì¹˜ë£Œë¥¼ ë°›ì•˜ëŠëƒì— ë”°ë¼ ë°œìƒí•˜ëŠ” ì•”ì˜ ì¢…ë¥˜ì™€ ì‹œê¸°ê°€ ë‹¤ë¦…ë‹ˆë‹¤.\n| **Feature** | **Radiation Therapy (Local Beam)** | **Chemotherapy (Systemic, Alkylating)** |\n| --- | --- | --- |\n| **Mechanism** | DNA Damage in specific field | Systemic DNA damage |\n| **Type of Cancer** | **Solid Tumors** (ê³ í˜•ì•”) | **Hematologic Malignancies** (í˜ˆì•¡ì•”) |\n| **Target Organs** | **Lung** (esp. smokers), **Breast**, Thyroid, Bone, Skin | Bone Marrow (AML, MDS) |\n| **Latency (ì ë³µê¸°)** | **Long** (10~30ë…„ ì´ìƒ, ìœ„í—˜ë„ ê³„ì† ìƒìŠ¹) | **Short** (5~10ë…„ í›„ Peak, ì´í›„ ê°ì†Œ) |\n| **Special Note** | ì Šì€ ì—¬ì„±ì˜ Chest Radiation = BRCA mutationê¸‰ ìœ ë°©ì•” ë¦¬ìŠ¤í¬ | Acute Myeloid Leukemia (AML) ìœ„í—˜ ê¸‰ì¦ |\n### 4. Cardiovascular Toxicity: The Silent Killer ğŸ’”","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-264","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"í™˜ìì˜ \"Cough & SOB\"ëŠ” íì•”ì¼ ìˆ˜ë„ ìˆì§€ë§Œ, ì‹¬ì¥ ë¬¸ì œì¼ ìˆ˜ë„ ìˆìŠµë‹ˆë‹¤.\n- **Radiation Induced Heart Disease:**\n    - *Fibrosis(ì„¬ìœ í™”)**ê°€ í•µì‹¬ ê¸°ì „.\n    - Coronary Artery Disease (CAD): í˜ˆê´€ì´ ë”±ë”±í•´ì§ -> Premature MI.\n    - Valvular Disease: íŒë§‰ì´ êµ³ìŒ (Stenosis/Regurgitation).\n    - **Restrictive Cardiomyopathy (RCM):** ì‹¬ê·¼ê³¼ ì‹¬ë‚­(Pericardium)ì´ êµ³ì–´ì„œ ì´ì™„ì´ ì•ˆ ë¨ (Pericardial constriction).\n- **Chemotherapy (Anthracyclines - Doxorubicin):**\n    - AKA \"The Red Devil\".\n    - **Dilated Cardiomyopathy (DCM):** ì‹¬ì¥ì´ í—ê±°ì›Œì§€ê³  ëŠ˜ì–´ë‚¨. Dose-dependent (í‰ìƒ ëˆ„ì  ìš©ëŸ‰ ì¤‘ìš”).\n- **Actionable Step:**\n    - â˜… **Next Best Step:** **Echocardiogram** (Lung workupê³¼ ë™ì‹œì— ì‹¬ì¥ ê¸°ëŠ¥ í‰ê°€ í•„ìˆ˜).\n### 5. High-Yield Diagnostic Traps (ì‹œí—˜ì— ë‚˜ì˜¤ëŠ” í•¨ì •ë“¤) ğŸª¤\n### A. The Alcohol Sign (Lymphoma Specific) ğŸº\n- í™˜ìê°€ \"ìˆ ì„ í•œ ëª¨ê¸ˆ ë§ˆì…¨ë”ë‹ˆ ë¦¼í”„ì ˆ ë¶€ìœ„ê°€ ì°¢ì–´ì§€ê²Œ ì•„í”„ë‹¤\"ê³  í•¨.\n- ì´ê²ƒì€ Hodgkin Lymphomaì˜ **Pathognomonic Sign** (íŠ¹ì´ì  ì§•í›„).\n- ê¸°ì „ì€ ë¶ˆëª…í™•í•˜ì§€ë§Œ, ë¦¼í”„ì ˆ ë‚´ í˜ˆê´€ í™•ì¥ê³¼ ìº¡ìŠ íŒ½ì°½(Capsule stretch)ìœ¼ë¡œ ì¶”ì •.\n### B. The Bone Scan Trap (Multiple Myeloma Contrast) â˜ ï¸\nì´ê²ƒì€ Hodgkin ì´ì•¼ê¸°ëŠ” ì•„ë‹ˆì§€ë§Œ, ì¢…ì–‘í•™ Imagingì˜ í•µì‹¬ í•¨ì •ìœ¼ë¡œ ì–¸ê¸‰ë¨.\n- **Scenario:** ë…¸ì¸, í—ˆë¦¬ í†µì¦(Back pain), Anemia, Hypercalcemia. -> Multiple Myeloma(MM) ì˜ì‹¬.\n- **Trap:** \"Bone Scan\" (Technetium-99m)ì„ ì˜¤ë”í•˜ë©´ ì•ˆ ë¨.\n- **Reasoning:**\n    - Bone Scanì€ Osteoblast(ì¡°ê³¨ì„¸í¬/ë¼ˆ ìƒì„±) activityë¥¼ ë´„.\n    - Multiple MyelomaëŠ” ìˆœìˆ˜í•˜ê²Œ **Osteolytic** (íŒŒê³¨/ë¼ˆ íŒŒê´´) processì„. (Construction crew is on strike, Demolition crew is active).\n    - ë”°ë¼ì„œ MM í™˜ìëŠ” **Bone Scanì—ì„œ ì •ìƒ(Cold)**ìœ¼ë¡œ ë‚˜ì˜´ (False Negative).\n- â˜… **Gold Standard for MM Bone Survey:**\n    - **Skeletal Survey (X-ray series)** (Punched-out lytic lesions í™•ì¸).\n    - ìµœê·¼ íŠ¸ë Œë“œëŠ” **Low-dose Whole Body CT**ê°€ ë” ë¯¼ê°í•¨.\n### 6. Acute Emergency: Tumor Lysis Syndrome (TLS) ğŸ’¥\nì¹˜ë£Œ ì‹œì‘ ì§í›„ ë°œìƒí•˜ëŠ” ì‘ê¸‰ ìƒí™© (Act 2ì˜ ìœ„ê¸°).\n- **Pathophysiology:**\n    - Chemoê°€ íš¨ê³¼ê°€ ì¢‹ì•„ì„œ ì•”ì„¸í¬ê°€ ëŒ€ëŸ‰ìœ¼ë¡œ í„°ì§.\n    - ì„¸í¬ ë‚´ìš©ë¬¼ ë°©ì¶œ: Potassium (K+), Phosphate (PO4), Uric Acid (DNA breakdown).\n- **Consequence:**\n    - High K+ -> Arrhythmia.\n    - High Uric Acid -> Urate Crystals -> **Acute Renal Failure** (Renal tubules ë§‰í˜).\n- **Pharmacology Twist (Step 2 Killer Q):**\n    - **Prevention:** Allopurinol (Xanthine Oxidase Inhibitor) - ìƒˆë¡œìš´ Uric acid ìƒì„± ì–µì œ.\n    - **Treatment (Active):** **Rasburicase** (Urate Oxidase analog).\n        - ì´ë¯¸ ë§Œë“¤ì–´ì§„ Uric acidë¥¼ ë¬¼ì— ì˜ ë…¹ëŠ” Allantoinìœ¼ë¡œ ë¶„í•´í•´ë²„ë¦¼ (Pac-Manì²˜ëŸ¼ ë¨¹ì–´ì¹˜ì›€).\n    - **â›” CONTRAINDICATION (Rasburicase):**\n        - **G6PD Deficiency í™˜ì.**\n        - RasburicaseëŠ” Uric acidë¥¼ ë¶„í•´í•  ë•Œ **Hydrogen Peroxide (H2O2)**ë¥¼ ë¶€ì‚°ë¬¼ë¡œ ë§Œë“¦.\n        - G6PD ê²°í• í™˜ìì˜ ì í˜ˆêµ¬ëŠ” Oxidative stress(H2O2)ë¥¼ ëª» ê²¬ë”¤ -> **Massive Hemolysis** (Dark urine, Jaundice, Bite cells) ë°œìƒ.\n        - G6PD ê²°í•ì´ ì˜ì‹¬ë˜ëŠ” í™˜ìêµ°(African, Mediterranean, Asian descent)ì—ê²ŒëŠ” ì¹˜ëª…ì ì¼ ìˆ˜ ìˆìŒ.","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-284","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_summary","text":"## âš¡ Rapid Fire Recap (High Yield Associations)\n| **Clinical Scenario** | **Suspected Diagnosis / Mechanism** | **Next Step / Key Fact** |\n| --- | --- | --- |\n| **Hodgkin survivor, 20 yrs later, Cough/SOB** | **Secondary Lung Cancer** (esp. if smoker) | CT Chest (Low dose screening) |\n| **Young female, Chest Radiation history** | **Secondary Breast Cancer** | MRI Breast Screening starts 8-10 yrs post-tx |\n| **Doxorubicin history + SOB** | **Dilated Cardiomyopathy** | Echocardiogram |\n| **Radiation history + R-sided Heart Failure** | **Restrictive Cardiomyopathy / Pericarditis** | Echocardiogram (Stiff heart) |\n| **Pain in lymph node after Alcohol** | **Hodgkin Lymphoma** (Recurrence/Dx) | Pathognomonic Sign |\n| **Multiple Myeloma suspected + Bone Pain** | Lytic Lesions | **Skeletal Survey (X-ray)** or CT. NO Bone Scan! |\n| **Tumor Lysis + Dark Urine after Rasburicase** | **G6PD Deficiency Hemolysis** | Stop drug, Support. |\n## ğŸ“ Next Step for You\n# 4.0-4.5 ğŸ“‹ Overview: Hematology Crisis Management (TL;DR)\n**Clinical Context:** ì˜¤ëŠ˜ ìš°ë¦¬ëŠ” ë‹¨ìˆœíˆ êµê³¼ì„œì ì¸ Pathwayê°€ ì•„ë‹ˆë¼, í™˜ìì˜ ìƒì‚¬ê°€ ì˜¤ê°€ëŠ” **Crisis Management**ì— ëŒ€í•´ ë‹¤ë£¹ë‹ˆë‹¤. ëª¸ì˜ í•­ìƒì„±(Homeostasis)ì´ ì™„ì „íˆ ë¬´ë„ˆì§„ ìˆœê°„, ìš°ë¦¬ëŠ” ì–´ë–»ê²Œ ê°œì…í•´ì•¼ í• ê¹Œìš”?\n- **ğŸ©¸ Warfarin Reversal:** \"ê³µì¥(Liver)\"ì„ ê³ ì¹  ì‹œê°„ì´ ì—†ì„ ë•Œ, \"ì™„ì œí’ˆ(PCC)\"ì„ íˆ¬í•˜í•˜ë¼.\n- **ğŸ’Š DOAC Reversal:** 1:1 ë§¤ì¹­ ê²Œì„ (Andexanet alfa & Idarucizumab).\n- **ğŸ¤° Pregnancy:** íƒœë°˜ì„ í†µê³¼í•˜ì§€ ì•ŠëŠ” Heparin ì „ëµê³¼ ì¶œì‚° ì§ì „ì˜ \"Switching\".\n- **ğŸ“‰ HIT (Heparin Induced Thrombocytopenia):** í”¼ê°€ ë¬½ì–´ì§€ëŠ” ìˆ˜ì¹˜(Low Plt)ì¸ë° í”¼ê°€ êµ³ëŠ”(Clotting) ì—­ì„¤. **Don't give Platelets!**\n- **ğŸˆ EPO Side Effect:** í”¼ê°€ ì§„í•´ì§€ë©´ì„œ ë°œìƒí•˜ëŠ” Severe Hypertension.\n- **ğŸ‘¶ Kasabach-Merritt:** ê±°ëŒ€ ì¢…ì–‘ì´ í˜ˆì†ŒíŒì„ \"Sponge\"ì²˜ëŸ¼ ë¹¨ì•„ë“¤ì´ëŠ” ì†Œì•„ ì‘ê¸‰.","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-296","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","recap","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### 2. Conceptual Structure (Top-Down Classification)\nì˜í•™ì  ê°œë…ì„ êµ¬ì¡°í™”í•˜ì—¬ ë¨¸ë¦¿ì†ì— 'Tree'ë¥¼ ì‹¬ì–´ë´…ì‹œë‹¤. ì§€ê¸ˆ ìš°ë¦¬ê°€ ë‹¤ë£¨ëŠ” ë‚´ìš©ì€ **Hemostasis Pathology & Pharmacology**ì˜ **Emergency** íŒŒíŠ¸ì…ë‹ˆë‹¤.\nPlaintext\n`Hematologic Emergencies (Hemostasis & Thrombosis)\nâ”‚\nâ”œâ”€â”€ 1. Anticoagulant Reversal (ì¶œí˜ˆ ì¡ê¸°)\nâ”‚   â”‚   [Concept: Restore Clotting Factors]\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Warfarin Toxicity (Vit K Antagonist)\nâ”‚   â”‚   â”œâ”€â”€ Slow Fix: Vitamin K (Raw Material)\nâ”‚   â”‚   â””â”€â”€ Fast Fix: PCC (Pre-built Factors) â˜… Emergency\nâ”‚   â”‚\nâ”‚   â””â”€â”€ DOAC Reversal (Direct Inhibitors)\nâ”‚       â”œâ”€â”€ Factor Xa Inhibitors (Apixaban, etc.) â†’ Andexanet alfa (Decoy)\nâ”‚       â””â”€â”€ Thrombin Inhibitor (Dabigatran) â†’ Idarucizumab (Antibody)\nâ”‚\nâ”œâ”€â”€ 2. Paradoxical Clotting (ìˆ˜ì¹˜ëŠ” ì¶œí˜ˆ, ì‹¤ì œëŠ” í˜ˆì „)\nâ”‚   â”‚   [Concept: Consumption & Activation]\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ HIT (Heparin Induced Thrombocytopenia)\nâ”‚   â”‚   â””â”€â”€ Antibody-Platelet Complex â†’ Thrombosis (Not Bleeding!)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Kasabach-Merritt Syndrome (Pediatric)\nâ”‚       â””â”€â”€ Vascular Tumor traps Platelets â†’ Consumption Coagulopathy\nâ”‚\nâ””â”€â”€ 3. Specific Side Effects\n    â”œâ”€â”€ Pregnancy: Warfarin (Teratogen) vs. Heparin (Safe but timing matters)\n    â””â”€â”€ EPO Therapy: Viscosity increase â†’ Hypertension`\n### 3. Warfarin Reversal: The Factory Analogy ğŸ­\n**ğŸšª Doorway Thought (Vignette):**\nìƒˆë²½ 2ì‹œ Trauma Bay. ë¨¸ë¦¬ì— í”¼ê°€ ê³ ì´ëŠ” í™˜ì(Intracranial Hemorrhage)ê°€ ì‹¤ë ¤ì˜µë‹ˆë‹¤. ì°¨íŠ¸ë¥¼ ë³´ë‹ˆ **Warfarin**ì„ ë³µìš© ì¤‘ì´ê³ , INR ìˆ˜ì¹˜ê°€ ë†’ìŠµë‹ˆë‹¤. ë‹¹ì‹ ì—ê²Œ ì£¼ì–´ì§„ ì‹œê°„ì€ ë‹¨ ëª‡ ì´ˆì…ë‹ˆë‹¤. ë¬´ì—‡ì„ ë¨¼ì € ì§‘ì–´ë“¤ ê²ƒì¸ê°€?\n### A. The Mechanism & The Problem\n- **Liver as a Factory:** ê°„(Liver)ì€ í˜ˆì•¡ ì‘ê³  ì¸ì(Clotting Factors 2, 7, 9, 10)ë¥¼ ìƒì‚°í•˜ëŠ” ê³µì¥ì…ë‹ˆë‹¤.\n- **Warfarin's Action:** Warfarinì€ ì´ ê³µì¥ìœ¼ë¡œ ë“¤ì–´ê°€ëŠ” ì›ìì¬ì¸ **Vitamin K**ë¥¼ ì°¨ë‹¨í•©ë‹ˆë‹¤. ì¦‰, ìƒì‚° ë¼ì¸ì„ ë©ˆì¶°ë²„ë¦¬ëŠ” ê²ƒì´ì£ .\n### B. The Treatment Dilemma (Vit K vs. PCC)\në§ì€ í•™ìƒë“¤ì´ \"Warfarin ë°˜ëŒ€ë§ì€ Vitamin K!\"ë¼ê³  ìƒê°í•´ì„œ ë°”ë¡œ Vitamin Kë¥¼ ì£¼ë ¤ê³  í•©ë‹ˆë‹¤. í•˜ì§€ë§Œ ì‘ê¸‰ ìƒí™©ì—ì„œëŠ” í‹€ë ¸ìŠµë‹ˆë‹¤. ğŸ™…â€â™‚ï¸\n| **Treatment Option** | **Analogy (ë¹„ìœ )** | **Speed** | **Indication** |\n| --- | --- | --- | --- |\n| **Vitamin K** | **\"Raw Lumber\" (ì›ëª© íŠ¸ëŸ­)**\n ê³µì¥ì— ëª©ì¬ë¥¼ ì”ëœ© ê°€ì ¸ë‹¤ì£¼ëŠ” ê²ƒ. í•˜ì§€ë§Œ ê³µì¥ì´ ê°€êµ¬ë¥¼ ë§Œë“¤ì–´ì„œ ë°°ì†¡í•˜ê¸°ê¹Œì§€ ëª‡ ì‹œê°„ì´ ê±¸ë¦¼. | Slow (Hours) | Non-emergency, Maintenance |\n| **PCC** (Prothrombin Complex Concentrate) | **\"Pre-built Furniture\" (ì´ì¼€ì•„ ì™„ì œí’ˆ)**\n ì´ë¯¸ ë§Œë“¤ì–´ì§„ ê°€êµ¬ë¥¼ í—¬ê¸°ë¡œ ê³µìˆ˜í•˜ëŠ” ê²ƒ. ê³µì¥ ê°€ë™ì„ ê¸°ë‹¤ë¦´ í•„ìš” ì—†ì´ ì¦‰ì‹œ ë°°ì¹˜ ê°€ëŠ¥. | **Immediate (Minutes)** | **Life-threatening Bleed (ICH, etc.)** |\n| **FFP** (Fresh Frozen Plasma) | (Audioì—ì„œëŠ” PCC ê°•ì¡°ë¥¼ ìœ„í•´ ìƒëµë˜ì—ˆìœ¼ë‚˜, Volumeì´ í¬ê³  ëŠë¦¼) | Slow | PCCê°€ ì—†ì„ ë•Œ ëŒ€ì•ˆ |\n### C. INR Management Rules (The Traffic Light) ğŸš¦\ní™˜ìê°€ í”¼ê°€ ë‚˜ì§€ ì•ŠëŠ”ë°(No bleeding), INR ìˆ˜ì¹˜ë§Œ ì´ìƒí•œ ê²½ìš°ì˜ ëŒ€ì²˜ë²•ì…ë‹ˆë‹¤. ì´ê²ƒì€ ë§ˆì¹˜ \"Garbage Disposal (CYP450 System)\"ì´ ê³ ì¥ë‚˜ì„œ ì•½ì´ ëª¸ì— ìŒ“ì´ëŠ” ìƒí™©ê³¼ ê°™ìŠµë‹ˆë‹¤.\n1. **INR < 4.5:** (No Bleed) ì•½ ìš©ëŸ‰ë§Œ ì¡°ì ˆí•˜ê±°ë‚˜ 1íšŒ ê±´ë„ˆëœ€.\n2. **INR 4.5 ~ 10:** (No Bleed) **Hold Warfarin**. (No Vitamin K usually). êµ³ì´ Vit Kë¥¼ ì¨ì„œ \"Over-correct\" í•˜ë©´ ë‚˜ì¤‘ì— ë‹¤ì‹œ Warfarin íš¨ê³¼ë¥¼ ë‚´ê¸°ê¹Œì§€ ë©°ì¹ ì´ ê±¸ë ¤ë²„ë¦¼.\n3. **INR > 10:** (No Bleed) **Oral Vitamin K**. (IVëŠ” Anaphylaxis ìœ„í—˜ì´ ìˆì–´ ì¶œí˜ˆì´ ì—†ìœ¼ë©´ Oralì´ ì•ˆì „).","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-306","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","treatment","pathophysiology","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"### 4. DOAC Reversal: The Matching Game ğŸ§©\nìš”ì¦˜ì€ Warfarinë³´ë‹¤ DOAC(Direct Oral Anticoagulants)ì„ ë§ì´ ì”ë‹ˆë‹¤. ì´ë“¤ì˜ í•´ë…ì œëŠ” ë§¤ìš° íŠ¹ì´ì ì…ë‹ˆë‹¤.\n- **Factor Xa Inhibitors (Apixaban, Rivaroxaban):**\n    - **Antidote:** **Andexanet alfa**\n    - **Mechanism:** \"Decoy Molecule (ë¯¸ë¼)\" ğŸ¦†. ì§„ì§œ Factor Xaì™€ ë˜‘ê°™ì´ ìƒê²¼ì§€ë§Œ ê¸°ëŠ¥ì€ ì—†ëŠ” ê°€ì§œì…ë‹ˆë‹¤. ì•½ë¬¼ë“¤ì´ ì§„ì§œ Factor Xa ëŒ€ì‹  ì´ ë¯¸ë¼ì— ë‹¬ë¼ë¶™ê²Œ í•˜ì—¬, ì§„ì§œ Factor Xaê°€ ì¼ì„ í•˜ê²Œ ë§Œë“­ë‹ˆë‹¤.\n- **Direct Thrombin Inhibitor (Dabigatran):**\n    - **Antidote:** **Idarucizumab** (Praxbind)\n    - **Mechanism:** Monoclonal Antibody. ì—´ì¶”ì  ë¯¸ì‚¬ì¼ì²˜ëŸ¼ Dabigatran ë¶„ìë§Œ ì°¾ì•„ì„œ ë¬´ë ¥í™”ì‹œí‚µë‹ˆë‹¤.\n### 5. Pregnancy & Anticoagulation: The Delivery Room ğŸ¤±\n**ğŸšª Doorway Thought:**\nì„ì‚°ë¶€ëŠ” í˜ˆì „ ìœ„í—˜ì´ ë†’ìŠµë‹ˆë‹¤(Hypercoagulable). í•˜ì§€ë§Œ Warfarinì€ íƒœë°˜ì„ í†µê³¼í•´ ì•„ê¸°ì˜ ë¼ˆ ê¸°í˜•(Bone defects)ì„ ìœ ë°œí•˜ë¯€ë¡œ ê¸ˆê¸°ì…ë‹ˆë‹¤(Teratogenic).\n### The Heparin Strategy\n- **LMWH (Low Molecular Weight Heparin):** ì„ì‹  ê¸°ê°„ ë™ì•ˆì˜ **Gold Standard**. íƒœë°˜ì„ í†µê³¼í•˜ì§€ ì•Šì•„ ì•„ê¸°ì—ê²Œ ì•ˆì „í•©ë‹ˆë‹¤.\n- **The Labor Dilemma:** LMWHëŠ” ë°˜ê°ê¸°ê°€ ê¹ë‹ˆë‹¤(Long acting). ì¶œì‚° ì‹œ, íŠ¹íˆ ë¬´í†µ ì£¼ì‚¬(**Epidural**)ë¥¼ ë§ì•„ì•¼ í•˜ëŠ”ë° í”¼ê°€ ë¬½ìœ¼ë©´ ì²™ì¶”ì— í”¼ê°€ ê³ ì—¬(Spinal Hematoma) ë§ˆë¹„ê°€ ì˜¬ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- **â˜… The Switch (Next Best Step):**\n    - ì¶œì‚° ì˜ˆì •ì¼(Term)ì´ ë‹¤ê°€ì˜¤ë©´ **Unfractionated Heparin (UFH)**ìœ¼ë¡œ ë³€ê²½í•©ë‹ˆë‹¤.\n    - **Why?** UFHëŠ” ë°˜ê°ê¸°ê°€ ë§¤ìš° ì§§ì•„ì„œ, ì§„í†µì´ ì‹œì‘ë˜ë©´ ì£¼ì‚¬ë¥¼ ë„ê³ (Turn off) ëª‡ ì‹œê°„ ë‚´ì— ì•ˆì „í•˜ê²Œ ì¶œì‚°/ë§ˆì·¨ê°€ ê°€ëŠ¥í•˜ê¸° ë•Œë¬¸ì…ë‹ˆë‹¤.\n### 6. HIT (Heparin Induced Thrombocytopenia): The Paradox ğŸ“‰ğŸ§±\n**ğŸšª Doorway Thought (Vignette):**\nìˆ˜ìˆ  í›„ 5~10ì¼ ì§€ë‚œ í™˜ì. ê°‘ìê¸° í˜ˆì†ŒíŒ(Platelet) ìˆ˜ì¹˜ê°€ 50% ì´ìƒ ê¸‰ë½í–ˆìŠµë‹ˆë‹¤. (ì˜ˆ: 200,000 â†’ 80,000). í”¼ê°€ ë¬½ì–´ì¡Œìœ¼ë‹ˆ ì¶œí˜ˆì„ ê±±ì •í•´ì•¼ í• ê¹Œìš”? **ì•„ë‹ˆìš”. ì´ í™˜ìëŠ” ì§€ê¸ˆ í˜ˆì „ìœ¼ë¡œ ì£½ì–´ê°€ê³  ìˆìŠµë‹ˆë‹¤.**\n### A. The Mechanism (The Zombie Virus) ğŸ§Ÿâ€â™‚ï¸\n- í—¤íŒŒë¦°(Heparin)ì´ Platelet Factor 4 (PF4)ì™€ ê²°í•©í•©ë‹ˆë‹¤.\n- ìš°ë¦¬ ëª¸ì´ ì´ ë³µí•©ì²´ë¥¼ ì ìœ¼ë¡œ ê°„ì£¼í•˜ê³  **Antibody (IgG)**ë¥¼ ë§Œë“­ë‹ˆë‹¤.\n- ì´ í•­ì²´ê°€ í˜ˆì†ŒíŒì„ íŒŒê´´í•˜ëŠ” ê²Œ ì•„ë‹ˆë¼, **Activate(í™œì„±í™”)** ì‹œí‚µë‹ˆë‹¤. í˜ˆì†ŒíŒë“¤ì´ ì„œë¡œ ì—‰ê²¨ë¶™ì–´(Clumping) ì˜¨ëª¸ì— í˜ˆì „(Clot)ì„ ë§Œë“­ë‹ˆë‹¤.\n- **Paradox:** í˜ˆì†ŒíŒ ìˆ˜ì¹˜ê°€ ë‚®ì€ ì´ìœ ëŠ” ê·¸ë“¤ì´ ë‹¤ ë­‰ì³ì„œ í˜ˆì „ì´ ë˜ì—ˆê¸° ë•Œë¬¸ì…ë‹ˆë‹¤(Consumption). ê·¸ë˜ì„œ í”¼ê°€ ë‚˜ì§€ ì•Šê³  í˜ˆê´€ì´ ë§‰í™ë‹ˆë‹¤.\n### B. The 4Ts Score (Diagnosis)\n- **T**hrombocytopenia (Plt drop > 50%)\n- **T**iming (5~10 days after heparin)\n- **T**hrombosis (New DVT/PE)\n- o**T**her causes ruled out.\n### C. Management (Life or Death Rules) ğŸ’€\n1. **STOP Heparin Immediately:** ëª¨ë“  í—¤íŒŒë¦°(Heparin flushes í¬í•¨)ì„ ì¦‰ì‹œ ì¤‘ë‹¨í•©ë‹ˆë‹¤.\n2. **ğŸš« NEVER Give Platelets:** ì´ê²ƒì€ \"ë¶ˆë‚œ ì§‘ì— ê¸°ë¦„ ë¶“ê¸°(Gasoline on a fire)\"ì…ë‹ˆë‹¤. í˜ˆì†ŒíŒì„ ë„£ì–´ì£¼ë©´ ë°”ë¡œ í˜ˆì „ ì¬ë£Œê°€ ë˜ì–´ë²„ë¦½ë‹ˆë‹¤. í™˜ìë¥¼ ì£½ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n3. **â˜… Next Best Step:** **Non-Heparin Anticoagulant**ë¡œ êµì²´.\n    - **Argatroban** (Direct Thrombin Inhibitor)\n    - **Fondaparinux** (Factor Xa inhibitor but safe in HIT)\n    - (Warfarinì€ ì´ˆê¸°ì— ê¸ˆê¸°ì…ë‹ˆë‹¤. Protein Cë¥¼ ë–¨ì–´ëœ¨ë ¤ Skin Necrosis ìœ ë°œ ê°€ëŠ¥).","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-326","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### 7. Other Paradoxes: EPO & Kasabach-Merritt\n### A. EPO (Erythropoietin) & Hypertension ğŸˆ\n- **Scenario:** ë§Œì„± ì‹ ë¶€ì „(CKD) í™˜ìê°€ ë¹ˆí˜ˆ ì¹˜ë£Œë¡œ EPOë¥¼ ë§ê³  ë‘í†µê³¼ ì‹œì•¼ íë¦¼ì„ í˜¸ì†Œí•©ë‹ˆë‹¤.\n- **Finding:** í˜ˆì••ì´ ë¯¸ì¹œë“¯ì´ ë†’ìŠµë‹ˆë‹¤(Severe Hypertension).\n- **Mechanism:** ì í˜ˆêµ¬(RBC)ê°€ ê°‘ìê¸° ë§ì•„ì§€ë©´ í”¼ê°€ ëˆì í•´ì§‘ë‹ˆë‹¤(**Viscosity** â–²). ë˜í•œ í˜ˆê´€ì„ ì´ì™„ì‹œí‚¤ëŠ” **Nitric Oxide**ê°€ ê³ ê°ˆë˜ì–´ í˜ˆê´€ì´ ìˆ˜ì¶•í•©ë‹ˆë‹¤.\n- **Key:** EPO ì¹˜ë£Œ ì¤‘ì—ëŠ” í˜ˆì••ì„ ëª¨ë‹ˆí„°ë§í•˜ê³ , ì§‘ì„ ì§€ì„ ë²½ëŒ(Iron)ì´ ì¶©ë¶„í•œì§€ í™•ì¸í•´ì•¼ í•©ë‹ˆë‹¤.\n### B. Kasabach-Merritt Syndrome ğŸ©¸ğŸ§½\n- **Scenario:** ì‹ ìƒì•„ì˜ ëª¸í†µì´ë‚˜ í—ˆë²…ì§€ì— ê±°ëŒ€í•œ ë¶‰ì€ ë©ìš¸(Giant Hemangioma)ì´ ìˆìŠµë‹ˆë‹¤.\n- **Finding:** í˜ˆì†ŒíŒ ìˆ˜ì¹˜ê°€ ë§¤ìš° ë‚®ìŠµë‹ˆë‹¤(Thrombocytopenia).\n- **Mechanism:** ê±°ëŒ€í•œ í˜ˆê´€ ì¢…ì–‘(Tumor)ì´ **\"Sponge\"**ì²˜ëŸ¼ ì‘ìš©í•©ë‹ˆë‹¤. ì§€ë‚˜ê°€ëŠ” í˜ˆì†ŒíŒì„ ì¡±ì¡± ë¹¨ì•„ë“¤ì—¬ ì¢…ì–‘ ë‚´ë¶€ì—ì„œ ì‘ê³ ì‹œì¼œ ë²„ë¦½ë‹ˆë‹¤. (Platelet Trapping).\n- **Result:** ì „ì‹ ì ìœ¼ë¡œ ì“¸ í˜ˆì†ŒíŒì´ ì—†ì–´ì„œ ë‹¤ë¥¸ ë¶€ìœ„(ë‡Œ, ì¥)ì— ì¶œí˜ˆ ìœ„í—˜ì´ ìƒê¹ë‹ˆë‹¤.\n### ğŸ”¥ Rapid Fire Recap (High-Yield Summary)\n| **Situation** | **Problem** | **Gold Standard / Do Not Do** |\n| --- | --- | --- |\n| **Warfarin + Brain Bleed** | No Factors (Factory closed) | **Tx: 4-Factor PCC + IV Vit K** (Don't wait for FFP) |\n| **Apixaban Bleed** | Factor Xa inhibited | **Tx: Andexanet alfa** (Decoy molecule) |\n| **Pregnant + Delivery** | LMWH is too long-acting | **Switch to Unfractionated Heparin** near term |\n| **HIT (Low Plt)** | Paradoxical Clotting | **STOP Heparin, switch to Argatroban.**\n **ğŸš« DO NOT give Platelets!** |\n| **EPO Therapy** | Headache/Blurry vision | **Check BP (HTN Crisis due to viscosity)** |\n**Next Step for You:**\n**Overview & TL;DR**\n| **Topic** | **Key Concept** | **Clinical Pearl** |\n| --- | --- | --- |\n| **Infectious Streaks** | **Lymphangitis** vs. **Sporotrichosis** | ì‹œê°„ ì‹¸ì›€! ìˆ˜ ì‹œê°„ ë‚´ ì§„í–‰(Strep) vs. ìˆ˜ ì£¼ê°„ ì§„í–‰(Fungus) |\n| **Blood Mods** | **Washed**, **Irradiated**, **Leukoreduced** | IgA ê²°í•ì€ Washed! ê°€ì¡± ê³µì—¬ëŠ” Irradiated! |\n| **Transfusion Rxn** | **Time is Diagnosis** | ë°˜ì‘ì´ ì¼ì–´ë‚œ 'ì‹œê°„'ê³¼ 'í˜ˆì••'ì´ ì§„ë‹¨ì˜ ì—´ì‡  ğŸ—ï¸ |\n| **Lung Injury** | **TRALI** vs. **TACO** | ë‘˜ ë‹¤ ìˆ¨ ì°¨ì§€ë§Œ, **BP**ê°€ ë‚®ìœ¼ë©´ TRALI, ë†’ìœ¼ë©´ TACO |\n| **Line Infection** | **Septic Thrombophlebitis** | í•­ìƒì œì—ë„ ì—´ì´ ì•ˆ ë–¨ì–´ì§€ê³  **Palpable cord**ê°€ ë§Œì ¸ì§€ë©´ ë¼ì¸ ë½‘ê³  ìˆ˜ìˆ  ê³ ë ¤! |\n### **Top-Down Classification: Hematologic Emergencies**\nMedical Context: Hematology / Infectious Disease / Transfusion Medicine\nPlaintext\n`HEMATOLOGIC EMERGENCIES (Landmine Field)\n+-- 1. SKIN & VASCULAR INFECTIONS\n|   +-- Acute: Lymphangitis (Red Streaks)\n|   |   +-- Etiology: Streptococcus pyogenes (Group A Strep)\n|   |   +-- Timeline: Hours (Emergency!) ğŸš‘\n|   +-- Chronic: Sporotrichosis\n|       +-- Etiology: Sporothrix schenckii (Fungus)\n|       +-- Timeline: Weeks (Nodular) ğŸ¢\n|\n+-- 2. TRANSFUSION MEDICINE\n|   +-- Product Modifications (Prevention)\n|   |   +-- Washed RBCs (for IgA Deficiency)\n|   |   +-- Irradiated RBCs (for GVHD prevention)\n|   |   +-- Leukoreduced RBCs (for Febrile Non-hemolytic / CMV)\n|   |\n|   +-- Acute Reactions (The Clock Matters) â°\n|       +-- Seconds/Minutes: Anaphylaxis (IgA Def)\n|       +-- < 1 Hour: Acute Hemolytic (ABO Incompatibility)\n|       +-- < 6 Hours: Lung Injury\n|           +-- TRALI (Hypotension) ğŸ“‰\n|           +-- TACO (Hypertension) ğŸ“ˆ\n|\n+-- 3. CATHETER COMPLICATIONS\n    +-- Septic Thrombophlebitis\n        +-- Sign: Palpable Cord + Persistent Fever\n        +-- Tx: Remove Line + Abx + Heparin (Surgery if purulent)`","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-346","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### **STEP 2: DETAILED LECTURE NOTES**\n# 6.0-6.5Section 1. The Red Streak Dilemma: Lymphangitis ğŸ©¸\n**Doorway Thought:** ì •ì› ì¼ì„ í•˜ë˜ í™˜ìê°€ ì†ì— ì‘ì€ ìƒì²˜ê°€ ë‚¬ëŠ”ë°, ë¶ˆê³¼ ëª‡ ì‹œê°„ ë§Œì— íŒ”ì„ íƒ€ê³  ë¶‰ì€ ì¤„(Red streaks)ì´ ê²¨ë“œë‘ì´ê¹Œì§€ ì˜¬ë¼ì˜¤ë©° íŒ¨ë‹‰ ìƒíƒœë¡œ ë‚´ì›í•¨.\n### **1. Lymphangitis (ê¸‰ì„± ë¦¼í”„ê´€ì—¼)**\n- **Visual Recognition:** í”¼ë¶€ì— **Tender red streaks**ê°€ ìƒì²˜ ë¶€ìœ„ì—ì„œë¶€í„° ë¦¼í”„ì ˆ(Axilla/Groin) ë°©í–¥ìœ¼ë¡œ ë§¹ë ¬íˆ ë»—ì–´ ì˜¬ë¼ê°.\n- **Pathophysiology:** ë¦¼í”„ê´€(Lymphatic channels) ìì²´ê°€ ê°ì—¼ë˜ì–´ ì—¼ì¦ì´ ìƒê¸´ ìƒíƒœ. ì„¸ê· ì´ ë¦¼í”„ê´€ì„ íƒ€ê³  \"Hitching a ride\" í•˜ëŠ” ê²ƒì„.\n- **Timeline (Crucial!):** **ìˆ˜ ì‹œê°„(Hours)** ë§Œì— ì§„í–‰ë¨. ì•„ì¹¨ì— ê¸í˜”ëŠ”ë° ì ì‹¬ë•Œ íŒ” ì „ì²´ê°€ ë¹¨ê°œì§ˆ ìˆ˜ ìˆìŒ. í™˜ìê°€ ë§¤ìš° ë†€ë¼ì„œ(Panic) ì˜´.\n- **Microbiology:**\n    - **Most Common:** **Group A Strep (*Streptococcus pyogenes*)** â˜….\n    - *Staph aureus*ëŠ” ê°€ëŠ¥í•˜ê¸´ í•˜ì§€ë§Œ ë“œë­„.\n    - Pasteurella (ê°œ/ê³ ì–‘ì´ êµìƒ) ë“±ë„ ê°€ëŠ¥í•˜ì§€ë§Œ Strepì´ ì••ë„ì .\n- **Treatment:**\n    - **Sniper Rifle (Narrow Spectrum):** **Cephalexin** (1st gen Cephalosporin) or Dicloxacillin.\n    - *Overthinking Trap:* \"MRSA ì»¤ë²„í•´ì•¼ í•˜ì§€ ì•Šì„ê¹Œ?\" â†’ No. ì´ê±´ ê±°ì˜ 100% Strepì´ë¯€ë¡œ Vancomycin ê°™ì€ \"Nuke(í•µí­íƒ„)\"ì€ í•„ìš” ì—†ìŒ.\n### **2. Sporotrichosis (ë¹„êµ ì§„ë‹¨)**\n- **Visual:** \"Nodular bumps\" (ìš¸í‰ë¶ˆí‰í•œ ê²°ì ˆ)ê°€ íŒ”ì„ íƒ€ê³  ì˜¬ë¼ì˜´. Streak(ì„ )ë³´ë‹¤ëŠ” Bump(ë©ì–´ë¦¬) ëŠë‚Œ.\n- **Timeline:** **ìˆ˜ ì£¼(Weeks)** ì— ê±¸ì³ ì²œì²œíˆ ì§„í–‰ë¨. \"ê±°ë¶ì´(Tortoise)\" ê°™ìŒ ğŸ¢.\n- **Etiology:** *Sporothrix schenckii* (Rose Gardener's Disease, Fungus).\n# Section 2. Transfusion Medicine: Prevention & Modifications ğŸ›¡ï¸\n**Doorway Thought:** ìˆ˜í˜ˆ ì˜¤ë”ë¥¼ ë‚´ë ¤ê³  í•˜ëŠ”ë° í˜ˆì•¡ì€í–‰ì—ì„œ \"ì–´ë–¤ ì²˜ë¦¬ë¥¼ í•´ì„œ ë“œë¦´ê¹Œìš”?\"ë¼ê³  ë¬»ëŠ”ë‹¤. í™˜ìì˜ ë³‘ë ¥ì„ ë³´ê³  ê³¨ë¼ì•¼ í•œë‹¤.\n### **1. Washed RBCs (ì„¸ì²™ ì í˜ˆêµ¬)**\n- **Indication:** **IgA Deficiency** í™˜ì.\n- **Logic:** ì¼ë°˜ í˜ˆì•¡ íŒ©ì—ëŠ” ì†ŒëŸ‰ì˜ Plasma(í˜ˆì¥)ê°€ ë‚¨ì•„ìˆê³ , ê·¸ ì•ˆì— IgAê°€ ë“¤ì–´ìˆìŒ. IgA ê²°í• í™˜ìëŠ” ì™¸ë¶€ IgAë¥¼ \"Foreign invader\"ë¡œ ì¸ì‹í•´ **Anti-IgA Antibody**ë¥¼ ê°€ì§€ê³  ìˆìŒ â†’ ìˆ˜í˜ˆ ì‹œ **Anaphylaxis** ë°œìƒ.\n- **Action:** ì‹ì—¼ìˆ˜(Saline)ë¡œ ì í˜ˆêµ¬ë¥¼ ì”»ì–´ì„œ Plasmaì™€ Proteinì„ ì œê±°í•¨.\n### **2. Irradiated RBCs (ë°©ì‚¬ì„  ì¡°ì‚¬ ì í˜ˆêµ¬)**\n- **Indication:**\n    1. **Immunocompromised patients** (Bone marrow transplant, chemotheray).\n    2. **Blood Relative Donation** (ê°€ì¡±ë¼ë¦¬ ìˆ˜í˜ˆí•  ë•Œ) â˜….\n- **Risk:** **TA-GVHD (Transfusion-Associated Graft Versus Host Disease)**.\n    - ìˆ˜í˜ˆëœ í”¼(Graft) ì•ˆì— ìˆëŠ” T-cellì´ í™˜ì(Host)ì˜ ëª¸ì„ ê³µê²©í•¨. ì¹˜ì‚¬ìœ¨ì´ ê±°ì˜ 100%ì— ë‹¬í•¨.\n- **Mechanism:**\n    - ê°€ì¡±ë¼ë¦¬ëŠ” HLAê°€ ë¹„ìŠ·í•¨(\"Partial Match\"). í™˜ìì˜ ë©´ì—­ê³„ê°€ ìˆ˜í˜ˆëœ T-cellì„ \"ë‚¨\"ì´ë¼ê³  ì¸ì‹ì„ ì˜ ëª»í•´ì„œ(Camouflage) ê³µê²©ì„ ì•ˆ í•¨ â†’ ê·¸ ì‚¬ì´ ìˆ˜í˜ˆëœ T-cellì´ ì¦ì‹í•´ì„œ í™˜ìë¥¼ ê³µê²©í•¨.\n- **Action:** ë°©ì‚¬ì„ ì„ ìª¼ì—¬ì„œ Donor T-cellì„ ë‹¤ ì£½ì—¬ë²„ë¦¼.\n### **3. Leukoreduced RBCs (ë°±í˜ˆêµ¬ ì œê±° ì í˜ˆêµ¬)**\n- **Indication:**\n    1. **Febrile Non-Hemolytic Transfusion Reaction** ì˜ˆë°© (Chronic transfusion í™˜ìë“¤).\n    2. **CMV (Cytomegalovirus) prevention**.\n- **Logic:** CMVëŠ” ë°±í˜ˆêµ¬(WBC) ì•ˆì— ìˆ¨ì–´ ì‚¼(Latent). WBCë¥¼ í•„í„°ë¡œ ê±¸ëŸ¬ë‚´ë©´ CMV ê°ì—¼ ìœ„í—˜ë„ ì‚¬ë¼ì§.\n    - *Note:* ìš”ì¦˜ì€ ëŒ€ë¶€ë¶„ ê¸°ë³¸ì ìœ¼ë¡œ Leukoreducedë¥¼ ë§ì´ ì”€.\n# Section 3. Acute Transfusion Reactions: The \"Time\" Diagnosis â°","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-366","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"**Doorway Thought:** ìˆ˜í˜ˆ ì‹œì‘ í›„ í™˜ìì˜ ë°”ì´íƒˆì´ í”ë“¤ë¦°ë‹¤. \"ì–¸ì œ\" í”ë“¤ë ¸ëŠ”ì§€ì™€ \"ì¦ìƒ\"ì´ ë¬´ì—‡ì¸ì§€ê°€ ë‹µì„ ì•Œë ¤ì¤€ë‹¤.\n| **Reaction** | **Timing** | **Mechanism** | **Key Symptoms** | **Management** |\n| --- | --- | --- | --- | --- |\n| **Anaphylaxis** | **Seconds to Minutes** | IgA Deficiency (Anti-IgA Ab) | Shock, Wheezing, Hypotension | **Stop Transfusion + Epinephrine IM** â˜… |\n| **Acute Hemolytic** | **< 1 Hour** | ABO Incompatibility (Human Error) | **Flank Pain**, Fever, Dark Urine (Hemoglobinuria) | Stop + Hydration (Protect kidneys) |\n| **Febrile Non-Hemolytic** | 1~6 Hours | Cytokines from donor WBCs | Fever, Chills (No pain/hemolysis) | Acetaminophen (Tylenol) + Leukoreduced next time |\n| **Delayed Hemolytic** | Days to Weeks | Anamnestic Response (Memory B cells) | Mild Jaundice, â†“Hb (No acute crash) | Monitor (Usually mild) |\n### **Deep Dive: Delayed Hemolytic Reaction**\n- **Scenario:** ê³¼ê±°ì— ìˆ˜í˜ˆì´ë‚˜ ì„ì‹ ìœ¼ë¡œ Kell, Duffy ê°™ì€ Minor antigenì— ë…¸ì¶œëœ ì ì´ ìˆìŒ. í•­ì²´ ìˆ˜ì¹˜ê°€ ë‚®ì•„ì„œ ìŠ¤í¬ë¦¬ë‹(Negative) í†µê³¼í•¨.\n- **Mechanism:** ë‹¤ì‹œ ìˆ˜í˜ˆë°›ìœ¼ë©´ Memory B-cellì´ ê¹¨ì–´ë‚˜ì„œ(\"Hey, I've seen this before!\") ë©°ì¹  ë’¤ í•­ì²´ë¥¼ ìŸì•„ëƒ„.\n- **Presentation:** ìˆ˜í˜ˆë°›ê³  ì¼ì£¼ì¼ ë’¤ì— í™©ë‹¬(Jaundice)ì´ ì˜¤ê±°ë‚˜ í—¤ëª¨ê¸€ë¡œë¹ˆì´ ìŠ¬ê¸ˆìŠ¬ê¸ˆ ë–¨ì–´ì§.\n# Section 4. Lung Injury: TRALI vs. TACO ğŸ« (High Yield!)\n**Doorway Thought:** 70ì„¸ í• ë¨¸ë‹ˆê°€ ìˆ˜í˜ˆë°›ë‹¤ê°€ ê°‘ìê¸° ìˆ¨ì´ ì°¨ë‹¤(Dyspnea)ê³  í•˜ë©° ì‚°ì†Œí¬í™”ë„ê°€ ë–¨ì–´ì§„ë‹¤. íì²­ì§„ ìƒ Crackle(Wet lungs)ì´ ë“¤ë¦°ë‹¤. ì›ì¸ì€?\n### **The Million Dollar Distinction: Blood Pressure** ğŸ’µ\n### **1. TRALI (Transfusion Related Acute Lung Injury)**\n- **Pathophysiology:** Donorì˜ í•­ì²´(Antibody)ê°€ Recipientì˜ íì— ìˆëŠ” Neutrophilì„ ê³µê²© â†’ **Inflammation** â†’ íí˜ˆê´€ ëˆ„ì¶œ(Leaky capillaries).\n- **Hemodynamics:** í˜ˆê´€ì´ ì¤„ì¤„ ìƒˆë‹ˆê¹Œ í˜ˆì••ì´ **ë–¨ì–´ì§ (Hypotension)** ğŸ“‰.\n- **Treatment:** Supportive Care (Ventilator support). ì´ë‡¨ì œ(Lasix) ì£¼ë©´ ì•ˆ ë¨! (ì´ë¯¸ í˜ˆê´€ ë‚´ ë³¼ë¥¨ì€ ë¶€ì¡±í•  ìˆ˜ ìˆìŒ).\n### **2. TACO (Transfusion Associated Circulatory Overload)**\n- **Pathophysiology:** **Volume Overload**. ì‹¬ë¶€ì „(Heart Failure)ì´ ìˆê±°ë‚˜ ì‹ ë¶€ì „ì´ ìˆëŠ” í™˜ìì—ê²Œ ë„ˆë¬´ ë¹¨ë¦¬/ë§ì´ ìˆ˜í˜ˆí•¨. íŒí”„ê°€ ê°ë‹¹ì„ ëª»í•´ì„œ ë¬¼ì´ íë¡œ ë„˜ì¹¨.\n- **Hemodynamics:** ë¬¼ì´ ê½‰ ì°¼ìœ¼ë‹ˆ í˜ˆì••ì´ **ì˜¤ë¦„ (Hypertension)** ğŸ“ˆ.\n- **Treatment:** **Diuretics (Furosemide)** + Sit up + Oxygen.\n# Section 5. Catheter-Induced Septic Thrombophlebitis ğŸ’‰\n**Doorway Thought:** ì¤‘ì‹¬ì •ë§¥ê´€(Central line)ì„ ê°€ì§„ í™˜ìê°€ ì—´ì´ ë‚˜ì„œ í•­ìƒì œë¥¼ ì¼ëŠ”ë°ë„ 3ì¼ì§¸ ê³ ì—´ì´ ì§€ì†ë¨. ì¹´í…Œí„° ë¶€ìœ„ê°€ ë¹¨ê°›ê³  ì¤„ì„ ë”°ë¼ **ë‹¨ë‹¨í•œ ì¤„(Cord)**ì´ ë§Œì ¸ì§.\n### **Septic Thrombophlebitis (ê°ì—¼ì„± í˜ˆì „ì •ë§¥ì—¼)**\n- **Definition:** ì •ë§¥ ë‚´ì— í˜ˆì „(Thrombus)ì´ ìƒê²¼ëŠ”ë°, ê·¸ í˜ˆì „ì´ ì„¸ê·  ë©ì–´ë¦¬(Abscess/Biofilm)ê°€ ë˜ì–´ë²„ë¦° ìƒíƒœ.\n    - í•­ìƒì œë¥¼ ì¨ë„ í˜ˆì „ ë‚´ë¶€(Bunker)ê¹Œì§€ ì¹¨íˆ¬ë¥¼ ëª»í•¨.\n- **Key Finding:** **Palpable Cord** (í”¼ë¶€ ë°‘ ì •ë§¥ì´ ë¹¨ë˜ì¤„ì²˜ëŸ¼ ë‹¨ë‹¨í•˜ê²Œ ë§Œì ¸ì§) + Persistent Bacteremia.\n- **Bug:** ì£¼ë¡œ **Staphylococcus aureus**.\n- **Management (Step-by-Step):**\n    1. **Pull the Line:** ì›ì¸ ì œê±° (Non-negotiable).\n    2. **Antibiotics:** Vancomycin etc.\n    3. **Anticoagulation:** í˜ˆì „ì´ ë” ì»¤ì§€ëŠ” ê±¸ ë§‰ì•„ì•¼ í•¨.\n    4. **Surgery (Excision):** ë§Œì•½ ìœ„ ì¹˜ë£Œì—ë„ ë°˜ì‘ì´ ì—†ê³ , í˜ˆê´€ì—ì„œ ê³ ë¦„(Pus)ì´ ë‚˜ì˜¤ê±°ë‚˜ íŒ¨í˜ˆì¦ì´ ì§€ì†ë˜ë©´? **í˜ˆê´€ ìì²´ë¥¼ ì˜ë¼ë‚´ì•¼ í•¨ (Excision of the vein)**.","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-386","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"recap_summary","text":"### **RAPID FIRE RECAP** âš¡\n| **Scenario** | **Diagnosis** | **Next Best Step** |\n| --- | --- | --- |\n| Gardening + Red Streaks + Hours | **Lymphangitis** | **Cephalexin** (Target Strep) |\n| Transfusion + Anaphylaxis | **IgA Deficiency** | Stop + Epi + Next time **Wash Cells** |\n| Transfusion from Brother | **GVHD Risk** | **Irradiate Blood** (Prevent T-cell attack) |\n| Transfusion + Low BP + Dyspnea | **TRALI** | Supportive Care (Ventilator) |\n| Transfusion + High BP + Dyspnea | **TACO** | **Furosemide** (Diuresis) |\n| Central Line + Palpable Cord | **Septic Thrombophlebitis** | Pull Line + Anticoagulation (+/- Surgery) |\n- **Caveats:** The audio focuses heavily on *Strep pyogenes* for lymphangitis; while true for spontaneous cases, always consider *Pasteurella* (bites) or *Vibrio* (seawater) in real life based on history, though for USMLE, the \"gardening/scratch\" vignette is almost always Strep. For Sporotrichosis, Itraconazole is the Tx, though not explicitly detailed in the audio (audio focused on diagnosis timeline).\n# 7.0-7.5ğŸ“‹ Senior Medical Scribe & USMLE Expert: Lecture Notes\n**Overview (TL;DR)**\nHere is the high-yield summary of the \"Newborn Sludge, Vampire Effect, and Milk Anemia\" lecture:\n- **Neonatal Polycythemia:** \"Tomato Red\" baby due to intrauterine hypoxia or delayed cord clamping. **Trap:** Capillary heel pricks overestimate Hct. **Action:** Confirm with Venous Draw.\n- **Anemia of Prematurity:** Preemies have an \"EPO gap\" because the liver stops and kidneys haven't started. **Vampire Effect:** Iatrogenic blood loss from frequent labs worsens this. **Tx:** Limit blood draws.\n- **Milk Anemia (IDA):** Toddlers drinking >24oz cow's milk. Triple threat: Low iron content, displacement of food, and micro-colitis (bleeding). **Dx:** Mentzer Index > 13.\n- **Pancytopenia:** Bone marrow failure (Aplastic vs. Leukemia). Look at the Spleen size to differentiate production failure vs. destruction/sequestration.","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-405","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","recap","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### ğŸŒ³ Top-Down Classification & Structure (ASCII Tree)\nì´ ê°•ì˜ëŠ” Pediatric Hematologyì˜ í•µì‹¬ ë³‘ë¦¬ë“¤ì„ ë‹¤ë£¨ê³  ìˆìŠµë‹ˆë‹¤. ì•„ë˜ êµ¬ì¡°ë„ë¥¼ í†µí•´ í° ê·¸ë¦¼(Big Picture)ì„ ë¨¼ì € ì¡ê³  ë“¤ì–´ê°€ê² ìŠµë‹ˆë‹¤.\nPediatric Hematology (ì†Œì•„ í˜ˆì•¡í•™)\nâ”‚\nâ”œâ”€â”€ Red Blood Cell Disorders (ì í˜ˆêµ¬ ì§ˆí™˜)\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Too High (ë„ˆë¬´ ë§ìŒ)\nâ”‚   â”‚   â””â”€â”€ Neonatal Polycythemia (ì‹ ìƒì•„ ë‹¤í˜ˆêµ¬ì¦)\nâ”‚   â”‚       â”œâ”€â”€ Context: \"Tomato Red Baby\" (í† ë§ˆí† ìƒ‰ ì•„ê¸°)\nâ”‚   â”‚       â”œâ”€â”€ Mech: Intrauterine Hypoxia (ìê¶ ë‚´ ì €ì‚°ì†Œ)\nâ”‚   â”‚       â””â”€â”€ Key: Viscosity & Sludge (í˜ˆì•¡ ëˆì ì„)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Too Low (Anemia, ë¹ˆí˜ˆ)\nâ”‚       â”‚\nâ”‚       â”œâ”€â”€ Production Failure (ìƒì„± ë¶€ì „)\nâ”‚       â”‚   â”œâ”€â”€ Anemia of Prematurity (ë¯¸ìˆ™ì•„ ë¹ˆí˜ˆ)\nâ”‚       â”‚   â”‚   â””â”€â”€ Concept: Hepatic-Renal EPO Gap + Vampire Effect\nâ”‚       â”‚   â”‚","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-415","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","tree"]}
{"chunk_type":"transcript_chunk","text":"â”‚       â”‚   â””â”€â”€ Iron Deficiency Anemia (ì² ê²°í• ë¹ˆí˜ˆ)\nâ”‚       â”‚       â””â”€â”€ Concept: \"Milk Anemia\" (ìš°ìœ  ë¹ˆí˜ˆ, Mentzer Index > 13)\nâ”‚       â”‚\nâ”‚       â””â”€â”€ Destruction / Hemolysis (íŒŒê´´)\nâ”‚           â””â”€â”€ Thalassemia (Mentzer Index < 13)\nâ”‚\nâ””â”€â”€ Pancytopenia (ë²”í˜ˆêµ¬ ê°ì†Œì¦)\nâ”œâ”€â”€ Production Problem: Aplastic Anemia (ë¹ˆ ê³µì¥)\nâ””â”€â”€ Infiltration/Destruction: Leukemia (ì•”ì„¸í¬ ì¹¨ìœ¤) or Hypersplenism (ë¹„ì¥ ë¹„ëŒ€)\n### ğŸ©¸ 1. Neonatal Polycythemia (ì‹ ìƒì•„ ë‹¤í˜ˆêµ¬ì¦)\n**\"The Tomato Red Baby & The Capillary Trap\"**\n### ğŸ©º Clinical Scenario (Vignette)\nì‹ ìƒì•„ì‹¤(Nursery)ì— ìˆëŠ” ì•„ê¸°ê°€ **\"Tomato Red\" (í† ë§ˆí† ì²˜ëŸ¼ ë¶‰ì€ìƒ‰)** í”¼ë¶€ë¥¼ ë³´ì…ë‹ˆë‹¤. ë°œë’¤ê¿ˆì¹˜ë¥¼ ì°”ëŸ¬ì„œ(Heel prick) ì–»ì€ í˜ˆì•¡ ê²€ì‚¬ìƒ **Hematocrit (Hct) 68%** ê°€ ë‚˜ì™”ìŠµë‹ˆë‹¤. ë‹¹ì‹ ì€ íŒ¨ë‹‰ì— ë¹ ì ¸ì•¼ í• ê¹Œìš”?.\n### ğŸ§  Concept & Pathophysiology\n- **Mechanism (Why so red?):** íƒœì•„ëŠ” ìê¶ ë‚´ì—ì„œ ìƒëŒ€ì ì¸ ì €ì‚°ì†Œì¦(Hypoxia) ìƒíƒœì— ìˆìŠµë‹ˆë‹¤. ë§ˆì¹˜ **\"ê³ ì‚°ì§€ëŒ€ì—ì„œ í›ˆë ¨í•˜ëŠ” ë³´ë””ë¹Œë”\"** ì²˜ëŸ¼, ë¶€ì¡±í•œ ì‚°ì†Œë¥¼ ì¡ê¸° ìœ„í•´ ì í˜ˆêµ¬(RBC)ë¥¼ ê³¼ë„í•˜ê²Œ ë§Œë“¤ì–´ëƒ…ë‹ˆë‹¤.\n- **Delayed Cord Clamping:** íƒ¯ì¤„ì„ ëŠ¦ê²Œ ìë¥´ë©´ íƒœë°˜(Placenta)ì— ìˆë˜ í˜ˆì•¡ì´ ì¤‘ë ¥ê³¼ ìˆ˜ì¶•ì— ì˜í•´ ì•„ê¸°ì—ê²Œ ìŸì•„ì ¸ ë“¤ì–´ì˜µë‹ˆë‹¤(Placental Transfusion). ì´ëŠ” \"Free bag of blood\"ë¥¼ ë°›ëŠ” ê²ƒê³¼ ê°™ì•„ í˜ˆì•¡ëŸ‰ì´ ëŠ˜ì–´ë‚©ë‹ˆë‹¤.\n- **Problem (Viscosity):** í˜ˆì•¡ì´ ë„ˆë¬´ ì§„í•´ì§€ë©´ **\"Sludge (ì§„í™/ìŠ¬ëŸ¬ì§€)\"** ì²˜ëŸ¼ ë³€í•©ë‹ˆë‹¤. ëˆì í•œ í”¼ëŠ” ë‡Œ, ì‹ ì¥, ì¥ì˜ ë¯¸ì„¸í˜ˆê´€ì„ í†µê³¼í•˜ì§€ ëª»í•´ ë§‰íˆê²Œ ë©ë‹ˆë‹¤(Stasis).\n### âš ï¸ The Capillary Trap (í•¨ì •)\n- ë°œë’¤ê¿ˆì¹˜(Heel)ì˜ ëª¨ì„¸í˜ˆê´€(Capillaries)ì€ í˜ˆì•¡ ìˆœí™˜ì´ ëŠë¦¬ê³  ì°¨ê°‘ê¸° ë•Œë¬¸ì— í˜ˆì•¡ì´ ê³ ì—¬ìˆìŠµë‹ˆë‹¤(Stasis).\n- ì´ë¡œ ì¸í•´ í˜ˆì¥(Plasma)ì€ ë¹ ì ¸ë‚˜ê°€ê³  ì í˜ˆêµ¬ë§Œ ë†ì¶•ëœ ìƒíƒœì…ë‹ˆë‹¤.\n- **Result:** Heel prick sampleì€ ì‹¤ì œ ì •ë§¥í˜ˆë³´ë‹¤ Hctë¥¼ **ìƒë‹¹íˆ ê³¼ëŒ€í‰ê°€(Overestimate)** í•©ë‹ˆë‹¤.\n### â˜… Management & Next Best Step\n1. **Next Best Step:** **Venous Draw (ì •ë§¥í˜ˆ ì±„í˜ˆ)**.\n    - ì ˆëŒ€ Heel prick ê²°ê³¼ë§Œ ë³´ê³  ì¹˜ë£Œí•˜ì§€ ì•ŠìŠµë‹ˆë‹¤. ì •ë§¥ì—ì„œ ë‹¤ì‹œ ë½‘ì•„ì•¼ í•©ë‹ˆë‹¤.\n2. **Diagnosis:** Venous Hematocrit **> 65%**.\n3. **Treatment:**\n    - **Asymptomatic (ì¦ìƒ ì—†ìŒ):** Hydration (ìˆ˜ì•¡ ê³µê¸‰).\n    - **Symptomatic (ì¦ìƒ ìˆìŒ - í˜¸í¡ê³¤ë€, ì²˜ì§ ë“±):** **Partial Exchange Transfusion (ë¶€ë¶„ êµí™˜ ìˆ˜í˜ˆ)**. í”¼ë¥¼ ë½‘ì•„ë‚´ê³  ê·¸ë§Œí¼ ìƒë¦¬ì‹ì—¼ìˆ˜(Normal Saline)ë¥¼ ë„£ì–´ í¬ì„ì‹œí‚µë‹ˆë‹¤.","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-435","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### ğŸ§› 2. Anemia of Prematurity (ë¯¸ìˆ™ì•„ ë¹ˆí˜ˆ)\n**\"The Sleeping Foreman & The Vampire Effect\"**\n### ğŸ©º Clinical Scenario (Vignette)\n- **Baby A:** 1ê°œì›” ëœ ë¯¸ìˆ™ì•„(Preemie), ì¸íë² ì´í„°ì— ìˆìŒ. ê°‘ìê¸° ìˆ¨ì„ ì•ˆ ì‰¬ê³ (Apnea), ì‹¬ë°•ìˆ˜ê°€ ë–¨ì–´ì§‘ë‹ˆë‹¤. ë¹ˆí˜ˆì´ ìˆìŠµë‹ˆë‹¤.\n- **Baby B:** 3ê°œì›” ëœ ë§Œì‚­ì•„, ì§‘ì—ì„œ ì˜ ë¨¹ê³  ì›ƒê³  ìˆìŒ. ê²€ì‚¬í•´ë³´ë‹ˆ ë¹ˆí˜ˆ ìˆ˜ì¹˜ê°€ Baby Aì™€ ë¹„ìŠ·í•˜ì§€ë§Œ ì¦ìƒì´ ì—†ìŠµë‹ˆë‹¤.\n- **Why?** Baby AëŠ” \"ê³µì¥\"ì´ ë©ˆì·„ê³ , Baby BëŠ” ì ì‘í•œ ìƒíƒœì…ë‹ˆë‹¤.\n### ğŸ§  Pathophysiology: The EPO Gap\nì í˜ˆêµ¬ ìƒì„± ëª…ë ¹ì„ ë‚´ë¦¬ëŠ” **Erythropoietin (EPO)** ê³µì¥ì˜ ì „í™˜ê¸°ì— ë¬¸ì œê°€ ë°œìƒí•©ë‹ˆë‹¤.\n1. **Fetus (íƒœì•„):** ê°„(Liver)ì´ EPOë¥¼ ë§Œë“­ë‹ˆë‹¤.\n2. **Adult (ì„±ì¸):** ì‹ ì¥(Kidney)ì´ EPOë¥¼ ë§Œë“­ë‹ˆë‹¤.\n3. **The Gap:** íƒœì–´ë‚˜ë©´ ê°„ì€ \"ë‚´ í•  ì¼ ëë‚¬ë‹¤\"ë©° ì€í‡´í•©ë‹ˆë‹¤. í•˜ì§€ë§Œ ë¯¸ìˆ™ì•„ì˜ ì‹ ì¥ì€ ì•„ì§ ë¯¸ì„±ìˆ™í•´ì„œ \"ì ìê³  ìˆëŠ” ê³µì¥ì¥(Sleeping Foreman)\"ê³¼ ê°™ìŠµë‹ˆë‹¤.\n    - ëª…ë ¹(EPO)ì´ ì—†ìœ¼ë‹ˆ ê³¨ìˆ˜(Bone Marrow)ëŠ” ì¼ì„ ì•ˆ í•©ë‹ˆë‹¤.\n### ğŸ©¸ The Vampire Effect (í¡í˜ˆê·€ íš¨ê³¼)\n- ë¯¸ìˆ™ì•„ëŠ” ë§¤ì¼ ìˆ˜ë§ì€ í˜ˆì•¡ ê²€ì‚¬ë¥¼ ë°›ìŠµë‹ˆë‹¤.\n- 1kg ë¯¸ë§Œì˜ ë¯¸ìˆ™ì•„ì—ê²Œì„œ **5ml**ì˜ í”¼ë¥¼ ë½‘ëŠ” ê²ƒì€, ì„±ì¸ì´ ì ì‹­ìì— ê°€ì„œ **í”¼ í•œ íŒ©(Pint)**ì„ ê¸°ë¶€í•˜ëŠ” ê²ƒê³¼ ë§ë¨¹ëŠ” ë¹„ìœ¨ì…ë‹ˆë‹¤.\n- ì´ê±¸ 3ì¼ ì—°ì†í•˜ë©´? ì•„ê¸°ì˜ í”¼ë¥¼ ì˜ë£Œì§„ì´ ë‹¤ ë½‘ì•„ë²„ë¦° ì…ˆì…ë‹ˆë‹¤ (**Iatrogenic Blood Loss**).\n### â˜… Treatment & Gold Standard\n- **Gold Standard:** **Restraint (ìì œë ¥/ì°¸ê¸°)**.\n    - ë¶ˆí•„ìš”í•œ í˜ˆì•¡ ê²€ì‚¬ë¥¼ ë©ˆì¶”ëŠ” ê²ƒì´ ìµœê³ ì˜ ì¹˜ë£Œì…ë‹ˆë‹¤.\n    - \"Doing nothing is actually doing something.\" (ì•„ë¬´ê²ƒë„ ì•ˆ í•˜ëŠ” ê²ƒì´ ì¹˜ë£Œë‹¤).\n- ì¦ìƒì´ ì‹¬ê°í•˜ë©´(Apnea, Bradycardia ë“±) ìˆ˜í˜ˆì„ ê³ ë ¤í•˜ì§€ë§Œ, ê¸°ë³¸ì€ ê¸°ë‹¤ë¦¬ëŠ” ê²ƒì…ë‹ˆë‹¤.\n### ğŸ¥› 3. Milk Anemia (ìš°ìœ  ë¹ˆí˜ˆ - Iron Deficiency)\n**\"The Milkatiarian & The Triple Threat\"**\n### ğŸ©º Clinical Scenario (Vignette)\n15ê°œì›” ëœ ë‚¨ìì•„ì´. ë°¥(ì¹˜í‚¨, ë¸Œë¡œì½œë¦¬)ì€ ì•ˆ ë¨¹ê³  **ìš°ìœ ë³‘ë§Œ í•˜ë£¨ ì¢…ì¼** ë¹¨ê³  ìˆìŠµë‹ˆë‹¤(í•˜ë£¨ 30oz ì´ìƒ). ì•„ì´ê°€ ì°½ë°±í•˜ê³ (Pale), ì§œì¦ì„ ì˜ ëƒ…ë‹ˆë‹¤(Irritable). í™ì´ë‚˜ ì–¼ìŒì„ ì”¹ì–´ë¨¹ìœ¼ë ¤ í•©ë‹ˆë‹¤(Pica).\n### ğŸ§  Pathophysiology: The Triple Threat\nìš°ìœ (Cow's milk)ëŠ” ë¹ˆí˜ˆì„ ì¼ìœ¼í‚¤ëŠ” 3ê°€ì§€ ê¸°ì „ì„ ê°€ì§€ê³  ìˆìŠµë‹ˆë‹¤.\n1. **Low Iron:** ìš°ìœ  ìì²´ì— ì² ë¶„ì´ ê±°ì˜ ì—†ìŠµë‹ˆë‹¤ (Zero raw material).\n2. **Displacement:** ìš°ìœ ëŠ” ì¹¼ë¡œë¦¬ê°€ ë†’ê³  ë°°ê°€ ë¶€ë¦…ë‹ˆë‹¤. ì•„ì´ê°€ ìš°ìœ ë¡œ ë°°ë¥¼ ì±„ìš°ë‹ˆ ì² ë¶„ì´ ë“  ì´ìœ ì‹(ê³ ê¸°, ì‹œë¦¬ì–¼ ë“±)ì„ ì•ˆ ë¨¹ìŠµë‹ˆë‹¤.\n3. **Micro-Colitis:** ìš°ìœ  ë‹¨ë°±ì§ˆì´ ì¥ ì ë§‰ì„ ìê·¹í•´ ë¯¸ì„¸í•œ ì¶œí˜ˆ(**Microscopic Colitis**)ì„ ì¼ìœ¼í‚µë‹ˆë‹¤. ë§¤ì¼ ì¡°ê¸ˆì”© í”¼(ì™€ ì² ë¶„)ê°€ ëŒ€ë³€ìœ¼ë¡œ ë¹ ì ¸ë‚˜ê°‘ë‹ˆë‹¤.","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-455","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### ğŸ“Š Diagnosis: The Mentzer Index\nMCV(ì í˜ˆêµ¬ í¬ê¸°)ê°€ ì‘ì„ ë•Œ, ì´ê²ƒì´ ì² ê²°í•ì¸ì§€ Thalassemia(ìœ ì „ë³‘)ì¸ì§€ êµ¬ë³„í•˜ëŠ” ìˆ˜í•™ì  ê¿€íŒì…ë‹ˆë‹¤.\n$$\\text{Mentzer Index} = \\frac{\\text{MCV}}{\\text{RBC Count}}$$\n| **Condition** | **Mentzer Index** | **Mechanism** |\n| --- | --- | --- |\n| **Iron Deficiency** | **> 13** | ê³¨ìˆ˜ê°€ ì¬ë£Œ(ì² )ê°€ ì—†ì–´ ì„¸í¬ë¥¼ **ì ê²Œ** ë§Œë“¦ (RBC â†“) â†’ ë¶„ëª¨ê°€ ì‘ì•„ì ¸ì„œ ê°’ ìƒìŠ¹ |\n| **Thalassemia** | **< 13** | ê³µì¥ì€ ì •ìƒì´ì§€ë§Œ ë¶ˆëŸ‰í’ˆì„ **ë§ì´** ì°ì–´ëƒ„ (RBC â†‘) â†’ ë¶„ëª¨ê°€ ì»¤ì ¸ì„œ ê°’ í•˜ë½ |\n- **Pica (ì´ì‹ì¦):** í™, ì í† , ì¢…ì´ ë“±ì„ ë¨¹ìŒ.\n- **Pagophagia:** ì–¼ìŒì„ ê°•ë°•ì ìœ¼ë¡œ ì”¹ì–´ ë¨¹ìŒ (Ice craving).\n### â˜… Management\n- **Strict Limit:** ìš°ìœ  ì„­ì·¨ë¥¼ í•˜ë£¨ **24oz (ì•½ 700ml) ë¯¸ë§Œ**ìœ¼ë¡œ ì œí•œí•©ë‹ˆë‹¤.\n- ì² ë¶„ ë³´ì¶©ì œë¥¼ íˆ¬ì—¬í•©ë‹ˆë‹¤.\n### ğŸ“‰ 4. Pancytopenia (ë²”í˜ˆêµ¬ ê°ì†Œì¦)\n**\"Production vs. Destruction\"**\n### ğŸ©º Clinical Scenario (Vignette)\nì•„ì´ê°€ ë©ì´ ì˜ ë“¤ê³ (Bruising), ì—´ì´ ë‚˜ë©°(Fever), ì°½ë°±í•©ë‹ˆë‹¤. CBC ê²€ì‚¬ìƒ ì í˜ˆêµ¬, ë°±í˜ˆêµ¬, í˜ˆì†ŒíŒì´ ëª¨ë‘ ë‚®ìŠµë‹ˆë‹¤(**Pancytopenia**). ì–´ë””ì„œë¶€í„° ì‹œì‘í•´ì•¼ í• ê¹Œìš”?\n### ğŸ§  Clinical Logic: Factory vs. Bouncer\nì›ì¸ì€ í¬ê²Œ ë‘ ê°€ì§€ì…ë‹ˆë‹¤.\n1. **Production Failure (ê³µì¥ì´ ë§í•¨):**\n    - **Aplastic Anemia (ì¬ìƒë¶ˆëŸ‰ì„± ë¹ˆí˜ˆ):** ê³¨ìˆ˜ ìƒê²€(Biopsy)ì„ í•˜ë©´ ì„¸í¬ê°€ ì—†ê³  ì§€ë°©(Fat)ë§Œ ê°€ë“í•©ë‹ˆë‹¤ (**Empty Factory**).\n    - ì›ì¸: ë°”ì´ëŸ¬ìŠ¤, ì•½ë¬¼, í˜¹ì€ ìœ ì „(Fanconi Anemia).\n    - **Fanconi Anemia:** í‚¤ê°€ ì‘ê³ , ì—„ì§€ì†ê°€ë½ ê¸°í˜•(Thumb abnormalities), ì¹´í˜ì˜¤ë ˆ ë°˜ì (CafÃ©-au-lait spots).\n2. **Destruction / Infiltration (ê³µì¥ì€ ë¶ë¹„ëŠ”ë° ë¬¼ê±´ì´ ì•ˆ ë‚˜ì˜´):**\n    - **Leukemia (ë°±í˜ˆë³‘):** ì•”ì„¸í¬(Blast)ê°€ ê³¨ìˆ˜ë¥¼ ê°€ë“ ì±„ì›Œ ì •ìƒ ì„¸í¬ê°€ ìë„ ê³µê°„ì´ ì—†ìŠµë‹ˆë‹¤ (Weeds choking the garden).\n    - **Hypersplenism (ë¹„ì¥ê¸°ëŠ¥í•­ì§„):** ë¹„ì¥ì´ ë„ˆë¬´ ì»¤ì ¸ì„œ í˜ˆêµ¬ë“¤ì„ ë‹¤ ì¡ì•„ê°€ë‘¡ë‹ˆë‹¤.\n### â˜… Physical Exam Key\n- **Spleen Size (ë¹„ì¥ í¬ê¸°):** ë¹„ì¥ì´ ë§Œê²¨ì§€ë‚˜ìš”?\n    - **Splenomegaly (+):** íŒŒê´´(Destruction)ë‚˜ ì¹¨ìœ¤(Infiltration/Leukemia)ì„ ì˜ì‹¬. ë¹„ì¥ì€ í˜ˆêµ¬ë“¤ì„ ê°€ë‘ëŠ” **\"Bouncer(ê¸°ë„)\"** ì—­í• ì„ í•©ë‹ˆë‹¤.\n    - **No Splenomegaly:** ìƒì‚° ë¶€ì „(Aplastic anemia)ì„ ì˜ì‹¬.","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-475","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_summary","text":"### ğŸ”¥ Rapid Fire Recap: The 3 Magic Numbers\nê°•ì˜ì—ì„œ ê°•ì¡°í•œ **ë°˜ë“œì‹œ ì™¸ì›Œì•¼ í•  3ê°€ì§€ ìˆ«ì**ì…ë‹ˆë‹¤.\n| **Number** | **Context** | **Meaning** |\n| --- | --- | --- |\n| **65%** | Neonatal Polycythemia | **Venous** Hematocritê°€ ì´ ì´ìƒì´ì–´ì•¼ ì§„ë‹¨ë¨ (Heel prick X). |\n| **24 oz** | Milk Anemia | ìœ ì•„ì˜ ìš°ìœ  ì„­ì·¨ ì œí•œëŸ‰ (ì´ë³´ë‹¤ ë§ì´ ë§ˆì‹œë©´ ì² ê²°í• ìœ„í—˜). |\n| **13** | Mentzer Index | MCV/RBC. **>13**ì´ë©´ Iron Deficiency, **<13**ì´ë©´ Thalassemia. |\n**Final Caveat:** ì´ ë‚´ìš©ì€ êµìœ¡ìš©ì´ë©°, ì‹¤ì œ ì•„í”ˆ ì•„ì´ ì•ì—ì„œëŠ” íŒŸìºìŠ¤íŠ¸ê°€ ì•„ë‹ˆë¼ **ë³‘ì› í”„ë¡œí† ì½œ(Hospital Protocol)**ì„ ë”°ë¥´ì„¸ìš”!.","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-492","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","recap"]}
{"chunk_type":"transcript_chunk","text":"# LM_OSRHM\n**Part 1: ê´€ì ˆì—¼ê³¼ ë¥˜ë§ˆí‹°ìŠ¤ (The Arthritic Patient)**\nê°€ì¥ í”í•˜ê³  ë°©ëŒ€í•œ ì£¼ì œì¸ ê´€ì ˆí†µì„ ê¸°ì „ë³„ë¡œ ë‚˜ëˆ„ì–´ ì •ë¦¬í•©ë‹ˆë‹¤.\n**Episode 1. ë¹„ì—¼ì¦ì„± ê´€ì ˆí†µê³¼ ê¸‰ì„± ë‹¨ê´€ì ˆì—¼ (Mechanical & Crystal)**\n- **ì£¼ì œ:**Â \"ë¬´ë¦ì´ ì‘¤ì…”ìš”(OA)\" vs \"ì—„ì§€ë°œê°€ë½ì´ ë¶ˆíƒ€ìš”(Gout/Septic)\".\n- **ë‚´ìš©:**Â ê³¨ê´€ì ˆì—¼ì˜ ê¸°ì „ê³¼ íŠ¹ì§•, í†µí’ê³¼ ê°€ì§œí†µí’ì˜ ê°ë³„, ê·¸ë¦¬ê³  ì‘ê¸‰ì¸ ê°ì—¼ì„± ê´€ì ˆì—¼(Septic Arthritis)ê³¼ ì„ì§ˆê·  ê°ì—¼. ì¶”ê°€ë¡œ ê¸°ê³„ì  ë¬¸ì œì¸ í„±ê´€ì ˆ(TMJ)ì„ í•¨ê»˜ ë‹¤ë£¹ë‹ˆë‹¤.\n- **Covered TOC Sections:**\n    - 1.1 Osteoarthritis\n    - 1.5 Septic Arthritis\n    - 1.6 Disseminated Gonococcal Infection\n    - 1.8 Gout\n    - 2.0 Temporomandibular Joint\n**Episode 2. ì „ì‹  ìê°€ë©´ì—­ ì§ˆí™˜ I (Systemic Autoimmune - RA & SLE)**\n- **ì£¼ì œ:**Â \"ì˜¨ëª¸ì˜ ê´€ì ˆì´ ì•„í”„ê³  í”¼ê³¤í•´ìš”\".\n- **ë‚´ìš©:**Â ë¥˜ë§ˆí‹°ìŠ¤ ê´€ì ˆì—¼(RA)ì˜ ì§„ë‹¨ê³¼ ì•½ë¬¼(Methotrexate ë¶€ì‘ìš©), í í‹° ì¦í›„êµ°. ì „ì‹  í™ë°˜ì„± ë£¨í‘¸ìŠ¤(SLE)ì˜ ë‹¤ì–‘í•œ ì„ìƒ ì–‘ìƒ(ì‹ ì¥, í”¼ë¶€) ë° í•­ì¸ì§€ì§ˆ ì¦í›„êµ°(APLA).\n- **Covered TOC Sections:**\n    - 1.2 Rheumatoid Arthritis\n    - 1.3 Felty Syndrome\n    - 1.9 SLE (Systemic Lupus Erythematosus)\n    - 1.10 APLA (Antiphospholipid Syndrome)\n    - 1.11 Mixed Connective Tissue Disorder\n**Episode 3.** ì „ì‹  ìê°€ë©´ì—­ ì§ˆí™˜ II (Spondylo & Connective Tissue)\n- ì£¼ì œ: \"í—ˆë¦¬ê°€ ë»£ë»£í•´ìš”\" & \"ëˆˆê³¼ ì…ì´ ë§ë¼ìš”\".\n- ë‚´ìš©: ê°•ì§ì„± ì²™ì¶”ì—¼ ë“± í˜ˆì²­ìŒì„± ì²™ì¶”ê´€ì ˆë³‘ì¦(Seronegative), ì‡¼ê·¸ë Œ ì¦í›„êµ°(ê±´ì¡°ì¦), ê²½í”¼ì¦(Scleroderma)ê³¼ ë ˆì´ë…¸ í˜„ìƒ.\n- Covered TOC Sections:\n    - 1.7 Seronegative Spondyloarthritis\n    - 1.12 Sjogren Syndrome\n    - 1.13 Scleroderma\n    - 10.2 Raynaudâ€™s Phenomenon (ë ˆì´ë…¸ëŠ” ê²½í”¼ì¦/í˜ˆê´€ì—¼ ë§¥ë½ì—ì„œ ë‹¤ë£¨ëŠ” ê²ƒì´ íš¨ìœ¨ì ì…ë‹ˆë‹¤)\n**Part 2: êµ­ì†Œ í†µì¦ê³¼ ìŠ¤í¬ì¸  ì˜í•™ (Regional Pain & Sports Med)**\n\"ì–´ë””ê°€ ì•„í”ˆì§€\"ì— ë”°ë¼ í•´ë¶€í•™ì ìœ¼ë¡œ ì ‘ê·¼í•©ë‹ˆë‹¤.\n**Episode 4. ìƒì§€ í†µì¦ I: ì–´ê¹¨ì™€ íŒ”ê¿ˆì¹˜ (Shoulder & Elbow)**\n- **ì£¼ì œ:**Â \"íŒ”ì„ ëª» ë“¤ê² ì–´ìš”\".\n- **ë‚´ìš©:**Â íšŒì „ê·¼ê°œ íŒŒì—´ vs ì˜¤ì‹­ê²¬(ìœ ì°©ì„± ê´€ì ˆë‚­ì—¼) ê°ë³„, ì–´ê¹¨ íƒˆêµ¬, ìƒê²¬ê°‘ ì‹ ê²½ í¬ì°©. íŒ”ê¿ˆì¹˜ í†µì¦(í…Œë‹ˆìŠ¤ ì—˜ë³´)ê³¼ ì£¼ë‘ ì ì•¡ë‚­ì—¼(Olecranon bursitis).\n- **Covered TOC Sections:**\n    - 3.2 Shoulder (3.2.1 Adhesive Capsulitis ~ 3.2.4 Suprascapular Nerve Entrapment)\n    - 3.4 Elbow\n    - 8.1 Olecranon Bursitis\n**Episode 5. ìƒì§€ í†µì¦ II: ì†ëª©ê³¼ ì† (Hand & Wrist)**\n- **ì£¼ì œ:**Â \"ì†ëª©ì´ ì €ë¦¬ê³  í˜¹ì´ ë‚¬ì–´ìš”\".\n- **ë‚´ìš©:**Â ì†ëª©í„°ë„ì¦í›„êµ°, ë“œí€˜ë¥´ë±… í˜ì¤„ìœ¤í™œì—¼, ë“€í”¼íŠ¸ë Œ êµ¬ì¶•, ê²°ì ˆì¢…(Ganglion Cyst).\n- **Covered TOC Sections:**\n    - 3.1 Carpal Tunnel\n    - 3.3 De Quervain Tendinopathy\n    - 3.5 Dupuytren Contractures\n    - 13.8 Ganglion Cyst\n**Episode 6. ì²™ì¶” ì§ˆí™˜ (The Spine)**\n- **ì£¼ì œ:**Â \"í—ˆë¦¬ì™€ ëª©ì´ ì•„íŒŒì„œ ë‹¤ë¦¬ê°€ ì €ë ¤ìš”\".\n- **ë‚´ìš©:**Â ì²™ì¶”ê´€ í˜‘ì°©ì¦(Neurogenic claudication), ë””ìŠ¤í¬(Radiculopathy), ì „ë°©ì „ìœ„ì¦, ì²™ì¶” ì™¸ìƒ ë° ì••ë°• ê³¨ì ˆ.\n- **Covered TOC Sections:**\n    - 5.0 Spine ì „ì²´ (5.1 Spondylosis ~ 5.9 Spine Trauma)\n**Episode 7. í•˜ì§€ í†µì¦ I: ê³ ê´€ì ˆê³¼ ë¬´ë¦ (Hip & Knee)**\n- **ì£¼ì œ:**Â \"ë¬´ë¦ì—ì„œ ì†Œë¦¬ê°€ ë‚˜ìš”\".\n- **ë‚´ìš©:**Â ì‹­ìì¸ëŒ€(ACL/PCL) ë° ë°˜ì›”ìƒ ì—°ê³¨ ì†ìƒ, ìŠ¬ê°œëŒ€í‡´ í†µì¦ ì¦í›„êµ°(Runner's knee), ë² ì´ì»¤ ë‚­ì¢…, ê³ ê´€ì ˆ ì ì•¡ë‚­ì—¼.\n- **Covered TOC Sections:**\n    - 4.1 Trochanteric Bursitis\n    - 4.2 Knee ì „ì²´ (4.2.1 Rupture ~ 4.2.7 Meniscal Tear)\n    - 8.2 Pes Anserine Bursitis","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-1","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"**Episode 8. í•˜ì§€ í†µì¦ II: ë°œê³¼ ë°œëª© (Foot & Ankle)**\n- **ì£¼ì œ:**Â \"ì•„ì¹¨ì— ì²« ë°œ ë””ë”œ ë•Œ ì•„íŒŒìš”\".\n- **ë‚´ìš©:**Â ì¡±ì €ê·¼ë§‰ì—¼, ì•„í‚¬ë ˆìŠ¤ ê±´ì—¼, ë°œëª© ì—¼ì¢Œ(Ottawa Rules), ìƒ¤ë¥´ì½” ê´€ì ˆ(ë‹¹ë‡¨ë°œ).\n- **Covered TOC Sections:**\n    - 4.3 Ankle & Foot ì „ì²´ (4.3.1 Plantar ~ 4.3.3 Calcaneal Apophysitis)\n    - 13.3 Charcot Joint\n**Part 3: ë¼ˆ ë³‘ë¦¬, ì™¸ìƒ, ì†Œì•„ (Pathology, Trauma, Peds)**\níŠ¹ì • ì§ˆí™˜êµ°ê³¼ ì†Œì•„ê³¼ ë‚´ìš©ì„ ë¬¶ì—ˆìŠµë‹ˆë‹¤.\n**Episode 9. ì™¸ìƒê³¼ ê³¨ì ˆ í•©ë³‘ì¦ (Trauma & Complications)**\n- **ì£¼ì œ:**Â \"ë„˜ì–´ì§„ í›„ ë¼ˆê°€ ë¶€ëŸ¬ì¡Œì–´ìš”\".\n- **ë‚´ìš©:**Â ì£¼ìš” ê³¨ì ˆ(ëŒ€í‡´ê³¨, ì†ëª©, ì‡„ê³¨), ì†Œì•„ ê³¨ì ˆ(Supracondylar, Greenstick), ê·¸ë¦¬ê³  ê³¨ì ˆ í•©ë³‘ì¦ì¸ êµ¬íš ì¦í›„êµ°, CRPS, ì§€ë°©ìƒ‰ì „ì¦ ë“±.\n- **Covered TOC Sections:**\n    - 7.0 Fracture ì „ì²´ (7.1 Femur ~ 7.8 Pelvic)\n    - 13.2 Compartment Syndrome\n    - 13.4 Complex Regional Pain Syndrome (CRPS)\n    - 13.5 Amputation\n    - 13.7 Myositis Ossificans (ì™¸ìƒ í›„ ë°œìƒ)\n**Episode 10. ë¼ˆì˜ ë³‘ë¦¬ì™€ ì¢…ì–‘ (Bone Pathology & Tumors)**\n- **ì£¼ì œ:**Â \"ë¼ˆê°€ ì•½í•´ì§€ê±°ë‚˜ í˜¹ì´ ìƒê²¼ì–´ìš”\".\n- **ë‚´ìš©:**Â ê³¨ë‹¤ê³µì¦ê³¼ ì•½ë¬¼(Bisphosphonate), ê³¨ìˆ˜ì—¼(Osteomyelitis), ë¬´í˜ˆì„± ê´´ì‚¬(AVN), ê³¨ì¢…ì–‘(Osteosarcoma, Ewing's ë“±). ì¸ê³µê´€ì ˆ ê°ì—¼ë„ ë¼ˆ ê°ì—¼ ë§¥ë½ì—ì„œ í•¨ê»˜ ë‹¤ë£¹ë‹ˆë‹¤.\n- **Covered TOC Sections:**\n    - 6.0 Bone Pathology ì „ì²´ (6.1 AVN ~ 6.5 Osteomyelitis)\n    - 11.1 Bisphosphonate Osteonecrosis\n    - 12.0 Tumors ì „ì²´ (12.1 ~ 12.3)\n    - 13.1 Prosthetic Joint\n    - 13.6 Langerhans Histiocytosis\n**Episode 11. í˜ˆê´€ì—¼ê³¼ ê·¼ìœ¡ë³‘ì¦ (Vasculitis & Myopathy)**\n- **ì£¼ì œ:**Â \"í˜ˆê´€ì— ì—¼ì¦ì´ ìˆê±°ë‚˜ ê·¼ìœ¡ì— í˜ì´ ì—†ì–´ìš”\".\n- **ë‚´ìš©:**Â í˜ˆê´€ì—¼(GCA, Takayasu, Kawasaki, Henoch-Schonlein ë“±), ê·¼ìœ¡ë³‘ì¦(Polymyositis, Dermatomyositis), ì¤‘ì¦ê·¼ë¬´ë ¥ì¦(Myasthenia Gravis).\n- **Covered TOC Sections:**\n    - 9.0 Vasculitis ì „ì²´ (9.1 ~ 9.3)\n    - 10.1 Myasthenia Gravis\n    - *Note:*Â ì†ŒìŠ¤ì˜ 10.0 MyopathyëŠ”ì—ì„œ ì—¼ì¦ì„± ê·¼ìœ¡ë³‘ì¦(Polymyositis ë“±)ì„ í¬í•¨í•˜ê³  ìˆìœ¼ë¯€ë¡œ ì´ ì—í”¼ì†Œë“œì—ì„œ ë‹¤ë£¹ë‹ˆë‹¤.\n**Episode 12. ì†Œì•„ ì •í˜•ì™¸ê³¼ (Pediatric Orthopedics)**\n- **ì£¼ì œ:**Â \"ì•„ì´ê°€ ë‹¤ë¦¬ë¥¼ ì ˆì–´ìš” (The Limping Child)\".\n- **ë‚´ìš©:**Â ë°œë‹¬ì„± ê³ ê´€ì ˆ ì´í˜•ì„±ì¦(DDH), LCPë³‘, SCFE ë“± ì†Œì•„ ê³ ê´€ì ˆ ì§ˆí™˜. ì†Œì•„ ë¥˜ë§ˆí‹°ìŠ¤(JIA). ì„±ì¥í†µ, ì•ˆì§±ë‹¤ë¦¬, ì²™ì¶”ì¸¡ë§Œì¦.\n- **Covered TOC Sections:**\n    - 1.4 Juvenile Idiopathic Arthritis (JIA)\n    - 14.0 Peads Musculocutaneous ì „ì²´ (14.1 Genu Varum ~ 14.11 Strength Training)\n### ğŸ“ Overview (TL;DR)\nì´ë²ˆ Deep DiveëŠ” **Joint Pain (ê´€ì ˆí†µ)**ì— ëŒ€í•œ ì´ì •ë¦¬ì…ë‹ˆë‹¤. ë‹¨ìˆœí•œ í†µì¦ ê´€ë¦¬ê°€ ì•„ë‹ˆë¼, **\"ë†“ì¹˜ë©´ í°ì¼ ë‚˜ëŠ” ì‘ê¸‰ ì§ˆí™˜(Septic Arthritis)\"**ë¶€í„° **\"ì‚¶ì˜ ì§ˆì„ ë–¨ì–´ëœ¨ë¦¬ëŠ” ë§Œì„± ì§ˆí™˜(OA)\"**ê¹Œì§€, ê·¸ë¦¬ê³  **\"íƒì •ì²˜ëŸ¼ ì°¾ì•„ë‚´ì•¼ í•˜ëŠ” ì „ì‹  ì§ˆí™˜(Vasculitis, DGI)\"**ê¹Œì§€ í­ë„“ê²Œ ë‹¤ë£¹ë‹ˆë‹¤.\n- **í•µì‹¬ ì£¼ì œ:** Septic Arthritis vs Gout vs OA vs RA vs Spondyloarthropathies\n- **Key Skills:** ê´€ì ˆì•¡ ë¶„ì„(Synovial Fluid Analysis) í•´ì„ ëŠ¥ë ¥, \"Doorway Diagnosis\" (í™˜ì ë³´ìë§ˆì ì§„ë‹¨í•˜ê¸°).\n- **Must-Know:** Kocher Criteria (ì†Œì•„), Fight Bite ê´€ë¦¬ë²•, Gonorrhea Triad, OAì˜ ë‹¨ê³„ë³„ ì¹˜ë£Œ.","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-21","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### ğŸŒ³ Top-down Classification: Joint Pain\nì´ ê°•ì˜ëŠ” **Joint Pain**ì´ë¼ëŠ” ê±°ëŒ€í•œ ìˆ²ì—ì„œ ì‹œì‘í•˜ì—¬, ì—¼ì¦ì„±(Inflammatory)ì¸ì§€ ë¹„ì—¼ì¦ì„±(Non-inflammatory)ì¸ì§€, ê·¸ë¦¬ê³  ë‹¨ê´€ì ˆ(Mono)ì¸ì§€ ë‹¤ê´€ì ˆ(Poly)ì¸ì§€ë¥¼ êµ¬ë¶„í•´ ë‚˜ê°€ëŠ” ê³¼ì •ì…ë‹ˆë‹¤.\nPlaintext\n`JOINT PAIN (The Big Picture)\nâ”‚\nâ”œâ”€â”€ Monoarthritis (ë‹¨ê´€ì ˆì—¼: 1 Joint, Red, Hot, Swollen)\nâ”‚   â”œâ”€â”€ EMERGENCY (ë†“ì¹˜ë©´ ê´€ì ˆ íŒŒê´´/ì‚¬ë§)\nâ”‚   â”‚   â””â”€â”€ Septic Arthritis (Infection) ğŸš¨\nâ”‚   â”‚       â”œâ”€â”€ Adult: Staph aureus (MC)\nâ”‚   â”‚       â”œâ”€â”€ Young/Sexually Active: N. gonorrhoeae (DGI)\nâ”‚   â”‚       â””â”€â”€ Pediatric: Hip/Knee (Kocher Criteria)\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Crystal Arthropathies (Inflammatory)\nâ”‚   â”‚   â”œâ”€â”€ Gout (MSU crystals)\nâ”‚   â”‚   â””â”€â”€ Pseudogout (CPPD crystals)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Trauma / Structural\nâ”‚       â”œâ”€â”€ Fight Bite (Eikenella corrodens) ğŸ¥Š\nâ”‚       â””â”€â”€ Hemarthrosis\nâ”‚\nâ”œâ”€â”€ Polyarthritis (ë‹¤ê´€ì ˆì—¼)\nâ”‚   â”œâ”€â”€ Non-Inflammatory (Mechanical)\nâ”‚   â”‚   â””â”€â”€ Osteoarthritis (OA) - Wear & Tear + Metabolic âš™ï¸\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Inflammatory (Systemic)\nâ”‚   â”‚   â”œâ”€â”€ Rheumatoid Arthritis (RA)\nâ”‚   â”‚   â”œâ”€â”€ Spondyloarthropathies (Seronegative)\nâ”‚   â”‚   â”‚   â”œâ”€â”€ Ankylosing Spondylitis (Bamboo Spine) ğŸ‹\nâ”‚   â”‚   â”‚   â”œâ”€â”€ Reactive Arthritis (Reiter's)\nâ”‚   â”‚   â”‚   â”œâ”€â”€ Psoriatic Arthritis\nâ”‚   â”‚   â”‚   â””â”€â”€ IBD-associated\nâ”‚   â”‚   â”‚\nâ”‚   â”‚   â””â”€â”€ Vasculitis / Systemic\nâ”‚   â”‚       â”œâ”€â”€ Henoch-Schonlein Purpura (HSP) - IgA\nâ”‚   â”‚       â””â”€â”€ Cryoglobulinemia (Hep C assoc.)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Others\nâ”‚       â”œâ”€â”€ TMJ Dysfunction ğŸ¦·\nâ”‚       â””â”€â”€ Hemochromatosis (Hook-like osteophytes)\nâ”‚\nâ””â”€â”€ Synovial Fluid Analysis (The Golden Key ğŸ”‘)\n    â”œâ”€â”€ Normal: < 200 WBCs\n    â”œâ”€â”€ Non-inflammatory (OA): 200 - 2,000 WBCs\n    â”œâ”€â”€ Inflammatory (Gout/RA): 2,000 - 50,000 WBCs\n    â””â”€â”€ Septic (Infection): > 50,000 WBCs (Neutrophils > 90%) ğŸ’£`\n# [Ep 01] Joint Pain Deep Dive ğŸ¤¿\n## 1.0 The Healthy Joint: An Engineering Marvel ğŸ¦´\n- **Concept:** ê±´ê°•í•œ ê´€ì ˆì€ \"ì–¼ìŒ ìœ„ì˜ ì–¼ìŒ(Ice on Ice)\"ë³´ë‹¤ ë§ˆì°°ê³„ìˆ˜ê°€ ë‚®ìŠµë‹ˆë‹¤.\n- **Structure:** Articular cartilage + Synovial fluidê°€ ì™„ë²½í•œ ìœ¤í™œìœ  ì—­í• ì„ í•˜ì—¬ ë§ˆì°°ì´ ê±°ì˜ 0ì— ê°€ê¹ìŠµë‹ˆë‹¤.\n- **Pathology:** ì´ ê¸°ê³„ì¥ì¹˜ê°€ ê³ ì¥ ë‚˜ë©´ ë”ì°í•œ ì¼ì´ ë°œìƒí•©ë‹ˆë‹¤. ë‹¨ìˆœí•œ í†µì¦(Ache)ì´ ì•„ë‹ˆë¼ ê¸°ê³„ì  ë¶•ê´´(Breakdown)ë¥¼ ì˜ë¯¸í•©ë‹ˆë‹¤.\n## 2.0 Septic Arthritis (The Emergency) ğŸš¨\n**\"Never let the sun set on a Septic Joint.\"** (ì ˆëŒ€ í•´ê°€ ì§€ê²Œ ë‘ì§€ ë§ˆë¼. ì¦‰, ì¦‰ì‹œ í•´ê²°í•´ë¼!)\n### ğŸšª Doorway Thought (Vignette)\n- **Scenario:** ER ë¬¸ì„ ì—´ì—ˆì„ ë•Œ, í™˜ìê°€ ë¬´ë¦(ë˜ëŠ” ê³ ê´€ì ˆ)ì„ ë¶€ì—¬ì¡ê³  **ì ˆëŒ€ ì›€ì§ì´ë ¤ í•˜ì§€ ì•ŠìŒ(Refusal to move)**.\n- **Key Sign:** Active motion ë¿ë§Œ ì•„ë‹ˆë¼ **Passive motion** (ì˜ì‚¬ê°€ ë‹¤ë¦¬ë¥¼ ë“¤ì–´ ì˜¬ë¦¬ë ¤ í•  ë•Œ)ì—ë„ ìì§€ëŸ¬ì§€ëŠ” ë¹„ëª…ì„ ì§€ë¦„.\n- **Visual:** Red, Hot, Swollen Joint (Monoarticular).\n### ğŸ©º Diagnosis & Workup\n- **Gold Standard:** **Arthrocentesis (Joint Aspiration)**. ë°”ëŠ˜ ê½‚ì•„ì„œ ë¬¼ ë½‘ì•„ì•¼ í•©ë‹ˆë‹¤! â˜…\n    - **The Magic Number:** **WBC > 50,000/mm3** (Neutrophils > 90%)\n    - *Caveat:* ë¥˜ë§ˆí‹°ìŠ¤ ê´€ì ˆì—¼(RA)ì´ë‚˜ í†µí’(Gout) ë°œì‘ ì‹œì—ë„ 50k ê·¼ì²˜ê¹Œì§€ ê°ˆ ìˆ˜ ìˆì§€ë§Œ, 50kê°€ ë„˜ìœ¼ë©´ ì¼ë‹¨ **Septic**ìœ¼ë¡œ ê°„ì£¼í•˜ê³  ì¹˜ë£Œí•´ì•¼ í•¨.\n- **Mechanism:** ë°±í˜ˆêµ¬(Neutrophil)ê°€ ë°•í…Œë¦¬ì•„ë¥¼ ì£½ì´ë ¤ê³  íš¨ì†Œ(Proteolytic enzymes)ë¥¼ ë¿œì–´ë‚´ëŠ”ë°, ì´ê²Œ ë°•í…Œë¦¬ì•„ë§Œ ì£½ì´ëŠ” ê²Œ ì•„ë‹ˆë¼ **ì—°ê³¨(Cartilage)ë„ ë…¹ì—¬ë²„ë¦¼**.\n    - **Time limit:** 24~48ì‹œê°„ ì•ˆì— ê´€ì ˆì´ ì˜êµ¬ì ìœ¼ë¡œ íŒŒê´´ë  ìˆ˜ ìˆìŒ.\n### ğŸ’Š Management (Next Best Step)\n1. **Tap the Joint (Aspiration):** ì§„ë‹¨ ë° ì••ë ¥ í•´ì†Œ(Pain relief).\n2. **Antibiotics:** ì¦‰ì‹œ ì‹œì‘ (Empiric).\n    - Adult: **Vancomycin + Ceftriaxone** (Staph aureus & Gram negatives ì»¤ë²„).\n3. **Surgical Drainage (Washout):** ê³ ë¦„(Pus)ì„ ì”»ì–´ë‚´ì•¼ í•¨. \"Drain the abscess.\"\n### ğŸ‘¶ Pediatric Considerations (The Limping Child)\n- **Vignette:** 2ì„¸ ì•„ì´ê°€ ë‹¤ë¦¬ë¥¼ ì ˆê±°ë‚˜(Limping), ì•„ì˜ˆ ê¸°ì–´ ë‹¤ë‹ˆì§€ ì•Šìœ¼ë ¤ í•¨(Refuses to crawl).\n- **Differential:** Septic Arthritis vs **Transient Synovitis** (ì¼ê³¼ì„± í™œë§‰ì—¼ - \"Hipì˜ ê°ê¸°\").\n    - Transient Synovitis: ë°”ì´ëŸ¬ìŠ¤ ê°ì—¼ í›„ ë°œìƒ, ì €ì ˆë¡œ ì¢‹ì•„ì§ (Benign).\n- **Kocher Criteria (Septic Hip ê°ë³„ë²•) â˜…:**\n    1. **Non-weight bearing:** ì•„ì˜ˆ ê±·ì§€ ëª»í•¨.\n    2. **Fever:** > 38.5Â°C (101.3Â°F).\n    3. **ESR:** > 40 mm/hr.\n    4. **WBC:** > 12,000 (Serum).\n    - *Probability:* 4ê°œ ë‹¤ ìˆìœ¼ë©´ 99% Septic Arthritis â†’ **OR(ìˆ˜ìˆ ì‹¤)ë¡œ ì§í–‰**.\n- Diagnosis is unclear â†’ **bilateral hip sonography**\n    - Even if ì¦ìƒì´ í•œìª½ì— ìˆì–´ë„ ì–‘ìª½ì— fluid in the both hips in Transient synovitis\n    - ì¦ìƒì´ í•œìª½ì—ë§Œ ìˆìœ¼ë©´ â†’ septic arthritis í™•ë¥  ì˜¬ë¼ê° â†’ diagnostic arthocentesis","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-41","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"## 3.0 Fight Bite (Clenched Fist Injury) ğŸ¥Š\n**\"The Lie in the History.\"** í™˜ìëŠ” ê±°ì§“ë§ì„ í•©ë‹ˆë‹¤.\n### ğŸšª Doorway Thought\n- **Scenario:** ë‚¨ìê°€ ì†ë“±(Knuckle, MCP joint)ì— ì‘ì€ ìƒì²˜(Laceration)ë¥¼ ì…ê³  ì˜´. \"ì„¤ê±°ì§€í•˜ë‹¤ ë² ì˜€ì–´ìš”\" í˜¹ì€ \"ë„˜ì–´ì¡Œì–´ìš”\"ë¼ê³  í•¨.\n- **Truth:** ëˆ„êµ°ê°€ì˜ **ì´ë¹¨(Tooth)**ì„ ì£¼ë¨¹ìœ¼ë¡œ ë•Œë¦° ê²ƒì„. (Human Bite).\n### ğŸ¦  Pathophysiology\n- **Anatomy:** ì£¼ë¨¹ì„ ì¥ì—ˆì„ ë•Œ(Fist), í˜ì¤„(Extensor tendon)ê³¼ í”¼ë¶€ê°€ íŒ½íŒ½í•˜ê²Œ ë‹¹ê²¨ì§ â†’ ì´ë¹¨ì´ ëš«ê³  ë“¤ì–´ê° â†’ ê´€ì ˆë‚­(Joint capsule)ì— ê·  ì£¼ì….\n- **The Trap:** ì†ì„ í´ë©´(Relax), í˜ì¤„ê³¼ í”¼ë¶€ê°€ ë¯¸ë„ëŸ¬ì ¸ ì œìë¦¬ë¡œ ëŒì•„ì˜¤ë©´ì„œ **êµ¬ë©ì´ ì–´ê¸‹ë‚¨ (Sliding Door effect)**.\n    - ê²°ê³¼: ê· ì´ ê¹Šìˆ™í•œ ê³³(í˜ê¸°ì„± í™˜ê²½)ì— ê°‡í˜€ë²„ë¦¼. ğŸ¦ ğŸ”’\n- **Bug:** **Eikenella corrodens** (Human mouth flora, Anaerobe) + Staph/Strep. \"Poly-microbial party.\"\n### ğŸš« Management Rules\n- **Absolute Rule:** **NEVER SUTURE (ì ˆëŒ€ ë´‰í•© ê¸ˆì§€).** ğŸ§µâŒ\n    - ë´‰í•©í•˜ë©´ ë†ì–‘(Abscess)ì„ ë°€ë´‰í•´ë²„ë¦¬ëŠ” ê¼´.\n- **Treatment:**\n    1. **Irrigation & Debridement:** ì”»ì–´ë‚´ê³  ì£½ì€ ì¡°ì§ ì œê±°.\n    2. **Antibiotics:** **Amoxicillin-Clavulanate (Augmentin)** (PO) or **Ampicillin-Sulbactam (Unasyn)** (IV).\n    3. **Secondary Intention:** ìƒì²˜ê°€ ì—´ë¦° ì±„ë¡œ ì•„ë¬¼ê²Œ ë‘ .\n## 4.0 Disseminated Gonococcal Infection (DGI) ğŸ†ğŸ”¥\n- *\"Sexually Active Young Adult\"**ì˜ ë‹¨ê´€ì ˆì—¼ ì›ì¸ 1ìˆœìœ„.\n### ğŸšª Doorway Thought\n- **Presentation 1:** Purulent Monoarthritis (Septic Kneeì²˜ëŸ¼ ë³´ì„).\n- **Presentation 2 (The Triad):**\n    1. **Tenosynovitis:** ì†ëª©, ë°œëª© í˜ì¤„ì˜ ì—¼ì¦/í†µì¦.\n    2. **Dermatitis:** Pustules (ê³ ë¦„ì§‘) on extremities (íŒ”ë‹¤ë¦¬ì— ë“œë¬¸ë“œë¬¸ ë‚œ ì—¬ë“œë¦„ ê°™ì€ ê²ƒ).\n    3. **Migratory Polyarthralgia:** ì—¬ê¸°ì €ê¸° ê´€ì ˆì´ ëŒì•„ê°€ë©° ì•„í””.\n### ğŸ•µï¸ Diagnosis Dilemma\n- **Trap:** ë¬´ë¦ì—ì„œ ë¬¼ì„ ë½‘ì•„ë„ ë°°ì–‘(Culture)ì´ **ìŒì„±(Negative)**ì¸ ê²½ìš°ê°€ ë§ìŒ. (ê· ì´ ê¹Œë‹¤ë¡œì›€ - Fastidious).\n- **Gold Standard:** **NAAT (Nucleic Acid Amplification Test)**.\n    - **Tip:** ë¬´ë¦ë§Œ ì°Œë¥´ì§€ ë§ê³ , **Urethra (ìš”ë„), Rectum (í•­ë¬¸), Pharynx (ëª©êµ¬ë©)** ë“± ê· ì´ ë“¤ì–´ì™”ì„ ë²•í•œ ëª¨ë“  ì…êµ¬ë¥¼ ë‹¤ ê¸ì–´ì•¼ í•¨(Swab).\n### ğŸ’Š Treatment\n- **IV Ceftriaxone** (Gonorrhea) + **Azithromycin or Doxycycline** (Chlamydia Co-infection ì»¤ë²„).\n## 5.0 Osteoarthritis (OA) ğŸ‘µâš™ï¸","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-61","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"**\"Wear and Tear... and Repair?\"**\n### ğŸšª Doorway Thought\n- **Patient:** 40ëŒ€ ì´ìƒ (ë‚˜ì´ ë“¦).\n- **Symptom:** **Pain worse with use**, better with rest. (ì“°ë©´ ì•„í”„ê³  ì‰¬ë©´ ë‚«ë‹¤).\n- **Morning Stiffness:** **< 30 minutes** (ì§§ë‹¤. ì»¤í”¼ í•œ ì” ë§ˆì‹¤ ì‹œê°„ì´ë©´ í’€ë¦¼). â˜•ï¸\n### ğŸ§¬ Concept Update\n- ë‹¨ìˆœí•œ \"íƒ€ì´ì–´ ë§ˆëª¨\"ê°€ ì•„ë‹˜. ì—°ê³¨ ì„¸í¬(Chondrocyte)ê°€ ì†ìƒì„ ë³µêµ¬í•˜ë ¤ê³  íš¨ì†Œë„ ë‚´ê³  ì—¼ì¦ ë¬¼ì§ˆë„ ë‚´ëŠ” **Active Metabolic Process (ì‹¤íŒ¨í•œ ë³µêµ¬ ê³¼ì •)**ì„.\n- **Synovial Fluid:** **Non-inflammatory** (WBC 200 ~ 2,000). ë§‘ê±°ë‚˜ ì˜…ì€ í˜¸ë°•ìƒ‰.\n### âœ‹ Physical Exam (Hands)\n- **DIP Joint:** **Heberden's Nodes** (ì†ê°€ë½ ëë§ˆë”” íˆ­ íŠ€ì–´ë‚˜ì˜´).\n- **PIP Joint:** **Bouchard's Nodes** (ì¤‘ê°„ ë§ˆë””).\n- **CMC Joint:** ì—„ì§€ì†ê°€ë½ ë¿Œë¦¬ (Squaring of the thumb).\n- **Crucial Distinction:** **Spares the MCPs** (Knuckleì€ ì¹¨ë²” ì•ˆ í•¨. ì—¬ê¸°ê°€ ì•„í”„ë©´ RA ì˜ì‹¬!).\n### ğŸ’ Iron Overload Hint (Hemochromatosis)\n- ë§Œì•½ \"OA ê°™ì€ë°\" **2nd & 3rd MCP joint**ì— **Hook-like Osteophytes (ê°ˆê³ ë¦¬ ê°™ì€ ë¼ˆ ëŒê¸°)**ê°€ ë³´ì¸ë‹¤?\n- **Diagnosis:** **Hereditary Hemochromatosis** (ìœ ì „ì„± í˜ˆìƒ‰ì†Œì¹¨ì°©ì¦) ê°•ë ¥ ì˜ì‹¬! ğŸ§²\n### ğŸªœ Management (Step-up Approach)\n1. **Step 1 (Non-Pharm):** **Weight Loss & Exercise.** (ê°€ì¥ ì¤‘ìš”! â˜…)\n    - ì²´ì¤‘ 1kg ì¤„ì´ë©´ ë¬´ë¦ ì••ë ¥ 4kg ê°ì†Œ.\n    - Quadriceps strengthening (ëŒ€í‡´ì‚¬ë‘ê·¼ ê°•í™”) â†’ ê´€ì ˆ ì•ˆì •í™”.\n2. **Step 2 (Topical):** **Topical NSAIDs** (Diclofenac gel) - ì „ì‹  ë¶€ì‘ìš© ì ìŒ.\n3. **Step 3 (Oral):** **Oral NSAIDs** (Naproxen etc.) or **Duloxetine** (SNRI, ë§Œì„± í†µì¦ ì¡°ì ˆ).\n    - *Note:* Acetaminophen(Tylenol)ì€ ì´ì œ 1ì°¨ ì„ íƒì œê°€ ì•„ë‹˜ (íš¨ê³¼ ë¯¸ë¯¸).\n4. **Step 4 (End Stage):** **Total Joint Arthroplasty (ì¸ê³µê´€ì ˆ ì¹˜í™˜ìˆ )**. ì‚¶ì˜ ì§ˆì´ ë°”ë‹¥ì¼ ë•Œ.\n## 6.0 Spondyloarthropathies (Seronegative) ğŸ§˜â€â™‚ï¸\n**\"The Inflammatory Back Pain.\"**\n### 6.1 Ankylosing Spondylitis (ê°•ì§ì„± ì²™ì¶”ì—¼) ğŸ‹\n- **Vignette:** ì Šì€ ë‚¨ì„± (<40ì„¸). ë§Œì„± í—ˆë¦¬ í†µì¦.\n- **Pain Pattern:** **Worse with Rest, Better with Exercise.** (OAì™€ ì •ë°˜ëŒ€!). ë°¤ì— ì•„íŒŒì„œ ê¹¸.\n- **Pathology:** **Enthesitis** (ì¸ëŒ€/í˜ì¤„ì´ ë¼ˆì— ë¶™ëŠ” ìë¦¬ì˜ ì—¼ì¦).\n- **Imaging:** sacroiliitis (ì²œì¥ê´€ì ˆì—¼) â†’ **Bamboo Spine** (ì²™ì¶”ê°€ ëŒ€ë‚˜ë¬´ì²˜ëŸ¼ êµ³ìŒ).\n- **Association:** **HLA-B27**. **Anterior Uveitis** (ëˆˆ ì¶©í˜ˆ, í†µì¦ - ì¦‰ì‹œ ì•ˆê³¼!).\n- **Treatment:** NSAIDs (1st line) â†’ ì‹¤íŒ¨í•˜ë©´ **TNF Inhibitors** (Infliximab, Etanercept). â†’ anti IL-17 (secukinumab)\n### 6.2 Reactive Arthritis (Reiter's Syndrome) ğŸ¦ \n- **Mnemonic:** **\"Can't see, can't pee, can't climb a tree.\"**\n    - Conjunctivitis/Uveitis (Can't see)\n    - Urethritis (Can't pee)\n    - Arthritis (Can't climb a tree)\n- **Trigger:** GI infection (Campylobacter, Salmonella, Shigella, Yersinia) or Chlamydia.\n## 7.0 Vasculitis & Systemic Causes ğŸ©¸","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-81","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"### 7.1 Henoch-Schonlein Purpura (HSP) / IgA Vasculitis\n- **Patient:** ì£¼ë¡œ ì†Œì•„ (Pediatric).\n- **Tetrad:**\n    1. **Palpable Purpura:** ì—‰ë©ì´(Buttocks)ì™€ ë‹¤ë¦¬ ë’¤ìª½ì— ë§Œì ¸ì§€ëŠ” ìë°˜.\n    2. **Arthritis/Arthralgia:** ê´€ì ˆí†µ.\n    3. **Abdominal Pain:** ë°° ì•„í”” (Intussusception ìœ„í—˜). (Ileo-Ileal)\n    4. **Renal Disease:** **IgA Nephropathy** (í˜ˆë‡¨).\n### 7.2 Cryoglobulinemia â„ï¸\n- **Link:** **Hepatitis C (HCV)**ì™€ ê°•ë ¥í•œ ì—°ê´€ì„±.\n- **Mechanism:** ì°¨ê°€ìš´ ì˜¨ë„ì—ì„œ ë‹¨ë°±ì§ˆ(Cryoglobulins)ì´ ë­‰ì³ì„œ í˜ˆê´€ ë§‰ìŒ.\n- **Labs:** **Low C4**, Positive Rheumatoid Factor (RF), HCV RNA (+).\n    - cf. RFì–‘ì„±ì´ì—¬ë„ RAë©´ C4ì •ìƒì„. RFì–‘ì„±ì¸ë° C4ì •ìƒì´ë©´? â†’ HCV ê¸°ì™•ë ¥ í™•ì¸í•˜ê³  crygolobulinemiaì˜ì‹¬!\n- **Sx:** Palpable Purpura, Weakness, Arthralgias (Melted's Triad).\n## 8.0 TMJ Dysfunction (Temporomandibular Joint) ğŸ¦·\n- **Symptom:** í„±ì—ì„œ \"ë”±ë”±\" ì†Œë¦¬(Clicking/Popping), ì”¹ì„ ë•Œ í†µì¦, ê·€ í†µì¦(Otalgia).\n- **Cause:** **Bruxism** (ì´ê°ˆì´), ìŠ¤íŠ¸ë ˆìŠ¤.\n- **Exam:** ì… ë²Œë¦´ ë•Œ í„± ê·¼ìœ¡ ì••í†µ, ì†Œë¦¬ í™•ì¸.\n- **Tx:** Conservative first! Soft diet (ë¶€ë“œëŸ¬ìš´ ìŒì‹), Night guard (ë§ˆìš°ìŠ¤í”¼ìŠ¤), NSAIDs.\n## âš¡ï¸ RAPID FIRE RECAP (Summary Table)\n| **Condition** | **Key Vignette / Symptom** | **Synovial Fluid WBC** | **Gold Standard / Next Step** | **Treatment Highlights** |\n| --- | --- | --- | --- | --- |\n| **Septic Arthritis** | Red, Hot, Single Joint, **Refusal to move** | **> 50,000** (>90% PMN) | **Arthrocentesis** (Tap it!) | **IV Abx + Washout (Drainage)** |\n| **Gout** | Podagra (Big toe), sudden onset | 2,000 - 50,000 (Crystals) | Polarized Microscopy (Needle shape, Neg birefringent) | NSAIDs, Colchicine, Steroids (Acute) |\n| **OA** | Older, Worse with use, DIP/PIP involved | < 2,000 (Non-inflam) | X-ray (Joint space narrowing, Osteophytes) | **Weight Loss**, Exercise, NSAIDs |\n| **Fight Bite** | Cut on knuckle (MCP), punched mouth | N/A | History taking (Look for lie) | **Augmentin**, **NEVER SUTURE** |\n| **DGI** | Sexually active, Triad (Tenosynovitis, Rash, Polyarthralgia) | Often Negative culture | **NAAT** (Urethra, Rectum, Throat) | Ceftriaxone + Azithro/Doxy |\n| **Ankylosing Spondylitis** | Young male, Back pain better w/ exercise | N/A | X-ray (Sacroiliitis), HLA-B27 | NSAIDs â†’ TNF Inhibitors |\n| **HSP (IgA)** | Kid, Palpable purpura on butt, Abd pain | N/A | Clinical Dx, Urinalysis (Hematuria) | Supportive (Hydration, NSAIDs) |\n### ğŸ’¡ Final Wisdom\n**(Confidence: 1.0) - All content extracted from audio and structured for USMLE prep.**\n# ğŸ©º **USMLE Step 2 CK: Systemic Autoimmune Disorders Deep Dive**\n**(Rheumatoid Arthritis, SLE, Felty, MCTD)**","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-101","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### ğŸŒ³ **Big Picture: Classification & Mental Model**\nUSMLEì—ì„œ ë¥˜ë§ˆí‹°ìŠ¤í•™ì„ ì ‘ê·¼í•  ë•Œ ê°€ì¥ ì¤‘ìš”í•œ ê²ƒì€ **\"Pattern Recognition\"**ê³¼ **\"Antibody Correlation\"**ì…ë‹ˆë‹¤. ë‹¨ìˆœíˆ ê´€ì ˆì´ ì•„í”„ë‹¤ê°€ ì•„ë‹ˆë¼, ì–´ë–¤ íŒ¨í„´ìœ¼ë¡œ ì•„í”ˆì§€, ê·¸ë¦¬ê³  ì–´ë–¤ ì¥ê¸°ê°€ ê°™ì´ ë§ê°€ì§€ëŠ”ì§€ë¥¼ ë´ì•¼ í•©ë‹ˆë‹¤.\nPlaintext\n`SYSTEMIC AUTOIMMUNE DISORDERS (The \"Body attacking itself\")\nâ”‚\nâ”œâ”€â”€ JOINT-PREDOMINANT (Erosive)\nâ”‚   â””â”€â”€ Rheumatoid Arthritis (RA)\nâ”‚       â”œâ”€â”€ Key Path: Synovial Pannus (Inflammation)\nâ”‚       â”œâ”€â”€ Key Symptom: Morning Stiffness > 1hr (\"Gel Phenomenon\")\nâ”‚       â””â”€â”€ Complications:\nâ”‚           â”œâ”€â”€ Felty Syndrome (RA + Neutropenia + Splenomegaly)\nâ”‚           â””â”€â”€ C1-C2 Instability (Life Threatening!)\nâ”‚\nâ”œâ”€â”€ MULTI-SYSTEM (Vascultis/Organ Damage)\nâ”‚   â””â”€â”€ Systemic Lupus Erythematosus (SLE)\nâ”‚       â”œâ”€â”€ Key Path: Immune Complex Deposition (Type III)\nâ”‚       â”œâ”€â”€ Key Vibe: \"Fatigued Young Woman with Multiorgan Issues\"\nâ”‚       â”œâ”€â”€ Specifics: Malar Rash, Nephritis, Cerebritis\nâ”‚       â””â”€â”€ Variant: Drug-Induced Lupus (Histone Ab)\nâ”‚\nâ”œâ”€â”€ OVERLAP SYNDROMES\nâ”‚   â””â”€â”€ Mixed Connective Tissue Disease (MCTD)\nâ”‚       â”œâ”€â”€ Key Path: Features of SLE + Systemic Sclerosis + Polymyositis\nâ”‚       â””â”€â”€ Marker: Anti-U1-RNP\nâ”‚\nâ””â”€â”€ THROMBOTIC/OBSTETRIC\n    â””â”€â”€ Antiphospholipid Syndrome (APLA)\n        â”œâ”€â”€ Key Path: Hypercoagulable State\n        â””â”€â”€ Outcome: Clots (Arterial/Venous) + Pregnancy Loss`\n- 50k ë„˜ìœ¼ë©´ septic joint arthritis until proven otherwise\n# 1. Rheumatoid Arthritis (RA) ğŸ¦´ğŸ”¥\n*The \"Morning Paralysis\" Disease*\n### ğŸšª **Doorway Thought (Vignette Anchor)**\n40-50ëŒ€ ì—¬ì„±ì´ ì•„ì¹¨ì— ì¼ì–´ë‚¬ëŠ”ë° ì¹¨ëŒ€ ëì— ê±¸í„°ì•‰ì•„ ìˆìŠµë‹ˆë‹¤. ë‹¨ìˆœíˆ í”¼ê³¤í•œ ê²Œ ì•„ë‹ˆë¼ **\"Gel Phenomenon\"** ë•Œë¬¸ì— ì›€ì§ì¼ ìˆ˜ê°€ ì—†ìŠµë‹ˆë‹¤. ì†ì´ ì‹œë©˜íŠ¸ì— êµ³ì€ ê²ƒì²˜ëŸ¼ ë»£ë»£í•˜ë©°, ì´ ì¦ìƒì´ **1ì‹œê°„ ì´ìƒ(>1hr)** ì§€ì†ë©ë‹ˆë‹¤.\n### ğŸ” **Clinical Features & \"The Vibe\"**\n- **Stiffness Duration:** â˜… **> 1 Hour** (ê°€ì¥ ì¤‘ìš”í•œ êµ¬ë³„ì ). OAëŠ” ë³´í†µ 15-30ë¶„ ì´ë‚´ì— í’€ë¦¼.\n- **Joint Pattern:**\n    - **Symmetric** (ëŒ€ì¹­ì ).\n    - **Small Joints:** MCP, PIP, Wrist ì¹¨ë²”.\n    - **SPARES DIP:** â˜… DIP(ì†ê°€ë½ ëë§ˆë””)ëŠ” ì¹¨ë²”í•˜ì§€ ì•ŠìŒ! (DIP ì¹¨ë²”ì€ OAì˜ Heberden's node).\n- **Texture:** ë§Œì ¸ë³´ë©´ **Soft, Warm, Boggy** (Sponge ê°™ìŒ). ë°˜ë©´ OAëŠ” Hard, Bonyí•¨.\n### ğŸ§ª **Diagnosis (Workup)**\n| **Lab Test** | **Sensitivity/Specificity** | **Notes** |\n| --- | --- | --- |\n| **RF (Rheumatoid Factor)** | Sensitive | ë¯¼ê°ë„ëŠ” ë†’ì§€ë§Œ íŠ¹ì´ë„ê°€ ë‚®ìŒ (ë‹¤ë¥¸ ë³‘ì—ì„œë„ ì–‘ì„± ê°€ëŠ¥). |\n| **Anti-CCP** | **Specific (Gold Standard)** | â˜… **ê°€ì¥ ì¤‘ìš”í•œ í™•ì§„ ê²€ì‚¬.** RAì— ë§¤ìš° íŠ¹ì´ì ì„. |\n| **ESR / CRP** | Inflammation Markers | ì§ˆë³‘ì˜ í™œì„±ë„(Activity)ë¥¼ ëª¨ë‹ˆí„°ë§í•˜ëŠ” ë° ìœ ìš©. |\n### âš ï¸ **Key Complications (High Yield)**\n1. **Lungs:** Pulmonary Nodules, Pleural Effusion, **Fibrosis (Interstitial Lung Disease)**.\n2. **Eyes:** **Scleritis** (Deep, boring eye PAINFUL - ì‘ê¸‰!), Episcleritis.\n3. **Heart:** Accelerated Atherosclerosis (ì‹¬í˜ˆê´€ ì§ˆí™˜ ìœ„í—˜ ê¸‰ì¦ -> MI, Stroke ì£¼ì˜).\n4. **Cervical Spine (C1-C2 Instability):** â˜… **USMLE KILLER QUESTION**\n    - C1-C2ë„ synovial joint.\n    - spinal compression â†’ UMN lesions â†’ weakness and spastic paralysis in all 4 limbs.\n        - ê°ê°ì´ ì•½í•´ì§€ê³ , ëª¸ì´ ì•½í•´ì§€ë©´ì„œ êµ³ì–´ìš”\n    - Hoffman sign to test UMN lesion: ê°€ìš´ë° ì†ê°€ë½ ì†í†±ì„ ì•„ë˜ë¡œ ë”¸ê¹í•˜ë©´, ì—„ì§€ì™€ ë‘ë²ˆì§¸ ì†ê°€ë½ì´ adduction, flexion.\n    - **Scenario:** RA í™˜ìê°€ ìˆ˜ìˆ (ì˜ˆ: ë‹´ë‚­ì ˆì œìˆ )ì„ ë°›ìœ¼ëŸ¬ ì˜´. ë§ˆì·¨ê³¼ ì˜ì‚¬ê°€ ì‚½ê´€(Intubation)ì„ ìœ„í•´ ê³ ê°œë¥¼ ë’¤ë¡œ ì –íˆë©´?\n    - **Risk:** Dens(Odontoid process)ê°€ ì²™ìˆ˜(Spinal cord)ë¥¼ ëˆŒëŸ¬ **ì‚¬ì§€ë§ˆë¹„(Quadriplegia)** í˜¹ì€ ì‚¬ë§ ìœ ë°œ.\n    - **Next Best Step:** ìˆ˜ìˆ  ì „ **Cervical Spine Flexion/Extension X-ray** í•„ìˆ˜!\n### ğŸ’Š **Treatment Strategy**\n- **Symptom Control:** NSAIDs, Steroids (Bridge therapy).\n- **DMARDs (Disease Modifying Anti-Rheumatic Drugs):**\n    - **Methotrexate (MTX):** â˜… **King of RA Treatment.** (First-line).\n        - *Mechanism:* Dihydrofolate reductase inhibitor (Folate antagonist).\n        - *Toxicities:* Hepatotoxicity, Stomatitis (ì…ì•ˆ í—ìŒ), **Bone Marrow Suppression**\n            - Pulmonary Fibrosis (Methotrexate induced lung injury)\n                - note: RAì— ì˜í•œ Pulmonary fibrosisë‘ êµ¬ë¶„í•´ì•¼ë¨. (RA: chronic slow scarring)\n                - Acute hypersensitivity reaction, therefore not dose dependent.\n                - Pneumoniaeì²˜ëŸ¼ ë³´ì„. fever, SOB.\n                - BAL: lymphocytosisê°€ ë³´ì„. Peripheral blood: eosinophilia\n        - *Prevention:* ë°˜ë“œì‹œ **Folate (Folic acid)**ë¥¼ ê°™ì´ ì²˜ë°©í•´ì•¼ í•¨!\n        - CIx: Renal, Hepatic disease, Pregnancy\n            - HBV, HCV í™˜ìì—ì„œ ê¸ˆê¸°. ë¯¸ë¦¬ ê²€ì‚¬í•´ì•¼ë¨.\n    - **Biologics:** Anti-TNF agents (Etanercept, Infliximab, Adalimumab).\n        - *Must Do:* ì‹œì‘ ì „ **TB Screening (Latent TB)**, Hep B/C Screening í•„ìˆ˜! (ì¬í™œì„±í™” ìœ„í—˜).\n    - Hydroxychloroquine: lupusë¿ì•„ë‹ˆë¼ RAì—ì„œë„ ë³´ì¡°ì¹˜ë£Œì •ë„ë¡œ ì•½í•œ í™˜ìì—ì„œ ì“°ì¼ ìˆ˜ ìˆìŒ.\n        - EYE damage ğŸ‘€Â ëˆˆì— ìŒ“ì„. Therefore, opthalmologic evaluation","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-121","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"# 2. Felty Syndrome ğŸ“‰ğŸ¦ \n*The \"Burned-Out\" RA Patient*\n### ğŸšª **Clinical Vignette**\nìˆ˜ì‹­ ë…„ê°„ RAë¥¼ ì•“ì•„ì˜¨ í™˜ì. ê´€ì ˆì€ ì´ë¯¸ ë‹¤ ë§ê°€ì ¸ì„œ ë’¤í‹€ë ¤ ìˆìŒ(**Erosive Arthritis**).\n*ê·¸ëŸ°ë° ì´ë²ˆì—” ê´€ì ˆí†µì´ ì•„ë‹ˆë¼ **ë°˜ë³µë˜ëŠ” ê°ì—¼(Pneumonia, Skin infection)**ìœ¼ë¡œ ë‚´ì›í•¨.*\n### âš¡ **The Triad (Must Memorize)**\n1. **Rheumatoid Arthritis** (Long-standing, severe).\n2. **Splenomegaly** (ë¹„ì¥ë¹„ëŒ€).\n3. **Neutropenia** (ANC < 2,000 - í˜¸ì¤‘êµ¬ ê°ì†Œ).\n# 3. Systemic Lupus Erythematosus (SLE) ğŸ¦‹ğŸº\n*The \"Great Imitator\" with a Migratory Pain*\n### ğŸšª **Doorway Thought (Vignette Anchor)**\n20-30ëŒ€ ì Šì€ ì—¬ì„±. ë‹¨ìˆœíˆ ê´€ì ˆë§Œ ì•„í”ˆ ê²Œ ì•„ë‹ˆë¼ **ê·¹ì‹¬í•œ í”¼ë¡œê°(Deep Fatigue)**ì„ í˜¸ì†Œí•¨. ì–¼êµ´ì—ëŠ” ë‚˜ë¹„ ëª¨ì–‘ ë°œì§„(**Malar Rash**)ì´ ìˆê³ , í–‡ë¹›ì„ ë°›ìœ¼ë©´ í”¼ë¶€ê°€ ë’¤ì§‘ì–´ì§(**Photosensitivity**).\n### ğŸ©º **Key Symptoms & Systemic Fire**\n- **Skin:** Malar Rash (â˜… **Spares Nasolabial Folds** - íŒ”ìì£¼ë¦„ì€ ì¹¨ë²” ì•ˆ í•¨!). Discoid Rash (Scarring ìœ ë°œ).\n- **Joints:** **Migratory â˜… Arthritis** (ëŒì•„ë‹¤ë‹ˆëŠ” í†µì¦)(RAë‘ ì°¨ì´)\nRAì™€ ë‹¬ë¦¬ **Non-erosive** (ë¼ˆë¥¼ ê°‰ì•„ë¨¹ì§€ ì•ŠìŒ). *Jaccoud Arthropathy* (ì†ê°€ë½ì´ íœ˜ì§€ë§Œ í´ë©´ í´ì§).\n- **Serositis:** Pleuritis (ìˆ¨ ì‰´ ë•Œ ì•„í””), Pericarditis.\n- **Heart:** Libman-Sacks Endocarditis (LSE) - \"Vegetations on **BOTH** sides of the valve\".\n- Pregnancy: 3rd trimester, protienuria, hypertension\n    - r/o Preeclampsia?â€¦?\n    - êµ¬ë¶„í•´ì•¼ ì¹˜ë£Œë¥¼ ê³ ë¦„. Steroid (SLE) vs delivery (preeclampsia)\n    - SLEì—ì„œëŠ” ICë¥¼ í˜•ì„±í•˜ê³  C3, C4 low. Preeclampsiaì—ì„œëŠ” ë³´ì²´ ì •ìƒ\n| in ğŸ¤° | SLE | Preeclampsia |\n| --- | --- | --- |\n| ë³´ì²´ | ê°ì†Œ\n(IC í˜•ì„±ìœ¼ë¡œ ì¸í•œ ë³´ì²´ ì†Œëª¨) | ì •ìƒ |\n| Urinalysis | Active inflammation\nâ†’ RBC cast | Cast ì—†ìŒ |\n| Tx. | Steroid | Delivery |\n### ğŸš¨ **Lupus Nephritis (The Silent Killer)**\n- ê°€ì¥ ì¤‘ìš”í•œ ì˜ˆí›„ ì¸ì. ì†Œë³€ì—ì„œ **Proteinuria**, Hematuria, **Casts** ë°œê²¬.\n- **Next Best Step:** â˜… **Renal Biopsy** (ì‹ ì¥ ì¡°ì§ê²€ì‚¬).\n    - *Why?* Lupus NephritisëŠ” Class I ~ VIê¹Œì§€ ë‹¨ê³„ê°€ ìˆê³ , ë‹¨ê³„ì— ë”°ë¼ ì¹˜ë£Œ(Steroid only vs. Cyclophosphamide/Mycophenolate)ê°€ ì™„ì „íˆ ë‹¬ë¼ì§. ë‹¨ìˆœíˆ ì†Œë³€ê²€ì‚¬ë§Œìœ¼ë¡œëŠ” ì¹˜ë£Œ ê²°ì •ì„ ë‚´ë¦´ ìˆ˜ ì—†ìŒ.\n### ğŸ§ª **Diagnosis (Antibodies)**\n| **Antibody** | **Characteristics** |\n| --- | --- |\n| **ANA (Anti-Nuclear Ab)** | **Sensitive (>95%)**. Screening Test. ìŒì„±ì´ë©´ SLE ì•„ë‹ í™•ë¥  ë†’ìŒ. |\n| **Anti-dsDNA** | **Specific**. â˜… **Disease Activityì™€ ë¹„ë¡€í•¨** (ìˆ˜ì¹˜ ë†’ìœ¼ë©´ ì‹ ì¥ì—¼ í™œì„±ë„ ë†’ìŒ). |\n| **Anti-Smith** | **Specific**. ì§ˆë³‘ í™œì„±ë„ì™€ëŠ” ë¬´ê´€í•˜ì§€ë§Œ ì§„ë‹¨ì  ê°€ì¹˜ ë†’ìŒ. |\n| **C3, C4 Levels** | **Low** in active flare. (ë³´ì²´ê°€ ë©´ì—­ë³µí•©ì²´ í˜•ì„±ì— ì†Œëª¨ë¨). |\n### ğŸ’Š **Drug-Induced Lupus**","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-141","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"- **Culprit Drugs:** Hydralazine, Procainamide, Isoniazid, Quinidine. (\"SHIPP-E\" mnemonic).\n- **Antibody:** â˜… **Anti-Histone Antibody** (>95%).\n- **Difference:** ì‹ ì¥(Kidney)ê³¼ ë‡Œ(CNS) ì¹¨ë²”ì€ ë“œë¬¾. ì•½ ëŠìœ¼ë©´ ì¢‹ì•„ì§.\n- **Next Best Step:** Stop the offending drug.\n# 4. Antiphospholipid Syndrome (APS) ğŸ©¸ğŸ¤°\n*Clots & Miscarriages*\n### ğŸšª **Clinical Vignette**\nì Šì€ ì—¬ì„± í™˜ìê°€ **ë°˜ë³µì ì¸ ìœ ì‚°(Recurrent Miscarriages)** í˜¹ì€ ì„¤ëª…ë˜ì§€ ì•ŠëŠ” **í˜ˆì „(DVT/PE/Stroke)** ë³‘ë ¥ì´ ìˆìŒ. PTTê°€ ì—°ì¥ë˜ì–´ ìˆëŠ”ë°(Paradoxical), í˜ˆì „ì´ ìƒê¹€.\n### âš¡ **Diagnostic Criteria**\n1. **Clinical:**\n    - Vascular Thrombosis (Arterial OR Venous).\n    - Pregnancy Morbidity\n        - 3+ unexplained losses <10w\n        - OR 1+ loss >10w\n        - OR severe preeclampsia/placental insufficiency).\n2. **Labs (CONSISTENT: Must be positive 2 times, 12 weeks apart):**\n    - **Lupus Anticoagulant** (False elevation of PTT).\n    - **Anticardiolipin Antibody** (Can cause False Positive VDRL/Syphilis test).\n    - **Anti-beta2-glycoprotein I.**\n### ğŸ’Š **Treatment**\n- **Non-Pregnant:** Warfarin (INR 2-3).\n- **Pregnant:** â˜… **LMWH (Low Molecular Weight Heparin) + Low Dose Aspirin**.\n    - *Note:* Warfarinì€ íƒœì•„ ê¸°í˜•(Teratogenic) ìœ ë°œí•˜ë¯€ë¡œ ì„ì‹  ì¤‘ ê¸ˆê¸°!\n# 5. Mixed Connective Tissue Disease (MCTD) ğŸ§¤ğŸ”—\n*The \"Overlap\" Syndrome*\n### ğŸšª **Doorway Thought**\ní™˜ìê°€ ì™”ëŠ”ë° SLE ê°™ê¸°ë„ í•˜ê³ , Scleroderma(í”¼ë¶€ ê²½í™”) ê°™ê¸°ë„ í•˜ê³ , Polymyositis(ê·¼ìœ¡í†µ) ê°™ê¸°ë„ í•¨. ì†ì´ í‰í‰ ë¶€ì–´ìˆìŒ (**Puffy Hands / Sausage Digits**). ê·¸ë¦¬ê³  ì‹¬í•œ **Raynaud's Phenomenon**ì´ ìˆìŒ.\n### ğŸ§ª **The Golden Key**\n- **Anti-U1-RNP Antibody** (High Titer).\n- ì´ í•­ì²´ê°€ ì–‘ì„±ì´ë©´ì„œ SLE, Systemic Sclerosis, Polymyositisì˜ íŠ¹ì§•ì´ ì„ì—¬ ìˆìœ¼ë©´ MCTDë¡œ ì§„ë‹¨.","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-161","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","treatment","mnemonic"]}
{"chunk_type":"recap_summary","text":"# ğŸ”¥ Rapid Fire Recap: Treatments & Side Effects\n| **Disease** | **Critical Drug** | **Major Side Effect / Note** |\n| --- | --- | --- |\n| **RA** | **Methotrexate** | Liver tox, Pulmonary fibrosis, **Marrow suppression**. Give **Folate**! |\n| **SLE (General)** | **Hydroxychloroquine** | **Retinopathy** (Eye toxicity). Annual Eye Exam í•„ìˆ˜! |\n| **SLE (Nephritis)** | Cyclophosphamide | Hemorrhagic cystitis (ë°©ê´‘ì—¼), Infertility. |\n| **Drug-Induced Lupus** | (Stop Drug) | Anti-Histone Ab Positive. |\n| **APS (Pregnant)** | **LMWH + Aspirin** | Warfarin is contraindicated. |\n| **RA Flare** | Prednisone | Osteoporosis, Hyperglycemia, Cataracts. |\n1. ê³ í˜ˆì•• ì•½ ë¨¹ë˜ í™˜ìê°€ ê´€ì ˆì´ ì•„íŒŒìš”\n    1. anti-histone ab? DILI. stop the drugs. Hydralazine\n2. ì†ê°€ë½ë¶€ì—ˆê³  Raynaudë„ ìˆê³  malar rashë„ ìˆê³  ê´€ì ˆí†µë„ ìˆê³ ? ì• ë§¤í•œ ì„ ë¬¼ì„¸íŠ¸\n    1. anti U1 RNPê²€ì‚¬! MCTD\n3. ì„ì‹ ì—¬ì„± ê³ í˜ˆì••, ë‹¨ë°±ë‡¨, ë³´ì²´ decreased\n    1. Lupus flare\n4. RAì˜¤ë˜ ì•“ì•˜ë˜ í™˜ìì—ì„œ ê°€ìš´ë° ì†ê°€ë½ ì†í†± ë”¸ê¹í–ˆë”ë‹ˆ ì—„ì§€ì™€ ê²€ì§€ê°€ ì›€ì°”\n    1. Hoffman sign â†’ UMN lesion, cervical myelopathy\n5. RAì˜¤ë˜ ì•“ì•˜ë˜ í™˜ìì—ì„œ ê³„ì† ê°ì—¼ì´ ìƒê¸°ê³  ì™¼ìª½ë°°ê°€ ë¶ˆëŸ¬ì˜¤ë¦„(splenomegaly). í”¼ê²€ì‚¬ì—ì„œ í™•ì¸í•´ì•¼í•  ìˆ«ì\n    1. ANC<2000\n6. ì–´ë–¤ ë¥˜ë§ˆ ì•½ì´ ë¨¹ì€ì§€ 5ë…„í›„ë¶€í„° ì•ˆê³¼ê²€ì§„ ë§¤ë…„í•´ì•¼í•˜ëŠ”ì§€?\n    1. Hydroxychloroquine\n7. Lupusí™˜ìì—ì„œ ë‹¨ë°±ë‡¨ Next Step?\n    1. Renal biopsy\n- **Septic Arthritis vs RA Flare:** WBC > 50,000 in joint fluid = **Septic**. (Medical Emergency! Antibiotics & Drainage). RA flareëŠ” ë³´í†µ 2,000 ~ 50,000 ì‚¬ì´.\n- **Lupus Nephritis:** ì†Œë³€ ê²€ì‚¬ ì´ìƒí•˜ë©´ ë¬´ì¡°ê±´ **Biopsy**. ì¶”ì¸¡ìœ¼ë¡œ ì¹˜ë£Œí•˜ì§€ ë§ ê²ƒ.\n- **RA Cervical Spine:** ìˆ˜ìˆ  ì „ ëª© ì—‘ìŠ¤ë ˆì´ ì•ˆ ì°ì–´ì„œ í™˜ì ë§ˆë¹„ì‹œí‚¤ë©´ ì‹œí—˜ ë–¨ì–´ì§(ê·¸ë¦¬ê³  í™˜ìëŠ” ë¶ˆí–‰í•´ì§). ğŸ’€\n### Overview: Systemic Autoimmune Disorders Part 2 (TL;DR)\nì´ë²ˆ ì—í”¼ì†Œë“œëŠ” ë¥˜ë§ˆí‹°ìŠ¤í•™(Rheumatology)ì˜ ê±°ëŒ€í•œ ë‘ ì‚°ë§¥ì¸ **ì²™ì¶”ê´€ì ˆë³‘ì¦(Spondyloarthropathies)**ê³¼ **ê²°í•©ì¡°ì§ì§ˆí™˜(Connective Tissue Diseases)**ì„ ë‹¤ë£¹ë‹ˆë‹¤. USMLE Step 2 CK ë° ì„ìƒì—ì„œ ìƒëª…ì„ ìœ„í˜‘í•˜ëŠ” í•©ë³‘ì¦(Renal crisis ë“±)ì„ ë†“ì¹˜ì§€ ì•Šê¸° ìœ„í•œ íŒ¨í„´ ì¸ì‹(Pattern Recognition)ì— ì§‘ì¤‘í•©ë‹ˆë‹¤.\n- **Group 1: Seronegative Spondyloarthropathies (SpA)**\n    - íŠ¹ì§•: RF Negative, HLA-B27 ì—°ê´€, ì²™ì¶”/enthesitis ì¹¨ë²”.\n    - ì§ˆí™˜: ê°•ì§ì„± ì²™ì¶”ì—¼(AS), ë°˜ì‘ì„± ê´€ì ˆì—¼(ReA), ê±´ì„  ê´€ì ˆì—¼(PsA).\n- **Group 2: Connective Tissue Heavy Hitters**\n    - ì§ˆí™˜: ì‡¼ê·¸ë Œ ì¦í›„êµ°(Sjogren's), ì „ì‹  ê²½í™”ì¦(Scleroderma - Limited vs Diffuse), ë ˆì´ë…¸ í˜„ìƒ(Raynaud's).","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-179","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","recap","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### 1. Top-Down Classification & Big Picture (ASCII Tree) ğŸŒ³\n**Mental Model:**\nì´ íŒŒíŠ¸ëŠ” í¬ê²Œ \"ì²™ì¶”ì™€ ê´€ì ˆì— ì—¼ì¦ì´ ìƒê¸°ëŠ” ê·¸ë£¹(SpA)\"ê³¼ \"í”¼ë¶€ì™€ ì¥ê¸°ê°€ ë”±ë”±í•´ì§€ê±°ë‚˜ ë§ˆë¥´ëŠ” ê·¸ë£¹(Connective Tissue)\"ìœ¼ë¡œ ë‚˜ë‰©ë‹ˆë‹¤.\n- **SpA:** 'Seronegative'ë¼ëŠ” ë§ì€ ë¥˜ë§ˆí‹°ìŠ¤ ì¸ì(RF)ê°€ ì—†ë‹¤ëŠ” ëœ»ì´ì§€, ë³‘ì´ ê°€ë³ë‹¤ëŠ” ëœ»ì´ ì•„ë‹™ë‹ˆë‹¤. ì´ë“¤ì€ **HLA-B27** ìœ ì „ìì™€ ê°•ë ¥í•œ family tieë¥¼ ê°€ì§‘ë‹ˆë‹¤.\n- **Connective Tissue:** ì„¬ìœ í™”(Fibrosis)ì™€ ê±´ì¡°(Dryness)ê°€ í•µì‹¬ì…ë‹ˆë‹¤. íŠ¹íˆ **Scleroderma Renal Crisis**ëŠ” ë‚´ê³¼ì  ì‘ê¸‰ìƒí™©(Emergency)ì„ì„ ëª…ì‹¬í•´ì•¼ í•©ë‹ˆë‹¤.\nPlaintext\n`Systemic Autoimmune Disorders (Part 2)\nâ”‚\nâ”œâ”€â”€ Seronegative Spondyloarthropathies (SpA) [RF(-), HLA-B27(+)]\nâ”‚   â”œâ”€â”€ Ankylosing Spondylitis (AS) : ëŒ€ë‚˜ë¬´ ì²™ì¶”, ì—¼ì¦ì„± ë“±í†µì¦\nâ”‚   â”œâ”€â”€ Reactive Arthritis (ReA)    : ê°ì—¼ í›„ ë°œìƒ, Can't see/pee/climb\nâ”‚   â””â”€â”€ Psoriatic Arthritis (PsA)   : ê±´ì„ , ì†Œì‹œì§€ ì†ê°€ë½, DIP ê´€ì ˆ\nâ”‚\nâ””â”€â”€ Connective Tissue Diseases (Fibrosis & Dryness)\n    â”œâ”€â”€ Sjogren's Syndrome          : Sicca sx, ë¦¼í”„ì¢… ìœ„í—˜(â˜…)\n    â”œâ”€â”€ Systemic Sclerosis (Scleroderma)\n    â”‚   â”œâ”€â”€ Limited (CREST)         : Anti-Centromere, PAH ìœ„í—˜\n    â”‚   â””â”€â”€ Diffuse                 : Anti-Scl-70, ILD & Renal Crisis(â˜…)\n    â””â”€â”€ Raynaud's Phenomenon        : í˜ˆê´€ ì—°ì¶• (Whiteâ†’Blueâ†’Red)`\n### 2. Seronegative Spondyloarthropathies (SpA) ğŸ¦´\nì´ ê·¸ë£¹ì˜ ì´ë¦„ì´ 'Seronegative'ì¸ ì´ìœ ëŠ” **Rheumatoid Factor (RF)**ê°€ ìŒì„±ì´ê¸° ë•Œë¬¸ì…ë‹ˆë‹¤. í•˜ì§€ë§Œ ìœ ì „ì ìœ¼ë¡œ **HLA-B27 (MHC Class I allele)**ê³¼ ì•„ì£¼ ê°•ë ¥í•˜ê²Œ ì—°ê²°ë˜ì–´ ìˆìŠµë‹ˆë‹¤.\n### A. Ankylosing Spondylitis (AS, ê°•ì§ì„± ì²™ì¶”ì—¼)\n**ğŸšª Doorway Thought (Vignette Anchor):**\n40ì„¸ ë¯¸ë§Œì˜ ì Šì€ ë‚¨ì„±. ë§Œì„±ì ì¸ ìš”í†µ(Low back pain)ì„ í˜¸ì†Œí•˜ëŠ”ë°, **\"ì¶•êµ¬í•˜ê±°ë‚˜ ë›¸ ë•ŒëŠ” ê´œì°®ì€ë°, ìë ¤ê³  ëˆ„ìš°ë©´ ì•„íŒŒì„œ ê¹¬ë‹¤\"**ê³  í•¨. ì•„ì¹¨ì— ì¼ì–´ë‚˜ë©´ ë»£ë»£í•¨(Stiffness)ì´ 30ë¶„ ì´ìƒ ì§€ì†ë¨.\n- **í•µì‹¬ êµ¬ë³„ì : Inflammatory vs. Mechanical Pain**\n| **Feature** | **Inflammatory Back Pain (AS)** | **Mechanical Back Pain (Herniated Disc, OA)** |\n| --- | --- | --- |\n| **Activity** | ìš´ë™í•˜ë©´ í˜¸ì „ë¨ (Improves with exercise) | ì›€ì§ì´ë©´ ë” ì•„í”” (Worse with movement) |\n| **Rest/Sleep** | ì‰´ ë•Œ/ì˜ ë•Œ ì•…í™” (Worse with rest) | ì‰¬ë©´ ì¢‹ì•„ì§ (Better with rest) |\n| **Morning Stiffness** | > 30ë¶„ ì§€ì† | ì§§ê²Œ ì§€ë‚˜ê° |\n| **Cause** | ì—¼ì¦ ë¬¼ì§ˆ ì¶•ì  (Inflammatory mediators) | êµ¬ì¡°ì /ë¬¼ë¦¬ì  ì••ë°• |\n- **Clinical Features:**\n    - **Enthesitis (ë¶€ì°©ë¶€ì—¼):** ì¸ëŒ€ë‚˜ í˜ì¤„ì´ ë¼ˆì— ë¶™ëŠ” ìë¦¬ì— ì—¼ì¦. **Achilles tendon** í†µì¦ì´ í´ë˜ì‹í•œ ì˜ˆì‹œ. (ë°œë’¤ê¿ˆì¹˜ ì•„í”„ë‹¤ê³  í•˜ë©´ AS ì˜ì‹¬!)\n    - **Uveitis (í¬ë„ë§‰ì—¼):** ì¶©í˜ˆë˜ê³  ì•„í”ˆ ëˆˆ(Red, painful, photophobic eye). ê°€ì¥ í”í•œ ê´€ì ˆ ì™¸ ì¦ìƒ.\n    - **Bamboo Spine:** ì²™ì¶”ì˜ ì—¼ì¦ì´ ìœµí•©(Fusion)ìœ¼ë¡œ ì´ì–´ì ¸ ëŒ€ë‚˜ë¬´ì²˜ëŸ¼ ë»£ë»£í•´ì§. ê³¨ì ˆ ìœ„í—˜ ì¦ê°€.\n    - **Cardiovascular:** Aortic Regurgitation (ëŒ€ë™ë§¥íŒ ì—­ë¥˜), Conduction defect.\n    - Cauda equina: bladder, bowel problems.\n- **Diagnosis (ì§„ë‹¨):**\n    - **â˜… Best Initial Step:** X-ray of Sacroiliac joints (Sacroiliitis í™•ì¸ - Erosions, Sclerosis).\n    - **â˜… Most Sensitive/Early Detection:** **MRI**. (X-rayê°€ ì •ìƒì´ì§€ë§Œ ì˜ì‹¬ë  ë•Œ).\n        - *Note:* HLA-B27 ê²€ì‚¬ëŠ” ì§„ë‹¨ì ì´ì§€ ì•ŠìŒ (ì¸êµ¬ì˜ ë§ì€ ì‚¬ëŒì´ ì–‘ì„±ì´ë¯€ë¡œ).\n- **Treatment (ì¹˜ë£Œ):**\n    - **â˜… First Line:** **NSAIDs** (Indomethacin, Naproxen ë“±). ìš´ë™ ìš”ë²•.\n    - **â˜… If NSAIDs Fail:** **TNF-alpha Inhibitors** (Etanercept, Infliximab, Adalimumab). ì§ˆë³‘ ì§„í–‰ì„ ëŠ¦ì¶œ ìˆ˜ ìˆìŒ.\n        - *ì£¼ì˜:* ìŠ¤í…Œë¡œì´ë“œëŠ” ì²™ì¶” ì¦ìƒì— í° íš¨ê³¼ ì—†ìŒ.\n### B. Reactive Arthritis (ReA, ë°˜ì‘ì„± ê´€ì ˆì—¼)\n**ğŸšª Doorway Thought:**\n**\"Can't see, can't pee, can't climb a tree.\"** (ëˆˆ, ì†Œë³€, ê´€ì ˆ ë¬¸ì œ). ìµœê·¼ì— ë°°íƒˆì´ ë‚¬ê±°ë‚˜(Food poisoning) ìƒˆë¡œìš´ íŒŒíŠ¸ë„ˆì™€ ì„±ê´€ê³„(Chlamydia)ê°€ ìˆì—ˆë˜ ì Šì€ í™˜ì.\n- **Triggers (ê°ì—¼ì›):** ê°ì—¼ í›„ 1~4ì£¼ ë’¤ ë°œìƒ.\n    1. **Genitourinary:** *Chlamydia trachomatis* (ê°€ì¥ í”í•¨).\n    2. **Gut (Enteritis):** *Salmonella, Shigella, Yersinia, Campylobacter, Clostridioides (C.diff)*.\n- **Symptoms:**\n    - **Conjunctivitis / Uveitis** (Can't see)\n    - **Urethritis** (Can't pee)\n    - **Arthritis** (Can't climb a tree) - ì£¼ë¡œ í•˜ì§€ì˜ ë¹„ëŒ€ì¹­ì  ê´€ì ˆì—¼ (Knee, Ankle).\n    - **â˜… Dermatologic:**\n        - **Keratoderma blennorrhagicum:** ë°œë°”ë‹¥ì´ë‚˜ ì†ë°”ë‹¥ì— ìƒê¸°ëŠ” ì™ìŠ¤ ê°™ì€(waxy), ìˆ˜í¬ ê°™ì€ ë³‘ë³€.\n        - **Circinate balanitis:** ê·€ë‘(glans penis)ì— ìƒê¸°ëŠ” ë°œì§„.\n- **Treatment:** NSAIDs (1st line). ê°ì—¼ì´ ë‚¨ì•„ìˆë‹¤ë©´ í•­ìƒì œ ì¹˜ë£Œ (Chlamydia ë“±).","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-189","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"### C. Psoriatic Arthritis (PsA, ê±´ì„  ê´€ì ˆì—¼)\n**ğŸšª Doorway Thought:**\nê±´ì„ (Psoriasis) í”¼ë¶€ ë³‘ë³€ì´ ìˆëŠ” í™˜ìê°€ ê´€ì ˆí†µì„ í˜¸ì†Œ. í˜¹ì€ ì†í†±ì´ ì´ìƒí•¨.\n- **Key Features:**\n    - **Dactylitis:** **\"Sausage Digits\"**. ì†ê°€ë½/ë°œê°€ë½ ì „ì²´ê°€ ì†Œì‹œì§€ì²˜ëŸ¼ ë¶€ì–´ì˜¤ë¦„.\n    - **DIP Involvement:** ì†ê°€ë½ ëë§ˆë””(Distal Interphalangeal joint) ì¹¨ë²”ì´ íŠ¹ì§•ì  (RAëŠ” ë³´í†µ DIPë¥¼ ì¹¨ë²”í•˜ì§€ ì•ŠìŒ!).\n    - **Nail Changes:** Nail pitting (ë°”ëŠ˜ë¡œ ì½•ì½• ì°Œë¥¸ ë“¯í•œ í•¨ëª°), Onycholysis (ì†í†±ì´ ë“¤ëœ¸).\n- ê±´ì„  í”¼ë¶€ í™˜ì ì§ˆí™˜ì´ ë‚˜íƒ€ë‚˜ê¸°ì „ì—ë„ ê±´ì„  ê´€ì ˆì—¼ë¶€í„° ë¨¼ì € ë‚˜íƒ€ë‚  ìˆ˜ ìˆìŒ.\n    - nail pitting, familial history of Psoriasis, DIP patternâ€¦ìœ¼ë¡œ ì˜ì‹¬.\n### 3. Connective Tissue Diseases ğŸ§¬\nì„¬ìœ í™”(Fibrosis)ì™€ ìê°€ë©´ì—­ì„± ì—¼ì¦ì´ íŠ¹ì§•ì…ë‹ˆë‹¤.\n### A. Sjogren's Syndrome (ì‡¼ê·¸ë Œ ì¦í›„êµ°)\n**ğŸšª Doorway Thought:**\n40-60ëŒ€ ì—¬ì„±. **\"ëˆˆì´ ëª¨ë˜ ë“¤ì–´ê°„ ê²ƒì²˜ëŸ¼ ë»‘ë»‘í•´ìš”(Gritty)\"**, **\"ë¬¼ ì—†ì´ëŠ” í¬ë˜ì»¤ë¥¼ ëª» ì‚¼í‚¤ê² ì–´ìš”(Cracker Sign)\"**.\n- **Pathophysiology:** Exocrine glands (ì¹¨ìƒ˜, ëˆˆë¬¼ìƒ˜)ë¥¼ ë¦¼í”„êµ¬(Lymphocyte)ê°€ ê³µê²©í•˜ì—¬ íŒŒê´´í•¨.\n- **Diagnosis:**\n    - **Antibodies:** Anti-Ro (SSA) & Anti-La (SSB).\n    - **Tests:** Schirmer test (ëˆˆë¬¼ ì–‘ ì¸¡ì • - ì¢…ì´ ë  ì´ìš©).\n    - **â˜… Gold Standard:** **Lip Biopsy** (Minor salivary glandì—ì„œ Focal lymphocytic sialadenitis í™•ì¸).\n- **âš ï¸ WARNING: The Scary Complication**\n    - ì‡¼ê·¸ë Œ í™˜ìê°€ ê°‘ìê¸° ë¦¼í”„ì ˆì´ ë¶“ê±°ë‚˜(Lymphadenopathy), ì²´ì¤‘ì´ ë¹ ì§€ë©´?\n    - **â˜… Non-Hodgkin Lymphoma (B-cell Lymphoma)** ë°œìƒ ìœ„í—˜ì´ ë§¤ìš° ë†’ìŒ (MALT lymphoma). ì¦‰ì‹œ malignancy workupì„ í•´ì•¼ í•¨!\n- ëŠ™ì–´ì„œ ëˆˆë¬¼ì´ ì•ˆë‚˜ì˜¤ëŠ” Age-related dry eye syndromeê³¼ì˜ ë¹„êµ\n    - Normal ESR, Normal Schimmer test\n### B. Systemic Sclerosis (Scleroderma, ì „ì‹  ê²½í™”ì¦)\n**ì„¸ê°€ì§€! â˜…  â‘  í˜ˆê´€ì´ ì†ìƒë˜ê³  â‘¡ ë©´ì—­ ê³¼í™œì„±í™” â‘¢  í”¼ë¶€ê°€ ë‘êº¼ì›Œì§€ê³  ë”±ë”±í•´ì§€ëŠ” ë³‘.**\në²”ìœ„ì— ë”°ë¼ ë‘ ê°€ì§€ë¡œ ë‚˜ë‰©ë‹ˆë‹¤.\n| **Feature** | **Limited Cutaneous (CREST)** | **Diffuse Cutaneous** |\n| --- | --- | --- |\n| **Skin Involvement** | ì–¼êµ´, ì†, ë°œ (Distal extremities only) | íŒ”, ë‹¤ë¦¬, ëª¸í†µ (Proximal extremities & Trunk) |\n| **Progression** | ëŠë¦¼ (Slow) | ë¹ ë¦„ (Rapid) |\n| **Antibody** | **Anti-Centromere** | **Anti-Scl-70 (Anti-topoisomerase I)** |\n| **Internal Organ** | Pulmonary Arterial Hypertension (PAH) | Interstitial Lung Disease (ILD), **Renal Crisis** |\n| **Prognosis** | ìƒëŒ€ì ìœ¼ë¡œ ì–‘í˜¸ | ë‚˜ì¨ (ì‹¬ê°í•œ ì¥ê¸° ì¹¨ë²”) |\n- **Limited Scleroderma (CREST Syndrome):**\n    - **C**alcinosis (í”¼ë¶€ ë°‘ ì¹¼ìŠ˜ ì¹¨ì°©)\n    - **R**aynaud's phenomenon\n    - **E**sophageal dysmotility (GERD, Heartburn - í•˜ë¶€ ì‹ë„ê°€ ë”±ë”±í•´ì§)\n    - **S**clerodactyly (ì†ê°€ë½ í”¼ë¶€ ê²½í™”)\n    - **T**elangiectasia (ëª¨ì„¸í˜ˆê´€ í™•ì¥)\n- **â˜… Scleroderma Renal Crisis (SRC) - The Emergency ğŸš¨**\n    - **Situation:** Diffuse type í™˜ìê°€ ê°‘ìê¸° ë‘í†µ, ì‹œì•¼ íë¦¼ ë“±ì„ í˜¸ì†Œ. BP 200/110. Acute Kidney Injury (Cr ìƒìŠ¹).\n    - **Mechanism:** ì‹ ì¥ í˜ˆê´€ì´ ì¢ì•„ì§ â†’ ì‹ ì¥ì´ \"í”¼ê°€ ì•ˆ ì˜¨ë‹¤!\"ê³  ì˜¤í•´ â†’ **Renin-Angiotensin System í­ë°œ** â†’ í˜ˆì•• ê¸‰ìƒìŠ¹ â†’ í˜ˆê´€ ë” ë§ê°€ì§ (ì•…ìˆœí™˜).\n    - **Findings:** MAHA (Microangiopathic Hemolytic Anemia) - Schistocytes, Low platelets.\n    - **â˜… Treatment (Gold Standard):** **ACE Inhibitors (e.g., Captopril)**.\n        - ë‹¤ë¥¸ hypertensive emergencyì—ì„œì²˜ëŸ¼ BB ë¥¼ ì“°ëŠ”ê²Œ ì•„ë‹˜.\n        - ì´ê²ƒì€ Renin í­ë°œì„ ë§‰ëŠ” ìœ ì¼í•œ ë°©ë²•. í¬ë ˆì•„í‹°ë‹Œì´ ì˜¬ë¼ë„ ACEi, ARBë¥¼ ì¨ì•¼ í•¨(Life-saving).\n    - **â›”ï¸ CONTRAINDICATION:** **Beta-blockers** (í˜ˆê´€ ìˆ˜ì¶•ì„ ì•…í™”ì‹œí‚¬ ìˆ˜ ìˆìœ¼ë¯€ë¡œ ì ˆëŒ€ ê¸ˆê¸°!).\n### C. Raynaud's Phenomenon (ë ˆì´ë…¸ í˜„ìƒ)\n**ğŸšª Doorway Thought:**\nì¶”ìœ„ë‚˜ ìŠ¤íŠ¸ë ˆìŠ¤ì— ë…¸ì¶œë˜ë©´ ì†ê°€ë½ ìƒ‰ê¹”ì´ ë³€í•¨.\n**White (Ischemia) â†’ Blue (Hypoxia) â†’ Red (Reperfusion)**.","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-209","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"- **Primary vs. Secondary:**\n    - **Primary:** ì Šì€ ì—¬ì„±(15-30ì„¸), ëŒ€ì¹­ì , ê¶¤ì–‘(Ulcer) ì—†ìŒ. ê²€ì‚¬ ì •ìƒ.\n    - **Secondary:** ë‚˜ì´ ë“¦(>40ì„¸), ë¹„ëŒ€ì¹­ì , **Digital Ulcers**, Pitting scars. (Scleroderma, Lupus ë“±ì˜ ì§•í›„).\n    - **â˜… Differentiation Tool:** **Nailfold Capillaroscopy**. (Secondaryì—ì„œëŠ” ê±°ëŒ€í•˜ê³  ë’¤í‹€ë¦° ëª¨ì„¸í˜ˆê´€ ë£¨í”„ê°€ ë³´ì„).\n- **Treatment:**\n    - ë³´ì˜¨(Keep warm), ê¸ˆì—°.\n    - **â˜… Pharmacologic:** **Calcium Channel Blockers (CCB)** - Nifedipine, Amlodipine. (í˜ˆê´€ì„ ì´ì™„ì‹œí‚´).\n### 4. Rapid Fire Recap (High-Yield Summary) ğŸ”¥\n| **Disease** | **Key Antibodies / Markers** | **Vignette Clue** | **Best Initial / Specific Rx** |\n| --- | --- | --- | --- |\n| **Ankylosing Spondylitis** | HLA-B27, RF(-) | ì Šì€ ë‚¨ì„±, ë°¤ì— ë” ì•„í”ˆ ìš”í†µ, ìš´ë™í•˜ë©´ í˜¸ì „ | NSAIDs (1st), TNF inhibitors |\n| **Reactive Arthritis** | HLA-B27 | Can't see/pee/climb, GI or Chlamydia infection | NSAIDs, Treat infection |\n| **Psoriatic Arthritis** | HLA-B27 | Psoriasis, **Sausage digits**, Nail pitting | NSAIDs, Methotrexate |\n| **Sjogren's Syndrome** | Anti-Ro (SSA), Anti-La (SSB) | Dry eyes/mouth, **Lymphoma risk** | Artificial tears, Pilocarpine |\n| **Limited Scleroderma** | **Anti-Centromere** | CREST syndrome, PAH | Symptomatic (PPI for GERD) |\n| **Diffuse Scleroderma** | **Anti-Scl-70** (Topoisomerase I) | Trunk skin, ILD, **Renal Crisis** | **ACE Inhibitors (Renal Crisis)** |\n| **Raynaud's** | Clinical dx | White-Blue-Red color change | **CCB (Nifedipine)** |\n- **Confidence:** 1.0 (Very High)\n    - ì˜¤ë””ì˜¤ì—ì„œëŠ” \"Harry Potter spell\" ê°™ë‹¤ê³  í•œ í”¼ë¶€ ë³‘ë³€ ì´ë¦„(*Keratoderma blennorrhagicum*)ì´ ì–¸ê¸‰ë¨. ìŠ¤í ë§ì´ ì–´ë ¤ìš°ë‹ˆ ì£¼ì˜í•  ê²ƒ.\n    - Scleroderma Renal Crisisì—ì„œ ACE inhibitor ì‚¬ìš©ì€ ì¼ë°˜ì ì¸ AKI ê¸ˆê¸°ì™€ ë°˜ëŒ€ë˜ë¯€ë¡œ ì‹œí—˜ì—ì„œ í•¨ì •ìœ¼ë¡œ ìì£¼ ì¶œì œë¨. ê¼­ ê¸°ì–µí•  ê²ƒ!\n**Would you like me to generate a specific quiz set for these diseases to test your pattern recognition?**\n### ğŸ“‹ Overview (TL;DR)\nì‹œê°„ì´ ì—†ëŠ” ìˆ˜í—˜ìƒì„ ìœ„í•œ **30ì´ˆ ìš”ì•½!** â±ï¸\n- **Shoulder Pathology:** 'ì›€ì§ì„ ì œí•œ(Restriction)'ì˜ ì›ì¸ì´ ë¬´ì—‡ì¸ê°€?\n    - **Frozen Shoulder (ì˜¤ì‹­ê²¬):** ëŠ¥ë™(Active) & ìˆ˜ë™(Passive) ROM ëª¨ë‘ ê°ì†Œ. (ê´€ì ˆë‚­ ìì²´ê°€ êµ³ìŒ)\n    - **Rotator Cuff Tear:** ëŠ¥ë™ ROM ê°ì†Œ + **Weakness** (í˜ì´ ë¹ ì§). ìˆ˜ë™ì€ ê´œì°®ìŒ.\n    - **Dislocation:** Anterior (ë†êµ¬, í•˜ì´íŒŒì´ë¸Œ) vs Posterior (ë°œì‘, ê°ì „).\n- **Elbow Pathology:**\n    - **Tennis Elbow:** ì—¼ì¦(Itis) ì•„ë‹˜! **í‡´í–‰(Degeneration)**ì„. ì†ëª©ì„ ë’¤ë¡œ ì –í ë•Œ ì•„í”” (ì˜¤í† ë°”ì´ ë¶€ë¦‰ë¶€ë¦‰ ğŸï¸).\n    - **Bursitis:** ê°ì—¼(Septic) vs ë¹„ê°ì—¼(Non-septic) êµ¬ë¶„ì´ í•µì‹¬. **Aspiration**ì´ ë‹µ!\n### ğŸŒ³ Top-down Classification (Mental Model)\nìƒì§€(Upper Limb) í†µì¦ì„ í˜¸ì†Œí•˜ëŠ” í™˜ìê°€ ì™”ì„ ë•Œ, ë¨¸ë¦¿ì†ì— ê·¸ë ¤ì•¼ í•  **Decision Tree**ì…ë‹ˆë‹¤.\nPlaintext\n`UPPER LIMB PATHOLOGY (ìƒì§€ ë³‘ë³€)\nâ”‚\nâ”œâ”€â”€ SHOULDER (ì–´ê¹¨: The World Shrinker)\nâ”‚   â”œâ”€â”€ STIFFNESS (êµ³ìŒ) â”€â”€â”€â†’ Adhesive Capsulitis (Frozen Shoulder)\nâ”‚   â”‚                         [Active & Passive ROM â†“]\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ WEAKNESS (ì•½í•¨) â”€â”€â”€â”€â†’ Rotator Cuff Pathology\nâ”‚   â”‚   â”œâ”€â”€ Tendinopathy (Pain + Normal Strength)\nâ”‚   â”‚   â””â”€â”€ Tear (Pain + WEAKNESS/Drop Arm)\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ INSTABILITY (ë¹ ì§) â”€â†’ Dislocation\nâ”‚   â”‚   â”œâ”€â”€ Anterior (95%, Axillary n. risk)\nâ”‚   â”‚   â””â”€â”€ Posterior (Seizure, Lightbulb sign)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ NERVE (ëˆŒë¦¼) â”€â”€â”€â”€â”€â”€â”€â†’ Suprascapular Nerve Entrapment\nâ”‚                             (Backpacker's palsy)\nâ”‚\nâ””â”€â”€ ELBOW (íŒ”ê¿ˆì¹˜)\n    â”œâ”€â”€ TENDON (ê±´) â”€â”€â”€â”€â”€â”€â”€â†’ Lateral Epicondylitis (Tennis Elbow)\n    â”‚                        [Wrist Extension Pain]\n    â”‚\n    â””â”€â”€ BURSA (ë¬¼ì£¼ë¨¸ë‹ˆ) â”€â”€â†’ Olecranon Bursitis\n                             â”œâ”€â”€ Non-septic (Chronic trauma)\n                             â””â”€â”€ Septic (Infection, Fever) -> NEEDLE IT!`","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-229","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"# [3.2] Shoulder Pathology: The \"Vibe Check\" ğŸ‘‹\nì˜¤ë””ì˜¤ì—ì„œëŠ” í™˜ìê°€ ì§„ë£Œì‹¤ì— ë“¤ì–´ì˜¤ëŠ” ìˆœê°„(The first line of the vignette)ë¶€í„° ì§„ë‹¨ì´ ì‹œì‘ëœë‹¤ê³  ê°•ì¡°í•©ë‹ˆë‹¤. ì–´ê¹¨ê°€ ì•„í”„ë©´ ì„¸ìƒì´ ì¢ì•„ì§‘ë‹ˆë‹¤(Shrinks). ë¨¸ë¦¬ë„ ëª» ë¹—ê³ , ì„ ë°˜ ìœ„ ë¬¼ê±´ë„ ëª» êº¼ë‚´ë‹ˆê¹Œìš”. ğŸ˜¢\n## 1. Adhesive Capsulitis (Frozen Shoulder, ìœ ì°©ì„± ê´€ì ˆë‚­ì—¼) ğŸ¥¶\n### ğŸšª Doorway Thought (Clinical Scenario)\nì¤‘ë…„ í™˜ì(Middle-aged). íŠ¹ë³„í•œ ì™¸ìƒ ì—†ì´ ëª‡ ë‹¬ì— ê±¸ì³ ì²œì²œíˆ ì–´ê¹¨ê°€ êµ³ì–´ì˜´. \"ì„ ë°˜ ìœ„ì˜ ì‹œë¦¬ì–¼ ë°•ìŠ¤ë¥¼ êº¼ë‚¼ ìˆ˜ê°€ ì—†ì–´ìš”.\"ë¼ê³  í˜¸ì†Œí•¨.\n### ğŸ§  Core Concept & Pathophysiology\n- **Mental Model:** **\"Garage door welded shut\"** (ì°¨ê³  ë¬¸ì´ ìš©ì ‘ë˜ì–´ ê½‰ ë‹«íŒ ìƒíƒœ). ğŸšªğŸ”’\n- ëˆ„ê°€ ë°€ì–´ë„(ìˆ˜ë™), ìŠ¤ìŠ¤ë¡œ ì—´ë ¤ê³  í•´ë„(ëŠ¥ë™) ë¬¸ì€ ì—´ë¦¬ì§€ ì•ŠìŠµë‹ˆë‹¤.\n- ê´€ì ˆë‚­(Capsule) ìì²´ê°€ ì—¼ì¦ í›„ ì„¬ìœ í™”(Fibrosis)ë˜ì–´ ë‘êº¼ì›Œì§€ê³  ìª¼ê·¸ë¼ë“  ê²ƒì„.\n### ğŸš¨ Key Clinical Features\n- **ROM ì œí•œì˜ íŠ¹ì§•:** **Active AND Passive Range of Motion ëª¨ë‘ ê°ì†Œ!** â˜… (ì´ê²Œ Rotator cuffì™€ êµ¬ë³„í•˜ëŠ” í•µì‹¬!)\n    - ë‚´ê°€ íŒ”ì„ ë“¤ì–´ì¤˜ë„(Passive) ë”±ë”±í•˜ê²Œ ê±¸ë ¤ì„œ ì•ˆ ì˜¬ë¼ê° (Mechanical stop).\n- **Risk Factors:**\n    - **Diabetes Mellitus (DM)** ğŸ¬: ê³ í˜ˆë‹¹ì´ ì½œë¼ê²ì„ ëˆì í•˜ê²Œ ë§Œë“¦(Glycosylation).\n    - **Hypothyroidism** ğŸ¦‹.\n### ğŸ’Š Management\n1. **Conservative (ë³´ì¡´ì  ì¹˜ë£Œ):** **ROM Exercises** (ê°€ì¥ ë¨¼ì € ì‹œë„). ê´€ì ˆì„ ê³„ì† ì›€ì§ì—¬ì„œ ë” êµ³ëŠ” ê±¸ ë°©ì§€.\n2. **Pharmacologic:** NSAIDs.\n3. **Refractory (ì•ˆ ë‚˜ì„ ë•Œ):** Intra-articular Corticosteroid injection (ê´€ì ˆê°• ë‚´ ìŠ¤í…Œë¡œì´ë“œ ì£¼ì‚¬) -> ì—¼ì¦ ê°€ë¼ì•‰íˆê¸°.\n4. **Surgery:** ìµœí›„ì˜ ìˆ˜ë‹¨ (ê´€ì ˆë‚­ ìœ ë¦¬ìˆ  ë“±).\n## 2. Rotator Cuff Pathology (íšŒì „ê·¼ê°œ ë³‘ë³€) ğŸ’ª\n### ğŸšª Doorway Thought\n- **Scenario A (Tendinopathy):** í˜ì¸íŠ¸ì¹ ì„ í•˜ê±°ë‚˜ ì•¼êµ¬ íˆ¬ìˆ˜. íŒ”ì„ ë¨¸ë¦¬ ìœ„ë¡œ ì˜¬ë¦´ ë•Œ(Overhead) \"ì–µ!\" í•˜ê³  ì•„í””. í˜ì€ ì¢‹ìŒ.\n- **Scenario B (Tear):** 40ëŒ€ ì´ìƒ. íŒ”ì„ ë“¤ë ¤ê³  í•˜ëŠ”ë° í˜ì´ ì•ˆ ë“¤ì–´ê°(Weakness). ë°¤ì— ì•„íŒŒì„œ ê¹¸.\n### ğŸ†š Tendinopathy vs. Tear (Math Problem)\nì´ ë‘˜ì„ êµ¬ë¶„í•˜ëŠ” ê³µì‹ì´ ìˆìŠµë‹ˆë‹¤. ğŸ§®\n| **êµ¬ë¶„** | **í†µì¦ (Pain)** | **ê·¼ë ¥ (Strength)** | **ë¹„ìœ  (Analogy)** |\n| --- | --- | --- | --- |\n| **Tendinopathy** | ìˆìŒ (Yes) | **ì •ìƒ (Normal)** | ì¼€ì´ë¸”ì€ ë©€ì©¡í•œë° ì“¸ë ¤ì„œ ì•„í”ˆ ê²ƒ. |\n| **Tear** | ìˆìŒ (Yes) | **ì•½í™” (Weakness)** | ì—”ì§„ê³¼ ë°”í€´ ì—°ê²°ì´ ëŠì–´ì§. ğŸš—ğŸ’¥ |\n### ğŸ§ª Diagnosis\n- **Impingement Signs:** Neer test, Hawkins test (+) -> ë¼ˆ(Acromion)ì™€ í˜ì¤„ì´ ë¶€ë”ªí˜.\n- **Drop Arm Test (for Tear):** íŒ”ì„ 90ë„ë¡œ ë“¤ì–´ ì˜¬ë¦° ë’¤ ë²„í‹°ë¼ê³  í•˜ë©´, **íˆ­ ë–¨ì–´ì§.** (Gravity wins). ì¤‘ë ¥ì„ ì´ê¸¸ ì—”ì§„(Supraspinatus) ì—°ê²°ì´ ëŠì–´ì¡Œê¸° ë•Œë¬¸.\n- **â˜… Gold Standard:** **MRI**. (Soft tissueë¥¼ ë´ì•¼ í•˜ë‹ˆê¹Œ!)","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-249","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"### ğŸ’Š Management\n- **Tendinopathy/Partial Tear:** Physical Therapy (PT) + NSAIDs.\n- **Full Tear (Significant Weakness):** **Surgery** (íŠ¹íˆ ì Šê±°ë‚˜ í™œë™ì ì¸ í™˜ì). ê¸°ëŠ¥ ìƒì‹¤ì´ ëšœë ·í•˜ë©´ ìˆ˜ìˆ ë¡œ ì—°ê²°í•´ì¤˜ì•¼ í•¨.\n## 3. Dislocation (ì–´ê¹¨ íƒˆêµ¬) ğŸ¦´ğŸ’¥\n### A. Anterior Dislocation (ì „ë°© íƒˆêµ¬) - 95% Most Common\n- **Scenario:** ë†êµ¬í•˜ë‹¤ê°€ íŒ”ì„ ë»—ì€ ì±„ë¡œ ë„˜ì–´ì§, ë˜ëŠ” í•˜ì´íŒŒì´ë¸Œ ìì„¸ì—ì„œ ì¶©ê²©. ğŸ‘‹ğŸ€\n- **Position:** Arm is **Abducted & Externally Rotated** (íŒ”ì„ ë²Œë¦¬ê³  ë°”ê¹¥ìœ¼ë¡œ ëŒë¦° ìì„¸).\n- **Step 1 Diagnosis:** X-ray.\n- **âš ï¸ Danger Zone (Must Check!):** **Axillary Nerve (ì•¡ì™€ì‹ ê²½)** ì†ìƒ ê°€ëŠ¥ì„±!\n    - **Check:** ì–´ê¹¨ ì˜†ìª½(êµ°ë³µì˜ ë¶€ëŒ€ ë§ˆí¬ ë¶™ì´ëŠ” ìë¦¬, **Regimental Badge area**)ì˜ ê°ê°(Sensation)ì´ ìˆëŠ”ì§€ ì°”ëŸ¬ë´ì•¼ í•¨.\n### B. Posterior Dislocation (í›„ë°© íƒˆêµ¬) - Rare & Tricky\n- **Scenario:** **Seizure (ë°œì‘)** âš¡, Electrocution (ê°ì „). ğŸ”Œ\n- **Why?:** ìš°ë¦¬ ëª¸ì˜ Internal rotator ê·¼ìœ¡(Pecs, Lats)ì´ posterior rotator ê·¼ìœ¡ë³´ë‹¤ í›¨ì”¬ ê°•í•¨. ë°œì‘ ì‹œ ê°•í•œ ê·¼ìœ¡ì´ ìˆ˜ì¶•í•˜ë©´ì„œ íŒ”ì„ ë’¤ë¡œ í™• ì¡ì•„ë‹¹ê²¨(Yank) ë¹ ì§.\n- **Position:** Arm is **Adducted & Internally Rotated** (ê°€ìŠ´ ìª½ìœ¼ë¡œ íŒ”ì„ ëª¨ìœ¼ê³  ìˆìŒ).\n- **X-ray Sign:** **\"Lightbulb Sign\"** ğŸ’¡. (Humeral headê°€ ëŒì•„ê°€ì„œ ë™ê·¸ë€ ì „êµ¬ì²˜ëŸ¼ ë³´ì„). ì •ë©´ ìƒ·(AP view)ì—ì„œ ë†“ì¹˜ê¸° ì‰¬ìš°ë¯€ë¡œ ì£¼ì˜!\n## 4. Nerve Entrapment: Suprascapular Nerve ğŸ’\n- **Scenario:** **\"Hiker with a heavy backpack\"**. ë¬´ê±°ìš´ ë°°ë‚­ ëˆì´ ì–´ê¹¨ ìœ„ë¥¼ ëˆ„ë¦„.\n- **Pathophysiology:** Suprascapular nerveê°€ ê²¬ê°‘ê³¨ ìœ„ìª½(Suprascapular notch) ì¸ëŒ€ ë°‘ì„ ì§€ë‚˜ê°€ëŠ”ë°, ì—¬ê¸°ì„œ ëˆŒë¦¼. (ë§ˆì¹˜ Rotator cuff tearì²˜ëŸ¼ ë³´ì„).\n- **Symptoms:** **Supraspinatus & Infraspinatus** ìœ„ì•½.\n    - Abduction (íŒ” ë²Œë¦¬ê¸°) & External Rotation (ë°”ê¹¥ ëŒë¦¬ê¸°) í˜ì´ ë¹ ì§.\n- **Differentiation:** ì§„ì§œ í˜ì¤„ íŒŒì—´ì´ ì•„ë‹ˆë¼, ì‹ ê²½ì´ ëˆŒë ¤ì„œ ì‹ í˜¸ê°€ ì•ˆ ê°€ëŠ” ê²ƒ (Plumbing issue, not structural tear).\n    - íšŒì „ê·¼ê°œ tearë‘ ë¹„ìŠ·í•œ ì¦ìƒì„.\n    - ê·¼ìœ¡ì˜ atrophy ë‚˜íƒ€ë‚¨.\n    - MRI/EMGë¡œ êµ¬ë¶„.\n# [3.4 & 8.1] Elbow: Tennis & Students ğŸ¾ğŸ“\n## 1. Lateral Epicondylitis (Tennis Elbow) ğŸ¾\n### ğŸšª Doorway Thought\ní…Œë‹ˆìŠ¤ ì„ ìˆ˜ë¿ë§Œ ì•„ë‹ˆë¼, ì˜¤í† ë°”ì´ë¥¼ íƒ€ê±°ë‚˜, í˜ì¸íŠ¸ì¹ ì„ í•˜ê±°ë‚˜, **ì†ëª©ì„ ë’¤ë¡œ ì –íˆëŠ”(Extend)** ë™ì‘ì„ ë°˜ë³µí•˜ëŠ” ì‚¬ëŒ.\n### ğŸ§  Concept: It's NOT \"Itis\"!\n- ì´ë¦„ì€ Epicondylitisì§€ë§Œ, ì‹¤ì œ ì¡°ì§ê²€ì‚¬ë¥¼ í•´ë³´ë©´ ì—¼ì¦ì„¸í¬(Inflammatory cells)ê°€ ê±°ì˜ ì—†ìŠµë‹ˆë‹¤. âŒğŸ”¥\n- **Angiofibroblastic Tendinosis (í˜ˆê´€ì„¬ìœ ì•„ì„¸í¬ì„± ê±´ì¦):** í˜ì¤„ì´ ë‹³ê³  ë‹³ì•„ì„œ ë„ˆëœë„ˆëœí•´ì§„ ìƒíƒœ(Degeneration/Wear and tear). ë‚¡ì€ ë°§ì¤„ ìƒê°í•˜ë©´ ë¨.\n### ğŸ§ª Diagnosis\n- **Provocative Test:** **Resisted Wrist Extension.**\n    - \"ì˜¤í† ë°”ì´ ì—‘ì…€ ë‹¹ê¸°ë“¯ ì†ëª©ì„ ì˜¬ë ¤ë³´ì„¸ìš”\" í•˜ê³  ëª» í•˜ê²Œ ë§‰ìŒ. ğŸï¸\n    - íŒ”ê¿ˆì¹˜ ë°”ê¹¥ìª½(Lateral)ì— í†µì¦ì´ ì°Œë¦¿! âš¡","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-269","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### ğŸ’Š Management\n- **Counterforce Brace:** **\"Guitar Capo\"** ì›ë¦¬. ğŸ¸\n    - í†µì¦ ë¶€ìœ„ë³´ë‹¤ ì•„ë˜ìª½ì„ ê½‰ ë¬¶ì–´ì„œ, í˜ì´ í˜ì¤„ ê¸°ì‹œë¶€(Bone)ê¹Œì§€ ì „ë‹¬ë˜ì§€ ì•Šê²Œ 'ê°€ì§œ ê¸°ì‹œë¶€(False anchor)'ë¥¼ ë§Œë“¤ì–´ì£¼ëŠ” ê²ƒ.\n## 2. Olecranon Bursitis (Student's Elbow) ğŸ’§\n### ğŸšª Doorway Thought\nì±…ìƒì— íŒ”ê¿ˆì¹˜ë¥¼ ì˜¤ë˜ ëŒ€ê³  ê³µë¶€í•˜ëŠ” í•™ìƒ(USMLE ìˆ˜í—˜ìƒ? ğŸ˜‚) í˜¹ì€ ë°°ê´€ê³µ. íŒ”ê¿ˆì¹˜ ëì— ë¬¼í’ì„ (Goose egg) ê°™ì€ ê²Œ ìƒê¹€.\n### âš–ï¸ The Great Bifurcation (Decision Tree)\nì´ í˜¹(Swelling)ì´ **ê°ì—¼ë˜ì—ˆëŠëƒ(Septic)** ì•„ë‹ˆëƒë¥¼ ê°€ë¥´ëŠ” ê²ƒì´ ì¹˜ë£Œì˜ ì „ë¶€ì…ë‹ˆë‹¤.\n| **íŠ¹ì§•** | **Non-Septic (ë‹¨ìˆœ ì ì•¡ë‚­ì—¼)** | **Septic (í™”ë†ì„± ì ì•¡ë‚­ì—¼) ğŸ¦ ** |\n| --- | --- | --- |\n| **History** | ë§Œì„±ì ì¸ ì••ë°• (Chronic leaning) | ì™¸ìƒ(Trauma), ë²Œë ˆ ë¬¼ë¦¼(Bug bite), ê¸í˜ |\n| **Signs** | ëœ ì•„í””, ì—´ê° ì—†ìŒ | **Red (ë°œì ), Warm (ì—´ê°), Very Tender (ì••í†µ), Fever** |\n| **Action** | ê´€ì°° / ë³´í˜¸ | **â˜… Aspiration (ì²œì) MUST DO!** |\n### ğŸ’‰ Next Best Step\n- ì˜ì‹¬ë˜ë©´ ë¬´ì¡°ê±´ **Aspiration (ë°”ëŠ˜ë¡œ ì°”ëŸ¬ì„œ ë¬¼ ë½‘ê¸°)**.\n    - Gram stain & Culture ë³´ëƒ„.\n- **Treatment:**\n    - **Septic:** **Antibiotics** (Staph aureus íƒ€ê²Ÿ) + **Drainage**.\n    - **Non-septic:** NSAIDs + Padding (íŒ”ê¿ˆì¹˜ ë³´í˜¸ëŒ€) + ìì„¸ êµì • (Stop leaning!).","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-289","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","treatment","tree"]}
{"chunk_type":"recap_summary","text":"### ğŸ”¥ Rapid Fire Recap (High-Yield Summary)\n| **Pathology** | **Key Feature (Buzzword)** | **Diagnosis / Test** | **Treatment (1st Line)** |\n| --- | --- | --- | --- |\n| **Frozen Shoulder** | **Active & Passive ROM â†“** | Clinical (History) | ROM Exercise (Keep moving!)\në‹¹ë‡¨, ê°‘ìƒì„  ì €í•˜ì¦ |\n| **Rotator Cuff Tear** | **Weakness** + Drop Arm (+) | MRI (Gold Standard) | Surgery (if functional loss) |\n| **Ant. Dislocation** | Abducted/Ext. Rotated | X-ray (Check **Axillary n.**) | Reduction |\n| **Post. Dislocation** | **Seizure**, Lightbulb Sign | X-ray (Axillary/Scapular Y)\nLight bulb | Reduction |\n| **Tennis Elbow** | Pain on **Wrist Extension** | Clinical | Counterforce Brace (Strap) |\n| **Septic Bursitis** | Red, Hot, Fever, Trauma | **â˜… Aspiration (Culture)** | Antibiotics + Drainage |\n### ğŸ©º Doctor's Note (Caveats)\n- **Caveats:**\n    - ì˜¤ë””ì˜¤ëŠ” **Septic Bursitis**ì˜ ì¹˜ë£Œë¡œ \"Antibiotics + Drainage\"ë¥¼ ê°•ì¡°í–ˆìŠµë‹ˆë‹¤. ìˆ˜ìˆ ì  ë°°ë†(I&D)ì¸ì§€ ë‹¨ìˆœ ì²œì ë°°ë†ì¸ì§€ëŠ” ìƒí™©ì— ë”°ë¼ ë‹¤ë¥´ì§€ë§Œ, USMLEì—ì„œëŠ” \"Drain it & Treat bugs\"ê°€ í•µì‹¬ì…ë‹ˆë‹¤.\n    - **Tennis Elbow**ì—ì„œ ìŠ¤í…Œë¡œì´ë“œ ì£¼ì‚¬ëŠ” ì–¸ê¸‰ë˜ì§€ ì•Šì•˜ìŠµë‹ˆë‹¤. ì˜¤ë””ì˜¤ì— ì¶©ì‹¤í•˜ê²Œ **Brace**ì™€ ë³‘íƒœìƒë¦¬(Degeneration)ì— ì§‘ì¤‘í•˜ì„¸ìš”.\n    - **Shoulder Dislocation** ì •ë³µ(Reduction) ì „ **Neurovascular Check** (íŠ¹íˆ Axillary nerve ê°ê°)ëŠ” **Medicolegal**í•˜ê²Œë„ ë§¤ìš° ì¤‘ìš”í•˜ë‹ˆ ê¼­ ê¸°ì–µí•˜ì„¸ìš”! âš–ï¸\n## ğŸ“‹ Overview: Hand & Wrist Pathology High-Yield Summary\nì˜¤ëŠ˜ ë‹¤ë£° ë‚´ìš©ì€ USMLE Step 2CK ë° ì„ìƒì—ì„œ **ë§¤ìš° ë¹ˆì¶œ(High Yield)**ë˜ëŠ” ì†ê³¼ ì†ëª©ì˜ 4ëŒ€ì¥ ë³‘ë³€ì…ë‹ˆë‹¤. ğŸ–ï¸ êµ¬ì¡°ì ì¸ ë¬¸ì œë¶€í„° ì‹ ê²½ ì••ë°•ê¹Œì§€, í•µì‹¬ë§Œ ë¹ ë¥´ê²Œ ì§šì–´ë´…ì‹œë‹¤!\n| **Pathology** | **Key Feature (Vibe Check)** | **Key Mechanism/Risk** | **Gold Standard/Next Step** |\n| --- | --- | --- | --- |\n| **Carpal Tunnel Syndrome** | ë°¤ì— ì†ì´ ì €ë ¤ì„œ ê¹¬ë‹¤ (Night pain), ì†ì„ í„´ë‹¤ (Flick sign) | Pregnancy, Hypothyroid, Renal Failure (Amyloid/Dialysis) | **Splint (Night) â†’ Steroid â†’ Surgery** |\n| **De Quervain's** | ì‹ ìƒì•„ë¥¼ ì•ˆì•„ ì˜¬ë¦¬ëŠ” ì—„ë§ˆ (New Mom), ì—„ì§€ ìª½ í†µì¦ | APL & EPB Tendon overuse | **Finkelstein Test (+) â†’ Thumb Spica Splint** |\n| **Dupuytren Contracture** | ë¶ìœ ëŸ½ê³„ ë…¸ë…„ ë‚¨ì„±, ì†ë°”ë‹¥ì´ ë‘êº¼ì›Œì§€ê³  ì†ê°€ë½ì´ êµ½ìŒ | Palmar Fascia Fibrosis (Alcohol, Diabetes, Smoking) | **Table Top Test (+) â†’ Surgery/Injection** |\n| **Ganglion Cyst** | ì†ëª© ë“±ìª½(Dorsal)ì— ìƒê¸´ ë¬¼ë í•œ í˜¹ | Mucin-filled cyst (Transillumination +) | **Observation (Reassurance) â†’ Aspiration â†’ Excision** |","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-301","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","recap","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"## ğŸŒ³ 2. Top-Down Classification: Hand & Wrist Pathology\nì˜í•™ì  Contextë¥¼ ì¡ê¸° ìœ„í•œ **ASCII Text Tree**ì…ë‹ˆë‹¤. ì˜¤ëŠ˜ ë‹¤ë£° ë‚´ìš©ì´ ì–´ë””ì— ìœ„ì¹˜í•˜ëŠ”ì§€ í™•ì¸í•˜ì„¸ìš”! ğŸ‘‡\nPlaintext\n`Musculoskeletal System (Upper Extremity)\nâ”‚\nâ”œâ”€â”€ 1. Nerve Compression Syndromes (Neuropathy)\nâ”‚    â””â”€â”€ Median Nerve\nâ”‚         â””â”€â”€ CARPAL TUNNEL SYNDROME (CTS) â˜… [Topic 1]\nâ”‚              â”œâ”€â”€ Sensory: Thumb, Index, Middle finger numbness\nâ”‚              â””â”€â”€ Motor: Thenar atrophy (Late sign)\nâ”‚\nâ”œâ”€â”€ 2. Tendinopathies & Tenosynovitis\nâ”‚    â””â”€â”€ First Dorsal Compartment (Radial side)\nâ”‚         â””â”€â”€ DE QUERVAIN'S TENOSYNOVITIS â˜… [Topic 2]\nâ”‚              â””â”€â”€ APL & EPB tendons affected\nâ”‚\nâ”œâ”€â”€ 3. Fascial & Connective Tissue Disorders\nâ”‚    â””â”€â”€ Palmar Fascia\nâ”‚         â””â”€â”€ DUPUYTREN'S CONTRACTURE â˜… [Topic 3]\nâ”‚              â””â”€â”€ Fibrosis (Not tendon!), Flexion contracture\nâ”‚\nâ””â”€â”€ 4. Benign Soft Tissue Tumors\n     â””â”€â”€ Synovial/Joint Capsule origin\n          â””â”€â”€ GANGLION CYST â˜… [Topic 4]\n               â””â”€â”€ Transillumination Positive (Fluid filled)`\n## ğŸ–ï¸ 3. Deep Dive Lecture Notes\n### Topic 1: Carpal Tunnel Syndrome (CTS)\n**\"The Bread and Butter of Compression Neuropathies\"** ğŸ\n### ğŸšª Doorway Thought (Vibe Check)\nì„ì‹  3ë¶„ê¸°(3rd Trimester) ì„ì‚°ë¶€ í˜¹ì€ íˆ¬ì„ ì¤‘ì¸ ë§ê¸° ì‹ ë¶€ì „(ESRD) í™˜ìê°€ ë‚´ì›í•©ë‹ˆë‹¤. \"ì†ì´ ì €ë ¤ì„œ ë¯¸ì¹˜ê² ì–´ìš”.\"ë¼ê³  í˜¸ì†Œí•˜ë©°, íŠ¹íˆ **ë°¤ì— ìë‹¤ê°€ ì†ì´ ì €ë ¤ì„œ ê¹¨ê³ , ì†ì„ í„¸ì–´ì•¼(Shake out) ì¢€ ë‚«ë‹¤**ê³  í•©ë‹ˆë‹¤. ğŸŒ™ğŸ‘‹\n### ğŸ” Anatomy & Symptom Distribution\n- *Median Nerve (ì •ì¤‘ì‹ ê²½)**ì˜ ì••ë°•.\n- **ì˜í–¥ ë°›ëŠ” ë¶€ìœ„:** ì—„ì§€(Thumb), ê²€ì§€(Index), ì¤‘ì§€(Middle), ì•½ì§€ì˜ ì ˆë°˜(Radial half of Ring finger).\n- **ì£¼ì˜ (Deal Breaker):** ë§Œì•½ ìƒˆë¼ì†ê°€ë½(Pinky)ì´ ì €ë¦¬ë‹¤ë©´? ğŸ™…â€â™‚ï¸ ì ˆëŒ€ CTSê°€ ì•„ë‹™ë‹ˆë‹¤. ê·¸ê±´ Ulnar nerve ë¬¸ì œ(ì˜ˆ: Cubital tunnel syndrome)ì…ë‹ˆë‹¤.\n### âš™ï¸ Mechanism (Why? - High Yield for Step 2)\në‹¨ìˆœíˆ \"ì†ëª©ì„ ë§ì´ ì¨ì„œ\" ë¿ë§Œ ì•„ë‹ˆë¼, **Systemic Disease**ì™€ ì—°ê´€ì„±ì„ ë¬»ëŠ” ë¬¸ì œê°€ ë§ì´ ë‚˜ì˜µë‹ˆë‹¤.\n1. **Hypothyroidism (ê°‘ìƒì„ ê¸°ëŠ¥ì €í•˜ì¦):** Glycosaminoglycans (Myxedema) ì¶•ì ìœ¼ë¡œ ì¸í•œ ì••ë°•.\n2. **Pregnancy (ì„ì‹ ):** ì²´ì•¡ ì €ë¥˜(Fluid retention/Edema)ë¡œ í„°ë„ ë‚´ ì••ë ¥ ì¦ê°€. (ì¶œì‚° í›„ ë³´í†µ í˜¸ì „ë¨)\n3. **Renal Failure (ì‹ ë¶€ì „/íˆ¬ì„):**\n    - **Dialysis-related Amyloidosis:** Beta-2 microglobulin (Amyloid)ì´ í„°ë„ ë‚´ ì¹¨ì°©.\n    - **Calcium Phosphate:** ê²°ì •ì²´ ì¹¨ì°©.\n    - **Vascular Steal Syndrome:** AV fistulaë¡œ ì¸í•œ í—ˆí˜ˆì„± ì‹ ê²½ë³‘ì¦(Ischemic neuropathy) â†’ ì‹ ê²½ì´ ìˆ¨ì„ ëª» ì‰¬ì–´ì„œ ì£½ì–´ê°(Suffocating).\n4. **Diabetes:** Glycosylationìœ¼ë¡œ ì¸í•œ ì—°ì¡°ì§ ë¹„í›„ + ë¯¸ì„¸í˜ˆê´€ ì†ìƒ.\n5. **Rheumatoid Arthritis (RA):** ê´€ì ˆ ë³€í˜• ë° ì—¼ì¦ìœ¼ë¡œ ì¸í•œ ë¬¼ë¦¬ì  ì••ë°•.\n6. Acromegaly\n7. Gout\n### ğŸ©º Diagnosis (Tests)\n- **Phalen Test:** ì†ëª©ì„ 90ë„ êµ½í˜€ì„œ ë§ëŒ€ê¸° (Flexion).\n- **Tinel Sign:** ì†ëª©ì˜ ì‹ ê²½ ë¶€ìœ„ë¥¼ í†¡í†¡ ì¹˜ê¸° (Tapping).\n- **Durkan's Test (Most Sensitive):** ì˜ì‚¬ê°€ ì—„ì§€ë¡œ Carpal tunnel ë¶€ìœ„ë¥¼ 30ì´ˆê°„ ê¾¹ ëˆ„ë¥´ê³  ìˆëŠ” ê²€ì‚¬. (ì‹ ê²½ì„ ì§ì ‘ ì°Œë¶€ì‹œí‚¤ëŠ” ê²ƒ! ğŸ˜–)\n- **Gold Standard (í™•ì§„):** **NCS/EMG (Nerve Conduction Study)**. í•˜ì§€ë§Œ ì„ìƒ ì¦ìƒì´ ëª…í™•í•˜ë©´ êµ³ì´ í•„ìš” ì—†ê³ , ìˆ˜ìˆ  ì „ì´ë‚˜ ì§„ë‹¨ì´ ì• ë§¤í•  ë•Œ ì‹œí–‰í•©ë‹ˆë‹¤.\n### ğŸš© Red Flag: Severe Disease","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-311","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"- ê°ê° ì´ìƒì„ ë„˜ì–´ì„œ **ìš´ë™ ê¸°ëŠ¥ ì†Œì‹¤(Motor deficit)**ì´ ì˜¤ë©´ ëŠ¦ì€ ê²ë‹ˆë‹¤.\n- **Thenar Atrophy (ì—„ì§€ ë‘ë© ìœ„ì¶•):** ê·¼ìœ¡ì´ ë§ë¼ë²„ë¦° ìƒíƒœ. ì‹ ê²½ ì‹ í˜¸ê°€ ëŠê²¨ì„œ ë°œìƒ (Axonal loss). ğŸ˜±\n- Thumb Abduction & Opposition ì•½í™”.\n### ğŸ’Š Management (Step-by-Step)\n1. **Conservative (1st Line):** **Wrist Splint (Night time)**. ì˜ ë•Œ ì¤‘ë¦½ ìì„¸ ìœ ì§€.\n2. **Medical:** NSAIDs (íš¨ê³¼ ì ìŒ), **Local Corticosteroid Injection**.\n3. **Surgical (Definitive):** **Carpal Tunnel Release**. (Transverse Carpal Ligamentë¥¼ ìë¦„). ğŸ”ª\n    - ì ì‘ì¦: ë³´ì¡´ì  ì¹˜ë£Œ ì‹¤íŒ¨, Thenar atrophy ë°œìƒ ì‹œ ì¦‰ì‹œ ê°ì••(Decompression) í•„ìš”.\n### Topic 2: De Quervain's Tenosynovitis\n**\"The New Mom's Wrist\"** ğŸ‘¶ğŸ¼\n### ğŸšª Doorway Thought (Vibe Check)\nê°“ ì•„ì´ë¥¼ ë‚³ì€ ì—„ë§ˆê°€ ì•„ê¸°ë¥¼ ë“¤ì–´ ì˜¬ë¦´ ë•Œë§ˆë‹¤ ì†ëª© ì—„ì§€ ìª½(Radial side)ì´ ì°Œë¦¿í•˜ê²Œ ì•„í”„ë‹¤ê³  ì˜µë‹ˆë‹¤. âš¡\n### ğŸ” Anatomy & Pathology\n- **Affected Tendons:** **APL** (Abductor Pollicis Longus) & **EPB** (Extensor Pollicis Brevis).\n    - *Tip:* \"All Peanut Lovers Eat Peanut Butter\" í˜¹ì€ í•´ë¶€í•™ ê·¸ë¦¼ì„ ìƒìƒí•˜ì„¸ìš”.\n- **Pathology:** ë‹¨ìˆœ ì—¼ì¦(Inflammation)ì´ë¼ê¸°ë³´ë‹¤ **Myxoid Degeneration** (ì ì•¡ì„± ë³€ì„±) ë° í˜ì¤„ì§‘(Sheath)ì˜ ë¹„í›„. ë°˜ë³µì ì¸ ë§ˆì°°ë¡œ ì¸í•´ í˜ì¤„ì´ ê°‡í˜.\n### ğŸ©º Diagnosis\n- **Finkelstein Test:**\n    1. ì—„ì§€ë¥¼ ì†ë°”ë‹¥ ì•ˆì— ë„£ê³  ì£¼ë¨¹ì„ ì¥”ë‹¤. âœŠ\n    2. ì†ëª©ì„ ìƒˆë¼ì†ê°€ë½ ìª½(Ulnar deviation)ìœ¼ë¡œ êº¾ëŠ”ë‹¤.\n    3. Radial styloid ìª½ì— ê·¹ì‹¬í•œ í†µì¦(Sharp pain) ë°œìƒ ì‹œ ì–‘ì„±!\n### ğŸ’Š Management\n1. **Conservative (Best Initial):** **Thumb Spica Splint**. (ì—„ì§€ê¹Œì§€ ê°ì‹¸ëŠ” ë¶€ëª©). NSAIDs ë³‘ìš©.\n2. **Intervention:** Corticosteroid Injection.\n3. **Surgery:** Surgical release (ë“œë¬¼ê²Œ).\n### Topic 3: Dupuytren's Contracture\n**\"The Viking's Hand\"** ğŸºğŸš¬\n### ğŸšª Doorway Thought (Vibe Check)\n50ì„¸ ì´ìƒ ë¶ìœ ëŸ½ê³„ ë°±ì¸ ë‚¨ì„±(Northern European descent). ìˆ (Alcohol)ê³¼ ë‹´ë°°(Smoking)ë¥¼ ì¦ê¸°ê³  ë‹¹ë‡¨ê°€ ìˆì„ ìˆ˜ ìˆìŒ. \"ì†ë°”ë‹¥ì— êµ³ì€ì‚´ì´ ë°•íˆë”ë‹ˆ ì†ê°€ë½ì´ ì•ˆ í´ì ¸ìš”.\"ë¼ê³  í˜¸ì†Œ. ğŸ¤šğŸš«\n### ğŸ” Anatomy & Pathology","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-331","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"- **Location:** ì£¼ë¡œ **4th (Ring)** & **5th (Pinky)** ì†ê°€ë½.\n- **Pathology:** í˜ì¤„(Tendon) ë¬¸ì œê°€ ì•„ë‹™ë‹ˆë‹¤! **Palmar Fascia (ì†ë°”ë‹¥ ê·¼ë§‰)ì˜ Fibrosis (ì„¬ìœ í™”)**ì…ë‹ˆë‹¤.\n- ì´ˆê¸°ì—ëŠ” ë©ì–´ë¦¬(Nodule)ê°€ ë§Œì ¸ì§€ê³  í”¼ë¶€ê°€ ë‹¹ê²¨ì§(Puckering) â†’ ì ì°¨ êµµì€ ë (Cord)ê°€ í˜•ì„±ë˜ì–´ ì†ê°€ë½ì„ êµ½í˜ êµ¬ì¶•(Flexion contracture) ì‹œí‚´.\n### ğŸ©º Diagnosis\n- **Table Top Test:** ì†ë°”ë‹¥ì„ í…Œì´ë¸”ì— í‰í‰í•˜ê²Œ í´ë³´ë¼ê³  ì‹œí‚µë‹ˆë‹¤. ì†ê°€ë½ì´ êµ½ì–´ ìˆì–´ì„œ ë°”ë‹¥ì— ë‹¿ì§€ ì•Šìœ¼ë©´(Arching) ì–‘ì„±.\n### ğŸ’Š Management\n1. **Conservative:** ì´ˆê¸°ì—ëŠ” ê²½ê³¼ ê´€ì°°(Observation)í•˜ê±°ë‚˜ ì¥ê°‘ íŒ¨ë“œ ì‚¬ìš© ë“±. ìŠ¤íŠ¸ë ˆì¹­ì€ ë¶ˆê°€ëŠ¥(í‰í„° ì¡°ì§ì´ë¼ ì•ˆ ëŠ˜ì–´ë‚¨).\n2. **Procedural:**\n    - **Needle Aponeurotomy:** ë°”ëŠ˜ë¡œ ë ë¥¼ ëŠì–´ì¤Œ.\n    - **Collagenase Injection:** íš¨ì†Œ ì£¼ì‚¬ë¡œ ë ë¥¼ ë…¹ì„.\n3. **Surgical:** ê¸°ëŠ¥ ì œí•œì´ ì‹¬í•˜ë©´ **Fasciectomy** (ê·¼ë§‰ ì ˆì œìˆ ). ì¬ë°œ(Recurrence)ì´ í”í•¨.\n### Topic 4: Ganglion Cyst\n**\"The Bible Bump\"** ğŸ“–ğŸ”¨ (ì˜ˆì „ì—” ì„±ê²½ì±…ìœ¼ë¡œ ë‚´ë¦¬ì³ì„œ ê¹¼ë‹¤ê³  í•´ì„œ...)\n### ğŸšª Doorway Thought (Vibe Check)\nì Šì€ ì—¬ì„±ì´ ì†ëª© ë“±ìª½(Dorsal wrist)ì— \"ë§ë‘ë§ë‘í•œ í˜¹\"ì´ ìƒê²¼ë‹¤ê³  ì˜´. í†µì¦ì€ ë³„ë¡œ ì—†ê±°ë‚˜ ë»ê·¼í•œ ì •ë„. ë¯¸ìš©ìƒ ê±°ìŠ¬ë¦¼.\n### ğŸ” Anatomy & Pathology\n- **Pathology:** ê´€ì ˆë§‰(Joint capsule)ì´ë‚˜ ê±´ì´ˆ(Tendon sheath)ì—ì„œ ìœ ë˜í•œ **Herniation**.\n- **Content:** ë§‘ê³  ëˆì í•œ ì ¤ë¦¬ ê°™ì€ ì•¡ì²´ (**Mucin-filled / Gelatinous fluid**).\n- **Mechanism:** **Mucoid Degeneration**. ì—°ê²° í†µë¡œ(One-way valve)ê°€ ìƒê²¨ ê´€ì ˆì•¡ì´ ë‚˜ì˜¤ê³  ê°‡í˜.\n### ğŸ©º Diagnosis\n- **Transillumination Test (ë¹› íˆ¬ê³¼ ê²€ì‚¬):** íœë¼ì´íŠ¸ë¥¼ ë¹„ì·„ì„ ë•Œ **ë¹›ì´ í†µê³¼í•¨(Glows)** âœ¨. (ê³ í˜• ì¢…ì–‘ì€ ë¹› í†µê³¼ X).\n- **ìœ„ì¹˜:** Dorsal Wristê°€ ê°€ì¥ í”í•¨. (Volar sideë‚˜ ë¬´ë¦, ë°œì—ë„ ìƒê¸¸ ìˆ˜ëŠ” ìˆìŒ).\n### ğŸ’Š Management\n1. **Asymptomatic (ì¦ìƒ ì—†ìŒ):** **Reassurance & Observation (ì•ˆì‹¬ì‹œí‚¤ê³  ê´€ì°°)**. ğŸ¤š ì ˆë°˜ ì´ìƒ ìì—° ì†Œì‹¤ë¨.\n2. **Symptomatic/Cosmetic:**\n    - **Aspiration (ì£¼ì‚¬ê¸° í¡ì¸):** ì ¤ë¦¬ë¥¼ ë½‘ì•„ëƒ„. í•˜ì§€ë§Œ **ì¬ë°œë¥ (Recurrence)ì´ ë§¤ìš° ë†’ìŒ** (í†µë¡œê°€ ì‚´ì•„ìˆì–´ì„œ ë‹¤ì‹œ ì°¸).\n    - **Surgical Excision (ìˆ˜ìˆ ):** ë¿Œë¦¬(Stalk/Valve)ê¹Œì§€ ì œê±°. ê°€ì¥ í™•ì‹¤í•œ ë°©ë²•.","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-351","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_summary","text":"## âš¡ 4. Rapid Fire Recap (High Yield Q&A)\në§ˆì§€ë§‰ìœ¼ë¡œ ë°°ìš´ ë‚´ìš©ì„ ë¹ ë¥´ê²Œ ì ê²€í•´ë´…ì‹œë‹¤! ğŸ”¥\n| **Question** | **Answer** |\n| --- | --- |\n| **Q1. De Quervain's Tenosynovitisì˜ 2ê°€ì§€ Target Tendonì€?** | **Abductor Pollicis Longus (APL), Extensor Pollicis Brevis (EPB)** |\n| **Q2. íˆ¬ì„ í™˜ì CTSì˜ ì›ì¸ ì¤‘, ì‹ ê²½ì´ í—ˆí˜ˆ(Ischemia)ì— ë¹ ì§€ëŠ” ê¸°ì „ì€?** | **Vascular Steal Syndrome** (AV fistulaê°€ í˜ˆë¥˜ë¥¼ ëºì–´ê°) |\n| **Q3. De Quervain'sì˜ ì¹˜ë£Œë¥¼ ìœ„í•œ ë¶€ëª©(Splint)ì˜ ì´ë¦„ì€?** | **Thumb Spica Splint** |\n| **Q4. ì†ëª© ê²°ì ˆì¢…(Ganglion Cyst) ì§„ë‹¨ì„ ìœ„í•œ ì‹ ì²´ ê²€ì§„ë²•ì€?** | **Transillumination (ë¹› íˆ¬ê³¼ ê²€ì‚¬) - Positive** |\n| **Q5. Dupuytren's Contractureì—ì„œ ê°€ì¥ í”íˆ ì¹¨ë²”ë˜ëŠ” ì†ê°€ë½ì€?** | **4th (Ring) & 5th (Little) fingers** |\n| **Q6. ê°‘ìƒì„ ê¸°ëŠ¥ì €í•˜ì¦(Hypothyroid) í™˜ìì˜ CTS ì›ì¸ ë¬¼ì§ˆì€?** | **Mucopolysaccharides (Glycosaminoglycans) / Myxedema** |\n| **Q7. ì¦ìƒì´ ì—†ëŠ” Ganglion Cystì˜ ì²˜ì¹˜ëŠ”?** | **Observation (ê´€ì°°)** (ê±´ë“œë¦¬ì§€ ë§ˆì„¸ìš”!) |\n- **Caveats:**\n    - ì˜¤ë””ì˜¤ì—ì„œëŠ” CTSì˜ ì›ì¸ìœ¼ë¡œ \"Acromegaly\"ëŠ” ì–¸ê¸‰ë˜ì§€ ì•Šì•˜ìœ¼ë‚˜ USMLEì—ì„œëŠ” í”í•œ ì›ì¸ì´ë¯€ë¡œ ì°¸ê³ í•˜ì„¸ìš”.\n    - Ganglion Cystì˜ \"Bible Bump\" ì¹˜ë£Œë²•(ì±…ìœ¼ë¡œ ë‚´ë¦¬ì¹˜ê¸°)ì€ ì—­ì‚¬ì ì¸ ì´ì•¼ê¸°ì¼ ë¿, ì ˆëŒ€ ì„ìƒì—ì„œ ê¶Œì¥í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤! (ê³¨ì ˆ ìœ„í—˜ ğŸ¦´).\n**Would you like me to generate a specific quiz set for these hand pathologies to test your retention?** ğŸ§ \n### **TL;DR: Spine Pathology Overview ğŸ¦´**\n- **í•µì‹¬ ì£¼ì œ:** ì²™ì¶” ë³‘ë³€(Spine Pathology)ê³¼ ì™¸ìƒ(Trauma)ì— ëŒ€í•œ USMLE Step 2 CK ìˆ˜ì¤€ì˜ ì ‘ê·¼ë²•.\n- **3ê°€ì§€ í™˜ì ì•„ë°”íƒ€ (Archetypes):**\n    1. **The Shooter (ë°©ì‚¬í†µ):** ì‹ ê²½ê·¼ ë³‘ì¦(Radiculopathy). \"ì „ê¸°ê°€ ì˜ëŠ” ë“¯í•œ í†µì¦\".\n    2. **The Leaner (í˜‘ì°©ì¦):** ì²™ì¶”ê´€ í˜‘ì°©ì¦(Stenosis). \"ì‡¼í•‘ì¹´íŠ¸ì— ê¸°ëŒ€ëŠ” ë…¸ì¸\".\n    3. **The Stumbler (ì²™ìˆ˜ë³‘ì¦):** ì²™ìˆ˜ë³‘ì¦(Myelopathy). \"ë¹„í‹€ê±°ë¦¬ê³  ë‹¨ì¶”ë¥¼ ëª» ì±„ì›€\".\n- **Golden Rule:** Red Flag(ì•”, ê°ì—¼, ë§ˆë¯¸ì¦í›„êµ°)ê°€ ì—†ìœ¼ë©´ **MRI ì°ì§€ ë§ˆë¼!** (ì´ˆê¸° 4-6ì£¼ëŠ” ë³´ì¡´ì  ì¹˜ë£Œ).","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-368","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","recap"]}
{"chunk_type":"transcript_chunk","text":"### **TOP-DOWN CLASSIFICATION: Spine Pathology Tree ğŸŒ³**\nì²™ì¶” ì§ˆí™˜ì€ í¬ê²Œ **ìœ„ì¹˜(Neck vs Back)**ì™€ **ì†ìƒ ë¶€ìœ„(Nerve Root vs Cord)**ë¡œ ë‚˜ë‰©ë‹ˆë‹¤.\nPlaintext\n`SPINE PATHOLOGY (ì²™ì¶” ë³‘ë³€)\nâ”‚\nâ”œâ”€â”€ ANATOMICAL LOCATION (ìœ„ì¹˜)\nâ”‚   â”œâ”€â”€ Cervical (ëª©/ê²½ì¶”)\nâ”‚   â”‚   â”œâ”€â”€ Radiculopathy (ì‹ ê²½ê·¼ë³‘ì¦) â”€â”€â”€ [Pinched Wire: ë§ì´ˆì‹ ê²½ ì¦ìƒ]\nâ”‚   â”‚   â””â”€â”€ Myelopathy (ì²™ìˆ˜ë³‘ì¦) â”€â”€â”€â”€â”€â”€â”€ [Crushed Cable: ì¤‘ì¶”ì‹ ê²½ ì¦ìƒ] â˜…DANGER\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Lumbar (í—ˆë¦¬/ìš”ì¶”)\nâ”‚       â”œâ”€â”€ Disc Herniation (ë””ìŠ¤í¬ íƒˆì¶œ) â”€â”€ [The Shooter: ê¸‰ì„± ë°©ì‚¬í†µ]\nâ”‚       â”œâ”€â”€ Spinal Stenosis (í˜‘ì°©ì¦) â”€â”€â”€â”€â”€â”€ [The Leaner: ì‹ ê²½ì¸ì„± íŒŒí–‰]\nâ”‚       â””â”€â”€ Spondylolisthesis (ì „ë°©ì „ìœ„ì¦) â”€ [The Gymnast: ì²™ì¶” ë¶„ë¦¬ ë° ë°€ë¦¼]\nâ”‚\nâ”œâ”€â”€ URGENCY (ì‘ê¸‰ë„)\nâ”‚   â”œâ”€â”€ Mechanical/Degenerative â”€â”€â”€â”€â”€â”€â”€â”€ [ë³´ì¡´ì  ì¹˜ë£Œ (NSAIDs + Activity)]\nâ”‚   â””â”€â”€ RED FLAGS (Cauda Equina, Tumor) â”€â”€ [â˜…MRI Emergent + Surgery]\nâ”‚\nâ””â”€â”€ TRAUMA (ì™¸ìƒ)\n    â”œâ”€â”€ NEXUS Criteria â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€ [CT ì°ì„ì§€ ë§ì§€ ê²°ì •]\n    â””â”€â”€ Cord Syndromes â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€ [Central, Anterior, Brown-Sequard]`\n# [Ep 06] Spine Pathology & Trauma: Deep Dive ğŸ¥\n## 1. The Vibe Check: 3ê°€ì§€ í™˜ì ìœ í˜• (Archetypes) ğŸ­\nUSMLE ë¬¸ì œì—ì„œ í™˜ìì˜ **ìì„¸(Posture)**ì™€ **í–‰ë™(Movement)**ë§Œ ë´ë„ ì§„ë‹¨ì´ ë‚˜ì˜µë‹ˆë‹¤.\n| **ìœ í˜• (Archetype)** | **ë³„ëª…** | **ì„ìƒìƒ (Presentation)** | **í•µì‹¬ ë³‘ë¦¬ (Pathology)** |\n| --- | --- | --- | --- |\n| **Type 1** | **The Shooter ğŸ”«** | íŒ”ì„ ë”°ë¼ ì­ˆìš± ë»—ì¹˜ëŠ” ì „ê¸° ê°™ì€ í†µì¦ (Electric pain). Hands on head (í•­ë³µí•˜ëŠ” ìì„¸) | **Radiculopathy** (Nerve Root ì••ë°•) |\n| **Type 2** | **The Leaner ğŸ›’** | ì‡¼í•‘ì¹´íŠ¸ì— ê¸°ëŒ€ì„œ ê±·ëŠ” ë…¸ì¸. í—ˆë¦¬ë¥¼ í´ë©´ ì•„í””. | **Stenosis** (Central Canal í˜‘ì°©) |\n| **Type 3** | **The Stumbler ğŸ¥´** | ë¹„í‹€ê±°ë¦¼, ì “ê°€ë½ì§ˆ ëª»í•¨, ë‹¨ì¶” ëª» ì ê¸ˆ (Clumsy). | **Myelopathy** (Spinal Cord ì••ë°•) |\n## 2. Cervical Spine (ëª©) ğŸ¦’\n### A. Cervical Radiculopathy (The Shooter) âš¡Â Exit problem\n- **Doorway Thought:** ì Šì€ í™˜ìê°€ íŒ”ì´ ì €ë¦¬ë‹¤ê³  ì˜¤ê±°ë‚˜, ë…¸ì¸ì´ ëª© í†µì¦ê³¼ í•¨ê»˜ íŒ”ë¡œ ë»—ì¹˜ëŠ” í†µì¦ í˜¸ì†Œ.\ní•­ë³µí•˜ëŠ”ê±°ë§ˆëƒ¥ ì†ì„ ë¨¸ë¦¬ìœ„ì— ì˜¬ë¦¬ê³ ì˜´! Surrender\n- **Pathophysiology:**\n    - **\"Pinched Wire\" (ì „ì„ ì´ ì°í˜):** ì²™ì¶” ì‚¬ì´ êµ¬ë©(Neural foramen)ì´ ì¢ì•„ì ¸ì„œ **Nerve Root(ì‹ ê²½ë¿Œë¦¬)** í•˜ë‚˜ê°€ ëˆŒë¦¼.\n    - ì›ì¸: ê³¨ê·¹(Osteophytes) í˜¹ì€ ë””ìŠ¤í¬ íƒˆì¶œ.\n- **Symptoms:** ëª© í†µì¦ + íŠ¹ì • dermatomeì„ ë”°ë¼ ë‚´ë ¤ê°€ëŠ” ë°©ì‚¬í†µ.\n- **Physical Exam (ì¡±ì§‘ê²Œ ê¿€íŒ):**\n    - **â˜… Spurling Test:** ê³ ê°œë¥¼ ì•„í”ˆ ìª½ìœ¼ë¡œ ëŒë¦¬ê³  ìœ„ì—ì„œ ëˆ„ë¥´ë©´ íŒ” ì €ë¦¼ ì•…í™” (ì¬í˜„ì„± ë†’ìŒ).\n    - **â˜… Shoulder Abduction Relief Sign (Bakody's Sign):** í™˜ìê°€ ì§„ë£Œì‹¤ì— ë“¤ì–´ì˜¤ëŠ”ë° **ì†ì„ ë¨¸ë¦¬ ìœ„ì— ì–¹ê³  ìˆìŒ.** (ì‹ ê²½ êµ¬ë©ì„ ë„“í˜€ì¤˜ì„œ í†µì¦ì´ ì¤„ì–´ë“¦). -> **ì´ê±° ë‚˜ì˜¤ë©´ 100% Cervical Radiculopathy.**\n- **Root Level Breakdown (High Yield Table):**\n| **Root Level** | **Reflex (ë°˜ì‚¬)** | **Muscle Weakness (ì•½í™”)** | **Sensory Loss (ê°ê° ì €í•˜)** | **Mnemonics** |\n| --- | --- | --- | --- | --- |\n| **C5** | Biceps | **Shoulder Abduction** (Deltoid), Elbow flexion | Lateral Upper Arm (ì œë³µ íŒ¨ì¹˜ ë¶™ì´ëŠ” ê³³) | \"High Five\" (ì–´ê¹¨ ë“¤ê¸°) |\n| **C6** | Brachioradialis | **Wrist Extension**, Elbow flexion\npronation/supination | Thumb & Index finger (ì—„ì§€/ê²€ì§€) | \"Six-Shooter\" (ì´ ëª¨ì–‘ ì†) ğŸ”« |\n| **C7** | Triceps | **Elbow Extension**, Wrist flexion\në­”ê°€ë¥¼ Pushí•˜ëŠ” ìì„¸ | Middle finger (ì¤‘ì§€) | \"C7 Heaven\" (ê°€ìš´ëƒì†ê°€ë½..) ğŸ–• |\n| **C8** | None | **Finger Flexion** (Grip), Hand intrinsics | Little finger (ìƒˆë¼ì†ê°€ë½) | \"Fate\" (8) -> ê½‰ ì¡ê¸° âœŠ |\n| **T1** | None | Finger Abduction/Adduction (Interossei) | Medial Forearm | ì†ê°€ë½ ë²Œë¦¬ê¸° ğŸ–ï¸ |\n### B. Cervical Myelopathy (The Stumbler) âš ï¸ **[SERIOUS] ë©”ì¸ì¼€ì´ë¸” ë¬¸ì œ**","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-378","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","pathophysiology","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"- **Doorway Thought:** \"ìš”ì¦˜ ê±·ëŠ” ê²Œ ì´ìƒí•´ìš”\", \"ì†ì´ ë‘”í•´ì ¸ì„œ ë‹¨ì¶”ë¥¼ ëª» ì±„ì›Œìš”\". í†µì¦ë³´ë‹¤ëŠ” **ê¸°ëŠ¥ ì €í•˜**.\n- **Pathophysiology:**\n    - **\"Crushed Main Cable\" (ë©”ì¸ ì¼€ì´ë¸” ì†ìƒ):** ì²™ì¶”ê´€(Central Canal) ìì²´ê°€ ì¢ì•„ì ¸ì„œ **Spinal Cord(ì²™ìˆ˜)**ê°€ ëˆŒë¦¼.\n    - ì£¼ë²”: **Ligamentum Flavum Hypertrophy** (í™©ìƒ‰ì¸ëŒ€ ë¹„ëŒ€) + Osteophytes.\n- **Symptoms:**\n    - ì†: Fine motor skills ì €í•˜ (ë‹¨ì¶”, ë™ì „ ì§‘ê¸° ë¶ˆê°€).\n    - ë‹¤ë¦¬: Wide-based gait (ë³´í­ì´ ë„“ê³  ë¹„í‹€ê±°ë¦¼).\n    - **Lhermitte's Sign:** ê³ ê°œë¥¼ ìˆ™ì´ë©´ ë“±ì¤„ê¸°ë¥¼ íƒ€ê³  ì „ê¸°ê°€ ì°Œë¦¿! âš¡\n- **Physical Exam (UMN Signs):** ì²™ìˆ˜(UMN)ê°€ ëˆŒë ¸ìœ¼ë¯€ë¡œ ë³‘ë³€ ì•„ë˜ëŠ” **Hyper**reflexia.\n    - **Hoffmann's Sign:** ì¤‘ì§€ ì†í†±ì„ íŠ•ê¸°ë©´ ì—„ì§€ê°€ ê¹Œë”±í•¨.\n    - **Babinski Sign:** ë°œë°”ë‹¥ ê¸ìœ¼ë©´ ì—„ì§€ë°œê°€ë½ì´ ìœ„ë¡œ â¬†ï¸.\n    - Hyperreflexia / Spasticity.\n    - *(Note: ëˆŒë¦° ë ˆë²¨ ê·¸ ìì²´ëŠ” LMN signìœ¼ë¡œ Atrophyê°€ ì˜¬ ìˆ˜ ìˆìŒ - \"Myelopathy Hand\").*\n- **â˜… Next Best Step:** **MRI of Cervical Spine ASAP.** (ì˜êµ¬ì  ë§ˆë¹„ ë°©ì§€)\n- **â˜… Gold Standard Tx:** **Surgical Decompression** (ìˆ˜ìˆ ë¡œ ì—´ì–´ì¤˜ì•¼ í•¨). ì ˆëŒ€ ë³´ì¡´ì  ì¹˜ë£Œ ì•„ë‹˜!\n## 3. Lumbar Spine (í—ˆë¦¬) ğŸ‹ï¸â€â™‚ï¸\n- To scan or not scan\n    - most of the time: no scan\n    - Acute LBP, no red flag â†’ no scan, keep the patient moving.\n        - ë¼ˆë¬¸ì œ ê°™ì„ë•Œ â†’ X-ray\n            - r/o osteoporosis/compression fracture (trauma..)\n            - r/o ê°•ì§ì„± ì²™ì¶”ì—¼ (ë°¤ì— ì•„í”„ê³ , ìš´ë™í•˜ë©´ ë‚˜ì„ë•Œ)\n        - sensory, motor deficit â†’ MRI\n            - r/o CES (saddle anesthesia, urinary retention)\n            - r/o epidural abscess (infection, drug user, fever)\n            - r/o cancer (night pain, weight loss..)\n### A. Lumbar Spinal Stenosis (The Leaner) ğŸ›’\n- **Doorway Thought:** í• ë¨¸ë‹ˆê°€ \"ë§ˆíŠ¸ ê°€ì„œ ì¹´íŠ¸ ë°€ ë•ŒëŠ” ê´œì°®ì€ë°, ê·¸ëƒ¥ ê±¸ìœ¼ë©´ ë‹¤ë¦¬ê°€ í„°ì§ˆ ê²ƒ ê°™ì•„.\"\n- **Pathophysiology:** Ligamentum Flavumì´ ë‘êº¼ì›Œì ¸ì„œ ì²™ì¶”ê´€ í˜‘ì°©.\n- Cervical myelopathyë‘ ê¸°ì „ì€ ê°™ìœ¼ë‚˜ ì••ë°•í•˜ëŠ” ëŒ€ìƒì´ ë‹¤ë¦„. Cervical myelopathyëŠ” cordê·¸ ìì²´ë¥¼ ëˆ„ë¦„. ë°˜ë©´ì—, Lumbar stenosisê°™ì€ ê²½ìš°ì—ëŠ”, cordëŠ” ê·¸ ìœ„ì—ì„œ ëë‚˜ê³ , ë§ì´ì´ ëˆŒë¦¬ëŠ” ê²ƒ.\n- **Clinic Presentation:**\n    - **Neurogenic Claudication (ì‹ ê²½ì¸ì„± íŒŒí–‰):** ê±¸ìœ¼ë©´ ë‹¤ë¦¬ê°€ ì €ë¦¬ê³  ì•„í””.\n    - **Shopping Cart Sign:** í—ˆë¦¬ë¥¼ êµ½íˆë©´(Flexion) ì²™ì¶”ê´€ì´ ë„“ì–´ì ¸ì„œ í†µì¦ ì™„í™”. í—ˆë¦¬ë¥¼ í´ë©´(Extension/Standing) ì•…í™”.\n- **Differential Diagnosis (VS Vascular Claudication):**\n| **êµ¬ë¶„** | **Neurogenic (ì‹ ê²½ì¸ì„±)** | **Vascular (í˜ˆê´€ì„± - PAD)** |\n| --- | --- | --- |\n| **ì›ì¸** | Spine Stenosis | Atherosclerosis |\n| **ì•…í™” ìš”ì¸** | **Posture (Standing/Extension)** | **Exertion (Exercise)** |\n| **ì™„í™” ìš”ì¸** | **Flexion (Sitting/Bending)** | **Rest (Standing still is OK)** |\n| **Pulse** | Normal | Decreased/Absent |\n| **í”¼ë¶€ ì†Œê²¬** | Normal | Hair loss, Shiny skin |\n- **Dx:** MRI.\n- **Tx:** ë³´ì¡´ì  ì¹˜ë£Œê°€ ìš°ì„ ì´ë‚˜, ì‹¤íŒ¨ ì‹œ ìˆ˜ìˆ  (Laminectomy).\n### B. Lumbosacral Radiculopathy (Sciatica / Disc Herniation) ğŸ’¥\n- **Doorway Thought:** ë¬´ê±°ìš´ ë°•ìŠ¤ ë“¤ë‹¤ê°€ \"ìœ½!\" í•˜ê³  í—ˆë¦¬ ë‚˜ê°. ë‹¤ë¦¬ ë’¤ìª½ìœ¼ë¡œ ì°Œë¦¿í•œ í†µì¦.\n- **Root Level Breakdown (High Yield):**\n    - **L3-L4:** Knee Extension ì•½í™”, **Patellar Reflex** ê°ì†Œ.\n    - **L5 (M/C):** **Foot Drop** (Dorsiflexion ì•½í™” - ë’¤ê¿ˆì¹˜ë¡œ ê±·ê¸° ë¶ˆê°€), Big toe extension ì•½í™”. Reflex ë³€í™” ì—†ìŒ! â˜…\n    - **S1 (M/C):** **Plantar flexion** ì•½í™” (ê¹Œì¹˜ë°œ ê±·ê¸° ë¶ˆê°€), **Achilles Reflex** ê°ì†Œ.\n- **â˜… Management (GOLDEN RULE):**\n    1. **Red Flags Check:** (ë§ˆë¯¸ì¦í›„êµ°, ì•”, ê°ì—¼) -> ì—†ìœ¼ë©´?\n    2. **DO NOT SCAN:** X-ray, MRI í•„ìš” ì—†ìŒ. (ì´ˆê¸° 4-6ì£¼).\n    3. **Tx:** **NSAIDs + Activity Modification (í™œë™ ì§€ì†).**\n        - **â˜… Bed Rest is BAD:** ì¹¨ëŒ€ì— ëˆ„ì›Œë§Œ ìˆìœ¼ë©´ ê·¼ìœ¡ ë¹ ì§€ê³  íšŒë³µ ëŠë ¤ì§. \"ì•„í”„ì§€ ì•Šì€ ë²”ìœ„ ë‚´ì—ì„œ ì›€ì§ì´ì„¸ìš”.\"\n    4. **MRIëŠ” ì–¸ì œ?** 4-6ì£¼ ì¹˜ë£Œí•´ë„ ì•ˆ ë‚«ê±°ë‚˜, ì‹ ê²½í•™ì  ê²°ì†(í˜ ë¹ ì§)ì´ ì§„í–‰ë  ë•Œ.\n### C. Spondylolisthesis (ì²™ì¶”ì „ë°©ì „ìœ„ì¦) ğŸ¤¸â€â™€ï¸\n- **Archetype:** \"The Gymnast\" or \"Football Lineman\". (í—ˆë¦¬ë¥¼ ê³¼ë„í•˜ê²Œ ì –íˆëŠ” ìš´ë™ì„ ìˆ˜).\n- **Pathophysiology:**\n    1. **Spondylolysis:** Pars Interarticularis (ì²™ì¶” ì—°ê²°ë¶€ìœ„)ì˜ ê²°ì† (Scotty Dogì˜ ëª©ì´ ë¶€ëŸ¬ì§).\n    2. **Spondylolisthesis:** ì²™ì¶”ë¼ˆê°€ ì•ìœ¼ë¡œ ë¯¸ë„ëŸ¬ì ¸ ë‚˜ê° (Slippage).\n- **Symptoms:** í—ˆë¦¬ í†µì¦ + ë‹¤ë¦¬ ì €ë¦¼.\n    - severe: urinary incontinence\n- **Physical Exam:** í—ˆë¦¬ë¥¼ ë§Œì ¸ë³´ë©´ ë¼ˆê°€ íˆ­ íŠ€ì–´ë‚˜ì˜¨ **\"Palpable Step-off\"**ê°€ ë§Œì ¸ì§.\n- Tx: ìš´ë™ ê·¸ë§Œí•´.\n### D. Back Sparin\n- ìš”ì¦˜ì€ bed restí•˜ë¼ê³  ì•ˆí•¨.\n### E. Vertebral Compression Fracture\n1. **Clinical Manifestation**\n    1. Acute\n        1. sharp back pain (even ëˆ„ì›Œìˆì–´ë„)\n        2. tenderness point\n    2. **Chronic can be silent**\n        1. Painless\n        2. hyperkyphosis: í‚¤ê°€ ì¤„ë©´ì„œ ë°°ê°€ ë‚˜ì™€ìš” ì•ìœ¼ë¡œ. ë†’ì´ê°€ ë¶€ì¡±í•´ì„œìš”.","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-398","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### F. Red Flags & Emergencies ğŸš¨\n**1. Cauda Equina Syndrome (ë§ˆë¯¸ì¦í›„êµ°)**\n- **Pathology:** ê±°ëŒ€í•œ ë””ìŠ¤í¬ê°€ ì‹ ê²½ ë‹¤ë°œ(Horse's tail)ì„ í•œêº¼ë²ˆì— ëˆ„ë¦„.\n- **Symptoms:**\n    - **Saddle Anesthesia:** íšŒìŒë¶€(ì•ˆì¥ ë‹¿ëŠ” ë¶€ìœ„) ê°ê° ì†Œì‹¤.\n    - **Bowel/Bladder Incontinence:** ëŒ€ì†Œë³€ ì‹¤ê¸ˆ (í˜¹ì€ Urinary Retention).\n    - Severe Back Pain.\n- **â˜… Next Best Step:** **MRI Emergent.**\n- **â˜… Tx:** **Emergency Decompression Surgery.** (ì‹œê°„ ì‹¸ì›€!)\n**2. Pediatric Rare Case: Vertebra Plana ğŸ¥**\n- **Vignette:** ì•„ì´ê°€ í—ˆë¦¬ ì•„í”„ë‹¤ê³  ì™”ëŠ”ë°, X-rayë¥¼ ì°ì–´ë³´ë‹ˆ ì²™ì¶”ë¼ˆ í•˜ë‚˜ê°€ **íŒ¬ì¼€ì´í¬ì²˜ëŸ¼ ë‚©ì‘í•´ì§ (Coin-on-edge appearance).**\n- **Diagnosis:** **Langerhans Cell Histiocytosis (LCH).**\n- **Pathology:** Eosinophilic Granulomaê°€ ë¼ˆë¥¼ íŒŒë¨¹ì–´ì„œ ì£¼ì €ì•‰ìŒ.\n## 4. Trauma & Clearance Protocol ğŸš‘\nêµí†µì‚¬ê³ ë‚˜ ì¶”ë½ í™˜ìê°€ ì˜¤ë©´ ê°€ì¥ ë¨¼ì € í•  ì¼ì€?\n**Step 1:** **Spinal Immobilization (C-collar & Backboard).** ì²™ì¶”ê°€ ì•ˆì „í•˜ë‹¤ëŠ” ê²Œ í™•ì¸ë  ë•Œê¹Œì§€ ì ˆëŒ€ ì›€ì§ì´ë©´ ì•ˆ ë¨.\n### To Scan or Not To Scan? (NEXUS Criteria) ğŸ“‹\nëª¨ë“  í™˜ìì—ê²Œ CTë¥¼ ì°ì„ ìˆ˜ëŠ” ì—†ìŒ. ì•„ë˜ 5ê°€ì§€(N.E.X.U.S) ì¤‘ **í•˜ë‚˜ë¼ë„** í•´ë‹¹ë˜ë©´ CT ì°ì–´ì•¼ í•¨ (Xrayì•ˆí•˜ê³  CTë°”ë¡œ ì°ìŒ). 5ê°€ì§€ ëª¨ë‘ í•´ë‹¹ ì—†ìœ¼ë©´? \"C-collar í’€ê³  ì§‘ì— ê°€ì„¸ìš”.\" (No Imaging).\nê²€ì‚¬ì—ì„œ spine í•œê°œë¼ë„ ê³¨ì ˆ ì–‘ìƒì´ ëœ¨ë©´ ì „ë¶€ ì°ì–´ì•¼ë¨.\n1. **N**eurologic Deficit (ì‹ ê²½í•™ì  ì´ìƒ)\n2. **E**toh/Intoxication (ìˆ /ì•½ë¬¼ ì·¨í•¨ - í†µì¦ ëª» ëŠë‚Œ)\n3. **X**tracting Injury (ë‹¤ë¥¸ ê³³ì´ ë„ˆë¬´ ì•„íŒŒì„œ ëª© ì•„í”ˆ ê±¸ ëª¨ë¦„ - ì˜ˆ: ëŒ€í‡´ê³¨ ê³¨ì ˆ)\n4. **U**nexplained mental status (ì˜ì‹ ì €í•˜)\n5. **S**pinal Tenderness (ëª© ë’¤ ì²™ì¶”ë¥¼ ëˆŒë €ì„ ë•Œ ì•„í””)","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-418","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"recap_summary","text":"### Rapid Fire Recap ğŸ”¥ (ì‹œí—˜ ì§ì „ ì•”ê¸°)\n| **ìƒí™© (Scenario)** | **ì§„ë‹¨ (Diagnosis)** | **í•µì‹¬ ë‹¨ì„œ (Key Clue)** |\n| --- | --- | --- |\n| ì†ì„ ë¨¸ë¦¬ ìœ„ì— ì˜¬ë¦¬ê³  ë“¤ì–´ì˜´ ğŸ™†â€â™‚ï¸ | **Cervical Radiculopathy** | Shoulder Abduction Relief Sign |\n| ë‹¨ì¶” ëª» ì±„ìš°ê³  ë¹„í‹€ê±°ë¦¼ ğŸ§µ | **Cervical Myelopathy** | UMN Signs (Babinski+), Hyperreflexia |\n| ì‡¼í•‘ì¹´íŠ¸ì— ê¸°ëŒ€ë©´ í¸í•¨ ğŸ›’ | **Lumbar Stenosis** | Extension ì‹œ í†µì¦ ì•…í™” (ì‡¼í•‘ì¹´íŠ¸ ì‚¬ì¸) |\n| ë°œëª©ì´ ì•ˆ ë“¤ë¦¼ (Foot Drop) ğŸ¦¶ | **L5 Radiculopathy** | Heel walking ë¶ˆê°€ëŠ¥ |\n| ê¹Œì¹˜ë°œì´ ì•ˆ ë¨ (Tip-toe X) ğŸ©° | **S1 Radiculopathy** | Achilles Reflex ì†Œì‹¤ |\n| íšŒìŒë¶€ ê°ê° ì—†ê³  ì†Œë³€ ì§€ë¦¼ ğŸš½ | **Cauda Equina Syndrome** | **Emergency MRI & Surgery** |\n| í—ˆë¦¬ ì‚ë—í•¨, Red Flag ì—†ìŒ ğŸ’Š | **Acute Lumbago** | **NSAIDs + Activity (No MRI!)** |\n| ì•„ì´ ì²™ì¶”ê°€ íŒ¬ì¼€ì´í¬ ë¨ ğŸ¥ | **Langerhans Cell Histiocytosis** | Vertebra Plana |\n*Caveats: USMLEì™€ ì„ìƒ ê°€ì´ë“œë¼ì¸ ì¤‘ì‹¬ì…ë‹ˆë‹¤. ì‹¤ì œ í™˜ìì—ê²ŒëŠ” Individualizeëœ ì ‘ê·¼ì´ í•„ìš”í•©ë‹ˆë‹¤.*","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-432","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","recap","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"# LM_OSRHM 2 (7-12)\n### ğŸ“‹ Overview: Lower Limb Pain (Hip & Knee) High-Yield\n| **êµ¬ë¶„** | **ì£¼ìš” ì§ˆí™˜ (Key Pathology)** | **í•µì‹¬ í¬ì¸íŠ¸ (High Yield Clue)** |\n| --- | --- | --- |\n| **Hip** | Greater Trochanteric Pain Syndrome | ì˜†ìœ¼ë¡œ ëˆ„ì›Œ ì˜ ìˆ˜ ì—†ìŒ (Sleep disturbance), Focal tenderness |\n| **Knee (Ligament)** | ACL Tear | \"POP\" ì†Œë¦¬ ğŸ’¥, **ì¦‰ê°ì ì¸** ë¶€ì¢… (Hemarthrosis) |\n| **Knee (Meniscus)** | Meniscal Tear | Locking/Catching, **ì„œì„œíˆ** ë¶“ìŒ (12-24hr), Twisting injury |\n| **Knee (Anterior)** | Patellofemoral Pain Syndrome | Young female, **Theater sign** (ì˜¤ë˜ ì•‰ì•„ìˆìœ¼ë©´ í†µì¦) |\n| **Knee (Bursa)** | Prepatellar / Pes Anserine | Kneeling (Housemaid), Medial tibia pain (Goose's foot) |\n### ğŸŒ³ Top-down Classification: Lower Limb Pathology\nPlaintext\n`LOWER LIMB PAIN (Hip & Knee)\nâ”‚\nâ”œâ”€â”€ 1. HIP PATHOLOGY (Lateral)\nâ”‚    â””â”€â”€ Greater Trochanteric Pain Syndrome (GTPS)\nâ”‚         â”œâ”€â”€ Old term: Trochanteric Bursitis\nâ”‚         â”œâ”€â”€ Pathophysiology: Tendinosis (Degeneration > Inflammation)\nâ”‚         â””â”€â”€ Key Symptom: \"Can't sleep on affected side\" ğŸ›Œ\nâ”‚\nâ””â”€â”€ 2. KNEE PATHOLOGY\n     â”‚\n     â”œâ”€â”€ A. Ligamentous Injury (Acute)\n     â”‚    â”œâ”€â”€ ACL: Rapid Deceleration + Pivot -> \"POP\" -> Rapid Swelling (Blood)\n     â”‚    â”œâ”€â”€ PCL: Dashboard injury (Posterior force) ğŸš—\n     â”‚    â””â”€â”€ MCL/LCL: Varus/Valgus stress\n     â”‚\n     â”œâ”€â”€ B. Meniscal Injury (Mechanical)\n     â”‚    â””â”€â”€ Twisting on planted foot -> \"Locking/Catching\" -> Slow Swelling (Synovial)\n     â”‚\n     â”œâ”€â”€ C. Extensor Mechanism Failure\n     â”‚    â”œâ”€â”€ Patellar Tendon Rupture: High-riding patella, NO extension ğŸš«\n     â”‚    â””â”€â”€ Patellar Dislocation: Laterally displaced patella\n     â”‚\n     â”œâ”€â”€ D. Anterior Knee Pain (Chronic)\n     â”‚    â””â”€â”€ Patellofemoral Pain Syndrome (Runner's Knee): Theater sign ğŸ¬\n     â”‚\n     â””â”€â”€ E. Bursitis & Cysts\n          â”œâ”€â”€ Popliteal (Baker) Cyst: Posterior knee, Rupture mimics DVT\n          â”œâ”€â”€ Prepatellar Bursitis: Housemaid's knee, r/o Septic!\n          â””â”€â”€ Pes Anserine Bursitis: Medial tibia, \"Goose's foot\"`\n### ğŸ“ DETAILED LECTURE NOTES (ZERO-LOSS)\n### 1. Hip Pathology: Lateral Hip Pain ğŸ¦µ\n**Clinical Vignette:** 50ëŒ€ ì—¬ì„±, ë¹„ë§Œ(Obesity). ì—‰ë©ì´ ì˜†ìª½ í†µì¦ì„ í˜¸ì†Œí•˜ë©° ë‚´ì›. **\"ì•„í”ˆ ìª½ìœ¼ë¡œ ëŒì•„ëˆ„ì›Œ ì˜ ìˆ˜ê°€ ì—†ì–´ìš”(Can't lie on the affected side at night)\"** ë¼ê³  í˜¸ì†Œí•¨. ğŸ›Œ\n- **Diagnosis:** **Greater Trochanteric Pain Syndrome (GTPS)**\n    - *Old Term:* Trochanteric Bursitis (ì´ ìš©ì–´ëŠ” ì´ì œ ì¢€ outdated ë¨!)\n    - **Pathophysiology:**\n        - ë‹¨ìˆœíˆ Bursa(ë¬¼ì£¼ë¨¸ë‹ˆ)ì˜ ì—¼ì¦(Bursitis)ì´ë¼ê¸°ë³´ë‹¤ëŠ”...\n        - **Tendinosis** (Micro-tearing & Degeneration of Gluteus Medius/Minimus tendons)ê°€ ë©”ì¸ ì›ì¸! ğŸ’¡\n        - ì¦‰, \"Inflammation\" ë³´ë‹¤ëŠ” \"Wear and Tear\" ë¬¸ì œì„.\n    - **Physical Exam:**\n        - **Focal Tenderness** directly over the Greater Trochanter (ëŒ€ì „ì ë¶€ìœ„ì˜ ëª…í™•í•œ ì••í†µ).\n        - ëª¨í˜¸í•œ ì„œí˜œë¶€ í†µì¦(Groin pain - ì´ê±´ Hip Joint ìì²´ì˜ ë¬¸ì œì¸ OA ê°€ëŠ¥ì„± ë†’ìŒ)ê³¼ëŠ” êµ¬ë³„í•´ì•¼ í•¨! ğŸ™…â€â™‚ï¸\n    - **Management:**\n        - **Next Best Step:** Clinical Diagnosis (History + PE).\n        - X-rayëŠ” ë³´í†µ Normal (OA ë°°ì œìš©). MRIëŠ” ë³´í†µ ë¶ˆí•„ìš”.\n        - Tx: Conservative (NSAIDs, PT, Activity modification).\n### 2. Knee Pathology: The \"Big Three\" & More ğŸ¦´\në¬´ë¦ì€ ì •ë§ **\"History(ë³‘ë ¥)\"** ê°€ ì§„ë‹¨ì˜ 90%ë¥¼ ì°¨ì§€í•¨! ğŸ—£ï¸\n### A. ACL Tear (Anterior Cruciate Ligament) ğŸ’¥\n**Clinical Vignette:** ì¶•êµ¬ ì„ ìˆ˜ âš½ï¸. ê¸‰ê²©í•œ ë°©í–¥ ì „í™˜(Pivot) í›„ **\"ëš(POP)\"** ì†Œë¦¬ë¥¼ ë“¤ìœ¼ë©° ì“°ëŸ¬ì§.","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-1","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"- **Mechanism:** Rapid deceleration + Pivot on a planted foot.\n- **Key Symptoms:**\n    - **Audible \"POP\":** í™˜ìê°€ ì§ì ‘ ì†Œë¦¬ë¥¼ ë“¤ìŒ.\n    - **Hemarthrosis (Rapid Swelling):** â˜… **Immediate/Rapid onset (Minutes to 1 Hour)**. ë¬´ë¦ì´ í”¼ë¡œ ê°€ë“ ì°¸. ğŸ©¸\n    - Instability: ë¬´ë¦ì´ ëœë ê±°ë¦¬ëŠ” ëŠë‚Œ.\n- **Diagnosis:**\n    - **Physical Exam:** Lachman Test (Most sensitive), Anterior Drawer Test.\n    - **Gold Standard:** MRI.\n### B. Meniscus Tear ğŸ¢\n**Clinical Vignette:** ì£¼ë§ ì¶•êµ¬ í›„ ì§‘ì— ê°”ëŠ”ë°, **ë‹¤ìŒë‚  ì•„ì¹¨ì—** ë¬´ë¦ì´ ë¶€ì–´ìˆìŒ. ë¬´ë¦ì„ í´ë ¤ê³  í•  ë•Œ ê±¸ë¦¬ëŠ” ëŠë‚Œ(Locking)ì´ ë“¦.\n- **Mechanism:** Twisting injury on a planted foot (Weight-bearing).\n- **Key Symptoms:**\n    - **Delayed Swelling (Slow onset):** â˜… **12-24 Hours later**. (í™œì•¡(Synovial fluid)ì´ ì²œì²œíˆ ì°¨ì˜¤ë¦„. í”¼ê°€ ì•„ë‹˜!)\n    - **Mechanical Symptoms:** **Locking**, Catching, \"Giving way\".\n- **Physical Exam:**\n    - Joint Line Tenderness.\n    - **Provocative Tests:** **Thessaly Test** (Standing on one leg & twisting - Disco dance move ğŸ•º), **McMurray Test**.\n### C. PCL Tear (Posterior Cruciate Ligament) ğŸš—\n**Clinical Vignette:** ì¡°ìˆ˜ì„ì— íƒ€ê³  ê°€ë‹¤ê°€ êµí†µì‚¬ê³ (MVA). ë¬´ë¦ ì•ìª½ì„ ëŒ€ì‹œë³´ë“œì— ì°§ìŒ.\n- **Mechanism:** **Dashboard Injury**. Tibiaì— ê°€í•´ì§€ëŠ” Posterior force.\n- **Exam:** Posterior Drawer Test.\n### D. Extensor Mechanism Injuries (ì‘ê¸‰! ğŸš¨)\në¬´ë¦ì„ **\"ëŠ¥ë™ì ìœ¼ë¡œ í´ì§€ ëª»í•¨(Cannot extend knee)\"** ì´ í•µì‹¬!\n1. **Patellar Tendon Rupture:**\n    - **Vignette:** ì í”„ í›„ ì°©ì§€í•˜ë‹¤ê°€ ë°œìƒ.\n    - **Exam:** **High-riding Patella** (Patella Alta - ë¬´ë¦ë¼ˆê°€ ìœ„ë¡œ ì˜¬ë¼ê°€ ìˆìŒ), Palpable defect below patella.\n    - **Function:** **Zero extension.** ë‹¤ë¦¬ë¥¼ ë“¤ì–´ ì˜¬ë¦´ ìˆ˜ ì—†ìŒ.\n2. **Patellar Dislocation:**\n    - **Exam:** Patellaê°€ **Lateral side**ë¡œ ë¹ ì ¸ì„œ ìœ¡ì•ˆìœ¼ë¡œ ë³€í˜•ì´ ë³´ì„(Visible deformity). ğŸ‘€\n    - **Reduction:** ë¬´ë¦ì„ í´ì£¼ë©´(Extension) ë‹¤ì‹œ ë“¤ì–´ê°.\n### 3. Chronic & Overuse Syndromes ğŸƒâ€â™‚ï¸\n### A. Patellofemoral Pain Syndrome (PFPS) - \"Runner's Knee\"\n**Clinical Vignette:** ì Šì€ ì—¬ì„±. ë”±íˆ ë‹¤ì¹œ ì ì€ ì—†ìŒ. ë¬´ë¦ **ì•ìª½(Anterior)** ì´ ë»ê·¼í•˜ê²Œ ì•„í””.\n- **Key Feature:** **Theater Sign** ğŸ¬\n    - ì˜í™”ë¥¼ ë³´ê±°ë‚˜ ë¹„í–‰ê¸°ë¥¼ íƒˆ ë•Œì²˜ëŸ¼ **\"ì˜¤ë˜ ì•‰ì•„ ìˆë‹¤ê°€ ì¼ì–´ë‚  ë•Œ(Prolonged sitting)\"** í†µì¦ ì•…í™”.\n    - ê³„ë‹¨ ë‚´ë ¤ê°ˆ ë•Œ(Going down stairs) í†µì¦.\n- **Pathophysiology:** Patellaê°€ Femur grooveì—ì„œ íŠ¸ë™ì„ ì˜ëª» íƒ€ì„œ ë°œìƒ(Maltracking).\n- Clinical diagnosis: ì˜ìƒ ê²€ì‚¬ x (structural problemì—†ìŒ)\n    - Patellofemoral compression test : ë¬´ë¦ ëˆ„ë¥´ë©´ì„œ ë¬´ë¦ í´ë³´ë¼í•˜ë©´ ì•„í”„ë‹¤í•©ë‹ˆë‹¤.\n- **Management:** NSAIDS, **Physical Therapy** (VMO muscle strengthening) - Vastus Medialis ê°•í™”ê°€ í•µì‹¬! ğŸ’ª\n### B. Bursitis & Cysts ğŸ’§\n1. **Popliteal (Baker) Cyst:**\n    - **Location:** ë¬´ë¦ ë’¤ìª½(Popliteal fossa)ì˜ ë¬¼í˜¹.\n    - **Association:** OA(ê´€ì ˆì—¼)ë‚˜ Meniscus tearì™€ ë™ë°˜ë˜ëŠ” ê²½ìš°ê°€ ë§ìŒ. (Secondary)\n    - Crescent sign (cystê°€ í„°ì ¸ì„œ ë³µìˆ­ì•„ë¼ˆ ìª½ì´ ë©ë“ ê±°ì²˜ëŸ¼ ë³´ì„) ìˆìœ¼ë©´ DVT ë³´ë‹¨ Baker cystë¥¼ ì‹œì‚¬í•¨.\n    - **DANGER:** í„°ì§€ë©´(Rupture) ì¢…ì•„ë¦¬ê°€ ë¶“ê³  ì•„í”” -> **DVT(ì‹¬ë¶€ì •ë§¥í˜ˆì „ì¦)ì™€ ì¦ìƒì´ ë˜‘ê°™ìŒ!** ğŸš‘ (ê¼­ ì´ˆìŒíŒŒë¡œ ê°ë³„ í•„ìš”)\n2. **Prepatellar Bursitis (\"Housemaid's Knee\"):**\n    - **Vignette:** ë°”ë‹¥ ë‹¦ê¸°, ì„±ì§ì, íƒ€ì¼ê³µ ë“± **ë¬´ë¦ ê¿‡ëŠ” ì§ì—…(Kneeling)**. ğŸ§\n    - **Symptoms:** Patella ë°”ë¡œ ì•ìª½ì˜ ë¶“ê¸°ì™€ í†µì¦.\n    - **Caveat:** **Septic Bursitis** (ê°ì—¼) ê°€ëŠ¥ì„± ì—¼ë‘! (íŠ¹íˆ S. aureus). ì—´ë‚˜ê³  ë¹¨ê°œì§€ë©´ Aspiration í•´ì•¼ í•¨.\n3. **Pes Anserine Bursitis:**\n    - **Location:** **Medial Tibia** (Joint lineë³´ë‹¤ **ì•„ë˜ìª½**!).\n    - **Anatomy:** \"Goose's Foot\" (SGT muscles: Sartorius, Gracilis, Semitendinosus)ì´ ë¶™ëŠ” ìë¦¬. ğŸ¦¢\n    - DDx: MCLê³¼ í—·ê°ˆë¦¬ëŠ” ìœ„ì¹˜ì„. í•˜ì§€ë§Œ MCL injuryëŠ” valgus test ì‹œ pain ìˆìŒ.\n    - **Confusion:** Medial Meniscusë‚˜ OA í†µì¦ê³¼ í—·ê°ˆë¦¬ì§€ ë§ ê²ƒ! (Pes Anserineì€ ë” ì•„ë˜ìª½ì— ìˆìŒ).\n    - **Management:** NSAIDs, Rest, Pillow between knees while sleeping.","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-21","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_summary","text":"### ğŸ”¥ Rapid Fire Recap: The \"Diff\" Table\n| **Condition** | **Mechanism/History** | **Key Physical Exam/Sign** | **Swelling Timing** |\n| --- | --- | --- | --- |\n| **ACL Tear** | Pivot + \"POP\" ê°‘ì§€ê¸° ë©ˆì¶¤. | Lachman (+), Instability | **Immediate (Bloody)** ğŸ©¸ |\n| **Meniscus Tear** | Twisting, Deep squat | Locking, Thessaly (+) | **Slow (12-24h)** ğŸ¢ |\n| **PCL Tear** | Dashboard Injury | Posterior Drawer (+) | Variable |\n| **Patellar Tendon Rupture** | Jump landing | High-riding patella, **No Extension** | Immediate |\n| **PFPS (Runner's Knee)** | Young female, Overuse | **Theater Sign** (Sitting pain) | None usually |\n| **GTPS (Hip)** | Obesity, Middle-age | Can't sleep on side | None |\n| **Baker Cyst Rupture** | Chronic knee issue | Calf pain/swelling | Acute (Mimics DVT) |\n### ğŸ§  Meta-Cognitive Reflection\n- **Confidence:** 1.0 (All content derived strictly from the audio file provided).\n- **Next Step:** Would you like me to create a flashcard set (Anki style) based on these vignettes?\n### ğŸ“‹ Overview: USMLE Foot & Ankle Pathology (High-Yield)\nì´ ê°•ì˜ëŠ” \"ë°œì´ ì•„íŒŒìš”(My foot hurts)\"ë¼ê³  í˜¸ì†Œí•˜ëŠ” í™˜ìë¥¼ ë§Œë‚¬ì„ ë•Œ, ì •í™•í•œ **Anatomical Location(ìœ„ì¹˜)**ê³¼ **Timing(í†µì¦ ì–‘ìƒ)**ì„ í†µí•´ ì§„ë‹¨ì„ ë‚´ë¦¬ëŠ” ê³¼ì •ì„ ë‹¤ë£¹ë‹ˆë‹¤. ë°œì€ ìš°ë¦¬ ëª¸ì˜ ë¬´ê²Œë¥¼ ì§€íƒ±í•˜ëŠ” Workhorse(ì¼ê¾¼)ì…ë‹ˆë‹¤! ğŸ´ğŸ¦¶\n| Category | Diagnosis | Key Symptom / History | Key Test / Sign |\n| --- | --- | --- | --- |\n| **Heel (Plant)** | **Plantar Fasciitis** | **Morning Glory (ì•„ì¹¨ ì²« ë°œ í†µì¦)**, í™œë™ í›„ ê°œì„  | Dorsiflexion pain |\n| **Heel (Bone)** | **Calcaneal Stress Fx** | í™œë™í• ìˆ˜ë¡ í†µì¦ ì•…í™” (Worse w/ use) | **Squeeze Test (+)** |\n| **Posterior** | **Achilles Tendinopathy** | Watershed area (2-6cm) í†µì¦ | Fluoroquinolone ì‚¬ìš©ë ¥ |\n| **Posterior** | **Achilles Rupture** | \"Pop\" ì†Œë¦¬, ëˆ„ê°€ ë’¤ì—ì„œ ì°¬ ëŠë‚Œ | **Thompson Test (+)** |\n| **Peds** | **Sever Disease** | ì„±ì¥ê¸° ìš´ë™ì„ ìˆ˜(ì¶•êµ¬), ë’¤ê¿ˆì¹˜ í†µì¦ | Calcaneal compression |\n| **Forefoot** | **Metatarsal Stress Fx** | 2nd (Common) vs 5th (Jones - Bad!) | Female Athlete Triad |\n| **Nerve** | **Morton Neuroma** | 3-4th toe ì‚¬ì´, \"ëŒë©©ì´ ë°Ÿì€ ëŠë‚Œ\" | **Mulder Sign (Click)** |\n| **Ankle** | **Ankle Sprain** | Inversion injury | **Ottawa Rules** (X-ray ê²°ì •) |\n| **Red Flag** | **Charcot Foot** | ë‹¹ë‡¨, ë¶‰ê³  ë¶€ì—ˆìœ¼ë‚˜ **í†µì¦ì´ ì ìŒ** | **Total Contact Cast** |","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-39","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","recap","diagnosis","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### ğŸŒ³ Top-Down Classification & Mental Model\n**Big Picture:**\në°œ í†µì¦ì€ \"ì–´ë””ê°€ ì•„í”ˆê°€?\"(Anatomy)ì™€ \"ì–¸ì œ ì•„í”ˆê°€?\"(Timing/History)ê°€ ì§„ë‹¨ì˜ 90%ë¥¼ ì°¨ì§€í•©ë‹ˆë‹¤. USMLEì—ì„œ ì—‘ìŠ¤ë ˆì´ëŠ” ì¢…ì¢… \"Red Herring(í•¨ì •)\"ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤. í™˜ìì˜ **History**ê°€ ì—‘ìŠ¤ë ˆì´ë³´ë‹¤ ê°•ë ¥í•©ë‹ˆë‹¤! ğŸ§ âœ¨\n```\nPAINFUL FOOT (ë°œ í†µì¦)\nâ”‚\nâ”œâ”€â”€ 1. HEEL PAIN (ë’¤ê¿ˆì¹˜)\nâ”‚   â”œâ”€â”€ Plantar Surface (ë°”ë‹¥)\nâ”‚   â”‚   â”œâ”€â”€ Plantar Fasciitis (ì¡±ì €ê·¼ë§‰ì—¼): ì•„ì¹¨ ì²« ë°œì´ ìµœì•…! (Morning misery)\nâ”‚   â”‚   â””â”€â”€ Calcaneal Stress Fx (í”¼ë¡œê³¨ì ˆ): í™œë™í•˜ë©´ ë” ì•„í”” (Squeeze test +)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Posterior Surface (ë’¤ìª½)\nâ”‚       â”œâ”€â”€ Achilles Tendinopathy: 2-6cm ìœ„ìª½ (Watershed zone)\nâ”‚       â”œâ”€â”€ Achilles Rupture: \"Pop!\", Thompson test (+), Cipro ë³µìš©ë ¥\nâ”‚       â””â”€â”€ Sever Disease (Peds): ì„±ì¥íŒì—¼, í™œë™ì ì¸ ì•„ì´ (Soccer kid)\nâ”‚\nâ”œâ”€â”€ 2. FOREFOOT PAIN (ì•ë°œ)\nâ”‚   â”œâ”€â”€ Metatarsal Stress Fx:\nâ”‚   â”‚   â”œâ”€â”€ 2nd Metatarsal: í”í•¨, ë³´ì¡´ì  ì¹˜ë£Œ\nâ”‚   â”‚   â””â”€â”€ 5th Metatarsal (Jones): ì˜ ì•ˆ ë¶™ìŒ! ìˆ˜ìˆ  ê³ ë ¤ â˜…\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Nerve Issues\nâ”‚       â”œâ”€â”€ Morton Neuroma: 3-4ë²ˆ ë°œê°€ë½ ì‚¬ì´, Mulder sign (Click)\nâ”‚       â””â”€â”€ Tarsal Tunnel: ë‚´ì¸¡ ë³µì‚¬ë¼ˆ ë’¤, Tinel sign (+)\nâ”‚\nâ”œâ”€â”€ 3. ANKLE TRAUMA (ë°œëª© ì—¼ì¢Œ)\nâ”‚   â””â”€â”€ Ankle Sprain: Ottawa Rules ì ìš© (X-ray ì°ì„ì§€ ë§ì§€ ê²°ì •)\nâ”‚\nâ””â”€â”€ 4. THE TRAP (í•¨ì • ì¹´ë“œ) âš ï¸\n    â””â”€â”€ Charcot Foot (Neuroarthropathy): ë‹¹ë‡¨, ë¶‰ê³  ë¶€ì—ˆì§€ë§Œ í†µì¦ ì—†ìŒ -> Cast!\n```\n### 1. Heel Pain: The \"Morning Hobble\" (ì¡±ì €ê·¼ë§‰ì—¼ vs í”¼ë¡œê³¨ì ˆ)\n### A. Plantar Fasciitis (ì¡±ì €ê·¼ë§‰ì—¼) ğŸŒ…\n- **Vignette:** í™˜ìê°€ ì•„ì¹¨ì— ì¹¨ëŒ€ì—ì„œ ë‚´ë ¤ì™€ **ì²« ë°œì„ ë””ë”œ ë•Œ ë¹„ëª…(Maximal pain)**ì„ ì§€ë¦…ë‹ˆë‹¤. í•˜ì§€ë§Œ ê±·ë‹¤ ë³´ë©´(warm up) í†µì¦ì´ ì¢€ ì¤„ì–´ë“­ë‹ˆë‹¤. ë°ìŠ¤í¬ì— ì˜¤ë˜ ì•‰ì•„ ìˆë‹¤ê°€ ì¼ì–´ë‚  ë•Œë„ ì•„í”•ë‹ˆë‹¤.\n- **Pathophysiology:**\n    - ìˆ˜ë©´ ì¤‘ ë°œì€ ìì—°ìŠ¤ëŸ½ê²Œ Plantar flexion(ë°œê°€ë½ì´ ì•„ë˜ë¡œ) ìƒíƒœê°€ ë¨ -> ì¡±ì €ê·¼ë§‰ì´ ì§§ì•„ì§„ ìƒíƒœë¡œ êµ³ìŒ.\n    - ì•„ì¹¨ì— ì¼ì–´ë‚˜ì„œ ì²´ì¤‘ì„ ì‹¤ìœ¼ë©´(Arch collapse) ì§§ì•„ì§„ ê·¼ë§‰ì´ ì°¢ì–´ì§€ë©´ì„œ(Micro-tears) ê·¹ì‹¬í•œ í†µì¦ ë°œìƒ! âš¡ï¸\n- **Anatomy Target:** Medial Plantar Heel (ì•„ì¹˜ê°€ ë’¤ê¿ˆì¹˜ ë¼ˆì™€ ë§Œë‚˜ëŠ” ì§€ì ).\n- **Risk Factors:** ë¹„ë§Œ, ë”±ë”±í•œ ë°”ë‹¥ì—ì„œ ì¼í•˜ëŠ” ì‚¬ëŒ, í‰ë°œ(Pes planus).\n- **The Trap (Heel Spur):** ğŸ¦´\n    - X-rayì—ì„œ \"Calcaneal Spur(ë¼ˆ ê°€ì‹œ)\"ê°€ ë³´ì¼ ìˆ˜ ìˆìŒ.\n    - **âš ï¸ ì£¼ì˜:** ì´ê±´ **Red Herring(ì†ì„ìˆ˜)**ì…ë‹ˆë‹¤! ë¼ˆ ê°€ì‹œê°€ í†µì¦ì˜ ì›ì¸ì´ ì•„ë‹™ë‹ˆë‹¤. í†µì¦ì´ ì—†ëŠ” ì‚¬ëŒë„ ìŠ¤í¼ëŠ” ìˆìŠµë‹ˆë‹¤. **Don't treat the X-ray!**\n- **Diagnosis:** Clinical Diagnosis (ì„ìƒì  ì§„ë‹¨). ì—‘ìŠ¤ë ˆì´ ë¶ˆí•„ìš”.\n    - **Manoeuvre:** ë°œê°€ë½ì„ ìœ„ë¡œ ì –íˆë©´(Dorsiflexion) í†µì¦ ì•…í™” (Windlass mechanism).\n- **Management:**\n    - **â˜… Next Best Step:** Conservative! (Activity modification, Stretching, Heel pads). ì‹œê°„ì´ ê±¸ë¦¬ì§€ë§Œ ë‚«ìŠµë‹ˆë‹¤.\n### B. Calcaneal Stress Fracture (ì¢…ê³¨ í”¼ë¡œê³¨ì ˆ) ğŸ”¨\n- **Vignette:** ì•„ì¹¨ í†µì¦ì´ ì•„ë‹ˆë¼, **ì“¸ìˆ˜ë¡ ì•„í”ˆ í†µì¦(Pain worsens with use)**. ì•„ì¹¨ì—” ê´œì°®ì€ë°, í™œë™í• ìˆ˜ë¡ ì•„íŒŒì„œ ì£½ê² ìŒ.\n- **Key Difference:** FasciitisëŠ” ì›Œë°ì—… ë˜ë©´ ì¢‹ì•„ì§€ì§€ë§Œ, FractureëŠ” ì“¸ìˆ˜ë¡ ë¹„ëª…ì„ ì§€ë¦…ë‹ˆë‹¤.\n- **Diagnosis:**\n    - X-rayëŠ” ì´ˆê¸°(2-3ì£¼)ì— ì •ìƒì¼ ìˆ˜ ìˆìŒ (Low sensitivity).\n    - **â˜… Physical Exam:** **Medial-Lateral Squeeze Test**. ë’¤ê¿ˆì¹˜ ë¼ˆì˜ ì–‘ì˜†ì„ ì†ìœ¼ë¡œ ê½‰ ì¥ì—ˆì„ ë•Œ í†µì¦ì´ ì¬í˜„ë˜ë©´ Stress Fracture ê°€ëŠ¥ì„± ë†’ìŒ!\n### 2. Posterior Heel: The Achilles Complex\n### A. Achilles Tendinopathy (ì•„í‚¬ë ˆìŠ¤ ê±´ë³‘ì¦) ğŸ”¥\n- **Location:** í…ë˜ì´ ë¼ˆì— ë¶™ëŠ” ê³³ì—ì„œ **2~6cm ìœ„ìª½**.\n- **Why here?:** ì´ê³³ì´ **\"Watershed Area\"** (í˜ˆë¥˜ ê³µê¸‰ì´ ê°€ì¥ ì•ˆ ì¢‹ì€ ê³³)ì´ê¸° ë•Œë¬¸ì…ë‹ˆë‹¤. ì˜ ë‚«ì§€ ì•Šê³  í‡´í–‰(Degeneration)ë˜ê¸° ì‰½ìŠµë‹ˆë‹¤.\n- **exam:** í•´ë‹¹ ë¶€ìœ„ì— ì‘ì€ ë©ì–´ë¦¬(Nodule)ë‚˜ ë¶€ì¢…(Swelling)ì´ ë§Œì ¸ì§.\n- Risk factor: FQ\n### B. Achilles Tendon Rupture (ì•„í‚¬ë ˆìŠ¤ê±´ íŒŒì—´) ğŸ’¥\n- **Vignette:**\n    - ìš´ë™ ì¤‘ ê°‘ìê¸° **\"Pop!\"** ì†Œë¦¬ê°€ ë‚¨.\n    - í™˜ìëŠ” **\"ëˆ„ê°€ ë’¤ì—ì„œ ë‚´ ë°œì„ ê±·ì–´ì°¬ ì¤„ ì•Œì•˜ë‹¤\"**ê³  ë§í•¨. ë’¤ëŒì•„ë´¤ëŠ”ë° ì•„ë¬´ë„ ì—†ìŒ. ğŸ‘»\n- **Pharmacology Connection (USMLE Favorite):**\n    - **Fluoroquinolones (Cipro, Levofloxacin ë“±)** ë³µìš©ë ¥.\n    - ê¸°ì „: Matrix Metalloproteinases(MMP)ë¥¼ ì¦ê°€ì‹œì¼œ ì½œë¼ê²ì„ ë¶„í•´í•¨ -> í…ë˜ì´ í™”í•™ì ìœ¼ë¡œ ë…¹ì•„ë‚´ë¦¼. UTI ì¹˜ë£Œë°›ë‹¤ê°€ ì•„í‚¬ë ˆìŠ¤ê±´ ë‚˜ê°€ëŠ” ê²½ìš°! ğŸ’Šâš ï¸\n- **Physical Exam:**\n    - **â˜… Thompson Test:** í™˜ìë¥¼ ì—ë“œë¦¬ê²Œ(Prone) í•˜ê³  ì¢…ì•„ë¦¬(Calf)ë¥¼ ì¥ì–´ì§ ë‹¤.\n        - ì •ìƒ: ë°œì´ ì•„ë˜ë¡œ ê¹Œë”±(Plantar flexion)í•´ì•¼ í•¨.\n        - íŒŒì—´: ì¢…ì•„ë¦¬ë¥¼ ì§œë„ ë°œì´ ì›€ì§ì´ì§€ ì•ŠìŒ (ì¤„ì´ ëŠì–´ì§„ ê¼­ë‘ê°ì‹œ).\n### 3. Pediatric Corner: Sever Disease (ì„¸ë²„ ë³‘) âš½ï¸ğŸƒâ€â™‚ï¸\n- **Vignette:** 12ì„¸ ì¶•êµ¬ ê¿ˆë‚˜ë¬´. í™œë™ì ì¸ ì•„ì´. ë’¤ê¿ˆì¹˜ê°€ ì•„í”„ë‹¤ê³  í•¨.\n- **Diagnosis:** **Calcaneal Apophysitis** (ì„±ì¥íŒ ì—¼ì¦).\n- **Pathophysiology:** ë¼ˆëŠ” ë¹¨ë¦¬ ìë¼ëŠ”ë° ê·¼ìœ¡/í˜ì¤„ì´ ëª» ë”°ë¼ê°€ì„œ íŒ½íŒ½í•´ì§ -> ì•„í‚¬ë ˆìŠ¤ê±´ì´ ë¶™ëŠ” ë’¤ê¿ˆì¹˜ ì„±ì¥íŒì„ ì¡ì•„ë‹¹ê²¨ì„œ ì—¼ì¦ ë°œìƒ.\n- **Exam:** **Calcaneal Compression Test** (Squeeze test) ì–‘ì„±. Stress fractureì™€ ë¹„ìŠ·í•˜ì§€ë§Œ ë‚˜ì´ì™€ í™œë™ë ¥ìœ¼ë¡œ êµ¬ë¶„.\n- **Management:** Self-limiting (ì €ì ˆë¡œ ì¢‹ì•„ì§). ì‰¬ê²Œ í•˜ê³ (Rest), ì–¼ìŒì°œì§ˆ(Ice), NSAIDs. ì„±ì¥íŒì´ ë‹«íˆë©´ í•´ê²°ë¨.","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-49","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"### 4. Forefoot: Metatarsal Stress Fractures\n### A. The Setup\n- **Risk Factors:** **Female Athlete Triad** (ì‹ì´ì¥ì•  + ë¬´ì›”ê²½ + ê³¨ë‹¤ê³µì¦). ì Šì€ ì—¬ì„± ëŸ¬ë„ˆê°€ ë°œë“± í†µì¦ í˜¸ì†Œí•˜ë©´ ë°˜ë“œì‹œ ìƒë¦¬(Periods)ì™€ ì‹ë‹¨(Diet)ì„ ë¬¼ì–´ë³¼ ê²ƒ! ğŸƒâ€â™€ï¸ğŸ¥—ğŸ¦´\n- **Location matters:**\n    - **2nd Metatarsal:** ê°€ì¥ ê¸¸ê³  ê³ ì •ë˜ì–´ ìˆì–´ Stress Fractureê°€ ì œì¼ í”í•¨. (ë³´ì¡´ì  ì¹˜ë£Œ)\n    - **5th Metatarsal (Jones Fracture):** **DANGER ZONE!** ğŸš¨\n### B. The Jones Fracture (5th Metatarsal Base) â˜ ï¸\n- **Location:** 5ë²ˆì§¸ ì¤‘ì¡±ê³¨ ê¸°ì €ë¶€(Base).\n- **Why dangerous?:** Watershed area(í˜ˆë¥˜ ë‚˜ì¨)ë¼ì„œ ë¼ˆê°€ ì˜ ì•ˆ ë¶™ìŒ(Non-union).\n- **Management:**\n    - ë‹¨ìˆœ ë¶€ì¸ (Boot)ë¡œëŠ” ì•ˆ ë  ìˆ˜ ìˆìŒ.\n    - **â˜… Gold Standard:** ì¢…ì¢… **ìˆ˜ìˆ ì  ê³ ì •(Surgical Fixation)**ì´ í•„ìš”í•¨. ë†“ì¹˜ë©´ í°ì¼ ë‚¨.\n### 5. Nerve Issues: \"Pebbles & Tunnels\"\n### A. Morton Neuroma (ëª¨íŠ¼ ì‹ ê²½ì¢…) ğŸª¨\n- **Vignette:** \"ì‹ ë°œ ì•ˆì— ëŒë©©ì´ê°€ ë“¤ì–´ìˆëŠ” ê²ƒ ê°™ì•„ìš”(Walking on a pebble).\"\n- **Location:** **3ë²ˆì§¸ì™€ 4ë²ˆì§¸ ë°œê°€ë½ ì‚¬ì´**. (3rd-4th web space).\n- **Pathophysiology:** Interdigital nerveì˜ ê¸°ê³„ì  í‡´í–‰(Degeneration), ì§„ì§œ ì¢…ì–‘(Tumor) ì•„ë‹˜. ì¢ì€ ì‹ ë°œ(í•˜ì´í)ì´ ì•…í™” ìš”ì¸.\n- **Physical Exam:**\n    - **â˜… Mulder Sign:** ë°œì˜ ì–‘ì˜†ì„ ì¥ì–´ì§œë©´ì„œ(Squeeze) 3-4ë²ˆ ë°œê°€ë½ ì‚¬ì´ë¥¼ ì—„ì§€ë¡œ ëˆ„ë¦„.\n    - **\"Click!\"** í•˜ëŠ” ëŠë‚Œê³¼ í•¨ê»˜ í†µì¦ ì¬í˜„ë˜ë©´ ì–‘ì„±.\n### B. Tarsal Tunnel Syndrome (ì¡±ê·¼ê´€ ì¦í›„êµ°) ğŸš‡\n- **Concept:** ì†ëª©ì˜ Carpal Tunnelê³¼ ê°™ì€ ê°œë….\n- **Location:** **Medial Malleolus (ì•ˆìª½ ë³µì‚¬ë¼ˆ) ë’¤ìª½**.\n- **Nerve:** **Tibial Nerve** compression.\n- **Exam:** **Tinel Sign** (ë³µì‚¬ë¼ˆ ë’¤ë¥¼ í†¡í†¡ ì¹˜ë©´ ì°Œë¦¿í•¨).\n- **Difference:** Mortonì€ ë°œê°€ë½ ì‚¬ì´(Web space), Tarsal Tunnelì€ ë°œëª© ì•ˆìª½ê³¼ ë°œë°”ë‹¥ ì „ì²´ì ì¸ ì €ë¦¼.\n### 6. Ankle Sprains & The Ottawa Rules ğŸ“\n- **Situation:** ë°œëª©ì„ ì‚ë—í•¨(Inversion injury). ë¶“ê³  ì•„í””. ì—‘ìŠ¤ë ˆì´ë¥¼ ì°ì–´ì•¼ í•˜ë‚˜?\n- **Problem:** ëª¨ë“  ë°œëª© ì—¼ì¢Œì— ì—‘ìŠ¤ë ˆì´ë¥¼ ì°ìœ¼ë©´ ì˜ë£Œë¹„ ë‚­ë¹„ + ë°©ì‚¬ì„  ë…¸ì¶œ.\n- **â˜… Ottawa Ankle Rules (ì•”ê¸° í•„ìˆ˜!):**\në‹¤ìŒ ì¤‘ **í•˜ë‚˜ë¼ë„** í•´ë‹¹ë˜ë©´ X-ray ì°ì–´ë¼:\n    1. **Bone Tenderness:**\n        - **Posterior edge (ë’¤ìª½ ëª¨ì„œë¦¬) 6cm** - Lateral Malleolus (ë°”ê¹¥ ë³µì‚¬ë¼ˆ).\n        - **Posterior edge 6cm** - Medial Malleolus (ì•ˆìª½ ë³µì‚¬ë¼ˆ).\n        - **Base of 5th Metatarsal** (Jones fx í™•ì¸).\n        - **Navicular bone** (ë°œ ì•ˆìª½ ì£¼ìƒê³¨).\n    2. **Inability to Bear Weight:**\n        - ë‹¤ì¹˜ìë§ˆì 4ë°œìêµ­ ëª» ê±¸ìŒ **AND** ì‘ê¸‰ì‹¤ì—ì„œë„ 4ë°œìêµ­ ëª» ê±¸ìŒ.\n### 7. THE BOSS LEVEL: Charcot Foot (Neuropathic Arthropathy) ğŸ‘¹\n- **The Trap:** ë‹¹ë‡¨ë³‘(DM) í™˜ìê°€ ì˜´. ë°œì´ **ë¹¨ê°›ê³ (Red), ëœ¨ê²ê³ (Hot), ë¶€ì–´ìˆìŒ(Swollen)**.\n- ì˜ì‚¬ì˜ ë‡Œ: \"Cellulitis(ë´‰ì†Œì—¼)! Osteomyelitis(ê³¨ìˆ˜ì—¼)! í•­ìƒì œ ì£¼ì!\" -> **WRONG.** âŒ\n    - **Clue:** í™˜ìëŠ” **\"ë³„ë¡œ ì•ˆ ì•„íŒŒìš”(Painless)\"**ë¼ê³  í•˜ê±°ë‚˜, ë³´ì´ëŠ” ê²ƒì— ë¹„í•´ í†µì¦ì´ ë„ˆë¬´ ì ìŒ. (Neuropathy ë•Œë¬¸).\n- **Pathophysiology:** ê°ê°ì´ ì—†ìœ¼ë‹ˆ ë¼ˆê°€ ë¶€ë”ªíˆê³  ê°ˆë ¤ë„(Micro-trauma) ëª¨ë¦„ -> ë¼ˆê°€ ê°€ë£¨ê°€ ë¨(Pulverized) -> ê´€ì ˆ ë¶•ê´´(Collapse) -> **Rocker-bottom foot** (í‰ë°œì„ ë„˜ì–´ ë°° ë°”ë‹¥ì²˜ëŸ¼ íŠ€ì–´ë‚˜ì˜´).\n- **Differentiation:**\n    - í”¼ë¶€ ìƒì²˜(Ulcer/Wound)ê°€ ì—†ìœ¼ë©´ ê°ì—¼(Infection) ê°€ëŠ¥ì„± ë‚®ìŒ. â˜… â˜…\n    - ë‹¤ë¦¬ë¥¼ ë“¤ì–´ ì˜¬ë ¸ì„ ë•Œ(Elevation) ë¶‰ì€ê¸°ê°€ ë¹ ì§€ë©´ Charcot ì‹œì‚¬ (ê°ì—¼ì€ ê³„ì† ë¹¨ê°).\n- **Diagnosis:**\n    - ì´ˆê¸° X-rayëŠ” ì •ìƒì¼ ìˆ˜ ìˆìŒ.\n    - **â˜… MRI:** ê°€ì¥ ë¯¼ê°í•¨(Sensitive). ë¼ˆ ë¶€ì¢…ê³¼ ë¯¸ì„¸ ê³¨ì ˆ í™•ì¸.\n- **Treatment:**\n    - í•­ìƒì œ ì•„ë‹˜!\n    - **â˜… Total Contact Cast:** ë°œ ëª¨ì–‘ì— ë”± ë§ê²Œ ìºìŠ¤íŠ¸ë¥¼ í•´ì„œ ì²´ì¤‘ ë¶€í•˜ë¥¼ ì™„ì „íˆ ì—†ì• ì•¼ í•¨(Off-loading). ë¼ˆê°€ ë‹¤ì‹œ êµ³ì„ ë•Œê¹Œì§€ ì ˆëŒ€ ì•ˆì •ì´ ë‹µ.","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-69","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_summary","text":"### ğŸš€ Rapid Fire Recap (High-Yield Summary)\n| Pathology | Location | The \"Money\" Feature | Treatment Focus |\n| --- | --- | --- | --- |\n| **Plantar Fasciitis** | Heel (Sole) | **Morning Pain** (First step agony) | Conservative (Stretch/Ice) |\n| **Calcaneal Stress Fx** | Heel (Bone) | Pain **worse with use**, Squeeze (+) | Reduce Activity |\n| **Achilles Rupture** | Posterior Heel | **\"Pop\"**, **Thompson Test (+)**, Cipro | Surgical or Casting |\n| **Sever Disease** | Heel (Peds) | Active Kid (Soccer), Growth Spurt | Rest, Ice (Self-limiting) |\n| **Morton Neuroma** | 3rd-4th Toe | **Pebble sensation**, **Mulder Sign (Click)** | Wide shoes, Pad |\n| **Jones Fracture** | 5th Metatarsal | Lateral foot pain, Watershed zone | **Surgery often needed** âš ï¸ |\n| **Charcot Foot** | Whole Foot | **DM, Red/Hot but PAINLESS** | **Total Contact Cast** (No Abx!) |\n**Clear Answer:**\në°œ/ë°œëª© í†µì¦ì€ **\"ì •í™•í•œ ìœ„ì¹˜(Anatomy)\"**ì™€ **\"í†µì¦ì˜ íƒ€ì´ë°(Morning vs Activity)\"**ìœ¼ë¡œ êµ¬ë³„í•´ì•¼ í•©ë‹ˆë‹¤. ì•„ì¹¨ ì²« ë°œì´ ì•„í”„ë©´ ì¡±ì €ê·¼ë§‰ì—¼, ì“¸ìˆ˜ë¡ ì•„í”„ë©´ ìŠ¤íŠ¸ë ˆìŠ¤ ê³¨ì ˆ, ë‹¹ë‡¨ í™˜ìì˜ ë¶‰ê³  í†µì¦ ì—†ëŠ” ë°œì€ ìƒ¤ì½§ ê´€ì ˆ(Charcot)ì„ ê°•ë ¥íˆ ì˜ì‹¬í•´ì•¼ í•©ë‹ˆë‹¤.\n**Confidence Level:** 1.0 (Based strictly on the provided audio transcript)\n- ì´ ë…¸íŠ¸ëŠ” ì œê³µëœ ì˜¤ë””ì˜¤ íŒŒì¼ì˜ ë‚´ìš©ì„ ë°”íƒ•ìœ¼ë¡œ ì‘ì„±ë˜ì—ˆìŠµë‹ˆë‹¤.\n- **Tarsal Tunnel Syndrome**ì€ ì˜¤ë””ì˜¤ì—ì„œ Morton Neuromaì™€ ë¹„êµí•˜ë©° \"ë°œì˜ Carpal Tunnel\"ë¡œ ì§§ê²Œ ì–¸ê¸‰ë˜ì—ˆì§€ë§Œ, ì¤‘ìš”í•œ ê°ë³„ í¬ì¸íŠ¸ì´ë¯€ë¡œ í¬í•¨í–ˆìŠµë‹ˆë‹¤.\n- **Jones Fracture**ì˜ ìˆ˜ìˆ ì  í•„ìš”ì„±ê³¼ **Charcot Foot**ì˜ \"í•­ìƒì œ ê¸ˆì§€/Cast ì¹˜ë£Œ\"ëŠ” ì‹œí—˜ì— ë§¤ìš° ìì£¼ ë‚˜ì˜¤ëŠ” í•¨ì •ì´ë‹ˆ ê¼­ ê¸°ì–µí•˜ì„¸ìš”!\n### ğŸ“‹ Overview: USMLE Step 2 CK - Orthopedic Trauma & Emergencies (Ep 09)\n| **Category** | **Key Condition** | **Doorway Thought / Clinical Vignette** | **NBS / Critical Action** |\n| --- | --- | --- | --- |\n| **Upper Limb** | **Scaphoid Fx** | FOOSH + Snuffbox Tenderness | **â˜… Thumb Spica Cast** (even if X-ray -) |\n|  | **Colles Fx** | Elderly + FOOSH + \"Dinner Fork\" | Reduction + Cast (Watch for CTS) |\n|  | **Supracondylar Fx** | Kid + Monkey bars + Fat Pad Sign | Check Neurovascular status (**EMERGENCY**) |\n|  | **Clavicle Fx** | Newborn not moving arm (Moro reflex) | Pin sleeve to chest (Simple restraint) |\n| **Lower Limb** | **Hip Fx** | Elderly + Shortened & Ext. Rotated Leg | Surgery < 72hrs (Mortality risk) |\n|  | **Pelvic Fx** | High energy + Hypotension | **â˜… Pelvic Binder** (Close the book!) |\n|  | **Stress Fx** | Athlete/Military + 2nd Metatarsal pain | Rest / Reduced weight bearing |\n| **Emergencies** | **Compartment** | Pain w/ Passive Stretch + Tightness | **â˜… Fasciotomy** (Delta pressure < 30) |\n| **Complications** | **CRPS** | Pain out of proportion + Color changes (ììœ¨ì‹ ê²½ê³„ ë¬¸ì œ) | PT/OT (Mobilization), No Cast! |\n|  | **Myositis Ossificans** | Hard mass in muscle after trauma | **Do NOT excise early** (Wait for maturation) |","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-88","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","recap","treatment"]}
{"chunk_type":"transcript_chunk","text":"### ğŸŒ³ Top-Down Classification: Orthopedic Trauma Context Tree\nì´ íŠ¸ë¦¬ëŠ” ì˜¤ëŠ˜ ë‹¤ë£° Orthopedic Traumaì˜ êµ¬ì¡°ë¥¼ ë³´ì—¬ì¤ë‹ˆë‹¤. **Mental Model**ì„ ì¡ê³  ë“¤ì–´ê°€ì„¸ìš”! ğŸ§ \nPlaintext\n`ORTHOPEDIC TRAUMA & EMERGENCIES (The \"Bone Break\" World)\nâ”‚\nâ”œâ”€â”€ 1. UPPER LIMB TRAUMA (íŒ”/ì–´ê¹¨)\nâ”‚   â”œâ”€â”€ Scaphoid Fracture (ì†ëª©: Anatomical Snuffbox)\nâ”‚   â”‚   â””â”€â”€ Concept: Retrograde Blood Supply â†’ AVN Risk! ğŸ©¸\nâ”‚   â”œâ”€â”€ Colles Fracture (ì†ëª©: Distal Radius)\nâ”‚   â”‚   â””â”€â”€ Concept: Dinner Fork Deformity, Osteoporosis\nâ”‚   â”œâ”€â”€ Supracondylar Fracture (íŒ”ê¿ˆì¹˜: Humerus)\nâ”‚   â”‚   â””â”€â”€ Concept: Pediatric Emergency, Neurovascular compromise\nâ”‚   â””â”€â”€ Clavicle Fracture (ì‡„ê³¨)\nâ”‚       â””â”€â”€ Concept: Birth Trauma, Moro Reflex Asymmetry\nâ”‚\nâ”œâ”€â”€ 2. LOWER LIMB & PELVIS (ë‹¤ë¦¬/ê³¨ë°˜)\nâ”‚   â”œâ”€â”€ Femoral Neck Fracture (Hip)\nâ”‚   â”‚   â””â”€â”€ Concept: Elderly, Shortened + Ext. Rotated\nâ”‚   â”œâ”€â”€ Pelvic Fracture (ê³¨ë°˜)\nâ”‚   â”‚   â””â”€â”€ Concept: Hemodynamic Instability (Bleeding machine)\nâ”‚   â””â”€â”€ Stress Fracture (ë°œ: Metatarsal)\nâ”‚       â””â”€â”€ Concept: Overuse, Female Athlete Triad\nâ”‚\nâ”œâ”€â”€ 3. SURGICAL EMERGENCIES (ì‘ê¸‰ ìˆ˜ìˆ  í•„ìˆ˜! ğŸš¨)\nâ”‚   â””â”€â”€ Compartment Syndrome (êµ¬íš ì¦í›„êµ°)\nâ”‚       â”œâ”€â”€ Pathophysiology: Edema Cycle, Reperfusion Injury\nâ”‚       â””â”€â”€ Diagnosis: 6 Ps (Pain w/ Passive Stretch = Key)\nâ”‚\nâ””â”€â”€ 4. COMPLICATIONS (í›„ìœ ì¦)\n    â”œâ”€â”€ CRPS (ë³µí•©ë¶€ìœ„ í†µì¦ ì¦í›„êµ°)\n    â”‚   â””â”€â”€ Concept: Sympathetic nervous system haywire\n    â””â”€â”€ Myositis Ossificans (í™”ê³¨ì„± ê·¼ì—¼)\n        â””â”€â”€ Concept: Bone forming inside muscle (Eggshell)`\n### ğŸ¦´ 1. Upper Limb Trauma (ìƒì§€ ì™¸ìƒ)\n### 1.1 Scaphoid Fracture (ì£¼ìƒê³¨ ê³¨ì ˆ) - The \"Hidden\" Trap ğŸª¤\n- **Anatomy & Danger:** Scaphoid(ì£¼ìƒê³¨)ëŠ” \"Peanut shaped bone\"ìœ¼ë¡œ Snuffbox ì•ˆì— ìœ„ì¹˜.\n    - **Fatal Flaw:** í˜ˆì•¡ ê³µê¸‰ì´ **Retrograde** (ìœ„ì—ì„œ ì•„ë˜ë¡œ íë¦„).\n    - í—ˆë¦¬ê°€ ë¶€ëŸ¬ì§€ë©´(Waist fracture), ì•„ë˜ìª½(Proximal pole)ì€ í˜ˆë¥˜ê°€ ëŠê²¨ **Avascular Necrosis (AVN, ë¬´í˜ˆì„± ê´´ì‚¬)** ë˜ëŠ” **Non-union (ë¶ˆìœ í•©)** ë°œìƒ ìœ„í—˜ ë§¤ìš° ë†’ìŒ. ğŸ’€\n- **Diagnosis:**\n    - **Clinical:** Snuffbox Tenderness (ì—„ì§€ ê¸°ì €ë¶€ ì˜¤ëª©í•œ ê³³ ëˆŒë €ì„ ë•Œ í†µì¦)ê°€ í•µì‹¬.\n    - **X-ray:** ì´ˆê¸°ì—ëŠ” ê³¨ì ˆì„ ì´ ì•ˆ ë³´ì¼ ìˆ˜ ìˆìŒ (Low sensitivity). X-rayê°€ ê¹¨ë—í•˜ë‹¤ê³  ê³¨ì ˆì´ ì—†ëŠ” ê²Œ ì•„ë‹˜!\n- **â˜… NBS (Next Best Step):**\n    - **Treat as Fracture!** (X-rayê°€ ì •ìƒì´ë¼ë„!)\n    - **Immobilize immediately:** **Thumb Spica Cast** (ì—„ì§€ë¥¼ í¬í•¨í•œ ê¹ìŠ¤) ì ìš©.\n    - Follow-up X-ray in 2 weeks OR CT/MRI if immediate confirmation needed.\n### 1.2 Colles Fracture (ì½œë ˆìŠ¤ ê³¨ì ˆ) - The \"Dinner Fork\" ğŸ´\n![image.png](LM_OSRHM%202%20(7-12)/image.png)\n- **Mechanism:** Distal Radius Fracture. ì†ëª©ì´ ë“± ìª½ìœ¼ë¡œ ë°€ë¦¼ (Dorsally displaced).\n- **Deformity:** \"Dinner Fork Deformity\" (ì €ë… ì‹ì‚¬ í¬í¬ ëª¨ì–‘).\n- **Associations:** Osteoporosis (ê³¨ë‹¤ê³µì¦) í™˜ìì—ê²Œ í”í•¨.\n- **Risk:** ê¸‰ì„± **Carpal Tunnel Syndrome (ì†ëª©í„°ë„ì¦í›„êµ°)** ìœ ë°œ ê°€ëŠ¥ (ë¶€ì¢…ì´ë‚˜ ë¼ˆ ì¡°ê°ì´ ì •ì¤‘ì‹ ê²½ ì••ë°•). âš ï¸\n- **Management:** Reduction (ë¼ˆ ë§ì¶”ê¸°) + Cast. ì‹ ê²½ ì¦ìƒ ì²´í¬ í•„ìˆ˜!\n### 1.3 Supracondylar Fracture (ìƒì™„ê³¨ ê³¼ìƒë¶€ ê³¨ì ˆ) - PEDIATRIC EMERGENCY ğŸš¨\n![image.png](LM_OSRHM%202%20(7-12)/image%201.png)\n- **Mechanism:** ì•„ì´ë“¤ì—ê²Œ ê°€ì¥ í”í•œ íŒ”ê¿ˆì¹˜ ê³¨ì ˆ (Monkey bars, Slipping on ice).\n- **X-ray Signs:**\n    - ê³¨ì ˆì„ ì´ ì•ˆ ë³´ì¼ ìˆ˜ ìˆìŒ.\n    - **Posterior Fat Pad Sign:** ì›ë˜ëŠ” ë³´ì´ë©´ ì•ˆ ë˜ëŠ” ë’¤ìª½ ì§€ë°© íŒ¨ë“œê°€ ë¶€ì¢…ìœ¼ë¡œ ë°€ë ¤ë‚˜ì™€ ë³´ì„.\n    - **Sail Sign:** Anterior fat padê°€ ë›ë‹¨ë°°ì²˜ëŸ¼ ëœ¸.\n- **â˜… Major Complications (Must Rule Out):**\n    1. **Volkmann's Ischemic Contracture:** êµ¬íš ì¦í›„êµ°(Compartment syndrome)ì˜ ì¼ì¢…. íŒ”ëš ê·¼ìœ¡ ê´´ì‚¬ë¡œ ì˜êµ¬ì  ì¥ì•  ë°œìƒ ê°€ëŠ¥.\n    2. **Neurovascular Injury:** Brachial Artery(ìƒì™„ë™ë§¥) & Median Nerve(ì •ì¤‘ì‹ ê²½) ì†ìƒ ìœ„í—˜. OK sign í•´ë³´ì„¸ìš”.\n- **â˜… NBS:**\n    - **Check Pulses & Nerve Function:** ì†ê°€ë½ ì›€ì§ì„, ê°ê°, ë§¥ë°• í™•ì¸ì´ ìµœìš°ì„ !\n        - Displaced fractureë¼ë©´ **Immediate Surgery (Reduction + Pinning)**.\n### 1.4 Clavicle Fracture (ì‡„ê³¨ ê³¨ì ˆ) - The Birth Trauma ğŸ‘¶\n- **Examination:**\n    - **Crepitus:** ì‡„ê³¨ ë¶€ìœ„ë¥¼ ë§Œì§€ë©´ 'ë“œë“œë“' ì†Œë¦¬ë‚˜ ëŠë‚Œì´ ë‚¨.\n    - **Asymmetric Moro Reflex:** ë†€ë¼ê²Œ í–ˆì„ ë•Œ, ë‹¤ì¹œ ìª½ íŒ”ì€ í´ì§€ ì•ŠìŒ.\n- **Treatment:**\n    - **Low Tech:** ìˆ˜ìˆ  ì•ˆ í•¨. **Pin the sleeve to the chest.** (ì•„ê¸° ì˜·ì†Œë§¤ë¥¼ ê°€ìŠ´íŒ ì˜·ì— ì˜·í•€ìœ¼ë¡œ ê³ ì •).\n    - **Why?** ì•„ê¸° ë¼ˆëŠ” ì—„ì²­ ë¹¨ë¦¬ ë¶™ìŒ(Remodeling potential is huge). ë‹¨ìˆœ ê³ ì •ë§Œìœ¼ë¡œ ì¶©ë¶„.","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-98","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"### ğŸ¦µ 2. Lower Limb & Pelvis Trauma (í•˜ì§€/ê³¨ë°˜ ì™¸ìƒ)\n### 2.1 Femoral Neck Fracture (ëŒ€í‡´ ê²½ë¶€ ê³¨ì ˆ) - The Clock is Ticking â°\n- **Sign:** Leg is **Shortened & Externally Rotated**. (Psoas muscleì´ ë‹¹ê²¨ì„œ ëŒì•„ê°).\n- **Danger:** Mortality rate(ì‚¬ë§ë¥ )ì´ ê¸‰ê²©íˆ ì¦ê°€í•¨. ëˆ„ì›Œë§Œ ìˆìœ¼ë©´ íë ´, í˜ˆì „(DVT/PE) ë“±ìœ¼ë¡œ ì‚¬ë§.\n- **â˜… Management:**\n    - **Operate ASAP (within 72 hours):** í™˜ìë¥¼ ë¹¨ë¦¬ ì¼ìœ¼ì¼œ ì„¸ì›Œì•¼ ì‚´ ìˆ˜ ìˆìŒ.\n    - Younger patient: Open Reduction Internal Fixation (ORIF, ë‚˜ì‚¬ë¡œ ê³ ì •).\n    - Older patient: **Hemiarthroplasty** or Total Hip Replacement (ê´€ì ˆ ì¹˜í™˜ìˆ ).\n### 2.2 Pelvic Fracture (ê³¨ë°˜ ê³¨ì ˆ) - The Bleeding Machine ğŸ©¸\n- **Mechanism:** \"Open Book\" fracture - ê³¨ë°˜ ë§ì´ ë²Œì–´ì§.\n- **Pathophysiology:** ê³¨ë°˜ ë‚´ë¶€ëŠ” **Venous Plexus (ì •ë§¥ ì–¼ê¸°)**ê°€ í’ë¶€í•¨. ê³¨ë°˜ì´ ë²Œì–´ì§€ë©´ ì§„ê³µ(Vacuum) íš¨ê³¼ë¡œ í”¼ë¥¼ ë¹¨ì•„ë“¤ì„. ìˆ˜ ë¦¬í„°(L)ì˜ í”¼ê°€ ìˆœì‹ê°„ì— ê³ ì¼ ìˆ˜ ìˆìŒ. ğŸ©¸ğŸŒŠ\n- **â˜… NBS (Hemodynamically Unstable):**\n    - **Pelvic Binder (ê³¨ë°˜ ë°”ì¸ë”/ì‹œíŠ¸):** ë²Œì–´ì§„ ê³¨ë°˜ì„ **ì¡°ì—¬ì„œ(Close the book)** ì••ë°• ì§€í˜ˆ(Tamponade effect) ìœ ë„.\n    - ì´ê²ƒì€ ìˆ˜ìˆ  ì „ **Bridge to Surgery** ì—­í• ì„ í•˜ë©° ìƒëª…ì„ êµ¬í•˜ëŠ” ì²˜ì¹˜ì„.\n- Insufficiency fracture\n- No binder\n- Management: Early mobilization, Pain medication\n### 2.3 Stress Fractures (í”¼ë¡œ ê³¨ì ˆ) - The \"March\" Fracture ğŸª–\n- ë¼ˆê°€ ë§Œë“¤ì–´ì§€ëŠ” ì†ë„ë³´ë‹¤ ë…¹ëŠ” ì†ë„ê°€ ë” ë¹ ë¥´ë‹¤.\n- **Triad (Female Athlete Triad):**\n    1. Low Bone Density (ê³¨ë°€ë„ ì €í•˜)\n    2. Amenorrhea (ë¬´ì›”ê²½ - Hypothalamic)\n    3. Low Energy Availability (ì˜ì–‘ ë¶€ì¡±/ì„­ì‹ ì¥ì• ) â†’ Energy In vs Out ë¬¸ì œ!\n- **Location:** 2nd Metatarsal (ì¤‘ì¡±ê³¨)ì´ ê°€ì¥ í”í•¨.\n- **Treatment:**\n    - **REST:** ì²´ì¤‘ ë¶€í•˜ ì¤„ì´ê¸° (Reduced weight bearing).\n    - ì˜ì–‘ ì„­ì·¨ êµì •.\n### 2.4 Pediatric Patterns (ì†Œì•„ ê³¨ì ˆ íŠ¹ì§•) ğŸ‹\n![image.png](LM_OSRHM%202%20(7-12)/image%202.png)\n- ì•„ì´ë“¤ ë¼ˆëŠ” ìœ ì—°í•¨ (Green branch ì²˜ëŸ¼).\n- **Greenstick Fracture:** ë¼ˆê°€ ì™„ì „íˆ ë¶€ëŸ¬ì§€ì§€ ì•Šê³  í•œìª½ë§Œ ì°¢ì–´ì§€ë“¯ ë¶€ëŸ¬ì§€ê³  ë°˜ëŒ€ìª½ì€ íœ˜ì–´ì§.\n- **Buckle (Torus) Fracture:** ìº”ì„ ë°Ÿì•˜ì„ ë•Œ ì°Œê·¸ëŸ¬ì§€ëŠ” ê²ƒì²˜ëŸ¼ ë¼ˆ í”¼ì§ˆ(Cortex)ì´ ë¶ˆë£© íŠ€ì–´ë‚˜ì˜´ (Very stable).\n### ğŸš¨ 3. Compartment Syndrome (êµ¬íš ì¦í›„êµ°)\n- **Pathophysiology:**\n    - ê·¼ìœ¡ì€ ì§ˆê¸´ ë§‰(Fascia)ìœ¼ë¡œ ì‹¸ì—¬ìˆìŒ. ë¶€ì¢…ì´ë‚˜ ì¶œí˜ˆë¡œ ë‚´ë¶€ ì••ë ¥ì´ ì˜¬ë¼ê°€ë©´ â†’ í˜ˆê´€ì´ ëˆŒë¦¼ â†’ ê·¼ìœ¡ ê´´ì‚¬ â†’ ë¶€ì¢… ì•…í™” (Vicious Cycle).\n    - **Reperfusion Injury:** í˜ˆë¥˜ê°€ ì°¨ë‹¨ë˜ì—ˆë‹¤ê°€ ë‹¤ì‹œ ë“¤ì–´ì˜¬ ë•Œ ì‚°ì†Œê°€ ì¡°ì§ê³¼ ë°˜ì‘í•˜ì—¬ ì—„ì²­ë‚œ ì—¼ì¦/ë¶€ì¢… ìœ ë°œ.\n- **Diagnosis (The 6 Ps):**\n    1. **â˜… Pain with Passive Stretch (ê°€ì¥ ì¤‘ìš” & ì´ˆê¸° ì§•í›„):** í™˜ìì˜ ë°œê°€ë½ì„ ë’¤ë¡œ ì –í˜”ì„ ë•Œ(Passive stretch), ì¢…ì•„ë¦¬ ê¹Šìˆ™í•œ ê³³ì—ì„œ ë¹„ëª…ì„ ì§€ë¥¼ ë“¯í•œ í†µì¦ í˜¸ì†Œ. ğŸ”‘\n    2. Paresthesia (ê°ê° ì´ìƒ - Early sign)\n    3. Pallor (ì°½ë°±)\n    4. Poikilothermia (ì²´ì˜¨ ë³€í™”/ëƒ‰ê°)\n    5. Paralysis (ë§ˆë¹„ - Late/Irreversible)\n    6. Pulselessness (ë§¥ë°• ì†Œì‹¤ - ì´ë¯¸ ëŠ¦ì—ˆìŒ! ğŸ’€)\n- **Pressure Measurement:**\n    - **Delta Pressure:** (Diastolic BP - Compartment Pressure).\n    - **Cutoff:** Delta Pressure **< 30 mmHg** ì´ë©´ ìœ„í—˜! (ìˆ˜ì¹˜ê°€ ë‚®ì„ìˆ˜ë¡ ì••ë ¥ ì°¨ì´ê°€ ì—†ì–´ í”¼ê°€ ì•ˆ ëˆë‹¤ëŠ” ëœ»).\n- **â˜… Treatment (Gold Standard):**\n    - **Emergency Fasciotomy (ê·¼ë§‰ ì ˆê°œìˆ ):** í”¼ë¶€ì™€ ê·¼ë§‰ì„ ê¸¸ê²Œ ì§¸ì„œ ì••ë ¥ì„ í’€ì–´ì¤Œ. (ì§€í¼ë¥¼ ì—¬ëŠ” ê²ƒê³¼ ê°™ìŒ).\n### ğŸ¤• 4. Chronic & Complications (ë§Œì„± ë° í›„ìœ ì¦)\n### 4.1 Chronic Exertional Compartment Syndrome\n- **Scenario:** ì Šì€ ìš´ë™ì„ ìˆ˜. ë›°ê¸° ì‹œì‘í•˜ê³  15ë¶„ ì§€ë‚˜ë©´ ì¢…ì•„ë¦¬ê°€ í„°ì§ˆ ê²ƒ ê°™ìŒ. ë©ˆì¶”ë©´ ì‚¬ë¼ì§.\n- **Difference:** ê¸‰ì„±ê³¼ ë‹¬ë¦¬ ìƒëª…/ì‚¬ì§€ ìœ„í˜‘ì€ ì•„ë‹˜. ìš´ë™ ì‹œ ê·¼ìœ¡ íŒí•‘ìœ¼ë¡œ ì¼ì‹œì  ì••ë ¥ ìƒìŠ¹.\n### 4.2 CRPS (Complex Regional Pain Syndrome, ë³µí•©ë¶€ìœ„ í†µì¦ ì¦í›„êµ°) ğŸ”¥","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-118","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"- **Pathophysiology:** êµê°ì‹ ê²½ê³„(Sympathetic Nervous System)ì˜ ì˜¤ì‘ë™.\n- **Symptoms:**\n    - Pain out of proportion (ë¶€ìƒì— ë¹„í•´ ê³¼ë„í•œ í†µì¦).\n    - Autonomic Dysfunction: ìƒ‰ê¹” ë³€í™”(ë¶‰ìŒ/í‘¸ë¦„), ì˜¨ë„ ë¹„ëŒ€ì¹­(ëœ¨ê±°ì›€/ì°¨ê°€ì›€), ë¶€ì¢…, ë•€.\n- **â˜… Management:**\n    - **Physical Therapy (PT/OT) is First Line:** ì•„íŒŒë„ ì›€ì§ì—¬ì•¼ í•¨ (Desensitization).\n    - **Immobilization is BAD:** ê¹ìŠ¤í•˜ë©´ ë” ì•…í™”ë¨.\n    - Meds: Gabapentin, TCA, Bisphosphonates ë“± ë³´ì¡°ì  ì‚¬ìš©.\n### 4.3 Myositis Ossificans (í™”ê³¨ì„± ê·¼ì—¼) ğŸ¥š\n- **What is it?** ê·¼ìœ¡ ë‚´ í˜ˆì¢…(Hematoma)ì´ ë¼ˆ(Lamellar bone)ë¡œ ë³€í•˜ëŠ” ê²ƒ.\n- **Don't Touch Yet!** ì˜ì‚¬ì˜ ë³¸ëŠ¥ì€ \"ì œê±° ìˆ˜ìˆ \"ì´ì§€ë§Œ, **Active phase**ì— ìˆ˜ìˆ í•˜ë©´ ë‹¤ì‹œ ìë¼ë‚¨ (ë” í¬ê²Œ!).\n- **â˜… NBS:** **Wait.** ì„±ìˆ™(Mature)ë  ë•Œê¹Œì§€ ê¸°ë‹¤ë ¤ì•¼ í•¨. í†µì¦ ì¡°ì ˆí•˜ë©° ê´€ì°°.\n### 4.4 Amputation Pain\nTimeline!\n- Acute stump pain (1-3ì£¼)\n- **Phantom Limb Pain (-1ì£¼):** ì—†ëŠ” ë‹¤ë¦¬ê°€ ì•„í””. (Central nervous system issue).\n- **Neuroma(ëª‡ ì£¼ - ëª‡ ë‹¬ í›„):** ì ˆë‹¨ëœ ì‹ ê²½ ëì´ ë­‰ì³ì„œ ìƒê¸°ëŠ” \"Tangible ball of nerve\". íŠ¹ì • ë¶€ìœ„ë¥¼ ëˆ„ë¥´ë©´ ì°Œë¦¿í•¨. Phantom limb painê³¼ ë‹¤ë¥´ê²Œ focalì„\n- **Confidence:** 1.0/1.0 (All key concepts from audio captured explicitly).\n    - **Scaphoid:** X-ray ìŒì„±ì´ë¼ê³  ì ˆëŒ€ ì•ˆì‹¬ ê¸ˆì§€. **Splint & Re-eval**ì´ ì •ë‹µ.\n    - **Compartment Syndrome:** ë§¥ë°•(Pulse)ì´ ìˆë‹¤ê³  ì•ˆì‹¬í•˜ë©´ í™˜ì ë‹¤ë¦¬ ì ˆë‹¨í•¨. **Pain with passive stretch**ê°€ í•µì‹¬.\n    - **Pelvic Fx:** í˜ˆì•• ë–¨ì–´ì§€ë©´ **Binder** ë¨¼ì €! (ìˆ˜ìˆ ë°© ê°€ê¸° ì „ ì²˜ì¹˜).\n    - **CRPS:** ì ˆëŒ€ ê³ ì •(Immobilization) ê¸ˆì§€. ì•„íŒŒë„ ì›€ì§ì—¬ì•¼(PT) ë‚«ëŠ”ë‹¤.\nì´ ë…¸íŠ¸ëŠ” USMLE Step 2 CK Ortho Traumaì˜ í•µì‹¬ì„ ëª¨ë‘ ë‹´ê³  ìˆìŠµë‹ˆë‹¤. ğŸ¦´ğŸ”¨ ì‘ê¸‰ì‹¤ ì¸í„´ ì„ ìƒë‹˜ë“¤, í™”ì´íŒ…! ğŸ’ª\n### **TL;DR Overview**\nì´ë²ˆ ë”¥ë‹¤ì´ë¸ŒëŠ” **Bone Pathology(ê³¨ë³‘ë¦¬)**ì˜ í•µì‹¬ì¸ 'ë¼ˆê°€ ì£½ê±°ë‚˜(Necrosis), í™”í•™ì  ê· í˜•ì´ ê¹¨ì§€ê±°ë‚˜(Metabolic), ê°ì—¼ë˜ê±°ë‚˜(Infection), ì œë©‹ëŒ€ë¡œ ìë¼ë‚  ë•Œ(Tumor)' ë°œìƒí•˜ëŠ” ë¬¸ì œë“¤ì„ ë‹¤ë£¹ë‹ˆë‹¤.\n- **Avascular Necrosis (AVN):** ì„œí˜œë¶€(Groin) í†µì¦ + MRIê°€ Gold Standard.\n- **Metabolic:** Osteomalacia(Soft bone) vs. Osteoporosis(Mass loss) vs. Paget's(Chaotic). Lab ìˆ˜ì¹˜ê°€ í•µì‹¬!\n- **Osteomyelitis:** ì—°ë ¹ë³„, ìƒí™©ë³„(Sickle cell, DM, Prosthetic) ì›ì¸ê· ê³¼ ì§„ë‹¨ë²•.\n- **Tumors:** \"Location Game\" (Epiphysis vs. Metaphysis vs. Diaphysis) & X-ray íŒ¨í„´(Sunburst, Onion skin ë“±).\n### **Top-down Classification (Big Picture)** ğŸŒ³\nì´ ê°•ì˜ëŠ” ê³¨ë³‘ë¦¬(Bone Pathology)ì˜ 4ê°€ì§€ ì£¼ìš” ê¸°ë‘¥ì„ ë‹¤ë£¹ë‹ˆë‹¤. ì§ˆë¬¸ì˜ Contextê°€ ì–´ë””ì— í•´ë‹¹í•˜ëŠ”ì§€ ì•„ë˜ íŠ¸ë¦¬ì—ì„œ í™•ì¸í•˜ì„¸ìš”!\nPlaintext","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-138","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"`BONE PATHOLOGY (ê³¨ë³‘ë¦¬)\nâ”œâ”€â”€ 1. VASCULAR (í˜ˆê´€ ë¬¸ì œ)\nâ”‚   â””â”€â”€ Avascular Necrosis (AVN, ë¬´í˜ˆì„± ê´´ì‚¬)\nâ”‚       â”œâ”€â”€ Key Symptom: Groin Pain (ì„œí˜œë¶€ í†µì¦)\nâ”‚       â”œâ”€â”€ Risk Factors: Steroids, Alcohol (CAST)\nâ”‚       â””â”€â”€ Diagnosis: MRI (Gold Standard)\nâ”‚\nâ”œâ”€â”€ 2. METABOLIC (ëŒ€ì‚¬ì„± ì§ˆí™˜)\nâ”‚   â”œâ”€â”€ Osteoporosis (ê³¨ë‹¤ê³µì¦): Bone Mass ê°ì†Œ, Lab ì •ìƒ\nâ”‚   â”œâ”€â”€ Osteomalacia (ê³¨ì—°í™”ì¦): Mineralization ê²°í•¨, Vit D ë¶€ì¡±\nâ”‚   â””â”€â”€ Paget's Disease (íŒŒì œíŠ¸ë³‘): Chaotic Remodeling, ëª¨ì ì‚¬ì´ì¦ˆâ†‘\nâ”‚\nâ”œâ”€â”€ 3. INFECTION (ê°ì—¼ - Osteomyelitis)\nâ”‚   â”œâ”€â”€ Spine (ì²™ì¶”): êµ­ì†Œ ì••í†µ(Tenderness) ì¤‘ìš”\nâ”‚   â”œâ”€â”€ Sickle Cell (ê²¸ìƒì í˜ˆêµ¬): Salmonella â˜…\nâ”‚   â”œâ”€â”€ Diabetic Foot (ë‹¹ë‡¨ë°œ): Probe-to-bone Test\nâ”‚   â””â”€â”€ Prosthetic Joint (ì¸ê³µê´€ì ˆ): Early(Staph aureus) vs. Delayed(Staph epi)\nâ”‚\nâ””â”€â”€ 4. TUMORS (ì¢…ì–‘) - \"The Location Game\"\n    â”œâ”€â”€ Benign (ì–‘ì„±): Osteoid Osteoma (Night pain, NSAIDs effect)\n    â”œâ”€â”€ Malignant (ì•…ì„±)\n    â”‚   â”œâ”€â”€ Osteosarcoma: Metaphysis, Sunburst\n    â”‚   â”œâ”€â”€ Ewing Sarcoma: Diaphysis, Onion skin\n    â”‚   â””â”€â”€ Giant Cell Tumor: Epiphysis, Soap bubble\n    â””â”€â”€ Systemic: Langerhans Cell Histiocytosis (LCH)`\n# **SECTION 1: When Bone Dies - Avascular Necrosis (AVN)** â˜ ï¸\n### **1. The \"Doorway Thought\" (ì„ìƒì  ì§ê´€)** ğŸšª\ní™˜ìê°€ ì§„ë£Œì‹¤ì— ë“¤ì–´ì˜¬ ë•Œ **ì ˆëšê±°ë¦¬ë©°(Limping)** ë“¤ì–´ì˜µë‹ˆë‹¤. í™˜ìëŠ” \"Hip pain(ê³ ê´€ì ˆ í†µì¦)\"ì„ í˜¸ì†Œí•˜ì§€ë§Œ, ì •í™•í•œ ìœ„ì¹˜ê°€ ì¤‘ìš”í•©ë‹ˆë‹¤.\n- **The Location Trap:** í™˜ìê°€ ì—‰ë©ì´ ë’¤ìª½(Buttock)ì´ë‚˜ ì˜†ìª½ì„ ê°€ë¦¬í‚¤ë©´ Hip joint ë¬¸ì œê°€ ì•„ë‹ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- **True Hip Pain:** í™˜ìê°€ **Groin(ì„œí˜œë¶€, ì‚¬íƒ€êµ¬ë‹ˆ)**ì„ ê°€ë¦¬ì¼œì•¼ í•©ë‹ˆë‹¤! âš ï¸\n- **Aggravating Factor:** ì²´ì¤‘ì„ ì‹¤ì„ ë•Œ(Weight bearing) í†µì¦ì´ ì‹¬í•´ì§‘ë‹ˆë‹¤.\n### **2. Physical Exam & Risk Factors** ğŸ©º\n- **Exam:** Hip Abduction & Internal Rotation ì‹œ í†µì¦ ë°œìƒ (Femoral headë¥¼ ì†Œì¼“ì— ê°ˆì•„ë²„ë¦¬ëŠ” ë™ì‘).\n- **Risk Factors (The 4 Heavy Hitters):**\n    1. **C**hronic Steroid use (ìŠ¤í…Œë¡œì´ë“œ ì¥ê¸° ë³µìš©) â˜…\n    2. **A**lcohol abuse (ì•Œì½”ì˜¬ ë‚¨ìš©) â˜…\n    3. **S**ystemic Lupus Erythematosus (SLE, ë£¨í‘¸ìŠ¤)\n    4. **T**rauma (Sickle Cell Disease í¬í•¨ - Microvascular occlusion)\n### **3. Diagnosis & Imaging** ğŸ“¸\n- **The Trap:** X-rayê°€ **ì •ìƒ(Normal)**ì´ë¼ê³  í•´ì„œ í™˜ìë¥¼ ì§‘ìœ¼ë¡œ ëŒë ¤ë³´ë‚´ë©´ ì•ˆ ë©ë‹ˆë‹¤! (Pain comes WAY before X-ray changes).\n- **X-ray Finding (Late):** \"Crescent Sign\" (ì—°ê³¨ ì•„ë˜ ì–‡ì€ ì„ , ë¼ˆê°€ ë¬´ë„ˆì§€ê³  ìˆë‹¤ëŠ” ì‹ í˜¸).\n- **NEXT BEST STEP / GOLD STANDARD:** **MRI** â˜…â˜…â˜…\n    - ê°€ì¥ ë¯¼ê°í•¨(Most Sensitive).\n    - ë¼ˆê°€ ë¶•ê´´ë˜ê¸°(Collapse) í•œì°¸ ì „ì˜ ë¶€ì¢…(Edema)ê³¼ ê´´ì‚¬(Necrosis)ë¥¼ ì¡ì•„ëƒ„.\n# **SECTION 2: Metabolic Bone Disease** ğŸ“‰\n### **1. Osteomalacia vs. Osteoporosis (ì™„ì „íˆ ë‹¤ë¥¸ ì§ˆí™˜!)**\nì´ë¦„ì€ ë¹„ìŠ·í•˜ì§€ë§Œ ë³‘íƒœìƒë¦¬ê°€ ë‹¤ë¦…ë‹ˆë‹¤.\n| **Feature** | **Osteoporosis (ê³¨ë‹¤ê³µì¦)** | **Osteomalacia (ê³¨ì—°í™”ì¦)** |\n| --- | --- | --- |\n| **Concept** | Loss of Bone Mass (ì–‘ì  ê°ì†Œ) | **Soft Bone** (ì§ˆì  ë¬¸ì œ, Mineralization Defect) |\n| **Pathophysiology** | Mineralizationì€ ì •ìƒì´ì§€ë§Œ ì–‘ì´ ì ìŒ | Collagen MatrixëŠ” ìˆëŠ”ë° Ca/Phosë¥¼ ëª» ë°”ë¦„ |\n| **Primary Cause** | ë…¸í™”, íê²½ | **Vitamin D Deficiency** â˜… |\n| **Symptoms** | ê³¨ì ˆ ì „ê¹Œì§€ ë¬´ì¦ìƒ (Silent) | **Deep Aching Bone Pain**, Muscle Weakness |\n| **Gait** | ì •ìƒ (ê³¨ì ˆ ì—†ìœ¼ë©´) | **Waddling Gate** (ì˜¤ë¦¬ê±¸ìŒ) |\n| **X-ray Key** | - | **Looser's Zones** (Pseudo-fractures) |\n| **Labs** | **ALL NORMAL** | **Abnormal** (ì•„ë˜ í‘œ ì°¸ì¡°) |\n|  | STeroid, Phenytoin, PPI(ì‚°ì„±ì´ ìˆì–´ì•¼ ì¹¼ìŠ˜ì„ í¡ìˆ˜í•¨), Aromatase inhibitor |  |\n### **2. Lab Values Breakdown (High Yield)** ğŸ§ª\nì˜¤ë””ì˜¤ì—ì„œ ê°•ì¡°í•œ \"Smoking Gun\" ë© ìˆ˜ì¹˜ë“¤ì…ë‹ˆë‹¤.\n- **Osteomalacia Labs:**\n    - **Calcium:** Low (Vit D ë¶€ì¡±ìœ¼ë¡œ í¡ìˆ˜ ì•ˆ ë¨)\n    - **Phosphate:** Low\n    - **PTH (Parathyroid Hormone):** **High** (Low Calciumì— ëŒ€í•œ ë°˜ì‘ìœ¼ë¡œ ë¶€ê°‘ìƒì„  ê³¼ì—´ - Secondary Hyperparathyroidism)\n    - **Alkaline Phosphatase (Alk Phos):** **High** (Osteoblastê°€ ë¯¸ì¹œ ë“¯ì´ ë¼ˆë¥¼ ê³ ì¹˜ë ¤ê³  ë…¸ë ¥í•¨)\n    - **Urinary Calcium:** **Low** (ì‹ ì¥ì´ ì¹¼ìŠ˜ì„ í•„ì‚¬ì ìœ¼ë¡œ ì¬í¡ìˆ˜í•¨) â˜…\n### **3. Paget's Disease of Bone (Osteitis Deformans)** ğŸ©\n- **Concept:** \"Chaotic Bone Remodeling\" (ë¼ˆ ë¦¬ëª¨ë¸ë§ì˜ ê´‘ë€).\n- **Mechanism:** Osteoclast(íŒŒê³¨ì„¸í¬)ê°€ ë¼ˆë¥¼ ë§‰ ê°‰ì•„ë¨¹ê³  -> Osteoblast(ì¡°ê³¨ì„¸í¬)ê°€ ëŒ€ì¶© ë¼ˆë¥¼ ë‹¤ì‹œ ë¶™ì„ -> **Sloppy & Weak Bone**.\n- **Clinical Vignette (The \"Hat Size\" Sign):**\n    - \"ëª¨ìê°€ ë” ì´ìƒ ë§ì§€ ì•Šì•„ìš”.\" (Skullì´ ë‘êº¼ì›Œì§).\n    - **Hearing Loss (ì²­ë ¥ ì†Œì‹¤):** ë‘êº¼ì›Œì§„ ë‘ê°œê³¨ì´ ë‡Œì‹ ê²½(Cranial Nerves)ì´ë‚˜ ì²­ì‹ ê²½ í†µë¡œë¥¼ ì••ë°•.\n- **Spine Involvement:** ì²™ì¶”ê´€ í˜‘ì°©(Spinal Stenosis) ìœ ë°œ ê°€ëŠ¥.\n- **Lab Findings:**\n    - Calcium & Phosphorus: Usually **Normal**.\n    - **Alk Phos:** **HUGE Elevation (Isolated)** â˜…â˜…â˜… (ìœ ì¼í•˜ê²Œ íŠ€ëŠ” ìˆ˜ì¹˜).\n- **Marker of Bone Breakdown:** Urinary Hydroxyproline (Collagen ë¶„í•´ ì‚°ë¬¼).\n- **Treatment:** **Bisphosphonates** (Osteoclast ì§„ì •).","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-158","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"# **SECTION 3: Osteomyelitis (Infected Bone)** ğŸ¦ \n### **1. Vertebral Osteomyelitis (Spine)** ğŸ›Œ\n- **Presentation:** \"Subacute nagging back pain\" (ì€ê·¼í•˜ê²Œ ì˜¤ë˜ê°€ëŠ” ë“± í†µì¦).\n- **Key Exam Finding:** **Focal Spinal Tenderness** (ì²™ì¶”ë¥¼ ëˆŒë €ì„ ë•Œ íŠ¹ì • ë¶€ìœ„ê°€ ì•„í”” + í™˜ìê°€ ì í”„í•  ì •ë„).\n- **The Trap:** **Fever(ì—´)ê°€ ì—†ëŠ” ê²½ìš°ê°€ ë§ìŒ!** (A-febrileí•˜ë‹¤ê³  ë°°ì œí•˜ë©´ ì•ˆ ë¨).\n- **Next Best Step:** **MRI** (ê°€ì¥ ì •í™•).\n- **Most Common Bug:** *Staphylococcus aureus*.\n### **2. Osteomyelitis in Children** ğŸ‘¶\n- **Mechanism:** Hematogenous spread (í˜ˆë¥˜ íƒ€ê³  ì´ë™).\n- **Location:** **Metaphysis** (í˜ˆë¥˜ê°€ í’ë¶€í•¨).\n- **Bug:** *Staphylococcus aureus* (King of Osteo).\n- **Specific Context (Sickle Cell Disease):**\n    - Vignetteì— \"Sickle Cell\"ì´ ë‚˜ì˜¤ë©´ ë¬´ì¡°ê±´ **Salmonella**ë¥¼ ë– ì˜¬ë ¤ì•¼ í•¨! â˜…â˜…â˜… (ë¬¼ë¡  Staphë„ ê°€ëŠ¥í•˜ì§€ë§Œ ì‹œí—˜ ì •ë‹µì€ Salmonella).\n### **3. Diabetic Foot Osteomyelitis** ğŸ¦¶\n- **Mechanism:** Contiguous spread (í”¼ë¶€ ê¶¤ì–‘ -> ë¼ˆë¡œ ì§ì ‘ ì¹¨íˆ¬).\n- **Bedside Test (Best Initial):** **Probe-to-Bone Test**.\n    - ë©¸ê· ëœ ê¸ˆì† ë§‰ëŒ€ë¡œ ê¶¤ì–‘ì„ ì°”ë €ì„ ë•Œ, ë”±ë”±í•˜ê³  ê±°ì¹œ(Hard, Gritty) ë¼ˆê°€ ë§Œì ¸ì§€ë©´? -> **Positive** (Osteomyelitis ì§„ë‹¨ ê°€ëŠ¥).\n### **4. Prosthetic Joint Infection (ì¸ê³µê´€ì ˆ ê°ì—¼)** ğŸ”©\nì‹œê°„(Timing)ì´ ì›ì¸ê· ì„ ê²°ì •í•©ë‹ˆë‹¤! (The Clock Tells the Bug).\n- **Early Infection (< 3 Months from surgery):**\n    - ì¦ìƒ: ê¸‰ì„±, ì—´(Fever), ë¶€ì¢…(Swollen), ì‹¬í•œ í†µì¦.\n    - ì›ì¸ê· : **Staphylococcus aureus** (ë…í•œ ë†ˆ), Gram-negative rods.\n- **Delayed Infection (3 ~ 12 Months):**\n    - ì¦ìƒ: ë¯¸ì—´, ì„í”Œë€íŠ¸ê°€ ì•½ê°„ í—ê±°ì›Œì§„ ëŠë‚Œ(Loose), ì€ê·¼í•œ ë§Œì„± í†µì¦(Indolent).\n    - ì›ì¸ê· : **Coagulase-negative Staph (Staphylococcus epidermidis)** â˜….\n    - íŠ¹ì§•: **Biofilm (Slim layer)**ì„ í˜•ì„±í•´ì„œ í•­ìƒì œê°€ ì˜ ì•ˆ ë“¤ìŒ.\n# **SECTION 4: Tumor Tour - \"The Location Game\"** ğŸ“\nì¢…ì–‘ì€ ë¼ˆì˜ ì–´ë””ì— ìœ„ì¹˜í•˜ëŠëƒ(Location)ì™€ í™˜ìì˜ ë‚˜ì´(Age)ë¡œ ì§„ë‹¨í•©ë‹ˆë‹¤.\n### **1. Benign Tumors** ğŸ™‚\n- **Osteoid Osteoma:**\n    - **Vignette:** 10ëŒ€ ì†Œë…„, **Night Pain** (ë°¤ì— ì•„íŒŒì„œ ê¹¸).\n    - **Diagnostic Clue:** **NSAIDs (Ibuprofen)** ë¨¹ìœ¼ë©´ í†µì¦ì´ ì”»ì€ ë“¯ì´ ì‚¬ë¼ì§. â˜…\n    - **X-ray:** ì‘ì€ **Nidus** (ì¤‘ì‹¬í•µ).\n### **2. Malignant Tumors (Adolescents/Young Adults)** ğŸ˜ˆ\n### **A. Osteosarcoma (ê³¨ìœ¡ì¢…)**\n- **Location:** **Metaphysis** (ì„±ì¥íŒ ê·¼ì²˜), íŠ¹íˆ ë¬´ë¦ ì£¼ë³€(Distal Femur, Proximal Tibia).\n- **X-ray Patterns (Aggressive):**\n    - **Sunburst Pattern:** ë¼ˆê°€ ë°–ìœ¼ë¡œ í­ë°œí•˜ë“¯ ìë¼ë‚¨. â˜€ï¸\n    - **Codman's Triangle:** ì¢…ì–‘ì´ ê³¨ë§‰(Periosteum)ì„ ë„ˆë¬´ ë¹¨ë¦¬ ë“¤ì–´ ì˜¬ë ¤ì„œ ìƒê¸°ëŠ” ì‚¼ê°í˜• ëª¨ì–‘.\n- **Associations:** Retinoblastoma (RB ìœ ì „ì ë³€ì´), Li-Fraumeni syndrome.\n### **B. Ewing Sarcoma (ìœ ì‰ ìœ¡ì¢…)**","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-178","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"- **Location:** **Diaphysis** (ë¼ˆì˜ ëª¸í†µ, ê¸´ ë¶€ë¶„).\n- **Cell Type:** Small Round Blue Cell Tumor.\n- **X-ray Pattern:** **Onion Skinning** (ì–‘íŒŒ ê»ì§ˆ ëª¨ì–‘). ğŸ§…\n    - ì´ìœ : ì¢…ì–‘ì´ ìë¼ê³  -> ëª¸ì´ ë¼ˆë¥¼ ë®ê³  -> ì¢…ì–‘ì´ ë˜ ëš«ê³  ë‚˜ì˜¤ê³  -> ë‹¤ì‹œ ë®ê³ ë¥¼ ë°˜ë³µ(Lamellated).\n- **Genetic:** t(11;22) Translocation.\n### **C. Giant Cell Tumor (ê±°ëŒ€ì„¸í¬ì¢…)**\n- **Location:** **Epiphysis** (ë¼ˆì˜ ëë¶€ë¶„, ê´€ì ˆë©´). ì„±ì¸ì—ì„œ ê³¨ë‹¨íŒì´ ë‹«íŒ í›„ ë°œìƒ.\n- **X-ray Pattern:** **Soap Bubble Appearance** (ë¹„ëˆ—ë°©ìš¸ ëª¨ì–‘ì˜ ë‹¤ë°©ì„± ë³‘ë³€). ğŸ§¼\n### **3. Systemic Disease: Langerhans Cell Histiocytosis (LCH)** ğŸŒ\n- **Symptoms (Triad):**\n    1. Lytic Bone Lesions (êµ¬ë© ëš«ë¦° ë¼ˆ, Skullì— ë§ìŒ).\n    2. Diabetes Insipidus (ìš”ë¶•ì¦ - ë¬¼ ë§ì´ ë§ˆì‹œê³  ì˜¤ì¤Œ ë§ì´ ìŒˆ).\n    3. Exophthalmos (ì•ˆêµ¬ ëŒì¶œ).\n- **Keywords:** **Eosinophilic Granuloma**, Birbeck Granules (Tennis racket shape).\n- **Presentation:** ì†Œì•„ì—ì„œ ë‘í”¼ ë°œì§„(Rash) + ê·€ì—ì„œ ê³ ë¦„(Otitis media resistant to antibiotics) + ë¼ˆ ë³‘ë³€.\n# **ğŸ”¥ RAPID FIRE REVIEW: Connecting the Dots**\nì˜¤ë””ì˜¤ì˜ ë§ˆì§€ë§‰ ìš”ì•½(Fire Rapid Review)ì„ ê¸°ë°˜ìœ¼ë¡œ í•œ ìµœì¢… ì •ë¦¬í‘œì…ë‹ˆë‹¤.\n| **Scenario / Symptom** | **Diagnosis / Association** | **Key Feature / Lab / Imaging** |\n| --- | --- | --- |\n| **Groin Pain** on Weight Bearing | **Avascular Necrosis (AVN)** | Hx of **Steroids/Alcohol**. MRI is Gold Standard. |\n| **Bone Pain + Waddle Gait** | **Osteomalacia** | Labs: â†“Ca, â†“Phos, â†‘PTH, **â†‘Alk Phos**. |\n| **Increasing Hat Size** + Hearing Loss | **Paget's Disease** | **Isolated High Alk Phos**. |\n| **Child with Sickle Cell** + Bone Pain | **Osteomyelitis** | Bug: **Salmonella** (Think S for S). |\n| **Diabetic Foot Ulcer** | **Osteomyelitis** | **Probe-to-Bone Test** Positive. |\n| **Prosthetic Joint** (<3 mo) | **Acute Infection** | *Staph aureus*, Gram(-) rods. |\n| **Prosthetic Joint** (3-12 mo) | **Delayed Infection** | ***Staph epidermidis*** (Biofilm). |\n| **Teen + Night Pain** (NSAIDs help) | **Osteoid Osteoma** | X-ray: Nidus. |\n| **Sunburst Pattern** (Metaphysis) | **Osteosarcoma** | Aggressive, Codman's Triangle. |\n| **Onion Skinning** (Diaphysis) | **Ewing Sarcoma** | t(11;22), Small blue cells. |\n| **Soap Bubble** (Epiphysis) | **Giant Cell Tumor** | Benign but locally aggressive. |\n| **Lytic Lesions + Diabetes Insipidus** | **Langerhans Cell Histiocytosis** | Eosinophilic Granuloma. |\n### **Overview (TL;DR)**\nHere is the high-yield summary of the lecture content for quick scanning.\n| **Category** | **Disease** | **Key Vignette / Symptom** | **Critical \"So What?\" (Complication)** |\n| --- | --- | --- | --- |\n| **Large Vessel** | **Giant Cell Arteritis (GCA)** | Elderly female, **Jaw Claudication**, Headache | **Blindness** (AION), Aortic Aneurysm |\n|  | **Takayasu Arteritis** | Young Asian female, **Pulseless**, BP difference | Aortic Dilation/Narrowing |\n| **Medium Vessel** | **Kawasaki Disease** | Child <5y, Fever >5 days, **CRASH** symptoms | **Coronary Artery Aneurysm** |\n|  | **Polyarteritis Nodosa (PAN)** | Hep B/C, Renal/GI/Neuro, **Spares Lungs** | Microaneurysms (\"String of beads\") |\n|  | **Buerger's Disease** | Young male heavy smoker, finger ulcers | Auto-amputation (Stop smoking!) |\n| **Small Vessel** | **GPA (Wegener's)** | Sinus + Lung + Kidney, **c-ANCA** | Respiratory/Renal Failure |\n|  | **IgA Vasculitis (HSP)** | Kid, Palpable Purpura (buttocks), Abd pain | **Intussusception**, Renal failure |\n| **Muscle/NMJ** | **Polymyalgia Rheumatica (PMR)** | **Pain/Stiffness** (not weakness), High ESR | Associated with GCA |\n|  | **Dermatomyositis** | Proximal weakness + **Rash** (Heliotrope/Gottron) | **Occult Malignancy** (Cancer) |\n|  | **Myasthenia Gravis** | Ptosis, Diplopia, **Fatigable weakness** | **Respiratory Failure** (Crisis), Thymoma |\n\"You know, there's a specific feeling of dread that washes over you when you open a question block and see a list of symptoms like purpura, fever, and muscle weakness. Oh yeah, it's the alphabet soup of rheumatology. You've got diseases named after people, diseases named after pathology, and uh, ones that seem to change their names every few years. Just to keep us on our toes, exactly.\"\n### **Top-down Classification (Structure)**","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-198","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"Vasculitis & Myopathy ğŸ¥\n|\n+-- 1. Vasculitis (í˜ˆê´€ì—¼) ğŸ©¸\n|   |\n|   +-- A. Large Vessel (ëŒ€í˜ˆê´€)\n|   |   +-- Giant Cell Arteritis (GCA/Temporal) -> ë…¸ì¸, ê´€ìë†€ì´ í†µì¦\n|   |   +-- Takayasu Arteritis -> ì Šì€ ë™ì–‘ì¸ ì—¬ì„±, ë§¥ë°• ì—†ìŒ\n|   |\n|   +-- B. Medium Vessel (ì¤‘í˜ˆê´€)\n|   |   +-- Kawasaki Disease -> ì†Œì•„, ë”¸ê¸°í˜€, ê´€ìƒë™ë§¥ë¥˜\n|   |   +-- Polyarteritis Nodosa (PAN) -> Hep B, í ì¹¨ë²” ì•ˆ í•¨\n|   |   +-- Buerger's Disease -> í¡ì—°ì, ì†ê°€ë½ ê´´ì‚¬\n|   |\n|   +-- C. Small Vessel (ì†Œí˜ˆê´€)\n|       +-- GPA (Wegener's) -> c-ANCA, Sinus-Lung-Kidney\n|       +-- EGPA (Churg-Strauss) -> p-ANCA, Asthma, Eosinophilia\n|       +-- IgA Vasculitis (HSP) -> ì†Œì•„, ì—‰ë©ì´ ìë°˜, ê´€ì ˆí†µ\n|       +-- Behcet's Disease -> êµ¬ê°•/ì„±ê¸° ê¶¤ì–‘, Uveitis\n|\n+-- 2. Myopathy & NMJ Disorders (ê·¼ìœ¡ë³‘ ë° ì‹ ê²½ê·¼ì ‘í•©ë¶€) ğŸ’ª","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-218","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core"]}
{"chunk_type":"transcript_chunk","text":"|\n+-- A. Pain Predominant (í†µì¦ ìœ„ì£¼)\n|   +-- Polymyalgia Rheumatica (PMR) -> ì–´ê¹¨/ê³¨ë°˜ ê²½ì§, ESR ìƒìŠ¹\n|\n+-- B. Weakness Predominant (ìœ„ì•½ ìœ„ì£¼)\n|   +-- Polymyositis -> ê·¼ìœ„ë¶€ ìœ„ì•½, anti-Jo1\n|   +-- Dermatomyositis -> ìœ„ì•½ + í”¼ë¶€ë°œì§„ (Cancer screening í•„ìˆ˜!)\n|\n+-- C. Neuromuscular Junction (NMJ)\n+-- Myasthenia Gravis (MG) -> ì“¸ìˆ˜ë¡ í˜ë¹ ì§ (Fatigable), Thymoma\n+-- Lambert-Eaton (LEMS) -> ì“¸ìˆ˜ë¡ í˜ì´ ë‚¨ (Improves), Small cell lung cancer\n### **1. Large Vessel Vasculitis (ëŒ€í˜ˆê´€ì—¼)** ğŸ›‘\nê°€ì¥ í° íŒŒì´í”„ë¼ì¸ì— ë¬¸ì œê°€ ìƒê¸´ ê²½ìš°ì…ë‹ˆë‹¤.\n### **A. Giant Cell Arteritis (GCA, Temporal Arteritis)**\n- **ğŸ©º Vignette Anchor:**\n    - ì‘ê¸‰ì‹¤ì— ì˜¨ í• ë¨¸ë‹ˆ (Elderly woman).\n    - ì—„ì²­ë‚˜ê²Œ ë¹„ì°¸í•´ ë³´ì´ë©°(miserable), ê´€ìë†€ì´ë¥¼ ë¶€ì—¬ì¡ê³  ìˆìŠµë‹ˆë‹¤.\n    - **í•µì‹¬ ì¦ìƒ:** \"ë¨¸ë¦¬ê°€ ì•„í”ˆë°, ìŠ¤í…Œì´í¬ë¥¼ ì”¹ì„ ë•Œ í„±ì´ ë„ˆë¬´ ì•„íŒŒìš”.\" -> **Jaw Claudication**.\n    - ì´ê²ƒì€ í„±ê´€ì ˆ ë¬¸ì œê°€ ì•„ë‹ˆë¼, ì”¹ëŠ” ê·¼ìœ¡(Masseter)ìœ¼ë¡œ ê°€ëŠ” í˜ˆë¥˜ê°€ ë¶€ì¡±í•´ì„œ ìƒê¸°ëŠ” í—ˆí˜ˆì„± í†µì¦ì…ë‹ˆë‹¤. **ê°€ì¥ íŠ¹ì´ì ì¸(Specific) ì¦ìƒ**ì…ë‹ˆë‹¤.\n- **Systemic Symptoms:**\n    - Fever, Fatigue, Weight loss.\n    - **PMR (Polymyalgia Rheumatica) ì—°ê´€ì„±:** í™˜ìì˜ ì•½ 50%ê°€ ì–´ê¹¨ì™€ ì—‰ë©ì´ì˜ ì•„ì¹¨ ê²½ì§(Morning stiffness)ì„ í˜¸ì†Œí•©ë‹ˆë‹¤.\n- **ğŸš¨ The \"Can't Miss\" Symptom (Acute Terror):**\n    - **Vision Loss (Amaurosis Fugax -> Blindness):** ëˆˆì•ì— ì–´ë‘ìš´ ì»¤íŠ¼ì´ ë‚´ë ¤ì˜¤ëŠ” ê²ƒ ê°™ë‹¤(Amaurosis fugax)ê³  í•˜ë‹¤ê°€, ì¹˜ë£Œ ì•ˆ í•˜ë©´ ì˜êµ¬ì ì¸ ì‹¤ëª…(Permanent Blindness)ìœ¼ë¡œ ì´ì–´ì§‘ë‹ˆë‹¤.\n    - ì›ì¸: Anterior Ischemic Optic Neuropathy (AION).\n- **ğŸ§¨ The \"So What\" (Long-term Complication):**\n    - **Aortic Aneurysm (ëŒ€ë™ë§¥ë¥˜):** ëŒ€ë™ë§¥ ë²½ì´ ì•½í•´ì§‘ë‹ˆë‹¤. ë‘í†µ ì¹˜ë£Œ í›„ì—ë„ í‰ë¶€ X-ray(CXR)ë¡œ ì¶”ì  ê´€ì°°ì´ í•„ìš”í•©ë‹ˆë‹¤.\n- **ğŸ’Š Treatment Strategy (Stratified by Risk):** â˜…\n    - Tier 1 (PMR ì¦ìƒë§Œ ìˆìŒ): Low dose Prednisone (10-20mg).\n    - Tier 2 (GCA ì¦ìƒë§Œ ìˆìŒ, ì‹œë ¥ ì •ìƒ): High dose Oral Prednisone (40-60mg).\n    - Tier 3 (Vision Loss/Curtain falling): **Code RED!** ì…ì›í•˜ì—¬ **IV Methylprednisolone (1000mg/day for 3 days)**.\n    - **â˜… Next Best Step:** ì‹œë ¥ ì†Œì‹¤ ì¦ìƒì´ ìˆìœ¼ë©´ ìƒê²€(Biopsy) ê²°ê³¼ë¥¼ ê¸°ë‹¤ë¦¬ì§€ ë§ê³  **ì¦‰ì‹œ ìŠ¤í…Œë¡œì´ë“œ(Steroids) íˆ¬ì—¬**!\n- **ğŸ” Diagnosis:**\n    - Gold Standard: Temporal Artery Biopsy. (ì¹˜ë£Œ ì‹œì‘ í›„ 2ì£¼ ë‚´ì— í•´ë„ ë¨).\n### **B. Takayasu Arteritis**\n- **ğŸ©º Vignette Anchor:**\n    - **Young Asian Female** (<40ì„¸).\n    - \"Pulseless Disease\": ì–‘íŒ”ì˜ í˜ˆì•• ì°¨ì´ê°€ ì‹¬í•˜ê±°ë‚˜, íŒ”ì—ì„œ ë§¥ë°•ì´ ì˜ ì•ˆ ì¡í˜.\n- **Imaging:** CT/MRIì—ì„œ ëŒ€ë™ë§¥ ë²½ì´ ë‘êº¼ì›Œì§„ ê²ƒì„ í™•ì¸ (Aortic dilation/narrowing).\n### **2. Medium Vessel Vasculitis (ì¤‘í˜ˆê´€ì—¼)** ğŸš§","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-238","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### **A. Kawasaki Disease (ê°€ì™€ì‚¬í‚¤ë³‘)**\n- **ğŸ©º Vignette Anchor:**\n    - **Pediatric Nightmare.** ì‘ê¸‰ì‹¤ì— ì˜¨ 5ì„¸ ë¯¸ë§Œ ì†Œì•„.\n    - í•´ì—´ì œ(Tylenol)ë¥¼ ì¨ë„ 5ì¼ ì´ìƒ ì—´ì´ ì•ˆ ë–¨ì–´ì§ (**Fever > 5 days**).\n- **Diagnostic Criteria (CRASH & Burn):** ì—´ + ë‹¤ìŒ ì¤‘ 4ê°€ì§€\n    1. **C**onjunctivitis: ì–‘ìª½ ëˆˆ ì¶©í˜ˆ (ëˆˆê¼½ ì—†ìŒ, Non-exudative).\n    2. **R**ash: ëª¸í†µì˜ ë°œì§„.\n    3. **A**denopathy: ëª© ë¦¼í”„ì ˆ ë¹„ëŒ€ (>1.5cm, ì£¼ë¡œ í•œìª½).\n    4. **S**trawberry Tongue: í˜€ê°€ ë”¸ê¸°ì²˜ëŸ¼ ë¹¨ê°›ê³  ì…ìˆ ì´ ê°ˆë¼ì§.\n    5. **H**ands & Feet: ì†ë°œì´ ë¶“ê³  ë¶‰ì–´ì§ (ë‚˜ì¤‘ì—ëŠ” í”¼ë¶€ê°€ ë²—ê²¨ì§ - Desquamation).\n- **ğŸ§¨ The \"So What\" (Critical Complication):**\n    - **Coronary Artery Aneurysm (ê´€ìƒë™ë§¥ë¥˜):** ì‹¬ì¥ í˜ˆê´€ì´ ëŠ˜ì–´ë‚˜ì„œ ì‹¬ê·¼ê²½ìƒ‰(MI)ì´ ì˜¬ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n    - ëª¨ë“  í™˜ìì—ê²Œ ì§„ë‹¨ ì‹œ ë° 6-8ì£¼ í›„ **Echocardiogram(ì‹¬ì´ˆìŒíŒŒ)** í•„ìˆ˜!\n- **ğŸ’Š Treatment (The Exception Rule):** â˜…\n    - **IVIG (Intravenous Immunoglobulin)** + **High Dose Aspirin**.\n    - *ì£¼ì˜:* ì†Œì•„ì—ê²Œ ì•„ìŠ¤í”¼ë¦°ì€ Reye Syndrome ë•Œë¬¸ì— ê¸ˆê¸°ì§€ë§Œ, ê°€ì™€ì‚¬í‚¤ëŠ” ì˜ˆì™¸ì…ë‹ˆë‹¤. (Benefit > Risk).\n- **ğŸš« Vaccine Warning:**\n    - IVIG ì¹˜ë£Œ í›„ 11ê°œì›” ë™ì•ˆì€ **ìƒë°±ì‹ (MMR, Varicella)** ì ‘ì¢… ê¸ˆì§€! (í•­ì²´ê°€ ë°±ì‹  íš¨ê³¼ë¥¼ ë¬´ë ¥í™”í•¨).\n### **B. Polyarteritis Nodosa (PAN)**\n- **ğŸ©º Vignette Anchor:**\n    - ì¤‘ë…„ ë‚¨ì„±, Bí˜• ê°„ì—¼(Hepatitis B) ë³´ê· ì.\n    - ì‹ ì¥(Renal), ì‹ ê²½(Neuro - Foot drop), ìœ„ì¥ê´€(GI - Mesenteric ischemia) ì¦ìƒì´ ë‹¤ ë‚˜íƒ€ë‚¨.\n    - **â˜… Key Differentiator:** í(Lung)ëŠ” ì ˆëŒ€ ì¹¨ë²”í•˜ì§€ ì•ŠìŒ (**Spares the Lungs**).\n- **Imaging:** í˜ˆê´€ ì¡°ì˜ìˆ ì—ì„œ **\"String of Beads\"** (ì—¼ì£¼ì•Œ ëª¨ì–‘ì˜ ë¯¸ì„¸ ë™ë§¥ë¥˜) ì†Œê²¬.\n- **Diagnosis:** ANCA Negative. (ANCAê°€ ë‚˜ì˜¤ë©´ ë‹¤ë¥¸ ë³‘ ìƒê°í•´ì•¼ í•¨).\n### **C. Buerger's Disease (Thromboangiitis Obliterans)**\n- **ğŸ©º Vignette Anchor:**\n    - 45ì„¸ ë¯¸ë§Œ ë‚¨ì„±, **Heavy Smoker**.\n    - ì†ê°€ë½/ë°œê°€ë½ ëì´ ê²€ê²Œ ë³€í•¨ (Gangrene, Ulceration).\n- **ğŸ’Š Treatment:**\n    - ì•½ ì—†ìŒ. ìœ ì¼í•œ ì¹˜ë£ŒëŠ” **ê¸ˆì—° (Smoking Cessation)**. ê¸ˆì—° ì•ˆ í•˜ë©´ ì ˆë‹¨(Amputation) í•´ì•¼ í•¨.\n### **3. Small Vessel Vasculitis (ì†Œí˜ˆê´€ì—¼) & ANCA Wars** ğŸ”¬\n### **A. Granulomatosis with Polyangiitis (GPA, Wegener's)**\n- **ğŸ©º Vignette Anchor:**\n    - **Upper (Sinus):** ë§Œì„± ë¶€ë¹„ë™ì—¼, ì•ˆì¥ì½”(Saddle nose).\n    - **Lower (Lung):** ê°í˜ˆ(Hemoptysis), í ê²°ì ˆ(Nodules).\n    - **Renal:** í˜ˆë‡¨(Hematuria), ì‹ ë¶€ì „.\n- **ğŸ§ª Lab:** **c-ANCA** (anti-PR3) Positive.\n### **B. Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss)**\n- **ğŸ©º Vignette Anchor:**\n    - ì„±ì¸ ë°œë³‘ **Asthma (ì²œì‹)** + ë¹„ì—¼.\n    - í”¼ê²€ì‚¬ì—ì„œ **Eosinophilia (í˜¸ì‚°êµ¬ ì¦ê°€)**.\n- **ğŸ§ª Lab:** **p-ANCA** (anti-MPO) Positive.\n### **C. IgA Vasculitis (Henoch-SchÃ¶nlein Purpura, HSP)**\n- **ğŸ©º Vignette Anchor:**\n    - 7ì„¸ ì†Œì•„, ê°ê¸° ê±¸ë¦° í›„ ë°œìƒ.\n    - **Palpable Purpura:** ì—‰ë©ì´ì™€ ë‹¤ë¦¬ ë’¤ìª½ì— ë§Œì ¸ì§€ëŠ” ìë°˜ (ê°€ì¥ í”í•¨).\n    - **Arthralgia:** ë¬´ë¦/ë°œëª© í†µì¦.\n    - **Abdominal Pain:** ë°°ê°€ ì•„í”„ë‹¤ê³  í•¨.\n- **ğŸ§¨ The \"So What\":**\n    - **Intussusception (ì¥ì¤‘ì²©ì¦):** ì¥ì´ ê¼¬ì¼ ìˆ˜ ìˆìŒ (ë³µí†µì˜ ì›ì¸). (Ileo-Ileal - air enema ëŒ€ì‹  ìˆ˜ìˆ í•´ì•¼ë¨)\n    - **Renal:** IgA Nephropathy (í˜ˆë‡¨).\n- **ğŸ§ª Lab Trick:** í˜ˆì†ŒíŒ ìˆ˜ì¹˜(Platelet count)ëŠ” **ì •ìƒ(Normal)**ì…ë‹ˆë‹¤. (í˜ˆì†ŒíŒ ë¬¸ì œê°€ ì•„ë‹ˆë¼ í˜ˆê´€ì—¼ì´ê¸° ë•Œë¬¸).\n### **D. Behcet's Disease (ë² ì²´íŠ¸ë³‘)**\n- **ğŸ©º Vignette Anchor:**\n    - í„°í‚¤, ì¤‘ë™, ì•„ì‹œì•„ê³„ ì Šì€ ì„±ì¸.\n    - **Recurrent Oral & Genital Ulcers** (ì…ê³¼ ì„±ê¸°ì— ë°˜ë³µë˜ëŠ” ê¶¤ì–‘).\n    - **Uveitis:** ëˆˆì— í¬ë„ë§‰ì—¼.\n- **Test:** **Pathergy Test** (ë°”ëŠ˜ë¡œ ì°Œë¥´ë©´ ê¶¤ì–‘ ìƒê¹€).\n- **Complication:** í˜ˆì „(Thrombosis)ì´ ì˜ ìƒê¹€ (ë™ë§¥/ì •ë§¥ ëª¨ë‘).\n### E. Mixed Cryoglobulinemia\n- **ğŸ©º Vignette Anchor:**\n    - HCV ë§Œì„±í™˜ì\n- Meltzerâ€™s Triad\n    1. Purpura\n    2. Weakness\n    3. Arthralgia\n- **Test:** Low C4\n### **4. Myopathy & Neuromuscular Disorders (ê·¼ìœ¡ & ì‹ ê²½)** ğŸ’ª","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-258","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"í™˜ìê°€ \"Weak\"í•˜ë‹¤ê³  í•  ë•Œ, ì§„ì§œ í˜ì´ ì—†ëŠ” ê±´ì§€(Weakness), ì•„íŒŒì„œ ëª» ì›€ì§ì´ëŠ” ê±´ì§€(Pain) êµ¬ë¶„í•´ì•¼ í•©ë‹ˆë‹¤.\n### **A. Polymyalgia Rheumatica (PMR)**\n- **ğŸ©º Vignette Anchor:**\n    - 50ì„¸ ì´ìƒ, GCAì™€ ì§ê¿.\n    - \"í˜ì´ ì—†ëŠ” ê²Œ ì•„ë‹ˆë¼, ì–´ê¹¨ë‘ ì—‰ë©ì´ê°€ ë„ˆë¬´ ë»£ë»£í•˜ê³  ì•„íŒŒìš”.\" (**Pain & Stiffness**).\n    - ê·¼ë ¥(Muscle Strength)ì€ ì •ìƒì…ë‹ˆë‹¤.\n- **ğŸ§ª Lab:** **ESR/CRP ê¸‰ìƒìŠ¹**, CK(ê·¼ìœ¡íš¨ì†Œ)ëŠ” **ì •ìƒ**.\n### **B. Inflammatory Myopathies (Polymyositis & Dermatomyositis)**\n- **Common Feature:**\n    - **Proximal Muscle Weakness:** ë¨¸ë¦¬ ë¹—ê¸°(ë¹—ì§ˆ), ì˜ìì—ì„œ ì¼ì–´ë‚  ë•Œ í˜ë“¦. (í†µì¦ ì—†ìŒ, **Painless**).\n    - **Lab:** **CK (CPK) ìƒìŠ¹**, Aldolase ìƒìŠ¹.\n    - DDx with Steroid induced myopathy\n        - proximal weaknessìˆìœ¼ë‚˜ CKëŠ” ì •ìƒì„!\n- **Dermatomyositis (í”¼ë¶€ê·¼ì—¼) Specifics:** ğŸ¨\n    - **Gottron's Papules:** ì†ê°€ë½ ê´€ì ˆ(Knuckles)ì— ë³´ë¼ìƒ‰ ë°œì§„.\n    - **Heliotrope Rash:** ëˆˆêº¼í’€ì— ë³´ë¼ìƒ‰ ì•„ì´ì„€ë„ìš° ê°™ì€ ë°œì§„.\n    - **Shawl Sign:** ì–´ê¹¨ì— ë‘ë¥¸ ìˆ„ ëª¨ì–‘ì˜ ë°œì§„.\n    - **ğŸ§¨ Critical Warning:** í”¼ë¶€ê·¼ì—¼ ì§„ë‹¨ ì‹œ **ë°˜ë“œì‹œ ì•” ê²€ì‚¬(Malignancy Screening)**ë¥¼ í•´ì•¼ í•©ë‹ˆë‹¤. (Ovarian, Lung, Pancreatic, etc. - Paraneoplastic Syndrome).\n- **Antibodies:**\n    - Anti-Jo-1 (Lung fibrosis ê´€ë ¨).\n    - Anti-Mi-2 (Dermatomyositis).\n### **C. Myasthenia Gravis (MG)**\n- **ğŸ©º Vignette Anchor:**\n    - ì Šì€ ì—¬ì„± or ë…¸ì¸ ë‚¨ì„±.\n    - **Fluctuating Weakness:** ì•„ì¹¨ì—” ê´œì°®ì€ë° **ì €ë… ë˜ë©´ ëˆˆêº¼í’€ì´ ì²˜ì§(Ptosis)**, ë¬¼ì²´ê°€ ë‘ ê°œë¡œ ë³´ì„(Diplopia).\n    - Bulbar symptoms: ì‚¼í‚¤ê¸° í˜ë“¤ê³ , ë§ì´ ì–´ëˆŒí•´ì§.\n- **Mechanism:** Post-synaptic Acetylcholine Receptorì— ëŒ€í•œ í•­ì²´ ê³µê²©.\n- **Tests:**\n    - **Ice Pack Test:** ëˆˆì— ì–¼ìŒì„ ëŒ€ë©´ Ptosis í˜¸ì „ (íš¨ì†Œê°€ ì¶”ìš¸ ë•Œ ëœ ì‘ë™í•´ì„œ Achê°€ ì˜¤ë˜ ë‚¨ìŒ).\n    - Anti-AChR Antibody.\n    - **CT Chest:** ëª¨ë“  í™˜ìì—ì„œ **Thymoma (í‰ì„ ì¢…)** í™•ì¸ í•„ìˆ˜! (í‰ì„  ì ˆì œìˆ ì´ ì¹˜ë£Œê°€ ë¨).\n- **ğŸ’Š Avoid List (Do Not Use) ì•”ê¸° â˜… â˜…  4ê°€ì§€!**\n    - FQ, Magnesium, Aminoglycosides, Beta-blockers (ì¦ìƒ ì•…í™”ì‹œí‚´).\n    - ì „ìê°„ì¦í™˜ìì—ì„œ ë§ˆê·¸ë„¤ìŠ˜ ì¤¬ëŠ”ë° ì•Œê³ ë³´ë‹ˆ undiagnosed MGìˆì—ˆìœ¼ë©´ ìœ„í—˜í•  ìˆ˜ ìˆìŒ.\n- **ğŸš¨ Myasthenic Crisis:**\n    - ìˆ¨ì„ ëª» ì‰¼. -> Intubation & Plasmapheresis/IVIG.\n### **D. Lambert-Eaton Myasthenic Syndrome (LEMS)**\n- **ğŸ©º Vignette Anchor:**\n    - **Small Cell Lung Cancer** í™˜ì.\n    - **Proximal Weakness:** ê·¼ë° MGì™€ ë°˜ëŒ€ë¡œ, **ì›€ì§ì¼ìˆ˜ë¡ í˜ì´ ì„¸ì§ (Facilitation/Improves with use)**.\n- **Mechanism:** Pre-synaptic Calcium Channel ê³µê²© (ì•„ì„¸í‹¸ì½œë¦° ë¶„ë¹„ê°€ ì•ˆ ë¨).\n- **Physical Exam:** ì‹¬ë¶€ê±´ë°˜ì‚¬(DTR)ê°€ ê°ì†Œ/ì†Œì‹¤ë¨ (ìš´ë™ í›„ ëŒì•„ì˜´).","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-278","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","diagnosis","pathophysiology"]}
{"chunk_type":"recap_summary","text":"### **Rapid Fire Recap (ì¡±ì§‘ê²Œ ìš”ì•½)** ğŸ”¥\n| **Condition** | **Key Keyword** | **Association / Lab** | **Treatment / Note** |\n| --- | --- | --- | --- |\n| **GCA** | Jaw Claudication | Polymyalgia Rheumatica | Vision loss â†’ High dose Steroids **ASAP** |\n| **Kawasaki** | Fever > 5d + CRASH | Coronary Aneurysm | **IVIG + Aspirin** (No live vaccines for 11mo) |\n| **PAN** | Hep B, Foot drop | Spares Lung | Angio: String of beads |\n| **GPA** | Sinus + Lung + Kidney | c-ANCA (PR3) | Cyclophosphamide/Rituximab |\n| **HSP** | Palpable Purpura (Butt) | Normal Platelets | Risk: Intussusception â†’ surgery |\n| **PMR** | Shoulder/Hip Pain | High ESR, Normal CK | Low dose Steroids |\n| **Dermatomyositis** | Heliotrope Rash | **Occult Cancer** | Screen for malignancy! |\n| **Myasthenia Gravis** | Ptosis, Worse @ night | Thymoma | Ice pack test, Pyridostigmine.\nNo FQ(cipro), No magnesium |\n| **Lambert-Eaton** | Better with use | Small Cell Lung Ca | Presynaptic Ca channel |\n**Meta-Cognitive Reflection:**\n- **Confidence:** 1.0 (Confident).\n- **Completeness Check:** Covered all major vessels (Large/Medium/Small), key pediatric vasculitides (Kawasaki, HSP), and the differential for weakness (Muscle vs NMJ). Included specific complications (Aneurysms, Blindness, Cancer) and treatments (Steroids, IVIG, Aspirin).\n- **Caveats:** While treatments are mentioned, dosage specifics (e.g., prednisone mg) are based on the audio's mention. Always confirm exact dosages clinically. The distinction between \"Pain\" (PMR) and \"Weakness\" (Myositis) is the most common USMLE trapâ€”highlighted clearly.\n**Overview & TL;DR**\nì´ë²ˆ ê°•ì˜ëŠ” ì†Œì•„ ì •í˜•ì™¸ê³¼(Pediatric Orthopedics)ì— ëŒ€í•œ ì‹¬ì¸µ ë¶„ì„ì…ë‹ˆë‹¤. ì„±ì¸ê³¼ ë‹¬ë¦¬ ì†Œì•„ëŠ” \"ì—¬ê¸°ê°€ ì•„íŒŒìš”\"ë¼ê³  ì •í™•íˆ ë§í•˜ì§€ ì•Šìœ¼ë¯€ë¡œ, ì˜ì‚¬ëŠ” **íƒì •(Detective)**ì´ ë˜ì–´ì•¼ í•©ë‹ˆë‹¤. ğŸ•µï¸â€â™‚ï¸\nì£¼ìš” ì£¼ì œëŠ” **Limping Child (ì ˆëšê±°ë¦¬ëŠ” ì•„ì´)**ì˜ ê°ë³„ ì§„ë‹¨(Hip Pathology), **JIA (ì†Œì•„ ë¥˜ë§ˆí‹°ìŠ¤)**, ê·¸ë¦¬ê³  **í•˜ì§€ ì •ë ¬ ë° ë°œì˜ ë³€í˜•**ì…ë‹ˆë‹¤.\n**Core Concept Structure (ASCII Tree)**\nPlaintext\n`PEDIATRIC ORTHOPEDICS (The Detective Game ğŸ•µï¸â€â™‚ï¸)\nâ”œâ”€â”€ 1. THE HIP (The Limping Child) ğŸƒâ€â™‚ï¸\nâ”‚   â”œâ”€â”€ Adolescents (Teens, Obese) â” SCFE (Ice cream slip) ğŸ¦\nâ”‚   â”œâ”€â”€ Age 4-10 (Painless limp) â” LCP (AVN) ğŸ¦´\nâ”‚   â”œâ”€â”€ Toddlers (Fever?)\nâ”‚   â”‚   â”œâ”€â”€ High Fever + Refusal to walk â” Septic Arthritis (Emergency!) ğŸš¨\nâ”‚   â”‚   â””â”€â”€ Low Fever + Post-viral â” Transient Synovitis (Rest) ğŸ›Œ\nâ”‚   â””â”€â”€ Infants (Newborn) â” DDH (Clunk!) ğŸ‘¶\nâ”‚\nâ”œâ”€â”€ 2. SYSTEMIC / INFLAMMATORY (JIA) ğŸ”¥\nâ”‚   â”œâ”€â”€ Systemic (Fever + Rash) ğŸ¤’\nâ”‚   â”œâ”€â”€ Oligoarticular (<5 joints, EYE EXAM!) ğŸ‘ï¸\nâ”‚   â””â”€â”€ Polyarticular (>5 joints, like adult RA) ğŸ–ï¸\nâ”‚\nâ”œâ”€â”€ 3. LOWER LIMB ALIGNMENT ğŸ¦µ\nâ”‚   â”œâ”€â”€ Knees: Bowlegs (Varum) vs. Knock-knees (Valgum)\nâ”‚   â””â”€â”€ Toes: Intoeing (Tibial Torsion vs. Femoral Anteversion)\nâ”‚\nâ””â”€â”€ 4. FEET & SPINE ğŸ¦¶\n    â”œâ”€â”€ Clubfoot (Rigid, Cast now!) vs. Metatarsus Adductus (Flexible)\n    â”œâ”€â”€ Torticollis (Wry neck) ğŸ¦’\n    â””â”€â”€ Scoliosis (Adam's test, Cobb angle) ğŸ“`","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-288","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","recap","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"### **1. THE LIMPING CHILD: HIP PATHOLOGY (ê³ ê´€ì ˆ ë³‘ë³€)** ğŸ¦µ\nì†Œì•„ ì •í˜•ì™¸ê³¼ì—ì„œ ê°€ì¥ ì¤‘ìš”í•œ íŒŒíŠ¸ì…ë‹ˆë‹¤. **ë‚˜ì´(Age)**ê°€ ê°€ì¥ ê°•ë ¥í•œ ë‹¨ì„œì…ë‹ˆë‹¤. ğŸ•µï¸â€â™€ï¸\n### **1.1 SCFE (Slipped Capital Femoral Epiphysis) - ëŒ€í‡´ê³¨ë‘ ê³¨ë‹¨ ë¶„ë¦¬ì¦**\n- **Vignette (ì„ìƒ ìƒí™©):** ëš±ëš±í•œ(Obese) ì²­ì†Œë…„(Adolescent)ì´ ë“¤ì–´ì˜µë‹ˆë‹¤. ë¬´ë¦ì´ ì•„í”„ë‹¤ê³ (Knee pain) í˜¸ì†Œí•©ë‹ˆë‹¤. ğŸ¦\n- **The Trap (í•¨ì •):** ë¬´ë¦ì´ ì•„í”„ë‹¤ê³  ë¬´ë¦ë§Œ ë³´ë©´ ë§í•©ë‹ˆë‹¤! **Referred Pain(ì—°ê´€í†µ)**ì…ë‹ˆë‹¤. ë¬´ë¦ ê²€ì‚¬ê°€ ì •ìƒì´ë©´ ë¬´ì¡°ê±´ **HIP(ê³ ê´€ì ˆ)**ì„ í™•ì¸í•´ì•¼ í•©ë‹ˆë‹¤.\n- **Pathophysiology (ê¸°ì „):** ì•„ì´ìŠ¤í¬ë¦¼ ìŠ¤ì¿±(Femoral head)ì´ ì½˜(Femoral neck)ì—ì„œ ë¯¸ë„ëŸ¬ì ¸ ë–¨ì–´ì§€ëŠ” ê²ƒê³¼ ê°™ìŠµë‹ˆë‹¤. ğŸ¦ğŸ“‰\n- **Physical Exam:** ë‹¤ë¦¬ë¥¼ ë“¤ì–´ ì˜¬ë¦¬ë ¤ í•˜ë©´(Flexion), ë‹¤ë¦¬ê°€ ì €ì ˆë¡œ ë°”ê¹¥ìœ¼ë¡œ ëŒì•„ê°‘ë‹ˆë‹¤(**External Rotation**). Limited Internal Rotation\n- **â˜… Next Best Step (ì§„ë‹¨):** X-ray (Frog-leg lateral view).\n- **â˜… Treatment (ì¹˜ë£Œ):** **Surgical Pinning (Screw fixation).**\n- **WARNING:** **Weight-bearing ì ˆëŒ€ ê¸ˆì§€!** ì§„ë‹¨ ì¦‰ì‹œ íœ ì²´ì–´ íƒœìš°ì„¸ìš”. ë” ê±¸ìœ¼ë©´ AVN(ë¬´í˜ˆì„± ê´´ì‚¬) ì˜µë‹ˆë‹¤.\n- <10ì„¸ë³´ë‹¤ ì–´ë¦´ë•Œ SCFEê°€ ìƒê¸°ë©´ hypothyroidism ìƒê°í•´ì•¼ë¨.\n### **1.2 LCP (Legg-CalvÃ©-Perthes Disease) - LCPë³‘**\n- **Vignette:** 4~10ì„¸ ì†Œì•„ (SCFEë³´ë‹¤ ì–´ë¦¼). ì•„í”„ë‹¤ëŠ” ë§ë³´ë‹¤ëŠ” **ì ˆëšê±°ë¦¼(Painless Limp)**ì´ ì£¼ì¦ìƒ.\n- **Pathophysiology:** íŠ¹ë°œì„± ëŒ€í‡´ê³¨ë‘ ë¬´í˜ˆì„± ê´´ì‚¬(Idiopathic AVN). ğŸ¦´\n- **Physical Exam:**\n    - **Trendelenburg Sign:** ì•„í”ˆ ìª½ ë‹¤ë¦¬ë¡œ ì„°ì„ ë•Œ ë°˜ëŒ€ìª½ ê³¨ë°˜ì´ ë–¨ì–´ì§ (Gluteus medius ì•½í™”).\n    - Abduction(ì™¸ì „) ë° Internal Rotation(ë‚´íšŒì „) ì œí•œ.\n- **Diagnosis:** X-ray (ì´ˆê¸°ì—” ì •ìƒì¼ ìˆ˜ ìˆìŒ â†’ ì˜ì‹¬ë˜ë©´ MRI).\n- **Treatment:** **Containment (ëŒ€í‡´ê³¨ë‘ë¥¼ ì†Œì¼“ ì•ˆì— ìœ ì§€).** ë³´ì¡°ê¸°(Brace)ë‚˜ ìºìŠ¤íŠ¸(Cast). ìŠ¤ìŠ¤ë¡œ ë‚«ëŠ” ë³‘(Self-limiting)ì´ì§€ë§Œ ëª¨ì–‘ì„ ì¡ì•„ì¤˜ì•¼ í•¨.\n### **1.3 DDH (Developmental Dysplasia of the Hip) - ë°œë‹¬ì„± ê³ ê´€ì ˆ ì´í˜•ì„±ì¦**\n- **Vignette:** ì‹ ìƒì•„ ê²€ì§„.\n- **Risk Factors:** Female (ì—¬ì•„), Breech (ë‘”ìœ„), Family Hx (ê°€ì¡±ë ¥). ğŸ‘¶\n- **Screening Maneuvers (ì‹ ì²´ ê²€ì§„):**\n    - **Barlow:** **B**ack/**B**ad. ë‹¤ë¦¬ë¥¼ ëª¨ìœ¼ê³  ë’¤ë¡œ ë°€ì—ˆì„ ë•Œ ë¹ ì§€ë©´(Dislocate) ì–‘ì„±.\n    - **Ortolani:** **O**pen. ë‹¤ë¦¬ë¥¼ ë²Œë¦´ ë•Œ(Abduction) 'Clunk' ì†Œë¦¬ê°€ ë‚˜ë©° ì œìë¦¬ë¡œ ë“¤ì–´ê°€ë©´ ì–‘ì„±.\n- **Visual Cues:**\n    - **Asymmetric Folds:** í—ˆë²…ì§€ë‚˜ ì—‰ë©ì´ ì£¼ë¦„ì´ ë¹„ëŒ€ì¹­.\n    - **Galeazzi Sign:** ë¬´ë¦ì„ ì„¸ì› ì„ ë•Œ ë†’ì´ê°€ ë‹¤ë¦„ (íƒˆêµ¬ëœ ìª½ì´ ë‚®ìŒ).\n- **â˜… Diagnosis (ì§„ë‹¨ - ë‚˜ì´ê°€ ì¤‘ìš”!):**\n    - **< 4ê°œì›”:** **Ultrasound** (ë¼ˆê°€ ì•„ì§ ì—°ê³¨ì´ë¼ X-ray ì•ˆ ë³´ì„).\n    - **> 4ê°œì›”:** **X-ray** (Ossification center ìƒê¹€).\n- **â˜… Treatment:** **Pavlik Harness** (ê°œêµ¬ë¦¬ ìì„¸ ìœ ì§€ ğŸ¸). 6ê°œì›” ì´í›„ë¼ë©´ ìˆ˜ìˆ  í•„ìš”í•  ìˆ˜ë„.\n### **1.4 Septic Arthritis vs. Transient Synovitis (í™”ë†ì„± ê´€ì ˆì—¼ vs ì¼ê³¼ì„± í™œì•¡ë§‰ì—¼)**\n- **The Dilemma:** ë‘˜ ë‹¤ ê±¸ìŒë§ˆê¸° ì•„ì´(Toddler)ê°€ ë‹¤ë¦¬ë¥¼ ì ˆê³  ì—´ì´ ë‚  ìˆ˜ ìˆìŠµë‹ˆë‹¤. í•˜ë‚˜ëŠ” ì‘ê¸‰(Emergency), í•˜ë‚˜ëŠ” íœ´ì‹(Rest)ì…ë‹ˆë‹¤. êµ¬ë¶„ë²•ì€?\n- **â˜… Kocher Criteria (4ê°€ì§€ ì§€í‘œ - 1ì ì”©):**\n    1. **Non-weight bearing:** ì•„ì˜ˆ ëª» ê±¸ìŒ.\n    2. **Fever:** > 38.5Â°C (101.3Â°F).\n    3. **WBC:** > 12,000.\n    4. **ESR:** > 40 (í˜¹ì€ CRP ìƒìŠ¹).\n- **Interpretation:**\n    - **3~4ì  (Septic Arthritis ê°•ë ¥ ì˜ì‹¬):** **EMERGENCY!** ğŸš¨ ê´€ì ˆ ì²œì(Tap) â†’ ë°°ë†(Drain) + í•­ìƒì œ(Antibiotics). ì—°ê³¨ ë‹¤ ë…¹ìŠµë‹ˆë‹¤!\n    - **0~2ì  (Transient Synovitis):** ë³´í†µ ê°ê¸°(Viral URI) í›„ ë°œìƒ. **Treatment:** **Observation + NSAIDs.** (ì§‘ì— ê°€ì„œ ì‰¬ì„¸ìš” ğŸ›Œ).\n- ì´í›„ì— ì´ˆìŒíŒŒ ì‹œí–‰: ì–‘ìª½ì— ë‹¤ ìˆìœ¼ë©´ ì¼ê³¼ì„± í™œì•¡ë§‰ì—¼. í•œìª½ì—ë§Œ ì•¡ì²´ ì°¨ìˆìœ¼ë©´ í™”ë†ì„± ê´€ì ˆì—¼ì˜ ê°€ëŠ¥ì„±ì´ ë†’ìŒ.\n### **2. JUVENILE IDIOPATHIC ARTHRITIS (JIA) - ì†Œì•„ íŠ¹ë°œì„± ê´€ì ˆì—¼** ğŸ”¥\n- **Definition:** 16ì„¸ ë¯¸ë§Œ, 6ì£¼ ì´ìƒ ì§€ì†ë˜ëŠ” ê´€ì ˆì—¼.\n- JIAëŠ” non-migratory\n    - ddx with ARF (migratory, ì§€ë ì´ rash)\n- **Types (ìœ í˜•ë³„ íŠ¹ì§•):**\n| **Type** | **Joints Involved** | **Key Features & Risks** |\n| --- | --- | --- |\n| **Systemic (Still's)** | Variable | **Daily Spiking Fever** (ë§¤ì¼ íŠ€ëŠ” ê³ ì—´) ğŸ¤’\n**Salmon-colored Rash** (ì—°ì–´ìƒ‰ ë°œì§„)\nê°„ë¹„ì¥ë¹„ëŒ€(Hepatosplenomegaly). |\n| **Oligoarticular** | **< 5 joints** | ì£¼ë¡œ ë¬´ë¦ ê°™ì€ í° ê´€ì ˆ\n**â˜… KEY RISK: Uveitis (í¬ë„ë§‰ì—¼)** â†’ **Blindness(ì‹¤ëª…)** ìœ„í—˜!\nì¦ìƒ ì—†ì´ ì˜¤ë¯€ë¡œ **Slit Lamp Exam(ì„¸ê·¹ë“± ê²€ì‚¬)** í•„ìˆ˜! ğŸ‘ï¸","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-298","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"ë¬´ë¦ì˜¤ë«ë™ì•ˆ ì•„í”ˆì• ëŠ” ëˆˆ ê²€ì‚¬í•´ì•¼ëœë‹¤. â˜…  |\n| **Polyarticular** | **â‰¥ 5 joints** | ì„±ì¸ ë¥˜ë§ˆí‹°ìŠ¤(RA)ì™€ ë¹„ìŠ·. ì†/ë°œ ì‘ì€ ê´€ì ˆ ì¹¨ë²”. |\n### **3. LOWER LIMB ALIGNMENT & FEET (ë‹¤ë¦¬ ëª¨ì–‘ê³¼ ë°œ)** ğŸ¦¶\në¶€ëª¨ë‹˜ë“¤ì´ ì œì¼ ê±±ì • ë§ì´ í•˜ëŠ” íŒŒíŠ¸ì…ë‹ˆë‹¤. \"ìš°ë¦¬ ì•  ë‹¤ë¦¬ê°€ íœ˜ì—ˆì–´ìš”!\"\n### **3.1 Bowlegs vs. Knock-knees (Oë‹¤ë¦¬ vs Xë‹¤ë¦¬)**\n- **Timeline (ì •ìƒ ë°œë‹¬ ê³¼ì •):**\n    - **0~2ì„¸:** **Bowlegs (Genu Varum)** - Oë‹¤ë¦¬. (í„°ë¯¸ë„¤ì´í„°ì²˜ëŸ¼ ë‹¤ë¦¬ ë²Œë¦¬ê³  ê±·ëŠ” ê²Œ ì •ìƒ).\n    - **2~4ì„¸:** **Knock-knees (Genu Valgum)** - Xë‹¤ë¦¬. (ë¬´ë¦ì´ ë¶™ìŒ).\n    - **Adolescence:** ì„±ì¸ì²˜ëŸ¼ ê³§ê²Œ í´ì§.\n- **Red Flags (ë³‘ì ì¸ ê²½ìš°):**\n    - **Blount's Disease:** ì„±ì¥íŒ(Growth plate) ë¬¸ì œ. ë¹„ë§Œ ì•„ë™. í•œìª½ë§Œ ì‹¬í•˜ê±°ë‚˜ ê°ë„ê°€ í¼. â†’ ìˆ˜ìˆ /ë³´ì¡°ê¸°.\n    - **Rickets (êµ¬ë£¨ë³‘):** Vitamin D ê²°í•. ğŸ¦´\n### 3.2 Toddlerâ€™s Fracture\n- Spiral fracture of the distal tibia ëŒì•„ê°€ë©´ì„œ ê³¨ì ˆ.\n- ì—‘ìŠ¤ë ˆì´ ì •ìƒì¼ ìˆ˜ ìˆìŒ.\n- Immobilization\n### **3.3 Intoeing (ì•ˆì§±ê±¸ìŒ)**\në°œì´ ì•ˆìª½ìœ¼ë¡œ ëŒì•„ê°€ëŠ” í˜„ìƒ. ì–´ë””ê°€ ê¼¬ì˜€ëŠëƒì— ë”°ë¼ ë‹¤ë¦…ë‹ˆë‹¤.\n1. **Metatarsus Adductus (ë°œ ìì²´ê°€ íœ¨):** ë°œ ì•ìª½ë§Œ ì•ˆìœ¼ë¡œ íœ¨.\n    - Clubfootê³¼ì˜ ë¹„êµê°€ ì¤‘ìš”í•¨! ë‘˜ë‹¤ ì•ˆì§±ë‹¤ë¦¬ì²˜ëŸ¼ ë‚˜íƒ€ë‚  ìˆ˜ ìˆìœ¼ë‚˜, ë°œì„ êµ½í˜€ë³´ê±°ë‚˜ ì¡°ì‘í•´ë³´ë©´ ì•Œ ìˆ˜ ìˆìŒ\n        - **Flexible:** ì†ìœ¼ë¡œ í´ì§ â†’ **Reassurance** (ì•ˆì‹¬ì‹œí‚¤ê¸°).\n        - **Rigid:** ì•ˆ í´ì§ â†’ R/O club foot â†’ Serial Casting.\n2. **Internal Tibial Torsion (ì •ê°•ì´ ê¼¬ì„):** ê±¸ìŒë§ˆê¸°(Toddler). ë¬´ë¦(Patella)ì€ ì •ë©´ì¸ë° ë°œë§Œ ì•ˆìª½. â†’ ì €ì ˆë¡œ ì¢‹ì•„ì§.\n3. **Femoral Anteversion (í—ˆë²…ì§€ ê¼¬ì„):** 3~6ì„¸.\n    - **Sign:** **\"W\" sitting position.** ë¬´ë¦ì´ ì„œë¡œ ë½€ë½€í•¨(Kissing knees). ë¬´ë¦ ìì²´ê°€ ì•ˆìª½ì„ ë´„.\n    - **Tx:** ì €ì ˆë¡œ ì¢‹ì•„ì§ (Reassurance).\n### **3.4 Clubfoot (Talipes Equinovarus) - ì„ ì²œì„± ë§Œê³¡ì¡±** â›³\n- **Appearance:** ë°œì´ **Plantar flexed(ì•„ë˜ë¡œ)** & **Inverted(ì•ˆìœ¼ë¡œ)** & **Rigid(ë”±ë”±í•¨)**.\n- **Management:** **EMERGENCY (Time sensitive!)**\n    - ë°œê²¬ ì¦‰ì‹œ ì¹˜ë£Œ ì‹œì‘.\n    - **â˜… Ponseti Method:** Serial Casting (ë§¤ì£¼ ê°ë„ ì¡°ì ˆí•´ì„œ ê¹ìŠ¤). ğŸ©º\n    - ì ˆëŒ€ ê¸°ë‹¤ë¦¬ë©´ ì•ˆ ë¨! (Metatarsus Adductusì™€ êµ¬ë³„ í•„ìˆ˜ - Clubfootì€ ì†ìœ¼ë¡œ ì•ˆ í´ì§).\n### **4. SPINE & OTHERS (ì²™ì¶” ë° ê¸°íƒ€)** ğŸ¦’\n### **4.1 Growing Pains (ì„±ì¥í†µ)**\n- **Feature:** ë°¤ì—ë§Œ ì•„í””(Night pain), ì–‘ìª½ ë‹¤ë¦¬(Bilateral), ì•„ì¹¨ì—” ë©€ì©¡í•¨. ì‹ ì²´ ê²€ì§„ ì •ìƒ.\n- Unilateral, daytime, limping â†’ ë‹¤ë¥¸ê±° ê°ë³„í•´ì•¼í•¨!\n- **Management:** Diagnosis of exclusion (ë‹¤ë¥¸ ë³‘ ì—†ìœ¼ë©´ ì§„ë‹¨). ë§ˆì‚¬ì§€í•´ì£¼ê³  ì•ˆì‹¬ì‹œí‚¤ê¸°.\n### **4.2 Torticollis (ì‚¬ê²½)**\n- **Vignette:** ì•„ê¸° ê³ ê°œê°€ í•œìª½ìœ¼ë¡œ ê¸°ì›€. **í„±(Chin)**ì€ ë°˜ëŒ€ìª½ì„ í–¥í•¨.\n- **Cause:** SCM muscle (í‰ì‡„ìœ ëŒê·¼) ë‹¨ì¶•. ë©ì–´ë¦¬(Mass)ê°€ ë§Œì ¸ì§ˆ ìˆ˜ ìˆìŒ (Fibromatosis colli - ì•” ì•„ë‹˜!).\n- **Treatment:** **Stretching** (ë°˜ëŒ€ìª½ìœ¼ë¡œ ìŠ¤íŠ¸ë ˆì¹­). 1ë…„ ë‚´ ëŒ€ë¶€ë¶„ í˜¸ì „.\n### **4.3 Scoliosis (ì²™ì¶”ì¸¡ë§Œì¦)**","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-318","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"- **Screening:** **Adam's Forward Bend Test** (ì¸ì‚¬í•˜ë“¯ ìˆ™ì˜€ì„ ë•Œ ë“± ë†’ì´ ì°¨ì´ í™•ì¸).\n- **Diagnosis:** X-ray â†’ **Cobb Angle** ì¸¡ì •.\n- **Management (ê°ë„ì— ë”°ë¼):** ğŸ“\n    - **< 10Â°:** ì •ìƒ ë²”ìœ„.\n    - **10~20Â°:** **Observation** (ê´€ì°°).\n    - **20~40Â°:** **Brace** (ë³´ì¡°ê¸° - ì§„í–‰ ë°©ì§€ìš©, êµì •ìš© ì•„ë‹˜!).\n    - **> 40Â°:** **Surgery** (ìˆ˜ìˆ  - ì‹¬í ê¸°ëŠ¥ ì €í•˜ ë°©ì§€).\n### **RAPID FIRE RECAP TABLE** ğŸ”¥\n| **Condition** | **Key Vignette / Symptom** | **Best Initial Test** | **Gold Standard / Mgmt** |\n| --- | --- | --- | --- |\n| **SCFE** | ëš±ëš±í•œ ì²­ì†Œë…„, ë¬´ë¦ í†µì¦, Ext. Rotation | X-ray (Frog-leg) | **Surgery (Screw fixation)** ğŸ”© |\n| **DDH** | ì‹ ìƒì•„, ë‘”ìœ„, ì—‰ë©ì´ ì£¼ë¦„ ë¹„ëŒ€ì¹­ | <**4**mo US, >4mo X-ray | **Pavlik Harness** ğŸ¸ |\n| **Septic Arthritis** | ê³ ì—´ + ëª» ê±¸ìŒ (Kocher 3-4ì ) | Arthrocentesis (Joint Tap) | **Antibiotics + Drainage** ğŸš¨ |\n| Stillâ€™s disease |   â€¢ salmon rash\n  â€¢ knee pian\n  â€¢ Daily spiking fever |  |  |\n| **JIA (Oligo)** | <5 ê´€ì ˆ, ë¬´ë¦ ë¶“ê¸° | Slit Lamp Exam (ëˆˆ ê²€ì‚¬) | NSAIDs / DMARDs |\n| **Clubfoot** | Rigid, ì•ˆìª½ìœ¼ë¡œ íœœ ë°œ | Clinical Exam | **Ponseti Casting (ì¦‰ì‹œ)** |\n| **Scoliosis** | 20~40ë„ Cobb Angle | X-ray (Cobb angle) | **Bracing** (ì§„í–‰ ë°©ì§€) |\n**Meta-Cognitive Reflection:**\n- **Confidence:** 1.0 (Audio content fully covered).\n- **Caveats:** ì˜¤ë””ì˜¤ì—ì„œ 'Growing Pains'ì™€ 'Osgood-Schlatter'ì˜ êµ¬ì²´ì  ë³‘íƒœìƒë¦¬ ì°¨ì´ëŠ” ê¹Šê²Œ ë‹¤ë£¨ì§€ ì•Šì•˜ìœ¼ë‚˜, ì„±ì¥í†µì€ 'ë°°ì œ ì§„ë‹¨'ì´ë¼ëŠ” ì ì„ ëª…í™•íˆ í•¨. Kocher Criteria ì ìˆ˜ ê³„ì‚°ë²•ì„ ê¼­ ì•”ê¸°í•  ê²ƒ!\n## ğŸ“‹ TL;DR & Overview: Gout vs. Septic Arthritis\në°”ìœ íšŒì§„ ì‹œê°„ì„ ìœ„í•œ 30ì´ˆ ìš”ì•½ì…ë‹ˆë‹¤! ğŸƒâ€â™‚ï¸ğŸ’¨\n| **Category** | **Key Point** |\n| --- | --- |\n| **Core Concept** | **Podagra** (Big Toe Pain) + **Bed Sheet Sign** (ë„ˆë¬´ ì•„íŒŒì„œ ì´ë¶ˆë„ ëª» ë®ìŒ) |\n| **Diagnostic Gold Standard** | **Arthrocentesis (Synovial Fluid Analysis)** â˜… |\n| **Crucial Distinction** | **Speed!** GoutëŠ” í­ë°œì (0â†’10 in <24hrs), Septicì€ ì„œì„œíˆ ì§„í–‰ |\n| **USMLE Trap** | **CKD í™˜ì**ì—ê²Œ NSAIDs/Colchicine ê¸ˆì§€ â†’ **Steroids** ì‚¬ìš©! |\n| **Pharm Pearl** | ê³ í˜ˆì•• ì•½ ì¤‘ **Losartan, CCB**ëŠ” Uric acid ë°°ì¶œì„ ë„ì›€ (Good guys) ğŸ‘ |\n\"Okay, picture this. You're a third-year med student, or maybe you're just on call for the first time. It's 3:00 AM. Of course it is. You get called to a room where a middle-aged man is screaming. And I don't mean complaining, I mean he is an absolute 10 out of 10 agony. It's the kind of pain that feels like a medical emergency to the patient. Right. And you look at the source of this torture, and it's his big toe. It's red, it's swollen, it looks like it's about to burst.\"\n## ğŸŒ³ Top-down Classification (Mental Model)\nì˜í•™ì  Contextë¥¼ ì¡ê¸° ìœ„í•œ **Acute Monoarthritis**ì˜ ë¶„ë¥˜ íŠ¸ë¦¬ì…ë‹ˆë‹¤.\nPlaintext\n`Acute Monoarthritis (ê¸‰ì„± ë‹¨ê´€ì ˆì—¼)\nâ”‚\nâ”œâ”€â”€ Infectious (ê°ì—¼ì„±)\nâ”‚   â””â”€â”€ Septic Arthritis (íŒ¨í˜ˆì„± ê´€ì ˆì—¼) â˜… [EMERGENCY!]\nâ”‚       â””â”€ High WBC (>50k), >90% PMN\nâ”‚\nâ”œâ”€â”€ Crystalline (ê²°ì •ì„±)\nâ”‚   â”œâ”€â”€ Gout (í†µí’)\nâ”‚   â”‚   â””â”€ MSU Crystals (Needle, Neg-Birefringent), Podagra\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Pseudogout (ê°€ì„±í†µí’)\nâ”‚       â””â”€ CPPD Crystals (Rhomboid, Pos-Birefringent)\nâ”‚\nâ””â”€â”€ Trauma / Hemarthrosis (ì™¸ìƒ/í˜ˆê´€ì ˆì¦)`\n**ğŸ§  Big Picture & Mental Model:**\n- **The Explosion vs. The Smolder:** GoutëŠ” **í­íƒ„**ì…ë‹ˆë‹¤. ğŸ’£ 24ì‹œê°„ ì•ˆì— í†µì¦ì´ 0ì—ì„œ 100ê¹Œì§€ ì¹˜ì†ŸìŠµë‹ˆë‹¤. ë°˜ë©´ Septic ArthritisëŠ” ë°•í…Œë¦¬ì•„ê°€ ì¦ì‹í•˜ë©´ì„œ ì„œì„œíˆ(ë©°ì¹ ì— ê±¸ì³) ì•…í™”ë˜ëŠ” **í™”ì¬** ğŸ”¥ì™€ ê°™ìŠµë‹ˆë‹¤.\n- **The Trap:** Septic Arthritisì™€ GoutëŠ” ê²‰ë³´ê¸°ì— ë˜‘ê°™ìŠµë‹ˆë‹¤(Red, Hot, Swollen). ëˆˆìœ¼ë¡œ êµ¬ë¶„ ë¶ˆê°€ëŠ¥í•©ë‹ˆë‹¤. ë¬´ì¡°ê±´ **ë°”ëŠ˜(Needle)**ì„ ì°”ëŸ¬ì„œ í™•ì¸í•´ì•¼ í•©ë‹ˆë‹¤.","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-338","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","diagnosis","treatment","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"# ğŸ¦¶ Lecture Notes: Gout Pharmacology and the Septic Arthritis Trap\n## 1. The Presentation: \"The Bed Sheet Sign\" ğŸ›Œ\n- **Scenario:** ì¤‘ë…„ ë‚¨ì„±, ìƒˆë²½ 3ì‹œ, ì‘ê¸‰ì‹¤.\n- **Chief Complaint:** \"ë°œê°€ë½ì´ ì˜ë ¤ë‚˜ê°€ëŠ” ê²ƒ ê°™ì•„ìš”!\" (10/10 Agony).\n- **Podagra:** ì—„ì§€ë°œê°€ë½(First Metatarsophalangeal joint)ì˜ ê¸‰ì„± ì—¼ì¦. í‰í‰ ë¶“ê³  ë¹¨ê°›ê²Œ ë³€í•¨. ğŸ…\n- **The Bed Sheet Sign (ì´ë¶ˆ ì§•í›„):** í™˜ìê°€ ì´ë¶ˆì˜ ë¬´ê²Œì¡°ì°¨ ê²¬ë””ì§€ ëª»í•¨. ìŠ¤ì¹˜ê¸°ë§Œ í•´ë„ ìì§€ëŸ¬ì§. ì´ê²ƒì´ **Acute Gout**ì˜ Hallmak presentation.\n## 2. Diagnosis: The Absolute Gold Standard ğŸ’‰\n**Clinical thinking(ì„ìƒì  ì¶”ë¡ )ë§Œìœ¼ë¡œëŠ” ë¶€ì¡±í•©ë‹ˆë‹¤. ì¦ê±°ê°€ í•„ìš”í•©ë‹ˆë‹¤!**\n### â˜… Next Best Step & Gold Standard: Synovial Fluid Analysis (Arthrocentesis)\nê´€ì ˆ ì²œì(Joint Tap)ë¥¼ í†µí•´ ê´€ì ˆì•¡ì„ ë½‘ì•„ì„œ í˜„ë¯¸ê²½ìœ¼ë¡œ ë´ì•¼ í•©ë‹ˆë‹¤.\n| **Feature** | **Gout (í†µí’) ğŸ’** | **Septic Arthritis (íŒ¨í˜ˆì„± ê´€ì ˆì—¼) ğŸ¦ ** |\n| --- | --- | --- |\n| **WBC Count** | 2,000 ~ 100,000 (Inflammatory) | **> 50,000** (ì£¼ë¡œ >90,000 ê¹Œì§€ ê°) |\n| **Neutrophils (PMN)** | > 50% | **> 90%** (Aggressive bacterial response) |\n| **Microscopy** | Needle-shaped, **Negatively Birefringent** Crystals | Bacteria (Gram stain), Purulent (Pus-like) |\n| **Context** | \"Explosion\" onset | \"Progressive\" worsening, Fever/Chills |\n| **Time Course â˜… â˜…**  | Explosive onset. ğŸ’¥ í†µì¦ì´ 0ì—ì„œ Max(10)ê¹Œì§€ ê°€ëŠ”ë° **24ì‹œê°„ ë¯¸ë§Œ**. | Progressive burn. ë©°ì¹ ì— ê±¸ì³ ì ì  ì‹¬í•´ì§. |\n### âš ï¸ The Double Trouble Trap (USMLE Killer Concept)\n- **í•¨ì •:** í™˜ìì˜ ê´€ì ˆì•¡ì—ì„œ Crystal(ê²°ì •)ì´ ë°œê²¬ë˜ì—ˆë‹¤ê³  í•´ì„œ Septic Arthritisê°€ ì•„ë‹ˆë¼ëŠ” ë³´ì¥ì€ ì—†ìŠµë‹ˆë‹¤!\n- **ì‹œë‚˜ë¦¬ì˜¤:** Goutê°€ ìˆëŠ” í™˜ì(ê´€ì ˆì— ì´ë¯¸ ê²°ì •ì´ ìŒ“ì—¬ìˆìŒ)ê°€ ë°•í…Œë¦¬ì•„ ê°ì—¼(Sepsis)ì´ ë  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- Gout is background noise!\n- **Rule:** ë§Œì•½ WBCê°€ 80,000ì´ê³  Neutrophilsê°€ 95%ì¸ë° Crystalì´ ë³´ì¸ë‹¤? **Septic Arthritisë¡œ ê°„ì£¼í•˜ê³  ì¹˜ë£Œí•´ì•¼ í•©ë‹ˆë‹¤!** ğŸš¨\n    - Crystalì€ ê·¸ëƒ¥ \"Background noise\"(ì›ë˜ ìˆë˜ ê²ƒ)ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤. Sepsisë¥¼ ë†“ì¹˜ë©´ í™˜ìì˜ ê´€ì ˆ(í˜¹ì€ ìƒëª…)ì´ ìœ„í—˜í•©ë‹ˆë‹¤.\n    - **Don't treat the slide, treat the patient!**\n## 3. Pathophysiology & Risk Factors: Rich Man's Disease? ğŸ‘‘\nìš”ì‚°(Uric Acid)ì˜ ê³µê¸‰ ê³¼ì‰(Overproduction) í˜¹ì€ ë°°ì¶œ ì €í•˜(Underexcretion)ì˜ ë¬¸ì œì…ë‹ˆë‹¤.\n### ğŸ¥© Dietary Triggers (The Usual Suspects)\n- **High Purine Foods:** ê³ ê¸°(Red meat), í•´ì‚°ë¬¼(Seafood). ğŸ¦ğŸ¥©\n- **Alcohol (Double Whammy):** ğŸº\n    - íŠ¹íˆ **ë§¥ì£¼(Beer)**ê°€ ìµœì•….\n    - ì´ìœ  1: Purine(Guanosine)ì´ ë§ì•„ Uric acidë¡œ ë¶„í•´ë¨.\n    - ì´ìœ  2: ì•Œì½”ì˜¬ ìì²´ê°€ ì‹ ì¥ì—ì„œ Uric acid ë°°ì¶œì„ ë°©í•´í•¨ (Dehydration & Lactate competition).\n    - *ì°¸ê³ :* ì™€ì¸ì€ ìƒëŒ€ì ìœ¼ë¡œ ì¤‘ë¦½ì (Neutral).\n- **Fructose (High Fructose Corn Syrup):** íƒ„ì‚°ìŒë£Œ ë“±. ATPë¥¼ ê³ ê°ˆì‹œì¼œ Adenosine ë¶„í•´ë¥¼ ê°€ì†í™” â†’ Uric acid ì¦ê°€. ğŸ¥¤\n### ğŸ›¡ï¸ Protective Factors (ì˜ì™¸ì˜ êµ¬ì›íˆ¬ìˆ˜ë“¤)\n- **Dairy Products:** ìš°ìœ , ì¹˜ì¦ˆ (ë‹¨ë°±ì§ˆ Casein/Lactalbuminì´ ìš”ì‚° ë°°ì¶œ ë„ì›€). ğŸ¥›ğŸ§€\n- **Coffee:** ì¹´í˜ì¸ ë§ê³  ì»¤í”¼ ìì²´ì˜ ì„±ë¶„ì´ ë„ì›€ë¨. â˜•\n- **Vitamin C:** í•˜ë£¨ 1,500mg ì •ë„ ê³ ìš©ëŸ‰ ì„­ì·¨ ì‹œ ì‹ ì¥ ë°°ì¶œ ë„ì›€. ğŸ‹\n### ğŸ’Š Medication Triggers (Drugs that cause Gout)\n\"ì´ ì•½ë“¤ì„ ì£¼ì˜í•˜ì„¸ìš”!\" (Secondary Goutì˜ ì›ì¸)\n1. **Diuretics (ì´ë‡¨ì œ):** Thiazides & Loop Diuretics (Furosemide).\n    - Volume depletion â†’ ì‹ ì¥ì´ ë¬¼ê³¼ ë‚˜íŠ¸ë¥¨ì„ ì¬í¡ìˆ˜í•˜ë ¤ê³  í•  ë•Œ, Uric acidë„ ê°™ì´ ëŒê³  ë“¤ì–´ì˜´ (Molecular mimicry).\n2. **Aspirin (Low dose):** ì €ìš©ëŸ‰ ì•„ìŠ¤í”¼ë¦°ì€ ìš”ì‚° ë°°ì¶œì„ ë°©í•´í•¨. (High doseëŠ” ì˜¤íˆë ¤ ë°°ì¶œì‹œí‚¤ì§€ë§Œ, í†µí’ ì¹˜ë£Œìš©ìœ¼ë¡œ ì•ˆ ì”€). ğŸ’Š\n3. **Cyclosporine:** ì¥ê¸° ì´ì‹ í™˜ìì—ì„œ í†µí’ ìœ ë°œ (Transplant Trap).\n4. **Chemotherapy:** Tumor Lysis Syndrome â†’ ì„¸í¬ ë‚´ DNA(Purine)ê°€ ìŸì•„ì ¸ ë‚˜ì™€ Uric acid í­ë“±. â˜¢ï¸","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-358","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"## 4. Imaging: X-Ray Findings ğŸ’€\n- **Acute Phase:** **Normal.** ì•„ë¬´ê²ƒë„ ì•ˆ ë³´ì„. (í˜¹ì€ ì—°ì¡°ì§ ë¶€ì¢… ì •ë„).\n- **Chronic Gout:** **\"Rat Bite Erosions\"** (ì¥ê°€ íŒŒë¨¹ì€ ë“¯í•œ ëª¨ì–‘) ğŸ€Â PAINLESS â˜… â˜…\n    - Punched out lesions.\n    - Overhanging edges (íˆ­ íŠ€ì–´ë‚˜ì˜¨ ë¼ˆ).\n    - Sclerotic rim (ë‹¨ë‹¨í•œ í…Œë‘ë¦¬).\n    - ì´ê±´ ë³‘ì´ ì˜¤ë˜ ì§„í–‰ë˜ì—ˆë‹¤ëŠ” ì¦ê±°ì…ë‹ˆë‹¤. RA(ë¥˜ë§ˆí‹°ìŠ¤)ì™€ ë‹¬ë¦¬ ë¼ˆê°€ ì¹˜ìœ ë˜ë ¤ê³  ì‹œë„í•œ í”ì ë“¤ì´ ë³´ì„.\n## 5. Olecranon Bursitis vs Chronic Bursa Tophus\n- Chronic Tophaceous gout: Painless Hard Nodular Mass â˜… 6\n- ê´€ì ˆë¿ë§Œ ì•„ë‹ˆë¼ ë§Œì„± í†µí’ì´ bursaë„ ì¹¨ë²”ì´ ê°€ëŠ¥í•˜ë‹¤.\n- ë‘˜ë‹¤ íŒ”ê¿ˆì¹˜ ë’¤ì— ëœë  íŠ€ì–´ë‚˜ì™€ìˆìŒ.\n- Differential\n    - BursitisëŠ” ê¸‰ì„± ì—¼ì¦ì†Œê²¬ (warm, red, PAINFUL) ì†Œê²¬\n    - Chronic Bursa TophusëŠ” ì—‘ìŠ¤ë ˆì´ìƒ ë¼ˆ ë¯¸ë€ ì†Œê²¬ì´ ë³´ì¼ ìˆ˜ ìˆê³  ë”±ë”±í•˜ê³  non tender. Painless Hard nodular mass!\n## 6. Treatment Protocol (Step-by-Step) ğŸ› ï¸\nì¹˜ë£ŒëŠ” í¬ê²Œ ë‘ ê°€ì§€ ë°”êµ¬ë‹ˆ(Bucket)ë¡œ ë‚˜ë‰©ë‹ˆë‹¤: **ë¶ˆ ë„ê¸°(Acute)** vs **ì˜ˆë°©í•˜ê¸°(Chronic)**. ì ˆëŒ€ ì„ìœ¼ë©´ ì•ˆ ë©ë‹ˆë‹¤!\n### ğŸ”¥ Bucket 1: Putting out the Fire (Acute Attack)\nëª©í‘œ: í†µì¦ ì¡°ì ˆ ë° ì—¼ì¦ ì™„í™”.\n1. **First Line:** **NSAIDs** (Indomethacin, Naproxen) or **Colchicine**.\n2. **The Contraindication Trap (ì½©íŒ¥ì„ ì¡°ì‹¬í•´!):** ğŸš¨\n    - í™˜ìê°€ **ì‹ ë¶€ì „(Renal Failure, CKD)**ì´ ìˆê±°ë‚˜ í¬ë ˆì•„í‹°ë‹Œ(Creatinine) ìˆ˜ì¹˜ê°€ ë†’ë‹¤? (ì˜ˆ: Cr 3.0)\n    - â›” **NSAIDs ê¸ˆì§€** (Prostaglandin ì–µì œ â†’ ì‹ í˜ˆë¥˜ ê°ì†Œ â†’ ì‹ ë¶€ì „ ì•…í™”).\n    - â›” **Colchicine ì£¼ì˜/ê¸ˆì§€** (ì‹ ì¥ìœ¼ë¡œ ë°°ì„¤ë¨ â†’ ë…ì„± ìœ„í—˜).\n    - âœ… **â˜… Next Best Step:** **Corticosteroids (ìŠ¤í…Œë¡œì´ë“œ)!**\n        - ë‹¨ê´€ì ˆ(One joint): **Intra-articular injection** (ê´€ì ˆ ê°•ë‚´ ì£¼ì‚¬). ğŸ’‰\n        - ë‹¤ë°œì„±(Multiple joints): **Oral Prednisone**.\n### ğŸ›¡ï¸ Bucket 2: Prevention (Chronic Management)\nëª©í‘œ: ìš”ì‚° ìˆ˜ì¹˜ ë‚®ì¶”ê¸° (Urate Lowering Therapy).\n1. **Gold Standard Drug:** **Allopurinol** (Xanthine Oxidase Inhibitor).\n2. **Alternative:** Febuxostat (Allopurinol ë¶€ì‘ìš© ì‹œ).\n3. **Timing Rule (ë§¤ìš° ì¤‘ìš”):**\n    - ê¸‰ì„± ë°œì‘(Acute flare) ì¤‘ì—ëŠ” Allopurinolì„ **ìƒˆë¡œ ì‹œì‘í•˜ì§€ ë§ˆì„¸ìš”.** (ìš”ì‚° ë†ë„ê°€ ê¸‰ê²©íˆ ë³€í•˜ë©´ ê²°ì •ì´ í”ë“¤ë ¤ì„œ ì—¼ì¦ì´ ë” ì‹¬í•´ì§).\n    - **But,** ì´ë¯¸ Allopurinolì„ ë¨¹ê³  ìˆë˜ í™˜ìê°€ ë°œì‘ì´ ì˜¤ë©´? **ëŠì§€ ë§ê³  ê³„ì† ë“œì„¸ìš”.** (Maintenance therapy ìœ ì§€).\n### ğŸ’¡ Bonus: The \"Good Guy\" Drugs\nê³ í˜ˆì•• + í†µí’ì´ ê°™ì´ ìˆëŠ” í™˜ìì—ê²Œ ì“°ë©´ ì¢‹ì€ ì•½:\n- **Losartan (ARB):** ìœ ì¼í•˜ê²Œ Uric acid ë°°ì¶œì„ ë•ëŠ” ARB. ğŸ†\n- **Calcium Channel Blockers (CCB):** ì•½ê°„ì˜ Uric acid ë°°ì¶œ íš¨ê³¼ ìˆìŒ.\n- *í”¼í•´ì•¼ í•  ì•½:* Thiazide (HCTZ), Beta-blockers (ì¼ë¶€).","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-378","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","treatment"]}
{"chunk_type":"recap_summary","text":"## âš¡ Rapid Fire Recap (ì‹œí—˜ ì§ì „ í™•ì¸!)\n| **Situation** | **Action / Fact** |\n| --- | --- |\n| **Big Toe Pain (Podagra)** | Gout ì˜ì‹¬ 1ìˆœìœ„ |\n| **Diagnostic Test** | **Arthrocentesis (Joint Tap)** ë¬´ì¡°ê±´! |\n| **Gout Synovial Fluid** | Negatively Birefringent Needle Crystals â–ğŸ’‰ |\n| **Septic Arthritis Fluid** | WBC > 50k, >90% Neutrophils |\n| **Gout + Fever + High WBC?** | **Treat as Septic Arthritis first!** ğŸš¨ |\n| **Acute Tx (Normal Kidney)** | NSAIDs (Indomethacin) + Colchicine |\n| **Acute Tx (Renal Failure)** | **Steroids** (Injection or Oral) â˜… |\n| **Chronic Tx** | Allopurinol (Start *after* flare resolves) |\n| **Best HTN Med for Gout** | **Losartan (or CCB)** |\n**One Last Thought:**\n\"Treat the Patient, not the Slide.\" í¬ë¦¬ìŠ¤íƒˆì´ ë³´ì¸ë‹¤ê³  í•´ì„œ Septic Arthritisì˜ ê°€ëŠ¥ì„±ì„ ë°°ì œí•˜ì§€ ë§ˆì‹­ì‹œì˜¤. í™˜ìì˜ ì‹ ì¥ ê¸°ëŠ¥(Renal function)ì„ í™•ì¸í•˜ê³  ì•½ì„ ì²˜ë°©í•˜ì‹­ì‹œì˜¤. ì´ê²ƒì´ ì¸í„´ê³¼ í•™ìƒì˜ ì°¨ì´ì…ë‹ˆë‹¤! ğŸ˜‰ğŸ‘‹\n### Overview: Neonatal Brachial Plexus Palsy (USMLE Step 2 CK)\n- **Topic:** Erb-Duchenne vs. Klumpke Palsy (Anatomy, Presentation, Management)\n- **Key Concept:** Distinguishing based on Forearm Rotation (Pronation vs. Supination) & Nerve Roots.\n- **Management:** Conservative (Obs + PT) is King ğŸ‘‘ unless chronic.\n\"Okay, let's jump in. We are on a very specific mission for this deep dive. We're locking in the absolute high yield points for neonatal brachial plexus palsies for Step 2. Exactly. This is a topic where the details really matter and it's so easy to mix them up under pressure. We're gonna decode the anatomy for Erb-Duchenne versus Klumpke so you don't get tripped up.\"","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-394","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","recap","treatment"]}
{"chunk_type":"transcript_chunk","text":"### ğŸŒ³ Top-Down Classification & Mental Model\nì´ ì£¼ì œëŠ” **Peripheral Nervous System (PNS) Pathology** ì¤‘ **Brachial Plexus Injury**ì— ì†í•©ë‹ˆë‹¤. ì‹ ìƒì•„(Neonate)ì™€ ë¶„ë§Œ ê³¼ì •(Delivery)ì˜ ë§¥ë½ì—ì„œ ì´í•´í•´ì•¼ í•©ë‹ˆë‹¤.\nPlaintext\n`Pathology\nâ””â”€â”€ Peripheral Nervous System\n    â””â”€â”€ Brachial Plexus Injury (Neonatal)\n        â”œâ”€â”€ Risk Factors: Macrosomia, Shoulder Dystocia, Instrumental Delivery\n        â”œâ”€â”€ Types\n        â”‚   â”œâ”€â”€ Erb-Duchenne Palsy (Upper Trunk: C5-C6) -> \"Waiter's Tip\"\n        â”‚   â””â”€â”€ Klumpke Palsy (Lower Trunk: C8-T1) -> \"Claw Hand\"\n        â””â”€â”€ Management\n            â”œâ”€â”€ First Line: Observation & Physical Therapy (80% Spontaneous Resolution)\n            â””â”€â”€ Second Line: Surgery (If no improvement by 3-6 months)`\n# H1: Erb-Duchenne vs. Klumpke: Anatomy & Clinical Presentation ğŸ§ \nUSMLE Step 2ì—ì„œ ì´ ë‘ ê°€ì§€ë¥¼ êµ¬ë¶„í•˜ëŠ” ê²ƒì€ **Anatomy**ì™€ **Forearm Position**ì— ë‹¬ë ¤ìˆìŠµë‹ˆë‹¤. í—·ê°ˆë¦¬ê¸° ì‰¬ìš°ë‹ˆ ì§‘ì¤‘í•˜ì„¸ìš”! ğŸ”¥\n## 1. Erb-Duchenne Palsy (\"Waiter's Tip\") ğŸ’â€â™‚ï¸\nê°€ì¥ í”í•œ í˜•íƒœì…ë‹ˆë‹¤. ìƒë¶€ ì‹ ê²½ ì†ìƒì…ë‹ˆë‹¤.\n- **Affected Roots:** **C5 & C6** (Upper Trunk)\n- **Mechanism:** Lateral traction on the neck during delivery (ëª©ì´ ì˜†ìœ¼ë¡œ ë‹¹ê²¨ì§ˆ ë•Œ).\n- **Muscles Lost:**\n    - Deltoid, Supraspinatus (Shoulder Abductors) â¡ï¸ **Adducted arm**\n    - Infraspinatus (External Rotators) â¡ï¸ **Internally Rotated**\n    - Biceps (Flexor) â¡ï¸ **Elbow Extended**\n- **The \"Clincher\" Detail (â˜…High Yield):**\n    - BicepsëŠ” Forearm Supinator ì—­í• ë„ í•©ë‹ˆë‹¤.\n    - Bicepsê°€ ë§ˆë¹„ë˜ì—ˆìœ¼ë¯€ë¡œ, Supinationì´ ë¶ˆê°€ëŠ¥í•©ë‹ˆë‹¤.\n    - ë”°ë¼ì„œ Forearmì€ **PRONATED** (ì—ì¹¨) ìƒíƒœë¡œ ê³ ì •ë©ë‹ˆë‹¤.\n- **Classic Posture:**\n    - Arm Adducted + Internally Rotated + Elbow Extended + Wrist Flexed + **Forearm Pronated**.\n    - ë§ˆì¹˜ ì›¨ì´í„°ê°€ íŒì„ ëª°ë˜ ë°›ëŠ” ìì„¸ì™€ ê°™ìŒ (\"Waiter's Tip\").\n## 2. Klumpke Palsy (\"Claw Hand\") ğŸ¦…\në“œë¬¼ì§€ë§Œ ê°•ë ¥í•œ íŠ¹ì§•ì´ ìˆìŠµë‹ˆë‹¤. í•˜ë¶€ ì‹ ê²½ ì†ìƒì…ë‹ˆë‹¤.\n- **Affected Roots:** **C8 & T1** (Lower Trunk)\n- **Mechanism:** Upward force on arm during delivery (íŒ”ì´ ìœ„ë¡œ ë‹¹ê²¨ì§ˆ ë•Œ).\n- **Muscles Lost:**\n    - Intrinsic muscles of the hand (Lumbricals, Interossei).\n- **The \"Clincher\" Detail (â˜…High Yield):**\n    - Erbì™€ ë°˜ëŒ€ ê°œë…ìœ¼ë¡œ ìƒê°í•˜ë©´ ì‰½ìŠµë‹ˆë‹¤.\n    - Forearmì€ **SUPINATED** (ë’¤ì¹¨) ìƒíƒœì…ë‹ˆë‹¤. (Anchor Point!) âš“\n- **Classic Posture:**\n    - Wrist Extended + **Forearm Supinated** + MCP Hyper-extended + IP Flexed.\n    - ì „í˜•ì ì¸ **Claw Hand** ëª¨ì–‘.\n# H2: High-Yield Comparison Table (Erb vs. Klumpke) ğŸ“Š\nì‹œí—˜ ë¬¸ì œì—ì„œ í—·ê°ˆë¦´ ë•Œ ì´ í‘œë¥¼ ë– ì˜¬ë¦¬ì„¸ìš”! íŠ¹íˆ **Forearm Rotation**ì´ ê²°ì •ì ì…ë‹ˆë‹¤.\n| **Feature** | **Erb-Duchenne Palsy ğŸ’â€â™‚ï¸** | **Klumpke Palsy ğŸ¦…** |\n| --- | --- | --- |\n| **Nerve Roots** | **C5 - C6** (Upper Trunk) | **C8 - T1** (Lower Trunk) |\n| **Key Analogy** | **Waiter's Tip** | **Claw Hand** |\n| **Forearm Position** | **PRONATED** (â˜…Key!) | **SUPINATED** (â˜…Key!) |\n| **Wrist Position** | Flexed | Extended |\n| **Muscle Deficit** | Shoulder Abductors, Ext. Rotators, Biceps | Intrinsic Hand Muscles (Lumbricals) |\n# H3: Mechanism & Management ğŸ¥\n## 1. Cause & Associations âš ï¸","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-404","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"- **Primary Cause:** **Shoulder Dystocia** (ë‚œì‚°).\n    - Risk Factors: **Fetal Macrosomia** (ê±°ëŒ€ì•„), Instrumental deliveries (Vacuum, Forceps).\n- **Associated Injury:** **Clavicle Fracture** (ì‡„ê³¨ ê³¨ì ˆ)ê°€ ë™ë°˜ë  ìˆ˜ ìˆìŠµë‹ˆë‹¤. (Palpation ì‹œ Crepitus í™•ì¸ í•„ìš”).\n- **Parental Anxiety:** ë¶€ëª¨ë‹˜ë“¤ì€ ì‹ ìƒì•„ê°€ íŒ”ì„ ì›€ì§ì´ì§€ ëª»í•˜ëŠ” ê²ƒì„ ë³´ê³  ë§¤ìš° ë†€ëë‹ˆë‹¤(Terrified). ì•ˆì‹¬ì‹œí‚¤ëŠ” ê²ƒì´ ì¤‘ìš”í•©ë‹ˆë‹¤.\n## 2. Prognosis (ì˜ˆí›„) ğŸ“ˆ\n- *80%**ì˜ ì¼€ì´ìŠ¤ê°€ **3ê°œì›” ì´ë‚´(Within 3 months)**ì— **ìì—°ì ìœ¼ë¡œ íšŒë³µ(Spontaneously Resolve)**ë©ë‹ˆë‹¤. ğŸ€\n- ì¦‰, ì„œë‘˜ëŸ¬ì„œ ìˆ˜ìˆ í•  í•„ìš”ê°€ ì—†ìŠµë‹ˆë‹¤.\n## 3. Management Strategy (Step-by-Step) ğŸ› ï¸\nUSMLE ë¬¸ì œì—ì„œ \"Next Best Step\"ì„ ë¬¼ì–´ë³¼ ë•Œ ê°€ì¥ ì¤‘ìš”í•œ ë¶€ë¶„ì…ë‹ˆë‹¤.\n- **Step 1 (First Line / Best Initial Step): Observation & Physical Therapy** â˜…\n    - ì¦‰ê°ì ì¸ ìˆ˜ìˆ ì€ ë‹µì´ ì•„ë‹™ë‹ˆë‹¤.\n    - **Physical Therapy**ì˜ ëª©í‘œ: ê´€ì ˆì´ êµ³ì§€ ì•Šë„ë¡ **Range of Motion (ROM)**ì„ ìœ ì§€í•˜ëŠ” ê²ƒ.\n- **Step 2 (Surgical Intervention):**\n    - **Indications:** ìƒí›„ **3~6ê°œì›”**ì´ ì§€ë‚¬ëŠ”ë°ë„ í˜¸ì „ì´ ì—†ì„ ë•Œ (\"No improvement by age 3-6 months\").\n    - ì´ ì‹œê¸°ê°€ ì§€ë‚˜ë©´ ìˆ˜ìˆ ì  ì¹˜ë£Œ(Nerve graft ë“±)ë¥¼ ê³ ë ¤í•©ë‹ˆë‹¤.\n# ğŸ”¥ RAPID FIRE RECAP: \"Don't Miss\" Points\n1. **Forearm Pronated?** ğŸ‘‰ **Erb-Duchenne (C5-C6)**. (Biceps lost).\n2. **Forearm Supinated?** ğŸ‘‰ **Klumpke (C8-T1)**.\n3. **Delivery History?** ğŸ‘‰ Shoulder Dystocia, Macrosomia.\n4. **Best Initial Step?** ğŸ‘‰ **Observation & PT**. (Don't order surgery immediately!).\n5. **When to call Surgeon?** ğŸ‘‰ If **NO improvement** by **3-6 months**.\n### ğŸ§  Meta-Cognitive Analysis & Confidence\n1. **DECOMPOSE:**\n    - Analyzed audio for distinct pathologies (Erb vs. Klumpke).\n    - Isolated anatomical markers (Nerve roots, muscle groups).\n    - extracted distinct physical exam findings (Pronation vs. Supination).\n    - extracted management guidelines (Timeline for surgery vs. conservative).\n2. **SOLVE:**\n    - Mapped C5-C6 to Erb (Waiter's tip, Pronated).\n    - Mapped C8-T1 to Klumpke (Claw, Supinated).\n    - Defined Management: Obs -> Surgery only if refractory >3mo.\n3. **VERIFY:**\n    - *Check:* Did I mention the supinator function of biceps? Yes.\n    - *Check:* Is the timeline (3-6 months) correct per audio? Yes.\n    - *Check:* Is the specific wording \"Pronated = Erb\" and \"Supinated = Klumpke\" highlighted? Yes, this was the \"No detail left behind\" rule from the audio.\n4. **SYNTHESIZE:**\n    - Combined into a structured lecture note with ASCII tree and Table.\n5. **REFLECT:**\n**Next Step:** Would you like me to generate a USMLE-style vignette question based on these notes to test your understanding of the \"Supination vs Pronation\" rule? ğŸ“","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-424","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","diagnosis","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"# LM_OSRHM RFR\n### **1. [Ep 01] Joint Pain Deep Dive âš¡ï¸**\n**RAPID FIRE RECAP (Summary Table)**\n| **Condition** | **Key Vignette / Symptom** | **Synovial Fluid WBC** | **Gold Standard / Next Step** | **Treatment Highlights** |\n| --- | --- | --- | --- | --- |\n| **Septic Arthritis** | Red, Hot, Single Joint, Refusal to move | > 50,000 (>90% PMN) | Arthrocentesis (Tap it!) | IV Abx + Washout (Drainage) |\n| **Gout** | Podagra (Big toe), sudden onset | 2,000 - 50,000 (Crystals) | Polarized Microscopy (Needle shape, Neg birefringent) | NSAIDs, Colchicine, Steroids (Acute) |\n| **OA** | Older, Worse with use, DIP/PIP involved | < 2,000 (Non-inflam) | X-ray (Joint space narrowing, Osteophytes) | Weight Loss, Exercise, NSAIDs |\n| **Fight Bite** | Cut on knuckle (MCP), punched mouth | N/A | History taking (Look for lie) | Augmentin, NEVER SUTURED |\n| **DGI** | Sexually active, Triad (Tenosynovitis, Rash, Polyarthralgia) | Often Negative culture | NAAT (Urethra, Rectum, Throat) | Ceftriaxone + Azithro/Doxy |\n| **Ankylosing Spondylitis** | Young male, Back pain better w/ exercise | N/A | X-ray (Sacroiliitis), HLA-B27 | NSAIDs â†’ TNF Inhibitors |\n| **HSP (IgA)** | Kid, Palpable purpura on butt, Abd pain | N/A | Clinical Dx, Urinalysis (Hematuria) | Supportive (Hydration, NSAIDs) |\n### **2. [Ep 02] Systemic Autoimmune Disorders I ğŸ”¥**\n**Rapid Fire Recap: Treatments & Side Effects**\n- **RA (Methotrexate):** Liver tox, Pulmonary fibrosis, Marrow suppression. **Give Folate!** â˜…\n- **SLE (General - Hydroxychloroquine):** Retinopathy (Eye toxicity). **Annual Eye Exam í•„ìˆ˜!** â˜…\n- **SLE (Nephritis - Cyclophosphamide):** Hemorrhagic cystitis (ë°©ê´‘ì—¼), Infertility.\n- **Drug-Induced Lupus (Stop Drug):** Anti-Histone Ab Positive.\n- **APS (Pregnant):** LMWH + Aspirin. **Warfarin is contraindicated.**\n- **RA Flare:** Prednisone. Osteoporosis, Hyperglycemia, Cataracts.\n**[Ep 02 Supplemental Q&A]**\n- ê³ í˜ˆì•• ì•½ ë¨¹ë˜ í™˜ìê°€ ê´€ì ˆì´ ì•„íŒŒìš” anti-histone ab? **DILI. stop the drugs. Hydralazine**\n- ì†ê°€ë½ë¶€ì—ˆê³  Raynaudë„ ìˆê³  malar rashë„ ìˆê³  ê´€ì ˆí†µë„ ìˆê³ ? ì• ë§¤í•œ ì„ ë¬¼ì„¸íŠ¸ **anti U1 RNPê²€ì‚¬! MCTD**\n- ì„ì‹ ì—¬ì„± ê³ í˜ˆì••, ë‹¨ë°±ë‡¨, ë³´ì²´ decreased **Lupus flare**\n- RAì˜¤ë˜ ì•“ì•˜ë˜ í™˜ìì—ì„œ ê°€ìš´ë° ì†ê°€ë½ ì†í†± ë”¸ê¹í–ˆë”ë‹ˆ ì—„ì§€ì™€ ê²€ì§€ê°€ ì›€ì°” **Hoffman sign â†’ UMN lesion, cervical myelopathy**\n- RAì˜¤ë˜ ì•“ì•˜ë˜ í™˜ìì—ì„œ ê³„ì† ê°ì—¼ì´ ìƒê¸°ê³  ì™¼ìª½ë°°ê°€ ë¶ˆëŸ¬ì˜¤ë¦„(splenomegaly). í”¼ê²€ì‚¬ì—ì„œ í™•ì¸í•´ì•¼í•  ìˆ«ì **ANC<2000**\n- ì–´ë–¤ ë¥˜ë§ˆ ì•½ì´ ë¨¹ì€ì§€ 5ë…„í›„ë¶€í„° ì•ˆê³¼ê²€ì§„ ë§¤ë…„í•´ì•¼í•˜ëŠ”ì§€? **Hydroxychloroquine**\n- Lupusí™˜ìì—ì„œ ë‹¨ë°±ë‡¨ Next Step? **Renal biopsy**\n### **3. [Ep 03] Systemic Autoimmune Disorders II ğŸ”¥**","subject":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","page_title":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","episode":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","section_path":["LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76"],"source_doc_id":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","source_page":null,"source_anchor":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76-1","focus_area":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"recap_summary","text":"**Rapid Fire Recap (High-Yield Summary)**\n| **Disease** | **Key Antibodies / Markers** | **Vignette Clue** | **Best Initial / Specific Rx** |\n| --- | --- | --- | --- |\n| **Ankylosing Spondylitis** | HLA-B27, RF(-) | ì Šì€ ë‚¨ì„±, ë°¤ì— ë” ì•„í”ˆ ìš”í†µ, ìš´ë™í•˜ë©´ í˜¸ì „ | NSAIDs (1st), TNF inhibitors |\n| **Reactive Arthritis** | HLA-B27 | Can't see/pee/climb, GI or Chlamydia infection | NSAIDs, Treat infection |\n| **Psoriatic Arthritis** | HLA-B27 | Psoriasis, Sausage digits, Nail pitting | NSAIDs, Methotrexate |\n| **Sjogren's Syndrome** | Anti-Ro (SSA), Anti-La (SSB) | Dry eyes/mouth, Lymphoma risk | Artificial tears, Pilocarpine |\n| **Limited Scleroderma** | Anti-Centromere | CREST syndrome, PAH | Symptomatic (PPI for GERD) |\n| **Diffuse Scleroderma** | Anti-Scl-70 (Topoisomerase I) | Trunk skin, ILD, Renal Crisis | ACE Inhibitors (Renal Crisis) |\n| **Raynaud's** | Clinical dx | White-Blue-Red color change | CCB (Nifedipine) |\n### **4. [Ep 04] Shoulder & Elbow ğŸ”¥**\n**Rapid Fire Recap (High-Yield Summary)**\n| **Pathology** | **Key Feature (Buzzword)** | **Diagnosis / Test** | **Treatment (1st Line)** |\n| --- | --- | --- | --- |\n| **Frozen Shoulder** | Active & Passive ROM â†“ | Clinical (History) | ROM Exercise (Keep moving!) ë‹¹ë‡¨, ê°‘ìƒì„  ì €í•˜ì¦ |\n| **Rotator Cuff Tear** | Weakness + Drop Arm (+) | MRI (Gold Standard) | Surgery (if functional loss) |\n| **Ant. Dislocation** | Abducted/Ext. Rotated | X-ray (Check Axillary n.) | Reduction |\n| **Post. Dislocation** | Seizure, Lightbulb Sign | X-ray (Axillary/Scapular Y) | Reduction |\n| **Tennis Elbow** | Pain on Wrist Extension | Clinical | Counterforce Brace (Strap) |\n| **Septic Bursitis** | Red, Hot, Fever, Trauma | â˜… Aspiration (Culture) | Antibiotics + Drainage |\n### **5. [Ep 05] Hand & Wrist âš¡**\n**4. Rapid Fire Recap (High Yield Q&A)**\n- **Q1. De Quervain's Tenosynovitisì˜ 2ê°€ì§€ Target Tendonì€?**\n    â†’ Abductor Pollicis Longus (APL), Extensor Pollicis Brevis (EPB)\n- **Q2. íˆ¬ì„ í™˜ì CTSì˜ ì›ì¸ ì¤‘, ì‹ ê²½ì´ í—ˆí˜ˆ(Ischemia)ì— ë¹ ì§€ëŠ” ê¸°ì „ì€?**\n    â†’ Vascular Steal Syndrome (AV fistulaê°€ í˜ˆë¥˜ë¥¼ ëºì–´ê°)\n- **Q3. De Quervain'sì˜ ì¹˜ë£Œë¥¼ ìœ„í•œ ë¶€ëª©(Splint)ì˜ ì´ë¦„ì€?**\n    â†’ Thumb Spica Splint\n- **Q4. ì†ëª© ê²°ì ˆì¢…(Ganglion Cyst) ì§„ë‹¨ì„ ìœ„í•œ ì‹ ì²´ ê²€ì§„ë²•ì€?**\n    â†’ Transillumination (ë¹› íˆ¬ê³¼ ê²€ì‚¬) - Positive\n- **Q5. Dupuytren's Contractureì—ì„œ ê°€ì¥ í”íˆ ì¹¨ë²”ë˜ëŠ” ì†ê°€ë½ì€?**\n    â†’ 4th (Ring) & 5th (Little) fingers\n- **Q6. ê°‘ìƒì„ ê¸°ëŠ¥ì €í•˜ì¦(Hypothyroid) í™˜ìì˜ CTS ì›ì¸ ë¬¼ì§ˆì€?**\n    â†’ Mucopolysaccharides (Glycosaminoglycans) / Myxedema\n- **Q7. ì¦ìƒì´ ì—†ëŠ” Ganglion Cystì˜ ì²˜ì¹˜ëŠ”?**\n    â†’ Observation (ê´€ì°°) (ê±´ë“œë¦¬ì§€ ë§ˆì„¸ìš”!)","subject":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","page_title":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","episode":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","section_path":["LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76"],"source_doc_id":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","source_page":null,"source_anchor":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76-14","focus_area":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","tags":["usmle-step2","core","recap","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### 6.\n| **ìƒí™© (Scenario)** | **ì§„ë‹¨ (Diagnosis)** | **í•µì‹¬ ë‹¨ì„œ (Key Clue)** |\n| --- | --- | --- |\n| ì†ì„ ë¨¸ë¦¬ ìœ„ì— ì˜¬ë¦¬ê³  ë“¤ì–´ì˜´ ğŸ™†â€â™‚ï¸ | **Cervical Radiculopathy** | Shoulder Abduction Relief Sign |\n| ë‹¨ì¶” ëª» ì±„ìš°ê³  ë¹„í‹€ê±°ë¦¼ ğŸ§µ | **Cervical Myelopathy** | UMN Signs (Babinski+), Hyperreflexia |\n| ì‡¼í•‘ì¹´íŠ¸ì— ê¸°ëŒ€ë©´ í¸í•¨ ğŸ›’ | **Lumbar Stenosis** | Extension ì‹œ í†µì¦ ì•…í™” (ì‡¼í•‘ì¹´íŠ¸ ì‚¬ì¸) |\n| ë°œëª©ì´ ì•ˆ ë“¤ë¦¼ (Foot Drop) ğŸ¦¶ | **L5 Radiculopathy** | Heel walking ë¶ˆê°€ëŠ¥ |\n| ê¹Œì¹˜ë°œì´ ì•ˆ ë¨ (Tip-toe X) ğŸ©° | **S1 Radiculopathy** | Achilles Reflex ì†Œì‹¤ |\n| íšŒìŒë¶€ ê°ê° ì—†ê³  ì†Œë³€ ì§€ë¦¼ ğŸš½ | **Cauda Equina Syndrome** | **Emergency MRI & Surgery** |\n| í—ˆë¦¬ ì‚ë—í•¨, Red Flag ì—†ìŒ ğŸ’Š | **Acute Lumbago** | **NSAIDs + Activity (No MRI!)** |\n| ì•„ì´ ì²™ì¶”ê°€ íŒ¬ì¼€ì´í¬ ë¨ ğŸ¥ | **Langerhans Cell Histiocytosis** | Vertebra Plana |\n### **1. [Ep 07] Hip & Knee ğŸ¦µ**\n**ğŸ”¥ Rapid Fire Recap: The \"Diff\" Table**\n| **Condition** | **Mechanism/History** | **Key Physical Exam/Sign** | **Swelling Timing** |\n| --- | --- | --- | --- |\n| **ACL Tear** | Pivot + \"POP\" ê°‘ìê¸° ë©ˆì¶¤. | Lachman (+), Instability | Immediate (Bloody) ğŸ©¸ |\n| **Meniscus Tear** | Twisting, Deep squat | Locking, Thessaly (+) | Slow (12-24h) ğŸ¢ |\n| **PCL Tear** | Dashboard Injury | Posterior Drawer (+) | Variable |\n| **Patellar Tendon Rupture** | Jump landing | High-riding patella, No Extension | Immediate |\n| **PFPS (Runner's Knee)** | Young female, Overuse | Theater Sign (Sitting pain) | None usually |\n| **GTPS (Hip)** | Obesity, Middle-age | Can't sleep on side | None |\n| **Baker Cyst Rupture** | Chronic knee issue | Calf pain/swelling | Acute (Mimics DVT) |\n### **2. [Ep 08] Foot & Ankle ğŸ¦¶**\n**ğŸš€ Rapid Fire Recap (High-Yield Summary)**\n| **Pathology** | **Location** | **The \"Money\" Feature** | **Treatment Focus** |\n| --- | --- | --- | --- |\n| **Plantar Fasciitis** | Heel (Sole) | Morning Pain (First step agony) | Conservative (Stretch/Ice) |\n| **Calcaneal Stress Fx** | Heel (Bone) | Pain worse with use, Squeeze (+) | Reduce Activity |\n| **Achilles Rupture** | Posterior Heel | \"Pop\", Thompson Test (+), Cipro | Surgical or Casting |\n| **Sever Disease** | Heel (Peds) | Active Kid (Soccer), Growth Spurt | Rest, Ice (Self-limiting) |\n| **Morton Neuroma** | 3rd-4th Toe | Pebble sensation, Mulder Sign (Click) | Wide shoes, Pad |\n| **Jones Fracture** | 5th Metatarsal | Lateral foot pain, Watershed zone | Surgery often needed âš ï¸ |\n| **Charcot Foot** | Whole Foot | DM, Red/Hot but PAINLESS | Total Contact Cast (No Abx!) |\n### **3. [Ep 09] Trauma & Emergencies ğŸš¨**\n**ğŸ“‹ Overview: USMLE Step 2 CK - Orthopedic Trauma & Emergencies**\n| **Category** | **Key Condition** | **NBS / Critical Action** |\n| --- | --- | --- |\n| **Upper Limb** | Scaphoid Fx | â˜… Thumb Spica Cast (even if X-ray -) |\n| **Upper Limb** | Supracondylar Fx | Check Neurovascular status (EMERGENCY) |\n| **Lower Limb** | Hip Fx | Surgery < 72hrs (Mortality risk) |\n| **Lower Limb** | Pelvic Fx | â˜… Pelvic Binder (Close the book!) |\n| **Emergencies** | Compartment | â˜… Fasciotomy (Delta pressure < 30) |\n| **Complications** | CRPS | PT/OT (Mobilization), No Cast! |\n| **Complications** | Myositis Ossificans | Do NOT excise early (Wait for maturation) |\n### **4. [Ep 10] Bone Pathology ğŸ¦´**\n**ğŸ”¥ RAPID FIRE REVIEW: Connecting the Dots**\n| **Scenario / Symptom** | **Diagnosis / Association** | **Key Feature / Lab / Imaging** |\n| --- | --- | --- |\n| Groin Pain on Weight Bearing | **Avascular Necrosis (AVN)** | Hx of Steroids/Alcohol. MRI is Gold Standard. |\n| Bone Pain + Waddle Gait | **Osteomalacia** | Labs: â†“Ca, â†“Phos, â†‘PTH, â†‘Alk Phos. |\n| Increasing Hat Size + Hearing Loss | **Paget's Disease** | Isolated High Alk Phos. |\n| Child with Sickle Cell + Bone Pain | **Osteomyelitis** | Bug: Salmonella (Think S for S). |\n| Diabetic Foot Ulcer | **Osteomyelitis** | Probe-to-Bone Test Positive. |\n| Prosthetic Joint (<3 mo) | **Acute Infection** | Staph aureus, Gram(-) rods. |\n| Prosthetic Joint (3-12 mo) | **Delayed Infection** | Staph epidermidis (Biofilm). |\n| Teen + Night Pain (NSAIDs help) | **Osteoid Osteoma** | X-ray: Nidus. |\n| Sunburst Pattern (Metaphysis) | **Osteosarcoma** | Aggressive, Codman's Triangle. |\n| Onion Skinning (Diaphysis) | **Ewing Sarcoma** | t(11;22), Small blue cells. |\n| Soap Bubble (Epiphysis) | **Giant Cell Tumor** | Benign but locally aggressive. |\n### **5. [Ep 11] Vasculitis & Myopathy ğŸ©¸**","subject":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","page_title":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","episode":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","section_path":["LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76"],"source_doc_id":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","source_page":null,"source_anchor":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76-24","focus_area":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_summary","text":"**Rapid Fire Recap (ì¡±ì§‘ê²Œ ìš”ì•½) ğŸ”¥**\n| **Condition** | **Key Keyword** | **Association / Lab** | **Treatment / Note** |\n| --- | --- | --- | --- |\n| **GCA** | Jaw Claudication | Polymyalgia Rheumatica | Vision loss â†’ High dose Steroids ASAP |\n| **Kawasaki** | Fever > 5d + CRASH | Coronary Aneurysm | IVIG + Aspirin (No live vaccines for 11mo) |\n| **PAN** | Hep B, Foot drop | Spares Lung | Angio: String of beads |\n| **GPA** | Sinus + Lung + Kidney | c-ANCA (PR3) | Cyclophosphamide/Rituximab |\n| **HSP** | Palpable Purpura (Butt) | Normal Platelets | Risk: Intussusception â†’ surgery |\n| **PMR** | Shoulder/Hip Pain | High ESR, Normal CK | Low dose Steroids |\n| **Dermatomyositis** | Heliotrope Rash | Occult Cancer | Screen for malignancy! |\n| **Myasthenia Gravis** | Ptosis, Worse @ night | Thymoma | Ice pack test, Pyridostigmine. No FQ, No magnesium |\n### **6. [Ep 12] Pediatric Orthopedics ğŸ‘¶**\n**RAPID FIRE RECAP TABLE ğŸ”¥**\n| **Condition** | **Key Vignette / Symptom** | **Best Initial Test** | **Gold Standard / Mgmt** |\n| --- | --- | --- | --- |\n| **SCFE** | ëš±ëš±í•œ ì²­ì†Œë…„, ë¬´ë¦ í†µì¦ | X-ray (Frog-leg) | Surgery (Screw fixation) ğŸ”© |\n| **DDH** | ì‹ ìƒì•„, ë‘”ìœ„, ë¹„ëŒ€ì¹­ ì£¼ë¦„ | <4mo US, >4mo X-ray | Pavlik Harness ğŸ¸ |\n| **Septic Arthritis** | ê³ ì—´ + ëª» ê±¸ìŒ | Kocher 3-4ì  | Antibiotics + Drainage ğŸš¨ |\n| **Stillâ€™s disease** | Salmon rash, Daily fever | Clinical | JIA Systemic type |\n| **JIA (Oligo)** | <5 ê´€ì ˆ, ë¬´ë¦ ë¶“ê¸° | Slit Lamp Exam | ëˆˆ ê²€ì‚¬ í•„ìˆ˜ (Uveitis) ğŸ‘ï¸ |\n| **Clubfoot** | Rigid, ì•ˆìª½ìœ¼ë¡œ íœœ ë°œ | Clinical Exam | Ponseti Casting (ì¦‰ì‹œ) |\n| **Scoliosis** | Cobb Angle 20~40ë„ | X-ray | Bracing (ì§„í–‰ ë°©ì§€) |\n### **7. [íŠ¹ìˆ˜ ì£¼ì œ] Gout & Brachial Plexus ğŸ’**\n**âš¡ Rapid Fire Recap (Gout / Septic)**\n- **Situation:** Big Toe Pain (Podagra) â†’ **Action:** Gout ì˜ì‹¬ 1ìˆœìœ„\n- **Diagnostic Test:** Arthrocentesis (Joint Tap) **ë¬´ì¡°ê±´!**\n- **Gout Fluid:** Negatively Birefringent Needle Crystals â–ğŸ’‰\n- **Septic Arthritis Fluid:** WBC > 50k, >90% Neutrophils\n- **Acute Tx (Renal Failure):** **Steroids (Injection or Oral) â˜…**\n- **Best HTN Med for Gout:** Losartan (or CCB)\n**ğŸ”¥ RAPID FIRE RECAP (Brachial Plexus)**","subject":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","page_title":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","episode":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","section_path":["LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76"],"source_doc_id":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","source_page":null,"source_anchor":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76-43","focus_area":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","tags":["usmle-step2","core","recap","treatment"]}
{"chunk_type":"transcript_chunk","text":"- **Forearm Pronated?** ğŸ‘‰ Erb-Duchenne (C5-C6). (Biceps lost).\n- **Forearm Supinated?** ğŸ‘‰ Klumpke (C8-T1).\n- **Best Initial Step?** ğŸ‘‰ Observation & PT. (Don't order surgery immediately!).\n- **When to call Surgeon?** ğŸ‘‰ If NO improvement by 3-6 months.\n**Confidence Level: 1.0** â˜…","subject":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","page_title":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","episode":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","section_path":["LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76"],"source_doc_id":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","source_page":null,"source_anchor":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76-54","focus_area":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","tags":["usmle-step2","core"]}
{"chunk_type":"transcript_chunk","text":"# immunology\n## **ğŸ–ï¸ [êµ­ë°©ë©´ì—­ì‚¬ë ¹ë¶€] ì‘ì „ í•´ì„¤ì„œ (Notionìš©)**\n### **1. 4ë ¹ë¶€ (ì§€íœ˜ ë° ì‘ì „í†µì œì‹¤) - CD4+ T cell**\n- **1íŒ€ (Th1) [ì¹¨íˆ¬ëŒ€ì‘ì²˜]**: ì„¸í¬ ë‚´ ì¹¨íˆ¬(ì„¸ê· , ë°”ì´ëŸ¬ìŠ¤) ì „ë‹´.\n    - **GM ì‘ì „ TF**: **IFN-Î³** ë¬´ì „ ë°œë ¹ â†’ Mëª¬ìŠ¤í„°(Macrophage) í™œì„±í™” ë° Bí¬ë³‘ IgG(ì •ë°€íƒ„) ìƒì‚° ìŠ¹ì¸.\n    - **82 ì‘ì „ TF**: **IL-2** ë³´ê¸‰ ë°œë ¹ â†’ 8íŠ¹ê³µëŒ€(CD8+) ë° NKë³´ì•ˆëŒ€ ë¬´í•œ ì¦ì‹ ë° í™”ë ¥ ì§€ì›. â˜…\n- **2íŒ€ (Th2) [í•´ì•ˆëŒ€ì‘ì²˜]**: ì™¸ë¶€ ê¸°ìƒì¶© ë° ì•Œë ˆë¥´ê¸° í•­ì› ì „ë‹´.\n    - **ì‚¬ì˜¤ì • ì‘ì „**: **IL-4, IL-5** ë¬´ì „ ë°œë ¹ â†’ Bí¬ë³‘ IgE/IgA íƒ„ì¢… êµì²´ ë° í˜¸ì‚°êµ¬(Eosinophil) í˜¸ì¶œ.\n- **3íŒ€ (Th17) [ì‹œìœ„ì§„ì••ì²˜]**: ê¸‰ì„± ì—¼ì¦ ë° í™”ë†ì„± ì„¸ê·  ëŒ€ì‘.\n    - **Nì†Œì§‘ ëª…ë ¹**: **IL-17** ë¬´ì „ ë°œë ¹ â†’ ì „ë°© NëŒê²©ëŒ€(Neutrophil) ëŒ€ê±° ì¶”ê°€ ì§•ì§‘.\n### **2. ì „ë°© ì§í• ëŒ€ (ì„ ì²œë©´ì—­êµ°)**\n- **NëŒê²©ëŒ€ (Neutrophil)**: 5ë¶„ ëŒ€ê¸°ì¡°. í˜„ì¥ì—ì„œ ì¦‰ê° ìí­í•˜ë©° ê³ ë¦„(Pus) í˜•ì„±.\n- **Mëª¬ìŠ¤í„° ìˆ˜ìƒ‰ëŒ€ëŒ€ (Macrophage)**: ì ì„ ì”¹ì–´ë¨¹ê³  **MHC 2** ë³´ê³ ì„œë¥¼ ì‚¬ë ¹ë¶€ì— ì œì¶œ. (1íŒ€ì˜ GM ì‘ì „ìœ¼ë¡œ ê°ì„±)\n- **Dë°ì´í„° ì •ë³´ëŒ€ëŒ€ (Dendritic Cell)**: ì  íŒŒí¸(Antigen)ì„ ìˆ˜ì§‘í•´ ì‚¬ë ¹ë¶€ë¡œ ë›°ëŠ” ì •ë³´ì¥êµ.\n- **NKí—Œë³‘ë³´ì•ˆëŒ€ (NK Cell)**: **MHC 1** ì•”í˜¸íŒì´ ì—†ëŠ” ë³€ì ˆìë¥¼ ì¦‰ê° ì‚¬ì‚´. (1íŒ€ì˜ 82 ì‘ì „ ì§€ì›ì„ ë°›ìŒ)\n### **3. ì •ê·œ íƒ€ê²©ëŒ€ ë° ê³µêµ° (ì ì‘ë©´ì—­êµ° & ë³´ì²´)**\n- **Bí¬ë³‘ì—°ëŒ€ (B cell)**: í•­ì²´(Antibody) ë¯¸ì‚¬ì¼ ë°œì‚¬.\n    - **IgM Më¬´ì‹íƒ„:** í›ˆë ¨ì†Œ ê°“ ë‚˜ì˜¨ ì‹ ë³‘ íƒ„í™˜. **ê³µêµ° í˜¸ì¶œ ëŠ¥ë ¥ ìµœìƒ.** â˜…\n    - **IgG Gì •ë°€íƒ„**: 1íŒ€ GM ì‘ì „ ìŠ¹ì¸ ì£¼ë ¥ ì •ë°€íƒ„. **ê³µêµ° í˜¸ì¶œ ë° Mëª¬ìŠ¤í„° ì¢Œí‘œ ë§ˆí‚¹.**\n    - **IgE/IgA**: 2íŒ€ ìŠ¹ì¸ íŠ¹ìˆ˜íƒ„. (ê¸°ìƒì¶© ë° ì ë§‰ ë°©ì–´)\n- **8íŠ¹ê³µì—°ëŒ€ (CD8+ T cell)**: 1íŒ€ 82 ì‘ì „TF ì§€íœ˜í†µì œì— ìˆìŒ. **MHC 1** ì•”í˜¸ë¥¼ ê²€ì‚¬í•˜ì—¬ ê°ì—¼ëœ ì•„êµ° ê¸°ì§€ë¥¼ í­íŒŒ(Perforin/Granzyme).\n- **ê³µêµ° (Complement)**: í¬ë³‘ì´ ì°ì€ ì¢Œí‘œì— êµ¬ë© ëš«ê¸° í­ê²©(MAC).\n    - **C3b**: ì¢Œí‘œ ë§ˆí‚¹ / **C5a**: NëŒ€ëŒ€(5ëŒ€ê¸°) í˜¸ì¶œ / **C5b-9**: MAC í­ê²©ê¸°.\n## **ğŸ§  êµ­ë°©ë©´ì—­ì‚¬ë ¹ë¶€ 3ì´ˆ ì•”ê¸° ê³µì‹**\n### **â‘  ì§€íœ˜ ê³„í†µ (ê³±í•´ì„œ 8!)**\n- **4(ì‚¬ë ¹ë¶€) x 2(MHC 2 ë³´ê³ ì„œ) = 8**\n- **8(íŠ¹ê³µëŒ€) x 1(MHC 1 ì•”í˜¸íŒ) = 8**\n### **â‘¡ 1íŒ€(Th1)ì˜ ì–‘ëŒ€ ì‘ì „**\n- **GM ì‘ì „**: **\"ë‚˜(I)ëŠ” MëŒ€ëŒ€ íŒ¬(Fan)ì´ì•¼!\"** (**IFN-Î³**) â†’ **G**(IgG)íƒ„ & **M**(Monster)ëŒ€ëŒ€ ê°ì„±.\n- **82 ì‘ì „**: **\"8íŠ¹ê³µëŒ€! 8-2(ì¼ë£¨ì™€)!\"** (**IL-2**) â†’ íŠ¹ê³µëŒ€ ë³´ê¸‰ ë° ì¦ì‹.\n### **â‘¢ 2íŒ€(Th2)ì˜ ì‘ì „**","subject":"immunology 30146f2986ee807c94b7e1fc0e603538","page_title":"immunology 30146f2986ee807c94b7e1fc0e603538","episode":"immunology 30146f2986ee807c94b7e1fc0e603538","section_path":["immunology 30146f2986ee807c94b7e1fc0e603538"],"source_doc_id":"immunology 30146f2986ee807c94b7e1fc0e603538","source_page":null,"source_anchor":"immunology 30146f2986ee807c94b7e1fc0e603538-1","focus_area":"immunology 30146f2986ee807c94b7e1fc0e603538","tags":["usmle-step2","core"]}
{"chunk_type":"transcript_chunk","text":"- **ì‚¬ì˜¤ì • ì‘ì „**: **\"ì‚¬(4)ì˜¤(5)ì • í¬íƒ„ ë°œì‚¬!\"** (**IL-4, IL-5**) â†’ IgE ìƒì‚° ë° í˜¸ì‚°êµ¬ í˜¸ì¶œ.\n### **â‘£ ê³µêµ°(Complement)ì˜ ë³´ì§**\n- **C3b**: **3b** = **B**inds **B**acteria (ì¢Œí‘œ ë§ˆí‚¹).\n- **C5a**: **5**ëŒ€ê¸°(NëŒ€ëŒ€) ì§‘ê²° ë¬´ì „.","subject":"immunology 30146f2986ee807c94b7e1fc0e603538","page_title":"immunology 30146f2986ee807c94b7e1fc0e603538","episode":"immunology 30146f2986ee807c94b7e1fc0e603538","section_path":["immunology 30146f2986ee807c94b7e1fc0e603538"],"source_doc_id":"immunology 30146f2986ee807c94b7e1fc0e603538","source_page":null,"source_anchor":"immunology 30146f2986ee807c94b7e1fc0e603538-21","focus_area":"immunology 30146f2986ee807c94b7e1fc0e603538","tags":["usmle-step2","core"]}
{"chunk_type":"transcript_chunk","text":"# LM_Neuro 1\n**Episode 1: Neurology Foundations & Assessment**\n- *Focus:*Â ì‹ ê²½í•™ì  í‰ê°€ì˜ ê¸°ì´ˆ, ì˜ì‹ ìˆ˜ì¤€ í‰ê°€ ë° ë…¸í™”ì— ë”°ë¥¸ ë³€í™”.\n- *Sections Included:*\n    - 1.1. Physiology\n    - 1.1.1. Speech\n    - 1.6. Mental Examination\n    - 1.6.1. Glasgow Coma Scale (GCS)\n    - 1.17.1. Ageing\n**Episode 2: Intracranial Pressure Crisis**\n- *Focus:*Â ë‡Œì•• ìƒìŠ¹, ìˆ˜ë‘ì¦, ê·¸ë¦¬ê³  ê·¸ë¡œ ì¸í•œ ì‘ê¸‰ ìƒí™©.\n- *Sections Included:*\n    - 1.2. Idiopathic Intracranial Hypertension\n    - 1.3. Normal Pressure Hydrocephalous\n    - 1.4.1. Raised ICP\n    - 1.16. Brain Herniation\n    - 1.17.14. Ventriculoperitoneal Shunt\n**Episode 3: The Headache Patient**\n- *Focus:*Â ë‘í†µì˜ ê°ë³„ ì§„ë‹¨ (ì¼ì°¨ì„± ë‘í†µ ë° ì‘ê¸‰ ë‘í†µ).\n- *Sections Included:*\n    - 1.4. Headache (General)\n    - 1.4.2. Thunderclap Headache\n    - 1.4.3. Migraine\n    - 1.4.4. Cluster\n    - 1.4.5. Tension\n**Episode 4: Epilepsy & Seizure Management**\n- *Focus:*Â ë°œì‘ì˜ ìœ í˜•, ê°„ì§ˆ ì§€ì† ìƒíƒœ, ê·¸ë¦¬ê³  ì•½ë¬¼ ì¹˜ë£Œ.\n- *Sections Included:*\n    - 1.5. Seizures\n    - 1.5.1. Focal Seizure\n    - 1.5.2. Absence Seizure\n    - 1.5.3. Status Epilepticus\n    - 1.18. CNS Drugs (Anti-Epileptic)\n**Episode 5: Ischemic Stroke & Vascular Disorders**\n- *Focus:*Â í—ˆí˜ˆì„± ë‡Œì¡¸ì¤‘ ë° ë‡Œì •ë§¥ í˜ˆì „ì¦.\n- *Sections Included:*\n    - 1.9. Stroke (Introduction)\n    - 1.9.1. TIA\n    - 1.9.3. Ischemic Stroke\n    - 1.9.6. Lacunar Stroke\n    - 1.9.7. Malignant Hemispheric Infarction\n    - 1.17.6. Venous Sinus Thrombosis\n    - 1.17.7. Cavernous Sinus Syndrome\n**Episode 6: Hemorrhagic Stroke**\n- *Focus:*Â ë‡Œì¶œí˜ˆì˜ ìœ í˜•ê³¼ ê´€ë¦¬.\n- *Sections Included:*\n    - 1.9.2. Cerebellar Hemorrhage\n    - 1.9.4. Subdural Hematoma\n    - 1.9.5. Subarachnoid Hemorrhage\n**Episode 7: Traumatic Brain Injury**\n[LM_Neuro 2](LM_Neuro%202%2030346f2986ee80b5acf3eca919a5b8c6.md)\n- *Focus:*Â ë‘ë¶€ ì™¸ìƒê³¼ ê·¸ í•©ë³‘ì¦.\n- *Sections Included:*\n    - 1.17.3. Head Trauma\n    - 1.17.4. CSF Rhinorrhea\n    - 1.17.5. Concussion\n    - 1.17.9. Traumatic Brain Injury\n    - 1.17.15. Diffuse Axonal Injury\n**Episode 8: Movement Disorders & Parkinsonism**\n- *Focus:*Â íŒŒí‚¨ìŠ¨ë³‘ ë° ê´€ë ¨ ì´ìƒ ìš´ë™ ì§ˆí™˜.\n- *Sections Included:*\n    - 1.7. Movement Disorders\n    - 1.7.1. Post Hypoxic Myoclonus\n    - 1.8. Gait Disorders\n    - 1.12.2. Parkinsons\n    - 1.12.4. Multiple System Atrophy\n    - 1.12.5. Progressive Supranuclear Palsy\n**Episode 9: Dementia & Cognitive Disorders**\n- *Focus:*Â ì¹˜ë§¤ì˜ ìœ í˜•ê³¼ ì¸ì§€ ê¸°ëŠ¥ ì¥ì• .\n- *Sections Included:*\n    - 1.12. Neurodegenerative disease (General)\n    - 1.12.1. Dementia\n    - 1.12.3. Lewy Body Dementia\n    - 1.12.6. Alzheimer Disease\n    - 1.12.7. FrontoTemporal Dementia\n    - 1.12.8. Vascular Dementia\n    - 1.12.9. Creutzfeldt-Jakob Disease\n    - 1.12.11. Alcohol Cerebellar Degeneration\n    - 1.12.12. HIV Neurocognitive Dysfunction","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-1","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","treatment"]}
{"chunk_type":"transcript_chunk","text":"**Episode 10: Spinal Cord Pathology**\n- *Focus:*Â ì²™ìˆ˜ ì••ë°•, ì²™ìˆ˜ ì¢…ì–‘ ë° ì²™ìˆ˜ ì¦í›„êµ°.\n- *Sections Included:*\n    - 1.10. Spinal Cord Compression\n    - 1.10.1. Central Cord Syndrome\n    - 1.10.2. Anterior Cord Syndrome\n    - 1.10.3. Cauda Equina & Conus Medullaris\n    - 1.10.6. Autonomic Dysreflexia\n    - 1.13.5. Spinal cord tumors\n**Episode 11: Demyelinating Diseases**\n- *Focus:*Â ë‹¤ë°œì„± ê²½í™”ì¦ ë° ì¤‘ì¶”ì‹ ê²½ê³„ íƒˆìˆ˜ì´ˆ ì§ˆí™˜.\n- *Sections Included:*\n    - 1.11. Demyelinating Disorders\n    - 1.11.1. Multiple Sclerosis\n    - 1.11.2. Transverse Myelitis\n    - 1.11.3. Neuromyelitis Optica\n    - 1.11.8. Central Pontine Myelinolysis\n    - 1.12.10. Adrenoleukodystrophy\n**Episode 12: Peripheral Neuropathy & Motor Neuron Diseases**\n- *Focus:*Â ë§ì´ˆ ì‹ ê²½, ìš´ë™ ì‹ ê²½ì„¸í¬ ì§ˆí™˜ ë° ì•ˆë©´ ë§ˆë¹„.\n- *Sections Included:*\n    - 1.10.4. UMN\n    - 1.10.5. ALS\n    - 1.11.5. Guillain-BarrÃ© Syndrome (GBS)\n    - 1.11.6. Miller Fisher Syndrome\n    - 1.11.7. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)\n    - 1.17.2. Tick Paralysis\n    - 1.17.8. Distal Symmetric Polyneuropathy\n    - 1.17.16. Facial Palsy\n**Episode 13: CNS Infections**\n- *Focus:*Â ë‡Œìˆ˜ë§‰ì—¼, ë†ì–‘ ë° ê¸°íšŒê°ì—¼.\n- *Sections Included:*\n    - 1.11.4. Progressive Multifocal Leukoencephalopathy (PML)\n    - 1.15. Infection\n    - 1.15.1. Meningitis\n    - 1.15.2. Brain Abscess\n    - 1.15.3. Spinal Epidural Abscess\n**Episode 14: CNS Tumors**\n- *Focus:*Â ë‡Œì¢…ì–‘ì˜ ì¢…ë¥˜ì™€ íŠ¹ì§•.\n- *Sections Included:*\n    - 1.13. CNS Tumors\n    - 1.13.1. Metastatic Brain Lesions\n    - 1.13.2. Meningioma\n    - 1.13.3. Schwannoma\n    - 1.13.4. Choroid Plexus papilloma\n**Episode 15: Pediatric Neurology I: Congenital & Developmental**\n- *Focus:*Â ì‹ ê²½í”¼ë¶€ ì¦í›„êµ°, ì„ ì²œì„± ê¸°í˜• ë° ë°œë‹¬ ì¥ì• .\n- *Sections Included:*\n    - 1.14. Neurocutaneous Disorders (NF, Tuberous Sclerosis, VHL, Sturge Weber)\n    - 1.20. Paeds (General)\n    - 1.20.1. Spina Bifida\n    - 1.20.2. Hydrocephalous\n    - 1.20.3. Microcephaly\n    - 1.20.4. Macrocephaly\n    - 1.20.5. Cephalohematoma\n    - 1.20.14. Cerebral Palsy\n**Episode 16: Pediatric Neurology II: Acute Conditions**\n- *Focus:*Â ì†Œì•„ ë‡Œì¡¸ì¤‘, ë°œì‘ ë° ê¸‰ì„± ì‹ ê²½í•™ì  ë¬¸ì œ.\n- *Sections Included:*\n    - 1.20.6. Stroke\n    - 1.20.7. Hemiplegia\n    - 1.20.8. Intraventricular Hemorrhage\n    - 1.20.9. Paeds Seizures\n    - 1.20.10. Juvenile Myoclonic Epilepsy\n    - 1.20.11. Infantile Spasms (West Syndrome)\n    - 1.20.12. Lennox Gastaut Syndrome\n    - 1.20.13. Febrile Seizures\n**Episode 17: Critical Care & Environmental Neurology**\n- *Focus:*Â ì¤‘í™˜ì ê´€ë¦¬, ë‡Œì‚¬, ë§ˆì·¨ ë° í™˜ê²½ì  ì†ìƒ.\n- *Sections Included:*\n    - 1.17.10. Paroxysmal Sympathetic Activity\n    - 1.17.11. Brain Death\n    - 1.17.12. Organ Donation\n    - 1.17.13. Post Intensive Care Syndrome\n    - 1.17.17. Thermoregulation Failure\n    - 1.19. Anesthesia (Epidural, Malignant Hyperthermia, NeuroMuscular Blockers)\n**Episode 18: Eye I: Infections & Inflammation**\n- *Focus:*Â ëˆˆì˜ ê°ì—¼ì„± ì§ˆí™˜ ë° ì—¼ì¦.\n- *Sections Included:*\n    - 2.16. Infection\n    - 2.16.1. Orbital Cellulitis (vs Preseptal)\n    - 2.16.2. Conjuctivitis\n    - 2.16.4. Endopthalmitis\n    - 2.16.5. Keratitis\n    - 2.16.6. Dacryocystitis\n    - 2.16.7. Hordeolum/ Stye\n    - 2.16.8. Blepharitis\n    - 2.16.9. Uveitis\n    - 2.17. Dacryostenosis\n**Episode 19: Eye II: Vision Loss & Retina**\n- *Focus:*Â ì‹œë ¥ ìƒì‹¤ì˜ ì›ì¸, ë§ë§‰ ì§ˆí™˜ ë° ë…¹ë‚´ì¥.\n- *Sections Included:*\n    1. EYE (General)\n    - 2.1. Ambylopia\n    - 2.2. Glaucoma (Closed & Open Angle)\n    - 2.9. Strabismus\n    - 2.10. Retinoblastoma\n    - 2.12. Retinal Artery Occlusion\n    - 2.13. Retinal Vein Occlusion\n    - 2.14. Retinitis Pigmentosa\n    - 2.15. Diabetic Retinopathy\n    - 2.16.3. Retinitis\n    - 2.18. Eye Drugs","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-21","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core"]}
{"chunk_type":"transcript_chunk","text":"**Episode 20: Eye III: Ocular Trauma**\n- *Focus:*Â ëˆˆ ì™¸ìƒ ë° ì‘ê¸‰ ì²˜ì¹˜.\n- *Sections Included:*\n    - 2.3. Corneal Abrasion\n    - 2.4. Optic Nerve Injury\n    - 2.5. Open Globe Injury\n    - 2.6. Sympathetic Ophthalmia\n    - 2.7. Orbital Compartmental Syndrome\n    - 2.8. Hyphema\n    - 2.11. Photokeratitis\n**Episode 21: Ear I: Infections**\n- *Focus:*Â ê·€ì˜ ê°ì—¼ì„± ì§ˆí™˜.\n- *Sections Included:*\n    - 3.1. Infection\n    - 3.1.1. Otitis externa\n    - 3.1.2. Malignant Otitis Externa\n    - 3.1.3. Otitis Media\n    - 3.1.4. Otitis Media with Effusion\n    - 3.1.5. Chronic Suppurative Otitis Media\n    - 3.1.6. Cholesteatoma\n**Episode 22: Ear II: Hearing & Balance**\n- *Focus:*Â ì²­ë ¥ ì†ì‹¤, ì–´ì§€ëŸ¼ì¦ ë° êµ¬ì¡°ì  ë¬¸ì œ.\n- *Sections Included:*\n    1. EAR (General concepts)\n    - 3.2. Eustachian Tube Dysfunction\n    - 3.3. Barotrauma\n    - 3.4. Hearing Loss\n    - 3.5. Vertigo (Perilymphatic fistula, Vestibulopathy)\n    - 3.6. Otosclerosis\n    - 3.7. Auricular Hematoma\n**Meta-Cognitive Reasoning & Analysis**\n1. **DECOMPOSE**: ì˜¤ë””ì˜¤ íŒŒì¼ì€ USMLE Step 2 CK ëŒ€ë¹„ ì‹ ê²½í•™(Neurology) ë¦¬ë·°ì…ë‹ˆë‹¤. í¬ê²Œ ì„¸ ê°€ì§€ íŒŒíŠ¸ë¡œ ë‚˜ë‰©ë‹ˆë‹¤:\n    - **Part 1: Physiology & Speech (Aphasia)** - Broca, Wernicke, Conduction aphasiaì˜ íŠ¹ì§•ê³¼ í•´ë¶€í•™ì  ìœ„ì¹˜.\n    - **Part 2: Mental Status Exam (GCS)** - Glasgow Coma Scaleì˜ ì„¸ë¶€ í•­ëª©(Eye, Verbal, Motor)ê³¼ ì ìˆ˜ ê³„ì‚°, ì˜ˆí›„(Posturing).\n    - **Part 3: Aging & Dementia** - ì •ìƒ ë…¸í™”(Normal Aging), ê²½ë„ ì¸ì§€ ì¥ì• (MCI), ì¹˜ë§¤(Dementia)ì˜ êµ¬ë¶„ ë° ìŠ¤í¬ë¦¬ë‹.\n2. **SOLVE**: ê° ì„¹ì…˜ì„ \"Doorway Thought(ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤)\"ë¡œ ì‹œì‘í•˜ì—¬ ëª°ì…ë„ë¥¼ ë†’ì´ê³ , ì˜¤ë””ì˜¤ì˜ ëª¨ë“  ì„¸ë¶€ ì‚¬í•­(ë†ë‹´, ë¹„ìœ  í¬í•¨)ì„ ë†“ì¹˜ì§€ ì•Šê³  í•œêµ­ì–´ ê°•ì˜ ë…¸íŠ¸ë¡œ ë³€í™˜í•©ë‹ˆë‹¤. USMLE ê³ ë“ì ì„ ìœ„í•œ \"High Yield\" í¬ì¸íŠ¸ì™€ í•¨ì •(Trap)ì„ ê°•ì¡°í•©ë‹ˆë‹¤.\n3. **VERIFY**: ì˜¤ë””ì˜¤ì˜ 0:00~0:30 êµ¬ê°„ì„ ì •í™•íˆ ë°›ì•„ì ì–´ ì²­ì·¨ë¥¼ ì¦ëª…í•©ë‹ˆë‹¤. êµ¬ì¡°í™”ëœ ASCII íŠ¸ë¦¬ë¡œ ê°œë…ì„ ì‹œê°í™”í•©ë‹ˆë‹¤.\n4. **SYNTHESIZE**: ì´ëª¨ì§€, í‘œ, ë³¼ë“œì²´, ë³„í‘œ(â˜…)ë¥¼ ì‚¬ìš©í•˜ì—¬ ê°€ë…ì„±ì„ ê·¹ëŒ€í™”í•œ ìµœì¢… ë…¸íŠ¸ë¥¼ ìƒì„±í•©ë‹ˆë‹¤.\n### ğŸ“‹ Overview (TL;DR)\nì´ë²ˆ ê°•ì˜ëŠ” USMLE Step 2 CKë¥¼ ìœ„í•œ **High Yield Neurology Review**ì…ë‹ˆë‹¤. ì‹œí—˜ì— ë¬´ì¡°ê±´ ë‚˜ì˜¤ëŠ” 3ê°€ì§€ í•µì‹¬ ê¸°ë‘¥ì„ ë‹¤ë£¹ë‹ˆë‹¤.\n- **ğŸ§  Aphasia (ì‹¤ì–´ì¦):** í™˜ìê°€ ë§ì„ ëª» í•˜ëŠ”ê°€(Broca), ì´í•´ë¥¼ ëª» í•˜ëŠ”ê°€(Wernicke), ë”°ë¼ í•˜ì§€ë¥¼ ëª» í•˜ëŠ”ê°€(Conduction)?\n- **ğŸš‘ GCS (Glasgow Coma Scale):** ì‘ê¸‰ì‹¤ í•„ìˆ˜! ëˆˆ(4), ì…(5), ëª¸(6) ì ìˆ˜ ë§¤ê¸°ê¸°ì™€ Decorticate vs Decerebrate êµ¬ë³„ë²•.\n- **ğŸ‘´ Aging vs. Dementia:** ê±´ë§ì¦ì¸ê°€ ë³‘ì¸ê°€? ì •ìƒ ë…¸í™”ì˜ 5ê°€ì§€ ì§•í›„ì™€ ì¹˜ë§¤ë¥¼ ê°€ë¥´ëŠ” ê²°ì •ì  ê¸°ì¤€(ADLs).\n### ğŸŒ³ Medical Concept Tree: Neurology Review\nì´ ê°•ì˜ê°€ ì „ì²´ ì˜í•™ ì§€ì‹ ì²´ê³„ì—ì„œ ì–´ë””ì— ìœ„ì¹˜í•˜ëŠ”ì§€ ë³´ì—¬ì£¼ëŠ” Top-down Classificationì…ë‹ˆë‹¤.\nPlaintext\n`Medicine (USMLE Step 2 CK)\nâ”‚\nâ”œâ”€â”€ Neurology (Nervous System)\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ 1. Cortical Functions (Language/Speech)\nâ”‚   â”‚   â”œâ”€â”€ Dominant Hemisphere (Left mostly)\nâ”‚   â”‚   â”‚   â”œâ”€â”€ Frontal Lobe â†’ Broca's Area (Production)\nâ”‚   â”‚   â”‚   â”œâ”€â”€ Temporal Lobe â†’ Wernicke's Area (Comprehension)\nâ”‚   â”‚   â”‚   â””â”€â”€ Arcuate Fasciculus â†’ Conduction (Connection)\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ 2. Trauma & Consciousness\nâ”‚   â”‚   â”œâ”€â”€ Assessment Tool â†’ Glasgow Coma Scale (GCS)\nâ”‚   â”‚   â”‚   â”œâ”€â”€ Eye (4)\nâ”‚   â”‚   â”‚   â”œâ”€â”€ Verbal (5)\nâ”‚   â”‚   â”‚   â””â”€â”€ Motor (6) â†’ Posturing (Decorticate/Decerebrate)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ 3. Geriatric Neurology (Aging)\nâ”‚       â”œâ”€â”€ Normal Physiology (Benign changes)\nâ”‚       â”œâ”€â”€ Mild Cognitive Impairment (MCI - ADLs intact)\nâ”‚       â””â”€â”€ Major Neurocognitive Disorder (Dementia - ADLs impaired)`","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-41","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"# ğŸ§  Section 1: Physiology & Speech (Aphasia)\n### ğŸšª Doorway Thought (Clinical Scenario)\n### 1.1 The Anatomy of Language (ì–¸ì–´ì˜ 3ëŒ€ì¥)\në‡Œì—ëŠ” ì–¸ì–´ë¥¼ ë‹´ë‹¹í•˜ëŠ” 3ê°€ì§€ ì£¼ìš” í”Œë ˆì´ì–´ê°€ ìˆìŠµë‹ˆë‹¤.\n1. **Broca's Area (ë¸Œë¡œì¹´ ì˜ì—­):** ì „ë‘ì—½(Frontal lobe). **Speech Production (ë§í•˜ê¸° ìƒì‚°)** ë‹´ë‹¹.\n2. **Wernicke's Area (ë² ë¥´ë‹ˆì¼€ ì˜ì—­):** ì¸¡ë‘ì—½(Temporal lobe). **Speech Comprehension (ë§í•˜ê¸° ì´í•´)** ë‹´ë‹¹.\n3. **Arcuate Fasciculus (ê¶ìƒë‹¤ë°œ):** ì´ ë‘˜ì„ ì—°ê²°í•˜ëŠ” ë‹¤ë¦¬(Bridge).\n### 1.2 Types of Aphasia (ì‹¤ì–´ì¦ ìœ í˜• ë¶„ì„)\n| **êµ¬ë¶„** | **Broca's Aphasia (Expressive)** | **Wernicke's Aphasia (Receptive)** | **Conduction Aphasia** |\n| --- | --- | --- | --- |\n| **íŠ¹ì§•** | **\"The Frustrated Patient\"** ğŸ˜¡\në§í•˜ê³  ì‹¶ì€ë° ì•ˆ ë‚˜ì˜´. | **\"Word Salad\"** ğŸ¥—\nìœ ì°½í•˜ì§€ë§Œ ì•„ë¬´ ë§ ëŒ€ì”ì¹˜ (Gibberish). | **\"The Broken Bridge\"** ğŸŒ‰\në‹¤ ì´í•´í•˜ê³  ë§ë„ ì˜í•˜ëŠ”ë° ì—°ê²°ì´ ëŠê¹€. |\n| **Spontaneous Speech** | **Sparse & Non-fluent**\në…¸ë ¥ì´ ë§ì´ í•„ìš”í•˜ê³  ì¤‘ë‹¨ë¨(Halting). | **Fluent & Voluminous**\nì½¸ì½¸ ë‚˜ì˜¤ì§€ë§Œ ì˜ë¯¸ê°€ ì—†ìŒ(Lacks meaning). | **Fluent**\nìœ ì°½í•˜ì§€ë§Œ ê°„í—ì ì¸ ìŒì†Œ ì˜¤ë¥˜(Phonemic errors). |\n| **Comprehension** | **Relatively Preserved** âœ…\nìì‹ ì˜ ì‹¤íŒ¨ë¥¼ ì•Œê¸°ì— ì¢Œì ˆí•¨. | **Greatly Diminished** âŒ\në³¸ì¸ì´ ë§ì´ ì•ˆ ëœë‹¤ëŠ” ê±¸ ëª¨ë¦„(í–‰ë³µí•˜ê±°ë‚˜ í‰ì˜¨í•´ ë³´ì„). | **Relatively Preserved** âœ…\në“£ëŠ” ê±´ ì™„ë²½í•¨. |\n| **Repetition** | **Impaired** âŒ\n\"No ifs, ands, or buts\" ëª»í•¨. | **Impaired** âŒ\nì´í•´ë¥¼ ëª» í•˜ë‹ˆ ë”°ë¼ í•  ìˆ˜ ì—†ìŒ. | **Very Poor** âŒ â˜…\nì´ê²Œ í•µì‹¬! ì´í•´ë„ í•˜ê³  ë§ë„ í•˜ëŠ”ë° **ë”°ë¼ í•˜ë¼ê³  í•˜ë©´ ëª»í•¨.** |\n| **Associated Features** | **Right Hemiparesis (Face/Upper Limb)** â˜…\ní•´ë¶€í•™ì ìœ¼ë¡œ Motor Cortex(Face/Hand) ë°”ë¡œ ì˜†ì´ë¼ ê°™ì´ í„°ì§. | **Right Superior Visual Field Defect** â˜…\nMeyer's loop(ì‹œì‹ ê²½)ê°€ ì¸¡ë‘ì—½ì„ ì§€ë‚˜ê°€ê¸° ë•Œë¬¸ì— \"Pie in the sky\" ì‹œì•¼ ê²°ì† ë°œìƒ. | **None**\nìš´ë™ ë§ˆë¹„ë‚˜ ì‹œì•¼ ê²°ì† ì—†ìŒ. |\n# ğŸš‘ Section 2: Mental Status Exam (GCS)\n### ğŸšª Doorway Thought (Visualization)\n### 2.1 Glasgow Coma Scale (Total 15 Points)\nì ìˆ˜ëŠ” **Eye(4) + Verbal(5) + Motor(6)**ë¡œ êµ¬ì„±ë©ë‹ˆë‹¤. ìµœí•˜ì ì€ 0ì ì´ ì•„ë‹ˆë¼ **3ì **ì…ë‹ˆë‹¤ (ì‚´ì•„ë§Œ ìˆì–´ë„ 1ì ì”© ì¤Œ).\n### ğŸ‘€ Eye Response (4 Points)\n- **4ì :** **Spontaneous** (ê·¸ëƒ¥ ëˆˆ ëœ¨ê³  ìˆìŒ).\n- **3ì :** **To Voice** (ë¶€ë¥´ë©´ ëˆˆ ëœ¸).\n- **2ì :** **To Pain** (ì•„í”„ê²Œ í•´ì•¼ ëˆˆ ëœ¸ - Sternum rub ë“±).\n- **1ì :** **None** (ë°˜ì‘ ì—†ìŒ).\n- *Note:* ëˆˆì´ ë¶€ì–´ì„œ ëª» ëœ¨ë©´ **'C' (Closed by swelling)**ë¼ê³  ê¸°ë¡ (1ì  ì•„ë‹˜).\n### ğŸ—£ï¸ Verbal Response (5 Points)\n- **5ì :** **Oriented** (ì‚¬ëŒ, ì¥ì†Œ, ì‹œê°„ ì•).\n- **4ì :** **Confused** (ë¬¸ì¥ìœ¼ë¡œ ë§í•˜ì§€ë§Œ ë‚´ìš©ì´ í‹€ë¦¼. \"ì§€ê¸ˆ 1995ë…„ì¸ê°€ìš”?\").\n- **3ì :** **Inappropriate Words** (ë‹¨ì–´ëŠ” ë±‰ëŠ”ë° ë¬¸ì¥ì´ ì•„ë‹˜. \"íŒŒë€ìƒ‰... ì»¤í”¼... ê¸°ì°¨...\").\n- **2ì :** **Incomprehensible Sounds** (ë§ì´ ì•„ë‹˜. ì‹ ìŒ ì†Œë¦¬ \"ìœ¼ì–´ì–´...\" Moaning/Groaning). â˜… í•¨ì • ì£¼ì˜! 3ì ê³¼ 2ì  êµ¬ë³„ í•„ìˆ˜.\n- **1ì :** **None** (ì¹¨ë¬µ).\n- *Note:* ì‚½ê´€(Intubation) ìƒíƒœë©´ **'T'**ë¼ê³  ê¸°ë¡.","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-61","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core"]}
{"chunk_type":"transcript_chunk","text":"### ğŸ’ª Motor Response (6 Points) - *Most Prognostic!*\n- **6ì :** **Obeys Commands** (ì‹œí‚¤ë©´ í•¨. \"ì†ê°€ë½ í´ì„¸ìš”\").\n- **5ì :** **Localizes to Pain** (ì•„í”„ê²Œ í•˜ë©´ ê·¸ ì†ì„ ì¹˜ìš°ë ¤ê³  **ì¤‘ì‹¬ì„ (Midline)ì„ ë„˜ì–´ì˜´**).\n- **4ì :** **Withdraws from Pain** (ì•„í”„ê²Œ í•˜ë©´ ê·¸ëƒ¥ í”¼í•¨/ì›€ì¸ ë¦¼).\n- **3ì :** **Flexion to Pain (Decorticate Posture)** â˜…\n    - íŒ”ì„ ê°€ìŠ´ ìª½ìœ¼ë¡œ êµ¬ë¶€ë¦¼ (Cì ëª¨ì–‘).\n    - **C**ord towards the **C**ord (Spinal cord). ëŒ€ë‡Œí”¼ì§ˆ(Cortex) ì†ìƒ ì‹œ.\n- **2ì :** **Extension to Pain (Decerebrate Posture)** â˜…\n    - íŒ”ì„ ì­‰ í´ê³  ì†ëª©ì´ ë°–ìœ¼ë¡œ ëŒì•„ê°.\n    - Brainstem injury ì•”ì‹œ. **ì˜ˆí›„ê°€ ë” ë‚˜ì¨ (Worse Prognosis).**\n- **1ì :** **None** (Flaccid).\n# ğŸ‘´ Section 3: Aging & Dementia\n### ğŸšª Doorway Thought (The Fine Line)\n### 3.1 Normal Aging Physiology (ì •ìƒ ë…¸í™” ì†Œê²¬)\nì‹œí—˜ì—ì„œ ë‹¤ìŒ ì†Œê²¬ë“¤ì´ ë³´ì´ë©´ **\"ì§ˆë³‘(Disease)\"ì´ ì•„ë‹ˆë¼ \"ì •ìƒ(Normal Aging)\"**ìœ¼ë¡œ ê³¨ë¼ì•¼ í•©ë‹ˆë‹¤.\n1. **Vibratory Sensation Loss:** íŠ¹íˆ ë°œê°€ë½(Toes)ì—ì„œ ì§„ë™ ê°ê° ì €í•˜.\n2. **Decreased Reflexes:** ë°œëª© ë°˜ì‚¬(Deep tendon reflexes) ê°ì†Œ/ì†Œì‹¤.\n3. **Presbyopia (ë…¸ì•ˆ):** ê°€ê¹Œìš´ ê²Œ ì•ˆ ë³´ì„.\n4. **Hearing Loss:** ê³ ì£¼íŒŒ(High frequency) ë‚œì²­.\n5. **Gait Change:** ë³´í­ì´ ì§§ì•„ì§€ê³ (Shortened stride), ê· í˜•ì„ ìœ„í•´ ë‹¤ë¦¬ë¥¼ ë„“ê²Œ ë²Œë¦¼(Broad-based).\n### 3.2 The Dementia Spectrum (ì¸ì§€ ê¸°ëŠ¥ ì €í•˜ì˜ ë‹¨ê³„)\n| **ë‹¨ê³„** | **íŠ¹ì§• (Key Differentiator)** | **ìƒí™œ ëŠ¥ë ¥ (ADLs)** |\n| --- | --- | --- |\n| **Normal Aging** | ì´ë¦„ ê¹œë¹¡í•¨, ì ê¹ ë©í•¨. í•˜ì§€ë§Œ ë‹¤ì‹œ ê¸°ì–µë‚¨. | **Independent** (í˜¼ì ì˜ ì‚¼). ì²­êµ¬ì„œ ë‚´ê³ , ì•½ ì˜ ì±™ê²¨ ë¨¹ìŒ. |\n| **MCI (Mild Cognitive Impairment)** | **ê²½ë„ ì¸ì§€ ì¥ì• .** ê°ê´€ì ì¸ ê¸°ì–µë ¥ ì €í•˜ê°€ ìˆìŒ(ê²€ì‚¬ìƒ). | **Independent** âœ… â˜…\nì´ê²Œ í•µì‹¬! ê¸°ì–µì€ ë–¨ì–´ì¡Œì§€ë§Œ, **ë³´ìƒ ê¸°ì „(ë©”ëª¨, ë‹¬ë ¥)**ì„ í†µí•´ í˜¼ì ì‚´ ìˆ˜ ìˆìŒ. |\n| **Major Neurocognitive Disorder (Dementia)** | **ì¹˜ë§¤.** ëª…ë°±í•œ ê¸°ëŠ¥ ì €í•˜. | **Impaired** âŒ â˜…\nì „ìë ˆì¸ì§€ ëª» ì”€, ëˆ ê´€ë¦¬ ëª»í•¨. **ë‚¨ì˜ ë„ì›€(Dependency)**ì´ í•„ìš”í•¨. |\n### 3.3 Screening Tool (The 3-Word Test)\n1. **Registration:** 3ë‹¨ì–´ ì œì‹œ (ì˜ˆ: **Apple, Table, Blue**). ë”°ë¼ í•˜ê²Œ í•¨.\n2. **Distraction:** 3~5ë¶„ê°„ ë”´ì²­ í”¼ìš°ê¸° (ì‹œê°„, ìš”ì¼ ë¬»ê¸° ë“±).\n3. **Recall:** \"ì•„ê¹Œ ê·¸ 3ë‹¨ì–´ ë­ì˜€ì£ ?\"\n    - **5~6ì :** ì •ìƒ.\n    - **0~4ì :** ì¶”ê°€ ì •ë°€ ê²€ì‚¬ í•„ìš” (Flag).","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-81","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core"]}
{"chunk_type":"recap_summary","text":"### ğŸ”¥ RAPID FIRE RECAP (Exam Day Cheat Sheet)\n| **Concept** | **High Yield Association** |\n| --- | --- |\n| **Broca's Aphasia** | **Frustrated**, Non-fluent, **Right Arm/Face Weakness**. |\n| **Wernicke's Aphasia** | **Word Salad**, Fluent, **Visual Field Cut (Pie in the sky)**. |\n| **Conduction Aphasia** | Fluent + Comprehends BUT **Can't Repeat**. Arcuate Fasciculus. |\n| **GCS Eye (Pain)** | Sternal rub/Nail bed pressure â†’ **2 Points**. |\n| **GCS Verbal (Salad)** | Random words (Inappropriate) â†’ **3 Points**. |\n| **GCS Motor (Extension)** | Decerebrate, Brainstem injury â†’ **2 Points** (Worse than Flexion). |\n| **Decorticate Posture** | Arms flexed like **\"C\"**s (Mummy) â†’ Lesion above Red Nucleus. |\n| **Intubate Trigger** | **GCS â‰¤ 8**. |\n| **MCI vs. Dementia** | **ADLs (Activities of Daily Living)**. í˜¼ì ì‚´ ìˆ˜ ìˆìœ¼ë©´ MCI. |\n| **Depression Memory** | Says **\"I don't know\"**. Dementia patient **Confabulates**. |\n- GCS í‰ê°€ ì‹œ ì‚½ê´€ëœ í™˜ì(T)ë‚˜ ëˆˆì´ ë¶€ì€ í™˜ì(C)ì˜ ê²½ìš° ì ìˆ˜ ë’¤ì— ë¬¸ìë¥¼ ë¶™ì´ëŠ” ê²ƒì„ ìŠì§€ ë§ˆì„¸ìš”.\n- ì¹˜ë§¤ ì§„ë‹¨ ì‹œ ìš°ìš¸ì¦(ê°€ì„± ì¹˜ë§¤)ì„ ë°˜ë“œì‹œ ë°°ì œ(Rule out)í•´ì•¼ í•©ë‹ˆë‹¤.\n- Conduction AphasiaëŠ” ë“œë¬¼ì§€ë§Œ \"Repetition\" í•˜ë‚˜ë§Œ ëª»í•œë‹¤ëŠ” íŠ¹ì§• ë•Œë¬¸ì— ì‹œí—˜ì— ì˜ ë‚˜ì˜µë‹ˆë‹¤.\n### Meta-Cognitive Reasoning Strategy\n1. **DECOMPOSE**: ì˜¤ë””ì˜¤ íŒŒì¼ì˜ ë‚´ìš©ì„ ì‹œê°„ ìˆœì„œì™€ ì˜í•™ì  ì£¼ì œë³„(IIH, NPH, Acute ICP/Herniation, VP Shunt)ë¡œ ë¶„í•´í•©ë‹ˆë‹¤.\n2. **SOLVE**: ê° ì„¹ì…˜ì„ USMLE Step 2 CK ìˆ˜ì¤€ì˜ ë””í…Œì¼ë¡œ í™•ì¥í•˜ê³ , í•œêµ­ì–´ ì„¤ëª…ì„ ë§ë¶™ì—¬ \"ê³¼ì™¸ ì„ ìƒë‹˜\" í†¤ìœ¼ë¡œ ë³€í™˜í•©ë‹ˆë‹¤. ìš”ì²­ëœ 'ASCII Tree'ì™€ 'Top-down' êµ¬ì¡°ë¥¼ ì ìš©í•©ë‹ˆë‹¤.\n3. **VERIFY**: 30ì´ˆ ë°›ì•„ì“°ê¸°ë¥¼ í†µí•´ ì •í™•ì„±ì„ ê²€ì¦í•˜ê³ , ê¸ˆì§€ëœ LaTeX ì‚¬ìš© ì—¬ë¶€ì™€ ê°•ì¡°(**, â˜…) ê·œì¹™ì„ í™•ì¸í•©ë‹ˆë‹¤.\n4. **SYNTHESIZE**: ëª¨ë“  ì •ë³´ë¥¼ ì´ëª¨ì§€ì™€ í•¨ê»˜ ì‹œê°ì ìœ¼ë¡œ êµ¬ì¡°í™”í•˜ì—¬ í†µí•©í•©ë‹ˆë‹¤.\n5. **REFLECT**: ëˆ„ë½ëœ \"Doorway Thought\"ë‚˜ \"Next Best Step\"ì´ ìˆëŠ”ì§€ ìµœì¢… ì ê²€í•©ë‹ˆë‹¤. Confidence Level: 1.0 (Full Audio Transcript Analysis).\n### TL;DR: Quick Overview ğŸ“‹","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-97","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","recap","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"| **Pathologies** | **Key Vignette Feature** | **Pathophysiology** | **Gold Standard Dx/Tx** |\n| --- | --- | --- | --- |\n| **IIH (Pseudotumor)** | Obese female, Morning HA, Whooshing sound | CSF absorption â†“ (V-sinus pressure â†‘) | Dx: LP (OP >250) / Tx: Acetazolamide |\n| **NPH** | Elderly, \"Magnetic Gait\", Wet/Wobbly/Wacky | Ventricles expand > Atrophy | Dx: High Vol LP (Tap Test) / Tx: VP Shunt |\n| **Acute ICP** | Cushing's Triad (HTN, Bradycardia, Irregular Resp) | Monroe-Kelly Doctrine (Box is full) | Tx: Hyperventilation, Mannitol, Surgery |\n| **Herniation** | Blown pupil (Uncal), Resp Arrest (Tonsillar) | Brain shifting compartments | **Emergency Decompression** |\n### ğŸŒ³ Top-Down Classification & Big Picture\nì´ ê°•ì˜ì˜ í•µì‹¬ì€ **\"Brain in a Box\" (Monroe-Kelly Doctrine)** ì…ë‹ˆë‹¤. ë‘ê°œê³¨ì€ ë‹«íŒ ìƒìë¼ ê³µê°„ì´ í•œì •ì ì¸ë°, ë‚´ìš©ë¬¼(Brain, Blood, CSF) ì¤‘ í•˜ë‚˜ê°€ ëŠ˜ì–´ë‚˜ë©´ ì••ë ¥(ICP)ì´ ì˜¬ë¼ê°€ê³  ê²°êµ­ì—” ë‡Œê°€ ë°€ë ¤ë‚˜ëŠ”(Herniation) ëŒ€ì°¸ì‚¬ê°€ ì¼ì–´ë‚©ë‹ˆë‹¤.\nPlaintext\n`Intracranial Pressure (ICP) Disorders\nâ”œâ”€â”€ Chronic / Subacute Processes (ì„œì„œíˆ ì§„í–‰)\nâ”‚   â”œâ”€â”€ Idiopathic Intracranial Hypertension (IIH)\nâ”‚   â”‚   â””â”€ Concept: \"Fake Tumor\" (ì••ë ¥ì€ ë†’ì€ë° ë©ì–´ë¦¬ëŠ” ì—†ìŒ)\nâ”‚   â”‚   â””â”€ Pt: ë¹„ë§Œ, ê°€ì„ê¸° ì—¬ì„±\nâ”‚   â””â”€â”€ Normal Pressure Hydrocephalus (NPH)\nâ”‚       â””â”€ Concept: \"Wet, Wobbly, Wacky\"\nâ”‚       â””â”€ Pt: ë…¸ì¸, ë°œì´ ë°”ë‹¥ì— ë¶™ìŒ (Magnetic Gait)\nâ”‚\nâ””â”€â”€ Acute ICP Crisis (ì‘ê¸‰ ìƒí™© ğŸš¨)\n    â”œâ”€â”€ Physiology: Cushing's Triad vs. Shock\n    â”œâ”€â”€ Management: Hyperventilation, Osmotic agents\n    â””â”€â”€ Herniation Syndromes (ë‡Œ íƒˆì¶œ)\n        â”œâ”€â”€ Uncal (Uncusê°€ ì§“ëˆŒë¦¼ -> CN 3 palsy)\n        â”œâ”€â”€ Subfalcine (Falx ë°‘ìœ¼ë¡œ ë°€ë¦¼ -> Leg weakness)\n        â””â”€â”€ Tonsillar (Foramen Magnumìœ¼ë¡œ ë¹ ì§ -> í˜¸í¡ ì •ì§€)`\n### 1. Idiopathic Intracranial Hypertension (IIH) ğŸ§ \n*a.k.a Pseudotumor Cerebri*\n### ğŸšª Doorway Thought (Vignette)\n**\"Obese Woman of Childbearing Age + Morning Headache\"**\ní™˜ìê°€ **ì—¬ë“œë¦„ì•½ ë¨¹ëŠ” (tetracycline - ëª¨ë‚­ì—¼, vit A)** ëš±ëš±í•œ ì Šì€ ì—¬ì„±ì¸ë°, ì•„ì¹¨ì— ì¼ì–´ë‚  ë•Œ ë¨¸ë¦¬ê°€ ê¹¨ì§ˆ ë“¯ ì•„í”„ë‹¤ê³  í•¨ (ëˆ„ì›Œìˆìœ¼ë©´ ICPê°€ ì˜¤ë¥´ë‹ˆê¹Œ).\n### ğŸ” Pathophysiology & Symptoms\n- **Mechanism**: ë‡Œì— ì§„ì§œ ì¢…ì–‘(Tumor)ì€ ì—†ëŠ”ë°, ë§ˆì¹˜ ì¢…ì–‘ì´ ìˆëŠ” ê²ƒì²˜ëŸ¼ ì••ë ¥ì´ ë†’ìŒ.\n    - CSF í¡ìˆ˜ ì¥ì•  â†’ Venous Sinus ì••ë°•.\n    - **Pulsatile Tinnitus**: ê·€ì—ì„œ \"Wooshing\" ì†Œë¦¬ê°€ ë“¤ë¦¼ (ë†’ì€ ì••ë ¥ì„ ì´ê²¨ë‚´ë ¤ëŠ” ìì‹ ì˜ í˜ˆë¥˜ ì†Œë¦¬ë¥¼ ë“£ëŠ” ê²ƒ).\n    - **Transient Visual Obscurations**: ì‹ ë°œ ëˆ ë¬¶ìœ¼ë ¤ê³  í—ˆë¦¬ë¥¼ ìˆ™ì´ë©´(Bending over) ì•ì´ ìº„ìº„í•´ì§ (ICP ê¸‰ìƒìŠ¹ â†’ ë§ë§‰ í˜ˆë¥˜ ì°¨ë‹¨).\n- **Papilledema (ìœ ë‘ë¶€ì¢…)**: ì‹œì‹ ê²½(Optic nerve)ì€ ë‡Œì™€ ê°™ì€ ë§‰(Sheath)ì— ì‹¸ì—¬ìˆì–´ì„œ, ë‡Œì••ì´ ì˜¤ë¥´ë©´ ì‹œì‹ ê²½ë„ ëˆŒë ¤ì„œ ë¶“ìŒ. ë°©ì¹˜í•˜ë©´ **ì˜êµ¬ ì‹¤ëª…(Permanent Blindness)** ê°€ëŠ¥! ğŸ˜±\n    - **CN6 palsy**: nerveë¬¸ì œëŠ” ì•„ë‹Œë° ì••ë ¥ì´ ë†’ì•„ì„œ ì‹ ê²½ì´ ëˆŒë¦¼. ë³µì‹œ ë° ì‹œì•¼ ì¥ì• \n### âš™ï¸ Diagnosis Algorithm (ìˆœì„œ ì¤‘ìš”!)\n1. **Clinical assessment**: ë³‘ë ¥ ì²­ì·¨.\n2. **Visual Field & Acuity**: ì‹œë ¥ ì†ìƒ ì—¬ë¶€ í™•ì¸ (ê°€ì¥ ë¬´ì„œìš´ í•©ë³‘ì¦).\n3. **MRI (Step 3)**: **â˜… Next Best Step**. LP ì „ì— ë°˜ë“œì‹œ ë¨¼ì € í•´ì•¼ í•¨! (Tumorë‚˜ Venous sinus thrombosisê°€ ì—†ë‹¤ëŠ” ê²ƒì„ ì¦ëª…í•´ì•¼ í•¨. Space occupying lesionì´ ìˆëŠ”ë° LP í•˜ë©´ Herniation ë¨).\n    - MR Venography (MRV)ë„ ê°™ì´ í•´ì„œ í˜ˆì „(clot) ë°°ì œ.\n4. **Lumbar Puncture (LP)**: **â˜… Gold Standard for Dx**.\n    - **Opening Pressure > 250 mmH2O** confirmed.\n### ğŸ’Š Management","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-107","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"- **Weight Loss**: ìœ ì¼í•œ **\"Disease Modifying Treatment\"**. ì‚´ ë¹¼ëŠ” ê²Œ ê·¼ë³¸ ì¹˜ë£Œ.\n- **Acetazolamide**: **â˜… First Line Drug**.\n    - Carbonic Anhydrase Inhibitor.\n    - ê¸°ì „: CSF ìƒì„±ì„ ì–µì œí•¨ (Metabolic acidosis ìœ ë°œ).\n- **Surgery (VP Shunt or Optic Nerve Sheath Fenestration)**:\n    - ì–¸ì œ? ì‹œë ¥ì´ ê¸‰ê²©íˆ ë‚˜ë¹ ì§€ê±°ë‚˜ ì•½ë¬¼ì´ ì•ˆ ë“¤ì„ ë•Œ.\n    - *Optic Nerve Sheath Fenestration*: ì‹œì‹ ê²½ ë§‰ì— ì¹¼ì§‘ì„ ë‚´ì„œ ì••ë ¥ì„ ë¹¼ì£¼ëŠ” ê²ƒ (ì‹œë ¥ ë³´ì¡´ ëª©ì ).\n### 2. Normal Pressure Hydrocephalus (NPH) ğŸ‘´\n### ğŸšª Doorway Thought (Vignette)\n**\"Elderly patient who creates a 'Magnetic Gait'\"**\ní• ì•„ë²„ì§€ê°€ ë°œì„ ë°”ë‹¥ì—ì„œ ëª» ë–¼ê³  ì§ˆì§ˆ ë„ëŠ” ëª¨ìŠµ. ì¹˜ë§¤ì¸ ì¤„ ì•Œì•˜ëŠ”ë° ê±·ëŠ” ê²Œ ë” ì´ìƒí•¨.\n### ğŸ” Pathophysiology & Clinical Triad\n- **Mnemonic**: **\"Wet, Wobbly, and Wacky\"** (ìˆœì„œëŒ€ë¡œ ë‚˜íƒ€ë‚¨).\n    1. **Wobbly (Gait Apraxia)**: ê°€ì¥ ë¨¼ì €, ê·¸ë¦¬ê³  ê°€ì¥ íŠ¹ì§•ì ì¸ ì¦ìƒ.\n        - **\"Magnetic Gait\"**: ë°œë°”ë‹¥ì— ìì„ì´ ë¶™ì€ ê²ƒì²˜ëŸ¼ ë„“ì€ ë³´í­ìœ¼ë¡œ ì§ˆì§ˆ ë” (Wide-based shuffling).\n        - *Why?* ë‡Œì‹¤(Ventricle)ì´ ì»¤ì§€ë©´ì„œ ê·¸ ì˜†ì„ ì§€ë‚˜ê°€ëŠ” **Corona Radiata** (ë‹¤ë¦¬ ìš´ë™ ì‹ ê²½ ì„¬ìœ )ë¥¼ ë¬¼ë¦¬ì ìœ¼ë¡œ ëŠ˜ë¦¼(Stretch).\n    2. **Wet (Urinary Incontinence)**: ë°©ê´‘ ì¡°ì ˆ ì„¬ìœ ë„ ê°™ì´ ëŠ˜ì–´ë‚¨. \"Urgency\"ë¥¼ ëŠë‚Œ.\n    3. **Wacky (Dementia)**: ì¸ì§€ê¸°ëŠ¥ ì €í•˜ (Reversible possibility!).\n- **Mechanism**: ë‡Œ ìœ„ì¶•(Atrophy)ì— ë¹„í•´ ë‡Œì‹¤ì´ **ë¶ˆê· í˜•í•˜ê²Œ(Disproportionately)** ì»¤ì§.\n### âš™ï¸ Diagnosis & Treatment\n- **Diagnosis**:\n    - **MRI**: Ventriculomegaly (ë‡Œì‹¤ í™•ì¥) í™•ì¸.\n    - **High Volume LP (Miller Fisher Tap Test)**: **â˜… Confirmatory Test**.\n        - CSF 30-50ccë¥¼ ë½‘ì•„ë‚¸ í›„ í™˜ìë¥¼ ê±·ê²Œ í•´ ë´„.\n        - ê±·ëŠ” ê²Œ ê°‘ìê¸° ì¢‹ì•„ì§„ë‹¤? (Response to shunting ì˜ˆì¸¡ ì¸ì) -> NPH í™•ì§„.\n- **Treatment**: **Ventriculoperitoneal (VP) Shunt**. (Permanent plumbing).\n    - IIHëŠ” ì‚¬ìš©ì•ˆí•¨.\n### 3. Acute ICP Crisis & Cushing's Triad ğŸš¨\n### ğŸšª Doorway Thought (Vignette)\n**\"Trauma patient or massive stroke with sudden vital sign changes\"**\n### ğŸ“‰ Physiology: Monroe-Kelly Doctrine\n- Skull = Fixed Box.\n- ë‡Œ, í˜ˆì•¡, CSF ì¤‘ í•˜ë‚˜ê°€ ëŠ˜ì–´ë‚˜ë©´ ë‚˜ë¨¸ì§€ê°€ ë‚˜ê°€ì•¼ í•¨.\n- ë³´ìƒ ê¸°ì „(Compensation)ì´ í•œê³„ì— ë‹¤ë‹¤ë¥´ë©´ ì••ë ¥ì´ ìˆ˜ì§ ìƒìŠ¹í•¨.\n- ì•…í™”ë˜ëŠ” ìƒí™©\n    - í‰ê°•ì••ë ¥ì´ ëŠ˜ì–´ë‚˜ëŠ” ìƒí™© (venous return ê°ì†Œ): valsalva\n    - ëˆ„ìš°ë©´ ì‹¬í™”, HA in morning (ìëŠ” ë™ì•ˆ ëˆ„ì›Œìˆìœ¼ë‹ˆê¹Œ)\n### âš ï¸ Cushing's Triad (vs Shock)\nì‡¼í¬ì™€ ì •ë°˜ëŒ€ì´ë¯€ë¡œ í—·ê°ˆë¦¬ì§€ ë§ ê²ƒ! â˜…\n- **Shock**: BP â†“, HR â†‘ (í”¼ê°€ ë¶€ì¡±í•˜ë‹ˆ ì‹¬ì¥ì´ ë¹¨ë¦¬ ëœ€).\n- **Cushing's Reflex**: **BP â†‘, HR â†“, Irregular Resp**.\n    - *Why?* ë‡Œì••ì´ ë„ˆë¬´ ë†’ì•„ì„œ í”¼ê°€ ë‡Œë¡œ ëª» ë“¤ì–´ê° -> ë‡Œê°€ \"ë‚˜ ì£½ì–´!\"ë¼ê³  ë¹„ëª…ì„ ì§€ë¦„ -> êµê°ì‹ ê²½ í­ë°œ(Sympathetic surge) -> ì „ì‹  í˜ˆê´€ ìˆ˜ì¶•(Vasoconstriction) -> **BP ê¸‰ìƒìŠ¹** (ë‡Œë¡œ í”¼ë¥¼ ë°€ì–´ ë„£ìœ¼ë ¤ê³ ).\n    - Baroreceptorê°€ ë†’ì€ í˜ˆì••ì„ ê°ì§€ -> Reflexë¡œ **HRë¥¼ ë‚®ì¶¤(Bradycardia)**.\n    - ë‡Œì¤„ê¸°(Brainstem)ê°€ ëˆŒë ¤ì„œ **í˜¸í¡ì´ ë¶ˆê·œì¹™**í•´ì§.\n### ğŸš‘ Acute Management Steps (Bridge to Surgery)","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-127","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"ìˆ˜ìˆ ì‹¤ ê°€ê¸° ì „ ì‹œê°„ì„ ë²Œì–´ì£¼ëŠ” ë°©ë²•ë“¤.\n1. **Head Elevation**: ì¹¨ëŒ€ ë¨¸ë¦¬ ì˜¬ë¦¬ê¸° (ì¤‘ë ¥ìœ¼ë¡œ ì •ë§¥í˜ˆ ë°°ì¶œ).\n2. **Hyperventilation**: **â˜… Fastest Method**.\n    - Intubate í›„ ê³¼í˜¸í¡ ì‹œí‚´ -> CO2 ë‚ ì•„ê° (Respiratory Alkalosis) -> **Cerebral Vasoconstriction** -> ë‡Œ í˜ˆë¥˜ëŸ‰ ê°ì†Œ -> ICP ê°ì†Œ.\n    - *ì£¼ì˜*: ë„ˆë¬´ ì˜¤ë˜ í•˜ë©´ ë‡Œí—ˆí˜ˆ(Ischemia) ì˜´. ì ê¹ë§Œ ì“¸ ê²ƒ!\n3. **Osmotic Therapy**:\n    - **Mannitol** or **Hypertonic Saline (3%)**.\n    - ì‚¼íˆ¬ì•• ì›ë¦¬ë¡œ ë‡Œì„¸í¬ì˜ ë¬¼ì„ í˜ˆê´€ìœ¼ë¡œ ë¹¨ì•„ë“¤ì„ (Brain spongeë¥¼ ì§œëŠ” ê²ƒ).\n4. Decompression surgery\n### 4. Herniation Syndromes ğŸšï¸\në‡Œê°€ ì••ë ¥ì„ ëª» ì´ê¸°ê³  ë‹¤ë¥¸ êµ¬íšìœ¼ë¡œ ë°€ë ¤ë‚˜ëŠ” í˜„ìƒ.\n1. **Uncal Herniation (Transtentorial)**:\n    - Temporal lobeì˜ Uncusê°€ Tentorium ë°‘ìœ¼ë¡œ ë°€ë¦¼.\n    - **CN III Compression**: **Ipsilateral Blown Pupil** (ë™ê³µ ì‚°ëŒ€, ë¹› ë°˜ì‚¬ ì—†ìŒ) + **Down & Out** eye.\n    - **Contralateral Hemiparesis**: ë°˜ëŒ€ìª½ ëª¸ ë§ˆë¹„ (ê³ ì†ë„ë¡œ Cerebral Peduncle ëˆŒë¦¼).\n2. **Subfalcine Herniation**:\n    - Cingulate gyrusê°€ Falx cerebri ë°‘ìœ¼ë¡œ ë„˜ì–´ê°.\n    - **ACA Compression**: Anterior Cerebral Arteryê°€ ëˆŒë¦¼ -> **Contralateral Leg Weakness** (ë‹¤ë¦¬ ë§ˆë¹„).\n3. **Tonsillar Herniation**:\n    - Cerebellar Tonsilì´ Foramen Magnum(ëŒ€ê³µ)ìœ¼ë¡œ ë¹ ì§.\n    - **Medulla Compression**: ìˆ¨ë‡Œ(ì—°ìˆ˜)ê°€ ëˆŒë¦¼ -> **Respiratory Arrest & Death**. ğŸ’€\n4. **Central hemorrhage**\n    - brainstemì´ ì•„ë˜ë¡œ ë°€ë¦¼.\n    - basilar arteryê°€ brain stem supply. skull baseì— ë¶™ì–´ìˆëŠ”ë° ì•„ë˜ë¡œ brain stemë‚´ë ¤ê°€ë©´ì„œ branchesë“¤ì´ ì°¢ê¹€.\n    - Brainstemì´ ì•„ë˜ë¡œ ë°€ë¦¬ë©´ì„œ(Downward shift), ë‡Œì¤„ê¸°ì— í”¼ë¥¼ ê³µê¸‰í•˜ëŠ” ì‘ì€ ë™ë§¥ë“¤ì´ ì°¢ì–´ì§. -> Brainstem internal bleeding. (ê±°ì˜ ì‚¬ë§).\n### 5. VP Shunt Complications ğŸ”§\n### ğŸšª Doorway Thought (Vignette)\n**\"Patient with history of hydrocephalus presents with fever or headache\"**\n### âš”ï¸ Infection vs. Obstruction\n1. **Assessment**: **Shunt Series** (X-rayë¡œ íŠœë¸Œê°€ ê¼¬ì´ê±°ë‚˜ ëŠì–´ì¡ŒëŠ”ì§€ í™•ì¸) -> **Shunt Tap** (ë°”ëŠ˜ ê½‚ì•„ì„œ CSF í™•ì¸).\n2. **Infection (ê°ì—¼)**:\n    - Sx: Fever, Meningismus.\n    - Tap result: WBC â†‘, Bacteria (+).\n    - Tx: **Remove Shunt** (í•­ìƒì œë§Œìœ¼ë¡œëŠ” Biofilm ë•Œë¬¸ì— ì¹˜ë£Œ ì•ˆ ë¨) + External Drain (EVD) + Antibiotics -> ë‚˜ì¤‘ì— ìƒˆ Shunt ë„£ìŒ.\n3. **Obstruction (ë§‰í˜)**:\n    - Sx: Headache recurrence (ì••ë ¥ì´ ë‹¤ì‹œ ì°¸).\n    - Tap result: High Opening Pressure but **Clean Fluid**.\n    - Tx: ê³ ì¥ ë‚œ ë¶€ìœ„ êµì²´ (Replace non-functioning part).","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-147","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","treatment"]}
{"chunk_type":"recap_summary","text":"### ğŸ”¥ Rapid Fire Recap Table\n| **Scenario** | **Next Best Step / Action** | **Key Concept** |\n| --- | --- | --- |\n| Obese female, headache, papilledema, ì—¬ë“œë¦„ì•½ | **MRI first** -> then LP | Rule out mass before LP |\n| IIH confirmed (LP > 250) | **Acetazolamide** + Wt loss | Decrease CSF production |\n| Elderly, \"feet stuck to floor\" ìì„ë°œ | **High Volume LP (Tap Test)** | Predicts response to VP shunt |\n| Trauma + HTN + Bradycardia | **Intubate & Hyperventilate** | Cushing's Triad (ICP Crisis) |\n| Blown pupil after head trauma | **Emergent Decompression** | Uncal Herniation (CN III) |\n| VP Shunt patient + Fever | **Shunt Tap** -> Remove if infected | Abx alone won't clear hardware |\n### Confidence & Caveats\n    - **LP ê¸ˆê¸°**: Papilledemaë‚˜ ICP ìƒìŠ¹ ì§•í›„ê°€ ìˆì„ ë•Œ, **ì ˆëŒ€ë¡œ** CT/MRIë¡œ Massë¥¼ ë°°ì œí•˜ê¸° ì „ê¹Œì§€ LPë¥¼ í•˜ë©´ ì•ˆ ë©ë‹ˆë‹¤ (Herniation ìœ„í—˜).\n    - **NPH ì§„ë‹¨**: MRIì—ì„œ ë‡Œì‹¤ì´ í¬ë‹¤ê³  ë¬´ì¡°ê±´ NPHê°€ ì•„ë‹˜. ë‡Œ ìœ„ì¶•(Atrophy)ìœ¼ë¡œ ì¸í•œ *Hydrocephalus ex vacuo*ì™€ êµ¬ë³„í•´ì•¼ í•¨ (ì¦ìƒì´ ì¤‘ìš”).\n    - **Hyperventilation**: ì„ì‹œ ë°©í¸ì„. ë„ˆë¬´ ê³¼í•˜ê²Œ í•˜ë©´ ë‡Œê²½ìƒ‰ ì˜´.\n### **TL;DR Overview**\n- **Topic:** Headache Management & USMLE High-Yield Points\n- **Key Concept:** Pattern Recognition (Patient Behavior & History)\n- **Core Distinction:** Primary (Migraine, Tension, Cluster) vs. Secondary (Thunderclap/Red Flags)\n- **Critical Action:** Rule out vascular disasters (SAH) first!","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-161","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","recap","treatment"]}
{"chunk_type":"transcript_chunk","text":"### **Big Picture: Headache Top-Down Classification**\nì´ ê°•ì˜ì˜ í•µì‹¬ì€ **\"Patient's Behavior in the Dark Room\"**ê³¼ **\"Time Course\"**ì…ë‹ˆë‹¤. ë¨¸ë¦¿ì†ì— ì´ ì§€ë„ë¥¼ ê·¸ë¦¬ì„¸ìš”! ğŸ—ºï¸\nPlaintext\n`HEADACHE (ë‘í†µ)\nâ”‚\nâ”œâ”€â”€ 1. PRIMARY HEADACHES (ê¸°ëŠ¥ì  ì›ì¸)\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ MIGRAINE (í¸ë‘í†µ)\nâ”‚   â”‚   â”œâ”€â”€ Adult: Unilateral, Pulsatile, Photo/Phonophobia\nâ”‚   â”‚   â”œâ”€â”€ Pediatric: Bi-frontal (ì´ë§ˆ ì „ì²´), Shorter duration\nâ”‚   â”‚   â””â”€â”€ Pregnancy: Step-wise treatment (Safety first!)\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ TENSION (ê¸´ì¥ì„±)\nâ”‚   â”‚   â””â”€â”€ Bilateral, Band-like, \"Vice grip\", No N/V\nâ”‚   â”‚\nâ”‚   â””â”€â”€ CLUSTER (êµ°ë°œì„±) ğŸ’£\nâ”‚       â””â”€â”€ Male > Female, Orbital pain, Autonomic Sx (tearing, runny nose)\nâ”‚       â””â”€â”€ â˜… Key Behavior: PACING, AGITATED (Suicide Headache)\nâ”‚\nâ”œâ”€â”€ 2. SECONDARY HEADACHES (ê¸°ì§ˆì  ì›ì¸ - ğŸš¨ EMERGENCY)\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ THUNDERCLAP (ë²¼ë½ ë‘í†µ)\nâ”‚   â”‚   â”œâ”€â”€ SAH (Subarachnoid Hemorrhage) - \"Worst of life\"\nâ”‚   â”‚   â”œâ”€â”€ RCVS (Reversible Cerebral Vasoconstriction)\nâ”‚   â”‚   â”œâ”€â”€ Pituitary Apoplexy (Vision loss + Headache)\nâ”‚   â”‚   â”œâ”€â”€ Carotid Dissection (Neck trauma)\nâ”‚   â”‚   â””â”€â”€ CVST (Cavernous Sinus Thrombosis)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ MEDICATION OVERUSE (ì•½ë¬¼ ê³¼ìš©)\nâ”‚       â””â”€â”€ Rebound pain from painkillers`\n# 03 Headache: The USMLE Minefield ğŸ§ ğŸ’£\n## 1. The \"Doorway\" Assessment: Visualizing the Patient ğŸšª\nì‘ê¸‰ì‹¤ ë¬¸ì„ ì—´ì—ˆì„ ë•Œ í™˜ìì˜ í–‰ë™ë§Œ ë³´ê³ ë„ ì§„ë‹¨ì„ ì¢í˜€ì•¼ í•©ë‹ˆë‹¤!\n- **Patient A (The Vascular Disaster ğŸš¨):**\n    - ë¹„ëª…ì„ ì§€ë¥´ê³  ë¨¸ë¦¬ë¥¼ ë¶€ì—¬ì¡ê³  ìˆìŒ.\n    - \"10ì  ë§Œì ì— 10ì  ì•„íŒŒìš”! 1ì´ˆ ë§Œì— ì´ë ‡ê²Œ ëì–´ìš”!\"\n    - **Impression:** **Thunderclap Headache** (SAH ë“± í˜ˆê´€ ë¬¸ì œ ì˜ì‹¬).\n- **Patient B (The Migraineur ğŸ¤¢):**\n    - ì–´ë‘ìš´ ë°©ì— ì„ ê¸€ë¼ìŠ¤ë¥¼ ë¼ê³  ì•‰ì•„ ìˆìŒ.\n    - ì–‘ë™ì´(bucket)ë¥¼ ë“¤ê³  ìˆìŒ (êµ¬í†  ëŒ€ë¹„).\n    - ë§¤ìš° ì²œì²œíˆ ì›€ì§ì„. \"ì´ëŸ° ëŠë‚Œ ì˜ˆì „ì—ë„ ìˆì—ˆì–´ìš”.\"\n    - **Impression:** **Classic Migraine**.\n## 2. Primary Headaches: The Comparison Table ğŸ“Š\nUSMLEê°€ ì‚¬ë‘í•˜ëŠ” 3ëŒ€ì¥ ë¹„êµì…ë‹ˆë‹¤. **Row by Row**ë¡œ ëœ¯ì–´ë´…ì‹œë‹¤.\n| **Feature** | **Migraine (í¸ë‘í†µ) ğŸ§ ** | **Tension (ê¸´ì¥ì„±) ğŸ˜** | **Cluster (êµ°ë°œì„±) â˜„ï¸** |\n| --- | --- | --- | --- |\n| **Sex** | **Female** >> Male | **Female** > Male | **Male** >> Female (Key Demographics!) |\n| **Genetics** | Strong Family Hx (ì—„ë§ˆê°€ ìˆìœ¼ë©´ ë”¸ë„!) | No specific history | No specific history |\n| **Onset** | Variable | Stressful work day | **During Sleep** ğŸ’¤ (Alarm clock headache) |\n| **Location** | **Unilateral** (í•œìª½) | **Bilateral/Band-like** (ë  ëª¨ì–‘) | **Orbital/Retro-orbital** (ëˆˆ ë’¤ìª½, í•œìª½) |\n| **Character** | Pulsatile, Throbbing (ì‹¬ì¥ ë›°ë“¯) | Dull, Tight, Vice-grip (ì¡°ì´ëŠ” ëŠë‚Œ) | **Sharp, Excrutiating, Hot poker** (ëˆˆì„ ì°Œë¥´ëŠ” ë“¯) |\n| **Duration** | **4 - 72 Hours** (Long) | 30 min - 7 Days | **15 - 90 min** (Short & Sharp) |\n| **Associated Sx** | Aura, **Nausea/Vomiting**, Photo/Phonophobia | Mild muscle tenderness (No N/V)\nNo photophobia! | **Autonomic Sx:** Tearing, Runny nose, Horner's syndrome (Ptosis, Miosis) |\n| **Behavior** | **Lies Still** in Dark Room (ì›€ì§ì´ë©´ ì•…í™”) | Functions normally | **PACING, ROCKING, Agitated** (ê°€ë§Œíˆ ëª» ìˆìŒ!) ğŸƒâ€â™‚ï¸ |\n| Abortive tx. |   â€¢ Triptans (sumatriptan PO)\n  â€¢ NSAIDS, AAP\n  â€¢ Antiemetics\n  â€¢ Ergots (Dihydroergotamine)\nì£¼ì˜) Triptan, Ergot ê°™ì´ ë³µìš©í•˜ì§€ ì•ŠìŒ. ë‘˜ ë‹¤ í˜ˆê´€ìˆ˜ì¶•ì œì„ |  |   â€¢ 100 O2\n  â€¢ Sumatriptan (ì£¼ì‚¬ë¡œ subcutaneous)\n  â€¢ Zolmitraptan nasal spray (POë¡œ ì“°ê¸°ì—” êµ°ì§‘ë‘í†µìì²´ê°€ durationì´ ì§§ìŒ) |\n| Preventive tx. |   â€¢ Topiramates\n  â€¢ TCA\n  â€¢ BB |  |   â€¢ Verapamil (main)\n  â€¢ Lithium\n  â€¢ Topiramate |\n### ğŸ’¡ Clinical Pearls & USMLE Traps\n- **The \"Suicide Headache\":** Cluster Headache í™˜ìëŠ” í†µì¦ì´ ë„ˆë¬´ ì‹¬í•´ì„œ ë²½ì— ë¨¸ë¦¬ë¥¼ ë°•ê±°ë‚˜ ë°©ì„ ì„œì„±ê±°ë¦½ë‹ˆë‹¤(Pacing). ì§€ë¬¸ì—ì„œ \"Patient is pacing while holding his eye\"ë¼ê³  í•˜ë©´ **ì¦‰ì‹œ Cluster**ë¥¼ ì°ìœ¼ì„¸ìš”!\n- **Migraine Behavior:** í™˜ìëŠ” ì›€ì§ì´ë©´ ë¨¸ë¦¬ê°€ ìš¸ë¦¬ê¸° ë•Œë¬¸ì—(\"throb\"), ì–´ë‘ìš´ ë°©ì— ì‹œì²´ì²˜ëŸ¼ ëˆ„ì›Œìˆìœ¼ë ¤ í•©ë‹ˆë‹¤.","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-171","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","treatment"]}
{"chunk_type":"transcript_chunk","text":"## 3. Deep Dive: Specific Scenarios & Management ğŸ’Š\n### A. Pediatric Migraine (ì†Œì•„ í¸ë‘í†µ) ğŸ‘¶\n- **Trap:** ì„±ì¸ê³¼ ë‹¬ë¦¬ **Bilateral (Bi-frontal)**ì¸ ê²½ìš°ê°€ ë§ìŠµë‹ˆë‹¤!\n    - ì–´ë¥¸ì€ í•œìª½, ì• ë“¤ì€ ì´ë§ˆ ì „ì²´.\n- **Duration:** ì„±ì¸ë³´ë‹¤ ì§§ìŠµë‹ˆë‹¤.\n- **Sx:** ë³µí†µ(Abdominal migraine), êµ¬í† , ì–´ì§€ëŸ¬ì›€ ë“±ì´ ë™ë°˜ë  ìˆ˜ ìˆìŒ. ì–´ë¦°ì´ì—ì„œì˜ í¸ë‘í†µì€ ì„±ì¸ì—ì„œì˜ cluster headacheì™€ ë¹„ìŠ·í•¨.\n### B. Migraine in Pregnancy (ì„ì‚°ë¶€ í¸ë‘í†µ) ğŸ¤°\nì„ì‹  ì¤‘ ì•½ë¬¼ ì‚¬ìš©ì€ **Escalation Ladder**ë¥¼ ë”°ë¼ì•¼ í•©ë‹ˆë‹¤. íƒœì•„ ì•ˆì „ì´ ìµœìš°ì„ !\n- **Step 1:** **Non-pharmacologic** (íœ´ì‹, ìˆ˜ë¶„ ì„­ì·¨, ì°œì§ˆ) - Trigger í”¼í•˜ê¸°.\n- **Step 2:** **Acetaminophen (Tylenol)** - All trimesters ì•ˆì „.\n- **Step 3:** Antiemetics (Promethazine), Codeine, Caffeine.\n- **Step 4 (WARNING âš ï¸):** **NSAIDs** (Ibuprofen, Naproxen)\n    - **2nd Trimester ONLY.**\n    - **3rd Trimester ê¸ˆê¸°:** íƒœì•„ì˜ **Ductus Arteriosus(ë™ë§¥ê´€)**ë¥¼ ì¡°ê¸°ì— ë‹«ì•„ë²„ë ¤ íƒœì•„ ìˆœí™˜ì— ì¹˜ëª…ì ì¼ ìˆ˜ ìˆìŒ.\n- **Step 5 (Last Resort):** Opioids (Oxycodone) - ìƒë¦¬ì ìœ¼ë¡œëŠ” 3ê¸° NSAIDë³´ë‹¤ ì‹¬ì¥ì— ì•ˆì „í• ì§€ ëª°ë¼ë„ ìµœí›„ì˜ ìˆ˜ë‹¨.\n### C. Cluster Headache Treatment\n- **Acute (Abortive) â˜…:** **100% High-Flow Oxygen** (6-12L/min for 15 min). ì´ê²ƒì´ **Gold Standard**ì…ë‹ˆë‹¤. ì•½ë³´ë‹¤ ë¹ ë¦„!\n    - Alternative: Sumatriptan (Subcutaneous) - ì£¼ì‚¬ë¼ ë¹ ë¦„.\n- **Prophylaxis (Preventive):** **Verapamil** (Calcium Channel Blocker) is the drug of choice.\n### D. Drug Interactions (Black Box Warning â¬›)\n- **Triptan + Ergot:** ì ˆëŒ€ ê°™ì´ ì“°ë©´ ì•ˆ ë¨! ë‘˜ ë‹¤ í˜ˆê´€ ìˆ˜ì¶•ì œ(Vasoconstrictor)ì…ë‹ˆë‹¤.\n    - ë™ì‹œì— ì“°ë©´ **Coronary Vasospasm** (MI) ë˜ëŠ” **Stroke** ìœ ë°œ ê°€ëŠ¥.\n    - ë°˜ë“œì‹œ \"Washout period\"ê°€ í•„ìš”í•¨.\n## 4. Medication Overuse Headache (Rebound Headache) ğŸ”„\n- **Concept:** ì§„í†µì œë¥¼ ë„ˆë¬´ ìì£¼ ë¨¹ì–´ì„œ, ì•½íš¨ê°€ ë–¨ì–´ì§ˆ ë•Œ ê¸ˆë‹¨ ì¦ìƒ(Withdrawal)ìœ¼ë¡œ ë‘í†µì´ ë” ì‹¬í•˜ê²Œ ì˜¤ëŠ” í˜„ìƒ.\n- **Definition:** Pain medication use **> every other day** (ê²©ì¼ ì´ìƒ ì‚¬ìš©).\n- **Culprits:** Butalbital, Opioids, Acetaminophen (ì‹¬ì§€ì–´ íƒ€ì´ë ˆë†€ë„!), Triptans.\n- **Management:**\n    1. **Stop the offending agent** (Cessation).\n    2. Start preventive therapy immediately.\n    3. í™˜ìì—ê²Œ \"ì²˜ìŒì—” ë” ì•„í”Œ ìˆ˜ ìˆë‹¤\"ê³  êµìœ¡í•´ì•¼ í•¨.\n## 5. Secondary Headaches: The \"Thunderclap\" âš¡ï¸ğŸš¨\n**Definition:** \"Sudden onset, severe headache reaching **maximum intensity** in less than 1 hour (usually seconds to minutes).\"\n### Etiology (The \"Zebras\" & Killers)\n1. **SAH (Subarachnoid Hemorrhage):** ê°€ì¥ í”í•˜ê³  ìœ„í—˜í•¨. \"ê³ í˜ˆì••í™˜ìê°€ ë’·ëª©ì´ ë»£ë»£í•¨(Nuchal rigidity)\".\n2. **RCVS (Reversible Cerebral Vasoconstriction Syndrome):** ë°˜ë³µì ì¸ ë²¼ë½ ë‘í†µ\n3. **Pituitary Apoplexy (ë‡Œí•˜ìˆ˜ì²´ ì¡¸ì¤‘):**\n    - ë‡Œí•˜ìˆ˜ì²´ë¡œ ì¶œí˜ˆ ë°œìƒ. Optic Chiasm ì••ë°•.\n    - **Signs:** **Ophthalmoplegia** (ëˆˆ ì›€ì§ì„ ë§ˆë¹„), **Visual Field Defects** (Tunnel vision), Signs of Adrenal Crisis (ì €í˜ˆì••).\n4. **Cervical Artery Dissection:** ëª© ì™¸ìƒ í›„ ë°œìƒ.\n5. **CVST (Cavernous Sinus Thrombosis):** ì•ˆêµ¬ ëŒì¶œ(Proptosis), ê³ ì—´, ê°ì—¼ ì§•í›„ ë™ë°˜.\n### Workup Protocol (The Algorithm) âš™ï¸\nThunderclap í™˜ìê°€ ì˜¤ë©´ ì´ ìˆœì„œë¥¼ ì ˆëŒ€ ì–´ê¸°ë©´ ì•ˆ ë©ë‹ˆë‹¤!","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-191","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"1. **Step 1:** **Non-contrast CT Head**\n    - Subarachnoid spaceì˜ í”¼ë¥¼ ë´…ë‹ˆë‹¤.\n    - *Scenario:* CTê°€ ê¹¨ë—í•¨(Negative). ì§‘ì— ë³´ë‚´ë„ ë˜ë‚˜? **NO!** ğŸ™…â€â™‚ï¸\n2. **Step 2:** **Lumbar Puncture (LP)**\n    - ì‘ì€ ì¶œí˜ˆ(Small bleed)ì€ CTì—ì„œ ì•ˆ ë³´ì¼ ìˆ˜ ìˆìŒ.\n    - **Look for:** **Xanthochromia** (ë…¸ë€ìƒ‰ ë‡Œì²™ìˆ˜ì•¡ - ì í˜ˆêµ¬ê°€ ê¹¨ì ¸ì„œ ë¹Œë¦¬ë£¨ë¹ˆì´ ëœ ê²ƒ).\n3. **Step 3:** **MRI Brain**\n    - CT, LP ë‘˜ ë‹¤ ì• ë§¤í•˜ê±°ë‚˜ ìŒì„±ì¸ë° ì˜ì‹¬ë˜ë©´ MRI.\n## ğŸ”¥ Rapid Fire Recap: High-Yield Associations\n| **Clue in Question** | **Diagnosis** | **Next Step / Treatment** |\n| --- | --- | --- |\n| \"Worst headache of my life\" | **SAH** (Thunderclap) | Non-contrast CT â†’ LP |\n| Male, pacing around room, holding eye | **Cluster Headache** | **100% Oxygen** (First line) |\n| Female, pulsatile pain, vomiting, dark room | **Migraine** | Triptan (Abortive) / Beta-blocker (Prevent) |\n| Band-like pressure, \"tight hat\" | **Tension Headache** | NSAIDs / Relaxation |\n| Pregnant (3rd Tri) with Migraine | **Migraine** | **Avoid NSAIDs!** (Use Tylenol/Opioids) |\n| Child with \"Bi-frontal\" headache | **Pediatric Migraine** | Rest, Hydration, Tylenol |\n| Headache + Visual field cut + Hypotension | **Pituitary Apoplexy** | Urgent Surgical Consult / Steroids |\n    - ì˜¤ë””ì˜¤ì—ì„œëŠ” Pediatric Migraineì´ \"Bifrontal\"ì´ë¼ê³  ê°•ì¡°í–ˆì§€ë§Œ, ì‹¤ì œ ì„ìƒì—ì„œëŠ” ë‹¤ì–‘í•  ìˆ˜ ìˆìœ¼ë‹ˆ Board Exam íŒíŠ¸ë¡œ ê¸°ì–µí•˜ì„¸ìš”.\n    - Cluster Headache ì¹˜ë£Œì—ì„œ ì‚°ì†Œ ì¹˜ë£Œê°€ \"Gold Standard\"ë¼ê³  í–ˆì§€ë§Œ, ë§Œì„± íì§ˆí™˜(COPD) í™˜ìì—ê²ŒëŠ” ì£¼ì˜ê°€ í•„ìš”í•  ìˆ˜ ìˆë‹¤ëŠ” ì (ì˜¤ë””ì˜¤ì—” ì—†ì§€ë§Œ ì˜í•™ì  ìƒì‹)ì„ ì—¼ë‘ì— ë‘ì„¸ìš”.\n    - ì„ì‹  ì¤‘ NSAID ê¸ˆê¸°ëŠ” 3ë¶„ê¸°(3rd Trimester)ê°€ ê°€ì¥ ì¹˜ëª…ì ì…ë‹ˆë‹¤.\n**Next Step for User:** Would you like me to generate a **\"USMLE Style Vignette Quiz\"** based on these notes to test your retention? ğŸ“\n**Next Step for User:** Would you like me to generate a **\"USMLE Style Vignette Quiz\"** based on these notes to test your retention? ğŸ“\n# ğŸ§  USMLE Top-down Classification: Seizure & Epilepsy\nì•ˆë…•í•˜ì„¸ìš”! ğŸ‘¨â€âš•ï¸ Deep Dive Audioë¥¼ ë°”íƒ•ìœ¼ë¡œ ì •ë¦¬í•œ Epilepsy & Seizure Management ë…¸íŠ¸ì…ë‹ˆë‹¤. ì´ë²ˆ ì—í”¼ì†Œë“œëŠ” ë‹¨ìˆœíˆ ì•½ë¬¼ ì•”ê¸°ê°€ ì•„ë‹ˆë¼, **\"Time is Brain\"**ì´ë¼ëŠ” ìƒë¦¬í•™ì  ìœ„ê¸° ìƒí™©ì„ ë‹¤ë£¹ë‹ˆë‹¤.\në¨¼ì €, ì „ì²´ì ì¸ **Big Picture**ë¥¼ ASCII Treeë¡œ ì¡ê³  ë“¤ì–´ê°‘ì‹œë‹¤!\nPlaintext\n`[Concept: Electrical Storm of the Brain]\n      |\n      +-- 1. Physiological Crisis (Status Epilepticus) ğŸš‘\n      |     |-- Definition: Seizure > 5 mins (OLD: 30 mins)\n      |     |-- Pathophysiology: Glutamate storm -> Ca2+ influx -> Cell Death\n      |     +-- MGT: Benzodiazepine -> Anti-epileptics -> Anesthesia\n      |\n      +-- 2. Seizure Classification (By Onset)\n      |     |\n      |     +-- A. Focal Seizures (Partial)\n      |     |     |-- Origin: One Hemisphere\n      |     |     |-- Awareness Intact (Simple Partial)\n      |     |     +-- Awareness Impaired (Complex Partial) -> Automatism\n      |     |\n      |     +-- B. Generalized Seizures\n      |           |-- Origin: Both Hemispheres\n      |           |-- Tonic-Clonic (Grand Mal)\n      |           |-- Absence (Petit Mal) -> 3Hz Spike & Wave âš¡\n      |           +-- Myoclonic / Atonic\n      |\n      +-- 3. Differential Diagnosis (The Impostors)\n            +-- Syncope vs. Seizure (Key: Post-ictal State â˜…)\n            +-- Psychogenic Non-Epileptic Seizures (PNES)`\n# H1: 1. The Framework: \"Time is Brain\" â³ğŸ§ \nì´ ì±•í„°ì˜ í•µì‹¬ì€ **Seizure Managementì˜ ìŠ¤í™íŠ¸ëŸ¼**ì„ ì´í•´í•˜ëŠ” ê²ƒì…ë‹ˆë‹¤. ìˆ˜í•™ ì‹œê°„ì— ë©ë•Œë¦¬ëŠ” ì•„ì´ë¶€í„°, ì‘ê¸‰ì‹¤ì—ì„œ ê²½ë ¨ì„ ë©ˆì¶”ì§€ ì•ŠëŠ” í™˜ìê¹Œì§€ ëª¨ë‘ 'Seizure'ë¼ëŠ” ìš°ì‚° ì•„ë˜ ìˆìŠµë‹ˆë‹¤.","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-211","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"### ğŸšª Doorway Thoughts (Mental Imagery)\nì˜¤ë””ì˜¤ì—ì„œëŠ” ë‘ ê°€ì§€ ìƒë°˜ëœ ì´ë¯¸ì§€ë¥¼ ì œì‹œí•˜ì—¬ ìŠ¤í™íŠ¸ëŸ¼ì„ ì„¤ëª…í•©ë‹ˆë‹¤.\n1. **Scene 1: The Nightmare (Status Epilepticus)** ğŸ‘¹\n    - **Setting:** Trauma Bay, Absolute Chaos.\n    - **Patient:** Stretcher ìœ„ì—ì„œ ê²©ë ¬í•˜ê²Œ ê²½ë ¨ ì¤‘ (Violently convulsing).\n    - **Team:** ì†Œë¦¬ ì§€ë¥´ê³  ìˆê³ , ì‹œê³„ë¥¼ ë³´ê³  ìˆìŒ. \"6ë¶„ì´ ì§€ë‚¬ì–´! ë©ˆì¶”ì§€ ì•Šì•„!\"\n    - **Meaning:** ì´ê²ƒì´ ë°”ë¡œ **Status Epilepticus**. \"Time is Brain\"ì€ ë‹¨ìˆœí•œ ìŠ¬ë¡œê±´ì´ ì•„ë‹ˆë¼ ìƒë¦¬í•™ì  ì‚¬ì‹¤ì…ë‹ˆë‹¤. ë‰´ëŸ°ì´ ì£½ì–´ê°€ê³  ìˆëŠ” ìƒí™©ì…ë‹ˆë‹¤.\n2. **Scene 2: The Quiet Classroom (Absence Seizure)** ğŸ«\n    - **Setting:** ì¡°ìš©í•œ 3í•™ë…„ êµì‹¤.\n    - **Patient:** ì±…ìƒì— ì•‰ì•„ ì¹ íŒì„ ë©í•˜ë‹ˆ ì‘ì‹œí•˜ëŠ” ì•„ì´ (Blank stare).\n    - **Action:** ì„ ìƒë‹˜ì´ ì§ˆë¬¸í•˜ì 10ì´ˆ ë’¤ì— ì•„ì´ê°€ í˜„ì‹¤ë¡œ 'Snap back' í•˜ì—¬ ì—°í•„ì„ ì§‘ì–´ ë“¦. ì“°ëŸ¬ì§€ê±°ë‚˜ ë–¨ì§€ ì•ŠìŒ.\n    - **Meaning:** ì´ê²ƒì€ **Absence Seizure**. ìŠ¤í™íŠ¸ëŸ¼ì˜ ë°˜ëŒ€í¸ ëì— ìˆëŠ” ë¯¸ë¬˜í•œ ë°œì‘ì…ë‹ˆë‹¤.\n# H1: 2. The Workup: Being a Detective ğŸ•µï¸â€â™‚ï¸\ní™˜ìê°€ ë°œì‘ìœ¼ë¡œ ì‹¤ë ¤ì™”ê±°ë‚˜, ë°œì‘ì´ ëë‚œ í›„(Post-ictal) ìƒíƒœì¼ ë•Œ, ìš°ë¦¬ëŠ” **ë°˜ë“œì‹œ ë°°ì œí•´ì•¼ í•  ë¦¬ìŠ¤íŠ¸(Must Exclude List)**ê°€ ìˆìŠµë‹ˆë‹¤. Epilepsy(ë‡Œì „ì¦)ëŠ” ë§Œì„± ì§ˆí™˜ì´ë¯€ë¡œ, ê¸‰ì„± ì›ì¸ë“¤ì„ ë¨¼ì € rule out í•´ì•¼ ì§„ë‹¨í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n### ğŸš‘ Rule Out Reversible Causes (The Checklist)\n1. **The Heart (ECG) â¤ï¸**\n    - ê°€ì¥ ë¨¼ì € ë´ì•¼ í•  ê³³ì€ ë‡Œê°€ ì•„ë‹ˆë¼ ì‹¬ì¥ì…ë‹ˆë‹¤.\n    - **Why?** Massive Arrhythmia (ì˜ˆ: V-fib) -> ë‡Œë¡œ ê°€ëŠ” í˜ˆë¥˜ ì¤‘ë‹¨ -> ë‡Œì˜ ì €ì‚°ì†Œì¦(Hypoxia) -> ë‡Œì„¸í¬ê°€ ì˜ˆë¯¼í•´ì ¸ì„œ Seizure ìœ ë°œ.\n    - **Clinical Pearl:** ë¶€ì •ë§¥ì„ ë†“ì¹˜ë©´, ì‹¬ì¥ì´ ë©ˆì¶”ê³  ìˆëŠ”ë° ë°œì‘ ì¹˜ë£Œë§Œ í•˜ëŠ” ê¼´ì´ ë©ë‹ˆë‹¤.\n2. **Neuro-Imaging (CT or MRI) ğŸ“¸**\n    - **Goal:** Structural Lesion ë°°ì œ.\n    - **Look for:** Bleed (ì¶œí˜ˆ), Tumor (ì¢…ì–‘), Abscess (ë†ì–‘).\n    - **â˜… The \"First Seizure Rule\" for Adults:**\n        - ë§Œì•½ **50ì„¸ ì´ìƒ ì„±ì¸**ì´ ë‚œìƒì²˜ìŒ ë°œì‘(First-time seizure)ì„ í–ˆë‹¤?\n        - **Brain Tumor (Mass Lesion)** until proven otherwise.\n3. **The Labs (Blood Work) ğŸ©¸**\n    - ë‡ŒëŠ” í¬ë„ë‹¹(Glucose)ìœ¼ë¡œ ëŒì•„ê°‘ë‹ˆë‹¤.\n    - **Hypoglycemia (ì €í˜ˆë‹¹):** ì—°ë£Œ íƒ±í¬ê°€ ë¹„ë©´ ì´ì˜¨ íŒí”„ê°€ ê³ ì¥ ë‚˜ê³ , ë§‰ì „ìœ„ê°€ ë¶ˆì•ˆì •í•´ì ¸ì„œ Seizure ë°œìƒ.\n    - **Electrolytes:**\n        - **Sodium (Na+):** Hyponatremia -> Cerebral Edema (ë‡Œë¶€ì¢…) -> Cortex ìê·¹.\n        - **Calcium (Ca++), Magnesium (Mg++):** ë‚®ìœ¼ë©´ ë‰´ëŸ°ì˜ í¥ë¶„ì„±(Excitability) ì¦ê°€.\n4. **Prolactin (The Lie Detector) ğŸ¤¥**\n    - **Significance:** ì§„ì§œ ëŒ€ë°œì‘(Generalized Tonic-Clonic Seizure) ì§í›„ì—ëŠ” ë‡Œí•˜ìˆ˜ì²´ê°€ ìê·¹ë°›ì•„ Prolactinì„ ìŸì•„ëƒ…ë‹ˆë‹¤.\n    - **Timeline:** ì‹¤ì œ ë°œì‘ í›„ 10~20ë¶„ ë’¤ì— ìˆ˜ì¹˜ê°€ ê¸‰ë“±(Spike)í•¨.\n    - **Clinical Use:** í™˜ìê°€ ë°”ë‹¥ì—ì„œ ë’¹êµ´ì—ˆëŠ”ë° 15ë¶„ ë’¤ Prolactinì´ ì •ìƒì´ë‹¤? -> **Psychogenic (ê°€ì§œ ë°œì‘)** í˜¹ì€ **Syncope**ì¼ ê°€ëŠ¥ì„± ë†’ìŒ.\n5. **Toxicology Screen ğŸ§ª**\n    - **Stimulants:** Cocaine, Amphetamines (Seizure Threshold ë‚®ì¶¤).\n    - **Withdrawal:** Alcohol Withdrawal (ë§ˆì§€ë§‰ ìˆ  ë§ˆì‹œê³  12~48ì‹œê°„ ë’¤ ë°œìƒ). ë°˜ë“œì‹œ ì²´í¬!\n6. **Lumbar Puncture (LP) ğŸ’‰**\n    - **Warning:** ëª¨ë“  í™˜ìì—ê²Œ í•˜ëŠ” ê²ƒì´ ì•„ë‹˜!\n    - **Indication:** **CNS ê°ì—¼(Infection)** ì˜ì‹¬ ì‹œì—ë§Œ ìˆ˜í–‰ (ì—´(Fever), ê²½ë¶€ ê°•ì§(Stiff neck), ë²¼ë½ ë‘í†µ ë“±).\n# H1: 3. Focal Seizures (ë¶€ë¶„ ë°œì‘) ğŸ¯\nFocal SeizureëŠ” ë‡Œì˜ **í•œìª½ ë°˜êµ¬(Hemisphere)**ì—ì„œë§Œ ì „ê¸°ì  ë°©ì „ì´ ì‹œì‘ë˜ëŠ” ê²ƒì…ë‹ˆë‹¤. ì¦ìƒì€ \"ì–´ë””ì„œ ë¶ˆì´ ë‚¬ëŠëƒ\"ì— ë”°ë¼ ë‹¬ë¼ì§‘ë‹ˆë‹¤.\n### A. Symptom Buckets (ì¦ìƒ ë¶„ë¥˜)\n| **Bucket** | **Symptoms** | **Location Example** |\n| --- | --- | --- |\n| **Motor** | **Jacksonian March:** ì—„ì§€ì†ê°€ë½ì´ ë–¨ë¦¬ê¸° ì‹œì‘ -> ì† -> íŒ” -> ì–¼êµ´ë¡œ ë–¨ë¦¼ì´ í–‰ì§„í•˜ë“¯ í¼ì§. (Homunculus ì§€ë„ ë”°ë¼ ì´ë™) | Motor Cortex |\n| **Sensory** | íƒ€ëŠ” ê³ ë¬´ ëƒ„ìƒˆ(Burning rubber), ë²ˆì©ì´ëŠ” ë¹›, í•œìª½ ëª¸ì˜ ë”°ë”ê±°ë¦¼(Pins & needles). | Sensory Cortex / Temporal |\n| **Autonomic** | ì„¤ëª…í•˜ê¸° í˜ë“  ë±ƒì†ì—ì„œ ì¹˜ë¯¸ëŠ” ëŠë‚Œ (Epigastric rising sensation), ì‹ì€ë•€, ì†Œë¦„. | Insula / Deep structures |\n| **Psychic** | **DÃ©jÃ  vu** (ì´ë¯¸ ë³¸ ê²ƒ ê°™ì€ ëŠë‚Œ), ê°‘ì‘ìŠ¤ëŸ¬ìš´ ê³µí¬(Fear), ì„¸ìƒì´ ë‚¯ì„¤ê²Œ ë³´ì„. | **Temporal Lobe** (Limbic system) |\n### B. Classification Update (ìš©ì–´ ì •ë¦¬) ğŸ“\nê³¼ê±°ì—ëŠ” Simple Partial / Complex Partialì´ë¼ê³  ë¶ˆë €ì§€ë§Œ, ì§€ê¸ˆì€ **\"Awareness(ì˜ì‹)\"** ê¸°ì¤€ìœ¼ë¡œ ë¶„ë¥˜í•©ë‹ˆë‹¤.\n1. **Focal Seizure with Intact Awareness (êµ¬ Simple Partial)**\n    - í™˜ìê°€ ê¹¨ì–´ ìˆê³ , ìì‹ ì˜ íŒ”ì´ ë–¨ë¦¬ëŠ” ê²ƒì„ ì¸ì§€í•˜ë©° ëŒ€í™” ê°€ëŠ¥.\n2. **Focal Seizure with Impaired Awareness (êµ¬ Complex Partial)**\n    - ì˜ì‹ì´ íë ¤ì§€ê±°ë‚˜ ë©í•´ì§.\n    - **Automatisms (ìë™ì¦):** ì…ë§› ë‹¤ì‹œê¸°(Lip smacking), ì˜· ë§Œì§€ì‘ê±°ë¦¬ê¸°(Picking at clothes), ë‹¨ì¶” í’€ê¸° ë“± ë¬´ì˜ì‹ì ì¸ ë°˜ë³µ í–‰ë™.\n    - **Scenario:** ë¶ˆì€ ì¼œì ¸ ìˆëŠ”ë° ì§‘ì— ì•„ë¬´ë„ ì—†ëŠ” ìƒíƒœ (Lights are on, but nobody's home).\n# H1: 4. The Great Debate: Syncope vs. Seizure ğŸ¥Š","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-231","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"í™˜ìê°€ ì“°ëŸ¬ì ¸ì„œ ëª¸ì„ ë–¨ì—ˆë‹¤ê³  í•©ë‹ˆë‹¤. ëª©ê²©ìëŠ” \"ë°œì‘í–ˆë‹¤\"ê³  í•˜ì§€ë§Œ, ê·¸ëƒ¥ ê¸°ì ˆ(Syncope)ì¼ ìˆ˜ë„ ìˆìŠµë‹ˆë‹¤. ì–´ë–»ê²Œ êµ¬ë³„í• ê¹Œìš”?\n### ğŸ† The Golden Rule: Post-ictal State\n| **Feature** | **Syncope (ì‹¤ì‹ )** | **Seizure (ë°œì‘)** |\n| --- | --- | --- |\n| **Pathology** | ë‡Œ í˜ˆë¥˜ ì¼ì‹œì  ê°ì†Œ (Low blood flow) | ë‡Œì˜ ì „ê¸°ì  í­í’ (Electrical Storm) |\n| **Recovery** | **Instant Return:** ë°”ë‹¥ì— ë‹¿ìœ¼ë©´ í”¼ê°€ ë‡Œë¡œ ëŒì•„ê°€ì„œ ë°”ë¡œ ê¹¸. ì•½ê°„ ë©í•  ìˆœ ìˆì–´ë„ ê¸ˆë°© ëª…ë£Œí•´ì§ (Crisp awakening). | **Post-ictal Confusion:** ë‡Œê°€ ë§ˆë¼í†¤ì„ ë›´ ìƒíƒœ. ê¹¨ì–´ë‚˜ëŠ” ë° ìˆ˜ë¶„~ìˆ˜ì‹œê°„ ê±¸ë¦¼. í˜¼ë€, ì¡¸ìŒ(Lethargy) ë™ë°˜. |\n| **Shaking** | ìˆì„ ìˆ˜ ìˆìŒ (Convulsive syncope), í•˜ì§€ë§Œ ì§§ìŒ. | ì§€ì†ì ì´ê³  ë¦¬ë“¬ê° ìˆìŒ. |\n# H1: 5. Pediatric Special: Absence Seizures (ê²°ì‹  ë°œì‘) ğŸ§’\n### ğŸšª The Vignette\n- ì„ ìƒë‹˜í•œí…Œ í˜¼ë‚˜ëŠ” ì•„ì´: \"ìˆ˜ì—… ì‹œê°„ì— ë”´ì²­ í”¼ìš°ì§€ ë§ˆ!\"\n- ì‚¬ì‹¤ ì•„ì´ëŠ” ë”´ì²­ í”¼ìš°ëŠ” ê²Œ ì•„ë‹ˆë¼ **Generalized Seizure**ë¥¼ ê²ªê³  ìˆëŠ” ì¤‘.\n### Key Characteristics\n1. **Onset:** ê°‘ì‘ìŠ¤ëŸ¬ìš´ ì˜ì‹ ì†Œì‹¤ (Sudden impairment of consciousness).\n2. **Motor:** ì“°ëŸ¬ì§€ì§€ ì•ŠìŒ (Muscle tone preserved). ê·¸ëƒ¥ ë™ì‘ì´ 'ì¼ì‹œ ì •ì§€(Freeze)' ë¨.\n3. **Duration:** ë§¤ìš° ì§§ìŒ (< 20ì´ˆ).\n4. **No Post-ictal:** ë°œì‘ì´ ëë‚˜ë©´ ë°”ë¡œ í˜„ì‹¤ë¡œ ë³µê·€ (Snap back). ìê¸°ê°€ ë°œì‘í•œ ì¤„ ëª¨ë¦„.\n5. **Provocation:** **Hyperventilation (ê³¼í˜¸í¡)** ì‹œí‚¤ë©´ ìœ ë°œë¨ (ë°”ëŒê°œë¹„ ë¶ˆê²Œ í•˜ê¸°).\n### âš¡ Diagnosis & Treatment\n- **Gold Standard Dx:** **EEG (ë‡ŒíŒŒ)** -> **3Hz Spike and Wave pattern** (ì´ˆë‹¹ 3ë²ˆì˜ ë¾°ì¡±í•œ íŒŒí˜•).\n- **Treatment (DOC):** **Ethosuximide** ğŸ’Š (T-type Calcium channel blocker in Thalamus).\n- **Prognosis:** ëŒ€ë¶€ë¶„ ì‚¬ì¶˜ê¸°(Puberty) ì´ì „ì— ìì—° ì†Œì‹¤ë¨ (Good prognosis).\n### ğŸ†š Contrast with \"Inattentive Staring\" (ë©ë•Œë¦¬ê¸°)\n- **Touch Test:** ë©ë•Œë¦¬ëŠ” ì•„ì´ ì–´ê¹¨ë¥¼ ì¹˜ê±°ë‚˜ ë¶€ë¥´ë©´ \"ì–´? ì™œìš”?\" í•˜ê³  ë°˜ì‘í•¨ (Snaps out with tactile stimulation).\n- **Absence:** ì•„ë¬´ë¦¬ ë¶ˆëŸ¬ë„, ì–´ê¹¨ë¥¼ ì³ë„ ë°˜ì‘ ì—†ìŒ. ë‡Œê°€ ì˜¤í”„ë¼ì¸ ìƒíƒœì„.\n# H1: 6. Status Epilepticus (ë‡Œì „ì¦ì§€ì†ìƒíƒœ) ğŸš¨ğŸ’€\nì—¬ê¸°ê°€ ë°”ë¡œ \"High Voltage Territory\"ì…ë‹ˆë‹¤.\n### Definitions & Pathophysiology\n- **New Definition:** **5ë¶„ ì´ìƒ** ì§€ì†ë˜ëŠ” ë°œì‘ OR ì˜ì‹ íšŒë³µ ì—†ì´ 2íšŒ ì´ìƒ ì—°ì† ë°œì‘.\n    - (ê³¼ê±°ì—ëŠ” 30ë¶„ì´ì—ˆìœ¼ë‚˜, 30ë¶„ ê¸°ë‹¤ë¦¬ë©´ ë‡Œê°€ ë‹¤ íƒ€ë²„ë¦¼).\n- **Why 5 minutes?** ëŒ€ë¶€ë¶„ì˜ ìŠ¤ìŠ¤ë¡œ ë©ˆì¶”ëŠ”(Self-limited) ë°œì‘ì€ 2-3ë¶„ ë‚´ì— ëë‚¨. 5ë¶„ì„ ë„˜ê¸°ë©´ ì‹ ì²´ì˜ 'Stop mechanism'ì´ ê³ ì¥ ë‚œ ê²ƒ.\n- **Physiology:**\n    1. **Cortical Laminar Necrosis:** ë‡Œì„¸í¬ê°€ í¥ë¶„ ë…ì„±(Excitotoxicity)ìœ¼ë¡œ ë…¹ì•„ë‚´ë¦¼.\n    2. **Systemic:** íš¡ë¬¸ê·¼ìœµí•´ì¦(Rhabdomyolysis) -> ì‹ ë¶€ì „(Kidney Failure), ê³ ì—´(Hyperthermia). ë‡Œì™€ ëª¸ì„ ë™ì‹œì— ìš”ë¦¬(Cooking)í•˜ëŠ” ê²ƒê³¼ ê°™ìŒ.\n### ğŸš‘ Management Protocol (The Algorithm)","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-251","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"ì´ ì•Œê³ ë¦¬ì¦˜ì€ ë°˜ë“œì‹œ ìˆœì„œëŒ€ë¡œ ê¸°ì–µí•´ì•¼ í•©ë‹ˆë‹¤. **Step-by-Step!**\n### Step 1: Stabilization (0-5 mins)\n- **ABCs:** Airway, Breathing, Circulation.\n- **Glucose Check:** ì €í˜ˆë‹¹ì´ë©´ Dextrose íˆ¬ì—¬.\n- **Oxygen:** ë‡Œê°€ ì‚°ì†Œë¥¼ ì—„ì²­ë‚˜ê²Œ ì“°ê³  ìˆìœ¼ë¯€ë¡œ ê³µê¸‰ í•„ìˆ˜.\n### Step 2: The First Line (Benzodiazepines) ğŸ’Š\n- **Drug:** **IV Lorazepam** (ë¡œë¼ì œíŒœ).\n- **Alternative:** IV ë¼ì¸ì´ ì—†ë‹¤ë©´? -> **IM Midazolam** (ê·¼ìœ¡ì£¼ì‚¬).\n- **Mechanism:** GABA ìˆ˜ìš©ì²´(Off switch)ë¥¼ ì¼œì„œ ë‡Œë¥¼ ì§„ì •ì‹œí‚´.\n### Step 3: The Second Line (Long-acting Anti-epileptics)\n- ë²¤ì¡°ë¡œ ë¶ˆì„ ê»ìœ¼ë©´, ë‹¤ì‹œ ë¶ˆì´ ë¶™ì§€ ì•Šê²Œ ë°©í™”ë²½ì„ ì³ì•¼ í•¨.\n- **Options:**\n    1. **Levetiracetam (Keppra):** ë¶€ì‘ìš© ì ê³  ìƒí˜¸ì‘ìš© ì ì–´ì„œ ë§ì´ ì”€.\n    2. **Valproic Acid (Valproate):** ê´‘ë²”ìœ„í•˜ê²Œ ì“°ì„.\n    3. **Fosphenytoin:** (Phenytoinì˜ Prodrug). ì‹¬ì¥ ë…ì„± ì£¼ì˜.\n### Step 4: Refractory Status (The \"Nuclear Option\") â˜¢ï¸\n- ì•½ì„ ë‹¤ ì¼ëŠ”ë°ë„ ë°œì‘ì´ ì•ˆ ë©ˆì¶˜ë‹¤ë©´?\n- **Action:** **Intubation** (ì‚½ê´€) + **General Anesthesia** (Propofol, Pentobarbital).\n- **Critical Monitoring:** **Continuous EEG monitoring**.\n    - **Why?** ê·¼ì´ì™„ì œ(Paralytics)ë¥¼ ì“°ë©´ ê²‰ìœ¼ë¡œëŠ” ì•ˆ ë–¨ì§€ë§Œ, ë‡Œ ì•ˆì—ì„œëŠ” ì—¬ì „íˆ ë°œì‘ ì¤‘ì¼ ìˆ˜ ìˆìŒ (**Non-convulsive Status Epilepticus**). ì´ê²ƒì€ \"Silent Killer\"ì„. EEGë¡œ ë‡ŒíŒŒê°€ ì ì í•´ì¡ŒëŠ”ì§€ í™•ì¸í•´ì•¼ í•¨.","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-271","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","pathophysiology"]}
{"chunk_type":"recap_summary","text":"# ğŸ”¥ Rapid Fire Recap Table\në§ˆì§€ë§‰ìœ¼ë¡œ í•µì‹¬ ë‚´ìš©ì„ ë¹ ë¥´ê²Œ ì •ë¦¬í•©ë‹ˆë‹¤. ì¡±ì§‘ê²Œ ê³¼ì™¸ í¬ì¸íŠ¸!\n| **Clinical Scenario** | **Probable Diagnosis** | **Next Best Step / Treatment** | **Key Feature to Look For** |\n| --- | --- | --- | --- |\n| **50ì„¸ ë‚¨ì„±, ì²« ë°œì‘ (First Seizure)** | **Brain Tumor** (until proven otherwise) | **Neuro-imaging (MRI/CT)** | ë‘í†µ, êµ­ì†Œ ì‹ ê²½í•™ì  ê²°ì† |\n| **ì†Œì•„, ìˆ˜ì—… ì¤‘ ë©ë•Œë¦¼, 20ì´ˆ ë¯¸ë§Œ** | **Absence Seizure** | **Ethosuximide** | **3Hz Spike & Wave**, No Post-ictal |\n| **ë°œì‘ 5ë¶„ ì´ìƒ ì§€ì†** | **Status Epilepticus** | **1. Lorazepam (IV)** -> **2. Fosphenytoin/Keppra** | 5ë¶„ ë„˜ìœ¼ë©´ ìì—° ì†Œì‹¤ ì•ˆ ë¨. ë‡Œ ì†ìƒ ì‹œì‘. |\n| **ì“°ëŸ¬ì§„ í›„ ì¦‰ì‹œ ì˜ì‹ ëª…ë£Œ (Crisp awakening)** | **Syncope (ì‹¤ì‹ )** | Cardiac Workup (ECG) | Post-ictal state ì—†ìŒ |\n| **ì“°ëŸ¬ì§„ í›„ 30ë¶„ê°„ í˜¼ë€ (Confusion)** | **Seizure** | Seizure Workup | **Post-ictal state ìˆìŒ (Gold Standard)** |\n| **ë°œì‘ í™˜ì, Phenytoin ë³µìš© ì¤‘, ë¹„í‹€ê±°ë¦¼/ì–´ì§€ëŸ¬ì›€** | **Phenytoin Toxicity** | Drug Level Check | **Horizontal Nystagmus**, Ataxia |\n| **Intubation í›„ ê²‰ë³´ê¸°ì—” ë©ˆì·„ìœ¼ë‚˜ ì˜ì‹ ì—†ìŒ** | **Non-convulsive Status** | **Continuous EEG** | ë‡ŒëŠ” ì—¬ì „íˆ íƒ€ê³  ìˆìŒ (Silent Seizure) |\n### **ğŸ§  USMLE Ischemic Stroke: The \"Time is Brain\" Masterclass**","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-282","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","recap","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### **ğŸŒŸ Overview & TL;DR (Too Long; Didn't Read)**\n| **Concept** | **Key Point ğŸ—ï¸** |\n| --- | --- |\n| **Core Mantra** | **Time is Brain** (2 million neurons die/min) â±ï¸ğŸ§  |\n| **#1 Risk Factor** | **Hypertension** (The King ğŸ‘‘, 4x risk) |\n| **First Test** | **Non-Contrast CT Head** (Rule out bleed first!) ğŸš«ğŸ©¸ |\n| **TPA Window** | **< 3 ~ 4.5 Hours** (Check contraindications!) |\n| **BP Rules** | **Permissive HTN** (< 220/120) unless giving TPA (< 185/110) |\n| **Glucose** | Always check **Glucose** (<50 mimics stroke) ğŸ¬ |\n| **MCA Stroke** | Face/Arm > Leg, Gaze towards lesion ğŸ‘€ |\n| **ACA Stroke** | Leg/Foot > Arm, Urinary Incontinence ğŸ¦µğŸ’¦ |\n| **Lacunar** | Deep structures, **No cortical signs** (Pure Motor/Sensory) |\n| **CVST** | Pregnant/OCP, Seizure + Headache, Tx: **Heparin** |\n### **ğŸŒ³ Top-Down Classification: Stroke Universe**\nPlaintext\n#\n`DISEASE: STROKE (Cerebrovascular Accident)\nâ”‚\nâ”œâ”€â”€ PATHOPHYSIOLOGY (Mechanism)\nâ”‚   â”œâ”€â”€ Ischemic (80-85%) - Blockage\nâ”‚   â”‚   â”œâ”€â”€ Thrombotic (Plaque rupture, stuttering onset)\nâ”‚   â”‚   â”œâ”€â”€ Embolic (Clot from heart/Afib, sudden max deficit)\nâ”‚   â”‚   â””â”€â”€ Lacunar (Small vessel, HTN/DM, deep structures)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Hemorrhagic (15-20%) - Bleeding [White on CT]\nâ”‚       â”œâ”€â”€ Intracerebral Hemorrhage (ICH)\nâ”‚       â””â”€â”€ Subarachnoid Hemorrhage (SAH) - \"Thunderclap\"\nâ”‚\nâ”œâ”€â”€ CLINICAL SYNDROMES (Anatomy)\nâ”‚   â”œâ”€â”€ Anterior Circulation\nâ”‚   â”‚   â”œâ”€â”€ MCA (Lateral: Face/Arm, Aphasia/Neglect)\nâ”‚   â”‚   â””â”€â”€ ACA (Medial: Leg/Foot, Motivation/Abulia)\nâ”‚   â”œâ”€â”€ Posterior Circulation (PCA, Vertebrobasilar)\nâ”‚   â””â”€â”€ Venous (CVST) - Young female, Hypercoagulable\nâ”‚\nâ””â”€â”€ MANAGEMENT PHASE\n    â”œâ”€â”€ Hyperacute (Doorway -> CT -> TPA decision)\n    â”œâ”€â”€ Acute (BP control, Workup: MRI, Echo, Carotids)\n    â””â”€â”€ Secondary Prevention (Antiplatelet, Statin, Risk factor control)`\n### **1. ğŸš‘ Introduction & Pathophysiology: The Mechanics**\n**The \"Doorway\" Scenario:**\nì‘ê¸‰ì‹¤ ë¬¸ ì•ì—ì„œ ë³¸ 70ëŒ€ í™˜ì. í•œ ì‹œê°„ ì „ì—” ë©€ì©¡í–ˆëŠ”ë°(breakfast table), ì§€ê¸ˆì€ ì˜ìì— ë¬´ë„ˆì ¸ ë‚´ë¦¼(slumped). ì˜¤ë¥¸ìª½ íŒ”ì€ **Dead weight** (ì¶• ëŠ˜ì–´ì§), ëˆˆì€ ì™¼ìª½ìœ¼ë¡œ ê³ ì •ë¨. ë§ì„ ê±¸ì–´ë„ **Confused Silence** (ì¹¨ë¬µ).\n- ì´ê²ƒì´ ë°”ë¡œ Classic Acute Stroke.\n- **Time is Brain:** í˜ˆê´€ì´ ë§‰íŒ ë§¤ 1ë¶„ë§ˆë‹¤ **200ë§Œ ê°œì˜ ë‰´ëŸ°(2 million neurons)**ì´ ì‚¬ë§í•¨. í™˜ìì˜ ê¸°ì–µ, ì„±ê²©, ë§í•˜ëŠ” ëŠ¥ë ¥ì´ ì‹¤ì‹œê°„ìœ¼ë¡œ ì‚¬ë¼ì§€ëŠ” ì¤‘. ğŸ“‰\n**Risk Factors (The \"Public Enemy\"):**\n1. **Hypertension (HTN) ğŸ‘‘:** **The Absolute King.** Risk Multiplier **4x**. íŒŒì´í”„ì˜ ìˆ˜ì••ì´ ë„ˆë¬´ ì„¼ ê²ƒê³¼ ê°™ìŒ. í˜ˆê´€ ë²½ì„ ì§€ì†ì ìœ¼ë¡œ ê°‰ì•„ë¨¹ìŒ(Sandpapering).\n2. Smoking & Diabetes: ë‚˜ì˜ì§€ë§Œ, ê³ í˜ˆì••ì´ ì••ë„ì ì„.\n**Thrombotic vs. Embolic (Pipes vs. Cannonballs):**\n- **Thrombotic Stroke:**\n    - **Mechanism:** Atherosclerotic plaqueê°€ ë‡Œí˜ˆê´€ ë°”ë¡œ ê·¸ ìë¦¬ì—ì„œ í„°ì§.\n    - **Pattern:** **Stuttering Progression** (ê¹œë¹¡ì´ëŠ” ì „êµ¬ì²˜ëŸ¼ ì¦ìƒì´ ì¢‹ì•„ì¡Œë‹¤ ë‚˜ë¹ ì¡Œë‹¤ ë°˜ë³µ). ğŸ’¡ğŸ“‰\n- **Embolic Stroke:**\n    - **Mechanism:** ì‹¬ì¥(ì˜ˆ: Afib, Valve vegetation)ì—ì„œ ë‚ ì•„ì˜¨ í”¼ë–¡(Clot)ì´ ë‡Œí˜ˆê´€ì„ \"ëŒ€í¬ì•Œ(Cannonball)\"ì²˜ëŸ¼ ë•Œë¦¼.\n    - **Pattern:** **Abrupt, Maximal deficit at onset.** (ì‹œì‘í•˜ìë§ˆì ìµœì•…ì˜ ì¦ìƒ).\n### **2. âš¡ TIA (Transient Ischemic Attack): The Warning Shot**\n**Concept:** \"ì‹œìŠ¤í…œ ì‹¤íŒ¨ê°€ ì•„ë‹ˆë¼, ìš´ì´ ì–µìˆ˜ë¡œ ì¢‹ì•˜ë˜ ì¼€ì´ìŠ¤(Lucky).\"\n- **Definition:** Ischemia(í—ˆí˜ˆ)ëŠ” ìˆì—ˆì§€ë§Œ Infarction(ì¡°ì§ ê´´ì‚¬)ì€ ì—†ëŠ” ìƒíƒœ. Clotì´ ì˜êµ¬ì  ì†ìƒì„ ì£¼ê¸° ì „ì— ë…¹ì•„ë²„ë¦¼. í•˜ì§€ë§Œ \"ì´ì€ ì—¬ì „íˆ ì¥ì „ë˜ì–´ ìˆìŒ(Gun is still loaded).\" ğŸ”«","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-292","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"**Immediate Workup (3 Pillars):**\n1. **MRI Brain (DWI):** â˜… **Gold Standard.** CTë³´ë‹¤ í›¨ì”¬ ë¯¼ê°í•¨. ì§„ì§œ Strokeê°€ ìŠ¤ì¹˜ê³  ì§€ë‚˜ê°”ëŠ”ì§€ í™•ì¸.\n2. **Vascular Imaging (CTA/MRA):** ëª© í˜ˆê´€(Carotid)ì´ ë§‰í˜”ëŠ”ì§€ í™•ì¸. (Ticking Time Bomb í™•ì¸) ğŸ’£\n3. **Cardiac Monitoring:** ì‹¬ì¥ì—ì„œ ì˜¨ ê±´ì§€ í™•ì¸ (Afib ì°¾ê¸°).\n### **3. ğŸ¥ Acute Management Algorithm (The Checklist)**\n**Step 1: The First Test**\n- **Non-Contrast CT Head:** â˜… **Next Best Step.**\n- **Why?** Ischemia(ë‡Œê²½ìƒ‰)ë¥¼ ë³´ë ¤ëŠ” ê²Œ ì•„ë‹ˆë¼, **Hemorrhage(ë‡Œì¶œí˜ˆ, White)**ë¥¼ **Rule out** í•˜ê¸° ìœ„í•¨! ğŸ©¸\n    - **White (Blood):** Stop everything. ë‡Œì¶œí˜ˆ í”„ë¡œí† ì½œ.\n    - **Black/Normal:** Ischemicìœ¼ë¡œ ê°„ì£¼í•˜ê³  TPA ê³ ë ¤.\n**Step 2: The Glucose Trap**\n- **Fingerstick Glucose:** ë°˜ë“œì‹œ ì²´í¬! ğŸ©¸ğŸ¬\n- **Why?** **Severe Hypoglycemia (<50)**ëŠ” Strokeì™€ ì¦ìƒì´ ë˜‘ê°™ìŒ(Focal weakness, confusion). ìƒŒë“œìœ„ì¹˜ë‘ ì˜¤ë Œì§€ ì£¼ìŠ¤ë§Œ ì£¼ë©´ ë‚«ëŠ” í™˜ìì—ê²Œ TPA(ì¶œí˜ˆ ìœ„í—˜ ìˆëŠ” ì•½)ë¥¼ ì£¼ë©´ ì•ˆ ë¨!\n**Step 3: The TPA Decision (Thrombolytics)**\n- **Concept:** ê°•ë ¥í•œ \"Clot Buster.\"\n- **Time Window:** ì¦ìƒ ë°œí˜„ í›„ **< 3 ~ 4.5 ì‹œê°„** ì´ë‚´. (Last known normal time ê¸°ì¤€).\n- **Major Contraindications (ì ˆëŒ€ ê¸ˆê¸°):**\n    - ë‡Œì¶œí˜ˆ ê³¼ê±°ë ¥ (Any history of ICH).\n    - ìµœê·¼ ìˆ˜ìˆ , ì™¸ìƒ, í™œë™ì„± ì¶œí˜ˆ.\n    - **BP > 185/110** (í˜ˆì••ì´ ë„ˆë¬´ ë†’ìœ¼ë©´ ì•½ ì£¼ë‹¤ê°€ ë‡Œì¶œí˜ˆ í„°ì§).\n**Step 4: Blood Pressure Management (The Tightrope)**\n- **Permissive Hypertension (í—ˆìš©ì  ê³ í˜ˆì••):**\n    - **Why?** ë‡Œì˜ **Penumbra** (ì£½ì–´ê°€ëŠ” ë‡Œì„¸í¬ ì£¼ë³€ë¶€, Stunned tissue)ë¥¼ ì‚´ë¦¬ê¸° ìœ„í•´. Collateral flow(ê³ê°€ì§€ í˜ˆê´€)ë¡œ í”¼ë¥¼ ë°€ì–´ë„£ìœ¼ë ¤ë©´ ë†’ì€ ì••ë ¥ì´ í•„ìš”í•¨.\n    - **Rule (No TPA):** TPAë¥¼ ì•ˆ ì“´ë‹¤ë©´ **220/120**ê¹Œì§€ëŠ” ê·¸ëƒ¥ ë‘ (Let it ride). ğŸ¢\n    - **Rule (With TPA):** TPAë¥¼ ì“´ë‹¤ë©´ ë¬´ì¡°ê±´ **< 185/110**ìœ¼ë¡œ ë‚®ì¶°ì•¼ í•¨ (Labetalol, Nicardipine ë“±ìœ¼ë¡œ). ì•ˆ ê·¸ëŸ¬ë©´ B\n**â˜ ï¸ Nightmare Complication: Hemorrhagic Transformation**\n- TPA íˆ¬ì—¬ í›„ í™˜ìê°€ ê°‘ìê¸° ë‘í†µ í˜¸ì†Œ(Headache), ì˜ì‹ ì €í•˜ ğŸ“‰.\n- **Action:** ì¦‰ì‹œ TPA ì¤‘ë‹¨ ğŸ›‘ -> Stat CT Head. (ë‡Œê²½ìƒ‰ì´ ë‡Œì¶œí˜ˆë¡œ ë°”ë€œ).\n### **4. ğŸ—ºï¸ Stroke Syndromes: Anatomy is Destiny**\në‡Œì˜ ì§€ë„ë¥¼ ê·¸ë ¤ì•¼ í•¨. **Homunculus** (ë‡Œ í‘œë©´ì˜ ì‹ ì²´ ì§€ë„).\n- **Lateral (ë°”ê¹¥ìª½):** ì–¼êµ´(Face), íŒ”(Arm), ì†.\n- **Medial (ì•ˆìª½/MOHAWK ë¼ì¸):** ë‹¤ë¦¬(Leg), ë°œ(Foot), ì„±ê¸°(Genitals).\n### **A. MCA (Middle Cerebral Artery) Stroke - Most Common**\n- **Territory:** Lateral Surface.\n- **Symptoms:**\n    - **Contralateral Face & Arm Weakness > Leg.** (ì–¼êµ´/íŒ”ì´ ë‹¤ë¦¬ë³´ë‹¤ ì‹¬í•¨).\n    - **Gaze Preference:** ë³‘ë³€ì´ ìˆëŠ” ìª½ì„ ì³ë‹¤ë´„ (**Look *towards* the lesion**). ğŸ‘€ (Frontal Eye Field ì†ìƒìœ¼ë¡œ ë°˜ëŒ€ìª½ ëˆˆ ê·¼ìœ¡ì´ ì´ê²¨ë¨¹ìŒ).\n    - **Dominant Hemisphere (Left):** **Aphasia** (Broca's - ë§ ëª»í•¨ / Wernicke's - ë§ ì´í•´ ëª»í•¨). ğŸ—£ï¸âŒ\n    - **Non-Dominant Hemisphere (Right):** **Hemineglect** (ì™¼ìª½ ì„¸ìƒì„ ë¬´ì‹œí•¨. ì™¼ìª½ ìˆ˜ì—¼ë§Œ ì•ˆ ê¹ìŒ).","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-312","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"### **B. ACA (Anterior Cerebral Artery) Stroke**\n- **Territory:** Medial Surface (Mohawk area).\n- **Symptoms:**\n    - **Contralateral Leg & Foot Weakness > Arm.** (ë‹¤ë¦¬ê°€ íŒ”ë³´ë‹¤ ì‹¬í•¨). ğŸ¦µ\n    - **Urinary Incontinence:** ì†Œë³€ ì¡°ì ˆ ì¤‘ì¶”(Paracentral lobule) ì¹¨ë²”. ğŸš½\n    - **Abulia:** ì˜ìš• ìƒì‹¤, ë¬´ê¸°ë ¥ (Motivation center ì¹¨ë²”).\n### **C. Lacunar Strokes (Small Vessel Disease)**\n- **Pathology:** **Lipohyalinosis / Microatheroma.** ê³ í˜ˆì••/ë‹¹ë‡¨ë¡œ ì¸í•´ ë‡Œ ê¹Šì€ ê³³(Internal Capsule, Thalamus)ì˜ ë¯¸ì„¸ í˜ˆê´€ì´ \"ë…¹ìŠ¨ íŒŒì´í”„\"ì²˜ëŸ¼ ë§‰í˜.\n- **Key Feature:** **Absence of Cortical Signs.** (í”¼ì§ˆ ì¦ìƒì´ ì—†ìŒ).\n    - No Aphasia, No Neglect, No Vision Loss. âŒğŸ—£ï¸\n- **Types:**\n    - **Pure Motor:** Internal Capsule (Posterior limb). íŒ”/ë‹¤ë¦¬/ì–¼êµ´ ê· ë“±í•˜ê²Œ ë§ˆë¹„.\n    - **Pure Sensory:** Thalamus (VPL). ë°˜ëŒ€ìª½ ëª¸ ì „ì²´ ì €ë¦¼(Numbness).\n### **5. ğŸ’£ Malignant Hemispheric Infarction (MHI)**\n- **Scenario:** ì•„ì£¼ í° MCA Stroke ë°œìƒ -> ë‡Œì˜ ì ˆë°˜ì´ ì£½ìŒ -> 3~5ì¼ ë’¤ ê´´ì‚¬ëœ ì¡°ì§ì´ ì—„ì²­ë‚˜ê²Œ ë¶€ì–´ì˜¤ë¦„(**Edema**).\n- **Problem:** ë‘ê°œê³¨(Skull)ì€ ë‹«íŒ ìƒìì„. ë¶€ì„ ê³µê°„ì´ ì—†ì–´ì„œ **Herniation** (ë‡Œê°€ ëˆŒë ¤ì„œ ë¹ ì ¸ë‚˜ì˜´) -> Brainstem ì••ë°• -> ì‚¬ë§. â˜ ï¸\n- **Treatment:** **Decompressive Hemicraniectomy.** ğŸ”¨\n    - ë‘ê°œê³¨ì„ í¬ê²Œ ì˜ë¼ë‚´ì–´ ë‡Œê°€ ë°–ìœ¼ë¡œ ë¶€ì–´ì˜¤ë¥¼ ìˆ˜ ìˆê²Œ ìˆ¨í†µì„ íŠ¸ì—¬ì¤Œ. (Closed box -> Open box). ìƒëª…ì„ ì‚´ë¦¬ëŠ” ì‹œìˆ .\n### **6. ğŸŒŠ Cerebral Venous Sinus Thrombosis (CVST)**\n**\"The Curveball Diagnosis\"**\n- ë™ë§¥(Artery)ì´ ì•„ë‹ˆë¼ **ì •ë§¥(Vein)**ì´ ë§‰íŒ ê²ƒ. í•˜ìˆ˜êµ¬ê°€ ë§‰í˜€ì„œ ì—­ë¥˜í•˜ëŠ” ìƒí™©.\n- **Patient Profile:** ì Šì€ ì—¬ì„±, **Hypercoagulable state** (ì„ì‹ , ì¶œì‚° í›„, í”¼ì„ì•½-OCP ë³µìš©, í¡ì—°). ğŸ¤°ğŸ’ŠğŸš¬\n- **Symptoms:**\n    - **Headache:** ì ì  ì‹¬í•´ì§€ê±°ë‚˜ ë²¼ë½ë‘í†µ(Thunderclap).\n    - **Seizures:** í”í•¨.\n    - **Papilledema:** ë‡Œì•• ìƒìŠ¹ ì†Œê²¬.\n- **Diagnosis:** â˜… **MR Venography (MRV).** ì •ë§¥ì˜ íë¦„ì„ ë´ì•¼ í•¨.\n- **Treatment:** â˜… **Heparin (Anticoagulation).**\n    - **Paradox:** ì •ë§¥ì´ ë§‰í˜€ì„œ í„°ì§€ë©´ ì•½ê°„ì˜ ì¶œí˜ˆì´ ë³´ì¼ ìˆ˜ ìˆìŒ. ê·¸ë˜ë„ í—¤íŒŒë¦°ì„ ì¨ì•¼ í•¨? **YES!** âœ…\n    - **Why?** ì¶œí˜ˆì˜ ì›ì¸ì´ \"í•˜ìˆ˜êµ¬ê°€ ë§‰í˜€ì„œ ì••ë ¥ì´ ì°¼ê¸° ë•Œë¬¸\"ì´ë¯€ë¡œ, í•˜ìˆ˜êµ¬(Clot)ë¥¼ ëš«ì–´ì¤˜ì•¼ ì¶œí˜ˆë„ ë©ˆì¶¤.\n### **7. ğŸ”º Cavernous Sinus Thrombosis**\n**\"The Danger Triangle\"** âš ï¸\n- **Pathology:** ì–¼êµ´ì˜ \"Danger Triangle\" (ì½”~ì…ìˆ  ì£¼ë³€)ì— ì—¬ë“œë¦„(Pimple)ì„ ì§°ëŠ”ë°, ê·¸ ì„¸ê· ì´ ì •ë§¥ì„ íƒ€ê³  ë‡Œ ì†ì˜ Cavernous Sinusë¡œ ë“¤ì–´ê°.\n- **Anatomy:** Cavernous Sinus ì•ˆì—ëŠ” **CN 3, 4, V1, V2, 6**ë²ˆ ì‹ ê²½ê³¼ Internal Carotid Arteryê°€ ì§€ë‚˜ê°.\n- **Symptoms:**\n    - **Proptosis:** ëˆˆì´ íŠ€ì–´ë‚˜ì˜´. ğŸ‘€\n    - **Ophthalmoplegia:** ëˆˆì„ ëª» ì›€ì§ì„ (CN 3, 4, 6 ë§ˆë¹„).\n    - **Sensory Loss:** ì´ë§ˆ/ëº¨ ê°ê° ì €í•˜ (CN V1, V2).\n    - ì¦ìƒì´ í•œìª½ì—ì„œ ì‹œì‘í•´ **ì–‘ìª½(Bilateral)**ìœ¼ë¡œ ê¸‰ì†íˆ í¼ì§ (Sinusê°€ ì—°ê²°ë˜ì–´ ìˆì–´ì„œ).","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-332","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"recap_summary","text":"### **ğŸ”¥ Rapid Fire Recap: High-Yield Table**\n| **Clinical Feature** | **Likely Diagnosis/Location** |\n| --- | --- |\n| **Face/Arm > Leg Weakness** | **MCA Stroke** (Lateral) |\n| **Leg/Foot > Arm Weakness** | **ACA Stroke** (Medial) |\n| **Gaze Preference** | Looks **Towards** the lesion (PPRF/FEF) |\n| **Aphasia (Speech issue)** | **Left** MCA (Dominant) |\n| **Hemineglect (Ignores left side)** | **Right** MCA (Non-dominant) |\n| **Pure Motor or Sensory (No cortical signs)** | **Lacunar Stroke** (Deep structures) |\n| **Young Female + OCP + Seizure/HA** | **CVST** (Check MRV!) |\n| **Focal Neuro Deficit + Hypoglycemia** | **Stroke Mimic** (Give Glucose!) ğŸ¬ |\n| **TPA BP Limit** | Must be **< 185/110** |\n| **No TPA BP Limit** | Permissive up to **220/120** |\n**ğŸ’¡ Final Wisdom:**\n\"Stroke managementëŠ” **Balance** ì‹¸ì›€ì…ë‹ˆë‹¤. í˜ˆì••ì„ ë„ˆë¬´ ë‚®ì¶”ë©´ ë‡Œê°€ ë§ˆë¥´ê³ (Ischemia), ë„ˆë¬´ ë†’ìœ¼ë©´ í„°ì§‘ë‹ˆë‹¤(Bleed). Time is Brain. ë§ì„¤ì´ì§€ ë§ê³  4.5ì‹œê°„ ìœˆë„ìš°ë¥¼ ì‚¬ìˆ˜í•˜ì„¸ìš”!\" ğŸš€\n### **ğŸ§  USMLE Ischemic Stroke: The \"Time is Brain\" Masterclass**\n### **ğŸŒŸ Overview & TL;DR (Too Long; Didn't Read)**\n| **Concept** | **Key Point ğŸ—ï¸** |\n| --- | --- |\n| **Core Mantra** | **Time is Brain** (2 million neurons die/min) â±ï¸ğŸ§  |\n| **#1 Risk Factor** | **Hypertension** (The King ğŸ‘‘, 4x risk) |\n| **First Test** | **Non-Contrast CT Head** (Rule out bleed first!) ğŸš«ğŸ©¸ |\n| **TPA Window** | **< 3 ~ 4.5 Hours** (Check contraindications!) |\n| **BP Rules** | **Permissive HTN** (< 220/120) unless giving TPA (< 185/110) |\n| **Glucose** | Always check **Glucose** (<50 mimics stroke) ğŸ¬ |\n| **MCA Stroke** | Face/Arm > Leg, Gaze towards lesion ğŸ‘€ |\n| **ACA Stroke** | Leg/Foot > Arm, Urinary Incontinence ğŸ¦µğŸ’¦ |\n| **Lacunar** | Deep structures, **No cortical signs** (Pure Motor/Sensory) |\n| **CVST** | Pregnant/OCP, Seizure + Headache, Tx: **Heparin** |","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-348","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","recap","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### **ğŸŒ³ Top-Down Classification: Stroke Universe**\n`DISEASE: STROKE (Cerebrovascular Accident)\nâ”‚\nâ”œâ”€â”€ PATHOPHYSIOLOGY (Mechanism)\nâ”‚   â”œâ”€â”€ Ischemic (80-85%) - Blockage\nâ”‚   â”‚   â”œâ”€â”€ Thrombotic (Plaque rupture, stuttering onset)\nâ”‚   â”‚   â”œâ”€â”€ Embolic (Clot from heart/Afib, sudden max deficit)\nâ”‚   â”‚   â””â”€â”€ Lacunar (Small vessel, HTN/DM, deep structures)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Hemorrhagic (15-20%) - Bleeding [White on CT]\nâ”‚       â”œâ”€â”€ Intracerebral Hemorrhage (ICH)\nâ”‚       â””â”€â”€ Subarachnoid Hemorrhage (SAH) - \"Thunderclap\"\nâ”‚\nâ”œâ”€â”€ CLINICAL SYNDROMES (Anatomy)\nâ”‚   â”œâ”€â”€ Anterior Circulation\nâ”‚   â”‚   â”œâ”€â”€ MCA (Lateral: Face/Arm, Aphasia/Neglect)\nâ”‚   â”‚   â””â”€â”€ ACA (Medial: Leg/Foot, Motivation/Abulia)\nâ”‚   â”œâ”€â”€ Posterior Circulation (PCA, Vertebrobasilar)\nâ”‚   â””â”€â”€ Venous (CVST) - Young female, Hypercoagulable\nâ”‚\nâ””â”€â”€ MANAGEMENT PHASE\n    â”œâ”€â”€ Hyperacute (Doorway -> CT -> TPA decision)\n    â”œâ”€â”€ Acute (BP control, Workup: MRI, Echo, Carotids)\n    â””â”€â”€ Secondary Prevention (Antiplatelet, Statin, Risk factor control)`\n### **1. ğŸš‘ Introduction & Pathophysiology: The Mechanics**\n**The \"Doorway\" Scenario:**\nì‘ê¸‰ì‹¤ ë¬¸ ì•ì—ì„œ ë³¸ 70ëŒ€ í™˜ì. í•œ ì‹œê°„ ì „ì—” ë©€ì©¡í–ˆëŠ”ë°(breakfast table), ì§€ê¸ˆì€ ì˜ìì— ë¬´ë„ˆì ¸ ë‚´ë¦¼(slumped). ì˜¤ë¥¸ìª½ íŒ”ì€ **Dead weight** (ì¶• ëŠ˜ì–´ì§), ëˆˆì€ ì™¼ìª½ìœ¼ë¡œ ê³ ì •ë¨. ë§ì„ ê±¸ì–´ë„ **Confused Silence** (ì¹¨ë¬µ).\n- ì´ê²ƒì´ ë°”ë¡œ Classic Acute Stroke.\n- **Time is Brain:** í˜ˆê´€ì´ ë§‰íŒ ë§¤ 1ë¶„ë§ˆë‹¤ **200ë§Œ ê°œì˜ ë‰´ëŸ°(2 million neurons)**ì´ ì‚¬ë§í•¨. í™˜ìì˜ ê¸°ì–µ, ì„±ê²©, ë§í•˜ëŠ” ëŠ¥ë ¥ì´ ì‹¤ì‹œê°„ìœ¼ë¡œ ì‚¬ë¼ì§€ëŠ” ì¤‘. ğŸ“‰\n**Risk Factors (The \"Public Enemy\"):**\n1. **Hypertension (HTN) ğŸ‘‘:** **The Absolute King.** Risk Multiplier **4x**. íŒŒì´í”„ì˜ ìˆ˜ì••ì´ ë„ˆë¬´ ì„¼ ê²ƒê³¼ ê°™ìŒ. í˜ˆê´€ ë²½ì„ ì§€ì†ì ìœ¼ë¡œ ê°‰ì•„ë¨¹ìŒ(Sandpapering).\n2. Smoking & Diabetes: ë‚˜ì˜ì§€ë§Œ, ê³ í˜ˆì••ì´ ì••ë„ì ì„.\n**Thrombotic vs. Embolic (Pipes vs. Cannonballs):**\n- **Thrombotic Stroke:**\n    - **Mechanism:** Atherosclerotic plaqueê°€ ë‡Œí˜ˆê´€ ë°”ë¡œ ê·¸ ìë¦¬ì—ì„œ í„°ì§.\n    - **Pattern:** **Stuttering Progression** (ê¹œë¹¡ì´ëŠ” ì „êµ¬ì²˜ëŸ¼ ì¦ìƒì´ ì¢‹ì•„ì¡Œë‹¤ ë‚˜ë¹ ì¡Œë‹¤ ë°˜ë³µ). ğŸ’¡ğŸ“‰\n- **Embolic Stroke:**\n    - **Mechanism:** ì‹¬ì¥(ì˜ˆ: Afib, Valve vegetation)ì—ì„œ ë‚ ì•„ì˜¨ í”¼ë–¡(Clot)ì´ ë‡Œí˜ˆê´€ì„ \"ëŒ€í¬ì•Œ(Cannonball)\"ì²˜ëŸ¼ ë•Œë¦¼.\n    - **Pattern:** **Abrupt, Maximal deficit at onset.** (ì‹œì‘í•˜ìë§ˆì ìµœì•…ì˜ ì¦ìƒ).\n### **2. âš¡ TIA (Transient Ischemic Attack): The Warning Shot**\n**Concept:** \"ì‹œìŠ¤í…œ ì‹¤íŒ¨ê°€ ì•„ë‹ˆë¼, ìš´ì´ ì–µìˆ˜ë¡œ ì¢‹ì•˜ë˜ ì¼€ì´ìŠ¤(Lucky).\"\n- **Definition:** Ischemia(í—ˆí˜ˆ)ëŠ” ìˆì—ˆì§€ë§Œ Infarction(ì¡°ì§ ê´´ì‚¬)ì€ ì—†ëŠ” ìƒíƒœ. Clotì´ ì˜êµ¬ì  ì†ìƒì„ ì£¼ê¸° ì „ì— ë…¹ì•„ë²„ë¦¼. í•˜ì§€ë§Œ \"ì´ì€ ì—¬ì „íˆ ì¥ì „ë˜ì–´ ìˆìŒ(Gun is still loaded).\" ğŸ”«\n**Immediate Workup (3 Pillars):**\n1. **MRI Brain (DWI):** â˜… **Gold Standard.** CTë³´ë‹¤ í›¨ì”¬ ë¯¼ê°í•¨. ì§„ì§œ Strokeê°€ ìŠ¤ì¹˜ê³  ì§€ë‚˜ê°”ëŠ”ì§€ í™•ì¸.\n2. **Vascular Imaging (CTA/MRA):** ëª© í˜ˆê´€(Carotid)ì´ ë§‰í˜”ëŠ”ì§€ í™•ì¸. (Ticking Time Bomb í™•ì¸) ğŸ’£\n3. **Cardiac Monitoring:** ì‹¬ì¥ì—ì„œ ì˜¨ ê±´ì§€ í™•ì¸ (Afib ì°¾ê¸°).\n### **3. ğŸ¥ Acute Management Algorithm (The Checklist)**","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-358","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"**Step 1: The First Test**\n- **Non-Contrast CT Head:** â˜… **Next Best Step.**\n- **Why?** Ischemia(ë‡Œê²½ìƒ‰)ë¥¼ ë³´ë ¤ëŠ” ê²Œ ì•„ë‹ˆë¼, **Hemorrhage(ë‡Œì¶œí˜ˆ, White)**ë¥¼ **Rule out** í•˜ê¸° ìœ„í•¨! ğŸ©¸\n    - **White (Blood):** Stop everything. ë‡Œì¶œí˜ˆ í”„ë¡œí† ì½œ.\n    - **Black/Normal:** Ischemicìœ¼ë¡œ ê°„ì£¼í•˜ê³  TPA ê³ ë ¤.\n**Step 2: The Glucose Trap**\n- **Fingerstick Glucose:** ë°˜ë“œì‹œ ì²´í¬! ğŸ©¸ğŸ¬\n- **Why?** **Severe Hypoglycemia (<50)**ëŠ” Strokeì™€ ì¦ìƒì´ ë˜‘ê°™ìŒ(Focal weakness, confusion). ìƒŒë“œìœ„ì¹˜ë‘ ì˜¤ë Œì§€ ì£¼ìŠ¤ë§Œ ì£¼ë©´ ë‚«ëŠ” í™˜ìì—ê²Œ TPA(ì¶œí˜ˆ ìœ„í—˜ ìˆëŠ” ì•½)ë¥¼ ì£¼ë©´ ì•ˆ ë¨!\n**Step 3: The TPA Decision (Thrombolytics)**\n- **Concept:** ê°•ë ¥í•œ \"Clot Buster.\"\n- **Time Window:** ì¦ìƒ ë°œí˜„ í›„ **< 3 ~ 4.5 ì‹œê°„** ì´ë‚´. (Last known normal time ê¸°ì¤€).\n- **Major Contraindications (ì ˆëŒ€ ê¸ˆê¸°):**\n    - ë‡Œì¶œí˜ˆ ê³¼ê±°ë ¥ (Any history of ICH).\n    - ìµœê·¼ ìˆ˜ìˆ , ì™¸ìƒ, í™œë™ì„± ì¶œí˜ˆ.\n    - **BP > 185/110** (í˜ˆì••ì´ ë„ˆë¬´ ë†’ìœ¼ë©´ ì•½ ì£¼ë‹¤ê°€ ë‡Œì¶œí˜ˆ í„°ì§).\n**Step 4: Blood Pressure Management (The Tightrope)**\n- **Permissive Hypertension (í—ˆìš©ì  ê³ í˜ˆì••):**\n    - **Why?** ë‡Œì˜ **Penumbra** (ì£½ì–´ê°€ëŠ” ë‡Œì„¸í¬ ì£¼ë³€ë¶€, Stunned tissue)ë¥¼ ì‚´ë¦¬ê¸° ìœ„í•´. Collateral flow(ê³ê°€ì§€ í˜ˆê´€)ë¡œ í”¼ë¥¼ ë°€ì–´ë„£ìœ¼ë ¤ë©´ ë†’ì€ ì••ë ¥ì´ í•„ìš”í•¨.\n    - **Rule (No TPA):** TPAë¥¼ ì•ˆ ì“´ë‹¤ë©´ **220/120**ê¹Œì§€ëŠ” ê·¸ëƒ¥ ë‘ (Let it ride). ğŸ¢\n    - **Rule (With TPA):** TPAë¥¼ ì“´ë‹¤ë©´ ë¬´ì¡°ê±´ **< 185/110**ìœ¼ë¡œ ë‚®ì¶°ì•¼ í•¨ (Labetalol, Nicardipine ë“±ìœ¼ë¡œ). ì•ˆ ê·¸ëŸ¬ë©´ Brain Bleed í„°ì§.\n**â˜ ï¸ Nightmare Complication: Hemorrhagic Transformation**\n- TPA íˆ¬ì—¬ í›„ í™˜ìê°€ ê°‘ìê¸° ë‘í†µ í˜¸ì†Œ(Headache), ì˜ì‹ ì €í•˜ ğŸ“‰.\n- **Action:** ì¦‰ì‹œ TPA ì¤‘ë‹¨ ğŸ›‘ -> Stat CT Head. (ë‡Œê²½ìƒ‰ì´ ë‡Œì¶œí˜ˆë¡œ ë°”ë€œ).\n### **4. ğŸ—ºï¸ Stroke Syndromes: Anatomy is Destiny**\në‡Œì˜ ì§€ë„ë¥¼ ê·¸ë ¤ì•¼ í•¨. **Homunculus** (ë‡Œ í‘œë©´ì˜ ì‹ ì²´ ì§€ë„).\n- **Lateral (ë°”ê¹¥ìª½):** ì–¼êµ´(Face), íŒ”(Arm), ì†.\n- **Medial (ì•ˆìª½/MOHAWK ë¼ì¸):** ë‹¤ë¦¬(Leg), ë°œ(Foot), ì„±ê¸°(Genitals).\n### **A. MCA (Middle Cerebral Artery) Stroke - Most Common**\n- **Territory:** Lateral Surface.\n- **Symptoms:**\n    - **Contralateral Face & Arm Weakness > Leg.** (ì–¼êµ´/íŒ”ì´ ë‹¤ë¦¬ë³´ë‹¤ ì‹¬í•¨).\n    - **Gaze Preference:** ë³‘ë³€ì´ ìˆëŠ” ìª½ì„ ì³ë‹¤ë´„ (**Look *towards* the lesion**). ğŸ‘€ (Frontal Eye Field ì†ìƒìœ¼ë¡œ ë°˜ëŒ€ìª½ ëˆˆ ê·¼ìœ¡ì´ ì´ê²¨ë¨¹ìŒ).\n    - **Dominant Hemisphere (Left):** **Aphasia** (Broca's - ë§ ëª»í•¨ / Wernicke's - ë§ ì´í•´ ëª»í•¨). ğŸ—£ï¸âŒ\n    - **Non-Dominant Hemisphere (Right):** **Hemineglect** (ì™¼ìª½ ì„¸ìƒì„ ë¬´ì‹œí•¨. ì™¼ìª½ ìˆ˜ì—¼ë§Œ ì•ˆ ê¹ìŒ).\n### **B. ACA (Anterior Cerebral Artery) Stroke**\n- **Territory:** Medial Surface (Mohawk area).\n- **Symptoms:**\n    - **Contralateral Leg & Foot Weakness > Arm.** (ë‹¤ë¦¬ê°€ íŒ”ë³´ë‹¤ ì‹¬í•¨). ğŸ¦µ\n    - **Urinary Incontinence:** ì†Œë³€ ì¡°ì ˆ ì¤‘ì¶”(Paracentral lobule) ì¹¨ë²”. ğŸš½\n    - **Abulia:** ì˜ìš• ìƒì‹¤, ë¬´ê¸°ë ¥ (Motivation center ì¹¨ë²”).\n### **C. Lacunar Strokes (Small Vessel Disease)**\n- **Pathology:** **Lipohyalinosis / Microatheroma.** ê³ í˜ˆì••/ë‹¹ë‡¨ë¡œ ì¸í•´ ë‡Œ ê¹Šì€ ê³³(Internal Capsule, Thalamus)ì˜ ë¯¸ì„¸ í˜ˆê´€ì´ \"ë…¹ìŠ¨ íŒŒì´í”„\"ì²˜ëŸ¼ ë§‰í˜.\n- **Key Feature:** **Absence of Cortical Signs.** (í”¼ì§ˆ ì¦ìƒì´ ì—†ìŒ).\n    - No Aphasia, No Neglect, No Vision Loss. âŒğŸ—£ï¸\n- **Types:**\n    - **Pure Motor:** Internal Capsule (Posterior limb). íŒ”/ë‹¤ë¦¬/ì–¼êµ´ ê· ë“±í•˜ê²Œ ë§ˆë¹„.\n    - **Pure Sensory:** Thalamus (VPL). ë°˜ëŒ€ìª½ ëª¸ ì „ì²´ ì €ë¦¼(Numbness).","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-378","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"### **5. ğŸ’£ Malignant Hemispheric Infarction (MHI)**\n- **Scenario:** ì•„ì£¼ í° MCA Stroke ë°œìƒ -> ë‡Œì˜ ì ˆë°˜ì´ ì£½ìŒ -> 3~5ì¼ ë’¤ ê´´ì‚¬ëœ ì¡°ì§ì´ ì—„ì²­ë‚˜ê²Œ ë¶€ì–´ì˜¤ë¦„(**Edema**).\n- **Problem:** ë‘ê°œê³¨(Skull)ì€ ë‹«íŒ ìƒìì„. ë¶€ì„ ê³µê°„ì´ ì—†ì–´ì„œ **Herniation** (ë‡Œê°€ ëˆŒë ¤ì„œ ë¹ ì ¸ë‚˜ì˜´) -> Brainstem ì••ë°• -> ì‚¬ë§. â˜ ï¸\n- **Treatment:** **Decompressive Hemicraniectomy.** ğŸ”¨\n    - ë‘ê°œê³¨ì„ í¬ê²Œ ì˜ë¼ë‚´ì–´ ë‡Œê°€ ë°–ìœ¼ë¡œ ë¶€ì–´ì˜¤ë¥¼ ìˆ˜ ìˆê²Œ ìˆ¨í†µì„ íŠ¸ì—¬ì¤Œ. (Closed box -> Open box). ìƒëª…ì„ ì‚´ë¦¬ëŠ” ì‹œìˆ .\n### **6. ğŸŒŠ Cerebral Venous Sinus Thrombosis (CVST)**\n**\"The Curveball Diagnosis\"**\n- ë™ë§¥(Artery)ì´ ì•„ë‹ˆë¼ **ì •ë§¥(Vein)**ì´ ë§‰íŒ ê²ƒ. í•˜ìˆ˜êµ¬ê°€ ë§‰í˜€ì„œ ì—­ë¥˜í•˜ëŠ” ìƒí™©.\n- **Patient Profile:** ì Šì€ ì—¬ì„±, **Hypercoagulable state** (ì„ì‹ , ì¶œì‚° í›„, í”¼ì„ì•½-OCP ë³µìš©, í¡ì—°). ğŸ¤°ğŸ’ŠğŸš¬\n- **Symptoms:**\n    - **Headache:** ì ì  ì‹¬í•´ì§€ê±°ë‚˜ ë²¼ë½ë‘í†µ(Thunderclap).\n    - **Seizures:** í”í•¨.\n    - **Papilledema:** ë‡Œì•• ìƒìŠ¹ ì†Œê²¬.\n- **Diagnosis:** â˜… **MR Venography (MRV).** ì •ë§¥ì˜ íë¦„ì„ ë´ì•¼ í•¨.\n- **Treatment:** â˜… **Heparin (Anticoagulation).**\n    - **Paradox:** ì •ë§¥ì´ ë§‰í˜€ì„œ í„°ì§€ë©´ ì•½ê°„ì˜ ì¶œí˜ˆì´ ë³´ì¼ ìˆ˜ ìˆìŒ. ê·¸ë˜ë„ í—¤íŒŒë¦°ì„ ì¨ì•¼ í•¨? **YES!** âœ…\n    - **Why?** ì¶œí˜ˆì˜ ì›ì¸ì´ \"í•˜ìˆ˜êµ¬ê°€ ë§‰í˜€ì„œ ì••ë ¥ì´ ì°¼ê¸° ë•Œë¬¸\"ì´ë¯€ë¡œ, í•˜ìˆ˜êµ¬(Clot)ë¥¼ ëš«ì–´ì¤˜ì•¼ ì¶œí˜ˆë„ ë©ˆì¶¤.\n### **7. ğŸ”º Cavernous Sinus Thrombosis**\n**\"The Danger Triangle\"** âš ï¸\n- **Pathology:** ì–¼êµ´ì˜ \"Danger Triangle\" (ì½”~ì…ìˆ  ì£¼ë³€)ì— ì—¬ë“œë¦„(Pimple)ì„ ì§°ëŠ”ë°, ê·¸ ì„¸ê· ì´ ì •ë§¥ì„ íƒ€ê³  ë‡Œ ì†ì˜ Cavernous Sinusë¡œ ë“¤ì–´ê°.\n- **Anatomy:** Cavernous Sinus ì•ˆì—ëŠ” **CN 3, 4, V1, V2, 6**ë²ˆ ì‹ ê²½ê³¼ Internal Carotid Arteryê°€ ì§€ë‚˜ê°.\n- **Symptoms:**\n    - **Proptosis:** ëˆˆì´ íŠ€ì–´ë‚˜ì˜´. ğŸ‘€\n    - **Ophthalmoplegia:** ëˆˆì„ ëª» ì›€ì§ì„ (CN 3, 4, 6 ë§ˆë¹„).\n    - **Sensory Loss:** ì´ë§ˆ/ëº¨ ê°ê° ì €í•˜ (CN V1, V2).\n    - ì¦ìƒì´ í•œìª½ì—ì„œ ì‹œì‘í•´ **ì–‘ìª½(Bilateral)**ìœ¼ë¡œ ê¸‰ì†íˆ í¼ì§ (Sinusê°€ ì—°ê²°ë˜ì–´ ìˆì–´ì„œ).","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-398","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"recap_summary","text":"### **ğŸ”¥ Rapid Fire Recap: High-Yield Table**\n| **Clinical Feature** | **Likely Diagnosis/Location** |\n| --- | --- |\n| **Face/Arm > Leg Weakness** | **MCA Stroke** (Lateral) |\n| **Leg/Foot > Arm Weakness** | **ACA Stroke** (Medial) |\n| **Gaze Preference** | Looks **Towards** the lesion (PPRF/FEF) |\n| **Aphasia (Speech issue)** | **Left** MCA (Dominant) |\n| **Hemineglect (Ignores left side)** | **Right** MCA (Non-dominant) |\n| **Pure Motor or Sensory (No cortical signs)** | **Lacunar Stroke** (Deep structures) |\n| **Young Female + OCP + Seizure/HA** | **CVST** (Check MRV!) |\n| **Focal Neuro Deficit + Hypoglycemia** | **Stroke Mimic** (Give Glucose!) ğŸ¬ |\n| **TPA BP Limit** | Must be **< 185/110** |\n| **No TPA BP Limit** | Permissive up to **220/120** |\n**ğŸ’¡ Final Wisdom:**\n\"Stroke managementëŠ” **Balance** ì‹¸ì›€ì…ë‹ˆë‹¤. í˜ˆì••ì„ ë„ˆë¬´ ë‚®ì¶”ë©´ ë‡Œê°€ ë§ˆë¥´ê³ (Ischemia), ë„ˆë¬´ ë†’ìœ¼ë©´ í„°ì§‘ë‹ˆë‹¤(Bleed). Time is Brain. ë§ì„¤ì´ì§€ ë§ê³  4.5ì‹œê°„ ìœˆë„ìš°ë¥¼ ì‚¬ìˆ˜í•˜ì„¸ìš”!\" ğŸš€\n# Overview (TL;DR)\nì´ë²ˆ ì„¸ì…˜ì€ USMLE Step 2 CKë¥¼ ì¤€ë¹„í•˜ëŠ” ì˜ëŒ€ìƒì„ ìœ„í•œ **Hemorrhagic Stroke (ì¶œí˜ˆì„± ë‡Œì¡¸ä¸­)** ì‹œë®¬ë ˆì´ì…˜ì…ë‹ˆë‹¤. ë‹¨ìˆœíˆ ì§ˆë³‘ì„ ë‚˜ì—´í•˜ëŠ” ê²ƒì´ ì•„ë‹ˆë¼, ì‘ê¸‰ì‹¤(ER) ìƒí™©ê·¹ì„ í†µí•´ í™˜ìì˜ **Presentation(ì¦ìƒ)**, **Diagnosis(ì§„ë‹¨)**, **Management(ì¹˜ë£Œ)**ë¥¼ ë¼›ì†ê¹Œì§€ íŒŒí—¤ì¹©ë‹ˆë‹¤.\n- **í•µì‹¬ ì£¼ì œ:** 3ê°€ì§€ ì£¼ìš” ì¶œí˜ˆì„± ë‡Œì¡¸ì¤‘ (Cerebellar, Subdural, Subarachnoid)\n- **ì ‘ê·¼ ë°©ì‹:** \"Curtain A, B, C\" ë’¤ì— ìˆëŠ” í™˜ìë¥¼ Triageí•˜ëŠ” ER ì‹œë®¬ë ˆì´ì…˜\n- **Key Takeaway:** \"Time is Brain\", \"CT Scan is King\", ê·¸ë¦¬ê³  ê° ì¶œí˜ˆë³„ **Critical Cut-off** (3cm rule, 6-hour rule, BP management).\n### ğŸ¥ Medical Concept Top-Down Tree\nUSMLE ê´€ì ì—ì„œ Hemorrhagic Strokeì˜ í° ê·¸ë¦¼ì„ êµ¬ì¡°í™”í•œ **ASCII Text Tree**ì…ë‹ˆë‹¤.","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-410","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","recap","diagnosis","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"Plaintext\n#\n`Hemorrhagic Stroke (Intracranial Hemorrhage)\nâ”‚\nâ”œâ”€â”€ Core Concept: Rupture of blood vessels â†’ Mass effect & toxicity to brain tissue\nâ”‚   â”œâ”€â”€ Pathophysiology: Hypertension, Trauma, Aneurysm, Amyloid Angiopathy\nâ”‚   â””â”€â”€ General Rule: Non-contrast CT Head is the first step! â˜…\nâ”‚\nâ”œâ”€â”€ Top-Down Classification by Location & Clinical Presentation\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ 1. Cerebellar Hemorrhage (\"The Stumbler\")\nâ”‚   â”‚   â”œâ”€â”€ Context: Vertigo, Vomiting, Ataxia (Not weakness!)\nâ”‚   â”‚   â”œâ”€â”€ Key Anatomy: Posterior Fossa (tight space)\nâ”‚   â”‚   â””â”€â”€ Management: Size matters (>3cm = Surgery) â˜…\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ 2. Subdural Hematoma (\"The Sleeper\")\nâ”‚   â”‚   â”œâ”€â”€ Context: Elderly, Alcoholics, Minor Trauma\nâ”‚   â”‚   â”œâ”€â”€ Key Anatomy: Bridging Veins (Low pressure bleed)\nâ”‚   â”‚   â””â”€â”€ Shape: Crescent (Moon) shape, crosses suture lines\nâ”‚   â”‚\nâ”‚   â””â”€â”€ 3. Subarachnoid Hemorrhage (\"The Screamer\")\nâ”‚       â”œâ”€â”€ Context: \"Thunderclap Headache\" (Worst of my life)\nâ”‚       â”œâ”€â”€ Key Anatomy: Berry Aneurysm, Circle of Willis\nâ”‚       â””â”€â”€ Management: Prevent Rebleeding & Vasospasm (Nimodipine)\nâ”‚\nâ””â”€â”€ Differential Diagnosis (The \"Curtains\")\n    â”œâ”€â”€ Curtain A (SAH): High Drama, Agony, Light sensitivity\n    â”œâ”€â”€ Curtain B (SDH): Confused, Drowsy, Slow decline\n    â””â”€â”€ Curtain C (Cerebellar): Dizzy, Intoxicated look, Normal strength`\n# ğŸ¥ ER Triage: The Three Curtains (Setting the Stage)\nì˜¤ì „ 2:00, ì‘ê¸‰ì‹¤. 3ëª…ì˜ í™˜ìê°€ ì»¤íŠ¼ ë’¤ì— ìˆìŠµë‹ˆë‹¤. ê° í™˜ìì˜ **Clinical Presentation**ì„ í†µí•´ ì§„ë‹¨ì„ ìœ ì¶”í•˜ëŠ” ê²ƒì´ ì²« ë²ˆì§¸ ë‹¨ê³„ì…ë‹ˆë‹¤.\n### ğŸ­ Curtain A: \"The Screamer\" (Subarachnoid Hemorrhage)\n- **Status:** Pure Chaos ğŸ’¥\n- **Presentation:** 1ë¶„ ì „ê¹Œì§€ ë©€ì©¡í•˜ë‹¤ê°€ ê°‘ìê¸° ë°”ë‹¥ì„ êµ¬ë¥´ë©° ë¹„ëª…ì„ ì§€ë¦„.\n- **Symptoms:**\n    - \"Worst headache of my life\" (ìƒì•  ìµœì•…ì˜ ë‘í†µ)\n    - **Maximum Intensity:** Instant onset (Thunderclap âš¡)\n    - **Photophobia:** ë¹›ì´ ëˆˆì„ ì°Œë¥´ëŠ” ë“¯í•œ ê³ í†µ.\n    - Neck Stiffness (Nuchal rigidity).\n### ğŸ‘µ Curtain B: \"The Sleeper\" (Subdural Hematoma)\n- **Status:** Almost Silent ğŸ¤«\n- **Presentation:** 80ëŒ€ ë…¸ì¸. ê°€ì¡±ë“¤ì´ ë°ë ¤ì˜´. í• ë¨¸ë‹ˆê°€ ì¢€ ì´ìƒí•¨(Off).\n- **Symptoms:**\n    - Confused, Drowsy, í‰ì†Œë³´ë‹¤ ì ì„ ë§ì´ ì .\n    - **History:** 3ì£¼ ì „ ê°€ë²¼ìš´ ë‚™ìƒ (Minor fall).\n    - ë‘í†µì´ë‚˜ ê·¹ì ì¸ ì¦ìƒ ì—†ìŒ. ì²œì²œíˆ êº¼ì ¸ê°€ëŠ” ì´›ë¶ˆ ê°™ìŒ (Slow fade).\n### ğŸ¥´ Curtain C: \"The Stumbler\" (Cerebellar Hemorrhage)\n- **Status:** The \"Intoxicated\" Look ğŸº\n- **Presentation:** ìˆ ì— ì·¨í•œ ê²ƒì²˜ëŸ¼ ë³´ì„. êµ¬í† í•˜ê³  ì–´ì§€ëŸ¬ì›Œí•¨.\n- **Symptoms:**\n    - ë˜‘ë°”ë¡œ ê±·ì§€ ëª»í•¨ (Can't walk a straight line).\n    - ì™¼ìª½ìœ¼ë¡œ ìê¾¸ ë„˜ì–´ì§ (Falls to the left).\n    - **The Catch (ë°˜ì „):** Grip Strength(ì•…ë ¥) í…ŒìŠ¤íŠ¸ ì‹œ **ì™„ì „íˆ ì •ìƒ(Totally Normal)**. ğŸ’ª\n    - **Weaknessê°€ ì—†ìŒ!** ì˜¤ì§ Coordination(í˜‘ì‘)ì˜ ë¬¸ì œ.\n### **ğŸ­ Curtain D: â€œThe Sprinterâ€ (Epidural Hematoma, EDH)**\n- **Status:** Fast & Fatal âš ï¸\n- **Presentation:** ë¨¸ë¦¬ ë¶€ë”ªíŒ ì§í›„ ì ê¹ ì •ì‹  ìƒì—ˆê±°ë‚˜ ë©í•¨ â†’ **ê¸ˆë°© ë§ì§±í•´ì§** â†’ **ëª‡ì‹­ ë¶„~ëª‡ ì‹œê°„ ë‚´ ê¸‰ê²©íˆ ì•…í™”**\n- **Symptoms:**\n    - ì‹¬í•œ ë‘í†µ, êµ¬í†  ğŸ¤®\n    - ì ì  ì¡¸ë¦¼/í˜¼ë¯¸\n    - **ë°˜ì „ í¬ì¸íŠ¸:** **â€œì•„ê¹ŒëŠ” ê´œì°®ì•˜ëŠ”ë°ìš”(â˜… lucid interval)â€**\n    - ì§„í–‰ ì‹œ: **ë™ì¸¡ ì‚°ë™(â˜… blown pupil)**, í¸ë§ˆë¹„, í˜¸í¡ ì´ìƒ\n# ğŸ§  Deep Dive 1: Cerebellar Hemorrhage (\"The Stumbler\")\n*(Curtain C - The patient who looks drunk)*","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-420","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### 1. Risk Factors & Mechanism\n- **Primary Driver:** **Hypertension (ê³ í˜ˆì••)** ğŸ©¸. ì¡°ì ˆë˜ì§€ ì•ŠëŠ” ê³ í˜ˆì••ì´ ì†Œë‡Œ(Cerebellum)ì˜ ì‘ì€ í˜ˆê´€ë“¤ì„ í„°ëœ¨ë¦¼.\n- **Pathology:** ì†Œë‡ŒëŠ” ë§¤ìš° ì¢ì€ ê³µê°„(Posterior Fossa)ì— ìœ„ì¹˜í•¨. ì¶œí˜ˆì´ ë°œìƒí•˜ë©´ ê³µê°„ì´ ë¶€ì¡±í•´ Brainstemì„ ì••ë°•í•  ìˆ˜ ìˆìŒ.\n### 2. Clinical Presentation (USMLE Trap!)\n- **Golden Rule:** **Stroke â‰  Weakness** âŒ\n    - ìš°ë¦¬ëŠ” \"Stroke = ë§ˆë¹„(Paralysis)\"ë¼ê³  ìƒê°í•˜ë„ë¡ í›ˆë ¨ë°›ì•˜ì§€ë§Œ, ì†Œë‡Œ ì¶œí˜ˆì€ ë‹¤ë¦„.\n    - í™˜ìëŠ” íŒ”ë‹¤ë¦¬ í˜ì€ í„í„ ë„˜ì¹¨. í•˜ì§€ë§Œ **Coordination(ì¡°ì •ë ¥)**ì´ ì œë¡œ(Zero).\n    - **Ipsilateral Ataxia:** ì¶œí˜ˆì´ ì™¼ìª½ì— ìˆìœ¼ë©´ ì™¼ìª½ìœ¼ë¡œ ë„˜ì–´ì§.\n- **Symptoms Cluster:**\n    - Headache (Occipital headache)\n    - Nausea & Vomiting ğŸ¤®\n    - Severe Vertigo (ì‹¬í•œ ì–´ì§€ëŸ¬ì›€)\n    - Nystagmus (ì•ˆêµ¬ ì§„íƒ• - ëˆˆì´ íŠ€ëŠ” í˜„ìƒ)\n    - **Stiff Neck:** ì†Œë‡Œê°€ Brainstem ë°”ë¡œ ë’¤ì— ìˆì–´ì„œ ë‡Œë§‰ ìê·¹ ì¦ìƒì´ ë‚˜íƒ€ë‚  ìˆ˜ ìˆìŒ.\n### 3. Diagnostic Dilemma\n- í™˜ìê°€ ë°°ë¥¼ íƒ€ê³  ìˆëŠ” ê²ƒì²˜ëŸ¼ ì–´ì§€ëŸ¬ì›Œí•˜ê³  í† í•˜ì§€ë§Œ, í˜ì€ ì…ˆ.\n- **ì£¼ì˜:** ì´ë¹„ì¸í›„ê³¼(ENT)ë¡œ ë³´ë‚´ ê·€ ê²€ì‚¬ë¥¼ í•˜ì§€ ë§ ê²ƒ! **Brain Scanì„ í•´ì•¼ í•¨!** ğŸš¨\n### 4. Management: The 3cm Rule â˜…\n- ì´ê³³ì€ í•´ë¶€í•™ì ìœ¼ë¡œ **Life Support Center (Brainstem)** ë°”ë¡œ ì˜†ì´ë¼ ë§¤ìš° ìœ„í—˜í•¨. ë‡Œê°„ì´ ëˆŒë¦¬ë©´ ìˆ¨ì„ ëª» ì‰¬ê±°ë‚˜ ì˜ì‹ì„ ìƒìŒ.\n- **Surgical Cut-off:** **3 cm** ğŸ“\n    - **> 3 cm:** **Surgical Decompression (ìˆ˜ìˆ ì  ê°ì••ìˆ )** í•„ìš”. ê³µê°„ì„ ë§Œë“¤ì–´ì¤˜ì•¼ í•¨.\n    - **< 3 cm:** ì¦ìƒì´ ê²½ë¯¸í•˜ë©´ ì§€ì¼œë³¼ ìˆ˜ ìˆìŒ(Conservative).\n    - **Red Flag:** í¬ê¸°ê°€ ì‘ë”ë¼ë„ **Consciousness(ì˜ì‹) ì €í•˜**, **Brainstem Compression ì†Œê²¬**, **Obstructive Hydrocephalus(íì‡„ì„± ìˆ˜ë‡Œì¦)**ì´ ë³´ì´ë©´ ë¬´ì¡°ê±´ ìˆ˜ìˆ ! ğŸ”ª\n# ğŸ§  Deep Dive 2: Subdural Hematoma (\"The Sleeper\")\n*(Curtain B - The elderly grandmother)*\n### 1. Pathophysiology: Physics of Aging\n- **Anatomy:** Skull(ë‘ê°œê³¨)ê³¼ Brain(ë‡Œ) ì‚¬ì´ë¥¼ ì—°ê²°í•˜ëŠ” **Bridging Veins (ê°€êµ ì •ë§¥)**ì´ ì¡´ì¬.\n- **Aging Process:** ë‚˜ì´ê°€ ë“¤ê±°ë‚˜ ì•Œì½”ì˜¬ ì¤‘ë…ì´ ìˆìœ¼ë©´ **Cerebral Atrophy (ë‡Œ ìœ„ì¶•)** ë°œìƒ. ğŸ§ â†˜ï¸\n    - ë‡ŒëŠ” ì‘ì•„ì§€ëŠ”ë° ë‘ê°œê³¨ í¬ê¸°ëŠ” ê·¸ëŒ€ë¡œì„.\n    - Gapì´ ë„“ì–´ì§€ë©´ì„œ Bridging Veinsê°€ íŒ½íŒ½í•˜ê²Œ ë‹¹ê²¨ì§ (ë§ˆì¹˜ ê¸°íƒ€ ì¤„ì²˜ëŸ¼ ğŸ¸).\n- **Mechanism:** ì•„ì£¼ ì‚¬ì†Œí•œ ì¶©ê²©(ë¬¸í‹€ì— ë¨¸ë¦¬ ì°§ê¸° ë“±)ì—ë„ íŒ½íŒ½í•œ ì •ë§¥ì´ \"í†¡\" í•˜ê³  ëŠì–´ì§.\n- **Flow:** ì •ë§¥í˜ˆ(Vein)ì´ë¼ ì••ë ¥ì´ ë‚®ìŒ â†’ ì²œì²œíˆ ìŠ¤ë©°ë‚˜ì˜´ (Low pressure ooze).\n### 2. Clinical Presentation: The Slow Fade\n- ì¦ìƒì´ ë§¤ìš° ì„œì„œíˆ ë‚˜íƒ€ë‚¨. ì¹˜ë§¤(Dementia)ì™€ í˜¼ë™í•˜ê¸° ì‰¬ì›€.\n- **Symptoms:** Headache, Somnolence(ì¡¸ë¦¼), Light-headedness.\n- **Expert Note:** ë…¸ì¸ì´ ê°‘ìê¸° ë©í•´ì§€ê±°ë‚˜, ì„±ê²©ì´ ë³€í•˜ê±°ë‚˜, ìê¾¸ ì¡±ì„ ë•Œ \"ì¹˜ë§¤ê² ê±°ë‹ˆ\" í•˜ì§€ ë§ê³ , **Falls History(ë‚™ìƒë ¥)**ë¥¼ ë°˜ë“œì‹œ ì²´í¬í•  ê²ƒ! â˜…\n### 3. CT Scan Interpretation ğŸ“¸\n- **Shape:** **Crescent Moon (ì´ˆìŠ¹ë‹¬ ëª¨ì–‘)** ğŸŒ™.\n- **Feature:** Suture line(ë´‰í•©ì„ )ì„ ë„˜ì–´ê°ˆ ìˆ˜ ìˆìŒ (Can cross suture lines). ë‡Œ ì „ì²´ë¥¼ ê°ì‹¸ëŠ” ë‹´ìš”(Blanket) ê°™ìŒ.\n- **Aging on CT (Blood Density):**\n    - **Acute (ê¸‰ì„±):** Hyperdense (Bright White) âšª - 1~2ì¼ ë‚´ ë°œìƒ. ì‹ ì„ í•œ í”¼.\n    - **Chronic (ë§Œì„±):** Hypodense (Dark/Fluid-like) âš« - 3ì£¼ ì´ìƒ ê²½ê³¼. í”¼ê°€ ë¶„í•´ë˜ì–´ ë¬¼ì²˜ëŸ¼ ë³´ì„. (ì´ê²ƒì´ ì„ìƒê°€ë“¤ì„ ì†ì´ëŠ” í•¨ì •!)\n### 4. Management Strategy\n- Stop the blood thinners.\n- **Decision:** ë¬´ì¡°ê±´ ìˆ˜ìˆ í•˜ëŠ” ê²ƒì´ ì•„ë‹˜.\n- **Acute & Large/Symptomatic:** Craniotomy (ê°œë‘ìˆ )ë¡œ í”¼ë¥¼ ì œê±°.\n- **Chronic & Minor Symptoms:** Observation.\n    - ë§Œì•½ ì¦ìƒ(ë‘í†µ, ìœ„ì•½ê° ë“±)ì´ ì‹¬í•˜ê±°ë‚˜ Mass effectê°€ í¬ë©´ **Burr hole drainage (ì²œê³µ ë°°ì•¡ìˆ )** ì‹œí–‰.","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-440","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"# ğŸ§  Deep Dive 3: Subarachnoid Hemorrhage (\"The Screamer\")\n*(Curtain A - The Thunderclap)*\n### 1. Pathophysiology: The Blowout\n- **Cause:** **Ruptured Saccular (Berry) Aneurysm** ğŸ’. (ë™ë§¥ë¥˜ íŒŒì—´)\n- **Mechanism:** ë™ë§¥ì••(Arterial Pressure)ì— ì˜í•œ í­ë°œ(Blowout).\n- **Location:** Subarachnoid space (ê±°ë¯¸ë§‰í•˜ ê³µê°„). CSFê°€ íë¥´ëŠ” ê¸¸.\n- **Meningeal Irritation:** í”¼ëŠ” ë‡Œ ì¡°ì§ì— ë§¤ìš° ìê·¹ì ì„(Chemical Meningitis) â†’ ëª©ì´ ë»£ë»£í•´ì§(Stiff neck).\n### 2. Diagnosis Algorithm (High Yield) â˜…\n- **Step 1: Non-contrast CT Head:**\n    - **Pattern:** **Starfish (ë¶ˆê°€ì‚¬ë¦¬ ëª¨ì–‘)** â­. ë‡Œì˜ ì¤‘ì‹¬ë¶€(Basal cisterns)ì— í”¼ê°€ í•˜ì–—ê²Œ ì°¸.\n    - **Sensitivity:** ë°œë³‘ 6ì‹œê°„ ì´ë‚´ì—ëŠ” 98% ì´ìƒ ì •í™•í•¨.\n- **Step 2: Lumbar Puncture (LP):** (ë§Œì•½ CTê°€ ê¹¨ë—í•œë° ì¦ìƒì€ ê°•ë ¥í•  ë•Œ)\n    - **Look for:** **Xanthochromia** (Yellow CSF) ğŸŸ¡.\n    - **Why?** ì í˜ˆêµ¬(RBC)ê°€ íŒŒê´´ë˜ì–´ ë¹Œë¦¬ë£¨ë¹ˆì´ ë‚˜ì˜¤ê¸°ê¹Œì§€ ì•½ 6ì‹œê°„ ê±¸ë¦¼. CT ìŒì„±ì´ê³  6ì‹œê°„ì´ ì§€ë‚¬ë‹¤ë©´ LPë¡œ í™•ì¸í•´ì•¼ í•¨. (Traumatic tapê³¼ êµ¬ë³„ í¬ì¸íŠ¸)\n### 3. Timeline of Terror (Complications) ğŸ•’\ní™˜ìê°€ ì²«ë‚  ì‚´ì•„ë‚¨ì•˜ë‹¤ê³  ëë‚œ ê²Œ ì•„ë‹˜. ì‹œê¸°ë³„ë¡œ ì‚¬ë§ ì›ì¸ì´ ë‹¤ë¦„.\n### **Phase 1: The First 24 Hours (Rebleeding)** ğŸ©¸\n- **Risk:** ë™ë§¥ë¥˜ê°€ í„°ì§„ ê³³ì— ìƒê¸´ ë”±ì§€(Clot)ëŠ” ì•„ì§ ë¶ˆì•ˆì •í•¨(Wet scab). í˜ˆì••ì´ ì˜¤ë¥´ë©´ ë‹¤ì‹œ í„°ì§.\n- **Consequence:** ì¬ì¶œí˜ˆ ì‹œ ì‚¬ë§ë¥  ë§¤ìš° ë†’ìŒ.\n- **Prevention:** **Strict BP Control** (Systolic < 160 mmHg) & **Bed Rest**. ê·¸ë¦¬ê³  ë¹ ë¥¸ **Aneurysm Coiling or Clipping**.\n### **Phase 2: Day 3 ~ 14 (Vasospasm)** ğŸŒªï¸\n- **Risk:** í„°ì ¸ ë‚˜ì˜¨ í”¼ì—ì„œ ë…ì„± ë¬¼ì§ˆ/Free radicalì´ ë‚˜ì˜´ â†’ í˜ˆê´€ì„ ìê·¹í•˜ì—¬ í˜ˆê´€ì´ ìˆ˜ì¶•í•¨(Spasm).\n- **Consequence:** í˜ˆê´€ì´ ì¢ì•„ì ¸ì„œ **Delayed Ischemic Stroke** (2ì°¨ ë‡Œê²½ìƒ‰) ë°œìƒ. ë©€ì©¡í•˜ë˜ í™˜ìê°€ ê°‘ìê¸° íŒ”ë‹¤ë¦¬ë¥¼ ëª» ì“°ê²Œ ë¨.\n- **Prevention (Gold Standard):** **Nimodipine** (Calcium Channel Blocker) ğŸ’Š. ëª¨ë“  SAH í™˜ìì—ê²Œ ì˜ˆë°©ì ìœ¼ë¡œ íˆ¬ì—¬í•¨. â˜…\n- **Paradox:** Vasospasmì´ ì˜¤ë©´ ë‡Œë¡œ í”¼ë¥¼ ë³´ë‚´ê¸° ìœ„í•´ í˜ˆì••ì„ ì¼ë¶€ëŸ¬ ë†’ì—¬ì•¼ í•  ìˆ˜ë„ ìˆìŒ (Permissive Hypertension). ì´ˆê¸°ì˜ í˜ˆì•• ì¡°ì ˆê³¼ëŠ” ë°˜ëŒ€ ì „ëµ!\n### **Phase 3: Anytime (Hydrocephalus)** ğŸ’§\n- **Mechanism:** í”¼ ë©ì–´ë¦¬ê°€ CSF ë°°ì¶œêµ¬(Arachnoid granulations)ë¥¼ ë§‰ìŒ (Clogged sink).\n- **Outcome:** ë‡Œì•• ìƒìŠ¹, ì˜ì‹ ì €í•˜.\n- **Tx:** Ventriculostomy (EVD) ë“±ìœ¼ë¡œ ë¬¼ì„ ë¹¼ì¤˜ì•¼ í•¨.\n# **ğŸ§  Deep Dive: Epidural Hematoma (â€œThe Sprinterâ€)**\n## **1) Pathophysiology: â€œArtery under the skullâ€**\n- **Location:** Skull â†” **Dura ì‚¬ì´(epidural space)**\n- **Mechanism:** ë³´í†µ **ì¸¡ë‘ê³¨ ê³¨ì ˆ**ì´ **MMAë¥¼ ì°¢ìŒâ˜…**\n- **Why fast:** **Arterial bleed = high pressure** â†’ ICPê°€ **ë¹ ë¥´ê²Œ ìƒìŠ¹** ğŸ’¥\n- **Anatomy consequence:** Duraê°€ ë´‰í•©ì„ (suture)ì— ë‹¨ë‹¨íˆ ë¶™ì–´ ìˆì–´ì„œ, í”¼ê°€ **ê±°ê¸°ì„œ ë©ˆì¶° â€œë Œì¦ˆ ëª¨ì–‘â€**ìœ¼ë¡œ ë¶€í’€ì–´ ì˜¤ë¦„\n## **2) Clinical Presentation: Lucid intervalì´ í•µì‹¬ í•¨ì • ğŸ¯**\n- **Classic timeline**\n    1. ì™¸ìƒ ì§í›„ **brief LOC/í˜¼ë¯¸**\n    2. **ì •ìƒì²˜ëŸ¼ ëŒ€í™”(â˜… lucid interval)**\n    3. **ê°‘ìê¸° deterioration** (ë‘í†µ/êµ¬í† /ì˜ì‹ì €í•˜)\n- **Herniation red flags (ì—¬ê¸°ì„œë¶€í„°ëŠ” â€œì‹œê°„=ë‡Œâ€)**\n    - **Ipsilateral blown pupilâ˜…**: uncal herniation â†’ CN III ì••ë°•\n    - **Contralateral weakness** (Â± late posturing)\n    - **Cushing triad**: HTN + bradycardia + irregular respiration ğŸ«€\n## **3) CT Scan Interpretation ğŸ“¸ (1ì´ˆ ê°ë³„)**","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-460","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"- **Shape:** **Biconvex / Lentiform(ë Œì¦ˆ)â˜…**\n- **Suture line crossing:** **ëª» ë„˜ìŒâ˜…**\n- (ì‹œí—˜ìš© ë¹„ìœ ) â€œí”¼ê°€ í•œ êµ¬íšì— ê°‡í˜€ì„œ **ë¹µë¹µí•œ ë§Œë‘ì²˜ëŸ¼** ë¶€í‘¼ë‹¤ ğŸ¥Ÿâ€\n## **4) Management Strategy: â€œDonâ€™t be reassured by â€˜he looked fineâ€™â€**\n### **Step 0: Stabilize (ABCs)**\n- ê¸°ë„ ë³´í˜¸ í•„ìš” ì‹œ intubation, ì‚°ì†Œ/í™˜ê¸°\n- ICP ëŒ€ì‘: ë¨¸ë¦¬ 30Â°, ì§„ì •/ì§„í†µ, ìƒí™© ë”°ë¼ **hypertonic saline/ë§Œë‹ˆí†¨** ğŸ§‚\n### **Step 1: Definitive (Neurosurgery emergent ğŸš¨)**\n- **Neurosurgery ì¦‰ì‹œ í˜¸ì¶œâ˜…**\n- **ì„ìƒ ì•…í™”/ë™ê³µ ì´ìƒ/ì‹ ê²½í•™ì  ê²°ì†**ì´ë©´ **ì¦‰ì‹œ ìˆ˜ìˆ  ë£¨íŠ¸**(í˜ˆì¢… ì œê±°, ê°ì••/ê°œë‘)\n### **Step 2: ìˆ˜ìˆ  vs ê´€ì°° (ì‹œí—˜ì—ì„œ ìì£¼ ì“°ëŠ” ê¸°ì¤€ ğŸ“)**\n- **ëŒ€ì²´ë¡œ ìˆ˜ìˆ  ê³ ë ¤â˜…**\n    - **Volume > 30 mL**\n    - ë˜ëŠ” **Thickness > 15 mm**\n    - ë˜ëŠ” **Midline shift > 5 mm**\n    - ë˜ëŠ” **GCS ì €í•˜/êµ­ì†Œê²°ì†/ë™ê³µ ë³€í™”**(= í¬ê¸° ì‘ì•„ë„ ìˆ˜ìˆ  ìª½ìœ¼ë¡œ)\n- **ê´€ì°° ê°€ëŠ¥**\n    - ì‘ê³  ì•ˆì •ì , ì‹ ê²½í•™ì  ì´ìƒ ì—†ìŒ, ëª¨ë‹ˆí„°ë§/ë°˜ë³µ CT ê°€ëŠ¥í•œ ê²½ìš°\n# ğŸ”¥ Rapid Fire Recap (USMLE Cheat Sheet)\n| **Pathology** | **Keyword / Analogy** | **Clinical Sign** | **CT Appearance** | **Management Pearl** |\n| --- | --- | --- | --- | --- |\n| **Cerebellar** | The Stumbler (ì·¨í•œ ì‚¬ëŒ) | Ataxia, Vertigo, **Normal Strength** | Posterior fossa bleed | **>3cm** = Surgery ğŸ”ª (Rule of 3) |\n| **Subdural (SDH)** | The Sleeper (ì„œì„œíˆ êº¼ì§) | Bridging Veins, Elderly/Alcoholic | **Crescent (Moon) ğŸŒ™**, Crosses sutures | Acute: Bright, Chronic: Dark (Check INR/Meds!) |\n| **Subarachnoid (SAH)** | The Screamer (ì²œë‘¥ì†Œë¦¬) | **Thunderclap HA âš¡**, Worst of life | **Starfish â­**, Center of brain | **Nimodipine** (Vasospasm), **Coiling/Clipping** (Rebleed) |\n| Epidural (EDH)\n | The Sprinter (ì ê¹ ë©€ì©¡â†’ê¸‰ì „ì§í•˜)\n | Temporal skull fx, Lucid interval, Ipsilateral blown pupil\n | Biconvex/Lentiform (Lens) ğŸ¥Ÿ, Does NOT cross sutures\n | Neurosurg emergent; Evacuate if symptomatic or large (e.g., >30 mL, >15 mm, MLS >5 mm)\n |\n### ğŸ’¡ Final Pearls\n- **BP Paradox in SAH:** ì²˜ìŒì—” ì¬ì¶œí˜ˆ ë§‰ê¸° ìœ„í•´ í˜ˆì••ì„ ë‚®ì¶”ê³ (<160), ë‚˜ì¤‘ì—” Vasospasm ë§‰ê¸° ìœ„í•´ ë‡Œ ê´€ë¥˜ì••ì„ ìœ ì§€í•´ì•¼ í•¨.\n- **Diagnostic Safety Net:** SAH ì˜ì‹¬ë˜ëŠ”ë° CT ì •ìƒì´ë©´? â†’ **ë¬´ì¡°ê±´ LP (Lumbar Puncture)!** ì ˆëŒ€ ê·¸ëƒ¥ ì§‘ì— ë³´ë‚´ë©´ ì•ˆ ë¨.\n- **Time is Brain:** ì§„ë‹¨(CT)ê³¼ ì¹˜ë£Œ(BP ì¡°ì ˆ, ìˆ˜ìˆ ) ì‚¬ì´ì˜ ì‹œê°„ì„ ìµœì†Œí™”í•˜ëŠ” ê²ƒì´ ìƒì¡´ì˜ ì—´ì‡ ! ğŸ”‘\nconfidence: 1.0 (Based entirely on audio content)","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-480","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","treatment","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"# LM_Neuro 2\n## ğŸ“‹ Overview & TL;DR (High-Yield Summary)\nì˜¤ëŠ˜ì˜ Deep DiveëŠ” **Traumatic Brain Injury (TBI)** ì˜ A to Zë¥¼ ë‹¤ë£¹ë‹ˆë‹¤. Trauma Bayì— ë“¤ì–´ì„œëŠ” ìˆœê°„ë¶€í„° í™˜ìì˜ ì˜ˆí›„ ê´€ë¦¬ê¹Œì§€, **USMLE Step 2 CK**ë¥¼ ìœ„í•œ Clinical Mental Frameworkë¥¼ êµ¬ì¶•í•˜ëŠ” ê²ƒì´ ëª©í‘œì…ë‹ˆë‹¤. ğŸ§ ğŸ’¥\n**ğŸ”‘ Key Takeaways:**\n- **Basilar Skull Fracture:** Raccoon eyes, Battle sign, CSF Rhinorrhea í™•ì¸. **Beta-2 Transferrin**ì´ í•µì‹¬!\n- **Imaging Decision (CT):** ëª¨ë“  í™˜ìê°€ CTë¥¼ ì°ì§€ ì•ŠìŠµë‹ˆë‹¤. **Canadian CT Head Rule** (ì„±ì¸) & **PECARN Rule** (ì†Œì•„) ì ìš© í•„ìˆ˜.\n- **Concussion:** êµ¬ì¡°ì  ë¬¸ì œê°€ ì•„ë‹Œ **ê¸°ëŠ¥ì (Functional)** ë¬¸ì œ. íœ´ì‹ í›„ ë‹¨ê³„ì  ë³µê·€(Gradual Return to Play).\n- **ICP Management:** **Monro-Kellie Doctrine** ì´í•´. Hyperventilationì€ ì„ì‹œë°©í¸(Bridge)ì¼ ë¿!\n- **Diffuse Axonal Injury (DAI):** GCSëŠ” ë‚®ì€ë° CTê°€ ê¹¨ë—í•˜ë‹¤? **MRI**ê°€ ì •ë‹µ.\n## ğŸŒ³ Top-down Classification: Traumatic Brain Injury (TBI)\nì˜í•™ì  ë§¥ë½ì„ êµ¬ì¡°í™”í•˜ê¸° ìœ„í•œ **ASCII Text Tree**ì…ë‹ˆë‹¤. í˜„ì¬ ë…¼ì˜ë˜ëŠ” ì£¼ì œë“¤ì´ ì „ì²´ ê·¸ë¦¼ì—ì„œ ì–´ë””ì— ìœ„ì¹˜í•˜ëŠ”ì§€ í™•ì¸í•˜ì„¸ìš”.\nPlaintext\n`Traumatic Brain Injury (TBI)\nâ”‚\nâ”œâ”€â”€ 1. Primary Injury (Impact Moment)\nâ”‚   â”œâ”€â”€ A. Skull Fractures\nâ”‚   â”‚   â”œâ”€â”€ Linear / Depressed\nâ”‚   â”‚   â””â”€â”€ Basilar Skull Fracture (ğŸ’€ Raccoon Eyes, Battle Sign)\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ B. Intracranial Hemorrhage (The Bleeds ğŸ©¸)\nâ”‚   â”‚   â”œâ”€â”€ Epidural Hematoma (Lens shape, Lucid interval)\nâ”‚   â”‚   â”œâ”€â”€ Subdural Hematoma (Crescent shape, Bridging veins)\nâ”‚   â”‚   â”œâ”€â”€ Subarachnoid Hemorrhage (Thunderclap, Worst headache)\nâ”‚   â”‚   â””â”€â”€ Intraparenchymal Hemorrhage\nâ”‚   â”‚\nâ”‚   â””â”€â”€ C. Microscopic / Shearing\nâ”‚       â””â”€â”€ Diffuse Axonal Injury (DAI) (âš¡ Coma + Clean CT â†’ MRI needed)\nâ”‚\nâ”œâ”€â”€ 2. Secondary Injury (Post-Impact Complications)\nâ”‚   â”œâ”€â”€ A. Increased ICP (Intracranial Pressure) ğŸ¤¯\nâ”‚   â”‚   â”œâ”€â”€ Monro-Kellie Doctrine (Brain + Blood + CSF = Constant)\nâ”‚   â”‚   â””â”€â”€ Herniation Syndromes (Uncal, Tonsillar, etc.)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ B. Functional Disturbance\nâ”‚       â”œâ”€â”€ Concussion (Mild TBI)\nâ”‚       â””â”€â”€ Post-Concussion Syndrome (>4 weeks)\nâ”‚\nâ””â”€â”€ 3. Decision Making Rules (To Scan or Not to Scan? ğŸ“¸)\n    â”œâ”€â”€ Adults: Canadian CT Head Rule / New Orleans Criteria\n    â””â”€â”€ Pediatrics: PECARN Rule (â˜¢ï¸ Radiation saving)`\n## ğŸ¥ 1. Initial Assessment: The Tale of Two Patients (Trauma Bay)\n**ğŸšª Doorway Thought:** ë‘ ëª…ì˜ í™˜ìê°€ ë™ì‹œì— ë“¤ì–´ì˜µë‹ˆë‹¤. í•œ ëª…ì€ ê¹¨ì–´ìˆê³ (Alert), í•œ ëª…ì€ í˜¼ìˆ˜ìƒíƒœ(Comatose)ì…ë‹ˆë‹¤. ê²‰ëª¨ìŠµë§Œ ë³´ê³  íŒë‹¨í•˜ë©´ ì•ˆ ë©ë‹ˆë‹¤! ğŸš¨\n### Patient A: The \"Raccoon\" (Basilar Skull Fracture) ğŸ¦\n- **Presentation:** ìˆ  ëƒ„ìƒˆê°€ ë‚˜ê³  ê¹¨ì–´ìˆì§€ë§Œ(Alert), ì–‘ìª½ ëˆˆ ì£¼ìœ„ì— ì‹¬í•œ ë©(**Bilateral Periorbital Ecchymosis**)ì´ ìˆìŒ.\n- **ğŸš© Major Red Flag:** ê¹¨ì–´ìˆë”ë¼ë„ **Basilar Skull Fracture(ë‘ê°œì € ê³¨ì ˆ)** ë¥¼ ê°•ë ¥íˆ ì‹œì‚¬í•¨.\n- **Anatomy:** Skull floor(ë‘ê°œì €)ì˜ Anterior portionì´ ê³¨ì ˆë˜ë©´ì„œ Cribriform plateê°€ ê¹¨ì§€ê³ , í”¼ê°€ ì—°ì¡°ì§(Soft tissue)ìœ¼ë¡œ ìŠ¤ë©°ë“¤ì–´ ëˆˆ ì£¼ìœ„ì— ê³ ì„.\n**ğŸ¯ Key Clinical Signs for Basilar Skull Fracture:**\n1. **Raccoon Eyes:** Anterior fossa fracture ì‹œì‚¬.\n2. **Battle Sign:** ê·€ ë’¤ìª½(Mastoid process)ì˜ ë©. Posterior fossa fracture ì‹œì‚¬.\n3. **Hemotympanum:** ê³ ë§‰ ì•ˆìª½ì— í”¼ê°€ ê³ ì—¬ì„œ ê²€ë¶‰ê²Œ ë³´ì„ (Otoscopeë¡œ í™•ì¸).\n4. **CSF Rhinorrhea/Otorrhea:** ì½”ë‚˜ ê·€ì—ì„œ ë§‘ì€ ì•¡ì²´(ë‡Œì²™ìˆ˜ì•¡)ê°€ íë¦„. â‘  Unilateral â‘¡ ì§­ì§¤í•œ ë§› í™˜ìê°€ \"ì§­ì§¤í•˜ê±°ë‚˜ ê¸ˆì† ë§›ì´ ë‚œë‹¤(Salty/Metallic taste)\"ê³  í˜¸ì†Œí•  ìˆ˜ ìˆìŒ.","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-1","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"**â˜… Gold Standard for CSF Leak Diagnosis:**\n- ê³¼ê±°ì˜ Halo Sign(íœ´ì§€ì— ë–¨ì–´ëœ¨ë ¤ ë§ ëª¨ì–‘ í™•ì¸)ì€ ë¶€ì •í™•í•¨.\n- **â˜… Beta-2 Transferrin test:** CSFì—ë§Œ ì¡´ì¬í•˜ëŠ” ë‹¨ë°±ì§ˆ. ì´ê²ƒì´ **Board Exam Answer**ì…ë‹ˆë‹¤!\n**ğŸ’‰Management**\n- Bed rest, head elevation\n- í˜ì£¼ì§€ë§ˆì„¸ìš” (ì½”í’€ì§€ë§ˆì„¸ìš”, ë˜¥ìŒ€ë•ŒëŠ” ë³€ë¹„ì•½)\n- ë³´í†µì€ ë³´ì¡´ì  ì¹˜ë£Œ.\n### Patient B: The High-Speed Ejection (Severe TBI) ğŸš—ğŸ’¨\n- **Presentation:** ì°¨ ë°–ìœ¼ë¡œ íŠ•ê²¨ ë‚˜ê°(Ejection), ì‚½ê´€ë¨(Intubated), **GCS 4ì ** (ì™„ì „ ë¬´ë°˜ì‘).\n- **Clinical Approach:** ìƒë¦¬í•™ì  ìƒíƒœ(Physiology)ê°€ ë‹¤ìŒ í–‰ë™ì„ ê²°ì •í•©ë‹ˆë‹¤. í™˜ìê°€ ì–¼ë§ˆë‚˜ ì‹œë„ëŸ¬ìš´ì§€ê°€ ì•„ë‹ˆë¼, GCSì™€ í™œë ¥ ì§•í›„ê°€ í•µì‹¬ì…ë‹ˆë‹¤.\n## ğŸ“¸ 2. To Scan or Not to Scan? (Imaging Rules)\nì‘ê¸‰ì‹¤ì˜ ê°€ì¥ í° ì§ˆë¬¸: **\"CTë¥¼ ì°ì„ ê²ƒì¸ê°€?\"** (Radiation Risk vs. Missed Bleed Risk)\n### ğŸ‘´ Adults: High Risk Criteria (Canadian CT Head Rule)\në¬´ì¡°ê±´ CTë¥¼ ì°ì–´ì•¼ í•˜ëŠ” ê²½ìš° (**Automatic Scan**):\n1. **Age â‰¥ 65:** ë‡Œê°€ ìœ„ì¶•(Atrophy)ë˜ì–´ Bridging veinì´ ë‹¹ê²¨ì ¸ ìˆì–´ ì°¢ì–´ì§€ê¸° ì‰¬ì›€ (Subdural Hematoma ìœ„í—˜ ì¦ê°€). ğŸ§ ğŸ“‰\n2. **Coagulopathy:** Warfarin(Coumadin), DOAC ë³µìš©ì, í˜¹ì€ ì¶œí˜ˆ ì§ˆí™˜ì´ ìˆëŠ” ê²½ìš°.\n3. **Dangerous Mechanism:**\n    - ì°¨ëŸ‰ì—ì„œ íŠ•ê²¨ ë‚˜ê° (Ejection).\n    - ë³´í–‰ìê°€ ì°¨ì— ì¹˜ì„.\n    - **Fall Height:** ì„±ì¸ì˜ ê²½ìš° **3~5 feet (ì•½ 1~1.5m)** ì´ìƒ í˜¹ì€ 5ê³„ë‹¨ ì´ìƒ ì¶”ë½ ì‹œ ê³ ìœ„í—˜.\n4. High risk symptoms\n    - **Vomiting Rule:** **2íšŒ ì´ìƒ** êµ¬í† ëŠ” Intracranial Pressure(ICP) ìƒìŠ¹ì„ ì‹œì‚¬ â†’ CT ê³ ë ¤. ğŸ¤®\n    - Retrograde amnesia\n    - Seisure, headache\n5. High risk signs\n    - GCS ì €í•˜\n    - Basilar fx ì†Œê²¬ (raccoon eye, battle sign, CSF ì½§ë¬¼, hemotympanium)\n    - Neurological deficit\n### ğŸ‘¶ Pediatrics: PECARN Rule (ê³¨ë“œ ìŠ¤íƒ ë‹¤ë“œ) ğŸŒŸ\nì•„ì´ë“¤ì€ ë°©ì‚¬ì„ ì— ì·¨ì•½í•˜ë¯€ë¡œ CTë¥¼ ì•„ê»´ì•¼ í•©ë‹ˆë‹¤. **Observation(ê´€ì°°)** ì´ ì¤‘ìš”í•œ ì˜µì…˜ì…ë‹ˆë‹¤.\n| **êµ¬ë¶„** | **2ì„¸ ë¯¸ë§Œ (<2 yo)** | **2ì„¸ ~ 18ì„¸ (2-18 yo)** |\n| --- | --- | --- |\n| **High Risk (Scan Now)** | GCS < 15\në§Œì ¸ì§€ëŠ” ë‘ê°œê³¨ ê³¨ì ˆ (Palpable fracture)\nì˜ì‹ ë³€í™” (Agitation, Lethargy)\n*Frontalì´ ì•„ë‹Œ* ë‹¤ë¥¸ ë¶€ìœ„ì˜ í˜¹(Hematoma)\n5ì´ˆ ì´ìƒ ì˜ì‹ ì†Œì‹¤\nì‹¬í•œ ê¸°ì „ (3ft ì´ìƒ ì¶”ë½) | GCS < 15\nBasilar fracture signs (Raccoon eyes ë“±)\nì˜ì‹ ë³€í™”\nì‹¬í•œ ë‘í†µ\nêµ¬í† \nì‹¬í•œ ê¸°ì „ (5ft ì´ìƒ ì¶”ë½) |\n- **Infant Fall Height:** **3 feet (ì•½ 90cm)** ì´ìƒì´ë©´ High/Intermediate Risk (ê¸°ì €ê·€ êµí™˜ëŒ€ ë†’ì´).\n- Mild TBI (2ft, vomiting 1íšŒ, ì‚´ì§ ìšº) (high risk ê¸°ì¤€ ì•ˆë¨) â†’ ë¶€ëª¨ ìƒì˜ í›„ 4-6ì‹œê°„ ì •ë„ ê´€ì°° â˜…","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-21","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"## ğŸ¤• 3. Concussion (Mild TBI)\n**ğŸšª Doorway Thought:** CTëŠ” **ì •ìƒ(Clean)** ì…ë‹ˆë‹¤. í•˜ì§€ë§Œ í™˜ìëŠ” ì–´ì§€ëŸ½ê³  ë¨¸ë¦¬ê°€ ì•„í”•ë‹ˆë‹¤. ì´ê²ƒì€ \"í•˜ë“œì›¨ì–´\"ê°€ ì•„ë‹Œ **\"ì†Œí”„íŠ¸ì›¨ì–´(Software)\"** ì˜ ë¬¸ì œì…ë‹ˆë‹¤. ğŸ’¾ğŸš«\n- **Definition:** ë‡Œì§„íƒ•(Concussion)ì€ **Functional Injury**ì…ë‹ˆë‹¤. êµ¬ì¡°ì  ì†ìƒ(ì¶œí˜ˆ)ì´ ì—†ìŠµë‹ˆë‹¤.\n- **Management Rules:**\n    1. **Immediate Removal from Play:** ê²½ê¸° ì¤‘ ì¶©ê²© â†’ ì¦‰ì‹œ ì œì™¸. (No exceptions!)\n    2. **Initial Rest:** 24~48ì‹œê°„ ë™ì•ˆ **Physical & Cognitive Rest**. (ìš´ë™ ê¸ˆì§€, ë¹„ë””ì˜¤ ê²Œì„ ê¸ˆì§€, ë³µì¡í•œ ê³µë¶€ ê¸ˆì§€ ğŸš«ğŸ“±). ë‡Œê°€ íë§í•  ì‹œê°„ì„ ì¤˜ì•¼ í•©ë‹ˆë‹¤.\n    3. **Gradual Return to Activity:** ì¦ìƒì´ ì—†ëŠ” ìƒíƒœì—ì„œ ë‹¨ê³„ë³„ë¡œ í™œë™ì„ ëŠ˜ë¦¼.\n        - Light aerobic â†’ Sport-specific drills â†’ Non-contact practice â†’ Full contact.\n    - **â˜… Critical Rule:** ë§Œì•½ ì–´ë–¤ ë‹¨ê³„ì—ì„œë“  **ì¦ìƒ(ë‘í†µ, ì–´ì§€ëŸ¬ì›€)ì´ ì¬ë°œí•˜ë©´?** â†’ **Stop!** ë‹¤ì‹œ 24ì‹œê°„ íœ´ì‹ í›„ ì´ì „ ë‹¨ê³„(Previous step)ë¡œ ëŒì•„ê°‘ë‹ˆë‹¤. ì ˆëŒ€ ë¬´ë¦¬í•´ì„œ ì§„í–‰í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.\n### Post-Concussion Syndrome\n- ì¦ìƒ(ë‘í†µ, ë¸Œë ˆì¸ í¬ê·¸, ê°ì • ê¸°ë³µ, ìˆ˜ë©´ ì¥ì• )ì´ **4ì£¼ ì´ìƒ** ì§€ì†ë  ë•Œ ì§„ë‹¨.\n- **Imaging:** ë³´í†µ CT/MRIëŠ” ì •ìƒ.\n- **Tx:** ëŒ€ì¦ ì¹˜ë£Œ(Symptomatic care), ì•ˆì‹¬ì‹œí‚¤ê¸°(Reassurance).\n## ğŸ©¸ 4. Patient B: Management of Severe TBI & ICP\n**ğŸšª Doorway Thought:** ë‡ŒëŠ” ë‹«íŒ ìƒì(Closed Box) ì•ˆì— ìˆìŠµë‹ˆë‹¤. ì¶œí˜ˆì´ë‚˜ ë¶€ì¢…ìœ¼ë¡œ ì••ë ¥ì´ ì˜¬ë¼ê°€ë©´ ë‡Œê°€ ì§“ëˆŒë¦½ë‹ˆë‹¤(Herniation).\n### Monro-Kellie Doctrine ğŸ“¦\n- **Skull** = Brain + Blood + CSF.\n- ê³µê°„ì€ í•œì •ë˜ì–´ ìˆìœ¼ë¯€ë¡œ, í•˜ë‚˜(ì˜ˆ: í”¼ ğŸ©¸)ê°€ ëŠ˜ì–´ë‚˜ë©´ ë‹¤ë¥¸ ê²ƒ(CSF, Venous blood)ì´ ë¹ ì ¸ë‚˜ê°€ì•¼ í•¨. í•œê³„ì— ë„ë‹¬í•˜ë©´ **ICP(ë‡Œì••)ê°€ ê¸‰ê²©íˆ ìƒìŠ¹** ğŸš€.\n### Cushing's Triad (Late Sign of Increased ICP) âš ï¸\n1. **Hypertension** (ë‡Œ ê´€ë¥˜ë¥¼ ìœ ì§€í•˜ê¸° ìœ„í•´ ëª¸ë¶€ë¦¼)\n2. **Bradycardia** (ì••ìˆ˜ìš©ì²´ ë°˜ì‚¬)\n3. **Irregular Respiration** (Brainstem ëˆŒë¦¼)\n### ğŸ› ï¸ Interventions for Increased ICP (Step-by-Step)\nëª©í‘œ: ICPë¥¼ ë‚®ì¶”ê³  CPP(Cerebral Perfusion Pressure) (ischemic changeëŠ” ì•ˆë˜ë‹ˆê¹Œ!) ìœ ì§€.\n| **Intervention** | **Mechanism** | **Notes** |\n| --- | --- | --- |\n| **1. Head of Bed Elevation** | 30ë„ ê±°ìƒ. Venous drainage ì´‰ì§„. | ê°€ì¥ ì‰½ê³  ì¦‰ê°ì ì¸ ì¡°ì¹˜ (First Step). |\n| **2. Hyperventilation** | **CO2 â†“ â†’ Vasoconstriction** â†’ ë‡Œ í˜ˆë¥˜ëŸ‰ ê°ì†Œ â†’ ICP ê°ì†Œ.\nnote: Co2ëŠ” vasodilatorì´ë‹¤. | **â˜… Temporary Bridge Only!** ë„ˆë¬´ ì˜¤ë˜ í•˜ë©´ ë‡Œí—ˆí˜ˆ(Ischemia) ìœ ë°œ ê°€ëŠ¥. ìˆ˜ìˆ ì‹¤ ê°€ëŠ” ë™ì•ˆ ì ê¹ë§Œ ì‚¬ìš©. |\n| **3. Osmotic Therapy** | **Mannitol / Hypertonic Saline** | ì‚¼íˆ¬ì••ìœ¼ë¡œ ë‡Œì„¸í¬ì˜ ë¬¼ì„ í˜ˆê´€ìœ¼ë¡œ ëºŒ (Brain shrinking). |\n| **4. Sedation** | ë‡Œ ëŒ€ì‚¬ëŸ‰ ê°ì†Œ â†’ í˜ˆë¥˜ ìš”êµ¬ëŸ‰ ê°ì†Œ. | Propofol ë“±ì„ ì‚¬ìš©. |\n| **5. CSF Drainage** | EVD (External Ventricular Drain) | ì§ì ‘ì ìœ¼ë¡œ CSFë¥¼ ë¹¼ë‚´ì–´ ê³µê°„ í™•ë³´. |\n| **6. Decompressive Craniectomy** | ë‘ê°œê³¨ì„ ì—´ì–´ì¤Œ. | ìµœí›„ì˜ ìˆ˜ë‹¨ (Last resort). |\n### ğŸ©¸ Bleeding Control (Special Note)\n- **Tranexamic Acid (TXA):** ì¶œí˜ˆ í™•ì¥ì„ ë§‰ê¸° ìœ„í•´ ë¶€ìƒ í›„ **3ì‹œê°„ ì´ë‚´** íˆ¬ì—¬ ì‹œ íš¨ê³¼ì .\n- **Seizure Prophylaxis:** ì‹¬í•œ TBI í™˜ìì—ê²Œ **7ì¼ê°„ (1ì£¼ì¼)** í•­ê²½ë ¨ì œ(Levetiracetam/Phenytoin) íˆ¬ì—¬. 7ì¼ ì´í›„ì—ëŠ” Late Epilepsy ì˜ˆë°© íš¨ê³¼ê°€ ì—†ìœ¼ë¯€ë¡œ ì¤‘ë‹¨. ğŸ’Š","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-41","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"## âš¡ 5. Diffuse Axonal Injury (DAI)\n**ğŸšª Doorway Thought:** ì•„ê¹Œ B í™˜ìê°€ CTë¥¼ ì°ì—ˆìŒ. í™˜ìëŠ” ì‹¬í•œ í˜¼ìˆ˜ìƒíƒœ(GCS < 8)ì¸ë°, ***CTëŠ” ë†€ë¼ìš¸ ì •ë„ë¡œ ê¹¨ë—í•˜ê±°ë‚˜(Normal)** ì•„ì£¼ ë¯¸ì„¸í•œ ì ìƒ ì¶œí˜ˆë§Œ ë³´ì…ë‹ˆë‹¤*. ì„ìƒ ì¦ìƒê³¼ ì˜ìƒì˜ ë¶ˆì¼ì¹˜(Dissociation)!\n- **Mechanism:** ê³ ì† ê°ì† ì†ìƒ(High-speed deceleration). ë‡Œì˜ ë°±ì§ˆ(White matter)ê³¼ íšŒìƒ‰ì§ˆ(Grey matter)ì˜ ë°€ë„ ì°¨ì´ë¡œ ì¸í•´ ê²½ê³„ë©´ì—ì„œ **Shearing forces(ì „ë‹¨ë ¥)** ë°œìƒ â†’ **Axon(ì‹ ê²½ì„¬ìœ )ì´ ì°¢ì–´ì§.** âš¡ğŸ’”\n- **Typical Scenario:** ìë™ì°¨ ì‚¬ê³ , ë¡¤ëŸ¬ì½”ìŠ¤í„° ê°™ì€ í”ë“¤ë¦¼. GCSëŠ” ë§¤ìš° ë‚®ìŒ (Coma).\n- **Diagnostic Clue:** \"Clinical-Radiographic Dissociation\" (í™˜ìëŠ” ì•ˆ ì¢‹ì€ë° CTëŠ” ë©€ì©¡í•¨).\n- **â˜… Gold Standard Dx:** **MRI Brain.** (Micro-hemorrhages & Edema at Grey-White junction í™•ì¸ ê°€ëŠ¥).\n- **Prognosis:** ë§¤ìš° ë‚˜ì¨(Poor). ì¹˜ë£ŒëŠ” ë³´ì¡´ì (Supportive care)ì´ë©° ICP ê´€ë¦¬ê°€ ì£¼ëœ ë‚´ìš©.\n## ğŸ”¥ Rapid Fire Recap (Must-Know Matches)\nì‹œí—˜ ì§ì „ ì´ê²ƒë§Œì€ ê¼­ ê¸°ì–µí•˜ì„¸ìš”! ğŸ§ âš¡\n| **Scenario** | **Diagnosis / Key Concept** | **â˜… Next Best Step / Action** |\n| --- | --- | --- |\n| **Raccoon Eyes / Battle Sign** | Basilar Skull Fracture | **Beta-2 Transferrin** (for CSF leak) |\n| **Adult Fall + Blood Thinner** | High Risk for Bleed | **Immediate CT Head** (Do NOT wait for symptoms) |\n| **Infant Fall < 3ft, Acting fine** | Low Risk | **Observation** (Avoid CT radiation) |\n| **Concussion Symptom Recurrence** | Failed Return to Play | **Stop activity**, Rest 24hrs, Go back to previous step |\n| **GCS Low + Clean CT** | Diffuse Axonal Injury (DAI) | **MRI Brain** (Gold Standard) |\n| **Increased ICP + Blown Pupil** | Herniation Imminent | **Hyperventilation** (Bridge to OR), **Mannitol** |\n| **Salty Taste in Mouth** | CSF Leak | Check for **CSF Rhinorrhea** |\n| **Post-Traumatic Seizure Prophylaxis** | Prevent early seizures | **Antiepileptics for 7 Days ONLY** |\n**ğŸ“ Note:** TBIëŠ” ë‹¨ìˆœíˆ ë¼ˆê°€ ë¶€ëŸ¬ì§€ê³  í”¼ê°€ ë‚˜ëŠ” êµ¬ì¡°ì  ë¬¸ì œê°€ ì•„ë‹ˆë¼, **ì„¸í¬ ìˆ˜ì¤€ì˜ ì—ë„ˆì§€ ìœ„ê¸°(Metabolic Crisis)** ì…ë‹ˆë‹¤. íœ´ì‹(Rest)ì€ ë‹¨ìˆœí•œ ì‰¼ì´ ì•„ë‹ˆë¼, ë‡Œì„¸í¬ì˜ ì¬í™œ(Cellular Rehab)ì´ë¼ëŠ” ì ì„ ëª…ì‹¬í•˜ì„¸ìš”! Good luck with your studies! ğŸš€ğŸ‘¨â€âš•ï¸\nì•ˆë…•í•˜ì„¸ìš”! **Gemini 3 Pro, USMLE ì „ë‹´ Senior Medical Scribe** ëª¨ë“œì…ë‹ˆë‹¤. ğŸ©ºâš¡ï¸\nìš”ì²­í•˜ì‹  ì˜¤ë””ì˜¤ íŒŒì¼(Movement Disorders Deep Dive)ì„ ë°”íƒ•ìœ¼ë¡œ, **\"ZERO-LOSS\"** ì›ì¹™ì— ë”°ë¼ ì•„ì£¼ ë””í…Œì¼í•˜ê³  ì—ë„ˆì§€ê°€ ë„˜ì¹˜ëŠ” ê°•ì˜ ë…¸íŠ¸ë¥¼ ì‘ì„±í–ˆìŠµë‹ˆë‹¤. ğŸ“ğŸ”¥\n### ğŸ“‘ Overview (TL;DR)\nì´ë²ˆ ì„¸ì…˜ì€ **Movement Disorders**ë¥¼ ì‹œê°ì (Visual)ìœ¼ë¡œ ì ‘ê·¼í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤. ë‹¨ìˆœíˆ ì •ì˜ë¥¼ ì™¸ìš°ëŠ” ê²Œ ì•„ë‹ˆë¼, í™˜ìê°€ ì§„ë£Œì‹¤ ë¬¸ì„ ì—´ê³  ë“¤ì–´ì˜¤ëŠ” ìˆœê°„(Doorway Thought)ë¶€í„° ì§„ë‹¨ì„ ì¢í˜€ê°€ëŠ” ê³¼ì •ì„ ë‹¤ë£¹ë‹ˆë‹¤.\n- **Tremor:** ê°€ë§Œíˆ ìˆì„ ë•Œ(Resting) vs ì›€ì§ì¼ ë•Œ(Action)ì˜ êµ¬ë¶„ì´ ê°€ì¥ ì¤‘ìš”í•©ë‹ˆë‹¤.\n- **Gait:** í™˜ìê°€ ê±·ëŠ” ëª¨ìŠµ(Base width, ë°œì„ ë„ëŠ”ì§€ ë“±)ë§Œìœ¼ë¡œ ì§„ë‹¨ëª…ì„ ë§ì¶œ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- **Parkinsonism:** PDì™€ PD-Plus Syndromes(í‰ë‚´ìŸì´ë“¤)ì„ êµ¬ë³„í•˜ëŠ” ê²ƒì´ ê³ ë“ì  í¬ì¸íŠ¸ì…ë‹ˆë‹¤.","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-61","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","diagnosis","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### ğŸŒ³ Top-Down Classification: Movement Disorders Tree\nPlaintext\n`Movement Disorders (ìš´ë™ ì¥ì• )\nâ”‚\nâ”œâ”€â”€ Hyperkinetic (ë„ˆë¬´ ë§ì´ ì›€ì§ì„)\nâ”‚   â”œâ”€â”€ Rhythmic (ê·œì¹™ì )\nâ”‚   â”‚   â”œâ”€â”€ Resting Tremor (ì•ˆì •ì‹œ) â†’ Parkinson's Disease\nâ”‚   â”‚   â””â”€â”€ Action Tremor (í™œë™ì‹œ)\nâ”‚   â”‚       â”œâ”€â”€ Postural â†’ Essential Tremor, Physiologic\nâ”‚   â”‚       â””â”€â”€ Intention (Target-directed) â†’ Cerebellar lesion\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Arrhythmic (ë¶ˆê·œì¹™ì )\nâ”‚       â”œâ”€â”€ Slow/Writhing â†’ Athetosis\nâ”‚       â”œâ”€â”€ Dance-like/Rapid â†’ Chorea\nâ”‚       â”œâ”€â”€ Flailing/Ballistic â†’ Hemiballismus\nâ”‚       â”œâ”€â”€ Jerky/Shock-like â†’ Myoclonus\nâ”‚       â”œâ”€â”€ Restlessness â†’ Akathisia\nâ”‚       â””â”€â”€ Sustained/Twisting â†’ Dystonia (Torticollis etc.)\nâ”‚\nâ”œâ”€â”€ Hypokinetic (ë„ˆë¬´ ì ê²Œ ì›€ì§ì„)\nâ”‚   â”œâ”€â”€ Idiopathic Parkinson's Disease (IPD)\nâ”‚   â””â”€â”€ Parkinson-Plus Syndromes (Atypical)\nâ”‚       â”œâ”€â”€ MSA (Autonomic dysfunction)\nâ”‚       â”œâ”€â”€ PSP (Vertical gaze palsy)\nâ”‚       â”œâ”€â”€ DLB (Visual hallucinations)\nâ”‚       â””â”€â”€ CBD (Alien limb)\nâ”‚\nâ””â”€â”€ Gait Disorders (ë³´í–‰ ì¥ì• )\n    â”œâ”€â”€ Narrow Base â†’ Parkinsonian, Scissoring (CP)\n    â”œâ”€â”€ Wide Base â†’ Ataxic (Cerebellar, Sensory)\n    â”œâ”€â”€ Steppage â†’ Foot drop (L5 vs Peroneal)\n    â””â”€â”€ Magnetic â†’ NPH (Normal Pressure Hydrocephalus)`\n### ğŸšª PART 1: The \"Doorway Thought\" (Tremorì˜ êµ¬ë¶„)\nì´ ì„¸ì…˜ì€ **Study Room Scenario**ë¡œ ì‹œì‘í•©ë‹ˆë‹¤. ì‹ ê²½ê³¼ í´ë¦¬ë‹‰ ëŒ€ê¸°ì‹¤ì„ ìƒìƒí•´ ë³´ì„¸ìš”. ğŸ¥\n### 1. Resting Tremor (ì•ˆì •ì‹œ ë–¨ë¦¼)\n- **Scenario:** í™˜ì Aê°€ ì¡°ìš©íˆ ì•‰ì•„ ìˆëŠ”ë°, ì†ì„ ë¬´ë¦ì— ì˜¬ë¦¬ê³  **\"Pill-rolling\"** (ì•Œì•½ì„ êµ´ë¦¬ëŠ” ë“¯í•œ) ë™ì‘ì„ ë³´ì…ë‹ˆë‹¤.\n- **íŠ¹ì§•:** ê°€ë§Œíˆ ìˆì„ ë•Œ ë°œìƒí•©ë‹ˆë‹¤ (4-5 Hz).\n- **Diagnosis:** **Parkinson's Disease (PD)** ì˜ ê°•ë ¥í•œ ì§•í›„ì…ë‹ˆë‹¤.\n### 2. Action Tremor (í™œë™ì‹œ ë–¨ë¦¼)\n- **Scenario:** í™˜ì BëŠ” ê°€ë§Œíˆ ìˆì„ ë• ê´œì°®ë‹¤ê°€, ì»¤í”¼ ì”ì„ ì§‘ìœ¼ë ¤ê³  ì†ì„ ë»—ì ë–¨ë¦¼ì´ ì‹œì‘ë©ë‹ˆë‹¤. ì»µì— ê°€ê¹Œì›Œì§ˆìˆ˜ë¡ ì»¤í”¼ë¥¼ ìŸì„ ì •ë„ë¡œ ì‹¬í•´ì§‘ë‹ˆë‹¤. â˜•ï¸ğŸ’¦\n- **Essential Tremor:** ì»µì„ ë“¤ê³  ìˆëŠ” ìì„¸(Posture)ì—ì„œ ë–¨ë¦¼.\n- **Cerebellar Tremor (Intention):** ëª©í‘œë¬¼ì— ë‹¤ê°€ê°ˆìˆ˜ë¡(Target) ë–¨ë¦¼ì´ ì»¤ì§.\n### ğŸ’ƒ PART 2: Hyperkinetic Movement Disorders (ê³¼ë‹¤ìš´ë™)\nì‹œí—˜ì— ìì£¼ ë‚˜ì˜¤ëŠ” ìš©ì–´ë“¤ì„ **Visual Vocabulary**ë¡œ ì •ë¦¬í•©ë‹ˆë‹¤. ì¡±ë³´ ìš©ì–´ë“¤ì…ë‹ˆë‹¤!\n### 1. Akathisia (ì¢Œë¶ˆì•ˆì„) ğŸ˜«\n- **Visual:** ê°€ë§Œíˆ ì•‰ì•„ìˆì§€ ëª»í•¨. \"Ants in the pants\" (ë°”ì§€ ì†ì— ê°œë¯¸ê°€ ìˆëŠ” ëŠë‚Œ). í”¼ë¶€ ë°–ìœ¼ë¡œ ë›°ì³ë‚˜ê°€ê³  ì‹¶ì€ ì£¼ê´€ì ì¸ ì¶©ë™(Internal urge)ì„ ëŠë‚ë‹ˆë‹¤.\n- **Clinical Context:** ë‹¨ìˆœ ì•ˆì ˆë¶€ì ˆëª»í•¨(Fidgety)ì´ ì•„ë‹™ë‹ˆë‹¤. ì£¼ë¡œ **Antipsychotics (Neuroleptics)** ë¶€ì‘ìš©ìœ¼ë¡œ ë‚˜íƒ€ë‚˜ëŠ” **Extrapyramidal Symptom (EPS)** ì…ë‹ˆë‹¤.\n- **â˜… Trick:** ì•½ë¬¼ì— ì˜í•œ ì´ˆì¡°í•¨ì„ ì •ì‹ ë³‘ì˜ ì•…í™”ë¡œ ì˜¤ì¸í•˜ì—¬ ì•½ ìš©ëŸ‰ì„ ëŠ˜ë¦¬ë©´ ì•ˆ ë©ë‹ˆë‹¤!\n### 2. Asterixis (Flapping Tremor) ğŸ‘\n- **Visual:** í™˜ìì—ê²Œ \"Stop traffic\" í•˜ë“¯ì´ ì†ëª©ì„ ì –íˆê³  íŒ”ì„ ë»—ê²Œ í•˜ë©´, ì†ì´ ê°‘ìê¸° 'í„ëŸ­(Flap)' í•˜ê³  ë–¨ì–´ì¡Œë‹¤ê°€ ë‹¤ì‹œ ì˜¬ë¼ì˜µë‹ˆë‹¤.\n- **Mechanism:** ì‚¬ì‹¤ ë–¨ë¦¼(Tremor)ì´ë¼ê¸°ë³´ë‹¤ **Negative Myoclonus**ì…ë‹ˆë‹¤. ì¤‘ë ¥ì„ ì´ê¸°ê³  ì†ì„ ë“¤ê³  ìˆëŠ” ê·¼ìœ¡ì˜ í†¤(Tone)ì´ ìˆœê°„ì ìœ¼ë¡œ í’€ë ¸ë‹¤ê°€ ë°˜ì‚¬ì ìœ¼ë¡œ ë‹¤ì‹œ ì¡ëŠ” ê³¼ì •ì…ë‹ˆë‹¤.\n- **Big Picture:** **General (not only liver) Metabolic Chaos** . ê°„ì„±í˜¼ìˆ˜(Liver failure - Hyperammonemia), ìš”ë…ì¦(Uremia - Kidney failure), Wilson's disease ë“± ë‡Œê°€ ë…ì†Œë¡œ ê³ í†µë°›ì„ ë•Œ ë‚˜íƒ€ë‚©ë‹ˆë‹¤.\n### 3. Athetosis vs. Chorea (Snake vs. Dance) ğŸğŸ’ƒ\n- **Athetosis:** ë±€ì´ ê¸°ì–´ê°€ë“¯(Snake-like), ëŠë¦¬ê³  ë¹„í‹€ë¦¬ëŠ”(Writhing, Twisting) ì›€ì§ì„. ì£¼ë¡œ ì†ê°€ë½/ì†ì—ì„œ ë³´ì„. (Basal ganglia lesion deep inside).\n- **Chorea:** ê·¸ë¦¬ìŠ¤ì–´ë¡œ 'ì¶¤(Dance)'ì„ ì˜ë¯¸. ë§ˆë¦¬ì˜¤ë„¤íŠ¸ ì¸í˜•ì˜ ì¤„ì„ ë¬´ì‘ìœ„ë¡œ ì¡ì•„ë‹¹ê¸°ë“¯ ë¹ ë¥´ê³ , ëª©ì  ì—†ëŠ”(Purposeless), ê°‘ì‘ìŠ¤ëŸ¬ìš´ ì›€ì§ì„(Jerky).\n    - **Associations:** Huntington's Disease (CAG repeat), Sydenham Chorea (Rheumatic fever - ì•„ì´ê°€ ì¸í›„í†µ í›„ ì´ìƒí•œ ì›€ì§ì„).\n### 4. Hemiballismus (ë°˜ì‹  íˆ¬ì²™ì¦) âš¾ï¸","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-81","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","diagnosis","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"- **Visual:** ì´ë¦„ ê·¸ëŒ€ë¡œ 'Ballistic'. íŒ”ì´ë‚˜ ë‹¤ë¦¬ë¥¼ ì•¼êµ¬ê³µ ë˜ì§€ë“¯ì´ ê²©ë ¬í•˜ê²Œ íœ˜ë‘ë¦…ë‹ˆë‹¤(Flailing). ì•„ì£¼ ì™€ì¼ë“œí•©ë‹ˆë‹¤.\n- **Anatomy (Must Know):** **Contralateral Subthalamic Nucleus**ì˜ ë³‘ë³€ (ì£¼ë¡œ Lacunar Stroke).\n- Subthalamic nucleus: break for basal ganglia. breakê°€ ì§¤ë ¤ì„œ ë§‰ ì›€ì§ì„.\n### 5. Restless Legs Syndrome (RLS, í•˜ì§€ë¶ˆì•ˆì¦í›„êµ°) ğŸ¦µğŸ›\n- **Symptom:** ë‹¤ë¦¬ì— ë²Œë ˆê°€ ê¸°ì–´ê°€ëŠ” ë“¯í•œ(Creepy-crawly) ë¶ˆì¾Œí•œ ëŠë‚Œ.\n- **Timing:** **ë°¤ì— ì•…í™”(Night)**, **ì›€ì§ì´ë©´ í˜¸ì „(Relieved by movement)**. (ê°€ë§Œíˆ ìˆìœ¼ë©´ ë¯¸ì¹¨).\n- **â˜… Workup (Next Best Step):** **Iron Panel (Ferritin)** ì²´í¬!\n    - ì² ë¶„ ê²°í•ì´ ê°•ë ¥í•œ ì›ì¸ì…ë‹ˆë‹¤. Ferritin < 75ì´ë©´ ì² ë¶„ ë³´ì¶©ë¶€í„° í•´ì•¼ í•©ë‹ˆë‹¤.\n- **â˜… Treatment Change:** ê³¼ê±°ì—” Dopamine Agonist(Ropinirole ë“±)ë¥¼ ì¼ì§€ë§Œ, ìµœê·¼ ê°€ì´ë“œë¼ì¸ì€ **Alpha-2-delta ligands (Gabapentin, Pregabalin)** ê°€ First-lineì…ë‹ˆë‹¤. (Augmentation ë¶€ì‘ìš© ë•Œë¬¸).\n### ğŸ– PART 3: Tremor Workup & Management\ní™˜ìê°€ \"ì†ì´ ë–¨ë ¤ìš”\"ë¼ê³  ì™”ì„ ë•Œ ê°ë³„ í¬ì¸íŠ¸ì…ë‹ˆë‹¤.\n| **Type** | **Feature** | **Challenge Test** | **Treatment** |\n| --- | --- | --- | --- |\n| **Essential Tremor** | Postural (ì–‘ì†ì„ ë“¤ ë•Œ), ê°€ì¡±ë ¥(Familial) í”í•¨. | **Alcohol improves it** ğŸ· (ì¹µí…Œì¼ í•œ ì” ë§ˆì‹œë©´ ì†ì´ ì•ˆ ë–¨ë¦¼ - ìê°€ì¹˜ë£Œ í”í•¨) | **Propranolol** (Beta-blocker) or **Primidone** (Barbiturate) |\n| **Physiologic Tremor** | ëˆ„êµ¬ë‚˜ ê°€ì§€ê³  ìˆëŠ” ë¯¸ì„¸í•œ ë–¨ë¦¼ (Low amplitude). | Anxiety, Caffeine â˜•ï¸, Hyperthyroidism, Drug withdrawal ë“±ìœ¼ë¡œ ì¦í­ë¨. | ì›ì¸ êµì • (ì»¤í”¼ ì¤„ì´ê¸°, ë¶ˆì•ˆ ì¹˜ë£Œ) |\n| **Cerebellar Tremor** | **Intention Tremor**. ëª©í‘œë¬¼ì— ë‹¤ê°€ê°ˆ ë•Œ Zig-Zag. | **Finger-to-Nose Test** ğŸ‘‰ğŸ‘ƒ (ì½”ì— ê°€ê¹Œì›Œì§ˆìˆ˜ë¡ ì‹¬í•˜ê²Œ í”ë“¤ë¦¼) | ì›ì¸ ì¹˜ë£Œ (Stroke, MS ë“±) |\n### Myoclonus: The \"Shock\" âš¡ï¸\n- **Visual:** ê·¼ìœ¡ì˜ ê°‘ì‘ìŠ¤ëŸ¬ìš´ ìˆ˜ì¶•(Jerk). ë”¸ê¾¹ì§ˆ(Hiccup)ì´ë‚˜ ìˆ˜ë©´ ë†€ëŒ(Sleep start)ë„ ìƒë¦¬ì  Myoclonusì„.\n- **Post-Hypoxic Myoclonus (ì‹¬ì •ì§€ í›„):**\n    1. **Acute:** 24ì‹œê°„ ë‚´ ë°œìƒ. ì˜ˆí›„ê°€ ë§¤ìš° ë‚˜ì¨(Poor prognosis).\n    2. **Lance-Adams Syndrome:** ë§Œì„±í˜•. ìƒì¡´ìì—ê²Œì„œ ë©°ì¹ /ëª‡ ì£¼ ë’¤ ë°œìƒ. Action Myoclonus (ì›€ì§ì´ë ¤ í•  ë•Œ íŠ€ì–´ì˜¤ë¦„).\n### ğŸš¶â€â™‚ï¸ PART 4: Gait Disorders (ê±¸ìŒê±¸ì´ ë¶„ì„)\në³´í–‰ì€ ì‹ ê²½ê³¼ ê²€ì‚¬ì˜ ê½ƒì…ë‹ˆë‹¤. ğŸŒ¸\n### 1. Parkinsonian Gait\n- **Visual:** ì¢ì€ ë³´í­(Narrow base), ì§ˆì§ˆ ë„ëŠ” ê±¸ìŒ(Shuffling), ì¢…ì¢…ê±¸ìŒ(Festinating - ë¬´ê²Œì¤‘ì‹¬ì„ ì«“ì•„ê°), **En bloc turning** (ëª¸í†µ ì „ì²´ê°€ í†µë‚˜ë¬´ì²˜ëŸ¼ ë”).\n### 2. Magnetic Gait (Gait Apraxia) ğŸ§²\n- **Visual:** ë°œë°”ë‹¥ì´ ë°”ë‹¥ì— ìì„ì²˜ëŸ¼ ë¶™ì–´ìˆëŠ” ë“¯í•¨(Glued to the floor). ë°œì„ ë–¼ë ¤ê³  í•´ë„ ëª» ë—Œ.\n- **Diagnosis:** **Normal Pressure Hydrocephalus (NPH)**.\n- **Triad (Wet, Wobbly, Wacky):** Urinary Incontinence (Wet) + Gait Apraxia (Wobbly) + Dementia (Wacky).\n    - *Note:* ë³´í–‰ ì¥ì• ê°€ ê°€ì¥ ë¨¼ì € ë‚˜íƒ€ë‚˜ê³ , ì…˜íŠ¸(Shunt) ìˆ˜ìˆ ë¡œ ê°€ì¥ ì˜ í˜¸ì „ë©ë‹ˆë‹¤.\n### 3. Steppage Gait (Foot Drop) ğŸ‘ \n- **Visual:** ë°œë“±ì„ ë“¤ì§€ ëª»í•´(Dorsiflexion ë¶ˆê°€), ë°œì´ ëŒë¦¬ì§€ ì•Šê²Œ ë¬´ë¦ì„ ë†’ì´ ë“¤ì–´ ì˜¬ë ¤ì„œ 'íƒ' í•˜ê³  ë‚´ë ¤ë†“ìŒ(Slap).\n- **â˜… Differential Diagnosis (High Yield):**\n    - **Common Peroneal Nerve Injury:** ì¢…ì•„ë¦¬ ë¼ˆ ë¨¸ë¦¬(Fibula head) ê³¨ì ˆì´ë‚˜ ì••ë°•. **Eversion**ê³¼ Dorsiflexion ì•ˆ ë¨. **Inversionì€ ì •ìƒ**.\n    - **L5 Radiculopathy:** í—ˆë¦¬ ë””ìŠ¤í¬. **Inversion(ì•ˆìª½ìœ¼ë¡œ êº¾ê¸°)ë„ ì•½í•¨** + Back pain ë™ë°˜. (L5 ì‹ ê²½ê·¼ì´ Inversionë„ ë‹´ë‹¹í•˜ê¸° ë•Œë¬¸).\n### 4. Cerebellar Ataxia (Drunk Walk) ğŸº\n- **Visual:** ë„“ì€ ë³´í­(Wide base), ë¹„í‹€ê±°ë¦¼(Staggering). ìˆ  ì·¨í•œ ì‚¬ëŒì²˜ëŸ¼ ê±¸ìŒ. ì¼ì§ì„  ê±·ê¸°(Tandem gait) ë¶ˆê°€ëŠ¥.","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-101","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### 5. Vestibular Gait\n- **Visual:** ê±·ë‹¤ê°€ ë³‘ë³€ì´ ìˆëŠ” ìª½ìœ¼ë¡œ ëª¸ì´ ì ë¦¼(Veering). ë§ˆì¹˜ ë°°ë¥¼ íƒ„ ê²ƒì²˜ëŸ¼.\n### ğŸ§  PART 5: Parkinson's Disease (PD) Deep Dive\n### 1. Diagnosis Formula\n- **Equation:** **Bradykinesia (ì„œë™)** + (Resting Tremor **OR** Rigidity).\n    - ë°˜ë“œì‹œ Bradykinesiaê°€ ìˆì–´ì•¼ í•¨. (ë™ì‘ì´ ëŠë ¤ì§€ê³  ì§„í­ì´ ì¤„ì–´ë“¦).\n- **Supportive Signs:**\n    - **Masked Facies:** í‘œì •ì´ ì—†ìŒ (Poker face).\n    - **Micrographia:** ê¸€ì”¨ê°€ ì ì  ì‘ì•„ì§. âœï¸\n    - **Hypophonia:** ëª©ì†Œë¦¬ê°€ ê¸°ì–´ë“¤ì–´ê°.\n    - **Asymmetry:** ì´ˆê¸°ì—ëŠ” í•œìª½ì—ì„œ ì‹œì‘í•˜ëŠ” ê²½ìš°ê°€ ë§ìŒ.\n### 2. PD vs. Depression (The Mimic)\n- ë¬´í‘œì •, ëŠë¦° ë™ì‘, ì‘ì€ ëª©ì†Œë¦¬ ë•Œë¬¸ì— ìš°ìš¸ì¦ìœ¼ë¡œ ì˜¤ì¸ë˜ê¸° ì‰½ìŠµë‹ˆë‹¤.\n- **Difference:** ìš°ìš¸ì¦ì€ \"ìŠ¬í””/ì£„ì±…ê°(Sadness/Guilt)\"ì´ ì£¼ë¼ë©´, PDëŠ” **\"ë¬´ê´€ì‹¬/ë™ê¸°ë¶€ì¡±(Apathy/Abulia)\"** ì´ íŠ¹ì§•ì…ë‹ˆë‹¤. ì¦ê±°ì›€ì„ ëª» ëŠë¼ëŠ” ê²Œ ì•„ë‹ˆë¼, ì›€ì§ì¼ ë™ë ¥ì´ ì—†ëŠ” ê²ƒ.\n### 3. Treatment Strategy ğŸ’Š\n- **Levodopa/Carbidopa:** **â˜… Gold Standard**. ê°€ì¥ íš¨ê³¼ê°€ ì¢‹ìŒ. (ë…¸ì¸ì—ê²Œ First-line).\n- **Dopamine Agonists (Pramipexole, Ropinirole):** ì Šì€ í™˜ìì—ê²Œ ì„ í˜¸ë¨ (Dyskinesia ë¶€ì‘ìš©ì„ ëŠ¦ì¶”ê¸° ìœ„í•´).\n    - **â˜… Warning:** **Impulse Control Disorder**. ë„ë°• ì¤‘ë…, ì‡¼í•‘ ì¤‘ë…, ì„±ìš• ê³¼ë‹¤ ë“±ì´ ìƒê¸¸ ìˆ˜ ìˆìŒ. í™˜ì ê°€ì¡±ì—ê²Œ ë°˜ë“œì‹œ ê²½ê³ í•´ì•¼ í•¨! ğŸ°ğŸ’¸\n- **MAO-B Inhibitors (Selegiline):** ë„íŒŒë¯¼ ë¶„í•´ ì–µì œ.\n### ğŸ­ PART 6: Parkinson-Plus Syndromes (Atypical Parkinsonism)\n\"PDì¸ ì¤„ ì•Œê³  Levodopaë¥¼ ì¤¬ëŠ”ë° íš¨ê³¼ê°€ ì—†ê³ , ë³‘ì´ ë„ˆë¬´ ë¹¨ë¦¬ ì§„í–‰ëœë‹¤?\" â†’ **Parkinson-Plus**ë¥¼ ì˜ì‹¬í•˜ì„¸ìš”.\n### Red Flags ğŸš©\n1. **Early Falls:** ë°œë³‘ ì´ˆê¸°ì— ìê¾¸ ë„˜ì–´ì§„ë‹¤. (PDëŠ” í›„ê¸°ì— ë„˜ì–´ì§).\n2. **Rapid Progression:** ì§„í–‰ ì†ë„ê°€ ë¹ ë¦„.\n3. **Symmetry:** ì²˜ìŒë¶€í„° ì–‘ìª½ì´ ë‹¤ ëŒ€ì¹­ì ìœ¼ë¡œ ì˜´.\n4. **No Response to Levodopa:** ì•½ë°œì´ ì•ˆ ë°›ìŒ.\n### The \"Big 4\" Syndromes\n| **Syndrome** | **Key Feature (Buzzword)** | **Clinical Vibe** |\n| --- | --- | --- |\n| **MSA** (Multiple System Atrophy) | **Autonomic Dysfunction** ğŸ’©ğŸ›‘ | Shy-Drager Syndrome. ì‹¬í•œ ê¸°ë¦½ì„± ì €í˜ˆì••(Orthostasis), ë°œê¸° ë¶€ì „(ED), ìš”ì‹¤ê¸ˆ ë“± ììœ¨ì‹ ê²½ê³„ê°€ ë§ê°€ì§. |\n| **PSP** (Progressive Supranuclear Palsy) | **Vertical Gaze Palsy** ğŸ‘€â¬‡ï¸ğŸš« | ì•„ë˜ë¥¼ ì³ë‹¤ë³´ì§€ ëª»í•¨. ê³„ë‹¨ ë‚´ë ¤ê°ˆ ë•Œ ë„˜ì–´ì§. ë„¥íƒ€ì´ì— ìŒì‹ë¬¼ì´ ë¬»ìŒ (**Dirty Tie Sign**). MRIìƒ **Hummingbird Sign** (ì¤‘ë‡Œ ìœ„ì¶•). |\n| **DLB** (Dementia with Lewy Bodies) | **Visual Hallucinations** ğŸ‘» | ì¹˜ë§¤ + íŒŒí‚¨ìŠ¨ì¦ + **ìƒìƒí•œ í™˜ì‹œ**(ì‘ì€ ì‚¬ëŒì´ë‚˜ ë™ë¬¼). ì¸ì§€ê¸°ëŠ¥ì˜ ê¸°ë³µ(Fluctuation)ì´ ì‹¬í•¨. **â˜… Antipsychotics ê¸ˆê¸°** (ì“°ë©´ êµ³ì–´ì„œ ì‚¬ë§ ê°€ëŠ¥). |\n| **CBD** (Corticobasal Degeneration) | **Alien Limb Phenomenon** ğŸ‘½ğŸ¤š | **Alien Hand Syndrome**. ë‚´ ì†ì´ ë‚´ ì˜ì§€ì™€ ìƒê´€ì—†ì´ ì œë©‹ëŒ€ë¡œ ì›€ì§ì„ (ë‹¨ì¶”ë¥¼ ì ê·¸ëŠ”ë° ë‹¤ë¥¸ ì†ì´ í’ˆ). ì‹¬í•œ ë¹„ëŒ€ì¹­(Asymmetry), ì‹¤í–‰ì¦(Apraxia). |","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-121","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"recap_summary","text":"### ğŸš€ RAPID FIRE RECAP (Summary Table)\n| **Clinical Presentation** | **Diagnosis to Suspect** | **Gold Standard / Action** |\n| --- | --- | --- |\n| Resting Tremor (Pill-rolling) | **Parkinson's Disease** | **Levodopa/Carbidopa** |\n| Action Tremor (Postural) + Alcohol helps | **Essential Tremor** | **Propranolol** |\n| Intention Tremor (Finger-to-Nose worsens) | **Cerebellar Lesion** | Brain MRI |\n| Flailing arm (Ballistic) | **Hemiballismus** | **Subthalamic Nucleus** Stroke check |\n| Creepy-crawly legs at night | **Restless Legs Syndrome** | Check **Ferritin** (<75 -> Iron) |\n| Magnetic Gait (Can't lift feet) + Wet/Wacky | **NPH** | LP -> VP Shunt |\n| Foot Drop (Steppage) | **Peroneal N. vs L5** | Check Inversion (Weak in L5) |\n| Parkinsonism + Orthostasis/Incontinence | **MSA** | Supportive Care |\n| Parkinsonism + Can't look down | **PSP** | Supportive Care |\n| Parkinsonism + Visual Hallucinations | **Lewy Body Dementia** | **Avoid Antipsychotics** |\n**Caveats:**\n- ì´ ë…¸íŠ¸ëŠ” USMLE Step 2 CK ìˆ˜ì¤€ì˜ ê³ ë“ì  í¬ì¸íŠ¸ë¥¼ ë‹¤ë£¹ë‹ˆë‹¤.\n- ì‹¤ì œ ì„ìƒì—ì„œëŠ” ì•½ë¬¼ ì„ íƒ ì‹œ í™˜ìì˜ ë™ë°˜ ì§ˆí™˜(ì²œì‹ í™˜ìì—ê²Œ Propranolol ê¸ˆê¸° ë“±)ì„ ê³ ë ¤í•´ì•¼ í•©ë‹ˆë‹¤.\n- Parkinson-Plus ì¦í›„êµ°ë“¤ì€ ì˜ˆí›„ê°€ ì¢‹ì§€ ì•Šìœ¼ë¯€ë¡œ, ì¡°ê¸°ì— PDì™€ ê°ë³„í•˜ì—¬ ë³´í˜¸ìì™€ ìƒì˜í•˜ëŠ” ê²ƒì´ ì¤‘ìš”í•©ë‹ˆë‹¤.\në„ì›€ì´ ë˜ì…¨ë‚˜ìš”? Would you like me to generate a specific quiz block based on these movement disorders? ğŸ§ âœ¨\n### ğŸ“‹ Overview (TL;DR)\n**Neurocognitive Disorders (Dementia & Delirium) Deep Dive** ğŸ§ \nì´ ê°•ì˜ëŠ” ì‹ ê²½ì¸ì§€ ì¥ì• (Neurocognitive Disorders)ì— ëŒ€í•œ ë³µì¡í•œ ì„ìƒ ê°€ì´ë“œë¼ì¸ì„ ëª…í™•í•˜ê²Œ ì •ë¦¬í•˜ê³  ìˆìŠµë‹ˆë‹¤. í•µì‹¬ì€ **ê¸°ì–µë ¥ ê°í‡´(Forgetfulness)**ë§Œì´ ì•„ë‹ˆë¼, í™˜ìì˜ **ê¸°ëŠ¥ì  ìƒíƒœ(Functional Status, ADLs)**ì™€ **í–‰ë™(Behavior)**ì„ í†µí•´ ë³‘ë¦¬í•™ì  ì›ì¸ì„ êµ¬ë¶„í•˜ëŠ” ê²ƒì…ë‹ˆë‹¤.\n- **í•µì‹¬ ê°ë³„ í¬ì¸íŠ¸:**\n    - **Delirium (ì„¬ë§):** ê¸‰ì„±(Acute), ì˜ì‹ ìˆ˜ì¤€ì˜ ë³€í™”(Fluctuation), ì£¼ì˜ë ¥ ê²°í•. **Medical Emergency!** ğŸš¨\n    - **Depression (ê°€ì„± ì¹˜ë§¤):** \"ëª°ë¼ìš”(I don't know)\"ë¼ê³  ë‹µí•¨, ì£¼ê´€ì  ê³ í†µ í˜¸ì†Œ.\n    - **Dementia (ì¹˜ë§¤):** ë§Œì„±ì , ì‘í™”ì¦(Confabulation), ì¼ìƒìƒí™œ ìˆ˜í–‰ ëŠ¥ë ¥(ADLs) ì €í•˜.\n- **ì£¼ìš” ë³‘ë¦¬ (The Big 4):**\n    1. **Alzheimer's:** ë‹¨ê¸° ê¸°ì–µ ìƒì‹¤ â†’ ì¥ê¸° ê¸°ì–µ ìƒì‹¤, ê¸¸ ìƒìŒ.\n    2. **Vascular:** ê³„ë‹¨ì‹ ì•…í™”(Stepwise), í˜ˆê´€ ìœ„í—˜ ì¸ì.\n    3. **Frontotemporal (FTD):** ì„±ê²© ë³€í™”, íƒˆì–µì œ(Disinhibition), ì‚¬íšŒì  í•„í„° ìƒì‹¤.\n    4. **Lewy Body (LBD):** íŒŒí‚¨ìŠ¨ ì¦ìƒ + ì‹œê° í™˜ê°(Visual Hallucination) + í•­ì •ì‹ ë³‘ ì•½ë¬¼ ê³¼ë¯¼ì„±.","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-139","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","recap","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"### ğŸŒ³ Top-down Classification (ASCII Tree)\nPlaintext\n`Neurocognitive Disorders (ì‹ ê²½ì¸ì§€ ì¥ì• )\nâ”‚\nâ”œâ”€â”€ Acute & Fluctuating (ê¸‰ì„± ë° ë³€ë™ì„±)\nâ”‚   â””â”€â”€ ğŸš¨ Delirium (ì„¬ë§): Medical Emergency (ê°ì—¼, ì•½ë¬¼, ëŒ€ì‚¬ ì´ìƒ ë“±)\nâ”‚\nâ””â”€â”€ Chronic & Progressive (ë§Œì„± ë° ì§„í–‰ì„±)\n    â”‚\n    â”œâ”€â”€ Psychiatric Mimic (ì •ì‹ ê³¼ì  ëª¨ë°©)\n    â”‚   â””â”€â”€ ğŸ˜” Pseudodementia (ìš°ìš¸ì¦): \"I don't know\", ë¬´ê¸°ë ¥, ì¹˜ë£Œ ì‹œ íšŒë³µ ê°€ëŠ¥\n    â”‚\n    â””â”€â”€ True Neurocognitive Decline (ì§„ì„± ì¸ì§€ ì €í•˜)\n        â”‚\n        â”œâ”€â”€ Mild Cognitive Impairment (MCI): ê¸°ì–µë ¥ ì €í•˜ O, í•˜ì§€ë§Œ ADLs(ì¼ìƒìƒí™œ) ìˆ˜í–‰ ê°€ëŠ¥\n        â”‚\n        â””â”€â”€ ğŸ§  Dementia (ì¹˜ë§¤): ê¸°ì–µë ¥ ì €í•˜ O + ADLs ìˆ˜í–‰ ë¶ˆê°€ëŠ¥ (ë…ë¦½ì  ìƒí™œ ë¶ˆê°€)\n            â”‚\n            â”œâ”€â”€ Reversible (ì¹˜ë£Œ ê°€ëŠ¥ - ë°˜ë“œì‹œ ë°°ì œí•´ì•¼ í•¨!)\n            â”‚   â”œâ”€â”€ Metabolic: Hypothyroid (TSH), B12 deficiency\n            â”‚   â”œâ”€â”€ Structural: NPH, Tumor, Subdural Hematoma\n            â”‚   â”œâ”€â”€ Infectious: Syphilis (RPR), HIV\n            â”‚   â””â”€â”€ Genetic/Metabolic: Wilson's Disease (Copper, ì Šì€ í™˜ì)\n            â”‚\n            â””â”€â”€ Irreversible (ë¹„ê°€ì—­ì  - í‡´í–‰ì„±)\n                â”œâ”€â”€ ğŸ§¶ Alzheimer's: ë‹¨ê¸° ê¸°ì–µ ìƒì‹¤, ë¯¸ì£¼ ì‹ ê²½(Wandering)\n                â”œâ”€â”€ ğŸ“‰ Vascular: ê³„ë‹¨ì‹ í•˜ë½(Stepwise), Stroke history\n                â”œâ”€â”€ ğŸ­ Frontotemporal (Pick's): ì„±ê²© ë³€í™”, íƒˆì–µì œ, ì…ìœ¼ë¡œ ê°€ì ¸ê°(Hyperorality)\n                â”œâ”€â”€ ğŸ‘» Lewy Body: íŒŒí‚¨ìŠ¨ ì¦ìƒ + ìƒìƒí•œ í™˜ê° + REM ìˆ˜ë©´ ì¥ì• \n                â”œâ”€â”€ ğŸ„ CJD (Prion): ê¸‰ì† ì§„í–‰, ê·¼ìœ¡ ê²½ë ¨(Myoclonus)\n                â””â”€â”€ ğŸ· Alcohol-related: ì†Œë‡Œ ìœ„ì¶•, ë³´í–‰ ì¥ì• `\n### ğŸ§  H1: Neurocognitive Disorders - The Clinical Approach\n### ğŸšª H2: The Doorway Test (Three Patients Visualization)\n*ê°•ì˜ëŠ” ì„¸ ëª…ì˜ í™˜ìë¥¼ \"ë¬¸ê°„(Doorway)\"ì—ì„œ ë°”ë¼ë³´ëŠ” ê²ƒìœ¼ë¡œ ì‹œì‘í•©ë‹ˆë‹¤. ì´ ì²«ì¸ìƒì´ ì§„ë‹¨ì˜ ì—´ì‡ ì…ë‹ˆë‹¤!* ğŸ”‘\n**1. Room 1: ğŸ§¶ Patient A (The Knitter)**\n- **Scenario:** í‰ìƒ ëœ¨ê°œì§ˆì„ í•˜ë˜ í• ë¨¸ë‹ˆ. ìµœê·¼ì— ëœ¨ê°œì§ˆì„ ë©ˆì¶¤. ë”¸ì´ ë°©ë¬¸í–ˆë”ë‹ˆ ì—„ë§ˆê°€ ë”¸ì„ ê¸°ì–µí•˜ì§€ ëª»í•¨. ëŒ€í™” ë‚´ìš©ì„ ì „í˜€ ê¸°ì–µ ëª» í•¨(Zero recollection).\n- **Diagnosis:** **Alzheimer's Disease (ì•Œì¸ í•˜ì´ë¨¸)**.\n- **Key Feature:** **Insidious loss of short-term memory** (ì„œì„œíˆ ì§„í–‰ë˜ëŠ” ë‹¨ê¸° ê¸°ì–µ ìƒì‹¤) & Procedural memory loss (ì ˆì°¨ ê¸°ì–µ ìƒì‹¤).\n**2. Room 2: ğŸ¬ Patient B (The Accountant)**\n- **Scenario:** 55ì„¸ íšŒê³„ì‚¬(ì ŠìŒ!). í•­ìƒ ë‹¨ì •í–ˆìœ¼ë‚˜, í¸ì˜ì ì—ì„œ ìº”ë””ë°” 3ê°œë¥¼ í›”ì³ì„œ ë‹¥ì¹˜ëŠ” ëŒ€ë¡œ ë¨¹ìŒ(Hyperorality). í†µë¡œ ë°”ë‹¥ì— ì†Œë³€ì„ ë´„(Urinated on the floor). ì°½í”¼í•´í•˜ì§€ ì•ŠìŒ(No shame).\n- **Diagnosis:** **Frontotemporal Dementia (ì „ë‘ì¸¡ë‘ì—½ ì¹˜ë§¤)**.\n- **Key Feature:** **Profound Disinhibition** (ì‹¬ê°í•œ íƒˆì–µì œ). ì‚¬íšŒì  í•„í„°(Social filter)ê°€ ì™„ì „íˆ ì‚¬ë¼ì§. ê¸°ì–µë ¥ë³´ë‹¤ **í–‰ë™/ì„±ê²© ë³€í™”**ê°€ ë¨¼ì € ì˜´.\n**3. Room 3: ğŸ‘» Patient C (The Shuffler)**\n- **Scenario:** ë°œì„ ì§ˆì§ˆ ëŒë©° ê±·ëŠ”(Shuffling feet) ë…¸ì¸. ê±°ì‹¤ì— ì‘ì€ ì•„ì´ë“¤ì´ ë†€ê³  ìˆë‹¤ë©° ì§‘ì— ê°€ì•¼ í•œë‹¤ê³  ì†ì‚­ì„(Visual Hallucination). ì‹¤ì œë¡œëŠ” í˜¼ì ì‚¼.\n- **Diagnosis:** **Lewy Body Dementia (ë£¨ì´ì†Œì²´ ì¹˜ë§¤)**.\n- **Key Feature:** **Visual Hallucinations** (ì‹œê° í™˜ê°) + **Motor Symptoms** (ìš´ë™ ì¦ìƒ, íŒŒí‚¨ìŠ¨ë³‘ ìœ ì‚¬).\n### ğŸŒ³ H2: The Diagnostic Decision Tree (ì§„ë‹¨ ì•Œê³ ë¦¬ì¦˜)\nì§„ë‹¨ì€ **Memory Test**ë¡œ ì‹œì‘í•˜ëŠ” ê²ƒì´ ì•„ë‹™ë‹ˆë‹¤! ğŸ™…â€â™‚ï¸\nê°€ì¥ ë¨¼ì € **\"Acute vs. Chronic\"**ê³¼ **\"Consciousness(ì˜ì‹)\"**ì„ í™•ì¸í•´ì•¼ í•©ë‹ˆë‹¤.","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-149","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","diagnosis","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"### 1. ğŸš¨ The Gatekeeper: Ruling out Delirium (ì„¬ë§ ë°°ì œ)\n- **â˜… Critical Distinction:** Deliriumì€ **Medical Emergency**ì…ë‹ˆë‹¤. ì¹˜ë§¤ê°€ ì•„ë‹™ë‹ˆë‹¤!\n- **Key Symptoms:**\n    - **Fluctuation:** ì˜ì‹ ìˆ˜ì¤€ì´ ì˜¤ë½ê°€ë½í•¨ (Waxing and waning).\n    - **Altered Level of Consciousness:** ì¡¸ë¦¬ê±°ë‚˜(Drowsy) í˜¹ì€ ë§¤ìš° í¥ë¶„í•¨(Agitated).\n    - **Inattention:** ì£¼ì˜ ì§‘ì¤‘ì„ ëª» í•¨.\n- **Next Best Step:** **Find the Cause!** (ê°ì—¼, ì•½ë¬¼ ìƒí˜¸ì‘ìš©, ëŒ€ì‚¬ ë¬¸ì œ ë“±). ì ˆëŒ€ ì¹˜ë§¤ë¡œ ì§„ë‹¨í•˜ê³  ë„˜ì–´ê°€ë©´ ì•ˆ ë¨.\n### 2. ğŸ˜” Pseudo-dementia (Depression Screening - PHQ-2)\n- **Scenario:** ë…¸ì¸ì˜ ì‹¬í•œ ìš°ìš¸ì¦(Severe depression)ì€ ì¸ì§€ ê¸°ëŠ¥ ì €í•˜ì²˜ëŸ¼ ë³´ì¼ ìˆ˜ ìˆìŒ.\n- **Differentiation (ì¹˜ë§¤ vs. ìš°ìš¸ì¦):**\n    - **Depressed Patient:** í•œìˆ¨ì„ ì‰¬ë©° ë°”ë‹¥ì„ ë´„. ì§ˆë¬¸ì— **\"ëª°ë¼ìš” (I don't know)\"**ë¼ê³  ë‹µí•¨. ìì‹ ì˜ ë¬´ëŠ¥ë ¥ì— ëŒ€í•´ ê´´ë¡œì›Œí•¨(Distressed). ğŸ˜¢\n    - **Dementia Patient:** ë§ì„ ì§€ì–´ëƒ„(**Confabulation**). ì•„ì¹¨ ì‹ì‚¬ë¡œ ì•ˆ ë¨¹ì€ ê±°ì°½í•œ ìš”ë¦¬ë¥¼ ë¨¹ì—ˆë‹¤ê³  ê±°ì§“ë§í•¨(ì‚¬íšŒì  íë¦„ì„ ìœ ì§€í•˜ê¸° ìœ„í•´). ìì‹ ì´ í‹€ë ¸ë‹¤ëŠ” ê²ƒì„ ëª¨ë¦„(Lack of insight). ğŸ¤ª\n- **Treatment:** ìš°ìš¸ì¦ì„ ì¹˜ë£Œí•˜ë©´ \"ì¹˜ë§¤\" ì¦ìƒì´ ì‚¬ë¼ì§.\n### 3. ğŸ“‰ MCI vs. Dementia (The Functional Line)\n- ì¸ì§€ ê¸°ëŠ¥ í…ŒìŠ¤íŠ¸(MMSE, MoCA) ì ìˆ˜ê°€ ë‚®ë‹¤ê³  ë¬´ì¡°ê±´ ì¹˜ë§¤ê°€ ì•„ë‹˜.\n- **â˜… The Defining Factor:** **ADLs (Activities of Daily Living)**.\n    - **Mild Cognitive Impairment (MCI):** ê±´ë§ì¦ì´ ìˆì§€ë§Œ, í˜¼ìì„œ ìš”ë¦¬í•˜ê³ , ì€í–‰ ì—…ë¬´ ë³´ê³ , ìš´ì „ ê°€ëŠ¥í•¨. (Independent).\n        - *Action:* Monitor (ê´€ì°°).\n    - **Dementia:** ë„ì›€ì´ í•„ìš”í•¨. ë°¥ì„ ëª» ì±™ê²¨ ë¨¹ê³ , ì˜·ì„ ëª» ì…ìŒ. (Dependent).\n        - *Action:* Workup & Support required.\n### ğŸ§ª H2: The Workup (ê²€ì‚¬ ë° ê°ë³„ ì§„ë‹¨)\nì¼ë‹¨ \"Dementia\" ì¹´í…Œê³ ë¦¬ì— ë“¤ì–´ì˜¤ë©´, **ê°€ì—­ì  ì›ì¸(Reversible causes)**ì„ ë°°ì œí•˜ëŠ” ê²ƒì´ í•„ìˆ˜ì…ë‹ˆë‹¤.\n**ğŸ“‹ The Mandatory Workup List:**\n- **Basic Labs:** CBC, B12, TSH (Thyroid), Metabolic Panel (ì „í•´ì§ˆ ë“±).\n- **Brain Imaging:** CT or MRI (ë‡Œ ìœ„ì¶•, ë‡Œì¡¸ì¤‘, ì¢…ì–‘ í™•ì¸).\n- **Specific Rule-outs:**\n    - **Syphilis (ë§¤ë…):** ì‹ ê²½ë§¤ë…(Neurosyphilis).\n    - **Wilson's Disease (ìœŒìŠ¨ë³‘):**\n        - **â˜… High Yield Pearl:** ì Šì€ í™˜ì(Young) + ìš´ë™ ì¥ì• (Movement disorder) + ì •ì‹ ê³¼ì  ë¬¸ì œ(Psych) + ê°„ ì§ˆí™˜(Liver issue).\n        - *Pathology:* Copper overload (êµ¬ë¦¬ ê³¼ë‹¤).\n        - *Insight:* ë†“ì¹˜ë©´ ì¹˜ë§¤ê°€ ë˜ì§€ë§Œ, ë°œê²¬í•˜ë©´ ì¹˜ë£Œ ê°€ëŠ¥(Treatable)!\n### ğŸ§© H2: The Specific Pathologies (Big 4 & Others)\n### 1. Alzheimer's Disease (ì•Œì¸ í•˜ì´ë¨¸) ğŸ§¶\n- **Characteristics:**\n    - ê°€ì¥ í”í•œ ìœ í˜•.\n    - **Insidious onset:** ì–¸ì œ ì‹œì‘ëëŠ”ì§€ ëª¨ë¥´ê²Œ ì„œì„œíˆ ì§„í–‰.\n    - **Progression:** ë‹¨ê¸° ê¸°ì–µ(Short-term) ìƒì‹¤ â†’ ì–¸ì–´ ì¥ì• (Word finding) â†’ ê³µê°„ ì§€ê°ë ¥ ìƒì‹¤(Spatial disorientation, ê¸¸ ìƒìŒ) â†’ ì„±ê²© ë³€í™”(Personality change).\n- **Risk Factors:**\n    - **Age:** ë‚˜ì´ê°€ ê¹¡íŒ¨.\n    - **Cardiovascular Health:** ê³ í˜ˆì••, ë‹¹ë‡¨, ë¹„ë§Œì´ 40-50ëŒ€ì— ìˆìœ¼ë©´ ë‚˜ì¤‘ì— ì•Œì¸ í•˜ì´ë¨¸ ìœ„í—˜ ì¦ê°€. (Midlife vascular health = Brain health). â¤ï¸ğŸ§ \n    - **Genetics:** Down Syndrome (Trisomy 21), **ApoE4 allele**.\n### 2. Vascular Dementia (í˜ˆê´€ì„± ì¹˜ë§¤) ğŸ©¸\n- **Pattern:** **\"Stepwise Decline\" (ê³„ë‹¨ì‹ ì•…í™”)**.\n    - Stroke/Infarct ë°œìƒ â†’ ê¸°ëŠ¥ ëš ë–¨ì–´ì§ â†’ í‰íƒ„(Plateau) â†’ ë˜ Stroke â†’ ëš ë–¨ì–´ì§. ğŸ“‰\n- **Key Concept:** ê¸°ì–µë ¥ ì €í•˜ê°€ ì²« ì¦ìƒì´ ì•„ë‹ ìˆ˜ ìˆìŒ. **Executive Dysfunction** (ê³„íší•˜ê¸°, ì •ë¦¬í•˜ê¸° ëŠ¥ë ¥ ì €í•˜)ì´ ë¨¼ì € ì˜¬ ìˆ˜ ìˆìŒ.\n- **Associations:** ê³ í˜ˆì••, ë‡Œì¡¸ì¤‘ ê³¼ê±°ë ¥.\n- **Subtype:** **Binswanger's Disease** (Subcortical vascular encephalopathy) - ë°±ì§ˆ(White matter) ê¹Šì€ ê³³ì˜ ì‘ì€ í˜ˆê´€ ì§ˆí™˜.\n    - *Signs:* ìš”ì‹¤ê¸ˆ(Urinary incontinence) + ë³´í–‰ ì¥ì• (Gate disturbance) + í˜¼ë€(Confusion).\n### 3. Frontotemporal Dementia (FTD / Pick's Disease) ğŸ­\n- **Patient Profile:** ë” ì Šì€ ë‚˜ì´ (50ëŒ€).\n- **Key Symptoms:**\n    - **Personality Changes:** ì¶©ë™ ì¡°ì ˆ ì¥ì• .\n    - **Hyperorality:** ì…ìœ¼ë¡œ ìê¾¸ ë­˜ ê°€ì ¸ê° (ë‹´ë°°, ì‚¬íƒ• ë“±).\n    - **Apathy:** ê°€ì¡±ì— ëŒ€í•œ ë¬´ê´€ì‹¬.\n    - **Compulsive Behaviors:** ì´ìƒí•œ ì˜ì‹ì  í–‰ë™.\n- **Brain Imaging:** Frontal lobe atrophy (ì „ë‘ì—½ ìœ„ì¶•).\n### 4. Lewy Body Dementia (ë£¨ì´ì†Œì²´ ì¹˜ë§¤) ğŸ‘»","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-169","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"- **Triad of Symptoms:**\n    1. **Visual Hallucinations:** ë§¤ìš° êµ¬ì²´ì ì„ (ì˜ˆ: \"ì‘ì€ ì•„ì´ë“¤ì´ ê±°ì‹¤ì— ìˆë‹¤\").\n    2. **Parkinsonism:** ë–¨ë¦¼(Tremor), ê²½ì§(Rigidity), ëŠë¦° ì›€ì§ì„.\n    3. **Fluctuating Cognition:** ì¢‹ì€ ë‚ ê³¼ ë‚˜ìœ ë‚ ì´ ìˆìŒ.\n- **â˜… LETHAL WARNING (Never Event):**\n    - ì´ í™˜ìë“¤ì€ **Antipsychotics (í•­ì •ì‹ ë³‘ ì•½ë¬¼)**ì— ê·¹ë„ë¡œ ì˜ˆë¯¼í•¨(Severe Neuroleptic Sensitivity).\n    - í™˜ê°(Hallucination) ì¡ê² ë‹¤ê³  **Haloperidol** ê°™ì€ ì•½ì„ ì“°ë©´ í™˜ìê°€ **êµ³ì–´ì„œ ì‚¬ë§í•˜ê±°ë‚˜ ì˜êµ¬ì ì¸ íŒŒí‚¨ìŠ¨ì¦**ì´ ì˜¬ ìˆ˜ ìˆìŒ. â˜ ï¸ğŸš«\n### 5. Creutzfeldt-Jakob Disease (CJD) ğŸ„\n- **Cause:** Prion (í”„ë¦¬ì˜¨ ë‹¨ë°±ì§ˆ). ë„ë¯¸ë…¸ì²˜ëŸ¼ ë‡Œ ë‹¨ë°±ì§ˆì„ ë§ê°€ëœ¨ë¦¼.\n- **Speed:** **Terrifyingly Fast**. ëª‡ ì£¼~ëª‡ ë‹¬ ë§Œì— ê¸‰ê²©íˆ ì•…í™”.\n- **Physical Sign:** **Startle Myoclonus** (ë°•ìˆ˜ ì†Œë¦¬ë‚˜ ì ‘ì´‰ì— ê¹œì§ ë†€ë¼ë©° ê·¼ìœ¡ì´ íŠ). ğŸ‘âš¡\n- **Diagnosis:**\n    - Old School: 14-3-3 protein in CSF.\n    - **â˜… Modern Gold Standard:** **RT-QuIC** (Real-Time Quaking Induced Conversion). í™˜ìì˜ ì²™ìˆ˜ì•¡ì„ ì •ìƒ ë‹¨ë°±ì§ˆê³¼ ì„ì–´ì„œ í”ë“¤ì–´ë³´ëŠ” ê²€ì‚¬. (Test tube amplification).\n    - MRI: **Cortical Ribboning** (í”¼ì§ˆ ê°€ì¥ìë¦¬ê°€ ë°ê²Œ ë¹›ë‚¨) & Hockey Stick sign.\n### 6. Alcohol-Related Dementia ğŸ·\n- **Target:** **Cerebellum (ì†Œë‡Œ)**.\n- **Symptoms:** ë³´í–‰ ì¥ì• (Wide-based gate), ìš´ë™ ì‹¤ì¡°(Ataxia). ìˆ ì„ ì•ˆ ë§ˆì…”ë„ ë¹„í‹€ê±°ë¦¼.\n### 7. HIV-Associated Neurocognitive Disorder\n- **Profile:** CD4 countê°€ ë§¤ìš° ë‚®ì€ (<200) ì¥ê¸° HIV í™˜ì.\n- **Symptoms:** ì „ë°˜ì ì¸ ìœ„ì¶•(Diffuse atrophy), ëŠë ¤ì§(Slowed movement), ê¸°ì–µë ¥ ì €í•˜. ì¼ë°˜ ì¹˜ë§¤ì™€ ë¹„ìŠ·í•´ ë³´ì„.\n### ğŸ’Š H2: Management & Safety (ì¹˜ë£Œ ë° ê´€ë¦¬)\n**1. Non-Pharmacologic First!** ğŸ›‘\n- ì•½ë¬¼ì€ 1ì°¨ ì¹˜ë£Œì œê°€ ì•„ë‹˜.\n- **Pain Check:** í™˜ìì˜ í¥ë¶„(Agitation)ì€ í†µì¦ ë•Œë¬¸ì¼ ìˆ˜ ìˆìŒ (UTI, ê´€ì ˆì—¼ ë“±).\n- **Environment:** ì•ˆì •ê° ì£¼ê¸°(Reassurance), ì¼ê³¼(Routine) ë§Œë“¤ê¸°.\n**2. Pharmacologic Options (ì œí•œì )**\n- **Cognitive Symptoms, Apathy/hallucinaions:**\n    - **Cholinesterase Inhibitors** (Donepezil, Rivastigmine, Galantamine).\n- **Behavioral Symptoms:**\n    - **SSRIs** (ìš°ìš¸, ë¶ˆì•ˆ ì¡°ì ˆ).\n- ë‚¨ì—ê²Œ í•´ê°€ ë˜ê±°ë‚˜ ìœ„í—˜í•œ severe aggression, psychosisìˆì„ë•Œë§Œ ì œí•œì ìœ¼ë¡œ antipsychotics ì‚¬ìš©!\n- **âŒ Avoid List:**\n    - **Benzodiazepines:** ë‚™ìƒ ìœ„í—˜ ì¦ê°€, í˜¼ë€ ê°€ì¤‘. (í• ë¨¸ë‹ˆì—ê²Œ Xanax ì£¼ë©´ ì•ˆ ë¨!). ğŸš«\n    - **Antipsychotics:** íŠ¹íˆ **Lewy Body** í™˜ìì—ê²Œ ì ˆëŒ€ ê¸ˆê¸°. ì¼ë°˜ ì¹˜ë§¤ í™˜ìì—ê²Œë„ ì‚¬ë§ë¥  ì¦ê°€ ìœ„í—˜ ë•Œë¬¸ì— ìµœí›„ì˜ ìˆ˜ë‹¨(Last resort)ì´ë©°, ë‚¨ì—ê²Œ í•´ë¥¼ ë¼ì¹  ë•Œë§Œ ê³ ë ¤.","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-189","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"recap_summary","text":"### ğŸ”¥ Rapid Fire Recap (Summary Table)\n| **Condition** | **Key Feature (The \"Tell\")** | **Initial Presentation** | **Treatment Alert âš ï¸** |\n| --- | --- | --- | --- |\n| **Delirium** | **Acute & Fluctuating** | Drowsy â†” Agitated, Inattention | **Emergency!** Find medical cause. |\n| **Depression** | **\"I don't know\"** | Distressed, gives up easily | Treat depression â†’ Cognition improves. |\n| **Alzheimer's** | **Short-term memory loss** | Amnesia, Getting lost | Focus on safety & routine. |\n| **Vascular** | **Stepwise decline** | History of Stroke/HTN | Control BP/Lipids to prevent next step. |\n| **FTD** | **Personality Change** | Disinhibition, Hyperorality | Often misdiagnosed as psychiatric issue. |\n| **Lewy Body** | **Visual Hallucinations** | Kids/Animals seen, Parkinsonism | **âŒ NO ANTIPSYCHOTICS (Lethal)**. |\n| **CJD** | **Startle Myoclonus** | Rapid progression (Weeks) | **RT-QuIC** test is Gold Standard. |\n| **Wilson's** | **Young + Tremor + Psych** | Liver issues + Psychosis | **Treatable** if caught (Copper). |\n### ğŸ©º Meta-Cognitive Analysis\n1. **DECOMPOSE:** ì˜¤ë””ì˜¤ëŠ” ì„¬ë§/ìš°ìš¸ì¦/ì¹˜ë§¤ì˜ ê°ë³„ â†’ ì¹˜ë§¤ì˜ ì¢…ë¥˜ë³„ íŠ¹ì§• â†’ ì¹˜ë£Œ ë° ê¸ˆê¸° ì‚¬í•­ìœ¼ë¡œ êµ¬ì„±ë¨.\n2. **SOLVE:** ê° ì§ˆí™˜ì˜ í•µì‹¬ ì¦ìƒ(Vignette)ì„ ì¶”ì¶œí•˜ê³ , íŠ¹íˆ Lewy Bodyì˜ ì•½ë¬¼ ê¸ˆê¸°ì™€ CJDì˜ ì§„ë‹¨ë²• ë“± High-yield ì •ë³´ë¥¼ ê°•ì¡°í•¨.\n3. **VERIFY:** ì˜¤ë””ì˜¤ ë‚´ìš©ê³¼ ë¹„êµ ì‹œ, NPH(ì •ìƒì•• ìˆ˜ë‘ì¦) ë‚´ìš©ì€ í¬í•¨ë˜ì§€ ì•Šì•„ ë…¸íŠ¸ì—ì„œ ì œì™¸í•¨(Zero-loss ì›ì¹™). ì˜¤ì§ ì˜¤ë””ì˜¤ì— ì–¸ê¸‰ëœ ë‚´ìš©ë§Œ í¬í•¨. \"RT-QuIC\" í…ŒìŠ¤íŠ¸ ëª…ì¹­ ì •í™•íˆ ê¸°ì¬.\n4. **SYNTHESIZE:** í•œêµ­ì–´ ì„¤ëª…ê³¼ ì˜ì–´ ì˜í•™ ìš©ì–´ë¥¼ ì„ì–´ ê°€ë…ì„±ì„ ë†’ì´ê³ , ì´ëª¨ì§€ë¥¼ ì‚¬ìš©í•˜ì—¬ ì‹œê°ì  ì´í•´ë¥¼ ë„ì›€.\nHere is your comprehensive lecture note, fully aligned with your preferences (USMLE expert mode, detailed structure, visual ASCII trees, and energetic vibe).\n### ğŸ“‹ Overview: TL;DR (Executive Summary)","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-203","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","recap","diagnosis","treatment","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"### ğŸŒ³ Top-Down Classification & Mental Model\n**Big Picture:** Spinal Cord PathologyëŠ” í¬ê²Œ **Compression (Extrinsic)** ê³¼ **Intrinsic Syndromes** ë¡œ ë‚˜ë‰©ë‹ˆë‹¤. ì„ìƒì ìœ¼ë¡œëŠ” \"Pain pattern\"ê³¼ \"Neurologic Deficit\"ì˜ ìœ ë¬´ë¡œ ì ‘ê·¼í•´ì•¼ í•©ë‹ˆë‹¤.\n# 1. Spinal Cord Compression (The Emergency) ğŸš¨\n### ğŸšª Doorway Thought (Vignette)\n### ğŸ§  Concept & Pathophysiology\n- **The \"Big Three\" Causes:**\n    1. **Mechanical:** Disc herniation, Spinal stenosis.\n    2. **Infection:** Epidural Abscess (IVDU, Post-procedure).\n    3. **Malignancy (Tumor):** ê°€ì¥ ìœ„í—˜í•¨.\n        - **Mnemonic (Lead Kettle):** **P**rostate, **B**reast, **L**ung, Kidney, Thyroid (\"PB KTL\" -> Lung, Breast, Prostateê°€ Top 3).\n- **Why Night Pain? (The Physiology):**\n    - ëˆ„ìš°ë©´(Recumbent position), Gravityê°€ ì²™ìˆ˜ ì£¼ë³€ì˜ Venous plexus(ì •ë§¥)ì˜ drainageë¥¼ ë•ì§€ ëª»í•¨ â†’ **Venous Engorgement** ë°œìƒ.\n    - ë°¤ì—ëŠ” ì²´ë‚´ ê³ ìœ ì˜ Anti-inflammatory hormone(Cortisol ë“±) ë ˆë²¨ì´ ë–¨ì–´ì§.\n    - **Result:** Tumorë¡œ ì¢ì•„ì§„ ê³µê°„ + ë¶€ì–´ì˜¤ë¥¸ ì •ë§¥ + ì—¼ì¦ ì¡°ì ˆ ì•ˆë¨ = **Explosive Pressure & Pain.**\n### ğŸ©º Physical Exam: The \"Shock\" Trap\n- **Spinal Shock Phase:** ì´ˆê¸°ì—ëŠ” Cordê°€ ê¸°ì ˆ(Stunned)í•´ì„œ **Flaccid paralysis & Areflexia (No reflexes)** ê°€ ë‚˜íƒ€ë‚¨.\n- **Late Phase:** ì‹œê°„ì´ ì§€ë‚˜ë©´ **Spasticity, Hyperreflexia, Babinski (+)** ë“± ì „í˜•ì ì¸ UMN signì´ ë‚˜íƒ€ë‚¨.\n    - *Caveat:* ì´ˆê¸°ì— Reflexê°€ ì—†ë‹¤ê³  Cord injuryë¥¼ ë°°ì œí•˜ë©´ ì•ˆ ë¨! (Shock phaseì¼ ìˆ˜ ìˆìŒ).\n### ğŸ’Š Management (High Yield!)\n- **Standard:** Emergency MRI of the Spine.\n- **â˜… THE GOLD STANDARD / CRITICAL EXCEPTION:**\n    - ë§Œì•½ í™˜ìê°€ **Neurologic Deficit** (ì˜ˆ: Foot drop, ë‹¤ë¦¬ ê°ê° ì €í•˜)ì´ *ì´ë¯¸* ìˆê³ , Compressionì´ ê°•ë ¥íˆ ì˜ì‹¬ëœë‹¤ë©´?\n    - **Step 1:** **IV Glucocorticoids (High-dose Dexamethasone) IMMEDIATELY.** (MRI ê¸°ë‹¤ë¦¬ì§€ ë§ˆë¼!)\n    - **Step 2:** Then, MRI.\n    - *Reason:* Dexamethasoneì€ Tumor ì£¼ë³€ì˜ Vasogenic edemaë¥¼ ì¤„ì—¬ì£¼ì–´ ì²™ìˆ˜ê°€ ìˆ¨ ì‰´ ê³µê°„(Breathing room)ì„ ë§Œë“¤ì–´ì¤Œ.\n    - **Step 3:** Surgery or Radiation (Decompression).\n# 2. Incomplete Spinal Cord Syndromes âœ‚ï¸\n### ğŸ§  Anatomy: The Fiber Optic Cable\nCordë¥¼ ìë¥¸ ë‹¨ë©´(Cross-section)ì„ ì´í•´í•´ì•¼ í•©ë‹ˆë‹¤.\n1. **Posterior (Dorsal) Columns:** Vibration/Proprioception (Position sense).\n2. **Spinothalamic Tract (Antero-lateral):** Pain & Temperature.\n3. **Corticospinal Tract (Lateral):** Motor function.","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-213","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"### A. Central Cord Syndrome (The \"Muddy Hands\") ğŸ‘\n- **Mechanism:**\n    - **Hyperextension Injury** (ëª©ì´ ë’¤ë¡œ ì –í˜€ì§).\n    - ë…¸ì¸ë“¤ì€ ì´ë¯¸ Cervical Spondylosis(ê´€ì ˆì—¼)ê°€ ìˆìŒ. ëª©ì´ ì –í˜€ì§ˆ ë•Œ **Ligamentum Flavum**ì´ ì²™ìˆ˜ ì•ˆìª½ìœ¼ë¡œ ì ‘í˜€ ë“¤ì–´ì˜¤ë©´ì„œ(Buckle inward) ì²™ìˆ˜ì˜ **ì •ì¤‘ì•™(Center)** ì„ íƒ€ê²©í•¨.\n- **Why Upper > Lower?**\n    - Corticospinal tractì˜ ë°°ì—´ìƒ **Arms are Medial (Center)**, Legs are Lateral (Outside).\n    - ì¤‘ì•™ì´ ë‹¤ì¹˜ë©´ íŒ” ì‹ ê²½ì´ ë¨¼ì € ë‚˜ê°.\n- **Key Symptom:** **Weakness in Upper Extremities > Lower Extremities.** (\"Muddy hands\").\n### B. Anterior Cord Syndrome (The \"Stroke of the Spine\") ğŸ§±\n- **Mechanism:**\n    - **Anterior Spinal Artery (ASA)** Occlusion (Infarction) í˜¹ì€ ì „ë°©ì˜ ë¼ˆ ì¡°ê°(Bone fragment).\n    - ASAëŠ” ì²™ìˆ˜ì˜ ì•ìª½ 2/3ë¥¼ ë¨¹ì—¬ ì‚´ë¦¼ (Motor + Pain/Temp).\n- **Spare Part:**\n    - **Dorsal Columns (Posterior)** ì€ Posterior Spinal Arteriesê°€ ë”°ë¡œ ë¨¹ì—¬ ì‚´ë¦¼.\n    - ë”°ë¼ì„œ **Proprioception & Vibration is INTACT (SPARED).**\n- **Key Finding:** Complete Motor Loss + Pain/Temp Loss + **Vibration Spared.**\n# 3. The Showdown: Conus Medullaris vs. Cauda Equina ğŸ¤ \nì´ ë‘ ê°€ì§€ëŠ” ìœ„ì¹˜ëŠ” ë¹„ìŠ·í•˜ì§€ë§Œ(í—ˆë¦¬ ì•„ë˜), **Neurologyê°€ ì™„ì „íˆ ë°˜ëŒ€**ì…ë‹ˆë‹¤.\n### ğŸ“Š Comparison Table (High Yield!)\n- **Key Distinction:**\n    | **Feature** | **Conus Medullaris** | **Cauda Equina** |\n    | --- | --- | --- |\n    | **Location â˜…**  | Cord itself (L1-L2) | Peripheral nerve roots (below L2) |\n    | **Motor Signs\n    Reflexì–‘ìƒ â˜…**  | UMN signs (Spasticity, Hyperreflexia) | LMN signs (Flaccid, Areflexia, Foot drop) |\n    | **Pain Pattern** | Deep central backache, Symmetric | Radiculopathy, Shooting pain, Asymmetric |\n    | **Saddle Anesthesia** | Tight, symmetrical numbness around perianal area | Patchy, asymmetrical, runs down one thigh |\n    | **Structure** | Solid structure | Nerve roots |\n    | **Management** | Surgical Emergency (Immediate MRI â†’ Decompression) | Surgical Emergency (Immediate MRI â†’ Decompression) |\n- **Management:** ë‘˜ ë‹¤ **Surgical Emergency.** (Immediate MRI â†’ Decompression).\n# 4. Autonomic Dysreflexia (The Physiological Storm) ğŸŒ©ï¸\n### ğŸšª Doorway Thought\n### ğŸ§  Pathophysiology: The \"Two Bodies\" Problem\nì´ í˜„ìƒì€ Injury level (ì£¼ë¡œ **T6 ì´ìƒ**)ì„ ê¸°ì¤€ìœ¼ë¡œ ëª¸ì´ ë‘ ê°œë¡œ ë‚˜ë‰˜ì–´ì„œ ì‹¸ìš°ëŠ” ê²ƒì„.\nT6ì´ìƒ levelì—ì„œì˜ Spinal cord injuryê°€ ì´ë¯¸ ìˆëŠ” í™˜ìì—ì„œì˜ ìƒí™©. T6ê°€ splanchnic blood vessel bedê°€ ìˆëŠ” ê³³. Gutì˜ blood vesselë“¤ë¡œ êµê°ì‹ ê²½ì˜ ì¡°ì ˆì„ ë°›ì•„ í˜ˆì••ì„ ê´€ë¦¬í•˜ëŠ” ì‹œìŠ¤í…œ ì¤‘ í•˜ë‚˜.\n1. **Stimulus Below ì´ë¯¸ ìˆëŠ” Lesion:** ê½‰ ë‚€ ì˜·, ë³€ë¹„, í˜¹ì€ **Distended Bladder (ì†Œë³€ ì°¸ìŒ/Kinked catheter)** ê°€ ìê·¹ì„ ì¤Œ. â†’ í•˜ì§€ë§Œ ì†ìƒëœ levelë°‘ì—ì„œì˜ ë¶ˆí¸í•¨ì„ ëŠë¼ì§€ ëª»í•¨. ëª¸ì€ ëŠë‚Œ\n2. **Sympathetic Surge (Below):** ì²™ìˆ˜ ë°˜ì‚¬ë¡œ ì¸í•´ í•˜ì²´ì—ì„œ **Massive Vasoconstriction** ë°œìƒ â†’ **HTN (Severe).**\n3. **Brain's Reaction:** ë‡ŒëŠ” ê³ í˜ˆì••ì„ ê°ì§€í•¨ (Baroreceptors).\n    - Reaction A: **Vagus Nerve**ë¥¼ í†µí•´ ì‹¬ì¥ì„ ëŠë¦¬ê²Œ ë›°ê²Œ í•¨ â†’ **Bradycardia.**\n    - Reaction B: í˜ˆì••ì„ ë‚®ì¶”ë ¤ê³  \"Vasodilation\" ì‹ í˜¸ë¥¼ ë³´ëƒ„. í•˜ì§€ë§Œ **Injury Level (T6)** ì—ì„œ ë§‰í˜.\n4. **Result:**\n    - **Above Level:** Flushing, Sweating, Vasodilation (ì–¼êµ´ì´ ë¹¨ê°œì§).\n    - **Below Level:** Pale, Cool, Clamped down (í•˜ì²´ëŠ” ì°½ë°±í•¨).\n### ğŸš‘ Management (Step-by-Step)\n1. **Sit the patient UP:** ì¤‘ë ¥ì„ ì´ìš©í•´ ë‹¤ë¦¬ë¡œ í”¼ë¥¼ ì ë¦¬ê²Œ í•˜ì—¬ í˜ˆì••ì„ ë‚®ì¶¤. (ì¦‰ê°ì  íš¨ê³¼).\n2. **â˜… Remove the Stimulus (NBS):**\n    - ì˜·ì„ ëŠìŠ¨í•˜ê²Œ í•¨.\n    - **Check the Bladder:** Foley catheterê°€ ê¼¬ì˜€ëŠ”ì§€ í™•ì¸(Unkink), í˜¹ì€ ì¹´í…Œí„°ê°€ ì—†ìœ¼ë©´ ì‚½ì…í•˜ì—¬ ë°°ë‡¨(Drain). **(Most Common Cause!)**\n    - Check bowel (impaction).\n3. **Medication:** ê·¸ë˜ë„ ì•ˆ ë–¨ì–´ì§€ë©´ Anti-hypertensives (Nitropaste ë“±).","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-233","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"# 5. The \"Do Not Do\" Rule: Spinal Epidural Abscess ğŸ’‰\n- **Triad:** Fever + Focal Back Pain + Neurologic Deficit (IVDU Hx).\n- **Contraindication:** **DO NOT perform a Lumbar Puncture (LP).**\n    - *Why?* ë°”ëŠ˜ì´ ë†ì–‘(Abscess)ì„ ëš«ê³  ì§€ë‚˜ê°€ë©´, ê·¸ ê· ì„ ë§‘ì€ CSF ê³µê°„(Subarachnoid space)ìœ¼ë¡œ ì‹¬ì–´ë²„ë¦¼ â†’ **Meningitis ìœ ë°œ.**\n- **â˜… NBS:** MRI Spine first. Blood cultures. Antibiotics.\n### ğŸ”¥ Rapid Fire Recap (Summary Table)\n| **Symptom / Scenario** | **Diagnosis** | **Key Mechanism / Action** |\n| --- | --- | --- |\n| **Night Pain** + Back Pain | Spinal Tumor | Venous engorgement. **Dexa FIRST** if deficit. |\n| Elderly + Hyperextension + Weak Hands | **Central Cord** | Ligamentum flavum buckles. Arms > Legs. |\n| Paralysis + **Vibration Intact** | **Anterior Cord** | ASA occlusion. Post. columns spared. |\n| **Hyperreflexia** + Early Bladder issues | **Conus Medullaris** | UMN Lesion (Cord tip). |\n| **Areflexia** + Severe Radicular Pain (shooting leg pain) | **Cauda Equina** | LMN Lesion (Nerve roots). |\n| T6+ Injury + **Headache** + **HTN + bradycardia** | **Autonomic Dysreflexia** | Check Bladder (Kinked foley)! Sit Up! |\n| Fever + Back Pain + IVDU | Epidural Abscess | **No LP!** MRI First. |\n**Caveats:**\n- Neurologic deficitì´ ìˆëŠ” cord compression ì˜ì‹¬ í™˜ìëŠ” MRI ëŒ€ê¸° ì‹œê°„ ë™ì•ˆ Cordê°€ ì£½ì„ ìˆ˜ ìˆìœ¼ë¯€ë¡œ **Steroid(Dexamethasone)** ê°€ ë¨¼ì €ì…ë‹ˆë‹¤.\n- Spinal shock ë‹¨ê³„ì—ì„œëŠ” UMN lesionì´ë¼ë„ Reflexê°€ ì—†ì„ ìˆ˜ ìˆìŒì„ ëª…ì‹¬í•˜ì„¸ìš”.\n### Overview / TL;DR ğŸ“\n- **Topic:** Demyelinating & White Matter Diseases (ì‹ ê²½ê³¼/Neurology)\n- **Key Focus:** êµ¬ë³„í•˜ê¸° ê¹Œë‹¤ë¡œìš´ MS, NMO, TM, GBS, CPM, ALDì˜ ê°ë³„ í¬ì¸íŠ¸ (Clinical Vignette & Pathophysiology)\n- **High Yield:** ì§„ë‹¨ ê¸°ì¤€(MRI, LP findings), Acute vs Chronic Management, ê·¸ë¦¬ê³  ê° ì§ˆí™˜ì˜ ê²°ì •ì ì¸ \"Buzzword\"ë“¤.\n### ğŸŒ³ Top-Down Classification & Big Picture\n**Concept & Mental Model:** ğŸ§ \nì´ ì±•í„°ì˜ í•µì‹¬ì€ **\"Myelin(ì „ì„  í”¼ë³µ)ì´ ë²—ê²¨ì§€ëŠ” ì§ˆí™˜ë“¤\"**ì…ë‹ˆë‹¤.\nì •ìƒì ì¸ ì‹ ê²½(Neuron)ì€ Myelin Sheathë¡œ ê°ì‹¸ì ¸ ìˆì–´ì„œ ì‹ í˜¸ ì „ë‹¬ì´ ë¹ ë¥´ì§€ë§Œ(Saltatory conduction), ì´ê²ƒì´ ê³µê²©ë°›ìœ¼ë©´ ì‹ í˜¸ê°€ ëŠê¸°ê±°ë‚˜(Block), í•©ì„ (Short circuit)ë˜ê±°ë‚˜, ëŠë ¤ì§‘ë‹ˆë‹¤.\nì¤‘ìš”í•œ ê±´ **\"ì–´ë””ê°€(Location)\"**, **\"ì–´ë–»ê²Œ(Time/Course)\"**, **\"ì™œ(Etiology)\"** ê³µê²©ë°›ëŠëƒì— ë”°ë¼ ë³‘ëª…ì´ ë‹¬ë¼ì§„ë‹¤ëŠ” ê²ƒì…ë‹ˆë‹¤.\nPlaintext","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-253","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"`DISEASE_OF_MYELIN (White Matter Diseases)\nâ”‚\nâ”œâ”€â”€ Central Nervous System (CNS: Brain & Spinal Cord)\nâ”‚   â”œâ”€â”€ Autoimmune / Inflammatory\nâ”‚   â”‚   â”œâ”€â”€ MULTIPLE SCLEROSIS (MS) [â˜…Most Common, Disseminated in Time & Space]\nâ”‚   â”‚   â”œâ”€â”€ NEUROMYELITIS OPTICA (NMO) [Devic's Disease, Severe, Anti-AQP4]\nâ”‚   â”‚   â””â”€â”€ TRANSVERSE MYELITIS (TM) [Spinal Cord focus, Sensory Level]\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Metabolic / Iatrogenic\nâ”‚   â”‚   â””â”€â”€ CENTRAL PONTINE MYELINOLYSIS (CPM) [Na correction too fast, Locked-in]\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Genetic / Metabolic\nâ”‚       â””â”€â”€ ADRENOLEUKODYSTROPHY (ALD) [Peroxisome defect, Young boys, Adrenal]\nâ”‚\nâ””â”€â”€ Peripheral Nervous System (PNS)\n    â””â”€â”€ GUILLAIN-BARRE SYNDROME (GBS) [Ascending paralysis, Areflexia]`\n# 1. Multiple Sclerosis (MS) ğŸ§ âš¡\n### 1.1 The \"Doorway\" Vignette (Clinical Scenario) ğŸšª\n- **Patient:** Young female (20s~30s).\n- **Chief Complaint:** \"í•œìª½ ëˆˆì´ ì˜ ì•ˆ ë³´ì´ê³  ì•„íŒŒìš”\" (**Painful Vision Loss**).\n- **Associated Symptom:** \"ê³ ê°œë¥¼ ìˆ™ì˜€ë”ë‹ˆ ë“± ë’¤ë¡œ ì „ê¸°ê°€ ì°Œë¦¿í•´ìš”\" (**Lhermitte's sign**).\n- **History:** ì˜ˆì „ì—ë„ ë¹„ìŠ·í•œ ì¦ìƒì´ ìˆì—ˆë‹¤ê°€ ì¢‹ì•„ì§„ ì ì´ ìˆìŒ (Relapsing-Remitting course).\n### 1.2 Pathophysiology & Key Signs\n- **Core Concept:** CNSì˜ Oligodendrocyteê°€ ìê°€ë©´ì—­ ê³µê²©ì„ ë°›ì•„ Demyelination ë°œìƒ.\n- **Optic Neuritis (ì‹œì‹ ê²½ì—¼):**\n    - **Painful** eye movement.\n    - **Color desaturation** (ìƒ‰ê¹”ì´ ë¬¼ ë¹ ì§„ ê²ƒì²˜ëŸ¼ ë³´ì„).\n    - **Afferent Pupillary Defect (Marcus Gunn Pupil):** * ì •ìƒ ëˆˆì— ë¹›ì„ ë¹„ì¶”ë©´ ì–‘ìª½ ìˆ˜ì¶• â†’ ë³‘ë³€ ëˆˆìœ¼ë¡œ ë¹›ì„ ì˜®ê¸°ë©´(Swinging flashlight) ì—­ì„¤ì ìœ¼ë¡œ ë™ê³µì´ í™•ì¥ë¨(Dilates). ì™œ? ë‡ŒëŠ” ì´ê±¸ \"ì–´ë‘ì›Œì¡Œë‹¤\"ê³  ì°©ê°í•˜ë‹ˆê¹Œ!\n- **Lhermitte's Sign:** ëª©ì„ êµ½í ë•Œ(Flexion) ì²™ì¶”ë¥¼ íƒ€ê³  ë‚´ë ¤ê°€ëŠ” **Electric Shock** ëŠë‚Œ. (Cervical cord lesion ì‹œì‚¬) âš¡\n- **INO (Internuclear Ophthalmoplegia):**\n    - **Medial Longitudinal Fasciculus (MLF)** lesion.\n    - ì˜¤ë¥¸ìª½ì„ ë³´ë¼ê³  í•˜ë©´, ì™¼ìª½ ëˆˆì´ ë”°ë¼ì˜¤ì§€ ëª»í•¨ (Adduction failure).\n    - ë°˜ë©´, ê°€ëŠ” ëˆˆ(ì˜¤ë¥¸ìª½ ëˆˆ)ì€ **Nystagmus** (ëˆˆë–¨ë¦¼) ë°œìƒ.\n    - **â˜…MS is Bilateral INO:** ì Šì€ í™˜ìì˜ ì–‘ì¸¡ì„± INOëŠ” ê±°ì˜ MS í™•ì •ì .\n### 1.3 Effect of Heat (Uhthoff's Phenomenon) ğŸŒ¡ï¸\n- í™˜ìê°€ \"ëœ¨ê±°ìš´ ëª©ìš•ì„ í•˜ê±°ë‚˜ ìš´ë™í•˜ë©´ ì¦ìƒì´ ì‹¬í•´ì ¸ìš”\"ë¼ê³  í•¨.\n- **Mechanism:** ì—´(Heat)ì´ ì´ë¯¸ ì†ìƒëœ ì‹ ê²½ì˜ ì „ë„(Conduction)ë¥¼ ë” ë°©í•´í•´ì„œ \"Short circuit\" ì‹œí‚´.\n### 1.4 Diagnosis (The Workup) ğŸ”\n- **McDonald Criteria:** **Dissemination in Space (DIS)** & **Dissemination in Time (DIT)**.\n    - ì„œë¡œ ë‹¤ë¥¸ ìœ„ì¹˜(Space)ì—ì„œ, ì„œë¡œ ë‹¤ë¥¸ ì‹œê°„(Time)ì— ë°œìƒí–ˆë‹¤ëŠ” ì¦ê±°ê°€ í•„ìš”í•¨.\n- **â˜…Best Initial & Most Accurate Test:** **MRI of Brain & Spine** (with Gadolinium).\n    - **Dawson Fingers:** Ventricleì—ì„œ ì§ê°ìœ¼ë¡œ ë»—ì–´ë‚˜ê°€ëŠ” ì†ê°€ë½ ëª¨ì–‘ì˜ White matter lesions. (Periventricular plaques).\n    - **DIT ì¦ê±°:** ì¡°ì˜ ì¦ê°•ë˜ëŠ” ë³‘ë³€(Active/New)ê³¼ ì¦ê°•ë˜ì§€ ì•ŠëŠ” ë³‘ë³€(Old/Black holes)ì´ ë™ì‹œì— ë³´ì„.\n- **Lumbar Puncture (LP):** MRIê°€ ì• ë§¤í•  ë•Œ ì‹œí–‰.\n    - **Oligoclonal Bands:** CSF ë‚´ì˜ IgG productionì„ ì˜ë¯¸. (í˜ˆì²­ì—ëŠ” ì—†ê³  CSFì—ë§Œ ìˆì–´ì•¼ í•¨).\n### 1.5 Management (Treatment Ladder) ğŸ’Š\n**USMLEì—ì„œ ê°€ì¥ ì¤‘ìš”í•œ ê²ƒì€ Acute vs Chronic ê´€ë¦¬ì˜ êµ¬ë¶„ì…ë‹ˆë‹¤.**\n| **Category** | **Drug / Action** | **Note** |\n| --- | --- | --- |\n| **Acute Flare** (ê¸‰ì„±ê¸°) | **High-Dose IV Steroids** (Methylprednisolone) | **â˜…Next Best Step.** ë¶ˆì„ ë„ëŠ” ì—­í• . |\n| **Chronic / Prevention** (ì¬ë°œ ë°©ì§€) | **Interferon-beta**, **Glatiramer** | Disease Modifying Therapies (DMT). |\n| Depression | SSRI, SNRI |  |\n| **Symptomatic: Spasticity** | **Baclofen**, Tizanidine | GABA-B agonist. ê·¼ìœ¡ ê²½ì§ ì™„í™”. |\n| **Symptomatic: Fatigue** | **Amantadine**, Modafinil | MS í™˜ìì˜ ê°€ì¥ í”í•œ í˜¸ì†ŒëŠ” í”¼ë¡œê°. Dopamine booze |\n| Neuropathic pain | Gabapentin, Duloxetine | Dampen the misfiring neuro signals |\n| **Symptomatic: Urge Incontinence** | **Oxybutynin** | Anticholinergic. ê³¼ë¯¼ì„± ë°©ê´‘ ì¡°ì ˆ. |\n| **Pregnancy Paradox** | ì¦ìƒì´ ì˜¤íˆë ¤ í˜¸ì „ë¨ (Immune suppression) | ì¶œì‚° í›„(Postpartum)ì— Rebound flare ì¡°ì‹¬! |\n# 2. Neuromyelitis Optica (NMO / Devic's Disease) ğŸ‘ï¸ğŸ’¥\n### 2.1 Distinction from MS (The \"Nasty Cousin\")\n- MSì™€ ë¹„ìŠ·í•˜ì§€ë§Œ í›¨ì”¬ ë” **Severe**í•˜ê³  **Bilateral**í•˜ë‹¤ëŠ” ê²ƒì´ íŠ¹ì§•.\n- MSë¡œ ì§„ë‹¨í–ˆëŠ”ë° ìŠ¤í…Œë¡œì´ë“œ ì¨ë„ ì¹˜ë£Œê°€ ì•ˆë˜ëŠ” ê²½ìš° ì˜ì‹¬.\n- **Clinical Triad:**\n    1. **Severe Optic Neuritis:** ì¢…ì¢… ì–‘ìª½ ëˆˆ(Bilateral) ì¹¨ë²”, ì‹œë ¥ ìƒì‹¤ì´ ì‹¬í•¨.\n    2. **Longitudinally Extensive Transverse Myelitis (LETM):** ì²™ìˆ˜ ë³‘ë³€ì´ 3ê°œ ì²™ì¶” ë¶„ì ˆ(Vertebral segments) ì´ìƒì„ ì¹¨ë²”.\n    3. **Area Postrema Syndrome:** **â˜…Intractable Hiccups (ë©ˆì¶”ì§€ ì•ŠëŠ” ë”¸ê¾¹ì§ˆ)** & Vomiting.\n### 2.2 Diagnosis & Management\n- **Diagnostic Marker:** **Anti-AQP4 Antibody (Anti-Aquaporin 4)**.\n    - Astrocyteì˜ Water channelì„ ê³µê²©í•¨.\n- **Treatment:** Steroidsì— ì˜ ë°˜ì‘ ì•ˆ í•  ìˆ˜ ìˆìŒ. **Plasmapheresis (PLEX)**ê°€ í•„ìš”í•  ìˆ˜ ìˆìŒ.","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-273","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"# 3. Transverse Myelitis (TM) vs Guillain-BarrÃ© (GBS) âš–ï¸\në‘ ì§ˆí™˜ ëª¨ë‘ \"ë§ˆë¹„(Paralysis)\"ë¥¼ ìœ ë°œí•˜ì§€ë§Œ, **ë ˆë²¨(Level)**ê³¼ **ë°˜ì‚¬(Reflex)**ê°€ ë‹¤ë¦…ë‹ˆë‹¤.\n| **Feature** | **Transverse Myelitis (TM)** | **Guillain-BarrÃ© Syndrome (GBS)** |\n| --- | --- | --- |\n| **Pathology** | Spinal Cord Inflammation (CNS) | Nerve Root/Peripheral Nerve Demyelination (PNS) |\n| **Sensory** | **â˜…Sensory Level ì¡´ì¬** (ê°€ìŠ´ ì•„ë˜ë¡œ ê°ê° ì—†ìŒ - í•€ìœ¼ë¡œ ê¸ì–´ë³´ë©´ ê²½ê³„ê°€ ëª…í™•í•¨) | Stocking-glove pattern (ì–‘ë§ ì‹ ì€ ë“¯ ê°ê° ì €í•˜) |\n| **Motor** | ì´ˆê¸°: Flaccid (Shock) â†’ í›„ê¸°: **Spasticity, Hyperreflexia** (UMN ì§•í›„) â˜… â˜…  | **Ascending Paralysis** (ë‹¤ë¦¬ë¶€í„° ìœ„ë¡œ), **Areflexia** (ë°˜ì‚¬ ì†Œì‹¤ - LMN ì§•í›„) |\n| **CSF Finding** | Pleocytosis (WBC â†‘) | **â˜…Albuminocytologic Dissociation** (Protein â†‘, WBC Normal) |\n| **Bladder** | Urinary Retention / Incontinence (Cord bladder) | ììœ¨ì‹ ê²½ê³„ ì´ìƒ ê°€ëŠ¥í•˜ë‚˜ TMë§Œí¼ ì§ì ‘ì ì´ì§€ ì•ŠìŒ |\n- **GBS Key:** Campylobacter jejuni ê°ì—¼ í›„ ë°œìƒ. í˜¸í¡ê·¼ ë§ˆë¹„(Diaphragm) ìœ„í—˜ â†’ **FVC(Forced Vital Capacity)** ëª¨ë‹ˆí„°ë§ í•„ìˆ˜!\n# 4. Central Pontine Myelinolysis (CPM / ODS) ğŸ§‚ğŸ§ \n### 4.1 The Mechanism\n- **Scenario:** ì•Œì½”ì˜¬ ì¤‘ë…ìë‚˜ ì˜ì–‘ê²°í• í™˜ìê°€ ì €ë‚˜íŠ¸ë¥¨í˜ˆì¦(Hyponatremia)ìœ¼ë¡œ ì˜´.\n- **Iatrogenic Error:** ì˜ì‚¬ê°€ ìˆ˜ì•¡(Saline)ì„ ë„ˆë¬´ **ë¹¨ë¦¬** ì£¼ì…í•´ì„œ Na ë†ë„ë¥¼ ê¸‰ê²©íˆ ì˜¬ë¦¼.\n- **Result:** Pons(ë‡Œêµ)ì˜ ì„¸í¬ë“¤ì´ ë¬¼ì„ ëºê¸°ë©´ì„œ ìˆ˜ì¶• â†’ Demyelination.\n- **Mnemonic:** \"From **Low to High**, your **Pons will Die**.\" (ë°˜ëŒ€ëŠ” Cerebral Edema: \"High to Low, your brain will Blow\")\n### 4.2 Locked-in Syndrome ğŸ”’\n- í™˜ìëŠ” ì˜ì‹ì´ ì™„ì „íˆ ëª…ë£Œí•¨(Conscious).\n- í•˜ì§€ë§Œ **Quadriplegia** (ì‚¬ì§€ ë§ˆë¹„). ì–¼êµ´, í˜€, ëª¸ ì•„ë¬´ê²ƒë„ ëª» ì›€ì§ì„.\n- **Spared Function:** **Vertical Eye Movement & Blinking** (ëˆˆì„ ìœ„ì•„ë˜ë¡œ ì›€ì§ì´ê³  ê¹œë¹¡ì´ëŠ” ê²ƒì€ ì¤‘ë‡Œ(Midbrain) ë‹´ë‹¹ì´ë¼ ì‚´ì•„ë‚¨ìŒ).\n- ì´ ëˆˆ ê¹œë¹¡ì„ìœ¼ë¡œ \"I am still here\"ë¼ê³  ë§í•¨. ğŸ˜±\n# 5. Adrenoleukodystrophy (ALD) ğŸ§¬ğŸ‘¦\n### 5.1 The Vignette\n- **Patient:** ì–´ë¦° ë‚¨ìì•„ì´ (Young boy). (X-linked)\n- **Symptoms:** í•™êµì—ì„œ ë¬¸ì œ í–‰ë™(Behavioral changes), ì„±ì  í•˜ë½, ì‹œì²­ê° ë¬¸ì œ ë°œìƒ.\n- **Physical Exam:** **Hyperpigmentation** (í”¼ë¶€ê°€ íƒœë‹í•œ ê²ƒì²˜ëŸ¼ ê¹Œë§£ê²Œ ë³€í•¨).\n### 5.2 Pathophysiology\n- **Defect:** Peroxisomeì˜ ë¬¸ì œë¡œ **Very Long Chain Fatty Acids (VLCFA)**ë¥¼ ë¶„í•´í•˜ì§€ ëª»í•¨.\n- **Effect:**\n    1. **Leuko- (Brain):** White matterì— ìŒ“ì—¬ì„œ Demyelination (ì¸ì§€ê¸°ëŠ¥ ì €í•˜).\n    2. **Adreno- (Adrenal):** ë¶€ì‹ (Adrenal cortex)ì— ìŒ“ì—¬ì„œ ë¶€ì‹  ê¸°ëŠ¥ ë¶€ì „ â†’ ACTH ì¦ê°€ â†’ MSH íš¨ê³¼ë¡œ í”¼ë¶€ ì¹¨ì°©(Tan skin).","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-293","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","pathophysiology","mnemonic"]}
{"chunk_type":"recap_summary","text":"### ğŸ”¥ RAPID FIRE RECAP: Diagnosis Buzzwords ğŸ”¥\n| **Disease** | **Clinical Buzzword / Vignette** | **Key Diagnostic Finding** |\n| --- | --- | --- |\n| **Multiple Sclerosis** | Painful eye movement, Electric shock (Lhermitte), Heat sensitivity (Uhthoff) | MRI: **Dawson Fingers** (Periventricular), LP: **Oligoclonal Bands** |\n| **Optic Neuritis** | Washed out colors (Red desaturation), APD | Swing Flashlight Test (+) |\n| **NMO (Devic's)** | Intractable **Hiccups**, Bilateral severe vision loss | **Anti-AQP4 Antibody** |\n| **Transverse Myelitis** | Defined **Sensory Level**, Bladder dysfunction | MRI Spine: Cord inflammation |\n| **Guillain-BarrÃ©** | Ascending paralysis, No reflexes (**Areflexia**) | CSF: **High Protein, Normal Cell** (Albuminocytologic Dissociation) |\n| **CPM (ODS)** | Hyponatremia corrected too fast, \"Locked-in\" | MRI: Hyperintensity in Pons |\n| **ALD** | School failure in boy + **Tanned skin** | **VLCFA** accumulation |\n### ğŸ’¡ Meta-Cognitive Reflection\n- **Confidence:** 1.0 (All requested details covered).\n- **Key Caveat:** MS ì¹˜ë£Œì œ ì¤‘ **Natalizumab**ì€ PML (JC virus reactivation) ìœ„í—˜ì´ ìˆìœ¼ë‹ˆ ì£¼ì˜í•´ì•¼ í•©ë‹ˆë‹¤. ì‹œê°ì  ë¬¸ì œ(Vision loss)ê°€ ì˜¤ë©´ ë‹¨ìˆœíˆ ëˆˆ ë¬¸ì œë¡œë§Œ ë³´ì§€ ë§ê³  ì‹ ê²½ê³„(CNS) ë¬¸ì œì¸ì§€ ê¼­ **Pupil**ì„ í™•ì¸í•˜ì„¸ìš”!","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-310","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","recap","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"# LM_Neuro 3\n**Overview: High-Yield Peripheral Neurology & MND**\n| **Disease Entity** | **Key Mechanism/Presentation** | **Gold Standard Dx / Key Lab** | **Treatment / Next Step** |\n| --- | --- | --- | --- |\n| **UMN Lesion** | Spasticity, Hyperreflexia, Babinski (+) | Clinical Exam (Pronator Drift) | MRI Brain/Spine |\n| **LMN Lesion** | Flaccidity, Atrophy, Fasciculations | Clinical Exam | EMG/NCS |\n| **ALS** | **Mixed UMN + LMN** (often same limb) | EMG (Widespread denervation) | Riluzole, NIV (BiPAP) |\n| **GBS** | Ascending paralysis, Areflexia | LP: Albuminocytologic dissociation | **IVIG or Plasmapheresis** (NO Steroids!) |\n| **Tick Paralysis** | Rapid Ascending paralysis | Find the Tick! | **Remove Tick** (Cure) |\n| **CIDP** | Chronic GBS (>8 weeks) | Nerve Conduction Study | **Steroids** (Differs from GBS) |\n| **Bell's Palsy** | Unilateral facial droop + **Forehead** | Clinical (excludes stroke) | Steroids +/- Acyclovir, Eye care |\n| **Stroke (Face)** | Lower face droop, **Forehead Spared** | MRI Brain | Stroke Protocol |\n### 1. DECOMPOSE: The Neurology Logical Framework (Top-Down Classification)\nì˜í•™ í•™ìŠµì˜ í•µì‹¬ì¸ **Big Picture**ë¥¼ ë¨¼ì € ì¡ê³  ê°‘ì‹œë‹¤! ğŸ§  ì‹ ê²½ê³„ ì§ˆí™˜ì€ ìœ„ì¹˜ì— ë”°ë¼ ì¦ìƒì´ ì™„ì „íˆ ë‹¬ë¼ì§€ê¸° ë•Œë¬¸ì—, ì´ êµ¬ì¡°ë¥¼ ë¨¸ë¦¿ì†ì— ë„£ê³  ì‹œì‘í•´ì•¼ í•©ë‹ˆë‹¤.\nPlaintext\n#\n`NERVOUS SYSTEM PATHOLOGY\nâ”‚\nâ”œâ”€â”€ CENTRAL NERVOUS SYSTEM (UMN: The \"Boss\")\nâ”‚   â”‚   (Brain & Spinal Cord)\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Stroke (Cortex)\nâ”‚   â”œâ”€â”€ Multiple Sclerosis (White Matter)\nâ”‚   â”œâ”€â”€ Spinal Cord Compression (e.g., Cervical Stenosis)\nâ”‚   â””â”€â”€ B12 Deficiency (Subacute Combined Degeneration)\nâ”‚\nâ”œâ”€â”€ PERIPHERAL NERVOUS SYSTEM (LMN: The \"Worker\")\nâ”‚   â”‚   (Anterior Horn Cell -> Nerve Root -> Nerve -> NMJ -> Muscle)\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Anterior Horn Cell: Polio, SMA\nâ”‚   â”œâ”€â”€ Nerve Root: Radiculopathy (Herniated Disc)\nâ”‚   â”œâ”€â”€ Peripheral Nerve:\nâ”‚   â”‚   â”œâ”€â”€ Polyneuropathy: GBS, CIDP, Diabetic Neuropathy\nâ”‚   â”‚   â””â”€â”€ Mononeuropathy: Bell's Palsy, Carpal Tunnel\nâ”‚   â”œâ”€â”€ NMJ: Myasthenia Gravis, Lambert-Eaton\nâ”‚   â””â”€â”€ Muscle: Polymyositis, Duchenne\nâ”‚\nâ””â”€â”€ THE HYBRID (UMN + LMN)\n    â””â”€â”€ Amyotrophic Lateral Sclerosis (ALS) â˜…â˜…â˜…`\n### 3. SOLVE: Detailed Lecture Notes ğŸ“\n### Section 1: The Foundation - UMN vs. LMN (The Wiring Diagram) ğŸ”Œ\nì‹ ê²½ê³¼ë¥¼ ì •ë³µí•˜ë ¤ë©´ ì´ \"ë°°ì„ ë„(Wiring)\"ë¥¼ ì´í•´í•´ì•¼ í•©ë‹ˆë‹¤. ì˜¤ë””ì˜¤ì—ì„œëŠ” **Boss vs. Worker** ë¹„ìœ ë¥¼ ì‚¬ìš©í–ˆìŠµë‹ˆë‹¤.\n- **UMN (Upper Motor Neuron - The Boss):** ë‡Œì—ì„œ ì²™ìˆ˜ê¹Œì§€ ëª…ë ¹ì„ ë‚´ë¦¬ëŠ” ì¡´ì¬.\n    - **ì—­í• :** ê·¼ìœ¡ì—ê²Œ \"ì›€ì§ì—¬\"ë¼ê³  ëª…ë ¹ë„ í•˜ì§€ë§Œ, **\"ì§„ì •í•´(Inhibit)\"**ë¼ê³  ì–µì œí•˜ëŠ” ì—­í• ì´ í•µì‹¬!\n    - **ì†ìƒ ì‹œ:** ì–µì œí•˜ëŠ” ë³´ìŠ¤ê°€ ì‚¬ë¼ì§ â†’  ê·¼ìœ¡ì´ ë¯¸ì³ ë‚ ëœ€.\n    - **ì¦ìƒ:** Spasticity (ë‹¨ë‹¨í•¨), Hyperreflexia (ë°˜ì‚¬ í•­ì§„), Babinski sign (+).\n- **LMN (Lower Motor Neuron - The Worker):** ì²™ìˆ˜ì—ì„œ ê·¼ìœ¡ìœ¼ë¡œ ì§ì ‘ ì—°ê²°ë˜ëŠ” ì¼ê¾¼.\n    - **ì—­í• :** ì „ë ¥ì„ ê³µê¸‰í•˜ê³  ì‹¤ì œë¡œ ì›€ì§ì´ê²Œ í•¨.\n    - **ì†ìƒ ì‹œ:** ì „ë ¥ ê³µê¸‰ ì°¨ë‹¨ â†’  ê·¼ìœ¡ì´ êµ¶ì–´ ì£½ìŒ.\n    - **ì¦ìƒ:** Flaccidity (íë¬¼íë¬¼), Atrophy (ìœ„ì¶•), Fasciculations (ì›€ì°”ê±°ë¦¼ - ì£½ì–´ê°€ëŠ” ì‹ í˜¸), Reflex ì†Œì‹¤.\n**ğŸ§ª Clinical Test: Pronator Drift (The Subtle UMN Detector)**\n- **ë°©ë²•:** í™˜ìê°€ ëˆˆì„ ê°ê³  ì†ë°”ë‹¥ì„ í•˜ëŠ˜ë¡œ í–¥í•˜ê²Œ(Pizza box ë“¤ë“¯ì´) íŒ”ì„ ë»—ìŒ.\n- **ì–‘ì„±(Positive):** íŒ”ì´ ì•„ë˜ë¡œ ë–¨ì–´ì§€ë©´ì„œ **ì†ë°”ë‹¥ì´ ì•ˆìª½ìœ¼ë¡œ ëŒì•„ê°(Pronation)**.\n- **ì˜ë¯¸:** Supinator(ì†ë°”ë‹¥ì„ ìœ„ë¡œ í•˜ëŠ” ê·¼ìœ¡)ê°€ Pronator(ì•„ë˜ë¡œ í•˜ëŠ” ê·¼ìœ¡)ë³´ë‹¤ ê¸°ëŠ¥ì ìœ¼ë¡œ ì•½í•´ì¡Œë‹¤ëŠ” ëœ». ì´ëŠ” ë¯¸ì„¸í•œ **UMN Lesion**ì„ ì¡ì•„ë‚´ëŠ” ìµœê³ ì˜ ì‹ ì²´ ê²€ì§„ì…ë‹ˆë‹¤!","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-1","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"### Section 2: The Diabetic Trap ğŸ¬ğŸ©¸\n*ë§ì€ í•™ìƒë“¤ì´ ì—¬ê¸°ì„œ í•¨ì •ì— ë¹ ì§‘ë‹ˆë‹¤! ì£¼ì˜í•˜ì„¸ìš”!* ğŸš¨\n- **Scenario:** ë‹¹ë‡¨ë³‘ í™˜ìê°€ ë°œì´ ì €ë¦¬ê³ (Burning, Tingling) ê°ê°ì´ ì—†ë‹¤ê³  ì˜´.\n- **Typical Thought:** \"ì•„, ë‹¹ë‡¨ë³‘ì„± ë§ì´ˆì‹ ê²½ë³‘ì¦(Diabetic Neuropathy)ì´ë„¤. Gabapentin ì£¼ì.\"\n- **THE TRAP:** ë§Œì•½ ë¬´ë¦ ë°˜ì‚¬ë¥¼ ì³¤ëŠ”ë° ë‹¤ë¦¬ê°€ **íŒ! íŠ€ì–´ë‚˜ê°„ë‹¤ë©´(Hyperreflexia)**? í˜¹ì€ ë°œë°”ë‹¥ì„ ê¸ì—ˆë”ë‹ˆ ì—„ì§€ê°€ ì˜¬ë¼ê°„ë‹¤ë©´(Babinski)?\n    - ë‹¹ë‡¨ë³‘ì„± ì‹ ê²½ë³‘ì¦ì€ ë§ì´ˆ ì‹ ê²½(LMN) ë¬¸ì œì´ë¯€ë¡œ ë°˜ì‚¬ê°€ ë–¨ì–´ì ¸ì•¼ ì •ìƒì…ë‹ˆë‹¤.\n    - **â˜… KEY POINT:** ë‹¹ë‡¨ í™˜ìì—ê²Œ **UMN Sign (Hyperreflexia, Babinski)**ì´ ë³´ì´ë©´ ì ˆëŒ€ ë‹¹ë‡¨ íƒ“ì„ í•˜ë©´ ì•ˆ ë¨!\n    - **â˜… Next Best Step:** **MRI of the Spine**. (Cervical/Thoracic Cord Compression, Tumor, or Disc Herniationì„ ì˜ì‹¬í•´ì•¼ í•¨). Burning feet ê³¼ ë‹¤ë¥¸ ì²™ì¶” ì‹ ê²½ê³„ ì§ˆí™˜ì´ ê°™ì´ ì˜¨ ê²ƒ!\n### Section 3: ALS (Amyotrophic Lateral Sclerosis) - The Hybrid Monster ğŸ‘¹\n**ğŸšª Doorway Thought (Room 2):**\në‚˜ì´ ë“  í™˜ì. ì˜¤ë¥¸ì†ì´ ë‘”í•˜ê³  ì•½í•´ì§(Clumsy). ìì„¸íˆ ë³´ë‹ˆ ê·¼ìœ¡ì´ ë§ëê³ (Atrophy), í”¼ë¶€ ë°‘ì—ì„œ ê·¼ìœ¡ì´ ê¿ˆí‹€ê±°ë¦¼(Fasciculations - **LMN**). ê·¸ëŸ°ë° ìµœê·¼ì— ë¬¼ ë§ˆì‹¤ ë•Œ ì‚¬ë ˆê°€ ë“¤ë¦¼(Swallowing issue).\n**1. Concept & Pathophysiology**\n- **Rule Breaker:** ì‹ ê²½ê³¼ ì§ˆí™˜ì€ ë³´í†µ UMN ì•„ë‹ˆë©´ LMNì¸ë°, ALSëŠ” **ë‘˜ ë‹¤(Both)** ë™ì‹œì— ë‚˜íƒ€ë‚©ë‹ˆë‹¤.\n- **Clinical Signature:** í•œ íŒ”ì—ì„œ **Wasted muscle (LMN)**ì„ ë³´ëŠ”ë°, ê·¸ íŒ”ì˜ ë°˜ì‚¬ë¥¼ ì¹˜ë©´ **Hyperactive (UMN)** ë°˜ì‘ì´ ë‚˜ì˜´. â†’  ì´ê±´ 100% ALS ì‹œì‚¬.\n- **Bulbar Symptoms:** ë‡Œê°„(Brainstem)ì˜ ìš´ë™ ì‹ ê²½ì„¸í¬ê°€ ì£½ìœ¼ë©´ì„œ ì‚¼í‚´ ê³¤ë€(Dysphagia), ë°œìŒ ì¥ì• (Dysarthria) ë°œìƒ. â†’  í¡ì¸ì„± íë ´(Aspiration Pneumonia)ì´ ì£¼ ì‚¬ë§ ì›ì¸.\n**2. Diagnosis & Treatment**\n- **â˜… Gold Standard Dx:** **EMG (Electromyography)**. ì „ì‹ ì˜ ê´‘ë²”ìœ„í•œ íƒˆì‹ ê²½(Widespread Denervation) ì†Œê²¬ì„ í™•ì¸.\n- **Tx:** **Riluzole** (Glutamate Inhibitor).\n    - ê¸°ì „: ê³¼ë„í•œ Glutamateê°€ ì‹ ê²½ì„ í¥ë¶„ì‹œì¼œ ì£½ì´ëŠ” ê²ƒ(Excitotoxicity)ì„ ë§‰ìŒ. ìƒëª…ì„ ì•½ê°„ ì—°ì¥í•¨.\n- **Supportive:** í˜¸í¡ ê·¼ìœ¡ì´ ì•½í•´ì§€ë¯€ë¡œ **NIV (Non-invasive Ventilation, e.g., BiPAP)**ê°€ ìƒì¡´ìœ¨ê³¼ ì‚¶ì˜ ì§ˆì— ê°€ì¥ ì¤‘ìš”í•¨.\n### Section 4: Guillain-Barre Syndrome (GBS) - The Ascending Nightmare ğŸªœ\n**ğŸšª Doorway Thought (Room 1):**\nì Šì€ ë‚¨ì. 2ì£¼ ì „ì— ì„¤ì‚¬ë³‘(Stomach bug) ì•“ìŒ. ë‹¤ ë‚«ë‚˜ ì‹¶ë”ë‹ˆ ë°œê°€ë½ì´ ì €ë¦¬ê³  í˜ì´ ë¹ ì§. ì´ í˜ ë¹ ì§ì´ ì ì  ë‹¤ë¦¬ ìœ„ë¡œ ì˜¬ë¼ì˜´(**Ascending Weakness**).\n**1. Pathophysiology: Molecular Mimicry ğŸ­**\n- **ì›ì¸ê· :** *Campylobacter jejuni* (ê°€ì¥ í”í•¨, ëœ ìµì€ ë‹­ê³ ê¸° ë“±), Viral illness.\n- **ê¸°ì „:** ë©´ì—­ ì²´ê³„ê°€ ê· ì„ ê³µê²©í•˜ë ¤ê³  í•­ì²´(Antibody)ë¥¼ ë§Œë“¤ì—ˆëŠ”ë°, ì´ í•­ì²´ê°€ ë§ì´ˆ ì‹ ê²½ì˜ ìˆ˜ì´ˆ(Myelin Sheath)ë¥¼ ê· ìœ¼ë¡œ ì°©ê°í•˜ê³  ê³µê²©í•¨.\n- **ê²°ê³¼:** ì „ì„  í”¼ë³µì´ ë²—ê²¨ì§ â†’  ì‹ ê²½ ì „ë„ ì°¨ë‹¨.\n**2. Clinical Presentation**\n- **Ascending Paralysis:** ë°œ â†’  ë‹¤ë¦¬ â†’  íŒ” â†’  í˜¸í¡ê·¼ (Diaphragm). í˜¸í¡ ë§ˆë¹„ê°€ ì˜¤ë©´ ì‚¬ë§ ê°€ëŠ¥!\n- **Areflexia:** LMN ë¬¸ì œì´ë¯€ë¡œ ì‹¬ë¶€ ê±´ ë°˜ì‚¬(DTR)ê°€ **ì™„ì „íˆ ì‚¬ë¼ì§**. (ë¬´ë¦ ì³ë„ ë°˜ì‘ ì—†ìŒ).\n**3. Diagnosis**","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-21","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"- **Lumbar Puncture (LP):** **Albuminocytologic Dissociation** (ë‹¨ë°±ì„¸í¬ í•´ë¦¬).\n    - Protein: **HIGH** (ì—¼ì¦ìœ¼ë¡œ ë‹¨ë°±ì§ˆ ìœ ì¶œ).\n    - WBC (Cell count): **NORMAL** (ì´ê²Œ í•µì‹¬! ë§Œì•½ WBCê°€ ë†’ìœ¼ë©´ ê°ì—¼/ì•” ì˜ì‹¬).\n**4. Treatment (High Yield!)**\n- **â˜… Gold Standard Tx:** **IVIG (Immunoglobulin)** or **Plasmapheresis** (í˜ˆì¥êµí™˜ìˆ  - ë‚˜ìœ í•­ì²´ë¥¼ ê±¸ëŸ¬ëƒ„).\n- **â˜… WARNING:** **Steroids (Prednisone) DO NOT WORK!** ì ˆëŒ€ ì£¼ë©´ ì•ˆ ë¨. (ì˜¤íˆë ¤ íšŒë³µì„ ë°©í•´í•  ìˆ˜ë„ ìˆìŒ).\n- **Vital Sign:** í˜¸í¡ ê¸°ëŠ¥(FVC, NIF) ëª¨ë‹ˆí„°ë§ í•„ìˆ˜. ìˆ¨ ëª» ì‰¬ë©´ ë°”ë¡œ ì‚½ê´€(Intubation).\n### Section 5: The Imposters (GBS Look-alikes) ğŸ•µï¸\n| **Disease** | **Key Feature** | **Diagnosis/Treatment** |\n| --- | --- | --- |\n| **Tick Paralysis** | **Rapidly** Ascending Paralysis (ì‹œê°„/ì¼ ë‹¨ìœ„, GBSë³´ë‹¤ ë¹ ë¦„).\nGBSê³¼ì˜ ì°¨ì´ì : CSFê°€ ì •ìƒ ì†Œê²¬ | **Tx: Remove the Tick!** ğŸ•·ï¸ (ì°¾ì•„ì„œ ë½‘ìœ¼ë©´ ë°”ë¡œ ë‚˜ìŒ) (ê·€ ë’¤ì— ìˆì„ìˆ˜ë„) |\n| **CIDP** | **Chronic** GBS. ì¦ìƒì´ **8ì£¼ ì´ìƒ** ì§€ì†ë¨. | **Tx: Steroids** work here! (GBSì™€ ê°€ì¥ í° ì°¨ì´ì ). |\n| **Miller Fisher** | GBSì˜ ì‚¬ì´Œ. **Triad:** 1. Ophthalmoplegia (ëˆˆ ë§ˆë¹„) 2. Ataxia (ë¹„í‹€ê±°ë¦¼) 3. Areflexia.\nâ€eye wobble, body wobble, no reflexâ€ | antibody: **Anti-GQ1b**. |\n### Section 6: Facial Nerve Palsy (Bell's vs. Stroke) ğŸ­\n**ğŸšª Doorway Thought (Room 3):**\nì¤‘ë…„ ì—¬ì„±, íŒ¨ë‹‰ ìƒíƒœ. ì•„ì¹¨ì— ì¼ì–´ë‚¬ëŠ”ë° ì™¼ìª½ ëˆˆì´ ì•ˆ ê°ê¸°ê³ , ì™¼ìª½ ì–¼êµ´ì´ ì³ì§. ì›ƒìœ¼ë ¤ê³  í•˜ë‹ˆ ì™¼ìª½ ì…ìˆ ì´ ì•ˆ ì›€ì§ì„. \"ì € ë‡Œì¡¸ì¤‘(Stroke) ì¸ê°€ìš”?\"\n**1. The Forehead Rule (ì ˆëŒ€ ì•”ê¸°!) â­**\nì–¼êµ´ ì‹ ê²½ í•´ë¶€í•™ ë•Œë¬¸ì— ë°œìƒí•˜ëŠ” í˜„ìƒì…ë‹ˆë‹¤.\n- **Upper Face (ì´ë§ˆ):** ë‡Œì˜ **ì–‘ìª½(Bilateral)**ì—ì„œ ì‹ í˜¸ë¥¼ ë°›ìŒ. (Backup Generator ìˆìŒ).\n- **Lower Face (ì…):** ë‡Œì˜ **ë°˜ëŒ€ìª½(Contralateral)**ì—ì„œë§Œ ì‹ í˜¸ë¥¼ ë°›ìŒ.\n**2. Differentiation Table**\n| **Feature** | **Bell's Palsy (LMN / Peripheral)** | **Stroke (UMN / Central)** |\n| --- | --- | --- |\n| **Pathology** | Facial Nerve (CN VII) ìì²´ì˜ ì—¼ì¦/ì••ë°•. | ë‡Œ(Cortex)ì˜ ê²½ìƒ‰/ì¶œí˜ˆ. |\n| **Forehead** | **Involved (ì´ë§ˆ ì£¼ë¦„ ëª» ì¡ìŒ)**. ğŸ˜¥ | **Spared (ì´ë§ˆ ì£¼ë¦„ ì¡ì„ ìˆ˜ ìˆìŒ)**. ğŸ¤¨ |\n| **Eye Closure** | ëˆˆì„ ëª» ê°ìŒ (ì•ˆêµ¬ ê±´ì¡° ìœ„í—˜). | ëˆˆ ê°ì„ ìˆ˜ ìˆìŒ (ë³´í†µ). |\n| **Treatment** | Steroids +/- Acyclovir (if viral suspected)\n**Eye Patch/Lubrication** (ì˜ ë•Œ ëˆˆ ë³´í˜¸ í•„ìˆ˜!). â˜…  | Stroke Protocol (MRI, tPA etc.) |\n- **Tip:** í™˜ìê°€ ëˆˆì¹ì„ ì¹˜ì¼œì˜¬ë¦´ ìˆ˜ ìˆë‹¤ë©´(ì´ë§ˆ ì£¼ë¦„ ê°€ëŠ¥) â†’  **STROKE ALERT!** ğŸš¨ (ë‡Œ ì•ˆìª½ ë¬¸ì œë¼ì„œ ë°±ì—… ì‹œìŠ¤í…œì´ ì‘ë™í•œ ê²ƒ).\n- ì•„ì˜ˆ ë‹¤ ë§ˆë¹„ê°€ ë˜ë©´? ì•ˆì¢‹ì•„ë³´ì´ëŠ”ê²Œ ì˜¤íˆë ¤ ì¢‹ì€ê±°ì„.\n- **Lyme Disease**\n    - ì–‘ìª½ì— ì˜¤ê±°ë‚˜, Bullâ€™s eyeê°€ ìˆê±°ë‚˜, ë“±ì‚°í•œ ì´ë ¥ì´ ìˆìœ¼ë©´ ì˜ì‹¬ â˜…\n    - ì–‘ìª½(Bilateral) Bell's Palsyê°€ ì˜¤ë©´ **Lyme Disease** (Borrelia burgdorferi)ë¥¼ ì˜ì‹¬í•´ì•¼ í•¨!\n    - ì˜ì‹¬í•´ì•¼ë˜ëŠ” ì´ìœ : ì¹˜ë£Œê°€ ë‹¬ë¼ì§€ê¸° ë•Œë¬¸ â˜…\n        - Lymeì—ì„œëŠ” ìŠ¤í…Œë¡œì´ë“œ ì£¼ì§€ ì•ŠìŒ (ê°ì—¼ì´ê¸° ë•Œë¬¸)\n        - Doxycycline\n### Section 7: Distal symmetric polyneuropathy\n- stocking and gloves pattern\n    - length dependent: toe ë¶€í„° ì‹œì‘\n- most common seen in clinics\n- Causes:\n    - DM\n    - Uremia (CKD)\n    - Chemotherapy drugs (Cisplatin, Paclitaxel)\n    - HIV (long standing)\n- Management:\n    - Symptoms only: Gabapentin","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-41","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"recap_summary","text":"### 4. RAPID FIRE RECAP: Key Associations ğŸ”¥\n- **Ascending Weakness + Diarrhea hx + CSF high protein normal WBC** â†’  **GBS** (Campylobacter). â†’ ìŠ¤í…Œë¡œì´ë“œ ì•ˆì¤Œ â˜… ! IVIG + plasmaphresis\n- **Ascending Weakness + Camping/Hiking + CSF normal + no fever** â†’  **Tick Paralysis** (Look for the tick!).\n- **Chronic GBS (>8 weeks)** â†’  **CIDP** (Give Steroids).\n- **Atrophy + Hyperreflexia (Mixed)** â†’  **ALS**.\n- **Diabetic with Hyperreflexia** â†’  **Spinal Cord Compression** (MRI Spine).\n- **Facial Droop + Forehead Wrinkles SPARED** â†’  **Stroke**.\n- **Facial Droop + Can't wrinkle forehead** â†’  **Bell's Palsy â†’ eye protection**\n- Facial Droop + Hiker â†’ r/o Lyme â†’ Doxycycline\n- Pronator drift â†’ UMN lesion (í”¼ìê°€ ì—ì–´ì§)\n### 5. SYNTHESIZE & REFLECT\n- **Caveats:** Audio specifically emphasizes avoiding steroids in GBS but using them in CIDP. Don't mix this up! Also, the distinction between \"Sparing the forehead\" (Central/Stroke) and \"Involving the forehead\" (Peripheral/Bell's) is the most common pimping question in neurology rotation. Memorize the wiring diagram!\n**Next Step for User:** Would you like me to create a detailed **Question Bank (Q-Bank)** style quiz based on these specific clinical vignettes to test your retention?\n### ğŸ“‹ Overview (TL;DR)","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-61","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","recap","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"ì˜¤ëŠ˜ì˜ **Deep Dive**ëŠ” USMLE Step 2 CKì˜ **High-Yield** í† í”½ì¸ **CNS Infections**ë¥¼ ë‹¤ë£¹ë‹ˆë‹¤. ë‹¨ìˆœí•œ ì•”ê¸°ê°€ ì•„ë‹ˆë¼, ë³‘ë™ ë³µë„ì—ì„œ í™˜ìë¥¼ ë§ˆì£¼ì³¤ì„ ë•Œ(**Doorway Thought**) ì–´ë–¤ ì§ê´€ì„ ê°€ì ¸ì•¼ í•˜ëŠ”ì§€ë¶€í„° ì‹œì‘í•˜ì—¬, **Meningitis, PML, Brain Abscess, Spinal Epidural Abscess**ê¹Œì§€ ì™„ë²½í•˜ê²Œ ì •ë¦¬í•©ë‹ˆë‹¤.\n- **PML**: CD4 < 200, **Non-enhancing** lesion. TreatmentëŠ” ì˜¤ì§ ë©´ì—­ë ¥ íšŒë³µë¿.\n- **Meningitis**: LP ê²°ê³¼ í•´ì„ì´ í•µì‹¬(Neutrophils vs Lymphocytes). SteroidëŠ” í•­ìƒì œ **ì „**ì—.\n- **Brain Abscess**: Ring-enhancing. **Lumbar Puncture ê¸ˆê¸°**.\n- **Spinal Epidural Abscess**: Back pain + Fever + Neuro deficit. **MRI Spine**ì´ ì •ë‹µ. **NEVER LP**.\n### ğŸŒ³ Top-down Classification (Structure)\nì´ ê°•ì˜ì˜ êµ¬ì¡°ë¥¼ í•œëˆˆì— ë³¼ ìˆ˜ ìˆëŠ” **ASCII Text Tree**ì…ë‹ˆë‹¤. ìš°ë¦¬ê°€ ì–´ë””ë¥¼ í•­í•´í•˜ê³  ìˆëŠ”ì§€ í™•ì¸í•˜ì„¸ìš”! ğŸ—ºï¸\nPlaintext\n#\n`CNS INFECTIONS (Deep Dive Map)\n+-- 1. THE DOORWAY THOUGHT (Mental Model & Triage)\n|   +-- Patient A: Meningitis (Stiff neck, Photophobia)\n|   +-- Patient B: Epidural Abscess (Focal back pain, IVDU)\n|\n+-- 2. PARENCHYMAL / WHITE MATTER DISEASE\n|   +-- PML (Progressive Multifocal Leukoencephalopathy)\n|       +-- Concept: JC Virus Reactivation (CD4 < 200)\n|       +-- Imaging: Non-enhancing white matter lesions\n|       +-- Mgmt: Anti-retroviral Therapy (ART)\n|\n+-- 3. MENINGEAL DISEASE (The Heavyweight Champion ğŸ¥Š)\n|   +-- Meningitis Types\n|   |   +-- Bacterial (Neutrophils, Low Glucose)\n|   |   +-- Viral (Lymphocytes, Normal Glucose)\n|   |   +-- TB (Lymphocytes, Very Low Glucose, High Protein)\n|   +-- Management Rules\n|       +-- CT before LP? (FAILS Mnemonic)\n|       +-- Empiric Abx (Vanc + Ceftriaxone +/- Ampicillin)\n|       +-- Steroids (Timing is key!)\n|\n+-- 4. FOCAL MASS LESIONS (Space Occupying)\n|   +-- Brain Abscess\n|       +-- Image: Ring-enhancing lesion\n|       +-- Rule: LP is CONTRAINDICATED â›”\n|       +-- Tx: Drainage + Abx\n|\n+-- 5. SPINAL CORD EMERGENCIES\n    +-- Spinal Epidural Abscess (SEA)\n        +-- Triad: Fever + Back Pain + Neuro Deficit\n        +-- Dx: MRI Spine (Gold Standard) â˜…\n        +-- Tx: Decompression (Surgery) + Abx`\n### ğŸ§  1. The Doorway Thought (Visualizing the Patient)\nì˜¤ë””ì˜¤ì—ì„œëŠ” **\"Doorway Thought\"**ë¼ëŠ” ë©˜íƒˆ ëª¨ë¸ì„ ì œì‹œí•©ë‹ˆë‹¤. ë³‘ì‹¤ ë¬¸ ì•ì— ì„°ì„ ë•Œ, í™˜ìì˜ ì²«ì¸ìƒë§Œìœ¼ë¡œ ê°ë³„ì§„ë‹¨ì„ ì‹œì‘í•˜ëŠ” í›ˆë ¨ì…ë‹ˆë‹¤.\n**Scenario A (Room A)**\n- **Patient:** 20ëŒ€ ëŒ€í•™ìƒ ğŸ§‘â€ğŸ“\n- **Sx:** High fever, Stiff neck (Nuchal rigidity), ì²œì¥ì˜ ë¶ˆë¹›ì„ ëª» ì³ë‹¤ë´„ (**Photophobia**).\n- **Impression:** ì „í˜•ì ì¸ **Meningitis**. ë‡Œê°€ ë¹„ëª…ì„ ì§€ë¥´ê³  ìˆìŒ. \"Lumbar Puncture!\"ë¥¼ ì™¸ì³ì•¼ í•¨.\n**Scenario B (Room B)**\n- **Patient:** IV Drug User (ê³¼ê±°ë ¥ ìˆìŒ) ğŸ’‰\n- **Sx:** Fever, Neck stiffnes ì—†ìŒ, Photophobia ì—†ìŒ. í•˜ì§€ë§Œ **ë“±ì˜ í•œ ê³³ì„ ì°Œë¥´ëŠ” ë“¯í•œ ê·¹ì‹¬í•œ í†µì¦ (Excruciating stabbing pain in one spot on the back)**.\n- **Impression:** ì´ê²ƒì€ **Spinal Epidural Abscess**.\n- **Danger:** ì´ ë‘˜ì„ êµ¬ë¶„ ëª»í•˜ë©´ í°ì¼ ë‚¨. í•˜ë‚˜ëŠ” ë‡Œ íƒˆì¶œ(Herniation), í•˜ë‚˜ëŠ” ì²™ìˆ˜ ë§ˆë¹„(Paralysis)ë¥¼ ìœ ë°œí•¨.\n### ğŸ¦  2. PML (Progressive Multifocal Leukoencephalopathy)\n**\"The Failure of Surveillance\"**\nëª¸ì˜ ê°ì‹œ ì²´ê³„ê°€ ë¬´ë„ˆì¡Œì„ ë•Œ(Immunosuppression) ë°œìƒí•˜ëŠ” ì§ˆí™˜ì…ë‹ˆë‹¤.\n- **Pathophysiology:**\n    - **JC Virus**ì˜ ì¬í™œì„±í™” (Reactivation). ëŒ€ë¶€ë¶„ì˜ ì‚¬ëŒë“¤ì€ ì´ë¯¸ ì´ ë°”ì´ëŸ¬ìŠ¤ë¥¼ ê°€ì§€ê³  ìˆì§€ë§Œ(Dormant), ë©´ì—­ê³„ê°€ ì–µì œí•˜ê³  ìˆìŒ.\n    - ë©´ì—­ì´ ë°”ë‹¥ì„ ì¹˜ë©´(CD4 < 200, Untreated AIDS), ë°”ì´ëŸ¬ìŠ¤ê°€ ê¹¨ì–´ë‚˜ ë‡Œì˜ ì‹ ê²½ì„ ê°ì‹¼ ì ˆì—°ì²´(Myelin)ë¥¼ ë²—ê²¨ë¨¹ê¸° ì‹œì‘í•¨ (**Demyelinating disease**).\n- **Clinical Presentation:**\n    - í­ë°œì ì¸ ì¦ìƒì´ ì•„ë‹˜. ì„œì„œíˆ ë‚˜ë¹ ì§ (**Insidious onset**).\n    - **Clumsy worsening**: Confusion, Paresis, Weakness, Ataxia, Vision changes.\n    - Meningitisì²˜ëŸ¼ ê¸‰ì„±ì´ ì•„ë‹˜.\n- **Diagnosis (Imaging is KEY ğŸ”‘):**\n    - **MRI Brain:** **Asymmetric White Matter Lesions**.\n    - **â˜… CRITICAL POINT:** ì´ ë³‘ë³€ì€ **Enhancement(ì¡°ì˜ ì¦ê°•)ê°€ ì—†ìŒ (Non-enhancing)**. Edema(ë¶€ì¢…)ë„ ì—†ìŒ.\n    - **Why?** EnhancementëŠ” ì—¼ì¦ ë°˜ì‘ìœ¼ë¡œ í˜ˆë¥˜ê°€ ëª°ë¦¬ëŠ” ê²ƒì¸ë°, PML í™˜ìëŠ” ë©´ì—­ê³„ê°€ ë„ˆë¬´ ì•½í•´(CD4 < 200) ì‹¸ì›€ì„ ê±¸ì§€ ëª»í•¨ -> ê·¸ë˜ì„œ ì¡°ì˜ ì¦ê°•ì´ ì•ˆ ë¨.\n        - *Contrast:* Ring-enhancing lesionì´ ë³´ì´ë©´? -> **Toxoplasmosis**ë‚˜ **CNS Lymphoma**ë¥¼ ì˜ì‹¬í•´ì•¼ í•¨.\n- **Confirmation:**\n    - **Lumbar Puncture (LP):** CSFì—ì„œ **JC Virus PCR** ì–‘ì„± í™•ì¸.\n    - Gold StandardëŠ” Brain Biopsyì§€ë§Œ, ë³´í†µ CSF PCRë¡œ ì¶©ë¶„í•¨.\n- **Treatment:**\n    - í•­ë°”ì´ëŸ¬ìŠ¤ì œ? NO âŒ. ì§ì ‘ ì£½ì´ëŠ” ì•½ ì—†ìŒ.\n    - **Management:** **Anti-retroviral Therapy (ART)**. í™˜ìì˜ ë©´ì—­ê³„(Immune system)ë¥¼ ë‹¤ì‹œ ì¬ê±´í•´ì„œ ìŠ¤ìŠ¤ë¡œ ì‹¸ìš°ê²Œ ë§Œë“œëŠ” ê²ƒì´ ìœ ì¼í•œ ë°©ë²•.","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-71","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"### ğŸ¥Š 3. Meningitis (The Heavyweight Champion)\nUSMLE ë³´ë“œ ì‹œí—˜ì—ì„œ ê°€ì¥ ë””í…Œì¼í•˜ê²Œ ë¬¼ì–´ë³´ëŠ” íŒŒíŠ¸ì…ë‹ˆë‹¤. **Viral vs. Bacterial vs. TB**ë¥¼ êµ¬ë¶„í•˜ëŠ” ê²ƒì´ í•µì‹¬!\n### ğŸ“Š CSF Analysis Breakdown (The Numbers Game)\n| **Type** | **WBC Count** | **Cell Type** | **Glucose** | **Protein** |\n| --- | --- | --- | --- | --- |\n| **Normal** | 0-5 | - | 40-70 (í˜ˆë‹¹ì˜ 2/3) | < 40 |\n| **Bacterial** ğŸ¦  | > 1,000 (War zone!) | **Neutrophils** â¬†ï¸ | **Low** (< 40) ğŸ”¥ | High (> 250) |\n| **Viral** ğŸ¦  | 100-1,000 (Quieter) | **Lymphocytes** â¬†ï¸ | **Normal** âœ… | Normal/Slight High (< 100) |\n| **TB / Fungal** ğŸ„ | 100-500 | **Lymphocytes** â¬†ï¸ | **Very Low** (< 10) ğŸ“‰ | **Very High** (> 250) ğŸ“ˆ |\n- **Bacterial:** ë°•í…Œë¦¬ì•„ì™€ í˜¸ì¤‘êµ¬(Neutrophil)ê°€ ì„¤íƒ•(Glucose)ì„ ë‹¤ ë¨¹ì–´ì¹˜ì›Œì„œ **Low Glucose**. ì£½ì€ ê· ê³¼ ì„¸í¬ ì‹œì²´ë“¤ ë•Œë¬¸ì— **High Protein**.\n- **Viral:** ë°”ì´ëŸ¬ìŠ¤ëŠ” ì„¤íƒ•ì„ ì•ˆ ë¨¹ìŒ -> **Normal Glucose** (ì´ê²Œ ê°€ì¥ í° íŒíŠ¸! â˜…)\n- **TB:** Lymphocyte + **Super Low Glucose** + High Protein = TB Meningitis.\n### ğŸ’Š Management Strategy (Rapid Fire)\n1. **Empiric Antibiotics (ê²½í—˜ì  í•­ìƒì œ):**\n    - **Standard (Age 2-50):** **Vancomycin + Ceftriaxone**. (Cover S. pneumo & N. meningitidis)\n    - **Age > 50:** ìœ„ ì¡°í•©ì— **+ Ampicillin** ì¶”ê°€ (d/t Listeria: Gram -positive rod)\n    - **Immunocompromised:** Vancomycin + Ampicillin + **Cefepime** (Ceftriaxone ëŒ€ì‹  cefepimeìœ¼ë¡œ ì—…ê·¸ë ˆì´ë“œí•¨. d/t pseudomonas)\n    - Neurosurgery or Trauma: Vancomycin + Cefepime\n2. **Steroids (Dexamethasone):**\n    - ì–¸ì œ? **í•­ìƒì œ ì£¼ê¸° ì „ í˜¹ì€ ë™ì‹œì— (Before or with first dose)**. í•­ìƒì œ ì£¼ê³  ë‚˜ì„œ ì£¼ë©´ íš¨ê³¼ ì—†ìŒ.\n    - ì™œ? ê· ì´ ì£½ìœ¼ë©´ì„œ ìŸì•„ë‚´ëŠ” ì—¼ì¦ ë¬¼ì§ˆì— ì˜í•œ ë‡Œ ì†ìƒ/ì²­ë ¥ ì†ì‹¤ ë°©ì§€ (S. pneumo ì˜ì‹¬ ì‹œ íŠ¹íˆ).\n3. **CT before LP? (Decision Point):**\n    - ì›ì¹™ì ìœ¼ë¡œëŠ” LPë¥¼ ë¹¨ë¦¬ í•´ì•¼ í•˜ì§€ë§Œ, ë‡Œì••ì´ ë†’ì€ ìƒíƒœì—ì„œ ë°”ëŠ˜ì„ ê½‚ìœ¼ë©´ **Brain Herniation** ìœ„í—˜ ìˆìŒ.\n    - **ì–¸ì œ ë‡Œì••ì´ ë†’ì„ì§€ ê±±ì •ë˜ì–´ì„œ CT ì°ì„ì§€ Mnemonic: FAILS**\n    (spinal epidural abscess, brain abscessì¼ë•Œ í•˜ë©´ì•ˆë¨)\n    ****(ì´ ì¤‘ í•˜ë‚˜ë¼ë„ ìˆìœ¼ë©´ CT ë¨¼ì € ì°ì–´ë¼!)\n        - **F** - **F**ocal Neurologic Deficit (ë§ˆë¹„ ë“±) (r/o brain abscess)\n        - **A** - **A**ltered Mental Status (ì˜ì‹ ë³€í™”) (r/o brain abscess)\n        - **I** - **I**mmunosuppression (ë©´ì—­ ì €í•˜) (r/o brain abscess)\n        - **L** - **L**esion (í”¼ë¶€ ë³‘ë³€ ë“±) (puncture site) (r/o spinal epidural abscess)\n        - **S** - **S**eizure (ë°œì‘) (r/o brain abscess)\n        - *Obviously high ICP sign (ìœ ë‘ë¶€ì¢…)*\n4. **Scenario**\n    - Fever, Neck stiffness, alert (ëŒ€ë‹µ ì˜í•¨) : ë°”ë¡œ LP â†’ antibiotics\n    - Confused (Seizure?) or history of HIV? : CT ì´¬ì˜ í›„ LP í•´ì•¼í•¨!\n        - But do no delay treatment!\n        - **Timing:** Blood Culture + Abx ë¨¼ì € ì£¼ê³  -> CT ì°ê³  -> LP\n        (CT ì°ëŠë¼ í•­ìƒì œ ëŠ¦ì¶”ì§€ ë§ˆë¼! â˜…)\n1. **Viralì˜ ê²½ìš°**\n    - ì£¼ë¡œ Conservative Tx.\n    - ì˜ˆì™¸: HSVì˜ì‹¬ë˜ë©´ acyclovir íˆ¬ì—¬\n1. **TBì˜ ê²½ìš°**\n    - Slow burn, chronic\n    - Imaging: basilar meningeal enhancement. (ë°”ë‹¥ì´ ë°ì•„ì§„ë‹¤.)\n        - basilar ì¹¨ë²”!\n        - â†’ cranial nerve palsy\n    - Management: Full anti TB  drugs + Steroids\n### ğŸŒ‹ 4. Brain Abscess (The Pimple in the Brain)\në‡Œ ì‹¤ì§ˆ(Parenchyma) ì•ˆì— ê³ ë¦„ ì£¼ë¨¸ë‹ˆ(Pus pocket)ê°€ ìƒê¸´ ê²ƒ.\n- **Anatomy is Destiny:** ìœ„ì¹˜ë¥¼ ë³´ë©´ ì›ì¸ì„ ì•Œ ìˆ˜ ìˆìŒ.\n    - **Single Lesion:** ì¸ì ‘í•œ ê³³ì—ì„œ ì§ì ‘ ì „íŒŒ (Direct spread).\n        - **Frontal Lobe:** Sinusitis (ë¶€ë¹„ë™ì—¼)ì—ì„œ ë„˜ì–´ì˜´.\n        - **Temporal Lobe / Cerebellum:** Otitis Media (ì¤‘ì´ì—¼) / Mastoiditisì—ì„œ ë„˜ì–´ì˜´.\n    - **Multiple Lesions:** í˜ˆì•¡ íƒ€ê³  ì˜´ (Hematogenous spread).\n        - Endocarditis, Osteomyelitis ë“±.\n        - ì£¼ë¡œ **Grey-White Matter Junction**ì— ìœ„ì¹˜ (í˜ˆê´€ì´ ì¢ì•„ì ¸ì„œ ê· ì´ ê±¸ë¦¬ëŠ” ê³³).\n- **Imaging:**\n    - **Ring-enhancing Lesion** with necrotic center. (ì£¼ë³€ì´ í™˜í•˜ê²Œ ë¹›ë‚˜ëŠ” ê³ ë¦¬ ëª¨ì–‘).\n    - PML(Non-enhancing)ê³¼ ì •ë°˜ëŒ€.\n- **Clinical Triad:**\n    - Headache + Fever + Focal Neuro Deficit. (í•˜ì§€ë§Œ FeverëŠ” 50%ì—ì„œë§Œ ë‚˜íƒ€ë‚¨).\n- **âš ï¸ DO NOT LP (LUMBAR PUNCTURE ê¸ˆê¸°):**\n    - Brain Abscessê°€ ì˜ì‹¬ë˜ë©´ LP ì ˆëŒ€ ê¸ˆì§€. ë‡Œì••ì´ ë†’ì•„ì ¸ **Herniation** ì‚¬ë§ ìœ„í—˜.\n- **Treatment:**\n    - **Aspiration / Surgical Drainage** (ê³ ë¦„ì„ ë¹¼ì•¼ í•¨) + Antibiotics.\n    - í•­ìƒì œë§Œìœ¼ë¡œëŠ” ìº¡ìŠ ë‚´ë¶€ë¡œ ì¹¨íˆ¬ê°€ ì–´ë ¤ì›€.\n### ğŸš¨ 5. Spinal Epidural Abscess (SEA) - A Neurologic Emergency\nì´ê±´ ì •ë§ ë†“ì¹˜ë©´ ì•ˆ ë˜ëŠ” ì‘ê¸‰ ìƒí™©ì…ë‹ˆë‹¤.\n- **Pathology:** Dura(ê²½ë§‰)ì™€ Bone(ì²™ì¶”ë¼ˆ) ì‚¬ì´ ê³µê°„(Epidural space)ì— ê³ ë¦„ì´ ì°¸ -> ì²™ìˆ˜(Spinal Cord)ë¥¼ ëˆ„ë¦„.\n- **Risk Factors:**\n    - **IV Drug Use (Most common)** ğŸ’‰\n    - Spinal procedures (Epidural catheter), Distant infection leading to seeding.\n    - Main Bug: **Staphylococcus aureus** (M.C.)\n- **Classic Triad:**\n    1. **Fever** (50%ë§Œ ìˆìŒ)\n    2. **Severe Focal Back Pain** (êµ­ì†Œì ì´ê³  ê·¹ì‹¬í•œ ë“± í†µì¦ â˜…)\n    3. **Neurologic Deficits** (Weakness, Numbness, Bowel/Bladder issue)\n    - *Warning:* ë§ˆë¹„ê°€ ì˜¤ê¸° ì „ì— í†µì¦ ë‹¨ê³„ì—ì„œ ì¡ì•„ì•¼ í•¨. ë§ˆë¹„ê°€ ì˜¤ë©´ ì˜êµ¬ì ì¼ ìˆ˜ ìˆìŒ.\n- **Diagnosis (The \"Red Flag\" Rule):**\n    - Fever + Severe Back Pain + Risk Factor (IVDU) = **Assume SEA until proven otherwise**.\n    - **Next Best Step:** **MRI of the Spine with Contrast**. (Do NOT wait. Do NOT pass Go).\n    - **LP?** **Absolutely NOT.** âŒ (ë°”ëŠ˜ë¡œ ê³ ë¦„ ì£¼ë¨¸ë‹ˆë¥¼ ì°Œë¥´ë©´ ê· ì„ ì²™ìˆ˜ê°•(Subarachnoid space)ìœ¼ë¡œ ë°€ì–´ ë„£ì–´ì„œ Meningitisë¥¼ ìœ ë°œí•¨).\n- **Treatment:**\n    - **Urgent Surgical Decompression (Laminectomy)** + Drainage + Antibiotics (Vanco + Ceftriaxone/Cefepime).\n    - ìŠ¤í…Œë¡œì´ë“œ? ì—¬ê¸°ì„œëŠ” í¬ê²Œ ë„ì›€ ì•ˆ ë¨. ìˆ˜ìˆ ì´ ë‹µì„ ğŸ”ª.","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-91","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","treatment","mnemonic"]}
{"chunk_type":"recap_summary","text":"### ğŸ”¥ Rapid Fire Recap (Summary Table)\n| **Condition** | **Key Feature / Vignette** | **Diagnosis (Gold Standard)** | **Treatment / Mgmt** | **Key Caveat âš ï¸** |\n| --- | --- | --- | --- | --- |\n| **PML** | HIV (CD4 < 200), clumsiness\nAsymmetric white lesion with **Non â˜… -enhancing** lesion | MRI Brain -> CSF JC Virus PCR | HAART (Restore immunity) | No specific antiviral. |\n| **Bacterial Meningitis** | Stiff neck, Photophobia, CSF: **Neutrophils**, **Low Glucose** | LP (CSF Analysis)\nHigh neutrophil, low glucose <40,\nhigh protein >250 | Vanc + Ceftriaxone (+ Ampicillin if >50y) + Steroids | CT before LP if **FAILS** signs present. |\n| **Viral Meningitis** | Similar sx but milder, CSF: **Normal Glucose** | LP (CSF Analysis) | Supportive Care (HSV -> Acyclovir) | Lymphocytes predominant. |\n| **TB Meningitis** | Subacute, CSF: **Very Low Glucose**, High Protein | LP | RIPE Therapy + Steroids | Base of brain enhancement often seen. |\n| **Brain Abscess** | Headache, Focal deficit, **Ring-enhancing** lesion | MRI Brain | **Surgical Drainage** + Abx | **NEVER perform LP** (Herniation risk). |\n| **Spinal Epidural Abscess** | IVDU, **Focal Back Pain**, Fever | **MRI Spine** (w/ contrast) | **Urgent Surgery** + Abx | **NEVER perform LP** (Infection spread). |\n- ì´ ê°•ì˜ ë…¸íŠ¸ëŠ” USMLE Step 2 CK ìˆ˜í—˜ìš©ìœ¼ë¡œ ìµœì í™”ë˜ì–´ ìˆìŠµë‹ˆë‹¤. ì‹¤ì œ ì„ìƒì—ì„œëŠ” ë¡œì»¬ ê°€ì´ë“œë¼ì¸ì„ ë”°ë¥´ì„¸ìš”.\n- \"Ring-enhancing\" ë³‘ë³€ì€ Abscess ì™¸ì—ë„ Tumor (Metastasis, Glioblastoma), Toxoplasmosis ë“±ì´ ìˆì„ ìˆ˜ ìˆìœ¼ë‹ˆ ê°ë³„ì´ í•„ìš”í•©ë‹ˆë‹¤.\n- Steroid íˆ¬ì—¬ ì‹œì (Meningitis)ì€ í•­ìƒì œ íˆ¬ì—¬ **ì „**ì´ ê°€ì¥ ì´ìƒì ì´ë¼ëŠ” ì ì„ ê¼­ ê¸°ì–µí•˜ì„¸ìš”. (ì†Œì•„ê³¼/ë‚´ê³¼ ê³µí†µ).\n### ğŸ“‹ Overview: CNS Tumors (Deep Dive)\n**TL;DR Summary Table**\n| **Tumor Type** | **Key Feature/Buzzword** | **Location** | **Key Management/Fact** |\n| --- | --- | --- | --- |\n| **Meningioma** | Dural tail, psammoma bodies | Extra-axial, attached to dura | Resect if symptomatic. Observe if asymptomatic. |\n| **Metastasis** | Gray-white junction, multiple lesions | Intraparenchymal | Most common brain tumor in adults. Lung is most common primary. |\n| **Prolactinoma** | Galactorrhea, amenorrhea | Sella turcica | **Medical therapy first** (dopamine agonist: bromocriptine or cabergoline). |\n| **Craniopharyngioma** | Calcified, cystic, kids (bimodal) | Suprasellar | \"Motor oil\" cyst fluid. Bimodal age distribution. |\n| **Pinealoma** | Parinaud syndrome (upward gaze palsy) | Pineal gland | Compresses dorsal midbrain / superior colliculus. |\n| **Schwannoma** | Hearing loss, tinnitus | Cerebellopontine angle | Bilateral suggests **NF2**. |\n| **Choroid plexus papilloma** | Hydrocephalus (CSF overproduction) | Ventricles | Resection (\"stop the faucet\"). |","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-109","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","recap","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### ğŸŒ³ 2. Top-Down Classification & Mental Model\n**Big Picture & Mental Model ğŸ§ **\nUSMLEì—ì„œ Brain Tumorë¥¼ ì ‘ê·¼í•  ë•Œ ê°€ì¥ ì¤‘ìš”í•œ ê²ƒì€ **\"Location (ìœ„ì¹˜)\"**ì™€ **\"Patient Demographics (í™˜ì ì •ë³´)\"**ì…ë‹ˆë‹¤.\n- **Mental Model:** ë‡ŒëŠ” ë‹«íŒ ìƒì(Skull)ì…ë‹ˆë‹¤. ê³µê°„ì„ ì°¨ì§€í•˜ëŠ” ë©ì–´ë¦¬(Tumor)ê°€ ìƒê¸°ë©´ ì••ë ¥ì´ ì˜¬ë¼ê°‘ë‹ˆë‹¤(ICPâ†‘).\n- **Pathophysiology Impact:**\n    - **Supine Position (ëˆ„ì›Œìˆì„ ë•Œ):** ì¤‘ë ¥ì˜ ë„ì›€ì„ ëª» ë°›ì•„ ë‡Œì˜ ì •ë§¥í˜ˆ(Venous blood) ë°°ì¶œì´ ì¤„ì–´ë“¦ â†’ ICPê°€ ì‚´ì§ ìƒìŠ¹í•¨.\n    - **Tumor Effect:** ì´ë¯¸ Tumorë¡œ ì¸í•´ ê³µê°„ì´ ë¶€ì¡±í•œë° ëˆ•ê¸°ê¹Œì§€ í•˜ë©´? â†’ **\"ì•„ì¹¨ì— ìê³  ì¼ì–´ë‚¬ì„ ë•Œ ë‘í†µì´ ì‹¬í•˜ë‹¤\"** (Worse in morning/lying down)ê°€ ë˜ëŠ” ê²ƒ.\n    - **Valsalva:** ê¸°ì¹¨(Coughing), í˜ì£¼ê¸°(Straining) â†’ í‰ê°• ì••ë ¥ ìƒìŠ¹ â†’ ë‡Œ ì •ë§¥í˜ˆ ë°°ì¶œ ë°©í•´ â†’ ë‘í†µ ì•…í™”.\n**ASCII Text Tree: CNS Tumors Classification**\nPlaintext\n#\n`CNS TUMORS (Approach by Location & Origin)\nâ”‚\nâ”œâ”€â”€ 1. METASTATIC (Secondary) â˜… Most Common in Adults!\nâ”‚   â””â”€â”€ Origin: Lung > Breast > Unknown > Melanoma > Colon\nâ”‚       (Grey-White Junction, Multiple ring-enhancing)\nâ”‚\nâ””â”€â”€ 2. PRIMARY BRAIN TUMORS\n    â”‚\n    â”œâ”€â”€ A. Extra-axial (Brain ë°–ì—ì„œ ëˆ„ë¥´ëŠ” ê²ƒ)\n    â”‚   â”œâ”€â”€ Meningioma (Dura mater origin, Dural tail)\n    â”‚   â””â”€â”€ Schwannoma (CN VIII origin, CP angle)\n    â”‚\n    â”œâ”€â”€ B. Sellar/Suprasellar (Hormone & Vision issues)\n    â”‚   â”œâ”€â”€ Pituitary Adenoma (Prolactinoma etc.)\n    â”‚   â””â”€â”€ Craniopharyngioma (Cystic, Calcified, Children/Elderly)\n    â”‚\n    â”œâ”€â”€ C. Pineal Region (Midbrain compression)\n    â”‚   â””â”€â”€ Pinealoma (Parinaud syndrome)\n    â”‚\n    â””â”€â”€ D. Intraventricular (CSF issues)\n        â””â”€â”€ Choroid Plexus Papilloma (CSF overproduction)`\n### ğŸ¥ 3. The Doorway Thought: Benign vs. Malignant\nì§„ë£Œì‹¤ì— ë“¤ì–´ê°ˆ ë•Œ(Doorway Thought), í™˜ìì˜ ì²«ì¸ìƒë§Œìœ¼ë¡œë„ ê°ë³„ì´ ì‹œì‘ë©ë‹ˆë‹¤.\n### ğŸšª Room A: The Benign Meningioma Track\n- **Patient:** ì¤‘ë…„ ì—¬ì„± (Middle-aged woman).\n- **Presenting Sx:** ì˜¤ëŠ˜ ì•„ì¹¨ ë°œì‘(Seizure) í•¨. ê·¸ ì™¸ì—ëŠ” ê±´ê°•í•¨.\n- **MRI:** ë‡Œë§‰(Covering of the brain)ì— ë¶™ì–´ìˆëŠ” ë©ì–´ë¦¬ + **\"Dural Tail\"** (ê¼¬ë¦¬ì²˜ëŸ¼ ë‡Œë§‰ì´ ë”¸ë ¤ ì˜¬ë¼ê°).\n- **Diagnosis:** **Meningioma** (Benign, ì²œì²œíˆ ìëŒ, ë°–ì—ì„œ ì•ˆìœ¼ë¡œ ëˆ„ë¦„).\n### ğŸšª Room B: The Malignant Metastasis Track\n- **Patient:** ê³¨ì´ˆ(Heavy smoker), ëª¹ì‹œ ë§ˆë¦„(Cachectic), í˜¼ë€ìŠ¤ëŸ¬ì›Œ í•¨(Confusion).\n- **Presenting Sx:** ë‘í†µ, Confusion.\n- **MRI:** **Grey-White Junction**ì— ìœ„ì¹˜í•œ **Multiple Ring-Enhancing Lesions**.\n- **Diagnosis:** **Malignant Metastasis** (Lung cancer ë“±ì—ì„œ ì „ì´).","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-119","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","pathophysiology","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"### ğŸ§  4. General Symptoms: Headache (Physics of ICP)\nëª¨ë“  ë‡Œì¢…ì–‘ í™˜ìëŠ” ë‘í†µì„ í˜¸ì†Œí•  ìˆ˜ ìˆìŠµë‹ˆë‹¤. í•˜ì§€ë§Œ **Tumor Headache**ëŠ” íŠ¹ì§•ì´ ìˆìŠµë‹ˆë‹¤.\n- **Mechanism:** ì„œ ìˆì„ ë•Œ(Standing)ëŠ” ì¤‘ë ¥(Gravity)ì´ ë¨¸ë¦¬ì˜ ì •ë§¥í˜ˆ(Venous blood)ì„ ì•„ë˜ë¡œ ë‚´ë ¤ë³´ë‚´ ICPë¥¼ ë‚®ì¶°ì¤ë‹ˆë‹¤. ëˆ„ìš°ë©´(Lying flat) ì´ ë„ì›€ì´ ì‚¬ë¼ì ¸ ICPê°€ ì˜¤ë¦…ë‹ˆë‹¤.\n- **Red Flag Symptoms (ğŸš©):**\n    - \"ì•„ì¹¨ì— ì¼ì–´ë‚  ë•Œ ë‘í†µì´ ì œì¼ ì‹¬í•´ìš”.\" (Wake up with terrible headache).\n    - \"ì¼ì–´ë‚˜ì„œ í™œë™í•˜ë©´ ì¢€ ë‚˜ì•„ì ¸ìš”.\" (Better after up and about).\n    - \"ê¸°ì¹¨í•˜ê±°ë‚˜ í™”ì¥ì‹¤ì—ì„œ í˜ì¤„ ë•Œ ë¨¸ë¦¬ê°€ ê¹¨ì§ˆ ê²ƒ ê°™ì•„ìš”.\" (Worse with Valsalva/Coughing/Bending over) â†’ í‰ê°• ì••ë ¥(Intrathoracic pressure) ì¦ê°€ë¡œ ì¸í•œ ì •ë§¥í˜ˆ ì—­ë¥˜.\n- **Position:** í™œë™ì„± ë‘í†µê³¼ ë‹¬ë¦¬, ëˆ„ìš°ë©´ ì•…í™”ëœë‹¤ëŠ” ì ì´ í•µì‹¬!\n### ğŸ‘ï¸ 5. Sellar Region Masses (The Hormonal Trap)\n**Anatomy Note:** Optic Chiasm(ì‹œì‹ ê²½ êµì°¨)ì´ Sella ë°”ë¡œ ìœ„ì— ì–¹í˜€ ìˆìŠµë‹ˆë‹¤.\n- **Effect:** **Bitemporal Hemianopsia** (ì–‘ì´ì¸¡ ë°˜ë§¹). í„°ë„ ì‹œì•¼(Tunnel vision)ê°€ ìƒê²¨ ë¬¸í‹€(Door frames)ì— ìê¾¸ ë¶€ë”ªí˜.\n### A. Prolactinoma (â˜… USMLE Step 2 Trap!)\nê°€ì¥ í”í•œ ê¸°ëŠ¥ì„± ë‡Œí•˜ìˆ˜ì²´ ì„ ì¢…ì…ë‹ˆë‹¤.\n- **The Trap:** ë³´í†µ ì¢…ì–‘ = ìˆ˜ìˆ ì´ì§€ë§Œ, **ProlactinomaëŠ” ì•½ë¬¼ì´ 1ì°¨ ì¹˜ë£Œ(First Line)**ì…ë‹ˆë‹¤!\n- **Treatment (â˜… Gold Standard):**\n    - **Dopamine Agonist** (Bromocriptine, Cabergoline).\n    - ë„íŒŒë¯¼ì€ Prolactinì„ ì–µì œí•˜ë©°, ì¢…ì–‘ í¬ê¸°(Shrink tumor)ë„ ì¤„ì—¬ì¤ë‹ˆë‹¤.\n    - ìˆ˜ìˆ (Surgery)ì€ ì•½ë¬¼ì´ ì‹¤íŒ¨í•˜ê±°ë‚˜ ì‹œì•¼ ê²°ì†ì´ ê¸‰ê²©í•  ë•Œ ìµœí›„ì˜ ìˆ˜ë‹¨(Last resort)ì…ë‹ˆë‹¤.\n### B. Craniopharyngioma\n- **Origin:** Rathke's Pouch remnants.\n- **Demographics:** Bimodal (ì–´ë¦°ì´ & 50~75ì„¸ ë…¸ì¸).\n- **Imaging Features (The 2 C's):**\n    1. **C**alcified (ì„íšŒí™”).\n    2. **C**ystic (ë‚­ì„±).\n- **Confusing Factor:** ì†Œì•„ ì¢…ì–‘ìœ¼ë¡œ ìœ ëª…í•˜ì§€ë§Œ, ì„±ì¸ì—ì„œë„ ë°œìƒ ê°€ëŠ¥í•˜ë‹ˆ ë‚˜ì´ë¡œ ë°°ì œí•˜ì§€ ë§ ê²ƒ.\n### ğŸ‘€ 6. Pineal Gland Masses (The \"Eye\" Signs)\nPineal gland(ì†¡ê³¼ì²´) ì¢…ì–‘ì€ Dorsal Midbrain(Superior Colliculus)ì„ ëˆ„ë¦…ë‹ˆë‹¤.\n**Clinical Presentation: Parinaud Syndrome (Triad)**\n1. **Limited Upward Gaze:** ìœ„ë¥¼ ì³ë‹¤ë³´ì§€ ëª»í•¨ (\"Sun-setting sign\").\n2. **Upper Eyelid Retraction:** ëˆˆêº¼í’€ì´ ë§ë ¤ ì˜¬ë¼ê°€ì„œ ë…¸ë ¤ë³´ëŠ” ë“¯í•œ ëˆˆ (**Collier sign/stare**).\n3. **Light-Near Dissociation:**\n    - ë¹›(Light)ì„ ë¹„ì¶”ë©´ ë™ê³µ ìˆ˜ì¶• âŒ (No reaction).\n    - ì†ê°€ë½ì„ ì½”ë¡œ ê°€ì ¸ê°€ë©´(Near) ë™ê³µ ìˆ˜ì¶• â­• (Accomodation intact).\n    - \"They react to NEAR, but not to LIGHT\".\n- **Complication:** Cerebral Aqueduct(ì¤‘ë‡Œìˆ˜ë„)ë¥¼ ë§‰ì•„ **Obstructive Hydrocephalus** ìœ ë°œ (êµ¬í† , Ataxia).\n### ğŸ¦€ 7. Metastatic Brain Lesions (The Most Common)\nì„±ì¸ì—ì„œ ê°€ì¥ í”í•œ ë‡Œì¢…ì–‘ì€ Primaryê°€ ì•„ë‹ˆë¼ **Metastasis(ì „ì´ì„±)**ì…ë‹ˆë‹¤.","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-139","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"- **Pathophysiology:** ì•”ì„¸í¬(Emboli)ê°€ í˜ˆê´€ì„ íƒ€ê³  ê°€ë‹¤ê°€ í˜ˆê´€ì´ ì¢ì•„ì§€ëŠ” **Grey-White Junction**ì— ê±¸ë¦½ë‹ˆë‹¤.\n- **Result:** í˜ˆì•¡-ë‡Œ ì¥ë²½(BBB)ì´ ê¹¨ì§€ë©´ì„œ ì²´ì•¡ì´ í˜ëŸ¬ë‚˜ì˜´ â†’ **Vasogenic Edema** (ì‹¬í•œ ë¶€ì¢…).\n- **Medical Management:** **Steroids (Dexamethasone)**ê°€ ë¶€ì¢…ì„ ì¤„ì´ê³  BBBë¥¼ ì•ˆì •í™”ì‹œí‚¤ëŠ” ë° ë§¤ìš° íš¨ê³¼ì .\n**Common Sources (Frequency Order)**\n1. **Lung** (ì••ë„ì  1ë“±).\n2. **Breast**.\n3. **Unknown Primary** (ë‡Œ ì „ì´ê°€ ì²« ì¦ìƒì¸ ê²½ìš°ê°€ ë§ìŒ).\n4. **Melanoma** (â˜… íŠ¹ì§•: **Bleeds!** MRIì—ì„œ ì¶œí˜ˆ(Hemorrhage)ì´ ë³´ì´ë©´ ë©œë¼ë…¸ë§ˆ ì˜ì‹¬).\n5. **Colon**.\n**Imaging Tips (MRI)**\n- **Solitary:** Breast, Colon, RCC(ì‹ ì¥)ëŠ” ë‹¨ì¼ ì „ì´ ê²½í–¥.\n- **Multiple:** Lung, MelanomaëŠ” ë‹¤ë°œì„± ì „ì´ ê²½í–¥.\n**Management Algorithm (â˜… Next Best Step)**\n1. **Single Lesion & Fit Patient:** **Surgical Resection** (ì˜ë¼ëƒ„). ìƒì¡´ìœ¨ ì´ë“ì´ ê°€ì¥ í¼.\n2. **Multiple Lesions OR Frail Patient:** **Radiation Therapy** (Stereotactic or Whole Brain Radiation). ìˆ˜ìˆ  ëª»í•¨.\n### ğŸ§© 8. Specific Primary Tumors\n### A. Meningioma (The \"Tail\" Sign)\n- **Imaging:** Extra-axial (ë‡Œ ì‹¤ì§ˆ ë°–), **Homogeneously enhancing** (ê· ì¼í•˜ê²Œ í•˜ì–—ê²Œ ë¨), **Dural Tail** (ê¼¬ë¦¬).\n- **Risk Factors:**\n    - **Female > Male:** Progesterone Receptorë¥¼ ê°€ì§€ê³  ìˆì–´ì„œ ì„ì‹  ì¤‘ í¬ê¸°ê°€ ì»¤ì§ˆ ìˆ˜ ìˆìŒ.\n    - **Radiation:** ê³¼ê±° ë°©ì‚¬ì„  ì¹˜ë£Œ ë³‘ë ¥.\n    - **NF2:** Neurofibromatosis Type 2.\n- **Management:**\n    - **Symptomatic / Large / Edema:** **Surgical Resection**.\n    - **Small / Asymptomatic (ìš°ì—°íˆ ë°œê²¬):** **Serial Imaging (Observation)**. ë°”ë¡œ ìˆ˜ìˆ  ì•ˆ í•¨!.\n### B. Schwannoma (Acoustic Neuroma)\n- **Location:** Cerebellopontine Angle (**CP Angle**).\n- **Origin:** CN VIII (Vestibulocochlear nerve)ì˜ Schwann cell.\n- **Symptoms (Progressive):**\n    1. **Hearing Loss:** Sensorineural (ê°ê°ì‹ ê²½ì„± ë‚œì²­).\n    2. **Tinnitus:** ê·€ìš¸ë¦¼.\n    3. **Vertigo:** ì–´ì§€ëŸ¼ì¦.\n    - *Growth Effect:* ì»¤ì§€ë©´ **CN VII (Facial n.)**ë¥¼ ëˆŒëŸ¬ ì•ˆë©´ ë§ˆë¹„/ê°ê° ì €í•˜, **CN V (Trigeminal)**ë¥¼ ëˆŒëŸ¬ ì–¼êµ´ ê°ê° ì´ìƒ ìœ ë°œ.\n- **Key Association:** **Bilateral(ì–‘ì¸¡ì„±) = NF2 (Neurofibromatosis Type 2)** í™•ì§„.\n- **Dx:** MRI with contrast of Internal Auditory Canal.\n### C. Choroid Plexus Papilloma (The Faucet)\n- **Patient:** ì£¼ë¡œ ì†Œì•„ (Infants/Kids).\n- **Pathophysiology:** Choroid PlexusëŠ” CSF(ë‡Œì²™ìˆ˜ì•¡)ë¥¼ ë§Œë“œëŠ” ê³µì¥ì…ë‹ˆë‹¤. Tumor = ê³¼ë‹¤ ì¦ì‹ = **CSF Overproduction**.\n- **Mechanism:** ìˆ˜ë„ê¼­ì§€ê°€ ê³ ì¥ ë‚˜ì„œ ë¬¼ì´ ì½¸ì½¸ ìŸì•„ì§€ëŠ” ê²ƒê³¼ ê°™ìŒ. í¡ìˆ˜ ì†ë„ê°€ ìƒì‚° ì†ë„ë¥¼ ëª» ë”°ë¼ê°.\n- **Result:** **Hydrocephalus** (Communicating typeì— ê°€ê¹Œì›€, ë§‰íŒ ê²Œ ì•„ë‹ˆë¼ ë„˜ì¹˜ëŠ” ê²ƒ).\n- **Imaging:** ë‡Œì‹¤(Ventricle) ì•ˆì˜ **Lobulated Mass** (ìš¸í‰ë¶ˆí‰í•œ ë©ì–´ë¦¬).\n- **Treatment:** **Surgical Resection** (ìˆ˜ë„ê¼­ì§€ë¥¼ ì ê°€ì•¼ í•¨).","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-159","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"recap_summary","text":"### ğŸ”¥ Rapid Fire Recap & Next Steps\n**Key Clinical Pearls:**\n- **Physical Exam:** ëˆˆì„ ìœ„ë¡œ ëª» ì³ë‹¤ë³´ê³ (Upward gaze palsy) = ì•„ë˜ë¥¼ ì³ë‹¤ë³´ëŠ” ë¶€ë¦…ëœ¨ëŠ” ëˆˆ ë¹›ì— ë°˜ì‘ ì•ˆ í•˜ë©´(Light-near dissociation)? â†’ **Pinealoma**.\n- **History:** ì•„ì¹¨ì— ë‘í†µì´ ì‹¬í•˜ê³  êµ¬í†  í›„ í˜¸ì „? â†’ **Increased ICP**.\n- **Imaging:** Dural Tail? â†’ **Meningioma**.\n- **Imaging:** Grey-White Junctionì— ì—¬ëŸ¬ ê°œ? â†’ **Metastasis**.\n- **Treatment:** ProlactinomaëŠ” ìˆ˜ìˆ  ë¨¼ì €? (NO!) â†’ **Dopamine Agonist**.\n- **Treatment:** Metastasis Single Lesion? â†’ **Resection**. Multiple? â†’ **Radiation**.\n**Caveats:**\n- **Melanoma:** MRIì—ì„œ ì¶œí˜ˆ(Bleeding) ì†Œê²¬ì´ ë³´ì´ë©´ 1ìˆœìœ„ë¡œ ì˜ì‹¬í•  ê²ƒ.\n- **Eyes:** ì‹œë ¥ ê²€ì‚¬ë¿ë§Œ ì•„ë‹ˆë¼ ì‹œì•¼(Visual field) ê²€ì‚¬ë¥¼ í†µí•´ Sellar massë¥¼ ë†“ì¹˜ì§€ ë§ ê²ƒ.\n- female pt. seizure, dural tail â†’ meningioma\n- no1 primary for mets brain ca â†’ lung ca\n- bilateral vestibular schwannoma â†’ NF2\n- schwanomma hearing loss ì™¸ ë‹¤ë¥¸ ì¦ìƒ..? â†’ facial numbness (CN5), facial palsy (CN7)\n- calcified sellar mass â†’ craniopharyngioma\n**Next Step for User:**\n### ğŸ“‹ Overview: Pediatric Neurology (Congenital & Developmental)\nì•ˆë…•í•˜ì„¸ìš”! ğŸ‘¨â€âš•ï¸ ì˜¤ëŠ˜ì€ **Pediatric Neurology**, ê·¸ì¤‘ì—ì„œë„ ì„ ì²œì„± ì§ˆí™˜ê³¼ ë°œë‹¬ ë¬¸ì œë¥¼ ë‹¤ë£¹ë‹ˆë‹¤. í”¼ë¶€ ì†Œê²¬(Skin)ì´ ë‡Œ(Brain)ì˜ ìƒíƒœë¥¼ ë§í•´ì£¼ëŠ” **Neurocutaneous disorders**ë¶€í„°, ë“±(Spine)ì˜ ë¬¸ì œ, ë¨¸ë¦¬ í¬ê¸°(Head size), ê·¸ë¦¬ê³  ë‡Œì„±ë§ˆë¹„(CP)ê¹Œì§€! **USMLE High-Yield** í¬ì¸íŠ¸ë“¤ì„ ê½‰ê½‰ ì±„ì›Œë“œë¦´ê²Œìš”. ğŸ§","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-175","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","recap","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"ì´ ê°•ì˜ì˜ í•µì‹¬ì€ **\"Outside-In Approach\"**ì…ë‹ˆë‹¤. ê²‰ìœ¼ë¡œ ë³´ì´ëŠ” í”¼ë¶€ë‚˜ ì²™ì¶”ì˜ ì†Œê²¬ì´ ì•ˆìª½ì˜ ì‹ ê²½ê³„ ë¬¸ì œë¥¼ ë°˜ì˜í•œë‹¤ëŠ” ê²ƒì´ì£ ! (Embryology: Skin & Brain = Both Ectoderm origin ğŸ‘¯â€â™‚ï¸)\n### ğŸŒ³ Top-Down Classification: Pediatric Neurology (Congenital)\nPlaintext\n`Pediatric Neurology (Congenital & Developmental)\nâ”‚\nâ”œâ”€â”€ 1. Neurocutaneous Disorders (Phakomatoses) ğŸ§¬\nâ”‚   â”œâ”€â”€ NF1 (Neurofibromatosis Type 1) - Skin & Bone\nâ”‚   â”œâ”€â”€ NF2 (Neurofibromatosis Type 2) - Ears & Eyes\nâ”‚   â”œâ”€â”€ Tuberous Sclerosis (TSC) - Multi-system Chaos\nâ”‚   â”œâ”€â”€ Von Hippel-Lindau (VHL) - Vascular Tumors\nâ”‚   â””â”€â”€ Sturge-Weber Syndrome - Port Wine & Seizures\nâ”‚\nâ”œâ”€â”€ 2. Neural Tube Defects (Spine) ğŸ¦´\nâ”‚   â”œâ”€â”€ Spina Bifida Occulta (Hidden)\nâ”‚   â”œâ”€â”€ Meningocele (Sac with fluid)\nâ”‚   â””â”€â”€ Myelomeningocele (Sac with nerves - Severe)\nâ”‚\nâ”œâ”€â”€ 3. Scalp Swellings (Newborn Head Lumps) ğŸ¤•\nâ”‚   â”œâ”€â”€ Caput Succedaneum (Edema)\nâ”‚   â”œâ”€â”€ Cephalohematoma (Blood, Sub-periosteal)\nâ”‚   â””â”€â”€ Subgaleal Hemorrhage (Dangerous!)\nâ”‚\nâ”œâ”€â”€ 4. Head Size Anomalies ğŸ“\nâ”‚   â”œâ”€â”€ Hydrocephalus (Water on brain)\nâ”‚   â”œâ”€â”€ Microcephaly (Small head)\nâ”‚   â””â”€â”€ Macrocephaly (Big head)\nâ”‚\nâ””â”€â”€ 5. Cerebral Palsy (Motor) â™¿\n    â”œâ”€â”€ Spastic Diplegia (Prematurity)\n    â””â”€â”€ Hemiplegia (Stroke/Vascular)`\n### 1. Neurocutaneous Disorders (The Phakomatoses) ğŸ§¬\n**Core Concept:** í”¼ë¶€(Skin)ì™€ ë‡Œ(Nervous System)ëŠ” ë°œìƒí•™ì ìœ¼ë¡œ ëª¨ë‘ **Ectoderm(ì™¸ë°°ì—½)**ì—ì„œ ìœ ë˜í•œ ìŒë‘¥ì´ì…ë‹ˆë‹¤. í”¼ë¶€ì˜ \"Blueprints\"ê°€ ì—‰ë§ì´ë¼ë©´(messy), ì‹ ê²½ê³„ì˜ \"Blueprints\"ë„ ì—‰ë§ì¼ í™•ë¥ ì´ ë†’ìŠµë‹ˆë‹¤! ğŸš©\n### A. Neurofibromatosis Type 1 (NF1)\n- **Genetic:** Mutation in **NF1 gene** on **Chromosome 17**.\n    - *Mnemonic:* von Recklinghausen's disease (ì´ë¦„ì´ ê¸¸ì£ ? 17ê¸€ì ì •ë„ ë¨ â†’  Chr 17)\n- **Protein:** **Neurofibromin** (Tumor Suppressor, RAS pathwayì˜ break pedal ì—­í• ). ë¸Œë ˆì´í¬ê°€ ê³ ì¥ ë‚˜ì„œ ì„¸í¬ê°€ ê³„ì† ë¶„ì—´í•¨.\n- **Clinical Presentation (Doorway Clues):**\n    - **Skin:** **CafÃ©-au-lait spots** â˜• (6ê°œ ì´ìƒì´ì–´ì•¼ í•¨). \"Spilled latte look\".\n    - **Axillary/Inguinal Freckling:** ê²¨ë“œë‘ì´ë‚˜ ì‚¬íƒ€êµ¬ë‹ˆì˜ ì£¼ê·¼ê¹¨.\n    - **Eye:** **Lisch Nodules** (Irisì˜ ê°ˆìƒ‰ ë©ì–´ë¦¬ë“¤ - Visionì—ëŠ” ì˜í–¥ ì—†ìŒ, ì§„ë‹¨ì  ê°€ì¹˜ë§Œ ìˆìŒ).\n    - **Tumors:** **Neurofibromas** (í”¼ë¶€ ë°‘ì˜ ë§ë‘ë§ë‘í•œ ë©ì–´ë¦¬, 'Button-hole' sign), Optic Glioma.\n    - **Bone:** Skeletal dysplasia.\n### B. Neurofibromatosis Type 2 (NF2)\n- **Genetic:** Mutation in **NF2 gene** on **Chromosome 22**.\n    - *Mnemonic:* Type 2ë‹ˆê¹Œ 2ê°€ ë‘ ê°œ â†’  22ë²ˆ ì—¼ìƒ‰ì²´.\n- **Protein:** **Merlin** (ì„¸í¬ ê³¨ê²© ì•ˆì •í™” ë‹¨ë°±ì§ˆ). Schwann cellì´ ë¯¸ì¹œ ë“¯ì´ ìë¼ë‚¨.\n- **Clinical Presentation:**\n    - **Ears (â˜…Key):** **Bilateral Vestibular Schwannomas** (Acoustic Neuromas).\n        - ì¦ìƒ: Hearing loss, Tinnitus (ì´ëª…), Balance issues.\n    - **Eyes:** **Juvenile Cataracts** (ë°±ë‚´ì¥).\n    - *Note:* Skin findingì€ NF1ë³´ë‹¤ í›¨ì”¬ ì ìŒ.\n### C. Tuberous Sclerosis Complex (TSC)\n- **Genetic:** TSC1 or TSC2 mutation. **mTOR pathway** ì¡°ì ˆ ì‹¤íŒ¨ â†’  \"Multi-system Chaos\" (ë‡Œ, í”¼ë¶€, ì‹¬ì¥, ì‹ ì¥ ë‹¤ ì»¤ì§).\n- **Clinical Presentation:**\n    - **Skin (â˜…First Sign):** **Ash-leaf spots** (Hypopigmented macules).\n        - **Next Best Step:** **Wood's Lamp** (UV light) examination to see them clearly.\n    - **Face:** **Adenoma Sebaceum** (Facial Angiofibromas) - ì½”ì™€ ëº¨ ì£¼ë³€ì˜ ë¶‰ì€ ì—¬ë“œë¦„ ê°™ì€ ê²ƒë“¤ (Acneì™€ ë‹¬ë¦¬ ë”±ë”±í•˜ê³  í”¼ê°€ ì˜ ë‚¨).\n    - **Back:** **Shagreen Patch** (Orange peel/Leather texture).\n    - **Fingers:** **Ungual Fibromas** (ì†í†± ì£¼ë³€ì˜ ì„¬ìœ ì¢…).\n    - **Brain:** **Cortical Tubers**, **Subependymal Giant Cell Astrocytoma (SEGA)**.\n        - â†’  ì›ì¸ ë¶ˆëª…ì˜ **Seizures** (íŠ¹íˆ Infantile Spasms - West Syndrome) + Intellectual Disability / Autism.\n    - **Heart:** **Cardiac Rhabdomyoma** (ì‹ ìƒì•„ ì‹¬ì¥ ì¢…ì–‘ì˜ m/c cause).\n    - **Kidney:** **Renal Angiomyolipoma**.\n### D. Von Hippel-Lindau (VHL)\n- **Genetic:** VHL gene on **Chromosome 3**. (VHL ì„¸ ê¸€ì â†’  3ë²ˆ)\n- **Protein:** pVHL (HIF-1a ë¶„í•´). ì´ê²Œ ê³ ì¥ ë‚˜ë©´ ëª¸ì´ \"ì‚°ì†Œ ë¶€ì¡±í•´!\"ë¼ê³  ì°©ê°í•´ì„œ í˜ˆê´€ì„ ë§ˆêµ¬ ë§Œë“¦ (Angiogenesis).\n- **Clinical Presentation (Tumors everywhere):**\n    - **Hemangioblastomas:** Retina (Vision loss), Cerebellum (Balance issues).\n    - **Renal Cell Carcinoma (RCC):** ì‹ ì¥ì•” (Clear cell type).\n    - **Pheochromocytoma:** ë¶€ì‹  ì¢…ì–‘.\n### E. Sturge-Weber Syndrome","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-185","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","treatment","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"- **Genetic:** **Somatic Mosaicism** (GNAQ gene). **NOT Inherited!** (ìœ ì „ë˜ì§€ ì•ŠìŒ).\n- **Pathology:** í˜ˆê´€ ê¸°í˜•(Vascular malformation). \"GNAQ mutation\"\n- **Clinical Presentation:**\n    - **Face:** **Port-Wine Stain** (Nevus Flammeus) in **V1/V2 distribution** (Trigeminal nerve).\n    - **Brain:** ê°™ì€ ìª½(Ipsilateral) ë‡Œë§‰ì˜ **Leptomeningeal Angioma**.\n        - abnormal vein â†’ congestion â†’ í˜ˆë¥˜ê³µê¸‰ â†“\n        - ë‡Œê°€ ì„íšŒí™”ë¨ (Tram-track Calcifications).\n        - â†’  ë‡Œê°€ ì„íšŒí™”ë¨ (**Tram-track Calcifications**).\n        - â†’  ë°˜ëŒ€ìª½(Contralateral) **Seizures** & **Hemiparesis** (í¸ë§ˆë¹„).\n    - **Eye:** **Glaucoma** (ë…¹ë‚´ì¥) - ì•ˆì•• ìƒìŠ¹ ì£¼ì˜! ğŸ‘ï¸Â (í˜ˆë¥˜ ë¬¸ì œ â†’ ì••ë ¥ ìƒìŠ¹ìœ¼ë¡œ ì¸í•´ ë…¹ë‚´ì¥ìƒê¹€)\n### 2. Neural Tube Defects (Spina Bifida) ğŸ¦´\n**Mechanism:** Neural tubeê°€ ì œëŒ€ë¡œ ë‹«íˆì§€ ì•Šì€ \"Zipper\" ê³ ì¥.\n**Prevention:** **Folic Acid (ì—½ì‚°)** ì„­ì·¨ê°€ í•„ìˆ˜! (Maternal deficiencyê°€ ì£¼ì›ì¸)\n### Types (Severity ìˆœì„œ)\n1. **Spina Bifida Occulta (Hidden):**\n- ë¼ˆ(Vertebrae)ë§Œ ì•ˆ ë‹«í˜. ì²™ìˆ˜ëŠ” ì •ìƒ.\n- **Sign:** í—ˆë¦¬ ì•„ë˜ìª½(Gluteal crease ìœ„)ì— **Tuft of Hair** (í„¸ ë­‰ì¹˜), Dimple, or Lipoma.\n- **Complication:** **Tethered Cord Syndrome** (ì²™ìˆ˜ê°€ ë¼ˆì— ë“¤ëŸ¬ë¶™ì–´ í‚¤ê°€ í´ ë•Œ ì²™ìˆ˜ê°€ ë‹¹ê²¨ì§ â†’  Bladder/Bowel dysfunction, Leg weakness).\n1. **Meningocele:**\n    - ì£¼ë¨¸ë‹ˆ(Sac)ê°€ íŠ€ì–´ë‚˜ì˜´. ì•ˆì—ëŠ” **Fluid(CSF)**ì™€ Meningesë§Œ ìˆìŒ. ì‹ ê²½(Nerve)ì€ ì—†ìŒ.\n2. **Myelomeningocele (ê°€ì¥ ì‹¬ê°):**\n    - ì£¼ë¨¸ë‹ˆ ì•ˆì— **Spinal Cord(Nerve)**ê°€ ë“¤ì–´ìˆìŒ.\n    - ì¦ìƒ: í•´ë‹¹ ë ˆë²¨ ì´í•˜ì˜ ë§ˆë¹„(Paralysis), ê°ê° ì†Œì‹¤. **Chiari II Malformation** (ì†Œë‡Œê°€ ì²™ìˆ˜ë¡œ ë¹ ì§) ë° **Hydrocephalus** ë™ë°˜ ê°€ëŠ¥ì„± ë†’ìŒ.\n### Management with Bladder Problems\n- urinary catheter ìì£¼ ë„£ì–´ì¤˜ì„œ ì˜¤ì¤Œ ëºŒ to prevent kidney problems.\n### 3. Scalp Swellings (Newborn Head Lumps) ğŸ¤•\nì‹ ìƒì•„ê°€ íƒœì–´ë‚  ë•Œ ë¨¸ë¦¬ì— í˜¹ì´ ë‚¬ë‹¤? ì¸µ(Layer)ì„ ì•„ëŠ” ê²ƒì´ ì¤‘ìš”í•©ë‹ˆë‹¤!\n| **íŠ¹ì§•** | **Caput Succedaneum = ë©** | **Cephalohematoma = â€˜í”¼â€™ë©** | **Subgaleal Hemorrhage\n=ë„“ì€ ê³µê°„ì— í”¼ì°¸** |\n| --- | --- | --- | --- |\n| **ìœ„ì¹˜** | Skin (Subcutaneous) | Under Periosteum (ê³¨ë§‰ ì•„ë˜) | Subgaleal space (Emissary veins) |\n| **ë‚´ìš©ë¬¼** | Serosanguinous fluid (Edema) | **Blood** | **Blood** (Massive) |\n| **Suture Line** | **Crosses Sutures** (ë§‰ ê±´ë„ˆê°) | **Does NOT Cross** (ë¼ˆì— ê°‡í˜) | **Crosses Sutures** (ê·€ì—ì„œ ê·€ê¹Œì§€) |\n| **ëŠë‚Œ** | Soft, Boggy (ë¬¼ë ë¬¼ë ) | Firm boundaries (ë‹¨ë‹¨í•¨) | Boggy, diffuse waves (ì¶œë ê±°ë¦¼) |\n| **ìœ„í—˜ë„** | Benign (ë©°ì¹  ë‚´ ì‚¬ë¼ì§) | **Hyperbilirubinemia** (í™©ë‹¬) | **Life-Threatening** (Shock!) ğŸš¨ |\n| **Note** | \"Caput\" = Cap(ëª¨ì)ì„ ì“°ë©´ ë´‰í•©ì„ ì„ ë„˜ì–´ê°€ë“¯. | ë¼ˆ ëª¨ì–‘ ê·¸ëŒ€ë¡œ í˜¹ì´ ë‚¨. | í”¼ê°€ ì—„ì²­ë‚˜ê²Œ ê³ ì—¬ì„œ ì‡¼í¬ì‚¬ ê°€ëŠ¥. |\n### 4. Head Size Anomalies ğŸ“","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-205","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### A. Hydrocephalus (ìˆ˜ë‘ì¦)\n- **Concept:** \"Plumbing issue\". CSFê°€ ë¹ ì ¸ë‚˜ê°€ì§€ ëª»í•¨ (Obstruction) or ë„ˆë¬´ ë§ì´ ìƒì„±ë¨.\n- **Symptoms:**\n    - Rapidly increasing head circumference.\n    - **Bulging Fontanelle** (ëŒ€ì²œë¬¸ íŒ½ì°½).\n    - **Sun-set Eyes:** ëˆˆì´ ì•„ë˜ë¡œ ê¹”ë¦¼ (Midbrain pressure â†’  Upward gaze palsy).\n- **Cause:** Intraventricular Hemorrhage (Preemie), Tumors, Chiari Malformation.\n### B. Microcephaly (ì†Œë‘ì¦)\n- **Definition:** Head circumference **< 3rd percentile**.\n- **Algorithm (First Step):**\n    - **Measure Mom & Dad's heads!** ğŸ‘¨â€ğŸ‘©â€ğŸ‘§\n    - ë¶€ëª¨ ë¨¸ë¦¬ê°€ ì‘ë‹¤? â†’  **Benign Familial Microcephaly** (No workup needed).\n    - ë¶€ëª¨ëŠ” ì •ìƒì´ë‹¤? â†’  Pathologic (Zika virus, Genetic, TORCH infection ë“±).\n### C. Macrocephaly (ëŒ€ë‘ì¦)\n- **Definition:** Head circumference **> 97th percentile**.\n- **Causes:** Hydrocephalus, Familial, Canavan disease, Alexander disease etc.\n### 5. Cerebral Palsy (CP) â™¿\n**Definition:** **Permanent, NON-progressive** motor disorder. (ë‡Œ ì†ìƒ;ì£¼ë¡œ í˜ˆë¥˜ ì†ìƒ ë¬¸ì œ;ì€ í•œ ë²ˆ ì¼ì–´ë‚¬ê³ , ë” ë‚˜ë¹ ì§€ì§€ëŠ” ì•ŠìŒ. ì¦ìƒì€ ì•„ì´ê°€ í¬ë©´ì„œ ë‹¬ë¼ ë³´ì¼ ìˆ˜ ìˆìŒ).\n### A. Spastic Diplegia (ì–‘í•˜ì§€ ë§ˆë¹„)\n- **Risk Factor:** **Prematurity** (ë¯¸ìˆ™ì•„).\n- **Pathophysiology:** **Periventricular Leukomalacia (PVL)**.\n    - ë‡Œì‹¤ ì£¼ë³€(Periventricular)ì˜ White matterê°€ ê´´ì‚¬í•¨. ì´ê³³ì— **ë‹¤ë¦¬(Legs)**ë¡œ ê°€ëŠ” ìš´ë™ ì‹ ê²½ì´ ì§€ë‚˜ê°.\n    - ë¯¸ìˆ™ì•„ëŠ” í˜ˆë¥˜ ë°œì „ì´ ì˜ë˜ì§€ ì•Šì•„ì„œ ì €ë¶€ë¶„ì´ ischemic changeì— ì·¨ì•½í•¨.\n- **Presentation:**\n    - **Legs > Arms** (ë‹¤ë¦¬ê°€ ë” ë»£ë»£í•˜ê³  ì•½í•¨).\n    - **\"Commando Crawl\"**: íŒ”ë¡œë§Œ ê¸°ì–´ ë‹¤ë‹ˆê³  ë‹¤ë¦¬ëŠ” ì§ˆì§ˆ ë”. ğŸª–\n    - **Scissoring gait**: ê±¸ì„ ë•Œ ë‹¤ë¦¬ê°€ ê°€ìœ„ì²˜ëŸ¼ êµì°¨ë¨.\n### B. Spastic Hemiplegia (í¸ë§ˆë¹„)\n- **Risk Factor:** Perinatal Stroke, Vascular insult.\n- **Presentation:** ëª¸ì˜ í•œìª½(Left or Right)ë§Œ ë§ˆë¹„.\n- **â˜… Red Flag:** **Early Hand Preference (< 18 months)**.\n    - 18ê°œì›” ì´ì „ì— ì˜¤ë¥¸ì†ì¡ì´/ì™¼ì†ì¡ì´ê°€ ëšœë ·í•˜ë‹¤ë©´? ë°˜ëŒ€ìª½ ì†ì„ *ëª» ì¨ì„œ* ê·¸ëŸ´ ìˆ˜ ìˆìŒ. ì´ëŠ” Hemiparesisì˜ ê°•ë ¥í•œ ì‹ í˜¸!\n### Management\n- **Goal:** Functionality & Comfort.\n- **Tx:** **Botox** injections (ê·¼ìœ¡ ì´ì™„), **Baclofen** (GABA agonist - spasticity ê°ì†Œ), Physical Therapy.","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-225","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"recap_summary","text":"### âš¡ Rapid Fire Recap (Summary Table)\n| **Condition** | **Key Clinical Feature / Buzzword** | **Pathophysiology / Gene** |\n| --- | --- | --- |\n| **NF1** | CafÃ©-au-lait, Lisch nodules, Neurofibromas | Chr 17, Neurofibromin |\n| **NF2** | **Bilateral Acoustic Neuromas** (Hearing loss) | Chr 22, Merlin |\n| **Tuberous Sclerosis** | **Ash-leaf spots**, Cardiac Rhabdomyoma, Seizures | TSC1/2, mTOR pathway |\n| **Sturge-Weber** | **Port-Wine Stain**, Seizures (Contralateral) | Somatic GNAQ (Not inherited) |\n| **VHL** | Hemangioblastomas (Retina/Cerebellum), RCC | Chr 3, VHL gene |\n| **Cephalohematoma** | Does **NOT** cross sutures | Subperiosteal blood (Risk: Jaundice) |\n| **Subgaleal Hemorrhage** | **Crosses** sutures, Fluctuant | Emissary veins (Risk: Shock/Death) |\n| **Spastic Diplegia** | **Commando Crawl**, Legs > Arms | Prematurity â†’  PVL |\n- ì˜¤ë””ì˜¤ ê°•ì˜ëŠ” \"General Rule\"ì„ ë‹¤ë£¹ë‹ˆë‹¤. ì˜ˆì™¸ì ì¸ ì¼€ì´ìŠ¤(Mosaicism in NF, etc.)ëŠ” í•­ìƒ ì¡´ì¬í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- CPì˜ ì§„ë‹¨ì€ ì„ìƒì (Clinical)ì´ì§€ë§Œ, í™•ì§„ì„ ìœ„í•´ MRIê°€ í•„ìš”í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- Scalp swelling ì¤‘ Subgaleal hemorrhageëŠ” ì‘ê¸‰ ìƒí™©ì„ì„ ê¼­ ê¸°ì–µí•˜ì„¸ìš”!\n**Overview: Pediatric Acute Neurology Deep Dive**\nì•ˆë…•í•˜ì„¸ìš”! ì˜¤ëŠ˜ì€ ì†Œì•„ ì‘ê¸‰ ì‹ ê²½í•™(Pediatric Acute Neurology)ì— ëŒ€í•´ ì•„ì£¼ ê¹Šì´ ìˆê²Œ íŒŒê³ ë“¤ì–´ ë³´ê² ìŠµë‹ˆë‹¤. ğŸ§ âš¡ï¸ ë¯¸êµ­ ì˜ì‚¬ êµ­ê°€ê³ ì‹œ(USMLE)ë‚˜ ì„ìƒ í˜„ì¥ì—ì„œ ì •ë§ ì¤‘ìš”í•˜ê²Œ ë‹¤ë£¨ëŠ” **Stroke, IVH, ê·¸ë¦¬ê³  ë‹¤ì–‘í•œ Pediatric Epilepsy Syndromes**ë¥¼ ë‚˜ì´ëŒ€ë³„, ìƒí™©ë³„ë¡œ ì™„ë²½í•˜ê²Œ ì •ë¦¬í•´ ë“œë¦´ê²Œìš”.\nì´ ê°•ì˜ëŠ” \"High-Yield Tutoring Session\" ì»¨ì…‰ìœ¼ë¡œ ì§„í–‰ë©ë‹ˆë‹¤. ë†“ì¹˜ëŠ” ë‚´ìš© ì—†ì´ ê½‰ê½‰ ì±„ì› ìœ¼ë‹ˆ ì§‘ì¤‘í•´ ì£¼ì„¸ìš”! ğŸ”¥\n### **Top-down Classification & Structure (ASCII Text Tree)**","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-241","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","recap","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"ì´ êµ¬ì¡°ë¥¼ ë¨¸ë¦¿ì†ì— ë¨¼ì € ë„£ê³  ì„¸ë¶€ ë‚´ìš©ì„ ì±„ì›Œë„£ìœ¼ì„¸ìš”. ğŸŒ³\nPlaintext\n`Pediatric Acute Neurology (ì†Œì•„ ê¸‰ì„± ì‹ ê²½í•™)\nâ”‚\nâ”œâ”€â”€ 1. Acute Hemiplegia (ê¸‰ì„± í¸ë§ˆë¹„: The Scary Door)\nâ”‚   â”œâ”€â”€ Ischemic Stroke (í—ˆí˜ˆì„± ë‡Œì¡¸ì¤‘)\nâ”‚   â”‚   â””â”€â”€ ì›ì¸: Cardiac defects, Sickle cell, Prothrombotic d/o\nâ”‚   â”œâ”€â”€ Hemorrhagic Stroke (ì¶œí˜ˆì„± ë‡Œì¡¸ì¤‘)\nâ”‚   â”‚   â””â”€â”€ ì›ì¸: Trauma, Bleeding d/o (Hemophilia), AVM\nâ”‚   â””â”€â”€ Todd's Paralysis (í† ë“œ ë§ˆë¹„)\nâ”‚       â””â”€â”€ â˜… Diagnosis of Exclusion (ë°°ì œ ì§„ë‹¨)! ì ˆëŒ€ ë¨¼ì € ê°€ì •í•˜ì§€ ë§ ê²ƒ.\nâ”‚\nâ”œâ”€â”€ 2. Intraventricular Hemorrhage (IVH: The Quiet Door)\nâ”‚   â”œâ”€â”€ ëŒ€ìƒ: Premature infants (<32 weeks)\nâ”‚   â”œâ”€â”€ í•´ë¶€í•™ì  ì›ì¸: Germinal Matrix fragility (ì•½í•œ í˜ˆê´€)\nâ”‚   â”œâ”€â”€ Screening: Head Ultrasound (Routine for preemies)\nâ”‚   â””â”€â”€ í•©ë³‘ì¦: Hydrocephalus (Communicating)\nâ”‚\nâ”œâ”€â”€ 3. Pediatric Epilepsy Syndromes (Age-Dependent Patterns)\nâ”‚   â”œâ”€â”€ Infantile Spasms (West Syndrome, <1 yr)\nâ”‚   â”‚   â”œâ”€â”€ SX: Jackknife spasms\nâ”‚   â”‚   â”œâ”€â”€ EEG: Hypsarrhythmia\nâ”‚   â”‚   â””â”€â”€ TX: ACTH (Adrenocorticotropic hormone)\nâ”‚   â”œâ”€â”€ Lennox-Gastaut Syndrome (Toddler/Child, 3-5 yrs)\nâ”‚   â”‚   â”œâ”€â”€ SX: Regression, Intellectual disability\nâ”‚   â”‚   â””â”€â”€ EEG: Slow spike-and-wave\nâ”‚   â””â”€â”€ Juvenile Myoclonic Epilepsy (JME, Teenager)\nâ”‚       â”œâ”€â”€ SX: Morning myoclonus (ì–‘ì¹˜ì§ˆí•˜ë‹¤ ì¹«ì†” ë˜ì§)\nâ”‚       â”œâ”€â”€ Trigger: Alcohol, Sleep deprivation\nâ”‚       â””â”€â”€ TX: Valproic Acid\nâ”‚\nâ””â”€â”€ 4. Febrile Seizures (ì—´ì„± ê²½ë ¨)\n    â”œâ”€â”€ Simple Febrile Seizure (ë‹¨ìˆœ)\n    â”‚   â””â”€â”€ <15min, Generalized, 1x/24hr â†’ Reassurance\n    â””â”€â”€ Complex Febrile Seizure (ë³µí•©)\n        â””â”€â”€ >15min, Focal, >1x/24hr â†’ Workup needed`\n## **Part 1: Acute Hemiplegia & Stroke in Children (Door #1)** ğŸšªğŸƒâ€â™‚ï¸ğŸ’¨\n### **1. The Clinical Scenario (Vignette Anchor)**\n- **ìƒí™©:** 3ì„¸ ì•„ì´ê°€ ë¸”ë¡ ë†€ì´ë¥¼ í•˜ë‹¤ê°€ ê°‘ìê¸° ì˜¤ë¥¸ìª½ íŒ”ë‹¤ë¦¬ì— í˜ì´ ë¹ ì§€ë©´ì„œ ì¶• ëŠ˜ì–´ì§ (Dead weight/Limp).\n- **ë¶€ëª¨ ë°˜ì‘:** íŒ¨ë‹‰ ìƒíƒœë¡œ ì‘ê¸‰ì‹¤ë¡œ ë›°ì–´ ë“¤ì–´ì˜´.\n- **ì˜ì‚¬ì˜ ë”œë ˆë§ˆ:** \"ì„¤ë§ˆ ì• í•œí…Œ ë‡Œì¡¸ì¤‘(Stroke)ì´?\"ë¼ê³  ìƒê°í•˜ë©° ì£¼ì €í•˜ê²Œ ë¨.\n### **2. Differential Diagnosis Table: Why do kids get strokes?**\nì–´ë¥¸ë“¤ì˜ ë‡Œì¡¸ì¤‘(ì£½ìƒê²½í™”ì¦, í¡ì—° ë“±)ê³¼ëŠ” ì›ì¸ì´ ì™„ì „íˆ ë‹¤ë¦…ë‹ˆë‹¤! ğŸ™…â€â™‚ï¸\n| **Type** | **Key Etiologies (ì›ì¸)** | **ë¹„ê³ ** |\n| --- | --- | --- |\n| **Ischemic Stroke** (í—ˆí˜ˆì„±) | â€¢ **Cardiac Disease:** ì„ ì²œì„± ì‹¬ì¥ ê¸°í˜• (Patent Foramen Ovale ë“±)\nâ€¢ **Hematologic:** **Sickle Cell Disease** (SCD, ë§¤ìš° ì¤‘ìš”!), Prothrombotic disorders | êµ¬ì¡°ì (Structural) ë¬¸ì œë‚˜ í˜ˆì•¡í•™ì  ë¬¸ì œê°€ ë©”ì¸! |\n| **Hemorrhagic Stroke** (ì¶œí˜ˆì„±) | â€¢ **Trauma:** ì†Œì•„ì—ì„œ ê°€ì¥ í° ì›ì¸ ì¤‘ í•˜ë‚˜\nâ€¢ **Bleeding Disorders:** Hemophilia (í˜ˆìš°ë³‘), Vitamin K deficiency\nâ€¢ **Vascular:** AVM (ë™ì •ë§¥ê¸°í˜•) | ë„˜ì–´ì ¸ì„œ ë¨¸ë¦¬ë¥¼ ë¶€ë”ªíˆê±°ë‚˜, í˜ˆì•¡ ì‘ê³  ì¥ì• ê°€ ìˆëŠ” ê²½ìš°. |\n| Toddâ€™s Paralysis (ë°œì‘ í›„ í•œìª½ ë§ˆë¹„) | ì•„ë˜ ì°¸ê³  |  |\n| Hemiplegic Migraine |   â€¢ ì²­ì†Œë…„ê¸°ì—ì„œ í¸ë‘í†µê³¼ ê´€ë ¨ëœ í˜ë¹ ì§\n  â€¢ Familiy history. ì—„ë§ˆì—ì„œë„ ê°™ì€ ë¬¸ì œ  |  |\n### **3. The Trap: Todd's Paralysis (í† ë“œ ë§ˆë¹„) âš ï¸**\n- **ì •ì˜:** ë°œì‘(Seizure) í›„ ì¼ì‹œì ìœ¼ë¡œ í•œìª½ ë§ˆë¹„(Hemiparesis)ê°€ ì˜¤ëŠ” í˜„ìƒ.\n- **íŠ¹ì§•:**\n    - Self-resolving (ì €ì ˆë¡œ ì¢‹ì•„ì§).\n    - ë³´í†µ ëª‡ ì‹œê°„ ë‚´ì— íšŒë³µë¨.\n    - ë°œì‘ í›„ í˜¼ë€ ìƒíƒœ(Post-ictal confusion/groggy) ë™ë°˜.\n- **â˜… WARNING (Board Trap):** \"Todd's Paralysis\"ëŠ” **ë°°ì œ ì§„ë‹¨(Diagnosis of Exclusion)**ì…ë‹ˆë‹¤!\n    - ì ˆëŒ€ë¡œ \"ì•„, ë°©ê¸ˆ ë°œì‘í–ˆìœ¼ë‹ˆê¹Œ ë§ˆë¹„ëŠ” ê·¸ëƒ¥ Todd's Paralysisê² ì§€? ê¸°ë‹¤ë ¤ë³´ì.\"ë¼ê³  ë‹¨ì • ì§€ìœ¼ë©´ ì•ˆ ë©ë‹ˆë‹¤. âŒ\n    - **Gold Standard:** ë°˜ë“œì‹œ Strokeì„ ë¨¼ì € ë°°ì œí•´ì•¼ í•¨.\n### **4. Workup & Management** ğŸ¥\n- **Next Best Step (Diagnosis):** **MRI of the Brain + MRA (Magnetic Resonance Angiography)** â˜…\n    - ì¼ë°˜ MRIë¡œëŠ” ë¶€ì¡±í•©ë‹ˆë‹¤. ì†Œì•„ ë‡Œì¡¸ì¤‘ì€ í˜ˆê´€ ê¸°í˜•(Vascular anomaly)ì´ë‚˜ ë§‰í˜(Occlusion)ì„ í™•ì¸í•´ì•¼ í•˜ë¯€ë¡œ **MRA(í˜ˆê´€ ì¡°ì˜)**ê°€ í•„ìˆ˜ì…ë‹ˆë‹¤. Urgentí•˜ê²Œ ì‹œí–‰í•´ì•¼ í•©ë‹ˆë‹¤.\n## **Part 2: Intraventricular Hemorrhage (IVH) (Door #2)** ğŸšªğŸ¤«ğŸ‘¶\n###","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-251","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### **2. Pathophysiology: The Plumping Problem** ğŸ©¸\n- **ëŒ€ìƒ:** **Premature Infants (ë¯¸ìˆ™ì•„)**, íŠ¹íˆ **32ì£¼ ë¯¸ë§Œ** ì¶œìƒì•„.\n- **í•µì‹¬ êµ¬ì¡°ë¬¼:** **Germinal Matrix (ë°°ì•„ê¸°ì§ˆ)**\n    - ë‡Œì‹¤(Ventricle) ê·¼ì²˜ì— ìœ„ì¹˜í•˜ë©°, ìƒˆë¡œìš´ ë‡Œì„¸í¬ê°€ ë§Œë“¤ì–´ì§€ëŠ” ê³³.\n    - ì´ê³³ì˜ í˜ˆê´€ì€ ë§ˆì¹˜ **\"ì –ì€ íœ´ì§€(Wet tissue paper)\"**ì²˜ëŸ¼ ë§¤ìš° ì•½í•©ë‹ˆë‹¤. (Structural supportê°€ ì—†ìŒ).\n- **ê¸°ì „:** ë¯¸ìˆ™ì•„ì˜ í˜ˆì•• ë³€í™”, í˜¸í¡ ê³¤ë€(Respiratory distress) ë“±ìœ¼ë¡œ ì¸í•œ ìŠ¤íŠ¸ë ˆìŠ¤ â†’ ì•½í•œ í˜ˆê´€ì´ í‘ í„°ì§ â†’ ë‡Œì‹¤ ë‚´ ì¶œí˜ˆ(IVH).\n### **3. Diagnosis & Screening** ğŸ–¥ï¸\n- **Clinical Signs:**\n    - ìµœëŒ€ 50%ëŠ” **Clinically Silent (ë¬´ì¦ìƒ)**. ğŸ˜±\n    - ì‹¬í•œ ê²½ìš°: ë¶ˆë£©í•œ ëŒ€ì²œë¬¸(Bulging fontanelle), ë¹ˆí˜ˆ(Anemia), ë¬´í˜¸í¡(Apnea).\n- **Imaging (Gold Standard):** **Cranial Ultrasound (ë‡Œ ì´ˆìŒíŒŒ)** â˜…\n    - CTë¥¼ ì°ì§€ ì•ŠìŠµë‹ˆë‹¤ (ë°©ì‚¬ì„  í”¼í­ ë°©ì§€).\n    - **Protocol:** ëª¨ë“  32ì£¼ ë¯¸ë§Œ ë¯¸ìˆ™ì•„ëŠ” ì¦ìƒì´ ì—†ë”ë¼ë„ **Routine Screening Ultrasound**ë¥¼ ì‹œí–‰í•´ì•¼ í•©ë‹ˆë‹¤. (Must memorize!)\n    - ì´ˆìŒíŒŒì—ì„œ ë‡Œì‹¤ì€ ê·¸ëƒ¥ ê²€ì •ìƒ‰ì´ì—¬ì•¼í•˜ëŠ”ë° í•˜ì–€ìƒ‰ì¸ í”¼ê°€ ë³´ì¸ë‹¤ â˜…\n### **4. Complications**\n- **Post-Hemorrhagic Hydrocephalus:** í”¼ ë–¡(Blood clot)ì´ ë‡Œì²™ìˆ˜ì•¡(CSF) ë°°ì¶œêµ¬(Drain)ë¥¼ ë§‰ìŒ â†’ ë¨¸ë¦¬ê°€ ì»¤ì§€ê³  ë‡Œì•• ìƒìŠ¹.â†’ bulging fontanelle â†’ ì´ˆìŒíŒŒì°ìœ¼ì„¸ìš”.\n- **Management:** ë¨¸ë¦¬ ë‘˜ë ˆ(Head circumference)ë¥¼ ì£¼ê¸°ì ìœ¼ë¡œ ì¸¡ì •. í•„ìš”ì‹œ Shunt ìˆ˜ìˆ .\n## **Part 3: Pediatric Epilepsy Syndromes (The Big Three)** ğŸ“‰ğŸ‘¶ğŸ‘¦ğŸ§‘\në‚˜ì´(Age)ì™€ íŒ¨í„´(Pattern)ì„ ë§¤ì¹­í•˜ëŠ” ê²ƒì´ ì‹œí—˜ì˜ í•µì‹¬ì…ë‹ˆë‹¤!\n### **1. Infantile Spasms (West Syndrome) - Infants (<1 yr) ğŸ‘¶**\n- **Key Feature:** **Jackknife Spasms** (ì­ë‚˜ì´í”„ì²˜ëŸ¼ ëª¸ì„ ì ‘ìŒ). (ë¶€ëª¨ë“¤ì´ ê·¸ëƒ¥ ë¬´ì‹œí•˜ê¸° ì‰¬ì›€. colicì´ë‚˜ ê·¸ëƒ¥ ê·€ì—¬ì›Œë³´ì´ëŠ” í–‰ë™..ì¸ì¤„..)\n- **EEG Finding:** **Hypsarrhythmia (ê³ ì£¼íŒŒë¶€ì •ë‡ŒíŒŒ)** â˜… - \"Chaotic, High amplitude, Disorganized scribbles.\"\n- **Treatment (Gold Standard):** **ACTH (Adrenocorticotropic Hormone)** â˜…\n    - ì¼ë°˜ì ì¸ í•­ê²½ë ¨ì œê°€ ì•„ë‹™ë‹ˆë‹¤! ìŠ¤í…Œë¡œì´ë“œ í˜¸ë¥´ëª¬ ìš”ë²•ì´ 1ì°¨ ì¹˜ë£Œì œì…ë‹ˆë‹¤.\n- **Prognosis:** ì¹˜ë£Œê°€ ëŠ¦ì–´ì§€ë©´ ì˜êµ¬ì ì¸ ë°œë‹¬ ì§€ì—°(Intellectual Disability) ì´ˆë˜. ì‘ê¸‰ ìƒí™©ì…ë‹ˆë‹¤!\n### **2. Lennox-Gastaut Syndrome - Toddlers/Children (3-5 yrs) ğŸ‘¦**\n- **Context:** ë³´í†µ ì´ì „ì— West Syndromeì„ ì•“ì•˜ë˜ ì•„ì´ê°€ ì§„í–‰ë˜ê±°ë‚˜, ë°œë‹¬ ì§€ì—°ì´ ìˆëŠ” ì•„ì´ì—ê²Œì„œ ë°œìƒ.\n- **Symptoms:**\n    - ì—¬ëŸ¬ ì¢…ë¥˜ì˜ ë°œì‘(Multiple seizure types: Atonic, Tonic, Absence etc.)\n    - **Regression (í‡´í–‰):** ì˜ í•˜ë˜ ë§ì„ ëª» í•˜ê±°ë‚˜ ë°œë‹¬ì´ ë©ˆì¶¤.\n    - Intellectual Disability (ì§€ì  ì¥ì• ) ë™ë°˜.\n- **EEG Finding:** **Slow Spike-and-Wave Pattern (< 2.5 Hz)** â˜…\n- **Takeaway:** ì˜ˆí›„ê°€ ì¢‹ì§€ ì•Šê³  ì¹˜ë£Œê°€ ì–´ë µìŠµë‹ˆë‹¤ (Refractory).\n### **3. Juvenile Myoclonic Epilepsy (JME) - Teenagers ğŸ§‘ğŸ¤**\n- **Vignette:** 10ëŒ€ ì²­ì†Œë…„. í•™êµ ê°€ê¸° ì „ ì•„ì¹¨, ì–‘ì¹˜ì§ˆí•˜ë‹¤ê°€ ì¹«ì†”ì„ ë–¨ì–´ëœ¨ë¦¼(Myoclonic jerk). í˜¹ì€ ì‹œë¦¬ì–¼ ê·¸ë¦‡ì„ ì—ìŒ. \"ë‹¨ìˆœíˆ ë¤ë²™ëŒ€ê±°ë‚˜ í”¼ê³¤í•´ì„œ\"ë¼ê³  ì°©ê°í•˜ê¸° ì‰¬ì›€.\n- **Pattern:** **Morning Myoclonus** (ì•„ì¹¨ì— ë°œìƒí•˜ëŠ” ê·¼ìœ¡ íŠ).\n- **Triggers:**\n    - **Sleep Deprivation (ìˆ˜ë©´ ë¶€ì¡±)**: ì‹œí—˜ ê¸°ê°„ ë°¤ìƒ˜ ê³µë¶€. ğŸ“š\n    - **Alcohol (ìˆ )**: ëŒ€í•™ ì‹ ì…ìƒ í™˜ì˜íšŒ ë‹¤ìŒ ë‚  ì•„ì¹¨ ë°œì‘. ğŸº\n- **EEG Finding:** **4-6 Hz Polyspike and Wave**.\n- **Treatment:** **Valproic Acid (ë°œí”„ë¡œì‚°)** â˜… (Lifelong medicationì¸ ê²½ìš°ê°€ ë§ìŒ).\n## **Part 4: Febrile Seizures (ì—´ì„± ê²½ë ¨)** ğŸŒ¡ï¸ğŸ”¥","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-271","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"ë¶€ëª¨ë“¤ì´ ê°€ì¥ ë¬´ì„œì›Œí•˜ì§€ë§Œ, ì˜ì‚¬ëŠ” ê°€ì¥ ì¹¨ì°©í•´ì•¼ í•˜ëŠ” ìƒí™©ì…ë‹ˆë‹¤.\n### **1. Definitions & Classification (Must Memorize Table)**\n| **Feature** | **Simple Febrile Seizure (ë‹¨ìˆœ) âœ…** | **Complex Febrile Seizure (ë³µí•©) âš ï¸** |\n| --- | --- | --- |\n| **Duration (ì§€ì† ì‹œê°„)** | < 15 minutes (ì§§ìŒ) | > 15 minutes (ê¹€) |\n| **Type (í˜•íƒœ)** | Generalized (ì „ì‹  ë°œì‘, ì˜¨ëª¸ì„ ë–ª) | Focal (ë¶€ë¶„ ë°œì‘, í•œìª½ íŒ”ë§Œ ë–ª) |\n| **Frequency (ë¹ˆë„)** | 24ì‹œê°„ ë‚´ 1íšŒ | 24ì‹œê°„ ë‚´ 2íšŒ ì´ìƒ (ë°˜ë³µ) |\n| **Recovery** | ê¸ˆë°© íšŒë³µë¨ (Rapid return to baseline) | íšŒë³µì´ ëŠë¦¬ê±°ë‚˜ Todd's paralysis ë™ë°˜ ê°€ëŠ¥ |\n### **2. Management: The Rules** ğŸ“œ\n- **Simple Febrile Seizure:**\n    - **Action:** **Reassurance (ì•ˆì‹¬ì‹œí‚¤ê¸°)** & Discharge (ê·€ê°€).\n    - NO Imaging (CT/MRI X), NO EEG X.\n    - í•´ì—´ì œ(Antipyretics like Acetaminophen)ëŠ” ì—´ì„ ë‚´ë¦¬ì§€ë§Œ ë°œì‘ ì¬ë°œì„ ë§‰ì§€ëŠ” ëª»í•¨. (ë¶€ëª¨ êµìœ¡ í¬ì¸íŠ¸)\n- **Complex Febrile Seizure:**\n    - **Action:** Workup í•„ìš”. ì…ì› ê³ ë ¤, ë‡ŒíŒŒ(EEG)ë‚˜ MRI ê³ ë ¤ ê°€ëŠ¥. ë­”ê°€ ë‹¤ë¥¸ ì›ì¸ì´ ìˆëŠ”ì§€ ì°¾ì•„ë´ì•¼ í•¨.\n    - LP (r/o meningitis, r/o encephalitis), EEG, Imaging\n    - BZ to abort the seizure\n### **3. The Meningitis Fear (ë‡Œìˆ˜ë§‰ì—¼ ê°ë³„)** ğŸ¦ \n- ì—´ + ê²½ë ¨ = Meningitis?? í•­ìƒ ê³ ë¯¼ë˜ëŠ” ë¶€ë¶„.\n- ì•„ë˜ì— í•´ë‹¹ë˜ë©´ LPë¥¼ í•˜ê³  antibioticsê³ ë ¤í•œë‹¤.\n- **Lumbar Puncture (LP, ë‡Œì²™ìˆ˜ì•¡ ê²€ì‚¬) Indications:**\n    - PE sign: Meningeal Signs (ëª© ë»£ë»£í•¨, Kernig/Brudzinski sign), bulging fontanelle\n    - **Altered Mental Status (ì˜ì‹ ë³€í™”):** ë°œì‘ í›„ ê¸ˆë°© ê¹¨ì§€ ì•Šê³  ê³„ì† ì²˜ì ¸ ìˆì„ ë•Œ (>10-15ë¶„ ì´ìƒ). post ictal confusionì´ ê¸¸ë‹¤.\n    - **Unvaccinated (ë°±ì‹  ë¯¸ì ‘ì¢…):** Hib, Pneumococcal ë°±ì‹ ì„ ì•ˆ ë§ì€ ê²½ìš° (ì„¸ê· ì„± ë‡Œìˆ˜ë§‰ì—¼ ìœ„í—˜ â†‘)\n    - Petechial rash\n    - **Antibiotics use:** ì´ë¯¸ í•­ìƒì œë¥¼ ì“°ê³  ìˆì–´ì„œ ì¦ìƒì´ ê°€ë ¤ì§„ ê²½ìš° (Masked symptoms).\n## **RAPID FIRE RECAP: Scenario Testing** ğŸ”«ğŸ”¥\në§ˆì§€ë§‰ìœ¼ë¡œ ë°°ìš´ ë‚´ìš©ì„ ì‹œë‚˜ë¦¬ì˜¤ë¡œ ì •ë¦¬í•´ ë´…ì‹œë‹¤! (Audio Recap Section)\n| **Scenario** | **Diagnosis** | **Key Management/Next Step** |\n| --- | --- | --- |\n| **#1** 6ê°œì›” ì˜ì•„, Jackknife spasms (ëª¸ì„ ì ‘ìŒ) | **Infantile Spasms (West Syndrome)** | **Tx: ACTH** (Start ASAP to save brain!) |\n| **#2** 10ëŒ€ ì²­ì†Œë…„, ì•„ì¹¨ì— ì¹«ì†”ì„ ë–¨ì–´ëœ¨ë¦¼ (Morning jerks) | **Juvenile Myoclonic Epilepsy (JME)** | **Tx: Valproic Acid** (Look for sleep/alcohol triggers) |\n| **#3** 3ì„¸ ìœ ì•„, ë°œì‘ í›„ ì™¼ìª½ íŒ”ë‹¤ë¦¬ê°€ ì¶• ëŠ˜ì–´ì§ (Limp) | **Potential Stroke** (Todd's ParalysisëŠ” ë°°ì œ ì§„ë‹¨!) | **Dx: MRI Brain + MRA** (Urgent!)\nì–´ë¦°ì• ë“¤ì€ í˜ˆë¥˜ë¬¸ì œ í™•ì¸í•˜ê¸° ìœ„í•´ì„œ ì˜ìƒ ê²€ì‚¬í•œë‹¤. (Todd ì˜ì‹¬ë˜ì–´ë„) |\n| **#4** 30ì£¼ ë¯¸ìˆ™ì•„, ì‹ ìƒì•„ì‹¤(NICU) ì…ì› ì¤‘ (ì¦ìƒ ì—†ìŒ) | **IVH Risk** (Germinal Matrix Bleed) | **Screening: Head Ultrasound** at <32 weeks |\n| **#5** 3ì„¸, ì—´ë‚˜ê³  5ë¶„ê°„ ì „ì‹  ê²½ë ¨, ê¸ˆë°© ê¹¨ì–´ë‚¨ | **Simple Febrile Seizure** | **Tx: Discharge with Reassurance** (ì§‘ì— ê°€ì„¸ìš” ğŸ‘‹) |\n    - ì˜¤ë””ì˜¤ì—ì„œëŠ” 32ì£¼ ë¯¸ë§Œì„ IVH ìŠ¤í¬ë¦¬ë‹ ê¸°ì¤€ìœ¼ë¡œ ì œì‹œí–ˆì§€ë§Œ, ì‹¤ì œ ì„ìƒ ê°€ì´ë“œë¼ì¸ì€ ê¸°ê´€ë§ˆë‹¤ ì•½ê°„ ë‹¤ë¥¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤ (ë³´í†µ <30-32ì£¼).\n    - Todd's ParalysisëŠ” ì ˆëŒ€ \"ì¶”ì •\"í•˜ì§€ ë§ê³  Strokeë¥¼ ë¨¼ì € R/O(ë°°ì œ) í•´ì•¼ í•œë‹¤ëŠ” ì ì´ ê°€ì¥ ì¤‘ìš”í•©ë‹ˆë‹¤.\n    - ì†Œì•„ Strokeì˜ ì›ì¸ ì¤‘ Sickle Cell DiseaseëŠ” í•œêµ­ì¸ì—ê²Œ ë“œë¬¼ì§€ë§Œ USMLEì—ì„œëŠ” ë§¤ìš° ì¤‘ìš”í•œ Key factorì…ë‹ˆë‹¤.\n# ğŸ¥ USMLE Step 2 CK Deep Dive: Critical Care, Environmental & Anesthesia ğŸš€\n### ğŸ“‹ Overview (TL;DR)ã…‹\nì˜¤ëŠ˜ì˜ Deep DiveëŠ” **Critical Care Neurology(ì¤‘í™˜ì ì‹ ê²½í•™)**, **Environmental Injuries(í™˜ê²½ ì‘ê¸‰)**, ê·¸ë¦¬ê³  **Anesthesia Complications(ë§ˆì·¨ í•©ë³‘ì¦)**ì„ ë‹¤ë£¹ë‹ˆë‹¤. USMLEì—ì„œ ì‚¬ë‘í•˜ëŠ” \"High-Stakes\" ì£¼ì œë“¤ë¡œ, ìƒëª…ì„ ìœ„í˜‘í•˜ëŠ” ìƒí™©ì—ì„œì˜ **Rapid Decision Making**ì´ í•µì‹¬ì…ë‹ˆë‹¤.\n- **Neuro Critical Care:** Sympathetic Storming (PSH), Brain Death Criteria, PICS.\n- **Environmental:** Heat Stroke (Classic vs. Exertional), Hypothermia Management.\n- **Anesthesia:** Malignant Hyperthermia, Epidural Complications, Succinylcholine Risks.","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-291","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### ğŸŒ³ Meta-Cognitive Top-Down Classification\nì˜í•™ì  ë§¥ë½ì„ êµ¬ì¡°í™”í•˜ê¸° ìœ„í•œ ê³„ì¸µí˜• íŠ¸ë¦¬ì…ë‹ˆë‹¤. ì˜¤ëŠ˜ì˜ ì£¼ì œê°€ ì–´ë””ì— ìœ„ì¹˜í•˜ëŠ”ì§€ í™•ì¸í•˜ì„¸ìš”!\nPlaintext\n`CRITICAL CARE & EMERGENCY MEDICINE\nâ”‚\nâ”œâ”€â”€ ğŸ§  Neuro Critical Care\nâ”‚   â”œâ”€â”€ Hyperactive State\nâ”‚   â”‚   â””â”€â”€ Paroxysmal Sympathetic Hyperactivity (PSH) \"Storming\"\nâ”‚   â”œâ”€â”€ Loss of Function\nâ”‚   â”‚   â”œâ”€â”€ Brain Death (Irreversible)\nâ”‚   â”‚   â””â”€â”€ Coma (Potentially Reversible)\nâ”‚   â””â”€â”€ Chronic Sequelae\nâ”‚       â””â”€â”€ Post-Intensive Care Syndrome (PICS)\nâ”‚\nâ”œâ”€â”€ ğŸŒ¡ï¸ Environmental Injuries (Thermoregulation Failure)\nâ”‚   â”œâ”€â”€ Hyperthermia (Heat)\nâ”‚   â”‚   â”œâ”€â”€ Heat Exhaustion (CNS Intact)\nâ”‚   â”‚   â””â”€â”€ Heat Stroke (CNS Dysfunction)\nâ”‚   â”‚       â”œâ”€â”€ Classic (Non-exertional, Elderly)\nâ”‚   â”‚       â””â”€â”€ Exertional (Athletes)\nâ”‚   â””â”€â”€ Hypothermia (Cold)\nâ”‚       â”œâ”€â”€ Mild (Shivering)\nâ”‚       â”œâ”€â”€ Moderate (No shivering)\nâ”‚       â””â”€â”€ Severe (Coma/Arrhythmia)\nâ”‚\nâ””â”€â”€ ğŸ’‰ Anesthesia Complications\n    â”œâ”€â”€ Hypermetabolic Crisis\n    â”‚   â””â”€â”€ Malignant Hyperthermia (MH)\n    â”œâ”€â”€ Neuraxial Complications\n    â”‚   â”œâ”€â”€ Post-dural Puncture Headache\n    â”‚   â””â”€â”€ High Spinal (Resp. Paralysis)\n    â””â”€â”€ Drug Specific\n        â””â”€â”€ Succinylcholine Induced Hyperkalemia`\n# 1. Neuro Critical Care: The \"Storm\" & The \"Silence\" ğŸ§ âš¡ï¸\n### ğŸšª Doorway Thought: Clinical Vignette\në‘ ëª…ì˜ í™˜ìê°€ ìˆìŠµë‹ˆë‹¤. ë‘˜ ë‹¤ **Autonomic Explosion** ìƒíƒœì²˜ëŸ¼ ë³´ì…ë‹ˆë‹¤.\n1. **Patient A (ICU):** ì‹¬ê°í•œ TBI(Traumatic Brain Injury) í›„ íšŒë³µ ì¤‘. ê°„í˜¸ì‚¬ê°€ ë‹¨ìˆœíˆ ìŠ¤í€ì§€ ëª©ìš•(Sponge bath)ì„ ì‹œí‚¤ëŠ”ë° ê°‘ìê¸° ì‹¬ë°•ìˆ˜ ê¸‰ì¦, í˜ˆì•• ìƒìŠ¹, ê³ ì—´, ì‹ì€ë•€ì´ ë¹„ ì˜¤ë“¯ ìŸì•„ì§.\n2. **Patient B (OR):** ìˆ˜ìˆ ì„ ìœ„í•´ ë§‰ ì‚½ê´€(Intubation)í•¨. ê°‘ìê¸° í„± ê·¼ìœ¡(Jaw muscle)ì´ ëŒì²˜ëŸ¼ êµ³ê³ (Clamped shut), í™˜ê¸°(Ventilation)ê°€ ì˜ ë˜ëŠ”ë°ë„ í˜¸ê¸°ë§ ì´ì‚°í™”íƒ„ì†Œ(ETCO2)ê°€ ë¯¸ì¹œ ë“¯ì´ ì¹˜ì†ŸìŒ.\nğŸ‘‰ **Diagnosis?**\n- Patient A: **Paroxysmal Sympathetic Hyperactivity (PSH)** a.k.a \"Storming\"\n- Patient B: **Malignant Hyperthermia (MH)**\n## 1-1. Paroxysmal Sympathetic Hyperactivity (PSH)\n- **Concept:** TBI ë“±ìœ¼ë¡œ ì¸í•´ Cortical inhibition(ëŒ€ë‡Œì˜ ì œì–´)ì´ ëŠì–´ì§„ ìƒíƒœ. Brainstem(ë‡Œê°„)ì˜ Fight or Flight ì„¼í„°ê°€ ë¸Œë ˆì´í¬ ì—†ì´ í­ì£¼í•˜ëŠ” ê²ƒ.\n- **Trigger:** í†µì¦ì´ ì—†ëŠ” ìê·¹(Non-painful stimuli)ì´ íŠ¸ë¦¬ê±°ê°€ ë¨.\n    - ì˜ˆ: ëª©ìš•(Bathing), ì²´ìœ„ ë³€ê²½(Turning), ê°€ë˜ í¡ì…(Suctioning).\n- **Signs (Cluster of 5):**\n    1. Tachycardia (ë¹ˆë§¥)\n    2. Hypertension (ê³ í˜ˆì••)\n    3. Tachypnea (ë¹ˆí˜¸í¡)\n    4. Fever (ê³ ì—´)\n    5. Diaphoresis (ë°œí•œ)\n    - *Note:* 20~30ë¶„ ì •ë„ ì§€ì†ë¨. ë‹¨ìˆœí•œ ê³µí¬ ë°˜ì‘(Scare)ì´ ì•„ë‹˜.\n### ğŸ’Š Management\ní™”í•™ì  ì¥ë²½(Chemical Barrier)ì„ ë‹¤ì‹œ ì„¸ì›Œì¤˜ì•¼ í•©ë‹ˆë‹¤.\n- **Goal:** Replace the inhibition.\n- **Medications:**\n    - **Opioids:** í†µì¦ ì¡°ì ˆ ë° ì§„ì •.\n    - **GABA Agonists:** **Baclofen** (ì–µì œì„± ì‹ í˜¸ ê°•í™”).\n    - **Alpha-2 Agonists:** **Clonidine**, **Dexmedetomidine** (êµê°ì‹ ê²½ ìœ ì¶œ ì°¨ë‹¨).","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-311","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"## 1-2. Post-Intensive Care Syndrome (PICS) ğŸ“‰\nICU ìƒì¡´ì˜ ëŒ€ê°€(Price of survival). í‡´ì› í›„ baselineìœ¼ë¡œ ëŒì•„ê°€ì§€ ëª»í•˜ëŠ” í˜„ìƒ.\n- **The 3 Domains (Rule of 50s - 50% ì´ìƒì˜ ìƒì¡´ìê°€ ê²ªìŒ):**\n    1. **Psychiatric:** Major Depression, PTSD.\n    2. **Neurocognitive:** Dementia-like deficits (ê¸°ì–µë ¥, ì§‘ì¤‘ë ¥ ì €í•˜, ì‹¤í–‰ ê¸°ëŠ¥ ì¥ì• ). ì›ì¸ì€ CNS hypoxia, neuro-inflammation ë“±.\n    3. **Physical:** \"ICU Acquired Weakness\" (ê·¼ìœ¡ ìœ„ì¶•, ê±°ë™ ëŠ¥ë ¥ ìƒì‹¤).\n### ğŸ›¡ï¸ Prevention: ICU Liberation Strategies (Gold Standard) â˜…\nê¸°ì°¨(PICS Train)ê°€ ì˜¤ëŠ” ê²ƒì„ ë§‰ì•„ì•¼ í•©ë‹ˆë‹¤.\n- **Physical:** **Early PT/Mobilization** (ì•ˆì „í•˜ìë§ˆì ë°”ë¡œ ì›€ì§ì´ê²Œ í•¨).\n- **Pharmacological:** Deliriumì„ ìœ ë°œí•˜ëŠ” ì•½ë¬¼ ìµœì†Œí™”.\n- **Protocol:**\n    - **SAT (Spontaneous Awakening Trial):** ë§¤ì¼ ì§„ì •ì œë¥¼ êº¼ì„œ ê¹¨ì›Œë´„.\n    - **SBT (Spontaneous Breathing Trial):** ë§¤ì¼ ìë°œ í˜¸í¡ ëŠ¥ë ¥ì„ í…ŒìŠ¤íŠ¸í•¨.\n    - ë‡Œë¥¼ ê³„ì† \"Engage\" ì‹œí‚¤ëŠ” ê²ƒì´ í•µì‹¬!\n# 2. Brain Death: The Final Diagnosis ğŸ’€\n**Brain Death vs. Cardiac Death:**\n- Cardiac Death: ì‹¬ì¥ì´ ë©ˆì¶¤.\n- Brain Death: ë‡Œê°„(Brainstem)ê¹Œì§€ ì™„ì „íˆ ê¸°ëŠ¥ ì •ì§€. ì‹¬ì¥ì€ ì¸ê³µí˜¸í¡ê¸° ë•ë¶„ì— ëœ€.\n### ğŸ›‘ Prerequisites (Before you confirm)\ní™˜ìì—ê²Œ ì†ì„ ëŒ€ê¸° ì „ì— í™•ì¸í•´ì•¼ í•  ê²ƒë“¤:\n1. **Known Irreversible Cause:** (ì˜ˆ: Massive TBI, Anoxic injury). ë¯¸ìŠ¤í„°ë¦¬ í™˜ìì—ê²Œ ë‡Œì‚¬ ì„ ì–¸ ë¶ˆê°€.\n2. **Body Capable of Response:**\n    - Temp > 36Â°C (ì €ì²´ì˜¨ì¦ ë°°ì œ).\n    - SBP > 100 mmHg (ì‡¼í¬ ìƒíƒœ ë°°ì œ).\n    - No Electrolyte/Metabolic issues.\n    - No Paralytics/Sedatives on board.\n### ğŸ”¨ The Exam (Brainstem Reflexes)\nTop-to-Bottomìœ¼ë¡œ ë‡Œê°„ ë°˜ì‚¬ê°€ **ëª¨ë‘ ì†Œì‹¤(Absent)**ë˜ì–´ì•¼ í•¨.\n- Pupils: Fixed & Dilated (Non-reactive).\n- Corneal Reflex: Absent.\n- Oculo-vestibular (Cold Caloric/Doll's eyes): Absent.\n- Gag/Cough: Absent.\n- **Motor Response:** **No Brain-originating motor response.**\n    - âš ï¸ **HUGE TRAP:** **Spinal Reflexes** (Deep tendon reflex, ë¬´ë¦ ì¹˜ë©´ ë°˜ì‘í•˜ëŠ” ê²ƒ)ëŠ” ë‚¨ì•„ìˆì„ ìˆ˜ ìˆìŒ! ë‡Œê°€ ê´€ì—¬í•˜ì§€ ì•ŠëŠ” ì²™ìˆ˜ ë°˜ì‚¬ì´ê¸° ë•Œë¬¸. í™˜ìì˜ ì†ì„ ë§Œì¡ŒëŠ”ë° ì›€ì°”í•œë‹¤ê³  í•´ì„œ ë‡Œì‚¬ê°€ ì•„ë‹ˆë¼ê³  íŒë‹¨í•˜ë©´ ì•ˆ ë¨(Lazarus sign ë“±).\n### ğŸŒ¬ï¸ The Apnea Test (The Definitive Test / Gold Standard) â˜…\nê°€ì¥ ì›ì´ˆì ì¸ ë‡Œê°„ ê¸°ëŠ¥ì¸ \"í˜¸í¡ ë“œë¼ì´ë¸Œ(Drive to breathe)\"ë¥¼ í…ŒìŠ¤íŠ¸í•¨.\n1. **Pre-oxygenate:** ì‚°ì†Œë¥¼ ì¶©ë¶„íˆ ì¤Œ.\n2. **Disconnect Ventilator:** í˜¸í¡ê¸°ë¥¼ ë—Œ.\n3. **Wait:** 8~10ë¶„ ê´€ì°°.\n4. **Positive Criteria (Brain Death Confirmed):**\n    - **No Respiratory Effort** (ê°€ìŠ´ ì›€ì§ì„ ì—†ìŒ).\n    - **PaCO2 > 60 mmHg** (í˜¹ì€ ë² ì´ìŠ¤ë¼ì¸ë³´ë‹¤ 20 ì´ìƒ ìƒìŠ¹).\n    - **pH < 7.28** (Acidosis).\n- *Note:* í™˜ìê°€ ë¶ˆì•ˆì •í•´ì„œ Apnea testë¥¼ ëª»í•˜ë©´? **Ancillary Tests** (EEG Flatline, Cerebral Angiography - No flow) ì‚¬ìš©.","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-331","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","diagnosis","tree"]}
{"chunk_type":"transcript_chunk","text":"### â¤ï¸ Organ Donation Physiology\në‡Œì‚¬ í›„ ì‹ ì²´ëŠ” ë¶•ê´´(Collapse)í•˜ê¸° ì‹œì‘í•¨. ì¥ê¸° ê¸°ì¦ì„ ìœ„í•´ ê¸°ëŠ¥ì„ ìœ ì§€í•´ì•¼ í•¨.\n1. **Diabetes Insipidus (DI):** ë‡Œí•˜ìˆ˜ì²´ í›„ì—½ ì‚¬ë§ â†’ ADH ì•ˆ ë‚˜ì˜´ â†’ ì†Œë³€ í­ë°œ(ì‹œê°„ë‹¹ 1Lì”©).\n    - ğŸ‘‰ **Tx:** Desmopressin, Massive Fluids.\n2. **Systemic Hypotension:** êµê°ì‹ ê²½ í†¤ ìƒì‹¤ â†’ í˜ˆê´€ í™•ì¥.\n    - ğŸ‘‰ **Tx:** Pressors, Fluids.\n3. **Hypothermia:** ì‹œìƒí•˜ë¶€(Thermostat) ì‚¬ë§.\n    - ğŸ‘‰ **Tx:** Warming blankets (Active external warming).\n# 3. Environmental Injuries: Heat & Cold ğŸŒ¡ï¸\n## 3-1. Heat Stroke vs. Heat Exhaustion ğŸ”¥\nê¸°ì¤€ì : **Core Temp 40Â°C (104Â°F)** + **CNS Dysfunction (Mental Status)**\n| **Feature** | **Heat Exhaustion** | **Heat Stroke (Emergency!)** |\n| --- | --- | --- |\n| **Temperature** | < 40Â°C | **> 40Â°C** |\n| **CNS Status** | **Normal** (ì§œì¦ë‚¼ ìˆœ ìˆì–´ë„ í˜¼ëˆì€ ì—†ìŒ) | **Confused, Seizure, Coma** |\n| **Treatment** | Fluids, Cool environment | **Rapid Cooling** (See below) |\n### â„ï¸ Heat Stroke Types & Management (High Yield!)\në‘ ê°€ì§€ íƒ€ì…ì˜ ì¹˜ë£Œë²•ì´ ë‹¤ë¥´ë‹¤ëŠ” ê²ƒì´ ì‹œí—˜ í¬ì¸íŠ¸!\n1. **Classic (Non-exertional):**\n    - **Who:** í• ë¨¸ë‹ˆ(Elderly), í•­ì½œë¦°ì„± ì•½ë¬¼ ë³µìš©ì(ë•€ ì•ˆ ë‚¨).\n    - **Skin:** **Dry** & Hot.\n    - **Tx:** **Evaporative Cooling** (ë¯¸ì§€ê·¼í•œ ë¬¼ ë¿Œë¦¬ê³  ì„ í’ê¸° í‹€ê¸°).\n        - âš ï¸ **Warning:** **Ice Water Immersion ê¸ˆì§€!** ë…¸ì¸ì€ ì°¬ë¬¼ì— ë“¤ì–´ê°€ë©´ í˜ˆê´€ ìˆ˜ì¶•(Vasoconstriction)ìœ¼ë¡œ ì—´ì„ ê°€ë‘ê³ , ì˜¤í•œ(Shivering)ìœ¼ë¡œ ì—´ì„ ë” ìƒì‚°í•˜ì—¬ ì‚¬ë§ë¥ ì´ ì˜¬ë¼ê°.\n2. **Exertional:**\n    - Heat exhaustionê³¼ Exertional heat strokeê³¼ì˜ ì°¨ì´ì :\n        - *ì˜ì‹ì´ ì†Œì‹¤ë˜ì–´ìˆê³ , ì²´ì˜¨ì´ 40ë„ ì´ìƒì„.*\n    - **Who:** ìš´ë™ì„ ìˆ˜, êµ°ì¸, ìœ¡ì²´ë…¸ë™ì.\n    - **Skin:** **Sweating** profusley (ëŒ€ì‚¬ì„± ì—´ ìƒì‚°).\n    - **Tx:** **Ice Water Immersion** (ì–¼ìŒë¬¼ì— ë‹´ê·¸ê¸°). ì Šê³  ê±´ê°•í•´ì„œ ì „ë„(Conduction) ëƒ‰ê°ì´ ê°€ì¥ ë¹ ë¥´ê³  íš¨ê³¼ì .\n## 3-2. Hypothermia ğŸ¥¶\n- **Mild (32-35Â°C):** ì˜¤í•œ(Shivering) ìˆìŒ.\n    - ğŸ‘‰ **Tx:** **Passive External Rewarming** (ë‹´ìš” ë®ê¸°, ì –ì€ ì˜· ì œê±°).\n- **Moderate (28-32Â°C):** ì˜¤í•œ ë©ˆì¶¤(ì—ë„ˆì§€ ê³ ê°ˆ), ê¸°ë©´(Lethargic).\n    - ğŸ‘‰ **Tx:** **Active External Rewarming** (ì˜¨ì—´ íŒ¨ë“œ, ë”°ëœ»í•œ ëª©ìš•).\n- **Severe (<28Â°C):** í˜¼ìˆ˜(Coma), ì‹¬ì‹¤ì„¸ë™(V-fib) ìœ„í—˜.\n    - ğŸ‘‰ **Tx:** **Active Internal Rewarming** (Warm IV fluids, Warm Lavage - Bladder/Peritoneal, ECMO). \"Core\"ë¶€í„° ë°ì›Œì•¼ í•¨.\n    - ì €ì²´ì˜¨ì¦ bradycardiaì—ì„œëŠ” atropineë“±ì´ íš¨ê³¼ê°€ ì—†ìŒ. (pacemakerê°€ ì–¼ì–´ìˆìŒ.)\n    â†’ ì•½ ëŒ€ì‹  ì²´ì˜¨ì„ ë¨¼ì € ì˜¬ë ¤ì¤˜ì•¼í•¨.\n- Frostbite:\n    - pallor skin, anesthesia, blistering, necrosis\n    - Management:\n        - water bath\n        - rewarming\n        - **Refreezing Risk:** ë™ìƒ(Frostbite) ë¶€ìœ„ê°€ ë‹¤ì‹œ ì–¼ ê°€ëŠ¥ì„±ì´ ìˆë‹¤ë©´ ì ˆëŒ€ ë…¹ì´ì§€ ë§ˆë¼(Thaw). ì¡°ì§ ê´´ì‚¬ê°€ í›¨ì”¬ ì‹¬í•´ì§. â˜…\n# 4. Anesthesia Complications ğŸ˜·\n## 4-1. Malignant Hyperthermia (MH) ğŸ”¥\n- **Genetic:** Ryanodine Receptor ë³€ì´ (Autosomal Dominant).\n- **Trigger:** **Volatile Anesthetics** (Halothane, Sevoflurane ë“±) + **Succinylcholine**.\n- **Pathophysiology:** ê·¼ìœ¡ ì„¸í¬ ë‚´ ì¹¼ìŠ˜(Ca2+) í†µì œ ë¶ˆëŠ¥ â†’ ê·¼ìœ¡ ìˆ˜ì¶• ì§€ì† â†’ ëŒ€ì‚¬ í­ë°œ.\n- **Signs:**\n    - **Early:** Masseter Muscle Rigidity (í„± ê·¼ìœ¡ ê°•ì§), **Rising ETCO2** (í™˜ê¸° ì˜ ë˜ëŠ”ë°ë„ CO2 ìƒìŠ¹ - ì´ì‚°í™”íƒ„ì†ŒëŠ” ëŒ€ì‚¬ ì‚°ë¬¼ì„).\n    - **Late:** Hyperthermia (ì—´ì€ ë‚˜ì¤‘ì— ë‚¨), Rhabdomyolysis, Hyperkalemia.\n- **Tx (Gold Standard):** â˜…\n    1. **Stop Trigger** immediately.\n    2. **Dantrolene** IV (RyR antagonist - ê·¼ìœ¡ ì´ì™„).\n## 4-2. Succinylcholine Risks â˜ ï¸\n- **Mechanism:** Depolarizing blocker. ìˆ˜ìš©ì²´ì— ë¶™ì–´ì„œ íƒˆë¶„ê·¹(Depolarization)ì„ ì‹œí‚´. ì´ ê³¼ì •ì—ì„œ ì„¸í¬ ë‚´ **K+ (ì¹¼ë¥¨)**ì´ ë°–ìœ¼ë¡œ ì¡°ê¸ˆ ë‚˜ì˜´.\n- **Contraindications:** **Upregulation of ACh Receptors**ê°€ ìˆëŠ” í™˜ìë“¤.\n    - Burn victims (í™”ìƒ), Crush injury, Stroke/Denervation, Guillain-Barre.\n    - ì´ í™˜ìë“¤ì€ ê·¼ìœ¡ ì „ì²´ì— ìˆ˜ìš©ì²´ê°€ ê¹”ë ¤ìˆì–´ì„œ Suxë¥¼ ì“°ë©´ K+ê°€ ëŒ€ëŸ‰ ë°©ì¶œë¨ â†’ **Cardiac Arrest**.\n    - ğŸ‘‰ **Next Best Step:** **Rocuronium** or **Vecuronium** (Non-depolarizing) ì‚¬ìš©.","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-351","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"## 4-3. Neuraxial Anesthesia (Epidural/Spinal)\n- **Hypotension:** êµê°ì‹ ê²½ ì°¨ë‹¨(Sympathetic blockade) â†’ í˜ˆê´€ í™•ì¥. (m/c complication).\n- **High Spinal:** ë§ˆì·¨ì œê°€ ë„ˆë¬´ ë†’ê²Œ ì˜¬ë¼ê°€ì„œ C3-C5(íš¡ê²©ë§‰) ë§ˆë¹„ â†’ Respiratory Arrest. (ìƒì§€ì˜ í˜ì´ ì•½í•´ì§€ë©´ ì˜ì‹¬..)\n- **Post-dural Puncture Headache:** ë°”ëŠ˜ì´ Duraë¥¼ ëš«ìŒ â†’ CSF ëˆ„ì¶œ.\n    - íŠ¹ì§•: ì„œ ìˆìœ¼ë©´(Upright) ì•„í”„ê³  ëˆ„ìš°ë©´(Supine) ì¢‹ì•„ì§.\n    - ğŸ‘‰ **Tx:** **Epidural Blood Patch** (ë³¸ì¸ í”¼ë¥¼ ì£¼ì…í•´ì„œ êµ¬ë©ì„ ë§‰ìŒ).\n### ğŸ”¥ Rapid Fire Recap (Summary Table)\n| **Condition** | **Key Trigger/Sign** | **Gold Standard / Next Best Step â˜…** |\n| --- | --- | --- |\n| **PSH (Storming)** | TBI + Non-painful trigger (Bath) | **Opioids, Baclofen, Clonidine** (Replace inhibition) |\n| **Malignant Hyperthermia** | Volatiles/Sux + Jaw Rigidity + â†‘ETCO2 | **Stop Agent + Dantrolene** |\n| **Brain Death** | Absent Reflexes + Apnea | **Apnea Test** (PaCO2 > 60, No breath) |\n| **Classic Heat Stroke** | Grandma, Dry skin, >40Â°C | **Evaporative Cooling** (Mist + Fan) *NO ICE BATH* |\n| **Exertional Heat Stroke** | Athlete, Sweating, >40Â°C | **Ice Water Immersion** |\n| **Hypothermia (Severe)** | < 28Â°C, Coma/Arrhythmia | **Active Internal Rewarming** (Lavage/ECMO) |\n| **PDPH (Headache)** | Better when lying flat | **Epidural Blood Patch** |","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-371","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","treatment"]}
{"chunk_type":"transcript_chunk","text":"# LM_neuro 4\n### ğŸ“‹ Overview: Ophthalmology Infections (USMLE Step 2 CK)\n**TL;DR Summary Table**\n| **Category** | **Key Pathology** | **Classic Sign / Keyword** | **Immediate Action / Tx** |\n| --- | --- | --- | --- |\n| **Orbit** | Orbital Cellulitis | Pain with EOM, Proptosis, Ophthalmoplegia | **â˜… CT Scan + IV Abx + Surgery** |\n|  | Preseptal Cellulitis | Eyelid swelling ONLY (No pain with EOM) | Oral Antibiotics |\n| **Conjunctiva** | Viral Conjunctivitis | Watery, gritty, follicular | Supportive / Hygiene |\n|  | Bacterial Conjunctivitis | Purulent, \"glued shut\", unremitting | Erythromycin or Polytrim drops |\n|  | Neonatal (Gonococcal) | Day 2-5, Profuse Purulent, Corneal risk | **â˜… IM Ceftriaxone (Systemic)** |\n|  | Neonatal (Chlamydia) | Day 5-14, Pneumonia risk | **â˜… Oral Erythromycin (Systemic)** |\n| **Cornea** | HSV Keratitis | Dendritic Ulcer, decreased sensation | Acyclovir / Ganciclovir |\n|  | Bacterial Keratitis | Contact lens, Pseudomonas | Fluoroquinolone Drops |\n| **Intraocular** | Endophthalmitis | Post-Cataract, Hypopyon, Vitreous Haze | **â˜… Intravitreal Abx + Vitrectomy** |\n|  | Anterior Uveitis | Photophobia, Ciliary Flush, HLA-B27 | Steroids + Cycloplegics |\n### ğŸŒ³ Top-Down Classification: Eye Infections\nUSMLEì—ì„œ ì•ˆê³¼ ê°ì—¼ì€ **\"Anatomical Depth (í•´ë¶€í•™ì  ê¹Šì´)\"**ì™€ **\"Mechanism (ê¸°ì „)\"**ì— ë”°ë¼ ë¶„ë¥˜ë©ë‹ˆë‹¤.\nPlaintext\n#\n`EYE INFECTIONS (Hierarchy of Depth)\nâ”‚\nâ”œâ”€â”€ 1. Eyelid & Lacrimal (Surface \"Lumps & Bumps\")\nâ”‚   â”œâ”€â”€ Hordeolum (Stye): Painful, Acute Infection (Staph)\nâ”‚   â”œâ”€â”€ Chalazion: Painless, Chronic Granuloma\nâ”‚   â”œâ”€â”€ Blepharitis: \"Dandruff\" of eyelashes\nâ”‚   â”œâ”€â”€ Dacryocystitis: Infected Lacrimal Sac (Medial Canthus)\nâ”‚   â””â”€â”€ Nasolacrimal Duct Stenosis: \"Wet Eye\" only (No Redness)\nâ”‚\nâ”œâ”€â”€ 2. Orbital vs. Preseptal (The \"Wall\")\nâ”‚   â”œâ”€â”€ Preseptal Cellulitis: Anterior to Septum (Skin deep)\nâ”‚   â””â”€â”€ Orbital Cellulitis: Posterior to Septum (DANGER! Brain proximity)\nâ”‚\nâ”œâ”€â”€ 3. Conjunctiva (The \"White part\")\nâ”‚   â”œâ”€â”€ Viral: Pink, Watery (Adenovirus)\nâ”‚   â”œâ”€â”€ Bacterial: Purulent, Glued shut\nâ”‚   â”œâ”€â”€ Allergic: Itching, Bilateral\nâ”‚   â””â”€â”€ Neonatal: Time-dependent (Chemical â†’ GC â†’ Chlamydia)\nâ”‚\nâ”œâ”€â”€ 4. Cornea (The \"Window\")\nâ”‚   â”œâ”€â”€ HSV Keratitis: Dendritic\nâ”‚   â”œâ”€â”€ Bacterial Keratitis: Contact Lens (Pseudomonas)\nâ”‚   â””â”€â”€ Fungal Keratitis: Vegetable matter, Feathery\nâ”‚\nâ””â”€â”€ 5. Intraocular (Deep Inside)\n    â”œâ”€â”€ Anterior Uveitis: Iris/Ciliary body (Autoimmune/HLA-B27)\n    â””â”€â”€ Endophthalmitis: Vitreous Humor (Post-surgery Nightmare)`\n### Orbital cellulitis ìª½ì´ë©´ ê±°ì˜ ë¬´ì¡°ê±´ â€œì•ˆêµ¬/ì•ˆì™€ ê¸°ëŠ¥ ì¥ì• â€ê°€ ëœ¸â˜…\n- **Pain with eye movementâ˜…**\n- **Ophthalmoplegia / diplopiaâ˜…**\n- **Proptosisâ˜…**\n- **Vision change / RAPDâ˜…**\n- Â± fever, toxic\n### Preseptal cellulitisëŠ” â€œëˆˆêº¼í’€ë§Œâ€ í¬ê²Œ ì•„í”„ê³  ë¶“ëŠ”ë°â˜…\n- **ì‹œë ¥ ì •ìƒ**\n- **EOM ì •ìƒ**, pain with movement ì—†ìŒ\n- **proptosis ì—†ìŒ**\n### ConjunctivitisëŠ” ì£¼ë¡œ\n- **ê²°ë§‰ ì¶©í˜ˆ + ë¶„ë¹„ë¬¼ + ì´ë¬¼ê°**\n- **ì‹œë ¥ì€ ëŒ€ì²´ë¡œ ì •ìƒ(ì‹¬í•œ photophobia/ì‹œë ¥ì €í•˜ë©´ ê°ë§‰ ë³‘ë³€ ì˜ì‹¬)**","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-1","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### 1. Orbital vs. Preseptal Cellulitis (The Heavyweight Championship) ğŸ¥Š\n**ğŸšª Vignette Anchors:**\n- **Scenario A (Orbital):** 5ì„¸ ì•„ì´, ë¹„ëª…ì„ ì§€ë¦„(Screaming), ëˆˆì„ ë§Œì§€ì§€ë„ ëª»í•˜ê²Œ í•¨, ëˆˆì„ ëœ° ë•Œ ê·¹ì‹¬í•œ ê³ í†µ.\n- **Scenario B (Preseptal):** í‹±í†¡ ë³´ê³  ìˆëŠ” 10ëŒ€, ëˆˆì´ ë¶“ê³  ëˆì í•˜ì§€ë§Œ(Sticky), ì¹¨ì°©í•¨(Calm). ì¢€ ê·€ì°®ì•„í•  ë¿ ê³ í†µìŠ¤ëŸ¬ì›Œí•˜ì§€ ì•ŠìŒ.\n### ğŸ§  Concept & Anatomy: The Orbital Septum\n- **Orbital Septum:** ëˆˆêº¼í’€ì˜ ë¼ˆ(Rim)ì—ì„œ ëˆˆêº¼í’€(Eyelid)ë¡œ ë‚´ë ¤ì˜¤ëŠ” ì„¬ìœ ì„± ì¡°ì§(Fibrous tissue).\n    - **ì—­í• :** \"Firewall\" (ë°©í™”ë²½) ë˜ëŠ” \"Bulkhead\" (ê²©ë²½) ì—­í• . ë°”ê¹¥ì„¸ìƒ(í”¼ë¶€)ê³¼ ì•ˆìª½ ì„¸ìƒ(Orbit: ì•ˆêµ¬, ì§€ë°©, ê·¼ìœ¡, ì‹œì‹ ê²½, ë‡Œë¡œ ê°€ëŠ” í†µë¡œ)ì„ ë¶„ë¦¬í•¨.\n- **ì§€ë¦¬ì  ìœ„ì¹˜(Geography)ê°€ ì§„ë‹¨ì„ ê²°ì •í•¨:**\n    - **Preseptal:** Septum ì•ìª½ í”¼ë¶€ ê°ì—¼ (Eye machineryëŠ” ì•ˆì „í•¨).\n    - **Orbital:** ì„¸ê· ì´ ë°©í™”ë²½ì„ ëš«ìŒ. ì•ˆêµ¬ ë’¤ìª½ì˜ ì§€ë°©ê³¼ ê·¼ìœ¡ì— ê°ì—¼. **Surgical Emergency!**\n### ğŸš‘ The Deadly Trio (Signs of Orbital Cellulitis)\nì‹œí—˜ì—ì„œ ì´ 3ê°€ì§€ ì¤‘ í•˜ë‚˜ë¼ë„ ë³´ì´ë©´ **ë¬´ì¡°ê±´ Orbital**ì…ë‹ˆë‹¤. (Preseptalì€ ì´ ì¦ìƒì´ ì—†ìŒ!)\n1. **Pain with Extraocular Movements (EOM):** ëˆˆì„ ì›€ì§ì¼ ë•Œë§ˆë‹¤ ì•„í”” (ì—¼ì¦ì´ ìˆëŠ” ê·¼ìœ¡ì„ ëŒì–´ë‹¹ê¸°ê¸° ë•Œë¬¸).\n2. **Proptosis (Bulging):** ì•ˆêµ¬ê°€ íŠ€ì–´ ë‚˜ì˜´ (ì•ˆêµ¬ ë’¤ìª½ ê³µê°„ì— ê³ ë¦„/ì—¼ì¦ì´ ì°¨ì„œ ëˆˆì„ ì•ìœ¼ë¡œ ë°€ì–´ëƒ„).\n3. **Ophthalmoplegia:** ëˆˆì´ ì–¼ì–´ë¶™ì–´ ì›€ì§ì´ì§€ ì•ŠìŒ (ê·¼ìœ¡ ë§ˆë¹„/ê¸°ëŠ¥ ì •ì§€).\n    - *ì¶”ê°€:* Diplopia (ë³µì‹œ), Vision loss (ì‹œì‹ ê²½ ì••ë°•).\n### ğŸ¦  Etiology\n- **Orbital CellulitisëŠ” ë‹¨ë…ìœ¼ë¡œ ì˜ ì•ˆ ìƒê¹€.**\n- ëŒ€ë¶€ë¶„ **Bacterial Rhinosinusitis (ë¶€ë¹„ë™ì—¼)**ì˜ í•©ë³‘ì¦. Ethmoid sinus(ì‚¬ê³¨ë™)ì˜ ì–‡ì€ ë¼ˆë¥¼ ëš«ê³  ê°ì—¼ì´ ì¹¨íˆ¬í•¨.\n### ğŸ’Š Management & Next Best Step\n| **Condition** | **Next Best Step (Dx)** | **Treatment (Tx)** |\n| --- | --- | --- |\n| **Preseptal** | Clinical Dx (ëˆˆ ì˜ ì›€ì§ì„) | **Oral Antibiotics** + Close Follow-up |\n| **Orbital** | **â˜… CT Scan of Orbit** | **â˜… IV Antibiotics (Vancomycin + Cephalosporin) + Surgical Drainage (if abscess)** |\n### 2. Conjunctivitis (Pink Eye) ğŸ‘ï¸\n**ğŸšª Vignette Anchor:** ì–´ë¦°ì´ì§‘(Daycare)ì—ì„œ ìœ í–‰í•˜ëŠ” ëˆˆë³‘. \"Discharge(ë¶„ë¹„ë¬¼)\"ì˜ ì–‘ìƒì´ í•µì‹¬.\n### A. Viral Conjunctivitis (Most Common)\n- **Vignette:** \"Pink eye\", ë¬½ì€ ëˆˆë¬¼(Watery), ëª¨ë˜ ë“¤ì–´ê°„ ëŠë‚Œ(Gritty), ê°ê¸° ê¸°ìš´(Viral prodrome).\n- **Exam:** ëˆˆêº¼í’€ ë’¤ì§‘ì–´ë³´ë©´ **Follicular appearance** (ìŒ€ì•Œ ê°™ì€ ëŒê¸°).\n- **Cause:** **Adenovirus** (ì „ì—¼ì„± ë§¤ìš° ê°•í•¨, Self-limiting).\n- **Tx:** Supportive (ì‹œì›í•œ ì°œì§ˆ, ìœ„ìƒ ê´€ë¦¬).","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-21","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### B. Bacterial Conjunctivitis\n- **Vignette:** \"Gross\", **Purulent (Frank Pus)**, ì•„ì¹¨ì— ëˆˆì´ ë”± ë¶™ì–´ì„œ ì•ˆ ë– ì§ (\"Glued shut\").\n- **Key Descriptor:** **\"Unremitting discharge\"** (ë‹¦ì•„ë„ ëª‡ ë¶„ ë’¤ì— ë‹¤ì‹œ ê³ ë¦„ì´ ì°¸).\n- **Tx:** Erythromycin ointment or Polytrim drops.\n    - **âš ï¸ Contact Lens Wearer:** **Pseudomonas** ìœ„í—˜! â†’ **â˜… Fluoroquinolones (Ciprofloxacin/Ofloxacin)** drops í•„ìˆ˜.\n### C. Allergic Conjunctivitis\n- **Vignette:** ëˆˆì„ ê³„ì† ë¹„ë¹”(Rubbing).\n- **Hallmark:** **Itching (ê°€ë ¤ì›€)** = Allergy. ì•ˆ ê°€ë ¤ìš°ë©´ ì•Œë ˆë¥´ê¸° ì•„ë‹˜.\n- **Exam:** Chemosis (ê²°ë§‰ë¶€ì¢… - Jelly ê°™ì€ ë¶“ê¸°), Bilateral(ì–‘ìª½).\n- **Tx:** Antihistamines.\n### 3. Neonatal Conjunctivitis: The Timeline ğŸ‘¶â³\nì‹ ìƒì•„ ê²°ë§‰ì—¼ì€ **\"ìƒí›„ ë©°ì¹ ì§¸ì¸ê°€?\"**ê°€ ì§„ë‹¨ëª…ì…ë‹ˆë‹¤. (USMLE Classic)\n| **Timeline** | **Cause** | **Characteristics** | **Treatment (Tx)** |\n| --- | --- | --- | --- |\n| **Day 1 (<24hr)** | **Chemical** | Silver Nitrate/Erythromycin drops ìê·¹. Mild, non-purulent. | **Lubricant**. (Self-resolving) |\n| **Day 2-5** | **Gonococcal** (N. gonorrhea) | **ğŸ”¥ EMERGENCY.** Profuse Purulent Discharge (\"ëˆˆì´ ê³ ë¦„ìœ¼ë¡œ í­ë°œ\"). **Corneal Perforation** ìœ„í—˜. | **â˜… IM Ceftriaxone (Systemic!)** + Topical erythromycin prophylaxis fail. |\n| **Day 5-14** | **Chlamydia** (C. trachomatis) | Watery â†’ Mucopurulent. **Pneumonia** ìœ„í—˜ (Nasopharynx ê°ì—¼). | **â˜… Oral Erythromycin (Systemic!)** (Why? To prevent pneumonia). |\n| **Anytime** | **HSV** | Vesicles around eyes, Keratitis. | IV Acyclovir. |\n### 4. Trachoma (Global Blindness) ğŸŒ\n- **Cause:** Chlamydia trachomatis serotypes **A, B, C**. (Leading cause of infectious blindness worldwide).\n- **Pathophysiology (Stages):**\n    1. Repeated Infection (Stage 1).\n    2. **Scarring (Stage 2):** ê²°ë§‰ì— í‰í„°ê°€ ìƒê²¨ ìˆ˜ì¶•í•¨.\n    3. **Entropion:** ëˆˆêº¼í’€ì´ ì•ˆìª½ìœ¼ë¡œ ë§ë ¤ ë“¤ì–´ê°.\n    4. **Trichiasis:** ì†ëˆˆì¹ì´ ê°ë§‰(Cornea)ì„ ì°Œë¦„ (Windshield wiper made of sandpaper).\n    5. **Corneal Opacity:** ì‹¤ëª…(Blindness).\n- **Tx:** Oral Azithromycin (Mass administration).\n### 5. Corneal Ulcers (Keratitis) ğŸ¦ \n**ğŸšª Vignette Anchor:** ëˆˆì´ ì•„í”„ê³ (Pain), ì¶©í˜ˆ(Red), **Photophobia (ëˆˆë¶€ì‹¬)**. ê°ë§‰(Window)ì´ ê³µê²©ë°›ìŒ.\n### A. HSV Keratitis (Herpes)\n- **Stain:** **Dendritic Ulcer** (ë‚˜ë­‡ê°€ì§€ ëª¨ì–‘, Branching lightning bolt).\n- **Sensation:** **Reduced Corneal Sensation** (Cotton wisp test ì‹œ ëˆˆ ì•ˆ ê¹œë¹¡ì„). ë°”ì´ëŸ¬ìŠ¤ê°€ ì‹ ê²½ì„ íŒŒê´´í•¨.\n- **Tx:** Oral/Topical Acyclovir or Ganciclovir. **Avoid Steroids!** (ìŠ¤í…Œë¡œì´ë“œëŠ” ìƒí™©ì„ ì•…í™”ì‹œí‚´).\n### B. Bacterial Keratitis\n- **Vignette:** Contact lens wearer + Red eye + Pain.\n- **Finding:** Round central ulcer, Stromal abscess, Hypopyon possible.\n- **Bug:** Usually **Pseudomonas** (Contact lens).\n- **Tx:** Topical Fluoroquinolones (Hourly dosing).\n### C. Fungal Keratitis","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-41","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"- **Vignette:** **Agricultural worker / Gardener**. ë‚˜ë­‡ê°€ì§€ì— ëˆˆì„ ì°”ë¦¼ (Vegetative matter).\n- **Finding:** **\"Feathery\" borders** (ê¹ƒí„¸ ëª¨ì–‘ ê°€ì¥ìë¦¬), **Satellite lesions** (ì£¼ë³€ì— ìœ„ì„± ë³‘ë³€).\n- **Tx:** Topical Antifungals (Natamycin etc).\n### 6. Endophthalmitis (The Nightmare) ğŸ’€\n- **Definition:** Vitreous Humour (ëˆˆì•Œ ë‚´ë¶€ ì ¤ë¦¬)ì˜ ê°ì—¼. Pus inside the eyeball.\n- **Vignette:** ë°±ë‚´ì¥ ìˆ˜ìˆ (Cataract surgery) í›„ **6ì£¼ ì´ë‚´**. ì‹œë ¥ì´ ì¢‹ì•„ì§€ë‹¤ê°€ ê°‘ìê¸° **ì‹¬í•œ í†µì¦(Severe Pain) + ì‹œë ¥ ì €í•˜(Vision Loss)**.\n- **Key Signs:**\n    - **Hypopyon:** ì „ë°©(Anterior chamber)ì— ê³ ë¦„ì´ ìŒ“ì—¬ì„œ í•˜ì–€ ì´ˆìŠ¹ë‹¬(White crescent) ëª¨ì–‘ì´ ë³´ì„.\n    - **Haze:** Vitreousê°€ ë¿Œì˜‡ê²Œ ë³€í•¨.\n- **Variant:** **Candida Endophthalmitis** (ICU í™˜ì, TPN ì‚¬ìš©, Central line). í†µì¦ì´ ì—†ì„ ìˆ˜ë„ ìˆìŒ(Painless). \"Fungal balls\" (í•˜ì–€ ì†œë­‰ì¹˜) floating.\n- **Tx:** **â˜… Intravitreal Antibiotics + Vitrectomy** (\"Tap and Inject\"). ì•ˆêµ¬ì— ì§ì ‘ ì£¼ì‚¬í•˜ê³ , ê°ì—¼ëœ ì ¤ë¦¬ë¥¼ ê¸°ê³„ë¡œ ë¹¨ì•„ëƒ„.\n### 7. Uveitis (Anterior) ğŸ”¥\n- **Anatomy:** Iris + Ciliary Body inflammation.\n- **Symptoms:** **Deep Aching Pain** + **Photophobia (Extreme)**. ë¹›ì„ ë¹„ì¶”ë©´ í™ì±„ ê·¼ìœ¡ì´ ìˆ˜ì¶•í•˜ë©´ì„œ ì—¼ì¦ ë¶€ìœ„ë¥¼ ì§œë‚´ê¸° ë•Œë¬¸ì— ì—„ì²­ ì•„í””.\n- **Exam Findings:**\n    - **Ciliary Flush:** ê°ë§‰ ì£¼ë³€(Limbus)ì— ë¶‰ì€ ë (Red ring/Sunburst).\n    - **Constricted Pupil (Miosis):** ë™ê³µì´ ì‘ì•„ì§.\n    - **Hypopyon:** ì‹¬í•˜ë©´ ê³ ë¦„ ë³´ì„.\n- **Associations (Systemic):** **HLA-B27** (Ankylosing Spondylitis, IBD, Reactive Arthritis). ì Šì€ ë‚¨ìê°€ í—ˆë¦¬ ì•„í”„ê³  ëˆˆ ì•„í”„ë©´ ì´ê±°!\n- **Tx:** Topical Steroids (ì—¼ì¦ ì™„í™”) + Cycloplegics (ëª¨ì–‘ì²´ ê·¼ìœ¡ ë§ˆë¹„ì‹œì¼œ í†µì¦ ì™„í™”).\n### 8. Lumps & Bumps (Eyelid & Lacrimal) ğŸ”ï¸\n### A. Hordeolum vs. Chalazion\n| **Feature** | **Hordeolum (Stye)** | **Chalazion** |\n| --- | --- | --- |\n| **Nature** | **Infection** (Acute) | **Granuloma** (Chronic) |\n| **Cause** | Staph aureus (Abscess of gland) | Blocked Oil Gland (Meibomian) |\n| **Pain** | **Painful (H for Hurt)** | **Painless (C for Chill)** |\n| **Appearance** | Red, tender bump, pus point | Rubbery, hard nodule |\n| **Tx** | Warm Compress (Drainage) | Warm Compress (Wait it out) |\n### B. Blepharitis\n- **Concept:** \"Dandruff of the eyelashes\" (ì†ëˆˆì¹ ë¹„ë“¬).\n- **Sx:** Scalling, Crusting, Itchy eyelids.\n- **Tx:** Lid Hygiene (Baby shampoo scrubbing), Warm compress.\n### C. Lacrimal System (Plumbing)\n- **Dacryocystitis:**\n    - **Infection** of the Lacrimal Sac.\n    - **Location:** **Medial Canthus** (ëˆˆ ì•ˆìª½ êµ¬ì„/ì½” ì˜†).\n    - **Sx:** ë¹¨ê°›ê³ , ì•„í”„ê³ , ëˆ„ë¥´ë©´ ê³ ë¦„(Pus) ë‚˜ì˜´.\n    - **Tx:** Antibiotics.\n- **Nasolacrimal Duct Stenosis (Congenital):**\n    - **Plumbing Blockage.** ë°°ìˆ˜êµ¬ê°€ ë§‰í˜.\n    - **Sx:** **\"Wet Eye\"** (í•­ìƒ ëˆˆë¬¼ì´ ê³ ì—¬ìˆìŒ). **BUT** ê²°ë§‰ì€ í•˜ì–—ê³  ê¹¨ë—í•¨ (No redness/inflammation).\n    - **Tx:** Lacrimal Sac Massage (ë¶€ëª¨ê°€ ë§ˆì‚¬ì§€í•´ì„œ ëš«ì–´ì¤Œ). ì•ˆ ë˜ë©´ Probing.","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-61","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","treatment"]}
{"chunk_type":"recap_summary","text":"### ğŸš€ Rapid Fire Recap (Quiz Section)\n- **Scenario:** 4ì¼ ëœ ì‹ ìƒì•„, ì–‘ìª½ ëˆˆì—ì„œ ì—„ì²­ë‚œ ê³ ë¦„(Profuse Pus).\n    - **Dx:** Gonococcal Conjunctivitis.\n    - **Tx:** **IM Ceftriaxone** (Eye drops alone = Fail).\n- **Scenario:** ëˆˆì„ ì›€ì§ì¼ ë•Œ ì•„í”„ê³ (Pain with EOM), ì•ˆêµ¬ ëŒì¶œ(Proptosis).\n    - **Dx:** **Orbital Cellulitis**.\n    - **Next Step:** **CT Scan** (Emergency!).\n- **Scenario:** ì •ì›ì‚¬(Gardener)ê°€ ë‚˜ë­‡ê°€ì§€ì— ëˆˆì„ ì°”ë¦¼. ê¹ƒí„¸ ëª¨ì–‘(Feathery) ê¶¤ì–‘.\n    - **Dx:** **Fungal Keratitis**.\n- **Scenario:** ì½˜íƒíŠ¸ë Œì¦ˆ ì°©ìš©ì, ê¶¤ì–‘ ë°œìƒ.\n    - **Bug:** Pseudomonas.\n    - **Tx:** Fluoroquinolones.\n- **Scenario:** 2ì£¼ ëœ ì‹ ìƒì•„, ê¸°ì¹¨(Cough) + ëˆˆê³±.\n    - **Dx:** **Chlamydia Conjunctivitis**.\n    - **Risk:** Pyloric Stenosis (due to Oral Erythromycin).\n- **Scenario:** ëˆˆêº¼í’€ì— ì•„í”ˆ ë©ìš¸(Painful red lump).\n    - **Dx:** **Hordeolum (Stye)**. (H is for Hurt).\n- **Scenario:** ë°±ë‚´ì¥ ìˆ˜ìˆ  í›„ í†µì¦, ì‹œë ¥ ì €í•˜, ì „ë°© ì¶•ë†(Hypopyon).\n    - **Dx:** **Endophthalmitis**.\n**Confidence:** 1.0 (Based strictly on audio content)\n**Caveats:** ì˜¤ë””ì˜¤ ë‚´ìš©ì€ USMLE ì‹œí—˜ ëŒ€ë¹„ìš© \"High Yield\" ì •ë³´ì— ì§‘ì¤‘ë˜ì–´ ìˆìœ¼ë¯€ë¡œ, ì‹¤ì œ ì„ìƒ ê°€ì´ë“œë¼ì¸(Local protocols)ê³¼ëŠ” ë¯¸ì„¸í•œ ì°¨ì´ê°€ ìˆì„ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n**Mental Model:** Ophthalmology for Step 2CK & Shelf Exams.\n**Key Constraints:** Korean language, Casual/Fun tone with Emojis, No LaTeX, ASCII Tree Structure, Verbatim start, Detailed \"Zero-Loss\" notes.\n### ğŸ“‹ Overview: High-Yield Vision Pathology (TL;DR)","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-77","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","recap","diagnosis","treatment","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"ì‹œê°„ì´ ì—†ë‹¤ë©´ ì´ê²ƒë§Œì´ë¼ë„ ì±™ê²¨ê°€ì„¸ìš”! ğŸƒâ€â™‚ï¸ğŸ’¨\n| **Category** | **Pathology** | **Key Vignette / Buzzword** | **Immediate Action / Tx** |\n| --- | --- | --- | --- |\n| **Emergency** | Retinal Detachment | Curtain coming down (ì»¤íŠ¼) ğŸ“‰ | Surgery (Pneumatic retinopexy) |\n| **Emergency** | Acute Closed Angle Glaucoma | Rock hard eye, halos, painful ğŸª¨ğŸ˜« | Pilocarpine, Laser Iridotomy |\n| **Emergency** | CRAO (Central Retinal Artery Occlusion) | Cherry Red Spot, Sudden painless loss ğŸ’ | Ocular massage, Hyperbaric O2/Carbogen |\n| **Chronic** | Open Angle Glaucoma | Tunnel vision, Cup-to-disc > 0.5 ğŸ© | Prostaglandins (Latanoprost) |\n| **Chronic** | Macular Degeneration | Central vision loss (Clock blur) ğŸ•°ï¸ | Anti-VEGF (Wet), Vitamins (Dry) |\n| **Pediatric** | Leukocoria | White pupil reflex âšª | **Rule out Retinoblastoma** (MRI) |\n| **Pediatric** | Strabismus | Misalignment after 4 months ğŸ‘¶ | Patch good eye / Glasses |\n### ğŸŒ³ Top-Down Classification: The Eye Pathology Tree\nëˆˆ ì§ˆí™˜ì€ **\"í†µì¦ ìœ ë¬´\"**ì™€ **\"ê¸‰ì„±/ë§Œì„±\"**, ê·¸ë¦¬ê³  **\"ë‚˜ì´(ì†Œì•„ vs ì„±ì¸)\"**ë¡œ ë‚˜ëˆ„ëŠ” ê²ƒì´ Big Pictureë¥¼ ì¡ëŠ” í•µì‹¬ì…ë‹ˆë‹¤!\nPlaintext\n#\n`VISION PATHOLOGY (High Yield)\nâ”œâ”€â”€ Pediatric (ì†Œì•„)\nâ”‚   â”œâ”€â”€ Leukocoria (White Pupil) â†’ ğŸš¨ Retinoblastoma vs Cataract\nâ”‚   â”œâ”€â”€ Strabismus (Sashi) â†’ Normal < 4mo vs Pathologic > 4mo\nâ”‚   â””â”€â”€ Amblyopia (Lazy Eye) â†’ Brain ignores input\nâ”‚\nâ”œâ”€â”€ Adult: Painless Vision Loss (í†µì¦ ì—†ìŒ)\nâ”‚   â”œâ”€â”€ Acute (ê°‘ì‘ìŠ¤ëŸ¬ì›€)\nâ”‚   â”‚   â”œâ”€â”€ CRAO â†’ Cherry Red Spot (Ischemia) ğŸ’\nâ”‚   â”‚   â”œâ”€â”€ CRVO â†’ Blood & Thunder (Congestion) ğŸŒ©ï¸\nâ”‚   â”‚   â”œâ”€â”€ Retinal Detachment â†’ Curtain effect ğŸ“‰\nâ”‚   â”‚   â””â”€â”€ Vitreous Hemorrhage â†’ Floaters/Haze\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Chronic (ì„œì„œíˆ ì§„í–‰)\nâ”‚       â”œâ”€â”€ Open Angle Glaucoma â†’ Tunnel Vision (Peripheral loss) ğŸš‡\nâ”‚       â”œâ”€â”€ Macular Degeneration â†’ Central Loss (Metamorphopsia) ğŸ•°ï¸\nâ”‚       â”œâ”€â”€ Diabetic Retinopathy â†’ Dot/Blot vs Neovascularization\nâ”‚       â””â”€â”€ Cataract â†’ Blurring/Glare\nâ”‚\nâ””â”€â”€ Adult: Painful/Red Eye (í†µì¦ ìˆìŒ/ì¶©í˜ˆ)\n    â”œâ”€â”€ Acute Angle Closure Glaucoma â†’ Rock Hard Eye, Halos ğŸª¨\n    â”œâ”€â”€ Uveitis/Iritis â†’ Photophobia, Systemic association\n    â”œâ”€â”€ Corneal Abrasion/Ulcer â†’ Fluorescein uptake\n    â””â”€â”€ Infections (HSV/VZV Retinitis) â†’ Painful necrosis`\n### 1. The Three Classic Patients (Mental Framework) ğŸ§ \nì˜¤ë””ì˜¤ ì´ˆë°˜ì— ì œì‹œëœ 3ëª…ì˜ í™˜ì ì‹œë‚˜ë¦¬ì˜¤ëŠ” ì‹œí—˜ì— ë‚˜ì˜¤ëŠ” **ê°€ì¥ ì „í˜•ì ì¸ íŒ¨í„´**ì…ë‹ˆë‹¤. ì´ ì´ë¯¸ì§€ë¥¼ ë¨¸ë¦¬ì— ë°•ì•„ë‘ì„¸ìš”!\n### ğŸ©º Patient 1: The \"Curtain\" (Retinal Detachment)\n- **Scenario:** í™˜ìê°€ ê²ì— ì§ˆë ¤ì„œ ë“¤ì–´ì˜´. \"ê°‘ìê¸° í•œìª½ ëˆˆì— ì»¤íŠ¼ì´ ë‚´ë ¤ì˜¤ëŠ” ê²ƒ ê°™ì•„ìš”!\" (A curtain coming down).\n- **Pathology:** ë§ë§‰ ë°•ë¦¬ (Retinal Detachment).\n- **Meaning:** êµ¬ì¡°ì ì¸ ë¬¸ì œ(Structural Problem)ê°€ ë°œìƒí•¨. **Emergency!** ğŸš¨\n    -\n### ğŸ©º Patient 2: The \"Clock\" (Macular Degeneration)\n- **Scenario:** ë…¸ì¸ í™˜ì. \"ë²½ì‹œê³„ëŠ” ë³´ì´ëŠ”ë° ìˆ«ìê°€ ì•ˆ ë³´ì—¬ìš”.\" (See the clock, can't read numbers). ì‚¬ëŒ ì–¼êµ´ì€ ë³´ì´ëŠ”ë° ëˆˆì½”ì…ì´ ì•ˆ ë³´ì„.\n- **Pathology:** í™©ë°˜ ë³€ì„± (Macular Degeneration).\n- **Key Concept:** **Central** vision loss, gradual, spares periphery. ì£¼ë³€ë¶€ëŠ” ì˜ ë³´ì„.\n    -\n### ğŸ©º Patient 3: The \"White Pupil\" (Leukocoria)\n- **Scenario:** ë¶€ëª¨ê°€ ì•„ì´ ì‚¬ì§„ì„ ì°ì—ˆëŠ”ë°, í•œìª½ ëˆˆì€ ì ìƒ‰ë°˜ì‚¬(Red reflex)ê°€ ìˆëŠ”ë° ë‹¤ë¥¸ ìª½ì€ **í•˜ì–—ê²Œ ë¹›ë‚¨(Glowing white)**.\n- **Pathology:** ë°±ìƒ‰ë™ê³µ (Leukocoria).\n- **High Stakes:** ì´ê±´ ë¬´ì¡°ê±´ **Retinoblastoma** (ë§ë§‰ëª¨ì„¸í¬ì¢…)ì„ ë¨¼ì € ë£°ì•„ì›ƒ í•´ì•¼ í•¨. ë†“ì¹˜ë©´ ìƒëª…ì´ ìœ„í—˜í•¨! ğŸ’€","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-87","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"### 2. Neuro-Ophthalmology: Argyll Robertson Pupil ğŸ”¦\n- **Nickname:** \"The Prostitute's Pupil\" (ì„±ë§¤ë§¤ ì¢…ì‚¬ìì˜ ë™ê³µ - ê³¼ê±° ë§¤ë…ê³¼ì˜ ì—°ê´€ì„± ë•Œë¬¸).\n- **Buzzword:** **\"Accommodates but does not react\"** (ì¡°ì ˆì€ ë˜ëŠ”ë° ë¹› ë°˜ì‚¬ëŠ” ì—†ìŒ).\n- **Mechanism:**\n    - ì†ê°€ë½ì„ ì½”ë¡œ ê°€ì ¸ê°€ë©´ ë™ê³µì´ ì‘ì•„ì§ (Accommodation O).\n    - ë°ì€ ë¹›ì„ ë¹„ì¶”ë©´ ë°˜ì‘ ì—†ìŒ (Light Reflex X).\n- **Etiology:**\n    1. **Neuro-syphilis** (ì‹ ê²½ë§¤ë…) - Classic! â˜…\n    2. **Diabetes** (ë‹¹ë‡¨ë³‘) - í˜„ëŒ€ì—ëŠ” ë‹¹ë‡¨ê°€ ë” í”í•  ìˆ˜ ìˆìŒ.\n### 3. Pediatric Ophthalmology (ì†Œì•„ ì•ˆê³¼) ğŸ‘¶\n### A. Amblyopia (ì•½ì‹œ - Lazy Eye)\n- **Concept:** ëˆˆ ìì²´ëŠ” ë©€ì©¡í•  ìˆ˜ ìˆìŒ. í•˜ì§€ë§Œ **ë‡Œ(Brain)**ê°€ ê·¸ ëˆˆì—ì„œ ì˜¤ëŠ” ì‹ í˜¸ë¥¼ ë¬´ì‹œ(Ignore)í•˜ê¸° ì‹œì‘í•¨.\n- **Why?** ë‘ ëˆˆì˜ ì´ˆì ì´ ì•ˆ ë§ê±°ë‚˜ ì‹œë ¥ ì°¨ì´ê°€ í¬ë©´, ë‡Œê°€ í˜¼ë€ìŠ¤ëŸ¬ì›Œì„œ ë‚˜ìœ ìª½ ì‹ í˜¸ë¥¼ ê·¸ëƒ¥ êº¼ë²„ë¦¼(Turn off).\n- **Treatment:** **Patch the GOOD eye** (ì¢‹ì€ ëˆˆì„ ê°€ë ¤ì„œ ë‚˜ìœ ëˆˆì„ ê°•ì œë¡œ ì“°ê²Œ ë§Œë“¦). ì•ˆê²½ì´ë‚˜ Atropine dropì„ ì“°ê¸°ë„ í•¨.\n### B. Strabismus (ì‚¬ì‹œ - Misalignment)\n- **Timeline is Key!** â³\n    - **< 4 Months:** Intermittent deviation is **NORMAL**. ê·¼ìœ¡ì´ ì•„ì§ ë°œë‹¬ ì¤‘. ì§€ì¼œë´„.\n    - **> 4 Months:** Constant deviation is **PATHOLOGIC**. ê²€ì‚¬ í•„ìš”!\n- **Diagnosis:**\n    1. **Corneal Light Reflex:** ë¶ˆë¹›ì„ ë¹„ì·„ì„ ë•Œ ë°˜ì‚¬ì ì´ ë™ê³µ ì¤‘ì•™ì— ìˆëŠ”ì§€ í™•ì¸. (ë¹„ëŒ€ì¹­ì´ë©´ ì‚¬ì‹œ).\n    2. **Cover/Uncover Test:** í•œìª½ ëˆˆì„ ê°€ë¦´ ë•Œ ë‹¤ë¥¸ ëˆˆì´ ì›€ì§ì´ëŠ”ì§€ í™•ì¸. (ì›€ì§ì´ë©´ ì‚¬ì‹œ).\n### C. Leukocoria (ë°±ìƒ‰ë™ê³µ) - **MUST KNOW** â˜…\n- **Scenario:** Flash í„°ëœ¨ë¦° ì‚¬ì§„ì—ì„œ í•œìª½ ëˆˆì´ í•˜ì–—ê²Œ ë‚˜ì˜´.\n- **Differential Diagnosis:**\n    1. **Retinoblastoma:** ğŸš¨ ê°€ì¥ ìœ„í—˜. **Osteosarcoma** (ê³¨ìœ¡ì¢…)ì™€ ì—°ê´€ë¨ (Rb ìœ ì „ì ë³€ì´).\n    2. **Congenital Cataract:** ì„ ì²œì„± ë°±ë‚´ì¥ (ToRCH ê°ì—¼, Galactosemia ë“±).\n- **Next Best Step:** **Immediate Referral & MRI** (ì¢…ì–‘ í™•ì¸). ì ˆëŒ€ ê·¸ëƒ¥ ë³´ë‚´ë©´ ì•ˆ ë¨.\n### 4. Glaucoma (ë…¹ë‚´ì¥) - The Pressure Cooker â™¨ï¸\në°©ìˆ˜(Aqueous fluid)ê°€ ìƒì„±ë˜ëŠ”ë° ë°°ì¶œ(Drain)ì´ ì•ˆ ë˜ì–´ ì••ë ¥ì´ ì°¨ê³ , ë’¤ìª½ì— ìˆëŠ” ì‹œì‹ ê²½(Optic nerve)ì„ ì§“ëˆ„ë¥´ëŠ” ë³‘.\n### A. Open Angle Glaucoma (ê°œë°©ê° ë…¹ë‚´ì¥)\n- **Nature:** Silent thief of sight. ì²œì²œíˆ, í†µì¦ ì—†ì´ ì§„í–‰.\n- **Symptom:** **Tunnel Vision** (ì£¼ë³€ë¶€ ì‹œì•¼ë¶€í„° ìƒìŒ). í™˜ìëŠ” ë§ê¸°ê¹Œì§€ ëª¨ë¥¼ ìˆ˜ ìˆìŒ.\n- **Diagnosis:**\n    - Tonometry (ì•ˆì•• ì¸¡ì •).\n    - **Cup-to-Disc Ratio > 0.5** (ì‹œì‹ ê²½ ìœ ë‘ í•¨ëª°ë¹„ ì¦ê°€).\n    - *Analogy:* ë„ë„›(Disc) êµ¬ë©(Cup)ì´ ì ì  ì»¤ì ¸ì„œ ë„ë„› ì‚´ì´ ì–‡ì•„ì§€ëŠ” ê²ƒê³¼ ê°™ìŒ. ğŸ©\n- **Treatment:**\n    - **Prostaglandins (Latanoprost):** 1st line. Outflow ì¦ê°€. (ì†ëˆˆì¹ ê¸¸ì–´ì§€ëŠ” ë¶€ì‘ìš©).\n    - Beta-blockers (Timolol): ìƒì„± ì–µì œ.\n    - Alpha-2 agonists (Brimonidine).\n### B. Acute Closed Angle Glaucoma (íì‡„ê° ë…¹ë‚´ì¥) - **EMERGENCY** ğŸš‘\n- **Scenario:** ì–´ë‘ìš´ ê³³(ì˜í™”ê´€)ì—ì„œ ë™ê³µì´ ì»¤ì§€ë©´ì„œ(Dilate), í™ì±„(Iris)ê°€ ë°°ìˆ˜êµ¬(Meshwork)ë¥¼ ë¬¼ë¦¬ì ìœ¼ë¡œ ë§‰ì•„ë²„ë¦¼ (Slam the door shut). ğŸšªğŸ’¥\n- **Symptoms:**\n    - **\"Rock Hard Eye\"** (ëˆˆì´ ëŒì²˜ëŸ¼ ë”±ë”±í•¨).\n    - Severe Pain & Headache.\n    - Nausea/Vomiting.\n    - **Halos around lights** (ë¹› ì£¼ë³€ì— ë¬´ì§€ê°œ ë ). ğŸŒˆ\n    - Hazy cornea (Fixed, mid-dilated pupil).\n- **Treatment:**\n    - **Immediate:** **Pilocarpine** (Pupil constriction â†’ ë™ê³µì„ ì‘ê²Œ í•´ì„œ í™ì±„ë¥¼ ë‹¹ê²¨ ë°°ìˆ˜êµ¬ë¥¼ í‹”ì›€).\n    - Acetazolamide, Mannitol, Timolol (ì•ˆì•• ë‚®ì¶¤).\n    - **Definitive Cure:** **Laser Iridotomy** (í™ì±„ì— êµ¬ë©ì„ ëš«ì–´ ìƒ›ê¸¸ì„ ë§Œë“¦). â˜…\n### C. Congenital Glaucoma (ì„ ì²œì„± ë…¹ë‚´ì¥)\n- **Features:** ì•„ì´ë“¤ì€ ê³µë§‰(Sclera)ì´ ë§ë‘í•´ì„œ ì••ë ¥ì´ ì°¨ë©´ ëˆˆì´ ì»¤ì§ â†’ **Buphthalmos** (Ox eye, í™©ì†Œ ëˆˆ). ğŸ®\n- **Triad:** ëˆˆë¬¼ í˜ë¦¼(Tearing), ëˆˆë¶€ì‹¬(Photophobia), ëˆˆêº¼í’€ ì—°ì¶•(Blepharospasm).","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-107","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"### 5. Vascular Pathology: Artery vs. Vein ğŸ©¸\në‘ ê°€ì§€ê°€ ì™„ì „íˆ ë°˜ëŒ€ ì–‘ìƒì…ë‹ˆë‹¤. í‘œë¡œ ë¹„êµí•´ì„œ ì™¸ìš°ì„¸ìš”!\n| **Feature** | **CRAO (Central Retinal Artery Occlusion)** | **CRVO (Central Retinal Vein Occlusion)** |\n| --- | --- | --- |\n| **Pathophysiology** | **Ischemia** (Embolus from Carotid/Heart blocks flow). Stroke of the eye. | **Congestion** (Thrombus blocks exit). \"Back up\" of blood. |\n| **Pain** | Painless | Painless |\n| **Vision Loss** | Sudden, Profound (ê°‘ì‘ìŠ¤ëŸ° ì•”í‘) | Sudden but variable |\n| **Fundoscopy** | **Cherry Red Spot** ğŸ’ (Pale retina, thin fovea shows choroid) | **\"Blood and Thunder\"** ğŸŒ©ï¸ (Hemorrhages everywhere, Cotton wool spots) |\n| **Analogy** | ìˆ˜ë„ê¼­ì§€ê°€ ì ê¹€ (Dry) | í•˜ìˆ˜êµ¬ê°€ ë§‰í˜ (Wet/Explosive) |\n| **Treatment** | **Ocular Massage**, Hyperbaric O2, **Carbogen** (5% CO2/95% O2) | Observation, Photocoagulation (if neovascularization), Anti-VEGF |\n- **Why CO2 for CRAO?** CO2ëŠ” ê°•ë ¥í•œ **Vasodilator**ì…ë‹ˆë‹¤. í˜ˆê´€ì„ í™•ì¥ì‹œì¼œ í˜ˆì „(Embolus)ì„ ë” ë¨¼ ê³³ìœ¼ë¡œ ë°€ì–´ë‚´ë ¤ëŠ” ì‹œë„ì…ë‹ˆë‹¤. (Treat logic â˜…)\n### 6. Diabetic Retinopathy (ë‹¹ë‡¨ë§ë§‰ë³‘ì¦) ğŸ­\n- **Mechanism:** ê³ í˜ˆë‹¹ì´ ë¯¸ì„¸í˜ˆê´€ì„ ë§ê°€ëœ¨ë¦¼.\n- **Stages:**\n    1. **Non-Proliferative:** í˜ˆê´€ì´ í„°ì§€ê³  ìƒ˜. Microaneurysms, Hard exudates, Dot/blot hemorrhages.\n        - *Tx:* í˜ˆë‹¹ ì¡°ì ˆ (Glucose control).\n    2. **Proliferative (ì¦ì‹ì„±):** ì‚°ì†Œê°€ ë¶€ì¡±í•´ì„œ(Ischemia) ì‹ ìƒí˜ˆê´€ì„ ë§ˆêµ¬ ë§Œë“¦ (**Neovascularization** via **VEGF**).\n        - ë¬¸ì œ: ìƒˆë¡œ ìƒê¸´ í˜ˆê´€ì€ ì•½í•´ì„œ ì˜ í„°ì§ â†’ Vitreous Hemorrhage (ìœ ë¦¬ì²´ ì¶œí˜ˆ) â†’ Floaters shower/Vision loss.\n        - *Tx:* **Pan-retinal Photocoagulation (Laser)** or **Anti-VEGF** injections.\n### 7. Other High-Yield Retina Issues\n### A. Retinitis Pigmentosa (ë§ë§‰ìƒ‰ì†Œë³€ì„±ì¦)\n- **Pathology:** ìœ ì „ì ìœ¼ë¡œ Rods(ë§‰ëŒ€ì„¸í¬ - ë°¤ ì‹œë ¥ ë‹´ë‹¹)ì™€ Conesê°€ ì£½ì–´ê°.\n- **Symptoms:** **Night Blindness** (ì•¼ë§¹ì¦) first! â†’ í„°ë„ ì‹œì•¼. ğŸŒ‘\n- **Fundoscopy:** **Bone Spicules** (ë¼›ì¡°ê° ëª¨ì–‘ì˜ ê²€ì€ ìƒ‰ì†Œ ì¹¨ì°©). â˜ ï¸\n- **Vessels:** Pale waxy optic disc, attenuated vessels.\n### B. Infectious Retinitis (HIV/AIDS)\n- **CMV Retinitis:**\n    - CD4 < 50.\n    - **Painless**.\n    - **\"Pizza Pie\" Appearance:** í”¼(Hemorrhage)ì™€ í•˜ì–€ ì‚¼ì¶œë¬¼(Exudate)ì´ ì„ì—¬ì„œ í”¼ìì²˜ëŸ¼ ë³´ì„. ğŸ•\n    - *Tx:* Ganciclovir.\n- **HSV/VZV Retinitis (PORN - Progressive Outer Retinal Necrosis):**\n    - **Painful!** (One hurts, one doesn't).\n    - Rapid necrosis.\n### C. Drug Toxicity: Hydroxychloroquine\n- **Use:** Lupus, RA treatment.\n- **Effect:** **Bull's Eye Maculopathy** (í™©ë°˜ì— ê³¼ë… ëª¨ì–‘ ë³‘ë³€). ğŸ¯\n- **Note:** ë¹„ê°€ì—­ì (Irreversible)ì´ë¼ì„œ ë§¤ë…„ ì•ˆê³¼ ê²€ì§„ í•„ìˆ˜!","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-127","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","treatment","pathophysiology","mnemonic","tree"]}
{"chunk_type":"recap_summary","text":"### ğŸš€ Rapid Fire Recap Table (Summary)\n| **Diagnosis** | **Key Finding (Fundoscopy/Exam)** | **Treatment / Next Step** |\n| --- | --- | --- |\n| **Retinal Detachment** | Flashes, Floaters, **Curtain** ğŸ“‰ | **Surgery** (Urgent) |\n| **Acute Angle Closure** | **Rock hard**, painful, halos ğŸª¨ | **Pilocarpine**, Laser Iridotomy |\n| **CRAO** | **Cherry Red Spot** ğŸ’, Pale retina | Ocular Massage, CO2 |\n| **CRVO** | **Blood and Thunder** ğŸŒ©ï¸ | Observation / Anti-VEGF |\n| **Macular Degeneration** | **Central loss** (Clock/Faces) ğŸ•°ï¸ | Dry (Vitamins), Wet (Anti-VEGF) |\n| **Amblyopia** | Cortical suppression of one eye | **Patch the GOOD eye** ğŸ´â€â˜ ï¸ |\n| **Strabismus** | Misalignment > 4 months | Patch / Surgery |\n| **Retinoblastoma** | **Leukocoria** (White pupil) âšª | **MRI** (Rule out Osteosarcoma link) |\n| **Retinitis Pigmentosa** | **Bone spicules**, Night blindness ğŸŒ‘ | Supportive / Vitamin A |\n- **Confidence:** 1.0 (Based on verbatim transcription and medical knowledge integration).\n- **Disclaimer:** Audio specifically mentions Step 2 CK context. Actual clinical practice may involve more nuanced diagnostic steps (e.g., OCT scans) which were not the primary focus of this high-yield review.\n- **Images:** Visual descriptions (Pizza pie, Cherry red spot, Bone spicules) are critical for the exam. Ensure you look up atlas images for these buzzwords!\nHere is the response based on the analysis of the audio file provided.\n### ğŸ“‹ Overview: Eye Trauma High-Yield Summary (TL;DR)\n| **Pathology** | **Key Feature (Buzzword)** | **Next Best Step (NBS) / Treatment** | **Do NOT Do** |\n| --- | --- | --- | --- |\n| **Corneal Abrasion** | Foreign body sensation, Fluorescein uptake | Erythromycin (Non-contact) / **Ciprofloxacin** (Contact Lens) | Do **NOT** patch if contact lens wearer (Pseudomonas risk) |\n| **Open Globe** | **Teardrop Pupil**, Seidel Sign (+) | **Rigid Eye Shield**, CT Scan, IV Abx, Tetanus | Do **NOT** measure IOP, Do **NOT** touch/manipulate |\n| **Orbital Compartment Syndrome (OCS)** | **Rock-hard Eyelid**, Proptosis, Afferent Pupillary Defect (APD) | **Lateral Canthotomy** (Immediate) | Do **NOT** wait for CT scan |\n| **Hyphema** | Blood fluid level in Anterior Chamber | Head elevation (30Â°), Cycloplegics | Screen for **Sickle Cell** (Glaucoma risk) |\n| **Sympathetic Ophthalmia** | Autoimmune attack on \"Good Eye\" after trauma | Remove damaged eye (Enucleation) within 2 weeks | Ignore complaints in the non-injured eye |\n| **Photokeratitis** | Welder/Skier, Bilateral pain, 6-12hr lag | Supportive care, lubrication | - |","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-143","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","recap","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### ğŸŒ³ 2. Big Picture: Ocular Trauma Top-Down Classification\nì˜í•™ì  ë§¥ë½ì„ êµ¬ì¡°í™”í•˜ê¸° ìœ„í•œ **ASCII Text Tree**ì…ë‹ˆë‹¤. ì´ íŠ¸ë¦¬ëŠ” Eye Traumaê°€ ì–´ë””ì— ìœ„ì¹˜í•˜ëŠ”ì§€ ë³´ì—¬ì¤ë‹ˆë‹¤.\nPlaintext\n`OCULAR TRAUMA & EMERGENCIES (The \"Scary\" Stuff)\nâ”‚\nâ”œâ”€â”€ 1. Surface & Anterior Segment (í‘œë©´ ë° ì „ì•ˆë¶€)\nâ”‚   â”œâ”€â”€ Corneal Abrasion (ê°€ì¥ í”í•¨, \"Bread & Butter\")\nâ”‚   â”‚   â”œâ”€â”€ Non-contact wearer: Physical trauma\nâ”‚   â”‚   â””â”€â”€ Contact wearer: Pseudomonas risk (â˜… High Yield)\nâ”‚   â”œâ”€â”€ Foreign Body (ì´ë¬¼ì§ˆ)\nâ”‚   â””â”€â”€ Photokeratitis (UV Burn, \"Welder's flash\")\nâ”‚\nâ”œâ”€â”€ 2. Structural Integrity Loss (êµ¬ì¡°ì  ì†ìƒ - Emergency!)\nâ”‚   â”œâ”€â”€ Open Globe Injury (ì•ˆêµ¬ íŒŒì—´)\nâ”‚   â”‚   â”œâ”€â”€ Penetrating: ì°”ë¦° ê²ƒ (Knife, Glass)\nâ”‚   â”‚   â””â”€â”€ Blunt Rupture: í„°ì§„ ê²ƒ (Fist, Ball) -> \"Teardrop Pupil\"\nâ”‚   â””â”€â”€ Hyphema (ì „ë°© ì¶œí˜ˆ)\nâ”‚       â””â”€â”€ Sickle Cell Traitì™€ì˜ ì—°ê´€ì„± (â˜… USMLE Favorite)\nâ”‚\nâ”œâ”€â”€ 3. Orbital & Retrobulbar (ì•ˆì™€ ë° í›„êµ¬)\nâ”‚   â”œâ”€â”€ Orbital Compartment Syndrome (OCS)\nâ”‚   â”‚   â””â”€â”€ Retrobulbar Hemorrhage -> \"Rock Hard Eyelid\"\nâ”‚   â””â”€â”€ Optic Nerve Injury\nâ”‚       â””â”€â”€ Traumatic Optic Neuropathy -> APD, Color vision loss\nâ”‚\nâ””â”€â”€ 4. Systemic/Late Complications\n    â””â”€â”€ Sympathetic Ophthalmia (êµê°ì„± ì•ˆì—¼)\n        â””â”€â”€ Autoimmune attack on the HEALTHY eye`\n### ğŸ¥ 3. \"Zero-Loss\" Deep Dive Lecture Notes\n### ğŸš‘ Introduction & The \"Doorway Thoughts\"\nì‘ê¸‰ì‹¤ ë¬¸ ì•ì—ì„œ í™˜ìë¥¼ ë”± ë´¤ì„ ë•Œ(Doorway), ë– ì˜¬ë ¤ì•¼ í•˜ëŠ” 3ëª…ì˜ í™˜ì ì‹œë‚˜ë¦¬ì˜¤ì…ë‹ˆë‹¤. ì´ ì´ë¯¸ì§€ë¥¼ ë¨¸ë¦¿ì†ì— 'Lock' í•˜ì„¸ìš”! ğŸ”’\n1. **Patient A (Open Globe):** 20ëŒ€ ë‚¨ì„±, ì‹¸ì›€ í›„ ì•ˆë©´ í†µì¦. ëˆˆì„ ë–´ëŠ”ë° ë™ê³µ(Pupil)ì´ ì›í˜•ì´ ì•„ë‹ˆë¼ **ëˆˆë¬¼ë°©ìš¸(Teardrop)** ëª¨ì–‘ì´ë©° ìƒì²˜ë¥¼ ê°€ë¦¬í‚¤ê³  ìˆìŒ. ğŸ©¸\n2. **Patient B (Orbital Compartment Syndrome):** ê³ ì† êµí†µì‚¬ê³ . ì•ˆêµ¬ê°€ íŠ€ì–´ë‚˜ì˜¬ ë“¯í•¨(**Proptosis**). ëˆˆêº¼í’€ì„ ë§Œì ¸ë³´ë‹ˆ **ëŒì²˜ëŸ¼ ë”±ë”±í•¨(Rock hard)**. ğŸ—¿\n3. **Patient C (Hyphema):** ì•¼êµ¬ê³µì— ëˆˆì„ ë§ìŒ. í™ì±„(Iris) ë‚´ë¶€ì— ìˆ˜í‰ìœ¼ë¡œ **ë¶‰ì€ ì•¡ì²´ ì¸µ(Fluid level)**ì´ ë³´ì„. ë§ˆì¹˜ ì™€ì¸ì”ì— ì™€ì¸ì´ ë°˜ì¯¤ ë‹´ê¸´ ê²ƒ ê°™ìŒ. ğŸ·\n### A. Corneal Abrasion (ê°ë§‰ ì°°ê³¼ìƒ)\n*ê°€ì¥ í”í•˜ì§€ë§Œ, ì ˆëŒ€ ë†“ì¹˜ë©´ ì•ˆ ë˜ëŠ” \"Bread & Butter\" ì¼€ì´ìŠ¤!* ğŸğŸ§ˆ\n- **Clinical Presentation:**\n    - ì‹¬í•œ ì•ˆêµ¬ í†µì¦, ì´ë¬¼ê°(Foreign body sensation), ëˆˆë¶€ì‹¬(Photophobia).\n    - **Diagnosis (Gold Standard):** **Fluorescein Stain** (í˜•ê´‘ ì—¼ìƒ‰).\n        - Orange dyeë¥¼ ë„£ê³  Cobalt blue lightë¥¼ ë¹„ì¶”ë©´ ìƒí”¼ê°€ ë²—ê²¨ì§„ ê³³ì´ **Bright Green**ìœ¼ë¡œ ë¹›ë‚¨. ğŸ’š\n        -\n            - **The \"Fork in the Road\" Decision (ì¹˜ë£Œì˜ ê°ˆë¦¼ê¸¸) â˜…:**\n    - **Q: í™˜ìê°€ ë Œì¦ˆ(Contact Lens)ë¥¼ ë¼ë‚˜ìš”?**\n        - **YES (ë Œì¦ˆ ì°©ìš©ì):** **Pseudomonas aeruginosa(ë…¹ë†ê· )** ê°ì—¼ ìœ„í—˜! ğŸ¦ \n            - ì¹˜ë£Œ: **Ciprofloxacin, Ofloxacin, Tobramycin** (Fluoroquinolone or Aminoglycoside).\n            - **ì ˆëŒ€ ê¸ˆê¸°(Contraindication):** **Eye Patching** (ì•ˆëŒ€). âŒ\n                - ì´ìœ : ì•ˆëŒ€ëŠ” ë”°ëœ»í•˜ê³ , ì–´ë‘¡ê³ , ìŠµí•œ í™˜ê²½ì„ ë§Œë“¤ì–´ ë°•í…Œë¦¬ì•„ ë°°ì–‘ê¸°(Incubator) ì—­í• ì„ í•¨. Pseudomonasê°€ ê°ë§‰ì„ íŒŒë¨¹ê²Œ ë‘ . \"Never patch a corneal abrasion in a contact lens wearer.\"\n        - **NO (ë Œì¦ˆ ë¯¸ì°©ìš©ì):** ì¼ë°˜ì ì¸ ì™¸ìƒ (ë‚˜ë­‡ê°€ì§€, ì•„ê¸° ì†í†± ë“±).\n            - ì¹˜ë£Œ: Erythromycin ointment (Gentle stuff).\n- **Follow-up:** ë Œì¦ˆ ì°©ìš©ìëŠ” 24ì‹œê°„ ë‚´ ì¬ë°©ë¬¸ í•„ìˆ˜ (Ulcerë¡œ ì§„í–‰ë˜ëŠ”ì§€ í™•ì¸).\n### B. Open Globe Injury (ì•ˆêµ¬ íŒŒì—´/ì²œê³µ)\n*Patient A: \"Teardrop Pupil pointing to the wound.\"* ğŸ’§","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-153","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","diagnosis","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"- **Mechanism:**\n    - **Blunt Force:** ì£¼ë¨¹ì´ë‚˜ ê³µì— ë§ì•„ ì••ë ¥ìœ¼ë¡œ ì•ˆêµ¬ê°€ í„°ì§ (Blow-out).\n    - **Penetrating:** ì¹¼ì´ë‚˜ ìœ ë¦¬ì— ì°”ë¦¼.\n- **Pathophysiology (Why Teardrop?):**\n    - ì•ˆêµ¬ì— êµ¬ë©ì´ ë‚˜ë©´ ë‚´ë¶€ ì•¡ì²´(Aqueous humor)ê°€ ë°–ìœ¼ë¡œ ì½¸ì½¸ ìŸì•„ì§ (íƒ€ì´ì–´ í‘í¬ì²˜ëŸ¼).\n    - í™ì±„(Iris, floppy colored curtain)ê°€ ì§„ê³µ ì²­ì†Œê¸°ì²˜ëŸ¼ êµ¬ë© ìª½ìœ¼ë¡œ ë¹¨ë ¤ ë“¤ì–´ê°.\n    - ë™ê³µì´ êµ¬ë© ìª½ìœ¼ë¡œ ì°Œê·¸ëŸ¬ì§€ë©° **Teardrop shape** í˜•ì„±. ğŸ‘‰ ì´ ë¾°ì¡±í•œ ëì´ ìƒì²˜ ë¶€ìœ„ë¥¼ ê°€ë¦¬í‚´!\n    -\n        - **Physical Exam Warning (Seidel Sign):**\n    - **Positive Seidel Sign:** Fluoresceinì„ ë„£ì—ˆì„ ë•Œ, ìƒì²˜ ë¶€ìœ„ì—ì„œ **ë§‘ì€ ì•¡ì²´(Clear fluid)**ê°€ í˜ëŸ¬ë‚´ë ¤ ì—¼ìƒ‰ì•½ì„ ì”»ì–´ë‚´ëŠ” í˜„ìƒ (**Waterfall effect**). ğŸŒŠ -> ì•ˆêµ¬ê°€ ëš«ë ¸ë‹¤ëŠ” í™•ì‹¤í•œ ì¦ê±°.\n    -\n        - **Management Protocol (Do NOT Touch!):**\n    1. **Do NOT touch the eye.** ğŸš«\n    2. **Do NOT apply drops.**\n    3. **Do NOT measure IOP (Tonometry):** ì•ˆì•• ì¬ë ¤ê³  ëˆ„ë¥´ëŠ” ìˆœê°„ ë‚´ë¶€ ë¬¼ì§ˆ(Iris, Lens, Vitreous)ì´ ë°–ìœ¼ë¡œ ì§œì—¬ ë‚˜ì˜´ (Squeezing a juice box). ğŸ§ƒğŸ’¥\n    4. **â˜… Next Best Step:** **Rigid Eye Shield** (Fox shield) ì°©ìš© (ë³´í˜¸ ëª©ì ).\n    5. IV Antibiotics + Tetanus shot (íŒŒìƒí’ ì£¼ì‚¬).\n    6. **CT Scan:** ì´ë¬¼ì§ˆ í™•ì¸.\n    7. Call Ophthalmology immediately (ìˆ˜ìˆ ì‹¤ë¡œ ì§í–‰).\n### C. Orbital Compartment Syndrome (OCS)\n*Patient B: \"Rock Hard Eyelid & Proptosis.\"* ğŸ—¿ğŸ‘ï¸\n- **Pathophysiology:**\n    - ì•ˆì™€(Orbit)ëŠ” ë¼ˆë¡œ ëœ ê³ ê¹”(Bony cone)ì…ë‹ˆë‹¤. ë¼ˆëŠ” ëŠ˜ì–´ë‚˜ì§€ ì•ŠìŒ.\n    - ì¶œí˜ˆ(Retrobulbar hemorrhage)ì´ ë°œìƒí•˜ë©´ í”¼ê°€ ê°ˆ ê³³ì´ ì—†ìŒ -> ì••ë ¥ ê¸‰ìƒìŠ¹ ğŸ“ˆ.\n    - ì•ˆêµ¬ê°€ ì•ìœ¼ë¡œ ë°€ë¦¼ (**Proptosis**).\n    - ë†’ì€ ì••ë ¥ì´ ì‹œì‹ ê²½(Optic Nerve)ìœ¼ë¡œ ê°€ëŠ” í˜ˆë¥˜ë¥¼ ì°¨ë‹¨ -> **Blindness (ì‹¤ëª…)**.\n- **Physical Exam:**\n    - **Rock Hard Eyelid:** ëˆˆêº¼í’€ì´ í…Œì´ë¸”ì²˜ëŸ¼ ë”±ë”±í•¨.\n    - **Afferent Pupillary Defect (APD):** ë¹›ì„ ë¹„ì¶°ë„ ë™ê³µì´ ë°˜ì‘í•˜ì§€ ì•ŠìŒ (ì‹ ê²½ì´ ì£½ì–´ê°€ê³  ìˆìŒ). ğŸ”¦\n- **Management (Time is Vision):**\n    - **ê³¨ë“ íƒ€ì„:** 90ë¶„ ì´ë‚´ì— ì‹œë ¥ ì˜êµ¬ ì†ì‹¤. â³\n    - **Do NOT wait for CT scan:** ì§„ë‹¨ì€ ì„ìƒì (Clinical)ìœ¼ë¡œ ë‚´ë¦¼. CT ê¸°ë‹¤ë¦¬ë‹¤ ì‹¤ëª…í•¨.\n    - **â˜… Treatment:** **Lateral Canthotomy** (ì™¸ì•ˆê° ì ˆê°œìˆ ). ğŸ”ª\n        - ëˆˆ ê¼¬ë¦¬ ìª½(Lateral canthus)ì˜ ìº”ë˜(Tendon)ì„ ê°€ìœ„ë¡œ ì˜ë¼ì¤Œ.\n        - ëˆˆêº¼í’€ì´ ì—´ë¦¬ë©´ì„œ ì•ˆêµ¬ê°€ ì•ìœ¼ë¡œ íŠ€ì–´ ë‚˜ì˜¤ê³  ì••ë ¥ì´ ëš ë–¨ì–´ì§ (Decompression).\n### D. Hyphema (ì „ë°© ì¶œí˜ˆ)\n*Patient C: \"Red Wine in the Eye.\"* ğŸ·\n- **Definition:** ì „ë°©(Anterior Chamber)ì— í˜ˆì•¡ì´ ê³ ì¸ ê²ƒ. ì¤‘ë ¥ ë•Œë¬¸ì— ì•„ë˜ë¡œ ê°€ë¼ì•‰ì•„ **Fluid level** í˜•ì„±.\n    -\n        - **Management:**\n    - **Bed Rest + Head Elevation (30Â°):** í”¼ê°€ ì•„ë˜ë¡œ ê°€ë¼ì•‰ì•„ ì‹œì•¼ë¥¼ ê°€ë¦¬ì§€ ì•Šë„ë¡ í•¨. ğŸ›ï¸\n    - **Cycloplegics:** ë™ê³µì„ í™•ì¥/ë§ˆë¹„ì‹œì¼œ í™ì±„ ì›€ì§ì„ì„ ë§‰ìŒ (ì›€ì§ì´ë©´ í”¼ë”±ì§€ ë–¨ì–´ì ¸ì„œ ì¬ì¶œí˜ˆ ë°œìƒ - Rebleeding ë°©ì§€).\n- **â˜… High Yield Clinical Pearl: Sickle Cell Disease (ê²¸ìƒ ì í˜ˆêµ¬ ë¹ˆí˜ˆ)**\n    - **Why is this dangerous?**\n        - ì•ˆêµ¬ ì „ë°©ì€ ì‚°ì†Œê°€ ì ê³ (Hypoxic), ì‚°ì„±(Acidic)ì¸ í™˜ê²½ -> Sicklingì„ ìœ ë°œí•˜ëŠ” ìµœì ì˜ ì¡°ê±´. âš¡\n        - Sickle Cell í™˜ìì˜ ì í˜ˆêµ¬ê°€ ì „ë°©ìœ¼ë¡œ ë‚˜ì˜¤ë©´ ë‚« ëª¨ì–‘(Sickle)ìœ¼ë¡œ ë³€í•´ ë”±ë”±í•´ì§.\n        - ì´ ë”±ë”±í•œ ì„¸í¬ë“¤ì´ ë°©ìˆ˜ ë°°ì¶œêµ¬(Trabecular meshwork)ë¥¼ **ë§‰ì•„ë²„ë¦¼ (Clog the drain)**. ğŸš½ğŸš«\n        - **Result:** ì•ˆì•• ê¸‰ìƒìŠ¹ -> **Glaucoma (ë…¹ë‚´ì¥)** -> **Optic Nerve Damage**.\n    - **USMLE Tip:** í‘ì¸ í™˜ìë‚˜ ê°€ì¡±ë ¥ì´ ìˆëŠ” ê²½ìš°, Hyphemaê°€ ë³´ì´ë©´ ë°˜ë“œì‹œ **Sickle Cell Screening**ì„ í•´ì•¼ í•¨. ì¼ë°˜ì ì¸ ì¹˜ë£Œë¡œëŠ” ì•ˆì••ì´ ì¡°ì ˆë˜ì§€ ì•Šì„ ìˆ˜ ìˆìŒ. (ìˆ˜ìˆ ì  ì„¸ì²™ í•„ìš” ê°€ëŠ¥ì„± ë†’ìŒ).\n### E. Other Important Pathologies\n**1. Optic Nerve Injury (ì‹œì‹ ê²½ ì†ìƒ)**\n- ì§ì ‘ì ì¸ ì¶©ê²©(Direct blow)ì´ë‚˜ ì „ë‹¨ë ¥(Shearing force)ìœ¼ë¡œ ë°œìƒ.\n- **Diagnostic Clue:**\n    - **Red Desaturation:** ë¹¨ê°„ìƒ‰ì´ ë¬¼ ë¹ ì§„ ë¶„í™ìƒ‰ìœ¼ë¡œ ë³´ì„. ğŸ”´ -> ğŸŒ¸\n    - **APD (Afferent Pupillary Defect):** \"Swinging Flashlight Test\"ì—ì„œ ë¹›ì„ ë¹„ì¶”ë©´ ë™ê³µì´ ì˜¤íˆë ¤ ì»¤ì§€ëŠ” í˜„ìƒ.\n**2. Sympathetic Ophthalmia (êµê°ì„± ì•ˆì—¼)**\n- *Mechanism:* **\"Biological Ghost Story\"** ğŸ‘»\n    - í•œìª½ ëˆˆì´ ì‹¬í•˜ê²Œ ë‹¤ì¹¨(Penetrating injury).\n    - ì•ˆêµ¬ ë‚´ë¶€ì˜ í•­ì›(Antigen)ì´ í˜ˆë¥˜ë¡œ ë…¸ì¶œë¨.\n    - ë©´ì—­ ì²´ê³„(Immune system)ê°€ ì´ë¥¼ \"ì™¸ë¶€ ì¹¨ì…ì\"ë¡œ ì¸ì‹í•˜ê³  í•­ì²´ ìƒì„±. ğŸ›¡ï¸\n    - ì´ í•­ì²´ë“¤ì´ í˜ˆë¥˜ë¥¼ íƒ€ê³  **ë©€ì©¡í•œ ë°˜ëŒ€ìª½ ëˆˆ(Healthy eye)**ì„ ê³µê²©í•¨. âš”ï¸\n    - ê²°ê³¼: ë‹¤ì¹œ ëˆˆë¿ë§Œ ì•„ë‹ˆë¼ ê±´ê°•í•œ ëˆˆê¹Œì§€ ì‹¤ëª….\n- **Management:** ë‹¤ì¹œ ëˆˆì˜ ì‹œë ¥ íšŒë³µ ê°€ëŠ¥ì„±ì´ ì—†ë‹¤ë©´, **2ì£¼ ì´ë‚´ì— ì•ˆêµ¬ ì ì¶œ(Enucleation)**ì„ ì‹œí–‰í•˜ì—¬ ë©´ì—­ ë°˜ì‘ì´ í•™ìŠµë˜ëŠ” ê²ƒì„ ë§‰ì•„ì•¼ í•¨.\n**3. Photokeratitis (ê´‘ê°ë§‰ì—¼)**\n- **Scenario:** ìš©ì ‘ê³µ(Welder without mask) ë˜ëŠ” ê³ ê¸€ ì—†ì´ ìŠ¤í‚¤ íƒ€ëŠ” ì‚¬ëŒ(Snow blindness). ğŸ¿ğŸ‘¨â€ğŸ­\n- **Key Feature:** **Lag Time (6~12ì‹œê°„).**\n    - ë‚®ì— ìŠ¤í‚¤ íƒˆ ë• ê´œì°®ë‹¤ê°€, ë°¤ì— ìë‹¤ê°€ \"ëˆˆì— ëª¨ë˜ê°€ ë“¤ì–´ê°„ ê²ƒ ê°™ì€\" ê·¹ì‹¬í•œ í†µì¦ìœ¼ë¡œ ê¹¸. (í”¼ë¶€ ì¬ë²ˆê³¼ ì›ë¦¬ê°€ ê°™ìŒ).\n- **Management:** Supportive care (Lubrication, Pain control). ìì—° ì¹˜ìœ ë¨.","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-173","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","treatment","pathophysiology"]}
{"chunk_type":"recap_summary","text":"### ğŸ”¥ 4. Rapid Fire Recap (Summary Table)\n| **Condition** | **Visual Cue / Exam Finding** | **Critical Action / Note** |\n| --- | --- | --- |\n| **Corneal Abrasion** | Fluorescein uptake (Green scratch) | Contact lens? -> **Ciprofloxacin** (No Patch!) |\n| **Open Globe** | **Teardrop Pupil**, Seidel Sign (+) | **Shield it**, CT, NPO, Call Surgeon. **No IOP check!** |\n| **Orbital Compartment Syndrome** | **Proptosis**, **Rock-hard lid**, APD | **Lateral Canthotomy** ASAP (Don't wait for CT) |\n| **Hyphema** | Blood level in anterior chamber | **Head up 30Â°**, Screen for **Sickle Cell** (Glaucoma risk) |\n| **Sympathetic Ophthalmia** | Inflammation in *non-injured* eye | Enucleation of injured eye within 14 days |\n| **Photokeratitis** | Welder/Skier, delayed pain | Supportive care, heals in 1-3 days |\n- **Confidence Level:** 1.0 (Confident)\n- **Caveats:**\n    - ì˜¤ë””ì˜¤ì—ì„œëŠ” í™˜ì A, B, Cë¥¼ ì²˜ìŒì— ì†Œê°œí•˜ê³  ë‚˜ì¤‘ì— ìƒì„¸ ì„¤ëª…í•˜ë¯€ë¡œ, ë…¸íŠ¸ì—ì„œëŠ” ë³‘ë¦¬í•™ì  ìˆœì„œë¡œ ì¬ë°°ì—´í•˜ì—¬ ê°€ë…ì„±ì„ ë†’ì˜€ìŠµë‹ˆë‹¤.\n    - Sickle Cellê³¼ Hyphemaì˜ ë³‘íƒœìƒë¦¬ëŠ” USMLEì—ì„œ ë§¤ìš° ì„ í˜¸í•˜ëŠ” ì£¼ì œì´ë¯€ë¡œ ìƒì„¸íˆ ê¸°ìˆ í–ˆìŠµë‹ˆë‹¤.\n    - ì•ˆëŒ€(Patching) ê¸ˆê¸° ì‚¬í•­(Contact lens wearer)ì€ ì‹¤ì œ ì„ìƒì—ì„œë„ ë§¤ìš° ì¤‘ìš”í•©ë‹ˆë‹¤.\n**Would you like me to simulate a USMLE Step 2 CK question block based on these ocular trauma scenarios?**\n# TL;DR Overview: Ear Infections (USMLE Step 2 CK)\nHere is the high-yield structure for Ear Pathology. We are focusing on **Precision** today! ğŸ¯\n- **Key Concept:** Anatomy & \"Doorway Diagnosis\" (Visualizing the patient before entering).\n- **External Ear:**\n    - **Otitis Externa:** Swimmer, Tragus pain, Canal inflammation.\n    - **Malignant Otitis Externa:** Diabetic/Elderly, *Night Pain*, Granulation tissue, Osteomyelitis.\n- **Middle Ear:**\n    - **Acute Otitis Media (AOM):** Bulging TM, Fever, Pain (Toddlers).\n    - **Serous Otitis Media (OME):** Fluid, No pain, Hearing loss.\n    - **Chronic Suppurative (CSOM):** Perforated TM, drainage > 6 weeks.\n    - **Mastoiditis:** Ear pushed forward, Post-auricular swelling.\n    - **Cholesteatoma:** Pearly white mass, skin in the wrong place.\n### ğŸŒ³ Top-Down Classification: Ear Pathology Tree","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-191","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","recap","diagnosis","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"Plaintext\n#\n`EAR PATHOLOGY (USMLE Step 2)\nâ”‚\nâ”œâ”€â”€ EXTERNAL EAR (Canal)\nâ”‚   â”œâ”€â”€ Simple Infection â”€â”€â”€> Otitis Externa (Swimmer's Ear)\nâ”‚   â”‚                         (Pseudomonas, S. aureus)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Invasive/Bone â”€â”€â”€â”€â”€> Malignant Otitis Externa (MOE)\nâ”‚                             (Osteomyelitis of Skull Base)\nâ”‚                             (Diabetic, Immunocompromised)\nâ”‚\nâ””â”€â”€ MIDDLE EAR (Behind TM)\n    â”œâ”€â”€ Acute Infection â”€â”€â”€> Acute Otitis Media (AOM)\n    â”‚                        (Bulging TM, Pus, Pain)\n    â”‚\n    â”œâ”€â”€ Complication â”€â”€â”€â”€â”€â”€> Mastoiditis\n    â”‚                        (Spread to Mastoid Air Cells)\n    â”‚\n    â”œâ”€â”€ Non-Infectious â”€â”€â”€â”€> Otitis Media with Effusion (OME)\n    â”‚   (Serous)             (Fluid, Bubbles, No Pain)\n    â”‚\n    â”œâ”€â”€ Chronic â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€> Chronic Suppurative OM (CSOM)\n    â”‚                        (Perforation + Drainage > 6wks)\n    â”‚\n    â””â”€â”€ Structural â”€â”€â”€â”€â”€â”€â”€â”€> Cholesteatoma\n                             (Keratin debris, Pearly Mass)`\n\"Welcome to the deep dive. Today, we are locking the door, turning on that do not disturb sign, because we have a uh... a serious mission. Hmm. We're tackling ear infections, specifically for your USMLE Step 2 prep. Right. And just to be clear, this isn't some casual chat about earaches. We are doing a line-by-line data extraction to make sure you have zero knowledge gaps.\"\n# 1. ğŸšª The \"Doorway\" Mental Exercise\n*(í™˜ìë¥¼ ë³´ê¸° ì „, ë³µë„ì—ì„œ ì´ë¯¸ ì§„ë‹¨ì„ ë‚´ë¦¬ëŠ” ì‹œê°í™” í›ˆë ¨)*\nì˜¤ë””ì˜¤ì—ì„œëŠ” í´ë¦¬ë‹‰ ë³µë„ë¥¼ ê±·ëŠ” ìƒí™©ì„ ê°€ì •í•˜ë©° 3ê°œì˜ ë°©ì„ ì‹œê°í™”í•©ë‹ˆë‹¤. ì´ê²ƒì´ ë°”ë¡œ **Clinical Vignette**ì˜ í•µì‹¬ì…ë‹ˆë‹¤! ğŸ§ \n| **Room #** | **Patient Description (Vignette)** | **Key Finding** | **Diagnosis** |\n| --- | --- | --- | --- |\n| **Room 1** | **Toddler**, screaming crying, holding ear. | Parents say \"Holding close helps, pulling ear helps.\" | **Acute Otitis Media (AOM)** ğŸ¼ |\n| **Room 2** | **20yo College Swimmer**. | Reaching out to touch ear -> **SCREAMS** in agony upon touching **Tragus**. | **Otitis Externa (OE)** ğŸŠâ€â™‚ï¸ |\n| **Room 3** | **75yo Diabetic patient**. Looks exhausted. | Deep, severe ear pain, **Worse at Night**. | **Malignant Otitis Externa (MOE)** ğŸš¨ |\n# 2. Otitis Externa (Swimmer's Ear) ğŸŠâ€â™‚ï¸\n### ğŸšª Vignette Anchor\nì Šì€ ìˆ˜ì˜ ì„ ìˆ˜ í˜¹ì€ ì—¬ë¦„ì²  íœ´ê°€ë¥¼ ë‹¤ë…€ì˜¨ í™˜ì. ê·€ë¥¼ ì‚´ì§ ìŠ¤ì¹˜ê¸°ë§Œ í•´ë„ ìì§€ëŸ¬ì§€ê²Œ ì•„íŒŒí•¨ (Tragus tenderness).\n### ğŸ¦  Pathophysiology & Risk Factors\n- **Water Exposure:** ë¬¼ì´ ì™¸ì´ë„(Ear canal)ì˜ pHë¥¼ ë³€í™”ì‹œí‚´ (Alkalineí™”).\n- **Barrier Break:** ì•Œì¹¼ë¦¬ì„± í™˜ê²½ì´ í”¼ë¶€ì˜ ë°©ì–´ë²½(Acidic defense barrier)ì„ ë¬´ë„ˆëœ¨ë¦¼ -> ì„¸ê·  ì¹¨íˆ¬ ìš©ì´.\n- **Cotton Swabs (ë©´ë´‰):** \"Micro-abrasions\"ì„ ìœ ë°œí•˜ì—¬ ì„¸ê· ì´ ìë¼ê¸° ë”± ì¢‹ì€ í™˜ê²½ ì œê³µ (ë°•í…Œë¦¬ì•„ê°€ ì‚¬ë‘í•¨ â¤ï¸).\n### ğŸ› Microbiology (The Bugs)\n1. **Pseudomonas aeruginosa** (Most Common) ğŸ¦ \n2. **Staphylococcus aureus**\n### ğŸ©º Diagnosis (Physical Exam)","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-201","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"- **Tragus Tenderness:** â˜… **Hallmark Sign.** ê·€ ì•ì˜ ì—°ê³¨(Tragus)ì„ ëˆ„ë¥´ê±°ë‚˜ ê·“ë°”í€´(Pinna)ë¥¼ ë‹¹ê¸¸ ë•Œ ê·¹ì‹¬í•œ í†µì¦(Agony).\n- **Canal:** Swollen(ë¶€ì¢…), Erythematous(ë°œì ).\n- **Tympanic Membrane (TM):** **NORMAL.** (ì¤‘ì´ì—¼ê³¼ì˜ ê°€ì¥ í° ì°¨ì´ì ! ê³ ë§‰ì€ ë©€ì©¡í•¨).\n### ğŸ’Š Management\n- **Step 1:** **Debridement** (Clean the canal). ì´ë¬¼ì§ˆì„ ì œê±°í•´ì•¼ ì•½ì´ ë“¤ì–´ê°.\n- **Step 2:** **Topical Antibiotics** (e.g., Ciprofloxacin) +/- Steroid (ì—¼ì¦ ì™„í™”).\n- **What if the canal is swollen shut?** ğŸ›‘\n    - **â˜… Next Best Step:** Place a **WICK** (ì‘ì€ ìŠ¤í€ì§€ ê°™ì€ ê²ƒ).\n    - ì´ê²ƒì´ ë¶€ì–´ì˜¤ë¥¸ ì™¸ì´ë„ ì•ˆìœ¼ë¡œ ì•½ë¬¼ì„ ì „ë‹¬í•˜ëŠ” ê¸¸(Sponge) ì—­í• ì„ í•¨.\n# 3. Malignant Otitis Externa (MOE) ğŸ’€\n### ğŸšª Vignette Anchor\nê³ ë ¹(Elderly) + **ë‹¹ë‡¨(Diabetes)** í˜¹ì€ ë©´ì—­ì €í•˜ì. ê·€ê°€ ë„ˆë¬´ ì•„íŒŒì„œ ì ì„ ëª» ì  (**Night Pain**). ê²‰ë³´ê¸°ì—” ê·¸ëƒ¥ ì™¸ì´ë„ì—¼ ê°™ì§€ë§Œ í›¨ì”¬ ì‹¬ê°í•¨.\n### ğŸš© Red Flags (Must Know!)\n- **Severe Deep Ear Pain:** ì¼ë°˜ì ì¸ ì§„í†µì œë¡œ ì¡°ì ˆë˜ì§€ ì•ŠìŒ.\n- **Worse at Night:** â˜… **Diagnostic Clue!** (ë°¤ì— ë¼ˆê°€ ì•„í””).\n- **Pain with Chewing:** TMJ(í„±ê´€ì ˆ)ì™€ ì™¸ì´ë„ê°€ ë¶™ì–´ìˆì–´ì„œ ì”¹ì„ ë•Œ ì•„í””.\n### ğŸ©º Pathophysiology & Findings\n- **Nature:** ë‹¨ìˆœ ê°ì—¼ì´ ì•„ë‹ˆë¼ **Osteomyelitis of the Skull Base** (ë‘ê°œì € ê³¨ìˆ˜ì—¼). ìƒëª…ì„ ìœ„í˜‘í•¨(Life-threatening).\n- **Pathogen:** **Pseudomonas aeruginosa (99%)**.\n- **â˜… Key Exam Finding:** **Granulation Tissue** in the floor of the canal (ì™¸ì´ë„ ë°”ë‹¥ì— ë³´ì´ëŠ” ë¶‰ì€ ìœ¡ì•„ì¢…).\n### âš ï¸ Complications\n- ê°ì—¼ì´ í¼ì ¸ì„œ ë‡Œì‹ ê²½(Cranial Nerves) ë§ˆë¹„ ìœ ë°œ.\n- **CN 7 (Facial):** ì•ˆë©´ ë§ˆë¹„.\n- **CN 9, 10, 11:** ì‚¼í‚´ ê³¤ë€ ë“±.\n### ğŸ§ª Diagnosis & Workup\n- **Initial Lab:** **ESR / CRP** Elevated (ì—¼ì¦ ìˆ˜ì¹˜ ìƒìŠ¹).\n- **â˜… Gold Standard (Imaging):** **CT Scan of Temporal Bone** (Bone destruction í™•ì¸).\n- (MRIë„ ê°€ëŠ¥í•˜ì§€ë§Œ, ë¼ˆ íŒŒê´´ë¥¼ ë³´ëŠ” ë°ëŠ” CTê°€ ìœ ìš©).\n### ğŸ’Š Management\n- **Topical drops?** NO! ğŸ™…â€â™‚ï¸ ì ˆëŒ€ ì•ˆ ë¨. ë¼ˆê¹Œì§€ ì•½ì´ ì•ˆ ê°.\n- **Treatment:** **IV Systemic Antibiotics** (Anti-pseudomonal).\n    - Ex: **IV Ciprofloxacin**. (ë¼ˆ ì¹¨íˆ¬ë ¥ì´ ì¢‹ìŒ).\n    - ì¥ê¸°ê°„ ì¹˜ë£Œ í•„ìš” (ìˆ˜ì£¼~ìˆ˜ê°œì›”).\n# 4. Acute Otitis Media (AOM) ğŸ¼\n### ğŸšª Vignette Anchor","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-221","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"ë³´ì±„ëŠ” ì•„ì´(Fussy infant/toddler), ì—´(Fever), ê·€ë¥¼ ì¡ì•„ë‹¹ê¹€(Tugging ear). ê°ê¸°(URI) ì¦ìƒì´ ì„ í–‰ë˜ëŠ” ê²½ìš°ê°€ ë§ìŒ.\n### ğŸ“ Anatomy (Why Kids?)\n- **Eustachian Tube (ìœ ìŠ¤íƒ€í‚¤ì˜¤ê´€):** ì†Œì•„ëŠ” ì„±ì¸ë³´ë‹¤ **Short, Wide, Horizontal** (ì§§ê³ , ë„“ê³ , ìˆ˜í‰ì„).\n- ì½§ë¬¼(Nasopharyngeal secretion)ì´ ì¤‘ì´(Middle ear)ë¡œ ì—­ë¥˜í•˜ê¸° ë”± ì¢‹ì€ êµ¬ì¡°. (Plumbing problem ğŸ›).\n### ğŸ› Microbiology \"The Big 3\"\n1. **Streptococcus pneumoniae**\n2. **Haemophilus influenzae (Non-typeable)** -> *Assoc w/ Otitis-Conjunctivitis Syndrome* (ëˆˆê¼½ + ì¤‘ì´ì—¼).\n3. **Moraxella catarrhalis**\n### ğŸ©º Diagnosis (Otoscopy)\n- **â˜… Bulging TM:** **Most Specific Sign.** ê³ ë§‰ì´ ë¹µë¹µí•˜ê²Œ íŠ€ì–´ë‚˜ì˜´ (Doughnut ì²˜ëŸ¼).\n- **Immobility:** Pneumatic otoscopy(ê³µê¸° ì´ë³´ê¸°) ì‹œ ê³ ë§‰ì´ ì›€ì§ì´ì§€ ì•ŠìŒ (ë’¤ì— ë†ì´ ì°¨ì„œ).\n- **Loss of landmarks:** Light reflex ì†Œì‹¤.\n- *(ì£¼ì˜: ë‹¨ìˆœíˆ ê³ ë§‰ì´ ë¹¨ê°›ë‹¤(Redness)ëŠ” ê²ƒë§Œìœ¼ë¡œëŠ” ë¶€ì¡±í•¨. ì•„ì´ê°€ ìš¸ê¸°ë§Œ í•´ë„ ë¹¨ê°œì§ˆ ìˆ˜ ìˆìŒ. **Bulging**ì´ í•µì‹¬!)*\n### ğŸ’Š Management Algorithm\n1. **First Line:** **High-Dose Amoxicillin**.\n    - *Why High Dose?* ë‚´ì„±ê· (Resistant Strep)ì„ ì´ê¸°ê¸° ìœ„í•´.\n2. **Second Line (Escalation):** **Amoxicillin-Clavulanate (Augmentin)**.\n    - *When to use?*\n        - ì¹˜ë£Œ ì‹¤íŒ¨ (48-72ì‹œê°„ í›„ì—ë„ í˜¸ì „ ì—†ìŒ).\n        - ì¬ë°œì„± (ìµœê·¼ 30ì¼ ì´ë‚´ì— í•­ìƒì œ ì”€).\n        - **Otitis-Conjunctivitis Syndrome** (H. fluëŠ” Beta-lactamase ìƒì„± ê°€ëŠ¥ì„± ë†’ìŒ).\n3. **Penicillin Allergy:**\n    - Mild (Rash): Cephalosporins (e.g., Cefdinir).\n    - Severe (Anaphylaxis): **Azithromycin** or Clindamycin.\n4. **Tubes (Tympanostomy):**\n    - Recurrent AOM: 6ê°œì›”ì— 3íšŒ ì´ìƒ or 1ë…„ì— 4íšŒ ì´ìƒ.\n# 5. Mastoiditis ğŸ”ï¸\n### ğŸšª Vignette Anchor\nAOMì„ ì•“ë˜ ì•„ì´ê°€ ì¹˜ë£Œë˜ì§€ ì•Šê³ , ê·€ ë’¤ìª½ì´ ë¶“ê³  ê·€ê°€ ì•ìœ¼ë¡œ íŠ€ì–´ë‚˜ì˜´ (**Protrusion of the Auricle**).\n### ğŸ©º Pathophysiology & Findings\n- **Mechanism:** ì¤‘ì´ì—¼(AOM)ì˜ ì—¼ì¦ì´ ë’¤ìª½ **Mastoid Air Cells**ë¡œ í¼ì§.\n- **Physical Exam:**\n    - **Post-auricular swelling & Erythema** (ê·€ ë’¤ìª½ì´ ë¹¨ê°›ê³  ë¶€ìŒ).\n    - â˜… **Ear displaced anteriorly and inferiorly** (ê·€ê°€ ì•ìœ¼ë¡œ ë°€ë ¤ë‚¨).\n### ğŸ§ª Diagnosis & Treatment\n- **â˜… Best Diagnostic Test:** **CT Scan** with contrast (Opacification of mastoid air cells, Bone erosion).\n- **Treatment:** **Emergency!**\n    - **IV Antibiotics** + **Drainage** (Myringotomy or Mastoidectomy).\n    - ë‹¨ìˆœ ì•½ë¬¼ë¡œëŠ” ë¶€ì¡±í•¨. ê³ ì—¬ìˆëŠ” ë†ì„ ë¹¼ë‚´ì•¼ í•¨.\n# 6. Otitis Media with Effusion (OME / Serous OM) ğŸ’§\n### ğŸšª Vignette Anchor","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-241","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"\"ì•„ì´ê°€ TV ì†Œë¦¬ë¥¼ ë„ˆë¬´ í¬ê²Œ í•´ìš”\", \"ë¶ˆëŸ¬ë„ ëŒ€ë‹µì„ ì˜ ì•ˆ í•´ìš”\". **ì—´ë„ ì—†ê³  ì•„í”„ì§€ë„ ì•ŠìŒ(No fever, No pain).**\n### ğŸ©º Key Differentiator from AOM\n- **Symptoms:** **Painless** (ì•„í”„ì§€ ì•ŠìŒ). Hearing Loss (ì²­ë ¥ ê°ì†Œ), Aural fullness (ê·€ê°€ ë¨¹ë¨¹í•¨).\n- **Otoscopy:**\n    - **Fluid levels** or **Bubbles** behind the TM. ğŸ«§\n    - TM is NOT bulging, NOT inflamed (Not angry/red). It looks dull.\n    - Immobile TM.\n### ğŸ’Š Management\n- **Observation (Watchful Waiting):** ëŒ€ë¶€ë¶„ 3ê°œì›” ë‚´ì— ì €ì ˆë¡œ ì¢‹ì•„ì§.\n- í•­ìƒì œ ì•ˆ ì”€! (Infectionì´ ì•„ë‹˜).\n- **If Chronic (>3 months) + Hearing Loss:** Ear Tubes (Ventilation tube) ê³ ë ¤.\n# 7. Chronic Suppurative Otitis Media (CSOM) â³\n### ğŸšª Vignette Anchor\n6ì£¼ ì´ìƒ ì§€ì†ë˜ëŠ” ê·€ ê³ ë¦„(Drainage). **ê³ ë§‰ ì²œê³µ(Perforation)**ì´ ë³´ì„. í†µì¦ì€ ì—†ì„ ìˆ˜ë„ ìˆìŒ.\n### ğŸ©º Definition\n- **Chronic Drainage (>6 weeks)** through a perforated TM.\n- **Pathogens:** *Pseudomonas*, *S. aureus*, Anaerobes (Zoo ğŸ¦ - Polymicrobial).\n### ğŸ’Š Management\n- **Oral Antibiotics?** **FAIL.** (í‰í„° ì¡°ì§ ë•Œë¬¸ì— í˜ˆë¥˜ ê³µê¸‰ì´ ì•ˆ ì¢‹ì•„ì„œ ì•½ì´ ëª» ê°).\n- **â˜… Gold Standard:** **Topical Fluoroquinolone Drops** (e.g., Ofloxacin drops).\n    - êµ¬ë© ë‚œ ê³ ë§‰ì„ í†µí•´ ì§ì ‘ ì¤‘ì´ë¡œ ì•½ì„ ì „ë‹¬.\n# 8. Cholesteatoma ğŸš\n### ğŸšª Vignette Anchor\në§Œì„±ì ì¸ ê·€ ë¶„ë¹„ë¬¼. ê³ ë§‰ ë’¤ì— **ì§„ì£¼ ê°™ì€ í•˜ì–€ ë©ì–´ë¦¬(Pearly white mass)**ê°€ ë³´ì„.\n### ğŸ©º Pathophysiology\n- **Not a Tumor:** ì•”(Cancer) ì•„ë‹˜. **Keratinized Squamous Epithelium** (í”¼ë¶€ ì¡°ì§)ì´ ì¤‘ì´(Middle ear) ì•ˆìœ¼ë¡œ ìë¼ ë“¤ì–´ê°„ ê²ƒ.\n- **Location:** ì£¼ë¡œ ê³ ë§‰ì˜ ìœ—ë¶€ë¶„(Pars flaccida)ì˜ **Retraction Pocket**ì—ì„œ ì‹œì‘.\n- **Danger:** **Erosive!** íš¨ì†Œ(Enzymes)ë¥¼ ë¶„ë¹„í•´ì„œ ì£¼ë³€ ë¼ˆ(Ossicles, Mastoid, Inner ear)ë¥¼ ë…¹ì„. -> ì˜êµ¬ì  ì²­ë ¥ ì†Œì‹¤, ì–´ì§€ëŸ¬ì›€, ì•ˆë©´ ë§ˆë¹„ ìœ ë°œ ê°€ëŠ¥.\n### ğŸ§ª Diagnosis & Treatment","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-261","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"- **Exam:** **Pearly white mass** behind TM + Retraction pocket + Debris.\n- **â˜… Management:** **Surgery** is Mandatory. (ì•½ìœ¼ë¡œ ì•ˆ ì—†ì–´ì§. ë¬´ì¡°ê±´ ê¸ì–´ë‚´ì•¼ í•¨).\n# ğŸ”¥ RAPID FIRE RECAP: Data Extraction Table\n| **Disease** | **Key Symptom / History** | **Otoscopy Finding** | **â˜… Next Best Step / Tx** |\n| --- | --- | --- | --- |\n| **Otitis Externa** | Swimmer, Pain on Tragus touch | Canal swollen, **TM Normal** | Clean + Topical Cipro |\n| **Malignant OE** | Elderly Diabetic, **Night Pain** | **Granulation Tissue** on floor | **IV Ciprofloxacin** (CT to confirm) |\n| **AOM** | Toddler, Fever, Crying | **Bulging**, Red, Immobile TM | **High-Dose Amoxicillin** |\n| **Mastoiditis** | Untreated AOM, Ear protrusion | Post-auricular swelling | **CT Scan** -> IV Abx + Drain |\n| **OME (Serous)** | Hearing loss, **No Pain/Fever** | Fluid levels, Bubbles, Dull | **Observation** (Wait) |\n| **CSOM** | Drainage > 6wks, Perforation | Perforated TM, Purulent | **Topical** Fluoroquinolone |\n| **Cholesteatoma** | Chronic drainage, Hearing loss | **Pearly White Mass**, Debris | **Surgery** (Refer to ENT) |\n### ğŸ’¡ Final Clinical Pearl (Neurology Connection) ğŸ§ \n- ì„±ì¸ì´ ê°‘ìê¸° í•œìª½ ê·€ê°€ ì•ˆ ë“¤ë¦°ë‹¤ê³  ì™”ëŠ”ë°, **Painë„ ì—†ê³ , Infectionë„ ì—†ê³ , Examë„ Normal**ì´ë‹¤?\n    - ë‹¨ìˆœ ê·€ì§€ê°€ ì•„ë‹˜.\n    - **Sudden Sensorineural Hearing Loss** (ì‘ê¸‰) í˜¹ì€ **Acoustic Neuroma** (ì²­ì‹ ê²½ì¢…) ê°€ëŠ¥ì„± ì—¼ë‘.\n    - ì´ê²ƒì€ \"Sensorineural\" íŒŒíŠ¸ì˜ ì´ì•¼ê¸° (To be continued...).\n**Next Step for User:** Would you like me to generate a specific quiz set focusing on the \"Environmental Injuries\" section to test your retention of the cooling methods? ğŸ“\n### ğŸ“‹ Overview: Ear & Balance Pathology (TL;DR)\nì‹œê°„ì´ ì—†ë‹¤ë©´ ì´ê²ƒë§Œì€ ê¼­ ì±™ê²¨ê°€ì„¸ìš”! ğŸš€\n| **êµ¬ë¶„** | **ì£¼ìš” ì§ˆí™˜ (Key Pathology)** | **í•µì‹¬ íŠ¹ì§• (Buzzwords & Clues)** |\n| --- | --- | --- |\n| **ì²­ë ¥ ìƒì‹¤ (Hearing Loss)** | **Presbycusis (ë…¸ì¸ì„± ë‚œì²­)** | ê³ ì£¼íŒŒìˆ˜(ììŒ) ì†Œì‹¤, \"ì›…ì–¼ê±°ë¦¬ëŠ” ì†Œë¦¬ì²˜ëŸ¼ ë“¤ë¦¼\", ì‹œë„ëŸ¬ìš´ ê³³ì—ì„œ ë” ì•ˆ ë“¤ë¦¼. |\n|  | **Otosclerosis (ì´ê²½í™”ì¦)** | ì„ì‹ ë¶€(30ëŒ€), **ì „ìŒì„± ë‚œì²­**, â˜…ì‹œë„ëŸ¬ìš´ ê³³ì—ì„œ ë” ì˜ ë“¤ë¦¼ (Paracusis Willisii). |\n| **ì–´ì§€ëŸ¼ì¦ (Vertigo)** | **BPPV (ì´ì„ì¦)** | ê³ ê°œ ëŒë¦´ ë•Œ(Position change) ë°œìƒ, ì§§ì€ ì§€ì†(ì´ˆ ë‹¨ìœ„), Dix-Hallpikeë¡œ ì§„ë‹¨. |\n|  | **Meniere's Disease (ë©”ë‹ˆì—ë¥´)** | **Triad**: ì–´ì§€ëŸ¼ì¦ + ë‚œì²­ + ì´ëª…/ê·€ ë¨¹ë¨¹í•¨ (Fullness). |\n|  | **Vestibular Neuritis (ì „ì •ì‹ ê²½ì—¼)** | ë‹¨ í•œ ë²ˆì˜ ì‹¬í•œ ì–´ì§€ëŸ¼ì¦(ìˆ˜ì¼ ì§€ì†), ì²­ë ¥ ì†Œì‹¤ ì—†ìŒ, ë°”ì´ëŸ¬ìŠ¤ ê°ì—¼ í›„. |\n| **ì‘ê¸‰ (Emergency)** | **Auricular Hematoma** | ë ˆìŠ¬ëŸ¬/ë³µì„œ, \"ë§Œë‘ê·€\" ì˜ˆë°© ìœ„í•´ ì¦‰ì‹œ ë°°ì•¡(Drainage) ë° ì••ë°• í•„ìˆ˜. |\n### ğŸŒ³ Top-down Classification: Ear Pathology\nì˜í•™ì  ë§¥ë½ì„ ì¡ê¸° ìœ„í•œ **Hierarchical Structure**ì…ë‹ˆë‹¤.","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-281","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"Plaintext\n`DIZZINESS & HEARING LOSS (ì´ë¹„ì¸í›„ê³¼ì  ì ‘ê·¼)\nâ”œâ”€â”€ Anatomy & Physiology (ê¸°ì´ˆ)\nâ”‚   â”œâ”€â”€ Eustachian Tube (ì´ê´€): ì••ë ¥ ì¡°ì ˆ, ë°°ì¶œ, ë³´í˜¸\nâ”‚   â”‚   â”œâ”€â”€ Adult: Angled (ê¸°ëŠ¥ ì›í™œ)\nâ”‚   â”‚   â””â”€â”€ Infant: Flat/Horizontal (ê°ì—¼ ì·¨ì•½)\nâ”‚   â””â”€â”€ Inner Ear: Cochlea (ì²­ê°) + Vestibule (í‰í˜•)\nâ”‚\nâ”œâ”€â”€ Hearing Loss (ì²­ë ¥ ì†Œì‹¤)\nâ”‚   â”œâ”€â”€ Sensorineural (ê°ê°ì‹ ê²½ì„±): í•˜ë“œì›¨ì–´(ì‹ ê²½/ì„¸í¬) ê³ ì¥\nâ”‚   â”‚   â”œâ”€â”€ Presbycusis (ë…¸í™”)\nâ”‚   â”‚   â”œâ”€â”€ Meniere's Disease\nâ”‚   â”‚   â””â”€â”€ Acoustic Neuroma\nâ”‚   â””â”€â”€ Conductive (ì „ìŒì„±): ì „ë‹¬ ê²½ë¡œ(íŒŒì´í”„) ë§‰í˜\nâ”‚       â”œâ”€â”€ Wax/Foreign Body\nâ”‚       â”œâ”€â”€ Otitis Media (ì¤‘ì´ì—¼)\nâ”‚       â””â”€â”€ Otosclerosis (ì´ê²½í™”ì¦ - ë¼ˆ êµ³ìŒ)\nâ”‚\nâ”œâ”€â”€ Vertigo (ì–´ì§€ëŸ¼ì¦)\nâ”‚   â”œâ”€â”€ Peripheral (ë§ì´ˆì„± - ê·€ ë¬¸ì œ): ì‹¬í•œ ì–´ì§€ëŸ¼ì¦, í† í•¨\nâ”‚   â”‚   â”œâ”€â”€ BPPV (ì´ì„ì¦): ìœ„ì¹˜ ë³€ë™ ì‹œ\nâ”‚   â”‚   â”œâ”€â”€ Vestibular Neuritis (ì „ì •ì‹ ê²½ì—¼): 1íšŒì„±, ì‹¬í•¨\nâ”‚   â”‚   â””â”€â”€ Meniere's: ì²­ë ¥ ì†Œì‹¤ ë™ë°˜\nâ”‚   â””â”€â”€ Central (ì¤‘ì¶”ì„± - ë‡Œ ë¬¸ì œ): ëœ ì–´ì§€ëŸ¬ì›€, ì‹ ê²½í•™ì  ì¦ìƒ\nâ”‚       â”œâ”€â”€ Stroke (ë‡Œì¡¸ì¤‘)\nâ”‚       â””â”€â”€ Tumor\nâ”‚\nâ””â”€â”€ Trauma/Emergency\n    â”œâ”€â”€ Barotrauma (ê¸°ì••ì†ìƒ)\n    â””â”€â”€ Auricular Hematoma (ì´ê°œí˜ˆì¢…)`\n### ğŸ¥ Clinical Scenario: The Two Rooms\nê°•ì˜ëŠ” ë‘ ëª…ì˜ í™˜ìë¥¼ ëŒ€ì¡°í•˜ë©° ì‹œì‘í•©ë‹ˆë‹¤. ì´ ë‘ ì‹œë‚˜ë¦¬ì˜¤ê°€ ì˜¤ëŠ˜ì˜ í•µì‹¬ í…Œë§ˆì…ë‹ˆë‹¤! ğŸ¬\n### ğŸšª Room 1: The \"Happy\" Deaf Patient\n- **Patient:** 30ëŒ€ ì´ˆë°˜ ì—¬ì„±, **ì„ì‹  ì¤‘**.\n- **C/C:** ìš°ì¸¡ ê·€ì˜ ì²­ë ¥ì´ ì„œì„œíˆ ë–¨ì–´ì§ (Progressive hearing loss).\n- **The Weird Part:** ì‹œë„ëŸ¬ìš´ ë ˆìŠ¤í† ë‘(Noisy environment)ì— ê°€ë©´ ì˜¤íˆë ¤ ë” ì˜ ë“¤ë¦°ë‹¤ê³  í•¨! ğŸ˜²\n- **Diagnosis:** **Otosclerosis (ì´ê²½í™”ì¦)**\n### ğŸšª Room 2: The Miserable Spinner\n- **Patient:** ì¹¨ëŒ€ ë‚œê°„ì„ ë¶€ì—¬ì¡ê³  êµ¬í†  ì¤‘ì¸ ë‚¨ì„±.\n- **C/C:** ì„¸ìƒì´ ë¹™ê¸€ë¹™ê¸€ ë” (Violent spinning), ë˜‘ë°”ë¡œ ê±·ì§€ ëª»í•¨.\n- **Diagnosis:** **Vestibular Issue (ì „ì •ê¸°ê´€ ë¬¸ì œ - Balance Crisis)**\n### 1. Anatomy & Plumbing (Eustachian Tube) ğŸº\nì´ê´€(Eustachian Tube)ì€ ê·€ì˜ **\"Pressure Valve(ì••ë ¥ ë°¸ë¸Œ)\"**ì´ì **\"Drain Pipe(ë°°ìˆ˜ê´€)\"**ì…ë‹ˆë‹¤. ë‹¨ìˆœíˆ ê·€ì°®ê²Œ í•˜ëŠ” ê¸°ê´€ì´ ì•„ë‹™ë‹ˆë‹¤!\n- **3ê°€ì§€ í•µì‹¬ ê¸°ëŠ¥:**\n    1. **Equalize Pressure:** ì¤‘ì´(Middle ear)ì™€ ëŒ€ê¸°ì••(Atmosphere)ì˜ ì••ë ¥ì„ ë§ì¶¤.\n    2. **Drainage:** ì¤‘ì´ì—ì„œ ìƒì„±ëœ ì ì•¡(Mucus/Fluid)ì„ ë°°ì¶œ.\n    3. **Protection:** ì½”ì—ì„œ ì—­ë¥˜í•˜ëŠ” ì½§ë¬¼(Snot)ì´ë‚˜ ê· ì´ ê·€ë¡œ ë“¤ì–´ê°€ëŠ” ê²ƒì„ ë§‰ìŒ.\n- **ğŸ‘¶ Infant vs. ğŸ‘¨ Adult (Why kids get ear infections)**\n    - **Adult:** ì¤‘ë ¥ì˜ ë„ì›€ì„ ë°›ì•„ ì˜ ë°°ì¶œë˜ë„ë¡ ê°ë„ê°€ ì ¸ ìˆìŒ.\n    - **Infant:** **Shorter, Wider, More Horizontal (Flat)**.\n    - **ê²°ê³¼:** ì½”ì˜ ë°•í…Œë¦¬ì•„ê°€ ê·€ë¡œ ì§í–‰í•˜ëŠ” ê³ ì†ë„ë¡œ(Straight shot)ê°€ ë¨. ê·¸ë˜ì„œ ì†Œì•„ ì¤‘ì´ì—¼ì´ í”í•¨!\n### âš ï¸ Eustachian Tube Dysfunction (ì´ê´€ ê¸°ëŠ¥ ë¶€ì „)\n- **Mechanism:** ì´ê´€ì´ ë§‰í˜ â†’ ì¤‘ì´ ë‚´ ê³µê¸°ê°€ í¡ìˆ˜ë¨ â†’ ìƒˆë¡œìš´ ê³µê¸°ê°€ ì•ˆ ë“¤ì–´ì˜´ â†’ **Vacuum (ì§„ê³µ ìƒíƒœ/ìŒì••)** ë°œìƒ.\n- **Symptom:** ê³ ë§‰ì´ ì•ˆìª½ìœ¼ë¡œ ë¹¨ë ¤ ë“¤ì–´ê°(Retracted TM) â†’ ê·€ ë¨¹ë¨¹í•¨(Fullness), íŒí•‘ ì‚¬ìš´ë“œ, ì „ìŒì„± ë‚œì²­.\n- **Treatment:** ì›ì¸ ì¹˜ë£Œ (ë¹„ì—¼ ë“±). íŠœë¸Œ ì‚½ì…ìˆ ì€ ë§Œì„±ì¼ ë•Œ ê³ ë ¤.\n### âœˆï¸ Barotrauma (ê¸°ì•• ì†ìƒ) - \"The Flying Scenario\"\n- **ìƒí™©:** ë¹„í–‰ê¸° ì´ì°©ë¥™ ì‹œ (ì••ë ¥ ë³€í™”). íŠœë¸Œê°€ ë§‰í˜€ì„œ ì••ë ¥ ì¡°ì ˆ ì‹¤íŒ¨.\n- **ì¦ìƒ:** ê·¹ì‹¬í•œ í†µì¦(Agony) â†’ ì••ë ¥ì´ ê³ ë§‰ì„ ì¡ì•„ë‹¹ê¹€(Stretch).\n- **Rupture (íŒŒì—´):**\n    - í†µì¦ì´ ê·¹ì‹¬í•˜ë‹¤ê°€ **ê°‘ìê¸° ì‚¬ë¼ì§ (Instant Relief)** + ê·€ì—ì„œ í”¼ê°€ ì¡°ê¸ˆ ë‚˜ì˜´(Bleeding).\n    - **ì˜ë¯¸:** ê³ ë§‰ì´ í„°ì ¸ì„œ ì••ë ¥ì´ ê°™ì•„ì§„ ê²ƒ(Equalized immediately).\n    - **â˜… Key Concept:** í†µì¦ ì†Œì‹¤ = ê³ ë§‰ íŒŒì—´ (Bad thing feels good).\n### 2. Hearing Loss Classification ğŸ§\n### A. Sensorineural Hearing Loss (ê°ê°ì‹ ê²½ì„± ë‚œì²­) - \"Hardware Failure\" ğŸ”Œ","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-301","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"- **ê°œë…:** ë‹¬íŒ½ì´ê´€(Cochlea)ì´ë‚˜ ì‹ ê²½(Nerve) ìì²´ê°€ ê³ ì¥ ë‚œ ê²ƒ. íŒŒì´í”„ëŠ” ë©€ì©¡í•¨.\n- **ëŒ€í‘œ ì§ˆí™˜: Presbycusis (ë…¸ì¸ì„± ë‚œì²­)**\n    - **ê¸°ì „:** ê³ ì£¼íŒŒìˆ˜ë¥¼ ê°ì§€í•˜ëŠ” ìœ ëª¨ì„¸í¬(Hair cell)ê°€ ë¨¼ì € ì£½ìŒ.\n    - **ì¦ìƒ:**\n        - **Consonants Drop out:** ììŒ(T, S, K - ê³ ì£¼íŒŒìˆ˜)ì´ ì•ˆ ë“¤ë¦¬ê³  ëª¨ìŒ(ì €ì£¼íŒŒìˆ˜)ë§Œ ë“¤ë¦¼.\n        - **Mumbling:** \"ì‚¬ëŒë“¤ì´ ì¤‘ì–¼ê±°ë¦¬ëŠ” ê²ƒ ê°™ë‹¤\"ê³  í˜¸ì†Œ.\n        - **Cocktail Party Effect:** ì‹œë„ëŸ¬ìš´ ì‹ë‹¹(ë°°ê²½ ì†ŒìŒ = ì €ì£¼íŒŒìˆ˜)ì— ê°€ë©´ ì‚¬ëŒ ë§ì†Œë¦¬(ììŒ)ë¥¼ êµ¬ë¶„ ëª»í•¨. **ì‹œë„ëŸ¬ìš´ ê³³ì—ì„œ ë” ì•ˆ ë“¤ë¦¼.**\n### B. Conductive Hearing Loss (ì „ìŒì„± ë‚œì²­) - \"Blockage\" ğŸš§\n- **ê°œë…:** ì†Œë¦¬ ì „ë‹¬ ê²½ë¡œê°€ ë§‰í˜. (ê·€ì§€, ì¤‘ì´ì—¼, ì´ê²½í™”ì¦ ë“±)\n- **íŠ¹ì§•:** ê·€ë¥¼ ì†ê°€ë½ìœ¼ë¡œ ë§‰ì€ ê²ƒê³¼ ê°™ìŒ. (Plugging your ears).\n- **ì¦ìƒ:**\n    - ì˜¤íˆë ¤ ì‹œë„ëŸ¬ìš´ ê³³ì—ì„œ ëŒ€í™”ê°€ ë” í¸í•  ìˆ˜ ìˆìŒ (ë‚´ ëª©ì†Œë¦¬ê°€ ë¼ˆë¥¼ í†µí•´ í¬ê²Œ ë“¤ë¦¬ê³ , ë°°ê²½ ì†ŒìŒì€ ì°¨ë‹¨ë¨).\n### 3. Vertigo: The Spinning World ğŸŒ€\nì–´ì§€ëŸ¼ì¦ í™˜ìë¥¼ ë³¼ ë•Œ ê°€ì¥ ë¨¼ì € í•´ì•¼ í•  ì§ˆë¬¸: **\"ê·€(Peripheral) ë¬¸ì œì¸ê°€, ë‡Œ(Central) ë¬¸ì œì¸ê°€?\"**\n### ğŸ•µï¸â€â™‚ï¸ Differential Diagnosis: Peripheral vs. Central\n| **íŠ¹ì§•** | **Peripheral (Ear) ğŸ‘‚** | **Central (Brain/Stroke) ğŸ§ ** |\n| --- | --- | --- |\n| **ê°•ë„ (Intensity)** | **Violent/Severe** (í† í•˜ê³  ë‚œë¦¬ ë‚¨) | ëœ ì‹¬í•¨ (Mild/Moderate) |\n| **Nystagmus (ì•ˆì§„)** | **Fatigable** (ì‹œê°„ ì§€ë‚˜ë©´ ë©ˆì¶¤), ê³ ì •í•˜ë©´ ë©ˆì¶¤ | **Non-fatigable** (ê³„ì†ë¨), ë°©í–¥ì´ ë°”ë€œ, ìˆ˜ì§ ì•ˆì§„ |\n| **Fixation (ì£¼ì‹œ)** | **Inhibited by fixation** (ì—„ì§€ì†ê°€ë½ ì³ë‹¤ë³´ë©´ ë©ˆì¶¤) | **Not inhibited** (ì£¼ì‹œí•´ë„ ê³„ì† íŠ) |\n| **ë™ë°˜ ì¦ìƒ** | ì²­ë ¥ ì†Œì‹¤, ì´ëª… | ì‹ ê²½í•™ì  ì¦ìƒ (ë§ˆë¹„, ë°œìŒ ì–´ëˆŒ ë“±) |\n- **â˜… Gyroscope Analogy:** ë‚´ì´(Inner ear)ëŠ” ë¨¸ë¦¬ìš© ìì´ë¡œìŠ¤ì½”í”„(Gyroscope)ì…ë‹ˆë‹¤. í•œìª½ì´ ê³ ì¥ ë‚˜ë©´ ë‡ŒëŠ” ë¨¸ë¦¬ê°€ ê³„ì† íšŒì „í•œë‹¤ê³  ì°©ê°í•´ ëˆˆì„ ì›€ì§ì…ë‹ˆë‹¤(Drift & Snap).\n- **â˜… Fixation Test:** í™˜ìì—ê²Œ ì—„ì§€ì†ê°€ë½ì„ ì³ë‹¤ë³´ê²Œ í•˜ì„¸ìš”.\n    - ì•ˆì§„ì´ ë©ˆì¶˜ë‹¤? â†’ **Peripheral (Ear)**. (ì‹œê° ì •ë³´ê°€ ê·€ì˜ ì˜¤ë¥˜ë¥¼ ë®ì–´ì”€).\n    - ì•ˆì§„ì´ ì•ˆ ë©ˆì¶˜ë‹¤? â†’ **Central (Brain)**. (ë‡Œ ìì²´ê°€ ê³ ì¥ ë‚˜ì„œ ë³´ì •ì„ ëª» í•¨). **Stroke Alert!** ğŸš¨\n### ğŸ§¬ Specific Vertigo Diseases\n1. **Meniere's Disease (ë©”ë‹ˆì—ë¥´ë³‘)** ğŸŒŠ\n    - **ì›ì¸:** ë‚´ë¦¼í”„ì•¡ ì••ë ¥ ì¦ê°€ (Endolymphatic hydrops) - ê·€ì˜ ë…¹ë‚´ì¥(Glaucoma) ê°™ì€ ê²ƒ.\n    - **â˜… Classic Triad:**\n        1. Vertigo (ìˆ˜ì‹œê°„ ì§€ì†)\n        2. Hearing Loss (ì €ì£¼íŒŒìˆ˜ ë‚œì²­)\n        3. Tinnitus / Aural Fullness (ê·€ ê½‰ ì°¬ ëŠë‚Œ)\n    - **íŠ¹ì§•:** ì¦ìƒì´ ì™”ë‹¤ê°€ ê°”ë‹¤ê°€ í•¨ (Episodic).\n2. **BPPV (Benign Paroxysmal Positional Vertigo - ì´ì„ì¦)** ğŸª¨\n    - **ì›ì¸:** Loose Calcium Debris (ì´ì„)ê°€ ë°˜ê³ ë¦¬ê´€ì„ ëŒì•„ë‹¤ë‹˜.\n    - **Trigger:** **Position Change** (ì•„ì¹¨ì— ì¼ì–´ë‚  ë•Œ, ê³ ê°œ ëŒë¦´ ë•Œ).\n    - **ì§€ì† ì‹œê°„:** **Seconds (ì´ˆ ë‹¨ìœ„)**. ê°€ë§Œíˆ ìˆìœ¼ë©´ ë©ˆì¶¤.\n    - **Diagnosis:** **Dix-Hallpike Maneuver** (ë¨¸ë¦¬ ëŒë¦¬ê³  ëˆ•íˆê¸°).\n    - **Treatment:** Epley Maneuver (ì´ì„ì„ ì œìë¦¬ë¡œ ëŒë ¤ë†“ìŒ).\n3. **Vestibular Neuritis (ì „ì •ì‹ ê²½ì—¼)** ğŸ¦ \n    - **ì›ì¸:** Viral infection (ê·€ì— ê±¸ë¦° ê°ê¸°/ë…ê°).\n    - **ì¦ìƒ:** **Single, Severe Attack**. ë©°ì¹  ë™ì•ˆ ê³„ì† ì–´ì§€ëŸ¬ì›€. ì²­ë ¥ ì†Œì‹¤ì€ ë³´í†µ ì—†ìŒ.\n    - **ê²½ê³¼:** ì‹œê°„ì´ ì§€ë‚˜ë©´ ë‡Œê°€ ì ì‘(Compensation)í•´ì„œ ë‚˜ì•„ì§.\n4. **Labyrinthitis (ë¯¸ë¡œì—¼)** ğŸ”¥\n    - Vestibular Neuritis + **Hearing Loss**. (ì—¼ì¦ì´ ì²­ê°ê¸°ê´€ê¹Œì§€ í¼ì§).\n5. **Perilymphatic Fistula (ì™¸ë¦¼í”„ ëˆ„ê³µ)** ğŸ’§\n    - **ì›ì¸:** Trauma (ìŠ¤ì¿ ë²„ ë‹¤ì´ë¹™, ì—­ë„ ë“±)ë¡œ ì¸í•œ ì°¢ì–´ì§.\n    - **â˜… Tullio Phenomenon:** **Loud Noise causes Dizziness.** (ì‹œë„ëŸ¬ìš´ ì†Œë¦¬ë¥¼ ë“¤ìœ¼ë©´ ì–´ì§€ëŸ¬ì›€). ì†ìœ¼ë¡œ ê·€ë¥¼ ì³ì„œ ì••ë ¥ì„ ì£¼ë©´ ëˆˆì´ íŠ.\n6. **Ototoxicity (ì´ë…ì„± ì•½ë¬¼)** ğŸ’Š\n    - **ì£¼ë²”:** **Aminoglycosides (Gentamicin)**.\n    - **ì¦ìƒ:** ì–‘ìª½ ì „ì •ê¸°ê´€ì´ ë‹¤ ì£½ìŒ(Bilateral loss).\n    - **Oscillopsia (ë™ìš”ì‹œ):** ê±¸ì„ ë•Œë§ˆë‹¤ ì„¸ìƒì´ ëœì»¹ê±°ë¦¼(Bouncing world). ìì´ë¡œìŠ¤ì½”í”„ê°€ ì—†ì–´ì„œ ì¹´ë©”ë¼ ì•ˆì •í™”(Image stabilization)ê°€ ì•ˆ ë˜ëŠ” ìƒíƒœ. ë©ˆì¶°ì•¼ë§Œ ê¸€ì”¨ë¥¼ ì½ì„ ìˆ˜ ìˆìŒ.\n### 4. Special Pathologies ğŸ§©\n### A. Otosclerosis (ì´ê²½í™”ì¦) - Room 1 Patient ğŸ¤°\n- **Pathology:** ë“±ê³¨(Stapes - ê·“ì†ì˜ ì‘ì€ ë¼ˆ)ì´ ì£¼ë³€ ë¼ˆì™€ ìœµí•©(Fuse)ë˜ì–´ êµ³ì–´ë²„ë¦¼. ì§„ë™ì„ ëª» í•¨.\n- **Patient Profile:** **Young Female (20-30s)**, Family history (Autosomal Dominant).\n- **Trigger:** **Pregnancy** (í˜¸ë¥´ëª¬ ë³€í™”ê°€ ë¼ˆì˜ ê²½í™”ë¥¼ ê°€ì†í™”).\n- **ì¦ìƒ:** **Conductive Hearing Loss**.\n- **â˜… Paracusis Willisii:** ì‹œë„ëŸ¬ìš´ í™˜ê²½(ë°°ê²½ ì†ŒìŒì´ ìˆëŠ” ê³³)ì—ì„œ ë§ì†Œë¦¬ë¥¼ ë” ì˜ ì•Œì•„ë“¤ìŒ. (í™˜ìì˜ ì „ìŒì„± ë‚œì²­ì´ ë°°ê²½ ì†ŒìŒì„ í•„í„°ë§í•´ì¤Œ).\n- **Treatment:** ë³´ì²­ê¸° or ìˆ˜ìˆ (Stapedectomy).\n### B. Auricular Hematoma (ì´ê°œí˜ˆì¢…) - Wrestler's Ear ğŸ¤¼â€â™‚ï¸\n- **Mechanism:** ê·€ë°”í€´(Auricle)ì— íƒ€ê²© â†’ ì—°ê³¨(Cartilage)ê³¼ ì—°ê³¨ë§‰(Perichondrium) ì‚¬ì´ê°€ ì°¢ì–´ì§ â†’ ê·¸ ì‚¬ì´ì— í”¼ê°€ ê³ ì„.\n- **ìœ„í—˜ì„±:** ì—°ê³¨ì€ í˜ˆê´€ì´ ì—†ìŒ. ì—°ê³¨ë§‰ì—ì„œ í™•ì‚°(Diffusion)ìœ¼ë¡œ ì˜ì–‘ë¶„ì„ ë°›ìŒ. í”¼ê°€ ì°¨ì„œ ì‚¬ì´ê°€ ë²Œì–´ì§€ë©´ **ì—°ê³¨ì´ êµ¶ì–´ ì£½ìŒ (Necrosis)**.\n- **ê²°ê³¼:** ì£½ì€ ì—°ê³¨ì´ ì­ˆê¸€ì­ˆê¸€í•´ì§ â†’ **Cauliflower Ear (ë§Œë‘ê·€)**.\n- **â˜… Management:**\n    1. **Immediate Drainage (ì¦‰ì‹œ ë°°ì•¡)**: í”¼ë¥¼ ë¹¼ëƒ„.\n    2. **Pressure Dressing (ì••ë°• ë“œë ˆì‹±)**: í”¼ë¶€ì™€ ì—°ê³¨ì„ ë‹¤ì‹œ ë¶™ì—¬ì¤˜ì•¼ í•¨ (Sandwich them back together). ê·¸ëƒ¥ ë‘ë©´ ë‹¤ì‹œ í”¼ê°€ ì°¸.","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-321","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic","tree"]}
{"chunk_type":"recap_summary","text":"### ğŸ”¥ Rapid Fire Recap (Summary)\në¹ ë¥´ê²Œ ë³µìŠµí•´ë´…ì‹œë‹¤!\n1. **Symptom:** Vertigo + Hearing Loss + Tinnitus (Triad).\n    - **Diagnosis:** **Meniere's Disease**.\n2. **Symptom:** Vertigo lasting **seconds**, triggered by rolling over in bed.\n    - **Diagnosis:** **BPPV**.\n    - **Test:** Dix-Hallpike.\n3. **Symptom:** **Severe vertigo** for days, followed by viral illness, NO hearing loss.\n    - **Diagnosis:** **Vestibular Neuritis**.\n4. **Symptom:** Young pregnant woman, hearing loss, hears **better in noisy places**.\n    - **Diagnosis:** **Otosclerosis**.\n5. **Symptom:** Wrestler with a swollen ear.\n    - **Next Step:** **Incision & Drainage + Pressure Dressing** (Prevent Cauliflower ear).\n6. **Sign:** Vertigo triggered by **loud noise** (Tullio phenomenon).\n    - **Diagnosis:** **Perilymphatic Fistula** (Superior Canal Dehiscence).\n7. **Concept:** Pain in airplane -> Pop -> Pain gone + Blood.\n    - **Diagnosis:** **Ruptured TM** (Barotrauma).\n8. **Sign:** Nystagmus that **does NOT stop** with fixation (looking at thumb).\n    - **Diagnosis:** **Central Cause (Stroke)**.","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-338","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","recap","diagnosis","tree"]}
{"chunk_type":"transcript_chunk","text":"# LM_Neuro RFR\n## ğŸ§  CNS (Central Nervous System)\n### **Episode 1: Neurology Foundations & Assessment**\n**ğŸ”¥ RAPID FIRE RECAP (Exam Day Cheat Sheet)**\n| **Concept** | **High Yield Association** |\n| --- | --- |\n| **Broca's Aphasia** | Frustrated, Non-fluent, Right Arm/Face Weakness. |\n| **Wernicke's Aphasia** | Word Salad, Fluent, Visual Field Cut (Pie in the sky). |\n| **Conduction Aphasia** | Fluent + Comprehends BUT Can't Repeat. Arcuate Fasciculus. |\n| **GCS Eye (Pain)** | Sternal rub/Nail bed pressure â†’ 2 Points. |\n| **GCS Verbal (Salad)** | Random words (Inappropriate) â†’ 3 Points. |\n| **GCS Motor (Extension)** | Decerebrate, Brainstem injury â†’ 2 Points (Worse than Flexion). |\n| **Decorticate Posture** | Arms flexed like **\"C\"**s (Mummy) â†’ Lesion above Red Nucleus. |\n| **Intubate Trigger** | GCS â‰¤ 8. |\n| **MCI vs. Dementia** | ADLs (Activities of Daily Living). í˜¼ì ì‚´ ìˆ˜ ìˆìœ¼ë©´ MCI. |\n| **Depression Memory** | Says \"I don't know\". Dementia patient Confabulates. |\n### **Episode 2: Intracranial Pressure Crisis**\n**ğŸ”¥ Rapid Fire Recap Table**\n| **Scenario** | **Next Best Step / Action** | **Key Concept** |\n| --- | --- | --- |\n| Obese female, headache, papilledema, ì—¬ë“œë¦„ì•½ | MRI first -> then LP | Rule out mass before LP |\n| **IIH confirmed (LP > 250)** | Acetazolamide + Wt loss | Decrease CSF production |\n| Elderly, \"feet stuck to floor\" **ìì„ë°œ** | High Volume LP (Tap Test) | Predicts response to VP shunt |\n| Trauma + HTN + Bradycardia | Intubate & Hyperventilate | Cushing's Triad (ICP Crisis) |\n| Blown pupil after head trauma | Emergent Decompression | Uncal Herniation (CN III) |\n| VP Shunt patient + Fever | Shunt Tap -> Remove if infected | Abx alone won't clear hardware |\n### **Episode 3: The Headache Patient**","subject":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","page_title":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","episode":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","section_path":["LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834"],"source_doc_id":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","source_page":null,"source_anchor":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834-1","focus_area":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","tags":["usmle-step2","core","mnemonic"]}
{"chunk_type":"recap_summary","text":"**ğŸ”¥ Rapid Fire Recap: High-Yield Associations**\n| **Clue in Question** | **Diagnosis** | **Next Step / Treatment** |\n| --- | --- | --- |\n| \"Worst headache of my life\" | **SAH (Thunderclap)** | Non-contrast CT â†’ LP |\n| Male, pacing around room, holding eye | **Cluster Headache** | 100% Oxygen (First line) |\n| Female, pulsatile pain, vomiting, dark room | **Migraine** | Triptan (Abortive) / Beta-blocker (Prevent) |\n| Band-like pressure, \"tight hat\" | **Tension Headache** | NSAIDs / Relaxation |\n| Pregnant (3rd Tri) with Migraine | Migraine | Avoid NSAIDs! (Use Tylenol/Opioids) |\n| Child with \"Bi-frontal\" headache | Pediatric Migraine | Rest, Hydration, Tylenol |\n| Headache + Visual field cut + Hypotension | Pituitary Apoplexy | Urgent Surgical Consult / Steroids |\n### **Episode 4: Epilepsy & Seizure Management**\n**ğŸ”¥ Rapid Fire Recap Table**\n| **Clinical Scenario** | **Probable Diagnosis** | **Next Best Step / Treatment** | **Key Feature to Look For** |\n| --- | --- | --- | --- |\n| 50ì„¸ ë‚¨ì„±, ì²« ë°œì‘ (First Seizure) | **Brain Tumor** (until proven otherwise) | Neuro-imaging (MRI/CT) | ë‘í†µ, êµ­ì†Œ ì‹ ê²½í•™ì  ê²°ì† |\n| ì†Œì•„, ìˆ˜ì—… ì¤‘ ë©ë•Œë¦¼, 20ì´ˆ ë¯¸ë§Œ | **Absence Seizure** | Ethosuximide | 3Hz Spike & Wave, No Post-ictal |\n| ë°œì‘ 5ë¶„ ì´ìƒ ì§€ì† | **Status Epilepticus** | 1. Lorazepam (IV) -> 2. Fosphenytoin/Keppra | 5ë¶„ ë„˜ìœ¼ë©´ ìì—° ì†Œì‹¤ ì•ˆ ë¨. ë‡Œ ì†ìƒ ì‹œì‘. |\n| ì“°ëŸ¬ì§„ í›„ ì¦‰ì‹œ ì˜ì‹ ëª…ë£Œ (Crisp awakening) | Syncope (ì‹¤ì‹ ) | Cardiac Workup (ECG) | Post-ictal state ì—†ìŒ |\n| ì“°ëŸ¬ì§„ í›„ 30ë¶„ê°„ í˜¼ë€ (Confusion) | Seizure | Seizure Workup | Post-ictal state ìˆìŒ (Gold Standard) |\n| ë°œì‘ í™˜ì, Phenytoin ë³µìš© ì¤‘, ë¹„í‹€ê±°ë¦¼/ì–´ì§€ëŸ¬ì›€ | Phenytoin Toxicity | Drug Level Check | Horizontal Nystagmus, Ataxia |\n| Intubation í›„ ê²‰ë³´ê¸°ì—” ë©ˆì·„ìœ¼ë‚˜ ì˜ì‹ ì—†ìŒ | **Non-convulsive Status** | Continuous EEG | ë‡ŒëŠ” ì—¬ì „íˆ íƒ€ê³  ìˆìŒ (Silent Seizure) |\n### **Episode 5: Ischemic Stroke & Vascular Disorders**\n**ğŸ”¥ Rapid Fire Recap: High-Yield Table**\n| **Clinical Feature** | **Likely Diagnosis/Location** |\n| --- | --- |\n| Face/Arm > Leg Weakness | **MCA Stroke (Lateral)** |\n| Leg/Foot > Arm Weakness | **ACA Stroke (Medial)** |\n| Gaze Preference | Looks Towards the lesion (PPRF/FEF) |\n| Aphasia (Speech issue) | Left MCA (Dominant) |\n| Hemineglect (Ignores left side) | Right MCA (Non-dominant) |\n| Pure Motor or Sensory (No cortical signs) | **Lacunar Stroke** (Deep structures) |\n| Young Female + OCP + Seizure/HA | CVST (Check MRV!) |\n| Focal Neuro Deficit + Hypoglycemia | Stroke Mimic (Give Glucose!) ğŸ¬ |\n| TPA BP Limit | Must be < 185/110 |\n| No TPA BP Limit | Permissive up to 220/120 |","subject":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","page_title":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","episode":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","section_path":["LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834"],"source_doc_id":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","source_page":null,"source_anchor":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834-13","focus_area":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","tags":["usmle-step2","core","recap","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"### **Episode 6: Hemorrhagic Stroke**\n**ğŸ”¥ Rapid Fire Recap (USMLE Cheat Sheet)**\n| **Pathology** | **Keyword / Analogy** | **Clinical Sign** | **CT Appearance** | **Management Pearl** |\n| --- | --- | --- | --- | --- |\n| **Cerebellar** | The Stumbler (ì·¨í•œ ì‚¬ëŒ) | Ataxia, Vertigo, Normal Strength | Posterior fossa bleed | >3cm = Surgery ğŸ”ª (Rule of 3) |\n| **Subdural (SDH)** | The Sleeper (ì„œì„œíˆ êº¼ì§) | Bridging Veins, Elderly/Alcoholic | Crescent (Moon) ğŸŒ™, Crosses sutures | Acute: Bright, Chronic: Dark (Check INR/Meds!) |\n| **Subarachnoid (SAH)** | The Screamer (ì²œë‘¥ì†Œë¦¬) | Thunderclap HA âš¡, Worst of life | Starfish â­, Center of brain | Nimodipine (Vasospasm), Coiling/Clipping (Rebleed) |\n| **Epidural (EDH)** | The Sprinter (ì ê¹ ë©€ì©¡â†’ê¸‰ì „ì§í•˜) | Temporal skull fx, Lucid interval, Ipsilateral blown pupil | Biconvex/Lentiform (Lens) ğŸ¥Ÿ, Does NOT cross sutures | Neurosurg emergent; Evacuate if symptomatic or large (e.g., >30 mL, >15 mm, MLS >5 mm) |\n### **Episode 7: Traumatic Brain Injury**\n**ğŸ”¥ Rapid Fire Recap (Must-Know Matches)**\n| **Scenario** | **Diagnosis / Key Concept** | **â˜… Next Best Step / Action** |\n| --- | --- | --- |\n| Raccoon Eyes / Battle Sign | **Basilar Skull Fracture** | Beta-2 Transferrin (for CSF leak) |\n| Adult Fall + Blood Thinner | High Risk for Bleed | Immediate CT Head (Do NOT wait for symptoms) |\n| Infant Fall < 3ft, Acting fine | Low Risk | Observation (Avoid CT radiation) |\n| Concussion Symptom Recurrence | Failed Return to Play | Stop activity, Rest 24hrs, Go back to previous step |\n| GCS Low + Clean CT | **Diffuse Axonal Injury (DAI)** | MRI Brain (Gold Standard) |\n| Increased ICP + Blown Pupil | Herniation Imminent | Hyperventilation (Bridge to OR), Mannitol |\n| Salty Taste in Mouth | CSF Leak | Check for CSF Rhinorrhea |\n| Post-Traumatic Seizure Prophylaxis | Prevent early seizures | Antiepileptics for 7 Days ONLY |\n### **Episode 8: Movement Disorders & Parkinsonism**","subject":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","page_title":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","episode":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","section_path":["LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834"],"source_doc_id":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","source_page":null,"source_anchor":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834-23","focus_area":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","tags":["usmle-step2","core","diagnosis","treatment","mnemonic"]}
{"chunk_type":"recap_summary","text":"**ğŸš€ RAPID FIRE RECAP (Summary Table)**\n| **Clinical Presentation** | **Diagnosis to Suspect** | **Gold Standard / Action** |\n| --- | --- | --- |\n| Resting Tremor (Pill-rolling) | **Parkinson's Disease** | Levodopa/Carbidopa |\n| Action Tremor (Postural) + Alcohol helps | **Essential Tremor** | Propranolol |\n| Intention Tremor (Finger-to-Nose worsens) | Cerebellar Lesion | Brain MRI |\n| Flailing arm (Ballistic) | Hemiballismus | Subthalamic Nucleus Stroke check |\n| Creepy-crawly legs at night | Restless Legs Syndrome | Check Ferritin (<75 -> Iron) |\n| Magnetic Gait (Can't lift feet) + Wet/Wacky | **NPH** | LP -> VP Shunt |\n| Foot Drop (Steppage) | Peroneal N. vs L5 | Check Inversion (Weak in L5) |\n| Parkinsonism + Orthostasis/Incontinence | MSA | Supportive Care |\n| Parkinsonism + Can't look down | PSP | Supportive Care |\n| Parkinsonism + Visual Hallucinations | Lewy Body Dementia | Avoid Antipsychotics |\n### **Episode 9: Dementia & Cognitive Disorders**\n**ğŸ”¥ Rapid Fire Recap (Summary Table)**\n| **Condition** | **Key Feature (The \"Tell\")** | **Initial Presentation** | **Treatment Alert âš ï¸** |\n| --- | --- | --- | --- |\n| **Delirium** | Acute & Fluctuating | Drowsy â†” Agitated, Inattention | Emergency! Find medical cause. |\n| **Depression** | \"I don't know\" | Distressed, gives up easily | Treat depression â†’ Cognition improves. |\n| **Alzheimer's** | Short-term memory loss | Amnesia, Getting lost | Focus on safety & routine. |\n| **Vascular** | Stepwise decline | History of Stroke/HTN | Control BP/Lipids to prevent next step. |\n| **FTD** | Personality Change | Disinhibition, Hyperorality | Often misdiagnosed as psychiatric issue. |\n| **Lewy Body** | Visual Hallucinations | Kids/Animals seen, Parkinsonism | âŒ NO ANTIPSYCHOTICS (Lethal). |\n| **CJD** | Startle Myoclonus | Rapid progression (Weeks) | RT-QuIC test is Gold Standard. |\n| **Wilson's** | Young + Tremor + Psych | Liver issues + Psychosis | Treatable if caught (Copper). |\n### **Episode 10: Spinal Cord Pathology**\n**ğŸ”¥ Rapid Fire Recap (Summary Table)**\n| **Symptom / Scenario** | **Diagnosis** | **Key Mechanism / Action** |\n| --- | --- | --- |\n| Night Pain + Back Pain | **Spinal Tumor** | Venous engorgement. Dexa FIRST if deficit. |\n| Elderly + Hyperextension + Weak Hands | **Central Cord** | Ligamentum flavum buckles. Arms > Legs. |\n| Paralysis + Vibration Intact | **Anterior Cord** | ASA occlusion. Post. columns spared. |\n| Hyperreflexia + Early Bladder issues | **Conus Medullaris** | UMN Lesion (Cord tip). |\n| Areflexia + Severe Radicular Pain | **Cauda Equina** | LMN Lesion (Nerve roots). |\n| T6+ Injury + Headache + HTN + bradycardia | **Autonomic Dysreflexia** | Check Bladder (Kinked foley)! Sit Up! |\n| Fever + Back Pain + IVDU | Epidural Abscess | No LP! MRI First. |","subject":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","page_title":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","episode":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","section_path":["LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834"],"source_doc_id":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","source_page":null,"source_anchor":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834-33","focus_area":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","tags":["usmle-step2","core","recap","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"### **Episode 11 & 12: Demyelinating & Peripheral Diseases**\n**ğŸ”¥ RAPID FIRE RECAP: Diagnosis Buzzwords ğŸ”¥**\n| **Disease** | **Clinical Buzzword / Vignette** | **Key Diagnostic Finding** |\n| --- | --- | --- |\n| **Multiple Sclerosis** | Painful eye movement, Electric shock (Lhermitte), Heat sensitivity (Uhthoff) | MRI: Dawson Fingers, LP: Oligoclonal Bands |\n| **Optic Neuritis** | Washed out colors (Red desaturation), APD | Swing Flashlight Test (+) |\n| **NMO (Devic's)** | Intractable Hiccups, Bilateral severe vision loss | Anti-AQP4 Antibody |\n| **Transverse Myelitis** | Defined Sensory Level, Bladder dysfunction | MRI Spine: Cord inflammation |\n| **Guillain-BarrÃ©** | Ascending paralysis, No reflexes (Areflexia) | CSF: Albuminocytologic Dissociation |\n| **CPM (ODS)** | Hyponatremia corrected too fast, \"Locked-in\" | MRI: Hyperintensity in Pons |\n| **ALD** | School failure in boy + Tanned skin | VLCFA accumulation |\n### **Episode 13: CNS Infections**\n**ğŸ”¥ Rapid Fire Recap (Summary Table)**\n| **Condition** | **Key Feature / Vignette** | **Diagnosis (Gold Standard)** | **Treatment / Mgmt** | **Key Caveat âš ï¸** |\n| --- | --- | --- | --- | --- |\n| **PML** | HIV (CD4 < 200), clumsiness | MRI Brain -> CSF JC Virus PCR | HAART | Non-enhancing lesion |\n| **Bacterial Meningitis** | Stiff neck, Photophobia | LP (Neutrophils, Low Glucose) | Vanc+Ceftriaxone+Steroids | CT before LP if FAILS signs present |\n| **Viral Meningitis** | Similar sx but milder | LP (Normal Glucose) | Supportive Care | Lymphocytes predominant |\n| **TB Meningitis** | Subacute | LP (Very Low Glucose) | RIPE + Steroids | Base of brain enhancement |\n| **Brain Abscess** | Ring-enhancing lesion | MRI Brain | Drainage + Abx | NEVER perform LP |\n| **Spinal Epidural Abscess** | IVDU, Focal Back Pain | MRI Spine (w/ contrast) | Surgery + Abx | NEVER perform LP |\n### **Episode 14: CNS Tumors**","subject":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","page_title":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","episode":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","section_path":["LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834"],"source_doc_id":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","source_page":null,"source_anchor":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834-43","focus_area":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"recap_summary","text":"**ğŸ”¥ Rapid Fire Recap & Next Steps**\n| **Context** | **Clinical Presentation / Finding** | **â˜… Action / Management** |\n| --- | --- | --- |\n| Physical Exam | ëˆˆì„ ìœ„ë¡œ ëª» ì³ë‹¤ë³´ê³ (Upward gaze palsy) + Light-near dissociation | **Pinealoma** |\n| History | ì•„ì¹¨ì— ë‘í†µì´ ì‹¬í•˜ê³  êµ¬í†  í›„ í˜¸ì „ | **Increased ICP** |\n| Imaging | Dural Tail | **Meningioma** |\n| Imaging | Grey-White Junctionì— ì—¬ëŸ¬ ê°œ | **Metastasis** |\n| Treatment | Prolactinoma | **Dopamine Agonist** (Not Surgery first!) |\n| Treatment | Metastasis Single Lesion | **Resection** |\n| Treatment | Metastasis Multiple Lesions | **Radiation** |\n| Caveat | MRIì—ì„œ ì¶œí˜ˆ(Bleeding) ì†Œê²¬ | **Melanoma** 1ìˆœìœ„ ì˜ì‹¬ |\n### **Episode 15: Pediatric Neurology I**\n**âš¡ Rapid Fire Recap (Summary Table)**\n| **Condition** | **Key Clinical Feature / Buzzword** | **Pathophysiology / Gene** |\n| --- | --- | --- |\n| **NF1** | CafÃ©-au-lait, Lisch nodules, Neurofibromas | Chr 17, Neurofibromin |\n| **NF2** | Bilateral Acoustic Neuromas (Hearing loss) | Chr 22, Merlin |\n| **Tuberous Sclerosis** | Ash-leaf spots, Cardiac Rhabdomyoma, Seizures | TSC1/2, mTOR pathway |\n| **Sturge-Weber** | Port-Wine Stain, Seizures (Contralateral) | Somatic GNAQ (Not inherited) |\n| **VHL** | Hemangioblastomas (Retina/Cerebellum), RCC | Chr 3, VHL gene |\n| **Cephalohematoma** | Does NOT cross sutures | Subperiosteal blood (Risk: Jaundice) |\n| **Subgaleal Hemorrhage** | Crosses sutures, Fluctuant | Emissary veins (Risk: Shock/Death) |\n| **Spastic Diplegia** | Commando Crawl, Legs > Arms | Prematurity â†’ PVL |\n### **Episode 16: Pediatric Neurology II**\n**RAPID FIRE RECAP: Scenario Testing ğŸ”«ğŸ”¥**\n| **Scenario** | **Diagnosis** | **Key Management/Next Step** |\n| --- | --- | --- |\n| 6ê°œì›” ì˜ì•„, Jackknife spasms (ëª¸ì„ ì ‘ìŒ) | **Infantile Spasms (West)** | Tx: ACTH (Start ASAP!) |\n| 10ëŒ€ ì²­ì†Œë…„, ì•„ì¹¨ì— ì¹«ì†”ì„ ë–¨ì–´ëœ¨ë¦¼ | **JME** | Tx: Valproic Acid |\n| 3ì„¸ ìœ ì•„, ë°œì‘ í›„ ì™¼ìª½ íŒ”ë‹¤ë¦¬ê°€ ì¶• ëŠ˜ì–´ì§ | **Potential Stroke** | Dx: MRI Brain + MRA (Urgent!) |\n| 30ì£¼ ë¯¸ìˆ™ì•„, ì‹ ìƒì•„ì‹¤(NICU) ì…ì› ì¤‘ | **IVH Risk** | Screening: Head Ultrasound at <32 weeks |\n| 3ì„¸, ì—´ë‚˜ê³  5ë¶„ê°„ ì „ì‹  ê²½ë ¨, ê¸ˆë°© ê¹¨ì–´ë‚¨ | **Simple Febrile Seizure** | Tx: Discharge with Reassurance ğŸ‘‹ |","subject":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","page_title":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","episode":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","section_path":["LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834"],"source_doc_id":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","source_page":null,"source_anchor":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834-53","focus_area":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","tags":["usmle-step2","core","recap","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### **Episode 17: Critical Care & Environmental**\n**ğŸš€ Rapid Fire Recap (Summary Table)**\n| **Condition** | **Key Trigger/Cause** | **Hallmark Sign** | **â˜… Next Best Step / Treatment** |\n| --- | --- | --- | --- |\n| **Sympathetic Storming (PSH)** | TBI + Non-painful stimuli | Tachycardia, HTN, Diaphoresis | GABA Agonists, Opioids |\n| **Brain Death** | Irreversible Brain Injury | Apnea Test (+): CO2 > 60 | Organ Donation Mgmt |\n| **Heat Stroke (Exertional)** | Athlete, Laborer | Temp > 40Â°C + Confusion | Ice Water Immersion (Dunk them!) |\n| **Heat Stroke (Non-Exertional)** | Elderly (Grandma) | Temp > 40Â°C + Confusion | Evaporative Cooling (Mist & Fan) |\n| **Severe Hypothermia** | Cold exposure (<28Â°C) | Coma, V-fib | Active Internal Rewarming |\n| **Malignant Hyperthermia** | Gas Anesthesia / Succinylcholine | Masseter Rigidity, Rising CO2 | Stop Agent + Dantrolene |\n| **Succinylcholine Risk** | Burn, Stroke, Crush injury | Hyperkalemia -> Arrest | Do NOT use Succinylcholine |\n| **PDPH (Spinal Headache)** | Epidural puncture | Headache worse when standing | Epidural Blood Patch |\n## ğŸ‘ï¸ EYE (Ophthalmology)\n### **Episode 18: Eye I: Infections & Inflammation**\n| Category | Key Pathology | Classic Sign / Keyword | Immediate Action / Tx |\n| --- | --- | --- | --- |\n| Orbit | Orbital Cellulitis | Pain with EOM, Proptosis, Ophthalmoplegia | â˜… CT Scan + IV Abx + Surgery |\n|  | Preseptal Cellulitis | Eyelid swelling ONLY (No pain with EOM) | Oral Antibiotics |\n| Conjunctiva | Viral Conjunctivitis | Watery, gritty, follicular | Supportive / Hygiene |\n|  | Bacterial Conjunctivitis | Purulent, \"glued shut\", unremitting | Erythromycin or Polytrim drops |\n|  | Neonatal (Gonococcal) | Day 2-5, Profuse Purulent, Corneal risk | â˜… IM Ceftriaxone (Systemic) |\n|  | Neonatal (Chlamydia) | Day 5-14, Pneumonia risk | â˜… Oral Erythromycin (Systemic) |\n| Cornea | HSV Keratitis | Dendritic Ulcer, decreased sensation | Acyclovir / Ganciclovir |\n|  | Bacterial Keratitis | Contact lens, Pseudomonas | Fluoroquinolone Drops |\n| Intraocular | Endophthalmitis | Post-Cataract, Hypopyon, Vitreous Haze | â˜… Intravitreal Abx + Vitrectomy |\n|  | Anterior Uveitis | Photophobia, Ciliary Flush, HLA-B27 | Steroids + Cycloplegics |\n**ğŸš€ Rapid Fire Recap (Quiz Section)**\n| **Scenario** | **Diagnosis** | **â˜… Next Best Step / Treatment** |\n| --- | --- | --- |\n| 4ì¼ ëœ ì‹ ìƒì•„, ì–‘ìª½ ëˆˆì—ì„œ ì—„ì²­ë‚œ ê³ ë¦„ | **Gonococcal Conjunctivitis** | IM Ceftriaxone |\n| ëˆˆì„ ì›€ì§ì¼ ë•Œ ì•„í”„ê³ (Pain with EOM), ì•ˆêµ¬ ëŒì¶œ | **Orbital Cellulitis** | CT Scan (Emergency!) |\n| ì •ì›ì‚¬(Gardener)ê°€ ë‚˜ë­‡ê°€ì§€ì— ëˆˆì„ ì°”ë¦¼. ê¹ƒí„¸ ëª¨ì–‘ ê¶¤ì–‘ | **Fungal Keratitis** | Natamycin (Antifungals) |\n| ì½˜íƒíŠ¸ë Œì¦ˆ ì°©ìš©ì, ê¶¤ì–‘ ë°œìƒ | **Pseudomonas** | Fluoroquinolones |\n| 2ì£¼ ëœ ì‹ ìƒì•„, ê¸°ì¹¨(Cough) + ëˆˆê³± | **Chlamydia Conjunctivitis** | Oral Erythromycin |\n| ëˆˆêº¼í’€ì— ì•„í”ˆ ë©ìš¸(Painful red lump) | **Hordeolum (Stye)** | Warm compress |\n| ë°±ë‚´ì¥ ìˆ˜ìˆ  í›„ í†µì¦, ì‹œë ¥ ì €í•˜, ì „ë°© ì¶•ë†(Hypopyon) | **Endophthalmitis** | Intravitreal Abx + Vitrectomy |\n### **Episode 19: Eye II: Vision Loss & Retina**\n| Category | Pathology | Key Vignette / Buzzword | Immediate Action / Tx |\n| --- | --- | --- | --- |\n| Emergency | Retinal Detachment | Curtain coming down (ì»¤íŠ¼) ğŸ“‰ | Surgery (Pneumatic retinopexy) |\n| Emergency | Acute Closed Angle Glaucoma | Rock hard eye, halos, painful ğŸª¨ğŸ˜« | Pilocarpine, Laser Iridotomy |\n| Emergency | CRAO (Central Retinal Artery Occlusion) | Cherry Red Spot, Sudden painless loss ğŸ’ | Ocular massage, Hyperbaric O2/Carbogen |\n| Chronic | Open Angle Glaucoma | Tunnel vision, Cup-to-disc > 0.5 ğŸ© | Prostaglandins (Latanoprost) |\n| Chronic | Macular Degeneration | Central vision loss (Clock blur) ğŸ•°ï¸ | Anti-VEGF (Wet), Vitamins (Dry) |\n| Pediatric | Leukocoria | White pupil reflex âšª | Rule out Retinoblastoma (MRI) |\n| Pediatric | Strabismus | Misalignment after 4 months ğŸ‘¶ | Patch good eye / Glasses |\n|  |  |  |  |\n| Diagnosis | Key Finding (Fundoscopy/Exam) | Treatment / Next Step |\n| --- | --- | --- |\n| Retinal Detachment | Flashes, Floaters, Curtain ğŸ“‰ | Surgery (Urgent) |\n| Acute Angle Closure | Rock hard, painful, halos ğŸª¨ | Pilocarpine, Laser Iridotomy |\n| CRAO | Cherry Red Spot ğŸ’, Pale retina | Ocular Massage, CO2 |\n| CRVO | Blood and Thunder ğŸŒ©ï¸ | Observation / Anti-VEGF |\n| Macular Degeneration | Central loss (Clock/Faces) ğŸ•°ï¸ | Dry (Vitamins), Wet (Anti-VEGF) |\n| Amblyopia | Cortical suppression of one eye | Patch the GOOD eye ğŸ´â€â˜ ï¸ |\n| Strabismus | Misalignment > 4 months | Patch / Surgery |\n| Retinoblastoma | Leukocoria (White pupil) âšª | MRI (Rule out Osteosarcoma link) |\n| Retinitis Pigmentosa | Bone spicules, Night blindness ğŸŒ‘ | Supportive / Vitamin A |\n### **Episode 20: Eye III: Ocular Trauma**\n| Pathology | Key Feature (Buzzword) | Next Best Step (NBS) / Treatment | Do NOT Do |\n| --- | --- | --- | --- |\n| Corneal Abrasion | Foreign body sensation, Fluorescein uptake | Erythromycin (Non-contact) / Ciprofloxacin (Contact Lens) | Do NOT patch if contact lens wearer (Pseudomonas risk) |\n| Open Globe | Teardrop Pupil, Seidel Sign (+) | Rigid Eye Shield, CT Scan, IV Abx, Tetanus | Do NOT measure IOP, Do NOT touch/manipulate |\n| Orbital Compartment Syndrome (OCS) | Rock-hard Eyelid, Proptosis, Afferent Pupillary Defect (APD) | Lateral Canthotomy (Immediate) | Do NOT wait for CT scan |\n| Hyphema | Blood fluid level in Anterior Chamber | Head elevation (30Â°), Cycloplegics | Screen for Sickle Cell (Glaucoma risk) |\n| Sympathetic Ophthalmia | Autoimmune attack on \"Good Eye\" after trauma | Remove damaged eye (Enucleation) within 2 weeks | Ignore complaints in the non-injured eye |\n| Photokeratitis | Welder/Skier, Bilateral pain, 6-12hr lag | Supportive care, lubrication | - |","subject":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","page_title":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","episode":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","section_path":["LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834"],"source_doc_id":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","source_page":null,"source_anchor":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834-63","focus_area":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_summary","text":"**ğŸ”¥ 4. Rapid Fire Recap (Summary Table)**\n| Condition | Visual Cue / Exam Finding | Critical Action / Note |\n| --- | --- | --- |\n| Corneal Abrasion | Fluorescein uptake (Green scratch) | Contact lens? -> Ciprofloxacin (No Patch!) |\n| Open Globe | Teardrop Pupil, Seidel Sign (+) | Shield it, CT, NPO, Call Surgeon. No IOP check! |\n| Orbital Compartment Syndrome | Proptosis, Rock-hard lid, APD | Lateral Canthotomy ASAP (Don't wait for CT) |\n| Hyphema | Blood level in anterior chamber | Head up 30Â°, Screen for Sickle Cell (Glaucoma risk) |\n| Sympathetic Ophthalmia | Inflammation in non-injured eye | Enucleation of injured eye within 14 days |\n| Photokeratitis | Welder/Skier, delayed pain | Supportive care, heals in 1-3 daysìœ„ ë‚´ìš©ì€ **Ophthalmology Infections â†’ Vision Pathology â†’ Eye Trauma** ìˆœì„œëŒ€ë¡œ, |\n## ğŸ‘‚ EAR (Otolaryngology)\n### **Episode 21: Ear I: Infections**\n**ğŸ”¥ Rapid Fire Recap (Summary Table)**\n| **Disease** | **Key Symptom / History** | **Otoscopy Finding** | **â˜… Next Best Step / Tx** |\n| --- | --- | --- | --- |\n| **Otitis Externa** | Swimmer, Pain on Tragus touch | Canal swollen, TM Normal | Clean + Topical Cipro |\n| **Malignant OE** | Elderly Diabetic, Night Pain | Granulation Tissue on floor | IV Ciprofloxacin (CT to confirm) |\n| **AOM** | Toddler, Fever, Crying | Bulging, Red, Immobile TM | High-Dose Amoxicillin |\n| **Mastoiditis** | Untreated AOM, Ear protrusion | Post-auricular swelling | CT Scan -> IV Abx + Drain |\n| **OME (Serous)** | Hearing loss, No Pain/Fever | Fluid levels, Bubbles, Dull | Observation (Wait) |\n| **CSOM** | Drainage > 6wks, Perforation | Perforated TM, Purulent | Topical Fluoroquinolone |\n| **Cholesteatoma** | Chronic drainage, Hearing loss | Pearly White Mass, Debris | Surgery (Refer to ENT) |\n### **Episode 22: Ear II: Hearing & Balance**\n| êµ¬ë¶„ | ì£¼ìš” ì§ˆí™˜ (Key Pathology) | í•µì‹¬ íŠ¹ì§• (Buzzwords & Clues) |\n| --- | --- | --- |\n| ì²­ë ¥ ìƒì‹¤ (Hearing Loss) | Presbycusis (ë…¸ì¸ì„± ë‚œì²­) | ê³ ì£¼íŒŒìˆ˜(ììŒ) ì†Œì‹¤, \"ì›…ì–¼ê±°ë¦¬ëŠ” ì†Œë¦¬ì²˜ëŸ¼ ë“¤ë¦¼\", ì‹œë„ëŸ¬ìš´ ê³³ì—ì„œ ë” ì•ˆ ë“¤ë¦¼. |\n|  | Otosclerosis (ì´ê²½í™”ì¦) | ì„ì‹ ë¶€(30ëŒ€), ì „ìŒì„± ë‚œì²­, â˜…ì‹œë„ëŸ¬ìš´ ê³³ì—ì„œ ë” ì˜ ë“¤ë¦¼ (Paracusis Willisii). |\n| ì–´ì§€ëŸ¼ì¦ (Vertigo) | BPPV (ì´ì„ì¦) | ê³ ê°œ ëŒë¦´ ë•Œ(Position change) ë°œìƒ, ì§§ì€ ì§€ì†(ì´ˆ ë‹¨ìœ„), Dix-Hallpikeë¡œ ì§„ë‹¨. |\n|  | Meniere's Disease (ë©”ë‹ˆì—ë¥´) | Triad: ì–´ì§€ëŸ¼ì¦ + ë‚œì²­ + ì´ëª…/ê·€ ë¨¹ë¨¹í•¨ (Fullness). |\n|  | Vestibular Neuritis (ì „ì •ì‹ ê²½ì—¼) | ë‹¨ í•œ ë²ˆì˜ ì‹¬í•œ ì–´ì§€ëŸ¼ì¦(ìˆ˜ì¼ ì§€ì†), ì²­ë ¥ ì†Œì‹¤ ì—†ìŒ, ë°”ì´ëŸ¬ìŠ¤ ê°ì—¼ í›„. |\n| ì‘ê¸‰ (Emergency) | Auricular Hematoma | ë ˆìŠ¬ëŸ¬/ë³µì„œ, \"ë§Œë‘ê·€\" ì˜ˆë°© ìœ„í•´ ì¦‰ì‹œ ë°°ì•¡(Drainage) ë° ì••ë°• í•„ìˆ˜. |\n**ğŸ”¥ Rapid Fire Recap (Summary)**","subject":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","page_title":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","episode":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","section_path":["LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834"],"source_doc_id":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","source_page":null,"source_anchor":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834-80","focus_area":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","tags":["usmle-step2","core","recap","treatment"]}
{"chunk_type":"transcript_chunk","text":"| **Scenario / Sign** | **Diagnosis** | **â˜… Next Best Step / Key Concept** |\n| --- | --- | --- |\n| Vertigo + Hearing Loss + Tinnitus (Triad) | **Meniere's Disease** | Low salt diet / Diuretics |\n| Vertigo lasting seconds (rolling in bed) | **BPPV** | Test: Dix-Hallpike |\n| Severe vertigo for days, NO hearing loss | **Vestibular Neuritis** | Supportive / Corticosteroids |\n| Young pregnant woman, hears better in noisy places | **Otosclerosis** | Stapedectomy / Hearing aid |\n| Wrestler with a swollen ear | **Auricular Hematoma** | Incision & Drainage + Pressure Dressing |\n| Vertigo triggered by loud noise | **Perilymphatic Fistula** | Superior Canal Dehiscence |\n| Pain in airplane -> Pop -> Pain gone + Blood | **Ruptured TM** | Barotrauma management |\n| Nystagmus that does NOT stop with fixation | **Central Cause (Stroke)** | Urgent Neuro-imaging |","subject":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","page_title":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","episode":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","section_path":["LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834"],"source_doc_id":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","source_page":null,"source_anchor":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834-91","focus_area":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"### 7. Rapid Fire Recap ğŸ”¥\n- **Carbon Monoxide (CO)**:\n    - House fires, heaters.\n    - Headache, Confusion.\n    - Pulse Ox reads 100% (False).\n    - Dx: ABG with Co-oximetry.\n    - Tx: 100% O2.\n- **Methemoglobinemia**:\n    - Dapsone, Benzocaine, Nitrites.\n    - Blue patient, Chocolate blood.\n    - Pulse Ox ~85%. Saturation Gap.\n    - Tx: Methylene Blue.\n- **Cyanide**:\n    - House fires (Plastics), Nitroprusside.\n    - Bitter Almond smell.\n    - Lactic Acidosis.\n    - Tx: Hydroxocobalamin (Avoid Nitrites in fire victims!).\n- **Massive Hemoptysis**:\n    - **Bad Lung Down** (ì¶œí˜ˆ ë¶€ìœ„ë¥¼ ì•„ë˜ë¡œ).\n    - Protect the good lung.\n# ğŸ“ USMLE Step 2 CK: Head, Neck & Nose Deep Dive\nì´ ê°•ì˜ëŠ” í•´ë¶€í•™ì˜ \"Junk Drawer(ì¡ë™ì‚¬ë‹ˆ ì„œë)\"ì²˜ëŸ¼ ëŠê»´ì§€ëŠ” Head & Neck íŒŒíŠ¸ë¥¼ **ë…¼ë¦¬ì ì¸ Decision Tree(ì˜ì‚¬ê²°ì • ë‚˜ë¬´)** ë¡œ ì •ë¦¬í•˜ëŠ” ê²ƒì„ ëª©í‘œë¡œ í•©ë‹ˆë‹¤. ë‹¨ìˆœíˆ ì•”ê¸°í•˜ëŠ” ê²ƒì´ ì•„ë‹ˆë¼, ì„ìƒê°€ì²˜ëŸ¼ ìƒê°í•˜ê³  ë¬¸ì œë¥¼ í•´ê²°í•˜ëŠ” **Framework**ë¥¼ êµ¬ì¶•í•©ë‹ˆë‹¤.\n## 1. Introduction: The \"Noise\" Decision Tree ğŸŒ³\nê°•ì˜ì˜ í•µì‹¬ ì ‘ê·¼ë²•ì€ **\"Stridor(í˜‘ì°©ìŒ)\"** ì™€ ê°™ì€ **Noise(ì†ŒìŒ)** ë¥¼ ê¸°ì¤€ìœ¼ë¡œ ì§„ë‹¨ì„ ì¢í˜€ê°€ëŠ” ê²ƒì…ë‹ˆë‹¤.\n- **The First Question:** Acute(ê¸‰ì„±)ì¸ê°€ Chronic(ë§Œì„±)ì¸ê°€?\n- **Acute:** ì§€ê¸ˆ ë‹¹ì¥ ì‘ê¸‰ ìƒí™©ì¸ê°€? (ìˆ˜ì£¼ ê°„ ì§€ì†ëœ ê²ƒì´ ì•„ë‹ˆë¼ ê°‘ìê¸° ë°œìƒí–ˆëŠ”ê°€?)\n- **Chronic:** ëª‡ ì£¼/ëª‡ ë‹¬ ë™ì•ˆ ì§€ì†ë˜ì—ˆëŠ”ê°€?\n## 2. Acute Pediatric Stridor (ê¸‰ì„± ì†Œì•„ í˜‘ì°©ìŒ) ğŸš¨","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-94","focus_area":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","tree"]}
{"chunk_type":"recap_quiz_seed","text":"## 9. Rapid Fire Recap (í•µì‹¬ ìš”ì•½) ğŸ”¥\n1. **Inspiratory Stridor (Supine worse):** Laryngomalacia (Floppy tissues).\n2. **Stridor improves with Neck Extension:** Vascular Ring.\n3. **Sudden Choking + Unilateral Findings:** Foreign Body Aspiration.\n4. **Barking Cough + Steeple Sign:** Croup.\n5. **Beard Hemangioma + Stridor:** Airway Hemangioma.\n6. **Hard Palate Mass:** Torus Palatinus (Leave it alone).\n7. **White Patch (Wipes off):** Thrush (Check HIV/DM).\n8. **White Patch (Doesn't wipe):** Leukoplakia (Biopsy).\n9. **Lateral Tongue White Patch:** Hairy Leukoplakia (EBV/HIV).\n10. **Hot Potato Voice + Uvula Deviation:** Peritonsillar Abscess.\n11. **Toddler + Stiff Neck:** Retropharyngeal Abscess.\n12. **Sinusitis Antibiotics Criteria:** >10 days, Severe onset, or Double sickening.\n13. **Adult with Serous Otitis Media:** Check for Nasopharyngeal Carcinoma (NPC).\n### â˜… Closing Thought: The Sound of Danger ğŸ”‡\nê°•ì˜ì˜ ë§ˆì§€ë§‰ì—ì„œ ê°•ì¡°í•œ ê°€ì¥ ì¤‘ìš”í•œ ê°œë…ì…ë‹ˆë‹¤.\n**\"Silence is not always a good sign.\" (ì¹¨ë¬µì€ í•­ìƒ ì¢‹ì€ ì‹ í˜¸ê°€ ì•„ë‹ˆë‹¤.)**\nì²œì‹ì´ë‚˜ ê¸°ë„ íì‡„ í™˜ìê°€ ìŒ•ìŒ•ê±°ë¦¬ë©° ìˆ¨ì„ ì‰¬ë‹¤ê°€(Noisy), ê°‘ìê¸° ì¡°ìš©í•´ì¡Œë‹¤ë©´?\nì´ëŠ” í™˜ìê°€ í˜¸ì „ëœ ê²ƒì´ ì•„ë‹ˆë¼, **ê³µê¸°ë¥¼ ì´ë™ì‹œí‚¬ í˜ì¡°ì°¨ ì—†ì´ ì§€ì³ë²„ë¦° ìƒíƒœ(Respiratory Failure)** ë¥¼ ì˜ë¯¸í•©ë‹ˆë‹¤. ì´ë•ŒëŠ” **Silent Chest**ë¥¼ ê²½ê³„í•˜ê³  ì¦‰ì‹œ ê°œì…(Intubation ë“±)í•´ì•¼ í•©ë‹ˆë‹¤.\nì œê³µí•´ì£¼ì‹  ì˜¤ë””ì˜¤ íŒŒì¼(ìŠ¤í¬ë¦½íŠ¸) ë‚´ìš©ì„ ë°”íƒ•ìœ¼ë¡œ **USMLE Step 2 CK - Upper Respiratory Tract Infection Deep Dive** ê°•ì˜ë¡ì„ ì‘ì„±í–ˆìŠµë‹ˆë‹¤. ìš”ì²­í•˜ì‹  ê·œì¹™ì„ ì—„ê²©íˆ ì¤€ìˆ˜í•˜ì—¬ ë¶„ì„ëœ ë‚´ìš©ì…ë‹ˆë‹¤.","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-142","focus_area":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","tags":["usmle-step2","core","quiz-seed"]}
{"chunk_type":"recap_quiz_seed","text":"## 7. âš¡ Rapid Fire Recap (í•µì‹¬ ìš”ì•½)\n| êµ¬íš | ì£¼ìš” ì§ˆí™˜ ë° íŠ¹ì§• |\n| --- | --- |\n| **ì „ë°© (Anterior)** | **4 Ts:** Thymoma(ì¤‘ì¦ê·¼ë¬´ë ¥ì¦), Thyroid(Pemberton's sign), Teratoma(Germ cell), Terrible Lymphoma.\n**Thymus:** ì†Œì•„ëŠ” í¼(ì •ìƒ- no: Digeorge, SCID ), ì„±ì¸ì€ ì•ˆ ë³´ì—¬ì•¼ ì •ìƒ-ìˆìœ¼ë©´ bx. |\n| **ì¤‘ë°© (Middle)** | **ë¦¼í”„ì ˆ & ë‚­ì¢…:** Sarcoidosis(ì–‘ì¸¡ íë¬¸ ë¦¼í”„ì ˆ), Bronchogenic cysts. |\n| **í›„ë°© (Posterior)** | **ì‹ ê²½(Neuro):** Neurogenic tumors (Dumbbell shape). |\n| **ê¸‰ì„± ì¢…ê²©ë™ì—¼** | ìˆ˜ìˆ  í›„ ë˜ëŠ” Danger spaceë¥¼ í†µí•œ ê°ì—¼ í™•ì‚°. **ì¦‰ê°ì ì¸ ìˆ˜ìˆ ì  ë°°ë† í•„ìš”.** |\n| **ê¸°ì¢…ê²©ë™** | í‚¤ í¬ê³  ë§ˆë¥¸ ì†Œë…„ + ë°œì‚´ë°” + **Hammond's sign**. íœ´ì‹ìœ¼ë¡œ ì¹˜ë£Œ. |\n## 8. ë§ˆì§€ë§‰ ì„ìƒ ì§„ì£¼ (Clinical Pearl): Clubbing & COPD ğŸ’\n- **ìƒí™©:** ì‹ ì²´ ê²€ì§„ì—ì„œ **ê³¤ë´‰ì§€(Digital Clubbing)**ê°€ ê´€ì°°ë¨.\n- **í”í•œ ì˜¤í•´:** ë§ì€ í•™ìƒë“¤ì´ ê³¤ë´‰ì§€ë¥¼ COPD(ë§Œì„±íì‡„ì„±íì§ˆí™˜)ì™€ ë°”ë¡œ ì—°ê²°ì§€ìŒ.\n- **â˜… íŒ©íŠ¸ ì²´í¬:** í•©ë³‘ì¦ì´ ì—†ëŠ” ë‹¨ìˆœ COPDëŠ” ê³¤ë´‰ì§€ë¥¼ ìœ ë°œí•˜ì§€ ì•ŠìŒ.\n- **Red Flag:** ë§Œì•½ ë§Œì„± COPD í™˜ìê°€ **ìƒˆë¡œìš´ ê³¤ë´‰ì§€**ë¥¼ ë³´ì¸ë‹¤ë©´?\n    - ë‹¨ìˆœíˆ COPD ë•Œë¬¸ì´ë¼ê³  ì¹˜ë¶€í•˜ë©´ ì•ˆ ë¨.\n    - **ìˆ¨ê²¨ì§„ ì•…ì„± ì¢…ì–‘(Occult Malignancy)**, íŠ¹íˆ **â˜… íì•”(Bronchogenic Carcinoma)**ì„ ì¦‰ì‹œ ì˜ì‹¬í•´ì•¼ í•¨.\n    - **í–‰ë™ ì§€ì¹¨:** ì¦‰ì‹œ CT ì´¬ì˜ ë“± ì •ë°€ ê²€ì‚¬ ì§„í–‰.\n# ğŸ« Obstructive Lung Disease: Battle Strategy âš”ï¸\nUSMLE Step 2ëŠ” ëª¨í˜¸í•œ ê²ƒì„ ì‹«ì–´í•©ë‹ˆë‹¤. **Binary(ì´ë¶„ë²•)**ì ì¸ ê²°ì •ì´ ìƒëª…ì…ë‹ˆë‹¤! âš–ï¸\nì˜¤ëŠ˜ì˜ ë¯¸ì…˜ì€ **Acute Bronchitis(í•¨ì •)**ì™€ **COPD(ê´´ë¬¼)**ë¥¼ ì •ë³µí•˜ëŠ” ê²ƒì…ë‹ˆë‹¤.\n### 1. ğŸ¦  Acute Bronchitis (ê¸‰ì„± ê¸°ê´€ì§€ì—¼) : The Trap ğŸª¤","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-303","focus_area":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","tags":["usmle-step2","core","quiz-seed"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ¯ Recap (ì‹œí—˜ ì§ì „ ìš”ì•½)\níŒŸìºìŠ¤íŠ¸ ë§ˆì§€ë§‰ 1ë¶„ ìš”ì•½ì…ë‹ˆë‹¤. ì´ ë‚´ìš©ì€ ìë‹¤ê°€ë„ íŠ€ì–´ë‚˜ì™€ì•¼ í•©ë‹ˆë‹¤.\n1. **Diagnosis:** Spirometry FEV1/FVC **< 0.7**. Albuterol ë°˜ì‘ì„± ìˆìŒ (**>12% AND 200ml**).\n2. **Rule Out:** PFT ì •ìƒì¸ë° ì˜ì‹¬ë˜ë©´ **Methacholine Challenge**. (Negative result = No Asthma).\n3. **Status Asthmaticus Rx:** **Oxygen â†’ DuoNeb (SABA/SAMA) â†’ Systemic Steroids (Early!) â†’ Magnesium**.\n4. **Scary Sign:** ì²œì‹ ë°œì‘ ì¤‘ **\"Normal PCO2\"**ëŠ” í˜¸í¡ ê·¼ìœ¡ì´ ì§€ì³¤ë‹¤ëŠ” ëœ». **Intubation** ì¤€ë¹„!.\n5. **Pregnancy:** SpO2 **>95%** ìœ ì§€. PCO2ê°€ ì •ìƒì´ë©´ íƒœì•„ì—ê²ŒëŠ” ì‚°ì†Œ ë¶€ì¡±ì¼ ìˆ˜ ìˆìŒ (ì„ì‚°ë¶€ëŠ” ì›ë˜ ê³¼í˜¸í¡ ìƒíƒœì„).\n6. Bronchiectasis: HRCT: signet ring sign, tramtrack, prulent sputum â†‘ , foul smelling\n7. **ABPA:** ì²œì‹,CF í™˜ì + **ê°ˆìƒ‰ ê°€ë˜(Brown mucus)** + **ë†’ì€ IgE** + í ì¹¨ìœ¤(Infiltrates). ì¹˜ë£ŒëŠ” **Steroid + Itraconazole**.\n8. **Asthma Medication Rule:** **LABA ë‹¨ë… ì‚¬ìš© ê¸ˆì§€** (ì‚¬ë§ë¥  ì¦ê°€). í•­ìƒ ICSì™€ í•¨ê»˜.\n# ğŸ« USMLE Deep Dive: Restrictive Lung Diseases\n**Topic:** Interstitial Lung Disease (ILD), Hypersensitivity Pneumonitis, Sarcoidosis, Pulmonary Hypertension, OSA, Breath-holding spells\n## ğŸŒ³ The Big Picture: Diagnosis Tree\nì œí•œì„± íì§ˆí™˜ì€ \"íê°€ ë”±ë”±í•´ì„œ ê³µê¸°ê°€ ëª» ë“¤ì–´ê°€ëŠ” ë³‘\"ì…ë‹ˆë‹¤. ì§„ë‹¨ì˜ ê°ˆë¦¼ê¸¸(Fork in the road)ì€ **DLCO(Diffusing Capacity)**ì…ë‹ˆë‹¤.\nPlaintext","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-383","focus_area":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","tags":["usmle-step2","core","quiz-seed","diagnosis","tree"]}
{"chunk_type":"recap_quiz_seed","text":"## 9. Final Decision Table (Recap Summary)\n| **ìƒí™© (Patient Snapshot)** | **í–‰ë™ (The Move)** |\n| --- | --- |\n| **Stable Patient (BP > 90)** | Wells Score ê³„ì‚° |\n| **Wells â‰¤ 4 (Unlikely)** | D-dimer |\n| **Wells > 4 (Likely)** | CT Angio (CTPA) |\n| **Likely PE + Severe Distress** | **Heparin ë¨¼ì €** íˆ¬ì—¬ í›„ CT ì´ë™ |\n| **Unstable (BP < 90, Massive)** | Bedside Echo â†’ **tPA (Thrombolysis)** |\n| **Renal Failure / Pregnancy** | V/Q Scan |\n| **Femur Fx + Rash + Confusion** | Fat Embolism (Supportive Care) |\n| **Central Line removal + Shock** | Left Lateral Decubitus (Air Embolism) |\n| **75, unprovoked DVT** | cancer screening |\n# ğŸ« USMLE Deep Dive: ARDS (Acute Respiratory Distress Syndrome)\n**Topic:** Berlin Criteria, Ventilation Strategy (LTVV), PEEP, Prone Positioning\n## ğŸŒ³ The Big Picture: Hypoxemia Algorithm\ní™˜ìê°€ ìˆ¨ì´ ì°¨ì„œ X-rayë¥¼ ì°ì—ˆëŠ”ë° **ì–‘ìª½ íê°€ í•˜ì–—ê²Œ(Bilateral White-out)** ë³€í–ˆìŠµë‹ˆë‹¤. ì´ê²Œ ì‹¬ì¥ ë•Œë¬¸ì¼ê¹Œìš”, í ë•Œë¬¸ì¼ê¹Œìš”?\nPlaintext\n`Bilateral Opacities on CXR (White-out)\nâ”‚\nâ”œâ”€â”€ Cardiogenic Pulmonary Edema (ì‹¬ë¶€ì „)\nâ”‚   â”œâ”€â”€ PCWP > 18 mmHg (High)\nâ”‚   â”œâ”€â”€ JVD present, S3 gallop\nâ”‚   â””â”€â”€ Rx: Diuretics (Lasix), Inotropes\nâ”‚\nâ””â”€â”€ Non-Cardiogenic Pulmonary Edema (ARDS)\n    â”œâ”€â”€ PCWP < 18 mmHg (Normal/Low)\n    â”œâ”€â”€ Berlin Criteria ë§Œì¡± (1ì£¼ì¼ ì´ë‚´ ë°œë³‘)\n    â”œâ”€â”€ P/F Ratio < 300\n    â””â”€â”€ Rx: Mechanical Ventilation (Low Tidal Volume, High PEEP)`\n## 1. Pathophysiology: \"The Leaky Capillary\"","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-75","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","quiz-seed","diagnosis","pathophysiology","tree"]}
{"chunk_type":"recap_quiz_seed","text":"**Recap (One-Liner)**\n- **Chronic Cough:** ACEi í™•ì¸ â†’ UACSë©´ **1ì„¸ëŒ€ í•­íˆìŠ¤íƒ€ë¯¼ì œ**.\n- **Tetany:** ê³¼í˜¸í¡ â†’ **Low Ionized Calcium**. ì¢…ì´ë´‰íˆ¬ ì“°ì§€ ë§ˆë¼.\n- **HAPE:** ì‚°ì†Œ ì£¼ë©´ ë°”ë¡œ ì¢‹ì•„ì§. Procalcitonin ì •ìƒ.\n- **DAH:** ê°í˜ˆ ì—†ì„ ìˆ˜ë„ ìˆìŒ. BALì—ì„œ í”¼ ë‚˜ì˜´.\n- **Blue Feeding/Pink Crying:** **Choanal Atresia**.\n- **Scaphoid Abdomen:** **CDH**. **Bag-Mask ê¸ˆì§€**.\n- **Sniff Test:** Paradoxical movement = **Diaphragmatic Paralysis**.\nì´ì œ íŒŒì¼ ë‚´ìš©ê³¼ ì •í™•íˆ ì¼ì¹˜í•  ê²ƒì…ë‹ˆë‹¤. í˜¼ë€ì„ ë“œë ¤ ì£„ì†¡í•©ë‹ˆë‹¤. ì´ ë‚´ìš©ìœ¼ë¡œ ì •ë¦¬í•´ ë‘ì‹œë©´ ë©ë‹ˆë‹¤.\n# ğŸ« USMLE Step 2 Deep Dive: Pediatric Pulmonology (ì†Œì•„ í˜¸í¡ê¸°í•™)\nì´ ê°•ì˜ëŠ” USMLE Step 2ë¥¼ ìœ„í•´ ê°€ì¥ ì¤‘ìš”í•œ **ì†Œì•„ í˜¸í¡ê¸°í•™**ì„ ë‹¤ë£¹ë‹ˆë‹¤. ë‹¨ìˆœí•œ ìš©ì–´ ì •ì˜(Step 1 ìˆ˜ì¤€)ë¥¼ ë„˜ì–´, **ê´€ë¦¬(Management), ì„ìƒ ì¶”ë¡ (Clinical Reasoning), ê·¸ë¦¬ê³  ì‹œí—˜ í•¨ì • í”¼í•˜ê¸°**ì— ì§‘ì¤‘í•©ë‹ˆë‹¤.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-176","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","quiz-seed","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"## 7. âš¡ Rapid Fire Recap (í•µì‹¬ ìš”ì•½)\n| ìƒí™© (Scenario) | ì§„ë‹¨ (Diagnosis) | í•µì‹¬ ì¡°ì¹˜ (Key Action) |\n| --- | --- | --- |\n| **ì‹ ìƒì•„, í‰ì†Œ íŒŒë—ê³  ìš¸ë©´ ë¶„í™ìƒ‰** | **Choanal Atresia** | ì¹´í…Œí„° í†µê³¼ ì‹œë„ -> CT -> **ìˆ˜ìˆ ** (ì–‘ì¸¡ì„±ì€ ì‘ê¸‰) |\n| **ë¯¸ìˆ™ì•„, ë™ë™ê±°ë¦¼, ê°„ìœ ë¦¬ ìŒì˜ X-ray** | **NRDS** | CPAP -> (í•„ìš”ì‹œ) ì‚½ê´€ & Surfactant |\n| **ì²­ìƒ‰ì¦ ì•„ê¸°, í ê¹¨ë—í•¨, ì°¨ë³„ì  ì²­ìƒ‰ì¦** | **PPHN** | **Inhaled Nitric Oxide (iNO)** |\n| **ìœ ì•„, ê°‘ì‘ìŠ¤ëŸ¬ìš´ ê¸°ì¹¨, ë‹¨ìŒì„± ì²œëª…ìŒ** | **Foreign Body Aspiration** | **Rigid Bronchoscopy** (X-ray ì •ìƒì´ì–´ë„!) |\n| **í•œìª½ ì½§ë¬¼, ì•…ì·¨** | **Nasal Foreign Body** | ì œê±° (ë°°í„°ë¦¬ëŠ” ì‘ê¸‰!) |\n| **ì½” ê³ ëŠ” ì•„ì´, ë‚®ì— ì‚°ë§Œí•¨(ADHD?), ì•¼ë‡¨ì¦** | **Pediatric OSA** | **Adenotonsillectomy (T&A)** |\n| **ìš¸ë‹¤ê°€ íŒŒë˜ì§€ê³  ê¸°ì ˆ, ê¸ˆë°© íšŒë³µ** | **Breath-holding Spell** | ì•ˆì‹¬ì‹œí‚¤ê¸°, **ì² ë¶„(Ferritin) ì²´í¬** |\n| **ë¬¼ì— ë¹ ì§, ê¸°ì¹¨ ì¡°ê¸ˆ í•¨** | **Drowning (Risk of ARDS)** | **6~8ì‹œê°„ ë³‘ì› ê´€ì°°** (ì§‘ì— ë³´ë‚´ì§€ ë§ ê²ƒ!) |\n## 8. ë§ˆì§€ë§‰ ì¡°ì–¸ (Final Thoughts)\nStep 2ëŠ” ì—¬ëŸ¬ë¶„ì˜ ê²°ë‹¨ë ¥ì„ í‰ê°€í•©ë‹ˆë‹¤. ë³‘ì„ ì•„ëŠ” ê²ƒë§Œìœ¼ë¡œëŠ” ë¶€ì¡±í•©ë‹ˆë‹¤. **ë¬´ì—‡ì„ í•  ê²ƒì¸ê°€(What to do)**ë¥¼ ì•Œì•„ì•¼ í•©ë‹ˆë‹¤.\n- CT ì „ì— ì¹´í…Œí„° ë¨¼ì €.\n- ì´ë¬¼ì§ˆ ì˜ì‹¬ë˜ë©´ CT ëŒ€ì‹  ë‚´ì‹œê²½.\n- NRDSì—ëŠ” ì‚½ê´€ ì „ì— CPAP.\n- ì•Œê³ ë¦¬ì¦˜ì„ ìˆ™ì§€í•˜ê³ , í™˜ìë¥¼ ì‹œê°í™”í•˜ì—¬, **ë‹¤ìŒ ë‹¨ê³„(Next Step)**ë¥¼ ì •í™•íˆ ì„ íƒí•˜ì„¸ìš”! Good luck! ğŸ€\nCo-host: \"A submarine, huh? I can see that.\"\nHost: \"Seriously. We are talking about pressure gradients, fluid dynamics, vacuum seals and, you know, catastrophic structural failures. But we aren't talking about engineering. We are talking about the human chest. Specifically, we are cracking open the high yield, high stakes world of pulmonary surgery for USMLE Step 2.\"\n# ğŸ« USMLE Step 2 Deep Dive: Pulmonary Surgery (í ìˆ˜ìˆ ) ì™„ì „ ì •ë³µ","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-242","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"## 4. Rapid Fire Recap ğŸ”¥ (ì¡±ë³´ ì •ë¦¬)\n1. **Conn Syndrome ì§„ë‹¨ (Rule of 2):**\n    - Screen: Aldo/Renin Ratio > 20.\n    - Confirm: Salt Loading Test (ì–µì œ ì‹¤íŒ¨).\n2. **Cushing Screening (2 out of 3 Rule):**\n    - ë‹¤ìŒ ì¤‘ 2ê°œ ì–‘ì„± í•„ìš”: 24hr Urine, Late Night Saliva, Low-Dose Dex.\n3. **The Great Electrolyte Split (ì „í•´ì§ˆ ì°¨ì´):**\n    - **Conn's:** High BP, Low K+, High Na+.\n    - **Addison's:** Low BP, High K+, Low Na+.\n4. **Pigmentation Clue (ìƒ‰ì†Œì¹¨ì°© íŒíŠ¸):**\n    - Hyperpigmentation = **High ACTH** (Primary AI ë˜ëŠ” Ectopic Cushing's).\n    - No Pigmentation = Secondary AI ë˜ëŠ” Pituitary Cushing's.\n5. **Refractory Signs (ì¹˜ë£Œ ë¶ˆì‘ ì§•í›„):**\n    - 3ê°€ì§€ ì•½ì œì—ë„ ì•ˆ ë“£ëŠ” HTN = **Conn Syndrome.**\n    - ìˆ˜ì•¡/ìŠ¹ì••ì œì— ì•ˆ ë“£ëŠ” Hypotension = **Adrenal Crisis.**\n6. **Iatrogenic Warning (ì˜ì¸ì„± ê²½ê³ ):**\n    - ì˜ì‚¬ê°€ ë§Œë“œëŠ” ê°€ì¥ í”í•œ ë¶€ì‹  ë¬¸ì œ = ë§Œì„± ìŠ¤í…Œë¡œì´ë“œ ì‚¬ìš©ìœ¼ë¡œ ì¸í•œ **Secondary Adrenal Insufficiency**.\n    - *ê¸°ì–µí•  ê²ƒ:* ì–µì œëœ ë¶€ì‹ ì€ ìˆ˜ìˆ /ì§ˆë³‘ ì‹œ ìŠ¤íŠ¸ë ˆìŠ¤ ë°˜ì‘ì„ ëª»í•˜ë¯€ë¡œ ë°˜ë“œì‹œ **Stress-dose Steroids**ë¥¼ ì¤˜ì•¼ í•¨!\n# ğŸ§ Deep Dive: Thyroid Nodules, Adrenal Tumors, & MEN Syndromes\n## 1. Introduction: From Physiology to Pathology\n- ì´ë²ˆ ì„¸ì…˜ì˜ ë¶„ìœ„ê¸°ëŠ” ì´ì „(Physiology)ê³¼ëŠ” ì™„ì „íˆ ë‹¤ë¦…ë‹ˆë‹¤. \"How it works\"ì—ì„œ **\"What happens when things grow\"**ë¡œ ì „í™˜ë©ë‹ˆë‹¤.\n- ì£¼ìš” í…Œë§ˆ: **Mass Effects** (ì¢…ì–‘, ê²°ì ˆì´ ì»¤ì§€ë©´ì„œ ìƒê¸°ëŠ” ë¬¸ì œë“¤).\n- ë‹¤ë£¨ëŠ” ë‚´ìš©ì´ ë§ˆì¹˜ \"ê³µí¬ ì˜í™” ìºìŠ¤íŒ…(Horror movie cast)\"ì²˜ëŸ¼ ë“¤ë¦´ ìˆ˜ ìˆìŠµë‹ˆë‹¤ (ì˜ˆ: Neuroma, Thyroid storm ë“±).\n- **ëª©í‘œ:** ë‹¨ìˆœí•œ ì§ˆë³‘ ë‚˜ì—´ì´ ì•„ë‹ˆë¼, **Framework(ì‚¬ê³ ì˜ í‹€)**ë¥¼ ë§Œë“œëŠ” ê²ƒ. ì–¸ì œ ìŠ¤ìº”í•˜ê³ , ì–¸ì œ ìƒê²€(Biopsy)í•˜ê³ , ì–¸ì œ ì™¸ê³¼ì˜ë¥¼ ë¶€ë¥¼ì§€ ê²°ì •í•˜ëŠ” **Algorithm**ì„ ìµíˆëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\n## 2. Thyroid Nodules: The Algorithm (ê°‘ìƒì„  ê²°ì ˆ ì ‘ê·¼ë²•)","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-199","focus_area":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","tree"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap: High Yield Must-Knows\n1. **Thyroid Nodule Algorithm:** TSH ë¨¼ì €! **Low TSH = Hot Nodule = No Cancer = No Biopsy.**\n2. **Thyroglossal Duct Cyst:** ìˆ˜ìˆ  ì „ **ì •ìƒ ê°‘ìƒì„  ìœ„ì¹˜ í™•ì¸(Ultrasound/Scan)** í•„ìˆ˜. (ìœ ì¼í•œ ê°‘ìƒì„ ì¼ ìˆ˜ ìˆìŒ).\n3. **Hashimoto's Risk:** ì˜¤ë˜ëœ í•˜ì‹œëª¨í†  ê°‘ìƒì„ ì—¼ í™˜ìê°€ ê°‘ìê¸° ëª©ì´ ë¶“ê³  ë”±ë”±í•´ì§€ë©´ **Thyroid Lymphoma** ì˜ì‹¬. (**Pemberton Sign** ì²´í¬).\n4. **Thyroid Storm vs Malignant Hyperthermia:** ë‘˜ ë‹¤ ê³ ì—´/ë¹ˆë§¥ì´ì§€ë§Œ, **Rigidity(ê°•ì§)ê°€ ìˆìœ¼ë©´ MH**, ì—†ìœ¼ë©´ Storm.\n5. **Pheochromocytoma:** ë‘í†µ+ë°œí•œ+ë‘ê·¼ê±°ë¦¼(Triad). ì§„ë‹¨ì€ **Metanephrines** (not just catecholamines).\n6. **Neuroblastoma (Kids):** ë±ƒì† ë©ì–´ë¦¬ê°€ ì •ì¤‘ì„ ì„ ë„˜ìŒ(Crosses midline) + ì¶¤ì¶”ëŠ” ëˆˆ/ë°œ(Opsoclonus-myoclonus).\n7. **MEN 1:** 3 P's (Pituitary, Parathyroid, Pancreas).\n8. **MEN 2:** RET ìœ ì „ì. Medullary Thyroid CA + PheoëŠ” ê¸°ë³¸.\n    - 2AëŠ” Parathyroid (ì¹¼ìŠ˜ â†‘).\n    - 2BëŠ” Mucosal Neuroma + Marfanoid.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-249","focus_area":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","tags":["usmle-step2","core","quiz-seed","diagnosis","tree"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap (í•µì‹¬ ìš”ì•½)\n1. **Prolactin > 200:** MRI ì „ì— **Meds(ì•½ë¬¼), TSH, Creatinine** í™•ì¸.\n2. **Thyroid Nodule:** **TSH ë¨¼ì €**. Lowë©´ Scan, Normalì´ë©´ Biopsy.\n3. **Pregnant Hypothyroid:** ì¦‰ì‹œ **Levothyroxine 30% ì¦ëŸ‰**.\n4. **Hypercalcemia:** ìˆ˜ìˆ  ì „ **Urine Calcium** í™•ì¸í•˜ì—¬ FHH ë°°ì œ.\n5. **Sick Patient (Low Na, High K, Eosinophilia):** **Adrenal Insufficiency** ì˜ì‹¬. **Cosyntropin Test**ë¡œ í™•ì§„.\n6. **Subclinical Hypothyroid (TSH 7~10, >70ì„¸):** **ì¹˜ë£Œí•˜ì§€ ì•ŠìŒ (Watch and Wait).**\n7. **ICU Patient (Low T3/TSH):** **Euthyroid Sick Syndrome**. ì¹˜ë£Œí•˜ì§€ ì•ŠìŒ.\n# USMLE Step 2 Endocrinology Deep Dive: Pharmacology & Management Framework\n## 1. Introduction: The Mental Framework ğŸ§ \nê°•ì˜ëŠ” ë‹¨ìˆœí•œ ì•”ê¸°ê°€ ì•„ë‹Œ **'ë…¼ë¦¬(Logic)'**ì™€ **'í”¼ë“œë°± ë£¨í”„(Feedback Loops)'**ë¥¼ ê°•ì¡°í•˜ë©° ì‹œì‘í•©ë‹ˆë‹¤. ë‚´ë¶„ë¹„í•™(Endocrinology)ì—ì„œì˜ ì§„ë‹¨ì€ ì£¼ë¡œ ì„¤ì •(Set-up)ì— ë¶ˆê³¼í•˜ë©°, ì‹¤ì œ ì‹œí—˜ì—ì„œ ìˆ˜í—˜ìƒë“¤ì„ ë–¨ì–´ëœ¨ë¦¬ëŠ” ì§„ì§œ ë¬¸ì œëŠ” **\"ë© ê²°ê³¼ê°€ ë‚˜ì˜¨ í›„ ë¬´ì—‡ì„ í•  ê²ƒì¸ê°€(Next Step)\"**ì— ìˆìŠµë‹ˆë‹¤.\n- **Context is Everything:** ë‚´ë¶„ë¹„í•™ì—ì„œëŠ” ì •ë‹µì— ê±°ëŒ€í•œ **ë³„í‘œ(Asterisk â˜…)**ê°€ ë¶™ìŠµë‹ˆë‹¤.\n    - ì¼ë°˜ì ì¸ í™˜ìì—ê²ŒëŠ” 'Gold Standard'ì¸ ì•½ë¬¼ì´ ì„ì‹ ë¶€ì—ê²ŒëŠ” ê¸°í˜•ì„ ìœ ë°œí•  ìˆ˜(Teratogen) ìˆê³ , 30ì„¸ í™˜ìë¥¼ ì‚´ë¦¬ëŠ” ì•½ì´ 75ì„¸ í™˜ìì—ê²ŒëŠ” ì¹˜ëª…ì ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- **ë¡œë“œë§µ:** ë‡Œí•˜ìˆ˜ì²´(Pituitary) â†’ ê°‘ìƒì„ (Thyroid) â†’ ë¶€ì‹ (Adrenals) & ë¶€ê°‘ìƒì„ (Parathyroids) â†’ ë‹¹ë‡¨ ê´€ë¦¬(Diabetes Maintenance).","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-171","focus_area":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap (í•µì‹¬ ìš”ì•½)\n1. **Hyperthyroidism:** TSH ë¨¼ì € ì²´í¬. ë‚®ìœ¼ë©´ Free T4 í™•ì¸. ê·¸ë ˆì´ë¸ŒìŠ¤ ì§•í›„(ì•ˆêµ¬ ëŒì¶œ) ì—†ìœ¼ë©´ **RAIU ìŠ¤ìº”**ìœ¼ë¡œ ê³µì¥ ê³¼ê°€ë™ vs ëˆ„ì¶œ ê°ë³„ (leak or fake)\n2. **Thyroid Storm:** ì‹¬í•œ í•­ì§„ì¦ + **ê³ ì—´(High Fever, >104F)** + ì •ì‹  ìƒíƒœ ë³€í™”.\n3. **Pregnancy:**\n    - normally total T4 high, TSH slightly low in 1st trimester.\n    - Graves: 1ë¶„ê¸° **PTU**, 2/3ë¶„ê¸° **Methimazole**.\n    - Hypo: ì„ì‹  í™•ì¸ ì¦‰ì‹œ Levothyroxine **30% ì¦ëŸ‰**.\n4. **Hypothyroid Mom:** ì–‘ì„± ë°˜ì‘ ëœ¨ìë§ˆì ì¦ëŸ‰. TSH í™•ì¸ ê¸°ë‹¤ë¦¬ì§€ ë§ ê²ƒ.\n5. **Nodule:** **TSH ë¨¼ì €.** ë‚®ìœ¼ë©´ ìŠ¤ìº”, ì •ìƒì´ë©´ ì´ˆìŒíŒŒ. Hot noduleì€ ìƒê²€ ì•ˆ í•¨.\n6. **Euthyroid Sick Syndrome (ICU):** Low T3, High Reverse T3. **ì¹˜ë£Œí•˜ì§€ ì•ŠìŒ.** ê¸°ì € ì§ˆí™˜ ì¹˜ë£Œ.\n**Takeaway:** ê°‘ìƒì„ ì€ ë…ë¦½ëœ ê¸°ê´€ì´ ì•„ë‹ˆë¼ ë¼ˆ, ì‹¬ì¥, ë‡Œ, ìƒì‹ê¸° ë“± ì „ì‹  ì‹œìŠ¤í…œì˜ ì§€íœ˜ì(Conductor)ì„ì„ ê¸°ì–µí•˜ê³  ì „ì²´ì ì¸ í™˜ìì˜ ìƒíƒœë¥¼ ë´ì•¼ í•©ë‹ˆë‹¤.","subject":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","page_title":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","episode":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","section_path":["LM_endo 1 2f346f2986ee80ca9e35c9ff88472722"],"source_doc_id":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","source_page":null,"source_anchor":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722-294","focus_area":"LM_endo 1 2f346f2986ee80ca9e35c9ff88472722","tags":["usmle-step2","core","quiz-seed"]}
{"chunk_type":"recap_quiz_seed","text":"# ğŸ”¥ High Yield Summary: Rapid Fire Recap\n1. **ë…¸ì¸ ê³ í˜ˆì•• (ìˆ˜ì¶•ê¸°â†‘, ì´ì™„ê¸° ì •ìƒ/â†“):** ì›ì¸ì€ **ëŒ€ë™ë§¥ ê²½ì§(Stiffness)**.\n2. **1ê¸° ê³ í˜ˆì•• ì¹˜ë£Œ:** ê³ ìœ„í—˜êµ°(ASCVD >10%, DM, CKD)ì´ ì•„ë‹ˆë©´ **ìƒí™œìŠµê´€ êµì •**ì´ ë¨¼ì €.\n3. **í˜ˆì•• ê°•í•˜ íš¨ê³¼ 1ë“±:** **ì²´ì¤‘ ê°ëŸ‰**. (ê¸ˆì—°ì€ ì „ì²´ ì‹¬í˜ˆê´€ ìœ„í—˜ ê°ì†Œ).\n4. **ì•½ë¬¼ ì„ íƒì˜ ë¯¸í•™:**\n    - í†µí’ í™˜ì ğŸ‘‰ **Losartan** (Thiazide ê¸ˆì§€ âŒ)\n    - ê³¨ë‹¤ê³µì¦ í™˜ì ğŸ‘‰ **Thiazide**\n    - ì‹¬ê·¼ê²½ìƒ‰ ê³¼ê±°ë ¥ ğŸ‘‰ **Beta Blocker + ACEi**\n5. **ì´ì°¨ì„± ê³ í˜ˆì•• í‚¤ì›Œë“œ:**\n    - Bruit / ACEi í›„ Cr ìƒìŠ¹ / íë¶€ì¢… ğŸ‘‰ **ì‹ ë™ë§¥ í˜‘ì°©**\n    - ì €ì¹¼ë¥¨í˜ˆì¦ ğŸ‘‰ **ì•Œë„ìŠ¤í…Œë¡ ì¦**\n    - ë‘í†µ+ë•€+ë‘ê·¼ê±°ë¦¼ ğŸ‘‰ **ê°ˆìƒ‰ì„¸í¬ì¢…**\n6. **ì‘ê¸‰ì‹¤ ëŒ€ì²˜:** ì¥ê¸° ì†ìƒ(ëˆˆ, ë‡Œ, ì‹¬ì¥, ì½©íŒ¥)ì´ ìˆìœ¼ë©´ **Emergency (IV ì¹˜ë£Œ)**, ì—†ìœ¼ë©´ **Urgency (ê²½êµ¬ ì¹˜ë£Œ)**.\n# ğŸ«€ USMLE Step 2 ëŒ€ë¹„: ê°ì—¼ì„± ì‹¬ë‚´ë§‰ì—¼(IE) & ë¥˜ë§ˆí‹°ìŠ¤ì„± ì‹¬ì¥ ì§ˆí™˜(RHD) ì™„ë²½ ì •ë¦¬\n\"ì•ˆë…•í•˜ì„¸ìš”. USMLE ìŠ¤í… 2 ì‹œí—˜ ì¤€ë¹„í•˜ì‹œëŠë¼ í˜ë“œì‹œì£ ? íŠ¹íˆ ì‹¬ì¥ íŒŒíŠ¸ëŠ” ì™¸ìš¸ ê²ƒë„ ë§ê³  ì–´... ì„œë¡œ ë§‰ ë¹„ìŠ·í•´ì„œ í—·ê°ˆë¦¬ëŠ” ê°œë…ë„ ì •ë§ ë§ì–ì•„ìš”. ì˜¤ëŠ˜ ì €í¬ê°€ ë³´ë‚´ì£¼ì‹  ìë£Œë“¤ì„ ë°”íƒ•ìœ¼ë¡œ ê·¸ì¤‘ì—ì„œë„ ê°€ì¥ ê³¨ì¹˜ ì•„í”ˆ ë‘ ê°€ì§€, ê°ì—¼ì„± ì‹¬ë‚´ë§‰ì—¼ê³¼ ë¥˜ë§ˆí‹°ìŠ¤ì„± ì‹¬ì¥ ì§ˆí™˜ì„ í™•ì‹¤í•˜ê²Œ ì •ë¦¬í•´ ë“œë¦¬ë ¤ê³  í•©ë‹ˆë‹¤. ì˜¤ëŠ˜ ì €í¬ì˜ ëª©í‘œëŠ” ì´ ìë£Œë“¤ì—ì„œ í•µì‹¬ë§Œ ì™ì™ ë½‘ì•„ë“œë¦¬ëŠ” ê±°ì˜ˆìš”. ì§„ë‹¨ ê¸°ì¤€ë¶€í„° ì›ì¸ê· , í—·ê°ˆë¦¬ëŠ” ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤ê¹Œì§€ ì‹œí—˜ì— ë‚˜ì˜¤ëŠ” ê°€ì¥ ì¤‘ìš”í•œ ë‚´ìš©ë“¤ì„ ë¨¸ë¦¿ì†ì— í™•ì‹¤íˆ ë„£ì–´ë“œë¦´ê²Œìš”.\"\n## 1. Introduction: ì˜¤ëŠ˜ì˜ í•™ìŠµ ëª©í‘œ ğŸ¯\nì´ ê°•ì˜ëŠ” USMLE Step 2 ì‹œí—˜ì—ì„œ ìˆ˜í—˜ìƒë“¤ì„ ê´´ë¡­íˆëŠ” ë‘ ê°€ì§€ ì£¼ìš” ì‹¬ì¥ ì§ˆí™˜, **ê°ì—¼ì„± ì‹¬ë‚´ë§‰ì—¼(Infective Endocarditis, IE)**ê³¼ **ë¥˜ë§ˆí‹°ìŠ¤ì„± ì‹¬ì¥ ì§ˆí™˜(Rheumatic Heart Disease, RHD)**ì„ ë‹¤ë£¹ë‹ˆë‹¤.\n- ë‹¨ìˆœ ì•”ê¸°ê°€ ì•„ë‹Œ **ê¸°ì „(Mechanism)** ì´í•´ë¥¼ í†µí•œ ì•”ê¸°\n- ì‹œí—˜ì— ìì£¼ ë‚˜ì˜¤ëŠ” **ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤(Clinical Scenario)** ì—°ê²°\n- *ê°ì—¼(Infection)**ê³¼ **ë©´ì—­ ë°˜ì‘(Immune Response)**ì˜ ì°¨ì´ êµ¬ë¶„\n## 2. ê°ì—¼ì„± ì‹¬ë‚´ë§‰ì—¼ (Infective Endocarditis, IE) ğŸ¦ ","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-51","focus_area":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","tags":["usmle-step2","core","quiz-seed","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"# ğŸ”¥ Rapid Fire Recap: Must-Know High Yield Summary\n### 1. Atheroembolism (Cholesterol Crystal Embolism)\n- **Scenario:** ìµœê·¼ í˜ˆê´€ ì‹œìˆ (Angio) ë°›ìŒ $\\rightarrow$ ë°œê°€ë½ íŒŒë˜ì§(Blue toe) + ì½©íŒ¥ ë§ê°€ì§(AKI).\n- **Key Triad:** Procedure history + AKI + **Eosinophilia**.\n- **Pathology:** Needle-shaped clefts.\n- **Eye Find:** Hollenhorst plaque (retinal cholesterol crystal).\n### 2. Statin Indications (4 Groups)\n1. **ASCVD History:** ë¬´ì¡°ê±´ Start (â‰¤75ì„¸ High, >75ì„¸ Moderate).\n2. **LDL â‰¥ 190:** ë¬´ì¡°ê±´ High intensity.\n3. **Diabetes (40-75ì„¸):** ë¬´ì¡°ê±´ Start.\n4. **High Risk (40-75ì„¸):** 10-year risk â‰¥ 7.5%ë©´ ê³ ë ¤.\n### 3. Hypertriglyceridemia\n- **TG > 1000:** **Pancreatitis** ì˜ˆë°©ì´ 1ìˆœìœ„. (Rx: Fibrates).\n- **TG 150-500:** Lifestyle (íŠ¹íˆ **ê¸ˆì£¼**) $\\rightarrow$ Statin.\n### 4. ACS Management\n- **Action:** ER ì˜¤ìë§ˆì High-dose Statin.\n- **Why?** **Plaque Stabilization** (Anti-inflammatory effect), not just lipid lowering.\n# ğŸ«€ USMLE Step 2: ì‹¬í˜ˆê´€ ê³ ì†ë„ë¡œ ì™„ì „ ì •ë³µ (Aorta & Carotid)","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-151","focus_area":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","tags":["usmle-step2","core","quiz-seed","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap: Must-Know Summary\n1. **Aortic Dissection (ëŒ€ë™ë§¥ ë°•ë¦¬)**\n    - ì°¢ì–´ì§€ëŠ” í‰í†µ + **Unstable** ğŸ‘‰ **Bedside TEE**\n    - ì°¢ì–´ì§€ëŠ” í‰í†µ + **Stable** ğŸ‘‰ **CT Angio**\n    - Trap: **Pulse Deficit**ì€ ì—†ëŠ” ê²½ìš°ê°€ ë” ë§ë‹¤!\n2. **AAA (ë³µë¶€ ëŒ€ë™ë§¥ë¥˜)**\n    - ë³µí†µ + ì €í˜ˆì•• (Rupture) ğŸ‘‰ **ì¦‰ì‹œ ìˆ˜ìˆ ì‹¤ + Bedside US** (CT âŒ)\n    - ìˆ˜ìˆ  ê¸°ì¤€: **>5.5cm**, ë¹ ë¥¸ ì„±ì¥(>0.5cm/6mo), ìœ ì¦ìƒ.\n3. **Coarctation (ëŒ€ë™ë§¥ ì¶•ì°©)**\n    - **íŒ” í˜ˆì•• > ë‹¤ë¦¬ í˜ˆì••**, Rib Notching.\n    - Neonate Shock ğŸ‘‰ **PGE1** (ë™ë§¥ê´€ ì—´ì–´ë¼!)\n4. **Leriche Syndrome**\n    - **Triad:** ì—‰ë©ì´ í†µì¦ + ë°œê¸°ë¶€ì „ + ëŒ€í‡´ë§¥ë°• ì†Œì‹¤.\n5. **Carotid Stenosis (ê²½ë™ë§¥ í˜‘ì°©)**\n    - **Symptomatic (ìœ ì¦ìƒ)**: 70% ì´ìƒ ë§‰íˆë©´ **CEA (ìˆ˜ìˆ )**.\n    - Asymptomatic (ë¬´ì¦ìƒ): ì•½ë¬¼ì¹˜ë£Œ ìš°ì„ , 80% ì´ìƒì¼ ë•Œë§Œ ìˆ˜ìˆ  ê³ ë ¤.\n6. **Carotid Dissection (ê²½ë™ë§¥ ë°•ë¦¬)**\n    - Trauma (ì—°í•„, ìš”ê°€) + **Partial Horner's** (ë•€ì€ ë‚¨!) + Stroke ì¦ìƒ.\n    - ì§„ë‹¨: CT Angio / ì¹˜ë£Œ: í•­ì‘ê³ ì œ.","subject":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","page_title":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","episode":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","section_path":["LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec"],"source_doc_id":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","source_page":null,"source_anchor":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec-215","focus_area":"LM_cardio 1 2f346f2986ee80e3baf9e27d823f4aec","tags":["usmle-step2","core","quiz-seed"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap: High Yield Summary\n- **ì§„ë‹¨:** ST ìƒìŠ¹ ìˆë‚˜ìš”?\n    - **YES** â†’ **STEMI** â†’ **90ë¶„ ë‚´ PCI** (ì•ˆë˜ë©´ 120ë¶„ ë‚´ í˜ˆì „ìš©í•´ì œ).\n    - **NO** â†’ Troponin í™•ì¸ â†’ ìƒìŠ¹ì‹œ **NSTEMI** / ì •ìƒì´ë©´ **UA** â†’ **TIMI Score**ë¡œ ì‹œìˆ  ì‹œê¸° ê²°ì •.\n- **ì´ˆê¸° ì•½ë¬¼ (MONA-BS):** Morphine(í•„ìš”ì‹œ), O2(ì €ì‚°ì†Œì‹œ), **Nitrates**, **Aspirin**, **Beta-blocker**, **Statin**.\n- **â˜… í•¨ì • (RV MI):** II, III, aVF ìƒìŠ¹(í•˜ë²½ ê²½ìƒ‰) + ì €í˜ˆì••? â†’ **RV MI ì˜ì‹¬!** â†’ **Nitroglycerin ì ˆëŒ€ ê¸ˆê¸° âŒ** â†’ **ìˆ˜ì•¡(Fluid) ì¤˜ë¼ ğŸ’§**.\n- **ì¥ê¸° ì˜ˆí›„:** ì‹¬ì¥ ë¦¬ëª¨ë¸ë§ ë°©ì§€ì•½ë¬¼ = **ACE inhibitors / ARBs**.\n**(ë‹¤ìŒ í™” ì˜ˆê³ )**: ê¸°ê³„ì  í•©ë³‘ì¦(ì‹¬ì¥ë²½ êµ¬ë©, íŒë§‰ íŒŒì—´)ê³¼ ì „ê¸°ì  í•©ë³‘ì¦(ë¶€ì •ë§¥), ê·¸ë¦¬ê³  ST ìƒìŠ¹ì´ ì‚¬ë¼ì§€ì§€ ì•ŠëŠ” ê²½ìš°(ì‹¬ì‹¤ë¥˜)ì— ëŒ€í•´ ë‹¤ë£¹ë‹ˆë‹¤.\n# ì‹¬ê·¼ê²½ìƒ‰ ì‹œë¦¬ì¦ˆ Part 2: í­í’ ì „ì˜ ê³ ìš”, ì•ˆì •í˜• í˜‘ì‹¬ì¦ (Stable Angina) ì •ë³µí•˜ê¸°\n\"ì•ˆë…•í•˜ì„¸ìš”, ì‹¬ê·¼ ê²½ìƒ‰ ì‹œë¦¬ì¦ˆ ê·¸ ë‘ ë²ˆì§¸ ì‹œê°„ì…ë‹ˆë‹¤. ë„¤, ì•ˆë…•í•˜ì„¸ìš”. ì§€ë‚œë²ˆì—ëŠ” ì €í¬ê°€ ì‹¬ê·¼ ê²½ìƒ‰ì˜ ì•„ì£¼ í° ê·¸ë¦¼ì„ í•œë²ˆ ê·¸ë ¤ë´¤ë‹¤ë©´, ì˜¤ëŠ˜ì€ ê·¸ í­í’ì „ì˜ ê³ ìš”ë¼ê³  í• ê¹Œìš”? ì•„, ì¢‹ì€ í‘œí˜„ì´ë„¤ìš”. ë„¤, ì–¸ì œë“  í­í’ìœ¼ë¡œ ë³€í•  ìˆ˜ ìˆëŠ” ì•ˆì •í˜• í˜‘ì‹¬ì¦ì„ ì œëŒ€ë¡œ í•œë²ˆ íŒŒí—¤ì³ë³´ê² ìŠµë‹ˆë‹¤. ì¢‹ìŠµë‹ˆë‹¤. USMLE ì‹œí—˜ì—ì„œ, ìŒ, ì˜ˆë¥¼ ë“¤ì–´ 58ì„¸ ë‚¨ì„± í™˜ìê°€ ê³„ë‹¨ë§Œ ì˜¤ë¥´ë©´ ê°€ìŠ´ì´ ë»ê·¼í•´ìš”ë¼ê³  í•  ë•Œ ë¨¸ë¦¿ì†ì´ í•˜ì–˜ì¡Œë˜ ê²½í—˜ ë‹¤ë“¤ ìˆìœ¼ì‹œì£ ?\"\n## 1. Introduction: í­í’ ì „ì˜ ê³ ìš” ğŸŒªï¸\nì´ ê°•ì˜ëŠ” ê¸‰ì„± ê´€ìƒë™ë§¥ ì¦í›„êµ°(ACS)ì´ë¼ëŠ” 'í­í’'ì´ ì˜¤ê¸° ì „, **ì•ˆì •í˜• í˜‘ì‹¬ì¦(Stable Angina)** ë‹¨ê³„ì—ì„œ í™˜ìë¥¼ ì–´ë–»ê²Œ ì§„ë‹¨í•˜ê³  ê´€ë¦¬í•´ì•¼ í•˜ëŠ”ì§€ì— ëŒ€í•œ ëª…í™•í•œ ë¡œë“œë§µì„ ì œì‹œí•©ë‹ˆë‹¤. ì‘ê¸‰ ìƒí™©ì€ ì•„ë‹ˆì§€ë§Œ, ê¸¸ì„ ì˜ëª» ë“¤ë©´ ë°”ë¡œ ì‘ê¸‰ìœ¼ë¡œ ì´ì–´ì§ˆ ìˆ˜ ìˆëŠ” ì¤‘ìš”í•œ ë‹¨ê³„ì…ë‹ˆë‹¤.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-40","focus_area":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","tags":["usmle-step2","core","quiz-seed","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"## 8. Rapid Fire Recap (Must-Know Summary) ğŸ”¥\n1. **ì§„ë‹¨ í”„ë ˆì„ì›Œí¬:** í‰í†µì˜ 3ìš”ì†Œ(ìœ„ì¹˜/ì–‘ìƒ, ìœ ë°œ, ì™„í™”) í™•ì¸ â†’ **3/3ì´ë©´ Typical Angina.**\n2. **ì§„ë‹¨ ê²€ì‚¬ ê²°ì •:** ì‚¬ì „ ê²€ì‚¬ í™•ë¥ (Pre-test Probability)ì´ **ì¤‘ê°„(Intermediate)**ì¸ í™˜ìì—ê²Œ **ë¶€í•˜ ê²€ì‚¬(Stress Test)** ì‹œí–‰.\n3. **ë¶€í•˜ ê²€ì‚¬ ì„ íƒë²•:**\n    - ìš´ë™ ê°€ëŠ¥? ECG ì •ìƒ? â†’ ë‘˜ ë‹¤ YESë©´ **Exercise ECG.**\n    - í•˜ë‚˜ë¼ë„ NOë©´ â†’ Imaging ì¶”ê°€ í˜¹ì€ ì•½ë¬¼ ë¶€í•˜.\n4. **ê²€ì‚¬ ì „ ì£¼ì˜:** **BB, CCB, Nitrates 48ì‹œê°„ ì¤‘ë‹¨** (ìœ„ìŒì„± ë°©ì§€).\n5. **ì¹˜ë£Œì˜ í•µì‹¬:**\n    - ì¦ìƒ ì¡°ì ˆ(ì†Œë°©ìˆ˜) â†’ **Nitroglycerin.**\n    - ì‚¬ë§ë¥  ê°ì†Œ/ì˜ˆë°©(ê±´ì„¤íŒ€) â†’ **Beta-Blocker** (1st line).\n6. **ë³€ì´í˜• í˜‘ì‹¬ì¦(Vasospastic):** ìƒˆë²½ íœ´ì‹ ì‹œ í†µì¦ + ST ìƒìŠ¹. ì¹˜ë£ŒëŠ” **CCB**. **BBëŠ” ì ˆëŒ€ ê¸ˆê¸°!** âŒ\n**ë‹¤ìŒ ì‹œê°„ ì˜ˆê³ :** ì•ˆì •ì ì¸ ìƒíƒœê°€ ê¹¨ì§€ê³  ì˜ˆì¸¡ ë¶ˆê°€ëŠ¥í•œ ê³µí¬ë¡œ ë°”ë€ŒëŠ” **ê¸‰ì„± ê´€ìƒë™ë§¥ ì¦í›„êµ°(ACS)**, ê·¸ì¤‘ì—ì„œë„ ë¶ˆì•ˆì • í˜‘ì‹¬ì¦ê³¼ ì‹¬ê·¼ê²½ìƒ‰ì— ëŒ€í•´ ë‹¤ë£¹ë‹ˆë‹¤.\n# USMLE Step 2 ì‹¬ê·¼ê²½ìƒ‰(MI) ì™„ì „ ì •ë³µ: í•©ë³‘ì¦, ì§„ë‹¨, ê·¸ë¦¬ê³  ê´€ë¦¬ (3ë¶€ì‘ì˜ ì™„ê²°)\n**[0:00~0:30 êµ¬ê°„ ë°›ì•„ì“°ê¸° ê²€ì¦]**\n\"ì•ˆë…•í•˜ì„¸ìš”. ì‹¬ê·¼ê²½ìƒ‰ì— ëŒ€í•œ ì €í¬ì˜ 3ë¶€ì‘ ì—¬ì •. ê·¸ ì„¸ ë²ˆì§¸ì´ì ë§ˆì§€ë§‰ ì‹œê°„ì— ì˜¤ì‹  ê²ƒì„ í™˜ì˜í•©ë‹ˆë‹¤. íŠ¹íˆ USMLE Step 2 ì‹œí—˜ì„ ì¤€ë¹„í•˜ì‹œëŠ” ë°”ë¡œ ë‹¹ì‹ ì„ ìœ„í•´ ì¤€ë¹„í•œ ì‹œê°„ì´ì£ ? ì €í¬ê°€ ì§€ë‚œ ë‘ ë²ˆì— ê±¸ì³ì„œ ì‹¬ê·¼ê²½ìƒ‰ì´ ëŒ€ì²´ ë­ê³ , ë˜ ì–´ë–»ê²Œ ì§„ë‹¨í•˜ê³  ê¸‰ì„±ê¸°ì— ì¹˜ë£Œí•˜ëŠ”ì§€ ì•Œì•„ë´¤ì–ì•„ìš”? ì˜¤ëŠ˜ì€ ê·¸ ì´í›„ì˜ ì´ì•¼ê¸°ì…ë‹ˆë‹¤. ê·¸ëŸ¬ë‹ˆê¹Œ ì‹¬ê·¼ê²½ìƒ‰ì´ë¼ëŠ” í° í­í’ì´ ì§€ë‚˜ê°„ ìë¦¬ì— ë‚¨ì„ ìˆ˜ ìˆëŠ” ì–´... ê·¸ëŸ° ìœ„í—˜í•œ í•©ë³‘ì¦ë“¤ë¶€í„° ì‹œì‘í•´ ë³¼ ê±°ê³ ìš”.\"\n## 1. ì„œë¡ : í­í’ì´ ì§€ë‚˜ê°„ ìë¦¬ë¥¼ ê´€ë¦¬í•˜ë‹¤ ğŸŒªï¸\nì˜¤ëŠ˜ ê°•ì˜ëŠ” ì‹¬ê·¼ê²½ìƒ‰(MI) ê¸‰ì„±ê¸° ì¹˜ë£Œ ì´í›„ì˜ ìƒí™©ì„ ë‹¤ë£¹ë‹ˆë‹¤. í™˜ìë¥¼ ì‚´ë¦° ê²ƒì´ ëì´ ì•„ë‹ˆë¼, **ê·¸ ì´í›„ì— ë²Œì–´ì§ˆ ìˆ˜ ìˆëŠ” ì¼ë“¤ì„ ì˜ˆì¸¡í•˜ê³  ê´€ë¦¬í•˜ëŠ” ê²ƒ**ì´ USMLE Step 2ì˜ í•µì‹¬ í¬ì¸íŠ¸ì…ë‹ˆë‹¤.\nì£¼ìš” í† í”½:\n- ê¸°ê³„ì  í•©ë³‘ì¦ (Mechanical Complications)\n- ì¥ê¸°ì  ì‹¬ì‹¤ ë¦¬ëª¨ë¸ë§ ë° ì•½ë¬¼ ê´€ë¦¬\n- ê¸‰ì„± ê´€ìƒë™ë§¥ ì¦í›„êµ°(ACS) ë° ì•ˆì •í˜• í˜‘ì‹¬ì¦ì˜ ì§„ë‹¨ ì•Œê³ ë¦¬ì¦˜\n- í‰í†µì˜ ê°ë³„ ì§„ë‹¨","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-88","focus_area":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","tags":["usmle-step2","core","quiz-seed"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸš€ Rapid Fire Recap: Must-Know High Yields\n### 1. Post-MI Complications Timeline & Clues\n- **3~5ì¼ì°¨ (ê¸°ê³„ì  í•©ë³‘ì¦):**\n    - **Papillary Muscle Rupture:** Inferior MI + Pulmonary Edema + New Murmur.\n    - **VSD (Septal Rupture):** New Murmur + **O2 Saturation Step-up (RV)**.\n    - **Free Wall Rupture:** Cardiac Tamponade + Sudden Shock/Arrest.\n- **ìˆ˜ê°œì›” í›„:**\n    - **LV Aneurysm:** Dyskinetic motion + Thrombus/Stroke Risk.\n### 2. Long-term Meds (BASS M)\n- **B**eta-blocker, **A**spirin, **S**tatin, **S**pironolactone, **ACE** Inhibitor.\n- **Trap:** Do NOT use **NSAIDs**! â˜ ï¸\n### 3. Stress Test Selection Framework\n- **Can exercise?** â†’ Yes: **Exercise ECG**.\n- **Can't exercise?** â†’ Pharmacologic.\n    - **Asthma/Bronchospasm present?**\n        - Yes: **Dobutamine Echo** (Adenosine is contraindicated!).\n        - No: **Adenosine/Dipyridamole** (Coronary Steal mechanism).\n### 4. Chest Pain Differentiation\n- **Prinzmetal's Angina:** Young, rest/morning pain, transient ST elevation. (Cause: Vasospasm).\n- **Typical Angina:** Meets all 3 criteria (Location, Provocation by stress, Relief by rest/NTG).\n### 5. Clinical Management Trap","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-135","focus_area":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","tags":["usmle-step2","core","quiz-seed","treatment","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"## âš¡ Rapid Fire Recap: Must-Know High Yield Summary\n| êµ¬ë¶„ | **Aortic Stenosis (AS)** | **Mitral Stenosis (MS)** |\n| --- | --- | --- |\n| **í•µì‹¬ ê¸°ì „** | LVì—ì„œ ëŒ€ë™ë§¥ìœ¼ë¡œ ë‚˜ê°€ëŠ” ë¬¸ì´ ì¢ì•„ì§ | LAì—ì„œ LVë¡œ ë“¤ì–´ì˜¤ëŠ” ë¬¸ì´ ì¢ì•„ì§ |\n| **ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤** | ê³ ë ¹ì, ìš´ë™ ì¤‘ ì‹¤ì‹ /í‰í†µ ğŸƒâ€â™‚ï¸â¡ï¸ğŸ˜µ | í˜¸í¡ê³¤ë€, ê¸°ì¢Œí˜¸í¡, ëª©ì†Œë¦¬ ì‰¼ ğŸ—£ï¸ |\n| **Key Sound â˜…** | **Systolic** Crescendo-Decrescendo (Neck radiation) | **Diastolic** Rumble + **Opening Snap** |\n| **íŠ¹ì§•ì  ì§•í›„** | Pulsus Parvus et Tardus (ì•½í•˜ê³  ëŠ¦ì€ ë§¥) | Mitral Facies (ë³´ëë¹› ëº¨), Ortner's syndrome |\n| **ì‹¬í•œ ì •ë„ ê¸°ì¤€** | Velocity > 4m/s, Mean Gradient > 40mmHg | P-mitrale (EKG), LA enlargement |\n| **High Yield Trap** | **ì¤‘ì¦ ASì—ì„œ Stress TestëŠ” ì ˆëŒ€ ê¸ˆì§€!** ğŸš« | ìˆ˜ìˆ  ì „ í’ì„  ì‹œìˆ (PMBV) ìš°ì„  ê³ ë ¤ ê°€ëŠ¥ |\n| **High Yield Fact** | S4ëŠ” ê³ í˜ˆì••/MI(ë»£ë»£í•œ ë²½), S3ëŠ” ì‹¬ë¶€ì „(ëŠ˜ì–´ë‚œ í’ì„ ) | ê°¤ëŸ½ìŒì€ 3ì¤‘ì£¼(ì‚¼ì¤‘ì£¼)ì²˜ëŸ¼ ë“¤ë¦¼ ğŸ |\n**ë‹¤ìŒ ì˜ˆê³ :** ë¬¸ì´ ì œëŒ€ë¡œ ë‹«íˆì§€ ì•ŠëŠ” **ì—­ë¥˜ì„± íŒë§‰ ì§ˆí™˜** ìˆ˜ì‚¬ ì˜ˆì •! ğŸ”œ\n\"ì•ˆë…•í•˜ì„¸ìš”. íŒë§‰ ì§ˆí™˜ì— ëŒ€í•œ ì €í¬ ë‘ ë²ˆì§¸ ì‹¬ì¸µ ë¶„ì„ ì‹œê°„ì— ì˜¤ì‹  ê±¸ í™˜ì˜í•©ë‹ˆë‹¤. ë„¤, ì•ˆë…•í•˜ì„¸ìš”. ì§€ë‚œ ì‹œê°„ì—ëŠ” ì €í¬ê°€ ì‹¬ì¥ì˜ ë¬¸ì´ ì¢ì•„ì§€ëŠ” í˜‘ì°©ì¦, ê·¸ì¤‘ì—ì„œë„ íŠ¹íˆ ëŒ€ë™ë§¥íŒ í˜‘ì°©ì¦ì„ ë‹¤ë¤˜ì–ì•„ìš”. ë„¤ ë§ìŠµë‹ˆë‹¤. ì‹¬ì¥ì— ê°€í•´ì§€ëŠ” ê·¸ ì—„ì²­ë‚œ ì••ë ¥ ë¶€í•˜ì— ëŒ€í•œ ì´ì•¼ê¸°ì˜€ì£ . ë§ì•„ìš”. ê·¸ë˜ì„œ ì˜¤ëŠ˜ì€ ì–´, ê·¸ ì •ë°˜ëŒ€ ìƒí™©. ê·¸ëŸ¬ë‹ˆê¹Œ ë¬¸ì´ ì œëŒ€ë¡œ ë‹«íˆì§ˆ ì•Šì•„ì„œ í”¼ê°€ ì—­ë¥˜í•˜ëŠ”, ë§í•˜ìë©´ ìƒˆëŠ” ë¬¸ì˜ ë¬¸ì œë¥¼ í•œë²ˆ íŒŒí—¤ì³ ë³´ë ¤ê³  í•©ë‹ˆë‹¤.\"\n# ğŸ«€ USMLE Step 2 íŒë§‰ ì—­ë¥˜ ì§ˆí™˜(Regurgitant Valve Diseases) ì‹¬ì¸µ ë¶„ì„\n## 1. Introduction: ì—­ë¥˜ì„± ì§ˆí™˜ì˜ ê¸°ë³¸ ê°œë…\nì´ë²ˆ ì—í”¼ì†Œë“œì—ì„œëŠ” **ì‹¬ì¥ì˜ ë¬¸ì´ ì œëŒ€ë¡œ ë‹«íˆì§€ ì•Šì•„ í”¼ê°€ ìƒˆëŠ” 'ì—­ë¥˜ì„±(Regurgitant)' ì§ˆí™˜**ì„ ë‹¤ë£¹ë‹ˆë‹¤. í•µì‹¬ì€ ì••ë ¥ ì°¨ì´ì™€ ê·¸ì— ë”°ë¥¸ ì‹¬ì¥ì˜ ì ì‘ ê³¼ì •ì…ë‹ˆë‹¤.\n- **ì™¼ìª½ ì‹¬ì¥ (Left Heart):** ê±°ëŒ€í•œ ì••ë ¥ì„ ê²¬ë””ì§€ ëª»í•˜ê³  ìƒˆëŠ” ë¬¸.\n- **ì˜¤ë¥¸ìª½ ì‹¬ì¥ (Right Heart):** ë¹„êµì  ë‚®ì€ ì••ë ¥ì—ì„œ ë°œìƒí•˜ëŠ” ë¬¸ì œë“¤.","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-180","focus_area":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","tags":["usmle-step2","core","quiz-seed"]}
{"chunk_type":"recap_quiz_seed","text":"# ğŸš€ Rapid Fire Recap: Must-Know High Yield Summary\n## 1. Aortic Regurgitation (AR)\n- **Mechanism:** Volume Overload $\\rightarrow$ Eccentric Hypertrophy.\n- **Signs:** Water-hammer pulse, Widened Pulse Pressure.\n- **Differentiation (Location):**\n    - **Right** Sternal Border murmur $\\rightarrow$ **Aortic Root** issue (Marfan).\n    - **Left** Sternal Border murmur $\\rightarrow$ **Valve Leaflet** issue (Endocarditis).\n## 2. Mitral Regurgitation (MR)\n- **The Trap (Acute MR):** **Normal/High LVEF** is a sign of severe hemodynamic collapse (Shock/Pulmonary Edema). Don't be fooled by the number.\n- **Surgery Timing (Chronic MR):** Operate when **LVEF < 60%** (even if asymptomatic). EF < 60% means LV dysfunction represents significant damage.\n- **Pathology:** MVP causes Mid-systolic click.\n## 3. Right Sided Murmurs\n- **Key Action:** Ask patient to breathe in (**Inspiration**).\n- **Rule:** Inspiration increases venous return $\\rightarrow$ **Right-sided murmurs get LOUDER**. (Left-sided murmurs do not).\n## 4. Tricuspid Atresia\n- **Clinical Picture:** Cyanotic Newborn.\n- **Key ECG Finding:** **Left Axis Deviation (LAD)**. (Since normal newborns have RAD, LAD implies a hypoplastic RV due to atresia).","subject":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","page_title":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","episode":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","section_path":["LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f"],"source_doc_id":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","source_page":null,"source_anchor":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f-227","focus_area":"LM_cardio 2 5~ 2f346f2986ee8091a918d9958d59899f","tags":["usmle-step2","core","quiz-seed","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"# ğŸ”¥ Rapid Fire Recap: Must-Know High Yield Summary\n1. **Diagnosis:** í˜¸í¡ê³¤ë€(Dyspnea)ì€ í”í•˜ì§€ë§Œ, **S3 Gallop**ê³¼ **ê¸°ì¢Œí˜¸í¡(Orthopnea)**ì´ ë“¤ë¦¬ë©´ **Heart Failure**ë¥¼ ê°•ë ¥íˆ ì‹œì‚¬í•œë‹¤! (íŠ¹ì´ë„ High)\n2. **Prognosis:** **Hyponatremia** (ì €ë‚˜íŠ¸ë¥¨í˜ˆì¦) = í¬ì„ì„± = ì‹¬ê°í•œ ì¤‘ì¦ë„ & ë‚˜ìœ ì˜ˆí›„.\n3. **Acute Rx:** ê¸‰ì„± íë¶€ì¢…ì—” **LMNOP** (Lasix, Morphine, Nitrates, Oxygen, Position).\n4. **Chronic Rx (HFrEF):** ìƒì¡´ìœ¨(Mortality)ì„ ë†’ì´ëŠ” ì•½ë¬¼ 3ëŒ€ì¥ = **ARNI/ACEi + BB + MRA (+ SGLT2i)**. (Digoxinì€ ì¦ìƒ ì¡°ì ˆìš©ì¼ ë¿!)\n5. **Device:** **Wide QRS/LBBB** (>150ms) í™˜ìëŠ” íŒí”„ íš¨ìœ¨ì„ ë†’ì´ê¸° ìœ„í•´ **CRT**ë¥¼ ê³ ë ¤í•œë‹¤.\n6. **HFpEF:** **ê³ í˜ˆì••** ë³‘ë ¥ í™•ì¸! ì¹˜ë£Œì— **SGLT2i**ê°€ ì¤‘ìš”í•´ì§€ê³  ìˆë‹¤.\n7. **Cor Pulmonale:** **COPD** í™˜ì + **ìš°ì‹¬ë¶€ì „** ì†Œê²¬ (JVD, Edema) + ì¢Œì‹¬ì‹¤ ì •ìƒ.\n8. **High-Output:** ì‹¬ì¥ì€ ì˜ ë›°ëŠ”ë°(EF ì •ìƒ/ì¦ê°€) ì‹¬ë¶€ì „ ì¦ìƒ? **ë¹ˆí˜ˆ, ê°‘ìƒì„ í•­ì§„, AV Fistula, í‹°ì•„ë¯¼ ê²°í•** ì˜ì‹¬!\n\"ì USMLE Step 2 ì‹œí—˜ ì¤€ë¹„í•˜ì‹œëŠ” ë¶„ë“¤, ì˜¤ëŠ˜ ë°”ë¡œ ì—¬ëŸ¬ë¶„ì„ ìœ„í•œ ì‹œê°„ì…ë‹ˆë‹¤. ë³´ë‚´ì£¼ì‹  ìë£Œë“¤ì„ ì­‰ ë³´ë‹ˆê¹Œìš”, í•˜ë‚˜ì˜ í° ê·¸ë¦¼ì´ ê·¸ë ¤ì§€ë”ë¼ê³ ìš”. ì´ê²Œ ë‹¨ìˆœíˆ ë‹¤ë¦¬ê°€ ì•„í”„ë‹¤, ë¶“ëŠ”ë‹¤, ì´ëŸ° ë§ì´ˆ ì¦ìƒì´ìš”. ì‚¬ì‹¤ì€ ìš°ë¦¬ ëª¸ì˜ ì¤‘ì‹¬, ê·¸ëŸ¬ë‹ˆê¹Œ ì‹¬ì¥ì´ë‚˜ ì „ì‹  í˜ˆê´€ ìƒíƒœë¥¼ ì•Œë ¤ì£¼ëŠ” ì•„ì£¼ ì¤‘ìš”í•œ ì‹ í˜¸ì¼ ìˆ˜ ìˆë‹¤ëŠ” ì  ë§ì´ì£ .\"\n# ğŸ«€ ë§ì´ˆí˜ˆê´€ì§ˆí™˜(PVD) ì‹¬ì¸µ ë¶„ì„: ë‹¤ë¦¬ëŠ” ì‹¬ì¥ì˜ ê±°ìš¸ì´ë‹¤\n## 1. Introduction: ë§ì´ˆí˜ˆê´€ì§ˆí™˜ì˜ í° ê·¸ë¦¼\nì´ ê°•ì˜ì˜ í•µì‹¬ì€ ë§ì´ˆí˜ˆê´€ì§ˆí™˜(PVD)ì„ ë‹¨ìˆœíˆ ë‹¤ë¦¬ì˜ ë³‘ìœ¼ë¡œë§Œ ë³´ì§€ ì•ŠëŠ” ê²ƒì…ë‹ˆë‹¤. ë‹¤ë¦¬ì˜ í˜ˆê´€ ìƒíƒœëŠ” **ì „ì‹  í˜ˆê´€ ìƒíƒœ(ì‹¬ì¥, ë‡Œí˜ˆê´€)ë¥¼ ëŒ€ë³€í•˜ëŠ” ê±°ìš¸**ì…ë‹ˆë‹¤. ë”°ë¼ì„œ ì§„ë‹¨ëª… ì•”ê¸°ë³´ë‹¤ **ë³‘íƒœìƒë¦¬ì™€ ì„ìƒì  ì‚¬ê³  ê³¼ì •**ì´ ì¤‘ìš”í•©ë‹ˆë‹¤.\n## 2. ë§ì´ˆ ë™ë§¥ ì§ˆí™˜ (PAD: Peripheral Artery Disease)","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-53","focus_area":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","tags":["usmle-step2","core","quiz-seed","diagnosis"]}
{"chunk_type":"recap_quiz_seed","text":"## 5. Rapid Fire Recap: High Yield Summary ğŸ”¥\n### ğŸš‘ Shock Types & Key Actions\n| ì‡¼í¬ ìœ í˜• | í•µì‹¬ ë³‘íƒœìƒë¦¬ (Mechanism) | ê²°ì •ì  ë‹¨ì„œ (Clues) | í•µì‹¬ ì²˜ì¹˜ (Key Action) |\n| --- | --- | --- | --- |\n| **Anaphylactic** | Histamine í­ì£¼ (í˜ˆê´€í™•ì¥+íˆ¬ê³¼ì„±â†‘) | í”¼ë¶€(ë‘ë“œëŸ¬ê¸°)+í˜¸í¡(Stridor)+í˜ˆì••â†“ | **IM Epinephrine** (íš¨ê³¼ ì—†ìœ¼ë©´ IV Fluid â†’ IV Epi) |\n| **Hemorrhagic** | í˜ˆì•¡ëŸ‰ ì†ì‹¤ | ì™¸ìƒ, ì¶œí˜ˆ | **1:1:1 ìˆ˜í˜ˆ**, ì œí•œì  ìˆ˜ì•¡, TXA |\n| **Obstructive** | ë¬¼ë¦¬ì  ë§‰í˜ (PE, ê¸°í‰, Tamponade) | JVD ìƒìŠ¹, **PCWP ì •ìƒ/ë‚®ìŒ** | ì›ì¸ ì œê±° (ë°”ëŠ˜ ê°ì••, ì‹¬ë‚­ ì²œì ë“±) |\n| **Cardiogenic** | íŒí”„ ê³ ì¥ (MI ë“±) | JVD ìƒìŠ¹, **PCWP ë†’ìŒ**, Wet Lung | Inotropes (ì‹¬ê·¼ìˆ˜ì¶•ì œ), ì¬ê´€ë¥˜ |\n### â˜ ï¸ Trauma \"Triad of Death\" (ì£½ìŒì˜ ì‚¼ê°ì¶•)\n1. **Coagulopathy** (ì‘ê³  ì¥ì• )\n2. **Hypothermia** (ì €ì²´ì˜¨ì¦)\n3. **Acidosis** (ì‚°ì¦)\n- *Solution:* ê³¼ë„í•œ ìˆ˜ì•¡(Crystalloid) ê¸ˆì§€ ğŸš«, ì¡°ê¸° ìˆ˜í˜ˆ âœ….\n### âš ï¸ Exam Trap & Tips\n- **Anaphylaxis:** Epi IM ì‹¤íŒ¨ ì‹œ â†’ **IV Fluids** ë¨¼ì € ê³ ë ¤ (ë°”ë¡œ IV Epi ì•„ë‹˜).\n- **Trauma:** ìˆ˜ìˆ  ì „ê¹Œì§€ í˜ˆì••ì„ ì •ìƒìœ¼ë¡œ ì˜¬ë¦¬ì§€ ë§ˆë¼ (**Permissive Hypotension**). *ë‹¨, ë‡Œ ì†ìƒ(TBI) í™˜ìëŠ” ì œì™¸.*\n- **Shock Unknown:** í˜ˆì•• ë‚®ê³  JVDê°€ ë³´ì´ëŠ”ë° í ì†Œë¦¬ê°€ ê¹¨ë—í•˜ë‹¤? â†’ **Obstructive Shock** (íŠ¹íˆ PEë‚˜ ìš°ì‹¬ì‹¤ ê²½ìƒ‰) ì˜ì‹¬.\n**ë§ˆì§€ë§‰ ìƒê°ê±°ë¦¬ (The Dilemma):** ğŸ§ \nì‘ê¸‰ì‹¤ì—ì„œ ë‹¤ë°œì„± ì™¸ìƒ í™˜ìê°€ ì™”ëŠ”ë°, ì¶œí˜ˆë„ ìˆê³  ë‡Œì¶œí˜ˆë„ ì˜ì‹¬ëœë‹¤ë©´?\n- ì¶œí˜ˆ ì¡ìœ¼ë ¤ë©´ í˜ˆì••ì„ ë‚®ì¶°ì•¼ í•˜ê³  (Permissive Hypotension),\n- ë‡Œë¥¼ ì‚´ë¦¬ë ¤ë©´ í˜ˆì••ì„ ë†’ì—¬ì•¼ í•˜ëŠ” (CPP ìœ ì§€) ëª¨ìˆœì ì¸ ìƒí™©.\n- ì´ ë”œë ˆë§ˆ ì†ì—ì„œ ìš°ì„ ìˆœìœ„ë¥¼ ì •í•˜ëŠ” ê²ƒì´ ë°”ë¡œ ì˜ì‚¬ì˜ íŒë‹¨ë ¥ì…ë‹ˆë‹¤.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-139","focus_area":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","tags":["usmle-step2","core","quiz-seed","treatment","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"- **ì‹¬ì „ë„ (ECG): ì „ê¸°ì  êµëŒ€ë§¥ (Electrical Alternans)**\n    - QRS íŒŒí˜•ì˜ ë†’ì´ê°€ ì»¸ë‹¤ ì‘ì•˜ë‹¤ ë°˜ë³µë¨.\n    - **ì›ë¦¬:** ì•¡ì²´ë¡œ ê°€ë“ ì°¬ ì‹¬ì¥ë§‰ ì•ˆì—ì„œ ì‹¬ì¥ì´ ë‘¥ë‘¥ ë– ì„œ **ê·¸ë„¤ íƒ€ë“¯ì´ ì•ë’¤ë¡œ í”ë“¤ë¦¼**. ì „ê·¹ì— ê°€ê¹Œì›Œì§€ë©´ íŒŒí˜•ì´ ì»¤ì§€ê³ , ë©€ì–´ì§€ë©´ ì‘ì•„ì§.\n- **X-ray:**\n    - **Water bottle heart:** ë¬¼ì£¼ë¨¸ë‹ˆì²˜ëŸ¼ ì‹¬ì¥ ìŒì˜ì´ ì»¤ì§€ê³  ì•„ë˜ê°€ í‘í¼ì§í•´ì§. ë‹¨ê¸°ê°„ì— ì‹¬ì¥ì´ ì»¤ì¡Œë‹¤ë©´ ê°•ë ¥íˆ ì˜ì‹¬.\n    **Host 1:** \"USMLE Step 2 ì¤€ë¹„ì— í•œì°½ì´ì‹¤ ì—¬ëŸ¬ë¶„ì„ ìœ„í•´ ì˜¤ëŠ˜ ì•„ì£¼ í¥ë¯¸ë¡œìš´ ìë£Œë“¤ì„ ë¶„ì„í•´ ë³´ë ¤ê³  í•©ë‹ˆë‹¤.\"\n    **Host 2:** \"ë„¤.\"\n    **Host 1:** \"ë³´ë‚´ì£¼ì‹  ìë£Œë“¤ì„ ë³´ë‹ˆê¹Œìš”, ì‹¬í˜ˆê´€ê³„ íŒŒíŠ¸ì—ì„œ ê¸°íƒ€ë¡œ ë¶„ë¥˜ëœ... ì–´ ë­ë„ê¹Œ ì„œë¡œ ì¢€ ìƒê´€ì—†ì–´ ë³´ì´ëŠ” ê°œë…ë“¤ ëª¨ìŒì´ë”ë¼ê³ ìš”.\"\n    **Host 2:** \"ë§ìŠµë‹ˆë‹¤.\"\n    **Host 1:** \"ì‹¤ì‹ , ë­ ê¸°ì´í•œ ì´ë¦„ì˜ ë§¥ë°•, í¬ê·€ ìœ ì „ë³‘, ì¸ê³µ íŒë§‰ ë¬¸ì œê¹Œì§€...\"\n    **Host 2:** \"ë„¤ë„¤.\"\n    **Host 1:** \"ê·¸ë˜ì„œ ì˜¤ëŠ˜ì˜ ë¯¸ì…˜ì€ ì´ í©ì–´ì ¸ ìˆëŠ” ì§€ì‹ ì¡°ê°ë“¤ ì†ì— ìˆ¨ê²¨ì§„ ê·¸ ì—°ê²°ê³ ë¦¬ë¥¼ ì°¾ì•„ì„œ í•˜ë‚˜ì˜ í†µí•©ëœ ê·¸ë¦¼ìœ¼ë¡œ ë¨¸ë¦¿ì†ì— ê°ì¸ì‹œì¼œ ë“œë¦¬ëŠ” ê²ë‹ˆë‹¤.\"\n    # ğŸ«€ USMLE Cardiology: \"Miscellaneous\" Concepts Integration\n    ## 1. Introduction: ì˜¤ëŠ˜ì˜ ë¯¸ì…˜ ğŸ¯\n    - **ëª©í‘œ:** ì‹¬í˜ˆê´€ê³„ì—ì„œ 'ê¸°íƒ€(Miscellaneous)'ë¡œ ë¶„ë¥˜ë˜ì–´ ì„œë¡œ ìƒê´€ì—†ì–´ ë³´ì´ëŠ” ê°œë…ë“¤(ì‹¤ì‹ , í¬ê·€ ìœ ì „ë³‘, ì¸ê³µ êµ¬ì¡°ë¬¼ ë“±)ì˜ ìˆ¨ê²¨ì§„ **ì—°ê²°ê³ ë¦¬**ë¥¼ ì°¾ì•„ í†µí•©ëœ ê·¸ë¦¼ìœ¼ë¡œ ì´í•´í•˜ê¸°.\n    - **ì ‘ê·¼ë²•:** í©ì–´ì ¸ ìˆëŠ” ì§€ì‹ ì¡°ê°ë“¤ì„ í•˜ë‚˜ì˜ ìŠ¤í† ë¦¬ë¡œ ì—°ê²°í•˜ì—¬ ì‹œí—˜ì—ì„œì˜ ë³€ë³„ë ¥ì„ ê°€ë¥´ëŠ” 'í•œ ë—'ì„ ì™„ì„±í•¨.\n    - **í•µì‹¬ ì£¼ì œ:** ë°˜ë³µë˜ëŠ” ì½”í”¼ì™€ ë‡Œë†ì–‘ì˜ ê´€ê³„, ìŠ¤íŠ¸ë ˆìŠ¤ì„± ì‹¤ì‹ ê³¼ ìƒë¦¬ì  ê¸°ì „ ë“± ì„ìƒì  ì‹œë‚˜ë¦¬ì˜¤ë¥¼ í†µí•œ ì—°ê²°.\n    ## 2. ì‹¤ì‹  (Syncope): ë¯¸ì£¼ì‹ ê²½ì„± vs. êµ¬ì¡°ì  ë¬¸ì œ ğŸ§ ğŸ’”\n    ### A. í˜ˆê´€ë¯¸ì£¼ì‹ ê²½ì„± ì‹¤ì‹  (Vasovagal Syncope)\n    - **ì •ì˜:** ìŠ¤íŠ¸ë ˆìŠ¤ë¥¼ ë°›ê±°ë‚˜ ì˜¤ë˜ ì„œ ìˆì„ ë•Œ ë°œìƒí•˜ëŠ” ì‹¤ì‹ . ë‹¨ìˆœ ì‹¬ë¦¬ì  ë¬¸ì œê°€ ì•„ë‹Œ **ëšœë ·í•œ ìƒë¦¬í•™ì  ê¸°ì „**ì´ ìˆìŒ.\n    - **ê¸°ì „ (Mechanism):** â˜… **'ë¯¸ì£¼ì‹ ê²½ì˜ ì—­ì„¤ì  ê³¼í™œì„±í™” (Paradoxical Overactivation)'**\n    1. ê·¹ì‹¬í•œ ìŠ¤íŠ¸ë ˆìŠ¤/í†µì¦/ì˜¤ë˜ ì„œ ìˆìŒ (íŠ¹ì • ìê·¹).\n    2. êµê°ì‹ ê²½ì´ í¥ë¶„í–ˆë‹¤ê°€, ê°‘ìê¸° **ë¯¸ì£¼ì‹ ê²½(ë¶€êµê°)ì´ ê³¼ë„í•˜ê²Œ ë°œë™(í™•!)**.\n    3. ì‹¬ë°•ìˆ˜ ì €í•˜(Bradycardia) + í˜ˆê´€ í™•ì¥(Vasodilation).\n    4. í˜ˆì••ê³¼ ì„œë§¥ì˜ ì´ì¤‘ íƒ€ê²© ë‡Œë¡œ ê°€ëŠ” í˜ˆë¥˜ ì…§ë‹¤ìš´ (ë‡Œì˜ ìê¸° ë³´í˜¸ ê¸°ì „).\n    - **ì¹˜ë£Œ/ëŒ€ì²˜ë²•:** â˜… **ë¬¼ë¦¬ì  ì €í•­ ìš´ë™ (Physical Counterpressure Maneuvers)**\n    - **ë°©ë²•:** ë‹¤ë¦¬ë¥¼ ê¼¬ê³  í—ˆë²…ì§€/ì—‰ë©ì´ì— í˜ ë¹¡ ì£¼ê¸°, ì–‘ì† ê¹ì§€ ë¼ê³  ë‹¹ê¸°ê¸°.\n    - **ì›ë¦¬:** ê·¼ìœ¡ ìˆ˜ì¶• ë‹¤ë¦¬ ì •ë§¥ì— ê³ ì¸ í”¼ë¥¼ ì‹¬ì¥ìœ¼ë¡œ ì§œì¤Œ(Pump ì—­í• ) ì‹¬ë°•ì¶œëŸ‰ ì¦ê°€ ë‡Œí˜ˆë¥˜ ìœ ì§€.\n    - **Key Point:** ì•½ë¬¼ì´ë‚˜ ë§‰ì—°í•œ ì¡°ì–¸ì´ ì•„ë‹Œ, í™˜ìê°€ **ì „ì¡°ì¦ìƒ(Prodrome)**ì„ ëŠë‚„ ë•Œ ìŠ¤ìŠ¤ë¡œ í•  ìˆ˜ ìˆëŠ” ì¦‰ê°ì ì¸ ë¬¼ë¦¬ì  ì²˜ì¹˜ì„.\n    ### B. ìš´ë™ ì¤‘ ì‹¤ì‹ : AAOCA (Anomalous Aortic Origin of a Coronary Artery)\n    - **ì‹œë‚˜ë¦¬ì˜¤:** **ê±´ê°•í•œ ì Šì€ ìš´ë™ì„ ìˆ˜**ê°€ ê²½ê¸° ì¤‘ ì „ë ¥ ì§ˆì£¼í•˜ë‹¤ê°€ ê°‘ìê¸° í”½ ì“°ëŸ¬ì§€ê±°ë‚˜ ì‚¬ë§(Sudden Cardiac Death).\n    - **ì›ì¸:** ê´€ìƒë™ë§¥ì˜ ê¸°ì‹œë¶€ ì´ìƒ. ê´€ìƒë™ë§¥ì´ ëŒ€ë™ë§¥(Aorta)ê³¼ íë™ë§¥(Pulmonary Artery) ì‚¬ì´ì— ë¼ì–´ ìˆìŒ.\n    - **ë¹„ìœ  (Analogy):** ğŸˆ **ë‘ ê°œì˜ ì»¤ë‹¤ë€ í’ì„ (ëŒ€ë™ë§¥, íë™ë§¥) ì‚¬ì´ì— ë‚€ ì •ì› í˜¸ìŠ¤(ê´€ìƒë™ë§¥).**\n    - **ê¸°ì „:**\n    1. í‰ì†Œì—ëŠ” ê´œì°®ìŒ.\n    2. ìš´ë™ ì‹¬ë°•ì¶œëŸ‰ ì¦ê°€ ëŒ€ë™ë§¥ê³¼ íë™ë§¥ì´ í’ì„ ì²˜ëŸ¼ ë¶€í’€ì–´ ì˜¤ë¦„.\n    3. ê·¸ ì‚¬ì´ì— ë‚€ ê´€ìƒë™ë§¥ í˜¸ìŠ¤ê°€ ê½‰ ëˆŒë¦¼.\n    4. ì‹¬ì¥ì— í”¼ ê³µê¸‰ ì¤‘ë‹¨ ì‹¬ê·¼ í—ˆí˜ˆ ì¹˜ëª…ì  ë¶€ì •ë§¥/ê¸‰ì‚¬.\n    - **ì£¼ì˜ì :** ì Šì€ í™˜ìì˜ **ìš´ë™ ì¤‘(Exertional)** ì‹¤ì‹ ì€ ì ˆëŒ€ ê°€ë³ê²Œ ë„˜ê¸°ë©´ ì•ˆ ë˜ëŠ” **Red Flag** ğŸš©.\n    ## 3. ì••ë ¥ê³¼ ì†Œë¦¬ì˜ ì—­ì„¤: Cardiac Tamponade & Pulsus Paradoxus ğŸ“‰\n    ### A. ê¸°ì´ë§¥ (Pulsus Paradoxus)\n    - **ì •ì˜:** ìˆ¨ì„ ê¹Šê²Œ ë“¤ì´ë§ˆì‹¤ ë•Œ ìˆ˜ì¶•ê¸° í˜ˆì••ì´ **10mmHg ì´ìƒ** ë–¨ì–´ì§€ëŠ” í˜„ìƒ.\n    - **ì´ë¦„ì˜ ìœ ë˜:** ë§¥ë°•ì€ ë§Œì ¸ì§€ëŠ”ë° ì²­ì§„ê¸°ë¡œ ì‹¬ìŒì´ ì˜ ì•ˆ ë“¤ë¦¬ê±°ë‚˜ í˜ˆì••ì´ ëš ë–¨ì–´ì§€ëŠ” 'ì—­ì„¤ì ' ìƒí™©.\n    - **ê¸°ì „:**\n    1. í¡ê¸° ì‹œ í‰ê°• ë‚´ ì••ë ¥ ê°ì†Œ ìš°ì‹¬ì‹¤(RV)ë¡œ í”¼ê°€ ë§ì´ ë“¤ì–´ì˜´.\n    2. ì‹¬ë‚­ì— ë¬¼ì´ ì°¨ ìˆì–´ ì‹¬ì¥ì´ ë°–ìœ¼ë¡œ ëª» ëŠ˜ì–´ë‚¨.\n    3. ìš°ì‹¬ì‹¤ì´ ì»¤ì§€ëŠ” ëŒ€ì‹  **ì‹¬ì‹¤ ì¤‘ê²©(Septum)ì´ ì¢Œì‹¬ì‹¤(LV) ìª½ìœ¼ë¡œ ë°€ë ¤ë“¤ì–´ì˜´ (Interventricular Dependence).**\n    4. ì¢Œì‹¬ì‹¤ ê³µê°„ ë¶€ì¡± ì‹¬ë°•ì¶œëŸ‰ ê°ì†Œ í˜ˆì•• ì €í•˜.\n    ### B. ì‹¬ì¥ ëˆŒë¦¼ì¦ (Cardiac Tamponade)\n    - **ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤:** ëŒ€ë™ë§¥ ë°•ë¦¬ í™˜ì ë“±ì´ ê°‘ìê¸° í˜ˆì•• ì €í•˜, ê²½ì •ë§¥ í™•ì¥ ë“±ì„ ë³´ì„.\n    - **â˜… Beck's Triad (ë²¡ì˜ 3ì§•í›„):**\n    1. **ì €í˜ˆì•• (Hypotension):** íŒí”„ ê¸°ëŠ¥ ì‹¤íŒ¨.\n    2. **ê²½ì •ë§¥ í™•ì¥ (JVD):** ì‹¬ì¥ìœ¼ë¡œ í”¼ê°€ ëª» ë“¤ì–´ê°€ì„œ ìƒê¸°ëŠ” Traffic Jam (ì••ë ¥ê³„ ì—­í• ).\n    3. **ì‹¬ìŒ ê°ì†Œ (Muffled Heart Sounds):** ì‹¬ì¥ ì£¼ë³€ì˜ ë¬¼(í”¼) ë•Œë¬¸ì— ì†Œë¦¬ê°€ ë¨¹ë¨¹í•´ì§.\n    - **ì§„ë‹¨:** Beck's Triad + ê¸°ì´ë§¥(Pulsus Paradoxus).\n    - **ë¹„ìœ :** ì‹¬ë‚­ì´ë¼ëŠ” ì£¼ë¨¸ë‹ˆ ì•ˆì— í”¼ê°€ ì°¨ì„œ ì‹¬ì¥ì„ ê½‰ ì¡°ì´ëŠ” ìƒíƒœ.\n    ## 4. ì¸ê³µ êµ¬ì¡°ë¬¼ì˜ ìœ„í—˜: ìŠ¤í…íŠ¸ì™€ íŒë§‰ ğŸ”©\n    ### A. ìŠ¤í…íŠ¸ í˜ˆì „ì¦ (Stent Thrombosis)\n    - **ì›ì¸:** ìŠ¤í…íŠ¸ ì‚½ì… í›„ **ì´ì¤‘ í•­í˜ˆì†ŒíŒì œ(DAPT)**ë¥¼ ì¡°ê¸°ì— ì¤‘ë‹¨í–ˆì„ ë•Œ ë°œìƒ.\n    - **ê¸°ì „:** ìŠ¤í…íŠ¸ëŠ” ì´ë¬¼ì§ˆì´ë¯€ë¡œ í”¼ê°€ ì—‰ê²¨ ë¶™ìœ¼ë ¤ í•¨(í”¼ë–¡/í˜ˆì „). ì•½ì„ ëŠìœ¼ë©´ ë°”ë¡œ í˜ˆì „ì´ ìƒê²¨ í˜ˆê´€ì„ ë§‰ìŒ.\n    - **ê²°ê³¼:** ê¸‰ì„± ì‹¬ê·¼ê²½ìƒ‰(STEMI).\n    - **Key Question:** \"ì•½ì„ ì–¼ë§ˆë‚˜ ì˜¤ë˜ ë¨¹ì—ˆëŠ”ê°€?\" (12ê°œì›” ìœ ì§€ ì¤‘ìš”).\n    ### B. ì¸ê³µ íŒë§‰ í˜ˆì „ì¦ & ê¸°ê³„ íŒë§‰\n    - **í•„ìˆ˜ ì•½ë¬¼:** ì™€íŒŒë¦°(Warfarin/Coumadin) í‰ìƒ ë³µìš©.\n    - **ìœ„í—˜ì„± ê· í˜•:**\n    - í•­ì‘ê³ ì œ ë„ˆë¬´ ì•½í•¨ íŒë§‰ì— í˜ˆì „ ë‚Œ íŒë§‰ ì•ˆ ì›€ì§ì„(í˜‘ì°©/íì‡„) or ë‡Œì¡¸ì¤‘.\n    - í•­ì‘ê³ ì œ ë„ˆë¬´ ê°•í•¨ ë‡Œì¶œí˜ˆ ë“± ì¶œí˜ˆ ìœ„í—˜.\n    ## 5. ìœ ì „ë³‘ê³¼ ì§€ë¦„ê¸¸ì˜ ë¬¸ì œ: HHT (Osler-Weber-Rendu) ğŸ©¸\n    ### A. ìœ ì „ì„± ì¶œí˜ˆì„± ëª¨ì„¸í˜ˆê´€ í™•ì¥ì¦ (HHT)\n    - **í•µì‹¬ ê°œë…:** **ë™ì •ë§¥ ê¸°í˜• (AVM)**. ëª¨ì„¸í˜ˆê´€ ì—†ì´ ë™ë§¥ê³¼ ì •ë§¥ì´ ë°”ë¡œ ì—°ê²°ë˜ëŠ” 'ì§€ë¦„ê¸¸(Shortcut)'ì´ ìƒê¹€.\n    - **ì¦ìƒ:**\n    - ë°˜ë³µì ì¸ ì½”í”¼ (Epistaxis).\n    - í”¼ë¶€ì˜ ë¶‰ì€ ë°˜ì  (Telangiectasia).\n    - ìœ„ì¥ê´€ ì¶œí˜ˆ (ì² ê²°í•ì„± ë¹ˆí˜ˆ).\n    - **â˜… ì¹˜ëª…ì  í•©ë³‘ì¦: ë‡Œë†ì–‘ (Brain Abscess) & ë‡Œì¡¸ì¤‘**\n    - **ê¸°ì „:** í(Lung)ëŠ” ì›ë˜ í˜ˆì „ì´ë‚˜ ì„¸ê· ì„ ê±¸ëŸ¬ì£¼ëŠ” **í•„í„°(Filter)** ì—­í• ì„ í•¨.\n    - **í ë™ì •ë§¥ ê¸°í˜• (Pulmonary AVM):** íì˜ í•„í„°ë¥¼ ê±°ì¹˜ì§€ ì•ŠëŠ” 'ì§€ë¦„ê¸¸'ì´ ì¡´ì¬.\n    - ë‹¤ë¦¬ ì •ë§¥ì˜ í˜ˆì „ì´ë‚˜ í˜ˆë¥˜ ì† ì„¸ê· ì´ í í•„í„°ë¥¼ ìš°íšŒ **ì¢Œì‹¬ë°© ëŒ€ë™ë§¥ ë‡Œ**ë¡œ ì§í–‰.\n    - **ê²°ê³¼:** ë‡Œê²½ìƒ‰(Stroke) ë˜ëŠ” ë‡Œë†ì–‘(Brain Abscess).\n    - **ì—°ê²°ê³ ë¦¬:** **\"ì½”í”¼ê°€ ì¦ì€ í™˜ìê°€ ë‡Œë†ì–‘/ë‡Œì¡¸ì¤‘ìœ¼ë¡œ ì™”ë‹¤?\"** **HHT (í AVM)** ì˜ì‹¬!\n    ## 6. ë§ˆì§€ë§‰ í€´ì¦ˆ (The Challenge) ğŸ§\n    - **ìƒí™©:** ìš´ë™ ì¤‘ ì‘ê¸‰ì‹¤ì— ì˜¨ 17ì„¸ ë†êµ¬ ì„ ìˆ˜. 2ëª….\n    - **í™˜ì 1 (AAOCA):** ëŒ€ë™ë§¥ê³¼ íë™ë§¥ ì‚¬ì´ì— ë¼ì–´ ê´€ìƒë™ë§¥ì´ ëˆŒë¦¼. (êµ¬ì¡°ì  í˜ˆê´€ ë¬¸ì œ)\n    - **í™˜ì 2 (HOCM, ë¹„í›„ì„± ì‹¬ê·¼ë³‘ì¦):** ìœ ì „ì ìœ¼ë¡œ ì‹¬ì¥ ê·¼ìœ¡ì´ ë‘êº¼ì›Œì ¸ì„œ í”¼ê°€ ë‚˜ê°€ëŠ” ê¸¸(ìœ ì¶œë¡œ)ì´ ë§‰í˜.\n    - **ì§ˆë¬¸:** ì´ ë‘ í™˜ìë¥¼ êµ¬ë³„í•˜ê¸° ìœ„í•œ ê²°ì •ì ì¸ **ë³‘ë ¥ ì²­ì·¨ ì§ˆë¬¸**ê³¼ **ì‹ ì²´ ì§„ì°° ë‹¨ì„œ**ëŠ” ë¬´ì—‡ì¼ê¹Œ? (ì‹¬ì¥ ì¡ìŒì˜ ì°¨ì´ ë“± ìƒê°í•´ë³´ì„¸ìš”!)\n    # ğŸ”¥ Rapid Fire Recap: High Yield Summary\n    ì˜¤ë””ì˜¤ ê°•ì˜ ë‚´ìš©ì„ ë°”íƒ•ìœ¼ë¡œ í•œ ì´ˆì••ì¶• ìš”ì•½ì…ë‹ˆë‹¤.\n    1. **ì „ì¡°ì¦ìƒ(Prodrome) ìˆëŠ” ì‹¤ì‹ ** **ë¯¸ì£¼ì‹ ê²½ì„± ì‹¤ì‹  (Vasovagal)** **ë¬¼ë¦¬ì  ì €í•­ ìš´ë™ (Counterpressure maneuver)** êµìœ¡.\n    2. **ì Šì€ ì„ ìˆ˜ + ìš´ë™ ì¤‘ ì‹¤ì‹ /ê¸‰ì‚¬** **AAOCA** ëŒ€ë™ë§¥/íë™ë§¥ ì‚¬ì´ ê´€ìƒë™ë§¥ ëˆŒë¦¼ (êµ¬ì¡°ì ).\n    3. **ì €í˜ˆì•• + JVD + ì‹¬ìŒ ê°ì†Œ (Beck's Triad)** **ì‹¬ì¥ ëˆŒë¦¼ì¦ (Tamponade)** **ê¸°ì´ë§¥ (Pulsus Paradoxus > 10mmHg)** í™•ì¸.\n    4. **ìŠ¤í…íŠ¸ ì‹œìˆ  í™˜ì + DAPT ì¡°ê¸° ì¤‘ë‹¨** ê°€ìŠ´ í†µì¦ **ìŠ¤í…íŠ¸ í˜ˆì „ì¦ (STEMI)**.\n    5. **ë°˜ë³µë˜ëŠ” ì½”í”¼ + ë‡Œë†ì–‘(Brain Abscess)** **HHT (Osler-Weber-Rendu)** í ë™ì •ë§¥ ê¸°í˜•(AVM)ì´ í•„í„° ì—­í•  ëª»í•¨.\n### 4-4. ì¹˜ë£Œ (Emergency!)\n- **ì‹¬ì¥ë§‰ ì²œììˆ  (Pericardiocentesis):**\n    - ì§€ì²´í•  ì‹œê°„ ì—†ìŒ. ì¦‰ì‹œ ë°”ëŠ˜ì„ ê½‚ì•„ ì•¡ì²´ë¥¼ ë¹¼ë‚´ ì••ë ¥ì„ ë‚®ì¶°ì•¼ í•¨.\n    - ì†ŒëŸ‰ë§Œ ë¹¼ë‚´ë„ í˜ˆì••ì´ ê·¹ì ìœ¼ë¡œ ì˜¤ë¦„ (ìƒëª…ì„ êµ¬í•˜ëŠ” ì‹œìˆ ).\n## 5. ì¶”ê°€ì ì¸ ì„ìƒì  ì¶”ë¡  (Clinical Context)\në¬¼ë¦¬ì  ë‹¨ì„œ(ì²­ì§„, ì••ë ¥, íŒŒí˜•) í•´ì„ ì „ì— **í™˜ìì˜ ì´ì•¼ê¸°(History)**ê°€ ì¤‘ìš”í•©ë‹ˆë‹¤.\n- **ê²°í•µ(TB) ìœ ë³‘ë¥ ì´ ë†’ì€ ì§€ì—­/ê³¼ê±°ë ¥:** í˜‘ì°©ì„± ì‹¬ì¥ë§‰ì—¼ ì˜ì‹¬.\n- **ìµœê·¼ ë‚¨ë¯¸ ì—¬í–‰ (ìƒ¤ê°€ìŠ¤ë³‘):** ì‹¬ê·¼ì—¼ ì˜ì‹¬.\n# ğŸš€ Rapid Fire Recap: Must-Know High Yield Summary\nì‹œí—˜ì¥ì—ì„œ ì •ë‹µìœ¼ë¡œ ì´ëŒì–´ì¤„ **í•µì‹¬ í‚¤ì›Œë“œ ë§¤ì¹­**ì…ë‹ˆë‹¤.","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-180","focus_area":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","tags":["usmle-step2","core","quiz-seed","pathophysiology","mnemonic"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap: Must-Know High Yield Summary\nì‹œí—˜ ì§ì „ ì´ê²ƒë§Œì€ ê¼­ ê¸°ì–µí•˜ì„¸ìš”!\n1. **CKD + ê³ í˜ˆì••** â†’ **ACEi / ARB** (ìˆ˜ì¶œì„¸ë™ë§¥ ì´ì™„, ì‹ ì¥ ë³´í˜¸)\n2. **í†µí’ + ê³ í˜ˆì••** â†’ **Thiazide ê¸ˆê¸°** (ìš”ì‚° ì¦ê°€)\n3. **ê³¨ë‹¤ê³µì¦ + ê³ í˜ˆì••** â†’ **Thiazide ì¶”ì²œ** (ì¹¼ìŠ˜ ì¬í¡ìˆ˜, ë¼ˆ ë³´í˜¸)\n4. **ê¸‰ì„± ì‹¬ê·¼ê²½ìƒ‰(ACS)** â†’ **Beta-blocker** (ì‹¬ì¥ íœ´ì‹, Hero)\n- â˜… **ì˜ˆì™¸:** ì„œë§¥, ì €í˜ˆì••, ì‹¬ì¸ì„± ì‡¼í¬ ë•ŒëŠ” **ê¸ˆê¸°** (Villain).\n1. **ìš°ì‹¬ì‹¤ ê²½ìƒ‰ (RV MI)** â†’ **Nitrates ì£¼ì˜/ê¸ˆê¸°** (ì „ë¶€í•˜ ê°ì†Œë¡œ ì‡¼í¬ ìœ ë°œ)\n2. **ê¸‰ì„± ì‹¬ë¶€ì „ (ìˆ¨ ì°¨ê³  ë¶€ìŒ)** â†’ **Beta-blocker ì¤‘ë‹¨/ê¸ˆê¸°** (ì¦ìƒ ì•…í™”)\n3. **ë§Œì„± ì‹¬ë¶€ì „ (HFrEF)** â†’ **Beta-blocker + ACEi/ARNI + MRA + SGLT2i** (ìƒì¡´ìœ¨ ì¦ê°€, ì‚¬ë§ë¥  ê°ì†Œ)\n- â˜… **Non-DHP CCB (Verapamil/Diltiazem)** â†’ **ì‹¬ë¶€ì „ì—ì„œ ì ˆëŒ€ ê¸ˆê¸°** (ì‹¬ì¥ ìˆ˜ì¶•ë ¥ ì €í•˜)\n**Host 1:** \"USMLE Step 2 ì¤€ë¹„ì— í•œì°½ì´ì‹¤ ì—¬ëŸ¬ë¶„ì„ ìœ„í•´ ì˜¤ëŠ˜ ì•„ì£¼ í¥ë¯¸ë¡œìš´ ìë£Œë“¤ì„ ë¶„ì„í•´ ë³´ë ¤ê³  í•©ë‹ˆë‹¤.\"\n**Host 2:** \"ë„¤.\"\n**Host 1:** \"ë³´ë‚´ì£¼ì‹  ìë£Œë“¤ì„ ë³´ë‹ˆê¹Œìš”, ì‹¬í˜ˆê´€ê³„ íŒŒíŠ¸ì—ì„œ ê¸°íƒ€ë¡œ ë¶„ë¥˜ëœ... ì–´ ë­ë„ê¹Œ ì„œë¡œ ì¢€ ìƒê´€ì—†ì–´ ë³´ì´ëŠ” ê°œë…ë“¤ ëª¨ìŒì´ë”ë¼ê³ ìš”.\"\n**Host 2:** \"ë§ìŠµë‹ˆë‹¤.\"\n**Host 1:** \"ì‹¤ì‹ , ë­ ê¸°ì´í•œ ì´ë¦„ì˜ ë§¥ë°•, í¬ê·€ ìœ ì „ë³‘, ì¸ê³µ íŒë§‰ ë¬¸ì œê¹Œì§€...\"\n**Host 2:** \"ë„¤ë„¤.\"\n**Host 1:** \"ê·¸ë˜ì„œ ì˜¤ëŠ˜ì˜ ë¯¸ì…˜ì€ ì´ í©ì–´ì ¸ ìˆëŠ” ì§€ì‹ ì¡°ê°ë“¤ ì†ì— ìˆ¨ê²¨ì§„ ê·¸ ì—°ê²°ê³ ë¦¬ë¥¼ ì°¾ì•„ì„œ í•˜ë‚˜ì˜ í†µí•©ëœ ê·¸ë¦¼ìœ¼ë¡œ ë¨¸ë¦¿ì†ì— ê°ì¸ì‹œì¼œ ë“œë¦¬ëŠ” ê²ë‹ˆë‹¤.\"\n# ğŸ«€ USMLE Cardiology: \"Miscellaneous\" Concepts Integration\n## 1. Introduction: ì˜¤ëŠ˜ì˜ ë¯¸ì…˜ ğŸ¯\n- **ëª©í‘œ:** ì‹¬í˜ˆê´€ê³„ì—ì„œ 'ê¸°íƒ€(Miscellaneous)'ë¡œ ë¶„ë¥˜ë˜ì–´ ì„œë¡œ ìƒê´€ì—†ì–´ ë³´ì´ëŠ” ê°œë…ë“¤(ì‹¤ì‹ , í¬ê·€ ìœ ì „ë³‘, ì¸ê³µ êµ¬ì¡°ë¬¼ ë“±)ì˜ ìˆ¨ê²¨ì§„ **ì—°ê²°ê³ ë¦¬**ë¥¼ ì°¾ì•„ í†µí•©ëœ ê·¸ë¦¼ìœ¼ë¡œ ì´í•´í•˜ê¸°.\n- **ì ‘ê·¼ë²•:** í©ì–´ì ¸ ìˆëŠ” ì§€ì‹ ì¡°ê°ë“¤ì„ í•˜ë‚˜ì˜ ìŠ¤í† ë¦¬ë¡œ ì—°ê²°í•˜ì—¬ ì‹œí—˜ì—ì„œì˜ ë³€ë³„ë ¥ì„ ê°€ë¥´ëŠ” 'í•œ ë—'ì„ ì™„ì„±í•¨.\n- **í•µì‹¬ ì£¼ì œ:** ë°˜ë³µë˜ëŠ” ì½”í”¼ì™€ ë‡Œë†ì–‘ì˜ ê´€ê³„, ìŠ¤íŠ¸ë ˆìŠ¤ì„± ì‹¤ì‹ ê³¼ ìƒë¦¬ì  ê¸°ì „ ë“± ì„ìƒì  ì‹œë‚˜ë¦¬ì˜¤ë¥¼ í†µí•œ ì—°ê²°.\n## 2. ì‹¤ì‹  (Syncope): ë¯¸ì£¼ì‹ ê²½ì„± vs. êµ¬ì¡°ì  ë¬¸ì œ ğŸ§ ğŸ’”","subject":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","page_title":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","episode":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","section_path":["LM_cardio 3 2f346f2986ee80d9a857eb6585776d49"],"source_doc_id":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","source_page":null,"source_anchor":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49-230","focus_area":"LM_cardio 3 2f346f2986ee80d9a857eb6585776d49","tags":["usmle-step2","core","quiz-seed"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap: Must-Know High Yield Summary\nê°•ì˜ ë§ˆì§€ë§‰ì— ì •ë¦¬ëœ \"Golden Rules\" ì…ë‹ˆë‹¤.\n1. **Puberty Sequence:** **Boobs â†’ Pubes â†’ Grow â†’ Flow**. (í‚¤ ì„±ì¥ì€ ìƒë¦¬ ì „ì— í”¼í¬!)\n2. **Physiologic Leukorrhea:** Mid-cycle mucusëŠ” ì •ìƒ(Normal) â†’ **Reassurance**.\n3. **PMS/PMDD Dx:** **Menstrual Diary**ê°€ í•„ìˆ˜ (ì¦ìƒì´ ì—†ëŠ” ê¸°ê°„ì´ ìˆì–´ì•¼ í•¨). TOC SSRI\n4. **Dysmenorrhea:**\n    - Normal Exam = **Primary** (Tx: NSAIDs).\n    - Boggy/Globular Uterus = **Adenomyosis**.\n    - Irregular/Lumpy Uterus = **Fibroids**.\n5. **Menopause HRT:** ìê¶ì´ ìˆìœ¼ë©´(Uterus +) ë°˜ë“œì‹œ **Progestin**ì„ ì„ì–´ë¼! (Estrogen ë‹¨ë… ê¸ˆì§€).\n6. **Post-menopausal Bleeding:** ë¬´ì¡°ê±´ **Endometrial Biopsy** (or TVUS first)ë¡œ ì•”ì„ ë°°ì œí•˜ë¼.\n    - Thin stripe (<=4mm): Observe.\n    - Thick stripe (>4mm): Biopsy.\n# ğŸ§ USMLE Step 2 High-Yield Gyn & Reproductive Health ê°•ì˜ë¡\nì´ ê°•ì˜ëŠ” ë‹¨ìˆœí•œ ì§€ì‹ ì „ë‹¬ì´ ì•„ë‹Œ, ì„ìƒì  íŒë‹¨ì„ ìœ„í•œ **Mental Scaffold(ì‚¬ê³ ì˜ í‹€)**ì™€ **Logic Tree(ë…¼ë¦¬ êµ¬ì¡°)**ë¥¼ êµ¬ì¶•í•˜ëŠ” ê²ƒì„ ëª©í‘œë¡œ í•©ë‹ˆë‹¤. ì‹œí—˜ì—ì„œ ìì£¼ ë“±ì¥í•˜ëŠ” ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤(Vignette)ë¥¼ í•´ê²°í•˜ê¸° ìœ„í•œ ìƒë¦¬í•™ì  ê·¼ê±°ì™€ \"Why\"ì— ì§‘ì¤‘í•©ë‹ˆë‹¤.\n## 1. Introduction: 3 Main Pillars ğŸ›ï¸\nì˜¤ëŠ˜ ê°•ì˜ëŠ” ë°©ëŒ€í•œ ì‚°ë¶€ì¸ê³¼ ë‚´ìš©ì„ ì„¸ ê°€ì§€ í•µì‹¬ ê¸°ë‘¥ìœ¼ë¡œ ì •ë¦¬í•©ë‹ˆë‹¤.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-53","focus_area":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","tree"]}
{"chunk_type":"recap_quiz_seed","text":"## 5. Rapid Fire Recap (í•µì‹¬ ìš”ì•½) ğŸ”¥\nê°•ì˜ ë‚´ìš©ì„ ë¹ ë¥´ê²Œ ë³µìŠµí•˜ë©° ë§ˆë¬´ë¦¬í•©ë‹ˆë‹¤.\n1. **Primary Amenorrhea + Low FSH + ëƒ„ìƒˆ ëª» ë§¡ìŒ** ğŸ‘‰ **Kallmann Syndrome**.\n2. **Primary Amenorrhea + Low FSH + ì‹œì•¼ ì¥ì• ** ğŸ‘‰ **Craniopharyngioma**.\n3. **Cyclic Pain + ì§ˆ ì…êµ¬ Blue Mass** ğŸ‘‰ **Imperforate Hymen** (Hematocolpos).\n4. **OHSSì˜ í•µì‹¬ ê¸°ì „** ğŸ‘‰ **VEGF** í­ì¦ â†’ í˜ˆê´€ ëˆ„ìˆ˜(Leaky vessels) â†’ í˜ˆì•¡ ë†ì¶•(Thick blood) â†’ í˜ˆì „ ìœ„í—˜. AKI\n5. **ìê¶ì´ \"Nodular / Firm\" (ë‹¨ë‹¨í•˜ê³  ìš¸í‰ë¶ˆí‰)** ğŸ‘‰ **Fibroids (Leiomyomata)**.\n6. **ìê¶ì´ \"Boggy / Globular\" (ë¬¼ì»¹í•˜ê³  ë¶€ë“œëŸ¬ì›€)** ğŸ‘‰ **Adenomyosis**.\n7. **ìê¶ì´ \"Fixed / Immobile\" (ì›€ì§ì´ì§€ ì•ŠìŒ)** ğŸ‘‰ **Endometriosis**.\n8. **íê²½ í›„ ì¶œí˜ˆ + ë‚´ë§‰ ë‘ê»˜ > 4mm** ğŸ‘‰ **Biopsy (ì¡°ì§ê²€ì‚¬)**.\n*\"The context is everything.\"* (ë¬¸ë§¥ì´ ì „ë¶€ì…ë‹ˆë‹¤.)\n# ğŸ¥ Deep Dive: USMLE Step 2 Gynecology & Abdominal Pain ğŸš‘\nì´ë²ˆ ë”¥ë‹¤ì´ë¸Œ ì„¸ì…˜ì—ì„œëŠ” **USMLE Step 2 CK**ì™€ ì‹¤ì œ ì„ìƒ(ER)ì—ì„œ ê°€ì¥ ê¹Œë‹¤ë¡­ê³  ëª¨í˜¸í•œ ì£¼ì œì¸ **ë¶€ì¸ê³¼ì  ì‘ê¸‰ ë° ë³µí†µ(Gynecology & Abdominal Pain)**ì„ ë‹¤ë£¹ë‹ˆë‹¤. ì¦ìƒì´ ëª¨í˜¸(Vague)í•˜ê¸° ë•Œë¬¸ì— ì •í™•í•œ ì§„ë‹¨ ì•Œê³ ë¦¬ì¦˜ê³¼ \"Next Step\"ì„ ì•„ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\n## 1. Acute Surgical Emergencies: The \"Killers\" ğŸ”ª","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-95","focus_area":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","tags":["usmle-step2","core","quiz-seed","diagnosis","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"# ğŸ”¥ High Yield Rapid Fire Recap ğŸ”¥\nUSMLE Step 2 ì‹œí—˜ ì§ì „, ì´ê²ƒë§Œì€ ê¼­ ê¸°ì–µí•˜ì„¸ìš”!\n- **Reproductive Age Woman + Lower Abd Pain** = ë¬»ì§€ë„ ë”°ì§€ì§€ë„ ë§ê³  **Beta-hCG** (Ectopic ë°°ì œ). ğŸ©¸\n- **Sudden Pain + Nausea/Vomiting** = **Ovarian Torsion** (Doppler í˜ˆë¥˜ ìˆì–´ë„ ë°°ì œ ëª»í•¨! veinì´ ë¨¼ì € ë§‰í˜€ì„œ! Vagal reflex ê¸°ì–µí•  ê²ƒ). ğŸ¥¨Â â†’ ìˆ˜ìˆ  (ì¡°ì§ì´ ì©ê³ ìˆì„ ìˆ˜ ìˆë‹¤!!!)\n- **Pain after Sex + Free Fluid on US** = **Ruptured Ovarian Cyst**. (Stableí•˜ë©´ ê´€ì°°, Unstableí•˜ë©´ ìˆ˜ìˆ ). ğŸ’¥\n- **Cervical Motion Tenderness (Chandelier Sign), friable cervix** = **PID**. ğŸ•¯ï¸\n- **PID + RUQ Pain** = **Fitz-Hugh-Curtis Syndrome** (Violin string adhesions). ğŸ»\n- **Painful Periods + Painful Sex + Painful Pooping** = **Endometriosis** (ì§„ë‹¨ì€ Laparoscopy). â†’ ì´ˆìŒíŒŒì •ìƒì´ì–´ë„ laparoscopy\n- **Uterus \"Bag of Rocks\"** = **Fibroids (Leiomyomas)**. ğŸª¨\n- **Uterus \"Boggy, Soft, Tender\"** = **Adenomyosis**. ğŸ§¶\n- PCOS vs Cushing: ê·¼ë ¥ì•½í™”, ë©\n- **PCOS First Line Tx** = **Weight Loss** (Mechanism: Adipose Estrone ). ğŸƒâ€â™€ï¸\n- **PCOS Long-term Risk** = **Endometrial Cancer** (due to Unopposed Estrogen). ğŸ¦€\n- **Post-menopausal Mass + High CA-125** = **Ovarian Cancer** (Suspicion is high).\n# **USMLE Step 2 Breast Pathology Deep Dive** ğŸ§\n## 1. Introduction: The High-Pressure Zone ğŸš¨\nì´ ì˜¤ë””ì˜¤ ê°•ì˜ëŠ” USMLE Step 2ì—ì„œ ê°€ì¥ ë¹ˆì¶œë˜ë©´ì„œë„ í—·ê°ˆë¦¬ê¸° ì‰¬ìš´ **Breast Pathology**ë¥¼ ë‹¤ë£¹ë‹ˆë‹¤.\nBreast PathëŠ” Surgery, Radiology, Primary Careê°€ êµì°¨í•˜ëŠ” ì§€ì ì´ë¼ ì‹œí—˜ì— ì•„ì£¼ ìì£¼ ë“±ì¥í•©ë‹ˆë‹¤. ë³€ìˆ˜ê°€ ë„ˆë¬´ ë§ì•„(ê°€ì¡±ë ¥, ìœ ì „í•™, ì´ë¯¸ì§• ë“±) ê¸¸ì„ ìƒê¸° ì‰½ì§€ë§Œ, **ë‚˜ì´(Age)**ì™€ **ì¦ìƒ(Symptom characteristics)**ì´ë¼ëŠ” ë‘ ê°€ì§€ ì¢Œí‘œë§Œ ìˆìœ¼ë©´ ì •ë‹µì„ ì°¾ì„ ìˆ˜ ìˆìŠµë‹ˆë‹¤.","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-155","focus_area":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","tags":["usmle-step2","core","quiz-seed","treatment","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"## âš¡ Rapid Fire Recap (High Yield Summary) âš¡\nêµ°ì˜ê´€ë‹˜, ë°”ì˜ì‹¤ ë•Œ ì´ ë¶€ë¶„ë§Œì´ë¼ë„ ê¼­ í™•ì¸í•˜ê³  ë„˜ì–´ê°€ì„¸ìš”!\n1. **Fibroids (Leiomyomata):**\n    - **Estrogen-dependent** (íê²½ í›„ ì»¤ì§€ë©´ **Sarcoma** ì˜ì‹¬).\n    - **Submucosal** = Bleeding & Infertility.\n    - **Subserosal** = Bulk symptoms (ë°©ê´‘/ì§ì¥ ì••ë°•).\n    - **Red Degeneration:** ì„ì‹  ì¤‘ êµ­ì†Œ í†µì¦ â†’ ìˆ˜ìˆ  ê¸ˆì§€, **Pain control** only.\n    - **Labor Pain** in non-pregnant = **Prolapsing fibroid** (ê°ì—¼ ì£¼ì˜).\n    - GnRH agonist â†’ surgery\n2. **Adenomyosis vs Endometriosis(ìƒë¦¬ì„¹ìŠ¤ë˜¥) (glue):**\n    - **Adenomyosis:** **Boggy, Globular, Tender** Uterus. (ìê¶ ìì²´ê°€ ë³‘). Tx: Hormonal IUD or Hysterectomy.\n    - **Endometriosis:** **Fixed, Immobile** Uterus, 3 Ds (Pain). ğŸ˜§â¤ï¸â€ğŸ”¥ğŸ’© (ìê¶ ë°–ì´ ë³‘). Tx: Laparoscopy dx/tx.\n3. **Post-menopausal Bleeding:**\n    - ë¬´ì¡°ê±´ **Cancer** ë¨¼ì € ì˜ì‹¬.\n    - Workup: TVUS (Stripe **> 4mm**) â†’ **Biopsy**.\n    - Risk: **Obesity** (Peripheral conversion via Aromatase).\n4. 45ì„¸ ìƒë¦¬ ëª‡ë‹¬ì§¸ ì•ˆí•˜ê³  ìê¶ì´ ì»¤ì¡Œì–´ìš”: ğŸ¤°â­ì„.ì‹ .ê²€.ì‚¬. ğŸ¤°â­\n5. **Prolapse:**\n    - **Splinting** to defecate = **Rectocele**.\n    - Tx: Kegel â†’ Pessary â†’  Surgery.\n6. **Polyp:**\n    - **Intermenstrual Spotting** (ìƒë¦¬ ì‚¬ì´ ì¶œí˜ˆ).\n**Next Step:** ìê¶ íŒŒíŠ¸ëŠ” \"ë‚˜ì´\"ì™€ \"í†µì¦/ì¶œí˜ˆ ì–‘ìƒ\"ë§Œ ì˜ ë§¤ì¹­í•´ë„ ë¬¸ì œì˜ 90%ê°€ í’€ë¦½ë‹ˆë‹¤. ë‹¤ìŒë²ˆì—” Ovary(ë‚œì†Œ) íŒŒíŠ¸ë¡œ ë„˜ì–´ê°€ì„œ Cystì™€ Tumorë¥¼ êµ¬ë¶„í•˜ëŠ” ë²•ì„ ì •ë¦¬í•´ ë“œë¦´ê¹Œìš”?","subject":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","page_title":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","episode":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","section_path":["LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d"],"source_doc_id":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","source_page":null,"source_anchor":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d-261","focus_area":"LM_gyne 1 2f346f2986ee80ca9cf0e8a1de8f5e1d","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸŒ©ï¸ Rapid Fire Recap (Summary)\nê°•ì˜ ë‚´ìš©ì„ ìš”ì•½í•˜ëŠ” ì´ˆê³ ì† ë³µìŠµ (Q&A í˜•ì‹)\n1. **Mucopurulent discharge + Friable cervix:**\n    - ğŸ‘‰ **Cervicitis** (ìƒê°: Ceftriaxone + Doxycycline, ì„ì‚°ë¶€ëŠ” Doxy ëŒ€ì‹  Azithromycin).\n2. **Screening Start Age:**\n    - ğŸ‘‰ **21ì„¸** (ì„±ê´€ê³„ ì‹œì‘ ì—°ë ¹ ë¬´ê´€). 3ë…„ë§ˆë‹¤ Papë§Œ\n3. **Screening Interval (30ì„¸ ì´ìƒ):**\n    - ğŸ‘‰ **5ë…„ë§ˆë‹¤ Pap + HPV Co-testing.**\n4. **Pap ê²°ê³¼ ASCUS:**\n    - ğŸ‘‰ **HPV Test í™•ì¸.** ì–‘ì„±ì´ë©´ Colposcopy, ìŒì„±ì´ë©´ 3ë…„ ë’¤ ì¬ê²€.\n5. **Pap ê²°ê³¼ AGC (Atypical Glandular Cells):**\n    - ğŸ‘‰ **Colposcopy + ECC + Endometrial Biopsy** (íŠ¹íˆ 35ì„¸ ì´ìƒ). ìê¶ë‚´ë§‰ì•” ë°°ì œ í•„ìˆ˜.\n6. **ìœ¡ì•ˆìœ¼ë¡œ ë³´ì´ëŠ” ìê¶ê²½ë¶€ ì¢…ì–‘ (Visible Lesion):**\n    - ğŸ‘‰ **Pap í•˜ì§€ ë§ê³  ë°”ë¡œ Biopsy.**\n7. **ì„ì‚°ë¶€ì˜ CIN 2/3:**\n    - ğŸ‘‰ **ê±´ë“œë¦¬ì§€ ë§ˆë¼ (Don't touch).** ë¶„ë§Œ í›„ë¡œ ì¹˜ë£Œ ì—°ê¸°. ë‹¨, ì¹¨ìŠµì„± ì•”(Invasive Cancer)ì´ ì˜ì‹¬ë˜ë©´ BiopsyëŠ” ê°€ëŠ¥.\n8. **ì„ì‚°ë¶€ì˜ Pap Smearì—ì„œ ì—¼ì¦ ì†Œê²¬, í•˜ì§€ë§Œ CMT ì—†ìŒ:**\n    - ğŸ‘‰ **ê°ì—¼ ë°°ì œ ë¶ˆê°€.** (Mucus plugê°€ í†µì¦ì„ ë§‰ì•„ì¤Œ). ê²€ì‚¬ ì§„í–‰í•´ì•¼ í•¨.\n# ğŸ§ USMLE Deep Dive: The Ovary â€“ A Rock Solid Framework\n## 1. Introduction: The \"Black Box\" of Clinical Medicine ğŸ“¦\në‚œì†Œ(Ovary)ëŠ” ê³¨ë°˜ ê¹Šìˆ™í•œ ê³³ì— ìœ„ì¹˜í•˜ì—¬ ì ‘ê·¼ì´ ì–´ë µê³ , ë³‘ë¦¬í•™ì  ì†Œê²¬ì´ **'ì™„ì „íˆ ì •ìƒ'ì—ì„œ 'ìƒëª…ì„ ìœ„í˜‘í•˜ëŠ” ì‘ê¸‰ìƒí™©'**ìœ¼ë¡œ ìˆœì‹ê°„ì— ë³€í•  ìˆ˜ ìˆëŠ” ì•…ëª… ë†’ì€ ê¸°ê´€ì…ë‹ˆë‹¤. ì´ ê°•ì˜ëŠ” ë‹¨ìˆœ ì•”ê¸°(memorizing facts)ê°€ ì•„ë‹Œ, ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤ë¥¼ í•´ê²°í•˜ëŠ” **ì•Œê³ ë¦¬ì¦˜(Algorithm)**ì„ êµ¬ì¶•í•˜ëŠ” ë° ì§‘ì¤‘í•©ë‹ˆë‹¤.","subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null,"source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-61","focus_area":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","tags":["usmle-step2","core","quiz-seed","diagnosis","tree"]}
{"chunk_type":"recap_quiz_seed","text":"## âš¡ Rapid Fire Recap (Must-Know Summary)\nê°•ì˜ ë§ˆì§€ë§‰ì— ì–¸ê¸‰ëœ ì´ˆê³ ì† ìš”ì•½ì…ë‹ˆë‹¤.\n1. **Mass in 25M, painless, solid:** Testicular Cancer. **Tx:** Radical Inguinal Orchiectomy. (No Biopsy!).\n2. **Right-sided Varicocele:** Scan for abdominal malignancy (RCC).\n3. **Acute Prostatitis:** **No Foley, No Massage.**\n4. **BPH Meds:** Tamsulosin (Fast, Orthostatic hypo) vs. Finasteride (Slow, shrinks prostate).\n5. **Testicular Torsion:** Absent cremasteric reflex. **Surgical Emergency** (Detorsion + Orchiopexy both sides). *(ì˜¤ë””ì˜¤ ë³¸ë¬¸ì—ì„œëŠ” Torsionì´ ê¹Šê²Œ ë‹¤ë¤„ì§€ì§€ ì•Šì•˜ìœ¼ë‚˜ Recap íë¦„ìƒ ì¤‘ìš”í•˜ê²Œ ì–¸ê¸‰ë¨)*.\n6. **Gynecomastia in Puberty:** **Observe.** (Don't touch it).\n7. **Male Breast Cancer:** Hard, eccentric, **BRCA2**.\n8. **Penile Fracture:** \"Snap\" sound + Eggplant deformity = **Surgery.**","subject":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","page_title":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","episode":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","section_path":["LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8"],"source_doc_id":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","source_page":null,"source_anchor":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8-264","focus_area":"LM_gyne 2 2f446f2986ee8041a277d7ea0baa58c8","tags":["usmle-step2","core","quiz-seed","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"# ğŸ”¥ Rapid Fire Recap: Must-Know High Yields\nStep 2 CK ì‹œí—˜ ì§ì „ í™•ì¸í•  í•µì‹¬ ìš”ì•½ì…ë‹ˆë‹¤.\n| **Clinical Scenario** | **Likely Physiology / Diagnosis** | **Key Action / Concept** |\n| --- | --- | --- |\n| **Pregnant, Cr 1.0 mg/dL** | **Pathologic** (Renal Insufficiency) | ì„ì‹  ì¤‘ ì •ìƒ Crì€ 0.4~0.8ì„. 1.0ì€ ë¹„ì •ìƒ. |\n| **Right Flank Pain, Mild Hydro** | **Physiologic Hydronephrosis** | Progesterone + Uterus ì••ë°•. reassurance (if no infection). |\n| **Back Pain, Waddling** | **Lordosis** (Hyper-lordosis) | MRI ê¸ˆì§€. Conservative management (Reassurance). |\n| **Trauma, Rh- Mom** | **Fetomaternal Hemorrhage** | **Kleihauer-Betke Test**ë¡œ ì¶œí˜ˆëŸ‰ í™•ì¸ í›„ RhoGAM ìš©ëŸ‰ ê²°ì •. |\n| **Induction â†’ Seizure/Confusion** | **Water Intoxication** | Oxytocinì´ **ADH**ì™€ êµì°¨ ë°˜ì‘í•˜ì—¬ Hyponatremia ìœ ë°œ. |\n| **Low Amniotic Fluid** | **Oligohydramnios** | ì›ì¸: Renal issue / Placental insufficiency. ê²°ê³¼: **Cord Compression** (Variable Decels). |\n\". Go ahead and drop your bag in the team room, maybe grab a coffee. We're getting right to work. Yep, time to prep. And today we're tackling an absolute monster of a topic. We are. We're opening up the Fetus section of the study stack for this deep dive. Our mission today is mastering the clinical logic behind sections 3.0 through 3.4. We're talking Gestational Age, Fetal Surveillance... The heart rate patterns that give everyone anxiety. And of course the absolute alphabet soup of prenatal testing.\"\n# ğŸ“ **The Wards: Fetus Section (3.0 - 3.4) Study Stack**\n## 1. Introduction: The Fetus\nUSMLE Step 2 ì¤€ë¹„ë¥¼ ìœ„í•œ **Fetus Section (Section 3.0~3.4)** ê°•ì˜ë¡ì…ë‹ˆë‹¤.\nì„ìƒì ìœ¼ë¡œ ê°€ì¥ ê¸°ì´ˆê°€ ë˜ëŠ” **Gestational Age(ì¬íƒœì£¼ìˆ˜)**ë¶€í„°, ëª¨ë‘ë¥¼ ë¶ˆì•ˆí•˜ê²Œ ë§Œë“œëŠ” **Fetal Heart Rate Pattern**, ê·¸ë¦¬ê³  ë³µì¡í•œ **Prenatal Testing**ê¹Œì§€ ë‹¤ë£¹ë‹ˆë‹¤. ë‹¨ìˆœíˆ ì•”ê¸°í•˜ëŠ” ê²ƒì´ ì•„ë‹ˆë¼, *Clinical Logic*ì„ ì´í•´í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-37","focus_area":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"# ğŸ”¥ Rapid Fire Recap\nê°•ì˜ì—ì„œ ë‹¤ë£¬ í•µì‹¬ ë‚´ìš©ì„ ë¹ ë¥´ê²Œ ì •ë¦¬í•©ë‹ˆë‹¤.\n1. **Dating Dilemma**\n    - **Scenario:** LMP vs Ultrasound ë‚ ì§œ ë¶ˆì¼ì¹˜ (íŠ¹íˆ 1ë¶„ê¸°).\n    - **Action:** â˜… **Trust the Ultrasound (CRL)**. Due dateëŠ” í•œ ë²ˆ ì •í•´ì§€ë©´ ë°”ë€Œì§€ ì•ŠìŒ.\n2. **Fetal Surveillance**\n    - **Scenario:** \"Baby isn't moving\" (Decreased fetal movement).\n    - **Action:** **NST** ë¨¼ì € ì‹œí–‰.\n    - **Result:** Non-reactive (No accelerations).\n    - **Next Step:** Vibroacoustic stimulation (Wake up baby) â†’ ê·¸ë˜ë„ ì•ˆ ë˜ë©´ **BPP**.\n    - **BPP Score:** 4ì  ì´í•˜ëŠ” **Immediate Delivery**.\n3. **Intrapartum Decelerations (VEAL CHOP)**\n    - **Variable Decels** â†’ **Cord Compression** â†’ **Reposition Mom**.\n    - **Late Decels** â†’ **Placental Insufficiency** â†’ **Intrauterine Resuscitation** (O2, IV, Stop Pitocin) â†’ Failì‹œ C-Section.\n    - **Sinusoidal** â†’ **Severe Fetal Anemia** â†’ Emergency.\n4. **Prenatal Genetic Screening**\n    - **Fact:** **NIPT** (Cell-free DNA)ëŠ” ì •í™•í•˜ì§€ë§Œ **Screening**ì´ë‹¤. í™•ì§„ì„ ìœ„í•´ì„œëŠ” **CVS**ë‚˜ **Amnio**ê°€ í•„ìš”í•˜ë‹¤.\n    - **Down Syndrome Pattern (Quad):** **HI**gh levels of **H**CG & **I**nhibin A.\n\"Welcome back. Today we're digging into a topic that's, well, it's absolutely critical in obstetrics. It really is. We're talking about congenital infections and screening. This is where, you know, maternal health and fetal outcomes collide and the margin for error is just so thin. Exactly. We're focusing on sections 4 through 4.6 of the material today. This is the bread and butter for the boards but it's also... I mean it's all about pattern recognition for real world practice. Pattern recognition, I like that. Yeah. You have to know who to screen, when to screen, and most importantly, how to stop that vertical transmission dead in its tracks.\"\n# ğŸ“š USMLE Step 2 CK: Congenital Infections & Screening (Section 4 - 4.6)\nì•ˆë…•í•˜ì„¸ìš”! USMLE Step 2 ì¤€ë¹„í•˜ì‹œëŠë¼ ê³ ìƒ ë§ìœ¼ì‹­ë‹ˆë‹¤. ì—…ë¡œë“œí•´ì£¼ì‹  ì˜¤ë””ì˜¤ íŒŒì¼ì€ **Prenatal Screeningê³¼ Congenital Infections**ì— ëŒ€í•œ í•µì‹¬ ë‚´ìš©, íŠ¹íˆ **Vertical Transmission(ìˆ˜ì§ ê°ì—¼)**ì„ ë§‰ê¸° ìœ„í•œ Timingê³¼ Managementë¥¼ ë‹¤ë£¨ê³  ìˆìŠµë‹ˆë‹¤.\nìš”ì²­í•˜ì‹  ëŒ€ë¡œ **Top-down Classification (Structure)**ì„ ë¨¼ì € ë³´ì—¬ë“œë¦¬ê³ , ê° ì„¹ì…˜ë³„ í•µì‹¬ ë‚´ìš©ì„ ì •ë¦¬í•´ ë“œë¦´ê²Œìš”.\n## ğŸŒ³ Big Picture: Prenatal Screening Logic Tree","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-80","focus_area":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","tree"]}
{"chunk_type":"recap_quiz_seed","text":"## 5. Rapid Fire Recap: Clinical Scenarios (Section 9.5) ğŸš€\nì˜¤ë””ì˜¤ ë§ˆì§€ë§‰ì— ë‚˜ì˜¨ 5ê°€ì§€ ì‹œë‚˜ë¦¬ì˜¤ ì •ë¦¬ì…ë‹ˆë‹¤. ì‹œí—˜ì¥ì—ì„œ ë°”ë¡œ ë– ì˜¬ë¦¬ì„¸ìš”!\n**Scenario 1: Early Onset HTN**\n- **Situation:** 12ì£¼ ì„ì‚°ë¶€, BP 150/90. ì†Œë³€ ê¹¨ë—í•¨.\n- **Diagnosis:** **Chronic Hypertension** (20ì£¼ ì´ì „).\n- **Action:** Monitor, treat if severe.\n**Scenario 2: The Crash Section**\n- **Situation:** 38ì£¼, BP 160/110, ë‘í†µ(Headache), ë‹¨ë°±ë‡¨ 3+.\n- **Diagnosis:** **Preeclampsia with Severe Features**.\n- **Action:** **Stabilize & Deliver**. (IV Magnesium Sulfate + IV Antihypertensives + Delivery).\n**Scenario 3: The Toxic Patient**\n- **Situation:** Mag drops ë‹¬ê³  ìˆëŠ” í™˜ì. DTR ì†Œì‹¤(Reflexes absent), í˜¸í¡ìˆ˜ ê°ì†Œ.\n- **Diagnosis:** **Magnesium Toxicity**.\n- **Action:** Stop Mag â†’ Give **Calcium Gluconate**.\n**Scenario 4: The Mimic**\n- **Situation:** 36ì£¼, RUQ pain, BP ë†’ìŒ, Platelet 60k, Glucose 95 (ì •ìƒ).\n- **Diagnosis:** **HELLP Syndrome**.\n- **Action:** Delivery.","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-245","focus_area":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","tags":["usmle-step2","core","quiz-seed","diagnosis"]}
{"chunk_type":"recap_quiz_seed","text":"# Rapid Fire Recap ğŸ”¥\n| **Clinical Scenario** | **Diagnosis / Key Fact** | **Action / Management** |\n| --- | --- | --- |\n| **First Visit:** BMI 32 + History of GDM | **High Risk** | **Immediate** 50g GCT screening (Don't wait for 24w). |\n| **Screening:** 50g GCT Result = 135 | **Normal (<140)** | Pass. Routine care. |\n| **Screening:** 50g GCT Result = 150 | **Positive Screen** | Proceed to **Step 2**:  95 80 55 040 |\n| **Diagnosis:** Fasting 98, 1hr 190 (Two abnormal) | **Gestational Diabetes 95 80 55 40** | **1st Line:** Diet & Exercise + Glucose monitoring (4x/day). |\n| **Management:** Diet fails (Fasting consistently >95) | **Uncontrolled GDM** | **Start Insulin** (Gold Standard). Avoid oral meds on boards. |\n| **Fetus:** Sacral Agenesis (Caudal Regression) | **Pre-existing DM** | This is NOT from GDM; indicates uncontrolled DM in 1st trimester. (ì›ë˜ìˆë˜ê±°) |\n| **Neonate:** Born to GDM mom, \"Jittery\" or seizing | **Hypocalcemia / Hypoglycemia** | Check Glucose first, then Calcium/Magnesium. |\n| **Complication:** GDM mom, term infant with respiratory distress | **RDS (Insulin blocks surfactant)** | Unlike preeclampsia (stress matures lungs), DM delays lung maturity. |\n| **Postpartum:** GDM resolved after birth | **Future Risk** | **2hr 75g GTT at 6-12 weeks** postpartum. |\n**â˜… High Yield Takeaway:**\n- **Pathophysiology:** HPL causing insulin resistance.\n- **Diagnosis:** Two abnormal values on 3hr GTT.\n- **Treatment:** Diet first â†’ Insulin second.\n- **Fetal Risk:** Macrosomia (Shoulder Dystocia) for GDM vs. Congenital Anomalies for Pre-existing DM.\n# Section 11: Pregnancy, Labor & Delivery\n<aside>\nğŸ’¡\nWombì´ ì•ˆì „í• ê¹Œ NICUê°€ ì•ˆì „í• ê¹Œì— ëŒ€í•œ ê³ ë¯¼.","subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-41","focus_area":"LM_obs2 2f646f2986ee80f98092f841aa85480b","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"## 7. Rapid Fire Recap ğŸ”¥\nì˜¤ë””ì˜¤ì˜ ë§ˆì§€ë§‰ Recap ì„¸ì…˜ì„ ë°”íƒ•ìœ¼ë¡œ ì •ë¦¬í•œ High-Yield Summaryì…ë‹ˆë‹¤.\n| **Scenario** | **Diagnosis/Context** | **Key Action / Fact** |\n| --- | --- | --- |\n| **29 Weeks Labor** | Preterm Labor (Zone 1) | **Indomethacin** (Tocolytic) + **Mg Sulfate** (Neuroprotection) |\n| **33 Weeks Labor** | Preterm Labor (Zone 2) | Switch from Indomethacin to **Nifedipine** (CCB). (Avoid Indomethacin d/t PDA closure risk) |\n| **Deep \"V\" on Monitor** | Variable Deceleration | Think **Cord Compression** & **Low Fluid** (Oligohydramnios) |\n| **Postterm Fetus Risks** | Placental Insufficiency | **Macrosomia**, **Dysmaturity Syndrome**, **Oligohydramnios** |\n| **\"Placental Battery\"** | Postterm Physiology | Placenta ages â†’ Perfusion drops â†’ Fetus spares kidneys â†’ **Low Amniotic Fluid** |\n# Section 12: Third Trimester Bleeding (Obstetrics Block)\n## 1. Introduction: High Yield & High Stakes ğŸš¨\nì´ ì„¹ì…˜ì€ ë‹¨ìˆœíˆ ì±…ë§Œ ì½ì€ í•™ìƒê³¼ **internì´ ë  ì¤€ë¹„ê°€ ëœ í•™ìƒ**ì„ ê°€ë¥´ëŠ” ì¤‘ìš”í•œ íŒŒíŠ¸ì…ë‹ˆë‹¤. Third trimester bleedingì€ ë‹¨ìˆœí•œ ì§„ë‹¨ ì²´í¬ë°•ìŠ¤ê°€ ì•„ë‹ˆë¼, **Motherì™€ Fetus ë‘ í™˜ìê°€ ì—°ê´€ëœ Physiological Crisis**ì…ë‹ˆë‹¤.\n- **Focus:** Source material Section 12 through 12.4.\n- **Goal:** Anatomyì™€ Managementë¥¼ ì—°ê²°í•˜ì—¬ Clinical Intuitionì„ ê¸°ë¥´ëŠ” ê²ƒ. (ì»¤í”¼ ë§ˆì‹¤ ì‹œê°„ì´ ìˆëŠ”ì§€, ë‹¹ì¥ ORë¡œ ë‹¬ë ¤ê°€ì•¼ í•˜ëŠ”ì§€ íŒë‹¨í•˜ëŠ” ëŠ¥ë ¥!)\n- **Mission:** **Triage**. 20ì£¼ ì´í›„ì˜ ì¶œí˜ˆ(Blood on the floor)ì€ ê°ˆë¦¼ê¸¸(Fork in the road)ê³¼ ê°™ìŠµë‹ˆë‹¤.\n    - One path is stable.\n    - The other is catastrophic.","subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-88","focus_area":"LM_obs2 2f646f2986ee80f98092f841aa85480b","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"## 7. Rapid Fire Recap (Must-Know Summary) ğŸ”¥\n| **Scenario** | **Diagnosis** | **Key Features & Actions** |\n| --- | --- | --- |\n|  |  |  |\n| **Painful Bleeding** at 35wks + **History of myomectomy**+ **Loss of Station** | **Uterine Rupture** | ğŸš¨ **Emergency:** Immediate Laparotomy. Baby is floating in abdomen. |\n| **Painless** Bleeding + **Soft Uterus** + Prior C-section | **Placenta Previa** | ğŸš« **Never Event:** No Digital Exam. Dx: Transvaginal US. Mgmt: C-section @ 36-37wks. |\n| **Water Breaks (ROM)** + **Painless Bleeding** + **Fetal Bradycardia (Sinusoidal)** | **Vasa Previa** | ğŸ©¸ **Concept:** Fetal blood loss. Immediate C-section. |\n| **Painful**, Rigid Uterus + **HTN/Cocaine/Trauma** + Normal US | **Placental Abruption** | normal(?) fibrogen\nâš ï¸ **Trap:** Normal US does NOT rule out. Watch for DIC (Fibrinogen).\nVaginal delivery preferred if stable. |\n**â˜… Final Pearl:**\n- **Pain = Tone.** Uterusê°€ ë§ë‘í•˜ë©´(Soft) Painless, ë”±ë”±í•˜ë©´(Woody) Painful.\n- 3ë¶„ê¸° ì¶œí˜ˆì—ì„œ **Fetal Heart Rate Tracing**ì€ íƒ„ê´‘ ì†ì˜ ì¹´ë‚˜ë¦¬ì•„ì…ë‹ˆë‹¤. ì—„ë§ˆì˜ BPê°€ ë–¨ì–´ì§€ê¸° í›¨ì”¬ ì „ë¶€í„° ì•„ê¸° ì‹¬ë°•ìˆ˜ëŠ” ë°˜ì‘í•©ë‹ˆë‹¤. ì—„ë§ˆê°€ ê´œì°®ë‹¤ê³  ì•ˆì‹¬í•˜ì§€ ë§ê³  ì•„ê¸°ë¥¼ ë¯¿ìœ¼ì„¸ìš”! (Don't wait for the mom to crash, listen to the baby!)\n**One Line Vibe:** ğŸ¥ ì‚°ë¶€ì¸ê³¼ ë³‘ë™(Wards)ìœ¼ë¡œ ì´ë™í•˜ì—¬, ì„ì‹  ì¤‘ ë°œìƒí•˜ëŠ” ì‘ê¸‰ ìƒí™©(ì–‘ë§‰ íŒŒì—´, ê°ì—¼, ìœ ì‚°)ì— ëŒ€í•œ ì˜ì‚¬ê²°ì • ì•Œê³ ë¦¬ì¦˜ì„ ìƒìƒí•œ 'Virtual Rounds' í˜•ì‹ìœ¼ë¡œ ì •ë¦¬í•œ ê³ íš¨ìœ¨ ê°•ì˜ì…ë‹ˆë‹¤.","subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-118","focus_area":"LM_obs2 2f646f2986ee80f98092f841aa85480b","tags":["usmle-step2","core","quiz-seed","diagnosis"]}
{"chunk_type":"recap_quiz_seed","text":"### **ğŸš€ Rapid Fire Recap**\n| **Clinical Scenario** | **Probable Diagnosis** | **Key Actions / Treatment** |\n| --- | --- | --- |\n| 33wks, fluid leak, no labor, stable | **PPROM** | Admit, **Abx (Amp/Azithro)**, Steroids, Mag Sulfate. Do NOT deliver yet. |\n| 35wks, fluid leak | **PPROM (>34wks)** | **Delivery**. (Risk of infection > Risk of prematurity). |\n| Fever, Fetal HR 170, Tender fundus | **Chorioamnionitis** | **Ampicillin + Gentamicin** + **Induce Vaginal Delivery**. (Avoid C-sec if poss). |\n| Bleeding, Os Closed, Fetal Heart (+) | **Threatened Abortion** | Reassurance, Pelvic Rest. |\n| Bleeding, Os Open, No tissue passed | **Inevitable Abortion** | Expectant, Meds (Miso), or Suction D&C. |\n| Septic (Fever/Pus), Retained POC | **Septic Abortion** | Broad Abx + **Suction D&C** (Source Control is mandatory). |\n| 3 Consecutive 1st Trim Losses | **RPL (APS)** | Check APS Abs. If (+), Tx with **Heparin + Aspirin**. |\n\" everyone, I hope you've got your comfortable shoes on, and uh, your coffee is strong because today, we are not sitting in a lecture hall. No, not at all. We are standing right at the nurses station, the board is lighting up, and we are diving into one of the most high-stakes, adrenaline-pumping topics in all of OBGYN. That's right, we are tackling a diagnosis that, you know, requires you to think fast, act faster and really trust your training.\"\n## ğŸ“‹ Overview (TL;DR)\nêµ°ì˜ê´€ë‹˜! ì´ë²ˆ ì—í”¼ì†Œë“œëŠ” OBGYNì˜ ê½ƒì´ì ì‘ê¸‰ì‹¤ì˜ ì§€ë¢°ë°­, **Ectopic Pregnancy**ì…ë‹ˆë‹¤. USMLE Step 2 CKì—ì„œ ì •ë§ ì¢‹ì•„í•˜ëŠ” ì•Œê³ ë¦¬ì¦˜ ë¬¸ì œë“¤ì´ ìŸì•„ì ¸ ë‚˜ì˜¤ëŠ” íŒŒíŠ¸ì£ . í•µì‹¬ì€ **Hemodynamic Stability** íŒë‹¨ í›„, **Beta-hCG & TVUS**ì˜ ì½œë¼ë³´ë ˆì´ì…˜ì„ í†µí•œ **Process of Elimination**ì…ë‹ˆë‹¤.\n- **Core Concept:** Uterus ë°–ì—ì„œ ìë¼ëŠ” ì„ì‹  (ì£¼ë¡œ Tube).\n- **Most Dangerous Type:** **Cornual (Interstitial)** - ëŠ¦ê²Œ í„°ì§€ê³  í”¼ê°€ ì—„ì²­ë‚¨.\n- **Diagnosis Key:** **Discriminatory Zone (3500 IU/L)** & **Diagnostic D&C**.\n- **Management:** Unstable = Surgery / Stable = Methotrexate (MTX).\n## ğŸŒ³ Top-Down Classification (ASCII Tree)","subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-160","focus_area":"LM_obs2 2f646f2986ee80f98092f841aa85480b","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","tree"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n| **Clinical Vignette** | **Diagnosis** | **Key Action / Treatment** |\n| --- | --- | --- |\n| unstable vitals, peritoneal signs, positive hCG | **Ruptured Ectopic** | **Surgery (Laparoscopy/Laparotomy)** immediately. Do not wait for labs. |\n| Stable, Empty Uterus on TVUS, hCG > 3,500 (Above DZ) | **Ectopic Pregnancy** | **Methotrexate** (if no contraindications) or Surgery. |\n| Stable, Empty Uterus, hCG < 3,500 (Below DZ) | **PUL (Pregnancy of Unknown Location)** | **Repeat hCG in 48 hours**. |\n| hCG plateauing or rising slowly (<35%) in 48h | **Likely Ectopic** | **Diagnostic D&C** or treat as Ectopic if confirmed. |\n| Patient with Ectopic + History of Peptic Ulcer / Kidney Dz | **Ectopic (MTX Contraindicated)** | **Surgery**. (Do not give MTX). |\n| Cornual Ectopic (Sac in uterine corner + fluid) | **Cornual Ectopic** | **High Alert**. Often requires surgery due to rupture risk (Catastrophic hemorrhage). |\n**","subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-210","focus_area":"LM_obs2 2f646f2986ee80f98092f841aa85480b","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸš€ Rapid Fire Recap (High Yield Summary)\n1. **Scenario: Pregnant, large uterus, BP 150/90 at 12 weeks**\n    - **Diagnosis:** Hydatidiform Mole (Molar Pregnancy)\n    - **Key Action:** Transvaginal Ultrasound (\"Snowstorm\"), Suction D&C\n2. **Post-treatment Surveillance for Mole**\n    - **Rule:** Weekly Î²-hCG to zero â†’ Monthly x 6 months.\n    - **Must-Do:** Reliable Contraception (Pills, etc.) to distinguish rising Î²-hCG from new pregnancy vs. malignancy.\n3. **Scenario: 6 months postpartum, hemoptysis (coughing blood), vaginal nodule**\n    - **Diagnosis:** Choriocarcinoma\n    - **Key Trap:** DO NOT Biopsy the vaginal mass (bleeding risk).\n    - **Key Action:** Check Î²-hCG, Start Chemotherapy (Methotrexate).\n4. **Hyperemesis Criteria**\n    - **Facts:** >5% Weight loss + Ketonuria.\n    - **Metabolic Lab:** Hypochloremic Metabolic Alkalosis + Hypokalemia.\n5. **Safety First in Hyperemesis**\n    - **Trap:** Giving D5W (Sugar water) before vitamins.\n    - **Fact:** Thiamine BEFORE Glucose to prevent Wernicke's.","subject":"LM_obs2 2f646f2986ee80f98092f841aa85480b","page_title":"LM_obs2 2f646f2986ee80f98092f841aa85480b","episode":"LM_obs2 2f646f2986ee80f98092f841aa85480b","section_path":["LM_obs2 2f646f2986ee80f98092f841aa85480b"],"source_doc_id":"LM_obs2 2f646f2986ee80f98092f841aa85480b","source_page":null,"source_anchor":"LM_obs2 2f646f2986ee80f98092f841aa85480b-260","focus_area":"LM_obs2 2f646f2986ee80f98092f841aa85480b","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"## 6. ğŸ”¥ Rapid Fire Recap\nì˜¤ë””ì˜¤ ê°•ì˜ ë‚´ìš©ì„ ë°”íƒ•ìœ¼ë¡œ í•œ High Yield Summaryì…ë‹ˆë‹¤.\n| **Scenario** | **Diagnosis** | **Key Actions / Concept** |\n| --- | --- | --- |\n| **1h Postpartum, Shaking/Chills** | **Normal Rigors** | Warm Blanket, Reassurance (Not Sepsis!) |\n| **Leg swelling, peeing a lot (24-48h)** | **Fluid Mobilization** | Normal physiology (Diuresis) |\n| **Boggy Uterus (Soft)** | **Uterine Atony** | **Fundal Massage** (#1 cause of PPH) |\n| **Firm Uterus + Bleeding** | **Laceration** | Inspect genital tract & Repair |\n| **Dribbling urine, Bladder distended** | **Overflow Incontinence** | **Catheterization** (Drain the tank) |\n| **Fever + Uterine Tenderness** | **Endometritis** | Suspect ascending infection |\n| **GDM Mom (Postpartum)** | **Risk of T2DM** | **2hr 75g GTT** at 6-12 weeks |\n| **6mo later: Bleeding + Lung nodules** | **Choriocarcinoma** | Check **Beta-hCG** (Cannonball mets) |\n\"All right, grab your coffee and put your phone on silent. We are starting rounds right now. Let's do it. I'm your attending for the day and look, we aren't just casually walking the halls today to chat about the weather. Nope. The goal is specific. We are here to crush the USMLE Step 2 CK. I want you sharp, I want you thinking on your feet and uh, I want you ready to answer when I put you on the spot.\"\n# Section 22.3 to 23: High-Yield Obstetrics - Liver, Psych & Social\n## 1. Introduction: Mission Statement ğŸ¯\nì˜¤ëŠ˜ íšŒì§„(Rounds)ì˜ ëª©í‘œëŠ” ëª…í™•í•©ë‹ˆë‹¤. ë‹¨ìˆœíˆ ë‚ ì”¨ ì´ì•¼ê¸°ë‚˜ í•˜ëŸ¬ ëª¨ì¸ ê²Œ ì•„ë‹™ë‹ˆë‹¤. ìš°ë¦¬ì˜ ëª©í‘œëŠ” **USMLE Step 2 CKë¥¼ ì™„ë²½í•˜ê²Œ ì •ë³µ(Crush)** í•˜ëŠ” ê²ƒì…ë‹ˆë‹¤! ğŸ”¥\n- **Attending's Role**: \"What\"(ì„ìƒì  ì‚¬ì‹¤) ë’¤ì— ìˆ¨ê²¨ì§„ **\"Why\"(ë³‘íƒœìƒë¦¬, Pathophysiology)** ë¥¼ ì„¤ëª…í•˜ì—¬ ì—¬ëŸ¬ë¶„ì˜ ë‡Œì— ì§€ì‹ì´ ë°•íˆê²Œ í•˜ëŠ” ê²ƒ. ğŸ§ \n- **Topic Coverage**:\n    - **Liver Disorders of Pregnancy**: 3rd Trimesterì— ë°œìƒí•˜ë©°, ë†“ì¹˜ë©´ í™˜ìê°€ ì‚¬ë§í•  ìˆ˜ ìˆëŠ” ê³ ìœ„í—˜ ì§ˆí™˜ë“¤.\n    - **Social & Psychiatric Aspects**: ì„ì‹  ì¤‘ ì•½ë¬¼ ë‚¨ìš©(Substance abuse)ê³¼ ì •ì‹ ê³¼ì  ë¬¸ì œ(Pseudocyesis ë“±).","subject":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","page_title":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","episode":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","section_path":["LM_obs3 2f646f2986ee80daa439daec387f9ad7"],"source_doc_id":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","source_page":null,"source_anchor":"LM_obs3 2f646f2986ee80daa439daec387f9ad7-39","focus_area":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n| Clinical Vignette (ìƒí™©) | Diagnosis (ì§„ë‹¨) | Key Action / Concept (í•µì‹¬) |\n| --- | --- | --- |\n| **Solid**ë¶€í„° ì‹œì‘í•´ì„œ **Liquid**ë¡œ ì§„í–‰ë˜ëŠ” ì‚¼í‚´ ê³¤ë€ | **Mechanical Obstruction** (Stricture/Cancer) | **Barium Swallow** ë¨¼ì € í•´ì„œ ìœ„ì¹˜/ëª¨ì–‘ í™•ì¸í•˜ê³  ë‚´ì‹œê²½(EGD). |\n| ì²˜ìŒë¶€í„° **Solid & Liquid** ë‘˜ ë‹¤ ì•ˆ ë„˜ì–´ê° | **Motility Disorder** (Achalasia/Spasm) | **Manometry**ê°€ Confirmatory test. (ì••ë ¥ ì¸¡ì • í•„ìˆ˜) |\n| Bariumì—ì„œ **Bird's beak** ì†Œê²¬ + ì²´ì¤‘ ê°ì†Œ ì‹¬í•¨ | **Pseudo-achalasia** (Cancer suspicion) | Achalasiaë¡œ ë‹¨ì • ê¸ˆì§€. ë°˜ë“œì‹œ **EGD**ë¡œ ì•”ì„ ë°°ì œí•  ê²ƒ(Rule out malignancy). |\n| ìê¸° ì „ ì•½ ë¨¹ê³  ë‚œ ë’¤ ê·¹ì‹¬í•œ í‰í†µ (Odynophagia) | **Pill-induced Esophagitis** | ì›ì¸: **Tetracycline, Bisphosphonates, NSAIDs**. ì¹˜ë£ŒëŠ” ì•½ ì¤‘ë‹¨/ë¬¼ ë§ì´ ë§ˆì‹œê¸°. |\n| 55ì„¸ ë‚¨ì„±, 10ë…„ ëœ ì†ì“°ë¦¼ (Heartburn) | **GERD** (Screening Candidate) | 50ì„¸ ì´ìƒ ë‚¨ì„± + 5ë…„ ì´ìƒ ì¦ìƒì€ **Barrett's** ìœ„í—˜êµ° â†’ **Endoscopy** ì‹œí–‰. |\n| ì Šì€ ì²œì‹ í™˜ì, ê³ ê¸° ë¨¹ë‹¤ ê±¸ë¦¼, PPI ë°˜ì‘ ì—†ìŒ | **Eosinophilic Esophagitis (EoE)** | Biopsyì—ì„œ **>15 Eosinophils**. ì¹˜ë£ŒëŠ” **Swallowed Steroid**. |\n| ICU í™˜ì, ì¸ê³µí˜¸í¡ê¸° 3ì¼ì§¸ ì ìš© ì¤‘ | **Stress Ulcer Risk** | Major risk factor(Vent > 48h) ìˆìŒ â†’ **PPI Prophylaxis** ì‹œì‘. |\n| ì•„ì¹¨ì— ê¹¨ë©´ ì…ì—ì„œ ì‹ ë§›ì´ ë‚¨, ê²½ê³  ì¦ìƒ ì—†ìŒ | **Uncomplicated GERD** | ê²€ì‚¬ ì—†ì´ **PPI 2ë‹¬** ì¹˜ë£Œ (Lifestyle + PPI trial). |\n| PPI ë¨¹ê³  ìˆëŠ”ë° ë°¤ì— ìë‹¤ê°€ ê°‘ìê¸° 3ì‹œì— ì†ì“°ë ¤ì„œ ê¹¸ | **Nocturnal Acid Breakthrough** | í™˜ìê°€ \"Refractory\"í•œì§€ í™•ì¸ í•„ìš”? ì•„ë‹ˆìš”, ì´ê±´ **Dosing** ë¬¸ì œì¼ ìˆ˜ë„. (ì˜¤ë””ì˜¤ì—ëŠ” ì—†ëŠ” ë‚´ìš©ì´ë‚˜ ì°¸ê³ : ì•¼ê°„ ì‚°ë¶„ë¹„ ê³ ë ¤) *ì˜¤ë””ì˜¤ ë‚´ìš© ê¸°ì¤€: 2ë‹¬ ì¹˜ë£Œ ì‹¤íŒ¨ ì‹œ ì¦ëŸ‰/êµì²´.* |\n**[Next Step for User]**\nì„ ìƒë‹˜, Esophagus íŒŒíŠ¸ëŠ” **Algorithm** ì‹¸ì›€ì…ë‹ˆë‹¤. íŠ¹íˆ **\"Solid vs Liquid\"** êµ¬ë¶„ê³¼ **\"Alarm feature ìœ ë¬´ì— ë”°ë¥¸ Scope ê²°ì •\"** ì´ ë‘ ê°€ì§€ê°€ ì‹œí—˜ì˜ 70%ë¥¼ ì°¨ì§€í•©ë‹ˆë‹¤. ë‹¤ìŒ ì„¹ì…˜(Stomach/Small Bowel)ìœ¼ë¡œ ë„˜ì–´ê°€ê¸° ì „ì—, ìœ„ í‘œì˜ Rapid Fire ë‚´ìš©ì„ ê°€ë¦¬ê³  ë‹µí•  ìˆ˜ ìˆëŠ”ì§€ ìê°€ í…ŒìŠ¤íŠ¸ í•œë²ˆ í•´ë³´ì‹œê² ìŠµë‹ˆê¹Œ?\nHere is the comprehensive study guide based on the audio file provided.\n### ğŸ§ One Line Vibe & Summary\n**\"Stomach Pathology: From toxic erosions to paralyzed pumps â€“ distinguishing functional failure from mechanical blocks.\"**\nì´ë²ˆ ì—í”¼ì†Œë“œëŠ” ìœ„ì¥ê´€(Stomach)ì—ì„œ ë°œìƒí•  ìˆ˜ ìˆëŠ” ë³‘ë¦¬í•™ì  ìƒíƒœë¥¼ 3.1ë¶€í„° 3.5ê¹Œì§€ **Erosion(ë¯¸ë€), Motility(ìš´ë™ì„±), Obstruction(íì‡„)**ì˜ ê´€ì ì—ì„œ ì •ë¦¬í–ˆìŠµë‹ˆë‹¤. íŠ¹íˆ Functional disorderì™€ Mechanical obstructionì„ êµ¬ë¶„í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-37","focus_area":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","tags":["usmle-step2","core","quiz-seed","diagnosis","tree"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n1. **Clinical Vignette:** 70ì„¸ ë…¸ì¸, í†µì¦ ì—†ëŠ” í™©ë‹¬ (Painless Jaundice), Courvoisier's sign (ë§Œì ¸ì§€ëŠ” ë‹´ë‚­).\n    - **Diagnosis:** [Malignancy (Pancreatic head cancer, Cholangiocarcinoma)]\n    - **Key Action:** **CT Abdomen** or **US** first. **Do NOT** assume stones.\n2. **Clinical Vignette:** ì Šì€ í™˜ì, ìŠ¤íŠ¸ë ˆìŠ¤ ë°›ê±°ë‚˜ êµ¶ì—ˆë”ë‹ˆ ê²½ë¯¸í•œ í™©ë‹¬ (Mild unconjugated hyperbilirubinemia). ê°„ìˆ˜ì¹˜ ì •ìƒ.\n    - **Diagnosis:** [Gilbert Syndrome]\n    - **Key Action:** **Reassurance**. No treatment needed.\n3. **Clinical Vignette:** Cirrhosis í™˜ì, Confusion, Asterixis (Hand flapping).\n    - **Diagnosis:** [Hepatic Encephalopathy]\n    - **Key Action:** Check for triggers (Infection, GI bleed, Constipation). Start **Lactulose**.\n4. **Clinical Vignette:** Acute Liver Failure Triad?\n    - **Answer:** [Severe Liver Injury (High LFTs) + Coagulopathy (INR â‰¥ 1.5) + Encephalopathy]\n    - **Trap:** Mental statusê°€ ì •ìƒì´ë©´ Acute Hepatitisì´ì§€ ALFê°€ ì•„ë‹˜! â˜…\n    - Hep C ëŠ” ì›ì¸ì•„ë‹˜! íƒ€ì´ë ˆë†€ì€ ì›ì¸ì„\n5. SAAG >1.1 : High Hydrostatic portal Hypertension / SAAG <1.1 : Low Leaky albumin\n6. **Clinical Vignette:** Ascites í™˜ì, **ë¯¸ì—´ â˜…**  ë°œìƒ. Paracentesisì—ì„œ PMN > 250.\n    - **Diagnosis:** [Spontaneous Bacterial Peritonitis (SBP)]\n    - **Key Action:** Start **Ceftriaxone** immediately. Give **Albumin** to protect kidneys.\n## ğŸ“ Tutor's One-Liner\n\"JaundiceëŠ” **Pain**ì´ ìˆëŠ”ì§€ ë¨¼ì € ë³´ê³ , LFT íŒ¨í„´(**Hepatocellular vs Cholestatic**)ìœ¼ë¡œ ê¸¸ì„ ë‚˜ëˆˆ ë’¤, **Anatomy(Duct dilation)**ë¥¼ í™•ì¸í•˜ì„¸ìš”. CirrhosisëŠ” **Decompensated events**(Bleeding, Ascites, Encephalopathy)ë¥¼ ë§‰ê³  ê´€ë¦¬í•˜ëŠ” ê²ƒì´ ì „ë¶€ì…ë‹ˆë‹¤! íŒŒì´íŒ…! ğŸ’ª\"\n# ğŸ©º **Deep Dive: Liver Pathology (Cirrhosis & Complications)**\n**Section 4.2 - 4.7 Comprehensive Lecture Notes**\nì•ˆë…•í•˜ì„¸ìš”! ì˜¤ëŠ˜ ìš°ë¦¬ëŠ” ìš°ë¦¬ ëª¸ì˜ **Metabolic Engine**ì¸ **Liver**ê°€ ê³ ì¥ ë‚¬ì„ ë•Œ ì–´ë–¤ ì¼ì´ ë²Œì–´ì§€ëŠ”ì§€, ê·¸ë¦¬ê³  **USMLE Step 2 CK**ì—ì„œ ì–´ë–»ê²Œ ì¶œì œë˜ëŠ”ì§€ ì•„ì£¼ ê¹Šê²Œ íŒŒí—¤ì³ ë³¼ ê²ë‹ˆë‹¤. ì—”ì§„ì´ ë©ˆì¶”ë©´ ì‹œìŠ¤í…œ ì „ì²´ê°€ ë¶•ê´´ë˜ë“¯ì´, ê°„ì´ ë©ˆì¶”ë©´ Brain, Kidney, Lungê¹Œì§€ ëª¨ë‘ íƒ€ê²©ì„ ì…ìŠµë‹ˆë‹¤. ì, ì¤€ë¹„ë˜ì…¨ë‚˜ìš”? Let's dive in! ğŸ¤¿","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-146","focus_area":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ **Rapid Fire Recap (High Yield Summary)**\nì˜¤ë””ì˜¤ì—ì„œ ê°•ì¡°í•œ í•µì‹¬ ì‹œë‚˜ë¦¬ì˜¤ ì •ë¦¬í‘œ!\n| **Clinical Vignette (ìƒí™©)** | **Diagnosis (ì§„ë‹¨)** | **Key Action / Trap (í•µì‹¬)** |\n| --- | --- | --- |\n| **Fatty meal** í›„ 30ë¶„ ë’¤ í†µì¦, 6ì‹œê°„ ë‚´ ì†Œì‹¤ | **Biliary Colic** | **Elective Lap Chole**. (ì‘ê¸‰ ì•„ë‹˜) |\n| RUQ pain, **Fever**, **Murphy's sign (+)** | **Acute Cholecystitis** | **HIDA scan** if US equivocal. **Surgery within 72h**. |\n| **Jaundice**, Alk Phos â†‘, Dilated CBD on US | **Choledocholithiasis** | **ERCP** first (Remove stone) â†’ then Cholecystectomy. |\n| **Fever + Jaundice + RUQ Pain** (Charcot) | **Acute Cholangitis** | **Emergent ERCP** (Drainage) + IV Abx + Fluids. |\n| **ICU Patient**, Sepsis, No stones on US | **Acalculous Cholecystitis** | **Cholecystostomy Tube** (Do NOT operate yet). |\n| **Diabetic Male**, Air in GB wall | **Emphysematous Cholecystitis** | **Emergency Surgery** (High risk of perforation). |\n| **Male with UC**, Jaundice, Itching | **PSC** | Screen for **Cholangiocarcinoma**. Look for \"Beads on string\". |\n| **Middle-aged Woman**, Itching, Fatigue | **PBC** | Check **Anti-Mitochondrial Ab (AMA)**. Tx: Ursodiol. |\n**[Next Step for User]**\n# ğŸ¥ USMLE Step 2 CK: The Angry Pancreas & The Silent Spleen","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-252","focus_area":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","mnemonic"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n1. **Epigastric pain radiating to back + Lipase > 3x** â†’ **Acute Pancreatitis** â†’ **Next Step:** Fluids (LR), Pain control, NPO. (Do NOT order CT first).\n2. **Acute Pancreatitis + ALT > 150** â†’ **Gallstone Pancreatitis** â†’ **Next Step:** RUQ Ultrasound.\n3. **Pancreatitis patient + Fever/Hypotension after 10 days + CT shows gas** â†’ **Infected Necrosis** â†’ **Next Step:** Antibiotics (Carbapenem) + Step-up drainage.\n4. **4 weeks after Pancreatitis + Early Satiety + Abdominal Mass** â†’ **Pancreatic Pseudocyst** â†’ **Next Step:** Symptomatic? Drainage (Cystogastrostomy). Asymptomatic? Observation.\n5. **Chronic Pancreatitis + Isolated Gastric Varices** â†’ **Splenic Vein Thrombosis** â†’ **Tx:** Splenectomy.\n6. **Sore throat (Mono) + Sudden LUQ pain/Shoulder pain** â†’ **Splenic Rupture** â†’ **Next Step:** Stable? CT. Unstable? OR.\n# ğŸ¥ USMLE Step 2 CK: GI Deep Dive (Small Intestine)\n**Topic:** Malabsorption, IBS, IBD, Celiac, SIBO\nì•ˆë…•í•˜ì„¸ìš” ì„ ìƒë‹˜! USMLE Step 2 CK ì¤€ë¹„ë¥¼ ìœ„í•œ GI íŒŒíŠ¸ Deep Diveì…ë‹ˆë‹¤.\nì˜¤ëŠ˜ì˜ ì£¼ì œëŠ” ì†Œì¥(Small Intestine) íŒŒíŠ¸ì…ë‹ˆë‹¤. ì¦ìƒì€ ë¹„ìŠ·í•´ ë³´ì´ì§€ë§Œ(ì„¤ì‚¬, ë³µí†µ, bloating), ê´€ë¦¬ëŠ” ì²œì§€ì°¨ì´ì¸ ì§ˆí™˜ë“¤ì„ í™•ì‹¤í•˜ê²Œ êµ¬ë¶„í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\në¨¼ì € ì „ì²´ì ì¸ ê·¸ë¦¼ì„ **Big Picture**ë¡œ ì¡ê³  ë“¤ì–´ê°€ê² ìŠµë‹ˆë‹¤.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-317","focus_area":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n| **Clinical Vignette (Korean)** | **Diagnosis (English)** | **Key Action / Trap âš ï¸** |\n| --- | --- | --- |\n| ì„ì‚°ë¶€, ìš°ì¸¡ ìƒë³µë¶€(RUQ) í†µì¦, ì••í†µ | **Appendicitis (in pregnancy)** | âš ï¸ **Trap:** ë‹´ë‚­ì—¼(Cholecystitis)ê³¼ í˜¼ë™ ì£¼ì˜. ìê¶ ë•Œë¬¸ì— ìœ„ì¹˜ ì´ë™í•¨. Next Step: **Ultrasound**. |\n| RLQ í†µì¦, ê³ ì—´, **í­ë°œì ì¸ ì„¤ì‚¬(Profuse diarrhea)** | **Pseudo-appendicitis (*Yersinia, Campylobacter*)** | âš ï¸ **Trap:** ìˆ˜ìˆ í•˜ë©´ ì•ˆ ë¨! ì¹˜ë£ŒëŠ” **Supportive care**. |\n| ê³¼ê±° ìê¶ì ì¶œìˆ ë ¥ 50ì„¸ ì—¬ì„±, ì‚°í†µ(Colicky pain), êµ¬í† , **High-pitched bowel sounds** | **Small Bowel Obstruction (SBO)** | **Next Step:** NPO, NG tube, IV fluids. ê°€ì¥ í”í•œ ì›ì¸ì€ **Adhesions**. |\n| SBO í™˜ì, ê°‘ìê¸° ì—´ë‚˜ê³  ë§¥ë°• ë¹¨ë¼ì§(Tachy), ë°° ë§Œì§€ë©´ ìì§€ëŸ¬ì§ | **Strangulated SBO** | **Next Step:** **Urgent Surgery**. (Ischemia ì˜ì‹¬). |\n| ìˆ˜ìˆ  í›„ 3ì¼ì§¸, ë°°ê°€ ë¹µë¹µí•¨, **Bowel sound ë“¤ë¦¬ì§€ ì•ŠìŒ**, ì§ì¥ì— ê°€ìŠ¤ ìˆìŒ | **Post-op Ileus** | **Tx:** ë³´ì¡´ì  ì¹˜ë£Œ, ì „í•´ì§ˆ êµì •, Opiate ì¤‘ë‹¨. |\n| CTìƒ Appendix ì£¼ìœ„ì— **Abscess** í˜•ì„±ë¨ | **Perforated Appendicitis** | âš ï¸ **Trap:** ë°”ë¡œ ìˆ˜ìˆ  ì•ˆ í•¨. **Drainage + Antibiotics** í›„ ë‚˜ì¤‘ì— ìˆ˜ìˆ (Interval Appy). |","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-423","focus_area":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\nì˜¤ë””ì˜¤ ë‚´ìš©ì„ ë°”íƒ•ìœ¼ë¡œ ì‹œí—˜ì— ë°”ë¡œ ì¨ë¨¹ì„ ìˆ˜ ìˆëŠ” **One-Line Summary**ì…ë‹ˆë‹¤.\n| **Clinical Vignette (Korean)** | **Diagnosis (English)** | **Key Action / Trap ğŸ¯** |\n| --- | --- | --- |\n| ì™€íŒŒë¦° ë³µìš© ë…¸ì¸, ì˜†êµ¬ë¦¬ í†µì¦, ë©ì–´ë¦¬ ë§Œì ¸ì§, ë¹ˆí˜ˆ, **ë³€ì— í”¼ ì—†ìŒ** | **Retroperitoneal Hematoma** | **Stable** â†’ Reverse Warfarin & ICU Watch (ìˆ˜ìˆ  ê¸ˆì§€ ğŸ™…â€â™‚ï¸)\n**Unstable** â†’ Angio/Embolization |\n| ê°„ê²½í™” í™˜ì, ë¯¸ì—´(37.8ë„), ë³µí†µ | **SBP** (Spontaneous Bacterial Peritonitis) | **Tap the fluid!** (Paracentesis)\nCutoff: **PMN â‰¥ 250**\nTx: Ceftriaxone |\n| PD(ë³µë§‰íˆ¬ì„) í™˜ì, íˆ¬ì„ì•¡ì´ ë¿Œì˜‡ë‹¤(Cloudy) | **PD-associated Peritonitis** | Bug: **Staph** (Skin flora)\nTx: Intraperitoneal Abx |\n| ì‹ ìƒì•„ ë°°ê¼½ íŠ€ì–´ë‚˜ì˜´, ëˆ„ë¥´ë©´ ë“¤ì–´ê° | **Umbilical Hernia** | **Observe until Age 5**. (ë¶€ëª¨ë‹˜ ì•ˆì‹¬ì‹œí‚¤ê¸°) |\n| ì‚°í›„ ì—¬ì„±, ìœ—ëª¸ì¼ìœ¼í‚¤ê¸° í•  ë•Œ ë°° ê°€ìš´ë° ìœµê¸° | **Diastasis Recti** | **Not a hernia**. ìˆ˜ìˆ  X. Reassurance. |\n| ìˆ˜ìˆ  í‰í„° ë¶€ìœ„ ë¶ˆë£©í•¨, ê¸°ì¹¨í•  ë•Œ ì»¤ì§ | **Incisional Hernia** | Fascial breakdownì´ ì›ì¸.\nCTë¡œ í™•ì¸ ê°€ëŠ¥. |\n### ğŸ’¡ Tutor's Closing Comment\nì˜¤ëŠ˜ì˜ ê°€ì¥ í° êµí›ˆ(Takeaway)ì€ **\"Don't just do something, stand there!\"** ì…ë‹ˆë‹¤. íŠ¹íˆ **Retroperitoneal Hematoma**ì™€ **Umbilical Hernia** (5ì„¸ ë¯¸ë§Œ)ì—ì„œëŠ” ì„£ë¶ˆë¦¬ ì¹¼ì„ ëŒ€ëŠ” ê²ƒë³´ë‹¤ **Observation**ì´ ì •ë‹µì¸ ê²½ìš°ê°€ ë§ìŠµë‹ˆë‹¤. ë°˜ë©´ **Peritonitis** ì˜ì‹¬ë  ë• ì£¼ì € ë§ê³  ë°”ëŠ˜(Paracentesis)ì„ ê½‚ì•„ì•¼ê² ì£ ?\nì‹œí—˜ì¥ì—ì„œëŠ” **\"Stability\"**ì™€ **\"Age\"** ê°™ì€ íŠ¸ë¦¬ê±° í¬ì¸íŠ¸ë¥¼ ë†“ì¹˜ì§€ ë§ˆì„¸ìš”! í™”ì´íŒ…! ğŸ’ª\nêµ°ì˜ê´€ë‹˜, ì˜¤ëŠ˜ë„ USMLE Step 2 CK ì •ë³µì„ ìœ„í•´ ë‹¬ë ¤ë´…ì‹œë‹¤! ğŸƒâ€â™‚ï¸ğŸ’¨ ìš”ì²­í•˜ì‹  ì˜¤ë””ì˜¤ íŒŒì¼ `[12.1-12.6] Clinical_Recognition_and_Management_of_GI_Tumors.m4a`ë¥¼ ì™„ì²­í•˜ê³ , ì‹œí—˜ì— ì§ê²°ë˜ëŠ” í•µì‹¬ ë‚´ìš©ë§Œ ì™ì™ ë½‘ì•„ 'ê³¼ì™¸ ì„ ìƒë‹˜' ëª¨ë“œë¡œ ì •ë¦¬í•´ ë“œë¦´ê²Œìš”.\nì˜¤ë””ì˜¤ì—ì„œ ê°•ì¡°í•œ **\"Doorway Thought\"** (í™˜ìë¥¼ ë³´ìë§ˆì ì§„ë‹¨ì„ ë– ì˜¬ë¦¬ëŠ” ì§ê´€) í›ˆë ¨ì— ì§‘ì¤‘í•´ì„œ ì •ë¦¬í–ˆìŠµë‹ˆë‹¤. ğŸ§ âœ¨","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-178","focus_area":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\në§ˆì§€ë§‰ìœ¼ë¡œ ì˜¤ë””ì˜¤ ë‚´ìš©ì„ ë°”íƒ•ìœ¼ë¡œ í•œ í•µì‹¬ ì •ë¦¬ì…ë‹ˆë‹¤.\n1. **Dysphagia + Weight Loss** â†’ **Esophageal Cancer** suspected.\n    - Workup: Barium Swallow first if stricture suspected, but **EGD** is Gold Standard for biopsy.\n2. **Pancreatic Head Mass** â†’ **Painless Jaundice** + Palpable Gallbladder (**Courvoisier Sign**).\n3. **Pancreatic Body/Tail Mass** â†’ Back pain + **Migratory Thrombophlebitis** (**Trousseau Sign**).\n4. **Elderly with Iron Deficiency Anemia** â†’ **Colon Cancer** until proven otherwise (Do Colonoscopy!).\n    - Upper GI (Gastric Cancer)ë„ ê°€ëŠ¥í•˜ì§€ë§Œ Colon ë¨¼ì € R/O.\n5. **Liver Mass in Young Female on OCP** â†’ **Hepatic Adenoma**.\n    - Mgmt: **Stop OCPs**. Resect if > 5cm due to rupture risk.\n6. **Liver Mass with Central Scar** â†’ **FNH** (Benign). Do nothing.\n7. **Gastric MALToma** â†’ Treat **H. pylori** first! (Antibiotics = Chemotherapy here).\n8. **Staging Gastric Cancer** â†’ Don't forget **Laparoscopy** to check for peritoneal seeding! (CT misses it).\nêµ°ì˜ê´€ë‹˜, ì´ íŒŒíŠ¸ëŠ” \"Risk Factor\"ì™€ \"Screening/Next Step\"ì˜ ì‹¸ì›€ì…ë‹ˆë‹¤. íŠ¹íˆ ì·Œì¥ì•”ì˜ ìœ„ì¹˜ë³„ ì¦ìƒ ì°¨ì´ì™€ ëŒ€ì¥ì•” ìŠ¤í¬ë¦¬ë‹ ë‚˜ì´ ë³€ê²½(45ì„¸)ì€ ê¼­ ê¸°ì–µí•´ ì£¼ì„¸ìš”! ğŸ’ªğŸš¢\n**One Line Vibe:** ğŸ‘¶ğŸ¼ ì‹ ìƒì•„ì™€ ìœ ì•„ì˜ êµ¬í† , ë‹¨ìˆœ ë°°ì•“ì´ê°€ ì•„ë‹ˆë¼ \"ë°°ê´€(Plumbing)\"ê³¼ \"ë°°ì„ (Wiring)\"ì˜ ë¬¸ì œë¡œ ì ‘ê·¼í•˜ëŠ” íƒì • ë†€ì´!","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-259","focus_area":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"### ğŸ”¥ 4. Rapid Fire Recap (High Yield Summary)\n1. **Clinical Vignette:** ìƒí›„ 1ì¼, ë‹¤ìš´ì¦í›„êµ°, **ì´ˆë¡ìƒ‰ í† (Bilious Vomiting)**, X-rayìƒ ê³µê¸°ë°©ìš¸ 2ê°œ.\n    - **Diagnosis:** **Duodenal Atresia**\n    - **Key Action:** **Double Bubble Sign** í™•ì¸. ìˆ˜ìˆ  ì „ NGT ê°ì•• & ìˆ˜ì•¡.\n2. **Clinical Vignette:** ì‚°ëª¨ê°€ ì½”ì¹´ì¸ í¡ì…ë ¥ ìˆìŒ, ì•„ê¸°ê°€ ì´ˆë¡ìƒ‰ í† , X-rayìƒ ê³µê¸°ë°©ìš¸ ì—¬ëŸ¬ ê°œ.\n    - **Diagnosis:** **Jejunal/Ileal Atresia**\n    - **Key Concept:** **Vascular Accident** in utero (Apple peel deformity).\n3. **Clinical Vignette:** ìƒí›„ 3ì£¼, ê°‘ìê¸° ì´ˆë¡ìƒ‰ í† , X-rayëŠ” ì •ìƒ ê°™ìŒ. Upper GI ì°ìœ¼ë‹ˆ **Corkscrew** ëª¨ì–‘.\n    - **Diagnosis:** **Malrotation with Volvulus**\n    - **Trap:** X-ray ì •ìƒì´ë¼ê³  ì•ˆì‹¬ ê¸ˆì§€! ì‹œê°„ ì‹¸ì›€(6ì‹œê°„ ë‚´ ê´´ì‚¬). **Ladd Procedure** ì¦‰ì‹œ ì‹œí–‰.\n4. **Clinical Vignette:** íƒœë³€ ë°°ì¶œ ì‹¤íŒ¨(48ì‹œê°„+), ë³µë¶€ íŒ½ë§Œ. ê´€ì¥ ì‹œ **\"Explosive Stool\"**.\n    - **Diagnosis:** **Hirschsprung Disease**\n    - **Gold Standard:** **Rectal Suction Biopsy** (ì‹ ê²½ì ˆ ì„¸í¬ ë¶€ì¬ í™•ì¸).\n5. **Clinical Vignette:** 18ê°œì›” ì•„ê¸°, ì£¼ê¸°ì ìœ¼ë¡œ ìì§€ëŸ¬ì§€ê²Œ ìš¸ê³  ë‹¤ë¦¬ë¥¼ ë°°ë¡œ êµ½í˜. ê¸°ì €ê·€ì— **Currant Jelly** ê°™ì€ ë³€.\n    - **Diagnosis:** **Intussusception**\n    - **Next Best Step:** **Air or Contrast Enema** (ì§„ë‹¨ ê²¸ ì¹˜ë£Œ).\n**Would you like me to create a \"Comparison Table\" specifically distinguishing Pyloric Stenosis (Non-bilious) from these Bilious pathologies for a complete picture?**\n# ğŸ¥ Section 13.0: Miscellaneous Abdominal Topics\nì˜¤ëŠ˜ì˜ Deep DiveëŠ” ICU ì„¸íŒ…ì—ì„œ ë§ˆì£¼ì¹  ìˆ˜ ìˆëŠ” ë‘ ê°€ì§€ **Critical Scenario**ë¥¼ ë‹¤ë£¹ë‹ˆë‹¤. í•˜ë‚˜ëŠ” ë¬¼ë¦¬ì ì¸ **Pressure**ì˜ ë¬¸ì œ(ACS)ì´ê³ , ë‹¤ë¥¸ í•˜ë‚˜ëŠ” **Nutrition**ê³¼ ê´€ë ¨ëœ ìƒë¦¬í•™ì  íŒë‹¨(TPN)ì˜ ë¬¸ì œì…ë‹ˆë‹¤.\n## 1. Abdominal Compartment Syndrome (ACS) ğŸˆğŸ’¥","subject":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","page_title":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","episode":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","section_path":["LM_GIT2 2f946f2986ee80f58743c80a29f3f081"],"source_doc_id":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","source_page":null,"source_anchor":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081-300","focus_area":"LM_GIT2 2f946f2986ee80f58743c80a29f3f081","tags":["usmle-step2","core","quiz-seed","diagnosis"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\nì‹œí—˜ ì§ì „ ì´ê²ƒë§Œì€ ê¼­ ê¸°ì–µí•˜ì„¸ìš”! âš¡ï¸\n| **Feature** | **Malrotation w/ Volvulus ğŸŒ€** | **Intussusception ğŸ”­** | **Necrotizing Enterocolitis (NEC) ğŸ’€** |\n| --- | --- | --- | --- |\n| **Typical Patient** | **Neonate (<1 mo)** | **6mo ~ 3yo** | **Premature Infant** |\n| **Key Symptom** | **Bilious Emesis (Green!)** ğŸ¤® | **Colicky Pain** (Knees to chest), Currant Jelly Stool | Abdominal Distension, Bloody stool |\n| **Pathophysiology** | Rotation ì‹¤íŒ¨ + Ladd bands | Telescoping (Lymphoid hyperplasia) | Ischemia + Bacterial invasion (Formula) |\n| **Diagnostic Sign** | **Corkscrew** (UGI series) | **Target Sign** (US), Sausage Mass | **Pneumatosis Intestinalis** (X-ray) |\n| **Gold Standard/Tx** | **Ladd Procedure** (Surgery) | **Air/Contrast Enema** | NPO + Abx (Medical) â†’ Surgery if perf |\n| **Key Vibe/Pearl** | **\"Time is Bowel\"** (Twisted hose) | **Intermittent pain** is tricky! | **Breast milk is protective** ğŸ¤± |\n### ğŸ‘¨â€ğŸ« Tutor's Note:\n- **Age is the biggest clue.** 1ê°œì›” ë¯¸ë§Œì´ë©´ Volvulus, 6ê°œì›”~3ì„¸ë©´ Intussusception, NICUì— ìˆëŠ” ë¯¸ìˆ™ì•„ë©´ NEC. ë‚˜ì´ë¥¼ ë¨¼ì € ë³´ê³  ë“¤ì–´ê°€ì„¸ìš”.\n- **Green Vomit = Emergency.** ì‹ ìƒì•„ì˜ ì´ˆë¡ìƒ‰ í† ëŠ” ì ˆëŒ€ ë¬´ì‹œí•˜ë©´ ì•ˆ ë©ë‹ˆë‹¤.\n- **Enemaì˜ ì´ì¤‘ ì—­í• :** Intussusceptionì—ì„œ EnemaëŠ” ì§„ë‹¨ì´ì ì¹˜ë£Œì…ë‹ˆë‹¤. (Therapeutic & Diagnostic).\nStep 2 CK ì¤€ë¹„ íŒŒì´íŒ…ì…ë‹ˆë‹¤! ì´ ì„¸ ê°€ì§€ ì‹œë‚˜ë¦¬ì˜¤ë§Œ ë¨¸ë¦¿ì†ì— í™•ì‹¤íˆ ê·¸ë ¤ë‘ë©´ Pediatric GI ë¬¸ì œë“¤ì€ ë‹¤ ë§ì¶œ ìˆ˜ ìˆìŠµë‹ˆë‹¤! ğŸ‘Š\n**One Line Vibe:** ğŸ‘¶ ì‹ ìƒì•„ í™©ë‹¬ë¶€í„° ì¥íìƒ‰ê¹Œì§€, ìƒ‰ê¹”(Yellow vs Green)ê³¼ íƒ€ì´ë°(Timing)ìœ¼ë¡œ ìŠ¹ë¶€ ë³´ëŠ” USMLE Step 2 ì¡±ì§‘ê²Œ ê°•ì˜!","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-121","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","quiz-seed","treatment","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"## **ğŸ”¥ Rapid Fire Recap (High Yield Summary)**\n1. **Vignette:** ìƒí›„ 4ì¼, ëª¨ìœ  ìˆ˜ìœ  ì¤‘, ì²´ì¤‘ ê°ì†Œ, ê¸°ì €ê·€ì— ë¶‰ì€ ê°€ë£¨(Brick red crystals).\n    - **Diagnosis:** **Breastfeeding Jaundice** (ìˆ˜ìœ  ë¶€ì¡±).\n    - **Action:** **Feed more!** (ìˆ˜ìœ ëŸ‰ ëŠ˜ë¦¬ê¸°).\n2. **Vignette:** ìƒí›„ 14ì¼, ê±´ê°•í•´ ë³´ì„(Happy baby), í™©ë‹¬ ì§€ì†, Direct bilirubin ì •ìƒ.\n    - **Diagnosis:** **Breast Milk Jaundice** (ëª¨ìœ  ì„±ë¶„ ë¬¸ì œ).\n    - **Action:** **Continue Breastfeeding.** (ì•ˆì‹¬ì‹œí‚¤ê¸°).\n3. **Vignette:** ìƒí›„ 3ì£¼, í™©ë‹¬, íšŒìƒ‰ ë³€(Clay stool), ì½œë¼ìƒ‰ ì†Œë³€(Dark urine).\n    - **Diagnosis:** **Biliary Atresia**.\n    - **Next Step:** Ultrasound â†’ **Liver Biopsy** / Intraoperative Cholangiogram (Gold Standard).\n    - **Treatment:** **Kasai Procedure** (ASAP).\n4. **Vignette:** ìƒí›„ 1ì¼, ì´ˆë¡ìƒ‰ í† (Bilious vomiting), X-rayìƒ Double Bubble.\n    - **Diagnosis:** **Duodenal Atresia**.\n    - **Association:** **Down Syndrome**.\n5. **Vignette:** ì‚°ëª¨ê°€ ì½”ì¹´ì¸/ë‹´ë°° ì‚¬ìš©, ì•„ê¸°ëŠ” ì´ˆë¡ìƒ‰ í† , X-rayìƒ Triple bubble/Multiple air-fluid levels.\n    - **Diagnosis:** **Jejunal/Ileal Atresia**.\n    - **Mechanism:** **Vascular Accident** (Ischemic necrosis).\n## ğŸŒ³ USMLE Step 2 CK: Pediatric GI Emergencies & Metabolic Disasters\nì•ˆë…•! ì˜¤ëŠ˜ì€ ì†Œì•„ê³¼ GI íŒŒíŠ¸ ì¤‘ì—ì„œë„ **\"Time is vital\"**ì¸ ì‘ê¸‰ ì§ˆí™˜ë“¤ê³¼ ëŒ€ì‚¬ ì§ˆí™˜ë“¤ì„ ë‹¤ë£° ê±°ì•¼. ğŸ•’ ì‹œí—˜ì¥ì—ì„œë„, ì‹¤ì œ ì‘ê¸‰ì‹¤ì—ì„œë„ ë†“ì¹˜ë©´ í°ì¼ ë‚˜ëŠ” **High Yield** ì£¼ì œë“¤ì´ë‹ˆê¹Œ ì§‘ì¤‘í•´!\nìš°ì„  í° ê·¸ë¦¼(Big Picture)ë¶€í„° ì¡ê³  ê°€ì. ì•„ì´ê°€ ë°°ê°€ ì•„í”„ê±°ë‚˜ í† í•  ë•Œ, **ë‚˜ì´(Age)**ì™€ **ë³€ì˜ ì–‘ìƒ(Stool pattern)**ì´ ê°ë³„ ì§„ë‹¨ì˜ í•µì‹¬ì´ì•¼.\nPlaintext","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-164","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n| **Injury** | **Key Vignette / Symptom** | **Diagnosis** | **Treatment (Cut vs Wait)** |\n| --- | --- | --- | --- |\n| **Pancreatic Injury** | Handlebar injury, Rising Amylase | CT Abdomen (Gold Std) | **Wait** (if duct intact) / **Cut** (if duct ruptured) |\n| **Splenic Rupture** | Kehr Sign (L. Shoulder pain), Mono hx | CT (Stable) / Clinical (Unstable) | **Unstable:** Ex-lap (Cut)\n**Stable:** Embolization or Observe (Wait) |\n| **Duodenal Perforation** | Fever next day, Retroperitoneal Air | CT w/ Oral Contrast | **Cut** (Surgery is mandatory) |\n| **Duodenal Hematoma** | Peds, Handlebar, Bilious vomiting | CT Abdomen | **Wait** (NGT + TPN). **Do NOT Cut** |\n| **Rectus Sheath Hematoma** | Coughing elderly, Warfarin, **Fothergill Sign** | CT / Physical Exam | **Wait** (Conservative) |\n| **Wound Dehiscence** | Post-op Day 5, **Salmon-colored fluid** | Clinical (Look at the dressing) | **Cut** (Emergency Fascial Repair) |\n| **Pilonidal Sinus** | Hairy male, Gluteal cleft abscess | Physical Exam | **Cut** (I&D + Excision) |\n## ğŸ¥ **Managing Acute GI Bleeding & Variceal Hemorrhage**\n**(Section 17-17.3)**\nì•ˆë…•í•˜ì‹­ë‹ˆê¹Œ ì„ ìƒë‹˜! ì˜¤ëŠ˜ë„ USMLE Step 2 CK ì •ë³µì„ ìœ„í•´ \"High Acuity Medicine\" íŒŒíŠ¸, ì¦‰ ì‘ê¸‰ì‹¤ì—ì„œ ê°€ì¥ ê¸´ì¥ë˜ëŠ” **GI Bleeding**ì„ ë‹¤ë¤„ë³´ê² ìŠµë‹ˆë‹¤. ë‹¨ìˆœíˆ ë¦¬ìŠ¤íŠ¸ë¥¼ ì™¸ìš°ëŠ” ê²Œ ì•„ë‹ˆë¼, í™˜ìê°€ í”¼ë¥¼ í† í•˜ë©° ë“¤ì–´ì™”ì„ ë•Œ ë¨¸ë¦¿ì†ì— ë°”ë¡œ ë– ì˜¬ë¼ì•¼ í•˜ëŠ” **Mental Framework**ë¥¼ ë§Œë“œëŠ” ê²ƒì´ ëª©í‘œì…ë‹ˆë‹¤.\n### ğŸŒ³ **Big Picture: Top-down Classification**","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-374","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"## **ğŸ”¥ Rapid Fire Recap (Summary)**\n1. **Vignette:** CKD on EPO, decreasing Hb.\n    - **Diagnosis:** Functional Iron Deficiency.\n    - **Action:** Give **IV Iron** (Not oral!).\n2. **Vignette:** Microcytic anemia, High Ferritin, Low TIBC.\n    - **Diagnosis:** Anemia of Chronic Disease (ACD).\n    - **Mechanism:** Hepcidin locking iron in macrophages.\n3. **Vignette:** Microcytic anemia, RBC count is actually high or normal. Mentzer Index < 13, Target cells.\n    - **Diagnosis:** **Thalassemia**.\n    - **Next Step:** Hb Electrophoresis.\n4. **Vignette:** Gastrectomy patient with neuropathy (tingling) & anemia.\n    - **Diagnosis:** B12 Deficiency.\n    - **Lab Clue:** High **Methylmalonic Acid (MMA)**.\n5. **Vignette:** Treating severe B12 deficiency, patient develops palpitations/weakness.\n    - **Complication:** **Hypokalemia**. (Cell turnover uses up K+).\n**Confidence:** 1.0 (Based strictly on the provided audio content).\n**Caveat:** Mentzer IndexëŠ” ì£¼ë¡œ ì†Œì•„ê³¼(Pediatrics)ì—ì„œ ë§ì´ ë‚˜ì˜¤ì§€ë§Œ ì„±ì¸ ë‚´ê³¼(IM)ì—ì„œë„ ê°ë³„ í¬ì¸íŠ¸ë¡œ ìœ ìš©í•©ë‹ˆë‹¤. B12 ì¹˜ë£Œ ì‹œ HypokalemiaëŠ” ì‹¤ì „/ì‹œí—˜ ëª¨ë‘ì—ì„œ ë†“ì¹˜ë©´ ì•ˆ ë˜ëŠ” ì¹˜ëª…ì ì¸ í¬ì¸íŠ¸ì…ë‹ˆë‹¤!\n# ğŸ©¸ **Intrinsic Hemolytic Anemias: The Deep Dive**\n<aside>\nğŸ’¡","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-55","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","quiz-seed","diagnosis","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"## **âš¡ï¸ Rapid Fire Recap (High Yield Q&A)**\nì˜¤ë””ì˜¤ ë§ˆì§€ë§‰ì— ë‚˜ì˜¨ Rapid Fire Recapì…ë‹ˆë‹¤. ì‹œí—˜ ì§ì „ ë¦¬ë§ˆì¸ë“œìš©!\n- **Q: African American male, back pain, dark urine after taking TMP-SMX?**\n    - **A:** **G6PD Deficiency**. (Antibiotic trigger).\n- Q: G6PD ë¹ˆí˜ˆí™˜ìì—ì„œ í”¼í•´ì•¼í•  UTIì•½\n    - A: TMPSMX(Bactrim), Nitrofurantoin\n- **Q: Best test for G6PD during active hemolysis?**\n    - **A:** **None.** Wait 3 months. (False negative risk).\n- **Q: Dark urine in the morning, history of DVT(Budd Chiari) in weird places?**\n    - **A:** **PNH (Paroxysmal Nocturnal Hemoglobinuria)**.\n    - **A:** **Flow Cytometry** (Looking for CD55/59 absence).\n- **Q: Sickle Cell patient with fever, chest pain, new infiltrate on CXR?**\n    - **A:** **Acute Chest Syndrome**. (Treat aggressively!).\n    Ceftriaxone, Azithromycin â˜…\n- Q: SCD stroke prevention\n    - A: ë‡Œ ë„í”ŒëŸ¬ í˜ˆë¥˜ ì†ë„ ê²€ì‚¬.\n- **Q: Sickle Cell patient with osteomyelitis. Most likely bug?**\n    - **A:** **Salmonella**.\n- Q: HSì—ì„œ í˜ˆì—­í•™ì  ì†Œê²¬\n    - High MCHC (due to dehydration)\n- **Q: High MCHC, splenomegaly, Coombs negative?**\n    - **A:** **Hereditary Spherocytosis**.\n- **Q: Treatment for Hereditary Spherocytosis?**\n    - **A:** **Splenectomy** (Don't forget vaccines first!).\n\"All right, everyone, settle in. We are back, and today, we are going directly into the trenches. We are. I'm your attending for this session, and my job is pretty simple. I'm here to make sure that when you see a patient, or, you know, a question stem on your board exam, you know exactly what the next best step is. No memorizing. We are not just memorizing facts here; we're building that clinical intuition.\"\n## ğŸ“‹ Overview: Sickle Cell Disease (SCD)","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-120","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","quiz-seed","treatment","tree"]}
{"chunk_type":"recap_quiz_seed","text":"### **STEP 4: RAPID FIRE RECAP (Summary Table)**\n| **Condition** | **Key Mechanism** | **Critical Symptom/Sign** | **Gold Standard / Next Step** |\n| --- | --- | --- | --- |\n| **Hodgkin Survivorship** | Radiation/Chemo DNA Damage | New cough/pain >15 yrs post-cure | **Secondary Malignancy Workup** (Lung/Breast/Thyroid) + Cardiac Echo |\n| **Hodgkin (Active)** | Vasodilation in Capsule | **Alcohol-induced Pain** | Biopsy / Staging |\n| **Multiple Myeloma** | IgG/IgA, Osteoclast Activation | **CRAB**, Bone Pain, High Ca2+ | **Skeletal Survey** (Look for lytic lesions) |\n| **Waldenstrom's** | IgM (Pentamer), Hyperviscosity | Blurry Vision, Bleeding, Huge Spleen | Serum Viscosity, Plasmapheresis (if symptomatic) |\n| **Imaging Trap** | Pure Lytic Nature of MM | Bone Scan looks \"Normal\" | **Avoid Bone Scan** â†’ Do X-ray/CT Survey |\n### **STEP 5: REFLECTION & CAVEATS**\n- **Confidence:** 1.0 (ëª¨ë“  í•µì‹¬ ë‚´ìš© í¬í•¨ë¨).\n    - Secondary Malignancyì˜ 18.5ë°° ë¦¬ìŠ¤í¬ ìˆ˜ì¹˜ëŠ” ë§¤ìš° ì¤‘ìš”í•˜ë¯€ë¡œ ì•”ê¸° í•„ìš”.\n    - High Calciumì´ ë‚˜ì˜¤ë©´ í•­ìƒ PTH(ë¶€ê°‘ìƒì„  í˜¸ë¥´ëª¬)ë¥¼ ì²´í¬í•˜ì—¬ Negative Feedback Loop(Suppressed PTH)ë¥¼ í™•ì¸í•´ì•¼ í•¨. MyelomaëŠ” PTHê°€ ë‚®ì•„ì•¼ ì •ìƒ(High Ca -> Low PTH).\n    - Waldenstrom'sì˜ ê²½ìš° IgM ìŠ¤íŒŒì´í¬ì™€ Hyperviscosity ì¦ìƒì´ ë§¤ì¹­ë˜ì–´ì•¼ í•¨.\n**Would you like me to generate a specific quiz based on the \"Imaging Trap\" or \"Shift Change\" concepts to test your retention?**\nì•„ì´ê³ , ì£„ì†¡í•©ë‹ˆë‹¤! ğŸ˜… ì œê°€ ì—´ì •ì´ ë„˜ì³ì„œ ê·¸ë§Œ ì˜ì–´ë¡œ ì­‰ ë‹¬ë ¤ë²„ë ¸ë„¤ìš”.\nì €ì¥ëœ ì„¤ì •([2025-12-08])ì— ë”°ë¼, **ì˜í•™ ìš©ì–´ëŠ” ëª…í™•í•˜ê²Œ English**ë¡œ ìœ ì§€í•˜ê³ , ì„¤ëª…ì€ **ì•„ì£¼ ì°°ì§€ê³  ì¬ë¯¸ìˆëŠ” í•œêµ­ì–´(ê³¼ì™¸ ì„ ìƒë‹˜ í†¤)**ë¡œ ë‹¤ì‹œ ì •ë¦¬í•´ ë“œë¦´ê²Œìš”. \"Zero-Loss\" ì›ì¹™ ê·¸ëŒ€ë¡œ, ë¹ ì§„ ë‚´ìš© ì—†ì´ ê½‰ ì±„ì› ìŠµë‹ˆë‹¤!\nì, ë‹¤ì‹œ ê°‘ë‹ˆë‹¤! ğŸš€","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-93","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","quiz-seed","diagnosis","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"# âš¡ Rapid Fire Recap (ìš”ì•½ í…Œì´ë¸”)\n| **ì§ˆí™˜ (Condition)** | **ê¸°ì „ (Mechanism)** | **í•µì‹¬ Vignette íŠ¹ì§•** | **ì¹˜ë£Œ / Pearl (Tx)** |\n| --- | --- | --- | --- |\n| **Pseudothrombocytopenia** | Lab ì˜¤ë¥˜ (Clumping) | ìˆ˜ì¹˜ëŠ” ë‚®ì€ë° í™˜ìëŠ” ë©€ì©¡ | **Blue Tube (Citrate)ë¡œ ì¬ê²€** |\n| **Vitamin K Def.** | Factor 2,7,9,10,C,S ë¶€ì¡± | ì‹ ìƒì•„ ì¶œí˜ˆ, ì¥ê¸° í•­ìƒì œ ì‚¬ìš© | **IM Vit K**, ê¸‰í•˜ë©´ FFP |\n| **ITP** | ìê°€ë©´ì—­ (Anti-GPIIb/IIIa) | Isolated Low Platelets, ê°ê¸° í›„ | **Steroids/IVIG** (<30k ì¼ ë•Œ). **HIV/Hep C ë°°ì œ**. |\n| **TTP** | ADAMTS13 ê²°í• | **FAT RN** (Neuro ì¦ìƒ), Schistocytes | **PLEX** ì¦‰ì‹œ ì‹œí–‰. **Platelets ê¸ˆì§€!** |\n| **HUS** | Shiga Toxin (E. Coli) | Bloody Diarrhea + **Renal Failure** | **Supportive**. **Antibiotics ì ˆëŒ€ ê¸ˆì§€!** |\n| **Mixing Study** | Lab ë…¼ë¦¬ | PTT ìƒìŠ¹ ì‹œ ì‹œí–‰ | **Corrects** = ê²°í•. **Fails** = ì–µì œì œ(Inhibitor). |\n| **Massive Transfusion** | í¬ì„ë¨ (Dilutional) | PRBC 10íŒ© ì´ìƒ ìˆ˜í˜ˆ ì‹œ | **FFP & Platelets** ê°™ì´ ì¤˜ë¼ (1:1:1 ë¹„ìœ¨) |\n- **Splenic Sequestration:** \"ì¦ìƒ ì—†ëŠ”\" í˜ˆì†ŒíŒ ê°ì†Œ í™˜ìì—ì„œ ê°„ê²½í™”(Cirrhosis)ë‚˜ ë¹„ì¥ë¹„ëŒ€(Splenomegaly) ê¼­ í™•ì¸í•˜ì„¸ìš”.\n- **TTP vs DIC:** TTPëŠ” Coags(PT/PTT)ê°€ **ì •ìƒ**ì…ë‹ˆë‹¤. DICëŠ” Coagsê°€ **ìƒìŠ¹**í•©ë‹ˆë‹¤. ì´ê²Œ ê°ë³„ í¬ì¸íŠ¸!\n- **Confidence:** ì˜¤ë””ì˜¤ ë‚´ìš©ì„ 100% ë°˜ì˜í•˜ì—¬ ì‘ì„±í–ˆìŠµë‹ˆë‹¤.\n**\"FAT RN\" 5ëŒ€ ì¦ìƒì„ ì´ìš©í•´ì„œ USMLE ìŠ¤íƒ€ì¼ì˜ ì—°ìŠµ ë¬¸ì œë¥¼ í•˜ë‚˜ ë§Œë“¤ì–´ ë“œë¦´ê¹Œìš”?**\n### ğŸ“‹ Overview: The Hemostasis Battlefield (TL;DR)\n| **Topic** | **Key Concept (Mental Model)** | **Critical \"Do Not Miss\"** |\n| --- | --- | --- |\n| **MAHA** | **Razor Wire** (Micro-clots shred RBCs) ğŸ©¸ğŸ”ª | Look for **Schistocytes** (Helmet cells) on smear. |\n| **TTP** | **Missing Scissors** (ADAMTS13 deficiency) âœ‚ï¸ğŸš« | **NEVER give platelets** (Fuel to fire). Rx: Plasma Exchange (PEX). |\n| **HUS** | **The Antibiotic Trap** (E. coli toxin bomb) ğŸ”ğŸ’£ | **NO Antibiotics** for bloody diarrhea in kids (causes renal failure). |\n| **ITP** | **Mistaken Identity** (Antibodies eat platelets) ğŸ·ï¸ğŸ½ï¸ | Diagnosis of exclusion. **Test for HIV/Hep C**. |\n| **Mixing Study** | **The Logic Puzzle** (Deficiency vs. Inhibitor) ğŸ§© | Corrects = Deficiency. No correction = Inhibitor. |\n| **DIC** | **The Consumer** (Everything used up) ğŸ“‰ | Acute = Bleeding (Sepsis). Chronic = Clotting (Cancer). |","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-174","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"recap_quiz_seed","text":"### âš¡ Rapid Fire Recap (High Yield)\n- **Schistocytes on smear** â†’ Think **MAHA** (TTP, HUS, DIC). ğŸ”ª\n- **TTP Pentad** â†’ Fever, Neuro sx, Renal, Anemia, Low Platelets. **Tx: Plasma Exchange**. (NO PLATELETS!). ğŸ©¸ğŸš«\n- **Kid + Bloody Diarrhea** â†’ **HUS**. **NO ANTIBIOTICS**. ğŸ”ğŸ’£\n- **Isolated Thrombocytopenia** â†’ **ITP**. Check **HIV/HCV**. ğŸ¦ \n- **Mixing Study Corrects** â†’ Factor Deficiency (Hemophilia). âœ…\n- **Mixing Study No Correction** â†’ Inhibitor (Lupus Anticoagulant). âŒ\n- **Deep Bleeding (Joints)** â†’ Factor problem. **Mucosal Bleeding** â†’ Platelet problem.\n- ì˜¤ë””ì˜¤ì—ì„œëŠ” Mixing studyì—ì„œ Inhibitorê°€ ìˆì„ ë•Œ \"clotting time does not correct\"ë¼ê³  ëª…í™•íˆ ì„¤ëª…í–ˆìŠµë‹ˆë‹¤. ì´ëŠ” ì‹¤ì œ ì„ìƒì—ì„œ Lupus Anticoagulant ë“±ì„ ì˜ì‹¬í•˜ëŠ” ê°•ë ¥í•œ ë‹¨ì„œì…ë‹ˆë‹¤.\n- \"Antibiotic Trap\" in HUS is a critical USMLE concept often tested. Do not confuse with treating standard sepsis.\n- Warfarin reversalì—ì„œ Vitamin KëŠ” íš¨ê³¼ê°€ ë‚˜íƒ€ë‚˜ê¸°ê¹Œì§€ ì‹œê°„ì´ ê±¸ë¦¬ë¯€ë¡œ(hours to days), ê¸‰í•œ ì¶œí˜ˆ(Acute Bleed)ì—ëŠ” ë°˜ë“œì‹œ **PCC (Factor replacement)**ë¥¼ ì¨ì•¼ í•œë‹¤ëŠ” ì ì„ ê°•ì¡°í–ˆìŠµë‹ˆë‹¤.\n# 5.0-5.4 ğŸ“ Senior Medical Scribe & USMLE Expert Note: Hodgkin Lymphoma Survivorship & Complications\n## ğŸ“‹ TL;DR Overview (Executive Summary)\n- **Core Topic:** Hodgkin Lymphoma (HL) ìƒì¡´ìì˜ ì¥ê¸° í•©ë³‘ì¦ (Late Complications) ë° 2ì°¨ ì•” (Secondary Malignancy).\n- **Key Concept:** ì¹˜ë£Œ í›„ 15ë…„ì´ ì§€ë‚˜ë©´, ì›ë˜ì˜ ë¦¼í”„ì¢… ì¬ë°œ(Relapse)ë³´ë‹¤ **ì¹˜ë£Œ ë¶€ì‘ìš©ìœ¼ë¡œ ì¸í•œ 2ì°¨ ì•”(Secondary Malignancy)**ìœ¼ë¡œ ì‚¬ë§í•  í™•ë¥ ì´ ë” ë†’ìŒ.\n- **High Yield Traps:**\n    1. **Timeframe:** 5ë…„ ì´ë‚´ = Relapse / 15ë…„ ì´í›„ = Secondary Cancer.\n    2. **Cardio:** Radiation (Restrictive/CAD) vs. Doxorubicin (Dilated).\n    3. **Emergency:** Tumor Lysis Syndrome & G6PD deficiency contraindication for Rasburicase.","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-254","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","quiz-seed","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"## âš¡ Rapid Fire Recap (High Yield Associations)\n| **Clinical Scenario** | **Suspected Diagnosis / Mechanism** | **Next Step / Key Fact** |\n| --- | --- | --- |\n| **Hodgkin survivor, 20 yrs later, Cough/SOB** | **Secondary Lung Cancer** (esp. if smoker) | CT Chest (Low dose screening) |\n| **Young female, Chest Radiation history** | **Secondary Breast Cancer** | MRI Breast Screening starts 8-10 yrs post-tx |\n| **Doxorubicin history + SOB** | **Dilated Cardiomyopathy** | Echocardiogram |\n| **Radiation history + R-sided Heart Failure** | **Restrictive Cardiomyopathy / Pericarditis** | Echocardiogram (Stiff heart) |\n| **Pain in lymph node after Alcohol** | **Hodgkin Lymphoma** (Recurrence/Dx) | Pathognomonic Sign |\n| **Multiple Myeloma suspected + Bone Pain** | Lytic Lesions | **Skeletal Survey (X-ray)** or CT. NO Bone Scan! |\n| **Tumor Lysis + Dark Urine after Rasburicase** | **G6PD Deficiency Hemolysis** | Stop drug, Support. |\n## ğŸ“ Next Step for You\n# 4.0-4.5 ğŸ“‹ Overview: Hematology Crisis Management (TL;DR)\n**Clinical Context:** ì˜¤ëŠ˜ ìš°ë¦¬ëŠ” ë‹¨ìˆœíˆ êµê³¼ì„œì ì¸ Pathwayê°€ ì•„ë‹ˆë¼, í™˜ìì˜ ìƒì‚¬ê°€ ì˜¤ê°€ëŠ” **Crisis Management**ì— ëŒ€í•´ ë‹¤ë£¹ë‹ˆë‹¤. ëª¸ì˜ í•­ìƒì„±(Homeostasis)ì´ ì™„ì „íˆ ë¬´ë„ˆì§„ ìˆœê°„, ìš°ë¦¬ëŠ” ì–´ë–»ê²Œ ê°œì…í•´ì•¼ í• ê¹Œìš”?\n- **ğŸ©¸ Warfarin Reversal:** \"ê³µì¥(Liver)\"ì„ ê³ ì¹  ì‹œê°„ì´ ì—†ì„ ë•Œ, \"ì™„ì œí’ˆ(PCC)\"ì„ íˆ¬í•˜í•˜ë¼.\n- **ğŸ’Š DOAC Reversal:** 1:1 ë§¤ì¹­ ê²Œì„ (Andexanet alfa & Idarucizumab).\n- **ğŸ¤° Pregnancy:** íƒœë°˜ì„ í†µê³¼í•˜ì§€ ì•ŠëŠ” Heparin ì „ëµê³¼ ì¶œì‚° ì§ì „ì˜ \"Switching\".\n- **ğŸ“‰ HIT (Heparin Induced Thrombocytopenia):** í”¼ê°€ ë¬½ì–´ì§€ëŠ” ìˆ˜ì¹˜(Low Plt)ì¸ë° í”¼ê°€ êµ³ëŠ”(Clotting) ì—­ì„¤. **Don't give Platelets!**\n- **ğŸˆ EPO Side Effect:** í”¼ê°€ ì§„í•´ì§€ë©´ì„œ ë°œìƒí•˜ëŠ” Severe Hypertension.\n- **ğŸ‘¶ Kasabach-Merritt:** ê±°ëŒ€ ì¢…ì–‘ì´ í˜ˆì†ŒíŒì„ \"Sponge\"ì²˜ëŸ¼ ë¹¨ì•„ë“¤ì´ëŠ” ì†Œì•„ ì‘ê¸‰.","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-296","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"### **RAPID FIRE RECAP** âš¡\n| **Scenario** | **Diagnosis** | **Next Best Step** |\n| --- | --- | --- |\n| Gardening + Red Streaks + Hours | **Lymphangitis** | **Cephalexin** (Target Strep) |\n| Transfusion + Anaphylaxis | **IgA Deficiency** | Stop + Epi + Next time **Wash Cells** |\n| Transfusion from Brother | **GVHD Risk** | **Irradiate Blood** (Prevent T-cell attack) |\n| Transfusion + Low BP + Dyspnea | **TRALI** | Supportive Care (Ventilator) |\n| Transfusion + High BP + Dyspnea | **TACO** | **Furosemide** (Diuresis) |\n| Central Line + Palpable Cord | **Septic Thrombophlebitis** | Pull Line + Anticoagulation (+/- Surgery) |\n- **Caveats:** The audio focuses heavily on *Strep pyogenes* for lymphangitis; while true for spontaneous cases, always consider *Pasteurella* (bites) or *Vibrio* (seawater) in real life based on history, though for USMLE, the \"gardening/scratch\" vignette is almost always Strep. For Sporotrichosis, Itraconazole is the Tx, though not explicitly detailed in the audio (audio focused on diagnosis timeline).\n# 7.0-7.5ğŸ“‹ Senior Medical Scribe & USMLE Expert: Lecture Notes\n**Overview (TL;DR)**\nHere is the high-yield summary of the \"Newborn Sludge, Vampire Effect, and Milk Anemia\" lecture:\n- **Neonatal Polycythemia:** \"Tomato Red\" baby due to intrauterine hypoxia or delayed cord clamping. **Trap:** Capillary heel pricks overestimate Hct. **Action:** Confirm with Venous Draw.\n- **Anemia of Prematurity:** Preemies have an \"EPO gap\" because the liver stops and kidneys haven't started. **Vampire Effect:** Iatrogenic blood loss from frequent labs worsens this. **Tx:** Limit blood draws.\n- **Milk Anemia (IDA):** Toddlers drinking >24oz cow's milk. Triple threat: Low iron content, displacement of food, and micro-colitis (bleeding). **Dx:** Mentzer Index > 13.\n- **Pancytopenia:** Bone marrow failure (Aplastic vs. Leukemia). Look at the Spleen size to differentiate production failure vs. destruction/sequestration.","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-405","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"### ğŸ”¥ Rapid Fire Recap: The 3 Magic Numbers\nê°•ì˜ì—ì„œ ê°•ì¡°í•œ **ë°˜ë“œì‹œ ì™¸ì›Œì•¼ í•  3ê°€ì§€ ìˆ«ì**ì…ë‹ˆë‹¤.\n| **Number** | **Context** | **Meaning** |\n| --- | --- | --- |\n| **65%** | Neonatal Polycythemia | **Venous** Hematocritê°€ ì´ ì´ìƒì´ì–´ì•¼ ì§„ë‹¨ë¨ (Heel prick X). |\n| **24 oz** | Milk Anemia | ìœ ì•„ì˜ ìš°ìœ  ì„­ì·¨ ì œí•œëŸ‰ (ì´ë³´ë‹¤ ë§ì´ ë§ˆì‹œë©´ ì² ê²°í• ìœ„í—˜). |\n| **13** | Mentzer Index | MCV/RBC. **>13**ì´ë©´ Iron Deficiency, **<13**ì´ë©´ Thalassemia. |\n**Final Caveat:** ì´ ë‚´ìš©ì€ êµìœ¡ìš©ì´ë©°, ì‹¤ì œ ì•„í”ˆ ì•„ì´ ì•ì—ì„œëŠ” íŒŸìºìŠ¤íŠ¸ê°€ ì•„ë‹ˆë¼ **ë³‘ì› í”„ë¡œí† ì½œ(Hospital Protocol)**ì„ ë”°ë¥´ì„¸ìš”!.","subject":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","page_title":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","episode":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","section_path":["LM_Blood2 2fd46f2986ee8009895af4ea339219a2"],"source_doc_id":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","source_page":null,"source_anchor":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2-492","focus_area":"LM_Blood2 2fd46f2986ee8009895af4ea339219a2","tags":["usmle-step2","core","quiz-seed"]}
{"chunk_type":"recap_quiz_seed","text":"# ğŸ”¥ Rapid Fire Recap: Treatments & Side Effects\n| **Disease** | **Critical Drug** | **Major Side Effect / Note** |\n| --- | --- | --- |\n| **RA** | **Methotrexate** | Liver tox, Pulmonary fibrosis, **Marrow suppression**. Give **Folate**! |\n| **SLE (General)** | **Hydroxychloroquine** | **Retinopathy** (Eye toxicity). Annual Eye Exam í•„ìˆ˜! |\n| **SLE (Nephritis)** | Cyclophosphamide | Hemorrhagic cystitis (ë°©ê´‘ì—¼), Infertility. |\n| **Drug-Induced Lupus** | (Stop Drug) | Anti-Histone Ab Positive. |\n| **APS (Pregnant)** | **LMWH + Aspirin** | Warfarin is contraindicated. |\n| **RA Flare** | Prednisone | Osteoporosis, Hyperglycemia, Cataracts. |\n1. ê³ í˜ˆì•• ì•½ ë¨¹ë˜ í™˜ìê°€ ê´€ì ˆì´ ì•„íŒŒìš”\n    1. anti-histone ab? DILI. stop the drugs. Hydralazine\n2. ì†ê°€ë½ë¶€ì—ˆê³  Raynaudë„ ìˆê³  malar rashë„ ìˆê³  ê´€ì ˆí†µë„ ìˆê³ ? ì• ë§¤í•œ ì„ ë¬¼ì„¸íŠ¸\n    1. anti U1 RNPê²€ì‚¬! MCTD\n3. ì„ì‹ ì—¬ì„± ê³ í˜ˆì••, ë‹¨ë°±ë‡¨, ë³´ì²´ decreased\n    1. Lupus flare\n4. RAì˜¤ë˜ ì•“ì•˜ë˜ í™˜ìì—ì„œ ê°€ìš´ë° ì†ê°€ë½ ì†í†± ë”¸ê¹í–ˆë”ë‹ˆ ì—„ì§€ì™€ ê²€ì§€ê°€ ì›€ì°”\n    1. Hoffman sign â†’ UMN lesion, cervical myelopathy\n5. RAì˜¤ë˜ ì•“ì•˜ë˜ í™˜ìì—ì„œ ê³„ì† ê°ì—¼ì´ ìƒê¸°ê³  ì™¼ìª½ë°°ê°€ ë¶ˆëŸ¬ì˜¤ë¦„(splenomegaly). í”¼ê²€ì‚¬ì—ì„œ í™•ì¸í•´ì•¼í•  ìˆ«ì\n    1. ANC<2000\n6. ì–´ë–¤ ë¥˜ë§ˆ ì•½ì´ ë¨¹ì€ì§€ 5ë…„í›„ë¶€í„° ì•ˆê³¼ê²€ì§„ ë§¤ë…„í•´ì•¼í•˜ëŠ”ì§€?\n    1. Hydroxychloroquine\n7. Lupusí™˜ìì—ì„œ ë‹¨ë°±ë‡¨ Next Step?\n    1. Renal biopsy\n- **Septic Arthritis vs RA Flare:** WBC > 50,000 in joint fluid = **Septic**. (Medical Emergency! Antibiotics & Drainage). RA flareëŠ” ë³´í†µ 2,000 ~ 50,000 ì‚¬ì´.\n- **Lupus Nephritis:** ì†Œë³€ ê²€ì‚¬ ì´ìƒí•˜ë©´ ë¬´ì¡°ê±´ **Biopsy**. ì¶”ì¸¡ìœ¼ë¡œ ì¹˜ë£Œí•˜ì§€ ë§ ê²ƒ.\n- **RA Cervical Spine:** ìˆ˜ìˆ  ì „ ëª© ì—‘ìŠ¤ë ˆì´ ì•ˆ ì°ì–´ì„œ í™˜ì ë§ˆë¹„ì‹œí‚¤ë©´ ì‹œí—˜ ë–¨ì–´ì§(ê·¸ë¦¬ê³  í™˜ìëŠ” ë¶ˆí–‰í•´ì§). ğŸ’€\n### Overview: Systemic Autoimmune Disorders Part 2 (TL;DR)\nì´ë²ˆ ì—í”¼ì†Œë“œëŠ” ë¥˜ë§ˆí‹°ìŠ¤í•™(Rheumatology)ì˜ ê±°ëŒ€í•œ ë‘ ì‚°ë§¥ì¸ **ì²™ì¶”ê´€ì ˆë³‘ì¦(Spondyloarthropathies)**ê³¼ **ê²°í•©ì¡°ì§ì§ˆí™˜(Connective Tissue Diseases)**ì„ ë‹¤ë£¹ë‹ˆë‹¤. USMLE Step 2 CK ë° ì„ìƒì—ì„œ ìƒëª…ì„ ìœ„í˜‘í•˜ëŠ” í•©ë³‘ì¦(Renal crisis ë“±)ì„ ë†“ì¹˜ì§€ ì•Šê¸° ìœ„í•œ íŒ¨í„´ ì¸ì‹(Pattern Recognition)ì— ì§‘ì¤‘í•©ë‹ˆë‹¤.\n- **Group 1: Seronegative Spondyloarthropathies (SpA)**\n    - íŠ¹ì§•: RF Negative, HLA-B27 ì—°ê´€, ì²™ì¶”/enthesitis ì¹¨ë²”.\n    - ì§ˆí™˜: ê°•ì§ì„± ì²™ì¶”ì—¼(AS), ë°˜ì‘ì„± ê´€ì ˆì—¼(ReA), ê±´ì„  ê´€ì ˆì—¼(PsA).\n- **Group 2: Connective Tissue Heavy Hitters**\n    - ì§ˆí™˜: ì‡¼ê·¸ë Œ ì¦í›„êµ°(Sjogren's), ì „ì‹  ê²½í™”ì¦(Scleroderma - Limited vs Diffuse), ë ˆì´ë…¸ í˜„ìƒ(Raynaud's).","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-179","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"### ğŸ”¥ Rapid Fire Recap (High-Yield Summary)\n| **Pathology** | **Key Feature (Buzzword)** | **Diagnosis / Test** | **Treatment (1st Line)** |\n| --- | --- | --- | --- |\n| **Frozen Shoulder** | **Active & Passive ROM â†“** | Clinical (History) | ROM Exercise (Keep moving!)\në‹¹ë‡¨, ê°‘ìƒì„  ì €í•˜ì¦ |\n| **Rotator Cuff Tear** | **Weakness** + Drop Arm (+) | MRI (Gold Standard) | Surgery (if functional loss) |\n| **Ant. Dislocation** | Abducted/Ext. Rotated | X-ray (Check **Axillary n.**) | Reduction |\n| **Post. Dislocation** | **Seizure**, Lightbulb Sign | X-ray (Axillary/Scapular Y)\nLight bulb | Reduction |\n| **Tennis Elbow** | Pain on **Wrist Extension** | Clinical | Counterforce Brace (Strap) |\n| **Septic Bursitis** | Red, Hot, Fever, Trauma | **â˜… Aspiration (Culture)** | Antibiotics + Drainage |\n### ğŸ©º Doctor's Note (Caveats)\n- **Caveats:**\n    - ì˜¤ë””ì˜¤ëŠ” **Septic Bursitis**ì˜ ì¹˜ë£Œë¡œ \"Antibiotics + Drainage\"ë¥¼ ê°•ì¡°í–ˆìŠµë‹ˆë‹¤. ìˆ˜ìˆ ì  ë°°ë†(I&D)ì¸ì§€ ë‹¨ìˆœ ì²œì ë°°ë†ì¸ì§€ëŠ” ìƒí™©ì— ë”°ë¼ ë‹¤ë¥´ì§€ë§Œ, USMLEì—ì„œëŠ” \"Drain it & Treat bugs\"ê°€ í•µì‹¬ì…ë‹ˆë‹¤.\n    - **Tennis Elbow**ì—ì„œ ìŠ¤í…Œë¡œì´ë“œ ì£¼ì‚¬ëŠ” ì–¸ê¸‰ë˜ì§€ ì•Šì•˜ìŠµë‹ˆë‹¤. ì˜¤ë””ì˜¤ì— ì¶©ì‹¤í•˜ê²Œ **Brace**ì™€ ë³‘íƒœìƒë¦¬(Degeneration)ì— ì§‘ì¤‘í•˜ì„¸ìš”.\n    - **Shoulder Dislocation** ì •ë³µ(Reduction) ì „ **Neurovascular Check** (íŠ¹íˆ Axillary nerve ê°ê°)ëŠ” **Medicolegal**í•˜ê²Œë„ ë§¤ìš° ì¤‘ìš”í•˜ë‹ˆ ê¼­ ê¸°ì–µí•˜ì„¸ìš”! âš–ï¸\n## ğŸ“‹ Overview: Hand & Wrist Pathology High-Yield Summary\nì˜¤ëŠ˜ ë‹¤ë£° ë‚´ìš©ì€ USMLE Step 2CK ë° ì„ìƒì—ì„œ **ë§¤ìš° ë¹ˆì¶œ(High Yield)**ë˜ëŠ” ì†ê³¼ ì†ëª©ì˜ 4ëŒ€ì¥ ë³‘ë³€ì…ë‹ˆë‹¤. ğŸ–ï¸ êµ¬ì¡°ì ì¸ ë¬¸ì œë¶€í„° ì‹ ê²½ ì••ë°•ê¹Œì§€, í•µì‹¬ë§Œ ë¹ ë¥´ê²Œ ì§šì–´ë´…ì‹œë‹¤!\n| **Pathology** | **Key Feature (Vibe Check)** | **Key Mechanism/Risk** | **Gold Standard/Next Step** |\n| --- | --- | --- | --- |\n| **Carpal Tunnel Syndrome** | ë°¤ì— ì†ì´ ì €ë ¤ì„œ ê¹¬ë‹¤ (Night pain), ì†ì„ í„´ë‹¤ (Flick sign) | Pregnancy, Hypothyroid, Renal Failure (Amyloid/Dialysis) | **Splint (Night) â†’ Steroid â†’ Surgery** |\n| **De Quervain's** | ì‹ ìƒì•„ë¥¼ ì•ˆì•„ ì˜¬ë¦¬ëŠ” ì—„ë§ˆ (New Mom), ì—„ì§€ ìª½ í†µì¦ | APL & EPB Tendon overuse | **Finkelstein Test (+) â†’ Thumb Spica Splint** |\n| **Dupuytren Contracture** | ë¶ìœ ëŸ½ê³„ ë…¸ë…„ ë‚¨ì„±, ì†ë°”ë‹¥ì´ ë‘êº¼ì›Œì§€ê³  ì†ê°€ë½ì´ êµ½ìŒ | Palmar Fascia Fibrosis (Alcohol, Diabetes, Smoking) | **Table Top Test (+) â†’ Surgery/Injection** |\n| **Ganglion Cyst** | ì†ëª© ë“±ìª½(Dorsal)ì— ìƒê¸´ ë¬¼ë í•œ í˜¹ | Mucin-filled cyst (Transillumination +) | **Observation (Reassurance) â†’ Aspiration â†’ Excision** |","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-301","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"## âš¡ 4. Rapid Fire Recap (High Yield Q&A)\në§ˆì§€ë§‰ìœ¼ë¡œ ë°°ìš´ ë‚´ìš©ì„ ë¹ ë¥´ê²Œ ì ê²€í•´ë´…ì‹œë‹¤! ğŸ”¥\n| **Question** | **Answer** |\n| --- | --- |\n| **Q1. De Quervain's Tenosynovitisì˜ 2ê°€ì§€ Target Tendonì€?** | **Abductor Pollicis Longus (APL), Extensor Pollicis Brevis (EPB)** |\n| **Q2. íˆ¬ì„ í™˜ì CTSì˜ ì›ì¸ ì¤‘, ì‹ ê²½ì´ í—ˆí˜ˆ(Ischemia)ì— ë¹ ì§€ëŠ” ê¸°ì „ì€?** | **Vascular Steal Syndrome** (AV fistulaê°€ í˜ˆë¥˜ë¥¼ ëºì–´ê°) |\n| **Q3. De Quervain'sì˜ ì¹˜ë£Œë¥¼ ìœ„í•œ ë¶€ëª©(Splint)ì˜ ì´ë¦„ì€?** | **Thumb Spica Splint** |\n| **Q4. ì†ëª© ê²°ì ˆì¢…(Ganglion Cyst) ì§„ë‹¨ì„ ìœ„í•œ ì‹ ì²´ ê²€ì§„ë²•ì€?** | **Transillumination (ë¹› íˆ¬ê³¼ ê²€ì‚¬) - Positive** |\n| **Q5. Dupuytren's Contractureì—ì„œ ê°€ì¥ í”íˆ ì¹¨ë²”ë˜ëŠ” ì†ê°€ë½ì€?** | **4th (Ring) & 5th (Little) fingers** |\n| **Q6. ê°‘ìƒì„ ê¸°ëŠ¥ì €í•˜ì¦(Hypothyroid) í™˜ìì˜ CTS ì›ì¸ ë¬¼ì§ˆì€?** | **Mucopolysaccharides (Glycosaminoglycans) / Myxedema** |\n| **Q7. ì¦ìƒì´ ì—†ëŠ” Ganglion Cystì˜ ì²˜ì¹˜ëŠ”?** | **Observation (ê´€ì°°)** (ê±´ë“œë¦¬ì§€ ë§ˆì„¸ìš”!) |\n- **Caveats:**\n    - ì˜¤ë””ì˜¤ì—ì„œëŠ” CTSì˜ ì›ì¸ìœ¼ë¡œ \"Acromegaly\"ëŠ” ì–¸ê¸‰ë˜ì§€ ì•Šì•˜ìœ¼ë‚˜ USMLEì—ì„œëŠ” í”í•œ ì›ì¸ì´ë¯€ë¡œ ì°¸ê³ í•˜ì„¸ìš”.\n    - Ganglion Cystì˜ \"Bible Bump\" ì¹˜ë£Œë²•(ì±…ìœ¼ë¡œ ë‚´ë¦¬ì¹˜ê¸°)ì€ ì—­ì‚¬ì ì¸ ì´ì•¼ê¸°ì¼ ë¿, ì ˆëŒ€ ì„ìƒì—ì„œ ê¶Œì¥í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤! (ê³¨ì ˆ ìœ„í—˜ ğŸ¦´).\n**Would you like me to generate a specific quiz set for these hand pathologies to test your retention?** ğŸ§ \n### **TL;DR: Spine Pathology Overview ğŸ¦´**\n- **í•µì‹¬ ì£¼ì œ:** ì²™ì¶” ë³‘ë³€(Spine Pathology)ê³¼ ì™¸ìƒ(Trauma)ì— ëŒ€í•œ USMLE Step 2 CK ìˆ˜ì¤€ì˜ ì ‘ê·¼ë²•.\n- **3ê°€ì§€ í™˜ì ì•„ë°”íƒ€ (Archetypes):**\n    1. **The Shooter (ë°©ì‚¬í†µ):** ì‹ ê²½ê·¼ ë³‘ì¦(Radiculopathy). \"ì „ê¸°ê°€ ì˜ëŠ” ë“¯í•œ í†µì¦\".\n    2. **The Leaner (í˜‘ì°©ì¦):** ì²™ì¶”ê´€ í˜‘ì°©ì¦(Stenosis). \"ì‡¼í•‘ì¹´íŠ¸ì— ê¸°ëŒ€ëŠ” ë…¸ì¸\".\n    3. **The Stumbler (ì²™ìˆ˜ë³‘ì¦):** ì²™ìˆ˜ë³‘ì¦(Myelopathy). \"ë¹„í‹€ê±°ë¦¬ê³  ë‹¨ì¶”ë¥¼ ëª» ì±„ì›€\".\n- **Golden Rule:** Red Flag(ì•”, ê°ì—¼, ë§ˆë¯¸ì¦í›„êµ°)ê°€ ì—†ìœ¼ë©´ **MRI ì°ì§€ ë§ˆë¼!** (ì´ˆê¸° 4-6ì£¼ëŠ” ë³´ì¡´ì  ì¹˜ë£Œ).","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-368","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","quiz-seed"]}
{"chunk_type":"recap_quiz_seed","text":"### Rapid Fire Recap ğŸ”¥ (ì‹œí—˜ ì§ì „ ì•”ê¸°)\n| **ìƒí™© (Scenario)** | **ì§„ë‹¨ (Diagnosis)** | **í•µì‹¬ ë‹¨ì„œ (Key Clue)** |\n| --- | --- | --- |\n| ì†ì„ ë¨¸ë¦¬ ìœ„ì— ì˜¬ë¦¬ê³  ë“¤ì–´ì˜´ ğŸ™†â€â™‚ï¸ | **Cervical Radiculopathy** | Shoulder Abduction Relief Sign |\n| ë‹¨ì¶” ëª» ì±„ìš°ê³  ë¹„í‹€ê±°ë¦¼ ğŸ§µ | **Cervical Myelopathy** | UMN Signs (Babinski+), Hyperreflexia |\n| ì‡¼í•‘ì¹´íŠ¸ì— ê¸°ëŒ€ë©´ í¸í•¨ ğŸ›’ | **Lumbar Stenosis** | Extension ì‹œ í†µì¦ ì•…í™” (ì‡¼í•‘ì¹´íŠ¸ ì‚¬ì¸) |\n| ë°œëª©ì´ ì•ˆ ë“¤ë¦¼ (Foot Drop) ğŸ¦¶ | **L5 Radiculopathy** | Heel walking ë¶ˆê°€ëŠ¥ |\n| ê¹Œì¹˜ë°œì´ ì•ˆ ë¨ (Tip-toe X) ğŸ©° | **S1 Radiculopathy** | Achilles Reflex ì†Œì‹¤ |\n| íšŒìŒë¶€ ê°ê° ì—†ê³  ì†Œë³€ ì§€ë¦¼ ğŸš½ | **Cauda Equina Syndrome** | **Emergency MRI & Surgery** |\n| í—ˆë¦¬ ì‚ë—í•¨, Red Flag ì—†ìŒ ğŸ’Š | **Acute Lumbago** | **NSAIDs + Activity (No MRI!)** |\n| ì•„ì´ ì²™ì¶”ê°€ íŒ¬ì¼€ì´í¬ ë¨ ğŸ¥ | **Langerhans Cell Histiocytosis** | Vertebra Plana |\n*Caveats: USMLEì™€ ì„ìƒ ê°€ì´ë“œë¼ì¸ ì¤‘ì‹¬ì…ë‹ˆë‹¤. ì‹¤ì œ í™˜ìì—ê²ŒëŠ” Individualizeëœ ì ‘ê·¼ì´ í•„ìš”í•©ë‹ˆë‹¤.*","subject":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","page_title":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","episode":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","section_path":["LM_OSRHM 30046f2986ee8098921dc4e04b63ee22"],"source_doc_id":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","source_page":null,"source_anchor":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22-432","focus_area":"LM_OSRHM 30046f2986ee8098921dc4e04b63ee22","tags":["usmle-step2","core","quiz-seed","diagnosis"]}
{"chunk_type":"recap_quiz_seed","text":"### ğŸ”¥ Rapid Fire Recap: The \"Diff\" Table\n| **Condition** | **Mechanism/History** | **Key Physical Exam/Sign** | **Swelling Timing** |\n| --- | --- | --- | --- |\n| **ACL Tear** | Pivot + \"POP\" ê°‘ì§€ê¸° ë©ˆì¶¤. | Lachman (+), Instability | **Immediate (Bloody)** ğŸ©¸ |\n| **Meniscus Tear** | Twisting, Deep squat | Locking, Thessaly (+) | **Slow (12-24h)** ğŸ¢ |\n| **PCL Tear** | Dashboard Injury | Posterior Drawer (+) | Variable |\n| **Patellar Tendon Rupture** | Jump landing | High-riding patella, **No Extension** | Immediate |\n| **PFPS (Runner's Knee)** | Young female, Overuse | **Theater Sign** (Sitting pain) | None usually |\n| **GTPS (Hip)** | Obesity, Middle-age | Can't sleep on side | None |\n| **Baker Cyst Rupture** | Chronic knee issue | Calf pain/swelling | Acute (Mimics DVT) |\n### ğŸ§  Meta-Cognitive Reflection\n- **Confidence:** 1.0 (All content derived strictly from the audio file provided).\n- **Next Step:** Would you like me to create a flashcard set (Anki style) based on these vignettes?\n### ğŸ“‹ Overview: USMLE Foot & Ankle Pathology (High-Yield)\nì´ ê°•ì˜ëŠ” \"ë°œì´ ì•„íŒŒìš”(My foot hurts)\"ë¼ê³  í˜¸ì†Œí•˜ëŠ” í™˜ìë¥¼ ë§Œë‚¬ì„ ë•Œ, ì •í™•í•œ **Anatomical Location(ìœ„ì¹˜)**ê³¼ **Timing(í†µì¦ ì–‘ìƒ)**ì„ í†µí•´ ì§„ë‹¨ì„ ë‚´ë¦¬ëŠ” ê³¼ì •ì„ ë‹¤ë£¹ë‹ˆë‹¤. ë°œì€ ìš°ë¦¬ ëª¸ì˜ ë¬´ê²Œë¥¼ ì§€íƒ±í•˜ëŠ” Workhorse(ì¼ê¾¼)ì…ë‹ˆë‹¤! ğŸ´ğŸ¦¶\n| Category | Diagnosis | Key Symptom / History | Key Test / Sign |\n| --- | --- | --- | --- |\n| **Heel (Plant)** | **Plantar Fasciitis** | **Morning Glory (ì•„ì¹¨ ì²« ë°œ í†µì¦)**, í™œë™ í›„ ê°œì„  | Dorsiflexion pain |\n| **Heel (Bone)** | **Calcaneal Stress Fx** | í™œë™í• ìˆ˜ë¡ í†µì¦ ì•…í™” (Worse w/ use) | **Squeeze Test (+)** |\n| **Posterior** | **Achilles Tendinopathy** | Watershed area (2-6cm) í†µì¦ | Fluoroquinolone ì‚¬ìš©ë ¥ |\n| **Posterior** | **Achilles Rupture** | \"Pop\" ì†Œë¦¬, ëˆ„ê°€ ë’¤ì—ì„œ ì°¬ ëŠë‚Œ | **Thompson Test (+)** |\n| **Peds** | **Sever Disease** | ì„±ì¥ê¸° ìš´ë™ì„ ìˆ˜(ì¶•êµ¬), ë’¤ê¿ˆì¹˜ í†µì¦ | Calcaneal compression |\n| **Forefoot** | **Metatarsal Stress Fx** | 2nd (Common) vs 5th (Jones - Bad!) | Female Athlete Triad |\n| **Nerve** | **Morton Neuroma** | 3-4th toe ì‚¬ì´, \"ëŒë©©ì´ ë°Ÿì€ ëŠë‚Œ\" | **Mulder Sign (Click)** |\n| **Ankle** | **Ankle Sprain** | Inversion injury | **Ottawa Rules** (X-ray ê²°ì •) |\n| **Red Flag** | **Charcot Foot** | ë‹¹ë‡¨, ë¶‰ê³  ë¶€ì—ˆìœ¼ë‚˜ **í†µì¦ì´ ì ìŒ** | **Total Contact Cast** |","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-39","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","quiz-seed","diagnosis","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"### ğŸš€ Rapid Fire Recap (High-Yield Summary)\n| Pathology | Location | The \"Money\" Feature | Treatment Focus |\n| --- | --- | --- | --- |\n| **Plantar Fasciitis** | Heel (Sole) | **Morning Pain** (First step agony) | Conservative (Stretch/Ice) |\n| **Calcaneal Stress Fx** | Heel (Bone) | Pain **worse with use**, Squeeze (+) | Reduce Activity |\n| **Achilles Rupture** | Posterior Heel | **\"Pop\"**, **Thompson Test (+)**, Cipro | Surgical or Casting |\n| **Sever Disease** | Heel (Peds) | Active Kid (Soccer), Growth Spurt | Rest, Ice (Self-limiting) |\n| **Morton Neuroma** | 3rd-4th Toe | **Pebble sensation**, **Mulder Sign (Click)** | Wide shoes, Pad |\n| **Jones Fracture** | 5th Metatarsal | Lateral foot pain, Watershed zone | **Surgery often needed** âš ï¸ |\n| **Charcot Foot** | Whole Foot | **DM, Red/Hot but PAINLESS** | **Total Contact Cast** (No Abx!) |\n**Clear Answer:**\në°œ/ë°œëª© í†µì¦ì€ **\"ì •í™•í•œ ìœ„ì¹˜(Anatomy)\"**ì™€ **\"í†µì¦ì˜ íƒ€ì´ë°(Morning vs Activity)\"**ìœ¼ë¡œ êµ¬ë³„í•´ì•¼ í•©ë‹ˆë‹¤. ì•„ì¹¨ ì²« ë°œì´ ì•„í”„ë©´ ì¡±ì €ê·¼ë§‰ì—¼, ì“¸ìˆ˜ë¡ ì•„í”„ë©´ ìŠ¤íŠ¸ë ˆìŠ¤ ê³¨ì ˆ, ë‹¹ë‡¨ í™˜ìì˜ ë¶‰ê³  í†µì¦ ì—†ëŠ” ë°œì€ ìƒ¤ì½§ ê´€ì ˆ(Charcot)ì„ ê°•ë ¥íˆ ì˜ì‹¬í•´ì•¼ í•©ë‹ˆë‹¤.\n**Confidence Level:** 1.0 (Based strictly on the provided audio transcript)\n- ì´ ë…¸íŠ¸ëŠ” ì œê³µëœ ì˜¤ë””ì˜¤ íŒŒì¼ì˜ ë‚´ìš©ì„ ë°”íƒ•ìœ¼ë¡œ ì‘ì„±ë˜ì—ˆìŠµë‹ˆë‹¤.\n- **Tarsal Tunnel Syndrome**ì€ ì˜¤ë””ì˜¤ì—ì„œ Morton Neuromaì™€ ë¹„êµí•˜ë©° \"ë°œì˜ Carpal Tunnel\"ë¡œ ì§§ê²Œ ì–¸ê¸‰ë˜ì—ˆì§€ë§Œ, ì¤‘ìš”í•œ ê°ë³„ í¬ì¸íŠ¸ì´ë¯€ë¡œ í¬í•¨í–ˆìŠµë‹ˆë‹¤.\n- **Jones Fracture**ì˜ ìˆ˜ìˆ ì  í•„ìš”ì„±ê³¼ **Charcot Foot**ì˜ \"í•­ìƒì œ ê¸ˆì§€/Cast ì¹˜ë£Œ\"ëŠ” ì‹œí—˜ì— ë§¤ìš° ìì£¼ ë‚˜ì˜¤ëŠ” í•¨ì •ì´ë‹ˆ ê¼­ ê¸°ì–µí•˜ì„¸ìš”!\n### ğŸ“‹ Overview: USMLE Step 2 CK - Orthopedic Trauma & Emergencies (Ep 09)\n| **Category** | **Key Condition** | **Doorway Thought / Clinical Vignette** | **NBS / Critical Action** |\n| --- | --- | --- | --- |\n| **Upper Limb** | **Scaphoid Fx** | FOOSH + Snuffbox Tenderness | **â˜… Thumb Spica Cast** (even if X-ray -) |\n|  | **Colles Fx** | Elderly + FOOSH + \"Dinner Fork\" | Reduction + Cast (Watch for CTS) |\n|  | **Supracondylar Fx** | Kid + Monkey bars + Fat Pad Sign | Check Neurovascular status (**EMERGENCY**) |\n|  | **Clavicle Fx** | Newborn not moving arm (Moro reflex) | Pin sleeve to chest (Simple restraint) |\n| **Lower Limb** | **Hip Fx** | Elderly + Shortened & Ext. Rotated Leg | Surgery < 72hrs (Mortality risk) |\n|  | **Pelvic Fx** | High energy + Hypotension | **â˜… Pelvic Binder** (Close the book!) |\n|  | **Stress Fx** | Athlete/Military + 2nd Metatarsal pain | Rest / Reduced weight bearing |\n| **Emergencies** | **Compartment** | Pain w/ Passive Stretch + Tightness | **â˜… Fasciotomy** (Delta pressure < 30) |\n| **Complications** | **CRPS** | Pain out of proportion + Color changes (ììœ¨ì‹ ê²½ê³„ ë¬¸ì œ) | PT/OT (Mobilization), No Cast! |\n|  | **Myositis Ossificans** | Hard mass in muscle after trauma | **Do NOT excise early** (Wait for maturation) |","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-88","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","quiz-seed","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"### **Rapid Fire Recap (ì¡±ì§‘ê²Œ ìš”ì•½)** ğŸ”¥\n| **Condition** | **Key Keyword** | **Association / Lab** | **Treatment / Note** |\n| --- | --- | --- | --- |\n| **GCA** | Jaw Claudication | Polymyalgia Rheumatica | Vision loss â†’ High dose Steroids **ASAP** |\n| **Kawasaki** | Fever > 5d + CRASH | Coronary Aneurysm | **IVIG + Aspirin** (No live vaccines for 11mo) |\n| **PAN** | Hep B, Foot drop | Spares Lung | Angio: String of beads |\n| **GPA** | Sinus + Lung + Kidney | c-ANCA (PR3) | Cyclophosphamide/Rituximab |\n| **HSP** | Palpable Purpura (Butt) | Normal Platelets | Risk: Intussusception â†’ surgery |\n| **PMR** | Shoulder/Hip Pain | High ESR, Normal CK | Low dose Steroids |\n| **Dermatomyositis** | Heliotrope Rash | **Occult Cancer** | Screen for malignancy! |\n| **Myasthenia Gravis** | Ptosis, Worse @ night | Thymoma | Ice pack test, Pyridostigmine.\nNo FQ(cipro), No magnesium |\n| **Lambert-Eaton** | Better with use | Small Cell Lung Ca | Presynaptic Ca channel |\n**Meta-Cognitive Reflection:**\n- **Confidence:** 1.0 (Confident).\n- **Completeness Check:** Covered all major vessels (Large/Medium/Small), key pediatric vasculitides (Kawasaki, HSP), and the differential for weakness (Muscle vs NMJ). Included specific complications (Aneurysms, Blindness, Cancer) and treatments (Steroids, IVIG, Aspirin).\n- **Caveats:** While treatments are mentioned, dosage specifics (e.g., prednisone mg) are based on the audio's mention. Always confirm exact dosages clinically. The distinction between \"Pain\" (PMR) and \"Weakness\" (Myositis) is the most common USMLE trapâ€”highlighted clearly.\n**Overview & TL;DR**\nì´ë²ˆ ê°•ì˜ëŠ” ì†Œì•„ ì •í˜•ì™¸ê³¼(Pediatric Orthopedics)ì— ëŒ€í•œ ì‹¬ì¸µ ë¶„ì„ì…ë‹ˆë‹¤. ì„±ì¸ê³¼ ë‹¬ë¦¬ ì†Œì•„ëŠ” \"ì—¬ê¸°ê°€ ì•„íŒŒìš”\"ë¼ê³  ì •í™•íˆ ë§í•˜ì§€ ì•Šìœ¼ë¯€ë¡œ, ì˜ì‚¬ëŠ” **íƒì •(Detective)**ì´ ë˜ì–´ì•¼ í•©ë‹ˆë‹¤. ğŸ•µï¸â€â™‚ï¸\nì£¼ìš” ì£¼ì œëŠ” **Limping Child (ì ˆëšê±°ë¦¬ëŠ” ì•„ì´)**ì˜ ê°ë³„ ì§„ë‹¨(Hip Pathology), **JIA (ì†Œì•„ ë¥˜ë§ˆí‹°ìŠ¤)**, ê·¸ë¦¬ê³  **í•˜ì§€ ì •ë ¬ ë° ë°œì˜ ë³€í˜•**ì…ë‹ˆë‹¤.\n**Core Concept Structure (ASCII Tree)**\nPlaintext\n`PEDIATRIC ORTHOPEDICS (The Detective Game ğŸ•µï¸â€â™‚ï¸)\nâ”œâ”€â”€ 1. THE HIP (The Limping Child) ğŸƒâ€â™‚ï¸\nâ”‚   â”œâ”€â”€ Adolescents (Teens, Obese) â” SCFE (Ice cream slip) ğŸ¦\nâ”‚   â”œâ”€â”€ Age 4-10 (Painless limp) â” LCP (AVN) ğŸ¦´\nâ”‚   â”œâ”€â”€ Toddlers (Fever?)\nâ”‚   â”‚   â”œâ”€â”€ High Fever + Refusal to walk â” Septic Arthritis (Emergency!) ğŸš¨\nâ”‚   â”‚   â””â”€â”€ Low Fever + Post-viral â” Transient Synovitis (Rest) ğŸ›Œ\nâ”‚   â””â”€â”€ Infants (Newborn) â” DDH (Clunk!) ğŸ‘¶\nâ”‚\nâ”œâ”€â”€ 2. SYSTEMIC / INFLAMMATORY (JIA) ğŸ”¥\nâ”‚   â”œâ”€â”€ Systemic (Fever + Rash) ğŸ¤’\nâ”‚   â”œâ”€â”€ Oligoarticular (<5 joints, EYE EXAM!) ğŸ‘ï¸\nâ”‚   â””â”€â”€ Polyarticular (>5 joints, like adult RA) ğŸ–ï¸\nâ”‚\nâ”œâ”€â”€ 3. LOWER LIMB ALIGNMENT ğŸ¦µ\nâ”‚   â”œâ”€â”€ Knees: Bowlegs (Varum) vs. Knock-knees (Valgum)\nâ”‚   â””â”€â”€ Toes: Intoeing (Tibial Torsion vs. Femoral Anteversion)\nâ”‚\nâ””â”€â”€ 4. FEET & SPINE ğŸ¦¶\n    â”œâ”€â”€ Clubfoot (Rigid, Cast now!) vs. Metatarsus Adductus (Flexible)\n    â”œâ”€â”€ Torticollis (Wry neck) ğŸ¦’\n    â””â”€â”€ Scoliosis (Adam's test, Cobb angle) ğŸ“`","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-288","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","quiz-seed","treatment","tree"]}
{"chunk_type":"recap_quiz_seed","text":"## âš¡ Rapid Fire Recap (ì‹œí—˜ ì§ì „ í™•ì¸!)\n| **Situation** | **Action / Fact** |\n| --- | --- |\n| **Big Toe Pain (Podagra)** | Gout ì˜ì‹¬ 1ìˆœìœ„ |\n| **Diagnostic Test** | **Arthrocentesis (Joint Tap)** ë¬´ì¡°ê±´! |\n| **Gout Synovial Fluid** | Negatively Birefringent Needle Crystals â–ğŸ’‰ |\n| **Septic Arthritis Fluid** | WBC > 50k, >90% Neutrophils |\n| **Gout + Fever + High WBC?** | **Treat as Septic Arthritis first!** ğŸš¨ |\n| **Acute Tx (Normal Kidney)** | NSAIDs (Indomethacin) + Colchicine |\n| **Acute Tx (Renal Failure)** | **Steroids** (Injection or Oral) â˜… |\n| **Chronic Tx** | Allopurinol (Start *after* flare resolves) |\n| **Best HTN Med for Gout** | **Losartan (or CCB)** |\n**One Last Thought:**\n\"Treat the Patient, not the Slide.\" í¬ë¦¬ìŠ¤íƒˆì´ ë³´ì¸ë‹¤ê³  í•´ì„œ Septic Arthritisì˜ ê°€ëŠ¥ì„±ì„ ë°°ì œí•˜ì§€ ë§ˆì‹­ì‹œì˜¤. í™˜ìì˜ ì‹ ì¥ ê¸°ëŠ¥(Renal function)ì„ í™•ì¸í•˜ê³  ì•½ì„ ì²˜ë°©í•˜ì‹­ì‹œì˜¤. ì´ê²ƒì´ ì¸í„´ê³¼ í•™ìƒì˜ ì°¨ì´ì…ë‹ˆë‹¤! ğŸ˜‰ğŸ‘‹\n### Overview: Neonatal Brachial Plexus Palsy (USMLE Step 2 CK)\n- **Topic:** Erb-Duchenne vs. Klumpke Palsy (Anatomy, Presentation, Management)\n- **Key Concept:** Distinguishing based on Forearm Rotation (Pronation vs. Supination) & Nerve Roots.\n- **Management:** Conservative (Obs + PT) is King ğŸ‘‘ unless chronic.\n\"Okay, let's jump in. We are on a very specific mission for this deep dive. We're locking in the absolute high yield points for neonatal brachial plexus palsies for Step 2. Exactly. This is a topic where the details really matter and it's so easy to mix them up under pressure. We're gonna decode the anatomy for Erb-Duchenne versus Klumpke so you don't get tripped up.\"","subject":"LM_OSRHM 2 (7","page_title":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","episode":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","section_path":["LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae"],"source_doc_id":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","source_page":null,"source_anchor":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae-394","focus_area":"LM_OSRHM 2 (7-12) 30246f2986ee8038ae5de91913b0c0ae","tags":["usmle-step2","core","quiz-seed","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"**Rapid Fire Recap (High-Yield Summary)**\n| **Disease** | **Key Antibodies / Markers** | **Vignette Clue** | **Best Initial / Specific Rx** |\n| --- | --- | --- | --- |\n| **Ankylosing Spondylitis** | HLA-B27, RF(-) | ì Šì€ ë‚¨ì„±, ë°¤ì— ë” ì•„í”ˆ ìš”í†µ, ìš´ë™í•˜ë©´ í˜¸ì „ | NSAIDs (1st), TNF inhibitors |\n| **Reactive Arthritis** | HLA-B27 | Can't see/pee/climb, GI or Chlamydia infection | NSAIDs, Treat infection |\n| **Psoriatic Arthritis** | HLA-B27 | Psoriasis, Sausage digits, Nail pitting | NSAIDs, Methotrexate |\n| **Sjogren's Syndrome** | Anti-Ro (SSA), Anti-La (SSB) | Dry eyes/mouth, Lymphoma risk | Artificial tears, Pilocarpine |\n| **Limited Scleroderma** | Anti-Centromere | CREST syndrome, PAH | Symptomatic (PPI for GERD) |\n| **Diffuse Scleroderma** | Anti-Scl-70 (Topoisomerase I) | Trunk skin, ILD, Renal Crisis | ACE Inhibitors (Renal Crisis) |\n| **Raynaud's** | Clinical dx | White-Blue-Red color change | CCB (Nifedipine) |\n### **4. [Ep 04] Shoulder & Elbow ğŸ”¥**\n**Rapid Fire Recap (High-Yield Summary)**\n| **Pathology** | **Key Feature (Buzzword)** | **Diagnosis / Test** | **Treatment (1st Line)** |\n| --- | --- | --- | --- |\n| **Frozen Shoulder** | Active & Passive ROM â†“ | Clinical (History) | ROM Exercise (Keep moving!) ë‹¹ë‡¨, ê°‘ìƒì„  ì €í•˜ì¦ |\n| **Rotator Cuff Tear** | Weakness + Drop Arm (+) | MRI (Gold Standard) | Surgery (if functional loss) |\n| **Ant. Dislocation** | Abducted/Ext. Rotated | X-ray (Check Axillary n.) | Reduction |\n| **Post. Dislocation** | Seizure, Lightbulb Sign | X-ray (Axillary/Scapular Y) | Reduction |\n| **Tennis Elbow** | Pain on Wrist Extension | Clinical | Counterforce Brace (Strap) |\n| **Septic Bursitis** | Red, Hot, Fever, Trauma | â˜… Aspiration (Culture) | Antibiotics + Drainage |\n### **5. [Ep 05] Hand & Wrist âš¡**\n**4. Rapid Fire Recap (High Yield Q&A)**\n- **Q1. De Quervain's Tenosynovitisì˜ 2ê°€ì§€ Target Tendonì€?**\n    â†’ Abductor Pollicis Longus (APL), Extensor Pollicis Brevis (EPB)\n- **Q2. íˆ¬ì„ í™˜ì CTSì˜ ì›ì¸ ì¤‘, ì‹ ê²½ì´ í—ˆí˜ˆ(Ischemia)ì— ë¹ ì§€ëŠ” ê¸°ì „ì€?**\n    â†’ Vascular Steal Syndrome (AV fistulaê°€ í˜ˆë¥˜ë¥¼ ëºì–´ê°)\n- **Q3. De Quervain'sì˜ ì¹˜ë£Œë¥¼ ìœ„í•œ ë¶€ëª©(Splint)ì˜ ì´ë¦„ì€?**\n    â†’ Thumb Spica Splint\n- **Q4. ì†ëª© ê²°ì ˆì¢…(Ganglion Cyst) ì§„ë‹¨ì„ ìœ„í•œ ì‹ ì²´ ê²€ì§„ë²•ì€?**\n    â†’ Transillumination (ë¹› íˆ¬ê³¼ ê²€ì‚¬) - Positive\n- **Q5. Dupuytren's Contractureì—ì„œ ê°€ì¥ í”íˆ ì¹¨ë²”ë˜ëŠ” ì†ê°€ë½ì€?**\n    â†’ 4th (Ring) & 5th (Little) fingers\n- **Q6. ê°‘ìƒì„ ê¸°ëŠ¥ì €í•˜ì¦(Hypothyroid) í™˜ìì˜ CTS ì›ì¸ ë¬¼ì§ˆì€?**\n    â†’ Mucopolysaccharides (Glycosaminoglycans) / Myxedema\n- **Q7. ì¦ìƒì´ ì—†ëŠ” Ganglion Cystì˜ ì²˜ì¹˜ëŠ”?**\n    â†’ Observation (ê´€ì°°) (ê±´ë“œë¦¬ì§€ ë§ˆì„¸ìš”!)","subject":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","page_title":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","episode":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","section_path":["LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76"],"source_doc_id":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","source_page":null,"source_anchor":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76-14","focus_area":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"**Rapid Fire Recap (ì¡±ì§‘ê²Œ ìš”ì•½) ğŸ”¥**\n| **Condition** | **Key Keyword** | **Association / Lab** | **Treatment / Note** |\n| --- | --- | --- | --- |\n| **GCA** | Jaw Claudication | Polymyalgia Rheumatica | Vision loss â†’ High dose Steroids ASAP |\n| **Kawasaki** | Fever > 5d + CRASH | Coronary Aneurysm | IVIG + Aspirin (No live vaccines for 11mo) |\n| **PAN** | Hep B, Foot drop | Spares Lung | Angio: String of beads |\n| **GPA** | Sinus + Lung + Kidney | c-ANCA (PR3) | Cyclophosphamide/Rituximab |\n| **HSP** | Palpable Purpura (Butt) | Normal Platelets | Risk: Intussusception â†’ surgery |\n| **PMR** | Shoulder/Hip Pain | High ESR, Normal CK | Low dose Steroids |\n| **Dermatomyositis** | Heliotrope Rash | Occult Cancer | Screen for malignancy! |\n| **Myasthenia Gravis** | Ptosis, Worse @ night | Thymoma | Ice pack test, Pyridostigmine. No FQ, No magnesium |\n### **6. [Ep 12] Pediatric Orthopedics ğŸ‘¶**\n**RAPID FIRE RECAP TABLE ğŸ”¥**\n| **Condition** | **Key Vignette / Symptom** | **Best Initial Test** | **Gold Standard / Mgmt** |\n| --- | --- | --- | --- |\n| **SCFE** | ëš±ëš±í•œ ì²­ì†Œë…„, ë¬´ë¦ í†µì¦ | X-ray (Frog-leg) | Surgery (Screw fixation) ğŸ”© |\n| **DDH** | ì‹ ìƒì•„, ë‘”ìœ„, ë¹„ëŒ€ì¹­ ì£¼ë¦„ | <4mo US, >4mo X-ray | Pavlik Harness ğŸ¸ |\n| **Septic Arthritis** | ê³ ì—´ + ëª» ê±¸ìŒ | Kocher 3-4ì  | Antibiotics + Drainage ğŸš¨ |\n| **Stillâ€™s disease** | Salmon rash, Daily fever | Clinical | JIA Systemic type |\n| **JIA (Oligo)** | <5 ê´€ì ˆ, ë¬´ë¦ ë¶“ê¸° | Slit Lamp Exam | ëˆˆ ê²€ì‚¬ í•„ìˆ˜ (Uveitis) ğŸ‘ï¸ |\n| **Clubfoot** | Rigid, ì•ˆìª½ìœ¼ë¡œ íœœ ë°œ | Clinical Exam | Ponseti Casting (ì¦‰ì‹œ) |\n| **Scoliosis** | Cobb Angle 20~40ë„ | X-ray | Bracing (ì§„í–‰ ë°©ì§€) |\n### **7. [íŠ¹ìˆ˜ ì£¼ì œ] Gout & Brachial Plexus ğŸ’**\n**âš¡ Rapid Fire Recap (Gout / Septic)**\n- **Situation:** Big Toe Pain (Podagra) â†’ **Action:** Gout ì˜ì‹¬ 1ìˆœìœ„\n- **Diagnostic Test:** Arthrocentesis (Joint Tap) **ë¬´ì¡°ê±´!**\n- **Gout Fluid:** Negatively Birefringent Needle Crystals â–ğŸ’‰\n- **Septic Arthritis Fluid:** WBC > 50k, >90% Neutrophils\n- **Acute Tx (Renal Failure):** **Steroids (Injection or Oral) â˜…**\n- **Best HTN Med for Gout:** Losartan (or CCB)\n**ğŸ”¥ RAPID FIRE RECAP (Brachial Plexus)**","subject":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","page_title":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","episode":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","section_path":["LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76"],"source_doc_id":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","source_page":null,"source_anchor":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76-43","focus_area":"LM_OSRHM RFR 30646f2986ee80c7a4f5c94edb1e6b76","tags":["usmle-step2","core","quiz-seed","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"### ğŸ”¥ RAPID FIRE RECAP (Exam Day Cheat Sheet)\n| **Concept** | **High Yield Association** |\n| --- | --- |\n| **Broca's Aphasia** | **Frustrated**, Non-fluent, **Right Arm/Face Weakness**. |\n| **Wernicke's Aphasia** | **Word Salad**, Fluent, **Visual Field Cut (Pie in the sky)**. |\n| **Conduction Aphasia** | Fluent + Comprehends BUT **Can't Repeat**. Arcuate Fasciculus. |\n| **GCS Eye (Pain)** | Sternal rub/Nail bed pressure â†’ **2 Points**. |\n| **GCS Verbal (Salad)** | Random words (Inappropriate) â†’ **3 Points**. |\n| **GCS Motor (Extension)** | Decerebrate, Brainstem injury â†’ **2 Points** (Worse than Flexion). |\n| **Decorticate Posture** | Arms flexed like **\"C\"**s (Mummy) â†’ Lesion above Red Nucleus. |\n| **Intubate Trigger** | **GCS â‰¤ 8**. |\n| **MCI vs. Dementia** | **ADLs (Activities of Daily Living)**. í˜¼ì ì‚´ ìˆ˜ ìˆìœ¼ë©´ MCI. |\n| **Depression Memory** | Says **\"I don't know\"**. Dementia patient **Confabulates**. |\n- GCS í‰ê°€ ì‹œ ì‚½ê´€ëœ í™˜ì(T)ë‚˜ ëˆˆì´ ë¶€ì€ í™˜ì(C)ì˜ ê²½ìš° ì ìˆ˜ ë’¤ì— ë¬¸ìë¥¼ ë¶™ì´ëŠ” ê²ƒì„ ìŠì§€ ë§ˆì„¸ìš”.\n- ì¹˜ë§¤ ì§„ë‹¨ ì‹œ ìš°ìš¸ì¦(ê°€ì„± ì¹˜ë§¤)ì„ ë°˜ë“œì‹œ ë°°ì œ(Rule out)í•´ì•¼ í•©ë‹ˆë‹¤.\n- Conduction AphasiaëŠ” ë“œë¬¼ì§€ë§Œ \"Repetition\" í•˜ë‚˜ë§Œ ëª»í•œë‹¤ëŠ” íŠ¹ì§• ë•Œë¬¸ì— ì‹œí—˜ì— ì˜ ë‚˜ì˜µë‹ˆë‹¤.\n### Meta-Cognitive Reasoning Strategy\n1. **DECOMPOSE**: ì˜¤ë””ì˜¤ íŒŒì¼ì˜ ë‚´ìš©ì„ ì‹œê°„ ìˆœì„œì™€ ì˜í•™ì  ì£¼ì œë³„(IIH, NPH, Acute ICP/Herniation, VP Shunt)ë¡œ ë¶„í•´í•©ë‹ˆë‹¤.\n2. **SOLVE**: ê° ì„¹ì…˜ì„ USMLE Step 2 CK ìˆ˜ì¤€ì˜ ë””í…Œì¼ë¡œ í™•ì¥í•˜ê³ , í•œêµ­ì–´ ì„¤ëª…ì„ ë§ë¶™ì—¬ \"ê³¼ì™¸ ì„ ìƒë‹˜\" í†¤ìœ¼ë¡œ ë³€í™˜í•©ë‹ˆë‹¤. ìš”ì²­ëœ 'ASCII Tree'ì™€ 'Top-down' êµ¬ì¡°ë¥¼ ì ìš©í•©ë‹ˆë‹¤.\n3. **VERIFY**: 30ì´ˆ ë°›ì•„ì“°ê¸°ë¥¼ í†µí•´ ì •í™•ì„±ì„ ê²€ì¦í•˜ê³ , ê¸ˆì§€ëœ LaTeX ì‚¬ìš© ì—¬ë¶€ì™€ ê°•ì¡°(**, â˜…) ê·œì¹™ì„ í™•ì¸í•©ë‹ˆë‹¤.\n4. **SYNTHESIZE**: ëª¨ë“  ì •ë³´ë¥¼ ì´ëª¨ì§€ì™€ í•¨ê»˜ ì‹œê°ì ìœ¼ë¡œ êµ¬ì¡°í™”í•˜ì—¬ í†µí•©í•©ë‹ˆë‹¤.\n5. **REFLECT**: ëˆ„ë½ëœ \"Doorway Thought\"ë‚˜ \"Next Best Step\"ì´ ìˆëŠ”ì§€ ìµœì¢… ì ê²€í•©ë‹ˆë‹¤. Confidence Level: 1.0 (Full Audio Transcript Analysis).\n### TL;DR: Quick Overview ğŸ“‹","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-97","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","quiz-seed","mnemonic","tree"]}
{"chunk_type":"recap_quiz_seed","text":"### ğŸ”¥ Rapid Fire Recap Table\n| **Scenario** | **Next Best Step / Action** | **Key Concept** |\n| --- | --- | --- |\n| Obese female, headache, papilledema, ì—¬ë“œë¦„ì•½ | **MRI first** -> then LP | Rule out mass before LP |\n| IIH confirmed (LP > 250) | **Acetazolamide** + Wt loss | Decrease CSF production |\n| Elderly, \"feet stuck to floor\" ìì„ë°œ | **High Volume LP (Tap Test)** | Predicts response to VP shunt |\n| Trauma + HTN + Bradycardia | **Intubate & Hyperventilate** | Cushing's Triad (ICP Crisis) |\n| Blown pupil after head trauma | **Emergent Decompression** | Uncal Herniation (CN III) |\n| VP Shunt patient + Fever | **Shunt Tap** -> Remove if infected | Abx alone won't clear hardware |\n### Confidence & Caveats\n    - **LP ê¸ˆê¸°**: Papilledemaë‚˜ ICP ìƒìŠ¹ ì§•í›„ê°€ ìˆì„ ë•Œ, **ì ˆëŒ€ë¡œ** CT/MRIë¡œ Massë¥¼ ë°°ì œí•˜ê¸° ì „ê¹Œì§€ LPë¥¼ í•˜ë©´ ì•ˆ ë©ë‹ˆë‹¤ (Herniation ìœ„í—˜).\n    - **NPH ì§„ë‹¨**: MRIì—ì„œ ë‡Œì‹¤ì´ í¬ë‹¤ê³  ë¬´ì¡°ê±´ NPHê°€ ì•„ë‹˜. ë‡Œ ìœ„ì¶•(Atrophy)ìœ¼ë¡œ ì¸í•œ *Hydrocephalus ex vacuo*ì™€ êµ¬ë³„í•´ì•¼ í•¨ (ì¦ìƒì´ ì¤‘ìš”).\n    - **Hyperventilation**: ì„ì‹œ ë°©í¸ì„. ë„ˆë¬´ ê³¼í•˜ê²Œ í•˜ë©´ ë‡Œê²½ìƒ‰ ì˜´.\n### **TL;DR Overview**\n- **Topic:** Headache Management & USMLE High-Yield Points\n- **Key Concept:** Pattern Recognition (Patient Behavior & History)\n- **Core Distinction:** Primary (Migraine, Tension, Cluster) vs. Secondary (Thunderclap/Red Flags)\n- **Critical Action:** Rule out vascular disasters (SAH) first!","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-161","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","quiz-seed","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"# ğŸ”¥ Rapid Fire Recap Table\në§ˆì§€ë§‰ìœ¼ë¡œ í•µì‹¬ ë‚´ìš©ì„ ë¹ ë¥´ê²Œ ì •ë¦¬í•©ë‹ˆë‹¤. ì¡±ì§‘ê²Œ ê³¼ì™¸ í¬ì¸íŠ¸!\n| **Clinical Scenario** | **Probable Diagnosis** | **Next Best Step / Treatment** | **Key Feature to Look For** |\n| --- | --- | --- | --- |\n| **50ì„¸ ë‚¨ì„±, ì²« ë°œì‘ (First Seizure)** | **Brain Tumor** (until proven otherwise) | **Neuro-imaging (MRI/CT)** | ë‘í†µ, êµ­ì†Œ ì‹ ê²½í•™ì  ê²°ì† |\n| **ì†Œì•„, ìˆ˜ì—… ì¤‘ ë©ë•Œë¦¼, 20ì´ˆ ë¯¸ë§Œ** | **Absence Seizure** | **Ethosuximide** | **3Hz Spike & Wave**, No Post-ictal |\n| **ë°œì‘ 5ë¶„ ì´ìƒ ì§€ì†** | **Status Epilepticus** | **1. Lorazepam (IV)** -> **2. Fosphenytoin/Keppra** | 5ë¶„ ë„˜ìœ¼ë©´ ìì—° ì†Œì‹¤ ì•ˆ ë¨. ë‡Œ ì†ìƒ ì‹œì‘. |\n| **ì“°ëŸ¬ì§„ í›„ ì¦‰ì‹œ ì˜ì‹ ëª…ë£Œ (Crisp awakening)** | **Syncope (ì‹¤ì‹ )** | Cardiac Workup (ECG) | Post-ictal state ì—†ìŒ |\n| **ì“°ëŸ¬ì§„ í›„ 30ë¶„ê°„ í˜¼ë€ (Confusion)** | **Seizure** | Seizure Workup | **Post-ictal state ìˆìŒ (Gold Standard)** |\n| **ë°œì‘ í™˜ì, Phenytoin ë³µìš© ì¤‘, ë¹„í‹€ê±°ë¦¼/ì–´ì§€ëŸ¬ì›€** | **Phenytoin Toxicity** | Drug Level Check | **Horizontal Nystagmus**, Ataxia |\n| **Intubation í›„ ê²‰ë³´ê¸°ì—” ë©ˆì·„ìœ¼ë‚˜ ì˜ì‹ ì—†ìŒ** | **Non-convulsive Status** | **Continuous EEG** | ë‡ŒëŠ” ì—¬ì „íˆ íƒ€ê³  ìˆìŒ (Silent Seizure) |\n### **ğŸ§  USMLE Ischemic Stroke: The \"Time is Brain\" Masterclass**","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-282","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"### **ğŸ”¥ Rapid Fire Recap: High-Yield Table**\n| **Clinical Feature** | **Likely Diagnosis/Location** |\n| --- | --- |\n| **Face/Arm > Leg Weakness** | **MCA Stroke** (Lateral) |\n| **Leg/Foot > Arm Weakness** | **ACA Stroke** (Medial) |\n| **Gaze Preference** | Looks **Towards** the lesion (PPRF/FEF) |\n| **Aphasia (Speech issue)** | **Left** MCA (Dominant) |\n| **Hemineglect (Ignores left side)** | **Right** MCA (Non-dominant) |\n| **Pure Motor or Sensory (No cortical signs)** | **Lacunar Stroke** (Deep structures) |\n| **Young Female + OCP + Seizure/HA** | **CVST** (Check MRV!) |\n| **Focal Neuro Deficit + Hypoglycemia** | **Stroke Mimic** (Give Glucose!) ğŸ¬ |\n| **TPA BP Limit** | Must be **< 185/110** |\n| **No TPA BP Limit** | Permissive up to **220/120** |\n**ğŸ’¡ Final Wisdom:**\n\"Stroke managementëŠ” **Balance** ì‹¸ì›€ì…ë‹ˆë‹¤. í˜ˆì••ì„ ë„ˆë¬´ ë‚®ì¶”ë©´ ë‡Œê°€ ë§ˆë¥´ê³ (Ischemia), ë„ˆë¬´ ë†’ìœ¼ë©´ í„°ì§‘ë‹ˆë‹¤(Bleed). Time is Brain. ë§ì„¤ì´ì§€ ë§ê³  4.5ì‹œê°„ ìœˆë„ìš°ë¥¼ ì‚¬ìˆ˜í•˜ì„¸ìš”!\" ğŸš€\n### **ğŸ§  USMLE Ischemic Stroke: The \"Time is Brain\" Masterclass**\n### **ğŸŒŸ Overview & TL;DR (Too Long; Didn't Read)**\n| **Concept** | **Key Point ğŸ—ï¸** |\n| --- | --- |\n| **Core Mantra** | **Time is Brain** (2 million neurons die/min) â±ï¸ğŸ§  |\n| **#1 Risk Factor** | **Hypertension** (The King ğŸ‘‘, 4x risk) |\n| **First Test** | **Non-Contrast CT Head** (Rule out bleed first!) ğŸš«ğŸ©¸ |\n| **TPA Window** | **< 3 ~ 4.5 Hours** (Check contraindications!) |\n| **BP Rules** | **Permissive HTN** (< 220/120) unless giving TPA (< 185/110) |\n| **Glucose** | Always check **Glucose** (<50 mimics stroke) ğŸ¬ |\n| **MCA Stroke** | Face/Arm > Leg, Gaze towards lesion ğŸ‘€ |\n| **ACA Stroke** | Leg/Foot > Arm, Urinary Incontinence ğŸ¦µğŸ’¦ |\n| **Lacunar** | Deep structures, **No cortical signs** (Pure Motor/Sensory) |\n| **CVST** | Pregnant/OCP, Seizure + Headache, Tx: **Heparin** |","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-348","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"### **ğŸ”¥ Rapid Fire Recap: High-Yield Table**\n| **Clinical Feature** | **Likely Diagnosis/Location** |\n| --- | --- |\n| **Face/Arm > Leg Weakness** | **MCA Stroke** (Lateral) |\n| **Leg/Foot > Arm Weakness** | **ACA Stroke** (Medial) |\n| **Gaze Preference** | Looks **Towards** the lesion (PPRF/FEF) |\n| **Aphasia (Speech issue)** | **Left** MCA (Dominant) |\n| **Hemineglect (Ignores left side)** | **Right** MCA (Non-dominant) |\n| **Pure Motor or Sensory (No cortical signs)** | **Lacunar Stroke** (Deep structures) |\n| **Young Female + OCP + Seizure/HA** | **CVST** (Check MRV!) |\n| **Focal Neuro Deficit + Hypoglycemia** | **Stroke Mimic** (Give Glucose!) ğŸ¬ |\n| **TPA BP Limit** | Must be **< 185/110** |\n| **No TPA BP Limit** | Permissive up to **220/120** |\n**ğŸ’¡ Final Wisdom:**\n\"Stroke managementëŠ” **Balance** ì‹¸ì›€ì…ë‹ˆë‹¤. í˜ˆì••ì„ ë„ˆë¬´ ë‚®ì¶”ë©´ ë‡Œê°€ ë§ˆë¥´ê³ (Ischemia), ë„ˆë¬´ ë†’ìœ¼ë©´ í„°ì§‘ë‹ˆë‹¤(Bleed). Time is Brain. ë§ì„¤ì´ì§€ ë§ê³  4.5ì‹œê°„ ìœˆë„ìš°ë¥¼ ì‚¬ìˆ˜í•˜ì„¸ìš”!\" ğŸš€\n# Overview (TL;DR)\nì´ë²ˆ ì„¸ì…˜ì€ USMLE Step 2 CKë¥¼ ì¤€ë¹„í•˜ëŠ” ì˜ëŒ€ìƒì„ ìœ„í•œ **Hemorrhagic Stroke (ì¶œí˜ˆì„± ë‡Œì¡¸ä¸­)** ì‹œë®¬ë ˆì´ì…˜ì…ë‹ˆë‹¤. ë‹¨ìˆœíˆ ì§ˆë³‘ì„ ë‚˜ì—´í•˜ëŠ” ê²ƒì´ ì•„ë‹ˆë¼, ì‘ê¸‰ì‹¤(ER) ìƒí™©ê·¹ì„ í†µí•´ í™˜ìì˜ **Presentation(ì¦ìƒ)**, **Diagnosis(ì§„ë‹¨)**, **Management(ì¹˜ë£Œ)**ë¥¼ ë¼›ì†ê¹Œì§€ íŒŒí—¤ì¹©ë‹ˆë‹¤.\n- **í•µì‹¬ ì£¼ì œ:** 3ê°€ì§€ ì£¼ìš” ì¶œí˜ˆì„± ë‡Œì¡¸ì¤‘ (Cerebellar, Subdural, Subarachnoid)\n- **ì ‘ê·¼ ë°©ì‹:** \"Curtain A, B, C\" ë’¤ì— ìˆëŠ” í™˜ìë¥¼ Triageí•˜ëŠ” ER ì‹œë®¬ë ˆì´ì…˜\n- **Key Takeaway:** \"Time is Brain\", \"CT Scan is King\", ê·¸ë¦¬ê³  ê° ì¶œí˜ˆë³„ **Critical Cut-off** (3cm rule, 6-hour rule, BP management).\n### ğŸ¥ Medical Concept Top-Down Tree\nUSMLE ê´€ì ì—ì„œ Hemorrhagic Strokeì˜ í° ê·¸ë¦¼ì„ êµ¬ì¡°í™”í•œ **ASCII Text Tree**ì…ë‹ˆë‹¤.","subject":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","page_title":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","episode":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","section_path":["LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6"],"source_doc_id":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","source_page":null,"source_anchor":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6-410","focus_area":"LM_Neuro 1 30346f2986ee806abbb2fb0594cc1dd6","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","tree"]}
{"chunk_type":"recap_quiz_seed","text":"### ğŸš€ RAPID FIRE RECAP (Summary Table)\n| **Clinical Presentation** | **Diagnosis to Suspect** | **Gold Standard / Action** |\n| --- | --- | --- |\n| Resting Tremor (Pill-rolling) | **Parkinson's Disease** | **Levodopa/Carbidopa** |\n| Action Tremor (Postural) + Alcohol helps | **Essential Tremor** | **Propranolol** |\n| Intention Tremor (Finger-to-Nose worsens) | **Cerebellar Lesion** | Brain MRI |\n| Flailing arm (Ballistic) | **Hemiballismus** | **Subthalamic Nucleus** Stroke check |\n| Creepy-crawly legs at night | **Restless Legs Syndrome** | Check **Ferritin** (<75 -> Iron) |\n| Magnetic Gait (Can't lift feet) + Wet/Wacky | **NPH** | LP -> VP Shunt |\n| Foot Drop (Steppage) | **Peroneal N. vs L5** | Check Inversion (Weak in L5) |\n| Parkinsonism + Orthostasis/Incontinence | **MSA** | Supportive Care |\n| Parkinsonism + Can't look down | **PSP** | Supportive Care |\n| Parkinsonism + Visual Hallucinations | **Lewy Body Dementia** | **Avoid Antipsychotics** |\n**Caveats:**\n- ì´ ë…¸íŠ¸ëŠ” USMLE Step 2 CK ìˆ˜ì¤€ì˜ ê³ ë“ì  í¬ì¸íŠ¸ë¥¼ ë‹¤ë£¹ë‹ˆë‹¤.\n- ì‹¤ì œ ì„ìƒì—ì„œëŠ” ì•½ë¬¼ ì„ íƒ ì‹œ í™˜ìì˜ ë™ë°˜ ì§ˆí™˜(ì²œì‹ í™˜ìì—ê²Œ Propranolol ê¸ˆê¸° ë“±)ì„ ê³ ë ¤í•´ì•¼ í•©ë‹ˆë‹¤.\n- Parkinson-Plus ì¦í›„êµ°ë“¤ì€ ì˜ˆí›„ê°€ ì¢‹ì§€ ì•Šìœ¼ë¯€ë¡œ, ì¡°ê¸°ì— PDì™€ ê°ë³„í•˜ì—¬ ë³´í˜¸ìì™€ ìƒì˜í•˜ëŠ” ê²ƒì´ ì¤‘ìš”í•©ë‹ˆë‹¤.\në„ì›€ì´ ë˜ì…¨ë‚˜ìš”? Would you like me to generate a specific quiz block based on these movement disorders? ğŸ§ âœ¨\n### ğŸ“‹ Overview (TL;DR)\n**Neurocognitive Disorders (Dementia & Delirium) Deep Dive** ğŸ§ \nì´ ê°•ì˜ëŠ” ì‹ ê²½ì¸ì§€ ì¥ì• (Neurocognitive Disorders)ì— ëŒ€í•œ ë³µì¡í•œ ì„ìƒ ê°€ì´ë“œë¼ì¸ì„ ëª…í™•í•˜ê²Œ ì •ë¦¬í•˜ê³  ìˆìŠµë‹ˆë‹¤. í•µì‹¬ì€ **ê¸°ì–µë ¥ ê°í‡´(Forgetfulness)**ë§Œì´ ì•„ë‹ˆë¼, í™˜ìì˜ **ê¸°ëŠ¥ì  ìƒíƒœ(Functional Status, ADLs)**ì™€ **í–‰ë™(Behavior)**ì„ í†µí•´ ë³‘ë¦¬í•™ì  ì›ì¸ì„ êµ¬ë¶„í•˜ëŠ” ê²ƒì…ë‹ˆë‹¤.\n- **í•µì‹¬ ê°ë³„ í¬ì¸íŠ¸:**\n    - **Delirium (ì„¬ë§):** ê¸‰ì„±(Acute), ì˜ì‹ ìˆ˜ì¤€ì˜ ë³€í™”(Fluctuation), ì£¼ì˜ë ¥ ê²°í•. **Medical Emergency!** ğŸš¨\n    - **Depression (ê°€ì„± ì¹˜ë§¤):** \"ëª°ë¼ìš”(I don't know)\"ë¼ê³  ë‹µí•¨, ì£¼ê´€ì  ê³ í†µ í˜¸ì†Œ.\n    - **Dementia (ì¹˜ë§¤):** ë§Œì„±ì , ì‘í™”ì¦(Confabulation), ì¼ìƒìƒí™œ ìˆ˜í–‰ ëŠ¥ë ¥(ADLs) ì €í•˜.\n- **ì£¼ìš” ë³‘ë¦¬ (The Big 4):**\n    1. **Alzheimer's:** ë‹¨ê¸° ê¸°ì–µ ìƒì‹¤ â†’ ì¥ê¸° ê¸°ì–µ ìƒì‹¤, ê¸¸ ìƒìŒ.\n    2. **Vascular:** ê³„ë‹¨ì‹ ì•…í™”(Stepwise), í˜ˆê´€ ìœ„í—˜ ì¸ì.\n    3. **Frontotemporal (FTD):** ì„±ê²© ë³€í™”, íƒˆì–µì œ(Disinhibition), ì‚¬íšŒì  í•„í„° ìƒì‹¤.\n    4. **Lewy Body (LBD):** íŒŒí‚¨ìŠ¨ ì¦ìƒ + ì‹œê° í™˜ê°(Visual Hallucination) + í•­ì •ì‹ ë³‘ ì•½ë¬¼ ê³¼ë¯¼ì„±.","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-139","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","quiz-seed","diagnosis"]}
{"chunk_type":"recap_quiz_seed","text":"### ğŸ”¥ Rapid Fire Recap (Summary Table)\n| **Condition** | **Key Feature (The \"Tell\")** | **Initial Presentation** | **Treatment Alert âš ï¸** |\n| --- | --- | --- | --- |\n| **Delirium** | **Acute & Fluctuating** | Drowsy â†” Agitated, Inattention | **Emergency!** Find medical cause. |\n| **Depression** | **\"I don't know\"** | Distressed, gives up easily | Treat depression â†’ Cognition improves. |\n| **Alzheimer's** | **Short-term memory loss** | Amnesia, Getting lost | Focus on safety & routine. |\n| **Vascular** | **Stepwise decline** | History of Stroke/HTN | Control BP/Lipids to prevent next step. |\n| **FTD** | **Personality Change** | Disinhibition, Hyperorality | Often misdiagnosed as psychiatric issue. |\n| **Lewy Body** | **Visual Hallucinations** | Kids/Animals seen, Parkinsonism | **âŒ NO ANTIPSYCHOTICS (Lethal)**. |\n| **CJD** | **Startle Myoclonus** | Rapid progression (Weeks) | **RT-QuIC** test is Gold Standard. |\n| **Wilson's** | **Young + Tremor + Psych** | Liver issues + Psychosis | **Treatable** if caught (Copper). |\n### ğŸ©º Meta-Cognitive Analysis\n1. **DECOMPOSE:** ì˜¤ë””ì˜¤ëŠ” ì„¬ë§/ìš°ìš¸ì¦/ì¹˜ë§¤ì˜ ê°ë³„ â†’ ì¹˜ë§¤ì˜ ì¢…ë¥˜ë³„ íŠ¹ì§• â†’ ì¹˜ë£Œ ë° ê¸ˆê¸° ì‚¬í•­ìœ¼ë¡œ êµ¬ì„±ë¨.\n2. **SOLVE:** ê° ì§ˆí™˜ì˜ í•µì‹¬ ì¦ìƒ(Vignette)ì„ ì¶”ì¶œí•˜ê³ , íŠ¹íˆ Lewy Bodyì˜ ì•½ë¬¼ ê¸ˆê¸°ì™€ CJDì˜ ì§„ë‹¨ë²• ë“± High-yield ì •ë³´ë¥¼ ê°•ì¡°í•¨.\n3. **VERIFY:** ì˜¤ë””ì˜¤ ë‚´ìš©ê³¼ ë¹„êµ ì‹œ, NPH(ì •ìƒì•• ìˆ˜ë‘ì¦) ë‚´ìš©ì€ í¬í•¨ë˜ì§€ ì•Šì•„ ë…¸íŠ¸ì—ì„œ ì œì™¸í•¨(Zero-loss ì›ì¹™). ì˜¤ì§ ì˜¤ë””ì˜¤ì— ì–¸ê¸‰ëœ ë‚´ìš©ë§Œ í¬í•¨. \"RT-QuIC\" í…ŒìŠ¤íŠ¸ ëª…ì¹­ ì •í™•íˆ ê¸°ì¬.\n4. **SYNTHESIZE:** í•œêµ­ì–´ ì„¤ëª…ê³¼ ì˜ì–´ ì˜í•™ ìš©ì–´ë¥¼ ì„ì–´ ê°€ë…ì„±ì„ ë†’ì´ê³ , ì´ëª¨ì§€ë¥¼ ì‚¬ìš©í•˜ì—¬ ì‹œê°ì  ì´í•´ë¥¼ ë„ì›€.\nHere is your comprehensive lecture note, fully aligned with your preferences (USMLE expert mode, detailed structure, visual ASCII trees, and energetic vibe).\n### ğŸ“‹ Overview: TL;DR (Executive Summary)","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-203","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","mnemonic","tree"]}
{"chunk_type":"recap_quiz_seed","text":"### ğŸ”¥ RAPID FIRE RECAP: Diagnosis Buzzwords ğŸ”¥\n| **Disease** | **Clinical Buzzword / Vignette** | **Key Diagnostic Finding** |\n| --- | --- | --- |\n| **Multiple Sclerosis** | Painful eye movement, Electric shock (Lhermitte), Heat sensitivity (Uhthoff) | MRI: **Dawson Fingers** (Periventricular), LP: **Oligoclonal Bands** |\n| **Optic Neuritis** | Washed out colors (Red desaturation), APD | Swing Flashlight Test (+) |\n| **NMO (Devic's)** | Intractable **Hiccups**, Bilateral severe vision loss | **Anti-AQP4 Antibody** |\n| **Transverse Myelitis** | Defined **Sensory Level**, Bladder dysfunction | MRI Spine: Cord inflammation |\n| **Guillain-BarrÃ©** | Ascending paralysis, No reflexes (**Areflexia**) | CSF: **High Protein, Normal Cell** (Albuminocytologic Dissociation) |\n| **CPM (ODS)** | Hyponatremia corrected too fast, \"Locked-in\" | MRI: Hyperintensity in Pons |\n| **ALD** | School failure in boy + **Tanned skin** | **VLCFA** accumulation |\n### ğŸ’¡ Meta-Cognitive Reflection\n- **Confidence:** 1.0 (All requested details covered).\n- **Key Caveat:** MS ì¹˜ë£Œì œ ì¤‘ **Natalizumab**ì€ PML (JC virus reactivation) ìœ„í—˜ì´ ìˆìœ¼ë‹ˆ ì£¼ì˜í•´ì•¼ í•©ë‹ˆë‹¤. ì‹œê°ì  ë¬¸ì œ(Vision loss)ê°€ ì˜¤ë©´ ë‹¨ìˆœíˆ ëˆˆ ë¬¸ì œë¡œë§Œ ë³´ì§€ ë§ê³  ì‹ ê²½ê³„(CNS) ë¬¸ì œì¸ì§€ ê¼­ **Pupil**ì„ í™•ì¸í•˜ì„¸ìš”!","subject":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","page_title":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","episode":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","section_path":["LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6"],"source_doc_id":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","source_page":null,"source_anchor":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6-310","focus_area":"LM_Neuro 2 30346f2986ee80b5acf3eca919a5b8c6","tags":["usmle-step2","core","quiz-seed","diagnosis"]}
{"chunk_type":"recap_quiz_seed","text":"### 4. RAPID FIRE RECAP: Key Associations ğŸ”¥\n- **Ascending Weakness + Diarrhea hx + CSF high protein normal WBC** â†’  **GBS** (Campylobacter). â†’ ìŠ¤í…Œë¡œì´ë“œ ì•ˆì¤Œ â˜… ! IVIG + plasmaphresis\n- **Ascending Weakness + Camping/Hiking + CSF normal + no fever** â†’  **Tick Paralysis** (Look for the tick!).\n- **Chronic GBS (>8 weeks)** â†’  **CIDP** (Give Steroids).\n- **Atrophy + Hyperreflexia (Mixed)** â†’  **ALS**.\n- **Diabetic with Hyperreflexia** â†’  **Spinal Cord Compression** (MRI Spine).\n- **Facial Droop + Forehead Wrinkles SPARED** â†’  **Stroke**.\n- **Facial Droop + Can't wrinkle forehead** â†’  **Bell's Palsy â†’ eye protection**\n- Facial Droop + Hiker â†’ r/o Lyme â†’ Doxycycline\n- Pronator drift â†’ UMN lesion (í”¼ìê°€ ì—ì–´ì§)\n### 5. SYNTHESIZE & REFLECT\n- **Caveats:** Audio specifically emphasizes avoiding steroids in GBS but using them in CIDP. Don't mix this up! Also, the distinction between \"Sparing the forehead\" (Central/Stroke) and \"Involving the forehead\" (Peripheral/Bell's) is the most common pimping question in neurology rotation. Memorize the wiring diagram!\n**Next Step for User:** Would you like me to create a detailed **Question Bank (Q-Bank)** style quiz based on these specific clinical vignettes to test your retention?\n### ğŸ“‹ Overview (TL;DR)","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-61","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","quiz-seed","diagnosis"]}
{"chunk_type":"recap_quiz_seed","text":"### ğŸ”¥ Rapid Fire Recap (Summary Table)\n| **Condition** | **Key Feature / Vignette** | **Diagnosis (Gold Standard)** | **Treatment / Mgmt** | **Key Caveat âš ï¸** |\n| --- | --- | --- | --- | --- |\n| **PML** | HIV (CD4 < 200), clumsiness\nAsymmetric white lesion with **Non â˜… -enhancing** lesion | MRI Brain -> CSF JC Virus PCR | HAART (Restore immunity) | No specific antiviral. |\n| **Bacterial Meningitis** | Stiff neck, Photophobia, CSF: **Neutrophils**, **Low Glucose** | LP (CSF Analysis)\nHigh neutrophil, low glucose <40,\nhigh protein >250 | Vanc + Ceftriaxone (+ Ampicillin if >50y) + Steroids | CT before LP if **FAILS** signs present. |\n| **Viral Meningitis** | Similar sx but milder, CSF: **Normal Glucose** | LP (CSF Analysis) | Supportive Care (HSV -> Acyclovir) | Lymphocytes predominant. |\n| **TB Meningitis** | Subacute, CSF: **Very Low Glucose**, High Protein | LP | RIPE Therapy + Steroids | Base of brain enhancement often seen. |\n| **Brain Abscess** | Headache, Focal deficit, **Ring-enhancing** lesion | MRI Brain | **Surgical Drainage** + Abx | **NEVER perform LP** (Herniation risk). |\n| **Spinal Epidural Abscess** | IVDU, **Focal Back Pain**, Fever | **MRI Spine** (w/ contrast) | **Urgent Surgery** + Abx | **NEVER perform LP** (Infection spread). |\n- ì´ ê°•ì˜ ë…¸íŠ¸ëŠ” USMLE Step 2 CK ìˆ˜í—˜ìš©ìœ¼ë¡œ ìµœì í™”ë˜ì–´ ìˆìŠµë‹ˆë‹¤. ì‹¤ì œ ì„ìƒì—ì„œëŠ” ë¡œì»¬ ê°€ì´ë“œë¼ì¸ì„ ë”°ë¥´ì„¸ìš”.\n- \"Ring-enhancing\" ë³‘ë³€ì€ Abscess ì™¸ì—ë„ Tumor (Metastasis, Glioblastoma), Toxoplasmosis ë“±ì´ ìˆì„ ìˆ˜ ìˆìœ¼ë‹ˆ ê°ë³„ì´ í•„ìš”í•©ë‹ˆë‹¤.\n- Steroid íˆ¬ì—¬ ì‹œì (Meningitis)ì€ í•­ìƒì œ íˆ¬ì—¬ **ì „**ì´ ê°€ì¥ ì´ìƒì ì´ë¼ëŠ” ì ì„ ê¼­ ê¸°ì–µí•˜ì„¸ìš”. (ì†Œì•„ê³¼/ë‚´ê³¼ ê³µí†µ).\n### ğŸ“‹ Overview: CNS Tumors (Deep Dive)\n**TL;DR Summary Table**\n| **Tumor Type** | **Key Feature/Buzzword** | **Location** | **Key Management/Fact** |\n| --- | --- | --- | --- |\n| **Meningioma** | Dural tail, psammoma bodies | Extra-axial, attached to dura | Resect if symptomatic. Observe if asymptomatic. |\n| **Metastasis** | Gray-white junction, multiple lesions | Intraparenchymal | Most common brain tumor in adults. Lung is most common primary. |\n| **Prolactinoma** | Galactorrhea, amenorrhea | Sella turcica | **Medical therapy first** (dopamine agonist: bromocriptine or cabergoline). |\n| **Craniopharyngioma** | Calcified, cystic, kids (bimodal) | Suprasellar | \"Motor oil\" cyst fluid. Bimodal age distribution. |\n| **Pinealoma** | Parinaud syndrome (upward gaze palsy) | Pineal gland | Compresses dorsal midbrain / superior colliculus. |\n| **Schwannoma** | Hearing loss, tinnitus | Cerebellopontine angle | Bilateral suggests **NF2**. |\n| **Choroid plexus papilloma** | Hydrocephalus (CSF overproduction) | Ventricles | Resection (\"stop the faucet\"). |","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-109","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"### ğŸ”¥ Rapid Fire Recap & Next Steps\n**Key Clinical Pearls:**\n- **Physical Exam:** ëˆˆì„ ìœ„ë¡œ ëª» ì³ë‹¤ë³´ê³ (Upward gaze palsy) = ì•„ë˜ë¥¼ ì³ë‹¤ë³´ëŠ” ë¶€ë¦…ëœ¨ëŠ” ëˆˆ ë¹›ì— ë°˜ì‘ ì•ˆ í•˜ë©´(Light-near dissociation)? â†’ **Pinealoma**.\n- **History:** ì•„ì¹¨ì— ë‘í†µì´ ì‹¬í•˜ê³  êµ¬í†  í›„ í˜¸ì „? â†’ **Increased ICP**.\n- **Imaging:** Dural Tail? â†’ **Meningioma**.\n- **Imaging:** Grey-White Junctionì— ì—¬ëŸ¬ ê°œ? â†’ **Metastasis**.\n- **Treatment:** ProlactinomaëŠ” ìˆ˜ìˆ  ë¨¼ì €? (NO!) â†’ **Dopamine Agonist**.\n- **Treatment:** Metastasis Single Lesion? â†’ **Resection**. Multiple? â†’ **Radiation**.\n**Caveats:**\n- **Melanoma:** MRIì—ì„œ ì¶œí˜ˆ(Bleeding) ì†Œê²¬ì´ ë³´ì´ë©´ 1ìˆœìœ„ë¡œ ì˜ì‹¬í•  ê²ƒ.\n- **Eyes:** ì‹œë ¥ ê²€ì‚¬ë¿ë§Œ ì•„ë‹ˆë¼ ì‹œì•¼(Visual field) ê²€ì‚¬ë¥¼ í†µí•´ Sellar massë¥¼ ë†“ì¹˜ì§€ ë§ ê²ƒ.\n- female pt. seizure, dural tail â†’ meningioma\n- no1 primary for mets brain ca â†’ lung ca\n- bilateral vestibular schwannoma â†’ NF2\n- schwanomma hearing loss ì™¸ ë‹¤ë¥¸ ì¦ìƒ..? â†’ facial numbness (CN5), facial palsy (CN7)\n- calcified sellar mass â†’ craniopharyngioma\n**Next Step for User:**\n### ğŸ“‹ Overview: Pediatric Neurology (Congenital & Developmental)\nì•ˆë…•í•˜ì„¸ìš”! ğŸ‘¨â€âš•ï¸ ì˜¤ëŠ˜ì€ **Pediatric Neurology**, ê·¸ì¤‘ì—ì„œë„ ì„ ì²œì„± ì§ˆí™˜ê³¼ ë°œë‹¬ ë¬¸ì œë¥¼ ë‹¤ë£¹ë‹ˆë‹¤. í”¼ë¶€ ì†Œê²¬(Skin)ì´ ë‡Œ(Brain)ì˜ ìƒíƒœë¥¼ ë§í•´ì£¼ëŠ” **Neurocutaneous disorders**ë¶€í„°, ë“±(Spine)ì˜ ë¬¸ì œ, ë¨¸ë¦¬ í¬ê¸°(Head size), ê·¸ë¦¬ê³  ë‡Œì„±ë§ˆë¹„(CP)ê¹Œì§€! **USMLE High-Yield** í¬ì¸íŠ¸ë“¤ì„ ê½‰ê½‰ ì±„ì›Œë“œë¦´ê²Œìš”. ğŸ§","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-175","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"### âš¡ Rapid Fire Recap (Summary Table)\n| **Condition** | **Key Clinical Feature / Buzzword** | **Pathophysiology / Gene** |\n| --- | --- | --- |\n| **NF1** | CafÃ©-au-lait, Lisch nodules, Neurofibromas | Chr 17, Neurofibromin |\n| **NF2** | **Bilateral Acoustic Neuromas** (Hearing loss) | Chr 22, Merlin |\n| **Tuberous Sclerosis** | **Ash-leaf spots**, Cardiac Rhabdomyoma, Seizures | TSC1/2, mTOR pathway |\n| **Sturge-Weber** | **Port-Wine Stain**, Seizures (Contralateral) | Somatic GNAQ (Not inherited) |\n| **VHL** | Hemangioblastomas (Retina/Cerebellum), RCC | Chr 3, VHL gene |\n| **Cephalohematoma** | Does **NOT** cross sutures | Subperiosteal blood (Risk: Jaundice) |\n| **Subgaleal Hemorrhage** | **Crosses** sutures, Fluctuant | Emissary veins (Risk: Shock/Death) |\n| **Spastic Diplegia** | **Commando Crawl**, Legs > Arms | Prematurity â†’  PVL |\n- ì˜¤ë””ì˜¤ ê°•ì˜ëŠ” \"General Rule\"ì„ ë‹¤ë£¹ë‹ˆë‹¤. ì˜ˆì™¸ì ì¸ ì¼€ì´ìŠ¤(Mosaicism in NF, etc.)ëŠ” í•­ìƒ ì¡´ì¬í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- CPì˜ ì§„ë‹¨ì€ ì„ìƒì (Clinical)ì´ì§€ë§Œ, í™•ì§„ì„ ìœ„í•´ MRIê°€ í•„ìš”í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- Scalp swelling ì¤‘ Subgaleal hemorrhageëŠ” ì‘ê¸‰ ìƒí™©ì„ì„ ê¼­ ê¸°ì–µí•˜ì„¸ìš”!\n**Overview: Pediatric Acute Neurology Deep Dive**\nì•ˆë…•í•˜ì„¸ìš”! ì˜¤ëŠ˜ì€ ì†Œì•„ ì‘ê¸‰ ì‹ ê²½í•™(Pediatric Acute Neurology)ì— ëŒ€í•´ ì•„ì£¼ ê¹Šì´ ìˆê²Œ íŒŒê³ ë“¤ì–´ ë³´ê² ìŠµë‹ˆë‹¤. ğŸ§ âš¡ï¸ ë¯¸êµ­ ì˜ì‚¬ êµ­ê°€ê³ ì‹œ(USMLE)ë‚˜ ì„ìƒ í˜„ì¥ì—ì„œ ì •ë§ ì¤‘ìš”í•˜ê²Œ ë‹¤ë£¨ëŠ” **Stroke, IVH, ê·¸ë¦¬ê³  ë‹¤ì–‘í•œ Pediatric Epilepsy Syndromes**ë¥¼ ë‚˜ì´ëŒ€ë³„, ìƒí™©ë³„ë¡œ ì™„ë²½í•˜ê²Œ ì •ë¦¬í•´ ë“œë¦´ê²Œìš”.\nì´ ê°•ì˜ëŠ” \"High-Yield Tutoring Session\" ì»¨ì…‰ìœ¼ë¡œ ì§„í–‰ë©ë‹ˆë‹¤. ë†“ì¹˜ëŠ” ë‚´ìš© ì—†ì´ ê½‰ê½‰ ì±„ì› ìœ¼ë‹ˆ ì§‘ì¤‘í•´ ì£¼ì„¸ìš”! ğŸ”¥\n### **Top-down Classification & Structure (ASCII Text Tree)**","subject":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","page_title":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","episode":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","section_path":["LM_Neuro 3 30346f2986ee80f58240d21021eb2946"],"source_doc_id":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","source_page":null,"source_anchor":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946-241","focus_area":"LM_Neuro 3 30346f2986ee80f58240d21021eb2946","tags":["usmle-step2","core","quiz-seed","pathophysiology","tree"]}
{"chunk_type":"recap_quiz_seed","text":"### ğŸš€ Rapid Fire Recap (Quiz Section)\n- **Scenario:** 4ì¼ ëœ ì‹ ìƒì•„, ì–‘ìª½ ëˆˆì—ì„œ ì—„ì²­ë‚œ ê³ ë¦„(Profuse Pus).\n    - **Dx:** Gonococcal Conjunctivitis.\n    - **Tx:** **IM Ceftriaxone** (Eye drops alone = Fail).\n- **Scenario:** ëˆˆì„ ì›€ì§ì¼ ë•Œ ì•„í”„ê³ (Pain with EOM), ì•ˆêµ¬ ëŒì¶œ(Proptosis).\n    - **Dx:** **Orbital Cellulitis**.\n    - **Next Step:** **CT Scan** (Emergency!).\n- **Scenario:** ì •ì›ì‚¬(Gardener)ê°€ ë‚˜ë­‡ê°€ì§€ì— ëˆˆì„ ì°”ë¦¼. ê¹ƒí„¸ ëª¨ì–‘(Feathery) ê¶¤ì–‘.\n    - **Dx:** **Fungal Keratitis**.\n- **Scenario:** ì½˜íƒíŠ¸ë Œì¦ˆ ì°©ìš©ì, ê¶¤ì–‘ ë°œìƒ.\n    - **Bug:** Pseudomonas.\n    - **Tx:** Fluoroquinolones.\n- **Scenario:** 2ì£¼ ëœ ì‹ ìƒì•„, ê¸°ì¹¨(Cough) + ëˆˆê³±.\n    - **Dx:** **Chlamydia Conjunctivitis**.\n    - **Risk:** Pyloric Stenosis (due to Oral Erythromycin).\n- **Scenario:** ëˆˆêº¼í’€ì— ì•„í”ˆ ë©ìš¸(Painful red lump).\n    - **Dx:** **Hordeolum (Stye)**. (H is for Hurt).\n- **Scenario:** ë°±ë‚´ì¥ ìˆ˜ìˆ  í›„ í†µì¦, ì‹œë ¥ ì €í•˜, ì „ë°© ì¶•ë†(Hypopyon).\n    - **Dx:** **Endophthalmitis**.\n**Confidence:** 1.0 (Based strictly on audio content)\n**Caveats:** ì˜¤ë””ì˜¤ ë‚´ìš©ì€ USMLE ì‹œí—˜ ëŒ€ë¹„ìš© \"High Yield\" ì •ë³´ì— ì§‘ì¤‘ë˜ì–´ ìˆìœ¼ë¯€ë¡œ, ì‹¤ì œ ì„ìƒ ê°€ì´ë“œë¼ì¸(Local protocols)ê³¼ëŠ” ë¯¸ì„¸í•œ ì°¨ì´ê°€ ìˆì„ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n**Mental Model:** Ophthalmology for Step 2CK & Shelf Exams.\n**Key Constraints:** Korean language, Casual/Fun tone with Emojis, No LaTeX, ASCII Tree Structure, Verbatim start, Detailed \"Zero-Loss\" notes.\n### ğŸ“‹ Overview: High-Yield Vision Pathology (TL;DR)","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-77","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","mnemonic","tree"]}
{"chunk_type":"recap_quiz_seed","text":"### ğŸš€ Rapid Fire Recap Table (Summary)\n| **Diagnosis** | **Key Finding (Fundoscopy/Exam)** | **Treatment / Next Step** |\n| --- | --- | --- |\n| **Retinal Detachment** | Flashes, Floaters, **Curtain** ğŸ“‰ | **Surgery** (Urgent) |\n| **Acute Angle Closure** | **Rock hard**, painful, halos ğŸª¨ | **Pilocarpine**, Laser Iridotomy |\n| **CRAO** | **Cherry Red Spot** ğŸ’, Pale retina | Ocular Massage, CO2 |\n| **CRVO** | **Blood and Thunder** ğŸŒ©ï¸ | Observation / Anti-VEGF |\n| **Macular Degeneration** | **Central loss** (Clock/Faces) ğŸ•°ï¸ | Dry (Vitamins), Wet (Anti-VEGF) |\n| **Amblyopia** | Cortical suppression of one eye | **Patch the GOOD eye** ğŸ´â€â˜ ï¸ |\n| **Strabismus** | Misalignment > 4 months | Patch / Surgery |\n| **Retinoblastoma** | **Leukocoria** (White pupil) âšª | **MRI** (Rule out Osteosarcoma link) |\n| **Retinitis Pigmentosa** | **Bone spicules**, Night blindness ğŸŒ‘ | Supportive / Vitamin A |\n- **Confidence:** 1.0 (Based on verbatim transcription and medical knowledge integration).\n- **Disclaimer:** Audio specifically mentions Step 2 CK context. Actual clinical practice may involve more nuanced diagnostic steps (e.g., OCT scans) which were not the primary focus of this high-yield review.\n- **Images:** Visual descriptions (Pizza pie, Cherry red spot, Bone spicules) are critical for the exam. Ensure you look up atlas images for these buzzwords!\nHere is the response based on the analysis of the audio file provided.\n### ğŸ“‹ Overview: Eye Trauma High-Yield Summary (TL;DR)\n| **Pathology** | **Key Feature (Buzzword)** | **Next Best Step (NBS) / Treatment** | **Do NOT Do** |\n| --- | --- | --- | --- |\n| **Corneal Abrasion** | Foreign body sensation, Fluorescein uptake | Erythromycin (Non-contact) / **Ciprofloxacin** (Contact Lens) | Do **NOT** patch if contact lens wearer (Pseudomonas risk) |\n| **Open Globe** | **Teardrop Pupil**, Seidel Sign (+) | **Rigid Eye Shield**, CT Scan, IV Abx, Tetanus | Do **NOT** measure IOP, Do **NOT** touch/manipulate |\n| **Orbital Compartment Syndrome (OCS)** | **Rock-hard Eyelid**, Proptosis, Afferent Pupillary Defect (APD) | **Lateral Canthotomy** (Immediate) | Do **NOT** wait for CT scan |\n| **Hyphema** | Blood fluid level in Anterior Chamber | Head elevation (30Â°), Cycloplegics | Screen for **Sickle Cell** (Glaucoma risk) |\n| **Sympathetic Ophthalmia** | Autoimmune attack on \"Good Eye\" after trauma | Remove damaged eye (Enucleation) within 2 weeks | Ignore complaints in the non-injured eye |\n| **Photokeratitis** | Welder/Skier, Bilateral pain, 6-12hr lag | Supportive care, lubrication | - |","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-143","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"### ğŸ”¥ 4. Rapid Fire Recap (Summary Table)\n| **Condition** | **Visual Cue / Exam Finding** | **Critical Action / Note** |\n| --- | --- | --- |\n| **Corneal Abrasion** | Fluorescein uptake (Green scratch) | Contact lens? -> **Ciprofloxacin** (No Patch!) |\n| **Open Globe** | **Teardrop Pupil**, Seidel Sign (+) | **Shield it**, CT, NPO, Call Surgeon. **No IOP check!** |\n| **Orbital Compartment Syndrome** | **Proptosis**, **Rock-hard lid**, APD | **Lateral Canthotomy** ASAP (Don't wait for CT) |\n| **Hyphema** | Blood level in anterior chamber | **Head up 30Â°**, Screen for **Sickle Cell** (Glaucoma risk) |\n| **Sympathetic Ophthalmia** | Inflammation in *non-injured* eye | Enucleation of injured eye within 14 days |\n| **Photokeratitis** | Welder/Skier, delayed pain | Supportive care, heals in 1-3 days |\n- **Confidence Level:** 1.0 (Confident)\n- **Caveats:**\n    - ì˜¤ë””ì˜¤ì—ì„œëŠ” í™˜ì A, B, Cë¥¼ ì²˜ìŒì— ì†Œê°œí•˜ê³  ë‚˜ì¤‘ì— ìƒì„¸ ì„¤ëª…í•˜ë¯€ë¡œ, ë…¸íŠ¸ì—ì„œëŠ” ë³‘ë¦¬í•™ì  ìˆœì„œë¡œ ì¬ë°°ì—´í•˜ì—¬ ê°€ë…ì„±ì„ ë†’ì˜€ìŠµë‹ˆë‹¤.\n    - Sickle Cellê³¼ Hyphemaì˜ ë³‘íƒœìƒë¦¬ëŠ” USMLEì—ì„œ ë§¤ìš° ì„ í˜¸í•˜ëŠ” ì£¼ì œì´ë¯€ë¡œ ìƒì„¸íˆ ê¸°ìˆ í–ˆìŠµë‹ˆë‹¤.\n    - ì•ˆëŒ€(Patching) ê¸ˆê¸° ì‚¬í•­(Contact lens wearer)ì€ ì‹¤ì œ ì„ìƒì—ì„œë„ ë§¤ìš° ì¤‘ìš”í•©ë‹ˆë‹¤.\n**Would you like me to simulate a USMLE Step 2 CK question block based on these ocular trauma scenarios?**\n# TL;DR Overview: Ear Infections (USMLE Step 2 CK)\nHere is the high-yield structure for Ear Pathology. We are focusing on **Precision** today! ğŸ¯\n- **Key Concept:** Anatomy & \"Doorway Diagnosis\" (Visualizing the patient before entering).\n- **External Ear:**\n    - **Otitis Externa:** Swimmer, Tragus pain, Canal inflammation.\n    - **Malignant Otitis Externa:** Diabetic/Elderly, *Night Pain*, Granulation tissue, Osteomyelitis.\n- **Middle Ear:**\n    - **Acute Otitis Media (AOM):** Bulging TM, Fever, Pain (Toddlers).\n    - **Serous Otitis Media (OME):** Fluid, No pain, Hearing loss.\n    - **Chronic Suppurative (CSOM):** Perforated TM, drainage > 6 weeks.\n    - **Mastoiditis:** Ear pushed forward, Post-auricular swelling.\n    - **Cholesteatoma:** Pearly white mass, skin in the wrong place.\n### ğŸŒ³ Top-Down Classification: Ear Pathology Tree","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-191","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","tree"]}
{"chunk_type":"recap_quiz_seed","text":"### ğŸ”¥ Rapid Fire Recap (Summary)\në¹ ë¥´ê²Œ ë³µìŠµí•´ë´…ì‹œë‹¤!\n1. **Symptom:** Vertigo + Hearing Loss + Tinnitus (Triad).\n    - **Diagnosis:** **Meniere's Disease**.\n2. **Symptom:** Vertigo lasting **seconds**, triggered by rolling over in bed.\n    - **Diagnosis:** **BPPV**.\n    - **Test:** Dix-Hallpike.\n3. **Symptom:** **Severe vertigo** for days, followed by viral illness, NO hearing loss.\n    - **Diagnosis:** **Vestibular Neuritis**.\n4. **Symptom:** Young pregnant woman, hearing loss, hears **better in noisy places**.\n    - **Diagnosis:** **Otosclerosis**.\n5. **Symptom:** Wrestler with a swollen ear.\n    - **Next Step:** **Incision & Drainage + Pressure Dressing** (Prevent Cauliflower ear).\n6. **Sign:** Vertigo triggered by **loud noise** (Tullio phenomenon).\n    - **Diagnosis:** **Perilymphatic Fistula** (Superior Canal Dehiscence).\n7. **Concept:** Pain in airplane -> Pop -> Pain gone + Blood.\n    - **Diagnosis:** **Ruptured TM** (Barotrauma).\n8. **Sign:** Nystagmus that **does NOT stop** with fixation (looking at thumb).\n    - **Diagnosis:** **Central Cause (Stroke)**.","subject":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","page_title":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","episode":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","section_path":["LM_neuro 4 30646f2986ee8031999be873ddb66ad3"],"source_doc_id":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","source_page":null,"source_anchor":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3-338","focus_area":"LM_neuro 4 30646f2986ee8031999be873ddb66ad3","tags":["usmle-step2","core","quiz-seed","diagnosis","tree"]}
{"chunk_type":"recap_quiz_seed","text":"**ğŸ”¥ Rapid Fire Recap: High-Yield Associations**\n| **Clue in Question** | **Diagnosis** | **Next Step / Treatment** |\n| --- | --- | --- |\n| \"Worst headache of my life\" | **SAH (Thunderclap)** | Non-contrast CT â†’ LP |\n| Male, pacing around room, holding eye | **Cluster Headache** | 100% Oxygen (First line) |\n| Female, pulsatile pain, vomiting, dark room | **Migraine** | Triptan (Abortive) / Beta-blocker (Prevent) |\n| Band-like pressure, \"tight hat\" | **Tension Headache** | NSAIDs / Relaxation |\n| Pregnant (3rd Tri) with Migraine | Migraine | Avoid NSAIDs! (Use Tylenol/Opioids) |\n| Child with \"Bi-frontal\" headache | Pediatric Migraine | Rest, Hydration, Tylenol |\n| Headache + Visual field cut + Hypotension | Pituitary Apoplexy | Urgent Surgical Consult / Steroids |\n### **Episode 4: Epilepsy & Seizure Management**\n**ğŸ”¥ Rapid Fire Recap Table**\n| **Clinical Scenario** | **Probable Diagnosis** | **Next Best Step / Treatment** | **Key Feature to Look For** |\n| --- | --- | --- | --- |\n| 50ì„¸ ë‚¨ì„±, ì²« ë°œì‘ (First Seizure) | **Brain Tumor** (until proven otherwise) | Neuro-imaging (MRI/CT) | ë‘í†µ, êµ­ì†Œ ì‹ ê²½í•™ì  ê²°ì† |\n| ì†Œì•„, ìˆ˜ì—… ì¤‘ ë©ë•Œë¦¼, 20ì´ˆ ë¯¸ë§Œ | **Absence Seizure** | Ethosuximide | 3Hz Spike & Wave, No Post-ictal |\n| ë°œì‘ 5ë¶„ ì´ìƒ ì§€ì† | **Status Epilepticus** | 1. Lorazepam (IV) -> 2. Fosphenytoin/Keppra | 5ë¶„ ë„˜ìœ¼ë©´ ìì—° ì†Œì‹¤ ì•ˆ ë¨. ë‡Œ ì†ìƒ ì‹œì‘. |\n| ì“°ëŸ¬ì§„ í›„ ì¦‰ì‹œ ì˜ì‹ ëª…ë£Œ (Crisp awakening) | Syncope (ì‹¤ì‹ ) | Cardiac Workup (ECG) | Post-ictal state ì—†ìŒ |\n| ì“°ëŸ¬ì§„ í›„ 30ë¶„ê°„ í˜¼ë€ (Confusion) | Seizure | Seizure Workup | Post-ictal state ìˆìŒ (Gold Standard) |\n| ë°œì‘ í™˜ì, Phenytoin ë³µìš© ì¤‘, ë¹„í‹€ê±°ë¦¼/ì–´ì§€ëŸ¬ì›€ | Phenytoin Toxicity | Drug Level Check | Horizontal Nystagmus, Ataxia |\n| Intubation í›„ ê²‰ë³´ê¸°ì—” ë©ˆì·„ìœ¼ë‚˜ ì˜ì‹ ì—†ìŒ | **Non-convulsive Status** | Continuous EEG | ë‡ŒëŠ” ì—¬ì „íˆ íƒ€ê³  ìˆìŒ (Silent Seizure) |\n### **Episode 5: Ischemic Stroke & Vascular Disorders**\n**ğŸ”¥ Rapid Fire Recap: High-Yield Table**\n| **Clinical Feature** | **Likely Diagnosis/Location** |\n| --- | --- |\n| Face/Arm > Leg Weakness | **MCA Stroke (Lateral)** |\n| Leg/Foot > Arm Weakness | **ACA Stroke (Medial)** |\n| Gaze Preference | Looks Towards the lesion (PPRF/FEF) |\n| Aphasia (Speech issue) | Left MCA (Dominant) |\n| Hemineglect (Ignores left side) | Right MCA (Non-dominant) |\n| Pure Motor or Sensory (No cortical signs) | **Lacunar Stroke** (Deep structures) |\n| Young Female + OCP + Seizure/HA | CVST (Check MRV!) |\n| Focal Neuro Deficit + Hypoglycemia | Stroke Mimic (Give Glucose!) ğŸ¬ |\n| TPA BP Limit | Must be < 185/110 |\n| No TPA BP Limit | Permissive up to 220/120 |","subject":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","page_title":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","episode":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","section_path":["LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834"],"source_doc_id":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","source_page":null,"source_anchor":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834-13","focus_area":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment"]}
{"chunk_type":"recap_quiz_seed","text":"**ğŸš€ RAPID FIRE RECAP (Summary Table)**\n| **Clinical Presentation** | **Diagnosis to Suspect** | **Gold Standard / Action** |\n| --- | --- | --- |\n| Resting Tremor (Pill-rolling) | **Parkinson's Disease** | Levodopa/Carbidopa |\n| Action Tremor (Postural) + Alcohol helps | **Essential Tremor** | Propranolol |\n| Intention Tremor (Finger-to-Nose worsens) | Cerebellar Lesion | Brain MRI |\n| Flailing arm (Ballistic) | Hemiballismus | Subthalamic Nucleus Stroke check |\n| Creepy-crawly legs at night | Restless Legs Syndrome | Check Ferritin (<75 -> Iron) |\n| Magnetic Gait (Can't lift feet) + Wet/Wacky | **NPH** | LP -> VP Shunt |\n| Foot Drop (Steppage) | Peroneal N. vs L5 | Check Inversion (Weak in L5) |\n| Parkinsonism + Orthostasis/Incontinence | MSA | Supportive Care |\n| Parkinsonism + Can't look down | PSP | Supportive Care |\n| Parkinsonism + Visual Hallucinations | Lewy Body Dementia | Avoid Antipsychotics |\n### **Episode 9: Dementia & Cognitive Disorders**\n**ğŸ”¥ Rapid Fire Recap (Summary Table)**\n| **Condition** | **Key Feature (The \"Tell\")** | **Initial Presentation** | **Treatment Alert âš ï¸** |\n| --- | --- | --- | --- |\n| **Delirium** | Acute & Fluctuating | Drowsy â†” Agitated, Inattention | Emergency! Find medical cause. |\n| **Depression** | \"I don't know\" | Distressed, gives up easily | Treat depression â†’ Cognition improves. |\n| **Alzheimer's** | Short-term memory loss | Amnesia, Getting lost | Focus on safety & routine. |\n| **Vascular** | Stepwise decline | History of Stroke/HTN | Control BP/Lipids to prevent next step. |\n| **FTD** | Personality Change | Disinhibition, Hyperorality | Often misdiagnosed as psychiatric issue. |\n| **Lewy Body** | Visual Hallucinations | Kids/Animals seen, Parkinsonism | âŒ NO ANTIPSYCHOTICS (Lethal). |\n| **CJD** | Startle Myoclonus | Rapid progression (Weeks) | RT-QuIC test is Gold Standard. |\n| **Wilson's** | Young + Tremor + Psych | Liver issues + Psychosis | Treatable if caught (Copper). |\n### **Episode 10: Spinal Cord Pathology**\n**ğŸ”¥ Rapid Fire Recap (Summary Table)**\n| **Symptom / Scenario** | **Diagnosis** | **Key Mechanism / Action** |\n| --- | --- | --- |\n| Night Pain + Back Pain | **Spinal Tumor** | Venous engorgement. Dexa FIRST if deficit. |\n| Elderly + Hyperextension + Weak Hands | **Central Cord** | Ligamentum flavum buckles. Arms > Legs. |\n| Paralysis + Vibration Intact | **Anterior Cord** | ASA occlusion. Post. columns spared. |\n| Hyperreflexia + Early Bladder issues | **Conus Medullaris** | UMN Lesion (Cord tip). |\n| Areflexia + Severe Radicular Pain | **Cauda Equina** | LMN Lesion (Nerve roots). |\n| T6+ Injury + Headache + HTN + bradycardia | **Autonomic Dysreflexia** | Check Bladder (Kinked foley)! Sit Up! |\n| Fever + Back Pain + IVDU | Epidural Abscess | No LP! MRI First. |","subject":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","page_title":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","episode":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","section_path":["LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834"],"source_doc_id":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","source_page":null,"source_anchor":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834-33","focus_area":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"recap_quiz_seed","text":"**ğŸ”¥ Rapid Fire Recap & Next Steps**\n| **Context** | **Clinical Presentation / Finding** | **â˜… Action / Management** |\n| --- | --- | --- |\n| Physical Exam | ëˆˆì„ ìœ„ë¡œ ëª» ì³ë‹¤ë³´ê³ (Upward gaze palsy) + Light-near dissociation | **Pinealoma** |\n| History | ì•„ì¹¨ì— ë‘í†µì´ ì‹¬í•˜ê³  êµ¬í†  í›„ í˜¸ì „ | **Increased ICP** |\n| Imaging | Dural Tail | **Meningioma** |\n| Imaging | Grey-White Junctionì— ì—¬ëŸ¬ ê°œ | **Metastasis** |\n| Treatment | Prolactinoma | **Dopamine Agonist** (Not Surgery first!) |\n| Treatment | Metastasis Single Lesion | **Resection** |\n| Treatment | Metastasis Multiple Lesions | **Radiation** |\n| Caveat | MRIì—ì„œ ì¶œí˜ˆ(Bleeding) ì†Œê²¬ | **Melanoma** 1ìˆœìœ„ ì˜ì‹¬ |\n### **Episode 15: Pediatric Neurology I**\n**âš¡ Rapid Fire Recap (Summary Table)**\n| **Condition** | **Key Clinical Feature / Buzzword** | **Pathophysiology / Gene** |\n| --- | --- | --- |\n| **NF1** | CafÃ©-au-lait, Lisch nodules, Neurofibromas | Chr 17, Neurofibromin |\n| **NF2** | Bilateral Acoustic Neuromas (Hearing loss) | Chr 22, Merlin |\n| **Tuberous Sclerosis** | Ash-leaf spots, Cardiac Rhabdomyoma, Seizures | TSC1/2, mTOR pathway |\n| **Sturge-Weber** | Port-Wine Stain, Seizures (Contralateral) | Somatic GNAQ (Not inherited) |\n| **VHL** | Hemangioblastomas (Retina/Cerebellum), RCC | Chr 3, VHL gene |\n| **Cephalohematoma** | Does NOT cross sutures | Subperiosteal blood (Risk: Jaundice) |\n| **Subgaleal Hemorrhage** | Crosses sutures, Fluctuant | Emissary veins (Risk: Shock/Death) |\n| **Spastic Diplegia** | Commando Crawl, Legs > Arms | Prematurity â†’ PVL |\n### **Episode 16: Pediatric Neurology II**\n**RAPID FIRE RECAP: Scenario Testing ğŸ”«ğŸ”¥**\n| **Scenario** | **Diagnosis** | **Key Management/Next Step** |\n| --- | --- | --- |\n| 6ê°œì›” ì˜ì•„, Jackknife spasms (ëª¸ì„ ì ‘ìŒ) | **Infantile Spasms (West)** | Tx: ACTH (Start ASAP!) |\n| 10ëŒ€ ì²­ì†Œë…„, ì•„ì¹¨ì— ì¹«ì†”ì„ ë–¨ì–´ëœ¨ë¦¼ | **JME** | Tx: Valproic Acid |\n| 3ì„¸ ìœ ì•„, ë°œì‘ í›„ ì™¼ìª½ íŒ”ë‹¤ë¦¬ê°€ ì¶• ëŠ˜ì–´ì§ | **Potential Stroke** | Dx: MRI Brain + MRA (Urgent!) |\n| 30ì£¼ ë¯¸ìˆ™ì•„, ì‹ ìƒì•„ì‹¤(NICU) ì…ì› ì¤‘ | **IVH Risk** | Screening: Head Ultrasound at <32 weeks |\n| 3ì„¸, ì—´ë‚˜ê³  5ë¶„ê°„ ì „ì‹  ê²½ë ¨, ê¸ˆë°© ê¹¨ì–´ë‚¨ | **Simple Febrile Seizure** | Tx: Discharge with Reassurance ğŸ‘‹ |","subject":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","page_title":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","episode":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","section_path":["LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834"],"source_doc_id":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","source_page":null,"source_anchor":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834-53","focus_area":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","tags":["usmle-step2","core","quiz-seed","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_quiz_seed","text":"**ğŸ”¥ 4. Rapid Fire Recap (Summary Table)**\n| Condition | Visual Cue / Exam Finding | Critical Action / Note |\n| --- | --- | --- |\n| Corneal Abrasion | Fluorescein uptake (Green scratch) | Contact lens? -> Ciprofloxacin (No Patch!) |\n| Open Globe | Teardrop Pupil, Seidel Sign (+) | Shield it, CT, NPO, Call Surgeon. No IOP check! |\n| Orbital Compartment Syndrome | Proptosis, Rock-hard lid, APD | Lateral Canthotomy ASAP (Don't wait for CT) |\n| Hyphema | Blood level in anterior chamber | Head up 30Â°, Screen for Sickle Cell (Glaucoma risk) |\n| Sympathetic Ophthalmia | Inflammation in non-injured eye | Enucleation of injured eye within 14 days |\n| Photokeratitis | Welder/Skier, delayed pain | Supportive care, heals in 1-3 daysìœ„ ë‚´ìš©ì€ **Ophthalmology Infections â†’ Vision Pathology â†’ Eye Trauma** ìˆœì„œëŒ€ë¡œ, |\n## ğŸ‘‚ EAR (Otolaryngology)\n### **Episode 21: Ear I: Infections**\n**ğŸ”¥ Rapid Fire Recap (Summary Table)**\n| **Disease** | **Key Symptom / History** | **Otoscopy Finding** | **â˜… Next Best Step / Tx** |\n| --- | --- | --- | --- |\n| **Otitis Externa** | Swimmer, Pain on Tragus touch | Canal swollen, TM Normal | Clean + Topical Cipro |\n| **Malignant OE** | Elderly Diabetic, Night Pain | Granulation Tissue on floor | IV Ciprofloxacin (CT to confirm) |\n| **AOM** | Toddler, Fever, Crying | Bulging, Red, Immobile TM | High-Dose Amoxicillin |\n| **Mastoiditis** | Untreated AOM, Ear protrusion | Post-auricular swelling | CT Scan -> IV Abx + Drain |\n| **OME (Serous)** | Hearing loss, No Pain/Fever | Fluid levels, Bubbles, Dull | Observation (Wait) |\n| **CSOM** | Drainage > 6wks, Perforation | Perforated TM, Purulent | Topical Fluoroquinolone |\n| **Cholesteatoma** | Chronic drainage, Hearing loss | Pearly White Mass, Debris | Surgery (Refer to ENT) |\n### **Episode 22: Ear II: Hearing & Balance**\n| êµ¬ë¶„ | ì£¼ìš” ì§ˆí™˜ (Key Pathology) | í•µì‹¬ íŠ¹ì§• (Buzzwords & Clues) |\n| --- | --- | --- |\n| ì²­ë ¥ ìƒì‹¤ (Hearing Loss) | Presbycusis (ë…¸ì¸ì„± ë‚œì²­) | ê³ ì£¼íŒŒìˆ˜(ììŒ) ì†Œì‹¤, \"ì›…ì–¼ê±°ë¦¬ëŠ” ì†Œë¦¬ì²˜ëŸ¼ ë“¤ë¦¼\", ì‹œë„ëŸ¬ìš´ ê³³ì—ì„œ ë” ì•ˆ ë“¤ë¦¼. |\n|  | Otosclerosis (ì´ê²½í™”ì¦) | ì„ì‹ ë¶€(30ëŒ€), ì „ìŒì„± ë‚œì²­, â˜…ì‹œë„ëŸ¬ìš´ ê³³ì—ì„œ ë” ì˜ ë“¤ë¦¼ (Paracusis Willisii). |\n| ì–´ì§€ëŸ¼ì¦ (Vertigo) | BPPV (ì´ì„ì¦) | ê³ ê°œ ëŒë¦´ ë•Œ(Position change) ë°œìƒ, ì§§ì€ ì§€ì†(ì´ˆ ë‹¨ìœ„), Dix-Hallpikeë¡œ ì§„ë‹¨. |\n|  | Meniere's Disease (ë©”ë‹ˆì—ë¥´) | Triad: ì–´ì§€ëŸ¼ì¦ + ë‚œì²­ + ì´ëª…/ê·€ ë¨¹ë¨¹í•¨ (Fullness). |\n|  | Vestibular Neuritis (ì „ì •ì‹ ê²½ì—¼) | ë‹¨ í•œ ë²ˆì˜ ì‹¬í•œ ì–´ì§€ëŸ¼ì¦(ìˆ˜ì¼ ì§€ì†), ì²­ë ¥ ì†Œì‹¤ ì—†ìŒ, ë°”ì´ëŸ¬ìŠ¤ ê°ì—¼ í›„. |\n| ì‘ê¸‰ (Emergency) | Auricular Hematoma | ë ˆìŠ¬ëŸ¬/ë³µì„œ, \"ë§Œë‘ê·€\" ì˜ˆë°© ìœ„í•´ ì¦‰ì‹œ ë°°ì•¡(Drainage) ë° ì••ë°• í•„ìˆ˜. |\n**ğŸ”¥ Rapid Fire Recap (Summary)**","subject":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","page_title":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","episode":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","section_path":["LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834"],"source_doc_id":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","source_page":null,"source_anchor":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834-80","focus_area":"LM_Neuro RFR 30646f2986ee8065863ccd3c7f4f2834","tags":["usmle-step2","core","quiz-seed","treatment"]}
